Citrus Sinensis ID: 011005

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490------
Protein Sequence
MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGNILDLPSCDTTKPATLFVEIFLPLTIVLSVIVFACLLLAKRKYKKPKLEERATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDISISELRN
Secondary Structure (PSIPRED)
ccEEEcccccccccccccEEEcccccccccccHHHHccccccEEEcccccccccccHHHcccccccEEEcccccccccccHHHcccccccEEccccccccccccccccccccccccccccccccccccccccccccccccccEEEHHHHHHHHHHHHHHHHHHHHHHHHHcccHHHHccccccccEEEEcccccccHHHHHHHHHccccccEEEEccccEEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHcccccccccEEEEEEcccccEEEEcccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEccccccccccccccccEEEcccccccccccccccccccccccccHHHHHHHHHHcccccHHHHHccccccccccccccccccccccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHcccccccccccccccEEccccc
Secondary Structure Prediction (SSPRO)
cccEccccHHHHHcccccEEEEEEccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccccEEEccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccHcccccccccHHHHccccccccHHHHHHHHcccccccEEccccccEEEEEEcccccEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEcccHHHcEEcccHccEEEccHcHHHHccccccEEEEEEcccccccHHHHHcccccccccHHHHHHHHHHHHcccccHHHHHHHHHHHHHcccHHHHccHHHccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHccccccccccccccccHHHccc
Coil and Loop (DISEMBL)
mykigiippeignlknlikldvgsnsligpipsalgsltnlsnldlssnklsgkippeiaSMKYLTQldlsnnniqgsipgeitklsrldylnlssnklsgpvpfsnndlssMHTVvslspnnglcgnildlpscdttkpatLFVEIFLPLTIVLSVIVFACLLLAKrkykkpkleeratnnidvfsiwnydgrivyEDLIEatedfdirycigtggygsvykaqlpngkvfalKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFcnlhnnedavELDWAKRVNIVKAMAHALAYlhhdcspsiihrdissnnillNSKLEAFVADFGTArllhadssnrtllagtygyiapeLAYTMVMTEKCDVYSFGVVTLEVLmgkhprdilsslssssdpkimlidvldqrlpppvdrkvIRDILLISTVSFAclqsnpksrptmqSVSQEFLitrktplvkhaaiqdisISELRN
Flexible Loop (DISEMBL)
mykigiippeigNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGNILDLPSCDTTKPATLFVEIFLPLTIVLSVIVFACLLLAKrkykkpkleeratnnidvfsiwnyDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSlssssdpkIMLIDvldqrlpppvDRKVIRDILLISTVSFaclqsnpksrptmQSVSQEFLitrktplvkhaaiqdisiselrn
Low Complexity Region (SEG)
MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSAlgsltnlsnldlssnklsGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGNILDLPSCDTTKPATLFVEIFLPLTIVLSVIVFACLLLAKRKYKKPKLEERATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIlsslssssDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDISISELRN
Disordered region (IsUnstruct)
***IGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTN*******************ASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNL*******************HTVVSLSPNNGLCGNILDLPSCDTTKPATLFVEIFLPLTIVLSVIVFACLLLAKRKYKKPKLEERATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDI**********KIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQ***************FLITRKTPLVKHAAI**********
Disordered Region (DISOPRED)
MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLC**********************LPLTIVLSVIVFACLLLAKR*******************IWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEE***IKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQE******************SIS****
Disordered Region (DISEMBL)
MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGNILDLPSCDTTKPATLFVEIFLPLTIVLSVIVFACLLLAKRKYKKPKLEERATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQS**********VSQEFLITRKTPLVKHAAIQDISISELRN
Disordered Region (DISPRO)
*YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGNILDLPS****KPATLFVEIFLPLTIVLSVIVFACLLLAKRKYKKPKLEERATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL*T*********************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGNILDLPSCDTTKPATLFVEIFLPLTIVLSVIVFACLLLAKRKYKKPKLEERATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDISISELRN
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	496	2.2.26 [Sep-21-2011]
Q8VZG8	1045	Probable LRR receptor-lik	yes	no	0.925	0.439	0.438	1e-109
Q9LP24	1120	Probable leucine-rich rep	no	no	0.931	0.412	0.432	1e-106
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.919	0.413	0.392	4e-80
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.929	0.418	0.343	1e-79
Q9M2Z1	1002	Leucine-rich repeat recep	no	no	0.945	0.468	0.372	7e-76
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.925	0.366	0.348	1e-75
O49545	1003	Leucine-rich repeat recep	no	no	0.947	0.468	0.370	3e-75
O49318	1124	Probable leucine-rich rep	no	no	0.911	0.402	0.372	4e-75
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.927	0.368	0.342	7e-75
C0LGF4	591	LRR receptor-like serine/	no	no	0.915	0.768	0.369	2e-74

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  397 bits (1019), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 213/486 (43%), Positives = 314/486 (64%), Gaps = 27/486 (5%)

Query: 7    IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLT 66
            IPP + NL  L  +++  N L   IP  L  L+ L  LDLS N+L G+I  +  S++ L 
Sbjct: 566  IPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLE 625

Query: 67   QLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLC 126
            +LDLS+NN+ G IP     +  L ++++S N L GP+P  +N         +   N  LC
Sbjct: 626  RLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIP--DNAAFRNAPPDAFEGNKDLC 683

Query: 127  GNI---LDLPSCDTT------KPATLFVEIFLPLT---IVLSVI--VFACLLLAKRKYKK 172
            G++     L  C  T      K   L + I +P+    I+LSV   +F C    +++ K+
Sbjct: 684  GSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICF---RKRTKQ 740

Query: 173  PKLEERATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVF 232
             +    + +  +  SI+++DG++ Y+++I+AT +FD +Y IGTGG+G VYKA+LPN  + 
Sbjct: 741  IEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IM 799

Query: 233  ALKKLHTSEELAFI-----KSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERG 287
            A+KKL+ + + +       + F NE + L+++ HRN+VKL+G+C H++  FL+YEYMERG
Sbjct: 800  AVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERG 859

Query: 288  SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEA 347
            SL   L N+++A +LDW KR+N+VK +AHAL+Y+HHD SP+I+HRDISS NILL    EA
Sbjct: 860  SLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEA 919

Query: 348  FVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
             ++DFGTA+LL  DSSN + +AGTYGY+APELAY M +TEKCDVYSFGV+TLEV+ G+HP
Sbjct: 920  KISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHP 979

Query: 408  RDILSSLSSS-SDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQ 466
             D++S+LSSS  D  + L  + D RLP P   ++  ++L I  V+  CL S+P++RPTM 
Sbjct: 980  GDLVSTLSSSPPDATLSLKSISDHRLPEPTP-EIKEEVLEILKVALLCLHSDPQARPTML 1038

Query: 467  SVSQEF 472
            S+S  F
Sbjct: 1039 SISTAF 1044

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1

 Score =  385 bits (988), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 230/532 (43%), Positives = 318/532 (59%), Gaps = 70/532 (13%)

Query: 4    IGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIP------- 56
             G +P  IGNL NL +L +  N L G +P+ L  LTNL +LDLSSN  S +IP       
Sbjct: 595  FGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFL 654

Query: 57   ----------------PEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
                            P ++ +  LTQLDLS+N + G IP +++ L  LD L+LS N LS
Sbjct: 655  KLHDMNLSRNKFDGSIPRLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLS 714

Query: 101  GPVP-------------FSNNDLSS---------MHTVVSLSPNNGLCGNILDL---PSC 135
            G +P              SNN L             T  +L  N GLC NI      P  
Sbjct: 715  GLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCR 774

Query: 136  DTTKP---ATLFVEIFLPLTIVLSVIVFAC-----LLLAKRKYKKPKLEERATN-NIDVF 186
            +  KP     L V I +P+  VL VI+  C       + KRK +  +  +  T  N+ +F
Sbjct: 775  ELKKPKKNGNLVVWILVPILGVL-VILSICANTFTYCIRKRKLQNGRNTDPETGENMSIF 833

Query: 187  SIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTS--EELA 244
            S+   DG+  Y+D+IE+T +FD  + IGTGGY  VY+A L +  + A+K+LH +  EE++
Sbjct: 834  SV---DGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDTIDEEIS 889

Query: 245  ---FIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE 301
                 + F NE + L+++ HRN+VKL+G+C H++  FLIYEYME+GSL   L N+E+A  
Sbjct: 890  KPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKR 949

Query: 302  LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD 361
            L W KR+N+VK +AHAL+Y+HHD    I+HRDISS NILL++   A ++DFGTA+LL  D
Sbjct: 950  LTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTD 1009

Query: 362  SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPK 421
            SSN + +AGTYGY+APE AYTM +TEKCDVYSFGV+ LE+++GKHP D++SSLSSS    
Sbjct: 1010 SSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPGEA 1069

Query: 422  IMLIDVLDQRLPPPVDRKVIRDILL-ISTVSFACLQSNPKSRPTMQSVSQEF 472
            + L  + D+R+  P  R   R+ LL +  ++  CLQ+NP+SRPTM S+S  F
Sbjct: 1070 LSLRSISDERVLEP--RGQNREKLLKMVEMALLCLQANPESRPTMLSISTTF 1119

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  298 bits (764), Expect = 4e-80,   Method: Compositional matrix adjust.
 Identities = 193/492 (39%), Positives = 271/492 (55%), Gaps = 36/492 (7%)

Query: 5    GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLS-NLDLSSNKLSGKIPPEIASMK 63
            G IP  +GNL  L +L +G N   G IP  LGSLT L   L+LS NKL+G+IPPE++++ 
Sbjct: 591  GTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLV 650

Query: 64   YLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
             L  L L+NNN+ G IP     LS L   N S N L+GP+P   N   SM + +    N 
Sbjct: 651  MLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPLLRN--ISMSSFIG---NE 705

Query: 124  GLCGNILD--------LPSCDTTKPATLFVEIFLPLTIVL----SVIVFACLLLAKRKYK 171
            GLCG  L+         PS  T KP  +     + +T  +    S+++ A ++   R+  
Sbjct: 706  GLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPV 765

Query: 172  KPKLEERATNNIDVFSIWNY---DGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPN 228
            +              S+  Y        ++DL+ AT++FD  + +G G  G+VYKA LP 
Sbjct: 766  RTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPA 825

Query: 229  GKVFALKKLHTSEELA----FIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM 284
            G   A+KKL ++ E         SF+ E   L  + HRNIVKL+G+C H+    L+YEYM
Sbjct: 826  GYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYM 885

Query: 285  ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK 344
             +GSL   LH  + +  LDW+KR  I    A  LAYLHHDC P I HRDI SNNILL+ K
Sbjct: 886  PKGSLGEILH--DPSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDK 943

Query: 345  LEAFVADFGTARLLHA-DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM 403
             EA V DFG A+++    S + + +AG+YGYIAPE AYTM +TEK D+YS+GVV LE+L 
Sbjct: 944  FEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLT 1003

Query: 404  GKHP-------RDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQ 456
            GK P        D+++ + S      +   VLD RL    D +++  +L +  ++  C  
Sbjct: 1004 GKAPVQPIDQGGDVVNWVRSYIRRDALSSGVLDARLTLE-DERIVSHMLTVLKIALLCTS 1062

Query: 457  SNPKSRPTMQSV 468
             +P +RP+M+ V
Sbjct: 1063 VSPVARPSMRQV 1074

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  297 bits (760), Expect = 1e-79,   Method: Compositional matrix adjust.
 Identities = 192/559 (34%), Positives = 277/559 (49%), Gaps = 98/559 (17%)

Query: 5    GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
            G IPPEIGNL  ++  ++ SN L G IP  LGS   +  LDLS NK SG I  E+  + Y
Sbjct: 513  GEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVY 572

Query: 65   LTQLDLSNNNIQGSIP---GEITKLSRLDY----------------------LNLSSNKL 99
            L  L LS+N + G IP   G++T+L  L                        LN+S N L
Sbjct: 573  LEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNL 632

Query: 100  SGPVP-------------FSNNDLSS---------MHTVVSLSPNNGLCGNILD------ 131
            SG +P              ++N LS          M  ++    NN L G + D      
Sbjct: 633  SGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQR 692

Query: 132  -----------------------LPSCDT---------TKPATLFVEIFLPLTIVLSVIV 159
                                   +P  D+          +   L +   +  ++ L   +
Sbjct: 693  MDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIGSVFLITFL 752

Query: 160  FACLLLAKRKYKKPKLEERATNNIDVFSIWNYDGR-IVYEDLIEATEDFDIRYCIGTGGY 218
              C  + +R+     LE++     DV   + +  +   Y+ L++AT +F     +G G  
Sbjct: 753  GLCWTIKRREPAFVALEDQTKP--DVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGAC 810

Query: 219  GSVYKAQLPNGKVFALKKLHTSEELAFI-KSFKNEAQVLSQVLHRNIVKLYGYCLHKKCM 277
            G+VYKA++  G+V A+KKL++  E A    SF+ E   L ++ HRNIVKLYG+C H+   
Sbjct: 811  GTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSN 870

Query: 278  FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSN 337
             L+YEYM +GSL   L   E    LDW  R  I    A  L YLHHDC P I+HRDI SN
Sbjct: 871  LLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSN 930

Query: 338  NILLNSKLEAFVADFGTARLLHAD-SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGV 396
            NILL+ + +A V DFG A+L+    S + + +AG+YGYIAPE AYTM +TEKCD+YSFGV
Sbjct: 931  NILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGV 990

Query: 397  VTLEVLMGKHP-------RDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLIST 449
            V LE++ GK P        D+++ +  S    I  I++ D RL    D++ + ++ L+  
Sbjct: 991  VLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIPTIEMFDARLDTN-DKRTVHEMSLVLK 1049

Query: 450  VSFACLQSNPKSRPTMQSV 468
            ++  C  ++P SRPTM+ V
Sbjct: 1050 IALFCTSNSPASRPTMREV 1068

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1

 Score =  285 bits (728), Expect = 7e-76,   Method: Compositional matrix adjust.
 Identities = 194/521 (37%), Positives = 272/521 (52%), Gaps = 52/521 (9%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
           G +P  IGNL  + KL +  N   G IP  +G L  LS LD S N  SG+I PEI+  K 
Sbjct: 470 GSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKL 529

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVP-------------FSNNDLS 111
           LT +DLS N + G IP E+T +  L+YLNLS N L G +P             FS N+LS
Sbjct: 530 LTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLS 589

Query: 112 ---------SMHTVVSLSPNNGLCGNILDLPSCDTT-----KPATLFVEIFLPLTIVLSV 157
                    S     S   N+ LCG  L  P    T     KP +   ++ L L ++   
Sbjct: 590 GLVPSTGQFSYFNYTSFVGNSHLCGPYLG-PCGKGTHQSHVKPLSATTKLLLVLGLLFCS 648

Query: 158 IVFACLLLAKRKYKKPKLEERATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGG 217
           +VFA + + K +  +   E +A   +  F   ++      +D++++ ++ +I   IG GG
Sbjct: 649 MVFAIVAIIKARSLRNASEAKAW-RLTAFQRLDF----TCDDVLDSLKEDNI---IGKGG 700

Query: 218 YGSVYKAQLPNGKVFALKKLHT-SEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKC 276
            G VYK  +P G + A+K+L T S   +    F  E Q L ++ HR+IV+L G+C + + 
Sbjct: 701 AGIVYKGTMPKGDLVAVKRLATMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHET 760

Query: 277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 336
             L+YEYM  GSL   LH  +    L W  R  I    A  L YLHHDCSP I+HRD+ S
Sbjct: 761 NLLVYEYMPNGSLGEVLHGKKGG-HLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKS 819

Query: 337 NNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAPELAYTMVMTEKCDVYSF 394
           NNILL+S  EA VADFG A+ L    ++  +  +AG+YGYIAPE AYT+ + EK DVYSF
Sbjct: 820 NNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSF 879

Query: 395 GVVTLEVLMGKHP-------RDILSSLSSSSDP-KIMLIDVLDQRLPPPVDRKVIRDILL 446
           GVV LE++ GK P        DI+  + S +D  K  ++ V+D RL        + ++  
Sbjct: 880 GVVLLELITGKKPVGEFGDGVDIVQWVRSMTDSNKDCVLKVIDLRL----SSVPVHEVTH 935

Query: 447 ISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQ 487
           +  V+  C++     RPTM+ V Q      K PL K  A +
Sbjct: 936 VFYVALLCVEEQAVERPTMREVVQILTEIPKIPLSKQQAAE 976

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  284 bits (726), Expect = 1e-75,   Method: Compositional matrix adjust.
 Identities = 186/534 (34%), Positives = 282/534 (52%), Gaps = 75/534 (14%)

Query: 5    GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
            G IP EIGNL+ L  L++  N L GP+PS +G L+ L  L LS N L+G+IP EI  ++ 
Sbjct: 710  GSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQD 769

Query: 65   L-TQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
            L + LDLS NN  G IP  I+ L +L+ L+LS N+L G VP    D+ S+   ++LS NN
Sbjct: 770  LQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLG-YLNLSYNN 828

Query: 124  ---------------------GLCGNILDLPSCD--------TTKPATLFVEIFLPLTIV 154
                                 GLCG+   L  C+        +  P T+ +   +     
Sbjct: 829  LEGKLKKQFSRWQADAFVGNAGLCGS--PLSHCNRAGSKNQRSLSPKTVVIISAISSLAA 886

Query: 155  LSVIVFACLLLAKRK---YKKPK------LEERATNNIDVFSIWNYDGRIVYEDLIEATE 205
            ++++V   +L  K+    +KK +          +++   +FS       I ++D++EAT 
Sbjct: 887  IALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATH 946

Query: 206  DFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIV 265
              +  + IG+GG G VYKA+L NG+  A+KK+   ++L   KSF  E + L  + HR++V
Sbjct: 947  YLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLV 1006

Query: 266  KLYGYCLHKK--CMFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAY 320
            KL GYC  K      LIYEYM  GS++  LH NE+  +   L W  R+ I   +A  + Y
Sbjct: 1007 KLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEY 1066

Query: 321  LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA----DSSNRTLLAGTYGYIA 376
            LH+DC P I+HRDI S+N+LL+S +EA + DFG A++L      ++ + T+ AG+YGYIA
Sbjct: 1067 LHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIA 1126

Query: 377  PELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPP-- 434
            PE AY++  TEK DVYS G+V +E++ GK P + +      +D    +  VLD   PP  
Sbjct: 1127 PEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAM--FDEETDMVRWVETVLDT--PPGS 1182

Query: 435  ---------------PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
                           P + +    +L    ++  C +S P+ RP+ +  S+  L
Sbjct: 1183 EAREKLIDSELKSLLPCEEEAAYQVL---EIALQCTKSYPQERPSSRQASEYLL 1233

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1

 Score =  282 bits (722), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 195/527 (37%), Positives = 272/527 (51%), Gaps = 57/527 (10%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
           G +PP IGN   + KL +  N   GPIPS +G L  LS +D S N  SG+I PEI+  K 
Sbjct: 469 GPLPPAIGNFTGVQKLLLDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKL 528

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVP-------------FSNNDLS 111
           LT +DLS N + G IP EIT +  L+YLNLS N L G +P             FS N+LS
Sbjct: 529 LTFVDLSRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLS 588

Query: 112 ---------SMHTVVSLSPNNGLCGNILDLPSCD----------TTKPATLFVEIFLPLT 152
                    S     S   N  LCG  L  P  D          +  P +  +++ L L 
Sbjct: 589 GLVPGTGQFSYFNYTSFLGNPDLCGPYLG-PCKDGVAKGGHQSHSKGPLSASMKLLLVLG 647

Query: 153 IVLSVIVFACLLLAKRKYKKPKLEERATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYC 212
           +++  I FA + + K +  K   E RA   +  F   ++      +D++++ ++ +I   
Sbjct: 648 LLVCSIAFAVVAIIKARSLKKASESRAW-RLTAFQRLDF----TCDDVLDSLKEDNI--- 699

Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHT-SEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG GG G VYK  +PNG + A+K+L   S   +    F  E Q L ++ HR+IV+L G+C
Sbjct: 700 IGKGGAGIVYKGVMPNGDLVAVKRLAAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFC 759

Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
            + +   L+YEYM  GSL   LH  +    L W  R  I    A  L YLHHDCSP I+H
Sbjct: 760 SNHETNLLVYEYMPNGSLGEVLHGKKGG-HLHWDTRYKIALEAAKGLCYLHHDCSPLIVH 818

Query: 332 RDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAPELAYTMVMTEKC 389
           RD+ SNNILL+S  EA VADFG A+ L    ++  +  +AG+YGYIAPE AYT+ + EK 
Sbjct: 819 RDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKS 878

Query: 390 DVYSFGVVTLEVLMGKHP-------RDILSSLSSSSDP-KIMLIDVLDQRLPPPVDRKVI 441
           DVYSFGVV LE++ G+ P        DI+  +   +D  K  ++ VLD RL        I
Sbjct: 879 DVYSFGVVLLELVTGRKPVGEFGDGVDIVQWVRKMTDSNKDSVLKVLDPRL----SSIPI 934

Query: 442 RDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQD 488
            ++  +  V+  C++     RPTM+ V Q      K P  K   + +
Sbjct: 935 HEVTHVFYVAMLCVEEQAVERPTMREVVQILTEIPKLPPSKDQPMTE 981

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  282 bits (722), Expect = 4e-75,   Method: Compositional matrix adjust.
 Identities = 188/505 (37%), Positives = 267/505 (52%), Gaps = 53/505 (10%)

Query: 5    GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLS-NLDLSSNKLSGKIPPEIASMK 63
            G IP  IGNL +L +L +G N   G IP  LG L++L   ++LS N  SG+IPPEI ++ 
Sbjct: 603  GNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLH 662

Query: 64   YLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
             L  L L+NN++ G IP     LS L   N S N L+G +P +   +    T+ S   N 
Sbjct: 663  LLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHT--QIFQNMTLTSFLGNK 720

Query: 124  GLCGNILDLPSCDTTKPATLFVE-----------------------IFLPLTIVLSVIVF 160
            GLCG    L SCD +  +   +                          L + IV+  +  
Sbjct: 721  GLCGG--HLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRN 778

Query: 161  ACLLLAKRKY-KKPKLEERATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYG 219
                 A   + K+P  +E      D++ +     R   +D++EAT+ F   Y +G G  G
Sbjct: 779  PVEPTAPYVHDKEPFFQES-----DIYFV--PKERFTVKDILEATKGFHDSYIVGRGACG 831

Query: 220  SVYKAQLPNGKVFALKKLHTSEELAFIKS------FKNEAQVLSQVLHRNIVKLYGYCLH 273
            +VYKA +P+GK  A+KKL ++ E     S      F+ E   L ++ HRNIV+LY +C H
Sbjct: 832  TVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYH 891

Query: 274  K--KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
            +      L+YEYM RGSL   LH  +    +DW  R  I    A  LAYLHHDC P IIH
Sbjct: 892  QGSNSNLLLYEYMSRGSLGELLHGGKSH-SMDWPTRFAIALGAAEGLAYLHHDCKPRIIH 950

Query: 332  RDISSNNILLNSKLEAFVADFGTARLLHAD-SSNRTLLAGTYGYIAPELAYTMVMTEKCD 390
            RDI SNNIL++   EA V DFG A+++    S + + +AG+YGYIAPE AYTM +TEKCD
Sbjct: 951  RDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCD 1010

Query: 391  VYSFGVVTLEVLMGKHPRDILSS---LSSSSDPKI----MLIDVLDQRLPPPVDRKVIRD 443
            +YSFGVV LE+L GK P   L     L++ +   I    +  ++LD  L    D  ++  
Sbjct: 1011 IYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNHIRDHSLTSEILDPYLTKVEDDVILNH 1070

Query: 444  ILLISTVSFACLQSNPKSRPTMQSV 468
            ++ ++ ++  C +S+P  RPTM+ V
Sbjct: 1071 MITVTKIAVLCTKSSPSDRPTMREV 1095

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  281 bits (720), Expect = 7e-75,   Method: Compositional matrix adjust.
 Identities = 184/537 (34%), Positives = 274/537 (51%), Gaps = 77/537 (14%)

Query: 5    GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
            G IP EIGNL  L  L++  N   G +P A+G L+ L  L LS N L+G+IP EI  ++ 
Sbjct: 709  GSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQD 768

Query: 65   L-TQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVV------ 117
            L + LDLS NN  G IP  I  LS+L+ L+LS N+L+G VP S  D+ S+  +       
Sbjct: 769  LQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNL 828

Query: 118  --------------SLSPNNGLCGNILDLPSCDTTKP----------ATLFVEIFLPLTI 153
                          S   N GLCG+   L  C+  +           + + +     LT 
Sbjct: 829  GGKLKKQFSRWPADSFLGNTGLCGS--PLSRCNRVRSNNKQQGLSARSVVIISAISALTA 886

Query: 154  VLSVIVFACLLLAKR------------KYKKPKLEERATNNIDVFSIWNYDGRIVYEDLI 201
            +  +I+   L   +R             Y       +AT+   +F        I +ED++
Sbjct: 887  IGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHK-PLFRNGASKSDIRWEDIM 945

Query: 202  EATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLH 261
            EAT +    + IG+GG G VYKA+L NG+  A+KK+   ++L   KSF  E + L ++ H
Sbjct: 946  EATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRH 1005

Query: 262  RNIVKLYGYCLHKK--CMFLIYEYMERGSLFCNLHNNEDAVE-----LDWAKRVNIVKAM 314
            R++VKL GYC  K      LIYEYM+ GS++  LH ++  +E     LDW  R+ I   +
Sbjct: 1006 RHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGL 1065

Query: 315  AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL----HADSSNRTLLAG 370
            A  + YLHHDC P I+HRDI S+N+LL+S +EA + DFG A++L      ++ + T  A 
Sbjct: 1066 AQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFAC 1125

Query: 371  TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD------------ILSSLSSSS 418
            +YGYIAPE AY++  TEK DVYS G+V +E++ GK P D            + + L  + 
Sbjct: 1126 SYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAG 1185

Query: 419  DPKIMLIDVLDQRLPP--PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
              +  LI   D +L P  P +      +L    ++  C +++P+ RP+ +      L
Sbjct: 1186 SARDKLI---DPKLKPLLPFEEDAACQVL---EIALQCTKTSPQERPSSRQACDSLL 1236

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGF4|FEI1_ARATH LRR receptor-like serine/threonine-protein kinase FEI 1 OS=Arabidopsis thaliana GN=FEI1 PE=1 SV=1

 Score =  280 bits (715), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 184/498 (36%), Positives = 272/498 (54%), Gaps = 44/498 (8%)

Query: 4   IGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMK 63
           +G +PP+IG L +L  L + +N+L G IP+ALG+ T L  + L SN  +G IP E+  + 
Sbjct: 87  MGPLPPDIGKLDHLRLLMLHNNALYGAIPTALGNCTALEEIHLQSNYFTGPIPAEMGDLP 146

Query: 64  YLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
            L +LD+S+N + G IP  + +L +L   N+S+N L G +P  ++ + S  +  S   N 
Sbjct: 147 GLQKLDMSSNTLSGPIPASLGQLKKLSNFNVSNNFLVGQIP--SDGVLSGFSKNSFIGNL 204

Query: 124 GLCGNILDLPSCDTTKPATLFVEIFL-------PLTIVLSVIVFACLLLA---------K 167
            LCG  +D+   D +   +   +           L I  S  V A LL+A          
Sbjct: 205 NLCGKHVDVVCQDDSGNPSSHSQSGQNQKKNSGKLLISASATVGALLLVALMCFWGCFLY 264

Query: 168 RKYKKPKLEERATNNIDVFSIWNYDGRIVY--EDLIEATEDFDIRYCIGTGGYGSVYKAQ 225
           +K  K +++  A +     SI  + G + Y  +D+I+  E  +  + IG GG+G+VYK  
Sbjct: 265 KKLGKVEIKSLAKDVGGGASIVMFHGDLPYSSKDIIKKLEMLNEEHIIGCGGFGTVYKLA 324

Query: 226 LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYME 285
           + +GKVFALK++    E  F + F+ E ++L  + HR +V L GYC       L+Y+Y+ 
Sbjct: 325 MDDGKVFALKRILKLNE-GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLLYDYLP 383

Query: 286 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL 345
            GSL   LH  E   +LDW  RVNI+   A  L+YLHHDCSP IIHRDI S+NILL+  L
Sbjct: 384 GGSLDEALH--ERGEQLDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSNILLDGNL 441

Query: 346 EAFVADFGTARLLHADSSN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG 404
           EA V+DFG A+LL  + S+  T++AGT+GY+APE   +   TEK DVYSFGV+ LEVL G
Sbjct: 442 EARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSG 501

Query: 405 KHPRDI------------LSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSF 452
           K P D             L  L S   P+    D++D    P  +   +  +  + +++ 
Sbjct: 502 KRPTDASFIEKGLNVVGWLKFLISEKRPR----DIVD----PNCEGMQMESLDALLSIAT 553

Query: 453 ACLQSNPKSRPTMQSVSQ 470
            C+  +P+ RPTM  V Q
Sbjct: 554 QCVSPSPEERPTMHRVVQ 571

Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	496
296085303	789	unnamed protein product [Vitis vinifera]	0.943	0.593	0.577	1e-159
359484066	843	PREDICTED: probable LRR receptor-like se	0.943	0.555	0.577	1e-159
296085307	874	unnamed protein product [Vitis vinifera]	0.971	0.551	0.549	1e-155
359484068	868	PREDICTED: probable leucine-rich repeat	0.971	0.555	0.549	1e-155
225465647	820	PREDICTED: probable LRR receptor-like se	0.897	0.542	0.558	1e-153
359488983	758	PREDICTED: probable LRR receptor-like se	0.983	0.643	0.528	1e-153
359484063	1003	PREDICTED: probable LRR receptor-like se	0.951	0.470	0.553	1e-152
359488981	757	PREDICTED: probable LRR receptor-like se	0.983	0.644	0.525	1e-151
225466223	736	PREDICTED: probable leucine-rich repeat	0.961	0.648	0.547	1e-147
225452694	783	PREDICTED: probable LRR receptor-like se	0.981	0.621	0.545	1e-146

>gi|296085303|emb|CBI29035.3| unnamed protein product [Vitis vinifera]

 Score =  568 bits (1463), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 284/492 (57%), Positives = 355/492 (72%), Gaps = 24/492 (4%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
           G IPP I NLKNLI L +  N+L G IPS+LG L +L+  ++S N+++G IP  I ++  
Sbjct: 277 GSIPPIIWNLKNLIHLRLDHNNLTGVIPSSLGYLIHLNEFNISGNRINGHIPSTIGNLNN 336

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVP-------------FSNNDL- 110
           LT+LDLS N I G IP ++  L RL YLNLS NKLSG +P              S+NDL 
Sbjct: 337 LTRLDLSANLIHGKIPSQVQNLKRLTYLNLSHNKLSGSIPTLLIYDHIKPSLDLSHNDLE 396

Query: 111 -------SSMHTVVSLSPNNGLCGNILDLPSCDTTKPATLFVEIFLPLTIVLSVIVFACL 163
                   S  +  S   N GLCG+I  LP C      T  + I L  T+ L  +V   L
Sbjct: 397 GHIPFELQSKFSQGSFDNNKGLCGDIKGLPHCKEEYKTTRIIVISLSTTLFLFFVVLGFL 456

Query: 164 LLAKRKYKKPKLEERATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYK 223
           LL+ RK +K + +E  T N D+FS+WNYDG+I YED+I+ATEDFDI+YCIGTGGYGSVYK
Sbjct: 457 LLS-RKTRKIQTKEIPTKNGDIFSVWNYDGKIAYEDIIKATEDFDIKYCIGTGGYGSVYK 515

Query: 224 AQLPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY 281
           AQLP G V ALKKLH  E  E  ++KSF+NE Q+LS++ HRNIVKL GYCLHK+CMFLIY
Sbjct: 516 AQLPTGNVVALKKLHGWERDEAIYLKSFQNEVQILSKIRHRNIVKLQGYCLHKRCMFLIY 575

Query: 282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL 341
            YM RGSL+C L N  +A+ELDW KRVN+VK++ HA+ Y+HHDC+P IIHRDISSNNILL
Sbjct: 576 NYMGRGSLYCVLSNEVEALELDWIKRVNVVKSIVHAVCYMHHDCTPPIIHRDISSNNILL 635

Query: 342 NSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEV 401
           +SKL+AF++DFGTARLLH DSSN+TLLAGTYGYIAPELAYTMV+TEKCDVYSFGVV LE 
Sbjct: 636 DSKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALET 695

Query: 402 LMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKS 461
           +MGKHP ++ + LSSSS   IML ++LD RLP P D++V RD++L+  ++  C+ SNP+S
Sbjct: 696 MMGKHPGELFTLLSSSSTQNIMLTNILDSRLPSPQDQQVARDVVLVVWLALKCIHSNPRS 755

Query: 462 RPTMQSVSQEFL 473
           RPTMQ +  + L
Sbjct: 756 RPTMQHILSKLL 767

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484066|ref|XP_002271307.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  568 bits (1463), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 284/492 (57%), Positives = 355/492 (72%), Gaps = 24/492 (4%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
           G IPP I NLKNLI L +  N+L G IPS+LG L +L+  ++S N+++G IP  I ++  
Sbjct: 331 GSIPPIIWNLKNLIHLRLDHNNLTGVIPSSLGYLIHLNEFNISGNRINGHIPSTIGNLNN 390

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVP-------------FSNNDL- 110
           LT+LDLS N I G IP ++  L RL YLNLS NKLSG +P              S+NDL 
Sbjct: 391 LTRLDLSANLIHGKIPSQVQNLKRLTYLNLSHNKLSGSIPTLLIYDHIKPSLDLSHNDLE 450

Query: 111 -------SSMHTVVSLSPNNGLCGNILDLPSCDTTKPATLFVEIFLPLTIVLSVIVFACL 163
                   S  +  S   N GLCG+I  LP C      T  + I L  T+ L  +V   L
Sbjct: 451 GHIPFELQSKFSQGSFDNNKGLCGDIKGLPHCKEEYKTTRIIVISLSTTLFLFFVVLGFL 510

Query: 164 LLAKRKYKKPKLEERATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYK 223
           LL+ RK +K + +E  T N D+FS+WNYDG+I YED+I+ATEDFDI+YCIGTGGYGSVYK
Sbjct: 511 LLS-RKTRKIQTKEIPTKNGDIFSVWNYDGKIAYEDIIKATEDFDIKYCIGTGGYGSVYK 569

Query: 224 AQLPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY 281
           AQLP G V ALKKLH  E  E  ++KSF+NE Q+LS++ HRNIVKL GYCLHK+CMFLIY
Sbjct: 570 AQLPTGNVVALKKLHGWERDEAIYLKSFQNEVQILSKIRHRNIVKLQGYCLHKRCMFLIY 629

Query: 282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL 341
            YM RGSL+C L N  +A+ELDW KRVN+VK++ HA+ Y+HHDC+P IIHRDISSNNILL
Sbjct: 630 NYMGRGSLYCVLSNEVEALELDWIKRVNVVKSIVHAVCYMHHDCTPPIIHRDISSNNILL 689

Query: 342 NSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEV 401
           +SKL+AF++DFGTARLLH DSSN+TLLAGTYGYIAPELAYTMV+TEKCDVYSFGVV LE 
Sbjct: 690 DSKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYTMVVTEKCDVYSFGVVALET 749

Query: 402 LMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKS 461
           +MGKHP ++ + LSSSS   IML ++LD RLP P D++V RD++L+  ++  C+ SNP+S
Sbjct: 750 MMGKHPGELFTLLSSSSTQNIMLTNILDSRLPSPQDQQVARDVVLVVWLALKCIHSNPRS 809

Query: 462 RPTMQSVSQEFL 473
           RPTMQ +  + L
Sbjct: 810 RPTMQHILSKLL 821

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296085307|emb|CBI29039.3| unnamed protein product [Vitis vinifera]

 Score =  553 bits (1426), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 282/513 (54%), Positives = 362/513 (70%), Gaps = 31/513 (6%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
           G IPP I NLKNLI L +  N+L G IPS LG L +L+  ++  N++ G IP +I ++  
Sbjct: 365 GSIPPVIWNLKNLIHLRLDHNNLTGVIPS-LGYLIHLNVFNIRRNRIRGHIPSKIGNLNN 423

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVP-------------FSNNDLS 111
           LT LDLS+N I G IP ++  L  L+ LNLS NKLSG +P             FS+ND  
Sbjct: 424 LTSLDLSDNLIDGKIPSQLQNLKSLESLNLSHNKLSGHIPPLSIYIHKGSSIDFSHNDFE 483

Query: 112 SM--HTVVSLSP------NNGLCGNILDLPSCDTTKPATLFVEIFLPLTIVLSVIVFACL 163
               H +  + P      N GLCG    LP C       L +   L   + LS +    L
Sbjct: 484 GHIPHELQFVYPPRVFGHNKGLCGEREGLPHCKRGHKTILIIS--LSTILFLSFVALGIL 541

Query: 164 LLAKRKYKKPKLEERATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYK 223
           LL+ RK ++ + +  +T N D+FS+WNYDG+I YED+IEATEDFDI+YCIGTGGYGSVYK
Sbjct: 542 LLS-RKTRRNQTKATSTKNGDIFSVWNYDGKIAYEDIIEATEDFDIKYCIGTGGYGSVYK 600

Query: 224 AQLPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY 281
           AQLP G V ALKKLH  E  E  ++KSF+NE QVLS++ HRNI+KL+GYCLHK+CMFLIY
Sbjct: 601 AQLPTGNVVALKKLHGWERDEATYLKSFQNEVQVLSKIQHRNIIKLHGYCLHKRCMFLIY 660

Query: 282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL 341
           +YMERGSL+C L N  +A+ELDW KRVN++K++ HAL Y+HHD +P IIHRD+SSNNILL
Sbjct: 661 KYMERGSLYCVLSNEVEALELDWIKRVNVIKSIVHALCYMHHDSTPPIIHRDVSSNNILL 720

Query: 342 NSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEV 401
           + KL+AF++DFGTARLLH DSSN+TLLAGTYGYIAPELAYTM +TEKCDVYSFGVV LE 
Sbjct: 721 DFKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYTMAVTEKCDVYSFGVVALET 780

Query: 402 LMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKS 461
           +MG+HPR++ + LSSSS   IML D+LD RLP P DR+V RD++L+  ++  C+ SNP+S
Sbjct: 781 MMGRHPRELFTLLSSSSAQNIMLTDILDSRLPSPQDRQVARDVVLVVWLALKCIHSNPRS 840

Query: 462 RPTMQSVSQEFLITRKTPLVKHAAIQDISISEL 494
           RPTMQ +S + LI  ++P ++      IS+ +L
Sbjct: 841 RPTMQHISSKLLI--QSPFLE--PFHGISLWQL 869

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484068|ref|XP_002271708.2| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710-like [Vitis vinifera]

 Score =  553 bits (1424), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 282/513 (54%), Positives = 362/513 (70%), Gaps = 31/513 (6%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
           G IPP I NLKNLI L +  N+L G IPS LG L +L+  ++  N++ G IP +I ++  
Sbjct: 359 GSIPPVIWNLKNLIHLRLDHNNLTGVIPS-LGYLIHLNVFNIRRNRIRGHIPSKIGNLNN 417

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVP-------------FSNNDLS 111
           LT LDLS+N I G IP ++  L  L+ LNLS NKLSG +P             FS+ND  
Sbjct: 418 LTSLDLSDNLIDGKIPSQLQNLKSLESLNLSHNKLSGHIPPLSIYIHKGSSIDFSHNDFE 477

Query: 112 SM--HTVVSLSP------NNGLCGNILDLPSCDTTKPATLFVEIFLPLTIVLSVIVFACL 163
               H +  + P      N GLCG    LP C       L +   L   + LS +    L
Sbjct: 478 GHIPHELQFVYPPRVFGHNKGLCGEREGLPHCKRGHKTILIIS--LSTILFLSFVALGIL 535

Query: 164 LLAKRKYKKPKLEERATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYK 223
           LL+ RK ++ + +  +T N D+FS+WNYDG+I YED+IEATEDFDI+YCIGTGGYGSVYK
Sbjct: 536 LLS-RKTRRNQTKATSTKNGDIFSVWNYDGKIAYEDIIEATEDFDIKYCIGTGGYGSVYK 594

Query: 224 AQLPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY 281
           AQLP G V ALKKLH  E  E  ++KSF+NE QVLS++ HRNI+KL+GYCLHK+CMFLIY
Sbjct: 595 AQLPTGNVVALKKLHGWERDEATYLKSFQNEVQVLSKIQHRNIIKLHGYCLHKRCMFLIY 654

Query: 282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL 341
           +YMERGSL+C L N  +A+ELDW KRVN++K++ HAL Y+HHD +P IIHRD+SSNNILL
Sbjct: 655 KYMERGSLYCVLSNEVEALELDWIKRVNVIKSIVHALCYMHHDSTPPIIHRDVSSNNILL 714

Query: 342 NSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEV 401
           + KL+AF++DFGTARLLH DSSN+TLLAGTYGYIAPELAYTM +TEKCDVYSFGVV LE 
Sbjct: 715 DFKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPELAYTMAVTEKCDVYSFGVVALET 774

Query: 402 LMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKS 461
           +MG+HPR++ + LSSSS   IML D+LD RLP P DR+V RD++L+  ++  C+ SNP+S
Sbjct: 775 MMGRHPRELFTLLSSSSAQNIMLTDILDSRLPSPQDRQVARDVVLVVWLALKCIHSNPRS 834

Query: 462 RPTMQSVSQEFLITRKTPLVKHAAIQDISISEL 494
           RPTMQ +S + LI  ++P ++      IS+ +L
Sbjct: 835 RPTMQHISSKLLI--QSPFLE--PFHGISLWQL 863

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225465647|ref|XP_002270862.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  547 bits (1410), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 275/492 (55%), Positives = 343/492 (69%), Gaps = 47/492 (9%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
           G IPP I NLKNLI L +  N+L G IPS+LG L +L   ++S N++SG+IP  I ++  
Sbjct: 331 GSIPPIIWNLKNLIHLRLDHNNLTGVIPSSLGYLIHLHEFNISGNQISGQIPSSIGNLNN 390

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVP-------------FSNNDL- 110
           LT+LDLS+N I G IP ++  L RL YLNLS NKLSG +P              S NDL 
Sbjct: 391 LTRLDLSDNLIHGKIPSQVQNLKRLVYLNLSHNKLSGSIPTLLIYDHIRPSLDLSYNDLE 450

Query: 111 -------SSMHTVVSLSPNNGLCGNILDLPSCDTTKPATLFVEIFLPLTIVLSVIVFACL 163
                   S  +  S   N GLCG+I  LP C      T  +                  
Sbjct: 451 GHIPFELQSKFSQGSFDNNKGLCGDIKGLPHCKEEYKTTRIIT----------------- 493

Query: 164 LLAKRKYKKPKLEERATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYK 223
                  +K + +E  T N D+FS+WNYDG+I YED+I+ATEDFDI+YCIGTGGYGSVYK
Sbjct: 494 -------RKIQTKEIPTKNGDIFSVWNYDGKIAYEDIIKATEDFDIKYCIGTGGYGSVYK 546

Query: 224 AQLPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY 281
           AQLP G V ALKKLH  E  E  ++KSF+NE Q+LS++ HRNIVKL GYCLHK+CMFLIY
Sbjct: 547 AQLPTGNVVALKKLHGWETDEATYLKSFQNEVQILSKIRHRNIVKLQGYCLHKRCMFLIY 606

Query: 282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL 341
            YM RGSL+C L N  +A+ELDW KRVN+VK++ HA+ Y+HHDC+P IIHRDISSNNILL
Sbjct: 607 NYMGRGSLYCVLSNEVEALELDWIKRVNVVKSIVHAVCYMHHDCTPPIIHRDISSNNILL 666

Query: 342 NSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEV 401
           +SKL+AF++DFGT+RLLH DSSN+TLL+GTYGYIAPELAYTMV+TEKCDVYSFGVV LE 
Sbjct: 667 DSKLDAFLSDFGTSRLLHPDSSNQTLLSGTYGYIAPELAYTMVVTEKCDVYSFGVVALET 726

Query: 402 LMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKS 461
           +MGKHP ++ + LSSSS   IML D+LD RLP P D++V RD++L+  ++  C+ SNP+S
Sbjct: 727 MMGKHPGELFTLLSSSSTQNIMLTDMLDSRLPSPQDQQVARDVVLVVWLALKCIHSNPRS 786

Query: 462 RPTMQSVSQEFL 473
           RPTMQ +S + L
Sbjct: 787 RPTMQHISSKLL 798

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359488983|ref|XP_002277433.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  546 bits (1408), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 282/534 (52%), Positives = 360/534 (67%), Gaps = 46/534 (8%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTN------------------------ 40
           G IPPEIG +KNL KL++G N+L G IPS+ G+LTN                        
Sbjct: 226 GPIPPEIGGMKNLNKLNLGYNNLTGVIPSSFGNLTNMNSLSFRGNQISGFIPLEIWYLLN 285

Query: 41  LSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
           LS LDLS N++SG IP EI ++K L+ LD+SNN I G IP ++  L  + Y NLS N LS
Sbjct: 286 LSYLDLSENQISGFIPEEIVNLKKLSHLDMSNNLISGKIPSQLGNLKEVKYFNLSHNNLS 345

Query: 101 GPVPFS--------------NNDLSSMHT--VVSLSPNNGLCGNILDLPSCDTTKPATLF 144
           G +P+S              NN L       V +   N GLCG I   P C      TL 
Sbjct: 346 GTIPYSISSNYNKWTLIDLSNNRLEGQTRAPVEAFGHNKGLCGEIKGRPRCKKRHQITLI 405

Query: 145 VEIFLPLTIVLSVIVFACLLLAKRKYKKPKLEERATNNIDVFSIWNYDGRIVYEDLIEAT 204
           + + L  T++LS+ +   L   +R  K   LE     N D+FSIW+YDG I Y+D+I+AT
Sbjct: 406 IVVSLSTTLLLSIAILGFLFHKRRIRKNQLLETTKVKNGDLFSIWDYDGVIAYQDIIQAT 465

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHR 262
           EDFDI+YCIGTGGYGSVY+AQLP+GKV ALKKLH  E  +  ++KSF+NE Q+L+++ HR
Sbjct: 466 EDFDIKYCIGTGGYGSVYRAQLPSGKVVALKKLHGWERGDPTYLKSFENEVQMLTRIRHR 525

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
           NIVKL+G+CLHK+CMFL+Y+YME+GSL+C L +  +AVELDW KRVN+VK++A+AL+Y+H
Sbjct: 526 NIVKLHGFCLHKRCMFLVYKYMEKGSLYCMLRDEVEAVELDWIKRVNVVKSIANALSYMH 585

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
           HDC   IIHRDISSNNILL+SKLEAFV+DFGTARLL  DSSNRTLL GTYGYIAPELAYT
Sbjct: 586 HDCDLPIIHRDISSNNILLDSKLEAFVSDFGTARLLDNDSSNRTLLVGTYGYIAPELAYT 645

Query: 383 MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR 442
           MV+TEKCD+YSFG+V LE +MG HP + ++SLSSSS     L DVLD RL  P   +V  
Sbjct: 646 MVVTEKCDIYSFGMVALETMMGMHPGEFVTSLSSSSTQNTTLKDVLDSRLSSPKSTQVAN 705

Query: 443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDISISELRN 496
           +I LI +++  CL SNP+ RP+MQ VS + + TR  P      I  IS+ +L++
Sbjct: 706 NIALIVSLALKCLHSNPQFRPSMQEVSSKLVSTRSFP----QPISTISLLQLKD 755

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484063|ref|XP_002270651.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  545 bits (1405), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 274/495 (55%), Positives = 347/495 (70%), Gaps = 23/495 (4%)

Query: 2   YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAS 61
           Y   +IP  +GNL NL+ L +  NSL+G IPS++G+L NL+  ++  N++ G IP EI +
Sbjct: 487 YLSSVIPSSLGNLTNLVTLSLTLNSLVGAIPSSVGNLINLTEFNICGNQIRGCIPFEIGN 546

Query: 62  MKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVP-----------FSNNDL 110
           +K +  LDLS+N I   IP ++  L  L+ LNLS NKLSG +P            S NDL
Sbjct: 547 LKNMASLDLSDNLINVKIPSQLQNLESLENLNLSHNKLSGHIPTLPKYGWLSIDLSYNDL 606

Query: 111 SSM--------HTVVSLSPNNGLCGNILDLPSCDTTKPATLFVEIFLPLTIVLSVIVFAC 162
                      H+    S N GLCG I   P C       L   I +   + L   VF  
Sbjct: 607 EGHIPIELQLEHSPEVFSYNKGLCGEIKGWPHCKRGHKTMLITTIAISTILFLLFAVFGF 666

Query: 163 LLLAK--RKYKKPKLEERATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGS 220
           LLL++  R+ +     ++   N D+FSIWNYDG+I YED+IEATEDFDI+YCIGTGGYG+
Sbjct: 667 LLLSRKMRQNQTKTPLKKNEKNGDIFSIWNYDGKIAYEDIIEATEDFDIKYCIGTGGYGT 726

Query: 221 VYKAQLPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMF 278
           VYKAQLP G V ALKKLH  E  E  + KSF+NE QVLS++ HRNI+KL+GYCLHK+CMF
Sbjct: 727 VYKAQLPTGNVVALKKLHGWERDEATYFKSFQNEVQVLSKIQHRNIIKLHGYCLHKRCMF 786

Query: 279 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNN 338
           LIY+YMERGSLF  L N  +A+ELDW KRVN+VK++ HAL Y+HHD +  IIHRDISS+N
Sbjct: 787 LIYKYMERGSLFGVLSNEVEALELDWIKRVNVVKSIVHALCYMHHDYTLPIIHRDISSSN 846

Query: 339 ILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVT 398
           ILL+SKL+AF++DFGTARLLH DSSN+T+LAGTYGYIAPELAYTMV+TEKCDVYSFGVV 
Sbjct: 847 ILLDSKLDAFLSDFGTARLLHHDSSNQTVLAGTYGYIAPELAYTMVVTEKCDVYSFGVVA 906

Query: 399 LEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSN 458
           LE +MGKHPR++ + LSSSS   IML D+LD RLP P D++V RD++L+  ++  C+ SN
Sbjct: 907 LETMMGKHPRELFTLLSSSSAQSIMLTDILDSRLPSPQDQQVARDVVLVVWLALKCIHSN 966

Query: 459 PKSRPTMQSVSQEFL 473
           P+SRPTMQ +S   L
Sbjct: 967 PRSRPTMQLISSRLL 981

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359488981|ref|XP_002275364.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  540 bits (1391), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 280/533 (52%), Positives = 358/533 (67%), Gaps = 45/533 (8%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTN------------------------ 40
           G IPPEIG +KNL KL++G N+L G IPS+ G+LTN                        
Sbjct: 226 GPIPPEIGKMKNLNKLNLGYNNLTGVIPSSFGNLTNMNSLSFRGNQISGFIPPEIGHLLN 285

Query: 41  LSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
           LS LDLS N++SG IP E+ ++K L+ LD+SNN I G IP ++  L  + Y NLS N LS
Sbjct: 286 LSYLDLSENQISGFIPEEMVNLKKLSHLDMSNNLISGKIPSQLGNLKEVKYFNLSHNNLS 345

Query: 101 GPVPFS-------------NNDLSSMHT--VVSLSPNNGLCGNILDLPSCDTTKPATLFV 145
           G +P+S             NN L       V +   N GLCG I     C      TL +
Sbjct: 346 GTIPYSISSNYRWTLIDLSNNRLEGQARAPVEAFGHNKGLCGEIKGWARCKKRHQITLII 405

Query: 146 EIFLPLTIVLSVIVFACLLLAKRKYKKPKLEERATNNIDVFSIWNYDGRIVYEDLIEATE 205
            + L  T++LSV +   L   +R  K   LE     N D+FSIW++DG I Y+D+I+ATE
Sbjct: 406 VVSLSTTLLLSVAILGFLFHKRRIRKNQLLETTKVKNGDLFSIWDFDGVIAYQDIIQATE 465

Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLH--TSEELAFIKSFKNEAQVLSQVLHRN 263
           DFDI+YCIGTGGYGSVY+AQLP+GKV ALKKLH    E+  ++KSF+NE Q+L+++ HRN
Sbjct: 466 DFDIKYCIGTGGYGSVYRAQLPSGKVVALKKLHGWEREDPTYLKSFENEVQMLTRIRHRN 525

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           IVKL+G+CLHK+CMFL+Y+YME+GSL+C L +  +AVELDW KRVN+VK++A+AL+Y+HH
Sbjct: 526 IVKLHGFCLHKRCMFLVYKYMEKGSLYCMLRDEVEAVELDWIKRVNVVKSIANALSYMHH 585

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
           DC   IIHRDISSNNILL+SKLEAFV+DFGTARLL  DSSNRTLLAGTYGYIAPELAYTM
Sbjct: 586 DCDLPIIHRDISSNNILLDSKLEAFVSDFGTARLLDNDSSNRTLLAGTYGYIAPELAYTM 645

Query: 384 VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD 443
           V+TEKCDVYSFG+V LE +MG HP + ++SLSSSS     L DVLD RL  P   +V  +
Sbjct: 646 VVTEKCDVYSFGMVALETMMGMHPGEFITSLSSSSTQNTTLKDVLDSRLSSPKSTRVANN 705

Query: 444 ILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDISISELRN 496
           I LI +++  CL  NP+  P+MQ VS + + TR  P      I  IS+ +L++
Sbjct: 706 IALIVSLALKCLHFNPQFCPSMQEVSSKLVSTRSFP----QPISAISLLQLKD 754

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225466223|ref|XP_002267065.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710 [Vitis vinifera] gi|147859823|emb|CAN79273.1| hypothetical protein VITISV_014885 [Vitis vinifera]

 Score =  526 bits (1356), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 266/486 (54%), Positives = 353/486 (72%), Gaps = 9/486 (1%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
           G IP EIG+LK L+ L + +N L+G IP  LG+  +L  L +  N+L+G IP EI  +  
Sbjct: 243 GSIPSEIGSLKKLVDLALDNNKLVGVIPKELGNCHSLRYLSMKFNRLNGSIPSEIGGLVA 302

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNG 124
           L +LDLS NNI G+IP +    + L+YL+LS N L G VPF   +L       +   N G
Sbjct: 303 LRKLDLSVNNISGTIPLQFQNFNSLEYLDLSYNYLEGYVPF---ELHLPSLFRAFEHNKG 359

Query: 125 LCGNI-LDLPSCDTTKPATLFVEIFLPL--TIVLSVIVFACLLLAKRKYKKPKLEE-RAT 180
           LCG+    +P C      T+ + + + L   +++S I+F  LL+ +RK +K + EE   T
Sbjct: 360 LCGDTKFGIPPCRKRNRITIIIIVVICLCSALLISSIIFGVLLIWRRKTRKLQPEEATTT 419

Query: 181 NNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHT- 239
            N D+FSIW+YDG+I YED+IEATEDFDI+YCIGTGGYGSVY+A+L NGK  ALKKLHT 
Sbjct: 420 QNGDIFSIWDYDGKIAYEDIIEATEDFDIKYCIGTGGYGSVYRAKLTNGKEVALKKLHTL 479

Query: 240 -SEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNED 298
            S+   ++KSF NE +VLS++ HRNIVKLYG+CLHK+CMFL+YEYMERGSL C L +  +
Sbjct: 480 ESQNPTYMKSFTNEVRVLSKIRHRNIVKLYGFCLHKRCMFLVYEYMERGSLHCVLSDEIE 539

Query: 299 AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL 358
           A+E DW KRVN+VK++A+AL+Y+H+DC P ++HRDISS NILL+S+  A V+DFGTARLL
Sbjct: 540 ALEFDWIKRVNVVKSIANALSYMHNDCIPPLLHRDISSGNILLDSEFRAVVSDFGTARLL 599

Query: 359 HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSS 418
             DSSN+TLLAGTYGY+APELAYTMV+TEKCDVYSFGV+TLE++MGKHPR++++ LS+SS
Sbjct: 600 DPDSSNQTLLAGTYGYVAPELAYTMVVTEKCDVYSFGVLTLEIMMGKHPRELVTILSTSS 659

Query: 419 DPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT 478
              IML+D+LD RL P +D +VI +++LI  ++  C+  NP SRPTMQ V +EF      
Sbjct: 660 SQNIMLVDILDPRLAPHIDPEVIDNVVLIIRLALKCINLNPTSRPTMQHVCKEFETCTPF 719

Query: 479 PLVKHA 484
           P+  HA
Sbjct: 720 PIPFHA 725

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225452694|ref|XP_002276873.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  525 bits (1353), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 275/504 (54%), Positives = 352/504 (69%), Gaps = 17/504 (3%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
           G IP +IG L  L  LD+  + L G +PS+LGSLT L++L+L  N+++G IPPEI ++K 
Sbjct: 282 GSIPHQIGTLTELTYLDLSWSELTGAMPSSLGSLTKLTSLNLCMNQINGSIPPEIGNIKD 341

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVP--FSNN------DLSSMHTV 116
           L  LDL  N I G IP ++ KL RL+ L+LS N+LSG +P   +NN      DLS    +
Sbjct: 342 LVSLDLHRNLISGEIPSKLKKLKRLECLDLSYNRLSGKIPPFLTNNSDWEKLDLSHNDDL 401

Query: 117 VSLSP--NNGLCGNILDLPSCDTTKPATLFVEIFLPLTIVLSVIVFACLLLAKRKYKKPK 174
              +P  +NG       +P+ DTT   T+   + L L  V  ++  ACL   KRK +   
Sbjct: 402 EGYTPFVHNGGEKTGAQVPTRDTTSQHTIITPLLLTLVFVTLILGLACLWWKKRKVQPES 461

Query: 175 LEERATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFAL 234
           +  +   N D+FSIW+YDGRI +ED+I ATEDFDIRYCIG GGYGSVY+AQLP+G V  +
Sbjct: 462 MATK--KNGDLFSIWDYDGRIAFEDIISATEDFDIRYCIGVGGYGSVYRAQLPSGNVVVV 519

Query: 235 KKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCN 292
           KKLH SE  E  +++SFKNE Q+L ++ HRNIVKL+GYCLH +CMFLI  YMERGSL C 
Sbjct: 520 KKLHRSEIDEPTYLRSFKNEVQMLEEIRHRNIVKLHGYCLHNRCMFLICMYMERGSLNCM 579

Query: 293 LHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF 352
           L N  +AVELDW KRVNIVK MAHAL+Y+HHDC+P IIHRDISSNNILL+SKLE FV+DF
Sbjct: 580 LSNEVEAVELDWVKRVNIVKNMAHALSYMHHDCTPPIIHRDISSNNILLDSKLEGFVSDF 639

Query: 353 GTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILS 412
           GTARLL   SSN+TL+AGTYGYIAPE AYTM++TEKCDVYSFGVV LE ++GKHP ++++
Sbjct: 640 GTARLLDPSSSNQTLIAGTYGYIAPEFAYTMIVTEKCDVYSFGVVALETMIGKHPGELIT 699

Query: 413 SLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           SL SS    IML DVLD RL  P D +V +D++ +  ++  C+  NP+SRPTMQ +S + 
Sbjct: 700 SLLSSLCQDIMLRDVLDSRLSLPEDLQVAKDVVFVVLLALKCIHPNPQSRPTMQQISYKL 759

Query: 473 LITRKTPLVKHAAIQDISISELRN 496
           L     P  K +    IS+ EL+N
Sbjct: 760 L--GNIPFPK-SPFYAISLHELKN 780

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	496
TAIR|locus:2138268	1045	AT4G08850 [Arabidopsis thalian	0.929	0.441	0.411	8.7e-95
TAIR|locus:2011339	1120	AT1G35710 [Arabidopsis thalian	0.919	0.407	0.415	2e-88
TAIR|locus:2160791	1102	AT5G63930 [Arabidopsis thalian	0.927	0.417	0.364	2.3e-69
TAIR|locus:2058759	589	FEI2 "FEI 2" [Arabidopsis thal	0.929	0.782	0.377	1.2e-67
TAIR|locus:2020417	1101	AT1G17230 [Arabidopsis thalian	0.925	0.416	0.345	4.6e-67
TAIR|locus:2168907	966	XIP1 "XYLEM INTERMIXED WITH PH	0.917	0.471	0.371	8.5e-67
TAIR|locus:2097310	1002	BAM2 "BARELY ANY MERISTEM 2" [	0.947	0.469	0.363	3.4e-66
TAIR|locus:2206179	592	FEI1 "FEI 1" [Arabidopsis thal	0.935	0.783	0.366	1.2e-65
TAIR|locus:2139885	1013	AT4G28650 [Arabidopsis thalian	0.927	0.454	0.357	1.5e-64
TAIR|locus:2169965	1003	BAM1 "BARELY ANY MERISTEM 1" [	0.923	0.456	0.362	2.8e-64

TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)]

 Score = 943 (337.0 bits), Expect = 8.7e-95, P = 8.7e-95
 Identities = 199/484 (41%), Positives = 295/484 (60%)

Query:     7 IPPEIGNLKNLIKLDVGSNSLIGPIPSAXXXXXXXXXXXXXXXXXXGKIPPEIASMKYLT 66
             IPP + NL  L  +++  N L   IP                    G+I  +  S++ L 
Sbjct:   566 IPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLE 625

Query:    67 QLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLC 126
             +LDLS+NN+ G IP     +  L ++++S N L GP+P  +N         +   N  LC
Sbjct:   626 RLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIP--DNAAFRNAPPDAFEGNKDLC 683

Query:   127 GNI---LDLPSCDTT------KPATLFVEIFLPLTIVLSVI-VFACLLLAKRKYKKPKLE 176
             G++     L  C  T      K   L + I +P+   + ++ V A + +  RK  K ++E
Sbjct:   684 GSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTK-QIE 742

Query:   177 ERATNNI--DVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFAL 234
             E   +    +  SI+++DG++ Y+++I+AT +FD +Y IGTGG+G VYKA+LPN  + A+
Sbjct:   743 EHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAV 801

Query:   235 KKLHTSEELAFI-----KSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL 289
             KKL+ + + +       + F NE + L+++ HRN+VKL+G+C H++  FL+YEYMERGSL
Sbjct:   802 KKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSL 861

Query:   290 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFV 349
                L N+++A +LDW KR+N+VK +AHAL+Y+HHD SP+I+HRDISS NILL    EA +
Sbjct:   862 RKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKI 921

Query:   350 ADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
             +DFGTA+LL  DSSN + +AGTYGY+APELAY M +TEKCDVYSFGV+TLEV+ G+HP D
Sbjct:   922 SDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGD 981

Query:   410 IXXXXXXXX-DPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
             +         D  + L  + D RLP P   ++  ++L I  V+  CL S+P++RPTM S+
Sbjct:   982 LVSTLSSSPPDATLSLKSISDHRLPEPTP-EIKEEVLEILKVALLCLHSDPQARPTMLSI 1040

Query:   469 SQEF 472
             S  F
Sbjct:  1041 STAF 1044

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)]

 Score = 883 (315.9 bits), Expect = 2.0e-88, P = 2.0e-88
 Identities = 201/484 (41%), Positives = 291/484 (60%)

Query:     7 IPPEIGNLKNLIKLDVGSNSLIGPIPSAXXXXXXXXXXXXXXXXXXGKIPPEIASMKYLT 66
             IP    +   L  +++  N   G IP                    G+IP +++S++ L 
Sbjct:   646 IPQTFDSFLKLHDMNLSRNKFDGSIPRLSKLTQLTQLDLSHNQLD-GEIPSQLSSLQSLD 704

Query:    67 QLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLC 126
             +LDLS+NN+ G IP     +  L  +++S+NKL GP+P  +       T  +L  N GLC
Sbjct:   705 KLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLP--DTPTFRKATADALEENIGLC 762

Query:   127 GNILD--LPSC-DTTKP---ATLFVEIFLPLTIVLSVIVFACL-----LLAKRKYKKPKL 175
              NI    L  C +  KP     L V I +P+  VL VI+  C       + KRK +  + 
Sbjct:   763 SNIPKQRLKPCRELKKPKKNGNLVVWILVPILGVL-VILSICANTFTYCIRKRKLQNGRN 821

Query:   176 EERATN-NIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFAL 234
              +  T  N+ +FS+   DG+  Y+D+IE+T +FD  + IGTGGY  VY+A L +  + A+
Sbjct:   822 TDPETGENMSIFSV---DGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAV 877

Query:   235 KKLHTS--EELA--FIKS-FKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL 289
             K+LH +  EE++   +K  F NE + L+++ HRN+VKL+G+C H++  FLIYEYME+GSL
Sbjct:   878 KRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSL 937

Query:   290 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFV 349
                L N+E+A  L W KR+N+VK +AHAL+Y+HHD    I+HRDISS NILL++   A +
Sbjct:   938 NKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKI 997

Query:   350 ADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
             +DFGTA+LL  DSSN + +AGTYGY+APE AYTM +TEKCDVYSFGV+ LE+++GKHP D
Sbjct:   998 SDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGD 1057

Query:   410 IXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIRDILL-ISTVSFACLQSNPKSRPTMQSV 468
             +           + L  + D+R+  P  R   R+ LL +  ++  CLQ+NP+SRPTM S+
Sbjct:  1058 LVSSLSSSPGEALSLRSISDERVLEP--RGQNREKLLKMVEMALLCLQANPESRPTMLSI 1115

Query:   469 SQEF 472
             S  F
Sbjct:  1116 STTF 1119

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)]

 Score = 709 (254.6 bits), Expect = 2.3e-69, P = 2.3e-69
 Identities = 178/488 (36%), Positives = 250/488 (51%)

Query:     5 GIIPPEIGNLKNLIKLDVGSNSLIGPIP-SAXXXXXXXXXXXXXXXXXXGKIPPEIASMK 63
             G IP  +GNL  L +L +G N   G IP                     G+IPPE++++ 
Sbjct:   591 GTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLV 650

Query:    64 YLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNN-DLSSMHTVVSL-SP 121
              L  L L+NNN+ G IP     LS L   N S N L+GP+P   N  +SS      L  P
Sbjct:   651 MLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPLLRNISMSSFIGNEGLCGP 710

Query:   122 NNGLCGNILDL-PSCDTTKPATLFVEIFLPLTIVL----SVIVFACLLLAKRKYKKPKLE 176
                 C       PS  T KP  +     + +T  +    S+++ A ++   R+  +    
Sbjct:   711 PLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVAS 770

Query:   177 ERATNNIDVFSIWNY----DGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVF 232
                       S+  Y    +G   ++DL+ AT++FD  + +G G  G+VYKA LP G   
Sbjct:   771 SAQDGQPSEMSLDIYFPPKEG-FTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTL 829

Query:   233 ALKKLHTSEELA----FIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGS 288
             A+KKL ++ E         SF+ E   L  + HRNIVKL+G+C H+    L+YEYM +GS
Sbjct:   830 AVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGS 889

Query:   289 LFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF 348
             L   LH  + +  LDW+KR  I    A  LAYLHHDC P I HRDI SNNILL+ K EA 
Sbjct:   890 LGEILH--DPSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH 947

Query:   349 VADFGTARLLHAD-SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
             V DFG A+++    S + + +AG+YGYIAPE AYTM +TEK D+YS+GVV LE+L GK P
Sbjct:   948 VGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAP 1007

Query:   408 -------RDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPK 460
                     D+            +   VLD RL    D +++  +L +  ++  C   +P 
Sbjct:  1008 VQPIDQGGDVVNWVRSYIRRDALSSGVLDARLTLE-DERIVSHMLTVLKIALLCTSVSPV 1066

Query:   461 SRPTMQSV 468
             +RP+M+ V
Sbjct:  1067 ARPSMRQV 1074

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2058759 FEI2 "FEI 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 687 (246.9 bits), Expect = 1.2e-67, P = 1.2e-67
 Identities = 184/488 (37%), Positives = 258/488 (52%)

Query:     5 GIIPPEIGNLKNLIKLDVGSNSLIGPIPSAXXXXXXXXXXXXXXXXXXGKIPPEIASMKY 64
             G +PPE+G L  L  L + +N+L   IP++                  G IP EI ++  
Sbjct:    87 GPLPPELGKLDQLRLLMLHNNALYQSIPASLGNCTALEGIYLQNNYITGTIPSEIGNLSG 146

Query:    65 LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNG 124
             L  LDLSNNN+ G+IP  + +L RL   N+S+N L G +P  ++ L +  +  S + N  
Sbjct:   147 LKNLDLSNNNLNGAIPASLGQLKRLTKFNVSNNFLVGKIP--SDGLLARLSRDSFNGNRN 204

Query:   125 LCGNILDL---PSCDTT---KPATLFVEIFLPLTIVLSVIVFACLLLAKR------KYKK 172
             LCG  +D+    S ++T    P          L I  S  V   LL+A         YKK
Sbjct:   205 LCGKQIDIVCNDSGNSTASGSPTGQGGNNPKRLLISASATVGGLLLVALMCFWGCFLYKK 264

Query:   173 PKLEERATNNIDV---FSIWNYDGRIVY--EDLIEATEDFDIRYCIGTGGYGSVYKAQLP 227
                 E  +  IDV    SI  + G + Y  +D+I+  E  +  + IG GG+G+VYK  + 
Sbjct:   265 LGRVESKSLVIDVGGGASIVMFHGDLPYASKDIIKKLESLNEEHIIGCGGFGTVYKLSMD 324

Query:   228 NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERG 287
             +G VFALK++    E  F + F+ E ++L  + HR +V L GYC       L+Y+Y+  G
Sbjct:   325 DGNVFALKRIVKLNE-GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLLYDYLPGG 383

Query:   288 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEA 347
             SL   LH   +  +LDW  RVNI+   A  LAYLHHDCSP IIHRDI S+NILL+  LEA
Sbjct:   384 SLDEALHKRGE--QLDWDSRVNIIIGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEA 441

Query:   348 FVADFGTARLLHADSSN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKH 406
              V+DFG A+LL  + S+  T++AGT+GY+APE   +   TEK DVYSFGV+ LEVL GK 
Sbjct:   442 RVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKL 501

Query:   407 PRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK---VIRDIL-LISTVSFACLQSNPKSR 462
             P D             +   + + R    VD     V R+ L  + +++  C+ S+P  R
Sbjct:   502 PTDASFIEKGFNIVGWLNFLISENRAKEIVDLSCEGVERESLDALLSIATKCVSSSPDER 561

Query:   463 PTMQSVSQ 470
             PTM  V Q
Sbjct:   562 PTMHRVVQ 569

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009664 "plant-type cell wall organization" evidence=RCA;IMP

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0000272 "polysaccharide catabolic process" evidence=RCA

GO:0005982 "starch metabolic process" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)]

 Score = 688 (247.2 bits), Expect = 4.6e-67, P = 4.6e-67
 Identities = 169/489 (34%), Positives = 251/489 (51%)

Query:     5 GIIPPEIGNLKNLIKLDVGSNSLIGPIP-SAXXXXXXXXXXXXXXXXXXGKIPPEIASMK 63
             G IP   G+L  L++L +G N L   IP                     G IP  + +++
Sbjct:   585 GEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQ 644

Query:    64 YLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
              L  L L++N + G IP  I  L  L   N+S+N L G VP  +  +       + + N+
Sbjct:   645 MLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVP--DTAVFQRMDSSNFAGNH 702

Query:   124 GLCGNILD-----LPSCDTT---------KPATLFVEIFLPLTIVLSVIVFACLLLAKRK 169
             GLC +        +P  D+          +   L +   +  ++ L   +  C  + +R+
Sbjct:   703 GLCNSQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIGSVFLITFLGLCWTIKRRE 762

Query:   170 YKKPKLEERATNNIDVFSIWNYDGR-IVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPN 228
                  LE++     DV   + +  +   Y+ L++AT +F     +G G  G+VYKA++  
Sbjct:   763 PAFVALEDQTKP--DVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSG 820

Query:   229 GKVFALKKLHTSEELAFI-KSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERG 287
             G+V A+KKL++  E A    SF+ E   L ++ HRNIVKLYG+C H+    L+YEYM +G
Sbjct:   821 GEVIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKG 880

Query:   288 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEA 347
             SL   L   E    LDW  R  I    A  L YLHHDC P I+HRDI SNNILL+ + +A
Sbjct:   881 SLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQA 940

Query:   348 FVADFGTARLLHAD-SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKH 406
              V DFG A+L+    S + + +AG+YGYIAPE AYTM +TEKCD+YSFGVV LE++ GK 
Sbjct:   941 HVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKP 1000

Query:   407 P-------RDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNP 459
             P        D+           I  I++ D RL    D++ + ++ L+  ++  C  ++P
Sbjct:  1001 PVQPLEQGGDLVNWVRRSIRNMIPTIEMFDARLDTN-DKRTVHEMSLVLKIALFCTSNSP 1059

Query:   460 KSRPTMQSV 468
              SRPTM+ V
Sbjct:  1060 ASRPTMREV 1068

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2168907 XIP1 "XYLEM INTERMIXED WITH PHLOEM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 680 (244.4 bits), Expect = 8.5e-67, P = 8.5e-67
 Identities = 189/509 (37%), Positives = 264/509 (51%)

Query:     5 GIIPPEIGNLKNLIKLDVGSNSLIGPIPSAXXXXXXXXXXXXXXXXXXGKIPPEIASMKY 64
             G+IP E+ +  NL+KLD+ +N L GPIPS                     IP  ++++K 
Sbjct:   450 GVIPHELSHSTNLVKLDLSNNQLSGPIPSEVGRLRKLNLLVLQGNHLDSSIPDSLSNLKS 509

Query:    65 LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNG 124
             L  LDLS+N + G IP  +++L     +N SSN+LSGP+P S   L     V S S N  
Sbjct:   510 LNVLDLSSNLLTGRIPENLSELLPTS-INFSSNRLSGPIPVS---LIRGGLVESFSDNPN 565

Query:   125 LC------GNILDLPSCDTT----KPATLFVEIFLPLTIVLSVIVFACLLLAKRKYKKPK 174
             LC       + L  P C       K ++++  +     +VL VI+F    L +R  K   
Sbjct:   566 LCIPPTAGSSDLKFPMCQEPHGKKKLSSIWAILVSVFILVLGVIMF---YLRQRMSKNRA 622

Query:   175 LEERATNNIDVFSIWNYD----GRIVYE--DLIEATEDFDIRYCIGTGGYGSVYKAQLPN 228
             + E+  +     S ++YD     RI ++  +++E+  D +I   +G GG G+VY+ +L +
Sbjct:   623 VIEQ--DETLASSFFSYDVKSFHRISFDQREILESLVDKNI---VGHGGSGTVYRVELKS 677

Query:   229 GKVFALKKLHT-------SEELAFI-KSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI 280
             G+V A+KKL +       SE+   + K  K E + L  + H+NIVKL+ Y     C  L+
Sbjct:   678 GEVVAVKKLWSQSNKDSASEDKMHLNKELKTEVETLGSIRHKNIVKLFSYFSSLDCSLLV 737

Query:   281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNIL 340
             YEYM  G+L+  LH     V L+W  R  I   +A  LAYLHHD SP IIHRDI S NIL
Sbjct:   738 YEYMPNGNLWDALHKG--FVHLEWRTRHQIAVGVAQGLAYLHHDLSPPIIHRDIKSTNIL 795

Query:   341 LNSKLEAFVADFGTARLLHA--DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVT 398
             L+   +  VADFG A++L A    S  T++AGTYGY+APE AY+   T KCDVYSFGVV 
Sbjct:   796 LDVNYQPKVADFGIAKVLQARGKDSTTTVMAGTYGYLAPEYAYSSKATIKCDVYSFGVVL 855

Query:   399 LEVLMGKHPRD--------IXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIRDILLISTV 450
             +E++ GK P D        I        D K  LI+ LD+RL      K   D++    V
Sbjct:   856 MELITGKKPVDSCFGENKNIVNWVSTKIDTKEGLIETLDKRLSE--SSKA--DMINALRV 911

Query:   451 SFACLQSNPKSRPTMQSVSQEFLITRKTP 479
             +  C    P  RPTM  V Q  L+   TP
Sbjct:   912 AIRCTSRTPTIRPTMNEVVQ--LLIDATP 938

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010051 "xylem and phloem pattern formation" evidence=IMP

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 677 (243.4 bits), Expect = 3.4e-66, P = 3.4e-66
 Identities = 183/503 (36%), Positives = 254/503 (50%)

Query:     5 GIIPPEIGNLKNLIKLDVGSNSLIGPIPSAXXXXXXXXXXXXXXXXXXGKIPPEIASMKY 64
             G IPPEIG L+ L KLD   N   G I                     G IP E+  MK 
Sbjct:   494 GSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKI 553

Query:    65 LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNG 124
             L  L+LS N++ GSIP  I  +  L  ++ S N LSG VP S    S  +   S   N+ 
Sbjct:   554 LNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVP-STGQFSYFN-YTSFVGNSH 611

Query:   125 LCGNILDLPSCDT----TKPATLFVEIFLPLTIVLSVIVFACLLLAKRKYKKPKLEERAT 180
             LCG  L      T     KP +   ++ L L ++   +VFA + + K +  +   E +A 
Sbjct:   612 LCGPYLGPCGKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEAKAW 671

Query:   181 NNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHT- 239
               +  F   ++      +D++++ ++ +I   IG GG G VYK  +P G + A+K+L T 
Sbjct:   672 R-LTAFQRLDF----TCDDVLDSLKEDNI---IGKGGAGIVYKGTMPKGDLVAVKRLATM 723

Query:   240 SEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDA 299
             S   +    F  E Q L ++ HR+IV+L G+C + +   L+YEYM  GSL   LH  +  
Sbjct:   724 SHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGG 783

Query:   300 VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH 359
               L W  R  I    A  L YLHHDCSP I+HRD+ SNNILL+S  EA VADFG A+ L 
Sbjct:   784 -HLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQ 842

Query:   360 ADSSNRTL--LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPR-------DI 410
                ++  +  +AG+YGYIAPE AYT+ + EK DVYSFGVV LE++ GK P        DI
Sbjct:   843 DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFGDGVDI 902

Query:   411 XXXXXXXXDP-KIMLIDVLDQRLPP-PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
                     D  K  ++ V+D RL   PV      ++  +  V+  C++     RPTM+ V
Sbjct:   903 VQWVRSMTDSNKDCVLKVIDLRLSSVPV-----HEVTHVFYVALLCVEEQAVERPTMREV 957

Query:   469 SQEFLITRKTPLVKH-AAIQDIS 490
              Q      K PL K  AA  D++
Sbjct:   958 VQILTEIPKIPLSKQQAAESDVT 980

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009740 "gibberellic acid mediated signaling pathway" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010162 "seed dormancy process" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2206179 FEI1 "FEI 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 668 (240.2 bits), Expect = 1.2e-65, P = 1.2e-65
 Identities = 181/494 (36%), Positives = 265/494 (53%)

Query:     2 YKI-GIIPPEIGNLKNLIKLDVGSNSLIGPIPSAXXXXXXXXXXXXXXXXXXGKIPPEIA 60
             +KI G +PP+IG L +L  L + +N+L G IP+A                  G IP E+ 
Sbjct:    84 HKIMGPLPPDIGKLDHLRLLMLHNNALYGAIPTALGNCTALEEIHLQSNYFTGPIPAEMG 143

Query:    61 SMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLS 120
              +  L +LD+S+N + G IP  + +L +L   N+S+N L G +P S+  LS   +  S  
Sbjct:   144 DLPGLQKLDMSSNTLSGPIPASLGQLKKLSNFNVSNNFLVGQIP-SDGVLSGF-SKNSFI 201

Query:   121 PNNGLCGNILDLPSCDTT-KPATLFV------EIFLPLTIVLSVIVFACLLLAKR----- 168
              N  LCG  +D+   D +  P++         +    L I  S  V A LL+A       
Sbjct:   202 GNLNLCGKHVDVVCQDDSGNPSSHSQSGQNQKKNSGKLLISASATVGALLLVALMCFWGC 261

Query:   169 -KYKK-PKLEERATNNIDV---FSIWNYDGRIVY--EDLIEATEDFDIRYCIGTGGYGSV 221
               YKK  K+E ++    DV    SI  + G + Y  +D+I+  E  +  + IG GG+G+V
Sbjct:   262 FLYKKLGKVEIKSLAK-DVGGGASIVMFHGDLPYSSKDIIKKLEMLNEEHIIGCGGFGTV 320

Query:   222 YKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY 281
             YK  + +GKVFALK++    E  F + F+ E ++L  + HR +V L GYC       L+Y
Sbjct:   321 YKLAMDDGKVFALKRILKLNE-GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLLY 379

Query:   282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL 341
             +Y+  GSL   LH  E   +LDW  RVNI+   A  L+YLHHDCSP IIHRDI S+NILL
Sbjct:   380 DYLPGGSLDEALHV-ERGEQLDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSNILL 438

Query:   342 NSKLEAFVADFGTARLLHADSSN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLE 400
             +  LEA V+DFG A+LL  + S+  T++AGT+GY+APE   +   TEK DVYSFGV+ LE
Sbjct:   439 DGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLE 498

Query:   401 VLMGKHPRDIXXXXXXXXDPKIMLIDVLDQR----LPPPVDRKVIRDILLISTVSFACLQ 456
             VL GK P D             +   + ++R    + P  +   +  +  + +++  C+ 
Sbjct:   499 VLSGKRPTDASFIEKGLNVVGWLKFLISEKRPRDIVDPNCEGMQMESLDALLSIATQCVS 558

Query:   457 SNPKSRPTMQSVSQ 470
              +P+ RPTM  V Q
Sbjct:   559 PSPEERPTMHRVVQ 572

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009664 "plant-type cell wall organization" evidence=RCA;IMP

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0016301 "kinase activity" evidence=IMP

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0000272 "polysaccharide catabolic process" evidence=RCA

GO:0005982 "starch metabolic process" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0016049 "cell growth" evidence=RCA

GO:0019761 "glucosinolate biosynthetic process" evidence=RCA

GO:0030243 "cellulose metabolic process" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0046777 "protein autophosphorylation" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)]

 Score = 650 (233.9 bits), Expect = 1.5e-64, Sum P(2) = 1.5e-64
 Identities = 174/487 (35%), Positives = 250/487 (51%)

Query:     5 GIIPPEIGNLKNLIKLDVGSNSLIGPIPSAXXXXXXXXXXXXXXXXXXGKIPPEIASMKY 64
             G +P +  +  +L  LD+ SN+L G IPS+                  G+IP +I +M  
Sbjct:   490 GEVPDQFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSA 549

Query:    65 LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNG 124
             L  LDLSNN++ G +P  I     L+ LN+S NKL+GPVP  N  L +++    L  N+G
Sbjct:   550 LAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPI-NGFLKTINPD-DLRGNSG 607

Query:   125 LCGNILDLPSC---DTTKPATLFVEIFLP--LTIVLSVIVFACLLLAKRKYKKPKLEERA 179
             LCG +L   S     T+  ++L  +  +   L  + SV+    L +  R   K K     
Sbjct:   608 LCGGVLPPCSKFQRATSSHSSLHGKRIVAGWLIGIASVLALGILTIVTRTLYK-KWYSNG 666

Query:   180 TNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCI------GTGGYGSVYKAQLPNGK-VF 232
                 +  S   +  R++    +  T   DI  CI      G G  G VYKA++     V 
Sbjct:   667 FCGDETASKGEWPWRLMAFHRLGFTAS-DILACIKESNMIGMGATGIVYKAEMSRSSTVL 725

Query:   233 ALKKLHTSE---ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL 289
             A+KKL  S    E      F  E  +L ++ HRNIV+L G+  + K M ++YE+M  G+L
Sbjct:   726 AVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNL 785

Query:   290 FCNLHNNEDAVEL--DWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEA 347
                +H    A  L  DW  R NI   +AH LAYLHHDC P +IHRDI SNNILL++ L+A
Sbjct:   786 GDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDA 845

Query:   348 FVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
              +ADFG AR++       +++AG+YGYIAPE  YT+ + EK D+YS+GVV LE+L G+ P
Sbjct:   846 RIADFGLARMMARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRP 905

Query:   408 RDIXXXXXXXXDP----KIMLIDVLDQRLPPPVD--RKVIRDILLISTVSFACLQSNPKS 461
              +               KI     L++ L P V   R V  ++LL+  ++  C    PK 
Sbjct:   906 LEPEFGESVDIVEWVRRKIRDNISLEEALDPNVGNCRYVQEEMLLVLQIALLCTTKLPKD 965

Query:   462 RPTMQSV 468
             RP+M+ V
Sbjct:   966 RPSMRDV 972

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010067 "procambium histogenesis" evidence=ISS

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 660 (237.4 bits), Expect = 2.8e-64, P = 2.8e-64
 Identities = 180/497 (36%), Positives = 250/497 (50%)

Query:     5 GIIPPEIGNLKNLIKLDVGSNSLIGPIPSAXXXXXXXXXXXXXXXXXXGKIPPEIASMKY 64
             G IP E+G L+ L K+D   N   G I                     G+IP EI +MK 
Sbjct:   493 GPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKI 552

Query:    65 LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNG 124
             L  L+LS N++ GSIPG I+ +  L  L+ S N LSG VP +     S     S   N  
Sbjct:   553 LNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQ--FSYFNYTSFLGNPD 610

Query:   125 LCGNILDLPSCD-TTK---------PATLFVEIFLPLTIVLSVIVFACLLLAKRKYKKPK 174
             LCG  L  P  D   K         P +  +++ L L +++  I FA + + K +  K  
Sbjct:   611 LCGPYLG-PCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKARSLKKA 669

Query:   175 LEERATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFAL 234
              E RA   +  F   ++      +D++++ ++ +I   IG GG G VYK  +PNG + A+
Sbjct:   670 SESRAWR-LTAFQRLDF----TCDDVLDSLKEDNI---IGKGGAGIVYKGVMPNGDLVAV 721

Query:   235 KKLHT-SEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNL 293
             K+L   S   +    F  E Q L ++ HR+IV+L G+C + +   L+YEYM  GSL   L
Sbjct:   722 KRLAAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVL 781

Query:   294 HNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG 353
             H  +    L W  R  I    A  L YLHHDCSP I+HRD+ SNNILL+S  EA VADFG
Sbjct:   782 HGKKGG-HLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFG 840

Query:   354 TARLLHADSSNRTL--LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPR--- 408
              A+ L    ++  +  +AG+YGYIAPE AYT+ + EK DVYSFGVV LE++ G+ P    
Sbjct:   841 LAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEF 900

Query:   409 ----DIXXXXXXXXDP-KIMLIDVLDQRLPP-PVDRKVIRDILLISTVSFACLQSNPKSR 462
                 DI        D  K  ++ VLD RL   P     I ++  +  V+  C++     R
Sbjct:   901 GDGVDIVQWVRKMTDSNKDSVLKVLDPRLSSIP-----IHEVTHVFYVAMLCVEEQAVER 955

Query:   463 PTMQSVSQEFLITRKTP 479
             PTM+ V Q      K P
Sbjct:   956 PTMREVVQILTEIPKLP 972

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0043621 "protein self-association" evidence=IDA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00031862001 SubName- Full=Chromosome undetermined scaffold_60, whole genome shotgun sequence; (722 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	496
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-52
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-50
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-46
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-45
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-42
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-42
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-42
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-41
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-39
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-38
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-38
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	8e-33
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-32
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-32
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-31
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-30
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-30
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-29
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-29
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-28
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-28
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-28
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-27
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-27
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-27
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-26
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-26
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-25
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-25
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-25
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-25
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-25
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	9e-25
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-24
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-24
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	9e-24
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-23
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-23
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-23
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-23
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-22
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-22
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-22
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-22
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-22
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-22
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-22
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-22
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-21
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-21
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-21
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-21
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-21
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-21
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-21
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-21
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	8e-21
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-20
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-20
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-19
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-19
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-19
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-19
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-19
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-19
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-19
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	8e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-19
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	9e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	9e-19
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-18
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-18
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-18
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-18
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-18
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	8e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-17
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-17
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-17
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-17
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-17
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-17
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-17
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-17
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-17
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-17
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-17
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	6e-17
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-17
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-17
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-16
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-16
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-16
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-16
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-16
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-16
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-16
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-16
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-16
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-16
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	9e-16
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	9e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-15
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-15
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-15
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-15
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-15
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-15
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	8e-15
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	8e-15
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	8e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-14
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-14
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-14
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-14
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-14
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-14
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-14
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	7e-14
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-13
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-13
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-13
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-13
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-13
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	8e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-12
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-12
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-12
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-12
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-12
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-12
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	7e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-12
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-11
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-11
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-11
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-11
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	6e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	8e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	9e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-10
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-10
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-10
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-10
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-10
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-10
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	6e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	7e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-09
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	8e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-08
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-08
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-08
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-08
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-08
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	5e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	8e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	9e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-07
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	6e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	7e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	8e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	8e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	5e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-04
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	9e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	0.001
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.001

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  176 bits (450), Expect = 3e-52
 Identities = 76/267 (28%), Positives = 118/267 (44%), Gaps = 20/267 (7%)

Query: 207 FDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIV 265
           ++I   +G G +G VY A+    GK+ A+K +   +     +    E ++L ++ H NIV
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
           +LY     +  ++L+ EY E G LF +L      +  D A+    ++ +  AL YLH   
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLF-DLLKKRGRLSEDEARF--YLRQILSALEYLH--- 114

Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVM 385
           S  I+HRD+   NILL+      +ADFG AR L       T   GT  Y+APE+      
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFVGTPEYMAPEVLLGKGY 173

Query: 386 TEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD-- 443
            +  D++S GV+  E+L GK P               +   +   + P P     I    
Sbjct: 174 GKAVDIWSLGVILYELLTGKPP------FPGDDQLLELFKKIGKPKPPFPPPEWDISPEA 227

Query: 444 ILLISTVSFACLQSNPKSRPTMQSVSQ 470
             LI       L  +P+ R T +   Q
Sbjct: 228 KDLIR----KLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  183 bits (467), Expect = 4e-50
 Identities = 140/489 (28%), Positives = 231/489 (47%), Gaps = 54/489 (11%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
           G +P ++G+L  L++L +  N L G IP  L S   L +LDLS N+LSG+IP   + M  
Sbjct: 489 GAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPV 548

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNG 124
           L+QLDLS N + G IP  +  +  L  +N+S N L G +P +   L+   + V  + N  
Sbjct: 549 LSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAV--AGNID 606

Query: 125 LCG--NILDLPSC---DTTKPATLFVEIFLPLTIVLSVIVFACLLLAKRKYKKPKLEERA 179
           LCG      LP C     T     ++   L   +VL+++ F  + +  R   + K   R 
Sbjct: 607 LCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELK---RV 663

Query: 180 TNNIDVFSIWNYDGR----IVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKV-FAL 234
            N    + +  +D +    I   D++ + ++ ++   I  G  G+ YK +     + F +
Sbjct: 664 ENEDGTWELQFFDSKVSKSITINDILSSLKEENV---ISRGKKGASYKGKSIKNGMQFVV 720

Query: 235 KKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLH 294
           K+++    +       +E   + ++ H NIVKL G C  +K  +LI+EY+E  +L   L 
Sbjct: 721 KEINDVNSIP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR 775

Query: 295 NNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT 354
           N      L W +R  I   +A AL +LH  CSP+++  ++S   I+++ K E  +     
Sbjct: 776 N------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL 828

Query: 355 ARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSL 414
             LL  D+      A    Y+APE   T  +TEK D+Y FG++ +E+L GK P D    +
Sbjct: 829 PGLLCTDTKCFISSA----YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV 884

Query: 415 SSS---------SDPKI-MLIDVLDQRLPPPVDRKVI---RDILLISTVSFACLQSNPKS 461
             S         SD  + M ID       P +   V     +I+ +  ++  C  ++P +
Sbjct: 885 HGSIVEWARYCYSDCHLDMWID-------PSIRGDVSVNQNEIVEVMNLALHCTATDPTA 937

Query: 462 RPTMQSVSQ 470
           RP    V +
Sbjct: 938 RPCANDVLK 946

Length = 968

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  160 bits (407), Expect = 6e-46
 Identities = 83/263 (31%), Positives = 121/263 (46%), Gaps = 16/263 (6%)

Query: 212 CIGTGGYGSVYKAQLPN-GKVFALKKLHTSEEL-AFIKSFKNEAQVLSQVLHRNIVKLYG 269
            +G+G +G+VYKA+    GK+ A+K L    E     ++ + E ++L ++ H NIV+L  
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               K  ++L+ EY E G LF  L        L   +   I   +   L YLH   S  I
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLH---SNGI 119

Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE--LAYTMVMTE 387
           IHRD+   NILL+      +ADFG A+ L   SS+ T   GT  Y+APE  L        
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY-GP 178

Query: 388 KCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLI 447
           K DV+S GV+  E+L GK P    + L    D   ++  +L   L     +         
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSGENIL----DQLQLIRRILGPPLEFDEPKWSSGSEEAK 234

Query: 448 STVSFACLQSNPKSRPTMQSVSQ 470
             +   CL  +P  RPT + + Q
Sbjct: 235 DLIK-KCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  158 bits (401), Expect = 1e-45
 Identities = 70/191 (36%), Positives = 106/191 (55%), Gaps = 8/191 (4%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           +G GG+G+VY A+    GK  A+K +   +  + ++    E ++L ++ H NIVKLYG  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
             +  ++L+ EY E GSL   L  NE   +L   + + I+  +   L YLH   S  IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLH---SNGIIH 115

Query: 332 RDISSNNILLNSK-LEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAYTMVMTEKC 389
           RD+   NILL+S   +  +ADFG ++LL +D S    + GT  Y+APE L      +EK 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175

Query: 390 DVYSFGVVTLE 400
           D++S GV+  E
Sbjct: 176 DIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  149 bits (380), Expect = 5e-42
 Identities = 76/281 (27%), Positives = 126/281 (44%), Gaps = 50/281 (17%)

Query: 213 IGTGGYGSVYKAQL------PNGKVFALKKL--HTSEELAFIKSFKNEAQVLSQVLHRNI 264
           +G G +G VYK  L         KV A+K L    SEE    + F  EA ++ ++ H NI
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKV-AVKTLKEGASEEE--REEFLEEASIMKKLSHPNI 63

Query: 265 VKLYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
           V+L G C   + ++++ EYM  G L  F  L  + + + L     + +   +A  + YL 
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLDF--LRKHGEKLTLKD--LLQMALQIAKGMEYLE 119

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI-----AP 377
              S + +HRD+++ N L+   L   ++DFG +R ++ D   R       G +     AP
Sbjct: 120 ---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR---KRGGGKLPIKWMAP 173

Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQ-----RL 432
           E       T K DV+SFGV+  E+           +L     P +   +VL+      RL
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIF----------TLGEQPYPGMSNEEVLELLEDGYRL 223

Query: 433 PPPVDR-KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           P P +    + +++L       C   +P+ RPT   + ++ 
Sbjct: 224 PRPENCPDELYELML------QCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  150 bits (380), Expect = 5e-42
 Identities = 76/275 (27%), Positives = 125/275 (45%), Gaps = 38/275 (13%)

Query: 213 IGTGGYGSVYKAQL----PNGKVF-ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G G +G VYK  L       +V  A+K L        I+ F  EA+++ ++ H NIVKL
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 268 YGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
            G C  ++ + ++ EYM  G L  +  L  N    EL  +  ++    +A  + YL    
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDY--LRKNRPK-ELSLSDLLSFALQIARGMEYLE--- 120

Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA-GTYGYIAPELAYTMV 384
           S + IHRD+++ N L+   L   ++DFG +R L+ D   +         ++APE      
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180

Query: 385 MTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLDQ-----RLPPPVD- 437
            T K DV+SFGV+  E+  +G+ P            P +   +VL+      RLP P + 
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPY-----------PGMSNAEVLEYLKKGYRLPKPPNC 229

Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
              +  ++L       C   +P+ RPT   + +  
Sbjct: 230 PPELYKLML------QCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  149 bits (380), Expect = 6e-42
 Identities = 77/275 (28%), Positives = 127/275 (46%), Gaps = 39/275 (14%)

Query: 213 IGTGGYGSVYKAQLPNGKVF-----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G G +G VYK +L           A+K L        I+ F  EA+++ ++ H N+VKL
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 268 YGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
            G C  ++ ++++ EYME G L  +  L  N    +L  +  ++    +A  + YL    
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSY--LRKNRP--KLSLSDLLSFALQIARGMEYLE--- 119

Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA-GTYGYIAPELAYTMV 384
           S + IHRD+++ N L+   L   ++DFG +R L+ D   R         ++APE      
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 385 MTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLDQ-----RLP-PPVD 437
            T K DV+SFGV+  E+  +G+ P            P +   +VL+      RLP PP  
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPY-----------PGMSNEEVLEYLKNGYRLPQPPNC 228

Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
              + D++L       C   +P+ RPT   + +  
Sbjct: 229 PPELYDLML------QCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  147 bits (373), Expect = 5e-41
 Identities = 85/272 (31%), Positives = 122/272 (44%), Gaps = 41/272 (15%)

Query: 206 DFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
            F+I   IG GG+G VYKA     GK  A+K +    +    +   NE Q+L +  H NI
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK-EKIINEIQILKKCKHPNI 59

Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN------IVKAMAHAL 318
           VK YG  L K  ++++ E+   GSL       +D ++    + +       + K +   L
Sbjct: 60  VKYYGSYLKKDELWIVMEFCSGGSL-------KDLLK-STNQTLTESQIAYVCKELLKGL 111

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
            YLH   S  IIHRDI + NILL S  E  + DFG +  L +D+  R  + GT  ++APE
Sbjct: 112 EYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL-SDTKARNTMVGTPYWMAPE 167

Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR 438
           +        K D++S G+  +E+  GK P          S+   M          PP  R
Sbjct: 168 VINGKPYDYKADIWSLGITAIELAEGKPPY---------SELPPMKALFKIATNGPPGLR 218

Query: 439 ------KVIRDILLISTVSFACLQSNPKSRPT 464
                    +D L        CLQ NP+ RPT
Sbjct: 219 NPEKWSDEFKDFLKK------CLQKNPEKRPT 244

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  141 bits (359), Expect = 6e-39
 Identities = 76/271 (28%), Positives = 118/271 (43%), Gaps = 45/271 (16%)

Query: 212 CIGTGGYGSVYKAQLP-NGKVFALKKLHTSEEL-AFIKSFKNEAQVLSQVLHRNIVKLYG 269
            +G G +GSVY A     G++ A+K +  S +    +++ + E ++LS + H NIV+ YG
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66

Query: 270 YCLHK-KCMFLIY-EYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHALAYLHH 323
               + K    I+ EY+  GSL   L       E  +     ++    + +   LAYLH 
Sbjct: 67  SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI-----RKY--TRQILEGLAYLH- 118

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH--ADSSNRTLLAGTYGYIAPELAY 381
             S  I+HRDI   NIL++S     +ADFG A+ L           + GT  ++APE+  
Sbjct: 119 --SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDP-----KIM---LIDVLDQRLP 433
                   D++S G   +E+  GK P       S   +P     KI        + + L 
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPP------WSELGNPMAALYKIGSSGEPPEIPEHLS 230

Query: 434 PPVDRKVIRDILLISTVSFACLQSNPKSRPT 464
                   +D L        CL+ +PK RPT
Sbjct: 231 E-----EAKDFLR------KCLRRDPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  140 bits (355), Expect = 2e-38
 Identities = 80/267 (29%), Positives = 119/267 (44%), Gaps = 25/267 (9%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
            D +    +G G  G VYK +  P GK++ALKK+H   +  F K    E + L       
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           +VK YG    +  + ++ EYM+ GSL   L       E   A    I + +   L YLH 
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY---IARQILKGLDYLHT 117

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL---- 379
                IIHRDI  +N+L+NSK E  +ADFG +++L           GT  Y++PE     
Sbjct: 118 K--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGE 175

Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKI--MLIDVLDQRLPPPVD 437
           +Y+       D++S G+  LE  +GK P            P    ++  + D   P    
Sbjct: 176 SYSY----AADIWSLGLTLLECALGKFP------FLPPGQPSFFELMQAICDGPPPSLPA 225

Query: 438 RKVIRDILLISTVSFACLQSNPKSRPT 464
            +   +      +S ACLQ +PK RP+
Sbjct: 226 EEFSPE--FRDFIS-ACLQKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  139 bits (354), Expect = 3e-38
 Identities = 74/283 (26%), Positives = 123/283 (43%), Gaps = 47/283 (16%)

Query: 213 IGTGGYGSVYKAQL---PNGKVF-ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           +G G +G VYK +L          A+K L         K F  EA+V+ ++ H N+V+L 
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62

Query: 269 GYCLHKKCMFLIYEYMERGSL------FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
           G C  ++ ++L+ EYME G L         +  + +   L     ++    +A  + YL 
Sbjct: 63  GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI-----AP 377
              S   +HRD+++ N L+   L   ++DFG +R ++ D   R     T G +     AP
Sbjct: 123 ---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRK---KTGGKLPIRWMAP 176

Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP------RDILSSLSSSSDPKIMLIDVLDQ 430
           E     + T K DV+SFGV+  E+  +G  P       ++L  L                
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK------------GY 224

Query: 431 RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           RLP P      + +++L      +C Q +P+ RPT   + +  
Sbjct: 225 RLPKPEYCPDELYELML------SCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  125 bits (316), Expect = 8e-33
 Identities = 72/265 (27%), Positives = 117/265 (44%), Gaps = 16/265 (6%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +D +    +G G  G V K    P GK+ A+K +      A  K    E  +L +     
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           IV  YG   +   + +  EYM+ GSL   L   +  +      ++ +  A+   L YLH 
Sbjct: 61  IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAV--AVLKGLTYLHE 118

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
                IIHRD+  +NIL+NS+ +  + DFG +  L  +S  +T   GT  Y+APE     
Sbjct: 119 KH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKT-FVGTSSYMAPERIQGN 174

Query: 384 VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRL--PPPVDRKVI 441
             + K D++S G+  +E+  G+ P          +DP   + ++L   +  PPP      
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFP------YPPENDPPDGIFELLQYIVNEPPPRLPSGK 228

Query: 442 RDILLISTVSFACLQSNPKSRPTMQ 466
                   V+  CL  +P+ RP+ +
Sbjct: 229 FSPDFQDFVN-LCLIKDPRERPSYK 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  124 bits (314), Expect = 3e-32
 Identities = 72/261 (27%), Positives = 119/261 (45%), Gaps = 27/261 (10%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G  G VYKA     GK  A+KK+   ++    +   NE  ++    H NIV  Y   
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQN--KELIINEILIMKDCKHPNIVDYYDSY 84

Query: 272 LHKKCMFLIYEYMERGSL-----FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
           L    ++++ EYM+ GSL        +  NE  +         + + +   L YLH   S
Sbjct: 85  LVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQI-------AYVCREVLQGLEYLH---S 134

Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMT 386
            ++IHRDI S+NILL+      +ADFG A  L  + S R  + GT  ++APE+       
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYG 194

Query: 387 EKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL 446
            K D++S G++ +E+  G+ P           +P +  + ++  +  PP+          
Sbjct: 195 PKVDIWSLGIMCIEMAEGEPPY--------LREPPLRALFLITTKGIPPLKNPEKWSPEF 246

Query: 447 ISTVSFACLQSNPKSRPTMQS 467
              ++  CL  +P+ RP+ + 
Sbjct: 247 KDFLNK-CLVKDPEKRPSAEE 266

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  122 bits (310), Expect = 5e-32
 Identities = 78/283 (27%), Positives = 127/283 (44%), Gaps = 39/283 (13%)

Query: 206 DFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRN 263
            ++I   IG G +G VY  +   +GK++ LK++  S       +   NE ++L ++ H N
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLF--------CNLHNNEDAVELDWAKRVNIVKAMA 315
           I+K Y     K  + ++ EY + G L               E+ + LDW   V +     
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI-LDWF--VQLCL--- 114

Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI 375
            AL YLH   S  I+HRDI   NI L S     + DFG +++L +       + GT  Y+
Sbjct: 115 -ALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYL 170

Query: 376 APEL----AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQR 431
           +PEL     Y      K D++S G V  E+   KHP +         +  + L   + + 
Sbjct: 171 SPELCQNKPY----NYKSDIWSLGCVLYELCTLKHPFE--------GENLLELALKILKG 218

Query: 432 LPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI 474
             PP+  +   +  L + VS + LQ +P+ RP++  + Q   I
Sbjct: 219 QYPPIPSQYSSE--LRNLVS-SLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  124 bits (310), Expect = 3e-31
 Identities = 84/284 (29%), Positives = 128/284 (45%), Gaps = 19/284 (6%)

Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEEL--AFIKSFKNEAQVLSQVLH-R 262
            + I   +G G +G VY A+    K+ ALK L    E     ++ F  E Q+L+ + H  
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
           NIVKLY +   +  ++L+ EY++ GSL   L        L  ++ + I+  +  AL YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFV-ADFGTARLLHADSSNRTLLA------GTYGYI 375
              S  IIHRDI   NILL+         DFG A+LL    S  ++ A      GT GY+
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 376 APELAYTMV---MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSD-PKIMLIDVLDQR 431
           APE+   +     +   D++S G+   E+L G  P +   + S++S   KI+L       
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235

Query: 432 LPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             P             S +    L  +PK+R +  S     L+ 
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279

Length = 384

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  119 bits (300), Expect = 1e-30
 Identities = 76/256 (29%), Positives = 112/256 (43%), Gaps = 21/256 (8%)

Query: 212 CIGTGGYGSVYKA-QLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYG 269
            IG G +G VYK   L  G   A+K++   + +   +KS   E  +L  + H NIVK  G
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
                  +++I EY E GSL   +       E   A     V  +   LAYLH      +
Sbjct: 67  SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAV---YVYQVLQGLAYLH---EQGV 120

Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKC 389
           IHRDI + NIL        +ADFG A  L+  S +   + GT  ++APE+      +   
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTAS 180

Query: 390 DVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD-RKVIRDILLIS 448
           D++S G   +E+L G  P   L+ ++       +   V D   P P      ++D L+  
Sbjct: 181 DIWSLGCTVIELLTGNPPYYDLNPMA------ALFRIVQDDHPPLPEGISPELKDFLM-- 232

Query: 449 TVSFACLQSNPKSRPT 464
                C Q +P  RPT
Sbjct: 233 ----QCFQKDPNLRPT 244

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  118 bits (297), Expect = 2e-30
 Identities = 78/266 (29%), Positives = 129/266 (48%), Gaps = 29/266 (10%)

Query: 206 DFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHRN 263
           DF+I   IG G +G V+K  +  + +V+A+K++  S+     +    +EA+VL+++    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNN------EDAVELDWAKRVNIVKAMAHA 317
           I++ Y   L K  + ++ EY E G L   L         ED V   W   + I+      
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQV---WRFFIQILLG---- 113

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           LA+LH   S  I+HRDI S N+ L++     + D G A+LL  +++    + GT  Y++P
Sbjct: 114 LAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSP 170

Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD 437
           EL       EK DV++ GVV  E   GKHP D        ++ +  LI  + + + PPV 
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFD--------ANNQGALILKIIRGVFPPVS 222

Query: 438 RKVIRDILLISTVSFACLQSNPKSRP 463
           +   + +  +      CL  + + RP
Sbjct: 223 QMYSQQLAQLID---QCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  114 bits (289), Expect = 3e-29
 Identities = 73/260 (28%), Positives = 119/260 (45%), Gaps = 35/260 (13%)

Query: 213 IGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAF--IKSFKNEAQVLSQVLHRNIVKLYG 269
           +G G +G V   +  + GK++A+K L   + +    ++    E  +LS++ H  IVKL+ 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 270 YCLH-KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
           Y    ++ ++L+ EY   G LF +  + E     + A+       +  AL YLH   S  
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELF-SHLSKEGRFSEERARF--YAAEIVLALEYLH---SLG 113

Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL----AYTMV 384
           II+RD+   NILL++     + DFG A+ L ++ S      GT  Y+APE+     Y   
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173

Query: 385 MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRL--PPPVDRKVIR 442
                D +S GV+  E+L GK P         + D K +   +L   L  P  +  +  R
Sbjct: 174 ----VDWWSLGVLLYEMLTGKPPFY-------AEDRKEIYEKILKDPLRFPEFLSPEA-R 221

Query: 443 DILLISTVSFACLQSNPKSR 462
           D++         LQ +P  R
Sbjct: 222 DLIS------GLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  115 bits (290), Expect = 4e-29
 Identities = 86/299 (28%), Positives = 131/299 (43%), Gaps = 51/299 (17%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKL---HTSEELAFIKSFKNEAQVLSQVL 260
           E F +  CIG G +G VYKA      +V A+K +      +E+  I+    E Q LSQ  
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQ---QEIQFLSQCR 57

Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMA 315
              I K YG  L    +++I EY   GS         L     A          I++ + 
Sbjct: 58  SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF---------ILREVL 108

Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI 375
             L YLH +     IHRDI + NILL+ + +  +ADFG +  L +  S R    GT  ++
Sbjct: 109 LGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWM 165

Query: 376 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDP-KIMLIDVLDQRLPP 434
           APE+       EK D++S G+  +E+  G+ P        S   P +++   ++ +  PP
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKGEPPL-------SDLHPMRVLF--LIPKNNPP 216

Query: 435 PVDR----KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDI 489
            ++     K  +D      VS  CL  +PK RP+    ++E L   K   +K A     
Sbjct: 217 SLEGNKFSKPFKDF-----VS-LCLNKDPKERPS----AKELL---KHKFIKKAKKTSY 262

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  112 bits (282), Expect = 4e-28
 Identities = 68/210 (32%), Positives = 100/210 (47%), Gaps = 19/210 (9%)

Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           E FDI   +G G YGSVYKA     G+V A+K +   E+   ++    E  +L Q     
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPY 59

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSL-----FCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
           IVK YG       ++++ EY   GS+       N    E+ +         I+      L
Sbjct: 60  IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA-------ILYQTLKGL 112

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
            YLH   S   IHRDI + NILLN + +A +ADFG +  L    + R  + GT  ++APE
Sbjct: 113 EYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPE 169

Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHPR 408
           +   +    K D++S G+  +E+  GK P 
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGKPPY 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  112 bits (282), Expect = 5e-28
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 29/220 (13%)

Query: 206 DFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLH-----TSEELAFIKSFKNEAQVLSQV 259
           D+++   IG G +G+V K +   +GK+   K++        E+   +    +E  +L ++
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV----SEVNILREL 56

Query: 260 LHRNIVKLYGYCLHK--KCMFLIYEYMERGSLFCNLHN--------NEDAVELDWAKRVN 309
            H NIV+ Y   + +  + ++++ EY E G L   +           E+ +   W     
Sbjct: 57  KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI---W----R 109

Query: 310 IVKAMAHALAYLHH--DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL 367
           I+  +  AL   H+  D   +++HRD+   NI L++     + DFG A++L  DSS    
Sbjct: 110 ILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT 169

Query: 368 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
             GT  Y++PE    M   EK D++S G +  E+     P
Sbjct: 170 YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 7e-28
 Identities = 80/283 (28%), Positives = 123/283 (43%), Gaps = 55/283 (19%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALK--KLHTSEELAFIKSFKNEAQVLSQVLH 261
           ED+++   IG+G YG VYKA+ +  G++ A+K  KL   ++   I   + E  +L +  H
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEII---QQEISMLKECRH 59

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH----- 316
            NIV  +G  L +  ++++ EY   GSL          +             +A+     
Sbjct: 60  PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL---------QIAYVCRET 110

Query: 317 --ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGY 374
              LAYLH       IHRDI   NILL    +  +ADFG +  L A  + R    GT  +
Sbjct: 111 LKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYW 167

Query: 375 IAPELA-------YTMVMTEKCDVYSFGVVTLEVLMGK------HPRDILSSLSSSSDPK 421
           +APE+A       Y      KCD+++ G+  +E+   +      HP   L  +S S+ P 
Sbjct: 168 MAPEVAAVERKGGY----DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP- 222

Query: 422 IMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPT 464
                      PP +  K     +    +   CL  +PK RPT
Sbjct: 223 -----------PPKLKDKEKWSPVFHDFIK-KCLTKDPKKRPT 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  110 bits (278), Expect = 1e-27
 Identities = 87/276 (31%), Positives = 124/276 (44%), Gaps = 53/276 (19%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           IG G +G VY A  L  G++ A+K++     +   IK   +E +VL  + H N+VK YG 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH----ALAYLHHDCS 326
            +H++ +++  EY   G+L       E+ +E       ++++         LAYLH   S
Sbjct: 68  EVHREKVYIFMEYCSGGTL-------EELLEHGRILDEHVIRVYTLQLLEGLAYLH---S 117

Query: 327 PSIIHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNRTL-------LAGTYGYI 375
             I+HRDI   NI L+     KL     DFG A  L    +N T        LAGT  Y+
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKL----GDFGCAVKL---KNNTTTMGEEVQSLAGTPAYM 170

Query: 376 APELAYTMVMTEK---CDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRL 432
           APE+             D++S G V LE+  GK P   L +        IM    +    
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-----IMF--HVGAGH 223

Query: 433 PPPVDRKVIRDILLIST--VSF--ACLQSNPKSRPT 464
            PP     I D L +S     F   CL+S+PK RPT
Sbjct: 224 KPP-----IPDSLQLSPEGKDFLDRCLESDPKKRPT 254

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  110 bits (276), Expect = 3e-27
 Identities = 80/271 (29%), Positives = 124/271 (45%), Gaps = 39/271 (14%)

Query: 213 IGTGGYGSVYKA--QLPNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG G +G V +   +LP  K    A+K L           F  EA ++ Q  H NI++L 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
           G     + + +I EYME GSL   L  N+   +    + V +++ +A  + YL       
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMNY-- 127

Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG--YIAPE-LAYTMVM 385
            +HRD+++ NIL+NS L   V+DFG +R L    +  T   G     + APE +AY    
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR-KF 185

Query: 386 TEKCDVYSFGVVTLEVL-MGKHP------RDILSSLSSSSDPKIMLIDVLDQRLPPPVD- 437
           T   DV+SFG+V  EV+  G+ P      +D++ ++                RLPPP+D 
Sbjct: 186 TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED------------GYRLPPPMDC 233

Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
              +  ++L       C Q +   RPT   +
Sbjct: 234 PSALYQLML------DCWQKDRNERPTFSQI 258

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  109 bits (275), Expect = 3e-27
 Identities = 74/281 (26%), Positives = 132/281 (46%), Gaps = 48/281 (17%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           ++  +   IG G +G V        KV A+K L   ++    ++F  EA V++ + H N+
Sbjct: 6   KELKLGATIGKGEFGDVMLGDYRGQKV-AVKCL--KDDSTAAQAFLAEASVMTTLRHPNL 62

Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+L G  L    ++++ EYM +GSL   L +   AV +  A+++     +   + YL   
Sbjct: 63  VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLE-- 119

Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAYT 382
              + +HRD+++ N+L++  L A V+DFG A+      +++   +G     + APE    
Sbjct: 120 -EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALRE 173

Query: 383 MVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLDQ-----RL---- 432
              + K DV+SFG++  E+   G+ P            P+I L DV+       R+    
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPY-----------PRIPLKDVVPHVEKGYRMEAPE 222

Query: 433 --PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQE 471
             PP V  KV++D          C + +P  RPT + + ++
Sbjct: 223 GCPPEV-YKVMKD----------CWELDPAKRPTFKQLREQ 252

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  109 bits (274), Expect = 6e-27
 Identities = 81/279 (29%), Positives = 125/279 (44%), Gaps = 41/279 (14%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +D+++   IG G    VY A  LPN +  A+K++   +    +   + E Q +SQ  H N
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           +VK Y   +    ++L+  Y+  GSL   + ++     LD A    ++K +   L YLH 
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH- 119

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN----RTLLAGTYGYIAPEL 379
             S   IHRDI + NILL       +ADFG +  L          R    GT  ++APE 
Sbjct: 120 --SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE- 176

Query: 380 AYTMVMTE------KCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLP 433
               VM +      K D++SFG+  +E+  G  P    S        K++++ +  Q  P
Sbjct: 177 ----VMEQVHGYDFKADIWSFGITAIELATGAAP---YSKYPPM---KVLMLTL--QNDP 224

Query: 434 PPVDR--------KVIRDILLISTVSFACLQSNPKSRPT 464
           P ++         K  R   +IS     CLQ +P  RPT
Sbjct: 225 PSLETGADYKKYSKSFRK--MISL----CLQKDPSKRPT 257

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  107 bits (270), Expect = 1e-26
 Identities = 70/263 (26%), Positives = 115/263 (43%), Gaps = 27/263 (10%)

Query: 207 FDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRN 263
           F++   IG G +G V   Q     K+FA+K ++  +  E   +++  NE ++L ++ H  
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNL----HNNEDAVELDWAKRVNIVKAMAHALA 319
           +V L+     ++ M+L+ + +  G L  +L      +E+ V+         +  +  AL 
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-------WICEIVLALE 114

Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           YLH   S  IIHRDI  +NILL+ +    + DF  A  +  D +  T  +GT GY+APE+
Sbjct: 115 YLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD-TLTTSTSGTPGYMAPEV 170

Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK 439
                 +   D +S GV   E L GK P    S        +I         L P     
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD---QIRAKQETADVLYPATWST 227

Query: 440 VIRDILLISTVSFACLQSNPKSR 462
              D +         L+ +P+ R
Sbjct: 228 EAIDAIN------KLLERDPQKR 244

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  106 bits (267), Expect = 6e-26
 Identities = 73/296 (24%), Positives = 123/296 (41%), Gaps = 52/296 (17%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALK---KLHTSEELAFIKSFKNEAQVLSQV- 259
           +DF     IG G + +V  A+     K +A+K   K    +E   +K  K E +VL+++ 
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKK-VKYVKIEKEVLTRLN 59

Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H  I+KLY     ++ ++ + EY   G L   +        LD          +  AL 
Sbjct: 60  GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLALE 116

Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA---------- 369
           YLH   S  IIHRD+   NILL+  +   + DFGTA++L  +SS  +             
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 370 ----------GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSD 419
                     GT  Y++PEL       +  D+++ G +  ++L GK P         S++
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP------FRGSNE 227

Query: 420 P----KIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQE 471
                KI+ ++       PP  + +I  +L++          +P+ R  +     E
Sbjct: 228 YLTFQKILKLEYSFPPNFPPDAKDLIEKLLVL----------DPQDRLGVNEGYDE 273

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  105 bits (264), Expect = 1e-25
 Identities = 79/288 (27%), Positives = 127/288 (44%), Gaps = 51/288 (17%)

Query: 213 IGTGGYGSVYKAQ-LPNGK----VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K L         K   +EA V++ V H ++V+L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYL-- 321
            G CL  +   LI + M  G L   + N++D +     L+W   V I K M+    YL  
Sbjct: 75  LGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYLLNWC--VQIAKGMS----YLEE 127

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPEL 379
                  ++HRD+++ N+L+ +     + DFG A+LL  D        G     ++A E 
Sbjct: 128 KR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182

Query: 380 AYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLD-----QRLP 433
               + T K DV+S+GV   E++  G  P +            I  +++ D     +RLP
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYE-----------GIPAVEIPDLLEKGERLP 231

Query: 434 PPVDRKVIRDILLIST--VSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
            P        I  I    V   C   + +SRPT + +  EF    + P
Sbjct: 232 QP-------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 2e-25
 Identities = 84/289 (29%), Positives = 135/289 (46%), Gaps = 32/289 (11%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLH---RNIVKLY 268
           IG G YG+VY+   +P G+V ALK ++       +   + E  +LSQ+      NI K Y
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
           G  L    +++I EY E GS+   +     A  +       I++ +  AL Y+H      
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKV---G 121

Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTE- 387
           +IHRDI + NIL+ +     + DFG A LL+ +SS R+   GT  ++APE+       + 
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDT 181

Query: 388 KCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLI-DVLDQRLPPPVDRKVIRDILL 446
           K D++S G+   E+  G  P   + +  +     +MLI      RL      K++R+ + 
Sbjct: 182 KADIWSLGITIYEMATGNPPYSDVDAFRA-----MMLIPKSKPPRLEDNGYSKLLREFVA 236

Query: 447 ISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVK-HAAIQDISISEL 494
                 ACL   PK R +    ++E L   K+  +K H+      + EL
Sbjct: 237 ------ACLDEEPKERLS----AEELL---KSKWIKAHSKTPVSILKEL 272

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  103 bits (259), Expect = 5e-25
 Identities = 82/268 (30%), Positives = 132/268 (49%), Gaps = 32/268 (11%)

Query: 209 IRYCIGTGGYGSVYKAQL-PNGK---VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           I   IG G +G V + +L   GK     A+K L +       + F +EA ++ Q  H NI
Sbjct: 8   IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67

Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           + L G     + + +I E+ME G+L   L  N+   +    + V +++ +A  + YL   
Sbjct: 68  IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYL--- 122

Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI-----APEL 379
              + +HRD+++ NIL+NS L   V+DFG +R L  D+S+ T  +   G I     APE 
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182

Query: 380 AYTMVMTEKCDVYSFGVVTLEVL-MGKHPR-DILSSLSSSSDPKIMLIDVLDQ--RLPPP 435
                 T   DV+S+G+V  EV+  G+ P  D+     S+ D    +I+ ++Q  RLPPP
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-----SNQD----VINAIEQDYRLPPP 233

Query: 436 VDRKVIRDILLISTVSFACLQSNPKSRP 463
           +D       L++      C Q +  +RP
Sbjct: 234 MDCPTALHQLMLD-----CWQKDRNARP 256

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  103 bits (260), Expect = 6e-25
 Identities = 65/205 (31%), Positives = 98/205 (47%), Gaps = 24/205 (11%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           IG G YG VYKA+    G++ ALKK+    E+  F  +   E ++L ++ H NIV+L   
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 271 CLHKKC--MFLIYEYMER--GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
              K    +++++EYM+     L   L + E        K    +K +   L YLH +  
Sbjct: 67  VTSKGKGSIYMVFEYMDHDLTGL---LDSPEVKFTESQIKC--YMKQLLEGLQYLHSN-- 119

Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR-TLLAGTYGYIAPEL-----A 380
             I+HRDI  +NIL+N+     +ADFG AR     +S   T    T  Y  PEL      
Sbjct: 120 -GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATR 178

Query: 381 YTMVMTEKCDVYSFGVVTLEVLMGK 405
           Y      + D++S G +  E+ +GK
Sbjct: 179 Y----GPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 6e-25
 Identities = 71/262 (27%), Positives = 126/262 (48%), Gaps = 29/262 (11%)

Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLH--TSEELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G G +G V++    N    A+K L   T +   F+     EAQ++ ++ H  +++LY  
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLA----EAQIMKKLRHPKLIQLYAV 69

Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
           C  ++ ++++ E M+ GSL   L        L   + +++   +A  +AYL    + + I
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLE---AQNYI 125

Query: 331 HRDISSNNILLNSKLEAFVADFGTARLLHADSSN-RTLLAGTYGYIAPELAYTMVMTEKC 389
           HRD+++ N+L+       VADFG AR++  D    R        + APE A     + K 
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185

Query: 390 DVYSFGVVTLE-VLMGKHPRDILSSLSSSSDPKIMLIDVLDQ--RLPPPVD-RKVIRDIL 445
           DV+SFG++  E V  G+ P   +++          ++  +DQ  R+P P    K + DI+
Sbjct: 186 DVWSFGILLTEIVTYGRMPYPGMTNAE--------VLQQVDQGYRMPCPPGCPKELYDIM 237

Query: 446 LISTVSFACLQSNPKSRPTMQS 467
           L       C + +P  RPT ++
Sbjct: 238 L------DCWKEDPDDRPTFET 253

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  104 bits (262), Expect = 9e-25
 Identities = 79/284 (27%), Positives = 127/284 (44%), Gaps = 46/284 (16%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG+G  G+VYK    P G+++ALK ++ + E    +    E ++L  V H N+VK +   
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141

Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
            H   + ++ E+M+ GSL    H  ++    D A+++         +AYLH      I+H
Sbjct: 142 DHNGEIQVLLEFMDGGSLE-GTHIADEQFLADVARQI------LSGIAYLH---RRHIVH 191

Query: 332 RDISSNNILLNSKLEAFVADFGTARLLHA--DSSNRTLLAGTYGYIAPELAYTMVMTEKC 389
           RDI  +N+L+NS     +ADFG +R+L    D  N ++  GT  Y++PE   T +     
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV--GTIAYMSPERINTDLNHGAY 249

Query: 390 -----DVYSFGVVTLEVLMGKHP---------RDILSSLSSSSDPKIMLIDVLDQRLPPP 435
                D++S GV  LE  +G+ P           ++ ++  S  P+            P 
Sbjct: 250 DGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPE-----------APA 298

Query: 436 VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
              +  R    IS     CLQ  P  R +   + Q   I R  P
Sbjct: 299 TASREFRH--FIS----CCLQREPAKRWSAMQLLQHPFILRAQP 336

Length = 353

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 2e-24
 Identities = 81/277 (29%), Positives = 123/277 (44%), Gaps = 44/277 (15%)

Query: 213 IGTGGYGSVYKA--QLPNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           +G G +GSV K    + +GK    A+K L      A  K F  EA V++Q+ H  IV+L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELD---WAKRVNIVKAMAHALAYLHHDC 325
           G C  +  M L+ E    G L   L    +    D    A +V      A  +AYL    
Sbjct: 63  GVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLE--- 112

Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG-----YIAPELA 380
           S   +HRD+++ N+LL ++ +A ++DFG +R L A S      A T G     + APE  
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR--ATTAGRWPLKWYAPECI 170

Query: 381 YTMVMTEKCDVYSFGVVTLEVL-MGKHP-RDILSSLSSSSDPKIMLIDVLDQ--RLP-PP 435
                + K DV+S+GV   E    G  P  ++          +++   +L+   RLP P 
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-------KGAEVI--AMLESGERLPRPE 221

Query: 436 VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
              + I  I+L      +C +  P+ RPT   +   F
Sbjct: 222 ECPQEIYSIML------SCWKYRPEDRPTFSELESTF 252

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  101 bits (253), Expect = 3e-24
 Identities = 68/268 (25%), Positives = 125/268 (46%), Gaps = 36/268 (13%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKL-----HTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +GTG + S Y+A+ +  G + A+K++      +SE+   +++ + E ++++++ H +I++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNN---EDAVELDWAKRVNIVKAMAHALAYLHH 323
           + G         L  E+M  GS+   L      ++AV       +N  + +   L+YLH 
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI------INYTEQLLRGLSYLHE 121

Query: 324 DCSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTL----LAGTYGYIAPE 378
           +    IIHRD+   N+L++S  +   +ADFG A  L A  +        L GT  ++APE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD- 437
           +         CDV+S G V +E+   K P +        S+   ++  +      P +  
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA----EKHSNHLALIFKIASATTAPSIPE 234

Query: 438 --RKVIRDILLISTVSFACLQSNPKSRP 463
                +RD+ L       CL+  P+ RP
Sbjct: 235 HLSPGLRDVTL------RCLELQPEDRP 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  100 bits (250), Expect = 9e-24
 Identities = 83/277 (29%), Positives = 141/277 (50%), Gaps = 35/277 (12%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E+F +   +G+G +G V++    N    A+K L  S++L   + F+ E Q L ++ H+++
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKIL-KSDDLLKQQDFQKEVQALKRLRHKHL 64

Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           + L+  C   + +++I E ME+GSL   L + E  V L  A  +++   +A  +AYL   
Sbjct: 65  ISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLE-- 121

Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD---SSNRTLLAGTYGYIAPELAY 381
              + IHRD+++ NIL+   L   VADFG ARL+  D   SS++ +    Y + APE A 
Sbjct: 122 -EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI---PYKWTAPEAAS 177

Query: 382 TMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ-----RLP-P 434
               + K DV+SFG++  E+   G+ P            P +   +V DQ     R+P P
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQVPY-----------PGMNNHEVYDQITAGYRMPCP 226

Query: 435 PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQE 471
               + I  I+L       C  + P+ RP+ +++ +E
Sbjct: 227 AKCPQEIYKIML------ECWAAEPEDRPSFKALREE 257

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 99.5 bits (248), Expect = 1e-23
 Identities = 80/279 (28%), Positives = 128/279 (45%), Gaps = 38/279 (13%)

Query: 206 DFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           D  +++ +G G YG VY+          A+K L   E+   ++ F  EA V+ ++ H N+
Sbjct: 7   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 64

Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+L G C  +   ++I E+M  G+L   L    +  E++    + +   ++ A+ YL   
Sbjct: 65  VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLE-- 121

Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIAPE-LA 380
              + IHRD+++ N L+       VADFG +RL+  D+   T  AG      + APE LA
Sbjct: 122 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLA 178

Query: 381 YTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDV---LDQ--RL--P 433
           Y      K DV++FGV+  E+          ++   S  P I L  V   L++  R+  P
Sbjct: 179 YNKFSI-KSDVWAFGVLLWEI----------ATYGMSPYPGIDLSQVYELLEKGYRMERP 227

Query: 434 PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
                KV   +        AC Q NP  RP+   + Q F
Sbjct: 228 EGCPPKVYELMR-------ACWQWNPSDRPSFAEIHQAF 259

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 98.2 bits (245), Expect = 4e-23
 Identities = 74/283 (26%), Positives = 110/283 (38%), Gaps = 51/283 (18%)

Query: 213 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           +G G +G V + +     GKV   A+K L + +    +  F  EA ++  + H N+++LY
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDA-----VELDWAKRVNIVKAMAHALAYLHH 323
           G  L    M ++ E    GSL   L  +           D+A  V I   M     YL  
Sbjct: 63  GVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYA--VQIANGMR----YLE- 114

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL------HADSSNRTLLAGTYGYIAP 377
             S   IHRD+++ NILL S  +  + DFG  R L      +    +  +    + + AP
Sbjct: 115 --SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV---PFAWCAP 169

Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP------RDILSSLSSSSDPKIMLIDVLDQ 430
           E   T   +   DV+ FGV   E+   G+ P        IL             ID   +
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILK-----------KIDKEGE 218

Query: 431 RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
           RL  P           I  V   C   NP  RPT  ++ +   
Sbjct: 219 RLERPEACP-----QDIYNVMLQCWAHNPADRPTFAALREFLP 256

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 98.7 bits (246), Expect = 4e-23
 Identities = 77/297 (25%), Positives = 134/297 (45%), Gaps = 52/297 (17%)

Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL 272
           +G G +G VYKAQ     +FA  K+   E    ++ F  E  +LS+  H NIV LY    
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 273 HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN------IVKAMAHALAYLHHDCS 326
           ++  ++++ E+ + G+L        D++ L+  + +       + + M  AL +LH   S
Sbjct: 73  YENKLWILIEFCDGGAL--------DSIMLELERGLTEPQIRYVCRQMLEALNFLH---S 121

Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMT 386
             +IHRD+ + NILL    +  +ADFG +    +    R    GT  ++APE+    V  
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEV----VAC 177

Query: 387 E---------KCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD 437
           E         K D++S G+  +E+   + P   L+       P  +L+ +L    PP +D
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN-------PMRVLLKILKSE-PPTLD 229

Query: 438 R-----KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDI 489
           +         D L        CL  +P  RPT   + +   ++ ++    + AI+D+
Sbjct: 230 QPSKWSSSFNDFLKS------CLVKDPDDRPTAAELLKHPFVSDQS---DNKAIKDL 277

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 97.8 bits (244), Expect = 6e-23
 Identities = 83/273 (30%), Positives = 135/273 (49%), Gaps = 40/273 (14%)

Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLH--TSEELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G G +G V+          A+K L   T    AF++    EAQ++ ++ H  +V+LY  
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQ----EAQIMKKLRHDKLVQLYAV 69

Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
           C  ++ ++++ EYM +GSL   L + E   +L   + V++   +A  +AYL    S + I
Sbjct: 70  CSEEEPIYIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLE---SRNYI 125

Query: 331 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI---APELAYTMVMTE 387
           HRD+++ NIL+   L   +ADFG ARL+  D    T   G    I   APE A     T 
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEY--TAREGAKFPIKWTAPEAANYGRFTI 183

Query: 388 KCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKV 440
           K DV+SFG++  E++  G+ P            P +   +VL+Q     R+P P +  + 
Sbjct: 184 KSDVWSFGILLTEIVTYGRVPY-----------PGMTNREVLEQVERGYRMPRPPNCPEE 232

Query: 441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
           + D++L       C   +P+ RPT + + Q FL
Sbjct: 233 LYDLML------QCWDKDPEERPTFEYL-QSFL 258

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 97.5 bits (243), Expect = 1e-22
 Identities = 75/282 (26%), Positives = 124/282 (43%), Gaps = 46/282 (16%)

Query: 213 IGTGGYGSVYKAQLPNGK------VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G V+  +  + +      + A+K L  +      K F+ EA++L+   H NIVK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 267 LYGYCLHKKCMFLIYEYMERGSL--FCNLH---------NNEDAVELDWAKRVNIVKAMA 315
            YG C       +++EYME G L  F   H          +    EL  ++ + I   +A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR----TLLAGT 371
             + YL    S   +HRD+++ N L+   L   + DFG +R ++     R    T+L   
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP-- 187

Query: 372 YGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLD 429
             ++ PE + Y    TE  DV+SFGVV  E+   GK P   LS+          +I+ + 
Sbjct: 188 IRWMPPESIMYRKFTTES-DVWSFGVVLWEIFTYGKQPWYGLSNEE--------VIECIT 238

Query: 430 QRL---PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
           Q      P      + DI+L       C + +P+ R  ++ +
Sbjct: 239 QGRLLQRPRTCPSEVYDIML------GCWKRDPQQRINIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 97.0 bits (241), Expect = 1e-22
 Identities = 72/233 (30%), Positives = 114/233 (48%), Gaps = 19/233 (8%)

Query: 213 IGTGGYGSVYKA--QLPNGK--VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG G +G V++   ++P  K    A+K L         + F +EA ++ Q  H NI++L 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
           G     K   +I EYME G+L   L +++   E    + V +++ +A  + YL      +
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYL---SDMN 127

Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG---TYGYIAPELAYTMVM 385
            +HRD+++ NIL+NS LE  V+DFG +R+L  D       +G      + APE       
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187

Query: 386 TEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD 437
           T   DV+SFG+V  EV+  G+ P          S+ ++M       RLP P+D
Sbjct: 188 TSASDVWSFGIVMWEVMSFGERP------YWDMSNHEVMKAINDGFRLPAPMD 234

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  100 bits (250), Expect = 3e-22
 Identities = 63/141 (44%), Positives = 80/141 (56%), Gaps = 16/141 (11%)

Query: 4   IGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMK 63
            G IP  +GNLKNL  L +  N L GPIP ++ SL  L +LDLS N LSG+IP  +  ++
Sbjct: 249 TGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQ 308

Query: 64  YLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFS---NNDLSSMHTVVSLS 120
            L  L L +NN  G IP  +T L RL  L L SNK SG +P +   +N+L    TV+ LS
Sbjct: 309 NLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNL----TVLDLS 364

Query: 121 PNN-------GLC--GNILDL 132
            NN       GLC  GN+  L
Sbjct: 365 TNNLTGEIPEGLCSSGNLFKL 385

Length = 968

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 96.3 bits (240), Expect = 3e-22
 Identities = 72/282 (25%), Positives = 122/282 (43%), Gaps = 35/282 (12%)

Query: 213 IGTGGYGSVYKAQLPN-----GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G G +G V   +        G+  A+K L+ S E      F+ E ++L  + H NIVK 
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 268 YGYC--LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
            G C     + + LI EY+  GSL   L  + D  +++  + +     +   + YL    
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLG--- 126

Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS------SNRTLLAGTYGYIAPEL 379
           S   IHRD+++ NIL+ S+    ++DFG A++L  D                Y   APE 
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY---APEC 183

Query: 380 AYTMVMTEKCDVYSFGVVTLEVL-MGKH----PRDILSSLSSSSDPKIM--LIDVLD--Q 430
             T   +   DV+SFGV   E+   G      P + L  +  +    I+  L+++L   +
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243

Query: 431 RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           RLP P       ++  +  +   C ++ P+ RP+   +    
Sbjct: 244 RLPRP--PSCPDEVYDLMKL---CWEAEPQDRPSFADLILIV 280

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 99.2 bits (247), Expect = 6e-22
 Identities = 49/110 (44%), Positives = 73/110 (66%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
           G IP +IG+  +L  LD+G N L+G IP++L +LT+L  L L+SN+L G+IP E+  MK 
Sbjct: 154 GEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKS 213

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMH 114
           L  + L  NN+ G IP EI  L+ L++L+L  N L+GP+P S  +L ++ 
Sbjct: 214 LKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQ 263

Length = 968

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 95.2 bits (237), Expect = 7e-22
 Identities = 83/305 (27%), Positives = 133/305 (43%), Gaps = 43/305 (14%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           ED +    +G G  GSV K + +P G V A K +H   + +  K    E Q++ +     
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPY 64

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK-RVNIV----KAMAHAL 318
           IV  YG  L++  + +  E+M+ GSL        D +        V I+     A+   L
Sbjct: 65  IVSFYGAFLNENNICMCMEFMDCGSL--------DRIYKKGGPIPVEILGKIAVAVVEGL 116

Query: 319 AYL---HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI 375
            YL   H      I+HRDI  +NIL+NS+ +  + DFG +  L  +S   T + GT  Y+
Sbjct: 117 TYLYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGEL-INSIADTFV-GTSTYM 169

Query: 376 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQ----- 430
           +PE       T K DV+S G+  +E+ +GK P    +      D  + ++D+L Q     
Sbjct: 170 SPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP 229

Query: 431 --RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQD 488
             RLP     + +RD +        CL  +P  RPT Q       +    P ++     +
Sbjct: 230 PPRLPSSDFPEDLRDFVDA------CLLKDPTERPTPQ------QLCAMPPFIQALRASN 277

Query: 489 ISISE 493
           + +  
Sbjct: 278 VDLQA 282

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 95.0 bits (237), Expect = 7e-22
 Identities = 80/292 (27%), Positives = 116/292 (39%), Gaps = 50/292 (17%)

Query: 200 LIEATEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVL-- 256
           L + T  F++   IG G YG VYKA     G++ A+K +   E+    +  K E  +L  
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE--EEEIKEEYNILRK 58

Query: 257 -SQVLHRNIVKLYG-------YCLHKKCMFLIYEYMERGS---LFCNLHNNEDAVELDWA 305
            S   H NI   YG            + ++L+ E    GS   L   L      ++ +W 
Sbjct: 59  YSN--HPNIATFYGAFIKKNPPGNDDQ-LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWI 115

Query: 306 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR 365
               I++     LAYLH      +IHRDI   NILL    E  + DFG +  L +    R
Sbjct: 116 AY--ILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR 170

Query: 366 TLLAGTYGYIAPEL-----AYTMVMTEKCDVYSFGVVTLEVLMGK------HPRDILSSL 414
               GT  ++APE+             + DV+S G+  +E+  GK      HP   L  +
Sbjct: 171 NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI 230

Query: 415 SSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQ 466
             +  P +           P    K   D   IS     CL  N + RP M+
Sbjct: 231 PRNPPPTLK---------SPENWSKKFND--FISE----CLIKNYEQRPFME 267

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 95.2 bits (237), Expect = 8e-22
 Identities = 72/242 (29%), Positives = 101/242 (41%), Gaps = 41/242 (16%)

Query: 213 IGTGGYGSVYKAQLPNGK-VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           +G G  GSV K +L N   +FALK + T       K    E ++        IVK YG  
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68

Query: 272 LHKK-CMFLI-YEYMERGSLFCNLHNNEDAVELDWAKRVN---------IVKAMAHALAY 320
           L +      I  EY E GSL        D++     KR           I +++   L+Y
Sbjct: 69  LDESSSSIGIAMEYCEGGSL--------DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-- 378
           LH   S  IIHRDI  +NILL  K +  + DFG +      +S      GT  Y+APE  
Sbjct: 121 LH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGTFTGTSFYMAPERI 175

Query: 379 --LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQ--RLPP 434
               Y++      DV+S G+  LEV   + P           +P +  I++L     +P 
Sbjct: 176 QGKPYSI----TSDVWSLGLTLLEVAQNRFP------FPPEGEPPLGPIELLSYIVNMPN 225

Query: 435 PV 436
           P 
Sbjct: 226 PE 227

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 94.2 bits (235), Expect = 9e-22
 Identities = 68/243 (27%), Positives = 103/243 (42%), Gaps = 30/243 (12%)

Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKL--HTSEELAFIKSFKNEAQVLSQVLHRNIVKLYG 269
           +G GG+G V   ++    + FALK +      E    +   +E ++L +  H  IVKLY 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               KK ++++ EY   G L+  L    D    D       +  +  A  YLH+     I
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILR---DRGLFDEYTARFYIACVVLAFEYLHNR---GI 114

Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGYIAPELAYTMVMTEK 388
           I+RD+   N+LL+S     + DFG A+ L   S  +T    GT  Y+APE+         
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLK--SGQKTWTFCGTPEYVAPEIILNKGYDFS 172

Query: 389 CDVYSFGVVTLEVLMGKHP------------RDILSSLSSSSDPKIM------LIDVLDQ 430
            D +S G++  E+L G+ P             DIL        P  +      LI  L +
Sbjct: 173 VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLR 232

Query: 431 RLP 433
           R P
Sbjct: 233 RNP 235

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 94.2 bits (235), Expect = 1e-21
 Identities = 77/276 (27%), Positives = 130/276 (47%), Gaps = 41/276 (14%)

Query: 213 IGTGGYGSVYKAQLPN-GKVFALKKLHTSEELA--FIKSFKNEAQVLSQVLHRNIVKLYG 269
           I  G YG V+ A+  + G ++A+K +  ++ +    +     E  +LSQ     +VKLY 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 270 YCL-HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
           Y    KK ++L+ EY+  G L   L  N  +++ D A+    +  +  AL YLH   S  
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLE-NVGSLDEDVAR--IYIAEIVLALEYLH---SNG 113

Query: 329 IIHRDISSNNILLNS----KLEAFVADFG---------TARLLHADSSNRTLLAGTYGYI 375
           IIHRD+  +NIL++S    KL     DFG            L   +  ++ ++ GT  YI
Sbjct: 114 IIHRDLKPDNILIDSNGHLKL----TDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYI 168

Query: 376 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP 435
           APE+      ++  D +S G +  E L+G  P            P+ +  ++L+ ++  P
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVGIPP-------FHGETPEEIFQNILNGKIEWP 221

Query: 436 VDRKVIRD-ILLISTVSFACLQSNPKSRPTMQSVSQ 470
            D +V  + I LIS +    L  +P+ R   +S+ +
Sbjct: 222 EDVEVSDEAIDLISKL----LVPDPEKRLGAKSIEE 253

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 84/283 (29%), Positives = 126/283 (44%), Gaps = 44/283 (15%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIK-SFKNEAQVLSQVLHRNIVKLYGY 270
           +G G YG V K +    G++ A+KK   SE+   +K +   E +VL Q+ H NIV L   
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68

Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
              K  ++L++EY+ER +L   L  +   +  D  +    +  +  A+AY H   S +II
Sbjct: 69  FRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRS--YIWQLLQAIAYCH---SHNII 122

Query: 331 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNR-TLLAGTYGYIAPELAYTMVMTEK- 388
           HRDI   NIL++      + DFG AR L A  ++  T    T  Y APEL        K 
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKP 182

Query: 389 CDVYSFGVVTLEVLMGK-------------HPRDILSSLSSS------SDPK-------- 421
            DV++ G +  E+L G+               +  L  L  S      S+P+        
Sbjct: 183 VDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPE 242

Query: 422 IMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPT 464
               + L++R P  V    + D L       ACL+ +PK R T
Sbjct: 243 PSQPESLERRYPGKVSSPAL-DFLK------ACLRMDPKERLT 278

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 93.4 bits (232), Expect = 2e-21
 Identities = 66/210 (31%), Positives = 107/210 (50%), Gaps = 21/210 (10%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS--------EELAFIKSFKNEAQVLSQVLHRN 263
           IG+G +GSVY      +G++ A+K++            + + + +   E  +L ++ H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           IV+  G  L    + +  EY+  GS+   L NN  A E    +  N V+ +   L YLH 
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFEETLVR--NFVRQILKGLNYLH- 123

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS------SNRTLLAGTYGYIAP 377
             +  IIHRDI   NIL+++K    ++DFG ++ L A+S        R  L G+  ++AP
Sbjct: 124 --NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           E+      T K D++S G + +E+L GKHP
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 93.6 bits (232), Expect = 3e-21
 Identities = 77/268 (28%), Positives = 119/268 (44%), Gaps = 25/268 (9%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G +G V+K       KV A+K +   E    I+  + E  VLSQ     + K YG  
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYLHHDCSPS 328
           L    +++I EY+  GS         D +E   LD  +   I++ +   L YLH   S  
Sbjct: 72  LKDTKLWIIMEYLGGGSAL-------DLLEPGPLDETQIATILREILKGLDYLH---SEK 121

Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 388
            IHRDI + N+LL+   E  +ADFG A  L      R    GT  ++APE+        K
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181

Query: 389 CDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLIS 448
            D++S G+  +E+  G+ P   L  +      K++ +  + +  PP ++    +    + 
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELHPM------KVLFL--IPKNNPPTLEGNYSKP---LK 230

Query: 449 TVSFACLQSNPKSRPTMQSVSQEFLITR 476
               ACL   P  RPT + + +   I R
Sbjct: 231 EFVEACLNKEPSFRPTAKELLKHKFIVR 258

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 93.5 bits (233), Expect = 3e-21
 Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 13/198 (6%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHRNIVKLYGY 270
           IG G YG VYKA+    G++ A+KK+    E   I      E ++L ++ H NI+KL   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 271 CLHKKCMFLIYEYMERGSLFCNLHN--NEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
             HK  ++L++E+M+      +L+    +    L  +   + +  +   LA+ H   S  
Sbjct: 67  FRHKGDLYLVFEFMDT-----DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118

Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVM-TE 387
           I+HRD+   N+L+N++    +ADFG AR   +     T    T  Y APEL       + 
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYST 178

Query: 388 KCDVYSFGVVTLEVLMGK 405
             D++S G +  E+L  +
Sbjct: 179 PVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 92.8 bits (230), Expect = 4e-21
 Identities = 80/271 (29%), Positives = 120/271 (44%), Gaps = 27/271 (9%)

Query: 213 IGTGGYGSVYKAQLPNGK-VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G +G VYK      K V A+K +   E    I+  + E  VLSQ     I + YG  
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
           L    +++I EY+  GS    L        L+      I++ +   L YLH   S   IH
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLH---SERKIH 124

Query: 332 RDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           RDI + N+LL+ + +  +ADFG A  L      R    GT  ++APE+        K D+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADI 184

Query: 392 YSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV----DRKVIRDILLI 447
           +S G+  +E+  G+ P         +SD   M +  L  +  PP       K  ++ +  
Sbjct: 185 WSLGITAIELAKGEPP---------NSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVE- 234

Query: 448 STVSFACLQSNPKSRPTMQSVSQEFLITRKT 478
                ACL  +P+ RPT + + +   ITR T
Sbjct: 235 -----ACLNKDPRFRPTAKELLKHKFITRYT 260

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 92.3 bits (229), Expect = 5e-21
 Identities = 76/276 (27%), Positives = 122/276 (44%), Gaps = 40/276 (14%)

Query: 209 IRYCIGTGGYGSVY--KAQLPNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           I   IG G +G V   + +LP  +    A+K L         + F +EA ++ Q  H NI
Sbjct: 8   IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNI 67

Query: 265 VKLYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
           + L G     K + ++ EYME GSL  F   H+ +  V     + V +++ +A  + YL 
Sbjct: 68  IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV----IQLVGMLRGIASGMKYL- 122

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG---TYGYIAPEL 379
                  +HRD+++ NIL+NS L   V+DFG +R+L  D        G      + APE 
Sbjct: 123 --SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 180

Query: 380 AYTMVMTEKCDVYSFGVVTLEVL-MGKHP------RDILSSLSSSSDPKIMLIDVLDQRL 432
                 T   DV+S+G+V  EV+  G+ P      +D++ ++                RL
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG------------YRL 228

Query: 433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
           P P+D       L++      C Q +   RP  + +
Sbjct: 229 PAPMDCPAALHQLMLD-----CWQKDRNERPKFEQI 259

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 91.7 bits (228), Expect = 6e-21
 Identities = 69/260 (26%), Positives = 117/260 (45%), Gaps = 32/260 (12%)

Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLH---TSEELAFIKSFKNEAQVLSQVLHRNIVKLYG 269
           +G+G +G V+  +       A+K +     SE+      F  EA+V+ ++ H N+V+LYG
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED-----DFIEEAKVMMKLSHPNLVQLYG 66

Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
            C  ++ +F++ EYM  G L   L   +  +  +W   +++   +  A+ YL  +     
Sbjct: 67  VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNG---F 121

Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIAPELAYTMVMT 386
           IHRD+++ N L+       V+DFG AR +  D    T   GT     +  PE+      +
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY--TSSQGTKFPVKWAPPEVFDYSRFS 179

Query: 387 EKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLDQ-RLPPPVDRKVIRDI 444
            K DV+SFGV+  EV   GK P +  S+              L + +L P          
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR--LYRPKLAPTE-------- 229

Query: 445 LLISTVSFACLQSNPKSRPT 464
             + T+ ++C    P+ RP 
Sbjct: 230 --VYTIMYSCWHEKPEDRPA 247

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 92.2 bits (230), Expect = 6e-21
 Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 37/211 (17%)

Query: 212 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE-----------ELAFIKSFKNEAQVLSQV 259
            +G G YG VYKA+    G++ ALKK+               E++ +K  K         
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK--------- 56

Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NIVKL      ++ ++L++EY +   L   L      +  +  K   I+  +   LA
Sbjct: 57  -HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKS--IMYQLLRGLA 112

Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  I+HRD+   NIL+N      +ADFG AR         T    T  Y APE+
Sbjct: 113 YCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEI 169

Query: 380 -----AYTMVMTEKCDVYSFGVVTLEVLMGK 405
                 Y+       D++S G +  E++ GK
Sbjct: 170 LLGSKHYST----AVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 92.0 bits (228), Expect = 7e-21
 Identities = 76/270 (28%), Positives = 118/270 (43%), Gaps = 29/270 (10%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G +G V+K       +V A+K +   E    I+  + E  VLSQ     + K YG  
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
           L    +++I EY+  GS    L     A   D  +   ++K +   L YLH   S   IH
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLH---SEKKIH 124

Query: 332 RDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           RDI + N+LL+ + +  +ADFG A  L      R    GT  ++APE+        K D+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 184

Query: 392 YSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVS 451
           +S G+  +E+  G+ P         +SD   M +  L  +  PP    +  +     +  
Sbjct: 185 WSLGITAIELAKGEPP---------NSDMHPMRVLFLIPKNNPPT---LTGEF----SKP 228

Query: 452 F-----ACLQSNPKSRPTMQSVSQEFLITR 476
           F     ACL  +P  RPT + + +   I +
Sbjct: 229 FKEFIDACLNKDPSFRPTAKELLKHKFIVK 258

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 92.2 bits (230), Expect = 8e-21
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 26/213 (12%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           +DF+    +GTG +G V   +   +GK +ALK L  ++  +L  ++   NE ++L  + H
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK--RVNIVKAMAHALA 319
             +V LYG       ++L+ EY+  G LF +            A+     +V     AL 
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELF-SHLRKSGRFPEPVARFYAAQVVL----ALE 115

Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT-LLAGTYGYIAPE 378
           YLH      I++RD+   N+LL+S     + DFG A+ +      RT  L GT  Y+APE
Sbjct: 116 YLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV----KGRTYTLCGTPEYLAPE 168

Query: 379 LAYTMVMTEKC----DVYSFGVVTLEVLMGKHP 407
               +++++      D ++ G++  E+L G  P
Sbjct: 169 ----IILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 77/301 (25%), Positives = 135/301 (44%), Gaps = 44/301 (14%)

Query: 206 DFDIRYCIGTGGYGSVYKAQL-----PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           D  ++  +G G +G V+ A+         K+    K      LA  K F+ EA++L+ + 
Sbjct: 6   DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ 65

Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAV-----------ELDWAKR 307
           H +IVK YG C     + +++EYM+ G L  F   H  +  +           EL  ++ 
Sbjct: 66  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125

Query: 308 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR-- 365
           ++I   +A  + YL    S   +HRD+++ N L+ + L   + DFG +R +++    R  
Sbjct: 126 LHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 182

Query: 366 --TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKI 422
             T+L     ++ PE       T + DV+SFGV+  E+   GK P   LS          
Sbjct: 183 GHTMLP--IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS-------NTE 233

Query: 423 MLIDVLDQRL--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQE-FLITRKTP 479
           ++  +   R+   P V  K + DI+L       C Q  P+ R  ++ + +    + + TP
Sbjct: 234 VIECITQGRVLERPRVCPKEVYDIML------GCWQREPQQRLNIKEIYKILHALGKATP 287

Query: 480 L 480
           +
Sbjct: 288 I 288

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 94.1 bits (234), Expect = 3e-20
 Identities = 54/130 (41%), Positives = 73/130 (56%), Gaps = 4/130 (3%)

Query: 4   IGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMK 63
           +G IP  + NL +L  L + SN L+G IP  LG + +L  + L  N LSG+IP EI  + 
Sbjct: 177 VGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLT 236

Query: 64  YLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLS-PN 122
            L  LDL  NN+ G IP  +  L  L YL L  NKLSGP+P     + S+  ++SL   +
Sbjct: 237 SLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIP---PSIFSLQKLISLDLSD 293

Query: 123 NGLCGNILDL 132
           N L G I +L
Sbjct: 294 NSLSGEIPEL 303

Length = 968

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 91.0 bits (226), Expect = 3e-20
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 26/213 (12%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           +D +    +GTG +G V+  +   +   +ALK +   E   L   +   NE +VL +V H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH----- 316
             I++L+     ++ ++++ EY+  G LF  L N         + R +    + +     
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN---------SGRFSNSTGLFYASEIV 111

Query: 317 -ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT-LLAGTYGY 374
            AL YLH   S  I++RD+   NILL+ +    + DFG A+ L     +RT  L GT  Y
Sbjct: 112 CALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR----DRTWTLCGTPEY 164

Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ G++  E+L+G  P
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 90.1 bits (223), Expect = 3e-20
 Identities = 78/278 (28%), Positives = 131/278 (47%), Gaps = 35/278 (12%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLH--TSEELAFIKSFKNEAQVLSQVLHR 262
           E   +   +G G +G V+          A+K L   T    AF++    EAQV+ ++ H 
Sbjct: 6   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 61

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
            +V+LY   + ++ ++++ EYM +GSL  +    E    L   + V++   +A  +AY+ 
Sbjct: 62  KLVQLYA-VVSEEPIYIVTEYMSKGSLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 119

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAY 381
                + +HRD+ + NIL+   L   VADFG ARL+  +  + R        + APE A 
Sbjct: 120 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176

Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQ-----RLP-PP 435
               T K DV+SFG++  E          L++      P ++  +VLDQ     R+P PP
Sbjct: 177 YGRFTIKSDVWSFGILLTE----------LTTKGRVPYPGMVNREVLDQVERGYRMPCPP 226

Query: 436 VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
              + + D++        C +  P+ RPT + + Q FL
Sbjct: 227 ECPESLHDLMC------QCWRKEPEERPTFEYL-QAFL 257

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 89.7 bits (222), Expect = 4e-20
 Identities = 81/278 (29%), Positives = 126/278 (45%), Gaps = 42/278 (15%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALK--KLHTSEELAFIKSFKNEAQVLSQVLH 261
            D+++   +G+G YG VYKA+ L  G++ A+K  KL   ++ + I+    E  ++ +  H
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ---QEIFMVKECKH 65

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            NIV  +G  L ++ +++  EY   GSL    H      EL  A    + +     LAYL
Sbjct: 66  CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY---VCRETLQGLAYL 122

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
           H   S   +HRDI   NILL    +  +ADFG A  + A  + R    GT  ++APE+A 
Sbjct: 123 H---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVA- 178

Query: 382 TMVMTEK-------CDVYSFGVVTLEV------LMGKHPRDILSSLSSSSDPKIMLIDVL 428
                EK       CD+++ G+  +E+      +   HP   L  +S S+          
Sbjct: 179 ---AVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ-------- 227

Query: 429 DQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQ 466
               PP +  K        + V  + L  NPK RPT +
Sbjct: 228 ----PPKLKDKTKWSSTFHNFVKIS-LTKNPKKRPTAE 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 88.1 bits (218), Expect = 1e-19
 Identities = 77/268 (28%), Positives = 127/268 (47%), Gaps = 31/268 (11%)

Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL 272
           +G G +G V+          A+K L         +SF  EAQ++ ++ H  +V+LY   +
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP--ESFLEEAQIMKKLRHDKLVQLYA-VV 70

Query: 273 HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR 332
            ++ ++++ EYM +GSL   L +  +   L     V++   +A  +AY+      + IHR
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIER---MNYIHR 126

Query: 333 DISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           D+ S NIL+   L   +ADFG ARL+  +  + R        + APE A     T K DV
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 392 YSFGVVTLE-VLMGKHPRDILSSLSSSSDPKIMLIDVLDQ-----RLPPPVDRKVIRDIL 445
           +SFG++  E V  G+ P            P +   +VL+Q     R+P P D  +    L
Sbjct: 187 WSFGILLTELVTKGRVPY-----------PGMNNREVLEQVERGYRMPCPQDCPISLHEL 235

Query: 446 LISTVSFACLQSNPKSRPTMQSVSQEFL 473
           ++      C + +P+ RPT + + Q FL
Sbjct: 236 MLQ-----CWKKDPEERPTFEYL-QSFL 257

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 88.3 bits (219), Expect = 1e-19
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 34/215 (15%)

Query: 213 IGTGGYGSVYKAQL--PNGK----VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G VYK +L  PN +      A+K L  + E    + F+ EA+++S + H NIV 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 267 LYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAVE-----------LDWAKRVNIVKA 313
           L G C  ++   +++EY+  G L  F   ++    V            LD +  ++I   
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 314 MAHALAYL--HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-----SNRT 366
           +A  + YL  HH      +HRD+++ N L+   L   ++DFG +R +++       S   
Sbjct: 133 IAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187

Query: 367 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEV 401
           L      ++ PE       T + D++SFGVV  E+
Sbjct: 188 L---PVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 91.4 bits (227), Expect = 1e-19
 Identities = 48/150 (32%), Positives = 75/150 (50%), Gaps = 1/150 (0%)

Query: 20  LDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI 79
           L + +  L G IP+ +  L +L +++LS N + G IPP + S+  L  LDLS N+  GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 80  PGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGNILDLPSCDTTK 139
           P  + +L+ L  LNL+ N LSG VP +           + + N GLCG I  L +C    
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG-IPGLRACGPHL 541

Query: 140 PATLFVEIFLPLTIVLSVIVFACLLLAKRK 169
                + I   +++    +V   +   KR+
Sbjct: 542 SVGAKIGIAFGVSVAFLFLVICAMCWWKRR 571

Length = 623

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 67/268 (25%), Positives = 115/268 (42%), Gaps = 31/268 (11%)

Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL 272
           IG G +G VYK  L      A+K   ++      + F  EA++L Q  H NIVKL G C+
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 273 HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR 332
            K+ ++++ E +  GSL   L   ++ + +   K + +    A  + YL    S + IHR
Sbjct: 63  QKQPIYIVMELVPGGSLLTFLRKKKNRLTVK--KLLQMSLDAAAGMEYLE---SKNCIHR 117

Query: 333 DISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT----YGYIAPELAYTMVMTEK 388
           D+++ N L+       ++DFG +R    +    T+  G       + APE       T +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175

Query: 389 CDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQ-----RLPPPVDRKVIRD 443
            DV+S+G++  E            SL  +  P +      ++     R+P P        
Sbjct: 176 SDVWSYGILLWETF----------SLGDTPYPGMSNQQTRERIESGYRMPAPQLCPE--- 222

Query: 444 ILLISTVSFACLQSNPKSRPTMQSVSQE 471
              I  +   C   +P++RP+   +  E
Sbjct: 223 --EIYRLMLQCWAYDPENRPSFSEIYNE 248

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 88.0 bits (218), Expect = 2e-19
 Identities = 67/265 (25%), Positives = 111/265 (41%), Gaps = 31/265 (11%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           +G G YGSVYK    P G   A+K++    + +       E  +L + +   IV  YG  
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
             +  +++  EYM+ GSL            +       I  A+   L +L  +   +IIH
Sbjct: 69  FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIH 126

Query: 332 RDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTE---- 387
           RD+   N+L+N   +  + DFG +  L A  +   +  G   Y+APE   +    +    
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI--GCQSYMAPERIKSGGPNQNPTY 184

Query: 388 --KCDVYSFGVVTLEVLMGKHP------RDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK 439
             + DV+S G+  LE+ +G++P       +I + LS+       ++D     LP      
Sbjct: 185 TVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA-------IVDGDPPTLPSGYSDD 237

Query: 440 VIRDILLISTVSFACLQSNPKSRPT 464
             +D +        CL   P  RPT
Sbjct: 238 A-QDFVA------KCLNKIPNRRPT 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 87.0 bits (215), Expect = 3e-19
 Identities = 79/278 (28%), Positives = 123/278 (44%), Gaps = 34/278 (12%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALK--KLHTSEELAFIKSFKNEAQVLSQVLH 261
           EDF++   IG+G YG VYKA+ +  G++ A+K  KL   E+ A ++    E  ++    H
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ---QEIIMMKDCKH 65

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            NIV  +G  L +  +++  E+   GSL    H      E   A    + +     L YL
Sbjct: 66  SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY---VSRETLQGLYYL 122

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
           H   S   +HRDI   NILL       +ADFG +  + A  + R    GT  ++APE+A 
Sbjct: 123 H---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAA 179

Query: 382 TMV---MTEKCDVYSFGVVTLEV------LMGKHPRDILSSLSSSSDPKIMLIDVLDQRL 432
                   + CD+++ G+  +E+      +   HP   L  ++ S+              
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ------------ 227

Query: 433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
           PP +  K+         V  A L  NPK RPT + + Q
Sbjct: 228 PPKLKDKMKWSNSFHHFVKMA-LTKNPKKRPTAEKLLQ 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 87.4 bits (216), Expect = 3e-19
 Identities = 76/295 (25%), Positives = 131/295 (44%), Gaps = 56/295 (18%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ----LPNGK--VFALKKLHTSEELAFIKSFKNEAQVLSQ 258
            D  +++ +G G +G V+ A+    LP     + A+K L  + E A  + F+ EA++L+ 
Sbjct: 5   RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR-QDFQREAELLTV 63

Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRV-------- 308
           + H++IV+ YG C   + + +++EYM  G L  F   H   DA  L   + V        
Sbjct: 64  LQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSH-GPDAKILAGGEDVAPGQLTLG 122

Query: 309 ---NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS--- 362
               I   +A  + YL    S   +HRD+++ N L+   L   + DFG +R +++     
Sbjct: 123 QMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 179

Query: 363 -SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDP 420
              RT+L     ++ PE       T + D++SFGVV  E+   GK P   LS+  +    
Sbjct: 180 VGGRTMLP--IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---- 233

Query: 421 KIMLIDVLDQ-------RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
               I+ + Q       R  PP    +++           C Q  P+ R  ++ +
Sbjct: 234 ----IECITQGRELERPRTCPPEVYAIMQ----------GCWQREPQQRMVIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 86.1 bits (213), Expect = 5e-19
 Identities = 67/264 (25%), Positives = 124/264 (46%), Gaps = 28/264 (10%)

Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLH---TSEELAFIKSFKNEAQVLSQVLHRNIVKLYG 269
           +G+G +G V+  +       A+K ++    SEE      F  EA+V+ ++ H  +V+LYG
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE-----DFIEEAKVMMKLSHPKLVQLYG 66

Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
            C  +K ++++ E+ME G L   L   +  +  D    +++ + +   + YL  +   S 
Sbjct: 67  VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERN---SF 121

Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG-TYGYIAPELAYTMVMTEK 388
           IHRD+++ N L++S     V+DFG  R +  D    +  A     +  PE+      + K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181

Query: 389 CDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRL-PPPVDRKVIRDILL 446
            DV+SFGV+  EV   GK P          S+ +++ +     RL  P +    + +++ 
Sbjct: 182 SDVWSFGVLMWEVFTEGKMP------FEKKSNYEVVEMISRGFRLYRPKLASMTVYEVM- 234

Query: 447 ISTVSFACLQSNPKSRPTMQSVSQ 470
                ++C    P+ RPT   + +
Sbjct: 235 -----YSCWHEKPEGRPTFAELLR 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 86.2 bits (213), Expect = 6e-19
 Identities = 71/272 (26%), Positives = 126/272 (46%), Gaps = 36/272 (13%)

Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL 272
           +G G +G V+     N    A+K L        +++F  EA ++  + H  +V+LY    
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 273 HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR 332
            ++ +++I EYM +GSL   L ++E   ++   K ++    +A  +AY+      + IHR
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGG-KVLLPKLIDFSAQIAEGMAYIERK---NYIHR 127

Query: 333 DISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           D+ + N+L++  L   +ADFG AR++  +  + R        + APE       T K DV
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187

Query: 392 YSFGVVTLEVLM-GKHP------RDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV-IRD 443
           +SFG++  E++  GK P       D++S+L                R+P   +    + D
Sbjct: 188 WSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG------------YRMPRMENCPDELYD 235

Query: 444 ILLISTVSFACLQSNPKSRPT---MQSVSQEF 472
           I+        C +   + RPT   +QSV  +F
Sbjct: 236 IMK------TCWKEKAEERPTFDYLQSVLDDF 261

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 86.6 bits (215), Expect = 6e-19
 Identities = 56/196 (28%), Positives = 86/196 (43%), Gaps = 10/196 (5%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           IG G +G V+KA+    G+  ALKK+     E         E + L    H  +VKL   
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
             H     L+ EYM    L   L + E  +     K    ++ +   +AY+H   +  I+
Sbjct: 68  FPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKS--YMRMLLKGVAYMH---ANGIM 121

Query: 331 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNR-TLLAGTYGYIAPELAY-TMVMTEK 388
           HRD+   N+L+++     +ADFG ARL   +     +    T  Y APEL Y        
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPG 181

Query: 389 CDVYSFGVVTLEVLMG 404
            D+++ G +  E+L G
Sbjct: 182 VDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 86.1 bits (213), Expect = 7e-19
 Identities = 76/276 (27%), Positives = 123/276 (44%), Gaps = 33/276 (11%)

Query: 213 IGTGGYGSVYKAQLPNGKVFALKK--LHTSEELAFIKSFKN---EAQVLSQVLHRNIVKL 267
           +G G YG+VY      G++ A+K+  L TS  LA  K ++    E  +L  + H NIV+ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
            G CL    + +  E++  GS+   L+      E  + K     K +   +AYLH++C  
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC-- 122

Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT------LLAGTYGYIAPELAY 381
            ++HRDI  NN++L       + DFG AR L     + T       + GT  ++APE+  
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181

Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLP-PPVDRKV 440
                 K D++S G    E+  GK P        +S D    +  +   R   P +    
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPPL-------ASMDRLAAMFYIGAHRGLMPRLP--- 231

Query: 441 IRDILLISTVSF--ACLQSNPKSRPT-MQSVSQEFL 473
             D    + + F  +CL  +   RP+ +Q +  +FL
Sbjct: 232 --DSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 85.8 bits (212), Expect = 8e-19
 Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 19/204 (9%)

Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLH---TSEELAFIKSFKNEAQVLSQVLHRNIVKLYG 269
           IG+G +G V+       +  A+K +     SEE      F  EAQV+ ++ H  +V+LYG
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE-----DFIEEAQVMMKLSHPKLVQLYG 66

Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
            C  +  + L++E+ME G L   L              + +   +   +AYL       +
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQRGK--FSQETLLGMCLDVCEGMAYLESSN---V 121

Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHAD---SSNRTLLAGTYGYIAPELAYTMVMT 386
           IHRD+++ N L+       V+DFG  R +  D   SS  T     +   +PE+      +
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWS--SPEVFSFSKYS 179

Query: 387 EKCDVYSFGVVTLEVLM-GKHPRD 409
            K DV+SFGV+  EV   GK P +
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYE 203

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 86.7 bits (215), Expect = 8e-19
 Identities = 66/202 (32%), Positives = 96/202 (47%), Gaps = 19/202 (9%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIK-SFKNEAQVLSQVLHRNIVKLYGY 270
           IG G YG VY+A+   +G++ ALKK+    E   I  S   E  +L  + H NIV+L   
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 271 CL--HKKCMFLIYEYMER--GSLFCNLHN--NEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            +  H   +FL+ EY E+   SL  N+    +E  V+        ++  +   L YLH +
Sbjct: 75  VVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC-------LMLQLLRGLQYLHEN 127

Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM- 383
               IIHRD+  +N+LL  K    +ADFG AR     +   T    T  Y APEL     
Sbjct: 128 F---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCT 184

Query: 384 VMTEKCDVYSFGVVTLEVLMGK 405
             T   D+++ G +  E+L  K
Sbjct: 185 TYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 86.6 bits (215), Expect = 9e-19
 Identities = 55/190 (28%), Positives = 87/190 (45%), Gaps = 22/190 (11%)

Query: 207 FDIRYCIGTGGYGSVYKAQLPN---GKVFALKKLHTSEELA--FIKSFKNEAQVLSQVLH 261
           ++I  CIG G YG VYKA+  N   GK +A+KK    +E      +S   E  +L ++ H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 262 RNIVKLYGYCLHK--KCMFLIYEYMERGSL-FCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
            N+V L    L    K ++L+++Y E         H     V +  +   +++  + + +
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAF----VADFGTARLLHADSSNRTLLAG---- 370
            YLH   S  ++HRD+   NIL+  +        + D G ARL +A    + L       
Sbjct: 122 HYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL--KPLADLDPVV 176

Query: 371 -TYGYIAPEL 379
            T  Y APEL
Sbjct: 177 VTIWYRAPEL 186

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 86.0 bits (213), Expect = 9e-19
 Identities = 71/275 (25%), Positives = 135/275 (49%), Gaps = 44/275 (16%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKL---------HTSEELAFIKSFKNEAQVLSQVLHR 262
           IG G YG VY A  +  G++ A+K++         H S +   +K+ ++E + L  + H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHAL 318
           NIV+  G+   ++ + +  EY+  GS+   L       E  V           + +   L
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-------FFTEQVLEGL 121

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL---LHADSSNRTLLAGTYGYI 375
           AYLH   S  I+HRD+ ++N+L+++     ++DFG ++    ++ +  N + + G+  ++
Sbjct: 122 AYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS-MQGSVFWM 177

Query: 376 APEL--AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLP 433
           APE+  +Y+   + K D++S G V LE+  G+ P     ++++       +  + ++R  
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA-------MFKLGNKRSA 230

Query: 434 PPVDRKVIRDILLISTVS----FACLQSNPKSRPT 464
           PP+   V    + +S V+     AC   NP +RPT
Sbjct: 231 PPIPPDV---SMNLSPVALDFLNACFTINPDNRPT 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 85.9 bits (212), Expect = 1e-18
 Identities = 66/217 (30%), Positives = 108/217 (49%), Gaps = 29/217 (13%)

Query: 213 IGTGGYGSVYKAQLPN-----GKVF-ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G V+ A+  N      K+  A+K L  + + A  K F  EA++L+ + H +IVK
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR-KDFHREAELLTNLQHEHIVK 71

Query: 267 LYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAV---------ELDWAKRVNIVKAMA 315
            YG C+    + +++EYM+ G L  F   H   DAV         EL  ++ ++I + +A
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAH-GPDAVLMAEGNRPAELTQSQMLHIAQQIA 130

Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR----TLLAGT 371
             + YL    S   +HRD+++ N L+   L   + DFG +R +++    R    T+L   
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP-- 185

Query: 372 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP 407
             ++ PE       T + DV+S GVV  E+   GK P
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 84.9 bits (210), Expect = 2e-18
 Identities = 74/272 (27%), Positives = 134/272 (49%), Gaps = 37/272 (13%)

Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLH--TSEELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G G +G V+          A+K L   +    AF+     EA ++ Q+ H  +V+LY  
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLA----EANLMKQLQHPRLVRLYA- 68

Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
            + ++ +++I EYME GSL   L    + ++L   K +++   +A  +A++      + I
Sbjct: 69  VVTQEPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYI 124

Query: 331 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIAPELAYTMVMTE 387
           HRD+ + NIL++  L   +ADFG ARL+  + +  T   G      + APE       T 
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTI 182

Query: 388 KCDVYSFGVVTLE-VLMGKHPRDILSSLSSSSDPKIMLIDVLDQ--RLPPPVD-RKVIRD 443
           K DV+SFG++  E V  G+ P          ++P++  I  L++  R+P P +  + + +
Sbjct: 183 KSDVWSFGILLTEIVTYGRIP------YPGMTNPEV--IQNLERGYRMPRPDNCPEELYE 234

Query: 444 ILLISTVSFACLQSNPKSRPT---MQSVSQEF 472
           ++        C +  P+ RPT   ++SV ++F
Sbjct: 235 LMR------LCWKEKPEERPTFEYLRSVLEDF 260

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 85.9 bits (212), Expect = 2e-18
 Identities = 78/282 (27%), Positives = 132/282 (46%), Gaps = 39/282 (13%)

Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K L+ +        F +EA +++ + H ++V+L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL    + L+ + M  G L   +H ++D +     L+W   V I K M     YL  
Sbjct: 75  LGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC--VQIAKGMM----YLEE 127

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ S     + DFG ARLL  D        G     ++A E  +
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLD--QRLP-PPVD 437
               T + DV+S+GV   E++  G  P D +        P   + D+L+  +RLP PP+ 
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGI--------PTREIPDLLEKGERLPQPPI- 235

Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +   V   C   +  SRP  + ++ EF    + P
Sbjct: 236 --CTIDVYM---VMVKCWMIDADSRPKFKELAAEFSRMARDP 272

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 84.8 bits (210), Expect = 3e-18
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 23/211 (10%)

Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQV 259
              D    IG G  G V  A     G+  A+KK+        EL F     NE  ++   
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF-----NEVVIMRDY 73

Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSL---FCNLHNNEDAVELDWAKRVNIVKAMAH 316
            H NIV++Y   L    ++++ E++E G+L     +   NE+ +         +  A+  
Sbjct: 74  QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-------ATVCLAVLK 126

Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           AL++LH   +  +IHRDI S++ILL S     ++DFG    +  +   R  L GT  ++A
Sbjct: 127 ALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 183

Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PE+   +    + D++S G++ +E++ G+ P
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 83.8 bits (207), Expect = 4e-18
 Identities = 66/262 (25%), Positives = 123/262 (46%), Gaps = 32/262 (12%)

Query: 213 IGTGGYGSV----YKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           +GTG +G V    ++ Q  +  +  +K+   SE+      F  EA+V+ ++ H  +V+LY
Sbjct: 12  LGTGQFGVVKYGKWRGQY-DVAIKMIKEGSMSED-----EFIEEAKVMMKLSHEKLVQLY 65

Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
           G C  ++ ++++ EYM  G L   L  +    +   ++ + + K +   +AYL    S  
Sbjct: 66  GVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQP--SQLLEMCKDVCEGMAYLE---SKQ 120

Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIAPELAYTMVM 385
            IHRD+++ N L++ +    V+DFG +R +  D    ++  G+     +  PE+      
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV--GSKFPVRWSPPEVLLYSKF 178

Query: 386 TEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 444
           + K DV++FGV+  EV  +GK P +      ++S+    +   L    P     KV    
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMPYERF----NNSETVEKVSQGLRLYRPHLASEKVY--- 231

Query: 445 LLISTVSFACLQSNPKSRPTMQ 466
                + ++C     + RPT Q
Sbjct: 232 ----AIMYSCWHEKAEERPTFQ 249

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 84.4 bits (209), Expect = 4e-18
 Identities = 73/220 (33%), Positives = 108/220 (49%), Gaps = 34/220 (15%)

Query: 207 FDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHT-SEELAFIKSFKNEAQVLSQVLHRNI 264
           FDI   IG G YG VYKA+    G++ ALKK+   +E+  F  +   E ++L Q+ HRNI
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68

Query: 265 VKLY----------GYCLHKKCMFLIYEYMER---GSLFCNL-HNNEDAVELDWAKRVNI 310
           V L            +   K   +L++EYM+    G L   L H +ED ++       + 
Sbjct: 69  VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK-------SF 121

Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS----NRT 366
           +K +   L Y H     + +HRDI  +NILLN+K +  +ADFG ARL +++ S    N+ 
Sbjct: 122 MKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178

Query: 367 LLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGK 405
           +   T  Y  PEL           DV+S G +  E+   K
Sbjct: 179 I---TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 83.6 bits (207), Expect = 5e-18
 Identities = 69/264 (26%), Positives = 117/264 (44%), Gaps = 35/264 (13%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKL------HTSEELAFIKSFKNEAQVLSQVLHRNIV 265
           +G+G +GSVY+   L +G  FA+K++       T +E   +K  + E  +LS++ H NIV
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEA--VKQLEQEIALLSKLQHPNIV 65

Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
           +  G    +  +++  E +  GSL   L     +            + +   L YLH   
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSL-AKLLKKYGS--FPEPVIRLYTRQILLGLEYLH--- 119

Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAYTMV 384
             + +HRDI   NIL+++     +ADFG A+ +   S  ++   G+  ++APE +A    
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS-FKGSPYWMAPEVIAQQGG 178

Query: 385 MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD- 443
                D++S G   LE+  GK P        S  +    +  +   +  PP+   +  + 
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPP-------WSQLEGVAAVFKIGRSKELPPIPDHLSDEA 231

Query: 444 ---ILLISTVSFACLQSNPKSRPT 464
              IL        CLQ +P  RPT
Sbjct: 232 KDFILK-------CLQRDPSLRPT 248

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 83.3 bits (206), Expect = 8e-18
 Identities = 76/274 (27%), Positives = 120/274 (43%), Gaps = 35/274 (12%)

Query: 213 IGTGGYGSVYKA-----QLPNGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +GSV        Q   G+V A+KKL H++ E   ++ F+ E ++L  + H NIVK
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE--HLRDFEREIEILKSLQHDNIVK 69

Query: 267 LYGYCLH--KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
             G C    ++ + L+ EY+  GSL   L  + +   LD  K +     +   + YL   
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLG-- 125

Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI---APELAY 381
            S   +HRD+++ NIL+ S+    + DFG  ++L  D     +       I   APE   
Sbjct: 126 -SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184

Query: 382 TMVMTEKCDVYSFGVVTLEVL----MGKHPRDILSSLSSSSDPKIM----LIDVL--DQR 431
               +   DV+SFGVV  E+         P      +  +     M    LI++L  + R
Sbjct: 185 ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGR 244

Query: 432 LPPPVDRKV-IRDILLISTVSFACLQSNPKSRPT 464
           LP P      I  I+        C  ++P  RP+
Sbjct: 245 LPAPPGCPAEIYAIMK------ECWNNDPSQRPS 272

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 38/230 (16%)

Query: 203 ATEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKL--HTSEELAFIKSFKNEAQVLSQV 259
              D++I   +G G +G VYKA Q+  G+V ALKK+  H  ++   I + + E ++L ++
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL 64

Query: 260 LHRNIVKLY--------GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIV 311
            H N+V L              +  ++++  YM+       L  N   V+L  ++    +
Sbjct: 65  KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD--HDLSGLLENPS-VKLTESQIKCYM 121

Query: 312 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN------- 364
             +   + YLH      I+HRDI + NIL++++    +ADFG AR       N       
Sbjct: 122 LQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178

Query: 365 ----RTLLAGTYGYIAPELAYTMVMTEK-----CDVYSFGVVTLEVLMGK 405
                T L  T  Y  PEL    ++ E+      D++  G V  E+   +
Sbjct: 179 GTRKYTNLVVTRWYRPPEL----LLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 82.6 bits (204), Expect = 1e-17
 Identities = 73/274 (26%), Positives = 130/274 (47%), Gaps = 34/274 (12%)

Query: 213 IGTGGYGSVYKAQLPNG--KVFALKKLHTSEELAFIKSFK----------NEAQVLSQVL 260
           +G+G +G VYK +  N    + ALK+++     AF K  +          +E  ++ + L
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHN-PAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 261 -HRNIVKLYGYCLHKKCMFLIYEYMERGSL---FCNLHNNEDAVELDWAKRV-NIVKAMA 315
            H NIV+ Y   L    ++++ + +E   L   F +L   +        +R+ NI   M 
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT---EERIWNIFVQMV 123

Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI 375
            AL YLH +    I+HRD++ NNI+L    +  + DFG A+      S  T + GT  Y 
Sbjct: 124 LALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVVGTILYS 180

Query: 376 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP 435
            PE+       EK DV++FG +  ++   + P    + LS ++  KI  ++ + + LP  
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT--KI--VEAVYEPLPEG 236

Query: 436 VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVS 469
           +  + + D++       +CL  + ++RP +  VS
Sbjct: 237 MYSEDVTDVIT------SCLTPDAEARPDIIQVS 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 83.7 bits (207), Expect = 1e-17
 Identities = 69/216 (31%), Positives = 105/216 (48%), Gaps = 22/216 (10%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSEEL--AFIKSFKNEAQVLSQVLH 261
           +DF+I   IG G +G V   ++ N G+V+A+K L+  E L  A    F+ E  VL     
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK--RVNIVKAM--AHA 317
           R I  L+     +  ++L+ +Y   G L   L   ED +  D A+     +V A+   H 
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA-GTYGYIA 376
           L Y         +HRDI  +N+LL+      +ADFG+   L AD + ++ +A GT  YI+
Sbjct: 121 LGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171

Query: 377 PELAYTM-----VMTEKCDVYSFGVVTLEVLMGKHP 407
           PE+   M         +CD +S GV   E+L G+ P
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 72/269 (26%), Positives = 128/269 (47%), Gaps = 33/269 (12%)

Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL 272
           +G G +G V+          A+K L     +   ++F  EAQ++ ++ H  +V LY   +
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP--EAFLQEAQIMKKLRHDKLVPLYA-VV 70

Query: 273 HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR 332
            ++ ++++ E+M +GSL  +     D   L   + V++   +A  +AY+      + IHR
Sbjct: 71  SEEPIYIVTEFMGKGSLL-DFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHR 126

Query: 333 DISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           D+ + NIL+   L   +ADFG ARL+  +  + R        + APE A     T K DV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 392 YSFGVVTLE-VLMGKHPRDILSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RKVIRDI 444
           +SFG++  E V  G+ P            P ++  +VL+Q     R+P P    + + ++
Sbjct: 187 WSFGILLTELVTKGRVPY-----------PGMVNREVLEQVERGYRMPCPQGCPESLHEL 235

Query: 445 LLISTVSFACLQSNPKSRPTMQSVSQEFL 473
           + +      C + +P  RPT + + Q FL
Sbjct: 236 MKL------CWKKDPDERPTFEYI-QSFL 257

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 30/212 (14%)

Query: 212 CIGTGGYGSVYKA-QLPNGKVFALKKL-------HTSEELAFIKSFKNEAQVLSQVLHRN 263
            +G G +G VY    +  G+  A+K++        T +E   + + + E Q+L  + H  
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKE---VNALECEIQLLKNLQHER 65

Query: 264 IVKLYGYCLHKKCMFLIY-EYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHAL 318
           IV+ YG CL       I+ EYM  GS+       +D ++   A    + +     +   +
Sbjct: 66  IVQYYG-CLRDDETLSIFMEYMPGGSV-------KDQLKAYGALTETVTRKYTRQILEGV 117

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA---GTYGYI 375
            YLH   S  I+HRDI   NIL +S     + DFG ++ L    S+ T +    GT  ++
Sbjct: 118 EYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174

Query: 376 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +PE+        K DV+S G   +E+L  K P
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 40/280 (14%)

Query: 213 IGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHRNIVKLYGY 270
           +G G YG V K +    G++ A+KK   SE+   +K     E ++L Q+ H N+V L   
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68

Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV--NIVKAMAHALAYLHHDCSPS 328
              KK ++L++E+++  ++  +L    + ++    ++    I++     + + H   S +
Sbjct: 69  FRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILR----GIEFCH---SHN 120

Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 388
           IIHRDI   NIL++      + DFG AR L A     T    T  Y APEL   +V   K
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPEL---LVGDTK 177

Query: 389 ----CDVYSFGVVTLEVLMGK-------------HPRDILSSLSS------SSDPKIMLI 425
                D+++ G +  E+L G+             H    L +L          +P    +
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237

Query: 426 DVLDQRLPPPVDRKVIR-DILLISTVSFACLQSNPKSRPT 464
            + + +   P++++  +   L++      CL+ +P  RP+
Sbjct: 238 RLPEVKEIEPLEKRFPKLSGLVLDLAK-QCLRIDPDDRPS 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 71/268 (26%), Positives = 128/268 (47%), Gaps = 38/268 (14%)

Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL 272
           IG G +G+V + +    KV A+K +         ++F  E  V++++ H+N+V+L G  L
Sbjct: 14  IGEGEFGAVLQGEYTGQKV-AVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 273 HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR 332
           H   ++++ E M +G+L   L     A+ +   + +     +A  + YL    S  ++HR
Sbjct: 70  HNG-LYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLE---SKKLVHR 124

Query: 333 DISSNNILLNSKLEAFVADFGTARL--LHADSSNRTLLAGTYGYIAPELAYTMVMTEKCD 390
           D+++ NIL++    A V+DFG AR+  +  D+S   +      + APE       + K D
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEALKHKKFSSKSD 179

Query: 391 VYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLDQ-----RLPPPVDRKVIRDI 444
           V+S+GV+  EV   G+ P            PK+ L +V +      R+ PP        +
Sbjct: 180 VWSYGVLLWEVFSYGRAPY-----------PKMSLKEVKECVEKGYRMEPPEGCPADVYV 228

Query: 445 LLISTVSFACLQSNPKSRPTMQSVSQEF 472
           L+ S     C ++ PK RP+   + ++ 
Sbjct: 229 LMTS-----CWETEPKKRPSFHKLREKL 251

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 82.6 bits (204), Expect = 3e-17
 Identities = 74/248 (29%), Positives = 112/248 (45%), Gaps = 42/248 (16%)

Query: 205 EDFDIRYCIGTGGYGSVY----KAQLPNGKVFALKKLHTSEELAFIKS--FKNEAQVLSQ 258
           +DFD++  +G G +G V     KA    G ++A+K +  S  LA      F+ E  +LS 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKA---TGDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57

Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK--RVNIVKAM-- 314
                I +L      K  ++L+ EY   G L   L+  ED  + D A+     +V A+  
Sbjct: 58  SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHS 117

Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS-NRTLLAGTYG 373
            H + Y         +HRDI   N+L++      +ADFG+A  L A+   N  L  GT  
Sbjct: 118 VHQMGY---------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPD 168

Query: 374 YIAPELAYTMVMTEK------CDVYSFGVVTLEVLMGKHP----------RDILS---SL 414
           YIAPE+  TM    K      CD +S GV+  E++ G+ P           +I++    L
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL 228

Query: 415 SSSSDPKI 422
               DPK+
Sbjct: 229 KFPEDPKV 236

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 82.2 bits (204), Expect = 3e-17
 Identities = 87/319 (27%), Positives = 127/319 (39%), Gaps = 100/319 (31%)

Query: 207 FDIRYCIGTGGYGSVYKA-QLPNGKVFALKKL-----------HTSEELAFIKSFKNEAQ 254
           ++I   +G G YG V+KA      +V ALKK+            T  E+ F++   +   
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD--- 65

Query: 255 VLSQVLHRNIVKLYGYCLHK----KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNI 310
                 H NIVKL    + K    K ++L++EYME      +LH            R NI
Sbjct: 66  ------HPNIVKLLN--VIKAENDKDIYLVFEYME-----TDLHA---------VIRANI 103

Query: 311 VKAMAH---------ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD 361
           ++ +           AL Y+H   S ++IHRD+  +NILLNS     +ADFG AR L   
Sbjct: 104 LEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160

Query: 362 SSNRTLLAGTYGYIA------PEL-----AYTMVMTEKCDVYSFGVVTLEVLMGKHP--- 407
             N      T  Y+A      PE+      YT  +    D++S G +  E+L+GK P   
Sbjct: 161 EENPENPVLTD-YVATRWYRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGK-PLFP 214

Query: 408 --------RDILSSLSSSSDPKIMLID-----VLDQRLPPPVDRKVIRDIL--------- 445
                     I+  +   S   I  I       +   LP    RK + ++L         
Sbjct: 215 GTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSR-PRKPLDELLPKASDDALD 273

Query: 446 LISTVSFACLQSNPKSRPT 464
           L+       L  NP  R T
Sbjct: 274 LLK----KLLVFNPNKRLT 288

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 81.5 bits (202), Expect = 4e-17
 Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 36/203 (17%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLH-----------TSEELAFIKSFKNEAQVLSQVL 260
           IG G YG+VYKA+ L  G+  ALKK+            T  E+A +K        L    
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQ-------LESFE 59

Query: 261 HRNIVKLYGYCL-----HKKCMFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVK 312
           H NIV+L   C       +  + L++E+++      +L           L      ++++
Sbjct: 60  HPNIVRLLDVCHGPRTDRELKLTLVFEHVD-----QDLATYLSKCPKPGLPPETIKDLMR 114

Query: 313 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY 372
            +   + +LH   S  I+HRD+   NIL+ S  +  +ADFG AR+   + +  T +  T 
Sbjct: 115 QLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTL 170

Query: 373 GYIAPELAYTMVMTEKCDVYSFG 395
            Y APE+          D++S G
Sbjct: 171 WYRAPEVLLQSSYATPVDMWSVG 193

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 81.6 bits (201), Expect = 4e-17
 Identities = 73/279 (26%), Positives = 125/279 (44%), Gaps = 39/279 (13%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           IG G  G V  A +  +G+  A+K +        EL F     NE  ++    H+N+V++
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLF-----NEVVIMRDYQHQNVVEM 83

Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
           Y   L  + ++++ E+++ G+L     +      L+  +   + +++  AL YLH   S 
Sbjct: 84  YKSYLVGEELWVLMEFLQGGAL----TDIVSQTRLNEEQIATVCESVLQALCYLH---SQ 136

Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTE 387
            +IHRDI S++ILL       ++DFG    +  D   R  L GT  ++APE+        
Sbjct: 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGT 196

Query: 388 KCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK------VI 441
           + D++S G++ +E++ G+ P          SD  +  +  L    PPP  +       V+
Sbjct: 197 EVDIWSLGIMVIEMVDGEPP--------YFSDSPVQAMKRLRDS-PPPKLKNAHKISPVL 247

Query: 442 RDILLISTVSFACLQSNPKSRPTMQSVSQE-FLITRKTP 479
           RD L         L   P+ R T Q +    FL+    P
Sbjct: 248 RDFLE------RMLTREPQERATAQELLDHPFLLQTGLP 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 80.1 bits (197), Expect = 6e-17
 Identities = 67/265 (25%), Positives = 130/265 (49%), Gaps = 23/265 (8%)

Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL 272
           +G G +G V+ A        A+K +        +++F  EA V+  + H  +VKL+   +
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHA-VV 70

Query: 273 HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR 332
            K+ +++I E+M +GSL  +   +++  +    K ++    +A  +A++      + IHR
Sbjct: 71  TKEPIYIITEFMAKGSLL-DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHR 126

Query: 333 DISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           D+ + NIL+++ L   +ADFG AR++  +  + R        + APE       T K DV
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186

Query: 392 YSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTV 450
           +SFG++ +E++  G+ P   +S+      P++  I  L++    P       ++     +
Sbjct: 187 WSFGILLMEIVTYGRIPYPGMSN------PEV--IRALERGYRMPRPENCPEELY---NI 235

Query: 451 SFACLQSNPKSRPT---MQSVSQEF 472
              C ++ P+ RPT   +QSV  +F
Sbjct: 236 MMRCWKNRPEERPTFEYIQSVLDDF 260

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 80.2 bits (198), Expect = 7e-17
 Identities = 59/199 (29%), Positives = 88/199 (44%), Gaps = 14/199 (7%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAF--IKSFKNE-AQVLSQVLHRNIVKLY 268
           I  G +GSVY A+    G  FA+K L  S+ +A   + + K E A ++ Q     + KLY
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
                K  ++L+ EY+  G    +L      +  DWAK    +  +   +  LH      
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDC-ASLIKTLGGLPEDWAK--QYIAEVVLGVEDLHQR---G 117

Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 388
           IIHRDI   N+L++      + DFG +R    +        GT  Y+APE    +   + 
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK----FVGTPDYLAPETILGVGDDKM 173

Query: 389 CDVYSFGVVTLEVLMGKHP 407
            D +S G V  E L G  P
Sbjct: 174 SDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 80.5 bits (199), Expect = 7e-17
 Identities = 68/277 (24%), Positives = 111/277 (40%), Gaps = 48/277 (17%)

Query: 213 IGTGGYGSVYK---AQLPNGKVF---ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G VY+     +  G+     A+K ++ +  +     F NEA V+ +    ++V+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 267 LYGYCLHKKCMFLIYEYMERGSL------------FCNLHNNEDAVE-LDWAKRVNIVKA 313
           L G     +   ++ E M +G L                       + +  A  +     
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI----- 128

Query: 314 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG 373
            A  +AYL    +   +HRD+++ N ++   L   + DFG  R ++     R    G  G
Sbjct: 129 -ADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK---GGKG 181

Query: 374 -----YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDV 427
                ++APE     V T K DV+SFGVV  E+  + + P   LS+        ++    
Sbjct: 182 LLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK--FVIDGGH 239

Query: 428 LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPT 464
           LD     P       D LL   +   C Q NPK RPT
Sbjct: 240 LDLPENCP-------DKLL--ELMRMCWQYNPKMRPT 267

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 83.0 bits (205), Expect = 1e-16
 Identities = 57/143 (39%), Positives = 71/143 (49%), Gaps = 5/143 (3%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
           G IP  +  L+NL  L + SN+  G IP AL SL  L  L L SNK SG+IP  +     
Sbjct: 298 GEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNN 357

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNG 124
           LT LDLS NN+ G IP  +     L  L L SN L G +P S     S+  V     +N 
Sbjct: 358 LTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRV--RLQDNS 415

Query: 125 LCGNILDLPSCDTTKPATLFVEI 147
             G   +LPS  T  P   F++I
Sbjct: 416 FSG---ELPSEFTKLPLVYFLDI 435

Length = 968

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 74/281 (26%), Positives = 130/281 (46%), Gaps = 39/281 (13%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           IG G  G V  A +   GK  A+KK+        EL F     NE  ++    H N+V +
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-----NEVVIMRDYHHENVVDM 84

Query: 268 YGYCLHKKCMFLIYEYMERGSL---FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           Y   L    ++++ E++E G+L     +   NE+ +         +  ++  AL+YLH  
Sbjct: 85  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-------ATVCLSVLRALSYLH-- 135

Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
            +  +IHRDI S++ILL S     ++DFG    +  +   R  L GT  ++APE+   + 
Sbjct: 136 -NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP 194

Query: 385 MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI 444
              + D++S G++ +E++ G+ P          ++P +  +  +   LPP V     +D 
Sbjct: 195 YGTEVDIWSLGIMVIEMIDGEPP--------YFNEPPLQAMRRIRDNLPPRV-----KDS 241

Query: 445 LLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAA 485
             +S+V    L       P+ ++ +QE L   + P +K A 
Sbjct: 242 HKVSSVLRGFLDLMLVREPSQRATAQELL---QHPFLKLAG 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 69/216 (31%), Positives = 102/216 (47%), Gaps = 22/216 (10%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSEEL--AFIKSFKNEAQVLSQVLH 261
           EDF+I   IG G +G V   +L N  KVFA+K L+  E L  A    F+ E  VL    +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK----RVNIVKAMAHA 317
           + I  L+     +  ++L+ +Y   G L   L   ED +  D A+     + I     H 
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA-GTYGYIA 376
           L Y         +HRDI  +NIL++      +ADFG+   L  D + ++ +A GT  YI+
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171

Query: 377 PELAYTMV-----MTEKCDVYSFGVVTLEVLMGKHP 407
           PE+   M         +CD +S GV   E+L G+ P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 23/203 (11%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSE----ELAFIKSFKNEAQVLSQVLHRNIVKL 267
           IG G  G+VY A  +  G+  A+K+++  +    EL       NE  V+ +  H NIV  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELII-----NEILVMRENKHPNIVNY 81

Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYLHHD 324
               L    ++++ EY+  GSL        D V    +D  +   + +    AL +LH  
Sbjct: 82  LDSYLVGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH-- 132

Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
            S  +IHRDI S+NILL       + DFG    +  + S R+ + GT  ++APE+     
Sbjct: 133 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191

Query: 385 MTEKCDVYSFGVVTLEVLMGKHP 407
              K D++S G++ +E++ G+ P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 72/271 (26%), Positives = 119/271 (43%), Gaps = 32/271 (11%)

Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G +G V+  +L  +    A+K    +        F  EA++L Q  H NIV+L G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
             K+ ++++ E ++ G     L    +   L   + + +V+  A  + YL        IH
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKHC---IH 117

Query: 332 RDISSNNILLNSKLEAFVADFGTARLLHAD---SSNRTLLAGTYGYIAPE-LAYTMVMTE 387
           RD+++ N L+  K    ++DFG +R    D   +S   +      + APE L Y    +E
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176

Query: 388 KCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLDQ--RLPPP--VDRKVIR 442
             DV+SFG++  E   +G  P   LS+  +         + ++Q  RLP P      V R
Sbjct: 177 S-DVWSFGILLWEAFSLGAVPYANLSNQQTR--------EAIEQGVRLPCPELCPDAVYR 227

Query: 443 DILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
            +         C + +P  RP+  +V QE  
Sbjct: 228 LME-------RCWEYDPGQRPSFSTVHQELQ 251

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 62/196 (31%), Positives = 94/196 (47%), Gaps = 11/196 (5%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHRNIVKLYGY 270
           IG G YG V+K +    G++ A+KK   SE+   IK     E ++L Q+ H N+V L   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-HDCSPSI 329
              K+ + L++EY +  ++   L  N   V     K+  I+     A+ + H H+C    
Sbjct: 69  FRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKK--IIWQTLQAVNFCHKHNC---- 121

Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY-TMVMTEK 388
           IHRD+   NIL+  + +  + DFG AR+L     + T    T  Y APEL          
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPP 181

Query: 389 CDVYSFGVVTLEVLMG 404
            DV++ G V  E+L G
Sbjct: 182 VDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 16/211 (7%)

Query: 205 EDFDIRYCIGTGGYGSVYKA--QLPNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           ED  +  CIG G +G VY+     P  +    A+K        +  + F  EA ++ Q  
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65

Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H +IVKL G       ++++ E    G L   L  N+    LD A  +     ++ ALAY
Sbjct: 66  HPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAY 122

Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS---SNRTLLAGTYGYIAP 377
           L    S   +HRDI++ N+L++S     + DFG +R L  +S   +++  L     ++AP
Sbjct: 123 LE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP--IKWMAP 177

Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP 407
           E       T   DV+ FGV   E+LM G  P
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 76/282 (26%), Positives = 128/282 (45%), Gaps = 39/282 (13%)

Query: 213 IGTGGYGSVYKA-QLPNGK----VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 75  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLEE 127

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL AD        G     ++A E   
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184

Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D +        P   +  +L+  +RLP PP+ 
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 235

Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 236 --CTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 272

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 81.4 bits (201), Expect = 3e-16
 Identities = 44/119 (36%), Positives = 68/119 (57%), Gaps = 1/119 (0%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
           G IP  +G   NL  LD+ +N+L G IP  L S  NL  L L SN L G+IP  + + + 
Sbjct: 346 GEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRS 405

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
           L ++ L +N+  G +P E TKL  + +L++S+N L G +     D+ S+  ++SL+ N 
Sbjct: 406 LRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQ-MLSLARNK 463

Length = 968

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 68/279 (24%), Positives = 112/279 (40%), Gaps = 41/279 (14%)

Query: 206 DFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKK-----LHTSEELAFIKSFKNEAQVLSQV 259
           DF +   +G G YGSVYK + L + + +ALK+     +   E    +    NE ++L+ V
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV----NEIRILASV 56

Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNN--------EDAVELDWAKRVNIV 311
            H NI+      L    + ++ EY   G L   +           E  +   W     I 
Sbjct: 57  NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEI---W----RIF 109

Query: 312 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT 371
             +   L  LH      I+HRD+ S NILL +     + D G +++L  + +   +  GT
Sbjct: 110 IQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI--GT 164

Query: 372 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQR 431
             Y+APE+      + K D++S G +  E+     P +      S  D +  +       
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA----RSMQDLRYKVQRGKYPP 220

Query: 432 LPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
           +PP   +       L + +    LQ  PK RP    +  
Sbjct: 221 IPPIYSQD------LQNFIRS-MLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 75/283 (26%), Positives = 114/283 (40%), Gaps = 44/283 (15%)

Query: 213 IGTGGYGSVYKAQ---LPNGKV---FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G VY+          V    A+K L  S        F  EA ++S+  H+NIV+
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLH 322
           L G    +   F++ E M  G L   L  N    E    L     +   + +A    YL 
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133

Query: 323 HDCSPSIIHRDISSNNILLNSKLE---AFVADFGTARLLHADS----SNRTLLAGTYGYI 375
                  IHRDI++ N LL  K     A +ADFG AR ++  S      R +L     ++
Sbjct: 134 ---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP--IKWM 188

Query: 376 APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLDQRLPP 434
            PE     + T K DV+SFGV+  E+  +G  P          ++ ++M       RL P
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP------YPGRTNQEVMEFVTGGGRLDP 242

Query: 435 PVD-----RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           P        +++ D          C Q  P+ RP   ++ +  
Sbjct: 243 PKGCPGPVYRIMTD----------CWQHTPEDRPNFATILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 78.8 bits (195), Expect = 3e-16
 Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 27/214 (12%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEEL-AF-IKSFKNEAQVLSQVLH 261
           ++++    I  G YG VY+A+    G++ ALKKL   +E   F I S + E  +L ++ H
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63

Query: 262 RNIVKL----YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE-----LDWAKRVNIVK 312
            NIV +     G  L K  ++++ EY+E        H+ +  +E        ++   ++ 
Sbjct: 64  PNIVTVKEVVVGSNLDK--IYMVMEYVE--------HDLKSLMETMKQPFLQSEVKCLML 113

Query: 313 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY 372
            +   +A+LH +    I+HRD+ ++N+LLN++    + DFG AR   +     T L  T 
Sbjct: 114 QLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTL 170

Query: 373 GYIAPELAY-TMVMTEKCDVYSFGVVTLEVLMGK 405
            Y APEL       +   D++S G +  E+L  K
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 66/253 (26%), Positives = 118/253 (46%), Gaps = 45/253 (17%)

Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           IG G  G V  A +  +GK+ A+KK+        EL F     NE  ++    H N+V++
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 82

Query: 268 YGYCLHKKCMFLIYEYMERGSL---FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           Y   L    ++++ E++E G+L     +   NE+ +         +  A+  AL+ LH  
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-------AAVCLAVLKALSVLH-- 133

Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
            +  +IHRDI S++ILL       ++DFG    +  +   R  L GT  ++APEL   + 
Sbjct: 134 -AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP 192

Query: 385 MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP--------- 435
              + D++S G++ +E++ G+ P          ++P +  + ++   LPP          
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPP--------YFNEPPLKAMKMIRDNLPPKLKNLHKVSP 244

Query: 436 -----VDRKVIRD 443
                +DR ++RD
Sbjct: 245 SLKGFLDRLLVRD 257

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 77.9 bits (192), Expect = 3e-16
 Identities = 72/273 (26%), Positives = 123/273 (45%), Gaps = 35/273 (12%)

Query: 213 IGTGGYGSVYKAQL----PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKL 267
           IG G +G   KA L     +GK + +K+++ S+      +  + E  VLS + H NIV+ 
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64

Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNN------EDAVELDWAKRVNIVKAMAHALAYL 321
                    ++++ +Y E G L+  ++        ED + LDW   V I  A+ H     
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI-LDWF--VQICLALKHV---- 117

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
            HD    I+HRDI S NI L       + DFG AR+L++         GT  Y++PE+  
Sbjct: 118 -HD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICE 174

Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI 441
                 K D+++ G V  E+   KH  +       + + K +++ ++    PP       
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLKHAFE-------AGNMKNLVLKIIRGSYPPVSSHYSY 227

Query: 442 RDILLISTVSFACLQSNPKSRPTMQSVSQEFLI 474
               L+S +     + NP+ RP++ S+ ++  I
Sbjct: 228 DLRNLVSQL----FKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 65/235 (27%), Positives = 102/235 (43%), Gaps = 38/235 (16%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELA--FIKSFKNEAQVLSQVLH 261
           +DF++   IG G +G V+  +    G+V+A+K L  S+ +    I   + E  +L+    
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
             IVKLY     ++ ++L+ EYM  G L  NL   +D    + A+    +  +  AL  +
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLM-NLLIRKDVFPEETARF--YIAELVLALDSV 117

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA-------------------------R 356
           H       IHRDI  +NIL+++     +ADFG                            
Sbjct: 118 H---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174

Query: 357 LLHADSSNRTLLA----GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +   D   R + A    GT  YIAPE+        +CD +S GV+  E+L G  P
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 67/268 (25%), Positives = 118/268 (44%), Gaps = 41/268 (15%)

Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL 272
           +G G +G VYKA+       A  K+  ++    ++ +  E ++L+   H  IVKL G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 273 HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN------IVKAMAHALAYLHHDCS 326
               ++++ E+   G++        DA+ L+  + +       I + M  AL YLH   S
Sbjct: 80  WDGKLWIMIEFCPGGAV--------DAIMLELDRGLTEPQIQVICRQMLEALQYLH---S 128

Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMT 386
             IIHRD+ + N+LL    +  +ADFG +         R    GT  ++APE+     M 
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188

Query: 387 E-----KCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV- 440
           +     K D++S G+  +E+   + P   L       +P  +L+ +     PP + +   
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPPHHEL-------NPMRVLLKIAKSE-PPTLSQPSK 240

Query: 441 ----IRDILLISTVSFACLQSNPKSRPT 464
                RD L  +      L  +P++RP+
Sbjct: 241 WSMEFRDFLKTA------LDKHPETRPS 262

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 77.7 bits (191), Expect = 4e-16
 Identities = 71/262 (27%), Positives = 120/262 (45%), Gaps = 24/262 (9%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLH----TSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G G YG V   +   +GK + +KKL+    +  E    K+ + EAQ+LSQ+ H NIV  
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRER---KAAEQEAQLLSQLKHPNIVAY 64

Query: 268 YGYCLHKKCM-FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
                 +  + +++  + E G L+  L   +  +  +  + V     +A AL YLH    
Sbjct: 65  RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPE-NQVVEWFVQIAMALQYLHEK-- 121

Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMT 386
             I+HRD+ + N+ L       V D G AR+L       + L GT  Y++PEL       
Sbjct: 122 -HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYN 180

Query: 387 EKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL 446
            K DV++ G    E+   KH  +       + D   ++  +++ +LPP           L
Sbjct: 181 YKSDVWALGCCVYEMATLKHAFN-------AKDMNSLVYRIIEGKLPPMPKDYSPELGEL 233

Query: 447 ISTVSFACLQSNPKSRPTMQSV 468
           I+T+    L   P+ RP+++S+
Sbjct: 234 IATM----LSKRPEKRPSVKSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 75/281 (26%), Positives = 124/281 (44%), Gaps = 50/281 (17%)

Query: 207 FDIRYCIGTGGYGSVY--KAQLPNG----KVFALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           ++I   IG G +G +Y  KA+  +     K   L K+   E+    ++ K E  +L+++ 
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK----EASKKEVILLAKMK 57

Query: 261 HRNIVKLYGYCLHKKCMFLIYEY-----------MERGSLFCNLHNNEDAVELDWAKRVN 309
           H NIV  +        +F++ EY            +RG LF     +ED + L W   V 
Sbjct: 58  HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF-----SEDQI-LSWF--VQ 109

Query: 310 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTARLLHADSSNRTLL 368
           I   + H      HD    I+HRDI S NI L+   + A + DFG AR L+         
Sbjct: 110 ISLGLKHI-----HD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC 162

Query: 369 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVL 428
            GT  Y++PE+        K D++S G V  E+   KHP +        ++   +++ + 
Sbjct: 163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE-------GNNLHQLVLKIC 215

Query: 429 DQRLPPPVDRKVIRDI-LLISTVSFACLQSNPKSRPTMQSV 468
                 P+     RD+  LIS +     + +P+ RP++ S+
Sbjct: 216 QGYF-APISPNFSRDLRSLISQL----FKVSPRDRPSITSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 77.5 bits (191), Expect = 6e-16
 Identities = 60/265 (22%), Positives = 113/265 (42%), Gaps = 25/265 (9%)

Query: 213 IGTGGYGSVYKAQLPNG------KVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G V+ A+           +  +K L  +++      F+ E  +  ++ H+N+V+
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK--AMAHALAY-LHH 323
           L G C   +  ++I EY + G L   L   +   E      ++  +  A+   +A  + H
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS--SNRTLLAGTYGYIAPELAY 381
             +   +HRD+++ N L++S+ E  V+    ++ ++       R  L     ++APE   
Sbjct: 133 LSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPEAVQ 191

Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD-RK 439
               + K DV+SFGV+  EV   G+ P   L     S +  +  +      LP P     
Sbjct: 192 EDDFSTKSDVWSFGVLMWEVFTQGELPFYGL-----SDEEVLNRLQAGKLELPVPEGCPS 246

Query: 440 VIRDILLISTVSFACLQSNPKSRPT 464
            +  ++        C   NPK RP+
Sbjct: 247 RLYKLMT------RCWAVNPKDRPS 265

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 78.2 bits (192), Expect = 6e-16
 Identities = 74/274 (27%), Positives = 125/274 (45%), Gaps = 28/274 (10%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIK--SFKNEAQVLSQVLHRNIVKLYG 269
           IG G +G+VY A+ +   +V A+KK+  S + +  K      E + L ++ H N ++  G
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 270 YCLHKKCMFLIYEY-MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
             L +   +L+ EY +   S    +H       L   +   I       LAYLH   S +
Sbjct: 93  CYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAITHGALQGLAYLH---SHN 145

Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTE- 387
           +IHRDI + NILL    +  +ADFG+A +    +S      GT  ++APE+   M   + 
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAPEVILAMDEGQY 201

Query: 388 --KCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDIL 445
             K DV+S G+  +E+   K P   ++++S+        +  + Q   P +      D  
Sbjct: 202 DGKVDVWSLGITCIELAERKPPLFNMNAMSA--------LYHIAQNESPTLQSNEWSDYF 253

Query: 446 LISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                  +CLQ  P+ RPT + + +   + R+ P
Sbjct: 254 --RNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 78.2 bits (193), Expect = 6e-16
 Identities = 81/308 (26%), Positives = 129/308 (41%), Gaps = 52/308 (16%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +DF+    +G G  G V K    P+G + A K +H   + A       E +VL +     
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV------NIVKAMAHA 317
           IV  YG       + +  E+M+ GSL        D V L  A R+       I  A+   
Sbjct: 61  IVGFYGAFYSDGEISICMEHMDGGSL--------DQV-LKKAGRIPENILGKISIAVLRG 111

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           L YL       I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y++P
Sbjct: 112 LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSP 167

Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP----------------------RDILSSLS 415
           E       T + D++S G+  +E+ +G++P                      ++    +S
Sbjct: 168 ERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVS 227

Query: 416 S--SSDPKIMLI-DVLDQRL--PPPVDRKVIRDILLISTVSF--ACLQSNPKSRPTMQSV 468
                 P+ M I ++LD  +  PPP   K+           F   CL+ NPK R  ++ +
Sbjct: 228 GHPPDSPRPMAIFELLDYIVNEPPP---KLPSGAFSDEFQDFVDKCLKKNPKERADLKEL 284

Query: 469 SQEFLITR 476
           ++   I R
Sbjct: 285 TKHPFIKR 292

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 77.6 bits (192), Expect = 7e-16
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 20/203 (9%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKN--------EAQVLSQVLHRN 263
           +G G Y  VYKA     G++ A+KK+   E     K  K+        E ++L ++ H N
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGER----KEAKDGINFTALREIKLLQELKHPN 63

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           I+ L     HK  + L++E+ME   L   + +    + L  A   + +      L YLH 
Sbjct: 64  IIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLH- 119

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
             S  I+HRD+  NN+L+ S     +ADFG AR   + +   T    T  Y APEL +  
Sbjct: 120 --SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGA 177

Query: 384 VM-TEKCDVYSFGVVTLEVLMGK 405
                  D++S G +  E+L+  
Sbjct: 178 RHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 76.7 bits (189), Expect = 9e-16
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 15/214 (7%)

Query: 251 NEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNI 310
           NE  +LS + H NI+  Y + +    + +  EY   G+L+  +   +     +    +  
Sbjct: 48  NEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWY 106

Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG 370
           +  +  A++Y+H      I+HRDI + NI L       + DFG +++L ++ S    + G
Sbjct: 107 LFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVG 163

Query: 371 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQ 430
           T  Y++PEL   +    K D+++ G V  E+L  K   D       +++P  +++ ++  
Sbjct: 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD-------ATNPLNLVVKIVQG 216

Query: 431 RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPT 464
              P V       I L+     + LQ +P+ RPT
Sbjct: 217 NYTPVVSVYSSELISLVH----SLLQQDPEKRPT 246

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 77.2 bits (190), Expect = 9e-16
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 38/226 (16%)

Query: 208 DIRYC--IGTGGYGSVYKAQLPN---GKVF---ALKKLHTSEELAFIKSFKNEAQVLSQV 259
           +I Y   IG G +G V++A+ P     + F   A+K L           F+ EA ++++ 
Sbjct: 6   NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 65

Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNN-------------------EDAV 300
            H NIVKL G C   K M L++EYM  G L   L +                     + +
Sbjct: 66  DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125

Query: 301 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH- 359
            L   +++ I K +A  +AYL        +HRD+++ N L+   +   +ADFG +R ++ 
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182

Query: 360 AD----SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEV 401
           AD    S N  +      ++ PE  +    T + DV+++GVV  E+
Sbjct: 183 ADYYKASENDAI---PIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 76.9 bits (189), Expect = 9e-16
 Identities = 70/275 (25%), Positives = 125/275 (45%), Gaps = 34/275 (12%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           ++  +   IG G +G V        KV A+K +      A  ++F  EA V++Q+ H N+
Sbjct: 6   KELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIKND---ATAQAFLAEASVMTQLRHSNL 61

Query: 265 VKLYGYCLHKK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           V+L G  + +K  ++++ EYM +GSL   L +   +V L     +     +  A+ YL  
Sbjct: 62  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLE- 119

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
             + + +HRD+++ N+L++    A V+DFG   L    SS +        + APE     
Sbjct: 120 --ANNFVHRDLAARNVLVSEDNVAKVSDFG---LTKEASSTQDTGKLPVKWTAPEALREK 174

Query: 384 VMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR 442
             + K DV+SFG++  E+   G+ P            P+I L DV+     P V++    
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPY-----------PRIPLKDVV-----PRVEKGYKM 218

Query: 443 DI-----LLISTVSFACLQSNPKSRPTMQSVSQEF 472
           D       ++  V   C   +  +RP+   + ++ 
Sbjct: 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 84/309 (27%), Positives = 136/309 (44%), Gaps = 52/309 (16%)

Query: 184 DVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEE 242
           ++FS    D   ++ DL E          IG G +G+VY A+ +   +V A+KK+  S +
Sbjct: 6   ELFS--KDDPEKLFTDLRE----------IGHGSFGAVYFARDVRTNEVVAIKKMSYSGK 53

Query: 243 LAFIK--SFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAV 300
            +  K      E + L Q+ H N ++  G  L +   +L+ EY       C L +  D +
Sbjct: 54  QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY-------C-LGSASDIL 105

Query: 301 E-----LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA 355
           E     L   +   I       LAYLH   S   IHRDI + NILL       +ADFG+A
Sbjct: 106 EVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSA 162

Query: 356 RLLHADSSNRTLLAGTYGYIAPELAYTM---VMTEKCDVYSFGVVTLEVLMGKHPRDILS 412
            L+   +S      GT  ++APE+   M       K DV+S G+  +E+   K P   ++
Sbjct: 163 SLVSPANS----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218

Query: 413 SLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSF--ACLQSNPKSRPTMQSVSQ 470
           ++S+        +  + Q   P +      D       +F  +CLQ  P+ RP+ + + +
Sbjct: 219 AMSA--------LYHIAQNDSPTLSSNDWSD----YFRNFVDSCLQKIPQDRPSSEELLK 266

Query: 471 EFLITRKTP 479
              + R+ P
Sbjct: 267 HRFVLRERP 275

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 20/199 (10%)

Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIK--SFKNEAQVLSQVLHRNIVKLYGY 270
           +G G +G V+  +    +   + K    E++   +  + +NE QVL  + H NI++ Y  
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 271 CLHKKCMFLIYEYMERGSLF------CNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            L  K + ++ EY   G+L       CN   +ED           I+      L  LHH 
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDED----------TILHFFVQILLALHHV 117

Query: 325 CSPSIIHRDISSNNILLNS-KLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
            +  I+HRD+ + NILL+  K+   + DFG +++L + S   T++ GT  YI+PEL    
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV-GTPCYISPELCEGK 176

Query: 384 VMTEKCDVYSFGVVTLEVL 402
              +K D+++ G V  E+ 
Sbjct: 177 PYNQKSDIWALGCVLYELA 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 70/271 (25%), Positives = 126/271 (46%), Gaps = 32/271 (11%)

Query: 208 DIRY--CIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           DI+Y   +G G  G+VYKA  L   ++ A+K +     +   K   +E ++L +     I
Sbjct: 2   DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61

Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV------NIVKAMAHAL 318
           +  YG    +  + +  E+M+ GSL             D  +++       I  A+   L
Sbjct: 62  IGFYGAFFVENRISICTEFMDGGSL-------------DVYRKIPEHVLGRIAVAVVKGL 108

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
            YL    S  I+HRD+  +N+L+N++ +  + DFG +  L  +S  +T + GT  Y+APE
Sbjct: 109 TYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-VNSIAKTYV-GTNAYMAPE 163

Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPP-PVD 437
                      DV+S G+  +E+ +G+ P   +     S  P  +L  ++D+  P  PV 
Sbjct: 164 RISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVG 223

Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
           +   + +  I+     C++  PK RP  +++
Sbjct: 224 QFSEKFVHFITQ----CMRKQPKERPAPENL 250

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 77/282 (27%), Positives = 126/282 (44%), Gaps = 39/282 (13%)

Query: 213 IGTGGYGSVYKA-QLPNGK----VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P+G+      A+K L  +      K   +EA V++ V    + +L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      L+ + M  G L   +  N+D +     L+W   V I K M+    YL  
Sbjct: 75  LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWC--VQIAKGMS----YLE- 126

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ S     + DFG ARLL  D +      G     ++A E   
Sbjct: 127 --EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184

Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLD--QRLP-PPVD 437
               T + DV+S+GV   E++  G  P D          P   + D+L+  +RLP PP+ 
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYD--------GIPAREIPDLLEKGERLPQPPI- 235

Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   + + RP  + +  EF    + P
Sbjct: 236 --CTIDVYMIMV---KCWMIDSECRPRFRELVDEFSRMARDP 272

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 68/266 (25%), Positives = 116/266 (43%), Gaps = 26/266 (9%)

Query: 213 IGTGGYGSVYKAQLPNGKVFALK--KLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G G +G V+K  L +    A+K  K    +EL     F +EA++L Q  H NIVKL G 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI--KFLSEARILKQYDHPNIVKLIGV 60

Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
           C  ++ ++++ E +  G     L   +D  EL   + V      A  +AYL    S + I
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKD--ELKTKQLVKFALDAAAGMAYLE---SKNCI 115

Query: 331 HRDISSNNILLNSKLEAFVADFGTARLLHADS---SNRTLLAGTYGYIAPELAYTMVMTE 387
           HRD+++ N L+       ++DFG +R    D    S+  L      + APE       + 
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173

Query: 388 KCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL 446
           + DV+S+G++  E   +G  P   +++  +    +        Q+ P  V + + R    
Sbjct: 174 ESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQR---- 229

Query: 447 ISTVSFACLQSNPKSRPTMQSVSQEF 472
                  C    P++RP    + +E 
Sbjct: 230 -------CWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 78/280 (27%), Positives = 116/280 (41%), Gaps = 51/280 (18%)

Query: 213 IGTGGYGSVYKAQ----LPNGK------VFALKKLHTSEELAFIKSFKNEAQVLSQVLHR 262
           +G+G +G VY+      L  G       V  L+K  T +E    K F  EA ++S   H 
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK---KEFLKEAHLMSNFNHP 59

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHAL 318
           NIVKL G CL  +  ++I E ME G L   L +          L   + ++I   +A   
Sbjct: 60  NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAF-----VADFGTARLLHADSSNRTLLAGTYG 373
            YL        IHRD+++ N L++ K         + DFG AR ++     R    G   
Sbjct: 120 VYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176

Query: 374 --YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLDQ 430
             ++APE       T + DV+SFGV+  E+L +G+ P   L++            +VL  
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-----------QEVLQH 225

Query: 431 -----RL-PPPVDRKVIRDILLISTVSFACLQSNPKSRPT 464
                RL  P      I  ++        C   +P  RPT
Sbjct: 226 VTAGGRLQKPENCPDKIYQLMTN------CWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 76.7 bits (188), Expect = 2e-15
 Identities = 56/199 (28%), Positives = 100/199 (50%), Gaps = 15/199 (7%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G  G+V+ A  +  G+  A+K+++  ++    +   NE  V+ ++ + NIV      
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPK-KELIINEILVMKELKNPNIVNFLDSF 85

Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYLHHDCSPS 328
           L    +F++ EY+  GSL        D V    +D A+   + +    AL +LH +    
Sbjct: 86  LVGDELFVVMEYLAGGSL-------TDVVTETCMDEAQIAAVCRECLQALEFLHAN---Q 135

Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 388
           +IHRDI S+N+LL       + DFG    +  + S R+ + GT  ++APE+        K
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195

Query: 389 CDVYSFGVVTLEVLMGKHP 407
            D++S G++ +E++ G+ P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 77.8 bits (191), Expect = 2e-15
 Identities = 75/248 (30%), Positives = 116/248 (46%), Gaps = 35/248 (14%)

Query: 178 RATNNIDVFSIWNYDGRIVYE--DLIEATEDFDIRYCIGTGGYGSV----YKAQLPNGKV 231
           R   NID F   N   +IV +   L    ED+D+   IG G +G V    +K+   + KV
Sbjct: 16  RKNKNIDNF--LNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKS---SQKV 70

Query: 232 FALKKLHTSEELAFIKS--FKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL 289
           +A+K L   E +    S  F  E  +++      +V+L+      K ++++ EYM  G L
Sbjct: 71  YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDL 130

Query: 290 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFV 349
             NL +N D  E  WAK       +  AL  +H   S  +IHRD+  +N+LL+      +
Sbjct: 131 -VNLMSNYDVPE-KWAKFYT--AEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKL 183

Query: 350 ADFGTAR------LLHADSSNRTLLAGTYGYIAPELAYTM----VMTEKCDVYSFGVVTL 399
           ADFGT        ++  D++      GT  YI+PE+  +         +CD +S GV   
Sbjct: 184 ADFGTCMKMDETGMVRCDTA-----VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLF 238

Query: 400 EVLMGKHP 407
           E+L+G  P
Sbjct: 239 EMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 76.8 bits (189), Expect = 2e-15
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 24/211 (11%)

Query: 206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAF--IKSFKNEAQVLSQVLHR 262
           DF++   +GTG +G V  A+    G+ +A+K L   E L    ++    E  +L ++ H 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---LA 319
            IV +      +  ++ + E++  G LF +L            +  N V    HA   LA
Sbjct: 79  FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA--------GRFPNDVAKFYHAELVLA 130

Query: 320 --YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGYIA 376
             YLH   S  II+RD+   N+LL++K    V DFG A+ +     +RT  L GT  Y+A
Sbjct: 131 FEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLA 183

Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PE+  +    +  D ++ GV+  E + G  P
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 74/276 (26%), Positives = 121/276 (43%), Gaps = 31/276 (11%)

Query: 207 FDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLH-RNI 264
           F++   +G G YG VYK + +  G++ A+K +  +E+    +  K E  +L +  H RNI
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE--EEIKLEINMLKKYSHHRNI 75

Query: 265 VKLYGYCL------HKKCMFLIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHA 317
              YG  +      H   ++L+ E+   GS+   + N + +A++ DW     I + +   
Sbjct: 76  ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AYICREILRG 133

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           LA+LH   +  +IHRDI   N+LL    E  + DFG +  L      R    GT  ++AP
Sbjct: 134 LAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 190

Query: 378 ELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRL 432
           E+             + D++S G+  +E+  G  P           D   M    L  R 
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL---------CDMHPMRALFLIPRN 241

Query: 433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
           PPP  +        I  +   CL  N  SRP+ + +
Sbjct: 242 PPPKLKSKKWSKKFIDFIE-GCLVKNYLSRPSTEQL 276

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 75.5 bits (185), Expect = 5e-15
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 15/199 (7%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G  G+VY A  +  G+  A+K+++  ++    +   NE  V+ +  + NIV      
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSY 85

Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYLHHDCSPS 328
           L    ++++ EY+  GSL        D V    +D  +   + +    AL +LH   S  
Sbjct: 86  LVGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALDFLH---SNQ 135

Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 388
           +IHRDI S+NILL       + DFG    +  + S R+ + GT  ++APE+        K
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195

Query: 389 CDVYSFGVVTLEVLMGKHP 407
            D++S G++ +E++ G+ P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 75.0 bits (184), Expect = 5e-15
 Identities = 67/295 (22%), Positives = 128/295 (43%), Gaps = 54/295 (18%)

Query: 213 IGTGGYGSVYKAQ------LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G V KA              A+K L  +   + ++   +E  +L QV H +++K
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNL---------------HNNEDAVELDWAKRVNIV 311
           LYG C     + LI EY + GSL   L               + N   ++    + + + 
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 312 KAMAHA------LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS-- 363
             ++ A      + YL       ++HRD+++ N+L+    +  ++DFG +R ++ + S  
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIM 423
            R+       ++A E  +  + T + DV+SFGV+  E++          +L  +  P I 
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV----------TLGGNPYPGIA 234

Query: 424 ---LIDVLDQ--RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
              L ++L    R+  P +  + + +++L       C +  P  RPT   +S+E 
Sbjct: 235 PERLFNLLKTGYRMERPENCSEEMYNLML------TCWKQEPDKRPTFADISKEL 283

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 75.4 bits (185), Expect = 6e-15
 Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 16/213 (7%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSEEL--AFIKSFKNEAQVLSQVLH 261
           +DF+I   IG G +G V   ++ +  +++A+K L+  E L  A    F+ E  VL     
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA-HALAY 320
           + I  L+     +  ++L+ +Y   G L   L   ED +  D A+       +A H++  
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA-GTYGYIAPEL 379
           LH+      +HRDI  +N+LL+      +ADFG+   ++ D + ++ +A GT  YI+PE+
Sbjct: 121 LHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174

Query: 380 AYTM-----VMTEKCDVYSFGVVTLEVLMGKHP 407
              M         +CD +S GV   E+L G+ P
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 75.5 bits (185), Expect = 7e-15
 Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 20/210 (9%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +DF+    +G G  G V K Q  P+G + A K +H   + A       E QVL +     
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV------NIVKAMAHA 317
           IV  YG       + +  E+M+ GSL        D V L  AKR+       +  A+   
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSL--------DQV-LKEAKRIPEEILGKVSIAVLRG 115

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           LAYL       I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y++P
Sbjct: 116 LAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSP 171

Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           E       + + D++S G+  +E+ +G++P
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 75.1 bits (184), Expect = 8e-15
 Identities = 75/277 (27%), Positives = 117/277 (42%), Gaps = 32/277 (11%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIK--SFKNEAQVLSQVLHRNIVKLYG 269
           IG G +G+VY A      +V A+KK+  S +    K      E + L Q+ H N ++  G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 270 YCLHKKCMFLIYEY-MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
             L +   +L+ EY +   S    +H       L   +   I       LAYLH      
Sbjct: 89  CYLKEHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAITHGALQGLAYLHSHN--- 141

Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTE- 387
           +IHRDI + NILL    +  +ADFG+A      +S      GT  ++APE+   M   + 
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS----FVGTPYWMAPEVILAMDEGQY 197

Query: 388 --KCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDIL 445
             K DV+S G+  +E+   K P   ++++S+        +  + Q   P +      D  
Sbjct: 198 DGKVDVWSLGITCIELAERKPPLFNMNAMSA--------LYHIAQNDSPTLQSNEWTD-- 247

Query: 446 LISTVSFA--CLQSNPKSRPTMQSVSQEFLITRKTPL 480
             S   F   CLQ  P+ RP    + +   + R  P 
Sbjct: 248 --SFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPA 282

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 75.6 bits (186), Expect = 8e-15
 Identities = 78/255 (30%), Positives = 115/255 (45%), Gaps = 49/255 (19%)

Query: 178 RATNNIDVFSIWNYDGRIVYEDLIEA-------TEDFDIRYCIGTGGYGSVYKAQL---- 226
           R   NID     N+  R  YE   E         EDFD+   IG G +G V   QL    
Sbjct: 16  RKNKNID-----NFLSR--YEKAAEKITKLRMKAEDFDVIKVIGRGAFGEV---QLVRHK 65

Query: 227 PNGKVFALKKLHTSE-----ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY 281
            + +V+A+K L   E     + AF   F  E  +++      IV+L+      K ++++ 
Sbjct: 66  SSKQVYAMKLLSKFEMIKRSDSAF---FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122

Query: 282 EYMERGSLFCNLHNNEDAVELDWAK--RVNIVKAMA--HALAYLHHDCSPSIIHRDISSN 337
           EYM  G L  NL +N D  E  WA+     +V A+   H++ +         IHRD+  +
Sbjct: 123 EYMPGGDL-VNLMSNYDIPE-KWARFYTAEVVLALDAIHSMGF---------IHRDVKPD 171

Query: 338 NILLNSKLEAFVADFGTARLLHADSSNRTLLA-GTYGYIAPEL----AYTMVMTEKCDVY 392
           N+LL+      +ADFGT   + A+   R   A GT  YI+PE+            +CD +
Sbjct: 172 NMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 231

Query: 393 SFGVVTLEVLMGKHP 407
           S GV   E+L+G  P
Sbjct: 232 SVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 74.7 bits (183), Expect = 8e-15
 Identities = 70/241 (29%), Positives = 114/241 (47%), Gaps = 27/241 (11%)

Query: 185 VFSIWNYDGRIV-YEDLIEATEDFDIRYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSEE 242
           ++ ++ Y+  ++  E L + T+ ++I   IG G YG VYK     +G + A+K L    +
Sbjct: 1   LYGLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD 60

Query: 243 L-AFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNN 296
           +   I++  N  Q L    H N+VK YG       MF   + +  G L+     CN  + 
Sbjct: 61  VDEEIEAEYNILQSLPN--HPNVVKFYG-------MFYKADKLVGGQLWLVLELCNGGSV 111

Query: 297 EDAVE--LDWAKRVN---IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVAD 351
            + V+  L   +R++   I   +  AL  L H  +  IIHRD+  NNILL ++    + D
Sbjct: 112 TELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVD 171

Query: 352 FGTARLLHADSSNRTLLAGTYGYIAPEL-----AYTMVMTEKCDVYSFGVVTLEVLMGKH 406
           FG +  L +    R    GT  ++APE+      Y      +CDV+S G+  +E+  G  
Sbjct: 172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231

Query: 407 P 407
           P
Sbjct: 232 P 232

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 74.1 bits (183), Expect = 9e-15
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 33/209 (15%)

Query: 212 CIGTGGYGSVYKAQ-LPNGKVFALK----KLHTSEELAFIKSFKNEAQVLSQV-LHRNIV 265
            +G G +GSVY A+    G++ A+K    K ++ EE   ++    E + L ++  H NIV
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR----EVKSLRKLNEHPNIV 61

Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLHN---NEDAVELDWAKRVNIVKAMAHALAYLH 322
           KL         ++ ++EYME      NL+    +        +   +I+  +   LA++H
Sbjct: 62  KLKEVFRENDELYFVFEYME-----GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN-RTLLAGTYGYIAPEL-- 379
                   HRD+   N+L++      +ADFG AR     S    T    T  Y APE+  
Sbjct: 117 KH---GFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTRWYRAPEILL 171

Query: 380 ---AYTMVMTEKCDVYSFGVVTLEVLMGK 405
              +Y    +   D+++ G +  E+   +
Sbjct: 172 RSTSY----SSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 74.4 bits (182), Expect = 1e-14
 Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 15/199 (7%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G  G+VY A  +  G+  A+++++  ++    +   NE  V+ +  + NIV      
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSY 86

Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYLHHDCSPS 328
           L    ++++ EY+  GSL        D V    +D  +   + +    AL +LH   S  
Sbjct: 87  LVGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQ 136

Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 388
           +IHRDI S+NILL       + DFG    +  + S R+ + GT  ++APE+        K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 389 CDVYSFGVVTLEVLMGKHP 407
            D++S G++ +E++ G+ P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 71/276 (25%), Positives = 118/276 (42%), Gaps = 40/276 (14%)

Query: 213 IGTGGYGSVYKAQL-------PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNI 264
           +G G +G V +A            KV A+K L  +   +  ++  +E +++S +  H NI
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKV-AVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101

Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V L G C     + +I EY   G L   L    ++  L     ++    +A  +A+L   
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF-LTLEDLLSFSYQVAKGMAFL--- 157

Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY---GYIAPELAY 381
            S + IHRD+++ N+LL       + DFG AR +  D SN  +         ++APE  +
Sbjct: 158 ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND-SNYVVKGNARLPVKWMAPESIF 216

Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIM-------LIDVLDQRLPP 434
             V T + DV+S+G++  E+           SL S+  P +        LI    +   P
Sbjct: 217 NCVYTFESDVWSYGILLWEIF----------SLGSNPYPGMPVDSKFYKLIKEGYRMAQP 266

Query: 435 PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
                 I DI+        C  ++P  RPT + + Q
Sbjct: 267 EHAPAEIYDIMK------TCWDADPLKRPTFKQIVQ 296

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 17/209 (8%)

Query: 206 DFDIRYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
            +++   +G G +G     Q  N  + +A+K++   +  + ++  + EA +L+++ H NI
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNN------EDAVELDWAKRVNIVKAMAHAL 318
           V           ++++ EY + G L   +         ED + L W  +      M   +
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI-LQWFVQ------MCLGV 113

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
            ++H      ++HRDI S NI L    +  + DFG+ARLL +  +      GT  Y+ PE
Sbjct: 114 QHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE 170

Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +   M    K D++S G +  E+   KHP
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 17/201 (8%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHRNIVKLYGY 270
           IG G YG VYKA+     +  ALKK+   +E   + S    E  +L ++ H NIV+L   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHALAYLHHDCS 326
              +K ++L++EY++      +L  + D+   D+AK   ++K     +   +AY H   S
Sbjct: 70  VHSEKRLYLVFEYLD-----LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCH---S 120

Query: 327 PSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPE-LAYTMV 384
             ++HRD+   N+L++ +  A  +ADFG AR         T    T  Y APE L  +  
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRH 180

Query: 385 MTEKCDVYSFGVVTLEVLMGK 405
            +   D++S G +  E++  K
Sbjct: 181 YSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 71/280 (25%), Positives = 128/280 (45%), Gaps = 38/280 (13%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIK--SFKNEAQVLSQVLHRNIVKLYG 269
           IG G +G+VY A+ + N +V A+KK+  S + +  K      E + L ++ H N ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 270 YCLHKKCMFLIYEY-MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
             L +   +L+ EY +   S    +H  +   E++ A    +       LAYLH   S +
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAA---VTHGALQGLAYLH---SHN 135

Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTE- 387
           +IHRD+ + NILL+      + DFG+A ++   +       GT  ++APE+   M   + 
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMDEGQY 191

Query: 388 --KCDVYSFGVVTLEVLMGKHPRDILSSLS-----SSSDPKIMLIDVLDQRLPPPVDRKV 440
             K DV+S G+  +E+   K P   ++++S     + ++   +      +     VD   
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD--- 248

Query: 441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL 480
                       +CLQ  P+ RPT + + +   + R+ P 
Sbjct: 249 ------------SCLQKIPQDRPTSEVLLKHRFVLRERPP 276

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 76.0 bits (187), Expect = 2e-14
 Identities = 39/103 (37%), Positives = 63/103 (61%)

Query: 12  GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLS 71
           G++ NL  LD+ +N L G IP+ +GS ++L  LDL  N L GKIP  + ++  L  L L+
Sbjct: 137 GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLA 196

Query: 72  NNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMH 114
           +N + G IP E+ ++  L ++ L  N LSG +P+    L+S++
Sbjct: 197 SNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLN 239

Length = 968

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 62/250 (24%), Positives = 102/250 (40%), Gaps = 29/250 (11%)

Query: 232 FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL-- 289
            A+K L         + F  E ++LS++   NI +L G C     + +I EYME G L  
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 290 FCNLHNNEDAVELDWAKR------VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS 343
           F   H  E +     +K       + +   +A  + YL    S + +HRD+++ N L+  
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGK 165

Query: 344 KLEAFVADFGTARLLHA----DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTL 399
                +ADFG +R L++        R  L     ++A E       T K DV++FGV   
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLP--IRWMAWESVLLGKFTTKSDVWAFGVTLW 223

Query: 400 EVLM--GKHPRDILSSLSSSSDPKIMLIDVLDQRL---PPPVDRKVIRDILLISTVSFAC 454
           E+L    + P + L+      +      D   Q     PP   + +   +L        C
Sbjct: 224 EILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELML-------EC 276

Query: 455 LQSNPKSRPT 464
            + + + RPT
Sbjct: 277 WRRDEEDRPT 286

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 75.3 bits (185), Expect = 3e-14
 Identities = 44/123 (35%), Positives = 63/123 (51%), Gaps = 23/123 (18%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLT------NLSN--------------- 43
           G I   I  L  +  +++ +N L GPIP  + + +      NLSN               
Sbjct: 83  GKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNL 142

Query: 44  --LDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSG 101
             LDLS+N LSG+IP +I S   L  LDL  N + G IP  +T L+ L++L L+SN+L G
Sbjct: 143 ETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVG 202

Query: 102 PVP 104
            +P
Sbjct: 203 QIP 205

Length = 968

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 83/301 (27%), Positives = 132/301 (43%), Gaps = 45/301 (14%)

Query: 206 DFDIRYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSEELAFIKSF---KNEAQVLSQ 258
           +F++   +GTG YG V+  +       GK++A+K L  +  +   K+    + E QVL  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 259 VLHRN--IVKL-YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-M 314
           V  R   +V L Y +    K + LI +Y+  G LF +L+  E   E      V +  A +
Sbjct: 61  V-RRCPFLVTLHYAFQTDTK-LHLILDYVNGGELFTHLYQREHFTE----SEVRVYIAEI 114

Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYG 373
             AL +LH      II+RDI   NILL+S+    + DFG ++   A+   R     GT  
Sbjct: 115 VLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIE 171

Query: 374 YIAPELAYTMV--MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQR 431
           Y+APE+         +  D +S GV+T E+L G  P  +    +S S+   +   +L  +
Sbjct: 172 YMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSE---ISRRILKSK 228

Query: 432 LP-PPVDRKVIRDILLISTVSFACLQSNPKSR------------PTMQSVSQEFLITRKT 478
            P P       RD +         L+ +PK R            P  Q +  + L  ++ 
Sbjct: 229 PPFPKTMSAEARDFIQ------KLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKRI 282

Query: 479 P 479
           P
Sbjct: 283 P 283

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 72.8 bits (178), Expect = 3e-14
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 21/215 (9%)

Query: 207 FDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQVLHRNI 264
           F++   +G G YG VYK + +  G++ A+K +  T +E   IK   N  +  S   HRNI
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH--HRNI 65

Query: 265 VKLYGYCLHKKC------MFLIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHA 317
              YG  + K        ++L+ E+   GS+   + N + + ++ +W     I + +   
Sbjct: 66  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREILRG 123

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           L++LH      +IHRDI   N+LL    E  + DFG +  L      R    GT  ++AP
Sbjct: 124 LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 180

Query: 378 ELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHP 407
           E+             K D++S G+  +E+  G  P
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 71/238 (29%), Positives = 109/238 (45%), Gaps = 15/238 (6%)

Query: 178 RATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKK 236
           R   NID F     D      DL    ED+++   IG G +G V   +     KV+A+K 
Sbjct: 16  RKNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 75

Query: 237 LHTSEELAFIKS--FKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLH 294
           L   E +    S  F  E  +++      +V+L+      + ++++ EYM  G L  NL 
Sbjct: 76  LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLM 134

Query: 295 NNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT 354
           +N D  E  WA+       +  AL  +H   S   IHRD+  +N+LL+      +ADFGT
Sbjct: 135 SNYDVPE-KWARFYT--AEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGT 188

Query: 355 ARLLHADSSNRTLLA-GTYGYIAPELAYTM----VMTEKCDVYSFGVVTLEVLMGKHP 407
              ++ +   R   A GT  YI+PE+  +         +CD +S GV   E+L+G  P
Sbjct: 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 73.2 bits (180), Expect = 4e-14
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 24/211 (11%)

Query: 206 DFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTS--EELAFIKSFKNEAQVLSQVLHR 262
           DF I   +G GGYG V+ A+  + G++ ALK++  S   +L  ++    E  +L+     
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERG---SLFCNLHN-NEDAVELDWAKRVNIVKAMAHAL 318
            +VKL       + ++L  EY+  G   +L  NL   +ED      A+    V A+ H L
Sbjct: 62  WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDAL-HEL 120

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR--LLHADSSNRTLLAGTYGYIA 376
            Y+H D  P          N L+++     + DFG ++  + +A+S     + G+  Y+A
Sbjct: 121 GYIHRDLKPE---------NFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMA 166

Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PE+          D +S G +  E L G  P
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 72.5 bits (178), Expect = 4e-14
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 20/204 (9%)

Query: 213 IGTGGYGSVYKAQLPN-GKVFALKKLHTS-------EELAFIKSFKNEAQVLSQVLHRNI 264
           +G GG+G V   Q+   GK++A KKL          E++A      NE ++L +V  R I
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMAL-----NEKKILEKVSSRFI 55

Query: 265 VKLYGYCLHKKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           V L  Y    K  + L+   M  G L  +++N  +      A+ +     +   L +LH 
Sbjct: 56  VSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLHQ 113

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
                I++RD+   N+LL+      ++D G A  L          AGT GY+APE+    
Sbjct: 114 R---RIVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGYMAPEVLQGE 169

Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
           V     D ++ G    E++ G+ P
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 16/197 (8%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHRNIVKLYGY 270
           IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ H NIVKL   
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHALAYLHHDCS 326
              +  ++L++E++ +     +L    DA  L     + ++K+    +   LA+ H   S
Sbjct: 68  IHTENKLYLVFEFLHQ-----DLKKFMDASPLSGIP-LPLIKSYLFQLLQGLAFCH---S 118

Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAYTMVM 385
             ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE L      
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 178

Query: 386 TEKCDVYSFGVVTLEVL 402
           +   D++S G +  E++
Sbjct: 179 STAVDIWSLGCIFAEMV 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 72.0 bits (176), Expect = 5e-14
 Identities = 73/276 (26%), Positives = 122/276 (44%), Gaps = 30/276 (10%)

Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAF-----IKSFKNEAQVLSQVLHRNIVKL 267
           +G G +GSV + QL N     LK    + ++A      ++ F +EA  + +  H N+++L
Sbjct: 7   LGEGEFGSVMEGQL-NQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRL 65

Query: 268 YGYCLHKK------CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            G CL            +I  +M+ G L   L  +       +     +VK M    + +
Sbjct: 66  IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT--LLAGTYGYIAPEL 379
            +  S S IHRD+++ N +LN  +   VADFG ++ ++     R   +      +IA E 
Sbjct: 126 EYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIES 185

Query: 380 AYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ--RLPPPV 436
               V T K DV+SFGV   E+   G+ P      + +S      + D L Q  RL  P 
Sbjct: 186 LADRVYTTKSDVWSFGVTMWEIATRGQTP---YPGVENSE-----IYDYLRQGNRLKQPP 237

Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           D      +  + ++  +C   NPK RP+ +++  E 
Sbjct: 238 DC-----LDGLYSLMSSCWLLNPKDRPSFETLRCEL 268

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 72.0 bits (176), Expect = 5e-14
 Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 35/228 (15%)

Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL 272
           +G G +G VYKAQ     V A  K+  ++    ++ +  E  +L+   H NIVKL     
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 273 HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN------IVKAMAHALAYLHHDCS 326
           ++  ++++ E+   G++        DAV L+  + +       + K    AL YLH +  
Sbjct: 73  YENNLWILIEFCAGGAV--------DAVMLELERPLTEPQIRVVCKQTLEALNYLHEN-- 122

Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMT 386
             IIHRD+ + NIL     +  +ADFG +         R    GT  ++APE+    VM 
Sbjct: 123 -KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV----VMC 177

Query: 387 E---------KCDVYSFGVVTLEVLMGKHPRDILSSLS-----SSSDP 420
           E         K DV+S G+  +E+   + P   L+ +      + S+P
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP 225

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 71.4 bits (176), Expect = 7e-14
 Identities = 47/153 (30%), Positives = 73/153 (47%), Gaps = 21/153 (13%)

Query: 261 HRNIVKLYGYCLH-KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           + N +KLY Y +   K   LI +Y++ G LF  L        L  A+   I++ +  AL 
Sbjct: 68  NPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLKKEGK---LSEAEVKKIIRQLVEALN 123

Query: 320 YLHHDCSPSIIHRDISSNNILLN-SKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
            LH     +IIH DI   N+L + +K   ++ D+G  +++   S       GT  Y +PE
Sbjct: 124 DLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS----CYDGTLDYFSPE 176

Query: 379 ----LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
                 Y +      D ++ GV+T E+L GKHP
Sbjct: 177 KIKGHNYDVSF----DWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 71.6 bits (175), Expect = 8e-14
 Identities = 74/292 (25%), Positives = 127/292 (43%), Gaps = 25/292 (8%)

Query: 206 DFDIRYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSEELAFIKS---FKNEAQVLSQ 258
           +F++   +GTG YG V+  +      +GK++A+K L  +  +   K+    + E QVL  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 259 VLHRNIVKLYGYCLHKKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNI-VKAMAH 316
           +     +    Y       + LI +Y+  G LF +L   E   E    + V I    +  
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE----QEVQIYSGEIVL 116

Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGYI 375
           AL +LH      II+RDI   NILL+S     + DFG ++  H D   R     GT  Y+
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173

Query: 376 APELAY--TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSD--PKIMLIDVLDQR 431
           AP++         +  D +S GV+  E+L G  P  +    +S ++   +I+  +    +
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 233

Query: 432 LPPPVDRKVIRDILLISTVS-FACLQS---NPKSRPTMQSVSQEFLITRKTP 479
               + + +I+ +L+        C  S     K  P  Q ++ + L  +K P
Sbjct: 234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVP 285

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 70.7 bits (173), Expect = 1e-13
 Identities = 73/284 (25%), Positives = 120/284 (42%), Gaps = 41/284 (14%)

Query: 213 IGTGGYGSV--YKAQLPN---GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G G +G V  Y     N   G++ A+K L           +K E  +L  + H NIVK 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 268 YGYCLHK--KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
            G C  +  K + LI EY+  GSL   L  +    +L+ A+ +   + +   +AYLH   
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLH--- 124

Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLL---HADSSNRTLLAGTYGYIAPELAYT 382
           S   IHRD+++ N+LL++     + DFG A+ +   H     R        + A E    
Sbjct: 125 SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184

Query: 383 MVMTEKCDVYSFGVVTLEVLM----GKHPRDILSSL---SSSSDPKIMLIDVLD--QRLP 433
              +   DV+SFGV   E+L      + P      +          + LI++L+   RLP
Sbjct: 185 NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLP 244

Query: 434 PPVD-----RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            P +       ++++          C ++  K RPT +S+    
Sbjct: 245 CPKNCPQEVYILMKN----------CWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 72.9 bits (179), Expect = 2e-13
 Identities = 72/294 (24%), Positives = 125/294 (42%), Gaps = 45/294 (15%)

Query: 207 FDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHT--SEELAFIKSFKNEAQVLSQVLHRN 263
           +DI   IG GG G VY A  P   +  ALKK+    SE     K F  EA++ + ++H  
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN--NEDAVELDWAKR------VNIVKAMA 315
           IV +Y  C     ++    Y+E  +L   L +   ++++  + A++      ++I   + 
Sbjct: 64  IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123

Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD-------------- 361
             + Y+H   S  ++HRD+  +NILL    E  + D+G A     +              
Sbjct: 124 ATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 362 -SSNRTL---LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSS 417
             S+ T+   + GT  Y+APE    +  +E  D+Y+ GV+  ++L    P          
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP------YRRK 234

Query: 418 SDPKIMLIDVLDQRLPPPVDRKVIRDI-LLISTVSFACLQSNPKSRPTMQSVSQ 470
              KI         +  P++    R+I   +S ++   L  +P  R    SV +
Sbjct: 235 KGRKIS----YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAER--YSSVQE 282

Length = 932

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 82/299 (27%), Positives = 127/299 (42%), Gaps = 39/299 (13%)

Query: 195 IVYEDLIEATEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKL---HTSEELAFIKSFK 250
           I+++   + ++ ++I   IG G YG V+K     NG   A+K L   H  +E   I++  
Sbjct: 8   IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE--IEAEY 65

Query: 251 NEAQVLSQVLHRNIVKLYGYCLHKKC-----MFLIYEYMERGSLFCNLHNNEDAVE--LD 303
           N  + LS   H N+VK YG    K       ++L+ E        CN  +  D V+  L 
Sbjct: 66  NILKALSD--HPNVVKFYGMYYKKDVKNGDQLWLVLE-------LCNGGSVTDLVKGFLK 116

Query: 304 WAKRVN---IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA 360
             +R+    I   +  AL  L H      IHRD+  NNILL ++    + DFG +  L +
Sbjct: 117 RGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176

Query: 361 DSSNRTLLAGTYGYIAPEL-----AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS 415
               R    GT  ++APE+             +CDV+S G+  +E+  G  P   L+ L 
Sbjct: 177 TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP---LADLH 233

Query: 416 SSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI 474
               P   L  +   R PPP   +        +     CL  + + RPT+  + Q   I
Sbjct: 234 ----PMRALFKI--PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 65/257 (25%), Positives = 114/257 (44%), Gaps = 28/257 (10%)

Query: 206 DFDIRYCIGTGGYGSVY---KAQLPN-GKVFALKKLHTSEELAFIKSF---KNEAQVLSQ 258
           +F++   +GTG YG V+   K    + GK++A+K L  +  +   K+    + E  VL  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 259 VLHRNIVKLYGYCLHKKC-MFLIYEYMERGSLFCNL----HNNEDAVELDWAKRVNIVKA 313
           V     +    Y    +  + LI +Y+  G +F +L    + +ED V             
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRF-------YSGE 113

Query: 314 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTY 372
           +  AL +LH      I++RDI   NILL+S+    + DFG ++   ++   RT    GT 
Sbjct: 114 IILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTI 170

Query: 373 GYIAPELAYTMVMTEKC-DVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQR 431
            Y+APE+        K  D +S G++  E+L G  P  +    ++ S+    ++   D  
Sbjct: 171 EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-CDPP 229

Query: 432 LPP---PVDRKVIRDIL 445
            P    P  + ++  +L
Sbjct: 230 FPSFIGPEAQDLLHKLL 246

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 69/267 (25%), Positives = 112/267 (41%), Gaps = 63/267 (23%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSE-----ELAFIKSFKNEAQVLSQ 258
           +DF+    IG G +G V   Q  + G ++A+KKL  SE     ++A +++   E  +L++
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRA---ERDILAE 57

Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 314
             +  +VKLY     +  ++LI EY+  G +   L       E+      A+ +  + ++
Sbjct: 58  ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSI 117

Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS----------- 363
            H L Y         IHRDI  +N+LL++K    ++DFG    L                
Sbjct: 118 -HKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHAL 167

Query: 364 -----------------------NRTLLA----GTYGYIAPELAYTMVMTEKCDVYSFGV 396
                                  NR  LA    GT  YIAPE+       ++CD +S GV
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227

Query: 397 VTLEVLMGKHPRDILSSLSSSSDPKIM 423
           +  E+L+G  P    S     +  KI+
Sbjct: 228 IMYEMLVGYPP--FCSDNPQETYRKII 252

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 50/196 (25%), Positives = 98/196 (50%), Gaps = 8/196 (4%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           +G G Y +VYK +    G++ ALK++H   E     +   E  ++ ++ H NIV+L+   
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 272 LHKKCMFLIYEYMERG-SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
             +  + L++EYM++    + + H    A++ +  K  +    +   +A+ H +    ++
Sbjct: 68  HTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVK--SFTYQLLKGIAFCHEN---RVL 122

Query: 331 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAYTMVMTEKC 389
           HRD+   N+L+N + E  +ADFG AR      +  +    T  Y AP+ L  +   +   
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSI 182

Query: 390 DVYSFGVVTLEVLMGK 405
           D++S G +  E++ G+
Sbjct: 183 DIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 69.0 bits (169), Expect = 4e-13
 Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 9/202 (4%)

Query: 204 TEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEEL---AFIKSFKNEAQVLSQV 259
             +F I   IG G +  VYKA  L +G+V ALKK+   E +   A     K E  +L Q+
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59

Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNL-HNNEDAVELDWAKRVNIVKAMAHAL 318
            H N++K     +    + ++ E  + G L   + H  +    +           +  AL
Sbjct: 60  DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
            ++H   S  I+HRDI   N+ + +     + D G  R   + ++    L GT  Y++PE
Sbjct: 120 EHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 379 LAYTMVMTEKCDVYSFGVVTLE 400
             +      K D++S G +  E
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYE 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 69.9 bits (171), Expect = 5e-13
 Identities = 64/207 (30%), Positives = 90/207 (43%), Gaps = 31/207 (14%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLH---TSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           +G+G YGSV  A     G+  A+KKL     SE   F K    E  +L  + H N++ L 
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE--IFAKRAYRELTLLKHMQHENVIGLL 80

Query: 269 --------GYCLHKKCMFLIYEYMERG-SLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
                   G        +L+  YM+           +ED V+        +V  M   L 
Sbjct: 81  DVFTSAVSGDEFQD--FYLVMPYMQTDLQKIMGHPLSEDKVQY-------LVYQMLCGLK 131

Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y+H   S  IIHRD+   N+ +N   E  + DFG AR  HAD+   T    T  Y APE+
Sbjct: 132 YIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAE-MTGYVVTRWYRAPEV 185

Query: 380 AYT-MVMTEKCDVYSFGVVTLEVLMGK 405
               M   +  D++S G +  E+L GK
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 69.7 bits (171), Expect = 5e-13
 Identities = 65/261 (24%), Positives = 113/261 (43%), Gaps = 45/261 (17%)

Query: 206 DFDIRY----CIGTGGYGSVYKA-QLPNGKVFALKKL-HTSEELAFIKSFKNEAQVLSQV 259
           D   RY     IG+G YG V  A    +GK  A+KK+ H  +     K    E ++L   
Sbjct: 2   DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF 61

Query: 260 LHRNIVKLYGYCLHK----KCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIV 311
            H NI+ +           K ++++ + ME      +LH+    ++  +  +  +    +
Sbjct: 62  KHDNIIAIRDILRPPGADFKDVYVVMDLME-----SDLHHIIHSDQP-LTEEHIRY--FL 113

Query: 312 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR----TL 367
             +   L Y+H   S ++IHRD+  +N+L+N   E  + DFG AR L +  +      T 
Sbjct: 114 YQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTE 170

Query: 368 LAGTYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGKH--P-RDILSSLSSSSDPKIM 423
              T  Y APEL  ++   T   D++S G +  E+L  +   P ++ +  L        +
Sbjct: 171 YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK-------L 223

Query: 424 LIDVLDQRLPPPVDRKVIRDI 444
           ++ VL    P     +V+  I
Sbjct: 224 ILSVLGS--PSE---EVLNRI 239

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 69.2 bits (169), Expect = 7e-13
 Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 10/199 (5%)

Query: 213 IGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAF--IKSFKNEAQVLSQVL-HRNIVKLY 268
           +G G +G V+ A+L    + FA+K L     L    ++    E +VLS    H  +  LY
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
                K+ +F + EY+  G L  ++ +     + D  +       +   L +LH   S  
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLH---SKG 116

Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 388
           I++RD+  +NILL++     +ADFG  +      +      GT  YIAPE+         
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTS 176

Query: 389 CDVYSFGVVTLEVLMGKHP 407
            D +SFGV+  E+L+G+ P
Sbjct: 177 VDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 68.8 bits (168), Expect = 7e-13
 Identities = 77/290 (26%), Positives = 118/290 (40%), Gaps = 51/290 (17%)

Query: 213 IGTGGYGSV----YKAQLPN-GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G G +G V    Y  +  N G+  A+K L        I   K E ++L  + H NIVK 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 268 YGYCLHK--KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR--VNIVKAMAHALAYLHH 323
            G C       + LI E++  GSL   L  N++ + L    +  V I K M     YL  
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGM----DYLG- 126

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL---LAGTYGYIAPELA 380
             S   +HRD+++ N+L+ S+ +  + DFG  + +  D    T+   L     + APE  
Sbjct: 127 --SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184

Query: 381 YTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIM----------------L 424
                    DV+SFGV   E         +L+   S S P  +                L
Sbjct: 185 IQSKFYIASDVWSFGVTLYE---------LLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235

Query: 425 IDVLDQ--RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           + VL++  RLP P +       L+       C +  P  R T Q++ + F
Sbjct: 236 VRVLEEGKRLPRPPNCPEEVYQLMRK-----CWEFQPSKRTTFQNLIEGF 280

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 69.1 bits (170), Expect = 7e-13
 Identities = 55/221 (24%), Positives = 90/221 (40%), Gaps = 50/221 (22%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLH-----------TSEELAFIKSFKNEAQVLSQVL 260
           IG+G YG V  A     G+  A+KK+               E+  ++  +          
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR---------- 57

Query: 261 HRNIVKLYGYCLHKKCM-----FLIYEYMERGSLFCNLHN---NEDAVELDWAKRVNIVK 312
           H NI+ L               +++ E ME      +LH    +   +  D  +    + 
Sbjct: 58  HENIIGLLDILRPPSPEDFNDVYIVTELME-----TDLHKVIKSPQPLTDDHIQY--FLY 110

Query: 313 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG-- 370
            +   L YLH   S ++IHRD+  +NIL+NS  +  + DFG AR +  D   +  L    
Sbjct: 111 QILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167

Query: 371 -TYGYIAPELAYTMVMTEKC----DVYSFGVVTLEVLMGKH 406
            T  Y APEL   ++ + +     D++S G +  E+L  K 
Sbjct: 168 VTRWYRAPEL---LLSSSRYTKAIDIWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 69.1 bits (169), Expect = 8e-13
 Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 29/209 (13%)

Query: 213 IGTGGYGSVY---KAQLPN-GKVFALKKLHTSEELAFIK-----SFKNEAQVLSQVLHRN 263
           +G G +G V+   K   P+ G+++A+K L      A +K       K E  +L++V H  
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKK----ATLKVRDRVRTKMERDILAEVNHPF 59

Query: 264 IVKL-YGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHAL 318
           IVKL Y +    K ++LI +++  G LF  L       E+ V+   A+       +A AL
Sbjct: 60  IVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-------LALAL 111

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
            +LH   S  II+RD+   NILL+ +    + DFG ++             GT  Y+APE
Sbjct: 112 DHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 168

Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +      T+  D +SFGV+  E+L G  P
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 70.3 bits (172), Expect = 1e-12
 Identities = 39/100 (39%), Positives = 56/100 (56%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
           G IP  + +  NL KL + SNSL G IP +LG+  +L  + L  N  SG++P E   +  
Sbjct: 370 GEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPL 429

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVP 104
           +  LD+SNNN+QG I      +  L  L+L+ NK  G +P
Sbjct: 430 VYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP 469

Length = 968

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 22/209 (10%)

Query: 210 RYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           R  +G G YG VY A+ L      A+K++   +   +++    E  + S + HRNIV+  
Sbjct: 13  RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLHEEIALHSYLKHRNIVQYL 71

Query: 269 GYCLHKKCMFLIYEYMERGSL-------FCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
           G         +  E +  GSL       +  L +NE  +           K +   L YL
Sbjct: 72  GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIF-------YTKQILEGLKYL 124

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELA 380
           H +    I+HRDI  +N+L+N+      ++DFGT++ L   +       GT  Y+APE+ 
Sbjct: 125 HDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVI 181

Query: 381 YTMV--MTEKCDVYSFGVVTLEVLMGKHP 407
                      D++S G   +E+  GK P
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 70/292 (23%), Positives = 120/292 (41%), Gaps = 59/292 (20%)

Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+V+K   +P G       A+K +         +   +    +  + H  IV+L
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G C     + L+ +    GSL  ++  + D+++    L+W   V I K M     YL  
Sbjct: 75  LGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC--VQIAKGMY----YLEE 127

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD------SSNRTLLAGTYGYIAP 377
                ++HR++++ NILL S     +ADFG A LL+ D      S ++T +     ++A 
Sbjct: 128 HR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK----WMAL 180

Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLM-------GKHPRDILSSLSSS---SDPKIMLIDV 427
           E       T + DV+S+GV   E++        G  P ++   L      + P+I  IDV
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV 240

Query: 428 LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                                 V   C   +   RPT + ++ EF    + P
Sbjct: 241 Y--------------------MVMVKCWMIDENVRPTFKELANEFTRMARDP 272

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 67/275 (24%), Positives = 116/275 (42%), Gaps = 40/275 (14%)

Query: 209 IRYCIGTGGYGSVYKA--QLPNGK--VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           I   +GTG +G + +   +LP+ +    A+  L         + F  EA  L Q  H NI
Sbjct: 9   IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNI 68

Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+L G       M ++ EYM  G+L   L  +E   +L   + + ++  +A  + YL   
Sbjct: 69  VRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYL--- 123

Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR--TLLAGTYG--YIAPELA 380
                +H+ ++++ +L+NS L   ++ F   R L  D S    T ++G     + APE  
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYTTMSGKSPVLWAAPEAI 180

Query: 381 YTMVMTEKCDVYSFGVVTLEVL-MGKHP------RDILSSLSSSSDPKIMLIDVLDQRLP 433
                +   DV+SFG+V  EV+  G+ P      +D++ ++                RLP
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF------------RLP 228

Query: 434 PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
            P +   +   L++      C Q     RP    +
Sbjct: 229 APRNCPNLLHQLMLD-----CWQKERGERPRFSQI 258

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 11/201 (5%)

Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKN---EAQVLSQVLHRNIVKLY 268
           +G GG+G V   Q+   GK++A KKL+  + L   K ++    E ++L++V  R IV L 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLN-KKRLKKRKGYEGAMVEKRILAKVHSRFIVSL- 58

Query: 269 GYCLHKKC-MFLIYEYMERGSLFCNLHN-NEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
            Y    K  + L+   M  G L  +++N +E+       +       +   L +LH    
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-- 116

Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMT 386
             II+RD+   N+LL++     ++D G A  L    S     AGT G++APEL       
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175

Query: 387 EKCDVYSFGVVTLEVLMGKHP 407
              D ++ GV   E++  + P
Sbjct: 176 FSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 70/284 (24%), Positives = 116/284 (40%), Gaps = 55/284 (19%)

Query: 213 IGTGGYGSVYKAQL-----PNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIV 265
           +G G +G V KA+      PN     A+K L        +    +E +++  +  H+NI+
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 266 KLYGYCLHKKCMFLIYEYMERGSL------------FCNLHNNEDAVE-LDWAKRVNIVK 312
            L G C  +  ++++ EY   G+L            + +  +     E L     V+   
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139

Query: 313 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG-- 370
            +A  + +L    S   IHRD+++ N+L+       +ADFG AR +H     R    G  
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196

Query: 371 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKI---MLIDV 427
              ++APE  +  V T + DV+SFGV+  E+           +L  S  P I    L  +
Sbjct: 197 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF----------TLGGSPYPGIPVEELFKL 246

Query: 428 LDQ--RLPPPVD-----RKVIRDILLISTVSFACLQSNPKSRPT 464
           L +  R+  P +       ++RD          C    P  RPT
Sbjct: 247 LKEGYRMEKPQNCTQELYHLMRD----------CWHEVPSQRPT 280

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 73/272 (26%), Positives = 117/272 (43%), Gaps = 46/272 (16%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLH-RNIVKLYGY 270
           +G G YG V K + +P G + A+K++  +      K    +  +  + +     V  YG 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68

Query: 271 CLHKKCMFLIYEYME-------RGSLFCNLHNNEDAVELDWAK-RVNIVKAMAHALAYLH 322
              +  +++  E M+       +      L   ED +     K  V+IVKA    L YLH
Sbjct: 69  LFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDIL----GKIAVSIVKA----LEYLH 120

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL--- 379
              S  +IHRD+  +N+L+N   +  + DFG +  L  DS  +T+ AG   Y+APE    
Sbjct: 121 SKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDAGCKPYMAPERINP 177

Query: 380 -----AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPP 434
                 Y +    K DV+S G+  +E+  G+ P D      S   P   L  V+++  P 
Sbjct: 178 ELNQKGYDV----KSDVWSLGITMIELATGRFPYD------SWKTPFQQLKQVVEE--PS 225

Query: 435 PVDRKVIRDILLISTVSFA--CLQSNPKSRPT 464
           P   ++  +        F   CL+ N K RP 
Sbjct: 226 P---QLPAEKFSPEFQDFVNKCLKKNYKERPN 254

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 65/231 (28%), Positives = 99/231 (42%), Gaps = 38/231 (16%)

Query: 187 SIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSV-YKAQLPNGKVFALKKLHT--SEEL 243
           +IW       Y DL +          +G+G YG+V        G   A+KKL+     EL
Sbjct: 9   TIWEV--PDRYRDLKQ----------VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL 56

Query: 244 AFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCM------FLIYEYM--ERGSLFCNLHN 295
            F K    E ++L  + H N++ L         +      +L+  +M  + G L  +   
Sbjct: 57  -FAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKL 115

Query: 296 NEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA 355
           +ED ++        +V  M   L Y+H   +  IIHRD+   N+ +N   E  + DFG A
Sbjct: 116 SEDRIQF-------LVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 165

Query: 356 RLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGK 405
           R    DS   T    T  Y APE+    M  T+  D++S G +  E+L GK
Sbjct: 166 R--QTDSE-MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 67.8 bits (165), Expect = 2e-12
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 8/204 (3%)

Query: 205 EDFDIRYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +DF+    +G G  G V+K +  P+G + A K +H   + A       E QVL +     
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           IV  YG       + +  E+M+ GSL   L       E    K V+I  A+   L YL  
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKGLTYLRE 121

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
                I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y++PE     
Sbjct: 122 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSPERLQGT 177

Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             + + D++S G+  +E+ +G++P
Sbjct: 178 HYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 64/280 (22%), Positives = 119/280 (42%), Gaps = 40/280 (14%)

Query: 213 IGTGGYGSVYKAQL-----PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G   +G +YK  L      + ++ A+K L           F+ EA +++++ H NIV L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 268 YGYCLHKKCMFLIYEYMERGSLF-----------CNLHNNEDAV---ELDWAKRVNIVKA 313
            G    ++ + +++EY+ +G L                ++ED      LD    ++I   
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 314 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR----TLLA 369
           +A  + YL    S   +H+D+++ NIL+  +L   ++D G +R +++    R    +LL 
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 370 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVL 428
               ++ PE       +   D++SFGVV  E+   G  P          S+ +++ +   
Sbjct: 190 --IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP------YYGFSNQEVIEMVRK 241

Query: 429 DQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
            Q LP   D       L+       C Q  P  RP  + +
Sbjct: 242 RQLLPCSEDCPPRMYSLMTE-----CWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 31/211 (14%)

Query: 213 IGTGGYGSVYKAQL----PNGKVFALKKLHTSEELAFIKSFKNEAQ------VLSQVLHR 262
           +G GGYG V++ +       GK+FA+K L   ++   +++ K+ A       +L  V H 
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVL---KKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 263 NIVKL-YGYCLHKKCMFLIYEYMERGSLFCNLHNN----EDAVELDWAKRVNIVKAMAHA 317
            IV L Y +    K ++LI EY+  G LF +L       ED      ++   I  A+ H 
Sbjct: 61  FIVDLIYAFQTGGK-LYLILEYLSGGELFMHLEREGIFMEDTACFYLSE---ISLALEH- 115

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR-LLHADSSNRTLLAGTYGYIA 376
              LH      II+RD+   NILL+++    + DFG  +  +H  +   T   GT  Y+A
Sbjct: 116 ---LHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTIEYMA 168

Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PE+       +  D +S G +  ++L G  P
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 59/241 (24%), Positives = 100/241 (41%), Gaps = 34/241 (14%)

Query: 252 EAQVLSQVLHRNIVKLYGYCLHKK--CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN 309
           EA +L  V H +++++    +     CM L +       L+  L      + +D A  + 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY---SSDLYTYLTKRSRPLPIDQA--LI 161

Query: 310 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA 369
           I K +   L YLH   +  IIHRD+ + NI +N   +  + D G A+           LA
Sbjct: 162 IEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLGLA 217

Query: 370 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIM-----L 424
           GT    APE+        K D++S G+V  E+L   +P  I     S+ +  +      L
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEML--AYPSTIFEDPPSTPEEYVKSCHSHL 275

Query: 425 IDVLD------QRLPPPVDRKVIRDILLISTVSFACLQSNPKSR-PTMQSV----SQEFL 473
           + ++       +  P     +++R       + +A L+  P +R P  Q V      EFL
Sbjct: 276 LKIISTLKVHPEEFPRDPGSRLVRGF-----IEYASLERQPYTRYPCFQRVNLPIDGEFL 330

Query: 474 I 474
           +
Sbjct: 331 V 331

Length = 357

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 22/206 (10%)

Query: 213 IGTGGYGSVYKAQLPN-GKVFALK--KLHTSEELAFIKSFKNEA--QVLSQVLHRNIVKL 267
           IG G YG+VYKA+ P+ G   ALK  ++ T+E+   + + +  A  + L    H NIV+L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 268 YGYCLHKKC-----MFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALA 319
              C   +      + L++E++++     +L    D V    L      ++++     L 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-----DLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           +LH +C   I+HRD+   NIL+ S  +  +ADFG AR+     +  T +  T  Y APE+
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-LTPVVVTLWYRAPEV 178

Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGK 405
                     D++S G +  E+   K
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 25/208 (12%)

Query: 213 IGTGGYGSV----YKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           +G+G +G V    YK +     V A+K L    E +       EA+++ Q+ +  IV++ 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDV-AIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM---AHALAYLHHDC 325
           G C  +  M L+ E    G L   L   +D + +      N+V+ M   +  + YL    
Sbjct: 62  GVCEAEALM-LVMEMASGGPLNKFLSGKKDEITVS-----NVVELMHQVSMGMKYLE--- 112

Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG-----YIAPELA 380
             + +HRD+++ N+LL ++  A ++DFG ++ L AD S     A + G     + APE  
Sbjct: 113 GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARSAGKWPLKWYAPECI 170

Query: 381 YTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
                + + DV+S+G+   E    G+ P
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 24/209 (11%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLH-------TSEELAFIKSFKNEAQVLSQVLHRNI 264
           +G G +G VY    +  G+  A K++        TS+E   + + + E Q+L  + H  I
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKE---VSALECEIQLLKNLQHERI 66

Query: 265 VKLYGYCLH---KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
           V+ YG CL    +K + +  EYM  GS+   L       E    K     + +   ++YL
Sbjct: 67  VQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRK---YTRQILEGMSYL 122

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT---LLAGTYGYIAPE 378
           H   S  I+HRDI   NIL +S     + DFG ++ L     + T    + GT  +++PE
Sbjct: 123 H---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179

Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +        K DV+S G   +E+L  K P
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 68/269 (25%), Positives = 116/269 (43%), Gaps = 32/269 (11%)

Query: 213 IGTGGYGSVYKA-------QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIV 265
           +G G +G VY+          P  +V A+K ++ +  +     F NEA V+ +    ++V
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRV-AIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 266 KLYGYCLHKKCMFLIYEYMERG-------SLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
           +L G     +   +I E M RG       SL   + NN         K + +   +A  +
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG--YIA 376
           AYL+ +     +HRD+++ N ++       + DFG  R ++     R    G     +++
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189

Query: 377 PELAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP 435
           PE     V T   DV+SFGVV  E+  + + P   +S+       + +L  V++  L   
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-------EQVLRFVMEGGLLDK 242

Query: 436 VDRKVIRDILLISTVSFACLQSNPKSRPT 464
            D     D+L    +   C Q NPK RP+
Sbjct: 243 PDN--CPDMLF--ELMRMCWQYNPKMRPS 267

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 68.4 bits (167), Expect = 3e-12
 Identities = 51/157 (32%), Positives = 74/157 (47%), Gaps = 29/157 (18%)

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA---DSSNRTLLAGTYGY 374
           L  +HH  S  +IHRDI S NILL S     + DFG +++  A   D   RT   GT  Y
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-FCGTPYY 211

Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD-------ILSSLSSSSDPKIMLIDV 427
           +APE+      ++K D++S GV+  E+L  K P D       +  +L+   DP       
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP------- 264

Query: 428 LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPT 464
               LPP +  +       +  +  A L S+PK RP+
Sbjct: 265 ----LPPSISPE-------MQEIVTALLSSDPKRRPS 290

Length = 496

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 18/203 (8%)

Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFK------NEAQVLSQVLHRNIV 265
           +G GG+G V   Q+   GK++A KKL    E   IK  K      NE Q+L +V  R +V
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKL----EKKRIKKRKGESMALNEKQILEKVNSRFVV 63

Query: 266 KL-YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            L Y Y   K  + L+   M  G L  ++++  +A   +  + V     +   L  LH +
Sbjct: 64  SLAYAY-ETKDALCLVLTLMNGGDLKFHIYHMGEA-GFEEGRAVFYAAEICCGLEDLHQE 121

Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
               I++RD+   NILL+      ++D G A  +    + +  + GT GY+APE+     
Sbjct: 122 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNER 177

Query: 385 MTEKCDVYSFGVVTLEVLMGKHP 407
            T   D ++ G +  E++ G+ P
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 32/213 (15%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLH-------TSEELAFIKSFKNEAQVLSQVLHRNI 264
           +G G +G VY       G+  A+K++        TS+E   + + + E Q+L  +LH  I
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKE---VNALECEIQLLKNLLHERI 66

Query: 265 VKLYGYCLH---KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK----AMAHA 317
           V+ YG CL    ++ + +  E+M  GS+       +D ++   A   N+ +     +   
Sbjct: 67  VQYYG-CLRDPMERTLSIFMEHMPGGSI-------KDQLKSYGALTENVTRKYTRQILEG 118

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA---DSSNRTLLAGTYGY 374
           ++YLH   S  I+HRDI   NIL +S     + DFG ++ L       +    + GT  +
Sbjct: 119 VSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175

Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           ++PE+        K D++S G   +E+L  K P
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 61/225 (27%), Positives = 99/225 (44%), Gaps = 34/225 (15%)

Query: 208 DIRY--CIGTGGYGSVYKAQLPNGKV---FALKKLHTSEELAFIKSFKNEAQVLSQV-LH 261
           DI++   IG G +G V KA++    +    A+K++         + F  E +VL ++  H
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN-------------NEDAVELDWAKRV 308
            NI+ L G C H+  ++L  EY   G+L   L               N  A  L   + +
Sbjct: 68  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127

Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
           +    +A  + YL        IHRD+++ NIL+     A +ADFG +R           +
Sbjct: 128 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYV 178

Query: 369 AGTYG-----YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
             T G     ++A E     V T   DV+S+GV+  E++ +G  P
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 44/150 (29%), Positives = 76/150 (50%), Gaps = 15/150 (10%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHRNIVKLYGY 270
           IG G YG VYKA+    G++ ALKK+    E   + S    E  +L ++ H NIV+L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHALAYLHHDCS 326
              +  ++L++E+++      +L    D+  L       ++K+    +   +AY H   S
Sbjct: 67  VHSENKLYLVFEFLDL-----DLKKYMDSSPLT-GLDPPLIKSYLYQLLQGIAYCH---S 117

Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTAR 356
             ++HRD+   N+L++ +    +ADFG AR
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 66.0 bits (161), Expect = 5e-12
 Identities = 74/278 (26%), Positives = 116/278 (41%), Gaps = 49/278 (17%)

Query: 213 IGTGGYGSVYKAQLPN-----GKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHRN 263
           +G G +GSV + QL        KV A+K +    HT  E   I+ F +EA  +    H N
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKV-AVKTMKLDIHTYSE---IEEFLSEAACMKDFDHPN 62

Query: 264 IVKLYGYCLHKKCM------FLIYEYMERGSLFCNL---HNNEDAVELDWAKRVNIVKAM 314
           ++KL G C     +       +I  +M+ G L   L          +L     +  +  +
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122

Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY-- 372
           A  + YL    + + IHRD+++ N +L   +   VADFG ++ +++    R         
Sbjct: 123 ALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLD-- 429
            +IA E     V T K DV++FGV   E+   G+ P            P +   ++ D  
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY-----------PGVENHEIYDYL 228

Query: 430 ---QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPT 464
               RL  P D     D L     S  C +++PK RPT
Sbjct: 229 RHGNRLKQPED---CLDELYDLMYS--CWRADPKDRPT 261

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 65.9 bits (161), Expect = 5e-12
 Identities = 44/148 (29%), Positives = 79/148 (53%), Gaps = 12/148 (8%)

Query: 213 IGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHRNIVKLYGY 270
           IG G YG+V+KA+     ++ ALK++   ++   + S    E  +L ++ H+NIV+LY  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAV--ELDWAKRVNIVKAMAHALAYLHHDCSPS 328
               K + L++EY ++     +L    D+   ++D     + +  +   LA+ H   S +
Sbjct: 68  LHSDKKLTLVFEYCDQ-----DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHN 119

Query: 329 IIHRDISSNNILLNSKLEAFVADFGTAR 356
           ++HRD+   N+L+N   E  +ADFG AR
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 65.4 bits (159), Expect = 6e-12
 Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 18/197 (9%)

Query: 213 IGTGGYGSVYKA---QLPNGKVFALKKLHTSEELAFIK-SFKNEAQVLSQVLHRNIVKLY 268
           +G+G +G+V K       + K  A+K L        +K     EA V+ Q+ +  IV++ 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
           G C  +  M L+ E  E G L   L  N+   E +      +V  ++  + YL      +
Sbjct: 63  GICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNI---TELVHQVSMGMKYLEET---N 115

Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG-----YIAPELAYTM 383
            +HRD+++ N+LL ++  A ++DFG ++ L AD +     A T+G     + APE     
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK--AKTHGKWPVKWYAPECMNYY 173

Query: 384 VMTEKCDVYSFGVVTLE 400
             + K DV+SFGV+  E
Sbjct: 174 KFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 66.1 bits (161), Expect = 7e-12
 Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 38/225 (16%)

Query: 213 IGTGGYGSVYKA-----------QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLH 261
           +G G +G V +A           Q     V  LK   T ++LA + S     +++ +  H
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK--H 77

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNN-----EDAVE--------LDWAKRV 308
           +NI+ L G C  +  +++I EY  +G+L   L        +   +        L +   V
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH-----ADSS 363
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H       +S
Sbjct: 138 SCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194

Query: 364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
           N  L      ++APE  +  V T + DV+SFG++  E+  +G  P
Sbjct: 195 NGRL---PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 65.7 bits (160), Expect = 7e-12
 Identities = 70/278 (25%), Positives = 120/278 (43%), Gaps = 33/278 (11%)

Query: 213 IGTGGYGSVYKAQLP----NGKVFALKKLHTSEELAF-IKSFKNEAQVLSQVLHRNIVKL 267
           +G G +GSV +AQL     + +  A+K L      +  I+ F  EA  + +  H N++KL
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 268 YGYCLHKKCM------FLIYEYMERGSLFCNL---HNNEDAVELDWAKRVNIVKAMAHAL 318
            G  L  +         +I  +M+ G L   L      E+   L     V  +  +A  +
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIA 376
            YL    S + IHRD+++ N +LN  +   VADFG ++ +++    R   A      ++A
Sbjct: 127 EYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183

Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP 435
            E     V T   DV++FGV   E++  G+ P       +   + +I    +   RL  P
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMTRGQTP------YAGVENSEIYNYLIKGNRLKQP 237

Query: 436 VD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            D  + + +++        C    PK RP+ Q +  + 
Sbjct: 238 PDCLEDVYELM------CQCWSPEPKCRPSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 65.5 bits (160), Expect = 9e-12
 Identities = 70/262 (26%), Positives = 106/262 (40%), Gaps = 38/262 (14%)

Query: 196 VYEDLIEATEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLH-TSEELAFIKSFKNEA 253
             EDL +  E       IG G +G+V K    P+G + A+K++  T +E    +   +  
Sbjct: 2   TAEDLKDLGE-------IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLD 54

Query: 254 QVLSQVLHRNIVKLYGYCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAK-RV 308
            V+       IVK YG    +     CM L+   +++   +          E    K  V
Sbjct: 55  VVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAV 114

Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
             VKA+ +    L       IIHRD+  +NILL+      + DFG +  L  DS  +T  
Sbjct: 115 ATVKALNYLKEELK------IIHRDVKPSNILLDRNGNIKLCDFGISGQL-VDSIAKTRD 167

Query: 369 AGTYGYIAPEL-------AYTMVMTEKCDVYSFGVVTLEVLMGKHPRD----ILSSLSS- 416
           AG   Y+APE         Y +    + DV+S G+   EV  GK P      +   L+  
Sbjct: 168 AGCRPYMAPERIDPSARDGYDV----RSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQV 223

Query: 417 -SSDPKIMLIDVLDQRLPPPVD 437
              DP I+      +  P  V+
Sbjct: 224 VKGDPPILSNSEEREFSPSFVN 245

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 67.2 bits (164), Expect = 1e-11
 Identities = 47/132 (35%), Positives = 66/132 (50%), Gaps = 4/132 (3%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
           G IP  +G  ++L ++ +  NS  G +PS    L  +  LD+S+N L G+I      M  
Sbjct: 394 GEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPS 453

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNG 124
           L  L L+ N   G +P +     RL+ L+LS N+ SG VP     LS +   + LS N  
Sbjct: 454 LQMLSLARNKFFGGLP-DSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQ-LKLSENK- 510

Query: 125 LCGNILD-LPSC 135
           L G I D L SC
Sbjct: 511 LSGEIPDELSSC 522

Length = 968

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 38/218 (17%)

Query: 213 IGTGGYGSVYKAQL------PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G   +G VYK  L         +  A+K L    E    + FK+EA + S++ H NIV 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNL-----HNNEDAVE--------LDWAKRVNIVKA 313
           L G    ++ + +I+ Y     L   L     H++  + +        L+ A  V+IV  
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 314 MAHALAYL--HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT 371
           +A  + +L  HH     ++H+D+++ N+L+  KL   ++D G  R ++A +    L+  +
Sbjct: 133 IAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYA-ADYYKLMGNS 186

Query: 372 Y---GYIAPELAYTMVMTEKC----DVYSFGVVTLEVL 402
                +++PE     +M  K     D++S+GVV  EV 
Sbjct: 187 LLPIRWMSPE----AIMYGKFSIDSDIWSYGVVLWEVF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 16/202 (7%)

Query: 213 IGTGGYGSVYKAQLP-NGKVFALKKLH-----TSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           IG G +G V  A+   +GK +A+K L        +E   I + +N   +L  V H  +V 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERN--VLLKNVKHPFLVG 60

Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYLHHDC 325
           L+      + ++ + +++  G LF +L       E     R     A +A AL YLH   
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPE----PRARFYAAEIASALGYLH--- 113

Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVM 385
           S +I++RD+   NILL+S+    + DFG  +   A S   T   GT  Y+APE+      
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173

Query: 386 TEKCDVYSFGVVTLEVLMGKHP 407
               D +  G V  E+L G  P
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 55/207 (26%), Positives = 84/207 (40%), Gaps = 24/207 (11%)

Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSF-------------KNEAQVLSQV 259
           +G G +G+VY        +   KK    E L  +K                 EAQ+LS++
Sbjct: 8   LGKGSFGTVY--------LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL 59

Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H  IVK +   L +    +I EY E   L C L   +   +        + +     L 
Sbjct: 60  DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT--LSENQVCEWFIQLLL 117

Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
            +H+     I+HRD+ + NI L + L   + DFG +RLL       T   GT  Y++PE 
Sbjct: 118 GVHYMHQRRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFTGTPYYMSPEA 176

Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKH 406
                   K D++S G +  E+    H
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEMCCLAH 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 34/227 (14%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQ 258
           ED      IG G +G V +A +       N  +  LK+  +  +    + F  E +VL +
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH---RDFAGELEVLCK 58

Query: 259 V-LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWA-----------K 306
           +  H NI+ L G C ++  +++  EY   G+L   L  +   +E D A            
Sbjct: 59  LGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSR-VLETDPAFAKEHGTASTLT 117

Query: 307 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT 366
              +++  +     + +      IHRD+++ N+L+   L + +ADFG +R          
Sbjct: 118 SQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR------GEEV 171

Query: 367 LLAGTYG-----YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
            +  T G     ++A E     V T K DV+SFGV+  E++ +G  P
Sbjct: 172 YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 88/342 (25%), Positives = 142/342 (41%), Gaps = 76/342 (22%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTS-----EELAFIKSFKNEAQVLSQ 258
           +DF+    IG G +G V   Q  + G ++A+K L  +     E++A I++   E  +L +
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRA---ERDILVE 57

Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 314
                +VK++     K+ ++LI E++  G +   L      +E+A +   A+ V  + A+
Sbjct: 58  ADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI 117

Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA-------------RLLHAD 361
            H L +         IHRDI  +N+LL++K    ++DFG                L H  
Sbjct: 118 -HQLGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNP 167

Query: 362 SS------------------NRTLLA----GTYGYIAPELAYTMVMTEKCDVYSFGVVTL 399
            S                  NR  LA    GT  YIAPE+       + CD +S GV+  
Sbjct: 168 PSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227

Query: 400 EVLMGKHPRDILSSLSSSSDPKIMLIDVLDQR----LPP--PVDRKVIRDILLISTVSFA 453
           E+L+G  P         S  P+     V++ +     PP  P+  K    IL   T S  
Sbjct: 228 EMLIGYPP-------FCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSEN 280

Query: 454 CLQSNP----KSRPTMQSVSQEFLITRKTPL-VKHAAIQDIS 490
            + SN     KS P  + V    +  R   + ++  +I D S
Sbjct: 281 RIGSNGVEEIKSHPFFEGVDWGHIRERPAAIPIEIKSIDDTS 322

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 30/221 (13%)

Query: 213 IGTGGYGSVYKAQL-------PN--GKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHR 262
           +G G +G V  A+        PN   KV A+K L +      +    +E +++  +  H+
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKV-AVKMLKSDATEKDLSDLISEMEMMKMIGKHK 84

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSL-------------FCNLHNNEDAVELDWAKRVN 309
           NI+ L G C     +++I EY  +G+L             +C         +L +   V+
Sbjct: 85  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144

Query: 310 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA 369
               +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H     +    
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201

Query: 370 GTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
           G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 71/262 (27%), Positives = 109/262 (41%), Gaps = 36/262 (13%)

Query: 252 EAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIV 311
           EA +L  + H +I++L G   + K   LI     +  L+C L        +     + I 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYL---AAKRNIAICDILAIE 188

Query: 312 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAG 370
           +++  A+ YLH +    IIHRDI + NI +N   +  + DFG A      ++N+    AG
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAG 245

Query: 371 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP---RDILSSLSSSSDPKIMLIDV 427
           T    APEL          D++S G+V  E+         +D L      SD +I LI  
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDG-DCDSDRQIKLIIR 304

Query: 428 LDQRLPP--PVDRKVIRDILLISTVSFACLQSN--PKSRPTMQSVSQ-----EFLI---- 474
                P   P+D +   D + I        +S+  P SRP   ++ +     E+LI    
Sbjct: 305 RSGTHPNEFPIDAQANLDEIYIGL----AKKSSRKPGSRPLWTNLYELPIDLEYLICKML 360

Query: 475 ---TRKTP----LVKHAAIQDI 489
                  P    L+  AA QDI
Sbjct: 361 AFDAHHRPSAEALLDFAAFQDI 382

Length = 391

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 71/260 (27%), Positives = 107/260 (41%), Gaps = 70/260 (26%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE-----ELAFIKSFKNEAQVLSQ 258
           EDF     IG G +G V   Q    GK++A+K L  SE     +LA +K+   E  VL++
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKA---ERDVLAE 57

Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 314
                +V LY      + ++LI E++  G L   L      +ED      A+ V  ++A+
Sbjct: 58  SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAV 117

Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA-------------RLLHAD 361
            H L +         IHRDI  +NIL++      ++DFG +             +LL   
Sbjct: 118 -HKLGF---------IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGK 167

Query: 362 SS------------------------------NRTLLA----GTYGYIAPELAYTMVMTE 387
           S+                              NR L+A    GT  YIAPE+       +
Sbjct: 168 SNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227

Query: 388 KCDVYSFGVVTLEVLMGKHP 407
           +CD +S G +  E L+G  P
Sbjct: 228 ECDWWSLGAIMFECLIGWPP 247

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 14/201 (6%)

Query: 213 IGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLH---RNIVKLY 268
           +G G +G V  A+L   G+ FA+K L   +++  I        V  +VL     N    +
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKAL--KKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 269 GYCLH--KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
            YC    K+ +F + E++  G L  ++   +D    D  +       +   L +LH   S
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHI---QDKGRFDLYRATFYAAEIVCGLQFLH---S 114

Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMT 386
             II+RD+  +N++L+      +ADFG  +      +  +   GT  YIAPE+   +  T
Sbjct: 115 KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYT 174

Query: 387 EKCDVYSFGVVTLEVLMGKHP 407
              D +SFGV+  E+L+G+ P
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 22/205 (10%)

Query: 213 IGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQ--------VLSQVLHRN 263
           IG G +G V  A+   +GK +A+K L      A +K  K E +        +L  V H  
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKK---AILK--KKEQKHIMAERNVLLKNVKHPF 57

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYLH 322
           +V L+        ++ + +Y+  G LF +L       E     R     A +A AL YLH
Sbjct: 58  LVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPE----PRARFYAAEIASALGYLH 113

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S +II+RD+   NILL+S+    + DFG  +     S   +   GT  Y+APE+   
Sbjct: 114 ---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK 170

Query: 383 MVMTEKCDVYSFGVVTLEVLMGKHP 407
                  D +  G V  E+L G  P
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 19/210 (9%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKV--FALKKLHTSEEL--AFIKSFKNEAQVLSQVL 260
           EDF+    +GTG +G V  A   N      A+K+   S+ +    +    +E ++L+ + 
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNE---DAVELDWAKRVNIVKAMAHA 317
           H   V LYG    +  ++L+ E++  G  F  L  N+   + V   +A ++ ++      
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI------ 143

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
             YL    S +I++RD+   N+LL+      + DFG A+++  D+   TL  GT  YIAP
Sbjct: 144 FEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV--DTRTYTL-CGTPEYIAP 197

Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           E+   +   +  D ++ G+   E+L+G  P
Sbjct: 198 EILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 54/183 (29%), Positives = 82/183 (44%), Gaps = 24/183 (13%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKK-LHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           IG G +G V+KA+     ++ ALKK L  +E+  F  +   E ++L  + H N+V L   
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 271 CLHKKCMF-----LIYEYMERGSLFCN-----LHNNEDAVELDWAKRVNIVKAMAHALAY 320
           C  K   +       Y   E    FC      L +N+  V+   ++   ++K + + L Y
Sbjct: 80  CRTKATPYNRYKGSFYLVFE----FCEHDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYY 134

Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH---ADSSNR-TLLAGTYGYIA 376
           +H      I+HRD+ + NIL+       +ADFG AR          NR T    T  Y  
Sbjct: 135 IH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRP 191

Query: 377 PEL 379
           PEL
Sbjct: 192 PEL 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 50/175 (28%), Positives = 86/175 (49%), Gaps = 25/175 (14%)

Query: 249 FKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAVE----- 301
           F  E ++LS++   NI++L G C+ +  + +I EYME G L  F + H+ +D  E     
Sbjct: 66  FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125

Query: 302 ---------LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF 352
                    + ++  +++   +A  + YL    S + +HRD+++ N L+   L   +ADF
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADF 182

Query: 353 GTARLLHADS----SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM 403
           G +R L+A        R +L     ++A E       T   DV++FGV   E+LM
Sbjct: 183 GMSRNLYAGDYYRIQGRAVLP--IRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 20/204 (9%)

Query: 213 IGTGGYGSVYKAQLPNGKVF-ALKKLHTSEELAFIKSFKNEAQVLSQ--VLHRNIVKLYG 269
           IG G +G V  A+    + F A+K L   ++ A +K  K E  ++S+  VL +N+   + 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVL---QKKAILKK-KEEKHIMSERNVLLKNVKHPFL 58

Query: 270 YCLH-----KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYLHH 323
             LH        ++ + +Y+  G LF +L      +E     R     A +A AL YLH 
Sbjct: 59  VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE----PRARFYAAEIASALGYLH- 113

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
             S +I++RD+   NILL+S+    + DFG  +     +   +   GT  Y+APE+ +  
Sbjct: 114 --SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQ 171

Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
                 D +  G V  E+L G  P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 65.6 bits (160), Expect = 4e-11
 Identities = 35/92 (38%), Positives = 53/92 (57%), Gaps = 5/92 (5%)

Query: 39  TNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLS-RLDYLNLSSN 97
           + + ++DLS   +SGKI   I  + Y+  ++LSNN + G IP +I   S  L YLNLS+N
Sbjct: 69  SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNN 128

Query: 98  KLSGPVPFSNNDLSSMHTVVSLSPNNGLCGNI 129
             +G +P     + ++ T + LS NN L G I
Sbjct: 129 NFTGSIP--RGSIPNLET-LDLS-NNMLSGEI 156

Length = 968

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 20/200 (10%)

Query: 213 IGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           +G G Y +VYK +   NGK+ ALK +   EE     +   EA +L  + H NIV L+   
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72

Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNE------DAVELDWAKRVNIVKAMAHALAYLHHDC 325
             K+ + L++EY+   +  C   +        + V+L        +  +   L+Y+H   
Sbjct: 73  HTKETLTLVFEYVH--TDLCQYMDKHPGGLHPENVKL-------FLFQLLRGLSYIHQR- 122

Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVM 385
              I+HRD+   N+L++   E  +ADFG AR     S   +    T  Y  P++      
Sbjct: 123 --YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180

Query: 386 TEKC-DVYSFGVVTLEVLMG 404
              C D++  G + +E++ G
Sbjct: 181 YSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 64.0 bits (156), Expect = 4e-11
 Identities = 63/235 (26%), Positives = 100/235 (42%), Gaps = 40/235 (17%)

Query: 213 IGTGGYGSVYKAQLP-NGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           IG G +G V+    P +GK  ALKK+ +  + L   K    E ++L    H N++     
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67

Query: 271 -------CLHKKCMFLIYEYMERGSLFCNLHN--------NEDAVELDWAKRVNIVKAMA 315
                     +  ++++ E M+      +LH         + D V++        +  + 
Sbjct: 68  LQPPHIDPFEE--IYVVTELMQ-----SDLHKIIVSPQPLSSDHVKV-------FLYQIL 113

Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS-NRTLLAGTYGY 374
             L YLH   S  I+HRDI   N+L+NS     + DFG AR+   D S + T    T  Y
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170

Query: 375 IAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVL 428
            APE L  +   T   D++S G +  E+L  +    IL    S      ++ D+L
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRR----ILFQAQSPIQQLDLITDLL 221

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 44/163 (26%), Positives = 74/163 (45%), Gaps = 19/163 (11%)

Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKR 307
           H+NI+ L G C     +++I EY  +G+L   L                    ++ +   
Sbjct: 80  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139

Query: 308 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL 367
           V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +  
Sbjct: 140 VSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196

Query: 368 LAGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
             G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 63.5 bits (154), Expect = 6e-11
 Identities = 64/245 (26%), Positives = 102/245 (41%), Gaps = 52/245 (21%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           EDF+    IG G +G V   Q  + G V+A+K L  ++  E   +   + E  +L +   
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHA 317
             +VK++     K  ++LI E++  G +   L       E+  +   A+ V  + ++ H 
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI-HQ 119

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG------------------------ 353
           L +         IHRDI  +N+LL+SK    ++DFG                        
Sbjct: 120 LGF---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSD 170

Query: 354 -------TARLLHADSSNRTLLA----GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL 402
                  + R       NR  LA    GT  YIAPE+       + CD +S GV+  E+L
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Query: 403 MGKHP 407
           +G  P
Sbjct: 231 IGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 62.9 bits (153), Expect = 6e-11
 Identities = 62/203 (30%), Positives = 93/203 (45%), Gaps = 18/203 (8%)

Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFK------NEAQVLSQVLHRNIV 265
           +G GG+G V   Q+   GK++A KKL    E   IK  K      NE Q+L +V  R +V
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKL----EKKRIKKRKGEAMALNEKQILEKVNSRFVV 63

Query: 266 KL-YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            L Y Y   K  + L+   M  G L  +++N  +    D  + V     +   L  LH  
Sbjct: 64  SLAYAY-ETKDALCLVLTLMNGGDLKFHIYNMGNP-GFDEERAVFYAAEITCGLEDLH-- 119

Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
               I++RD+   NILL+      ++D G A  +    + R  + GT GY+APE+     
Sbjct: 120 -RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV-GTVGYMAPEVVKNER 177

Query: 385 MTEKCDVYSFGVVTLEVLMGKHP 407
            T   D +  G +  E++ GK P
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 21/203 (10%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVF-ALKKL--HTSEELAFIKSFKNEAQVLSQVL---HRNIV 265
           IG G YG V+KA+ L NG  F ALK++   T EE   + + + E  VL  +    H N+V
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 67

Query: 266 KLYGYCLHKKC-----MFLIYEYMERGSLFCNLHNNED-AVELDWAKRVNIVKAMAHALA 319
           +L+  C   +      + L++E++++  L   L    +  V  +  K  +++  +   L 
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK--DMMFQLLRGLD 124

Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           +LH   S  ++HRD+   NIL+ S  +  +ADFG AR +++     T +  T  Y APE+
Sbjct: 125 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVVVTLWYRAPEV 180

Query: 380 AYTMVMTEKCDVYSFGVVTLEVL 402
                     D++S G +  E+ 
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMF 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 63.5 bits (155), Expect = 7e-11
 Identities = 59/228 (25%), Positives = 93/228 (40%), Gaps = 40/228 (17%)

Query: 199 DLIEATEDFDIRY----CIGTGGYGSVYKAQLPNGKV-FALKKLHTS-EELAFIKSFKNE 252
           +L +   +   RY     +G+G YG V  A         A+KKL    +     K    E
Sbjct: 5   ELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRE 64

Query: 253 AQVLSQVLHRNIVKLYGYCLHKKC-------MFLIYEYMERGSLFCNLHN-------NED 298
            ++L  + H N++ L                ++L+   M       +L+N       ++D
Sbjct: 65  LRLLKHMDHENVIGLLD-VFTPASSLEDFQDVYLVTHLMGA-----DLNNIVKCQKLSDD 118

Query: 299 AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL 358
            ++        +V  +   L Y+H   S  IIHRD+  +NI +N   E  + DFG AR  
Sbjct: 119 HIQF-------LVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR-- 166

Query: 359 HADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGK 405
           H D    T    T  Y APE+    M   +  D++S G +  E+L GK
Sbjct: 167 HTD-DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 62.8 bits (153), Expect = 8e-11
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 14/204 (6%)

Query: 213 IGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAF--IKSFKNEAQVLSQV-LHRNIVKLY 268
           +G G +G V  A+L    +++A+K L     L    ++    E +VL+    H  + +L+
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
                K  +F + EY+  G L  ++  +      D  +       +   L +LH      
Sbjct: 63  SCFQTKDRLFFVMEYVNGGDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLH---ERG 116

Query: 329 IIHRDISSNNILLNSKLEAFVADFGTAR--LLHADSSNRTLLAGTYGYIAPELAYTMVMT 386
           II+RD+  +N+LL+S+    +ADFG  +  +L   +++     GT  YIAPE+       
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST--FCGTPDYIAPEILSYQPYG 174

Query: 387 EKCDVYSFGVVTLEVLMGKHPRDI 410
              D ++ GV+  E+L G+ P + 
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEG 198

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 62.0 bits (150), Expect = 9e-11
 Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 38/221 (17%)

Query: 213 IGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR-NIV 265
           IG G +G V KA++       +  +  +K+  + ++    + F  E +VL ++ H  NI+
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH---RDFAGELEVLCKLGHHPNII 59

Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNE-------------DAVELDWAKRVNIVK 312
            L G C H+  ++L  EY   G+L   L  +               A  L   + ++   
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 313 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY 372
            +A  + YL        IHRD+++ NIL+     A +ADFG +R           +  T 
Sbjct: 120 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTM 170

Query: 373 G-----YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
           G     ++A E     V T   DV+S+GV+  E++ +G  P
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 10/199 (5%)

Query: 213 IGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAF--IKSFKNEAQVLSQVL-HRNIVKLY 268
           +G G +G V  A+L    + FA+K L     L    ++    E +VL+    H  +  L+
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
                K+ +F + EY+  G L   + + + +   D A+       +   L +LH      
Sbjct: 63  CTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICGLQFLH---KKG 116

Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 388
           II+RD+  +N+LL+      +ADFG  +         +   GT  YIAPE+       E 
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNES 176

Query: 389 CDVYSFGVVTLEVLMGKHP 407
            D +SFGV+  E+L+G+ P
Sbjct: 177 VDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 56/235 (23%), Positives = 98/235 (41%), Gaps = 46/235 (19%)

Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSL-----------------FCNLHNNEDAVELD 303
           H+NI+ L G C     ++++ EY  +G+L                  C L   +    L 
Sbjct: 77  HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ----LT 132

Query: 304 WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS 363
           +   V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H    
Sbjct: 133 FKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDY 189

Query: 364 NRTLLAGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPK 421
            +    G     ++APE  +  V T + DV+SFGV+  E+           +L  S  P 
Sbjct: 190 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF----------TLGGSPYPG 239

Query: 422 IMLIDVLD-----QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQE 471
           I + ++        R+  P +     ++ +I      C  + P  RPT + + ++
Sbjct: 240 IPVEELFKLLKEGHRMDKPAN--CTHELYMIMR---ECWHAVPSQRPTFKQLVED 289

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 56/226 (24%), Positives = 89/226 (39%), Gaps = 44/226 (19%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKN-------------EAQVLSQ 258
           +G G YG V KA     GK+ A+KK+   E    +   +              E +++++
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
           + H NI+ L    +    + L+ + M    L   +      + L  ++   I+  + + L
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGL 132

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG----- 373
             LH       +HRD+S  NI +NSK    +ADFG AR       + TL           
Sbjct: 133 NVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189

Query: 374 ---------YIAPEL-----AYTMVMTEKCDVYSFGVVTLEVLMGK 405
                    Y APEL      Y        D++S G +  E+L GK
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKY----HFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 32/213 (15%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKL-------HTSEELAFIKSFKNEAQVLSQVLHRNI 264
           +G G +G VY       G+  A+K++        TS+E   + + + E Q+L  + H  I
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE---VNALECEIQLLKNLRHDRI 66

Query: 265 VKLYGYCLH---KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK----AMAHA 317
           V+ YG CL    +K + +  EYM  GS+       +D ++   A   N+ +     +   
Sbjct: 67  VQYYG-CLRDPEEKKLSIFVEYMPGGSI-------KDQLKAYGALTENVTRRYTRQILQG 118

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT---LLAGTYGY 374
           ++YLH   S  I+HRDI   NIL +S     + DFG ++ +     + T    + GT  +
Sbjct: 119 VSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175

Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           ++PE+        K DV+S     +E+L  K P
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 55/193 (28%), Positives = 87/193 (45%), Gaps = 32/193 (16%)

Query: 229 GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLH--RNIVKLYGYCLHKKCMFLIYEYMER 286
            + F LK L  S E +  +        L+ + H   N+V L+ Y + +  +FL+ ++ E 
Sbjct: 18  QQTFILKGLRKSSEYSRER--------LTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG 69

Query: 287 GSLFCN----LHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN 342
           G L+ +    L+  E+ V+  WA        M  AL  LH +    I+ RD++ NNILL+
Sbjct: 70  GKLWSHISKFLNIPEECVK-RWAAE------MVVALDALHRE---GIVCRDLNPNNILLD 119

Query: 343 SKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL 402
            +    +  F     +  DS +   +   Y   APE+      TE CD +S G +  E+L
Sbjct: 120 DRGHIQLTYFSRWSEV-EDSCDGEAVENMY--CAPEVGGISEETEACDWWSLGAILFELL 176

Query: 403 MGK-----HPRDI 410
            GK     HP  I
Sbjct: 177 TGKTLVECHPSGI 189

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 74/282 (26%), Positives = 116/282 (41%), Gaps = 54/282 (19%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTS---EELAFIKSFKNEAQVLSQVL 260
            D +    IG+G  G VYK +    G V A+K++  +   EE    K    +  V+ +  
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN---KRILMDLDVVLKS- 70

Query: 261 HR--NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN--------- 309
           H    IVK YGY +    +F+  E M   +    L            KR+          
Sbjct: 71  HDCPYIVKCYGYFITDSDVFICMELM--STCLDKL-----------LKRIQGPIPEDILG 117

Query: 310 -IVKAMAHALAYL--HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA-RLLHADSSNR 365
            +  A+  AL YL   H     +IHRD+  +NILL++     + DFG + RL+  DS  +
Sbjct: 118 KMTVAIVKALHYLKEKH----GVIHRDVKPSNILLDASGNVKLCDFGISGRLV--DSKAK 171

Query: 366 TLLAGTYGYIAPELAYTMVMTEK----CDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPK 421
           T  AG   Y+APE         K     DV+S G+  +E+  G+ P       +  ++ +
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK-----NCKTEFE 226

Query: 422 IMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRP 463
            +L  +L +  P     +        S V   CL  + + RP
Sbjct: 227 -VLTKILQEEPPSLPPNEGF-SPDFCSFVDL-CLTKDHRKRP 265

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 76/270 (28%), Positives = 115/270 (42%), Gaps = 42/270 (15%)

Query: 213 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG G +G VY   L   +G+    A+K L+   +L  ++ F  E  ++    H N++ L 
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 269 GYCLHKKCMFLI-YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM-------AHALAY 320
           G CL  +   L+   YM+ G L  N   +E             VK +       A  + Y
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLR-NFIRSE--------THNPTVKDLIGFGLQVAKGMEY 113

Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS----SNRTLLAGTYGYIA 376
           L    S   +HRD+++ N +L+      VADFG AR ++        N T       ++A
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170

Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP-RDILSSLSSSSDPKIMLIDVLDQRLPP 434
            E   T   T K DV+SFGV+  E++  G  P  D+      S D  + L+    +RL  
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----DSFDITVYLLQ--GRRLLQ 223

Query: 435 PVDRKVIRDILLISTVSFACLQSNPKSRPT 464
           P   +   D L    V  +C    P+ RPT
Sbjct: 224 P---EYCPDPLY--EVMLSCWHPKPEMRPT 248

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 11/203 (5%)

Query: 207 FDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSEELAFIKSFK-NEAQVLSQVLHRNI 264
           F++   +G G YG V K +    K + A+KK   SEE   +K     E ++L  +   NI
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62

Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+L      +  ++L++EY+E+  L       E   E+        V++  + L    H 
Sbjct: 63  VELKEAFRRRGKLYLVFEYVEKNML-------ELLEEMPNGVPPEKVRSYIYQLIKAIHW 115

Query: 325 CSPS-IIHRDISSNNILLNSKLEAFVADFGTAR-LLHADSSNRTLLAGTYGYIAPELAYT 382
           C  + I+HRDI   N+L++      + DFG AR L    ++N T    T  Y +PEL   
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG 175

Query: 383 MVMTEKCDVYSFGVVTLEVLMGK 405
               +  D++S G +  E+  G+
Sbjct: 176 APYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 18/203 (8%)

Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFK------NEAQVLSQVLHRNIV 265
           +G GG+G V   Q+   GK++A KKL        IK  K      NE ++L +V  R +V
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKR----IKKRKGEAMALNEKRILEKVNSRFVV 63

Query: 266 KL-YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            L Y Y   K  + L+   M  G L  +++N  +    D  + +     +   L  L  +
Sbjct: 64  SLAYAY-ETKDALCLVLTIMNGGDLKFHIYNMGNP-GFDEQRAIFYAAELCCGLEDLQRE 121

Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
               I++RD+   NILL+ +    ++D G A  +    + R  + GT GY+APE+     
Sbjct: 122 ---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV-GTVGYMAPEVINNEK 177

Query: 385 MTEKCDVYSFGVVTLEVLMGKHP 407
            T   D +  G +  E++ G+ P
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 63.3 bits (154), Expect = 2e-10
 Identities = 44/119 (36%), Positives = 68/119 (57%), Gaps = 10/119 (8%)

Query: 13  NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY-LTQLDLS 71
           N   ++ +D+   ++ G I SA+  L  +  ++LS+N+LSG IP +I +    L  L+LS
Sbjct: 67  NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126

Query: 72  NNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGNIL 130
           NNN  GSIP     +  L+ L+LS+N LSG +P   ND+ S  ++  L     L GN+L
Sbjct: 127 NNNFTGSIPR--GSIPNLETLDLSNNMLSGEIP---NDIGSFSSLKVLD----LGGNVL 176

Length = 968

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 18/203 (8%)

Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFK------NEAQVLSQVLHRNIV 265
           +G GG+G V   Q+   GK++A K+L    E   IK  K      NE Q+L +V  + +V
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRL----EKKRIKKRKGESMALNEKQILEKVNSQFVV 63

Query: 266 KL-YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            L Y Y   K  + L+   M  G L  +++N  +    +  + +     +   L  LH +
Sbjct: 64  NLAYAY-ETKDALCLVLTIMNGGDLKFHIYNMGNP-GFEEERALFYAAEILCGLEDLHRE 121

Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
              + ++RD+   NILL+      ++D G A  +    S R  + GT GY+APE+     
Sbjct: 122 ---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-GTVGYMAPEVLNNQR 177

Query: 385 MTEKCDVYSFGVVTLEVLMGKHP 407
            T   D +  G +  E++ G+ P
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 20/204 (9%)

Query: 213 IGTGGYGSVYKAQLPN-GKVFALKKL-------HTSEELAFIKSFKNEAQVLSQVLHRNI 264
           +G GG+G V   Q+ N GK++A KKL        + E++A +     E ++L +V    I
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALL-----EKEILEKVNSPFI 55

Query: 265 VKLYGYCLHKKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           V L  Y    K  + L+   M  G L  +++N      L+  + ++    +   + +LH 
Sbjct: 56  VNL-AYAFESKTHLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLH- 112

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
             S  I++RD+   N+LL+ +    ++D G A  L  D    T  AGT GY+APE+    
Sbjct: 113 --SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTITQRAGTNGYMAPEILKEE 169

Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             +   D ++ G    E++ G+ P
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 49/152 (32%), Positives = 69/152 (45%), Gaps = 33/152 (21%)

Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD------SSNRTLLAGTYGYIAPEL 379
           S   IHRD+++ NILL+      + DFG AR ++ D       S R  L     ++APE 
Sbjct: 192 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK----WMAPES 247

Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRL------- 432
            +  V T + DV+SFGV+  E+           SL +S  P + + +   QRL       
Sbjct: 248 IFDKVYTTQSDVWSFGVLLWEIF----------SLGASPYPGVQINEEFCQRLKDGTRMR 297

Query: 433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPT 464
            P      I  I+L      AC Q +PK RPT
Sbjct: 298 APENATPEIYRIML------ACWQGDPKERPT 323

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 14/150 (9%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           IG G YG VYK +    G++ A+KK+   SEE     +   E  +L ++ H NIV L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHALAYLHHDCS 326
            + +  ++LI+E+     L  +L    D++         +VK+    +   + + H   S
Sbjct: 68  LMQESRLYLIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---S 119

Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTAR 356
             ++HRD+   N+L+++K    +ADFG AR
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 60/240 (25%), Positives = 97/240 (40%), Gaps = 38/240 (15%)

Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
             +     IG G YG V  A   P G   A+KK+   E   F +    E ++L +  H N
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 264 IVKLY------GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 317
           I+ +        +      ++++ E ME      +L+       L        +  +   
Sbjct: 65  IIGILDIIRPPSFESFND-VYIVQELME-----TDLYKLIKTQHLSNDHIQYFLYQILRG 118

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL---LHADSSNRTLLAGTYGY 374
           L Y+H   S +++HRD+  +N+LLN+  +  + DFG AR+    H  +   T    T  Y
Sbjct: 119 LKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWY 175

Query: 375 IAPEL-----AYTMVMTEKCDVYSFGVVTLEVLM------GKHPRD----ILSSLSSSSD 419
            APE+      YT  +    D++S G +  E+L       GK        IL  L + S 
Sbjct: 176 RAPEIMLNSKGYTKAI----DIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQ 231

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 69/274 (25%), Positives = 114/274 (41%), Gaps = 34/274 (12%)

Query: 213 IGTGGYGSVYKAQL-------PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIV 265
           +G G +G VY+             +V A+K ++ S  L     F NEA V+      ++V
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRV-AVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 266 KLYGYCLHKKCMFLIYEYMERG-------SLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
           +L G     +   ++ E M  G       SL     NN         + + +   +A  +
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIA 376
           AYL+   +   +HRD+++ N ++       + DFG  R ++     R    G     ++A
Sbjct: 133 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189

Query: 377 PELAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDILSSLSSSSDPK-IMLIDVLDQRLPP 434
           PE     V T   D++SFGVV  E+  + + P      LS+    K +M    LDQ   P
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQP---YQGLSNEQVLKFVMDGGYLDQ---P 243

Query: 435 PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
               + + D++ +      C Q NPK RPT   +
Sbjct: 244 DNCPERVTDLMRM------CWQFNPKMRPTFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 65/236 (27%), Positives = 103/236 (43%), Gaps = 25/236 (10%)

Query: 213 IGTGGYGSVYKAQLP-NGKVFALKKLHTS-----EELAFIKSFKNEAQVLSQVLHRNIVK 266
           IG G +G V  A+   +G  +A+K L        +E   I + +N   +L  + H  +V 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERN--VLLKNLKHPFLVG 60

Query: 267 L-YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYLHHD 324
           L Y +   +K ++ + +Y+  G LF +L      +E     R     A +A A+ YLH  
Sbjct: 61  LHYSFQTAEK-LYFVLDYVNGGELFFHLQRERCFLE----PRARFYAAEVASAIGYLH-- 113

Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
            S +II+RD+   NILL+S+    + DFG  +         +   GT  Y+APE+     
Sbjct: 114 -SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEP 172

Query: 385 MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV 440
                D +  G V  E+L G  P         S D   M  ++L + L  P  + V
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP-------FYSRDVSQMYDNILHKPLQLPGGKTV 221

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 46/121 (38%), Positives = 68/121 (56%), Gaps = 7/121 (5%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           KI  +P  + NL NL  LD+  N L   +P  L +L+NL+NLDLS NK+S  +PPEI  +
Sbjct: 151 KIESLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELL 208

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN 122
             L +LDLSNN+I   +   ++ L  L  L LS+NKL          + ++  + +L  +
Sbjct: 209 SALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE----DLPESIGNLSNLETLDLS 263

Query: 123 N 123
           N
Sbjct: 264 N 264

Length = 394

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 66/265 (24%), Positives = 115/265 (43%), Gaps = 35/265 (13%)

Query: 213 IGTGGYGSVYKAQLP-NGKVFALKKL-----HTSEELAFIKSFKNEAQVLSQVL-HRNIV 265
           IG G Y  V   +L    +++A+K +     +  E++ ++++   E  V  Q   H  +V
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQT---EKHVFEQASNHPFLV 59

Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYLHHD 324
            L+     +  +F + EY+  G L  ++       E    +      A ++ AL YLH  
Sbjct: 60  GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEISLALNYLHER 115

Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
               II+RD+  +N+LL+S+    + D+G  +         +   GT  YIAPE+     
Sbjct: 116 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED 172

Query: 385 MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQ-------RLPPPVD 437
                D ++ GV+  E++ G+ P DI   + SS +P     D L Q       R+P  + 
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDI---VGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 229

Query: 438 RKVIRDILLISTVSFACLQSNPKSR 462
            K        ++V  + L  +PK R
Sbjct: 230 VKA-------ASVLKSFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 12/200 (6%)

Query: 213 IGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAF--IKSFKNEAQVLSQVL-HRNIVKLY 268
           +G G +G V  A+L  +G+++A+K L     L    ++    E ++LS    H  + +LY
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 269 GYCLHK-KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
             C      +F + E++  G L  ++  +      D A+       +  AL +LH     
Sbjct: 63  -CCFQTPDRLFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEITSALMFLH---DK 115

Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTE 387
            II+RD+  +N+LL+ +    +ADFG  +    +    +   GT  YIAPE+   M+   
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175

Query: 388 KCDVYSFGVVTLEVLMGKHP 407
             D ++ GV+  E+L G  P
Sbjct: 176 SVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 51/194 (26%), Positives = 88/194 (45%), Gaps = 18/194 (9%)

Query: 233 ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCN 292
           A+K L           F  E +++S++ + NI++L G C+    + +I EYME G L  N
Sbjct: 48  AVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL--N 105

Query: 293 LHNNEDAVELDWAKRVNIVKAMAHALAY--------LHHDCSPSIIHRDISSNNILLNSK 344
              ++  +E  +    NI       L Y        + +  S + +HRD+++ N L+ + 
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNH 165

Query: 345 LEAFVADFGTARLLHADS----SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLE 400
               +ADFG +R L++        R +L     ++A E       T   DV++FGV   E
Sbjct: 166 YTIKIADFGMSRNLYSGDYYRIQGRAVLP--IRWMAWESILLGKFTTASDVWAFGVTLWE 223

Query: 401 V--LMGKHPRDILS 412
           +  L  + P  +LS
Sbjct: 224 MFTLCKEQPYSLLS 237

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 60.3 bits (146), Expect = 4e-10
 Identities = 70/279 (25%), Positives = 112/279 (40%), Gaps = 41/279 (14%)

Query: 213 IGTGGYGSVYKAQLPNGKVFA---LKKLHTS----EELAFIKSFKNEAQVLSQVLHRNIV 265
           IG G +G V   +   G   A   +K+L  S    E+L F++    E Q   ++ H N++
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQ----EVQPYRELNHPNVL 58

Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH----ALAYL 321
           +  G C+      L+ E+   G L   L +N   V     K V  ++ MA      L +L
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV--LQRMACEVASGLLWL 116

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT--LLAGTYGYIAPEL 379
           H       IH D++  N  L + L   + D+G A   + +    T    A    ++APEL
Sbjct: 117 HQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173

Query: 380 A-------YTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLDQ- 430
                        T+K +++S GV   E+      P          SD +++   V +Q 
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP------YPDLSDEQVLKQVVREQD 227

Query: 431 -RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
            +LP P       D      + F  L   P++RPT + V
Sbjct: 228 IKLPKPQLDLKYSD-RWYEVMQFCWLD--PETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 34/226 (15%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKV-FALKK-------LHTSEELAFIKSFKNEAQVL 256
           EDF+    I  G YG+VY  +    +  FA+KK       L    +  F+     E  +L
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-----ERDIL 55

Query: 257 SQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 316
           +   +  +V ++     K+ + ++ EY+E G     L  N  A+ +D A R+   + +  
Sbjct: 56  TFAENPFVVSMFCSFETKRHLCMVMEYVEGGDC-ATLLKNIGALPVDMA-RMYFAETVL- 112

Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG---------TARLL--HADSSNR 365
           AL YLH   +  I+HRD+  +N+L+ S     + DFG         T  L   H +   R
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 366 TLL----AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
             L     GT  YIAPE+       +  D ++ G++  E L+G  P
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 62/262 (23%), Positives = 110/262 (41%), Gaps = 31/262 (11%)

Query: 213 IGTGGYGSVYKAQLP-NGKVFALKKL-----HTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           IG G Y  V   +L  N +++A+K +     H  E++ ++++   E  V  Q      + 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQT---EKHVFEQASSNPFLV 59

Query: 267 LYGYCLHKKC-MFLIYEYMERGSLFCNLHNNEDAVELD---WAKRVNIVKAMAHALAYLH 322
               C      +FL+ EY+  G L  ++       E     +A  + I      AL +LH
Sbjct: 60  GLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICI------ALNFLH 113

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
                 II+RD+  +N+LL++     + D+G  +         +   GT  YIAPE+   
Sbjct: 114 ER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG 170

Query: 383 MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQ--RLPPPVDRKV 440
                  D ++ GV+  E++ G+ P DI++     +    +   +L++  R+P  +  K 
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKA 230

Query: 441 IRDILLISTVSFACLQSNPKSR 462
                  S V    L  +PK R
Sbjct: 231 -------SHVLKGFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 61.8 bits (150), Expect = 6e-10
 Identities = 51/189 (26%), Positives = 84/189 (44%), Gaps = 30/189 (15%)

Query: 234 LKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY--GYCLHKKCMFLIYEYMERGSLFC 291
           L+     EE      F+ E  + +++ H NIV L   G       +F ++EY+   +L  
Sbjct: 11  LRTDAPEEEHQR-ARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLRE 68

Query: 292 NLHNN-----EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS--- 343
            L  +      +   L     + ++ A+A A     H+    I+HRD+   NI+++    
Sbjct: 69  VLAADGALPAGETGRL----MLQVLDALACA-----HN--QGIVHRDLKPQNIMVSQTGV 117

Query: 344 KLEAFVADFGTARLL----HADSSNRTL---LAGTYGYIAPELAYTMVMTEKCDVYSFGV 396
           +  A V DFG   LL     AD +  T    + GT  Y APE      +T   D+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177

Query: 397 VTLEVLMGK 405
           + LE L G+
Sbjct: 178 IFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 60.9 bits (147), Expect = 6e-10
 Identities = 55/207 (26%), Positives = 85/207 (41%), Gaps = 36/207 (17%)

Query: 249 FKNEAQVLSQVLHRNIVKL--------YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAV 300
            +NE   L ++ H NI+K+          Y + +K  F +Y +M   +      + +D  
Sbjct: 210 LENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF-----DWKDRP 264

Query: 301 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA 360
            L    R  I+K +  A+ Y+H      +IHRDI   NI LN   +  + DFGTA     
Sbjct: 265 LL-KQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK 319

Query: 361 DSSNRTL-LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-------------GKH 406
           +         GT    +PE+       E  D++S G++ L++L              GK 
Sbjct: 320 EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379

Query: 407 PRDILSSLSSSS----DPKIMLIDVLD 429
              I+ SLS       DP   L D +D
Sbjct: 380 LLKIIDSLSVCDEEFPDPPCKLFDYID 406

Length = 501

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.1 bits (143), Expect = 7e-10
 Identities = 33/126 (26%), Positives = 65/126 (51%), Gaps = 12/126 (9%)

Query: 216 GGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK 275
           G YG ++K ++       L K+       + +SF   A ++SQ+ H+++V  YG C+   
Sbjct: 20  GDYGELHKTEV-------LLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD 72

Query: 276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDIS 335
              ++ EY++ GSL   L  N++ + + W  ++ + K +A AL +L       + H ++ 
Sbjct: 73  ESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDK---GLTHGNVC 127

Query: 336 SNNILL 341
           + N+LL
Sbjct: 128 AKNVLL 133

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 76/302 (25%), Positives = 129/302 (42%), Gaps = 60/302 (19%)

Query: 207 FDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNI 264
           + I+  IG G YG V  A     G+  A+KK++   E ++       E ++L  + H +I
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 265 VKLYGYCLHK-----KCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMA 315
           V++    L       K +++++E ME      +LH     N+D   L        +  + 
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMES-----DLHQVIKANDD---LTPEHHQFFLYQLL 113

Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL---LAGTY 372
            AL Y+H   + ++ HRD+   NIL N+  +  + DFG AR+   D+           T 
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 373 GYIAPEL--AYTMVMTEKCDVYSFGVVTLEVLMGK---------HPRDILSSLSSSSDPK 421
            Y APEL  ++    T   D++S G +  EVL GK         H  D+++ L  +  P+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230

Query: 422 IM----------LIDVLDQRLP-------PPVDRKVIRDILLISTVSFACLQSNPKSRPT 464
            +           +  + ++ P       P  D   +R  LL   ++F     +PK RPT
Sbjct: 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALR--LLERLLAF-----DPKDRPT 283

Query: 465 MQ 466
            +
Sbjct: 284 AE 285

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 15/201 (7%)

Query: 213 IGTGGYGSVYKAQLPNG-KVFALKKLHTSEELAF--IKSFKNEAQVLSQVLHRNIVKLYG 269
           IG G +G V + +  +  +++ALK +  +  ++   +     E  VL+QV    IV L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA---MAHALAYLHHDCS 326
                + ++L+  ++  G LF +L             R ++ +A    A  L  L +   
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQRE---------GRFDLSRARFYTAELLCALENLHK 111

Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMT 386
            ++I+RD+   NILL+ +    + DFG  +L   D        GT  Y+APEL      T
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT 171

Query: 387 EKCDVYSFGVVTLEVLMGKHP 407
           +  D ++ GV+  E+L G  P
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 58.8 bits (143), Expect = 1e-09
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 35/206 (16%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLS----QVL-----HR 262
           IG G +  V KAQ    GK +A+K +         K FK+  QV +    Q L     H 
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCM--------KKHFKSLEQVNNLREIQALRRLSPHP 58

Query: 263 NIVKLYGYCLHKK--CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           NI++L      +K   + L++E M+  +L+  +   +    L   +  + +  +  +L +
Sbjct: 59  NILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRP--LPEKRVKSYMYQLLKSLDH 115

Query: 321 LHHDCSPSIIHRDISSNNILLNS---KLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           +H +    I HRDI   NIL+     KL    ADFG+ R ++      T    T  Y AP
Sbjct: 116 MHRN---GIFHRDIKPENILIKDDILKL----ADFGSCRGIY-SKPPYTEYISTRWYRAP 167

Query: 378 ELAYTM-VMTEKCDVYSFGVVTLEVL 402
           E   T      K D+++ G V  E+L
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 28/205 (13%)

Query: 213 IGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           +G G Y +V+K +      + ALK++    E     +   E  +L  + H NIV L+   
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 272 LHKKCMFLIYEYMER---------GSLFCNLHNNEDAVELDWAKRVNIVK-AMAHALAYL 321
             ++C+ L++EY++          G+L   +HN            V I    +   L+Y 
Sbjct: 73  HTERCLTLVFEYLDSDLKQYLDNCGNLMS-MHN------------VKIFMFQLLRGLSYC 119

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LA 380
           H      I+HRD+   N+L+N K E  +ADFG AR     +   +    T  Y  P+ L 
Sbjct: 120 HKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL 176

Query: 381 YTMVMTEKCDVYSFGVVTLEVLMGK 405
            +   +   D++  G +  E+  G+
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 49/207 (23%), Positives = 94/207 (45%), Gaps = 25/207 (12%)

Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAF--IKSFKNEAQVL---SQVLHRNIVK 266
           +G G +G V  A+    G+++A+K L   + +A   ++S   E ++    +   H  +V 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAY 320
           L+     +  +  + EY   G L  ++H              +  +A+ +A      L Y
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHIH----------TDVFSEPRAVFYAACVVLGLQY 116

Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELA 380
           LH +    I++RD+  +N+LL+++    +ADFG  +         +   GT  ++APE+ 
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVL 173

Query: 381 YTMVMTEKCDVYSFGVVTLEVLMGKHP 407
                T   D +  GV+  E+L+G+ P
Sbjct: 174 TETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 45/94 (47%), Positives = 59/94 (62%), Gaps = 4/94 (4%)

Query: 7   IPPEIGNLK-NLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYL 65
           IPP IG LK NL +LD+  N  I  +PS L +L NL NLDLS N LS  +P  ++++  L
Sbjct: 131 IPPLIGLLKSNLKELDLSDNK-IESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNL 188

Query: 66  TQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKL 99
             LDLS N I   +P EI  LS L+ L+LS+N +
Sbjct: 189 NNLDLSGNKIS-DLPPEIELLSALEELDLSNNSI 221

Length = 394

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 67/278 (24%), Positives = 118/278 (42%), Gaps = 33/278 (11%)

Query: 206 DFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKN---EAQVLSQVLH 261
           +F I   IG G +  VY+A  L + K  ALKK+   E +   K+ ++   E  +L Q+ H
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMD-AKARQDCVKEIDLLKQLNH 61

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELD-----WAKRVNIVKAMAH 316
            N++K     +    + ++ E  + G L   +   +    L      W   V +  A+ H
Sbjct: 62  PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121

Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
               +H   S  ++HRDI   N+ + +     + D G  R   + ++    L GT  Y++
Sbjct: 122 ----MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174

Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP--RDILSSLSSSSDPKIMLIDVLDQRLPP 434
           PE  +      K D++S G +  E+   + P   D ++  S        L   ++Q   P
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS--------LCQKIEQCDYP 226

Query: 435 PVDRKVIRDIL--LISTVSFACLQSNPKSRPTMQSVSQ 470
           P+  +   + L  L+S     C+  +P  RP +  V Q
Sbjct: 227 PLPTEHYSEKLRELVSM----CIYPDPDQRPDIGYVHQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 7/206 (3%)

Query: 206 DFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKN---EAQVLSQVLH 261
           +F I   IG G +  VY+A  L +G   ALKK+   + L   K+  +   E  +L Q+ H
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFD-LMDAKARADCIKEIDLLKQLNH 61

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            N++K Y   +    + ++ E  + G L   + + +    L   K V   K      + L
Sbjct: 62  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV--WKYFVQLCSAL 119

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
            H  S  ++HRDI   N+ + +     + D G  R   + ++    L GT  Y++PE  +
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHP 407
                 K D++S G +  E+   + P
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 55/206 (26%), Positives = 89/206 (43%), Gaps = 30/206 (14%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           +G G Y +VYK     NG++ ALK +    E     +   EA +L  + H NIV L+   
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72

Query: 272 LHKKCMFLIYEYMER----------GSLF-CNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
             K+ +  ++EYM            G L   N+             R+ + + +   LAY
Sbjct: 73  HTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNV-------------RLFMFQLL-RGLAY 118

Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-L 379
           +H      I+HRD+   N+L++   E  +ADFG AR     S   +    T  Y  P+ L
Sbjct: 119 IHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVL 175

Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGK 405
                 +   D++  G + +E+L G+
Sbjct: 176 LGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 58.0 bits (140), Expect = 4e-09
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 15/203 (7%)

Query: 213 IGTGGYGSVYKAQLPN-GKVFALKKLHTSE-----ELAFIKSFKNEAQVLSQVLHRNIVK 266
           IG G +G VY+ +  +  +++A+K L   E     E+A     +N            IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-HDC 325
           L         ++L+ +YM  G LF +L   E     D AK    +  +  AL +LH +D 
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQK-EGRFSEDRAKFY--IAELVLALEHLHKYD- 116

Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAYTMV 384
              I++RD+   NILL++     + DFG ++    D+       GT  Y+APE L     
Sbjct: 117 ---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173

Query: 385 MTEKCDVYSFGVVTLEVLMGKHP 407
            T+  D +S GV+  E+  G  P
Sbjct: 174 YTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 57.8 bits (139), Expect = 4e-09
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 23/205 (11%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLH-----TSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G V    +  +GK +A+K L        +E+A   +   E++VL    H  +  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLT---ESRVLKNTRHPFLTS 59

Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHALAYLH 322
           L      K  +  + EY+  G LF +L      +ED      A+ V+       AL YLH
Sbjct: 60  LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVS-------ALDYLH 112

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  I++RD+   N++L+      + DFG  +    D++      GT  Y+APE+   
Sbjct: 113 ---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED 169

Query: 383 MVMTEKCDVYSFGVVTLEVLMGKHP 407
                  D +  GVV  E++ G+ P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 57.0 bits (138), Expect = 5e-09
 Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 17/150 (11%)

Query: 213 IGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           +G G Y +VYK +    G++ ALK++    E     +   EA +L  + H NIV L+   
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72

Query: 272 LHKKCMFLIYEYMERG-SLFCNLHNNEDAVELDWAKRVNIVK----AMAHALAYLHHDCS 326
             KK + L++EY++     + +               ++ V+     +   LAY H    
Sbjct: 73  HTKKTLTLVFEYLDTDLKQYMDDCGG--------GLSMHNVRLFLFQLLRGLAYCHQR-- 122

Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTAR 356
             ++HRD+   N+L++ + E  +ADFG AR
Sbjct: 123 -RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 56.9 bits (137), Expect = 8e-09
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 25/206 (12%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLH-----TSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G V    +   G+ +A+K L        +E+A   +   E++VL    H  +  
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT---ESRVLQNTRHPFLTA 59

Query: 267 L-YGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHALAYL 321
           L Y +  H +  F++ EY   G LF +L       E+      A+ V+       AL YL
Sbjct: 60  LKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTEERARFYGAEIVS-------ALEYL 111

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
           H   S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+APE+  
Sbjct: 112 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 168

Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHP 407
                   D +  GVV  E++ G+ P
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 56.4 bits (136), Expect = 8e-09
 Identities = 60/241 (24%), Positives = 105/241 (43%), Gaps = 27/241 (11%)

Query: 249 FKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL--FCNLHN------NEDAV 300
           F  E +++S++   NI++L   C+    + +I EYME G L  F + H         D V
Sbjct: 66  FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125

Query: 301 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA 360
            + ++  + +   +A  + YL    S + +HRD+++ N L+       +ADFG +R L++
Sbjct: 126 TISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182

Query: 361 DS----SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM--GKHPRDILSSL 414
                   R +L     +++ E       T   DV++FGV   E+L    + P   LS  
Sbjct: 183 GDYYRIQGRAVLP--IRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240

Query: 415 SSSSDPKIMLIDVLDQ-RLP-PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
               +      D   Q  LP P +    +  ++L      +C + N K RP+ Q +    
Sbjct: 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLML------SCWRRNAKERPSFQEIHATL 294

Query: 473 L 473
           L
Sbjct: 295 L 295

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 25/52 (48%), Positives = 36/52 (69%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIP 56
           G IPP +G++ +L  LD+  NS  G IP +LG LT+L  L+L+ N LSG++P
Sbjct: 456 GNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 51/204 (25%), Positives = 91/204 (44%), Gaps = 26/204 (12%)

Query: 213 IGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           +G G Y +VYK +      + ALK++    E     +   E  +L  + H NIV L+   
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 272 LHKKCMFLIYEYMER---------GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
             +K + L++EY+++         G+   N+HN    V+L        +  +   L Y H
Sbjct: 74  HTEKSLTLVFEYLDKDLKQYLDDCGNSI-NMHN----VKL-------FLFQLLRGLNYCH 121

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAY 381
                 ++HRD+   N+L+N + E  +ADFG AR     +   +    T  Y  P+ L  
Sbjct: 122 RR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLG 178

Query: 382 TMVMTEKCDVYSFGVVTLEVLMGK 405
           +   + + D++  G +  E+  G+
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 59/301 (19%), Positives = 111/301 (36%), Gaps = 63/301 (20%)

Query: 212 CIGTGGYGSVYKAQLPNGKVFALKKLH----TSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           C        + K + P   + A+KK++    + E+L  ++    E     Q+ H NI+  
Sbjct: 9   CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQ---QEIITSRQLQHPNILPY 64

Query: 268 YGYCLHKKCMFLIYEYMERGS---LFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
               +    ++++   M  GS   L    H  E   EL  A    I+K + +AL Y+H  
Sbjct: 65  VTSFIVDSELYVVSPLMAYGSCEDLLKT-HFPEGLPELAIA---FILKDVLNALDYIHSK 120

Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTAR-LLHADSSNRTLLAGTYG------YIAP 377
                IHR + +++ILL+   +  ++    +  ++      R +            +++P
Sbjct: 121 ---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177

Query: 378 ELAYTMVM--TEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP 435
           E+    +    EK D+YS G+   E+  G  P               ML++ +   +P  
Sbjct: 178 EVLQQNLQGYNEKSDIYSVGITACELANGHVP-------FKDMPATQMLLEKVRGTVPCL 230

Query: 436 VDRKVIRDILL--------------------ISTVSFA---------CLQSNPKSRPTMQ 466
           +D+                              T +F+         CLQ +P+SRP+  
Sbjct: 231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSAS 290

Query: 467 S 467
            
Sbjct: 291 Q 291

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 51/193 (26%), Positives = 84/193 (43%), Gaps = 46/193 (23%)

Query: 296 NEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA 355
            ED + LD    ++    +A  +++L    S + IHRD+++ NILL       + DFG A
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA 261

Query: 356 RLLHADSS-----NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDI 410
           R +  DS+     N  L      ++APE  +  V T + DV+S+G++  E+         
Sbjct: 262 RDIRNDSNYVVKGNARL---PVKWMAPESIFNCVYTFESDVWSYGILLWEIF-------- 310

Query: 411 LSSLSSSSDPKIMLIDVLDQRLPPPVDR---KVIRDILLISTVSFA----------CLQS 457
             SL SS  P +            PVD    K+I++   + +   A          C  +
Sbjct: 311 --SLGSSPYPGM------------PVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDA 356

Query: 458 NPKSRPTMQSVSQ 470
           +P  RPT + + Q
Sbjct: 357 DPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 50.2 bits (121), Expect = 2e-08
 Identities = 25/61 (40%), Positives = 33/61 (54%), Gaps = 2/61 (3%)

Query: 40 NLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNK 98
          NL +LDLS+N+L+  IP      +  L  LDLS NN+    P   + L  L  L+LS N 
Sbjct: 1  NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 99 L 99
          L
Sbjct: 60 L 60

Length = 60

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 5/97 (5%)

Query: 314 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL-LHADSSNRTLLAGTY 372
           +A  L +LH   S  II+RD+  +N++L+++    +ADFG  +  +    + RT   GT 
Sbjct: 110 IAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTP 165

Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
            YIAPE+       +  D ++FGV+  E+L G+ P D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 45/152 (29%), Positives = 67/152 (44%), Gaps = 33/152 (21%)

Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD------SSNRTLLAGTYGYIAPEL 379
           S   IHRD+++ NILL+      + DFG AR ++ D         R  L     ++APE 
Sbjct: 191 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK----WMAPES 246

Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRL------- 432
            +  V T + DV+SFGV+  E+           SL +S  P + + +   +RL       
Sbjct: 247 IFDKVYTTQSDVWSFGVLLWEIF----------SLGASPYPGVQIDEEFCRRLKEGTRMR 296

Query: 433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPT 464
            P      I  I+L       C  +NP+ RPT
Sbjct: 297 APEYATPEIYSIML------DCWHNNPEDRPT 322

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 51/199 (25%), Positives = 91/199 (45%), Gaps = 10/199 (5%)

Query: 213 IGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAF--IKSFKNEAQVLS-QVLHRNIVKLY 268
           +G G +G V  A+L    +V+A+K L     L    +     E ++L+    H  +  L+
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
                K  +F + EY+  G L   +   + + + D  +       +  AL +LH      
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQI---QRSRKFDEPRSRFYAAEVTLALMFLHRH---G 116

Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 388
           +I+RD+  +NILL+++    +ADFG  +    +    T   GT  YIAPE+   +     
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPS 176

Query: 389 CDVYSFGVVTLEVLMGKHP 407
            D ++ GV+  E++ G+ P
Sbjct: 177 VDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 32/219 (14%)

Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIV 265
           DF+    +G G +G V            L +   ++EL  IK  K +  +    +   +V
Sbjct: 1   DFNFLMVLGKGSFGKV-----------MLAERKGTDELYAIKILKKDVVIQDDDVECTMV 49

Query: 266 KLYGYCLHKKCMFL---------------IYEYMERGSLFCNLHNNEDAVELDWAKRVNI 310
           +     L  K  FL               + EY+  G L   +++ +   +    + V  
Sbjct: 50  EKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFY 106

Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG 370
              ++  L +LH      II+RD+  +N++L+S+    +ADFG  +    D        G
Sbjct: 107 AAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCG 163

Query: 371 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
           T  YIAPE+       +  D +++GV+  E+L G+ P D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 59/244 (24%), Positives = 98/244 (40%), Gaps = 58/244 (23%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSE-----ELAFIKSFKNEAQVLSQVLHRNIVK 266
           IG G +G V    ++    ++A+K L  ++     + A +K+   E  +L++  +  +VK
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKA---ERDILAEADNEWVVK 65

Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
           LY     K  ++ + +Y+  G +   L       E D A R  I + +  A+  +H    
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG-IFEEDLA-RFYIAE-LTCAIESVH---K 119

Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTA---RLLH----------------------AD 361
              IHRDI  +NIL++      + DFG     R  H                      ++
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179

Query: 362 SSNRTL------------------LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM 403
                L                  L GT  YIAPE+      T+ CD +S GV+  E+L+
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239

Query: 404 GKHP 407
           G+ P
Sbjct: 240 GQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 55.9 bits (134), Expect = 4e-08
 Identities = 55/243 (22%), Positives = 109/243 (44%), Gaps = 37/243 (15%)

Query: 197 YEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVF------ALKKLHTSEELAFIKSFK 250
           Y+D      ++++   IG G +G V+  +    + F      + + L   E+   +    
Sbjct: 5   YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI--- 61

Query: 251 NEAQVLSQVLHRNIVKLYGYCLHK--KCMFLIYEYMERGSLFCNLHNNEDAV-ELDWAKR 307
            E  V+ ++ H+NIV+     L+K  + ++++ E+ + G L  N+        +++    
Sbjct: 62  -EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120

Query: 308 VNIVKAMAHALAYLHH----DCSPSIIHRDISSNNILLNSKLE----------------- 346
           V+I + + HALAY H+         ++HRD+   NI L++ +                  
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180

Query: 347 AFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY--TMVMTEKCDVYSFGVVTLEVLMG 404
           A + DFG ++ +  +S   + + GT  Y +PEL    T    +K D+++ G +  E+  G
Sbjct: 181 AKIGDFGLSKNIGIESMAHSCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239

Query: 405 KHP 407
           K P
Sbjct: 240 KTP 242

Length = 1021

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 34/220 (15%)

Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEA-----QVLSQVL 260
           DF+    +G G +G V            L +   ++EL  IK  K +       V   ++
Sbjct: 1   DFNFLMVLGKGSFGKV-----------MLAERKGTDELYAIKILKKDVVIQDDDVECTMV 49

Query: 261 HRNIVKLYG-----YCLHKKC------MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN 309
            + ++ L G       LH  C      ++ + EY+  G L   ++  +          V 
Sbjct: 50  EKRVLALSGKPPFLTQLHS-CFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVF 105

Query: 310 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA 369
               +A  L +LH   S  II+RD+  +N++L+S+    +ADFG  +    D        
Sbjct: 106 YAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC 162

Query: 370 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
           GT  YIAPE+       +  D ++FGV+  E+L G+ P +
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 71/284 (25%), Positives = 122/284 (42%), Gaps = 58/284 (20%)

Query: 216 GGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEA---QV---------LSQVLHRN 263
           G +G ++   L + K          EE  F+K+ K+ A   QV         L  + H+N
Sbjct: 17  GTFGRIFYGILIDEK-------PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQN 69

Query: 264 IVKLYGYC--LHKKCMFLIYEYMERGSL-----FCNLHNNEDAVELDWAKRVNIVKAMAH 316
           I+ +   C    +   F++Y YM  G+L      C L    +   L   + V++   +A 
Sbjct: 70  ILPILHVCIEDGEP-PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128

Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL-----H--ADSSNRTLLA 369
            ++YLH      +IH+DI++ N +++ +L+  + D   +R L     H   D+ NR +  
Sbjct: 129 GMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV-- 183

Query: 370 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLE-VLMGKHPR-DILSSLSSSSDPKIMLIDV 427
               ++A E       +   DV+SFGV+  E + +G+ P  +I        DP  M   +
Sbjct: 184 ---KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI--------DPFEMAAYL 232

Query: 428 LD-QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
            D  RL  P++     D L    V   C   +P+ RP+   + Q
Sbjct: 233 KDGYRLAQPIN---CPDELF--AVMACCWALDPEERPSFSQLVQ 271

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 54.8 bits (132), Expect = 4e-08
 Identities = 47/171 (27%), Positives = 72/171 (42%), Gaps = 25/171 (14%)

Query: 247 KSFKNEAQVLSQVLHRNIVKLYGYCLHKK--CMFL------IYEYMERGSLFCNLHNNED 298
           K+   E  +L  + HR I+ L      K   CM +      ++ Y++R            
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG---------- 180

Query: 299 AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL 358
              L   + + I + +  ALAYLH      IIHRD+ + NI L+    A + DFG A  L
Sbjct: 181 --PLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235

Query: 359 --HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
             H D+      +GT    +PEL        K D++S G+V  E+ +    
Sbjct: 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 53.8 bits (129), Expect = 5e-08
 Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 20/177 (11%)

Query: 234 LKKLHTSEE---LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLF 290
           LK L  S     LAF ++    A ++ QV H++IV LYG C+      ++ E++E G L 
Sbjct: 37  LKVLDPSHRDISLAFFET----ASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD 92

Query: 291 CNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVA 350
             +H   D +   W  +  + K +A AL+YL       ++H ++ + NILL    E    
Sbjct: 93  LFMHRKSDVLTTPW--KFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAR--EGIDG 145

Query: 351 DFGTARLLHADSSNRTLLA-----GTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEV 401
           + G    L       T+L+         +IAPE +  +  ++   D +SFG    E+
Sbjct: 146 ECGPFIKLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 53.7 bits (129), Expect = 7e-08
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 22/207 (10%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKK-LHTSEELAFIKSFKNEA---QVLSQVLHRNIVKL 267
           IG G YG VYKA+    GK+ ALKK     +E     +   E    Q+LS+ ++  IV+L
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY--IVRL 66

Query: 268 YGYCLH------KKCMFLIYEYMERG-SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
                H      K  ++L++EY++     F + +       L      + +  +   +A+
Sbjct: 67  LD-VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125

Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPE- 378
            H      ++HRD+   N+L++ +     +AD G  R       + T    T  Y APE 
Sbjct: 126 CH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEV 182

Query: 379 -LAYTMVMTEKCDVYSFGVVTLEVLMG 404
            L  T   T   D++S G +  E+   
Sbjct: 183 LLGSTHYST-PVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 53.9 bits (129), Expect = 7e-08
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 18/203 (8%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLH-----TSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G V    +   G+ +A+K L        +E+A   +   E +VL    H  +  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT---ENRVLQNSRHPFLTA 59

Query: 267 L-YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYLHHD 324
           L Y +  H +  F++ EY   G LF +L       E     R     A +  AL YLH +
Sbjct: 60  LKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSE----DRARFYGAEIVSALDYLHSE 114

Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
              ++++RD+   N++L+      + DFG  +    D +      GT  Y+APE+     
Sbjct: 115 --KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 172

Query: 385 MTEKCDVYSFGVVTLEVLMGKHP 407
                D +  GVV  E++ G+ P
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 54.1 bits (130), Expect = 7e-08
 Identities = 54/198 (27%), Positives = 83/198 (41%), Gaps = 48/198 (24%)

Query: 297 EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR 356
           ED+  LD    +     +A  + +L    S + IHRD+++ N+LL     A + DFG AR
Sbjct: 204 EDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260

Query: 357 LLHADSS-----NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIL 411
            +  DS+     N  L      ++APE  +  V T + DV+S+G++  E+          
Sbjct: 261 DIMNDSNYVVKGNARL---PVKWMAPESIFDCVYTVQSDVWSYGILLWEIF--------- 308

Query: 412 SSLSSSSDPKIMLIDVLDQRLPPPVDRK---VIRDILLISTVSFA----------CLQSN 458
            SL  S  P I+            V+ K   +++    +S   FA          C    
Sbjct: 309 -SLGKSPYPGIL------------VNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLE 355

Query: 459 PKSRPTMQSVSQEFLITR 476
           P  RPT   +SQ  LI R
Sbjct: 356 PTERPTFSQISQ--LIQR 371

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 53.5 bits (128), Expect = 8e-08
 Identities = 49/204 (24%), Positives = 92/204 (45%), Gaps = 26/204 (12%)

Query: 213 IGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           +G G Y +V+K +      + ALK++    E     +   E  +L  + H NIV L+   
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 272 LHKKCMFLIYEYMER---------GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
              K + L++EY+++         G++  ++HN    V++        +  +   LAY H
Sbjct: 74  HTDKSLTLVFEYLDKDLKQYMDDCGNIM-SMHN----VKI-------FLYQILRGLAYCH 121

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAY 381
                 ++HRD+   N+L+N + E  +ADFG AR     +   +    T  Y  P+ L  
Sbjct: 122 RR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG 178

Query: 382 TMVMTEKCDVYSFGVVTLEVLMGK 405
           +   + + D++  G +  E+  G+
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 53.5 bits (128), Expect = 9e-08
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 10/197 (5%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 85  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 141

Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y APE+    M   + 
Sbjct: 142 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 198

Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 199 VDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 35/110 (31%), Positives = 63/110 (57%), Gaps = 12/110 (10%)

Query: 234 LKKLHTSEE--LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFC 291
           LK L +     LAF ++    A ++SQ+ H+++VKLYG C+  + + ++ EY++ G L  
Sbjct: 35  LKVLGSDHRDSLAFFET----ASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDV 89

Query: 292 NLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL 341
            LH  ++ V L W  ++++ K +A AL YL       ++H ++   NIL+
Sbjct: 90  FLHREKNNVSLHW--KLDVAKQLASALHYLE---DKKLVHGNVCGKNILV 134

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 23/206 (11%)

Query: 213 IGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG GG+G VY  +  + GK++A+K L        IK  + E   L++ +  ++V   G C
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKR----IKMKQGETLALNERIMLSLVST-GDC 56

Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY-------LHHD 324
               CM   +   ++ S   +L N  D   L +    + V + A    Y       L H 
Sbjct: 57  PFIVCMSYAFHTPDKLSFILDLMNGGD---LHYHLSQHGVFSEAEMRFYAAEIILGLEHM 113

Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA--GTYGYIAPE-LAY 381
            +  +++RD+   NILL+      ++D G A     D S +   A  GT+GY+APE L  
Sbjct: 114 HNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQK 169

Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHP 407
            +      D +S G +  ++L G  P
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 47/210 (22%), Positives = 96/210 (45%), Gaps = 20/210 (9%)

Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKL-----HTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           IG G Y  V   +L    +++A+K +     +  E++ ++++ K+  +  S   H  +V 
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASN--HPFLVG 60

Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELD---WAKRVNIVKAMAHALAYLHH 323
           L+     +  +F + E++  G L  ++       E     ++  +++      AL +LH 
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISL------ALNFLH- 113

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
                II+RD+  +N+LL+++    + D+G  +         +   GT  YIAPE+    
Sbjct: 114 --ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGE 171

Query: 384 VMTEKCDVYSFGVVTLEVLMGKHPRDILSS 413
                 D ++ GV+  E++ G+ P DI+  
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGM 201

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 14/199 (7%)

Query: 213 IGTGGYGSV---YKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           +G+G YGSV   Y  +L   KV A+KKL    + L   +    E ++L  + H N++ L 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQ-KV-AVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 269 GYCLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
                   +    E Y+    +  +L+N     +L       ++  +   L Y+H   S 
Sbjct: 81  DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH---SA 137

Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMT 386
            IIHRD+  +N+ +N   E  + DFG AR   AD      +A T  Y APE+    M   
Sbjct: 138 GIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMTGYVA-TRWYRAPEIMLNWMHYN 194

Query: 387 EKCDVYSFGVVTLEVLMGK 405
           +  D++S G +  E+L GK
Sbjct: 195 QTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 57/200 (28%), Positives = 89/200 (44%), Gaps = 18/200 (9%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           IG+G  G V  A     G   A+KKL    +     K    E  +L  V H+NI+ L   
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88

Query: 271 CLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
              +K +      +L+ E M+  +L   +H     +ELD  +   ++  M   + +LH  
Sbjct: 89  FTPQKSLEEFQDVYLVMELMD-ANLCQVIH-----MELDHERMSYLLYQMLCGIKHLH-- 140

Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
            S  IIHRD+  +NI++ S     + DFG AR    +      +   Y Y APE+   M 
Sbjct: 141 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY-YRAPEVILGMG 198

Query: 385 MTEKCDVYSFGVVTLEVLMG 404
             E  D++S G +  E++ G
Sbjct: 199 YKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 17/203 (8%)

Query: 213 IGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG GG+G VY  +  + GK++A+K L        IK  + E   L++ +  ++V   G C
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKR----IKMKQGETLALNERIMLSLVST-GDC 56

Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM----AHALAYLHHDCSP 327
               CM   +   ++     +L N  D         V   K M       +  L H  + 
Sbjct: 57  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR 116

Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA--GTYGYIAPE-LAYTMV 384
            +++RD+   NILL+      ++D G A     D S +   A  GT+GY+APE L     
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGTA 172

Query: 385 MTEKCDVYSFGVVTLEVLMGKHP 407
                D +S G +  ++L G  P
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 31/209 (14%)

Query: 213 IGTGGYGSVY----KAQLPNGKVFALKKLH-----TSEELAFIKSFKNEAQVLSQVLHRN 263
           +G G +G V     KA    GK +A+K L        +E+A   +   E++VL    H  
Sbjct: 3   LGKGTFGKVILVREKA---TGKYYAMKILKKEVIIAKDEVAHTLT---ESRVLQNTRHPF 56

Query: 264 IVKL-YGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHAL 318
           +  L Y +  H +  F++ EY   G LF +L      +ED      A+ V+       AL
Sbjct: 57  LTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSEDRARFYGAEIVS-------AL 108

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
            YLH   S  +++RD+   N++L+      + DFG  +   +D +      GT  Y+APE
Sbjct: 109 GYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +          D +  GVV  E++ G+ P
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 46/148 (31%), Positives = 65/148 (43%), Gaps = 18/148 (12%)

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           L Y+H   S  ++HRD+  +NIL+N   +  + DFG AR+        T    T  Y AP
Sbjct: 121 LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMTGYVSTRYYRAP 174

Query: 378 ELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV 436
           E+  T      + D++S G +  E+L GK        L    D       + D    PP 
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGK-------PLFPGKDHVNQFSIITDLLGTPPD 227

Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPT 464
           D  VI  I   +T+ F  +QS PK  P 
Sbjct: 228 D--VINTICSENTLRF--VQSLPKREPV 251

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 60/231 (25%), Positives = 94/231 (40%), Gaps = 70/231 (30%)

Query: 212 CIGTGGYGSVYKA--QLPNGKVFALKKLHTSEELAFIKSFKN---------EAQVLSQVL 260
            IG G YG V  A     N KV A+KK+          +F N         E ++L  + 
Sbjct: 12  PIGRGAYGIVCSAKNSETNEKV-AIKKIA--------NAFDNRIDAKRTLREIKLLRHLD 62

Query: 261 HRNIVKLYGYCLHKKCM-----------FLIYEYMERGSLFCNLHN--------NEDAVE 301
           H N++ +      K  M           +++YE M+      +LH         ++D  +
Sbjct: 63  HENVIAI------KDIMPPPHREAFNDVYIVYELMD-----TDLHQIIRSSQTLSDDHCQ 111

Query: 302 LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD 361
                    +  +   L Y+H   S +++HRD+  +N+LLN+  +  + DFG AR     
Sbjct: 112 Y-------FLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161

Query: 362 SSNRTLLAGTYGYIAPEL-----AYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
               T    T  Y APEL      YT  +    DV+S G +  E L+G+ P
Sbjct: 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAI----DVWSVGCIFAE-LLGRKP 207

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 22/203 (10%)

Query: 213 IGTGGYGSV---YKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G V   Y A L   +  A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +L+ E M+     C +      +ELD  +   ++  M   + +LH
Sbjct: 83  NVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHLH 136

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 137 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 192

Query: 383 MVMTEKCDVYSFGVVTLEVLMGK 405
           M   E  D++S G +  E++  K
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 51.2 bits (122), Expect = 6e-07
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 27/216 (12%)

Query: 207 FDIRYC-IGTGGYGSVYKAQLPNG---KVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR 262
           F+   C +G G YG VYKA+  +G   + +ALK++   E      S   E  +L ++ H 
Sbjct: 2   FEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI---EGTGISMSACREIALLRELKHP 58

Query: 263 NIVKLYGYCLH--KKCMFLIYEYMERGSL-FCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           N++ L    L    + ++L+++Y E         H    A +    K V + + M  +L 
Sbjct: 59  NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANK----KPVQLPRGMVKSLL 114

Query: 320 Y-----LHHDCSPSIIHRDISSNNILL----NSKLEAFVADFGTARLLHA---DSSNRTL 367
           Y     +H+  +  ++HRD+   NIL+      +    +AD G ARL ++     ++   
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 368 LAGTYGYIAPELAY-TMVMTEKCDVYSFGVVTLEVL 402
           +  T+ Y APEL       T+  D+++ G +  E+L
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 50.7 bits (121), Expect = 6e-07
 Identities = 55/244 (22%), Positives = 108/244 (44%), Gaps = 35/244 (14%)

Query: 238 HTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNE 297
           H    LAF ++    A ++SQV H ++  ++G C+      ++ E++E G L   L   +
Sbjct: 56  HRDIALAFFET----ASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK 111

Query: 298 DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL 357
             V + W  ++ + + +A AL+YL      +++H ++ + NILL       +A+ GT+  
Sbjct: 112 GRVPVAW--KITVAQQLASALSYLE---DKNLVHGNVCAKNILLARL---GLAE-GTSPF 162

Query: 358 LHADSSNRTLLAGT-------YGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLM-GKHPR 408
           +       +  A +         +IAPE +     ++   D +SFG   LE+   G+ P 
Sbjct: 163 IKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP- 221

Query: 409 DILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
                L   +  +         RLP P  ++       ++T+   CL   P  RP+ +++
Sbjct: 222 -----LKERTPSEKERFYEKKHRLPEPSCKE-------LATLISQCLTYEPTQRPSFRTI 269

Query: 469 SQEF 472
            ++ 
Sbjct: 270 LRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 51.4 bits (123), Expect = 7e-07
 Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 21/162 (12%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEEL--AFIKSFKNEAQVLSQVLH 261
           E+F I   I  G +G VY  +   N K++A+K +  ++ +    +   + E   L+    
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63

Query: 262 RNIVKLYGYCLHKKC-MFLIYEYMERGSLFCNLH-----NNEDAVELDWAKRVNIVKAMA 315
             IV LY Y L     ++L+ EY+  G +   LH     + E AV+         +  +A
Sbjct: 64  PFIVHLY-YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY--------ISEVA 114

Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL 357
            AL YLH      IIHRD+  +N+L++++    + DFG +++
Sbjct: 115 LALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 50.5 bits (121), Expect = 8e-07
 Identities = 56/258 (21%), Positives = 107/258 (41%), Gaps = 29/258 (11%)

Query: 220 SVYKAQLPNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGY----CLH 273
           S+YK    N +V     KK H   +   I   +NE + L ++   NI+K+YG+       
Sbjct: 35  SIYKGIFNNKEVIIRTFKKFHKGHK-VLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 274 KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-HDCSPSIIHR 332
              + LI EY  RG L   L   +D   L +  ++++       L  L+ +   P   ++
Sbjct: 94  LPRLSLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKP---YK 147

Query: 333 DISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV--MTEKCD 390
           +++S + L+    +  +   G  ++L +             Y + ++   +    T K D
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSPPFKNV---NFMVYFSYKMLNDIFSEYTIKDD 204

Query: 391 VYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTV 450
           +YS GVV  E+  GK P +   +L++     +++      +LP       +   L I  +
Sbjct: 205 IYSLGVVLWEIFTGKIPFE---NLTTKEIYDLIINKNNSLKLP-------LDCPLEIKCI 254

Query: 451 SFACLQSNPKSRPTMQSV 468
             AC   +   RP ++ +
Sbjct: 255 VEACTSHDSIKRPNIKEI 272

Length = 283

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 50.5 bits (120), Expect = 8e-07
 Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 35/220 (15%)

Query: 207 FDIRYC-IGTGGYGSVYKAQLPNG---KVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR 262
           F+   C +G G YG VYKA+  +G   K +ALK++   E      S   E  +L ++ H 
Sbjct: 2   FEYEGCKVGRGTYGHVYKAKRKDGKDEKEYALKQI---EGTGISMSACREIALLRELKHP 58

Query: 263 NIVKLYGYCL--HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN-----IVKAMA 315
           N++ L    L    + ++L+++Y E        H+    ++   A + N     + ++M 
Sbjct: 59  NVIALQKVFLSHSDRKVWLLFDYAE--------HDLWHIIKFHRASKANKKPMQLPRSMV 110

Query: 316 HALAY-----LHHDCSPSIIHRDISSNNILL----NSKLEAFVADFGTARLLHA---DSS 363
            +L Y     +H+  +  ++HRD+   NIL+      +    +AD G ARL ++     +
Sbjct: 111 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 170

Query: 364 NRTLLAGTYGYIAPELAY-TMVMTEKCDVYSFGVVTLEVL 402
           +   +  T+ Y APEL       T+  D+++ G +  E+L
Sbjct: 171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 57/229 (24%), Positives = 104/229 (45%), Gaps = 43/229 (18%)

Query: 207 FDI--RYC----IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV 259
           FD+  RY     +G G  G V+ A      K  A+KK+  ++  + +K    E +++ ++
Sbjct: 1   FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQS-VKHALREIKIIRRL 59

Query: 260 LHRNIVKLY--------------GYCLHKKCMFLIYEYMERGSLFCNLHNN----EDAVE 301
            H NIVK+Y              G       ++++ EYME  +   N+       E+   
Sbjct: 60  DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME--TDLANVLEQGPLSEEHAR 117

Query: 302 LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTARLLHA 360
           L        +  +   L Y+H   S +++HRD+   N+ +N++ L   + DFG AR++  
Sbjct: 118 L-------FMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDP 167

Query: 361 DSSNRTLLA---GTYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGK 405
             S++  L+    T  Y +P L  +    T+  D+++ G +  E+L GK
Sbjct: 168 HYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 48.2 bits (115), Expect = 1e-06
 Identities = 32/149 (21%), Positives = 59/149 (39%), Gaps = 20/149 (13%)

Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIV---KLYG 269
           +  G    VY     +   + LK   + E+ A     + E  +L Q+L R  +   K+  
Sbjct: 6   LKGGLTNRVYLLGTKDED-YVLKINPSREKGAD---REREVAIL-QLLARKGLPVPKVLA 60

Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
                   +L+ E++E           E   E+   ++ +I + +A  LA LH      +
Sbjct: 61  SGESDGWSYLLMEWIE----------GETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVL 110

Query: 330 IHRDISSNNILL-NSKLEAFVADFGTARL 357
            H D+   NIL+ + K+   + D+  A  
Sbjct: 111 CHGDLHPGNILVDDGKILGII-DWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 59/249 (23%), Positives = 98/249 (39%), Gaps = 64/249 (25%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAF--IKSFKNEAQVLSQVLHRNIVKLYG 269
           +G G +G V  A ++    ++A+K L   + L    +   K E  +L++  +  +V+LY 
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
               K  ++ + +Y+  G +   L       ED      A+    V+++ H + +     
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESV-HKMGF----- 122

Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTA---RLLH----------------------A 360
               IHRDI  +NIL++      + DFG     R  H                       
Sbjct: 123 ----IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178

Query: 361 DSSN-------------------RTL---LAGTYGYIAPELAYTMVMTEKCDVYSFGVVT 398
           D +N                   R L   L GT  YIAPE+      T+ CD +S GV+ 
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238

Query: 399 LEVLMGKHP 407
            E+L+G+ P
Sbjct: 239 YEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 56/233 (24%), Positives = 87/233 (37%), Gaps = 48/233 (20%)

Query: 213 IGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAF--IKSFKNEAQVLSQVLHRNIVKLYG 269
           +G G  G V+  +L   GK+FALK L   E +    +K    E ++L+ + H  +  LY 
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68

Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNN------EDAVELDWAKRVNIVKAMAHALAYLHH 323
               +  + L+ +Y   G LF  L         E+     +A  V +      AL YLH 
Sbjct: 69  SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARF-YAAEVLL------ALEYLH- 120

Query: 324 DCSPSIIHRDISSNNILLN-------------------SKLEAFVADFGTARLLHADSSN 364
                I++RD+   NILL+                       +     G+ R       +
Sbjct: 121 --LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178

Query: 365 RTLLA----------GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            T             GT  YIAPE+          D ++ G++  E+L G  P
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 22/203 (10%)

Query: 213 IGTGGYGSV---YKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G V   Y A L   +  A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89

Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +++ E M+     C +      +ELD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHLH 143

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR           +   Y Y APE+   
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILG 199

Query: 383 MVMTEKCDVYSFGVVTLEVLMGK 405
           M   E  D++S G +  E++ G 
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 42/152 (27%), Positives = 63/152 (41%), Gaps = 33/152 (21%)

Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD------SSNRTLLAGTYGYIAPEL 379
           S   IHRD+++ NILL+      + DFG AR ++ D         R  L     ++APE 
Sbjct: 197 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK----WMAPET 252

Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRL------- 432
            +  V T + DV+SFGV+  E+           SL +S  P + + +   +RL       
Sbjct: 253 IFDRVYTIQSDVWSFGVLLWEIF----------SLGASPYPGVKIDEEFCRRLKEGTRMR 302

Query: 433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPT 464
            P      +   +L       C    P  RPT
Sbjct: 303 APDYTTPEMYQTML------DCWHGEPSQRPT 328

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 58/248 (23%), Positives = 97/248 (39%), Gaps = 62/248 (25%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAF--IKSFKNEAQVLSQVLHRNIVKLYG 269
           +G G +G V  A ++    ++A+K L   + L    +   K E  +L++  +  +VKLY 
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 270 YCLHKKCMFLIYEYMERG---SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
               K  ++ + +Y+  G   SL   +    + +   +   + +     H + +      
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF------ 122

Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTA---RLLHA----------------------D 361
              IHRDI  +NIL++      + DFG     R  H                       D
Sbjct: 123 ---IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179

Query: 362 SSN-------RTL---------------LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTL 399
            SN       +TL               L GT  YIAPE+      T+ CD +S GV+  
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239

Query: 400 EVLMGKHP 407
           E+L+G+ P
Sbjct: 240 EMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 43.3 bits (103), Expect = 5e-06
 Identities = 24/60 (40%), Positives = 30/60 (50%)

Query: 16 NLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNI 75
          NL  LD+ +N L      A   L NL  LDLS N L+   P   + +  L  LDLS NN+
Sbjct: 1  NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 48.0 bits (114), Expect = 5e-06
 Identities = 66/277 (23%), Positives = 118/277 (42%), Gaps = 37/277 (13%)

Query: 213 IGTGGYGSVYKAQLPNGKVFA---LKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYG 269
           IG G +G V   ++ +G   A   +K+L  S  +     F  EAQ    + H N+++  G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA----YLHHDC 325
            C       L+ E+   G L   L +   A  +        ++ MA  +A    +LH + 
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELM--TPDPTTLQRMACEIALGLLHLHKN- 119

Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD----SSNRTLLAGTYGYIAPELA- 380
             + IH D++  N LL + L   + D+G +   + +    + ++  +     +IAPEL  
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVP--LRWIAPELVD 175

Query: 381 ------YTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLDQ--R 431
                   +  T++ +V+S GV   E+  +G  P          SD +++   V +Q  +
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP------YRHLSDEQVLTYTVREQQLK 229

Query: 432 LPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
           LP P  +  + D      + F  LQ  P+ RP+ + V
Sbjct: 230 LPKPRLKLPLSD-RWYEVMQFCWLQ--PEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 48.2 bits (115), Expect = 5e-06
 Identities = 55/215 (25%), Positives = 86/215 (40%), Gaps = 37/215 (17%)

Query: 213 IGTGGYGSV----YKAQLPNGKVFALKKL-----------HTSEELAFIKSFKNEAQVLS 257
           +G G YG V             V A+KK+               EL  ++ F+       
Sbjct: 8   LGQGAYGIVCSARNAETSEEETV-AIKKITNVFSKKILAKRALRELKLLRHFRG------ 60

Query: 258 QVLHRNIVKLYGYCLHKKCMF-LIYEYMERGSLFCNLHNN-EDAVELDWAKRVNIVKAMA 315
              H+NI  LY   +     F  +Y Y E   +  +LH        L  A   + +  + 
Sbjct: 61  ---HKNITCLYDMDIVFPGNFNELYLYEE--LMEADLHQIIRSGQPLTDAHFQSFIYQIL 115

Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD----SSNRTLLAGT 371
             L Y+H   S +++HRD+   N+L+N+  E  + DFG AR    +    +   T    T
Sbjct: 116 CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172

Query: 372 YGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGK 405
             Y APE+  +    T+  DV+S G +  E+L  K
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 48.2 bits (115), Expect = 5e-06
 Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 28/206 (13%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLH------TSEELAFIKSFKNEAQVLSQVLHRNIV 265
           IG+G  G V  A     G+  A+KKL       T  + A+      E  ++  V H+NI+
Sbjct: 24  IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY-----RELVLMKLVNHKNII 78

Query: 266 KLYGYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            L      +K +      +L+ E M+      NL      ++LD  +   ++  M   + 
Sbjct: 79  GLLNVFTPQKSLEEFQDVYLVMELMD-----ANLCQVIQ-MDLDHERMSYLLYQMLCGIK 132

Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           +LH   S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+
Sbjct: 133 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEV 188

Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGK 405
              M   E  D++S G +  E++ G 
Sbjct: 189 ILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 31/101 (30%), Positives = 48/101 (47%), Gaps = 5/101 (4%)

Query: 302 LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD 361
           L  A+   + + +  A+ Y+H +    IIHRDI + N+L+N   +  + DFG A      
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313

Query: 362 SSNRTL--LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLE 400
            S      +AGT    APE+      T   D++S G+V  E
Sbjct: 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 51/170 (30%), Positives = 73/170 (42%), Gaps = 37/170 (21%)

Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL---LAGTYG 373
           AL  +H      ++HRD+ S NI L       + DFG ++  ++DS +  +     GT  
Sbjct: 181 ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQ-YSDSVSLDVASSFCGTPY 236

Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP------RDILSS-LSSSSDPKIMLID 426
           Y+APEL      ++K D++S GV+  E+L    P      R+I+   L    DP      
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP------ 290

Query: 427 VLDQRLPPPVDR--KVIRDILLISTVSFACLQSNPKSRPTMQSVSQ-EFL 473
                 P PV    K + D L         L  NP  RPT Q +   EFL
Sbjct: 291 -----FPCPVSSGMKALLDPL---------LSKNPALRPTTQQLLHTEFL 326

Length = 478

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 32/104 (30%), Positives = 54/104 (51%), Gaps = 4/104 (3%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLT 66
           +   + NLKNL  L++ +N L   +P ++G+L+NL  LDLS+N++S      + S+  L 
Sbjct: 224 LLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLR 280

Query: 67  QLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDL 110
           +LDLS N++  +    I  L  L  L L+       +    N +
Sbjct: 281 ELDLSGNSLS-NALPLIALLLLLLELLLNLLLTLKALELKLNSI 323

Length = 394

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 27/155 (17%)

Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY---GYIAPELAYT 382
           S + +HRD+++ N+LL       + DFG AR +  D SN      T+    ++APE  + 
Sbjct: 255 SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD-SNYVSKGSTFLPVKWMAPESIFD 313

Query: 383 MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRL-------PPP 435
            + T   DV+S+G++  E+           SL  +  P +++      ++        P 
Sbjct: 314 NLYTTLSDVWSYGILLWEIF----------SLGGTPYPGMIVDSTFYNKIKSGYRMAKPD 363

Query: 436 VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
              + + DI++       C  S P+ RP+   +S 
Sbjct: 364 HATQEVYDIMV------KCWNSEPEKRPSFLHLSD 392

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 36.7 bits (86), Expect = 9e-04
 Identities = 17/38 (44%), Positives = 26/38 (68%), Gaps = 2/38 (5%)

Query: 39 TNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQ 76
          TNL  LDLS+N+++  +PP ++++  L  LDLS N I 
Sbjct: 1  TNLETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKIT 36

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.1 bits (87), Expect = 0.001
 Identities = 19/50 (38%), Positives = 26/50 (52%), Gaps = 1/50 (2%)

Query: 3  KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKL 51
          ++ +IP      L NL  LD+  N+L    P A   L +L +LDLS N L
Sbjct: 11 RLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 36.7 bits (86), Expect = 0.001
 Identities = 19/43 (44%), Positives = 26/43 (60%), Gaps = 2/43 (4%)

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSN 107
           L  LDLSNN I   +P  ++ L  L+ L+LS NK++   P SN
Sbjct: 3   LETLDLSNNQIT-DLP-PLSNLPNLETLDLSGNKITDLSPLSN 43

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 27/86 (31%), Positives = 46/86 (53%), Gaps = 5/86 (5%)

Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY---GYIAPELAYT 382
           S + +HRD+++ N+L+       + DFG AR +  D SN      T+    ++APE  + 
Sbjct: 257 SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD-SNYISKGSTFLPLKWMAPESIFN 315

Query: 383 MVMTEKCDVYSFGVVTLEVL-MGKHP 407
            + T   DV+SFG++  E+  +G  P
Sbjct: 316 NLYTTLSDVWSFGILLWEIFTLGGTP 341

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	496
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.84
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.84
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.83
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.83
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.79
smart00090	237	RIO RIO-like kinase.	99.79
PRK10345	210	hypothetical protein; Provisional	99.78
PRK14879	211	serine/threonine protein kinase; Provisional	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.74
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.74
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.74
PLN03150	623	hypothetical protein; Provisional	99.69
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.67
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.66
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.64
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.63
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.56
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.52
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.46
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.45
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.45
KOG1243	690	consensus Protein kinase [General function predict	99.44
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.42
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.41
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.39
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.37
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.3
PLN03150	623	hypothetical protein; Provisional	99.29
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.26
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.24
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.24
KOG3087	229	consensus Serine/threonine protein kinase [General	99.22
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.2
COG4248	637	Uncharacterized protein with protein kinase and he	99.16
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.15
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.11
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.11
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.1
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.09
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.07
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.07
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.06
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.06
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.04
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.03
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.02
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.0
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.93
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.92
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.87
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.85
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.85
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.78
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.75
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.74
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.69
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.64
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.63
PRK09902	216	hypothetical protein; Provisional	98.63
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.63
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.62
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.61
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.6
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.59
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.51
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.51
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.51
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.5
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.47
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.45
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.42
PF01636	239	APH: Phosphotransferase enzyme family This family	98.4
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.33
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.32
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.31
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.29
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.28
PLN02876	822	acyl-CoA dehydrogenase	98.21
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.21
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.21
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.21

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=6.1e-57  Score=500.04  Aligned_cols=455  Identities=29%  Similarity=0.484  Sum_probs=296.8

Q ss_pred             Cccc-cCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            2 YKIG-IIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         2 n~~~-~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      |++. .+|..+.++++|+.|+|++|++.+.+|+.+..+++|++|+|++|.+++.+|..+..+++|+.|+|++|++++.+|
T Consensus       485 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  564 (968)
T PLN00113        485 NQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIP  564 (968)
T ss_pred             CccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCC
Confidence            3443 355566666677777777777766666666667777777777777776666677777777777777777766666


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCCCCCCCC--CCCCCCCCCCCCcc-chhhhhhHHHHHHH
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGNI--LDLPSCDTTKPATL-FVEIFLPLTIVLSV  157 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~~~--~~~~~~~~~~~~~~-~~~i~~~~~~~~~~  157 (496)
                      ..+..+++|+.|++++|++++.+|.. ..+..+. -..+.+|+..|+..  ...++|........ ++.+++++++++++
T Consensus       565 ~~l~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~-~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~  642 (968)
T PLN00113        565 KNLGNVESLVQVNISHNHLHGSLPST-GAFLAIN-ASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVL  642 (968)
T ss_pred             hhHhcCcccCEEeccCCcceeeCCCc-chhcccC-hhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHH
Confidence            66666777777777777776666643 1122221 13456777788753  23455643211111 12222222222222


Q ss_pred             HHHHHHHHhHhhccChhhHHhhcCCCc-ceeeec--CCccccHHHHHHHHhCCCCcceeeecCCeeEEEEEe-CCCcEEE
Q 011005          158 IVFACLLLAKRKYKKPKLEERATNNID-VFSIWN--YDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFA  233 (496)
Q Consensus       158 i~~~~~~~~~r~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~va  233 (496)
                      ++++++++++|+++..+.......... ....+.  ....+.++++   ...|...+.||+|+||.||+|.. .++..||
T Consensus       643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~va  719 (968)
T PLN00113        643 ALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFV  719 (968)
T ss_pred             HHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEE
Confidence            222222222222211111000000000 000000  0112333343   45678888999999999999976 5789999


Q ss_pred             EEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHH
Q 011005          234 LKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA  313 (496)
Q Consensus       234 vK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~  313 (496)
                      ||++......     ...|++.+++++|||||++++++.+.+..++||||+++|+|.++++      .++|..+.+++.|
T Consensus       720 vK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~  788 (968)
T PLN00113        720 VKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIG  788 (968)
T ss_pred             EEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHH
Confidence            9998754321     2346888999999999999999999999999999999999999996      3789999999999


Q ss_pred             HHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCccccccccccccccccccCCcCcccchhh
Q 011005          314 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS  393 (496)
Q Consensus       314 i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws  393 (496)
                      +++|++|||..+..+|+||||||+||+++.++..++. ||........    ....+++.|+|||++.+..++.++||||
T Consensus       789 ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~sDv~S  863 (968)
T PLN00113        789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFISSAYVAPETRETKDITEKSDIYG  863 (968)
T ss_pred             HHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----CCccccccccCcccccCCCCCcccchhh
Confidence            9999999997667799999999999999999888775 6655433211    2236789999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCccccccCCCCC-------CcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHH
Q 011005          394 FGVVTLEVLMGKHPRDILSSLSSSSD-------PKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQ  466 (496)
Q Consensus       394 lG~il~el~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  466 (496)
                      |||++|||+||+.||+..........       .........+..+..... ........+.+++.+||+.||++|||++
T Consensus       864 ~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~  942 (968)
T PLN00113        864 FGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS-VNQNEIVEVMNLALHCTATDPTARPCAN  942 (968)
T ss_pred             HHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC-ccHHHHHHHHHHHHhhCcCCchhCcCHH
Confidence            99999999999999853221100000       000111122222222111 1223455678999999999999999999


Q ss_pred             HHHHHHHHhccC
Q 011005          467 SVSQEFLITRKT  478 (496)
Q Consensus       467 evl~~~~~~~~~  478 (496)
                      |+++.+....+.
T Consensus       943 evl~~L~~~~~~  954 (968)
T PLN00113        943 DVLKTLESASRS  954 (968)
T ss_pred             HHHHHHHHhhcc
Confidence            999998776553

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-53  Score=387.77  Aligned_cols=262  Identities=27%  Similarity=0.400  Sum_probs=219.3

Q ss_pred             CCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCC-eEEEEEEec
Q 011005          207 FDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK-CMFLIYEYM  284 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lV~e~~  284 (496)
                      .+..+.||+|..|+|||+.++ +++.+|+|.+....+....+++.+|++++++.+||+||.+||.|..+. ...++||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            444667999999999999775 688999999977667777889999999999999999999999999988 599999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      ++|||...+...+   .+++....+|+.+|++||.|||+  .++|+||||||+|+|++..|+|||||||.+..+...  .
T Consensus       161 DgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~  233 (364)
T KOG0581|consen  161 DGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--I  233 (364)
T ss_pred             CCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--h
Confidence            9999999998763   78999999999999999999996  479999999999999999999999999999887554  4


Q ss_pred             ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHH
Q 011005          365 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI  444 (496)
Q Consensus       365 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  444 (496)
                      ..+.+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+.....  ...........++....+.....   ...
T Consensus       234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~--~~~~~~~Ll~~Iv~~ppP~lP~~---~fS  308 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP--PYLDIFELLCAIVDEPPPRLPEG---EFS  308 (364)
T ss_pred             cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC--CCCCHHHHHHHHhcCCCCCCCcc---cCC
Confidence            5678999999999999999999999999999999999999999864310  01111122223333222222211   234


Q ss_pred             HHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          445 LLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       445 ~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      .++..|+..||++||.+|||++|+++|+|+++....
T Consensus       309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~  344 (364)
T KOG0581|consen  309 PEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP  344 (364)
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence            458899999999999999999999999999877554

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.8e-53  Score=387.22  Aligned_cols=264  Identities=26%  Similarity=0.344  Sum_probs=217.9

Q ss_pred             HHhCCCCcceeeecCCeeEEEEE-eCCCcEEEEEEcccchhHH------HHHHHHHHHHHHHhhcccccccccceeecCC
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELA------FIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK  275 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  275 (496)
                      ..+.|.+.+.||+|+||.|-+|. .++|+.||||++++.....      -...+.+|+++|++++|||||+++++|...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            45678889999999999999994 5689999999998753211      2234579999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC---CCeEEccc
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK---LEAFVADF  352 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~---~~~kl~Df  352 (496)
                      ..||||||++||.|.+.+-.+.   .+.+.....+++|++.|+.|||   +.||+||||||+|||++.+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEeccc
Confidence            9999999999999999998765   5677777889999999999999   8899999999999999776   77999999


Q ss_pred             cccccccCCCCCccccccccccccccccccCCcC---cccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhc
Q 011005          353 GTARLLHADSSNRTLLAGTYGYIAPELAYTMVMT---EKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD  429 (496)
Q Consensus       353 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  429 (496)
                      |+|+... ......+.||||.|.|||++.+..++   .++|+||+||+||-+++|.+||....      .......++..
T Consensus       324 GlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~------~~~sl~eQI~~  396 (475)
T KOG0615|consen  324 GLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY------TDPSLKEQILK  396 (475)
T ss_pred             chhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc------CCccHHHHHhc
Confidence            9999876 34445678999999999999877543   37899999999999999999997322      11223444444


Q ss_pred             CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          430 QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       430 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      .+... ....+.....+..+||.+||..||++|||++|+|+|+|+......
T Consensus       397 G~y~f-~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~  446 (475)
T KOG0615|consen  397 GRYAF-GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCL  446 (475)
T ss_pred             Ccccc-cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccccc
Confidence            44443 223355555667899999999999999999999999999866533

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-51  Score=394.85  Aligned_cols=278  Identities=40%  Similarity=0.679  Sum_probs=231.6

Q ss_pred             CccccHHHHHHHHhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhccccccccccee
Q 011005          192 DGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC  271 (496)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  271 (496)
                      ...++++++..+|++|...+.||+|+||.||+|..++|+.||||++....... .++|.+|+.++.+++|||+|+++|||
T Consensus        62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45688999999999999999999999999999999999999999887755432 46699999999999999999999999


Q ss_pred             ecCC-eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEc
Q 011005          272 LHKK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVA  350 (496)
Q Consensus       272 ~~~~-~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~  350 (496)
                      .+.+ +.+||+|||++|+|.++++..... .++|..+++|+.++|+||+|||+.+...|+||||||+|||+|+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9998 599999999999999999986654 78999999999999999999999877789999999999999999999999


Q ss_pred             cccccccccCCCCCcccc-ccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCC--------CCc
Q 011005          351 DFGTARLLHADSSNRTLL-AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSS--------DPK  421 (496)
Q Consensus       351 Dfg~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~--------~~~  421 (496)
                      |||+|+............ .||.+|+|||+...+..+.++||||||+++.|++||+.|.+.........        ...
T Consensus       220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~  299 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE  299 (361)
T ss_pred             CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence            999996654311111222 79999999999999999999999999999999999998876432111100        011


Q ss_pred             chhHhhhcCCCC-CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          422 IMLIDVLDQRLP-PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       422 ~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      ....++++.++. .....  ......+..++.+|++.+|.+||+|.||++.+.
T Consensus       300 ~~~~eiiD~~l~~~~~~~--~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~  350 (361)
T KOG1187|consen  300 GKLREIVDPRLKEGEYPD--EKEVKKLAELALRCLRPDPKERPTMSQVVKELE  350 (361)
T ss_pred             cchhheeCCCccCCCCCh--HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHH
Confidence            134556666654 22221  145666889999999999999999999988883

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.2e-51  Score=393.93  Aligned_cols=254  Identities=26%  Similarity=0.427  Sum_probs=221.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      .+|...+.||+|||+.+|.++. ..|+.||+|++.+..  .....+.+.+|+++.+.++|||||+++++|++.+.+|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5699999999999999999976 789999999997742  2334577899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      |+|..++|..+++...   .+++.+++.+.+||+.||.|||   +.+|+|||||..|+|++++.++||+|||+|..+..+
T Consensus        98 ELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999998544   7999999999999999999999   789999999999999999999999999999999888


Q ss_pred             CCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhh--cCCCCCCCChh
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVL--DQRLPPPVDRK  439 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  439 (496)
                      .....+.||||.|.|||++.....+..+||||+||++|.|+.|++||+..       ........+.  +..+|...+  
T Consensus       172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-------~vkety~~Ik~~~Y~~P~~ls--  242 (592)
T KOG0575|consen  172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-------TVKETYNKIKLNEYSMPSHLS--  242 (592)
T ss_pred             ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-------hHHHHHHHHHhcCcccccccC--
Confidence            78888899999999999999999999999999999999999999999732       1222233222  233333222  


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                           ....+||.++|++||.+|||+++|+.|.|+.+..
T Consensus       243 -----~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~  276 (592)
T KOG0575|consen  243 -----AEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGF  276 (592)
T ss_pred             -----HHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence                 2456899999999999999999999999994443

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-48  Score=373.76  Aligned_cols=258  Identities=33%  Similarity=0.533  Sum_probs=211.1

Q ss_pred             CCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCC-eEEEEEEe
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK-CMFLIYEY  283 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lV~e~  283 (496)
                      ++.+.+.+|+|+||+||+|.+.+...||||++.... +....+.|.+|+.++++++|||||+++|++.++. ..++||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            344555699999999999999655559999998754 2222678999999999999999999999999987 79999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEeCCCCCceEecCCC-CeEEccccccccccCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS-IIHRDISSNNILLNSKL-EAFVADFGTARLLHAD  361 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~-i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~  361 (496)
                      +++|+|.++++.. ....+++..++.++.||++|+.|||   +.+ ||||||||+|||++.++ ++||+|||+++.....
T Consensus       122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            9999999999875 3448999999999999999999999   667 99999999999999997 9999999999877543


Q ss_pred             CCCccccccccccccccccc--cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          362 SSNRTLLAGTYGYIAPELAY--TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                      ....+...||+.|||||++.  ...|+.++||||||+++|||+||+.||.....       ......+......+.....
T Consensus       198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-------~~~~~~v~~~~~Rp~~p~~  270 (362)
T KOG0192|consen  198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-------VQVASAVVVGGLRPPIPKE  270 (362)
T ss_pred             cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcCCCCCCCcc
Confidence            33344468999999999999  56999999999999999999999999974432       2222333323232222221


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                         ....+..++.+||..||++||++.+++..+.....
T Consensus       271 ---~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  271 ---CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             ---CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence               33357788899999999999999999998876554

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1e-48  Score=361.22  Aligned_cols=258  Identities=27%  Similarity=0.442  Sum_probs=210.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ..+|...+.||.|+||+||+|+++ ++..||||.+.... .....+.+..|+++++.++|||||.+++++..++..|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            467889999999999999999765 68999999998764 4455677899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC------CCeEEcccccc
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK------LEAFVADFGTA  355 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~------~~~kl~Dfg~~  355 (496)
                      |||+||+|.++++..+   .+++..++.++.|++.||++||   +++|+||||||+|||++..      -.+||+|||+|
T Consensus        89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            9999999999999876   7899999999999999999999   8899999999999999865      46899999999


Q ss_pred             ccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHh-hhcCCCCC
Q 011005          356 RLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLID-VLDQRLPP  434 (496)
Q Consensus       356 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~  434 (496)
                      +.+.. .....+.+|+|.|||||++....|+.|+|+||+|+++|++++|+.||+....       .+.... ..+....+
T Consensus       163 R~L~~-~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~-------~eL~~~~~k~~~~~~  234 (429)
T KOG0595|consen  163 RFLQP-GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP-------KELLLYIKKGNEIVP  234 (429)
T ss_pred             hhCCc-hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH-------HHHHHHHhccccccC
Confidence            98863 4456678999999999999999999999999999999999999999973221       111110 01111111


Q ss_pred             CCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          435 PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       435 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ....   .......+++...++.+|.+|-++.+-..+.+.....
T Consensus       235 ~~~~---~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  235 VLPA---ELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             chhh---hccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            1111   1111233666678888888999888888888776665

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=5.8e-49  Score=348.46  Aligned_cols=265  Identities=26%  Similarity=0.350  Sum_probs=213.0

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      +.|+...++|+|+||+|||++.+ +|+.||||++..+.+ ....+-..+|++++++++|+|+|.++++|..+..+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45778889999999999999876 599999999988764 4455667999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      ||+. ++.+-+.....  ..+...+.++++|++.|+.|+|   +++++||||||+|||++.+|.+||||||+|+.+..++
T Consensus        82 ~~dh-TvL~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPN--GVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             ecch-HHHHHHHhccC--CCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            9987 55555655443  5788899999999999999999   8899999999999999999999999999999998778


Q ss_pred             CCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCC-------CcchhHhhhc-----
Q 011005          363 SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSD-------PKIMLIDVLD-----  429 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~-----  429 (496)
                      ...+..+.|.+|+|||.+.+ ..|...+||||+||++.||++|.+-|...++.+.-..       -...-..++.     
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            88888999999999999988 6899999999999999999999999864433210000       0000000000     


Q ss_pred             --CCCCCCCC-----hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          430 --QRLPPPVD-----RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       430 --~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                        -++|.+..     .........+.+++.+||..||++|++-+|++.|.++.
T Consensus       236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd  288 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD  288 (396)
T ss_pred             eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence              01221111     11111222478999999999999999999999999884

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-49  Score=349.28  Aligned_cols=260  Identities=24%  Similarity=0.336  Sum_probs=210.3

Q ss_pred             hCCCCcceeeecCCeeEEEEE-eCCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccc-eeecCCe-EEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYG-YCLHKKC-MFLI  280 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~-~~lV  280 (496)
                      .+|++.++||+|.||+|||+. ..+|..+|.|.++-.. +....+....|+.++++++|||||++++ .+.+++. ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            458889999999999999994 5689999999998543 3455677899999999999999999998 4555444 8999


Q ss_pred             EEecCCCChhhhhhCC-CCCccCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEeCCCCCceEecCCCCeEEccccccccc
Q 011005          281 YEYMERGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHHDCSP-SIIHRDISSNNILLNSKLEAFVADFGTARLL  358 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  358 (496)
                      ||+|.+|+|..+++.. .....+++..+++++.|++.||.++|+...+ -|+||||||.|||++.+|.+||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            9999999999998753 2334699999999999999999999964322 3899999999999999999999999999999


Q ss_pred             cCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCCh
Q 011005          359 HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR  438 (496)
Q Consensus       359 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  438 (496)
                      ..........+|||.||+||.+.+..|+.+|||||+||++|||+.-++||..-       .-......+.....++-++.
T Consensus       179 ~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-------n~~~L~~KI~qgd~~~~p~~  251 (375)
T KOG0591|consen  179 SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-------NLLSLCKKIEQGDYPPLPDE  251 (375)
T ss_pred             cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-------cHHHHHHHHHcCCCCCCcHH
Confidence            77766677789999999999999999999999999999999999999999732       11122223333333322222


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          439 KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       439 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                         .....+..++..|+..||+.||+...+++....
T Consensus       252 ---~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  252 ---HYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             ---HhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence               223346788899999999999996666655443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-48  Score=353.54  Aligned_cols=254  Identities=28%  Similarity=0.437  Sum_probs=216.0

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      .++|++.+.||+|+||.||.++.+ .++.+|+|++++..-  ....+...+|..++.+++||.||+++..|++++.+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            467999999999999999999654 689999999987652  23456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      +||+.||.|..+|++..   .+++..+.-++..|+.||.|||   ++||+||||||+|||+|.+|+++|+|||+++....
T Consensus       104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999999766   7999999999999999999999   88999999999999999999999999999997766


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      .+....+.+||+.|||||++.+..|+..+|.||+|+++|||++|.+||..       .....+...+...+++.+..-  
T Consensus       178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-------~~~~~~~~~I~~~k~~~~p~~--  248 (357)
T KOG0598|consen  178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-------EDVKKMYDKILKGKLPLPPGY--  248 (357)
T ss_pred             CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-------ccHHHHHHHHhcCcCCCCCcc--
Confidence            66667778999999999999999999999999999999999999999963       333444555555553322210  


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCC----CHHHHHHHHHH
Q 011005          441 IRDILLISTVSFACLQSNPKSRP----TMQSVSQEFLI  474 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rp----s~~evl~~~~~  474 (496)
                        ......+++.++|..||++|.    ++.++-+|+|+
T Consensus       249 --ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF  284 (357)
T KOG0598|consen  249 --LSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFF  284 (357)
T ss_pred             --CCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccc
Confidence              112356888899999999996    57776666554

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-46  Score=347.27  Aligned_cols=266  Identities=24%  Similarity=0.385  Sum_probs=222.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEE-eCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .+.|++...||.|..++||+|+ .+.++.||||++.-.......+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            3579999999999999999995 567899999999887766667889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      ||.+||+.+++...-.. .+++..+..|.+++++||.|||   .+|.||||||+.|||++.+|.|||+|||.+..+...+
T Consensus       105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            99999999999875443 4899999999999999999999   7899999999999999999999999999988775544


Q ss_pred             CCc----ccccccccccccccccc--CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCC-
Q 011005          363 SNR----TLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP-  435 (496)
Q Consensus       363 ~~~----~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  435 (496)
                      ...    ...+||++|||||++..  ..|+.|+||||||++..||.+|+.||....+       -.+....+....+.+ 
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP-------mkvLl~tLqn~pp~~~  253 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP-------MKVLLLTLQNDPPTLL  253 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh-------HHHHHHHhcCCCCCcc
Confidence            332    44589999999999654  4789999999999999999999999974432       223333333333311 


Q ss_pred             ----CChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          436 ----VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       436 ----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                          ..+....-...+.+++..||+.||++|||++++++|.|+......
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence                111122223368899999999999999999999999999877554

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-47  Score=358.65  Aligned_cols=273  Identities=21%  Similarity=0.270  Sum_probs=218.9

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-ccccccccceeecCC-eEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKK-CMFL  279 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~l  279 (496)
                      ..++|.+.+.||.|.||.||+|+. ..|..||||+++..--.-+.---.||++.+++++ ||||+++.+.+.+.+ .+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            457899999999999999999954 5789999999987542211122378999999998 999999999999988 9999


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      |||||+. +|+++++..  ...|++..++.|+.||++||+|+|   .+|+.|||+||+|||+.....+||+|||+|+.+.
T Consensus        88 VfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccc
Confidence            9999975 999999876  448999999999999999999999   8899999999999999999999999999999875


Q ss_pred             CCCCCccccccccccccccccc-cCCcCcccchhhHHHHHHHHHhCCCCCccccccC---------CC-----CCCcchh
Q 011005          360 ADSSNRTLLAGTYGYIAPELAY-TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS---------SS-----SDPKIML  424 (496)
Q Consensus       360 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~---------~~-----~~~~~~~  424 (496)
                      .. ...+..+.|.+|+|||++. .+.|+.+.||||+|||++|+.+-++-|...+..+         +.     .......
T Consensus       162 Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  162 SK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             cC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence            43 3456678999999999865 6789999999999999999999999887554321         01     1111223


Q ss_pred             HhhhcCCCCCC----CChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCC
Q 011005          425 IDVLDQRLPPP----VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVK  482 (496)
Q Consensus       425 ~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~  482 (496)
                      ...+.-+++.-    .............+++.+|+++||++|||+.|+++|+|+.-..+...
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~~~  302 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRASGS  302 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccccc
Confidence            33333333322    11222234456789999999999999999999999999987766643

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-46  Score=359.59  Aligned_cols=259  Identities=24%  Similarity=0.372  Sum_probs=218.3

Q ss_pred             hCCCCcceeeecCCeeEEEEE-eCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      ..|.....||+|+.|.||.|. ...++.||||++....... .+-+.+|+.+|+..+|+|||.+++.|..++.+|+||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~-keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK-KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc-hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            568888899999999999994 5578899999997655332 25578999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      |+||+|.+.+...    .+++.++..|++.+++||+|||   .+||+|||||.+|||++.+|.+||+|||++..+.....
T Consensus       352 m~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  352 MEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             cCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            9999999999876    4899999999999999999999   88999999999999999999999999999999887776


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD  443 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  443 (496)
                      .....+|||.|||||+.....|.++.||||||++++||+.|.+||=...+        ....-.+.....+.... ....
T Consensus       425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P--------lrAlyLIa~ng~P~lk~-~~kl  495 (550)
T KOG0578|consen  425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP--------LRALYLIATNGTPKLKN-PEKL  495 (550)
T ss_pred             ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh--------HHHHHHHhhcCCCCcCC-cccc
Confidence            77788999999999999999999999999999999999999999842111        11111222222222211 2233


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          444 ILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       444 ~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      ...+.+|+.+||+.||++|+++.|+|+|+|+....+.
T Consensus       496 S~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p~  532 (550)
T KOG0578|consen  496 SPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKPE  532 (550)
T ss_pred             CHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCCH
Confidence            3458899999999999999999999999999655544

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-46  Score=359.41  Aligned_cols=251  Identities=27%  Similarity=0.479  Sum_probs=206.8

Q ss_pred             CCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecC
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYME  285 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~  285 (496)
                      .+...+.||+|.||+||.|.++....||+|.++...-  ..+.|.+|+++|++++|++||+++++|..++.++||||||+
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m--~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM--SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc--ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            3455677999999999999998888999999987542  22668899999999999999999999999889999999999


Q ss_pred             CCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCc
Q 011005          286 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR  365 (496)
Q Consensus       286 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  365 (496)
                      .|+|.++|.. .....++..+.+.++.||++|++||+   ++++|||||.++|||++++..+||+|||+|+...++....
T Consensus       285 ~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~  360 (468)
T KOG0197|consen  285 KGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA  360 (468)
T ss_pred             cCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence            9999999997 33447899999999999999999999   7899999999999999999999999999999554433322


Q ss_pred             c-ccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhh--cCCCCCCCChhHH
Q 011005          366 T-LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVL--DQRLPPPVDRKVI  441 (496)
Q Consensus       366 ~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  441 (496)
                      . ...-+..|.|||.+....++.+|||||||++|||++| |+.|+....       . ....+.+  ..+++.|..    
T Consensus       361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-------n-~ev~~~le~GyRlp~P~~----  428 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-------N-EEVLELLERGYRLPRPEG----  428 (468)
T ss_pred             cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-------H-HHHHHHHhccCcCCCCCC----
Confidence            1 1223458999999999999999999999999999998 888875322       1 1222222  245555543    


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          442 RDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                       .+..+.+++..||..+|++||||+.+...+...
T Consensus       429 -CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  429 -CPDEVYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             -CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence             344578899999999999999999887766543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-46  Score=355.34  Aligned_cols=254  Identities=26%  Similarity=0.413  Sum_probs=213.6

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMF  278 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  278 (496)
                      ...+|.+.+.||+|+|++|++|.. ..++.||||++.+.-  .+.-.+-+.+|-.+|.+| .||+|++++-.|.+...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            346799999999999999999954 479999999986643  122235567899999999 7999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccc
Q 011005          279 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL  358 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  358 (496)
                      +|+||+++|+|.+++.+.+   .|++..++.++.+|+.||+|||   +.|||||||||+|||+|++|+++|+|||.|+.+
T Consensus       151 FvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             EEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence            9999999999999999876   8999999999999999999999   889999999999999999999999999999987


Q ss_pred             cCCCCC-------------ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhH
Q 011005          359 HADSSN-------------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLI  425 (496)
Q Consensus       359 ~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  425 (496)
                      ......             ...++||..|.+||++.+...++.+|+|+|||++|+|+.|.+||...+       +.....
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N-------eyliFq  297 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN-------EYLIFQ  297 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc-------HHHHHH
Confidence            542211             144789999999999999999999999999999999999999997433       222222


Q ss_pred             hhh--cCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          426 DVL--DQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       426 ~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      .++  +...+....       ..+.+|+.+.|..||.+|+|.+||-+|+|+..
T Consensus       298 kI~~l~y~fp~~fp-------~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~  343 (604)
T KOG0592|consen  298 KIQALDYEFPEGFP-------EDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG  343 (604)
T ss_pred             HHHHhcccCCCCCC-------HHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence            222  233333322       24678999999999999999999999988743

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=8.3e-46  Score=322.97  Aligned_cols=267  Identities=25%  Similarity=0.340  Sum_probs=213.9

Q ss_pred             hCCCCcceeeecCCeeEEEEE-eCCCcEEEEEEcccchhH-HHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEEL-AFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .+|...+.+|+|.||.||+|+ .++|+.||||+++..+.. .......+|++.++.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            367778899999999999995 568999999999876422 223567899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      ||+. +|...+....  ..++...+.+++.++++|++|||   .+.|+||||||.|+|++.+|.+||+|||+|+.+..+.
T Consensus        82 fm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             eccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            9976 8988887643  36889999999999999999999   7899999999999999999999999999999998777


Q ss_pred             CCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCcccccc-------------CCCCCCcc----hh
Q 011005          363 SNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSL-------------SSSSDPKI----ML  424 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~-------------~~~~~~~~----~~  424 (496)
                      ......+-|.+|+|||.+.|. .|+..+||||.|||+.||+.|.+-|...++.             .....++.    ..
T Consensus       156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence            666666889999999998875 6899999999999999999998877543322             11111111    01


Q ss_pred             HhhhcCCCCCC-CChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          425 IDVLDQRLPPP-VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       425 ~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      .++.  ..+.+ .............+|+.+|+..||.+|+|+.|+++|.++.....
T Consensus       236 ~~~~--~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~  289 (318)
T KOG0659|consen  236 VKIQ--QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL  289 (318)
T ss_pred             HHHh--cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence            1111  11111 11112222334579999999999999999999999999987443

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-45  Score=349.09  Aligned_cols=281  Identities=27%  Similarity=0.357  Sum_probs=217.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEE-eCCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecC--CeEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK--KCMFL  279 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  279 (496)
                      .+.|+.++.||+|.||.||||+ ..+|+.||+|+++... .+....-..+|+.+|++++||||+++.+...+.  ..+||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            3457777889999999999995 5689999999998765 334455678999999999999999999988876  68999


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      |+|||++ +|.-++..  ....|+..++..+++|++.||+|||   ++||+|||||.+|||+|.+|.+||+|||+|+++.
T Consensus       196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999987 67666654  2347999999999999999999999   8899999999999999999999999999999886


Q ss_pred             CCCCC-ccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCcccccc---------CCCCCCcchhHhhh
Q 011005          360 ADSSN-RTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSL---------SSSSDPKIMLIDVL  428 (496)
Q Consensus       360 ~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~---------~~~~~~~~~~~~~~  428 (496)
                      ..... .+..+-|.+|+|||++.|. .|+.++|+||.||||.||++|++.|+.....         .....+..+....+
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence            65543 6677889999999998876 7999999999999999999999998744321         11111111110000


Q ss_pred             c----CCCCCCCChhH----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCcccccccc
Q 011005          429 D----QRLPPPVDRKV----IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDIS  490 (496)
Q Consensus       429 ~----~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~~~~~i~  490 (496)
                      .    .+...++....    ..-.....+|+..+|..||.+|.|+.++|++.|+...........++..+
T Consensus       350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p~~Lp~y~  419 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDPSSLPKYP  419 (560)
T ss_pred             CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCcccCCCCC
Confidence            0    00001111100    11123467899999999999999999999999996666665666555543

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9e-46  Score=345.24  Aligned_cols=260  Identities=27%  Similarity=0.414  Sum_probs=208.4

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCC--eEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK--CMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lV~  281 (496)
                      .++...+.||+|+||+||++... +|...|||.+....... .+.+.+|+.++++++|||||+++|......  .+++.|
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            35677888999999999999765 48999999987764333 577899999999999999999999855544  689999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC-CCCeEEccccccccccC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KLEAFVADFGTARLLHA  360 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~  360 (496)
                      ||+++|+|.+++.+.+.  .+++..+..+.+||++||+|||   ++||+||||||+|||++. ++.+||+|||+++....
T Consensus        96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            99999999999997654  6899999999999999999999   889999999999999999 79999999999987763


Q ss_pred             C---CCCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCC
Q 011005          361 D---SSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV  436 (496)
Q Consensus       361 ~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  436 (496)
                      .   ........||+.|||||++.++ ....++||||+||++.||+||+.||...      .........+......+..
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~~~~~P~i  244 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGREDSLPEI  244 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhccCCCCCC
Confidence            1   1223346799999999999963 3345999999999999999999999742      1111112222212111111


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      ..   .......+++.+|+..||++|||++++|+|+|.....+
T Consensus       245 p~---~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  245 PD---SLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             Cc---ccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            11   12234678999999999999999999999999988776

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-45  Score=354.31  Aligned_cols=257  Identities=22%  Similarity=0.357  Sum_probs=214.4

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccc----hhHHHHHHHHHHHHHHHhhc-ccccccccceeecCCe
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTS----EELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKC  276 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  276 (496)
                      ..++|.+.+.||+|+||+|+.|.+ .+++.||+|.+...    ......+.+.+|+.++++++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            456899999999999999999954 46899999976553    11123456678999999998 9999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC-CCeEEcccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTA  355 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~  355 (496)
                      .++||||+.||.|++++....   .+.+.++..++.|++.|++|||   .+||+||||||+|+|++.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            999999999999999998743   6888999999999999999999   7899999999999999999 99999999999


Q ss_pred             ccccCCCCCccccccccccccccccccCC-cC-cccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCC
Q 011005          356 RLLHADSSNRTLLAGTYGYIAPELAYTMV-MT-EKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLP  433 (496)
Q Consensus       356 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  433 (496)
                      ...........+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||+..       ........+......
T Consensus       169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-------~~~~l~~ki~~~~~~  241 (370)
T KOG0583|consen  169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-------NVPNLYRKIRKGEFK  241 (370)
T ss_pred             cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-------cHHHHHHHHhcCCcc
Confidence            88753445567789999999999999987 86 6899999999999999999999842       122222233333332


Q ss_pred             CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          434 PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       434 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      -+..-.    ...+..|+.+||..||.+|+|+.++++|+|++.
T Consensus       242 ~p~~~~----S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  242 IPSYLL----SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             CCCCcC----CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            222110    234678999999999999999999999999997

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.9e-46  Score=354.00  Aligned_cols=262  Identities=26%  Similarity=0.364  Sum_probs=221.8

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccc-hhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      ++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+. ..+.+.+.+.+|++++++++||||+.++++|+...++|+|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888899999999999999765 5889999998664 345677889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+.| +|..++....   .++++.+..++.|++.||.|||   +.+|.|||+||.|||++.++.+|+||||+|+.+....
T Consensus        82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            9987 9999998765   7899999999999999999999   8899999999999999999999999999999887766


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                      ...+...|||.|||||...+..|+..+|.||+||++||+.+|++||-..+        .....+.+-+....+    +..
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--------i~~Lv~~I~~d~v~~----p~~  222 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--------ITQLVKSILKDPVKP----PST  222 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--------HHHHHHHHhcCCCCC----ccc
Confidence            66667789999999999999999999999999999999999999984211        111122221211111    113


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCccc
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAA  485 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~~  485 (496)
                      ....+.+++...|.+||.+|.|..+++.|+|...+......++
T Consensus       223 ~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~  265 (808)
T KOG0597|consen  223 ASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPA  265 (808)
T ss_pred             ccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccc
Confidence            3345789999999999999999999999999988766554443

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.2e-44  Score=344.96  Aligned_cols=255  Identities=26%  Similarity=0.399  Sum_probs=210.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      .++|++...||+|+||.||+|+- .+|..+|+|+++++.  .....+.+..|-.+|...++|.||+++..|++++.+|||
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence            47899999999999999999964 469999999998865  334456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||++||++..+|....   .+++..+..++.+++.|++.+|   ..|+|||||||+|+|||..|++||+|||++..+..
T Consensus       220 MEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             EEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence            99999999999998765   7899999999999999999999   88999999999999999999999999999964311


Q ss_pred             C----------------------CCC-----c--------------------cccccccccccccccccCCcCcccchhh
Q 011005          361 D----------------------SSN-----R--------------------TLLAGTYGYIAPELAYTMVMTEKCDVYS  393 (496)
Q Consensus       361 ~----------------------~~~-----~--------------------~~~~gt~~y~aPE~~~~~~~~~~~Dvws  393 (496)
                      .                      ...     .                    ...+|||.|+|||++.+..|+..+|.||
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS  373 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS  373 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence            0                      000     0                    0136999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCC--CCCCCChhHHHHHHHHHHHHHhcccCCCCCCCC---HHHH
Q 011005          394 FGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQR--LPPPVDRKVIRDILLISTVSFACLQSNPKSRPT---MQSV  468 (496)
Q Consensus       394 lG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~ev  468 (496)
                      +|||+|||+.|.+||..       ..+......++.-+  +..+......   ....+||.+|+. ||++|.-   ++||
T Consensus       374 LG~ImyEmLvGyPPF~s-------~tp~~T~rkI~nwr~~l~fP~~~~~s---~eA~DLI~rll~-d~~~RLG~~G~~EI  442 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFCS-------ETPQETYRKIVNWRETLKFPEEVDLS---DEAKDLITRLLC-DPENRLGSKGAEEI  442 (550)
T ss_pred             HHHHHHHHHhCCCCCCC-------CCHHHHHHHHHHHhhhccCCCcCccc---HHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence            99999999999999963       33333333333322  3333222222   346789999999 9999985   8888


Q ss_pred             HHHHHHh
Q 011005          469 SQEFLIT  475 (496)
Q Consensus       469 l~~~~~~  475 (496)
                      -+|+|+.
T Consensus       443 K~HPfF~  449 (550)
T KOG0605|consen  443 KKHPFFK  449 (550)
T ss_pred             hcCCccc
Confidence            8887774

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-46  Score=344.29  Aligned_cols=257  Identities=31%  Similarity=0.443  Sum_probs=220.6

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      ..|+..++||+|.||.||||.+ ..++.||+|++.-............|+.++..++++||.++|+.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            4577778999999999999954 578999999998877666678889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      |.||++.+.+....   .+++..+.-|++++..|+.|||   ..+.+|||||+.|||+..+|.+|++|||.+..+.....
T Consensus        93 ~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            99999999998654   3466777778999999999999   78999999999999999999999999999998877766


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD  443 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  443 (496)
                      ...+++|||.|||||++.+..|+.++||||||++.+||.+|.+|+....++        ...-.+.+..++..+.   ..
T Consensus       167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm--------rvlflIpk~~PP~L~~---~~  235 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM--------RVLFLIPKSAPPRLDG---DF  235 (467)
T ss_pred             ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc--------eEEEeccCCCCCcccc---cc
Confidence            667899999999999999999999999999999999999999998755432        1122223333333333   22


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          444 ILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       444 ~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ...+.+|+..||..||+.|||+.++++|.|+.+..
T Consensus       236 S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  236 SPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             CHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence            33478999999999999999999999999998844

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-44  Score=350.41  Aligned_cols=260  Identities=24%  Similarity=0.366  Sum_probs=219.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      +-|.+.+.||.|+-|.|-.|++ .+|+.+|||.+....  .......+.+|+-+|+.+.|||++++|+.++++.++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4577889999999999999965 579999999997652  2223356789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||++||-|++++...+   .+++.++.++++||+.|+.|||   ..+|+|||+||+|+|++..+++||+|||+|.... +
T Consensus        92 Eyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-~  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEV-P  164 (786)
T ss_pred             EecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeeccc-C
Confidence            9999999999998766   7899999999999999999999   7899999999999999999999999999997653 4


Q ss_pred             CCCccccccccccccccccccCCcC-cccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVMT-EKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      +.-..+.||+|.|+|||++.|..|. .++||||.|||||.|+||+.||++       ..-......+..+....+..   
T Consensus       165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-------dNir~LLlKV~~G~f~MPs~---  234 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-------DNIRVLLLKVQRGVFEMPSN---  234 (786)
T ss_pred             CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-------ccHHHHHHHHHcCcccCCCc---
Confidence            4556678999999999999999986 589999999999999999999972       22222333444443333321   


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCc
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKH  483 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~  483 (496)
                        .....++|+.+|+..||++|.|++||++|+|....+-....
T Consensus       235 --Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  235 --ISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             --CCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence              12246789999999999999999999999999987665544

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-44  Score=315.76  Aligned_cols=250  Identities=26%  Similarity=0.394  Sum_probs=211.6

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      .++|+..+.||.|+||.|.+++.+ +|..+|+|++....  .....+...+|..+++.+.||.++++++.+.+...++||
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            357899999999999999999765 68899999998764  233445678999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||.+||.|+.++.+.+   ++++..++-++.||+.||+|||   +.+|++||+||+|||+|.+|.+||+|||.|+.+..
T Consensus       123 meyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             EeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            99999999999999876   7999999999999999999999   88999999999999999999999999999998854


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      .   .-+.||||.|+|||++....|..++|.||||+++|||+.|.+||..       ..+......++...+..|.--  
T Consensus       197 r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~-------~~~~~iY~KI~~~~v~fP~~f--  264 (355)
T KOG0616|consen  197 R---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD-------DNPIQIYEKILEGKVKFPSYF--  264 (355)
T ss_pred             c---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC-------CChHHHHHHHHhCcccCCccc--
Confidence            3   4568999999999999999999999999999999999999999963       233445555665555433221  


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHH
Q 011005          441 IRDILLISTVSFACLQSNPKSRP-----TMQSVSQEFLI  474 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~~~~  474 (496)
                         ...+.+|+.+.|+.|-.+|.     -..+|-.|+|+
T Consensus       265 ---s~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF  300 (355)
T KOG0616|consen  265 ---SSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWF  300 (355)
T ss_pred             ---CHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccc
Confidence               11356888899999999982     34455555555

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-44  Score=311.04  Aligned_cols=256  Identities=30%  Similarity=0.434  Sum_probs=216.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      .++|++.+.||+|.||.||.|+. +++-.||+|++.+..  ......++.+|+++.+.++||||+++|++|.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            46899999999999999999965 568899999998764  233456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      +||..+|.++..|...... .+++.....++.|++.|+.|+|   .++|+||||||+|+|++..+..||+|||.+..-. 
T Consensus       101 lEya~~gel~k~L~~~~~~-~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMK-RFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEecCCchHHHHHHhcccc-cccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            9999999999999954433 6888999999999999999999   8899999999999999999999999999996543 


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                       .....+.+||..|.+||...+..++..+|+|++|++.||++.|.+||....       ......++..-.+..+.    
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-------~~etYkrI~k~~~~~p~----  243 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-------HSETYKRIRKVDLKFPS----  243 (281)
T ss_pred             -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-------hHHHHHHHHHccccCCc----
Confidence             555677899999999999999999999999999999999999999997322       23333333332222221    


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                       .......++|.+|+..+|.+|.+..|++.|+|+...
T Consensus       244 -~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  244 -TISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             -ccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence             111246789999999999999999999999998753

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-46  Score=322.18  Aligned_cols=270  Identities=24%  Similarity=0.340  Sum_probs=219.7

Q ss_pred             HHhCCCCcceeeecCCeeEEEE-EeCCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      ..+.|++.+.||+|+|+.||++ ..+.|+.+|+|.+.... .....+.+.+|+.+.+.++||||+++.+.+.+....++|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            4567888899999999999999 45689999999886533 223457889999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC---CCCeEEcccccccc
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KLEAFVADFGTARL  357 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg~~~~  357 (496)
                      +|+|+|+.|..-+....   .+++..+-..+.||+.||+|+|   .++|+|||+||+|+++..   ..-+||+|||+|..
T Consensus        89 Fe~m~G~dl~~eIV~R~---~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVARE---FYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             EecccchHHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence            99999999976665542   6788889999999999999999   889999999999999954   34599999999999


Q ss_pred             ccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          358 LHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       358 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                      +. +.......+|||+|||||++...+|+..+|||+.|++||-|+.|.+||...+       .......++......+. 
T Consensus       163 l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~-------~~rlye~I~~g~yd~~~-  233 (355)
T KOG0033|consen  163 VN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-------QHRLYEQIKAGAYDYPS-  233 (355)
T ss_pred             eC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc-------HHHHHHHHhccccCCCC-
Confidence            87 5555667899999999999999999999999999999999999999996322       22223333333332221 


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCccccc
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQ  487 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~~~~  487 (496)
                      ..+........+|+.+||..||.+|.|+.|.|+|+|+..+....+.-..+
T Consensus       234 ~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~  283 (355)
T KOG0033|consen  234 PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQ  283 (355)
T ss_pred             cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhH
Confidence            11223334567999999999999999999999999998876655444333

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3e-44  Score=345.95  Aligned_cols=265  Identities=27%  Similarity=0.443  Sum_probs=213.9

Q ss_pred             HHHHHHHhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCe
Q 011005          198 EDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKC  276 (496)
Q Consensus       198 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  276 (496)
                      +++....+++.+...||+|.||+||+|.|-  -.||||++.... ..+..+.|++|+.++++-+|.||+-+.|||..+..
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            455555677888999999999999999984  368999997754 44567899999999999999999999999999887


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                       .||+.+|+|-+|+.+++..+  .+|...+.+.|+.||++|+.|||   .++|||||||..|||+.+++.|||+|||++.
T Consensus       463 -AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             -eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEeccccee
Confidence             99999999999999999765  37899999999999999999999   8899999999999999999999999999996


Q ss_pred             cccC--CCCCccccccccccccccccccC---CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCC
Q 011005          357 LLHA--DSSNRTLLAGTYGYIAPELAYTM---VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQR  431 (496)
Q Consensus       357 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  431 (496)
                      .-..  .........|...|||||+++..   +|++.+||||||+++|||++|..||.+..       .+..+..+=++.
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~-------~dqIifmVGrG~  609 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN-------RDQIIFMVGRGY  609 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC-------hhheEEEecccc
Confidence            5332  22233445678899999998743   68899999999999999999999997221       111111111222


Q ss_pred             CCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          432 LPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       432 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      +.+............+.+|+..||..++++||.+.+++..+.....
T Consensus       610 l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  610 LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            2223333333445568899999999999999999999997666555

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.8e-44  Score=329.10  Aligned_cols=253  Identities=22%  Similarity=0.387  Sum_probs=218.0

Q ss_pred             HhCCCCcceeeecCCeeEEEEE-eCCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      .-+|++.+.||+|.||.|-+|. ++.|+.||||.++++.  +.+..-.+.+|+++|+.++||||+.+|++|+.++...+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            3468888999999999999995 5789999999998865  344455678999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||..+|.|++++...+   .+++.+++.+++||+.|+.|||   +++++|||||.+|||+|.++++||+|||++..+..
T Consensus       132 MEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            99999999999999876   7999999999999999999999   88999999999999999999999999999988764


Q ss_pred             CCCCccccccccccccccccccCCcC-cccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMT-EKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                      . ...+++||+|-|.+||+..|..|. +.+|.||+|++||.|+.|..||+.       .+......++.......+....
T Consensus       206 ~-kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-------~Dhk~lvrQIs~GaYrEP~~PS  277 (668)
T KOG0611|consen  206 K-KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-------RDHKRLVRQISRGAYREPETPS  277 (668)
T ss_pred             c-cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-------chHHHHHHHhhcccccCCCCCc
Confidence            3 446778999999999999999985 689999999999999999999983       3344445555555444333221


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                            ...-||.+||..+|++|.|+.+|..|-|..-
T Consensus       278 ------dA~gLIRwmLmVNP~RRATieDiAsHWWvNw  308 (668)
T KOG0611|consen  278 ------DASGLIRWMLMVNPERRATIEDIASHWWVNW  308 (668)
T ss_pred             ------hHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence                  2346778999999999999999999998753

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-43  Score=338.30  Aligned_cols=251  Identities=26%  Similarity=0.366  Sum_probs=207.6

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|+||.||+|..+ +++.||+|.+....  .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36889999999999999999765 68999999986543  2233456889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            9999999999987654   6888999999999999999999   789999999999999999999999999999866432


Q ss_pred             CCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                         .....|++.|+|||++.+..++.++||||+||++|+|++|+.||....       .......+.......+..    
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~----  220 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN-------PFGIYEKILAGKLEFPRH----  220 (291)
T ss_pred             ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCcCCCcc----
Confidence               223568999999999999999999999999999999999999986321       111222222222221111    


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHHHHhc
Q 011005          442 RDILLISTVSFACLQSNPKSRPT-----MQSVSQEFLITR  476 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~~~~~~  476 (496)
                       ....+.+++.+||+.||.+||+     ++|+++|+|+..
T Consensus       221 -~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         221 -LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             -CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence             1224678999999999999995     999999999854

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-43  Score=331.05  Aligned_cols=263  Identities=25%  Similarity=0.343  Sum_probs=207.5

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhH-------------HHHHHHHHHHHHHHhhccccccccc
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEEL-------------AFIKSFKNEAQVLSQVLHRNIVKLY  268 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~~  268 (496)
                      ..++|++.+.||+|.||.|-+|+. .+++.||||++.+..-.             ...+...+|+.+|+++.|||||+++
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            357899999999999999999965 47999999999764311             1234788999999999999999999


Q ss_pred             ceeecCC--eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCC
Q 011005          269 GYCLHKK--CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE  346 (496)
Q Consensus       269 ~~~~~~~--~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~  346 (496)
                      ++..++.  .+|||+|||..|.+...   ......++..++++++.+++.||+|||   .+||+||||||+|+|++++|+
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCc
Confidence            9998754  69999999998876522   222324899999999999999999999   779999999999999999999


Q ss_pred             eEEccccccccccCCC-----CCccccccccccccccccccCC----cCcccchhhHHHHHHHHHhCCCCCccccccCCC
Q 011005          347 AFVADFGTARLLHADS-----SNRTLLAGTYGYIAPELAYTMV----MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSS  417 (496)
Q Consensus       347 ~kl~Dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~  417 (496)
                      +||+|||.+.......     ......+|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||-.       
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-------  321 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-------  321 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-------
Confidence            9999999998663221     1223368999999999988743    24589999999999999999999852       


Q ss_pred             CCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCC
Q 011005          418 SDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLV  481 (496)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~  481 (496)
                      .........++...+..+...   .....+.+|+.+||++||++|.+..+|..|+|..+.-...
T Consensus       322 ~~~~~l~~KIvn~pL~fP~~p---e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~  382 (576)
T KOG0585|consen  322 DFELELFDKIVNDPLEFPENP---EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP  382 (576)
T ss_pred             chHHHHHHHHhcCcccCCCcc---cccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence            112222333344433333222   1223477999999999999999999999999999874443

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.2e-43  Score=341.49  Aligned_cols=248  Identities=21%  Similarity=0.300  Sum_probs=203.2

Q ss_pred             ceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCC
Q 011005          211 YCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERG  287 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g  287 (496)
                      +.||+|+||.||+|.. .+|+.||+|.+....  .......+.+|+.++++++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999965 478999999987643  2233456788999999999999999999999999999999999999


Q ss_pred             ChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCccc
Q 011005          288 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL  367 (496)
Q Consensus       288 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  367 (496)
                      +|.+++....   .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  154 (323)
T cd05571          81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence            9999987654   6889999999999999999999   789999999999999999999999999999764333333445


Q ss_pred             cccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHH
Q 011005          368 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLI  447 (496)
Q Consensus       368 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  447 (496)
                      .+||+.|+|||++.+..++.++||||+||++|||++|+.||....       ...............+.     .....+
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-------~~~~~~~~~~~~~~~p~-----~~~~~~  222 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HEKLFELILMEEIRFPR-----TLSPEA  222 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC-------HHHHHHHHHcCCCCCCC-----CCCHHH
Confidence            679999999999999999999999999999999999999985321       11112222222221111     112246


Q ss_pred             HHHHHhcccCCCCCCC-----CHHHHHHHHHHhc
Q 011005          448 STVSFACLQSNPKSRP-----TMQSVSQEFLITR  476 (496)
Q Consensus       448 ~~li~~cl~~dP~~Rp-----s~~evl~~~~~~~  476 (496)
                      .+++.+||+.||++||     ++.++++|+|+..
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~  256 (323)
T cd05571         223 KSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS  256 (323)
T ss_pred             HHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            7899999999999999     8999999999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=6.6e-43  Score=337.31  Aligned_cols=269  Identities=22%  Similarity=0.303  Sum_probs=204.2

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|++.+.||+|+||+||+|..+ +++.||+|.+...........+.+|+.+++.++||||+++++++..+...++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            367999999999999999999765 6889999998765433333456789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+. ++|.+++....  ..++...+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            996 57877776542  25788999999999999999999   7899999999999999999999999999997654333


Q ss_pred             CCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCC----------CCCCcch--hH---h
Q 011005          363 SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS----------SSDPKIM--LI---D  426 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~----------~~~~~~~--~~---~  426 (496)
                      .......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||........          .......  ..   .
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence            33344568999999999865 4578899999999999999999999964321100          0000000  00   0


Q ss_pred             hhcCCCC--CCCC--hhHH--HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          427 VLDQRLP--PPVD--RKVI--RDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       427 ~~~~~~~--~~~~--~~~~--~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      .......  .+..  ....  .....+.+++.+||+.||++|||+.|+++|+|+..-.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            0000000  0000  0000  0012467899999999999999999999999997643

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.4e-43  Score=334.29  Aligned_cols=257  Identities=23%  Similarity=0.278  Sum_probs=203.7

Q ss_pred             CCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchh--HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          207 FDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      |+..+.||+|+||.||+|.. .+++.||+|.+.....  ......+.+|+.++++++|++|+++++++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            67788999999999999975 5789999999865431  22234578899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++|+|..++.... ...+++..+..++.|++.||+|||   +.+|+||||||+||++++++.++|+|||++....... 
T Consensus        82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            99999988876432 225889999999999999999999   7899999999999999999999999999998753322 


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD  443 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  443 (496)
                      ......|++.|+|||++.+..++.++||||+||++|+|++|+.||......    ............. ......   ..
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~----~~~~~~~~~~~~~-~~~~~~---~~  228 (285)
T cd05631         157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER----VKREEVDRRVKED-QEEYSE---KF  228 (285)
T ss_pred             eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc----hhHHHHHHHhhcc-cccCCc---cC
Confidence            223456899999999999999999999999999999999999999732210    0001111111110 000111   11


Q ss_pred             HHHHHHHHHhcccCCCCCCCC-----HHHHHHHHHHhc
Q 011005          444 ILLISTVSFACLQSNPKSRPT-----MQSVSQEFLITR  476 (496)
Q Consensus       444 ~~~l~~li~~cl~~dP~~Rps-----~~evl~~~~~~~  476 (496)
                      ...+.+|+.+||+.||++||+     ++++++|+|+..
T Consensus       229 s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~  266 (285)
T cd05631         229 SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKN  266 (285)
T ss_pred             CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence            224678999999999999997     899999999855

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.3e-43  Score=318.51  Aligned_cols=280  Identities=23%  Similarity=0.257  Sum_probs=215.8

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhH-HHHHHHHHHHHHHHhhcccccccccceeec--CCeEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEEL-AFIKSFKNEAQVLSQVLHRNIVKLYGYCLH--KKCMFL  279 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l  279 (496)
                      .++|+..+.|++|+||.||+|+++ +++.||+|+++..... ..--...+|+.++.+.+|||||.+-.+..-  -+..||
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            466888999999999999999765 6889999999875432 222345899999999999999999887653  457999


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      |||||+. +|..+++...  ..|...++.-+..|+++|++|||   ...|+||||||+|+|++..|.+||+|||+|+.+.
T Consensus       155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhc
Confidence            9999987 8988888655  47889999999999999999999   7899999999999999999999999999999998


Q ss_pred             CCCCCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccC-------------CCCCCcchhH
Q 011005          360 ADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS-------------SSSDPKIMLI  425 (496)
Q Consensus       360 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~-------------~~~~~~~~~~  425 (496)
                      .+....+..+-|.+|+|||.+.+. .|+++.|+||+|||+.||+++++-|...+...             ....+.....
T Consensus       229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l  308 (419)
T KOG0663|consen  229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL  308 (419)
T ss_pred             CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence            887777888899999999998875 69999999999999999999999886443221             0000100000


Q ss_pred             hhhc--CCCCCCCC---hhH--HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCccccccc
Q 011005          426 DVLD--QRLPPPVD---RKV--IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDI  489 (496)
Q Consensus       426 ~~~~--~~~~~~~~---~~~--~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~~~~~i  489 (496)
                      ....  .....++.   ...  ......-.+|+..+|..||.+|.|+.|.|+|-|+........+..+-.+
T Consensus       309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~  379 (419)
T KOG0663|consen  309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTW  379 (419)
T ss_pred             chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCC
Confidence            0000  00000000   000  0011234688899999999999999999999999886655555544443

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.5e-43  Score=355.67  Aligned_cols=257  Identities=26%  Similarity=0.420  Sum_probs=210.6

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMF  278 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  278 (496)
                      .+....+.||+|+||+||+|+..      +...||||.++...+.+..++|.+|++++..++|||||+++|.|.+++.++
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            45556778999999999999643      456799999999888778899999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCC-----------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCe
Q 011005          279 LIYEYMERGSLFCNLHNNED-----------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEA  347 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~  347 (496)
                      ||+|||..|+|.++|.....           ...++..+.+.|+.|||.|++||.   ++.+|||||.++|+||+++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEE
Confidence            99999999999999864321           223889999999999999999999   7789999999999999999999


Q ss_pred             EEccccccccccCCCCCc--cccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchh
Q 011005          348 FVADFGTARLLHADSSNR--TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIML  424 (496)
Q Consensus       348 kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~  424 (496)
                      ||+|||+++..-..+...  ....-..+|||||.+..+++|++||||||||+|||+++ |+.||..++       .++.+
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS-------n~EVI  715 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS-------NQEVI  715 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc-------hHHHH
Confidence            999999998654332211  11223569999999999999999999999999999998 899986432       33344


Q ss_pred             HhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          425 IDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                      ..+-..++-+-    +...+.++..|+..||+..|.+||+++||-..+.-.
T Consensus       716 e~i~~g~lL~~----Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~  762 (774)
T KOG1026|consen  716 ECIRAGQLLSC----PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW  762 (774)
T ss_pred             HHHHcCCcccC----CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence            44444443211    223455688999999999999999999997766443

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-42  Score=340.42  Aligned_cols=259  Identities=25%  Similarity=0.375  Sum_probs=202.0

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe------CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCC-
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKK-  275 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~-  275 (496)
                      .++|++.+.||+|+||.||+|.+      ..++.||+|++.........+.+.+|+.+++.+ +||||+++++++...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46899999999999999999964      235689999997654444456789999999999 8999999999887644 


Q ss_pred             eEEEEEEecCCCChhhhhhCCCC---------------------------------------------------------
Q 011005          276 CMFLIYEYMERGSLFCNLHNNED---------------------------------------------------------  298 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~---------------------------------------------------------  298 (496)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            58899999999999998875321                                                         


Q ss_pred             --CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC--Ccccccccccc
Q 011005          299 --AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NRTLLAGTYGY  374 (496)
Q Consensus       299 --~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y  374 (496)
                        ...+++.++..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......  ......+++.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              124778889999999999999999   78999999999999999999999999999986543221  11223456789


Q ss_pred             ccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHh
Q 011005          375 IAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFA  453 (496)
Q Consensus       375 ~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  453 (496)
                      +|||++.+..++.++||||||+++|||++ |..||.....      ................. .   .....+.+++.+
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~-~---~~~~~l~~li~~  312 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI------NEEFCQRLKDGTRMRAP-E---NATPEIYRIMLA  312 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc------cHHHHHHHhcCCCCCCC-C---CCCHHHHHHHHH
Confidence            99999999999999999999999999997 9999864221      11111111111111111 1   112347789999


Q ss_pred             cccCCCCCCCCHHHHHHHHHHh
Q 011005          454 CLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       454 cl~~dP~~Rps~~evl~~~~~~  475 (496)
                      ||+.||++|||+.|+++.+...
T Consensus       313 cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         313 CWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HccCChhhCcCHHHHHHHHHHH
Confidence            9999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=323.08  Aligned_cols=279  Identities=24%  Similarity=0.279  Sum_probs=216.7

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccc-hhHHHHHHHHHHHHHHHhhcccccccccceeec-----CC
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH-----KK  275 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~  275 (496)
                      ....|...+.||+|+||.|++|.. .+|+.||||++... ......++..+|++++++++|+||+.+.+.+..     -+
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            456677788999999999999965 47899999999843 233455778999999999999999999998865     34


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccc
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  355 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  355 (496)
                      ..|+|+|+|+ -+|...++.+.   .++...+..+++|+++||.|+|   +.+|+|||+||+|++++.+..+||+|||+|
T Consensus       100 DvYiV~elMe-tDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen  100 DVYLVFELME-TDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             eeEEehhHHh-hHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccce
Confidence            6899999994 58888888764   5888999999999999999999   889999999999999999999999999999


Q ss_pred             ccccCC--CCCccccccccccccccccc-cCCcCcccchhhHHHHHHHHHhCCCCCcccccc---------CCCCCCcch
Q 011005          356 RLLHAD--SSNRTLLAGTYGYIAPELAY-TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSL---------SSSSDPKIM  423 (496)
Q Consensus       356 ~~~~~~--~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~---------~~~~~~~~~  423 (496)
                      +.....  ....+..+.|.+|+|||++. ...|+.+.||||.|||+.||++|++-|......         .+.. ....
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP-~~e~  251 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP-SEED  251 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC-CHHH
Confidence            987543  22234567899999999865 568999999999999999999999998644322         0111 1111


Q ss_pred             --------hHhhhcC---CCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCccccccc
Q 011005          424 --------LIDVLDQ---RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDI  489 (496)
Q Consensus       424 --------~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~~~~~i  489 (496)
                              ....+..   ..+.+.............+|+++||..||.+|+|++|+++|+++.......+.+..+.+
T Consensus       252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~  328 (359)
T KOG0660|consen  252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPI  328 (359)
T ss_pred             HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCC
Confidence                    1111111   11111111112223456799999999999999999999999999988877777755544

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-43  Score=342.62  Aligned_cols=254  Identities=22%  Similarity=0.388  Sum_probs=214.0

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhc-ccccccccceeecCCeEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKCMF  278 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  278 (496)
                      ..++|.+.+.||+|.||+|+++..+ +++.+|||.+++..  ..++.+..+.|..++...+ ||.+++++.+|+.+++++
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            3467999999999999999999775 57899999999865  3345677888999988885 999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccc
Q 011005          279 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL  358 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  358 (496)
                      .||||+.||++..+.+..    .|++..+.-++..|+.||+|||   .+||||||||.+|||+|.+|++||+|||+++..
T Consensus       446 fvmey~~Ggdm~~~~~~~----~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIHTD----VFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEecCCCcEEEEEecc----cccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEeccccccccc
Confidence            999999999955444432    7999999999999999999999   889999999999999999999999999999987


Q ss_pred             cCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCCh
Q 011005          359 HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR  438 (496)
Q Consensus       359 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  438 (496)
                      ...+...++.+|||.|||||++.+..|+.++|.|||||+||||+.|..||.       ..++++....++......+.. 
T Consensus       519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~-------gddEee~FdsI~~d~~~yP~~-  590 (694)
T KOG0694|consen  519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP-------GDDEEEVFDSIVNDEVRYPRF-  590 (694)
T ss_pred             CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC-------CCCHHHHHHHHhcCCCCCCCc-
Confidence            766677888999999999999999999999999999999999999999996       334444444444444333321 


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHHHHHHh
Q 011005          439 KVIRDILLISTVSFACLQSNPKSRPTM-----QSVSQEFLIT  475 (496)
Q Consensus       439 ~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~~~~~  475 (496)
                          ...+...++.++|.++|++|.-+     .+|.+|+|+.
T Consensus       591 ----ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr  628 (694)
T KOG0694|consen  591 ----LSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFR  628 (694)
T ss_pred             ----ccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccc
Confidence                11235678889999999999954     6777776664

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.8e-42  Score=338.19  Aligned_cols=266  Identities=26%  Similarity=0.363  Sum_probs=209.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|++.+.||+|+||.||++..+ ++..||+|.+...........+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            367999999999999999999765 6888999998765444455678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++|+|.+++....   .+++..+..++.|++.||.|||+  ..+|+||||||+||+++.++.++|+|||++...... 
T Consensus        84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence            999999999997644   57889999999999999999994  246999999999999999999999999999765332 


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccC------CC-----C-------------
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS------SS-----S-------------  418 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~------~~-----~-------------  418 (496)
                       ......|++.|+|||++.+..++.++|||||||++|||++|+.||.......      ..     .             
T Consensus       158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (331)
T cd06649         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP  236 (331)
T ss_pred             -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence             2234568999999999999999999999999999999999999985321100      00     0             


Q ss_pred             -----------CCcchhHhhhc---CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          419 -----------DPKIMLIDVLD---QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       419 -----------~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                                 .......+...   ....+....  ......+.+|+.+||+.||++|||+.|+++|+|+....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPN--GVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             cccccccccccccchhHHHHHHHHHhCCCcCCCC--ccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                       00000000000   000000000  01123578999999999999999999999999997643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7.6e-43  Score=340.43  Aligned_cols=251  Identities=25%  Similarity=0.344  Sum_probs=207.9

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|+||.||+|.++ +++.||+|.+....  .....+.+.+|+.++++++||||+++++++..++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57899999999999999999765 68899999987643  2233456889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            9999999999987653   6788999999999999999999   789999999999999999999999999999866432


Q ss_pred             CCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                         .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....       .......+.......+..    
T Consensus       172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-------~~~~~~~i~~~~~~~p~~----  237 (329)
T PTZ00263        172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT-------PFRIYEKILAGRLKFPNW----  237 (329)
T ss_pred             ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC-------HHHHHHHHhcCCcCCCCC----
Confidence               224578999999999999999999999999999999999999986321       111222222232221111    


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHHHHhc
Q 011005          442 RDILLISTVSFACLQSNPKSRPT-----MQSVSQEFLITR  476 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~~~~~~  476 (496)
                       ....+.+++.+||+.||++||+     ++++++|+|+..
T Consensus       238 -~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        238 -FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             -CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence             1124678999999999999997     799999999865

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.7e-43  Score=335.17  Aligned_cols=264  Identities=22%  Similarity=0.263  Sum_probs=201.2

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      ++|++.+.||+|+||+||+|..+ +++.||+|.++..........+.+|+.++++++||||+++++++......++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56899999999999999999764 68899999987543333335677999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++ +|.+++....  ..+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++.......
T Consensus        85 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          85 LDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            975 8988886543  24788999999999999999999   78999999999999999999999999999976543333


Q ss_pred             Ccccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccC---------CCCC----Ccch-hHhhh
Q 011005          364 NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS---------SSSD----PKIM-LIDVL  428 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~---------~~~~----~~~~-~~~~~  428 (496)
                      ......+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||.......         ....    +... ..+..
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence            3344568899999998875 568899999999999999999999986322100         0000    0000 00000


Q ss_pred             cCCCCCCCChhH----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          429 DQRLPPPVDRKV----IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       429 ~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ....+.......    ........+|+.+||+.||.+|||++|+++|+|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            000000000000    0112346789999999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=340.10  Aligned_cols=256  Identities=22%  Similarity=0.301  Sum_probs=207.9

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|+||.||+|... +++.||+|++....  .......+.+|+++++.++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36889999999999999999765 58899999997643  2234466889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++|+|.+++....   .+++..+..++.|++.||.|||   ..+++||||||+||+++.++.+||+|||++..... 
T Consensus        81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            9999999999997644   6788999999999999999999   78999999999999999999999999999976543 


Q ss_pred             CCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhc--CCCCCC-CCh
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD--QRLPPP-VDR  438 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-~~~  438 (496)
                        ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....       .........  .....+ ...
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~  224 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP-------NETWENLKYWKETLQRPVYDD  224 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH-------HHHHHHHHhccccccCCCCCc
Confidence              23345789999999999999999999999999999999999999963221       111111111  111111 100


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          439 KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       439 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      ........+.+++.+||..+|++||+++|+++|+|+..
T Consensus       225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~  262 (333)
T cd05600         225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE  262 (333)
T ss_pred             cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence            00112235678999999999999999999999999875

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.5e-42  Score=341.84  Aligned_cols=258  Identities=28%  Similarity=0.388  Sum_probs=202.2

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      ++|+..+.||+|+||.||+|.+. +++.||+|.+...........+.+|+++++.++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            44667788999999999999764 68999999997655445557789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++|+|....       ..+...+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            9999986432       3456777889999999999999   78999999999999999999999999999987654333


Q ss_pred             Ccccccccccccccccccc-----CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCCh
Q 011005          364 NRTLLAGTYGYIAPELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR  438 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  438 (496)
                      ......||..|+|||++..     ...+.++|||||||++|||++|+.||.....     ................... 
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~-  297 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-----GDWASLMCAICMSQPPEAP-  297 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----ccHHHHHHHHhccCCCCCC-
Confidence            3344678999999998753     2334689999999999999999999962111     0001111111111111111 


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          439 KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       439 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                        ......+.+++.+||+.||++|||+.|+++|+|+.+..+.
T Consensus       298 --~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~  337 (353)
T PLN00034        298 --ATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG  337 (353)
T ss_pred             --CccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence              1122347899999999999999999999999999887554

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.3e-42  Score=339.48  Aligned_cols=252  Identities=24%  Similarity=0.336  Sum_probs=207.2

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCC--CcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPN--GKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      .++|++.+.||+|+||.||+|.+++  +..||+|.+....  .....+.+.+|+.+++.++||||+++++++..++..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3579999999999999999997543  3689999986543  22334567899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||||+++|+|.+++....   .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            999999999999997654   6889999999999999999999   7899999999999999999999999999998654


Q ss_pred             CCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          360 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       360 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                      ..   .....||+.|+|||++.+..++.++||||+||++|||++|+.||....       .......+.......+..  
T Consensus       183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-------~~~~~~~i~~~~~~~p~~--  250 (340)
T PTZ00426        183 TR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE-------PLLIYQKILEGIIYFPKF--  250 (340)
T ss_pred             CC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC-------HHHHHHHHhcCCCCCCCC--
Confidence            32   234578999999999999899999999999999999999999996321       122222333332221111  


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHhc
Q 011005          440 VIRDILLISTVSFACLQSNPKSRP-----TMQSVSQEFLITR  476 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~~~~~~  476 (496)
                         ....+.+++.+||+.||++|+     +++|+++|+|+..
T Consensus       251 ---~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~  289 (340)
T PTZ00426        251 ---LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN  289 (340)
T ss_pred             ---CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence               112367899999999999995     8999999999865

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-42  Score=335.25  Aligned_cols=247  Identities=25%  Similarity=0.342  Sum_probs=202.1

Q ss_pred             eeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCCCh
Q 011005          213 IGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL  289 (496)
Q Consensus       213 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g~L  289 (496)
                      ||+|+||.||+|... +++.||+|.+....  .......+.+|+.++++++||||+++++++..++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999765 58899999987542  223446678899999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCccccc
Q 011005          290 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA  369 (496)
Q Consensus       290 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  369 (496)
                      .+++....   .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||+++.............
T Consensus        81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  154 (312)
T cd05585          81 FHHLQREG---RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC  154 (312)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence            99997643   6899999999999999999999   78999999999999999999999999999976543333344567


Q ss_pred             cccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHH
Q 011005          370 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLIST  449 (496)
Q Consensus       370 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  449 (496)
                      ||+.|+|||++.+..++.++||||+||++|+|++|+.||....       ...............+.     .....+.+
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-------~~~~~~~~~~~~~~~~~-----~~~~~~~~  222 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-------VNEMYRKILQEPLRFPD-----GFDRDAKD  222 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-------HHHHHHHHHcCCCCCCC-----cCCHHHHH
Confidence            9999999999999999999999999999999999999996321       11222222222221111     11234678


Q ss_pred             HHHhcccCCCCCCC---CHHHHHHHHHHhcc
Q 011005          450 VSFACLQSNPKSRP---TMQSVSQEFLITRK  477 (496)
Q Consensus       450 li~~cl~~dP~~Rp---s~~evl~~~~~~~~  477 (496)
                      ++.+||+.||++||   ++.|+++|+|+...
T Consensus       223 li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         223 LLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             HHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence            99999999999997   57999999998753

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-43  Score=335.37  Aligned_cols=259  Identities=22%  Similarity=0.363  Sum_probs=220.8

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCe-EEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKC-MFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lV~  281 (496)
                      ++|...+.+|+|+||.++.++++ +++.+|+|++.-.. .....+....|+.++++++|||||.+.+.|.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56888999999999999999765 57889999987654 22334577899999999999999999999999988 99999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      +||+||++.+.+.+.. +..++++.+..++.|++.|++|||   +..|+|||||+.|||++.++.|+|+|||+|+.+..+
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999998765 557999999999999999999999   779999999999999999999999999999999877


Q ss_pred             CCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                      .....+.+|||.||+||++.+.+|..|+||||+||++|||++-+++|...       +...-...+...... +...   
T Consensus       160 ~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-------~m~~Li~ki~~~~~~-Plp~---  228 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-------NMSELILKINRGLYS-PLPS---  228 (426)
T ss_pred             hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-------chHHHHHHHhhccCC-CCCc---
Confidence            65677789999999999999999999999999999999999999999732       233333344433322 2222   


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          442 RDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      .....+..++..|++.+|+.||++.++|.++...+..
T Consensus       229 ~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  229 MYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             cccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence            2333577899999999999999999999998777655

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.2e-42  Score=335.14  Aligned_cols=248  Identities=22%  Similarity=0.301  Sum_probs=202.4

Q ss_pred             ceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCC
Q 011005          211 YCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERG  287 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g  287 (496)
                      +.||+|+||.||++.. .+|+.||+|.+....  .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3699999999999975 468999999987643  2233456778999999999999999999999999999999999999


Q ss_pred             ChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCccc
Q 011005          288 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL  367 (496)
Q Consensus       288 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  367 (496)
                      +|..++....   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++............
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  154 (323)
T cd05595          81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence            9998887654   6899999999999999999999   789999999999999999999999999998764333333344


Q ss_pred             cccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHH
Q 011005          368 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLI  447 (496)
Q Consensus       368 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  447 (496)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||....       ...............+..     ....+
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-------~~~~~~~~~~~~~~~p~~-----~~~~~  222 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HERLFELILMEEIRFPRT-----LSPEA  222 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHhcCCCCCCCC-----CCHHH
Confidence            679999999999999999999999999999999999999986321       111222222222211111     12246


Q ss_pred             HHHHHhcccCCCCCCC-----CHHHHHHHHHHhc
Q 011005          448 STVSFACLQSNPKSRP-----TMQSVSQEFLITR  476 (496)
Q Consensus       448 ~~li~~cl~~dP~~Rp-----s~~evl~~~~~~~  476 (496)
                      .+++.+||+.||++||     ++.++++|.|+..
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~  256 (323)
T cd05595         223 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  256 (323)
T ss_pred             HHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence            7899999999999998     8999999998865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.4e-42  Score=334.88  Aligned_cols=266  Identities=25%  Similarity=0.362  Sum_probs=208.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|++.+.||+|+||.||+|.++ ++..+|+|.+...........+.+|+++++.++|+||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468999999999999999999765 6888999988765444445678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++|+|.+++....   .+++..+..++.|++.||.|||+  ..+++|+||||+||+++.++.+||+|||++...... 
T Consensus        84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-  157 (333)
T cd06650          84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (333)
T ss_pred             cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence            999999999997643   57888999999999999999994  247999999999999999999999999999765332 


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccC----------CCCC-------------
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS----------SSSD-------------  419 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~----------~~~~-------------  419 (496)
                       ......|+..|+|||++.+..++.++||||+||++|+|++|+.||.......          ....             
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (333)
T cd06650         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR  236 (333)
T ss_pred             -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence             2233568899999999999899999999999999999999999986322100          0000             


Q ss_pred             ----------CcchhHhhhc---CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          420 ----------PKIMLIDVLD---QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       420 ----------~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                                +.........   ....+....  ......+.+|+.+||+.||++|||+.|+++|+|+....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPS--GVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             hhhhhcccccccccHHHHHHHHhcCCCccCCC--CCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                      0000000000   000000000  00123477999999999999999999999999997653

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.7e-42  Score=335.26  Aligned_cols=248  Identities=22%  Similarity=0.301  Sum_probs=201.7

Q ss_pred             ceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCC
Q 011005          211 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERG  287 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g  287 (496)
                      +.||+|+||.||++..+ +++.||+|++....  .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999754 68999999997643  2234466788999999999999999999999999999999999999


Q ss_pred             ChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCccc
Q 011005          288 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL  367 (496)
Q Consensus       288 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  367 (496)
                      +|..++....   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  154 (328)
T cd05593          81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT  154 (328)
T ss_pred             CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence            9998887643   6889999999999999999999   789999999999999999999999999998764333333344


Q ss_pred             cccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHH
Q 011005          368 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLI  447 (496)
Q Consensus       368 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  447 (496)
                      .+||+.|+|||++.+..++.++||||+||++|+|++|+.||....       ...............+.     .....+
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-------~~~~~~~~~~~~~~~p~-----~~~~~~  222 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HEKLFELILMEDIKFPR-----TLSADA  222 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC-------HHHHHHHhccCCccCCC-----CCCHHH
Confidence            679999999999999999999999999999999999999996321       11111111111111111     112246


Q ss_pred             HHHHHhcccCCCCCCC-----CHHHHHHHHHHhc
Q 011005          448 STVSFACLQSNPKSRP-----TMQSVSQEFLITR  476 (496)
Q Consensus       448 ~~li~~cl~~dP~~Rp-----s~~evl~~~~~~~  476 (496)
                      .+++.+||+.||++||     ++.|+++|+|+..
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~  256 (328)
T cd05593         223 KSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG  256 (328)
T ss_pred             HHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            7899999999999997     8999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.1e-42  Score=331.28  Aligned_cols=264  Identities=23%  Similarity=0.273  Sum_probs=202.3

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      ++|++.+.||+|+||+||+|.++ +++.||+|++.... .....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46899999999999999999775 68899999987643 22334567899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |++++.+..+....   ..+++..+..++.|++.||.|||   ..+++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            99987776554322   26889999999999999999999   7899999999999999999999999999998764322


Q ss_pred             C-CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCC--------CCCCcchhHhhh-----
Q 011005          363 S-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS--------SSDPKIMLIDVL-----  428 (496)
Q Consensus       363 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~--------~~~~~~~~~~~~-----  428 (496)
                      . ......|++.|+|||++.+..++.++||||+||++|||++|+.||........        ...+........     
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence            2 22335689999999999998999999999999999999999999964321100        000000000000     


Q ss_pred             -cCCCCCCCC-hh-----HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          429 -DQRLPPPVD-RK-----VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       429 -~~~~~~~~~-~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                       ....+.... ..     .......+.+++.+||+.||++|||++|+++|+|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence             000000000 00     00112357899999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.7e-42  Score=337.54  Aligned_cols=274  Identities=25%  Similarity=0.353  Sum_probs=204.9

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecC-----CeEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK-----KCMF  278 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~  278 (496)
                      +|++.+.||+|+||.||+|..+ +++.||+|++.... .......+.+|+.++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5888999999999999999754 68999999987532 222345678999999999999999999988543     2579


Q ss_pred             EEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccc
Q 011005          279 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL  358 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  358 (496)
                      +||||+. ++|.+.+....   .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 68888887543   6899999999999999999999   789999999999999999999999999999765


Q ss_pred             cCCCC---Ccccccccccccccccccc--CCcCcccchhhHHHHHHHHHhCCCCCccccccCC--------CCCCcch--
Q 011005          359 HADSS---NRTLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS--------SSDPKIM--  423 (496)
Q Consensus       359 ~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~--------~~~~~~~--  423 (496)
                      .....   ......||+.|+|||++.+  ..++.++||||+||++|||++|+.||........        .......  
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            33221   1233578999999999876  6788999999999999999999999964321000        0000000  


Q ss_pred             ---------hHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCcccc
Q 011005          424 ---------LIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAI  486 (496)
Q Consensus       424 ---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~~~  486 (496)
                               ....+....+.+...........+.+++.+||+.||++|||++|+++|+|+............
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~  305 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSA  305 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcccccccc
Confidence                     000011111111111000112346789999999999999999999999999876665544433

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-42  Score=333.44  Aligned_cols=263  Identities=24%  Similarity=0.320  Sum_probs=220.3

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeCC-CcEEEEEEcccchh--HHHHHHHHHHHHHHHhhc-ccccccccceeecCCeEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSEE--LAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKCMF  278 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  278 (496)
                      ....|++.+.||+|.||.||++..+. |+.+|+|.+.+...  ......+.+|+.+|+++. |||||.+++.++....++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            34678889999999999999997765 99999999977542  223467899999999998 999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC----CCeEEccccc
Q 011005          279 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK----LEAFVADFGT  354 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~----~~~kl~Dfg~  354 (496)
                      +|||+++||.|++.+...    .+++..+..++.|++.++.|||   +.||+|||+||+|+|+...    +.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999999876    3899999999999999999999   7899999999999999644    4799999999


Q ss_pred             cccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCC
Q 011005          355 ARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPP  434 (496)
Q Consensus       355 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  434 (496)
                      +..... .......+||+.|+|||++.+..|+..+||||+|+++|.|++|..||....       .......+.......
T Consensus       186 a~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~-------~~~~~~~i~~~~~~f  257 (382)
T KOG0032|consen  186 AKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET-------EFEIFLAILRGDFDF  257 (382)
T ss_pred             ceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC-------hhHHHHHHHcCCCCC
Confidence            998876 556677899999999999999999999999999999999999999997432       222333444443322


Q ss_pred             CCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCC
Q 011005          435 PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLV  481 (496)
Q Consensus       435 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~  481 (496)
                      .. ..+........+++.+|+..||.+|+|+.++++|+|+.......
T Consensus       258 ~~-~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~  303 (382)
T KOG0032|consen  258 TS-EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEAT  303 (382)
T ss_pred             CC-CCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccc
Confidence            11 11223334577999999999999999999999999987754443

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-43  Score=336.97  Aligned_cols=252  Identities=29%  Similarity=0.472  Sum_probs=205.7

Q ss_pred             cccHHHHHHHHhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeec
Q 011005          194 RIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH  273 (496)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  273 (496)
                      ++.|+++-+       .+-||.|+.|.||+|+++ ++.||||+++.-+        ..+++-+++++|+||+.|.|+|..
T Consensus       120 eiPFe~IsE-------LeWlGSGaQGAVF~Grl~-netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtq  183 (904)
T KOG4721|consen  120 EIPFEEISE-------LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQ  183 (904)
T ss_pred             cCCHHHhhh-------hhhhccCcccceeeeecc-CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecC
Confidence            455665533       456999999999999994 6889999986543        356888999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccc
Q 011005          274 KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG  353 (496)
Q Consensus       274 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  353 (496)
                      ...+|||||||..|-|++.|....   .+.......|.++||.|+.|||   .+.|||||||.-||||+.+..|||+|||
T Consensus       184 sPcyCIiMEfCa~GqL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFG  257 (904)
T KOG4721|consen  184 SPCYCIIMEFCAQGQLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFG  257 (904)
T ss_pred             CceeEEeeeccccccHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEecccc
Confidence            999999999999999999998765   6788888999999999999999   7899999999999999999999999999


Q ss_pred             ccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCC
Q 011005          354 TARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLP  433 (496)
Q Consensus       354 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  433 (496)
                      -++....- .....++||..|||||++.....++|+|||||||+||||+||..||........       +..+=...+.
T Consensus       258 TS~e~~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-------IwGVGsNsL~  329 (904)
T KOG4721|consen  258 TSKELSDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-------IWGVGSNSLH  329 (904)
T ss_pred             chHhhhhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-------EEeccCCccc
Confidence            99877544 445568899999999999999999999999999999999999999975432111       1111111121


Q ss_pred             CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          434 PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       434 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      -+...   ..+.-+.-|+..||+-.|..||+|.+++.|+.+....
T Consensus       330 LpvPs---tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe  371 (904)
T KOG4721|consen  330 LPVPS---TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE  371 (904)
T ss_pred             ccCcc---cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence            11111   1223366788899999999999999999998776543

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-42  Score=340.75  Aligned_cols=255  Identities=25%  Similarity=0.380  Sum_probs=208.6

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|.+.+.||+|+||+||+|... +++.||+|++....  .......+.+|++++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999765 68999999997643  1233466889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++++|.+++....   .++...+..++.||+.||+|||   ..|++||||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            9999999999998653   6899999999999999999999   789999999999999999999999999999876543


Q ss_pred             C-----------------------------CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCcccc
Q 011005          362 S-----------------------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILS  412 (496)
Q Consensus       362 ~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~  412 (496)
                      .                             .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            3                             12234568999999999999999999999999999999999999996322


Q ss_pred             ccCCCCCCcchhHhhhc--CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHHHHHhc
Q 011005          413 SLSSSSDPKIMLIDVLD--QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPT-MQSVSQEFLITR  476 (496)
Q Consensus       413 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~~~~~~~  476 (496)
                             .......+..  .....+....   ....+.+++.+|+. ||.+||+ ++|+++|+|+..
T Consensus       235 -------~~~~~~~i~~~~~~~~~p~~~~---~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~  290 (350)
T cd05573         235 -------LQETYNKIINWKESLRFPPDPP---VSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG  290 (350)
T ss_pred             -------HHHHHHHHhccCCcccCCCCCC---CCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence                   1112222222  1111111110   12346789999997 9999999 999999999854

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.4e-42  Score=332.70  Aligned_cols=248  Identities=26%  Similarity=0.364  Sum_probs=202.3

Q ss_pred             ceeeecCCeeEEEEEe----CCCcEEEEEEcccch---hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          211 YCIGTGGYGSVYKAQL----PNGKVFALKKLHTSE---ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      +.||+|+||.||++..    ..++.||+|.+....   .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999965    357899999987643   222335578899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++|+|.+.+....   .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            99999999987644   5788888899999999999999   78999999999999999999999999999875443333


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD  443 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  443 (496)
                      ......|++.|+|||++.+..++.++||||+|+++|||++|+.||....       ...............+..     .
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~-------~~~~~~~~~~~~~~~~~~-----~  223 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN-------RKKTIDKILKGKLNLPPY-----L  223 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC-------HHHHHHHHHcCCCCCCCC-----C
Confidence            3344578999999999999899999999999999999999999996321       122222333332221111     1


Q ss_pred             HHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHhc
Q 011005          444 ILLISTVSFACLQSNPKSRP-----TMQSVSQEFLITR  476 (496)
Q Consensus       444 ~~~l~~li~~cl~~dP~~Rp-----s~~evl~~~~~~~  476 (496)
                      ...+.+++.+||+.||++||     +++++++|+|+..
T Consensus       224 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~  261 (323)
T cd05584         224 TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRH  261 (323)
T ss_pred             CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence            12467899999999999999     8999999999854

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-42  Score=356.53  Aligned_cols=255  Identities=26%  Similarity=0.431  Sum_probs=209.5

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC--CCc----EEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP--NGK----VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMF  278 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  278 (496)
                      ...+..+.||+|+||.||.|...  .|.    .||||.+++..+.+....|.+|..+|+.++|||||+++|.+.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            44556778999999999999654  333    499999999887788899999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCC----CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccc
Q 011005          279 LIYEYMERGSLFCNLHNNED----AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  354 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  354 (496)
                      +++|||+||+|..+|.+.+.    ...++..+.+.++.|||+|+.||+   ++++|||||.++|+|++....|||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccch
Confidence            99999999999999987622    346899999999999999999999   78999999999999999999999999999


Q ss_pred             cccccCCCCC-cccc-ccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhH-hhhcC
Q 011005          355 ARLLHADSSN-RTLL-AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLI-DVLDQ  430 (496)
Q Consensus       355 ~~~~~~~~~~-~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~  430 (496)
                      |+.+...... .... .-...|||||.+.++.++.++|||||||++||++| |..||...       ....... -....
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~-------~n~~v~~~~~~gg  921 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR-------SNFEVLLDVLEGG  921 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc-------chHHHHHHHHhCC
Confidence            9954333221 1112 23458999999999999999999999999999998 88898632       2222222 33334


Q ss_pred             CCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          431 RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       431 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      +++.+..     .+..+.+++..||+.+|++||++..+++.+--
T Consensus       922 RL~~P~~-----CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~  960 (1025)
T KOG1095|consen  922 RLDPPSY-----CPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPA  960 (1025)
T ss_pred             ccCCCCC-----CChHHHHHHHHHccCChhhCccHHHHHhhhhh
Confidence            5555432     33457799999999999999999999986443

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-41  Score=337.54  Aligned_cols=259  Identities=21%  Similarity=0.266  Sum_probs=201.3

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      ++|.+.+.||+|+||.||+|.. .+++.||+|....       ..+.+|++++++++||||+++++++..+...++|+|+
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            5799999999999999999965 4688999997532       3467899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC-
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-  362 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  362 (496)
                      +. ++|.+++....   .+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.++|+|||+++...... 
T Consensus       165 ~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        165 YK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             CC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence            95 68888876543   6789999999999999999999   7799999999999999999999999999997543222 


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcc--------------------
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKI--------------------  422 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~--------------------  422 (496)
                      .......||+.|+|||++.+..++.++||||+||++|||++|+.||-.............                    
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            223345799999999999999999999999999999999999988642221110000000                    


Q ss_pred             --hhHhhh----cCCCCCC----CChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          423 --MLIDVL----DQRLPPP----VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       423 --~~~~~~----~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                        ......    ......+    ...........+.+++.+||+.||++|||++|+++|+|+...
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence              000000    0000000    001111223457899999999999999999999999999764

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.6e-42  Score=335.63  Aligned_cols=255  Identities=22%  Similarity=0.356  Sum_probs=203.2

Q ss_pred             ceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEEEEecCC
Q 011005          211 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLIYEYMER  286 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~  286 (496)
                      +.||+|+||.||+|..+ +++.||+|.++...  .....+.+.+|..+++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36999999999999764 68899999997643  223345678899999998 699999999999999999999999999


Q ss_pred             CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCcc
Q 011005          287 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT  366 (496)
Q Consensus       287 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  366 (496)
                      |+|..++....   .+++..+..++.|++.||.|||   +++++||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (329)
T cd05588          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS  154 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence            99998887543   6899999999999999999999   78999999999999999999999999999975433333344


Q ss_pred             ccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCC--CCcchhHhhhcCCCCCCCChhHHHHH
Q 011005          367 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSS--DPKIMLIDVLDQRLPPPVDRKVIRDI  444 (496)
Q Consensus       367 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  444 (496)
                      ...||+.|+|||++.+..++.++||||+||++|+|++|+.||+.........  ................+..     ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~-----~~  229 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRS-----LS  229 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCC-----CC
Confidence            5679999999999999999999999999999999999999997443211111  1111112222222221111     12


Q ss_pred             HHHHHHHHhcccCCCCCCCC------HHHHHHHHHHhc
Q 011005          445 LLISTVSFACLQSNPKSRPT------MQSVSQEFLITR  476 (496)
Q Consensus       445 ~~l~~li~~cl~~dP~~Rps------~~evl~~~~~~~  476 (496)
                      ..+.+++.+||+.||++||+      ++++++|+|+..
T Consensus       230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            24678999999999999997      789999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1e-41  Score=332.02  Aligned_cols=251  Identities=22%  Similarity=0.351  Sum_probs=201.6

Q ss_pred             CCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHH---HhhcccccccccceeecCCeEEEE
Q 011005          207 FDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVL---SQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      |.+.+.||+|+||.||+|... +++.||||.++...  .....+.+.+|+.++   +.++||||+++++++..++..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            667889999999999999754 68999999997543  222345566676665   456799999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+++|+|...+...    .+++..+..++.||+.||.|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            9999999998887643    6899999999999999999999   78999999999999999999999999999876543


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      ........+|++.|+|||.+.+..++.++|||||||++|+|++|+.||....       ...............+..   
T Consensus       154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~-------~~~~~~~i~~~~~~~p~~---  223 (324)
T cd05589         154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD-------EEEVFDSIVNDEVRYPRF---  223 (324)
T ss_pred             CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCCC---
Confidence            3333445679999999999999999999999999999999999999986321       111222222222211111   


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHhc
Q 011005          441 IRDILLISTVSFACLQSNPKSRP-----TMQSVSQEFLITR  476 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~~~~~~  476 (496)
                        ....+.+++.+||+.||.+||     ++.++++|+|+..
T Consensus       224 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~  262 (324)
T cd05589         224 --LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD  262 (324)
T ss_pred             --CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence              122467899999999999999     6999999998754

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.6e-43  Score=305.56  Aligned_cols=259  Identities=24%  Similarity=0.363  Sum_probs=212.5

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-------hHHHHHHHHHHHHHHHhhc-ccccccccceeec
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-------ELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLH  273 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~  273 (496)
                      .-+.|...+.||.|..++|-++.+ ++|+.+|+|++....       -....+.-..|+.+++++. ||+|+++.++++.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            456788888999999999999955 478899999885422       1122344568999999995 9999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccc
Q 011005          274 KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG  353 (496)
Q Consensus       274 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  353 (496)
                      +...++|+|.|+.|.|++++...-   .+++.+..+|++|+..|++|||   ...|+||||||+|||++++.+++|+|||
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccc
Confidence            999999999999999999998654   7899999999999999999999   8899999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccccccc------CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcc-hhHh
Q 011005          354 TARLLHADSSNRTLLAGTYGYIAPELAYT------MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKI-MLID  426 (496)
Q Consensus       354 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~  426 (496)
                      +++.+.. +......||||+|+|||.+..      ..|+..+|+||.|+|+|.++.|.+||...        ... +...
T Consensus       169 Fa~~l~~-GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--------kQmlMLR~  239 (411)
T KOG0599|consen  169 FACQLEP-GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--------KQMLMLRM  239 (411)
T ss_pred             eeeccCC-chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--------HHHHHHHH
Confidence            9998854 445566899999999998763      36788999999999999999999999522        222 2233


Q ss_pred             hhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          427 VLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ++.+... ..+..+........+|+.+||+.||.+|.|++|+|+|+|+...
T Consensus       240 ImeGkyq-F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  240 IMEGKYQ-FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             HHhcccc-cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            3333322 2223344445567899999999999999999999999999543

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.9e-41  Score=322.08  Aligned_cols=247  Identities=21%  Similarity=0.303  Sum_probs=198.4

Q ss_pred             ceeeecCCeeEEEEEeCCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeec----CCeEEEEEEec
Q 011005          211 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH----KKCMFLIYEYM  284 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lV~e~~  284 (496)
                      ..||+|++|.||+|.+ +|+.||||.+....  .....+.+.+|+.++++++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            6799999999999998 68899999997643  22334678899999999999999999999876    34689999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      ++|+|.+++....   .+++.....++.|++.|+.|||+  ..+++||||||+||++++++.+||+|||+++......  
T Consensus       105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            9999999998653   68899999999999999999994  2488899999999999999999999999998664322  


Q ss_pred             cccccccccccccccccc--CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          365 RTLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       365 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                       ....++..|+|||++.+  ..++.++||||||+++|||++|+.||....       ...................   .
T Consensus       178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~---~  246 (283)
T PHA02988        178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-------TKEIYDLIINKNNSLKLPL---D  246 (283)
T ss_pred             -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhcCCCCCCCC---c
Confidence             23467889999999976  688999999999999999999999997321       1112222221211111111   1


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      ....+.+++.+||+.||++|||++|+++.+....
T Consensus       247 ~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        247 CPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             CcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            2335789999999999999999999999886543

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.6e-42  Score=313.94  Aligned_cols=272  Identities=23%  Similarity=0.275  Sum_probs=210.3

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccc-cccccceeecCC------
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRN-IVKLYGYCLHKK------  275 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~------  275 (496)
                      ..|+..++||+|+||+||+|+. .+|+.||+|+++.... +.......+|+.++++++|+| ||.+++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            4466677899999999999965 4789999999987643 223345689999999999999 999999998877      


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccc
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDA-VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  354 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  354 (496)
                      .+++|+||++. +|..++...... ..++...+..+++||+.||+|||   +++|+||||||+|++++++|.+||+|||+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccch
Confidence            78999999965 899888876532 34666889999999999999999   88999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCcccccc-------------CCCCCC
Q 011005          355 ARLLHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSL-------------SSSSDP  420 (496)
Q Consensus       355 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~-------------~~~~~~  420 (496)
                      |+...-+....+..++|.+|+|||++.+. .|+...||||+|||++||++++.-|...+..             .....+
T Consensus       167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp  246 (323)
T KOG0594|consen  167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP  246 (323)
T ss_pred             HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence            99876666667778899999999999887 7999999999999999999999888644321             011111


Q ss_pred             cchhHhhhcCCCCCC-----CChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          421 KIMLIDVLDQRLPPP-----VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       421 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      ............+..     .............+++.+||+.+|.+|.|++.+++|+++......
T Consensus       247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~  311 (323)
T KOG0594|consen  247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK  311 (323)
T ss_pred             CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence            111110011011100     001011111346789999999999999999999999998765433

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1e-41  Score=329.28  Aligned_cols=262  Identities=22%  Similarity=0.320  Sum_probs=198.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCC-----------------CcEEEEEEcccchhHHHHHHHHHHHHHHHhhccccccc
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPN-----------------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK  266 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~  266 (496)
                      .++|.+.+.||+|+||.||+|.+++                 +..||+|.+...........+.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578899999999999999997532                 33699999877544445567899999999999999999


Q ss_pred             ccceeecCCeEEEEEEecCCCChhhhhhCCC----------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 011005          267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNE----------------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSII  330 (496)
Q Consensus       267 ~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~  330 (496)
                      +++++...+..++||||+++|+|.+++....                ....+++..+++++.||+.||.|||   +.+|+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            9999999999999999999999999886432                1124688889999999999999999   78999


Q ss_pred             EeCCCCCceEecCCCCeEEccccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh--CCC
Q 011005          331 HRDISSNNILLNSKLEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM--GKH  406 (496)
Q Consensus       331 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~--g~~  406 (496)
                      ||||||+|||++.++.+||+|||+++........  .....++..|+|||++.+..++.++||||||+++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            9999999999999999999999999765432211  122345778999999998899999999999999999987  556


Q ss_pred             CCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 011005          407 PRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       407 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~  472 (496)
                      ||......    .........................+..+.+++.+||+.||++|||+.|+.+.+
T Consensus       241 p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l  302 (304)
T cd05096         241 PYGELTDE----QVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL  302 (304)
T ss_pred             CCCcCCHH----HHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence            76532210    000000011110000000000001123578999999999999999999997765

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=8.4e-42  Score=331.74  Aligned_cols=248  Identities=23%  Similarity=0.377  Sum_probs=201.3

Q ss_pred             ceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEEEEecCC
Q 011005          211 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLIYEYMER  286 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~  286 (496)
                      +.||+|+||+||+|..+ +++.||+|.+....  .......+..|..+++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999765 58899999987543  223345667888888877 699999999999999999999999999


Q ss_pred             CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCcc
Q 011005          287 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT  366 (496)
Q Consensus       287 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  366 (496)
                      |+|.+++....   .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||+++..........
T Consensus        81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~  154 (320)
T cd05590          81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS  154 (320)
T ss_pred             chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence            99999887654   6889999999999999999999   78999999999999999999999999999876533333344


Q ss_pred             ccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHH
Q 011005          367 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL  446 (496)
Q Consensus       367 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  446 (496)
                      ...||+.|+|||++.+..++.++||||+|+++|+|++|+.||....       .......+.......+..     ....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-------~~~~~~~i~~~~~~~~~~-----~~~~  222 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN-------EDDLFEAILNDEVVYPTW-----LSQD  222 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-------HHHHHHHHhcCCCCCCCC-----CCHH
Confidence            5679999999999999999999999999999999999999996322       122222222222221110     1224


Q ss_pred             HHHHHHhcccCCCCCCCCH------HHHHHHHHHhc
Q 011005          447 ISTVSFACLQSNPKSRPTM------QSVSQEFLITR  476 (496)
Q Consensus       447 l~~li~~cl~~dP~~Rps~------~evl~~~~~~~  476 (496)
                      +.+++.+||+.||++||++      +++++|+|+..
T Consensus       223 ~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~  258 (320)
T cd05590         223 AVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE  258 (320)
T ss_pred             HHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence            6789999999999999998      99999999854

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.8e-42  Score=334.65  Aligned_cols=255  Identities=23%  Similarity=0.365  Sum_probs=201.7

Q ss_pred             ceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEEEEecCC
Q 011005          211 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLIYEYMER  286 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~  286 (496)
                      +.||+|+||.||+|..+ +++.||+|.+....  .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            36999999999999764 67899999987642  223345677888888877 799999999999999999999999999


Q ss_pred             CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCcc
Q 011005          287 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT  366 (496)
Q Consensus       287 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  366 (496)
                      |+|..++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~  154 (329)
T cd05618          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS  154 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence            99998887543   6899999999999999999999   78999999999999999999999999999976433333344


Q ss_pred             ccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCC-cc-hhHhhhcCCCCCCCChhHHHHH
Q 011005          367 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDP-KI-MLIDVLDQRLPPPVDRKVIRDI  444 (496)
Q Consensus       367 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~  444 (496)
                      ...||+.|+|||++.+..++.++||||+|+++|+|++|+.||............ .. ............+.     ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~-----~~~  229 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR-----SLS  229 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC-----CCC
Confidence            567899999999999999999999999999999999999999643321111111 11 11112222221111     112


Q ss_pred             HHHHHHHHhcccCCCCCCCC------HHHHHHHHHHhc
Q 011005          445 LLISTVSFACLQSNPKSRPT------MQSVSQEFLITR  476 (496)
Q Consensus       445 ~~l~~li~~cl~~dP~~Rps------~~evl~~~~~~~  476 (496)
                      ..+.+++.+||+.||++||+      +.++++|+|+..
T Consensus       230 ~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~  267 (329)
T cd05618         230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  267 (329)
T ss_pred             HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            24678999999999999998      589999998854

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.5e-42  Score=334.00  Aligned_cols=249  Identities=21%  Similarity=0.293  Sum_probs=201.1

Q ss_pred             ceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCC
Q 011005          211 YCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERG  287 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g  287 (496)
                      +.||+|+||.||++.. .+++.||+|.+....  .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3699999999999975 478999999997643  2223456778999999999999999999999999999999999999


Q ss_pred             ChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCccc
Q 011005          288 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL  367 (496)
Q Consensus       288 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  367 (496)
                      +|..++....   .+++..+..++.||+.||.|||+  ..+|+||||||+|||++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (325)
T cd05594          81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT  155 (325)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence            9998887543   68999999999999999999993  269999999999999999999999999998764433333344


Q ss_pred             cccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHH
Q 011005          368 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLI  447 (496)
Q Consensus       368 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  447 (496)
                      ..||+.|+|||++.+..++.++||||+||++|+|++|+.||....       ...............+..     ....+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~-------~~~~~~~i~~~~~~~p~~-----~~~~~  223 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HEKLFELILMEEIRFPRT-----LSPEA  223 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC-------HHHHHHHHhcCCCCCCCC-----CCHHH
Confidence            579999999999999999999999999999999999999985321       111111111121111111     12246


Q ss_pred             HHHHHhcccCCCCCCC-----CHHHHHHHHHHhc
Q 011005          448 STVSFACLQSNPKSRP-----TMQSVSQEFLITR  476 (496)
Q Consensus       448 ~~li~~cl~~dP~~Rp-----s~~evl~~~~~~~  476 (496)
                      .+++.+||+.||++|+     ++.++++|+|+..
T Consensus       224 ~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~  257 (325)
T cd05594         224 KSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG  257 (325)
T ss_pred             HHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence            7899999999999996     9999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-44  Score=314.85  Aligned_cols=258  Identities=28%  Similarity=0.417  Sum_probs=224.8

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      -|.+..+||+|+||.||||.++ .|+.+|||++....+   .+++..|+.+|++.+.|++|++||.+.....+|+|||||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD---LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD---LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch---HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            3677888999999999999654 699999999987654   467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      ..|+..+++....  ..+++.++..+++.-++||+|||   ...-+|||||+.|||++.+|.+||+|||.|-.+.+.-..
T Consensus       111 GAGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK  185 (502)
T KOG0574|consen  111 GAGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK  185 (502)
T ss_pred             CCCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence            9999999998654  37899999999999999999999   667899999999999999999999999999877655455


Q ss_pred             ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHH
Q 011005          365 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI  444 (496)
Q Consensus       365 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  444 (496)
                      ..+..|||.|||||++..-.|+.++||||+|++..||..|++||....++.         .-++.+.-+++....+..+.
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---------AIFMIPT~PPPTF~KPE~WS  256 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---------AIFMIPTKPPPTFKKPEEWS  256 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---------eeEeccCCCCCCCCChHhhh
Confidence            667889999999999999999999999999999999999999997655432         22233444555556677777


Q ss_pred             HHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          445 LLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       445 ~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      ..+.+++.+||...|++|-|+.++++|+|+....+.
T Consensus       257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~  292 (502)
T KOG0574|consen  257 SEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGC  292 (502)
T ss_pred             hHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcc
Confidence            889999999999999999999999999999887654

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.5e-41  Score=323.93  Aligned_cols=253  Identities=24%  Similarity=0.301  Sum_probs=200.9

Q ss_pred             eeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCCCh
Q 011005          213 IGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL  289 (496)
Q Consensus       213 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g~L  289 (496)
                      ||+|+||+||++..+ +++.||+|.+.....  ....+.+..|+++++.++|+||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999764 688999999875432  22335677899999999999999999999999999999999999999


Q ss_pred             hhhhhCC-CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCcccc
Q 011005          290 FCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL  368 (496)
Q Consensus       290 ~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  368 (496)
                      ..++... .....+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.++|+|||++.............
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  157 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY  157 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence            8887542 22346899999999999999999999   7899999999999999999999999999998765443333445


Q ss_pred             ccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHH
Q 011005          369 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLIS  448 (496)
Q Consensus       369 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  448 (496)
                      .||+.|+|||.+.+..++.++||||+|+++|+|++|+.||......   .................     .......+.
T Consensus       158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~-----~~~~~~~~~  229 (280)
T cd05608         158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK---VENKELKQRILNDSVTY-----PDKFSPASK  229 (280)
T ss_pred             CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc---hhHHHHHHhhcccCCCC-----cccCCHHHH
Confidence            7899999999999999999999999999999999999999632210   00011111111111110     111223467


Q ss_pred             HHHHhcccCCCCCCC-----CHHHHHHHHHHhc
Q 011005          449 TVSFACLQSNPKSRP-----TMQSVSQEFLITR  476 (496)
Q Consensus       449 ~li~~cl~~dP~~Rp-----s~~evl~~~~~~~  476 (496)
                      +++.+||+.||++||     +++++++|+|+..
T Consensus       230 ~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~  262 (280)
T cd05608         230 SFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD  262 (280)
T ss_pred             HHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence            899999999999999     8899999999965

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-42  Score=338.93  Aligned_cols=255  Identities=24%  Similarity=0.350  Sum_probs=204.7

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|+||+||+|... +++.||||++....  .......+.+|+.+++.++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999765 68999999997643  2233456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||+++.+...
T Consensus        81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            9999999999987644   6899999999999999999999   789999999999999999999999999998764321


Q ss_pred             CC--------------------------------------CccccccccccccccccccCCcCcccchhhHHHHHHHHHh
Q 011005          362 SS--------------------------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM  403 (496)
Q Consensus       362 ~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~  403 (496)
                      ..                                      .....+||+.|+|||++.+..++.++||||+||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            10                                      0012468999999999999999999999999999999999


Q ss_pred             CCCCCccccccCCCCCCcchhHhhhcC--CCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCC---HHHHHHHHHHhc
Q 011005          404 GKHPRDILSSLSSSSDPKIMLIDVLDQ--RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPT---MQSVSQEFLITR  476 (496)
Q Consensus       404 g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~~~~~~~  476 (496)
                      |..||.....       ..........  ....+...   .....+.+++.+|+. +|.+|++   ++|+++|+|+..
T Consensus       235 G~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~---~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~  301 (364)
T cd05599         235 GYPPFCSDNP-------QETYRKIINWKETLQFPDEV---PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG  301 (364)
T ss_pred             CCCCCCCCCH-------HHHHHHHHcCCCccCCCCCC---CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence            9999963221       1112222211  11111111   112246688889996 9999998   999999999854

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.5e-41  Score=338.11  Aligned_cols=255  Identities=23%  Similarity=0.332  Sum_probs=200.8

Q ss_pred             CCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .|++.+.||+|+||+||+|.. .+++.||+|++....  .......+.+|+.++++++|+||+++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            588899999999999999965 468899999997643  22344678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++|+|.+++....   .+++..+..++.||+.||+|||   ..+|+||||||+|||++.++.++|+|||+++......
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            999999999987654   5788889999999999999999   7899999999999999999999999999975431100


Q ss_pred             C-----------------------------------------------CccccccccccccccccccCCcCcccchhhHH
Q 011005          363 S-----------------------------------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFG  395 (496)
Q Consensus       363 ~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG  395 (496)
                      .                                               .....+||+.|+|||++.+..++.++||||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                               01234699999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCccccccCCCCCCcchhHhhhc--CCCCCCCChhHHHHHHHHHHHHHh--cccCCCCCCCCHHHHHHH
Q 011005          396 VVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD--QRLPPPVDRKVIRDILLISTVSFA--CLQSNPKSRPTMQSVSQE  471 (496)
Q Consensus       396 ~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~Rps~~evl~~  471 (496)
                      |++|||++|+.||....       ..........  .....+...   .....+.+++.+  |+..+|..||+++|+++|
T Consensus       236 ~il~elltG~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~~---~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         236 VILFEMLVGQPPFLAPT-------PTETQLKVINWENTLHIPPQV---KLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             hHHHHHHhCCCCCcCCC-------HHHHHHHHHccccccCCCCCC---CCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            99999999999996321       1111122221  111111110   011235677777  556666679999999999


Q ss_pred             HHHhc
Q 011005          472 FLITR  476 (496)
Q Consensus       472 ~~~~~  476 (496)
                      +|+..
T Consensus       306 p~f~~  310 (381)
T cd05626         306 PFFSE  310 (381)
T ss_pred             cccCC
Confidence            99864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2e-41  Score=329.88  Aligned_cols=253  Identities=22%  Similarity=0.346  Sum_probs=203.5

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcc-cccccccceeecCCeEEEEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH-RNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lV~  281 (496)
                      +|++.+.||+|+||.||+|..+ +++.||+|.+....  .....+.+..|..+++.+.| ++|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788999999999999999765 57889999987643  22334567889999999976 56888999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++|+|.+++....   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.++|+|||++......
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            9999999999887543   6788999999999999999999   789999999999999999999999999998754333


Q ss_pred             CCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                      ........||+.|+|||++.+..++.++||||+||++|+|++|+.||....       .......+.......+..    
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-------~~~~~~~i~~~~~~~~~~----  223 (324)
T cd05587         155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED-------EDELFQSIMEHNVSYPKS----  223 (324)
T ss_pred             CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCCCCCC----
Confidence            333445678999999999999999999999999999999999999996321       112222222222211111    


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCH-----HHHHHHHHHhc
Q 011005          442 RDILLISTVSFACLQSNPKSRPTM-----QSVSQEFLITR  476 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~~~~~~  476 (496)
                       ....+.+++.+||..||.+|++.     +++++|+|+..
T Consensus       224 -~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~  262 (324)
T cd05587         224 -LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR  262 (324)
T ss_pred             -CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence             11246789999999999999986     89999988754

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=343.56  Aligned_cols=258  Identities=24%  Similarity=0.351  Sum_probs=210.7

Q ss_pred             CCCCcceeeecCCeeEEEEEeCCC-cEEEEEEcccchhHHHHHHHHHHHHHHHhhc-cccccccccee-ec------CCe
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYC-LH------KKC  276 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~-~~------~~~  276 (496)
                      ++++.+.|.+|||+.||.|....+ ..||+|++... ++...+.+.+|+++|+.|. |+|||.+++.. ..      ..+
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            466788899999999999977665 99999999877 5566788999999999997 99999999933 22      135


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      ++|.||||.||.|-+++...... .|++.++++|+.|+++|+++||.. ..+|||||||-+|||++.+++.||||||.+.
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            78999999999999999876554 499999999999999999999976 7789999999999999999999999999997


Q ss_pred             cccCCCCCc---------ccccccccccccccc---ccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchh
Q 011005          357 LLHADSSNR---------TLLAGTYGYIAPELA---YTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIML  424 (496)
Q Consensus       357 ~~~~~~~~~---------~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~  424 (496)
                      .........         .....|+.|+|||.+   .+..+++|+|||||||+||-|+....||+....           
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-----------  263 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-----------  263 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------
Confidence            654333111         113478999999976   577899999999999999999999999974322           


Q ss_pred             HhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          425 IDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      ..++......+...   .....+.+||..||++||++||++.|++++++.....+.
T Consensus       264 laIlng~Y~~P~~p---~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~  316 (738)
T KOG1989|consen  264 LAILNGNYSFPPFP---NYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC  316 (738)
T ss_pred             eeEEeccccCCCCc---cHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence            22333333322221   223357899999999999999999999999998887665

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.3e-41  Score=334.30  Aligned_cols=258  Identities=26%  Similarity=0.377  Sum_probs=203.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe------CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCCe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKC  276 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  276 (496)
                      .++|++.+.||+|+||.||+|.+      ..+..||||+++........+.+.+|+.+++.+ +||||+++++++..++.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45799999999999999999963      246689999997654444456788999999999 89999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhCCCC----------------------------------------------------------
Q 011005          277 MFLIYEYMERGSLFCNLHNNED----------------------------------------------------------  298 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~----------------------------------------------------------  298 (496)
                      .++||||+++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999998864321                                                          


Q ss_pred             --------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          299 --------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       299 --------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                                    ...+++..+..++.||+.||.|||   +.+++||||||+||+++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          124788889999999999999999   789999999999999999999999999999866433221


Q ss_pred             --ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          365 --RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       365 --~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                        .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....       .......+..........   
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~---  340 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV-------DSKFYKMIKEGYRMLSPE---  340 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc-------hHHHHHHHHhCccCCCCC---
Confidence              112334567999999999999999999999999999998 8888863211       111122222211111111   


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          442 RDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      .....+.+++.+||+.||++|||+.|+++.+..
T Consensus       341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            112357899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.8e-41  Score=325.24  Aligned_cols=264  Identities=24%  Similarity=0.329  Sum_probs=196.2

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC--CCcEEEEEEcccchh-HHHHHHHHHHHHHHHhh---cccccccccceeec-----
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP--NGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQV---LHRNIVKLYGYCLH-----  273 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----  273 (496)
                      ++|++.+.||+|+||+||+|...  +++.||+|.+..... ......+.+|+.+++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36889999999999999999763  468899998865432 12224456778777776   59999999998852     


Q ss_pred             CCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccc
Q 011005          274 KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG  353 (496)
Q Consensus       274 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  353 (496)
                      ....++||||+. ++|.+++..... ..+++..+..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence            346899999996 589888875432 25789999999999999999999   7899999999999999999999999999


Q ss_pred             ccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCC---------CCCCcchh
Q 011005          354 TARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS---------SSDPKIML  424 (496)
Q Consensus       354 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~---------~~~~~~~~  424 (496)
                      +++..... .......|++.|+|||.+.+..++.++||||+|+++|||++|++||........         ...+....
T Consensus       156 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  234 (290)
T cd07862         156 LARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  234 (290)
T ss_pred             ceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence            99766433 223345689999999999999999999999999999999999999964321100         00000000


Q ss_pred             ------HhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          425 ------IDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       425 ------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                            ..........+...........+.+++.+||+.||++|||+.|+++|+|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                  00000000000000000112346789999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.2e-41  Score=333.52  Aligned_cols=256  Identities=25%  Similarity=0.360  Sum_probs=199.8

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|+||+||+|... +++.||+|++....  .......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47889999999999999999654 68899999997643  2233456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||++||+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            9999999999997653   6899999999999999999999   789999999999999999999999999998754321


Q ss_pred             CC-----------------------------------CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCC
Q 011005          362 SS-----------------------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKH  406 (496)
Q Consensus       362 ~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~  406 (496)
                      ..                                   .....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            10                                   0123479999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCcchhHhhhcC--CCCCCCChhHHHHHHHHHHHHHhccc--CCCCCCCCHHHHHHHHHHhc
Q 011005          407 PRDILSSLSSSSDPKIMLIDVLDQ--RLPPPVDRKVIRDILLISTVSFACLQ--SNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       407 p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~Rps~~evl~~~~~~~  476 (496)
                      ||....       .......+...  .+..+.....   ...+.+++.+++.  .++..||+++|+++|+|+..
T Consensus       235 Pf~~~~-------~~~~~~~i~~~~~~~~~p~~~~~---s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~  298 (363)
T cd05628         235 PFCSET-------PQETYKKVMNWKETLIFPPEVPI---SEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEG  298 (363)
T ss_pred             CCCCCC-------HHHHHHHHHcCcCcccCCCcCCC---CHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCC
Confidence            996321       11222222211  1111111001   1124456666443  23445799999999999854

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.9e-41  Score=329.62  Aligned_cols=248  Identities=23%  Similarity=0.359  Sum_probs=201.3

Q ss_pred             ceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEEEEecCC
Q 011005          211 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLIYEYMER  286 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~  286 (496)
                      +.||+|+||.||+|..+ +++.||+|.+....  .......+..|.++++.+ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            35899999999999765 57899999987643  223345567888888876 799999999999999999999999999


Q ss_pred             CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCcc
Q 011005          287 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT  366 (496)
Q Consensus       287 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  366 (496)
                      |+|...+....   .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.++|+|||++...........
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (321)
T cd05591          81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT  154 (321)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence            99998887554   6888999999999999999999   78999999999999999999999999999976543333344


Q ss_pred             ccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHH
Q 011005          367 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL  446 (496)
Q Consensus       367 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  446 (496)
                      ...||+.|+|||++.+..++.++||||+|+++|+|++|+.||....       ...............+..     ....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~-------~~~~~~~i~~~~~~~p~~-----~~~~  222 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN-------EDDLFESILHDDVLYPVW-----LSKE  222 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC-------HHHHHHHHHcCCCCCCCC-----CCHH
Confidence            5678999999999999999999999999999999999999996322       122222222222211110     1124


Q ss_pred             HHHHHHhcccCCCCCCC-------CHHHHHHHHHHhc
Q 011005          447 ISTVSFACLQSNPKSRP-------TMQSVSQEFLITR  476 (496)
Q Consensus       447 l~~li~~cl~~dP~~Rp-------s~~evl~~~~~~~  476 (496)
                      +.+++.+||+.||++||       +++++++|+|+..
T Consensus       223 ~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         223 AVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             HHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence            67899999999999999       9999999999754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-42  Score=333.11  Aligned_cols=262  Identities=28%  Similarity=0.436  Sum_probs=208.9

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC--CC--cE-EEEEEccc--chhHHHHHHHHHHHHHHHhhcccccccccceeecCCe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP--NG--KV-FALKKLHT--SEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKC  276 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~-vavK~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  276 (496)
                      .++..+.+.||+|+||.||+|.++  ++  .. ||||..+.  ........++.+|+++|+.++|||||++||++.....
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            345566789999999999999654  23  23 89999885  2345567889999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      +++|||+|+||+|.++|.+...  .++..++..++.+.+.||+|||   +++++||||.++|+|++.++.+||+|||+++
T Consensus       236 l~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~  310 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSR  310 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence            9999999999999999998764  6899999999999999999999   8899999999999999999999999999987


Q ss_pred             cccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCC
Q 011005          357 LLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP  435 (496)
Q Consensus       357 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  435 (496)
                      .............-+..|+|||.+....|++++|||||||++||+++ |..||.....       ......+.....+.+
T Consensus       311 ~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~-------~~v~~kI~~~~~r~~  383 (474)
T KOG0194|consen  311 AGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN-------YEVKAKIVKNGYRMP  383 (474)
T ss_pred             CCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH-------HHHHHHHHhcCccCC
Confidence            65311111111224568999999999999999999999999999998 8889864332       222222322222222


Q ss_pred             CChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          436 VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       436 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      ...   ..+..+..++.+||..||++||||.++.+.+........
T Consensus       384 ~~~---~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  384 IPS---KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             CCC---CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            222   223346778889999999999999999998877666554

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.1e-41  Score=333.02  Aligned_cols=257  Identities=23%  Similarity=0.353  Sum_probs=203.1

Q ss_pred             CCCCcceeeecCCeeEEEEEe----CCCcEEEEEEcccch---hHHHHHHHHHHHHHHHhhc-ccccccccceeecCCeE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSE---ELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKCM  277 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~  277 (496)
                      +|++.+.||+|+||.||++..    .+++.||+|.+....   .....+.+.+|+.+++.++ |+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478899999999999999965    358899999987532   2223456788999999994 99999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          278 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      ++||||+++|+|.+++....   .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999999987643   6889999999999999999999   78999999999999999999999999999986


Q ss_pred             ccCCCC-CccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCC
Q 011005          358 LHADSS-NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP  435 (496)
Q Consensus       358 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  435 (496)
                      ...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......   .................+
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~  231 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER---NTQSEVSRRILKCDPPFP  231 (332)
T ss_pred             ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC---CCHHHHHHHHhcCCCCCC
Confidence            543322 22345789999999998875 4788999999999999999999999632211   111111111111111111


Q ss_pred             CChhHHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHhc
Q 011005          436 VDRKVIRDILLISTVSFACLQSNPKSRP-----TMQSVSQEFLITR  476 (496)
Q Consensus       436 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~~~~~~  476 (496)
                        .   .....+.+++.+||+.||++||     +++++++|+|+..
T Consensus       232 --~---~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  272 (332)
T cd05614         232 --S---FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG  272 (332)
T ss_pred             --C---CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence              1   1122467899999999999999     8899999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4e-41  Score=325.78  Aligned_cols=267  Identities=19%  Similarity=0.237  Sum_probs=203.3

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      ++|.+.+.||+|+||.||+|..+ +++.||+|.+...........+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56889999999999999999765 67889999987544333334577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++ +|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........
T Consensus        86 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            975 8887776543  25788999999999999999999   78999999999999999999999999999976544333


Q ss_pred             Ccccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCC---------CCCCcc-----hhHhhh
Q 011005          364 NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS---------SSDPKI-----MLIDVL  428 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~---------~~~~~~-----~~~~~~  428 (496)
                      ......+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||........         ......     ......
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence            3344567899999998865 4688999999999999999999999963321000         000000     000000


Q ss_pred             cCCCCCCCC----hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          429 DQRLPPPVD----RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       429 ~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ....+....    .........+.+++.+||+.||++|||++|+++|+|+..-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence            000000000    0000112346789999999999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.1e-41  Score=335.13  Aligned_cols=259  Identities=25%  Similarity=0.325  Sum_probs=205.9

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      .++|++.+.||+|+||.||+|..+ +++.||+|.+....  .......+.+|+.+++.++||||+++++++..++..++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            467999999999999999999765 68899999986532  122334577899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+++|+|.+++...    .++...+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.....
T Consensus       122 ~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         122 MEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            9999999999988653    4788888899999999999999   78999999999999999999999999999987643


Q ss_pred             CCC-CccccccccccccccccccC----CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCC
Q 011005          361 DSS-NRTLLAGTYGYIAPELAYTM----VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP  435 (496)
Q Consensus       361 ~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  435 (496)
                      ... ......||+.|+|||++.+.    .++.++|||||||++|||++|+.||....       .......+........
T Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-------~~~~~~~i~~~~~~~~  267 (370)
T cd05596         195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-------LVGTYSKIMDHKNSLT  267 (370)
T ss_pred             CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC-------HHHHHHHHHcCCCcCC
Confidence            322 22345799999999998653    47889999999999999999999996322       1122223322211111


Q ss_pred             CChhHHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHHHHHhcc
Q 011005          436 VDRKVIRDILLISTVSFACLQSNPKS--RPTMQSVSQEFLITRK  477 (496)
Q Consensus       436 ~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~~~~~~~  477 (496)
                      ... .......+.+++.+||+.+|.+  |+|++|+++|+|+...
T Consensus       268 ~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         268 FPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             CCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence            111 0011234678999999999988  9999999999998753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.1e-41  Score=326.33  Aligned_cols=248  Identities=25%  Similarity=0.369  Sum_probs=196.6

Q ss_pred             ceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEEEEecCC
Q 011005          211 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLIYEYMER  286 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~  286 (496)
                      +.||+|+||.||+|... +++.||+|.++...  .....+....|..++... +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999764 57889999987643  122334456677777654 799999999999999999999999999


Q ss_pred             CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCcc
Q 011005          287 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT  366 (496)
Q Consensus       287 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  366 (496)
                      |+|..++....   .++...+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  154 (316)
T cd05592          81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS  154 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence            99999887643   6889999999999999999999   78999999999999999999999999999976543333344


Q ss_pred             ccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHH
Q 011005          367 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL  446 (496)
Q Consensus       367 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  446 (496)
                      ..+||+.|+|||++.+..++.++||||+||++|||++|+.||....       .......+.......+.     .....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~-----~~~~~  222 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED-------EDELFDSILNDRPHFPR-----WISKE  222 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCCCCC-----CCCHH
Confidence            5679999999999999999999999999999999999999996321       11112222221111111     01224


Q ss_pred             HHHHHHhcccCCCCCCCCH-HHHHHHHHHhc
Q 011005          447 ISTVSFACLQSNPKSRPTM-QSVSQEFLITR  476 (496)
Q Consensus       447 l~~li~~cl~~dP~~Rps~-~evl~~~~~~~  476 (496)
                      +.+++.+||+.||++||++ .++++|+|+..
T Consensus       223 ~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~  253 (316)
T cd05592         223 AKDCLSKLFERDPTKRLGVDGDIRQHPFFRG  253 (316)
T ss_pred             HHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence            6788999999999999986 47888888754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-41  Score=337.51  Aligned_cols=255  Identities=25%  Similarity=0.346  Sum_probs=201.8

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|.+.+.||+|+||+||+|.. .+++.||+|.+....  .....+.+.+|++++++++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4688999999999999999965 478999999986543  2334467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            9999999999987643   6788999999999999999999   789999999999999999999999999999643211


Q ss_pred             CC-----------------------------------------------CccccccccccccccccccCCcCcccchhhH
Q 011005          362 SS-----------------------------------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSF  394 (496)
Q Consensus       362 ~~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl  394 (496)
                      ..                                               .....+||+.|+|||++.+..++.++||||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            00                                               0012468999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCccccccCCCCCCcchhHhhhc--CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCC---CCHHHHH
Q 011005          395 GVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD--QRLPPPVDRKVIRDILLISTVSFACLQSNPKSR---PTMQSVS  469 (496)
Q Consensus       395 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---ps~~evl  469 (496)
                      ||++|||++|+.||....       ..........  ..+..+...   .....+.+++.+|+. +|.+|   +++.|++
T Consensus       235 Gvil~elltG~~Pf~~~~-------~~~~~~~i~~~~~~~~~p~~~---~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l  303 (377)
T cd05629         235 GAIMFECLIGWPPFCSEN-------SHETYRKIINWRETLYFPDDI---HLSVEAEDLIRRLIT-NAENRLGRGGAHEIK  303 (377)
T ss_pred             chhhhhhhcCCCCCCCCC-------HHHHHHHHHccCCccCCCCCC---CCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence            999999999999996322       1111112211  111111110   111246788999997 66665   5999999


Q ss_pred             HHHHHhc
Q 011005          470 QEFLITR  476 (496)
Q Consensus       470 ~~~~~~~  476 (496)
                      +|+|+..
T Consensus       304 ~hp~~~~  310 (377)
T cd05629         304 SHPFFRG  310 (377)
T ss_pred             cCCCcCC
Confidence            9999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.4e-41  Score=333.06  Aligned_cols=258  Identities=26%  Similarity=0.395  Sum_probs=202.6

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCCe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKC  276 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  276 (496)
                      .++|++.+.||+|+||.||+|...      ++..||+|+++..........+.+|+.+++.+ +|+||+++++++...+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            467999999999999999998642      34579999997654444456788999999999 89999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhCCCC----------------------------------------------------------
Q 011005          277 MFLIYEYMERGSLFCNLHNNED----------------------------------------------------------  298 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~----------------------------------------------------------  298 (496)
                      .++||||+++|+|.+++.....                                                          
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            9999999999999988854211                                                          


Q ss_pred             ---------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC--ccc
Q 011005          299 ---------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN--RTL  367 (496)
Q Consensus       299 ---------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~  367 (496)
                               ...+++..+++++.||+.||+|||   +++++||||||+||++++++.++|+|||+++........  ...
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                     124788889999999999999999   789999999999999999999999999999765433211  112


Q ss_pred             cccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHH
Q 011005          368 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL  446 (496)
Q Consensus       368 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  446 (496)
                      ..+++.|+|||++.+..++.++||||||+++|||++ |+.||.....       ..................   .....
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~-------~~~~~~~~~~~~~~~~~~---~~~~~  343 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV-------NSKFYKMVKRGYQMSRPD---FAPPE  343 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc-------cHHHHHHHHcccCccCCC---CCCHH
Confidence            234567999999999999999999999999999997 9999864221       111222222211111111   01235


Q ss_pred             HHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          447 ISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       447 l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      +.+++.+||+.||++|||+.++++.+..
T Consensus       344 l~~li~~cl~~dp~~RPs~~~l~~~l~~  371 (374)
T cd05106         344 IYSIMKMCWNLEPTERPTFSQISQLIQR  371 (374)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            7789999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.1e-41  Score=328.42  Aligned_cols=248  Identities=25%  Similarity=0.346  Sum_probs=197.4

Q ss_pred             ceeeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHHH-HHHhhcccccccccceeecCCeEEEEEEecCC
Q 011005          211 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEAQ-VLSQVLHRNIVKLYGYCLHKKCMFLIYEYMER  286 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~  286 (496)
                      +.||+|+||+||+|..+ +|+.||+|.+.....  ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36999999999999764 689999999875431  122234445544 56778999999999999999999999999999


Q ss_pred             CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCcc
Q 011005          287 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT  366 (496)
Q Consensus       287 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  366 (496)
                      |+|..++....   .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..........
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (323)
T cd05575          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS  154 (323)
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence            99999887643   6788999999999999999999   78999999999999999999999999999976443333344


Q ss_pred             ccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHH
Q 011005          367 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL  446 (496)
Q Consensus       367 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  446 (496)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||....       ..................     ....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~-----~~~~  222 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-------TAEMYDNILNKPLRLKPN-----ISVS  222 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-------HHHHHHHHHcCCCCCCCC-----CCHH
Confidence            5678999999999999999999999999999999999999986321       112222222222211111     1234


Q ss_pred             HHHHHHhcccCCCCCCCCH----HHHHHHHHHhc
Q 011005          447 ISTVSFACLQSNPKSRPTM----QSVSQEFLITR  476 (496)
Q Consensus       447 l~~li~~cl~~dP~~Rps~----~evl~~~~~~~  476 (496)
                      +.+++.+||+.||++||++    .|+++|+|+..
T Consensus       223 ~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~  256 (323)
T cd05575         223 ARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS  256 (323)
T ss_pred             HHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence            6789999999999999987    69999988743

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.2e-41  Score=326.68  Aligned_cols=248  Identities=23%  Similarity=0.351  Sum_probs=201.6

Q ss_pred             ceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEEEEecCC
Q 011005          211 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLIYEYMER  286 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~  286 (496)
                      +.||+|+||+||+|.++ +++.||+|.++...  .......+.+|..+++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999765 57899999987643  223345677888999888 699999999999999999999999999


Q ss_pred             CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCcc
Q 011005          287 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT  366 (496)
Q Consensus       287 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  366 (496)
                      |+|...+....   .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (318)
T cd05570          81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS  154 (318)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence            99998887654   6899999999999999999999   78999999999999999999999999999875433333334


Q ss_pred             ccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHH
Q 011005          367 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL  446 (496)
Q Consensus       367 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  446 (496)
                      ..+|++.|+|||++.+..++.++||||+||++|+|++|+.||....       ...............+.     .....
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-------~~~~~~~i~~~~~~~~~-----~~~~~  222 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-------EDELFQSILEDEVRYPR-----WLSKE  222 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-------HHHHHHHHHcCCCCCCC-----cCCHH
Confidence            4578999999999999999999999999999999999999996322       11112222222221111     11234


Q ss_pred             HHHHHHhcccCCCCCCCCH-----HHHHHHHHHhc
Q 011005          447 ISTVSFACLQSNPKSRPTM-----QSVSQEFLITR  476 (496)
Q Consensus       447 l~~li~~cl~~dP~~Rps~-----~evl~~~~~~~  476 (496)
                      +.+++.+||+.||++|||+     .++++|+|+..
T Consensus       223 ~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~  257 (318)
T cd05570         223 AKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE  257 (318)
T ss_pred             HHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            6789999999999999999     99999999865

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=325.69  Aligned_cols=263  Identities=24%  Similarity=0.329  Sum_probs=212.3

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      .+...+.++||+|-||+|..+...++..||||+++.........+|.+|+++|.+++||||+.++|.|..++.+++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            35567788999999999999999888999999999988878889999999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      |++|+|.+++.++... ...-....+|+.||+.|++||.   +.++||||+.++|+|++.++++||+|||+++.+-....
T Consensus       617 mEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence            9999999999987433 2455666789999999999999   78999999999999999999999999999985533322


Q ss_pred             C--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh--CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          364 N--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM--GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       364 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                      .  ....+-+.+|||||.+.-++++.++|||+||+++||+++  ...||..+...+    ......++.+..-.......
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~----vven~~~~~~~~~~~~~l~~  768 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ----VVENAGEFFRDQGRQVVLSR  768 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH----HHHhhhhhcCCCCcceeccC
Confidence            1  223456789999999999999999999999999999875  678886543211    11111222222222212222


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      +...+..+.+++.+||..|.++|||++++..++..
T Consensus       769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  769 PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence            23334457799999999999999999999877754

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.5e-41  Score=326.02  Aligned_cols=248  Identities=23%  Similarity=0.340  Sum_probs=197.6

Q ss_pred             ceeeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEEEEecCC
Q 011005          211 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLIYEYMER  286 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~  286 (496)
                      +.||+|+||.||+|.++ +|+.||+|.++....  .........|..++... +||||+++++++..++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            36999999999999765 688999999976431  12334566778887765 799999999999999999999999999


Q ss_pred             CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCcc
Q 011005          287 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT  366 (496)
Q Consensus       287 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  366 (496)
                      |+|..++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||+++..........
T Consensus        81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05620          81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS  154 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence            99998887643   6788999999999999999999   78999999999999999999999999999875433333344


Q ss_pred             ccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHH
Q 011005          367 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL  446 (496)
Q Consensus       367 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  446 (496)
                      ..+||+.|+|||++.+..++.++||||+|+++|||++|+.||....       ...............+.     .....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~-------~~~~~~~~~~~~~~~~~-----~~~~~  222 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD-------EDELFESIRVDTPHYPR-----WITKE  222 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCC-----CCCHH
Confidence            5678999999999999999999999999999999999999996321       11111111111111111     01124


Q ss_pred             HHHHHHhcccCCCCCCCCH-HHHHHHHHHhc
Q 011005          447 ISTVSFACLQSNPKSRPTM-QSVSQEFLITR  476 (496)
Q Consensus       447 l~~li~~cl~~dP~~Rps~-~evl~~~~~~~  476 (496)
                      +.+++.+||+.||++||++ +++++|+|+..
T Consensus       223 ~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~  253 (316)
T cd05620         223 SKDILEKLFERDPTRRLGVVGNIRGHPFFKT  253 (316)
T ss_pred             HHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence            6789999999999999997 58888998865

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.7e-41  Score=336.52  Aligned_cols=254  Identities=22%  Similarity=0.326  Sum_probs=200.3

Q ss_pred             CCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .|++.+.||+|+||+||+|.. .+++.||+|.+....  .......+.+|+.++++++|+||+++++.+..++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            588899999999999999975 468899999987643  22344678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++|+|.+++....   .++...+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            999999999987643   5788889999999999999999   7899999999999999999999999999975331100


Q ss_pred             -----------------------------------------------CCccccccccccccccccccCCcCcccchhhHH
Q 011005          363 -----------------------------------------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFG  395 (496)
Q Consensus       363 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG  395 (496)
                                                                     ......+||+.|+|||++.+..++.++||||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence                                                           001124689999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCccccccCCCCCCcchhHhhhc--CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 011005          396 VVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD--QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPT---MQSVSQ  470 (496)
Q Consensus       396 ~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~  470 (496)
                      |++|||++|+.||....       ..........  .....+...   .......+++.+|+ .+|++|++   ++|+++
T Consensus       236 vil~elltG~~Pf~~~~-------~~~~~~~i~~~~~~~~~p~~~---~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         236 VILYEMLVGQPPFLAQT-------PLETQMKVINWQTSLHIPPQA---KLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHHHHHHhCCCCCCCCC-------HHHHHHHHHccCCCcCCCCcc---cCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            99999999999996322       1111222221  111111111   11123556777765 59999997   999999


Q ss_pred             HHHHhc
Q 011005          471 EFLITR  476 (496)
Q Consensus       471 ~~~~~~  476 (496)
                      |+|+..
T Consensus       305 hp~f~~  310 (382)
T cd05625         305 HPFFKT  310 (382)
T ss_pred             CCCcCC
Confidence            999865

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.5e-41  Score=334.10  Aligned_cols=258  Identities=25%  Similarity=0.353  Sum_probs=204.3

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      ..++|++.+.||+|+||.||+|..+ +++.||+|.+....  .......+.+|+.+++.++||||+++++++..+...++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3578999999999999999999765 58899999986532  22234567889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||||+++|+|.+++...    .++...+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++....
T Consensus       121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            99999999999998653    4788889999999999999999   7899999999999999999999999999998764


Q ss_pred             CCCC-CccccccccccccccccccCC----cCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCC--C
Q 011005          360 ADSS-NRTLLAGTYGYIAPELAYTMV----MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQR--L  432 (496)
Q Consensus       360 ~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~  432 (496)
                      .... .....+||+.|+|||++.+..    ++.++||||+||++|+|++|+.||....       .......+....  +
T Consensus       194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~-------~~~~~~~i~~~~~~~  266 (370)
T cd05621         194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS-------LVGTYSKIMDHKNSL  266 (370)
T ss_pred             cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCccc
Confidence            3322 223467999999999987643    7789999999999999999999996322       111222232221  1


Q ss_pred             CCCCChhHHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHHHHHhcc
Q 011005          433 PPPVDRKVIRDILLISTVSFACLQSNPKS--RPTMQSVSQEFLITRK  477 (496)
Q Consensus       433 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~~~~~~~  477 (496)
                      ..+..   ......+.+++.+|+..+|.+  |+++.|+++|+|+...
T Consensus       267 ~~p~~---~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         267 NFPED---VEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             CCCCc---ccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            11111   111224567888999865544  8999999999999763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6e-41  Score=326.75  Aligned_cols=255  Identities=23%  Similarity=0.355  Sum_probs=201.9

Q ss_pred             ceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEEEEecCC
Q 011005          211 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLIYEYMER  286 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~  286 (496)
                      +.||+|+||.||+|... +++.||+|.+....  .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999764 67899999997643  223445678899999888 599999999999999999999999999


Q ss_pred             CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCcc
Q 011005          287 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT  366 (496)
Q Consensus       287 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  366 (496)
                      |+|..++....   .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (327)
T cd05617          81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS  154 (327)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence            99998887543   6899999999999999999999   78999999999999999999999999999975433333344


Q ss_pred             ccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHH
Q 011005          367 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL  446 (496)
Q Consensus       367 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  446 (496)
                      ..+||+.|+|||++.+..++.++||||+|+++|+|++|+.||..........................+..     ....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~-----~~~~  229 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF-----LSVK  229 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCC-----CCHH
Confidence            56799999999999999999999999999999999999999964322111111111112222222111111     1124


Q ss_pred             HHHHHHhcccCCCCCCCC------HHHHHHHHHHhc
Q 011005          447 ISTVSFACLQSNPKSRPT------MQSVSQEFLITR  476 (496)
Q Consensus       447 l~~li~~cl~~dP~~Rps------~~evl~~~~~~~  476 (496)
                      +.+++.+||+.||++|++      +.++++|+|+..
T Consensus       230 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~  265 (327)
T cd05617         230 ASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS  265 (327)
T ss_pred             HHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence            678999999999999998      579999998754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-42  Score=340.37  Aligned_cols=272  Identities=30%  Similarity=0.470  Sum_probs=224.7

Q ss_pred             CccccHHHHHHHHhC---------CCCcceeeecCCeeEEEEEeC----CCcEEEEEEcccchhHHHHHHHHHHHHHHHh
Q 011005          192 DGRIVYEDLIEATED---------FDIRYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSEELAFIKSFKNEAQVLSQ  258 (496)
Q Consensus       192 ~~~~~~~~~~~~~~~---------~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~  258 (496)
                      ....+|||.-++...         ..+.+.||.|.||.||+|+++    ....||||.++....+....+|..|+.||.+
T Consensus       607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ  686 (996)
T KOG0196|consen  607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ  686 (996)
T ss_pred             cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence            344566666555433         446778999999999999765    2457999999998877778899999999999


Q ss_pred             hcccccccccceeecCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCc
Q 011005          259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNN  338 (496)
Q Consensus       259 l~h~niv~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~N  338 (496)
                      ++||||+++.|.....+..+||+|||++|+|+.+|..+.  .+|++.+...+.++|+.|+.||.   +.++|||||.++|
T Consensus       687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARN  761 (996)
T KOG0196|consen  687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARN  761 (996)
T ss_pred             CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhh
Confidence            999999999999999999999999999999999998765  36999999999999999999999   7899999999999


Q ss_pred             eEecCCCCeEEccccccccccCCCCC-cccccc--ccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCcccccc
Q 011005          339 ILLNSKLEAFVADFGTARLLHADSSN-RTLLAG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSL  414 (496)
Q Consensus       339 il~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~  414 (496)
                      ||++.+..+|++|||+++.+.++... .+...|  +.+|.|||.+.-.+++.+|||||+|++|||.++ |..||...+. 
T Consensus       762 ILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-  840 (996)
T KOG0196|consen  762 ILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-  840 (996)
T ss_pred             eeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-
Confidence            99999999999999999988666533 222223  358999999999999999999999999999775 9999864321 


Q ss_pred             CCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          415 SSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       415 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                           .+....-..+.++|++.+.     +..+.+|+..||++|-.+||++.|++..+--.-+.|
T Consensus       841 -----QdVIkaIe~gyRLPpPmDC-----P~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  841 -----QDVIKAIEQGYRLPPPMDC-----PAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             -----HHHHHHHHhccCCCCCCCC-----cHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence                 2222223334677777654     345789999999999999999999999876544433

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.8e-41  Score=327.13  Aligned_cols=252  Identities=21%  Similarity=0.343  Sum_probs=203.1

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      +|.+.+.||+|+||.||+|..+ +++.||+|.+....  ..........|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788999999999999999765 57899999987643  122334567788888777 5899999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++|+|.+.+....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            9999999998887644   6889999999999999999999   789999999999999999999999999999765433


Q ss_pred             CCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                      ........||+.|+|||++.+..++.++||||+||++|||++|+.||....       .......+.......+..    
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-------~~~~~~~i~~~~~~~p~~----  223 (323)
T cd05616         155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-------EDELFQSIMEHNVAYPKS----  223 (323)
T ss_pred             CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCCc----
Confidence            333445678999999999999999999999999999999999999996321       122222233222221111    


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCH-----HHHHHHHHHh
Q 011005          442 RDILLISTVSFACLQSNPKSRPTM-----QSVSQEFLIT  475 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~~~~~  475 (496)
                       ....+.+++.+||+.||++|++.     .++++|+|+.
T Consensus       224 -~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~  261 (323)
T cd05616         224 -MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR  261 (323)
T ss_pred             -CCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcC
Confidence             12246789999999999999984     8899888764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=312.76  Aligned_cols=267  Identities=27%  Similarity=0.403  Sum_probs=211.7

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh--cccccccccceeecCC----eEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV--LHRNIVKLYGYCLHKK----CMF  278 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~~----~~~  278 (496)
                      ...+..+.+|+|+||.||||.+. ++.||||++....    .+.+.+|-++++..  +|+||++++++-..+.    .++
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecCHHH----HHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            34566778999999999999994 5999999997654    36678888887765  6999999999887766    799


Q ss_pred             EEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEEeCCCCCceEecCCCCeEEccc
Q 011005          279 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC------SPSIIHRDISSNNILLNSKLEAFVADF  352 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~------~~~i~H~dlkp~Nil~~~~~~~kl~Df  352 (496)
                      ||++|.+.|+|.++|..+    .++|.+..+|+..|++||+|||+..      +++|+|||||++|||+..+++..|+||
T Consensus       285 LVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             EEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            999999999999999976    6899999999999999999999854      778999999999999999999999999


Q ss_pred             cccccccCCCCC--ccccccccccccccccccCCc-C-----cccchhhHHHHHHHHHhCCCCCcc--ccc--------c
Q 011005          353 GTARLLHADSSN--RTLLAGTYGYIAPELAYTMVM-T-----EKCDVYSFGVVTLEVLMGKHPRDI--LSS--------L  414 (496)
Q Consensus       353 g~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~-----~~~DvwslG~il~el~~g~~p~~~--~~~--------~  414 (496)
                      |+|..+......  ....+||.+|||||++.+... .     .+.||||+|.+||||++....++.  ...        .
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev  440 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV  440 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence            999988644322  233789999999999887532 2     378999999999999997655431  111        1


Q ss_pred             CCCCCCcchhHhhhcCCCCCCCChhHH--HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          415 SSSSDPKIMLIDVLDQRLPPPVDRKVI--RDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       415 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      ...+..+.+..-++.++..+...+.+.  ..+..+.+.++.||+.||+.|.|+.=+-+.++.......
T Consensus       441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence            112222334444555555555544443  334568899999999999999999999888887776554

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-41  Score=321.38  Aligned_cols=258  Identities=23%  Similarity=0.262  Sum_probs=204.8

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .|++.+.||+|+||+||++... +++.||+|.+.....  ......+.+|+.++++++|+||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999764 689999999875431  2223456789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++|+|.+.+.... ...+++..+..++.|++.||.|||   +.+++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            999999998886532 236899999999999999999999   7799999999999999999999999999997654322


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                       ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||.....    ..........+...... .   ...
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~-~---~~~  227 (285)
T cd05605         157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE----KVKREEVERRVKEDQEE-Y---SEK  227 (285)
T ss_pred             -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch----hhHHHHHHHHhhhcccc-c---Ccc
Confidence             22334689999999999999999999999999999999999999963211    00001111111111111 1   111


Q ss_pred             HHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHhc
Q 011005          443 DILLISTVSFACLQSNPKSRP-----TMQSVSQEFLITR  476 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~~~~~~  476 (496)
                      ....+.+++.+||+.||++||     +++++++|+|+..
T Consensus       228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence            223467899999999999999     8999999999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.5e-41  Score=330.09  Aligned_cols=248  Identities=26%  Similarity=0.349  Sum_probs=201.1

Q ss_pred             ceeeecCCeeEEEEEe----CCCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecC
Q 011005          211 YCIGTGGYGSVYKAQL----PNGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYME  285 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~  285 (496)
                      +.||+|+||.||++..    .+|+.||+|.+..... ......+.+|++++++++||||+++++++..++..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5699999999999964    3688999999976432 2233456789999999999999999999999999999999999


Q ss_pred             CCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCc
Q 011005          286 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR  365 (496)
Q Consensus       286 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  365 (496)
                      +|+|.+++.+..   .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.++|+|||++..........
T Consensus        82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~  155 (318)
T cd05582          82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA  155 (318)
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence            999999987543   6899999999999999999999   7899999999999999999999999999998664443333


Q ss_pred             cccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHH
Q 011005          366 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDIL  445 (496)
Q Consensus       366 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  445 (496)
                      ....|++.|+|||.+.+..++.++||||||+++|||++|+.||....       ...............+..     ...
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~-------~~~~~~~i~~~~~~~p~~-----~~~  223 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD-------RKETMTMILKAKLGMPQF-----LSP  223 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC-------HHHHHHHHHcCCCCCCCC-----CCH
Confidence            44678999999999999889999999999999999999999986321       111222222222221111     112


Q ss_pred             HHHHHHHhcccCCCCCCCC-----HHHHHHHHHHhc
Q 011005          446 LISTVSFACLQSNPKSRPT-----MQSVSQEFLITR  476 (496)
Q Consensus       446 ~l~~li~~cl~~dP~~Rps-----~~evl~~~~~~~  476 (496)
                      .+.+++.+||+.||++||+     ..++++|+|+..
T Consensus       224 ~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~  259 (318)
T cd05582         224 EAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST  259 (318)
T ss_pred             HHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence            4678999999999999999     677998887743

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.2e-41  Score=317.60  Aligned_cols=256  Identities=27%  Similarity=0.407  Sum_probs=202.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+|+.++++++||||+++++++..++..++|||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e   86 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD-DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME   86 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc-hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence            35799999999999999999975 46889999998654322 23567889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++++|.+++....   .+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.++|+|||++.......
T Consensus        87 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          87 YCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            999999999887543   6789999999999999999999   7899999999999999999999999999998764433


Q ss_pred             CCccccccccccccccccc---cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          363 SNRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                      .......+++.|+|||.+.   ...++.++||||+|+++|||++|+.||........       ...........+....
T Consensus       161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~  233 (267)
T cd06646         161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-------LFLMSKSNFQPPKLKD  233 (267)
T ss_pred             cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-------heeeecCCCCCCCCcc
Confidence            3334456888999999874   34577899999999999999999999853321110       0000011111111111


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      .......+.+++.+||+.+|++|||++++++++|
T Consensus       234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            1112235789999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=292.88  Aligned_cols=260  Identities=23%  Similarity=0.346  Sum_probs=206.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEE-eCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCC-----eE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK-----CM  277 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~  277 (496)
                      .++|.+.+.||+|||+-||.++ ..+++.||+|++..... +..+..++|++..++++|||+++++++...+.     ..
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~-~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ-EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccch-HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            4689999999999999999996 55789999999987763 34577899999999999999999999886543     48


Q ss_pred             EEEEEecCCCChhhhhhCCCCCc-cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          278 FLIYEYMERGSLFCNLHNNEDAV-ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      |++++|...|+|.+.+....... .+++.++++|+.+|++||.+||.. ..+++||||||.|||+++++.+++.|||.++
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            99999999999999987654333 789999999999999999999954 3459999999999999999999999999997


Q ss_pred             cccCCCCC---------cccccccccccccccccc---CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchh
Q 011005          357 LLHADSSN---------RTLLAGTYGYIAPELAYT---MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIML  424 (496)
Q Consensus       357 ~~~~~~~~---------~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~  424 (496)
                      ...-.-..         ......|..|+|||.+.-   ...++++|||||||++|+|+.|..||+.......+.     .
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl-----a  252 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL-----A  252 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE-----E
Confidence            65322111         112347889999998864   457889999999999999999999998654422211     1


Q ss_pred             HhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          425 IDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      ..+....+..+....   ....+.+++..|++.||.+||++.+++.++-
T Consensus       253 LAv~n~q~s~P~~~~---yse~l~~lik~mlqvdP~qRP~i~~ll~~~d  298 (302)
T KOG2345|consen  253 LAVQNAQISIPNSSR---YSEALHQLIKSMLQVDPNQRPTIPELLSKLD  298 (302)
T ss_pred             EeeeccccccCCCCC---ccHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence            122222222222222   2235779999999999999999999998764

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-40  Score=319.09  Aligned_cols=264  Identities=24%  Similarity=0.346  Sum_probs=208.9

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      ++|++.+.||+|+||.||+|..+ +++.||+|.+...........+.+|+.++++++|+||+++++++...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36888999999999999999775 78999999887643334456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|..++........+++..+..++.|++.||.|||+  ..+++|+||||+||+++.++.++|+|||++......  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            9999999888765434468999999999999999999994  358999999999999999999999999999765322  


Q ss_pred             CccccccccccccccccccCC------cCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          364 NRTLLAGTYGYIAPELAYTMV------MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                      ......+++.|+|||.+.+..      ++.++||||+|+++|+|++|+.||.....    ...............+ ...
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~-~~~  231 (286)
T cd06622         157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY----ANIFAQLSAIVDGDPP-TLP  231 (286)
T ss_pred             ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch----hhHHHHHHHHhhcCCC-CCC
Confidence            223345788999999986543      47899999999999999999999863211    0000111111111111 111


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      .   .....+.+++.+||+.+|++||+++++++|+|+......
T Consensus       232 ~---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         232 S---GYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             c---ccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence            1   123346789999999999999999999999998777544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.4e-40  Score=317.18  Aligned_cols=258  Identities=24%  Similarity=0.358  Sum_probs=204.4

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      ++|++.+.||+|+||.||+|.+ .+++.||+|.+.........+.+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3678889999999999999965 578899999987654344456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|..+.       .+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++......  
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            9999986442       4678888899999999999999   789999999999999999999999999999765432  


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD  443 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  443 (496)
                      ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||............... ........+.....  ...
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~--~~~  225 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL-LQCIVDEDPPVLPV--GQF  225 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH-HHHHhccCCCCCCC--CcC
Confidence            223457899999999999999999999999999999999999998643321111111111 11111111111100  011


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          444 ILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       444 ~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ...+.+++.+||+.+|++||+++|+++|+|+...
T Consensus       226 ~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         226 SEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             CHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            2246789999999999999999999999998665

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.4e-40  Score=314.98  Aligned_cols=253  Identities=23%  Similarity=0.356  Sum_probs=201.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC----CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      .++|++.+.||+|+||.||+|.++    .+..||+|.++..........+.+|+.++++++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356889999999999999999653    4668999999876544445678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++++|||.+....
T Consensus        84 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          84 VTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            999999999999987643  26899999999999999999999   7899999999999999999999999999876542


Q ss_pred             CCCCC-ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          360 ADSSN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       360 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                      ..... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||.....       ....... ......+..
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-------~~~~~~~-~~~~~~~~~  230 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-------QDVIKAV-EDGFRLPAP  230 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHH-HCCCCCCCC
Confidence            22111 112234578999999999999999999999999999775 9999863321       1111111 111111111


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~  472 (496)
                      .   ..+..+.+++.+||+.+|++||+++|+++.+
T Consensus       231 ~---~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l  262 (266)
T cd05064         231 R---NCPNLLHQLMLDCWQKERGERPRFSQIHSIL  262 (266)
T ss_pred             C---CCCHHHHHHHHHHcCCCchhCCCHHHHHHHH
Confidence            1   1223577899999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.2e-41  Score=324.46  Aligned_cols=248  Identities=24%  Similarity=0.377  Sum_probs=196.9

Q ss_pred             ceeeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEEEEecCC
Q 011005          211 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLIYEYMER  286 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~  286 (496)
                      +.||+|+||+||+|... +++.||+|.++....  .........|..+++.. +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999765 578999999876421  22334566777888765 899999999999999999999999999


Q ss_pred             CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCcc
Q 011005          287 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT  366 (496)
Q Consensus       287 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  366 (496)
                      |+|.+++....   .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||+++..........
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05619          81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC  154 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence            99999987543   6788999999999999999999   78999999999999999999999999999875433333334


Q ss_pred             ccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHH
Q 011005          367 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL  446 (496)
Q Consensus       367 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  446 (496)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||....       ...............+  .   .....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-------~~~~~~~i~~~~~~~~--~---~~~~~  222 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD-------EEELFQSIRMDNPCYP--R---WLTRE  222 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCC--c---cCCHH
Confidence            4678999999999999999999999999999999999999986321       1111111111111111  0   01124


Q ss_pred             HHHHHHhcccCCCCCCCCHH-HHHHHHHHhc
Q 011005          447 ISTVSFACLQSNPKSRPTMQ-SVSQEFLITR  476 (496)
Q Consensus       447 l~~li~~cl~~dP~~Rps~~-evl~~~~~~~  476 (496)
                      +.+++.+||+.||++||++. ++++|+|+..
T Consensus       223 ~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~  253 (316)
T cd05619         223 AKDILVKLFVREPERRLGVKGDIRQHPFFRE  253 (316)
T ss_pred             HHHHHHHHhccCHhhcCCChHHHHcCcccCC
Confidence            67899999999999999996 8999988755

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.8e-41  Score=337.29  Aligned_cols=255  Identities=22%  Similarity=0.309  Sum_probs=200.8

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|+||.||+|..+ +++.||+|.+.....  ......+.+|+.++++++|+||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36899999999999999999754 689999999875431  223456789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++|+|.+++.+..   .++...+..++.||+.||+|||   +.+|+||||||+|||++.++.++|+|||++..+...
T Consensus        81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            9999999999997653   5788888999999999999999   789999999999999999999999999997533100


Q ss_pred             C-------------------------------------------CCccccccccccccccccccCCcCcccchhhHHHHH
Q 011005          362 S-------------------------------------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVT  398 (496)
Q Consensus       362 ~-------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il  398 (496)
                      .                                           ......+||+.|+|||++.+..++.++||||+||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            0                                           001124689999999999999999999999999999


Q ss_pred             HHHHhCCCCCccccccCCCCCCcchhHhhhc--CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCC---CHHHHHHHHH
Q 011005          399 LEVLMGKHPRDILSSLSSSSDPKIMLIDVLD--QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRP---TMQSVSQEFL  473 (496)
Q Consensus       399 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~evl~~~~  473 (496)
                      |||++|+.||.....       .........  .....+...   .....+.+++.+|+ .+|.+|+   ++.|+++|+|
T Consensus       235 yell~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~---~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~  303 (376)
T cd05598         235 YEMLVGQPPFLADTP-------AETQLKVINWETTLHIPSQA---KLSREASDLILRLC-CGAEDRLGKNGADEIKAHPF  303 (376)
T ss_pred             eehhhCCCCCCCCCH-------HHHHHHHhccCccccCCCCC---CCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCC
Confidence            999999999963321       111111111  111111100   11123556777766 5999999   9999999999


Q ss_pred             Hhc
Q 011005          474 ITR  476 (496)
Q Consensus       474 ~~~  476 (496)
                      +..
T Consensus       304 ~~~  306 (376)
T cd05598         304 FKG  306 (376)
T ss_pred             cCC
Confidence            864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.9e-41  Score=331.13  Aligned_cols=256  Identities=25%  Similarity=0.358  Sum_probs=205.3

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|.+.+.||+|+||+||+|..+ +++.||+|.++....  ....+.+.+|+.+++.++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36889999999999999999764 689999999976432  234466889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++|+|.+++....  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            9999999999997652  26889999999999999999999   789999999999999999999999999999876443


Q ss_pred             CCC-ccccccccccccccccc------cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCC--C
Q 011005          362 SSN-RTLLAGTYGYIAPELAY------TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQR--L  432 (496)
Q Consensus       362 ~~~-~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~  432 (496)
                      ... .....||+.|+|||++.      +..++.++||||+|+++|+|++|+.||.....       ......+....  .
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-------~~~~~~i~~~~~~~  228 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-------AKTYNNIMNFQRFL  228 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-------HHHHHHHHcCCCcc
Confidence            222 23346899999999987      45678899999999999999999999963221       11122222111  1


Q ss_pred             CCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       433 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      ..+...   .....+.+++.+|++ +|++|||+.++++|+|+..
T Consensus       229 ~~~~~~---~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~  268 (330)
T cd05601         229 KFPEDP---KVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK  268 (330)
T ss_pred             CCCCCC---CCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence            111100   112346788899998 9999999999999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.9e-41  Score=330.49  Aligned_cols=262  Identities=23%  Similarity=0.348  Sum_probs=207.7

Q ss_pred             hCCCCcceeeecCCeeEEEEE-eCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-c-----cccccccceeecCCeE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-H-----RNIVKLYGYCLHKKCM  277 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~  277 (496)
                      .+|.+.+.||+|+||.|-+|. .++++.||||+++....  ...+...|+.++..++ |     -|+|+++++|...+++
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~--f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR--FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH--HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            389999999999999999994 56799999999987653  4466788999999997 4     4899999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC--CCeEEcccccc
Q 011005          278 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK--LEAFVADFGTA  355 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~--~~~kl~Dfg~~  355 (496)
                      |||+|.++ -+|+++++.+... .++...++.++.||+.||.+||   ..+|||+||||+|||+.+.  ..+||+|||.|
T Consensus       264 ciVfELL~-~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  264 CIVFELLS-TNLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             eeeehhhh-hhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccc
Confidence            99999985 5999999987644 5899999999999999999999   8899999999999999754  46999999999


Q ss_pred             ccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCcccccc---------------------
Q 011005          356 RLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSL---------------------  414 (496)
Q Consensus       356 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~---------------------  414 (496)
                      +.....-   ...+.+..|+|||++.|.+|+.+.||||||||++||++|.+-|...+..                     
T Consensus       339 c~~~q~v---ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  339 CFESQRV---YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             cccCCcc---eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            8764332   2567888999999999999999999999999999999998777533221                     


Q ss_pred             -------CC-CCCC-----cc------------hhHhhhcC-CCCCCC---ChhHH-HHHHHHHHHHHhcccCCCCCCCC
Q 011005          415 -------SS-SSDP-----KI------------MLIDVLDQ-RLPPPV---DRKVI-RDILLISTVSFACLQSNPKSRPT  464 (496)
Q Consensus       415 -------~~-~~~~-----~~------------~~~~~~~~-~~~~~~---~~~~~-~~~~~l~~li~~cl~~dP~~Rps  464 (496)
                             .. ...+     ..            ........ +.++..   ..... .+...+.+++.+||.+||.+|+|
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t  495 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT  495 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence                   00 0000     00            00000111 122111   11111 34456899999999999999999


Q ss_pred             HHHHHHHHHHhc
Q 011005          465 MQSVSQEFLITR  476 (496)
Q Consensus       465 ~~evl~~~~~~~  476 (496)
                      +.|+++|+|++.
T Consensus       496 p~qal~Hpfl~~  507 (586)
T KOG0667|consen  496 PAQALNHPFLTG  507 (586)
T ss_pred             HHHHhcCccccc
Confidence            999999999983

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-40  Score=306.66  Aligned_cols=264  Identities=25%  Similarity=0.403  Sum_probs=208.9

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh--cccccccccceeecCC----e
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV--LHRNIVKLYGYCLHKK----C  276 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~~----~  276 (496)
                      ...+..+.+.||+|.||+||+|++ .|+.||||++...+.    +.+.+|.++++.+  +|+||+.+++.-..++    +
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE----~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE----RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             hhheeEEEEEecCccccceeeccc-cCCceEEEEecccch----hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            346788899999999999999999 589999999987654    5677888888775  8999999999876554    5


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEeCCCCCceEecCCCCeEEcc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD-----CSPSIIHRDISSNNILLNSKLEAFVAD  351 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-----~~~~i~H~dlkp~Nil~~~~~~~kl~D  351 (496)
                      +|||++|.+.|||+|+|...    .++....++++..+|.||+|||.+     .++.|.|||||+.|||+..++.+.|+|
T Consensus       284 LwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD  359 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  359 (513)
T ss_pred             EEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence            89999999999999999975    789999999999999999999974     378899999999999999999999999


Q ss_pred             ccccccccCCCCC----ccccccccccccccccccCCcC------cccchhhHHHHHHHHHhC----------CCCCccc
Q 011005          352 FGTARLLHADSSN----RTLLAGTYGYIAPELAYTMVMT------EKCDVYSFGVVTLEVLMG----------KHPRDIL  411 (496)
Q Consensus       352 fg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~------~~~DvwslG~il~el~~g----------~~p~~~~  411 (496)
                      +|+|.........    ....+||.+|||||++...-..      ..+||||||.++||+...          +.||...
T Consensus       360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~  439 (513)
T KOG2052|consen  360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV  439 (513)
T ss_pred             ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence            9999887655322    3457899999999998765321      369999999999999863          4565433


Q ss_pred             cccCCCCCCcchhHhhhcCCCCCCCChhHH--HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          412 SSLSSSSDPKIMLIDVLDQRLPPPVDRKVI--RDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       412 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      -+  .++..+.+..-+..+++.+.....+.  .....+.+++..||..+|..|.|+-.+-+.+-...+
T Consensus       440 Vp--~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  440 VP--SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CC--CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            22  22222334444444555544444333  334568899999999999999999998877765543

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-41  Score=317.39  Aligned_cols=262  Identities=21%  Similarity=0.331  Sum_probs=223.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .=|.+.+.||+|.|++|-+|++ -.|..||||++.+.. +......+..|+.+|+.++|||||++|++......+|+|.|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            4577888999999999999954 589999999997754 33344667899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe-cCCCCeEEccccccccccCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL-NSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~-~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      .-++|+|++++.+...  .+++..+.+++.||+.|+.|+|   ...+|||||||+||.+ ..-|-|||+|||++..+.+ 
T Consensus        98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P-  171 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP-  171 (864)
T ss_pred             ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCC-
Confidence            9999999999988765  5788999999999999999999   6789999999999866 5568999999999988754 


Q ss_pred             CCCccccccccccccccccccCCcC-cccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVMT-EKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      +....+.||+..|-|||++.|..|+ +++||||+|||||.|++|++||+.++       ..+....+++....-+.    
T Consensus       172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN-------DSETLTmImDCKYtvPs----  240 (864)
T KOG4717|consen  172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN-------DSETLTMIMDCKYTVPS----  240 (864)
T ss_pred             cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc-------chhhhhhhhcccccCch----
Confidence            4456678999999999999999987 58999999999999999999998543       33455666666655432    


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCcc
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHA  484 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~  484 (496)
                       .....+.+||..||..||.+|.|.+||..+.|.+.-.+....+
T Consensus       241 -hvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~  283 (864)
T KOG4717|consen  241 -HVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTA  283 (864)
T ss_pred             -hhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCcccc
Confidence             2233578999999999999999999999999998887766553

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.4e-40  Score=315.29  Aligned_cols=255  Identities=25%  Similarity=0.433  Sum_probs=204.8

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCC------CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMF  278 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  278 (496)
                      ++|++.+.||+|+||.||+|....      ...||+|.+...........+.+|+.++++++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468899999999999999997543      25799999876555455567899999999999999999999999988999


Q ss_pred             EEEEecCCCChhhhhhCCCCC-------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC
Q 011005          279 LIYEYMERGSLFCNLHNNEDA-------------VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL  345 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~~-------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~  345 (496)
                      ++|||+++|+|.+++......             ..+++..++.++.|++.||.|||   ..+++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            999999999999998754211             35788999999999999999999   78999999999999999999


Q ss_pred             CeEEccccccccccCCCC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcc
Q 011005          346 EAFVADFGTARLLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKI  422 (496)
Q Consensus       346 ~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~  422 (496)
                      .++|+|||++........  ......+++.|+|||.+.+..++.++||||||+++|||++ |..||....       .. 
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~-------~~-  233 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS-------NQ-  233 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC-------HH-
Confidence            999999999976533221  1223456788999999998899999999999999999998 999986321       11 


Q ss_pred             hhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          423 MLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       423 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      .....+.........   ...+..+.+++.+||+.||++||++.|+++++.
T Consensus       234 ~~~~~i~~~~~~~~~---~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05048         234 EVIEMIRSRQLLPCP---EDCPARVYALMIECWNEIPARRPRFKDIHTRLR  281 (283)
T ss_pred             HHHHHHHcCCcCCCc---ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHh
Confidence            122222222211111   122345789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.2e-40  Score=327.37  Aligned_cols=264  Identities=25%  Similarity=0.275  Sum_probs=199.8

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCC-----
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK-----  275 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  275 (496)
                      ..++|++.+.||+|+||.||+|... .|+.||+|.+.... .......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999764 68999999986532 2233466789999999999999999999886543     


Q ss_pred             -eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccc
Q 011005          276 -CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  354 (496)
Q Consensus       276 -~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  354 (496)
                       ..++||||+++ ++...+..     .++...+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCC
Confidence             47999999975 56655542     4788889999999999999999   78999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCC-------CCCCcc-----
Q 011005          355 ARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS-------SSDPKI-----  422 (496)
Q Consensus       355 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~-------~~~~~~-----  422 (496)
                      ++..... .......+|+.|+|||.+.+..++.++||||+|+++|+|++|+.||........       ...+..     
T Consensus       170 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (359)
T cd07876         170 ARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR  248 (359)
T ss_pred             ccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence            9765332 223345689999999999999999999999999999999999999964321000       000000     


Q ss_pred             ---hhHhhhcCCCCC---------------CCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          423 ---MLIDVLDQRLPP---------------PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       423 ---~~~~~~~~~~~~---------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                         ............               ............+.+|+.+||+.||++|||+.|+++|+|+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence               000000000000               000000011234679999999999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.7e-40  Score=323.07  Aligned_cols=253  Identities=21%  Similarity=0.348  Sum_probs=203.3

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhc-ccccccccceeecCCeEEEEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lV~  281 (496)
                      +|+..+.||+|+||+||+|..+ +++.||+|++....  .....+.+..|..+++.+. |++|+++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4777899999999999999764 68899999987643  2233456778888888886 577888999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++|+|.+++....   .+++.++..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            9999999999987644   6899999999999999999999   789999999999999999999999999999765433


Q ss_pred             CCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                      ........||+.|+|||++.+..++.++||||+|+++|+|++|+.||....       .......+.......+..    
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-------~~~~~~~i~~~~~~~p~~----  223 (323)
T cd05615         155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED-------EDELFQSIMEHNVSYPKS----  223 (323)
T ss_pred             CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCcc----
Confidence            333444578999999999999999999999999999999999999986321       122222333322221111    


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHHHHhc
Q 011005          442 RDILLISTVSFACLQSNPKSRPT-----MQSVSQEFLITR  476 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~~~~~~  476 (496)
                       ....+.+++.+||+.||.+|++     .+++++|+|+..
T Consensus       224 -~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~  262 (323)
T cd05615         224 -LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR  262 (323)
T ss_pred             -CCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence             1124678999999999999997     478888888764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3e-40  Score=310.80  Aligned_cols=253  Identities=28%  Similarity=0.423  Sum_probs=207.4

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      +|++.+.||+|++|.||+|..+ +++.|++|.+.... .......+.+|++++++++|||++++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999764 68999999886532 234456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+++.... ...+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||+++.......
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            99999999987642 236889999999999999999999   78999999999999999999999999999987654433


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD  443 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  443 (496)
                      ......+++.|+|||+..+..++.++||||||+++|+|++|+.||....       .............+... .   ..
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~-~---~~  225 (256)
T cd08529         157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-------QGALILKIIRGVFPPVS-Q---MY  225 (256)
T ss_pred             hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCCCCc-c---cc
Confidence            3344568899999999999999999999999999999999999986322       11112222222222111 1   12


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          444 ILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       444 ~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      ...+.+++.+||+.+|++||++.++++++|
T Consensus       226 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~  255 (256)
T cd08529         226 SQQLAQLIDQCLTKDYRQRPDTFQLLRNPS  255 (256)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHhhCCC
Confidence            235789999999999999999999999876

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-42  Score=331.24  Aligned_cols=260  Identities=24%  Similarity=0.347  Sum_probs=212.4

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      +-|.++..||.|+||.||||..++....|.-++....+......+.-|++|+..++||+||++++.|...+.+||..|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            44667778999999999999877655544433334444556788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      .||....++-.-+.  .+...++.-+++|++.||.|||   +..|||||||+.|||++-+|.++|+|||.+.........
T Consensus       112 ~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk  186 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK  186 (1187)
T ss_pred             CCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence            99999888775433  6899999999999999999999   789999999999999999999999999998766554455


Q ss_pred             ccccccccccccccccc-----cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          365 RTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       365 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                      ...+.|||.|||||+..     +.+|+.++||||||++|.||..+.+|-..+++         +..-+....-.++.--.
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp---------MRVllKiaKSePPTLlq  257 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP---------MRVLLKIAKSEPPTLLQ  257 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch---------HHHHHHHhhcCCCcccC
Confidence            66789999999999864     56899999999999999999999999654332         11111112222233334


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      +..+...+.+++.+||..||+.||++.++++|+|+....
T Consensus       258 PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  258 PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence            566777899999999999999999999999999997543

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.5e-40  Score=314.65  Aligned_cols=254  Identities=26%  Similarity=0.424  Sum_probs=204.6

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCC------CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMF  278 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  278 (496)
                      ++|.+.+.||+|+||.||+|...+      ++.||+|.++.....+..+.+.+|+++++.++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            568889999999999999997643      47899999987655445578899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCC-----------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCe
Q 011005          279 LIYEYMERGSLFCNLHNNE-----------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEA  347 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~  347 (496)
                      +||||+++++|.+++....           ....+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence            9999999999999987542           1235788999999999999999999   7899999999999999999999


Q ss_pred             EEccccccccccCCCC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchh
Q 011005          348 FVADFGTARLLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIML  424 (496)
Q Consensus       348 kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~  424 (496)
                      +|+|||+++.......  ......+++.|+|||++.+..++.++||||+|+++|||++ |+.||....       .....
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~-------~~~~~  234 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS-------NEEVI  234 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC-------HHHHH
Confidence            9999999976533221  1223345778999999999999999999999999999998 999985321       11122


Q ss_pred             HhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 011005          425 IDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~  472 (496)
                      .............    .....+.+++.+||+.||++||++.|+++.+
T Consensus       235 ~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l  278 (280)
T cd05049         235 ECITQGRLLQRPR----TCPSEVYDIMLGCWKRDPQQRINIKDIHERL  278 (280)
T ss_pred             HHHHcCCcCCCCC----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence            2222222222111    1223577999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.6e-40  Score=337.56  Aligned_cols=255  Identities=22%  Similarity=0.252  Sum_probs=204.2

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-C-CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-N-GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      .|.+.+.||+|++|.||+|... + ++.||+|.+..... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE-RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            4888999999999999999654 3 57788887655432 2335678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCC-CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          284 MERGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       284 ~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      +++|+|.+++... .....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            9999999887643 22335889999999999999999999   7899999999999999999999999999998764332


Q ss_pred             C--CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          363 S--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       363 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      .  .....+||+.|+|||++.+..++.++||||+||++|+|++|+.||....       ..............+.. .  
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-------~~~~~~~~~~~~~~~~~-~--  293 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-------QREIMQQVLYGKYDPFP-C--  293 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCC-c--
Confidence            2  1334569999999999999999999999999999999999999986321       11122222222221111 1  


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                       .....+.+++.+||+.||++||++.+++++.|..
T Consensus       294 -~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~  327 (478)
T PTZ00267        294 -PVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK  327 (478)
T ss_pred             -cCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHH
Confidence             1123477899999999999999999999987764

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.3e-40  Score=318.37  Aligned_cols=268  Identities=23%  Similarity=0.352  Sum_probs=213.8

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      .+|++.+.||+|+||.||+|.. .+++.|++|.+...... ....+.+|+.+++.++|+|++++++.+..+...++||||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            5788999999999999999975 46889999988764432 236688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+++...    .+++.++..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++........
T Consensus        99 ~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654          99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             cCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            9999999998643    4788999999999999999999   78999999999999999999999999999876544333


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD  443 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  443 (496)
                      ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.....       ............+. . ......
T Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~-~-~~~~~~  242 (296)
T cd06654         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATNGTPE-L-QNPEKL  242 (296)
T ss_pred             ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH-------HHhHHHHhcCCCCC-C-CCcccc
Confidence            33345688999999999998899999999999999999999999963221       11111111111110 0 001112


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCccccccc
Q 011005          444 ILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDI  489 (496)
Q Consensus       444 ~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~~~~~i  489 (496)
                      ...+.+++.+||..||++|||+.|++++.|+....+......+..+
T Consensus       243 ~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~~~~~~~~~  288 (296)
T cd06654         243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAA  288 (296)
T ss_pred             CHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCCccccHHHHHH
Confidence            2347789999999999999999999999999887666554444433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.1e-41  Score=315.93  Aligned_cols=249  Identities=34%  Similarity=0.523  Sum_probs=193.0

Q ss_pred             CcceeeecCCeeEEEEEeC-----CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          209 IRYCIGTGGYGSVYKAQLP-----NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       209 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      +.+.||.|.||.||+|.+.     .+..|+||.+.........+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999775     36789999997655555568899999999999999999999999988889999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++|+|.+++... ....+++..+..|+.||+.||.|||   +.+++|+||+++||+++.++.+||+|||++........
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence            9999999999876 2236899999999999999999999   67899999999999999999999999999987632221


Q ss_pred             C--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          364 N--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       364 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      .  .........|+|||.+.+..++.++||||||+++||+++ |+.||...       ................ ...  
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-------~~~~~~~~~~~~~~~~-~~~--  228 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-------DNEEIIEKLKQGQRLP-IPD--  228 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-------CHHHHHHHHHTTEETT-SBT--
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccccccccccccce-ecc--
Confidence            1  222446778999999999999999999999999999999 78887532       1222222222222211 111  


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~  472 (496)
                       .....+.+++.+||+.||++|||+.++++.+
T Consensus       229 -~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  229 -NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence             1123467899999999999999999999864

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4e-40  Score=310.06  Aligned_cols=249  Identities=26%  Similarity=0.428  Sum_probs=200.6

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      ++|++.+.||+|+||.||+|.++++..+|+|.+......  ...+.+|+.++++++||||+++++++..+...++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS--EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc--HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            468889999999999999999888889999988654322  256888999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      ++|+|.+++....  ..+++..+..++.|++.||.|||   ..+++||||+|+||++++++.++|+|||.++........
T Consensus        82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          82 ENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             CCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence            9999999987543  25889999999999999999999   789999999999999999999999999999765432221


Q ss_pred             -ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcC-CCCCCCChhHH
Q 011005          365 -RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ-RLPPPVDRKVI  441 (496)
Q Consensus       365 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  441 (496)
                       .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||....       ........... +...+.     
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~-------~~~~~~~i~~~~~~~~~~-----  224 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS-------NYEVVEMISRGFRLYRPK-----  224 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHHCCCCCCCCC-----
Confidence             112234568999999998899999999999999999999 899986321       11111222211 111111     


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 011005          442 RDILLISTVSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~~  472 (496)
                      .....+.+++.+||+.+|++|||++|+++.+
T Consensus       225 ~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            1123578999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-40  Score=314.13  Aligned_cols=259  Identities=31%  Similarity=0.453  Sum_probs=212.4

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      ++|++.+.||.|++|.||+|... +++.||+|.+...........+.+|+.+++.++|+|++++++++..+...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888899999999999999764 68899999987654444456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+++...    .+++..+..++.|++.|+.|||   +.+++|+||+|+||++++++.++|+|||+++.......
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            9999999998764    6789999999999999999999   78999999999999999999999999999988765433


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD  443 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  443 (496)
                      ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.....       ...... ......+......  .
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-------~~~~~~-~~~~~~~~~~~~~--~  223 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP-------MRVLFL-IPKNNPPSLEGNK--F  223 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch-------HHHHHH-hhhcCCCCCcccc--c
Confidence            34455788899999999998999999999999999999999999863221       111111 1111111111110  2


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          444 ILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       444 ~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      ...+.+++.+||..+|++|||++++++|+|+.+....
T Consensus       224 ~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         224 SKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             CHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence            2347789999999999999999999999999775443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-40  Score=306.20  Aligned_cols=258  Identities=23%  Similarity=0.315  Sum_probs=217.2

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCC-CcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      +.|++.+.||+|.-|+||+++..+ +..+|+|++.+..  ......++..|-+|++.++||.++.+|..++.++..|+||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            457778889999999999998764 5899999997754  2344567788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      |||+||+|..+++++.. ..+++..++-++..++-||+|||   -.|||+|||||+|||+.++|++.|+||.++......
T Consensus       157 eyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999999887654 47999999999999999999999   789999999999999999999999999997543110


Q ss_pred             --------------------------------C-C-----------------------CccccccccccccccccccCCc
Q 011005          362 --------------------------------S-S-----------------------NRTLLAGTYGYIAPELAYTMVM  385 (496)
Q Consensus       362 --------------------------------~-~-----------------------~~~~~~gt~~y~aPE~~~~~~~  385 (496)
                                                      . .                       ....++||-.|+|||++.|...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                       0112468889999999999999


Q ss_pred             CcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCC-
Q 011005          386 TEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPT-  464 (496)
Q Consensus       386 ~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-  464 (496)
                      +.++|.|+||+++|||+.|..||.       .........+++.+.+..+...   .....+.+||.+.|.+||.+|.. 
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFK-------G~~~~~Tl~NIv~~~l~Fp~~~---~vs~~akDLIr~LLvKdP~kRlg~  382 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFK-------GSNNKETLRNIVGQPLKFPEEP---EVSSAAKDLIRKLLVKDPSKRLGS  382 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcC-------CCCchhhHHHHhcCCCcCCCCC---cchhHHHHHHHHHhccChhhhhcc
Confidence            999999999999999999999997       3445566777777666554433   33345789999999999999998 


Q ss_pred             ---HHHHHHHHHHhc
Q 011005          465 ---MQSVSQEFLITR  476 (496)
Q Consensus       465 ---~~evl~~~~~~~  476 (496)
                         +.||-+|+|+..
T Consensus       383 ~rGA~eIK~HpFF~g  397 (459)
T KOG0610|consen  383 KRGAAEIKRHPFFEG  397 (459)
T ss_pred             ccchHHhhcCccccC
Confidence               999999988864

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-40  Score=318.24  Aligned_cols=264  Identities=27%  Similarity=0.355  Sum_probs=209.7

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      ++|++.+.||+|+||+||+|... +++.||+|.+.........+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56888899999999999999754 68899999887654444557789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+++....   .+++..+..++.+++.||.|||+  ..+++||||+|+||++++++.++|+|||++......  
T Consensus        85 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--  157 (284)
T cd06620          85 MDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--  157 (284)
T ss_pred             CCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence            99999999887643   58899999999999999999995  358999999999999999999999999998654322  


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHh----hhcCCCCCCCChh
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLID----VLDQRLPPPVDRK  439 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~  439 (496)
                      ......|+..|+|||++.+..++.++||||+||++|++++|+.||.................+    ......+....  
T Consensus       158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  235 (284)
T cd06620         158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS--  235 (284)
T ss_pred             ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc--
Confidence            122356889999999998889999999999999999999999999744321111111111111    11111111110  


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                       ......+.+++.+||+.||++|||+.|+++++|+.+..
T Consensus       236 -~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         236 -SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             -hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence             11223578999999999999999999999999887654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.5e-40  Score=327.36  Aligned_cols=264  Identities=23%  Similarity=0.272  Sum_probs=200.6

Q ss_pred             CCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCC-----eEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK-----CMF  278 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  278 (496)
                      +|++.+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999976 478999999986532 2233467889999999999999999999998776     789


Q ss_pred             EEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccc
Q 011005          279 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL  358 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  358 (496)
                      +||||+. ++|.+.+....   .+++..+..++.||+.||.|||   +.+++||||||+||+++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999996 57877776443   6899999999999999999999   789999999999999999999999999999765


Q ss_pred             cCCCC-CccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccC---------CCCCCcc-----
Q 011005          359 HADSS-NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS---------SSSDPKI-----  422 (496)
Q Consensus       359 ~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~---------~~~~~~~-----  422 (496)
                      ..... ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.......         .......     
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~  233 (372)
T cd07853         154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC  233 (372)
T ss_pred             ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            43222 22334678899999998874 47899999999999999999999996432110         0000000     


Q ss_pred             -hhHh-hhcCCCCCCCChh----HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          423 -MLID-VLDQRLPPPVDRK----VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       423 -~~~~-~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                       .... ........+....    .......+.+|+.+||+.||++|||+.|+++|+|+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  293 (372)
T cd07853         234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE  293 (372)
T ss_pred             HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence             0000 0000000000000    0001234678999999999999999999999999876

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.2e-40  Score=336.21  Aligned_cols=264  Identities=20%  Similarity=0.277  Sum_probs=194.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecC--------
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK--------  274 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------  274 (496)
                      ..+|++.+.||+|+||.||+|... +++.||||++....     ....+|+.+++.++||||+++++++...        
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            357999999999999999999764 68899999886543     2235799999999999999999876432        


Q ss_pred             CeEEEEEEecCCCChhhhhhCC-CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC-CeEEccc
Q 011005          275 KCMFLIYEYMERGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-EAFVADF  352 (496)
Q Consensus       275 ~~~~lV~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~-~~kl~Df  352 (496)
                      ..+++||||+++ ++.+++... .....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence            246799999975 676665432 22346899999999999999999999   78999999999999999664 7999999


Q ss_pred             cccccccCCCCCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCC-------CCCCcchh
Q 011005          353 GTARLLHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS-------SSDPKIML  424 (496)
Q Consensus       353 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~-------~~~~~~~~  424 (496)
                      |+++.+.... ......||+.|+|||++.+. .++.++||||+||++|||++|.+||........       ...+....
T Consensus       216 Gla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~  294 (440)
T PTZ00036        216 GSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ  294 (440)
T ss_pred             ccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            9998764332 22345689999999998764 689999999999999999999999964321100       00000000


Q ss_pred             Hhhhc-----CCCCCCCChhHH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          425 IDVLD-----QRLPPPVDRKVI-----RDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       425 ~~~~~-----~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      .....     ...+........     .....+.+|+.+||+.||.+|||+.|+++|+|+...
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence            00000     000100000000     112357899999999999999999999999998653

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.2e-40  Score=340.17  Aligned_cols=260  Identities=25%  Similarity=0.287  Sum_probs=206.4

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCC-----
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK-----  275 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  275 (496)
                      ..++|.+.+.||+|+||+||+|.. .+++.||||.+.... .......+.+|+.++..++|+|++++++.+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            357899999999999999999965 478999999986542 2334566789999999999999999988775432     


Q ss_pred             ---eEEEEEEecCCCChhhhhhCCC-CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcc
Q 011005          276 ---CMFLIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVAD  351 (496)
Q Consensus       276 ---~~~lV~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~D  351 (496)
                         ..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEe
Confidence               3689999999999999887532 2346889999999999999999999   78999999999999999999999999


Q ss_pred             ccccccccCCC--CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhc
Q 011005          352 FGTARLLHADS--SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD  429 (496)
Q Consensus       352 fg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  429 (496)
                      ||+++.+....  ......+||+.|+|||++.+..++.++||||||+++|||++|+.||....       ..........
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-------~~~~~~~~~~  259 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-------MEEVMHKTLA  259 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHhc
Confidence            99998764321  12334579999999999999999999999999999999999999996321       1111222222


Q ss_pred             CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          430 QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       430 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      ....+.. .   .....+.+++.+||+.||.+||++.++++|+|...
T Consensus       260 ~~~~~~~-~---~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        260 GRYDPLP-P---SISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             CCCCCCC-C---CCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence            2221111 1   11234778999999999999999999999987654

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.5e-40  Score=315.03  Aligned_cols=252  Identities=23%  Similarity=0.287  Sum_probs=196.0

Q ss_pred             eeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCCCh
Q 011005          213 IGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL  289 (496)
Q Consensus       213 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g~L  289 (496)
                      ||+|+||.||++..+ +|+.||+|.+.....  ....+.+..|++++++++||||+++++++..+...++||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999764 689999999865321  11234456799999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCccccc
Q 011005          290 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA  369 (496)
Q Consensus       290 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  369 (496)
                      .+.+..... ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++....... ......
T Consensus        81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~  155 (277)
T cd05607          81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRA  155 (277)
T ss_pred             HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccC
Confidence            888865432 25788999999999999999999   7899999999999999999999999999997764322 223356


Q ss_pred             cccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHH
Q 011005          370 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLIST  449 (496)
Q Consensus       370 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  449 (496)
                      |++.|+|||++.+..++.++||||+||++|||++|+.||.....   .....................    .....+.+
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  228 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE---KVAKEELKRRTLEDEVKFEHQ----NFTEESKD  228 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc---hhhHHHHHHHhhccccccccc----cCCHHHHH
Confidence            88999999999998999999999999999999999999863211   000111111111112111111    11234679


Q ss_pred             HHHhcccCCCCCCCCH----HHHHHHHHHhc
Q 011005          450 VSFACLQSNPKSRPTM----QSVSQEFLITR  476 (496)
Q Consensus       450 li~~cl~~dP~~Rps~----~evl~~~~~~~  476 (496)
                      ++.+||+.||++||++    ++++.|.|+..
T Consensus       229 li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~  259 (277)
T cd05607         229 ICRLFLAKKPEDRLGSREKNDDPRKHEFFKT  259 (277)
T ss_pred             HHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence            9999999999999999    55667777743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=9.7e-41  Score=325.24  Aligned_cols=248  Identities=25%  Similarity=0.343  Sum_probs=197.1

Q ss_pred             ceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHH-HHHhhcccccccccceeecCCeEEEEEEecCC
Q 011005          211 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQ-VLSQVLHRNIVKLYGYCLHKKCMFLIYEYMER  286 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~  286 (496)
                      +.||+|+||+||+|..+ +|+.||+|++....  .......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            35999999999999754 68999999987542  1222344555554 46778999999999999999999999999999


Q ss_pred             CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCcc
Q 011005          287 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT  366 (496)
Q Consensus       287 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  366 (496)
                      |+|..++....   .+++..+..++.||+.||+|||   +.||+||||||+|||++.++.+||+|||+++..........
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  154 (325)
T cd05604          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT  154 (325)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence            99998887543   6889999999999999999999   78999999999999999999999999999976433333344


Q ss_pred             ccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHH
Q 011005          367 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL  446 (496)
Q Consensus       367 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  446 (496)
                      ..+||+.|+|||++.+..++.++||||+||++|+|++|+.||....       ..................     ....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-------~~~~~~~~~~~~~~~~~~-----~~~~  222 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-------VAEMYDNILHKPLVLRPG-----ASLT  222 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-------HHHHHHHHHcCCccCCCC-----CCHH
Confidence            5679999999999999999999999999999999999999986321       122222223222211111     1124


Q ss_pred             HHHHHHhcccCCCCCCCCH----HHHHHHHHHhc
Q 011005          447 ISTVSFACLQSNPKSRPTM----QSVSQEFLITR  476 (496)
Q Consensus       447 l~~li~~cl~~dP~~Rps~----~evl~~~~~~~  476 (496)
                      +.+++.+|++.||.+||++    .++++|+|+..
T Consensus       223 ~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~  256 (325)
T cd05604         223 AWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES  256 (325)
T ss_pred             HHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence            6688999999999999976    58999988764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.9e-40  Score=323.25  Aligned_cols=247  Identities=24%  Similarity=0.322  Sum_probs=194.4

Q ss_pred             ceeeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHH-HHHHhhcccccccccceeecCCeEEEEEEecCC
Q 011005          211 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEA-QVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMER  286 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~  286 (496)
                      +.||+|+||+||+|.++ +++.||+|.+.....  ......+..|. .+++.++|+||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999765 578899999875431  12223344444 456778999999999999999999999999999


Q ss_pred             CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCcc
Q 011005          287 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT  366 (496)
Q Consensus       287 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  366 (496)
                      |+|.+++....   .++...+..++.||+.||.|||   +.||+||||||+||+++.++.++|+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~  154 (325)
T cd05602          81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS  154 (325)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence            99999987643   5788888899999999999999   78999999999999999999999999999976543333344


Q ss_pred             ccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHH
Q 011005          367 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL  446 (496)
Q Consensus       367 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  446 (496)
                      ..+||+.|+|||++.+..++.++||||+||++|+|++|+.||....       .................     .....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~i~~~~~~~~~-----~~~~~  222 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-------TAEMYDNILNKPLQLKP-----NITNS  222 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC-------HHHHHHHHHhCCcCCCC-----CCCHH
Confidence            5679999999999999999999999999999999999999986321       11122222222221111     11224


Q ss_pred             HHHHHHhcccCCCCCCCCHH----HHHHHHHHh
Q 011005          447 ISTVSFACLQSNPKSRPTMQ----SVSQEFLIT  475 (496)
Q Consensus       447 l~~li~~cl~~dP~~Rps~~----evl~~~~~~  475 (496)
                      +.+++.+||+.||.+||++.    ++.+|+|+.
T Consensus       223 ~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~  255 (325)
T cd05602         223 ARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFS  255 (325)
T ss_pred             HHHHHHHHcccCHHHCCCCCCCHHHHhcCcccC
Confidence            67899999999999999876    788887763

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.9e-40  Score=322.65  Aligned_cols=247  Identities=23%  Similarity=0.347  Sum_probs=195.3

Q ss_pred             ceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHH-HHHhhcccccccccceeecCCeEEEEEEecCC
Q 011005          211 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQ-VLSQVLHRNIVKLYGYCLHKKCMFLIYEYMER  286 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~  286 (496)
                      +.||+|+||.||+|... +++.||+|.+....  .......+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999764 68899999987543  1222334455544 57788999999999999999999999999999


Q ss_pred             CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCcc
Q 011005          287 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT  366 (496)
Q Consensus       287 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  366 (496)
                      |+|...+....   .++...+..++.||+.||.|||   ..+|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (321)
T cd05603          81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS  154 (321)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence            99998887543   6788889999999999999999   78999999999999999999999999999876433333344


Q ss_pred             ccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHH
Q 011005          367 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL  446 (496)
Q Consensus       367 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  446 (496)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||....       .......+.......+..     ....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~-----~~~~  222 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-------VSQMYDNILHKPLQLPGG-----KTVA  222 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-------HHHHHHHHhcCCCCCCCC-----CCHH
Confidence            4678999999999999999999999999999999999999986321       122222333322221111     1224


Q ss_pred             HHHHHHhcccCCCCCCCCH----HHHHHHHHHh
Q 011005          447 ISTVSFACLQSNPKSRPTM----QSVSQEFLIT  475 (496)
Q Consensus       447 l~~li~~cl~~dP~~Rps~----~evl~~~~~~  475 (496)
                      +.+++.+||+.||.+||++    .|+++|+|+.
T Consensus       223 ~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~  255 (321)
T cd05603         223 ACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFS  255 (321)
T ss_pred             HHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcC
Confidence            6789999999999999975    5888888764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.4e-41  Score=316.08  Aligned_cols=257  Identities=30%  Similarity=0.462  Sum_probs=204.3

Q ss_pred             CCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHH-HHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          207 FDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAF-IKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      |++.+.||+|+||+||++..+ +++.||+|.+........ .....+|+.++++++||||+++++++......++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            567889999999999999776 466899999988654332 223456999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      ++++|.+++....   .+++..+..++.|++.||.+||   +.+++|+||||+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN  154 (260)
T ss_dssp             TTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred             ccccccccccccc---cccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence            9999999998322   6899999999999999999999   679999999999999999999999999999765333344


Q ss_pred             ccccccccccccccccc-cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHH
Q 011005          365 RTLLAGTYGYIAPELAY-TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD  443 (496)
Q Consensus       365 ~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  443 (496)
                      .....+++.|+|||.+. +..++.++||||+|+++|+|++|..||.....    ..................... ....
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~-~~~~  229 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS----DDQLEIIEKILKRPLPSSSQQ-SREK  229 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH----HHHHHHHHHHHHTHHHHHTTS-HTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc----hhhhhhhhhcccccccccccc-cchh
Confidence            45567899999999998 88899999999999999999999999874310    001111111111111100000 0000


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          444 ILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       444 ~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ...+.+++.+||+.||++|||+.++++|+|+
T Consensus       230 ~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  230 SEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            1468899999999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.4e-40  Score=313.48  Aligned_cols=256  Identities=24%  Similarity=0.356  Sum_probs=201.8

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCe
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKC  276 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  276 (496)
                      ..++|++.+.||+|+||.||+|.++      .+..||+|++...........+.+|+.+++.++|+||+++++++..+..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4678999999999999999999653      3567999998654433445678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhCCCC-------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEE
Q 011005          277 MFLIYEYMERGSLFCNLHNNED-------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFV  349 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl  349 (496)
                      .++||||+++|+|.+++.....       ...+++..+..++.|++.||+|||   +.+++|+||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            9999999999999999875322       124678888999999999999999   779999999999999999999999


Q ss_pred             ccccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHh
Q 011005          350 ADFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLID  426 (496)
Q Consensus       350 ~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~  426 (496)
                      +|||+++........  .....+++.|+|||++.+..++.++||||||+++|||++ |..||....       .......
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-------~~~~~~~  233 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-------NEQVLRF  233 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHH
Confidence            999998765332211  112345678999999999999999999999999999999 788885321       1111111


Q ss_pred             hhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 011005          427 VLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~  472 (496)
                      ...........    .....+.+++.+||+.||++|||+.|+++.+
T Consensus       234 ~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  275 (277)
T cd05062         234 VMEGGLLDKPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSI  275 (277)
T ss_pred             HHcCCcCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHh
Confidence            11222111111    1123578999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.5e-40  Score=327.10  Aligned_cols=258  Identities=22%  Similarity=0.362  Sum_probs=202.9

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-ccccccccceeecCCe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKC  276 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  276 (496)
                      .++|.+.+.||+|+||.||+|.+.      .+..||||++.........+.+.+|+++++++. ||||+++++++.....
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            467889999999999999999752      234799999976554445567899999999996 9999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhCCCC----------------------------------------------------------
Q 011005          277 MFLIYEYMERGSLFCNLHNNED----------------------------------------------------------  298 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~----------------------------------------------------------  298 (496)
                      .++||||+++|+|.+++.....                                                          
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            9999999999999988865311                                                          


Q ss_pred             -----------------------------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC
Q 011005          299 -----------------------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS  343 (496)
Q Consensus       299 -----------------------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~  343 (496)
                                                         ...+++..+..++.|++.||+|||   +.+++||||||+||+++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence                                               124778888999999999999999   789999999999999999


Q ss_pred             CCCeEEccccccccccCCCC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCC
Q 011005          344 KLEAFVADFGTARLLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDP  420 (496)
Q Consensus       344 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~  420 (496)
                      ++.+||+|||+++.......  ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.....       
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~-------  345 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV-------  345 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch-------
Confidence            99999999999986543222  1222346778999999999999999999999999999997 9999863211       


Q ss_pred             cchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          421 KIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       421 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ..................   .....+.+++.+||+.||++|||+.++.+.+..
T Consensus       346 ~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~  396 (400)
T cd05105         346 DSTFYNKIKSGYRMAKPD---HATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES  396 (400)
T ss_pred             hHHHHHHHhcCCCCCCCc---cCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence            111111111111111111   122357889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-40  Score=310.04  Aligned_cols=254  Identities=24%  Similarity=0.368  Sum_probs=204.3

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch----hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE----ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      ++|++.+.||+|++|.||+|.. .+++.||+|.+....    .....+.+.+|++++++++||||+++++++..++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4688999999999999999975 468999999886532    12234568899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      |+||+++++|.+.+....   .++...+..++.|++.||.|||   ..+++|+||+|+||++++++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999999987643   5788899999999999999999   7899999999999999999999999999997654


Q ss_pred             CCCCCc---cccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCC
Q 011005          360 ADSSNR---TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV  436 (496)
Q Consensus       360 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  436 (496)
                      ......   ....++..|+|||.+.+..++.++||||+|+++|++++|+.||.....       ................
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~  228 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-------MAAIFKIATQPTNPQL  228 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-------HHHHHHHhccCCCCCC
Confidence            322111   234577899999999999999999999999999999999999863211       1111111111111111


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ..   .....+.+++.+||..+|++|||+.|+++|+|+
T Consensus       229 ~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         229 PS---HVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             Cc---cCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            11   122346789999999999999999999999885

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.9e-40  Score=328.27  Aligned_cols=262  Identities=24%  Similarity=0.341  Sum_probs=205.4

Q ss_pred             HHHHHHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCC
Q 011005          199 DLIEATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK  275 (496)
Q Consensus       199 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  275 (496)
                      ++....++|++.+.||+|+||.||+|.++ +++.||+|.+....  .....+.+.+|+.+++.++||||+++++++..+.
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            34445689999999999999999999765 68899999986532  2223455788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccc
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  355 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  355 (496)
                      ..++||||+++|+|.+++...    .++...+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            999999999999999998753    4788888999999999999999   789999999999999999999999999999


Q ss_pred             ccccCCCC-CccccccccccccccccccC----CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcC
Q 011005          356 RLLHADSS-NRTLLAGTYGYIAPELAYTM----VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQ  430 (496)
Q Consensus       356 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  430 (496)
                      ........ .....+||+.|+|||++.+.    .++.++||||+||++|||++|+.||....       .......+...
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-------~~~~~~~i~~~  262 (371)
T cd05622         190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-------LVGTYSKIMNH  262 (371)
T ss_pred             eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC-------HHHHHHHHHcC
Confidence            87643322 22346799999999998754    37889999999999999999999996322       11122222221


Q ss_pred             C--CCCCCChhHHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHHHHHhcc
Q 011005          431 R--LPPPVDRKVIRDILLISTVSFACLQSNPKS--RPTMQSVSQEFLITRK  477 (496)
Q Consensus       431 ~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~~~~~~~  477 (496)
                      .  ...+..   ......+.+++.+||..++.+  |++++|+++|+|+...
T Consensus       263 ~~~~~~~~~---~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         263 KNSLTFPDD---NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             CCcccCCCc---CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            1  111111   011224678889999844433  7899999999998653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.6e-40  Score=314.79  Aligned_cols=256  Identities=27%  Similarity=0.398  Sum_probs=202.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|.++..... ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e   86 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE-DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME   86 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence            35788888999999999999965 46889999998765322 23557889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++++|.+++....   .+++.++..++.|++.|+.|||   ..+++|+||||+||+++.++.++|+|||++.......
T Consensus        87 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          87 FCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             ccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence            999999999987544   6889999999999999999999   7799999999999999999999999999997665443


Q ss_pred             CCccccccccccccccccc---cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          363 SNRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                      .......|++.|+|||.+.   ...++.++||||+||++|+|++|+.||.....       ..............+....
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~  233 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP-------MRALFLMTKSNFQPPKLKD  233 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc-------hhhHHhhhccCCCCCcccc
Confidence            3344557899999999874   45578899999999999999999999853221       1111111111111111110


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      .......+.+++.+||+.+|++|||++++++|+|
T Consensus       234 ~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         234 KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             cCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            1111234678999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.2e-40  Score=314.76  Aligned_cols=256  Identities=26%  Similarity=0.408  Sum_probs=201.7

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecC------
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHK------  274 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------  274 (496)
                      +.+.|++.+.||+|+||.||+|... +++.||+|.+.....  ....+.+|+.+++++ +|+||+++++++...      
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            5678899999999999999999764 688899999865432  225678899999998 699999999998753      


Q ss_pred             CeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccc
Q 011005          275 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  354 (496)
Q Consensus       275 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  354 (496)
                      ...++||||+.+++|.+++.... ...+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.++|+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence            46899999999999999987643 235889999999999999999999   77999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccccc-----cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhc
Q 011005          355 ARLLHADSSNRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD  429 (496)
Q Consensus       355 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  429 (496)
                      +..............|++.|+|||++.     +..++.++||||+|+++|||++|+.||......       ........
T Consensus       158 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-------~~~~~~~~  230 (272)
T cd06637         158 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------RALFLIPR  230 (272)
T ss_pred             ceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-------HHHHHHhc
Confidence            986644333344567899999999986     346788999999999999999999998633211       11111111


Q ss_pred             CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          430 QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       430 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      .........   .....+.+++.+||..||.+|||+.|+++|+|+
T Consensus       231 ~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         231 NPAPRLKSK---KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCCCCCC---CcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            111111111   112247789999999999999999999999985

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1e-39  Score=309.10  Aligned_cols=253  Identities=28%  Similarity=0.398  Sum_probs=203.7

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCC----CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      ++|++.+.||+|+||+||+|.++.    ...||+|.++..........+.+|+.++++++|+||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            578999999999999999997642    4579999987655444556788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+++++|.+++.....  .+++..++.++.|++.|++|||   +.+++|+||||+||++++++.++|+|||+++....
T Consensus        84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          84 TEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            999999999999876432  6899999999999999999999   78999999999999999999999999999987752


Q ss_pred             CCCCc--cccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          361 DSSNR--TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       361 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                      .....  ....++..|+|||.+.+..++.++||||||+++|++++ |..||....       ..............+.. 
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~-  230 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS-------NQDVIKAVEDGYRLPPP-  230 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC-------HHHHHHHHHcCCCCCCC-
Confidence            22211  12234578999999999999999999999999999998 999985321       11111111111111111 


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      .   .....+.+++.+||+.+|++||++.|+++++.
T Consensus       231 ~---~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~  263 (266)
T cd05033         231 M---DCPSALYQLMLDCWQKDRNERPTFSQIVSTLD  263 (266)
T ss_pred             C---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            1   12235779999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.6e-40  Score=318.29  Aligned_cols=258  Identities=24%  Similarity=0.407  Sum_probs=203.6

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCc----EEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGK----VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      .+|++.+.||+|+||.||+|.+. +++    .||+|.+.........+.+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            56999999999999999999753 333    48999987654444557788999999999999999999999765 4679


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      |+||+++|+|.+++....  ..+++..++.++.||+.||+|||   +.+++||||||+||+++.++.+||+|||+++...
T Consensus        86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEcccccccccc
Confidence            999999999999998643  25788999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCCc--cccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCC
Q 011005          360 ADSSNR--TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV  436 (496)
Q Consensus       360 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  436 (496)
                      ......  ....++..|+|||.+.+..++.++||||||+++|||++ |+.||+....        .............+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~  232 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEISSILEKGERLPQ  232 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHhCCCCCCC
Confidence            433221  11234568999999999999999999999999999998 9999863211        111222222111111


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      ..   .....+.+++.+||+.||++||++.+++.++....+.+
T Consensus       233 ~~---~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         233 PP---ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             CC---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            11   11224678999999999999999999999987766544

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=7.2e-40  Score=316.74  Aligned_cols=264  Identities=26%  Similarity=0.349  Sum_probs=206.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      ++|++.+.||+|+||.||+|.+. ++..+|+|.+...........+.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36889999999999999999764 67889999887654444456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+++....   .+++..+..++.|++.||.|||+  ..+++|+||||+||+++.++.++|+|||++......  
T Consensus        81 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  153 (308)
T cd06615          81 MDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  153 (308)
T ss_pred             cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence            99999999997653   68899999999999999999994  258999999999999999999999999998765332  


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCC--------CC---------------
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSS--------DP---------------  420 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~--------~~---------------  420 (496)
                      ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||..........        ..               
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (308)
T cd06615         154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS  233 (308)
T ss_pred             ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence            2234568899999999988889999999999999999999999985321100000        00               


Q ss_pred             --cchhHhhhcC---CCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          421 --KIMLIDVLDQ---RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       421 --~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                        .....+..+.   ..++...  .......+.+++.+||+.||++|||+.|+++|+|+.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         234 PRPMAIFELLDYIVNEPPPKLP--SGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             cchhhHHHHHHHHhcCCCccCc--CcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence              0000000000   0000000  00112347899999999999999999999999999763

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-40  Score=324.23  Aligned_cols=268  Identities=23%  Similarity=0.267  Sum_probs=202.2

Q ss_pred             HHHHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecC----
Q 011005          201 IEATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK----  274 (496)
Q Consensus       201 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----  274 (496)
                      .+..++|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+.++++++|+||+++++++...    
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            34568899999999999999999965 468899999987643 223345677899999999999999999987543    


Q ss_pred             --CeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccc
Q 011005          275 --KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF  352 (496)
Q Consensus       275 --~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Df  352 (496)
                        ...+++++++ +++|.+++...    .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+||
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCC
Confidence              3478999987 77888877542    5899999999999999999999   789999999999999999999999999


Q ss_pred             cccccccCCCCCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCC--------CCCCcch
Q 011005          353 GTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS--------SSDPKIM  423 (496)
Q Consensus       353 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~--------~~~~~~~  423 (496)
                      |+++.....   .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||........        .......
T Consensus       163 g~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07878         163 GLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV  239 (343)
T ss_pred             ccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999865432   234568999999999877 5688999999999999999999999863221000        0000000


Q ss_pred             hH-------hhhcCCCCCCCChhH----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          424 LI-------DVLDQRLPPPVDRKV----IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       424 ~~-------~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      ..       ......++.......    ......+.+++.+||+.||++|||+.|+++|+|+.....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~  306 (343)
T cd07878         240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD  306 (343)
T ss_pred             HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence            00       000000000000000    001123678999999999999999999999999987543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=8.3e-41  Score=330.34  Aligned_cols=255  Identities=24%  Similarity=0.368  Sum_probs=202.2

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|+||.||+|..+ +++.||+|.+....  .......+.+|+.++..++|++|+++++.+..++..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888999999999999999765 68899999987543  2233466788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++|+|.+++....   .++...+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++......
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            9999999999987654   6889999999999999999999   789999999999999999999999999998754321


Q ss_pred             CC-----------------------------------CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCC
Q 011005          362 SS-----------------------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKH  406 (496)
Q Consensus       362 ~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~  406 (496)
                      ..                                   .....+||+.|+|||++.+..++.++||||+||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            00                                   0113468999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCcchhHhhhc--CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCC---CHHHHHHHHHHhc
Q 011005          407 PRDILSSLSSSSDPKIMLIDVLD--QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRP---TMQSVSQEFLITR  476 (496)
Q Consensus       407 p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~evl~~~~~~~  476 (496)
                      ||....       .......+..  ..+..+....   ....+.+++.+|+ .||.+|+   +++|+++|+|+..
T Consensus       235 Pf~~~~-------~~~~~~~i~~~~~~~~~p~~~~---~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~  298 (360)
T cd05627         235 PFCSET-------PQETYRKVMNWKETLVFPPEVP---ISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEG  298 (360)
T ss_pred             CCCCCC-------HHHHHHHHHcCCCceecCCCCC---CCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCC
Confidence            996322       1122222221  1111111100   1123567777776 4999998   4899999999865

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.8e-40  Score=316.94  Aligned_cols=270  Identities=24%  Similarity=0.355  Sum_probs=216.9

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.+++.++|+||+++++++..++..++|||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            46799999999999999999975 57999999998754432 23567899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++++|.+++.+.    .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++.......
T Consensus        97 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          97 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             ccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            99999999998653    4788899999999999999999   7899999999999999999999999999997664443


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                      .......+++.|+|||.+.+..++.++||||+|+++|++++|+.||.......       ..........+. . .....
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~-------~~~~~~~~~~~~-~-~~~~~  240 (297)
T cd06656         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYLIATNGTPE-L-QNPER  240 (297)
T ss_pred             cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch-------heeeeccCCCCC-C-CCccc
Confidence            33344568889999999999999999999999999999999999996322110       000000010000 0 00111


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCcccccccc
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDIS  490 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~~~~~i~  490 (496)
                      ....+.+++.+||+.+|++||+++++++|+|+....+..+....+.|.
T Consensus       241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~  288 (297)
T cd06656         241 LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLTPLIIAA  288 (297)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccccccCHHHHHH
Confidence            223467899999999999999999999999999888877766555443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-40  Score=322.37  Aligned_cols=258  Identities=26%  Similarity=0.351  Sum_probs=200.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|+||+||++..+ +++.||+|.+....  .....+.+.+|+.+++.++|+||+++++++..++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999765 58899999987532  2233456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++|+|.+++.+..  ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.++|+|||++......
T Consensus        81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            9999999999997532  25788999999999999999999   789999999999999999999999999999766433


Q ss_pred             CCC-cccccccccccccccccc-----CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCC--CC
Q 011005          362 SSN-RTLLAGTYGYIAPELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQR--LP  433 (496)
Q Consensus       362 ~~~-~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~  433 (496)
                      ... .....||+.|+|||++..     ..++.++||||+||++|+|++|+.||.....       ......+....  ..
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-------~~~~~~i~~~~~~~~  228 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHKEHFQ  228 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-------HHHHHHHHcCCCccc
Confidence            222 223468999999999873     4578899999999999999999999863211       11111121111  11


Q ss_pred             CCCChhHHHHHHHHHHHHHhcccCCCC--CCCCHHHHHHHHHHhc
Q 011005          434 PPVDRKVIRDILLISTVSFACLQSNPK--SRPTMQSVSQEFLITR  476 (496)
Q Consensus       434 ~~~~~~~~~~~~~l~~li~~cl~~dP~--~Rps~~evl~~~~~~~  476 (496)
                      .+..  .......+.+++.+|+..+++  .||+++++++|+|+..
T Consensus       229 ~~~~--~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~  271 (331)
T cd05597         229 FPPD--VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG  271 (331)
T ss_pred             CCCc--cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence            1110  001122456778887755443  4889999999999854

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5e-40  Score=309.28  Aligned_cols=253  Identities=30%  Similarity=0.460  Sum_probs=207.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCC-CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      ++|++.+.||+|+||.||+|...+ ++.+++|.+.....   .+.+.+|++++++++|+||+++++++..+...++++||
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            578899999999999999998764 78999999876543   46789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+++....  ..+++..+..++.|++.|+.|||   ..+++|+||+|+||+++.++.++|+|||++........
T Consensus        80 ~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          80 CGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             CCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            99999999987533  36899999999999999999999   77999999999999999999999999999987654433


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD  443 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  443 (496)
                      ......++..|+|||++.+..++.++||||||+++|+|++|+.||......       ...... ......... .....
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~-------~~~~~~-~~~~~~~~~-~~~~~  225 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM-------RAIFMI-PNKPPPTLS-DPEKW  225 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh-------hhhhhh-ccCCCCCCC-chhhc
Confidence            334455788999999999999999999999999999999999998643221       011111 111111111 11112


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          444 ILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       444 ~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ...+.+++.+||+.||++|||+.|+++|+|+
T Consensus       226 ~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         226 SPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             CHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            2347889999999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.4e-40  Score=316.69  Aligned_cols=265  Identities=22%  Similarity=0.253  Sum_probs=200.9

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      +|++.+.||+|++|.||+|..+ +++.||+|++.... .......+.+|+.++++++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999764 68999999986543 222335678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      ++ ++|.+++........+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 588888876554457899999999999999999999   78999999999999999999999999999976543333


Q ss_pred             CccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCC---------CCCC----cchhHhhhc
Q 011005          364 NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS---------SSDP----KIMLIDVLD  429 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~---------~~~~----~~~~~~~~~  429 (496)
                      ......+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||........         ....    .........
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK  236 (285)
T ss_pred             cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence            33334578899999988654 578899999999999999999999863221000         0000    000000000


Q ss_pred             CCCCCCC----ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          430 QRLPPPV----DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       430 ~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ...+...    ..........+.+++.+||+.||++|||+.++++|+|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            0000000    00000012346789999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-40  Score=309.02  Aligned_cols=256  Identities=29%  Similarity=0.434  Sum_probs=207.4

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      ++|++.+.||+|+||.||+|... +++.+++|.+...... ..+.+.+|++++++++||||+++++++..+...+++|||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            57889999999999999999764 5788999998765432 457789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+++....  ..++...+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  156 (262)
T cd06613          82 CGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA  156 (262)
T ss_pred             CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence            99999999887642  26889999999999999999999   78999999999999999999999999999987654333


Q ss_pred             CccccccccccccccccccC---CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          364 NRTLLAGTYGYIAPELAYTM---VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      ......++..|+|||.+.+.   .++.++||||+|+++|+|++|+.||.....       ....................
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~  229 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP-------MRALFLISKSNFPPPKLKDK  229 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhccCCCccccch
Confidence            33445688899999998876   888999999999999999999999863221       11111111121111111112


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      ......+.+++.+||+.+|.+|||+.+++.|.|
T Consensus       230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             hhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            233446889999999999999999999998865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.8e-40  Score=315.06  Aligned_cols=258  Identities=23%  Similarity=0.295  Sum_probs=203.5

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .|+..+.||+|+||.||+|... +++.||+|.+....  .......+.+|+.++++++|++++++++.+...+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3677889999999999999664 68899999986542  12223456789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++++|.+++..... ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          81 LMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             ecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            9999999988865332 35889999999999999999999   7899999999999999999999999999997653322


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                       ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||.....    ............ ........   .
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~----~~~~~~~~~~~~-~~~~~~~~---~  227 (285)
T cd05630         157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK----KIKREEVERLVK-EVQEEYSE---K  227 (285)
T ss_pred             -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCc----cchHHHHHhhhh-hhhhhcCc---c
Confidence             22334689999999999999999999999999999999999999963211    000001111111 01110000   1


Q ss_pred             HHHHHHHHHHhcccCCCCCCCC-----HHHHHHHHHHhc
Q 011005          443 DILLISTVSFACLQSNPKSRPT-----MQSVSQEFLITR  476 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps-----~~evl~~~~~~~  476 (496)
                      ....+.+++.+||+.||++|||     ++|+++|+|+..
T Consensus       228 ~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         228 FSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence            1224678999999999999999     999999999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=8e-40  Score=319.79  Aligned_cols=259  Identities=24%  Similarity=0.369  Sum_probs=201.9

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecC-C
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHK-K  275 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~  275 (496)
                      .++|++.+.||+|+||.||+|...      .++.||+|++.........+.+.+|+.+++++ +|+||+++++++... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            457999999999999999999532      35789999997654444456778999999999 799999999988654 5


Q ss_pred             eEEEEEEecCCCChhhhhhCCCC---------------------------------------------------------
Q 011005          276 CMFLIYEYMERGSLFCNLHNNED---------------------------------------------------------  298 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~---------------------------------------------------------  298 (496)
                      ..+++|||+++++|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            68899999999999998864221                                                         


Q ss_pred             -CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC--ccccccccccc
Q 011005          299 -AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN--RTLLAGTYGYI  375 (496)
Q Consensus       299 -~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~  375 (496)
                       ...+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.++|+|||++..+......  .....++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             125789999999999999999999   789999999999999999999999999999876433221  22234567899


Q ss_pred             cccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhc
Q 011005          376 APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFAC  454 (496)
Q Consensus       376 aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  454 (496)
                      |||++.+..++.++||||+||++|||++ |..||....       ........+..........   .....+.+++.+|
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~~c  312 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ-------IDEEFCRRLKEGTRMRAPE---YATPEIYSIMLDC  312 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC-------ccHHHHHHHhccCCCCCCc---cCCHHHHHHHHHH
Confidence            9999999999999999999999999998 999986321       1111212222211111111   1123477899999


Q ss_pred             ccCCCCCCCCHHHHHHHHHHh
Q 011005          455 LQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       455 l~~dP~~Rps~~evl~~~~~~  475 (496)
                      |+.+|++||++.|+++++-..
T Consensus       313 l~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         313 WHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             ccCChhhCcCHHHHHHHHHHH
Confidence            999999999999999998643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.2e-39  Score=310.59  Aligned_cols=257  Identities=28%  Similarity=0.428  Sum_probs=209.9

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      +.|+..+.||+|+||.||+|... +++.||+|.+...........+.+|++++++++|+||+++++++..+...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45778889999999999999764 58899999987654444557789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++|+|.+++...    .++...+..++.|++.|++|||   ..+++|+||+|+||+++.++.++++|||++........
T Consensus        84 ~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          84 LGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            9999999988653    5788889999999999999999   78999999999999999999999999999977644333


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD  443 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  443 (496)
                      ......++..|+|||++.+..++.++|+||||+++|||++|+.||......       . .........++..   ....
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-------~-~~~~~~~~~~~~~---~~~~  225 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-------R-VLFLIPKNNPPTL---TGEF  225 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-------h-HhhhhhcCCCCCC---chhh
Confidence            333456788999999999888999999999999999999999998643211       0 1111111111111   1123


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          444 ILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       444 ~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      ...+.+++.+||+.+|++||++.++++|.|+.+...
T Consensus       226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         226 SKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             hHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence            345789999999999999999999999999876543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=7.8e-40  Score=307.98  Aligned_cols=250  Identities=24%  Similarity=0.402  Sum_probs=201.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      ++|++.+.||+|+||+||+|.+.++..+|+|.+......  ...+.+|+.++++++||||+++++++......++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc--HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            468888999999999999998877778999998754321  256889999999999999999999999888899999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      .+|+|.+++.....  .+++..++.++.||+.||+|||   +.+++|+||||+||+++.++.+||+|||.++........
T Consensus        82 ~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          82 SNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             CCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence            99999999876432  6899999999999999999999   789999999999999999999999999999766443221


Q ss_pred             c-cccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          365 R-TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       365 ~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                      . ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.....       .................    .
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~----~  225 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-------SETVEKVSQGLRLYRPH----L  225 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHHhcCCCCCCCC----C
Confidence            1 11234567999999998889999999999999999998 9999863221       11111222221111111    1


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~  472 (496)
                      ....+.+++.+||+.||++||++.++++.+
T Consensus       226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         226 ASEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             CCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence            123578999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.7e-40  Score=336.38  Aligned_cols=271  Identities=19%  Similarity=0.285  Sum_probs=200.2

Q ss_pred             HHHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhccc------ccccccceeecC
Q 011005          202 EATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR------NIVKLYGYCLHK  274 (496)
Q Consensus       202 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~~  274 (496)
                      ...++|.+.+.||+|+||+||+|.+. .++.||||+++....  .......|+.+++.++|.      +++++++++...
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK--YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh--hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            35678999999999999999999764 678899999865322  224456788888887654      588888888764


Q ss_pred             -CeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC--------
Q 011005          275 -KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL--------  345 (496)
Q Consensus       275 -~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~--------  345 (496)
                       .+.++|||++ +++|.+++.+..   .+++..+..|+.||+.||+|||+  ..+|+||||||+|||++.++        
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccc
Confidence             5788999988 778988887543   68999999999999999999993  25999999999999998765        


Q ss_pred             --------CeEEccccccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCC-
Q 011005          346 --------EAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS-  416 (496)
Q Consensus       346 --------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~-  416 (496)
                              .+||+|||.+....   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||+....... 
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~  354 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL  354 (467)
T ss_pred             cccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                    49999999885432   223456799999999999999999999999999999999999999964321100 


Q ss_pred             -------CCCCcch--------hHhhhcC--CCCCCCCh------------hHHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 011005          417 -------SSDPKIM--------LIDVLDQ--RLPPPVDR------------KVIRDILLISTVSFACLQSNPKSRPTMQS  467 (496)
Q Consensus       417 -------~~~~~~~--------~~~~~~~--~~~~~~~~------------~~~~~~~~l~~li~~cl~~dP~~Rps~~e  467 (496)
                             ...+...        .......  .+.+....            ........+.+|+.+||+.||++|||++|
T Consensus       355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e  434 (467)
T PTZ00284        355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ  434 (467)
T ss_pred             HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence                   0000000        0000000  00000000            00011234679999999999999999999


Q ss_pred             HHHHHHHhccCCCCCc
Q 011005          468 VSQEFLITRKTPLVKH  483 (496)
Q Consensus       468 vl~~~~~~~~~~~~~~  483 (496)
                      +++|+|+....+..+.
T Consensus       435 ~L~Hp~~~~~~~~~~~  450 (467)
T PTZ00284        435 MTTHPYVLKYYPECRQ  450 (467)
T ss_pred             HhcCccccccCCcccc
Confidence            9999999987765433

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.4e-39  Score=308.25  Aligned_cols=260  Identities=22%  Similarity=0.286  Sum_probs=206.8

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|+||.||+|..+ +++.||+|.+....  .......+.+|+++++.++||||+++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            47899999999999999999764 78999999876422  2334466889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCC-CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          282 EYMERGSLFCNLHNNED-AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      ||+++|+|.+++..... ...++...+..++.|++.||+|||   ..+++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988864321 235788999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      .........+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||....      .........+.....++..  .
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~--~  230 (267)
T cd08228         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLFSLCQKIEQCDYPPLP--T  230 (267)
T ss_pred             hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc------ccHHHHHHHHhcCCCCCCC--h
Confidence            3333334568889999999998889999999999999999999999985211      1111122222221111111  1


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                      ......+.+++.+||+.+|++||++.++++.+...
T Consensus       231 ~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         231 EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            12234578999999999999999999999987654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=8.7e-40  Score=308.64  Aligned_cols=253  Identities=25%  Similarity=0.409  Sum_probs=203.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      .++|++.+.||+|+||.||+|...+++.||+|.+.....  ..+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            367899999999999999999988888999999875432  236788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+++.... ...+++..++.++.|++.||+|||   ..+++||||||+||+++.++.++|+|||++........
T Consensus        83 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          83 MAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            99999999987643 236788999999999999999999   78999999999999999999999999999987643221


Q ss_pred             C-ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          364 N-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       364 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                      . .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||....       ........ ......+...   
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-------~~~~~~~~-~~~~~~~~~~---  227 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS-------NSDVMSAL-QRGYRMPRME---  227 (261)
T ss_pred             eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC-------HHHHHHHH-HcCCCCCCCC---
Confidence            1 122335668999999998889999999999999999998 999985321       11111111 1111111111   


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          442 RDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      .....+.+++.+||..+|++||+++++.+.+.
T Consensus       228 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  259 (261)
T cd05072         228 NCPDELYDIMKTCWKEKAEERPTFDYLQSVLD  259 (261)
T ss_pred             CCCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence            11234778999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=6e-40  Score=309.75  Aligned_cols=254  Identities=28%  Similarity=0.487  Sum_probs=207.7

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      ...+|++.+.||+|+||.||+|..++++.+++|.+..... .....+.+|+.+++.++|+||+++++++...+..++|||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            4567999999999999999999988899999999876543 224568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++++|.+++.... ...+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus        83 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          83 LMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             ecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            999999999998653 336899999999999999999999   7799999999999999999999999999998765433


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcC-CCCCCCChhH
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ-RLPPPVDRKV  440 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  440 (496)
                      .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||....       ........... +.+.+.    
T Consensus       159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~----  227 (261)
T cd05148         159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-------NHEVYDQITAGYRMPCPA----  227 (261)
T ss_pred             ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-------HHHHHHHHHhCCcCCCCC----
Confidence            33333345678999999998899999999999999999998 899986322       11122222211 111111    


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                       .....+.+++.+||+.||++|||+.++++.+.
T Consensus       228 -~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~  259 (261)
T cd05148         228 -KCPQEIYKIMLECWAAEPEDRPSFKALREELD  259 (261)
T ss_pred             -CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence             11234779999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-41  Score=310.48  Aligned_cols=262  Identities=24%  Similarity=0.317  Sum_probs=197.4

Q ss_pred             CCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCC-----eEEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK-----CMFL  279 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~l  279 (496)
                      .|.-.+.+|.|+||.||+|.. .+++.||||+.-.+..     .-.+|+++|++++|||||++.-+|....     +..+
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            466678999999999999965 4579999999876542     2258999999999999999998886532     3568


Q ss_pred             EEEecCCCChhhhhhCC-CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC-CCeEEcccccccc
Q 011005          280 IYEYMERGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTARL  357 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~  357 (496)
                      |||||+. +|...+... .....++...+.-+.+||.+||.|||   +.+|+||||||.|+|+|.+ |.+||||||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999976 888887732 22336777888889999999999999   7899999999999999977 9999999999998


Q ss_pred             ccCCCCCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccC----------CCCCCcchh--
Q 011005          358 LHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS----------SSSDPKIML--  424 (496)
Q Consensus       358 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~----------~~~~~~~~~--  424 (496)
                      +.....+ .....|..|+|||.+.|. .|+.+.||||.||++.||+-|++-|...+...          .....+...  
T Consensus       176 L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn  254 (364)
T KOG0658|consen  176 LVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN  254 (364)
T ss_pred             eccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence            8665444 456688999999998875 79999999999999999999999987433210          000000000  


Q ss_pred             ---HhhhcCCCCC-CCCh-hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          425 ---IDVLDQRLPP-PVDR-KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       425 ---~~~~~~~~~~-~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                         .+.....+.. +... ..........+|+.++|+.+|.+|.++.|++.|+|+...
T Consensus       255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel  312 (364)
T KOG0658|consen  255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL  312 (364)
T ss_pred             cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence               0000000100 0000 011223457799999999999999999999999988654

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=7.6e-40  Score=311.88  Aligned_cols=255  Identities=30%  Similarity=0.439  Sum_probs=206.2

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      .|+..+.||+|+||.||+|.+. +++.||+|.+.........+.+.+|++++++++||||+++++++..+...++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4566778999999999999654 578899998875543344567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      ++++|.+++...    .+++..+..++.|++.|+.|||   ..+++|+||+|+||++++++.++++|||++.........
T Consensus        85 ~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06642          85 GGGSALDLLKPG----PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             CCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence            999999888643    5788999999999999999999   789999999999999999999999999999776543323


Q ss_pred             ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHH
Q 011005          365 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI  444 (496)
Q Consensus       365 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  444 (496)
                      .....++..|+|||++.+..++.++||||||+++|||++|+.|+.....       ...... ..........   ....
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-------~~~~~~-~~~~~~~~~~---~~~~  226 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP-------MRVLFL-IPKNSPPTLE---GQYS  226 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch-------hhHHhh-hhcCCCCCCC---cccC
Confidence            3334678899999999999999999999999999999999999863221       111111 1111111111   1122


Q ss_pred             HHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          445 LLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       445 ~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ..+.+++.+||+.+|++||++.++++|+|+.+..
T Consensus       227 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         227 KPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence            3477899999999999999999999999987643

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.2e-40  Score=316.85  Aligned_cols=267  Identities=20%  Similarity=0.232  Sum_probs=202.7

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      ++|.+.+.||+|+||.||+|..+ +++.||+|.+...........+.+|+.++++++|+||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56889999999999999999765 68899999987544333334577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      ++ ++|.+++....  ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++........
T Consensus        86 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            97 58888887543  25788999999999999999999   78999999999999999999999999999976543333


Q ss_pred             CccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCC--------CCCCcchhHhhh------
Q 011005          364 NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS--------SSDPKIMLIDVL------  428 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~--------~~~~~~~~~~~~------  428 (496)
                      ......+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||........        ............      
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  239 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence            33344678899999988654 578899999999999999999999863321000        000000000000      


Q ss_pred             cCCCCCCCC----hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          429 DQRLPPPVD----RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       429 ~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ....+....    .........+.+++.+||+.||.+|||++|+++|+|+..-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~  292 (301)
T cd07873         240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL  292 (301)
T ss_pred             ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            000000000    0000112246789999999999999999999999999543

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.2e-39  Score=322.79  Aligned_cols=264  Identities=23%  Similarity=0.253  Sum_probs=200.0

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecC------
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK------  274 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  274 (496)
                      ..++|.+.+.||+|+||.||+|... .++.||||++.... .....+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999754 68899999987542 223346678999999999999999999987543      


Q ss_pred             CeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccc
Q 011005          275 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  354 (496)
Q Consensus       275 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  354 (496)
                      ...++||||+++ ++...+..     .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCC
Confidence            357999999975 67666643     4788889999999999999999   78999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCC---------CCCCcc---
Q 011005          355 ARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS---------SSDPKI---  422 (496)
Q Consensus       355 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~---------~~~~~~---  422 (496)
                      ++..... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||........         ...+..   
T Consensus       173 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (364)
T cd07875         173 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  251 (364)
T ss_pred             ccccCCC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            9765332 222345689999999999999999999999999999999999999964321100         000000   


Q ss_pred             ---hhHhhhcCCC---------------CCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          423 ---MLIDVLDQRL---------------PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       423 ---~~~~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                         ........+.               ..............+.+++.+||+.||.+|||+.|+++|+|+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence               0000000000               00000000011234679999999999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.2e-40  Score=310.87  Aligned_cols=261  Identities=25%  Similarity=0.355  Sum_probs=209.8

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      ++|+..+.||+|+||.||+|..+ +++.+|+|.+...........+.+|++++++++||||+++++.+..++..++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35778889999999999999775 68899999987764445557788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS-PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      +++++|.+++....  ..++...+..++.|++.|++|||   + .+++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999999987653  36888999999999999999999   6 899999999999999999999999999987664322


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                      ..  ...++..|+|||.+.+..++.++||||+|+++|+|++|+.||......  ................+. ....  .
T Consensus       156 ~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~--~  228 (265)
T cd06605         156 AK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP--PDGIFELLQYIVNEPPPR-LPSG--K  228 (265)
T ss_pred             hh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc--cccHHHHHHHHhcCCCCC-CChh--h
Confidence            11  256788999999999999999999999999999999999998643210  000111111112111111 1111  1


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ....+.+++.+||..||++|||+.|+++++|+++.
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         229 FSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             cCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            23347799999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.6e-39  Score=310.63  Aligned_cols=255  Identities=23%  Similarity=0.397  Sum_probs=202.0

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-----CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-----PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      ++|++.+.||+|+||.||+|..     ..+..|++|.+...........+.+|+.++++++||||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4688889999999999999964     35678999999765544455678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCC--------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC
Q 011005          280 IYEYMERGSLFCNLHNNED--------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL  345 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~  345 (496)
                      ||||+++++|.+++.....              ...+++..+..++.|++.||.|||   +++++||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            9999999999998853221              224788899999999999999999   77999999999999999999


Q ss_pred             CeEEccccccccccCCCC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcc
Q 011005          346 EAFVADFGTARLLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKI  422 (496)
Q Consensus       346 ~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~  422 (496)
                      .++|+|||+++.......  ......++..|+|||++.+..++.++||||||+++|||++ |..||....        ..
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~--------~~  233 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS--------NQ  233 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--------HH
Confidence            999999999987643221  1222345678999999998889999999999999999998 998985321        11


Q ss_pred             hhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          423 MLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       423 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      ...+........+...   .....+.+++.+||+.||++||++.++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         234 EVIEMVRKRQLLPCSE---DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             HHHHHHHcCCcCCCCC---CCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence            1222222221111111   11234778999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1e-39  Score=312.08  Aligned_cols=258  Identities=22%  Similarity=0.286  Sum_probs=203.5

Q ss_pred             CCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          207 FDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      |+..+.||+|+||+||+|.+ .+++.||+|.+....  .......+.+|++++++++|+||+++++++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            66778899999999999966 468899999986543  122234567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+.+.... ...+++..+..++.|++.||.|||   +.+|+||||||+||++++++.++|+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            99999998886533 236899999999999999999999   7899999999999999999999999999997653322 


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD  443 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  443 (496)
                      ......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||.....       ...... ................
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~-------~~~~~~-~~~~~~~~~~~~~~~~  228 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE-------KVKREE-VDRRVLETEEVYSAKF  228 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH-------HHHHHH-HHHhhhccccccCccC
Confidence            22334689999999999999999999999999999999999999963211       111111 1111110000000111


Q ss_pred             HHHHHHHHHhcccCCCCCCCC-----HHHHHHHHHHhcc
Q 011005          444 ILLISTVSFACLQSNPKSRPT-----MQSVSQEFLITRK  477 (496)
Q Consensus       444 ~~~l~~li~~cl~~dP~~Rps-----~~evl~~~~~~~~  477 (496)
                      ...+.+++.+||+.||++||+     +.++++|.|+...
T Consensus       229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         229 SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             CHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            224678999999999999999     8899999998664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1e-39  Score=313.73  Aligned_cols=259  Identities=24%  Similarity=0.373  Sum_probs=209.4

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      .+|++.+.||.|++|.||+|.. .+++.|++|.+...... ..+.+.+|+.+++.++|+|++++++++...+..++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP-KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc-hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            4688899999999999999965 57899999988654322 235678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|..++...    .+++.++..++.|++.|++|||   +.+++||||+|+||+++.++.++|+|||++........
T Consensus        98 ~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          98 LAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             cCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            9999999988643    5789999999999999999999   78999999999999999999999999999886654433


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD  443 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  443 (496)
                      ......+++.|+|||.+.+..++.++||||||+++|++++|+.||.....       ............+ ... .....
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-------~~~~~~~~~~~~~-~~~-~~~~~  241 (296)
T cd06655         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALYLIATNGTP-ELQ-NPEKL  241 (296)
T ss_pred             cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhcCCc-ccC-CcccC
Confidence            33345688899999999998899999999999999999999999864221       1111111111111 000 01112


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          444 ILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       444 ~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      ...+.+++.+||..||++|||+.++++|+|+....+.
T Consensus       242 ~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~  278 (296)
T cd06655         242 SPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPL  278 (296)
T ss_pred             CHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcccc
Confidence            2347789999999999999999999999999876553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.7e-39  Score=305.58  Aligned_cols=251  Identities=23%  Similarity=0.383  Sum_probs=203.9

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      +|++.+.||+|+||.||++..+ +++.+|+|.+.........+.+.+|+.+++.++|+||+++++.+..++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788899999999999999765 688999999865443444567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      ++|+|.+.+.... ...++...++.++.|++.||.|||   +.+++|+||||+||++++++.++++|||.+.........
T Consensus        81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          81 DGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            9999998886532 235788999999999999999999   789999999999999999999999999999876544333


Q ss_pred             ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHH
Q 011005          365 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI  444 (496)
Q Consensus       365 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  444 (496)
                      .....+++.|+|||++.+..++.++|+||+|+++|+|++|+.||....       ..............+. ..   ...
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~-~~---~~~  225 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-------WKNLILKVCQGSYKPL-PS---HYS  225 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-------HHHHHHHHhcCCCCCC-Cc---ccC
Confidence            344568899999999999899999999999999999999999986321       1111222222222111 11   112


Q ss_pred             HHHHHHHHhcccCCCCCCCCHHHHHHH
Q 011005          445 LLISTVSFACLQSNPKSRPTMQSVSQE  471 (496)
Q Consensus       445 ~~l~~li~~cl~~dP~~Rps~~evl~~  471 (496)
                      ..+.+++.+||+.||++|||+.+++..
T Consensus       226 ~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         226 YELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            246789999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.3e-39  Score=308.34  Aligned_cols=259  Identities=28%  Similarity=0.448  Sum_probs=208.5

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      ++|++.+.||.|+||+||+|... ++..+++|.+.........+.+.+|+++++.++|+|++++++.+..++..++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46889999999999999999754 67889999987654333557789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+++........+++..+..++.|++.|+.|||   +.+++||||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999976543346899999999999999999999   78999999999999999999999999999987654332


Q ss_pred             C----ccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCCh
Q 011005          364 N----RTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR  438 (496)
Q Consensus       364 ~----~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  438 (496)
                      .    .....++..|+|||++... .++.++|+||||+++|+|++|+.||......       .......... +.....
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~~  229 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-------KVLMLTLQND-PPSLET  229 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-------hhHHHHhcCC-CCCcCC
Confidence            2    1334688899999998877 7889999999999999999999998643221       1111111111 111111


Q ss_pred             hH--HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          439 KV--IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       439 ~~--~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ..  ......+.+++.+||+.||++|||+.++++|+|+
T Consensus       230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            00  1122357799999999999999999999999885

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.4e-39  Score=316.26  Aligned_cols=258  Identities=23%  Similarity=0.348  Sum_probs=188.7

Q ss_pred             cceeeecCCeeEEEEEeC---CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeec--CCeEEEEEEec
Q 011005          210 RYCIGTGGYGSVYKAQLP---NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH--KKCMFLIYEYM  284 (496)
Q Consensus       210 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lV~e~~  284 (496)
                      ..+||+|+||+||+|..+   +++.||+|.+.....   ...+.+|+.++++++||||+++++++..  +...++||||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            457999999999999764   467899999865432   2446789999999999999999998854  45689999998


Q ss_pred             CCCChhhhhhCCC------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe----cCCCCeEEccccc
Q 011005          285 ERGSLFCNLHNNE------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL----NSKLEAFVADFGT  354 (496)
Q Consensus       285 ~~g~L~~~l~~~~------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~----~~~~~~kl~Dfg~  354 (496)
                      . ++|.+++....      ....++...+..++.||+.||+|||   +.+|+||||||+|||+    +.++.+||+|||+
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            6 47877765321      1235889999999999999999999   7899999999999999    4567899999999


Q ss_pred             cccccCCCC---CccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCC--cchhHhhh
Q 011005          355 ARLLHADSS---NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDP--KIMLIDVL  428 (496)
Q Consensus       355 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~--~~~~~~~~  428 (496)
                      ++.......   ......+|+.|+|||++.+. .++.++||||+||++|+|++|+.||...........+  ........
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~  238 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  238 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence            987643321   22345789999999998774 5889999999999999999999999633211000000  00000000


Q ss_pred             cC-------------CCCC----------------CCChh----HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          429 DQ-------------RLPP----------------PVDRK----VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       429 ~~-------------~~~~----------------~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ..             ..+.                .....    .......+.+++.+||+.||++|||++|+++|+|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            00             0000                00000    00001236789999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=5.4e-40  Score=320.85  Aligned_cols=260  Identities=26%  Similarity=0.326  Sum_probs=200.9

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|+||+||++..+ +++.+|+|.+....  .......+.+|+.++..++|++|+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46889999999999999999765 57789999986532  2223345788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++|+|.+++.....  .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.++|+|||++......
T Consensus        81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            99999999999976322  5788999999999999999999   789999999999999999999999999999765433


Q ss_pred             CCC-ccccccccccccccccc-----cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCC
Q 011005          362 SSN-RTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP  435 (496)
Q Consensus       362 ~~~-~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  435 (496)
                      ... ....+||+.|+|||++.     ...++.++|||||||++|||++|+.||....       .......+........
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~-------~~~~~~~i~~~~~~~~  228 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES-------LVETYGKIMNHKERFQ  228 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC-------HHHHHHHHhCCCcccc
Confidence            222 23357999999999986     3467889999999999999999999996322       1112222222111111


Q ss_pred             CChhHHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHHHHHhc
Q 011005          436 VDRKVIRDILLISTVSFACLQSNPKS--RPTMQSVSQEFLITR  476 (496)
Q Consensus       436 ~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~~~~~~  476 (496)
                      ...........+.+++.+|+..+|.+  |++++|+++|+|+..
T Consensus       229 ~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~  271 (332)
T cd05623         229 FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG  271 (332)
T ss_pred             CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence            11111111234667888888654444  789999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=8.1e-40  Score=322.88  Aligned_cols=265  Identities=23%  Similarity=0.249  Sum_probs=200.6

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecC------
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK------  274 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  274 (496)
                      ..++|++.+.||+|+||.||+|... .++.||+|++.... .......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999654 68899999987542 233346678899999999999999999988643      


Q ss_pred             CeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccc
Q 011005          275 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  354 (496)
Q Consensus       275 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  354 (496)
                      ...++||||+++ ++.+.+..     .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcc
Confidence            357999999975 66666643     4788889999999999999999   78999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCC---------CCCCc----
Q 011005          355 ARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS---------SSDPK----  421 (496)
Q Consensus       355 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~---------~~~~~----  421 (496)
                      ++..... .......+|+.|+|||++.+..++.++||||+||++|+|++|+.||........         ...+.    
T Consensus       166 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (355)
T cd07874         166 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_pred             cccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            9765332 222345789999999999999999999999999999999999999963221000         00000    


Q ss_pred             --chhHhhhcCCC---------------CCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          422 --IMLIDVLDQRL---------------PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       422 --~~~~~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                        ...........               .+............+.+++.+||+.||++|||+.|+++|+|+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence              00000000000               000000001112346799999999999999999999999999643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-40  Score=323.09  Aligned_cols=247  Identities=23%  Similarity=0.322  Sum_probs=194.8

Q ss_pred             eeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHHHHHHhh---cccccccccceeecCCeEEEEEEecCC
Q 011005          213 IGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQV---LHRNIVKLYGYCLHKKCMFLIYEYMER  286 (496)
Q Consensus       213 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lV~e~~~~  286 (496)
                      ||+|+||+||+|..+ +++.||+|.+.....  .........|..++.+.   .||||+++++++......++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999764 689999999865431  12233455677777665   699999999999999999999999999


Q ss_pred             CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCcc
Q 011005          287 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT  366 (496)
Q Consensus       287 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  366 (496)
                      |+|..++....   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.++|+|||++...........
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~  154 (330)
T cd05586          81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN  154 (330)
T ss_pred             ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence            99998887543   6899999999999999999999   78999999999999999999999999999976443333344


Q ss_pred             ccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHH
Q 011005          367 LLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDIL  445 (496)
Q Consensus       367 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  445 (496)
                      ..+||+.|+|||++.+. .++.++||||+||++|+|++|+.||....       .......+.......+...    ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~----~~~  223 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-------TQQMYRNIAFGKVRFPKNV----LSD  223 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC-------HHHHHHHHHcCCCCCCCcc----CCH
Confidence            56799999999998765 47899999999999999999999986321       1112222222222111110    122


Q ss_pred             HHHHHHHhcccCCCCCCC----CHHHHHHHHHHhc
Q 011005          446 LISTVSFACLQSNPKSRP----TMQSVSQEFLITR  476 (496)
Q Consensus       446 ~l~~li~~cl~~dP~~Rp----s~~evl~~~~~~~  476 (496)
                      .+.+++.+||+.||.+||    ++.++++|+|+..
T Consensus       224 ~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~  258 (330)
T cd05586         224 EGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD  258 (330)
T ss_pred             HHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence            466899999999999998    7999999999864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=5.1e-40  Score=320.80  Aligned_cols=260  Identities=22%  Similarity=0.312  Sum_probs=202.6

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|.+.+.||+|+||+||++..+ +++.||+|.+....  .......+.+|..++..++|++|+++++++...+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999765 67889999987532  2233455788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||++||+|.+++....  ..+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||++......
T Consensus        81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999999997632  26788999999999999999999   789999999999999999999999999999876543


Q ss_pred             CCC-cccccccccccccccccc-----CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCC
Q 011005          362 SSN-RTLLAGTYGYIAPELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP  435 (496)
Q Consensus       362 ~~~-~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  435 (496)
                      ... .....||+.|+|||++.+     ..++.++||||+|+++|+|++|+.||....       .......+.......+
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-------~~~~~~~i~~~~~~~~  228 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES-------LVETYGKIMNHEERFQ  228 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC-------HHHHHHHHHcCCCccc
Confidence            322 233568999999999876     467889999999999999999999996321       1112222222111111


Q ss_pred             CChhHHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHHHHHhc
Q 011005          436 VDRKVIRDILLISTVSFACLQSNPKS--RPTMQSVSQEFLITR  476 (496)
Q Consensus       436 ~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~~~~~~  476 (496)
                      ...........+.+++.+|+..++++  |++++++++|+|+..
T Consensus       229 ~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~  271 (331)
T cd05624         229 FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG  271 (331)
T ss_pred             CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence            11111111234678888999876554  568999999998754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-39  Score=304.65  Aligned_cols=253  Identities=25%  Similarity=0.429  Sum_probs=203.6

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      .++|++.+.||+|++|.||+|...+++.||+|.++....  ..+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            467899999999999999999887888999999876432  235688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+++.... ...+++..+..++.|++.|+.|||   +.+++||||||+||++++++.++|+|||++........
T Consensus        83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            99999999987644 336899999999999999999999   78999999999999999999999999999987653221


Q ss_pred             Cc-cccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          364 NR-TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       364 ~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                      .. .....+..|+|||.+.+..++.++||||||+++|+|++ |+.||....       ...... .+......+...   
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-------~~~~~~-~~~~~~~~~~~~---  227 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT-------NAEVLQ-QVDQGYRMPCPP---  227 (261)
T ss_pred             cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC-------HHHHHH-HHHcCCCCCCCC---
Confidence            11 11123457999999999999999999999999999999 999986321       111111 112211111111   


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          442 RDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      .....+.+++.+|++.+|++||++.++++.+.
T Consensus       228 ~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~  259 (261)
T cd05068         228 GCPKELYDIMLDCWKEDPDDRPTFETLQWKLE  259 (261)
T ss_pred             cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence            12235788999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.2e-39  Score=309.31  Aligned_cols=269  Identities=24%  Similarity=0.340  Sum_probs=207.3

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCe
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKC  276 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  276 (496)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|.+...........+.+|+.++++++|+||+++++++..+..
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999999643      2458999998765443444567889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhCCCC-------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEE
Q 011005          277 MFLIYEYMERGSLFCNLHNNED-------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFV  349 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl  349 (496)
                      .++||||+++|+|.+++.....       ....++..+..++.|++.||.|||   +++++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999975321       124567788899999999999999   789999999999999999999999


Q ss_pred             ccccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHh
Q 011005          350 ADFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLID  426 (496)
Q Consensus       350 ~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~  426 (496)
                      +|||+++........  .....++..|+|||.+.+..++.++||||||+++|||++ |..||....       .......
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~-------~~~~~~~  233 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-------NEQVLKF  233 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHH
Confidence            999999765432221  112234678999999999999999999999999999998 788885321       1111111


Q ss_pred             hhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCcccccccch
Q 011005          427 VLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDISI  491 (496)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~~~~~i~~  491 (496)
                      ...........    .....+.+++.+||+.||++|||+.++++.+...      -++.+.+|+|
T Consensus       234 ~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~------~~~~~~~~~~  288 (288)
T cd05061         234 VMDGGYLDQPD----NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD------LHPSFPEVSF  288 (288)
T ss_pred             HHcCCCCCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh------cCCCCCCCCC
Confidence            11111111111    1123578999999999999999999999887553      2445555554

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=6.8e-40  Score=313.72  Aligned_cols=266  Identities=26%  Similarity=0.411  Sum_probs=205.3

Q ss_pred             ccHHHHHHHHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceee
Q 011005          195 IVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCL  272 (496)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  272 (496)
                      +.++.+..+.++|++.+.||+|+||.||+|..+ +++.+|+|.+......  ...+.+|+.+++.+ +|+||+++++++.
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~   85 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI--DEEIEAEYNILKALSDHPNVVKFYGMYY   85 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch--HHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence            334556667889999999999999999999664 6789999987653322  25577899999999 6999999999874


Q ss_pred             -----cCCeEEEEEEecCCCChhhhhhCC-CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCC
Q 011005          273 -----HKKCMFLIYEYMERGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE  346 (496)
Q Consensus       273 -----~~~~~~lV~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~  346 (496)
                           .++..++||||+++++|.+++... .....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~  162 (286)
T cd06638          86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCC
Confidence                 345789999999999999887642 22336788999999999999999999   789999999999999999999


Q ss_pred             eEEccccccccccCCCCCcccccccccccccccccc-----CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCc
Q 011005          347 AFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPK  421 (496)
Q Consensus       347 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~  421 (496)
                      ++|+|||++..............|++.|+|||++..     ..++.++||||+|+++|+|++|+.||......       
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-------  235 (286)
T cd06638         163 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-------  235 (286)
T ss_pred             EEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-------
Confidence            999999999876543333344568999999998753     45788999999999999999999998643211       


Q ss_pred             chhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          422 IMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       422 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ...... .......... .......+.+++.+||+.||++|||+.|+++|+|+
T Consensus       236 ~~~~~~-~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         236 RALFKI-PRNPPPTLHQ-PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             HHHhhc-cccCCCcccC-CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            111111 1111111000 00112247789999999999999999999999885

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.3e-39  Score=304.95  Aligned_cols=254  Identities=27%  Similarity=0.400  Sum_probs=204.8

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeec-CCeEEEEEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH-KKCMFLIYE  282 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lV~e  282 (496)
                      +|++.+.||+|++|.||++..+ +++.||+|.+.... .....+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4888999999999999999764 57889999986543 22344568899999999999999999998764 446899999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++++|.+++.... ...+++.++..++.|++.|+++||   +.+++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            999999999987642 235899999999999999999999   7899999999999999999999999999998765443


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                      .......+++.|+|||++.+..++.++||||+|+++|++++|+.||....       .............+...    ..
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-------~~~~~~~~~~~~~~~~~----~~  225 (257)
T cd08223         157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-------MNSLVYRIIEGKLPPMP----KD  225 (257)
T ss_pred             CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHhcCCCCCc----cc
Confidence            33444568899999999999999999999999999999999999986221       11122222222222211    11


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ....+.+++.+|++.||++|||+.++++|+|+
T Consensus       226 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         226 YSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             cCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            22357799999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.6e-39  Score=304.52  Aligned_cols=253  Identities=23%  Similarity=0.360  Sum_probs=207.3

Q ss_pred             CCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          206 DFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      +|+..+.||+|+||.||.+.. .+++.+++|.+.... +....+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            478899999999999999964 468899999886543 234456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+++.... ...+++..+..++.|++.|+.|||   +.+++|+||+|+||++++++.+||+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999997653 336899999999999999999999   77999999999999999999999999999987654443


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD  443 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  443 (496)
                      ......+++.|+|||.+.+..++.++||||+|+++|+|++|..||...       ..................    ...
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-------~~~~~~~~~~~~~~~~~~----~~~  225 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT-------NPLNLVVKIVQGNYTPVV----SVY  225 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC-------CHHHHHHHHHcCCCCCCc----ccc
Confidence            334456899999999999888999999999999999999999998632       112222222222222211    111


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          444 ILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       444 ~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      ...+.+++.+||+.+|++||++.++++++|
T Consensus       226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~  255 (256)
T cd08221         226 SSELISLVHSLLQQDPEKRPTADEVLDQPL  255 (256)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence            234778999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.4e-39  Score=310.93  Aligned_cols=258  Identities=26%  Similarity=0.355  Sum_probs=204.4

Q ss_pred             CCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecC
Q 011005          207 FDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYME  285 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~  285 (496)
                      |++.+.||+|+||.||+|... ++..+++|.+..... ...+.+.+|+++++.++|+|++++++++..++..++|+||++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH-HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            677888999999999999765 477888888865432 334678899999999999999999999999999999999999


Q ss_pred             CCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCc
Q 011005          286 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR  365 (496)
Q Consensus       286 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  365 (496)
                      +++|...+....  ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++++|||++..........
T Consensus        86 ~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  160 (282)
T cd06643          86 GGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR  160 (282)
T ss_pred             CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence            999988876532  26899999999999999999999   7899999999999999999999999999997654333333


Q ss_pred             cccccccccccccccc-----cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          366 TLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       366 ~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      ....+++.|+|||++.     +..++.++||||+||++|+|++|+.||.....       ............+....  .
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~--~  231 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEPPTLAQ--P  231 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-------HHHHHHHhhcCCCCCCC--c
Confidence            4456889999999874     44577899999999999999999999863321       11111221111111000  1


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      ......+.+++.+||+.||++||++.++++|+|+.....
T Consensus       232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  270 (282)
T cd06643         232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN  270 (282)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence            112235789999999999999999999999999876544

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.7e-40  Score=328.35  Aligned_cols=260  Identities=21%  Similarity=0.260  Sum_probs=198.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      ..+|.+.+.||+|+||.||+|.++ .++.||||....       ..+.+|++++++++|+||+++++++..++..++|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            457999999999999999999765 478899996432       335689999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      ++. ++|..++....  ..+++..++.|+.|++.||.|||   ..+|+||||||+|||++.++.++|+|||+++......
T Consensus       241 ~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        241 KYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             ccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            995 68888876532  26899999999999999999999   7899999999999999999999999999998664322


Q ss_pred             CC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCC---------
Q 011005          363 SN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQR---------  431 (496)
Q Consensus       363 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------  431 (496)
                      ..  .....||+.|+|||++.+..++.++|||||||++|||++|..|+-..................+...         
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence            21  2235689999999999999999999999999999999998876422111000000001111111100         


Q ss_pred             ------------------CCCCCChhH---HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          432 ------------------LPPPVDRKV---IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       432 ------------------~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                                        .+......+   ......+.+|+.+||+.||++|||+.|+++|+|+..
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                              000000000   011124678999999999999999999999999864

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.8e-39  Score=307.83  Aligned_cols=260  Identities=23%  Similarity=0.364  Sum_probs=201.3

Q ss_pred             HHHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          202 EATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       202 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      .+++.+.....||+|+||.||+|.+. ++..|++|.+..... ...+.+.+|+.++++++|+||+++++++..++..++|
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            34566666778999999999999754 678899998876543 2346788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC-CCCeEEcccccccccc
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KLEAFVADFGTARLLH  359 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~  359 (496)
                      +||+++++|.+.+.........+...+..++.|++.||+|||   ..+++||||||+||+++. ++.++|+|||.+....
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            999999999999876432222377888899999999999999   789999999999999976 6789999999997664


Q ss_pred             CCCCCccccccccccccccccccCC--cCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          360 ADSSNRTLLAGTYGYIAPELAYTMV--MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       360 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                      ..........+++.|+|||++.+..  ++.++||||+|+++|+|++|+.||......      .............+...
T Consensus       161 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~  234 (268)
T cd06624         161 GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP------QAAMFKVGMFKIHPEIP  234 (268)
T ss_pred             cCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh------hhhHhhhhhhccCCCCC
Confidence            3333333346788999999986643  788999999999999999999998632210      00000000000111111


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      .   .....+.+++.+||+.+|++|||+.|+++|+|+
T Consensus       235 ~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         235 E---SLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             c---ccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            1   112347789999999999999999999999884

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-39  Score=304.94  Aligned_cols=250  Identities=25%  Similarity=0.429  Sum_probs=199.5

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      .+|++.+.||+|+||.||+|.++++..+|+|.+......  ...+.+|++++++++|+||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM   81 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence            358889999999999999998888888999998654321  245788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      ++++|.+++.....  .+++..++.++.|++.|++|||   +.+++||||||+||+++.++.+||+|||+++........
T Consensus        82 ~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          82 ANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             CCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            99999999876432  6899999999999999999999   789999999999999999999999999999765432211


Q ss_pred             c-cccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          365 R-TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       365 ~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                      . ....++..|+|||.+.+..++.++||||||+++|++++ |+.||.....       . ................   .
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~-~~~~~~~~~~~~~~~~---~  225 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-------S-EVVESVSAGYRLYRPK---L  225 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH-------H-HHHHHHHcCCcCCCCC---C
Confidence            1 11123457999999999999999999999999999999 8999863221       1 1111111111111111   1


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~  472 (496)
                      ....+.+++.+||..+|++|||+.|+++.+
T Consensus       226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            233578999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=8.9e-40  Score=313.24  Aligned_cols=263  Identities=25%  Similarity=0.318  Sum_probs=194.4

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh-HHHHHHHHHHHHHHHhh---cccccccccceeec-----CC
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQV---LHRNIVKLYGYCLH-----KK  275 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~  275 (496)
                      +|++.+.||+|+||+||+|..+ +++.||+|.+..... ......+.+|+.+++++   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4888999999999999999765 688999998875321 11123456777777766   69999999998864     34


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccc
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  355 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  355 (496)
                      ..++|||++.+ +|.+++..... ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCcc
Confidence            57999999975 88888875432 35899999999999999999999   789999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCC---------CCCCcchhH-
Q 011005          356 RLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS---------SSDPKIMLI-  425 (496)
Q Consensus       356 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~---------~~~~~~~~~-  425 (496)
                      ....... ......+++.|+|||++.+..++.++||||+||++|+|++|++||........         ......... 
T Consensus       156 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07863         156 RIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD  234 (288)
T ss_pred             ccccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence            8664322 22335678999999999999999999999999999999999999853211000         000000000 


Q ss_pred             -----hhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          426 -----DVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       426 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                           .........+...........+.+++.+||+.||++|||+.|+++|+|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                 0000000000000001112346799999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.9e-39  Score=305.81  Aligned_cols=253  Identities=24%  Similarity=0.371  Sum_probs=203.1

Q ss_pred             CCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccch-----hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-----ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      +|++.+.||+|+||+||+|...+++.+|+|.+....     .......+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            478889999999999999988889999999886432     123345688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      +||+++++|.+++....   .+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999997643   5788999999999999999999   77999999999999999999999999999976532


Q ss_pred             CC------CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcC-CCC
Q 011005          361 DS------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQ-RLP  433 (496)
Q Consensus       361 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~  433 (496)
                      ..      .......++..|+|||.+.+..++.++||||+|+++|++++|+.||.....       .......... ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~  227 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-------LAAMFYIGAHRGLM  227 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-------HHHHHHhhhccCCC
Confidence            11      112234578899999999999999999999999999999999999963221       1111111111 011


Q ss_pred             CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          434 PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       434 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      +....   .....+.+++.+||+.+|++||++.|+++|+|+
T Consensus       228 ~~~~~---~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         228 PRLPD---SFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCCCC---CCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            11111   112346789999999999999999999999874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=311.18  Aligned_cols=259  Identities=27%  Similarity=0.419  Sum_probs=208.0

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|++.+.||+|+||.||+|... +++.+|+|.+..... ...+.+.+|++++++++|+||+++++++..+...++|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE-EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH-HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            457899999999999999999764 688999999875543 334678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++++|.+++.....  .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (280)
T cd06611          83 FCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL  157 (280)
T ss_pred             ccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence            9999999999876432  5899999999999999999999   7799999999999999999999999999987664443


Q ss_pred             CCccccccccccccccccc-----cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          363 SNRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                      .......+++.|+|||.+.     +..++.++||||+|+++|+|++|+.||.....       ............+. ..
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~-~~  229 (280)
T cd06611         158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-------MRVLLKILKSEPPT-LD  229 (280)
T ss_pred             cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-------HHHHHHHhcCCCCC-cC
Confidence            3344456889999999875     34567799999999999999999999864321       11112221111111 00


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      . .......+.+++.+||+.+|++||++.++++|+|+...
T Consensus       230 ~-~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         230 Q-PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             C-cccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            0 11122346789999999999999999999999999766

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-39  Score=307.53  Aligned_cols=255  Identities=25%  Similarity=0.344  Sum_probs=203.3

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCC------CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCM  277 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  277 (496)
                      .++|++.+.||+|+||.||+|..++      +..||+|.+...........+.+|+.+++.++|+||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4578899999999999999997642      4689999987665444456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCC-------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEc
Q 011005          278 FLIYEYMERGSLFCNLHNNED-------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVA  350 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~  350 (496)
                      ++||||+++|+|.+++.....       ...+++..++.++.|++.||.|||   ..+++||||||+||+++.++.++|+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence            999999999999999875322       224788899999999999999999   7899999999999999999999999


Q ss_pred             cccccccccCCCC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhh
Q 011005          351 DFGTARLLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDV  427 (496)
Q Consensus       351 Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~  427 (496)
                      |||+++.......  ......++..|+|||.+.+..++.++||||||+++||+++ |+.||....       ........
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-------~~~~~~~~  234 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-------NEEVLKFV  234 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-------HHHHHHHH
Confidence            9999976543321  1223346778999999998889999999999999999998 999985321       11111111


Q ss_pred             hcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 011005          428 LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~  472 (496)
                      ...........    ....+.+++.+||+.+|++|||+.++++.+
T Consensus       235 ~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l  275 (277)
T cd05032         235 IDGGHLDLPEN----CPDKLLELMRMCWQYNPKMRPTFLEIVSSL  275 (277)
T ss_pred             hcCCCCCCCCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHh
Confidence            11111111111    133578999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.8e-39  Score=310.11  Aligned_cols=263  Identities=25%  Similarity=0.384  Sum_probs=205.6

Q ss_pred             cHHHHHHHHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeec
Q 011005          196 VYEDLIEATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLH  273 (496)
Q Consensus       196 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  273 (496)
                      +..++....+.|++.+.||+|+||.||+|.. .+++.+|+|.+.....  ....+..|+.+++++ +|+||+++++++..
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED--EEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH--HHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            3445555778999999999999999999976 4688999998865432  235678899999998 69999999999853


Q ss_pred             ------CCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCe
Q 011005          274 ------KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEA  347 (496)
Q Consensus       274 ------~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~  347 (496)
                            ....+++|||+++|+|.+++..... ..+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.+
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~  160 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEV  160 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCE
Confidence                  4578999999999999998875432 25788888999999999999999   7899999999999999999999


Q ss_pred             EEccccccccccCCCCCccccccccccccccccc-----cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcc
Q 011005          348 FVADFGTARLLHADSSNRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKI  422 (496)
Q Consensus       348 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~  422 (496)
                      +|+|||++..............|++.|+|||.+.     +..++.++||||+|+++|+|++|+.||......       .
T Consensus       161 ~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-------~  233 (282)
T cd06636         161 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-------R  233 (282)
T ss_pred             EEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-------h
Confidence            9999999876543333334456889999999876     346788999999999999999999998643211       1


Q ss_pred             hhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          423 MLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       423 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ..............   .......+.+++.+||+.||.+|||+.|+++|+|+
T Consensus       234 ~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         234 ALFLIPRNPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             hhhhHhhCCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            11111111111111   11122357899999999999999999999999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.5e-39  Score=307.30  Aligned_cols=256  Identities=25%  Similarity=0.342  Sum_probs=201.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCC------CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCM  277 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  277 (496)
                      .++|.+.+.||+|++|.||+|.+.+      +..|++|.+...........+.+|+.++++++|+||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            5679999999999999999997653      5678999887654444446788999999999999999999999998899


Q ss_pred             EEEEEecCCCChhhhhhCCCC----CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC---CeEEc
Q 011005          278 FLIYEYMERGSLFCNLHNNED----AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL---EAFVA  350 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~---~~kl~  350 (496)
                      ++||||+++++|.+++.....    ...+++..++.++.||+.||+|||   +.+++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence            999999999999999876432    235899999999999999999999   77999999999999998754   58999


Q ss_pred             cccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhh
Q 011005          351 DFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDV  427 (496)
Q Consensus       351 Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~  427 (496)
                      |||+++........  ......+..|+|||++.+..++.++|||||||++|||++ |+.||+....        ......
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--------~~~~~~  233 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--------QEVMEF  233 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHH
Confidence            99999876322211  112233567999999999999999999999999999997 9999863211        111222


Q ss_pred             hcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          428 LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      +..........   .....+.+++.+||+.+|++|||+.++++++.
T Consensus       234 ~~~~~~~~~~~---~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         234 VTGGGRLDPPK---GCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHcCCcCCCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            21111111101   11235778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-40  Score=292.62  Aligned_cols=273  Identities=22%  Similarity=0.351  Sum_probs=221.5

Q ss_pred             cHHHHHHHHhCCCCcceeeecCCeeEEEE-EeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-ccccccccceeec
Q 011005          196 VYEDLIEATEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLH  273 (496)
Q Consensus       196 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~  273 (496)
                      +|+|..+.+++.     ||+|+|+.|-.+ ...+|..||||++.+.. .....++.+|++++...+ |+||++++++|++
T Consensus        74 ~F~d~YkLt~e~-----LGeGAyasVqtcv~i~t~~EYAVKiidKq~-gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd  147 (463)
T KOG0607|consen   74 KFEDMYKLTSEL-----LGEGAYASVQTCVSIQTGKEYAVKIIDKQP-GHSRSRVFREVETFYQCQGHKNILQLIEFFED  147 (463)
T ss_pred             hHHHHHHhHHHH-----hcCccceeeeeeeeeccchhhhhhhhhcCC-chHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence            478888877754     999999999998 57789999999997763 234567889999999995 9999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCC---eEEc
Q 011005          274 KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE---AFVA  350 (496)
Q Consensus       274 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~---~kl~  350 (496)
                      +...|+|||.|.||+|..++++..   .|++.++..+.++|+.||.+||   ++||.|||+||+|||......   +|||
T Consensus       148 d~~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiC  221 (463)
T KOG0607|consen  148 DTRFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKIC  221 (463)
T ss_pred             cceEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeee
Confidence            999999999999999999998766   7999999999999999999999   889999999999999976544   7999


Q ss_pred             cccccccccCCCC-------Cccccccccccccccccc-----cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCC
Q 011005          351 DFGTARLLHADSS-------NRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSS  418 (496)
Q Consensus       351 Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~  418 (496)
                      ||.+...+.....       ...+.+|+..|||||+..     ...|+.++|.||||+|+|-|++|.+||.......=.+
T Consensus       222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW  301 (463)
T KOG0607|consen  222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW  301 (463)
T ss_pred             ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence            9999876532211       123467888999999753     2468899999999999999999999997554322111


Q ss_pred             CC-------cchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          419 DP-------KIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       419 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      +.       .....+-+...-....+..+........+++...+..|+.+|.++.++++|+|+.+-.+.
T Consensus       302 drGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  302 DRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             cCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            11       223344444444444555566666778899999999999999999999999999876554

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6.7e-39  Score=303.59  Aligned_cols=260  Identities=23%  Similarity=0.301  Sum_probs=207.3

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|+||.||+|... +|+.||+|.++...  .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999999776 78999999886422  2233567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCC-CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          282 EYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      ||+++|+|..++.... ....++...+..++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999886532 2335889999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      .........+++.|+|||.+.+..++.++||||+|+++|+|++|+.||....      .......+........+..  .
T Consensus       159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~--~  230 (267)
T cd08224         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIEKCDYPPLP--A  230 (267)
T ss_pred             CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC------ccHHHHHhhhhcCCCCCCC--h
Confidence            4333344568889999999999899999999999999999999999985321      0000111111111111111  1


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                      ......+.+++.+||..+|++|||+.++++.+...
T Consensus       231 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         231 DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            12223577899999999999999999999887543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.6e-39  Score=315.60  Aligned_cols=265  Identities=17%  Similarity=0.269  Sum_probs=197.6

Q ss_pred             Ccceeeec--CCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          209 IRYCIGTG--GYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       209 ~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      +.+.||+|  +|++||++.. ++|+.||+|.+.... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45679999  6789999965 578999999987643 2233456788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      ++|+|.+++..... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++++||+.+.........
T Consensus        82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            99999999875432 25889999999999999999999   789999999999999999999999999876543221111


Q ss_pred             -------cccccccccccccccccc--CCcCcccchhhHHHHHHHHHhCCCCCccccccCC------CCCC-----cchh
Q 011005          365 -------RTLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS------SSDP-----KIML  424 (496)
Q Consensus       365 -------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~------~~~~-----~~~~  424 (496)
                             .....++..|+|||++.+  ..++.++||||+||++|||++|+.||........      ...+     ....
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP  237 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence                   112346678999999876  4688999999999999999999999964321000      0000     0000


Q ss_pred             Hhhh---------cC----------CCCCC----CChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          425 IDVL---------DQ----------RLPPP----VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       425 ~~~~---------~~----------~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      .+..         +.          ..+..    ...........+.+++.+||+.||++|||++|+++|+|+.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence            0000         00          00000    000011122357899999999999999999999999999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.9e-39  Score=301.90  Aligned_cols=246  Identities=26%  Similarity=0.405  Sum_probs=195.3

Q ss_pred             ceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCCCh
Q 011005          211 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL  289 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g~L  289 (496)
                      +.||+|+||.||+|..+ +++.||+|.+......+....+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            35899999999999764 78899999887654444456789999999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCc--cc
Q 011005          290 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR--TL  367 (496)
Q Consensus       290 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~  367 (496)
                      .+++....  ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++..........  ..
T Consensus        81 ~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRTEG--PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            99987533  25789999999999999999999   7899999999999999999999999999987643221111  11


Q ss_pred             cccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHH
Q 011005          368 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL  446 (496)
Q Consensus       368 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  446 (496)
                      ...+..|+|||.+.+..++.++||||+|+++|||++ |..||.....        .................   .....
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--------~~~~~~~~~~~~~~~~~---~~~~~  224 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--------QQTREAIEQGVRLPCPE---LCPDA  224 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--------HHHHHHHHcCCCCCCcc---cCCHH
Confidence            123456999999999999999999999999999998 8888863221        11122222221111111   11235


Q ss_pred             HHHHHHhcccCCCCCCCCHHHHHHHH
Q 011005          447 ISTVSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       447 l~~li~~cl~~dP~~Rps~~evl~~~  472 (496)
                      +.+++.+||+.+|++|||+.|+++.+
T Consensus       225 ~~~li~~~l~~~p~~Rps~~~~~~~l  250 (252)
T cd05084         225 VYRLMERCWEYDPGQRPSFSTVHQEL  250 (252)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            77899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.9e-39  Score=304.13  Aligned_cols=254  Identities=24%  Similarity=0.386  Sum_probs=205.9

Q ss_pred             CCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          206 DFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      +|++.+.||+|+||.+|++.. .+++.||+|.+.... .....+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            588899999999999999965 468899999986532 223346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+.+..... ..+++..++.++.|++.|+.|||   +.+++|+||+|+||+++.++.++++|||++........
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            999999998875432 25788999999999999999999   78999999999999999999999999999976644332


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD  443 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  443 (496)
                      ......+++.|+|||++.+..++.++|+||||+++|++++|+.||...       ..............+....    ..
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-------~~~~~~~~~~~~~~~~~~~----~~  225 (256)
T cd08218         157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-------NMKNLVLKIIRGSYPPVSS----HY  225 (256)
T ss_pred             hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-------CHHHHHHHHhcCCCCCCcc----cC
Confidence            233345788999999999999999999999999999999999998622       1112222222222221111    11


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          444 ILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       444 ~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ...+.+++.+||+.+|++||++.++++|+|+
T Consensus       226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         226 SYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             CHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            2347789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.5e-40  Score=326.01  Aligned_cols=262  Identities=23%  Similarity=0.286  Sum_probs=201.3

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC---CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP---NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      ..+|.+.+.||+|+||.||+|...   .++.||+|.+....      ...+|++++++++||||+++++++......++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            357999999999999999999643   46789999886532      346899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      ||++. ++|.+++...   ..+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.++|+|||+++....
T Consensus       165 ~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        165 MPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             ehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            99996 5888888433   26899999999999999999999   78999999999999999999999999999976644


Q ss_pred             CCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCC------------------CCCC
Q 011005          361 DSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS------------------SSDP  420 (496)
Q Consensus       361 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~------------------~~~~  420 (496)
                      ....  .....||+.|+|||++.+..++.++||||+||++|||++|+.||........                  ....
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            3222  2245789999999999999999999999999999999999999854321100                  0000


Q ss_pred             cchhHhh---hcCCCCCCCC--hh--HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          421 KIMLIDV---LDQRLPPPVD--RK--VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       421 ~~~~~~~---~~~~~~~~~~--~~--~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      .......   .......+..  ..  .......+.+++.+||..||++|||+.|++.|+|+.+..
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence            0000000   0000000000  00  001123467899999999999999999999999997653

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.5e-39  Score=303.53  Aligned_cols=252  Identities=26%  Similarity=0.417  Sum_probs=200.9

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      .+|.+.+.||+|+||.||+|..+ .++.||+|.+.....  ....+.+|++++++++|+||+++++++...+..++||||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch--HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            45888899999999999999764 588999999875432  245688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+++.... ...+++..++.++.|++.||+|||   +.+++||||||+||++++++.++|+|||++........
T Consensus        84 ~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          84 MTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             CCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            99999999987543 235889999999999999999999   78999999999999999999999999999987643322


Q ss_pred             Cc-cccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          364 NR-TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       364 ~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                      .. ....++..|+|||.+.+..++.++||||||+++|||++ |..||....       .. ................   
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-------~~-~~~~~~~~~~~~~~~~---  228 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LS-QVYELLEKGYRMERPE---  228 (263)
T ss_pred             eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-------HH-HHHHHHHCCCCCCCCC---
Confidence            11 11223567999999999999999999999999999998 999985321       11 1111122211111111   


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          442 RDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      .....+.+++.+||+.||++|||+.++++.+.
T Consensus       229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~  260 (263)
T cd05052         229 GCPPKVYELMRACWQWNPSDRPSFAEIHQAFE  260 (263)
T ss_pred             CCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence            11235778999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=6.1e-39  Score=305.84  Aligned_cols=258  Identities=23%  Similarity=0.352  Sum_probs=200.6

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCc----EEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGK----VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      ++|++.+.||+|+||+||+|.+. +++    .+++|.+...........+..|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            56888999999999999999763 344    4788887654433445677888889999999999999998754 45778


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ++||+++|+|.+++....  ..+++..+..++.||+.||+|||   +.+++||||||+||++++++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            999999999999997543  26889999999999999999999   7799999999999999999999999999998664


Q ss_pred             CCCC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCC
Q 011005          360 ADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV  436 (496)
Q Consensus       360 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  436 (496)
                      ....  ......++..|+|||.+.+..++.++||||||+++||+++ |+.||.....        ....+.+........
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~  232 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--------HEVPDLLEKGERLAQ  232 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCcCCC
Confidence            3322  1223446778999999999999999999999999999998 9999863221        111222222111111


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      ...   ....+.+++.+||..||++|||+.|+++.+....+.+
T Consensus       233 ~~~---~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         233 PQI---CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             CCC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence            111   1224567889999999999999999999887655443

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.5e-39  Score=311.25  Aligned_cols=264  Identities=25%  Similarity=0.335  Sum_probs=202.6

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      ++|++.+.||+|++|.||+|..+ +++.||+|++..... ....+.+.+|+.++++++|+|++++++++..+...++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888999999999999999775 589999998865432 2233567899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |++++++..+.....   .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            999988887765433   5899999999999999999999   7899999999999999999999999999998775443


Q ss_pred             CCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCC----------CCCCcchh---Hhhh
Q 011005          363 SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS----------SSDPKIML---IDVL  428 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~----------~~~~~~~~---~~~~  428 (496)
                      .......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||........          ........   ....
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07847         155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF  234 (286)
T ss_pred             ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence            33334567889999999876 5678899999999999999999999964321100          00000000   0000


Q ss_pred             cC-CCCCCCChh-----HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          429 DQ-RLPPPVDRK-----VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       429 ~~-~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      .. ..+.+....     .......+.+++.+||+.||++|||+.|+++|+|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            00 001000000     00112457899999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.8e-39  Score=309.64  Aligned_cols=257  Identities=24%  Similarity=0.379  Sum_probs=203.3

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCCe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKC  276 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  276 (496)
                      .++|++.+.||+|+||.||+|...      ....+|+|.+...........+.+|+.+++++ +|+||+++++++..++.
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            467889999999999999999764      24679999987654444456788999999999 79999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhCC-------------CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC
Q 011005          277 MFLIYEYMERGSLFCNLHNN-------------EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS  343 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~  343 (496)
                      .+++|||+++|+|..++...             .....+++..++.++.|++.||+|||   ..+++||||||+||+++.
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~  167 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTE  167 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcC
Confidence            99999999999999998643             22346899999999999999999999   789999999999999999


Q ss_pred             CCCeEEccccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCC
Q 011005          344 KLEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDP  420 (496)
Q Consensus       344 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~  420 (496)
                      ++.++|+|||+++.+......  .....++..|+|||.+.+..++.++||||||+++||+++ |..||....       .
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-------~  240 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-------V  240 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC-------H
Confidence            999999999999876433211  112234568999999999999999999999999999997 999875321       1


Q ss_pred             cchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          421 KIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       421 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      . ................   .....+.+++.+||+.||++|||+.|+++++..
T Consensus       241 ~-~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~  290 (293)
T cd05053         241 E-ELFKLLKEGYRMEKPQ---NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR  290 (293)
T ss_pred             H-HHHHHHHcCCcCCCCC---CCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence            1 1111111111111111   112347789999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.1e-39  Score=309.27  Aligned_cols=256  Identities=24%  Similarity=0.369  Sum_probs=203.8

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCCe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKC  276 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  276 (496)
                      .++|.+.+.||+|+||.||+|...      .+..||+|.++........+.+.+|+++++++ +|+||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            467999999999999999999641      35579999987654444456789999999999 79999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      .++||||+.+|+|.+++..... ..+++.++..++.|++.||+|||   +.+++|+||||+||+++.++.++++|||+++
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence            9999999999999999975432 24899999999999999999999   7799999999999999999999999999998


Q ss_pred             cccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCC
Q 011005          357 LLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLP  433 (496)
Q Consensus       357 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  433 (496)
                      ........  .....++..|+|||.+.+..++.++||||+|+++|+|++ |..||.....       .............
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~  262 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV-------DSKFYKLIKEGYR  262 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-------hHHHHHHHHcCCc
Confidence            66433211  112345678999999999999999999999999999998 9999863221       1111222222111


Q ss_pred             CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          434 PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       434 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      .....   .....+.+++.+||+.+|++|||+.|+++.+.
T Consensus       263 ~~~~~---~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~  299 (302)
T cd05055         263 MAQPE---HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG  299 (302)
T ss_pred             CCCCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            11111   11235789999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-39  Score=313.05  Aligned_cols=258  Identities=23%  Similarity=0.327  Sum_probs=209.3

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhH--HHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEEL--AFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|++|+||+|... +++.||+|.+......  ...+.+.+|+++++.++|+||+++++.+...+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888999999999999999765 4899999999764322  34567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+.+++|.+++.... ...+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            9999999999987543 336899999999999999999999   789999999999999999999999999998754321


Q ss_pred             CC-----------------------------CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCcccc
Q 011005          362 SS-----------------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILS  412 (496)
Q Consensus       362 ~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~  412 (496)
                      ..                             ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            11                             0112357889999999999999999999999999999999999986322


Q ss_pred             ccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCC----HHHHHHHHHHhc
Q 011005          413 SLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPT----MQSVSQEFLITR  476 (496)
Q Consensus       413 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~evl~~~~~~~  476 (496)
                             ...............+...   .....+.+++.+||+.||++|||    ++|+++|+|+..
T Consensus       237 -------~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~  294 (316)
T cd05574         237 -------RDETFSNILKKEVTFPGSP---PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG  294 (316)
T ss_pred             -------hHHHHHHHhcCCccCCCcc---ccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence                   1222233333322222111   12345789999999999999999    999999999865

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.5e-39  Score=304.19  Aligned_cols=260  Identities=29%  Similarity=0.435  Sum_probs=213.2

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      ++|++.+.||+|++|.||+|..+ +++.|++|++...........+.+|+.++++++|+|++++++++..++..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888999999999999999776 58999999987765434557789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS-PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      +++++|.+++...   ..++...+..++.|++.|++|||   + .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            9999999999765   26899999999999999999999   7 899999999999999999999999999998775544


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                      .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....    ...............+ .....  .
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~~~~~-~~~~~--~  227 (264)
T cd06623         155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ----PSFFELMQAICDGPPP-SLPAE--E  227 (264)
T ss_pred             CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc----cCHHHHHHHHhcCCCC-CCCcc--c
Confidence            433345678899999999999999999999999999999999999864431    0111111222211111 11111  0


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ....+.+++.+||..+|++|||+.|+++++|+...
T Consensus       228 ~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         228 FSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence            23457899999999999999999999999998643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5e-39  Score=308.63  Aligned_cols=261  Identities=25%  Similarity=0.362  Sum_probs=206.6

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .+.|++.+.||+|+||.||+|... +++.|++|.+.... ....+.+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE   89 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence            367889999999999999999765 58899999987654 3345678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++++|..++....  ..+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.++|+|||++.......
T Consensus        90 ~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  164 (292)
T cd06644          90 FCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL  164 (292)
T ss_pred             cCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence            999999988876433  25789999999999999999999   7899999999999999999999999999987654333


Q ss_pred             CCccccccccccccccccc-----cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          363 SNRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                      .......+++.|+|||++.     ...++.++||||||+++|+|++|+.||.....       ............+....
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~  237 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEPPTLSQ  237 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-------HHHHHHHhcCCCccCCC
Confidence            3334456788999999985     34567899999999999999999999864321       11112221111111000


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                        .......+.+++.+||+.||++||++.|+++|+|+.....
T Consensus       238 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  277 (292)
T cd06644         238 --PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS  277 (292)
T ss_pred             --CcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence              1111224678999999999999999999999999865433

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=7.6e-39  Score=305.32  Aligned_cols=259  Identities=25%  Similarity=0.409  Sum_probs=203.8

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCc----EEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGK----VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMF  278 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  278 (496)
                      .++|++.+.||+|+||+||+|.+ .+++    .||+|.+...........+.+|+.+++.+.|+||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            35788999999999999999975 3444    48999987655444557788999999999999999999998764 467


Q ss_pred             EEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccc
Q 011005          279 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL  358 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  358 (496)
                      +++||+++|+|.+.+....  ..+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++..
T Consensus        85 l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence            9999999999999987543  26899999999999999999999   789999999999999999999999999999876


Q ss_pred             cCCCCCc--cccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCC
Q 011005          359 HADSSNR--TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP  435 (496)
Q Consensus       359 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  435 (496)
                      .......  ....+++.|+|||...+..++.++||||||+++|||++ |..||+...        .......+......+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------~~~~~~~~~~~~~~~  231 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP--------AREIPDLLEKGERLP  231 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHHCCCcCC
Confidence            4332211  11234568999999999999999999999999999998 899986321        111122222211111


Q ss_pred             CChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          436 VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       436 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      ...   .....+.+++.+||+.||++||++.++++.+......+
T Consensus       232 ~~~---~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         232 QPP---ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             CCc---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            111   12234678999999999999999999999887766655

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.3e-39  Score=310.85  Aligned_cols=265  Identities=27%  Similarity=0.378  Sum_probs=205.9

Q ss_pred             cHHHHHHHHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeec
Q 011005          196 VYEDLIEATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLH  273 (496)
Q Consensus       196 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  273 (496)
                      .+.++..+.++|.+.+.||+|+||.||+|.. .+++.+|+|.+.....  ....+.+|+.+++++ +|||++++++++..
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--VDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc--HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            3445555678999999999999999999976 4688999999865432  225567899999999 79999999999875


Q ss_pred             C-----CeEEEEEEecCCCChhhhhhCCC-CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCe
Q 011005          274 K-----KCMFLIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEA  347 (496)
Q Consensus       274 ~-----~~~~lV~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~  347 (496)
                      .     ...++||||+++++|.+++.... ....+++..++.++.|++.||.|||   ..+++|+||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence            3     35899999999999999886421 2336899999999999999999999   7799999999999999999999


Q ss_pred             EEccccccccccCCCCCccccccccccccccccccC-----CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcc
Q 011005          348 FVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM-----VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKI  422 (496)
Q Consensus       348 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~  422 (496)
                      +|+|||++..............++..|+|||.+...     .++.++||||+|+++|+|++|+.||.....       ..
T Consensus       168 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-------~~  240 (291)
T cd06639         168 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-------VK  240 (291)
T ss_pred             EEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-------HH
Confidence            999999998765433333345688899999987643     367899999999999999999999863221       11


Q ss_pred             hhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          423 MLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       423 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ......... ...... .......+.+++.+||+.+|++||++.|+++|+|+
T Consensus       241 ~~~~~~~~~-~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  290 (291)
T cd06639         241 TLFKIPRNP-PPTLLH-PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI  290 (291)
T ss_pred             HHHHHhcCC-CCCCCc-ccccCHHHHHHHHHHhhcChhhCcCHHHHhcCccc
Confidence            111111111 111100 11122347899999999999999999999999987

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.1e-39  Score=302.25  Aligned_cols=252  Identities=27%  Similarity=0.432  Sum_probs=201.9

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      .++|++.+.||+|+||.||+|..++++.||+|.+......  ...+.+|+.++++++|+||+++++++. .+..++||||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc--HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            4678999999999999999999888999999998764422  256889999999999999999999874 4568999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+++.... ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          82 MENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            99999999987543 336899999999999999999999   78999999999999999999999999999977653222


Q ss_pred             C-ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          364 N-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       364 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                      . .....++..|+|||.+.+..++.++||||||+++||+++ |+.||.....       . .....+......+...   
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~-~~~~~~~~~~~~~~~~---  226 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-------P-EVIQNLERGYRMPRPD---  226 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-------H-HHHHHHHcCCCCCCCC---
Confidence            1 222345678999999999999999999999999999999 9999863221       1 1111111111111111   


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          442 RDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      .....+.+++.+||+.+|++|||++++++.+.
T Consensus       227 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  258 (260)
T cd05067         227 NCPEELYELMRLCWKEKPEERPTFEYLRSVLE  258 (260)
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence            11235789999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.7e-39  Score=309.25  Aligned_cols=258  Identities=25%  Similarity=0.374  Sum_probs=205.7

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      .|.....||+|+||.||++... ++..||||.+..... ...+.+.+|+.+++.++|+||+++++.+..++..++||||+
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ-QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH-HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            3444566999999999999764 688999999865432 33466889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      ++++|.+++...    .+++.++..++.||+.||+|||   +.+++||||||+||++++++.++|+|||++.........
T Consensus       102 ~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~  174 (292)
T cd06658         102 EGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK  174 (292)
T ss_pred             CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence            999999988543    5788999999999999999999   779999999999999999999999999999765443333


Q ss_pred             ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHH
Q 011005          365 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI  444 (496)
Q Consensus       365 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  444 (496)
                      .....++..|+|||.+.+..++.++||||+|+++|||++|+.||.....       ..... ......+..... .....
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------~~~~~-~~~~~~~~~~~~-~~~~~  245 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP-------LQAMR-RIRDNLPPRVKD-SHKVS  245 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHH-HHHhcCCCcccc-ccccC
Confidence            3445688999999999988999999999999999999999999863221       11111 111111111111 11122


Q ss_pred             HHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          445 LLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       445 ~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      ..+.+++.+||..||.+|||++|+++|+|+....+.
T Consensus       246 ~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~  281 (292)
T cd06658         246 SVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP  281 (292)
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence            346788999999999999999999999999865544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.9e-39  Score=308.36  Aligned_cols=258  Identities=26%  Similarity=0.375  Sum_probs=200.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCC-C--cEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPN-G--KVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV  280 (496)
                      ++|++.+.||+|+||.||+|..++ +  ..+++|.++........+.+.+|+.+++++ +||||+++++++......++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578899999999999999997653 3  347888887543334456789999999999 699999999999999999999


Q ss_pred             EEecCCCChhhhhhCCC-------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCe
Q 011005          281 YEYMERGSLFCNLHNNE-------------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEA  347 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~  347 (496)
                      +||+++|+|.+++....             ....+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            99999999999987532             1125788999999999999999999   7899999999999999999999


Q ss_pred             EEccccccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHh
Q 011005          348 FVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLID  426 (496)
Q Consensus       348 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~  426 (496)
                      ||+|||++....... .......+..|+|||++.+..++.++||||||+++|||++ |..||....       .......
T Consensus       159 kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~-------~~~~~~~  230 (297)
T cd05089         159 KIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT-------CAELYEK  230 (297)
T ss_pred             EECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHH
Confidence            999999986432111 1111223457999999999899999999999999999997 999986321       1111111


Q ss_pred             hhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          427 VLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      . ..........   .....+.+++.+||+.+|.+|||++++++.+.....
T Consensus       231 ~-~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~  277 (297)
T cd05089         231 L-PQGYRMEKPR---NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE  277 (297)
T ss_pred             H-hcCCCCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1 1211111111   112347789999999999999999999888655443

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.3e-39  Score=309.05  Aligned_cols=268  Identities=28%  Similarity=0.334  Sum_probs=207.7

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeec--CCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH--KKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lV~  281 (496)
                      ++|...+.||.|++|.||+|..+ +++.+|+|.+...........+.+|++++++++||||+++++++..  .+..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788899999999999999774 6889999998765444455778999999999999999999998865  34789999


Q ss_pred             EecCCCChhhhhhCCC-CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          282 EYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      ||+++++|.+++.... ....++...+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            9999999988875422 2335788999999999999999999   78999999999999999999999999999876533


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh-
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK-  439 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  439 (496)
                      ..  .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||+.....  ................+...... 
T Consensus       158 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd06621         158 SL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP--PLGPIELLSYIVNMPNPELKDEPG  233 (287)
T ss_pred             cc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC--CCChHHHHHHHhcCCchhhccCCC
Confidence            22  22345788999999999999999999999999999999999999744220  01111111111111111100000 


Q ss_pred             -HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          440 -VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       440 -~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                       .......+.+++.+||+.+|++|||+.|+++|+|+.+...
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  274 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK  274 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence             0122345789999999999999999999999999955543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-39  Score=310.50  Aligned_cols=264  Identities=22%  Similarity=0.305  Sum_probs=199.2

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      ++|++.+.||+|++|.||+|..+ +++.||+|.+...........+.+|++++++++|+||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57889999999999999999765 68899999986543222224467899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +.+ +|.+++.....  .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||+++.......
T Consensus        85 ~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            985 89988875432  6788999999999999999999   78999999999999999999999999999876533222


Q ss_pred             Ccccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCC----------CCCCcch--hH---hh
Q 011005          364 NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS----------SSDPKIM--LI---DV  427 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~----------~~~~~~~--~~---~~  427 (496)
                      ......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||........          .......  ..   ..
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence            2233456789999999876 4578899999999999999999999863321000          0000000  00   00


Q ss_pred             hcCCCCCCCChh------HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          428 LDQRLPPPVDRK------VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       428 ~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ............      .......+.+++.+||+.+|++|||+.|+++|+|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            000000000000      00001346789999999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=9e-39  Score=302.76  Aligned_cols=259  Identities=21%  Similarity=0.294  Sum_probs=205.2

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|++|.||+|.. .+++.+|+|.+....  .......+.+|+.+++.++|+||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688889999999999999975 578999999886532  2334467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCC-CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          282 EYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      ||+++++|.+++.... ....+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999999886422 2336899999999999999999999   78999999999999999999999999999877654


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      .........++..|+|||.+.+..++.++||||+|+++|+|++|..||.....     ..............++...   
T Consensus       159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~---  230 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEQCDYPPLPS---  230 (267)
T ss_pred             CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-----hHHHHhhhhhcCCCCCCCc---
Confidence            43333345688899999999998999999999999999999999999853211     0011111111111111111   


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ......+.+++.+||+.||++|||+.+|++.+..
T Consensus       231 ~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         231 DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence            1123357899999999999999999999887643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=9.3e-39  Score=306.10  Aligned_cols=258  Identities=25%  Similarity=0.418  Sum_probs=203.8

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMF  278 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  278 (496)
                      .+|.+.+.||+|+||.||++...      ++..+|+|.+..... ...+.+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            56888999999999999999642      345689998876543 33467899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCC----------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeE
Q 011005          279 LIYEYMERGSLFCNLHNNE----------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF  348 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~k  348 (496)
                      +||||+++++|.+++....          ....+++..++.++.|++.||+|||   ..+++||||||+||++++++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence            9999999999999987432          1224899999999999999999999   78999999999999999999999


Q ss_pred             EccccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhH
Q 011005          349 VADFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLI  425 (496)
Q Consensus       349 l~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~  425 (496)
                      |+|||+++........  .....++..|+|||++.+..++.++||||||+++|+|++ |..||....       ......
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~-------~~~~~~  233 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-------NNEVIE  233 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHH
Confidence            9999999765432211  122335678999999999999999999999999999998 899986322       111122


Q ss_pred             hhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          426 DVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ............    .....+.+++.+||+.||.+|||+.|+++.+....+
T Consensus       234 ~i~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         234 CITQGRVLQRPR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHHcCCcCCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            222222111111    112347899999999999999999999888766543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.1e-38  Score=303.86  Aligned_cols=255  Identities=30%  Similarity=0.450  Sum_probs=207.5

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      +-|+..+.||+|+||.||+|.. .+++.||+|.+.........+.+.+|+.++++++||||+++++++..+...++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            3477788999999999999965 468899999886554444456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+++...    .+++..+..++.|++.|+.+||   ..+++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          84 LGGGSALDLLEPG----PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            9999999988643    5789999999999999999999   78999999999999999999999999999876644333


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD  443 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  443 (496)
                      ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.....       . .....+.....+....   ..
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~-~~~~~~~~~~~~~~~~---~~  225 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-------M-KVLFLIPKNNPPTLEG---NY  225 (277)
T ss_pred             hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-------H-HHHHHHhcCCCCCCCc---cc
Confidence            33345678899999999888889999999999999999999999863221       1 1111111111111111   11


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          444 ILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       444 ~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ...+.+++.+||+.+|++||++.++++|+|+.+.
T Consensus       226 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         226 SKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence            2346789999999999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.1e-39  Score=307.86  Aligned_cols=255  Identities=24%  Similarity=0.351  Sum_probs=200.3

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMF  278 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  278 (496)
                      .+|.+.+.||+|+||.||+|...      .++.||+|++...........+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            34777888999999999999753      357899999986554444567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCC-------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC
Q 011005          279 LIYEYMERGSLFCNLHNNE-------------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL  345 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~  345 (496)
                      +++||+.+++|.+++....             ....+++..+..++.|++.||+|+|   +++++||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence            9999999999999885321             1224788889999999999999999   78999999999999999999


Q ss_pred             CeEEccccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcc
Q 011005          346 EAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKI  422 (496)
Q Consensus       346 ~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~  422 (496)
                      .+||+|||+++........  .....+++.|+|||.+.+..++.++||||+|+++|||++ |..||....       ...
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-------~~~  234 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-------NQD  234 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-------HHH
Confidence            9999999998765432211  122345678999999998889999999999999999998 888875321       111


Q ss_pred             hhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          423 MLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       423 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      ............ ...   .....+.+++.+||+.+|++||++.++++.+.
T Consensus       235 ~~~~i~~~~~~~-~~~---~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         235 VIEMIRNRQVLP-CPD---DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             HHHHHHcCCcCC-CCC---CCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence            222222222211 111   12234778999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=6.3e-39  Score=318.75  Aligned_cols=259  Identities=23%  Similarity=0.363  Sum_probs=203.1

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-ccccccccceeecCC
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKK  275 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  275 (496)
                      ..++|.+.+.||+|+||.||+|.+.      .++.||+|++.........+.+.+|++++.++. ||||+++++++...+
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3456888899999999999999753      346899999986544444457889999999997 999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhCCCC---------------------------------------------------------
Q 011005          276 CMFLIYEYMERGSLFCNLHNNED---------------------------------------------------------  298 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~---------------------------------------------------------  298 (496)
                      ..++||||+++|+|.++++....                                                         
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            99999999999999999875321                                                         


Q ss_pred             --------------------------------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceE
Q 011005          299 --------------------------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNIL  340 (496)
Q Consensus       299 --------------------------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil  340 (496)
                                                            ...+++..++.++.|++.||+|||   ..+++||||||+||+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEE
Confidence                                                  123677788999999999999999   789999999999999


Q ss_pred             ecCCCCeEEccccccccccCCCC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCC
Q 011005          341 LNSKLEAFVADFGTARLLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSS  417 (496)
Q Consensus       341 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~  417 (496)
                      +++++.++|+|||+++.......  ......+++.|+|||.+.+..++.++||||||+++|||++ |..||....     
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~-----  346 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP-----  346 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC-----
Confidence            99999999999999986533221  1222356788999999999889999999999999999998 889985321     


Q ss_pred             CCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          418 SDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                        ........+..........   .....+.+++.+||..+|++||+++|+++.+..
T Consensus       347 --~~~~~~~~~~~~~~~~~p~---~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~  398 (401)
T cd05107         347 --MNEQFYNAIKRGYRMAKPA---HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD  398 (401)
T ss_pred             --chHHHHHHHHcCCCCCCCC---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence              1111122222211111111   112357889999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=9.7e-39  Score=306.45  Aligned_cols=259  Identities=25%  Similarity=0.411  Sum_probs=205.6

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMF  278 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  278 (496)
                      .+|.+.+.||+|+||.||+|...      ++..+++|.+..... ...+.+.+|+.++++++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            45888899999999999999642      355688898865443 23466889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCC-------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC
Q 011005          279 LIYEYMERGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL  345 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~  345 (496)
                      +||||+++++|.+++.....             ...+++..++.++.||+.|++|||   .++++||||||+||+++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCC
Confidence            99999999999999875421             235899999999999999999999   78999999999999999999


Q ss_pred             CeEEccccccccccCCCC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcc
Q 011005          346 EAFVADFGTARLLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKI  422 (496)
Q Consensus       346 ~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~  422 (496)
                      .++|+|||++........  ......++..|+|||++.+..++.++||||||+++|||++ |+.||.....       ..
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-------~~  233 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-------TE  233 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HH
Confidence            999999999976543221  1223456788999999999999999999999999999999 9999853221       11


Q ss_pred             hhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          423 MLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       423 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ..............    ...+..+.+++.+||+.||++|||+.++++.+....+.
T Consensus       234 ~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         234 VIECITQGRVLERP----RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HHHHHhCCCCCCCC----ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            11112222221111    11223577999999999999999999999999877553

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3e-39  Score=339.90  Aligned_cols=266  Identities=23%  Similarity=0.350  Sum_probs=204.9

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeec--CCeEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH--KKCMF  278 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~  278 (496)
                      ..++|.+.+.||+|+||+||+|.+. .+..||+|.+.... .......+..|+.+++.++||||++++++|..  ...++
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            4578999999999999999999765 57788999886532 23345678899999999999999999998854  45789


Q ss_pred             EEEEecCCCChhhhhhCCC-CCccCCHHHHHHHHHHHHHHHHHHHhCC----CCCeEEeCCCCCceEecC----------
Q 011005          279 LIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDC----SPSIIHRDISSNNILLNS----------  343 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~----~~~i~H~dlkp~Nil~~~----------  343 (496)
                      +||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+..    ..+|+||||||+|||++.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            9999999999999987532 2236899999999999999999999531    146999999999999964          


Q ss_pred             -------CCCeEEccccccccccCCCCCcccccccccccccccccc--CCcCcccchhhHHHHHHHHHhCCCCCcccccc
Q 011005          344 -------KLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSL  414 (496)
Q Consensus       344 -------~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~p~~~~~~~  414 (496)
                             .+.+||+|||++..+.... ......||+.|+|||++.+  ..++.++|||||||++|+|++|+.||..... 
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~-  248 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN-  248 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc-
Confidence                   2348999999998664332 2234578999999999864  4588999999999999999999999963221 


Q ss_pred             CCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          415 SSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       415 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                            .......+......+..    .....+.+|+..||+.+|++||++.|++++.|+....+.
T Consensus       249 ------~~qli~~lk~~p~lpi~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p  304 (1021)
T PTZ00266        249 ------FSQLISELKRGPDLPIK----GKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP  304 (1021)
T ss_pred             ------HHHHHHHHhcCCCCCcC----CCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence                  11111122111111111    112347789999999999999999999999999765443

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=8.9e-39  Score=306.83  Aligned_cols=265  Identities=25%  Similarity=0.371  Sum_probs=213.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.+++.++|||++++++++...+..++|+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   96 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP-KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME   96 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch-HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence            36799999999999999999965 46789999998654322 23567899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++++|.+++.+.    .+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        97 ~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          97 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             cCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            99999999998753    4788899999999999999999   7899999999999999999999999999987665444


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                      .......+++.|+|||.+.+..++.++||||||+++|++++|+.||.......       ..........+ .. .....
T Consensus       170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~-------~~~~~~~~~~~-~~-~~~~~  240 (293)
T cd06647         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYLIATNGTP-EL-QNPEK  240 (293)
T ss_pred             cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh-------heeehhcCCCC-CC-CCccc
Confidence            33444568889999999988889999999999999999999999996432210       00000000000 00 01111


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCccc
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAA  485 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~~  485 (496)
                      ....+.+++.+||+.+|++||++.++++|.|+....+..+-+.
T Consensus       241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~~  283 (293)
T cd06647         241 LSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTP  283 (293)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccccccc
Confidence            2234778999999999999999999999999998887765543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.4e-39  Score=302.95  Aligned_cols=252  Identities=27%  Similarity=0.425  Sum_probs=202.2

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--------hHHHHHHHHHHHHHHHhhcccccccccceeecCCe
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--------ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKC  276 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  276 (496)
                      +|.+...||+|++|.||+|... +++.||+|.+....        .....+.+.+|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4778889999999999999754 68899999886432        11233567899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      .++||||+++++|.+++....   .++...+..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||.++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            999999999999999997643   5788899999999999999999   7799999999999999999999999999998


Q ss_pred             cccCCCC------CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcC
Q 011005          357 LLHADSS------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQ  430 (496)
Q Consensus       357 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  430 (496)
                      .......      ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.....       ..........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~  227 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-------LQAIFKIGEN  227 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-------HHHHHHHhcc
Confidence            7653211      11223578899999999998999999999999999999999999963221       1111111111


Q ss_pred             CCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          431 RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       431 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ..+. ..   ......+.+++.+||+.||.+||++.|+++++|+
T Consensus       228 ~~~~-~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         228 ASPE-IP---SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             CCCc-CC---cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            1111 11   1122357789999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=9.4e-39  Score=306.41  Aligned_cols=256  Identities=25%  Similarity=0.405  Sum_probs=201.6

Q ss_pred             CCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      +|++.+.||+|+||.||+|...      ....+++|.+...........+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999653      2357889988765544445778999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCC---------------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCc
Q 011005          280 IYEYMERGSLFCNLHNNE---------------------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNN  338 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~N  338 (496)
                      |+||+.+|+|.+++....                     ....+++..++.++.|++.||.|||   +.+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            999999999999876421                     1124788999999999999999999   7899999999999


Q ss_pred             eEecCCCCeEEccccccccccCCCC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccC
Q 011005          339 ILLNSKLEAFVADFGTARLLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLS  415 (496)
Q Consensus       339 il~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~  415 (496)
                      |++++++.++|+|||+++.......  ......++..|+|||.+.+..++.++||||||+++|||++ |..||....   
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---  234 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA---  234 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence            9999999999999999976533221  1122345678999999998899999999999999999998 999985321   


Q ss_pred             CCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          416 SSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                           .....+........+...   .....+.+++.+||+.+|++||+++|+++.+...
T Consensus       235 -----~~~~~~~~~~~~~~~~~~---~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         235 -----PERLFNLLKTGYRMERPE---NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             -----HHHHHHHHhCCCCCCCCC---CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence                 112222222221111111   1123477899999999999999999999987643

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1e-38  Score=301.15  Aligned_cols=252  Identities=27%  Similarity=0.457  Sum_probs=200.8

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      .++|++.+.||+|+||.||+|..+++..+|+|.+......  .+.+.+|+.++++++|+|++++++++.. ...++||||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY   81 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC--HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence            3578999999999999999999888889999998764322  2568899999999999999999998854 457899999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+++.... ...+++..+..++.|++.||.|||   +.+++||||||+||++++++.++|+|||++........
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          82 MSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             cCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            99999999987643 235799999999999999999999   77999999999999999999999999999987643322


Q ss_pred             C-ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          364 N-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       364 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                      . .....++..|+|||.+.+..++.++||||||+++|+|++ |..||....       .. ...+.+......+...   
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-------~~-~~~~~~~~~~~~~~~~---  226 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-------NR-EVLEQVERGYRMPCPQ---  226 (260)
T ss_pred             ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-------HH-HHHHHHHcCCCCCCCC---
Confidence            1 112234567999999998899999999999999999999 899986321       11 1222222221211111   


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          442 RDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      .....+.+++.+|+..+|++|||+.++.+.+.
T Consensus       227 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  258 (260)
T cd05070         227 DCPISLHELMLQCWKKDPEERPTFEYLQSFLE  258 (260)
T ss_pred             cCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence            12235789999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.1e-39  Score=336.90  Aligned_cols=256  Identities=26%  Similarity=0.401  Sum_probs=198.3

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|+||.||+|... +++.||+|++....  .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57899999999999999999765 58999999987532  2334467899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCC--------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccc
Q 011005          282 EYMERGSLFCNLHNNE--------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG  353 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~--------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  353 (496)
                      ||++||+|.+++....        .....++..++.++.||+.||+|||   +.+|+||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999886421        1224567788999999999999999   7799999999999999999999999999


Q ss_pred             ccccccCCCC------------------CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccC
Q 011005          354 TARLLHADSS------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS  415 (496)
Q Consensus       354 ~~~~~~~~~~------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~  415 (496)
                      +++.......                  .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...... 
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~-  237 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR-  237 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence            9986621110                  011246899999999999999999999999999999999999999642110 


Q ss_pred             CCCCCcchhHhhhcCCCCCCCC-hhHHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHHHH
Q 011005          416 SSSDPKIMLIDVLDQRLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPT-MQSVSQEFL  473 (496)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~~~~  473 (496)
                           .....    .....+.. ......+..+.+++.+|++.||++||+ ++++++.+.
T Consensus       238 -----ki~~~----~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le  288 (932)
T PRK13184        238 -----KISYR----DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLE  288 (932)
T ss_pred             -----hhhhh----hhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                 00001    11110000 001112234778999999999999975 555555443

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.9e-39  Score=310.88  Aligned_cols=257  Identities=25%  Similarity=0.380  Sum_probs=199.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCc--EEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGK--VFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  279 (496)
                      .++|++.+.||+|+||.||+|.++ ++.  .+++|.+...........+.+|++++.++ +|+||+++++++...+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            357889999999999999999764 444  46777776543344456788999999999 89999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCC-------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCC
Q 011005          280 IYEYMERGSLFCNLHNNE-------------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE  346 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~  346 (496)
                      ||||+++|+|.+++....             ....+++.+++.++.|++.|++|||   +.+++||||||+||+++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence            999999999999987542             1235789999999999999999999   789999999999999999999


Q ss_pred             eEEccccccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhH
Q 011005          347 AFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLI  425 (496)
Q Consensus       347 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~  425 (496)
                      ++|+|||++...... .......++..|+|||++.+..++.++||||||+++|||+| |..||.....       ... .
T Consensus       163 ~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~~-~  233 (303)
T cd05088         163 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AEL-Y  233 (303)
T ss_pred             EEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-------HHH-H
Confidence            999999998643211 11112234567999999988889999999999999999998 9999853211       111 1


Q ss_pred             hhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          426 DVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                      +............   .....+.+++.+||+.+|++||+++++++.+...
T Consensus       234 ~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         234 EKLPQGYRLEKPL---NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             HHHhcCCcCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1111111111111   1123467899999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=317.67  Aligned_cols=253  Identities=25%  Similarity=0.393  Sum_probs=207.2

Q ss_pred             eeeecCCeeEEEEEeCC-CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCCChh
Q 011005          212 CIGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLF  290 (496)
Q Consensus       212 ~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g~L~  290 (496)
                      .||+|.||+||-|++.+ ...+|||-+....+ .+.+.+.+|+.+.++++|.|||+++|.+.+++..-+.||-.+||+|.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            59999999999997654 55789999877654 34577899999999999999999999999999999999999999999


Q ss_pred             hhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEec-CCCCeEEccccccccccCCCCCccccc
Q 011005          291 CNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN-SKLEAFVADFGTARLLHADSSNRTLLA  369 (496)
Q Consensus       291 ~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~  369 (496)
                      +++...=..-.-++.++-.+.+||++||.|||   ...|||||||-+|||++ -.|.+||+|||-++++..-.....++.
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT  737 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT  737 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence            99976432223367777789999999999999   77999999999999995 579999999999999877777777889


Q ss_pred             cccccccccccccC--CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHH
Q 011005          370 GTYGYIAPELAYTM--VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLI  447 (496)
Q Consensus       370 gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  447 (496)
                      ||..|||||++..+  .|..++|||||||++.||.||++||-.+...      ......+=-.+..++...   ......
T Consensus       738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp------qAAMFkVGmyKvHP~iPe---elsaea  808 (1226)
T KOG4279|consen  738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP------QAAMFKVGMYKVHPPIPE---ELSAEA  808 (1226)
T ss_pred             cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh------hHhhhhhcceecCCCCcH---HHHHHH
Confidence            99999999999865  5888999999999999999999999654321      111111111222333322   222346


Q ss_pred             HHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          448 STVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       448 ~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ..++.+|+.+||.+||++.++++.+|....
T Consensus       809 k~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  809 KNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             HHHHHHHcCCCcccCccHHHhccCcccccC
Confidence            789999999999999999999999998766

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=7.2e-39  Score=307.18  Aligned_cols=251  Identities=26%  Similarity=0.390  Sum_probs=207.0

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|+||.||++... +++.||+|.+....  .....+.+.+|++++++++||||+++++++..+...++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46889999999999999999764 68999999987543  2233466889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++++|.+++....   .++...+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            9999999999987653   6889999999999999999999   789999999999999999999999999999876433


Q ss_pred             CCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                         .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||....       ...............+..    
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~----  220 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-------PIQIYEKILEGKVRFPSF----  220 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhcCCccCCcc----
Confidence               234468899999999988888999999999999999999999986322       111222222222221111    


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHhc
Q 011005          442 RDILLISTVSFACLQSNPKSRP-----TMQSVSQEFLITR  476 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~~~~~~  476 (496)
                       ....+.+++.+||..||.+|+     +++|+++|+|+..
T Consensus       221 -~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~  259 (290)
T cd05580         221 -FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG  259 (290)
T ss_pred             -CCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccccc
Confidence             123567899999999999999     8999999998744

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.9e-38  Score=297.51  Aligned_cols=245  Identities=24%  Similarity=0.381  Sum_probs=196.1

Q ss_pred             eeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCCChhh
Q 011005          212 CIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFC  291 (496)
Q Consensus       212 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g~L~~  291 (496)
                      .||+|+||.||+|..++++.+|+|.+...........+.+|++++++++||||+++++++......++||||+++++|.+
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   81 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS   81 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence            58999999999999888999999998765444444568899999999999999999999999999999999999999999


Q ss_pred             hhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCc-ccccc
Q 011005          292 NLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR-TLLAG  370 (496)
Q Consensus       292 ~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~g  370 (496)
                      ++....  ..+++..+..++.|++.||.|+|   ..+++||||+|+||+++.++.++++|||++.......... ....+
T Consensus        82 ~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          82 FLRKKK--DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             HHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence            887543  25789999999999999999999   7899999999999999999999999999987543222111 12234


Q ss_pred             ccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHH
Q 011005          371 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLIST  449 (496)
Q Consensus       371 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  449 (496)
                      +..|+|||++.+..++.++||||||+++|++++ |..||.....       ...... ...........   .....+.+
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-------~~~~~~-~~~~~~~~~~~---~~~~~~~~  225 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-------QQAREQ-VEKGYRMSCPQ---KCPDDVYK  225 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-------HHHHHH-HHcCCCCCCCC---CCCHHHHH
Confidence            567999999998899999999999999999998 9999863221       111111 11111111101   11235788


Q ss_pred             HHHhcccCCCCCCCCHHHHHHHH
Q 011005          450 VSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       450 li~~cl~~dP~~Rps~~evl~~~  472 (496)
                      ++.+||+.+|++||++.|+++.+
T Consensus       226 li~~~l~~~p~~Rp~~~~l~~~l  248 (250)
T cd05085         226 VMQRCWDYKPENRPKFSELQKEL  248 (250)
T ss_pred             HHHHHcccCcccCCCHHHHHHHh
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1e-38  Score=301.47  Aligned_cols=252  Identities=26%  Similarity=0.403  Sum_probs=199.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      .++|++.+.||+|+||+||+|.++++..||+|++.....  ....+.+|++++++++|+||+++++.+.. ...++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   81 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence            357999999999999999999887777899999875432  12567899999999999999999998754 457899999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++|+|.+++.... ...+++..+..++.|++.||+|||   +.+++|+||||+||++++++.++|+|||.+........
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          82 MSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             CCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            99999999997542 235789999999999999999999   78999999999999999999999999999976643332


Q ss_pred             Cc-cccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          364 NR-TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       364 ~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                      .. ....++..|+|||+..+..++.++||||||+++|+|++ |+.||....       ......... .....+..   .
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~-------~~~~~~~~~-~~~~~~~~---~  226 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVLDQVE-RGYRMPCP---P  226 (262)
T ss_pred             ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-------hHHHHHHHh-cCCCCCCc---c
Confidence            21 22345678999999998899999999999999999999 888885321       111111111 11111111   1


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          442 RDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      .....+.+++.+|++.||++||++.++++.+.
T Consensus       227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~  258 (262)
T cd05071         227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE  258 (262)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence            22335789999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-39  Score=309.96  Aligned_cols=260  Identities=22%  Similarity=0.322  Sum_probs=198.8

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCC---------------CcEEEEEEcccchhHHHHHHHHHHHHHHHhhccccccccc
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPN---------------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY  268 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~  268 (496)
                      ..+|.+.+.||+|+||.||+|...+               ...||+|.++..........+.+|++++++++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3579999999999999999986532               2358999987654444456789999999999999999999


Q ss_pred             ceeecCCeEEEEEEecCCCChhhhhhCCCC---------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCce
Q 011005          269 GYCLHKKCMFLIYEYMERGSLFCNLHNNED---------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  339 (496)
Q Consensus       269 ~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Ni  339 (496)
                      +++......++||||+++++|.+++.....         ...+++..++.++.|++.||+|||   +.+++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhE
Confidence            999999999999999999999998865321         124688899999999999999999   78999999999999


Q ss_pred             EecCCCCeEEccccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh--CCCCCccccccC
Q 011005          340 LLNSKLEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM--GKHPRDILSSLS  415 (496)
Q Consensus       340 l~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~--g~~p~~~~~~~~  415 (496)
                      ++++++.+||+|||++.........  .....++..|+|||.+.+..++.++||||||+++|+|++  |..||.......
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            9999999999999999765432211  122344678999999999999999999999999999998  566765322100


Q ss_pred             CCCCCcchhHhhhc---CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          416 SSSDPKIMLIDVLD---QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       416 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                          ......+...   .........   ..+..+.+++.+||+.||++|||++++++.+.
T Consensus       241 ----~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 ----VIENTGEFFRNQGRQIYLSQTP---LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             ----HHHHHHHhhhhccccccCCCCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence                0000000000   100000000   11235789999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=303.90  Aligned_cols=256  Identities=29%  Similarity=0.466  Sum_probs=206.7

Q ss_pred             CCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc---ccccccccceeecCCeEEEEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL---HRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lV~  281 (496)
                      .|+..+.||+|+||.||+|.+ .+++.||+|.+...........+.+|+.++++++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477788899999999999975 5789999999876544444567889999999997   999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++++|.+++...    .+++..++.++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            999999999988653    6889999999999999999999   789999999999999999999999999999877554


Q ss_pred             CCCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          362 SSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      ........|+..|+|||.+.++ .++.++|+||||+++|+|++|+.||.......       .. .......++..... 
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-------~~-~~~~~~~~~~~~~~-  225 (277)
T cd06917         155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-------AM-MLIPKSKPPRLEDN-  225 (277)
T ss_pred             ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-------hh-hccccCCCCCCCcc-
Confidence            4334445788999999988754 56889999999999999999999996432211       00 11111111111110 


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                       .....+.+++.+||+.||++||++.|++++.|+....
T Consensus       226 -~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         226 -GYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             -cCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence             0223577899999999999999999999999996654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.5e-39  Score=309.52  Aligned_cols=263  Identities=22%  Similarity=0.290  Sum_probs=197.7

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      +|++.+.||+|+||.||+|..+ +|+.||+|.+..... ......+.+|++++++++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999764 688999999865321 22234567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      ++ ++|.+++....  ..+++..++.++.||++||.|||   ..+++||||||+||+++.++.++|+|||+++.......
T Consensus        81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            97 47877776432  25899999999999999999999   78999999999999999999999999999986644333


Q ss_pred             CccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCC----------CCCCcc--hhHhhhcC
Q 011005          364 NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS----------SSDPKI--MLIDVLDQ  430 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~----------~~~~~~--~~~~~~~~  430 (496)
                      ......+++.|+|||.+.+. .++.++||||+|+++|+|++|+.|+........          ......  ........
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            33345678899999998765 468899999999999999999998632111000          000000  00000000


Q ss_pred             CCCCCCC-h-----hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          431 RLPPPVD-R-----KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       431 ~~~~~~~-~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ....... .     ........+.+++.+||+.||.+|||++|+++|+|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            0000000 0     000112346789999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.1e-38  Score=308.49  Aligned_cols=260  Identities=23%  Similarity=0.359  Sum_probs=203.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC--------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecC
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP--------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHK  274 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  274 (496)
                      .++|.+.+.||+|+||.||+|...        +...+|+|.+...........+.+|+.+++++ +|+||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            357999999999999999999652        23579999998654334456788899999999 799999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhCCCC-------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe
Q 011005          275 KCMFLIYEYMERGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL  341 (496)
Q Consensus       275 ~~~~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~  341 (496)
                      +..++||||+++|+|.+++.....             ...+++.+++.++.|++.||+|||   +.+++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence            999999999999999999976432             125889999999999999999999   7799999999999999


Q ss_pred             cCCCCeEEccccccccccCCCCCc--cccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCC
Q 011005          342 NSKLEAFVADFGTARLLHADSSNR--TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSS  418 (496)
Q Consensus       342 ~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~  418 (496)
                      +.++.++|+|||.++.........  ....+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||....      
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------  247 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------  247 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC------
Confidence            999999999999997654322111  11224568999999999999999999999999999998 888875211      


Q ss_pred             CCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          419 DPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                        .......+......+...   .....+.+++.+||..+|++|||+.++++.+.....
T Consensus       248 --~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         248 --VEELFKLLKEGHRMDKPS---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             --HHHHHHHHHcCCCCCCCC---cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence              111222222221111111   112357789999999999999999999999876544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6.6e-39  Score=308.39  Aligned_cols=260  Identities=23%  Similarity=0.357  Sum_probs=199.8

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-----------------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhccccccc
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-----------------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK  266 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~  266 (496)
                      .++|++.+.||+|+||.||++...                 ++..||+|.+...........+.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            357999999999999999998543                 244689999876544444567899999999999999999


Q ss_pred             ccceeecCCeEEEEEEecCCCChhhhhhCCCC--------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCc
Q 011005          267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNED--------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNN  338 (496)
Q Consensus       267 ~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~N  338 (496)
                      +++++...+..++||||+++|+|.+++.....        ...+++..+..++.|++.||+|||   +.+++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhe
Confidence            99999999999999999999999999876421        124778889999999999999999   7799999999999


Q ss_pred             eEecCCCCeEEccccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh--CCCCCcccccc
Q 011005          339 ILLNSKLEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM--GKHPRDILSSL  414 (496)
Q Consensus       339 il~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~--g~~p~~~~~~~  414 (496)
                      |+++.++.++|+|||+++.+......  .....+++.|+|||...+..++.++||||||+++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            99999999999999999765432211  122334678999999888889999999999999999998  77887532211


Q ss_pred             CCCCCCcchhHhhhcC---CCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          415 SSSSDPKIMLIDVLDQ---RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       415 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      ..    ..........   ....+...   .....+.+++.+||+.||++||++.|+++.+.
T Consensus       241 ~~----~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         241 QV----IENTGEFFRDQGRQVYLPKPA---LCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HH----HHHHHHHHhhccccccCCCCC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            00    0000010000   00000000   11235779999999999999999999998763

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.7e-38  Score=306.83  Aligned_cols=259  Identities=23%  Similarity=0.361  Sum_probs=203.6

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe--------CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecC
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL--------PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHK  274 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  274 (496)
                      .++|.+.+.||+|+||.||+|..        .++..||+|.+.........+.+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            46788999999999999999964        134579999987654444457789999999999 799999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhCCCC-------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe
Q 011005          275 KCMFLIYEYMERGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL  341 (496)
Q Consensus       275 ~~~~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~  341 (496)
                      ...++||||+++|+|.+++.....             ...+++..+..++.||+.||+|||   +.+++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence            999999999999999999875421             235788899999999999999999   7899999999999999


Q ss_pred             cCCCCeEEccccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCC
Q 011005          342 NSKLEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSS  418 (496)
Q Consensus       342 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~  418 (496)
                      +.++.++|+|||+++........  .....+++.|+|||++.+..++.++||||||+++|++++ |..||....      
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------  244 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------  244 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------
Confidence            99999999999999876433221  122345678999999999899999999999999999998 788875221      


Q ss_pred             CCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          419 DPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                        .......+..........   .....+.+++.+||+.+|++|||+.|+++.+...-
T Consensus       245 --~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         245 --VEELFKLLKEGHRMDKPA---NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             --HHHHHHHHHcCCcCCCCC---CCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence              111122221111111111   12235778999999999999999999999985543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.4e-39  Score=308.82  Aligned_cols=264  Identities=26%  Similarity=0.354  Sum_probs=201.8

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      ++|++.+.||+|+||.||+|.++ +++.||+|.+..... ....+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999875 589999998865432 2234567899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |++++++..+.....   .+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            999998887765432   4899999999999999999999   7799999999999999999999999999998765443


Q ss_pred             CCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCC---------CCCCcc----hhHhhh
Q 011005          363 SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS---------SSDPKI----MLIDVL  428 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~---------~~~~~~----~~~~~~  428 (496)
                      .......++..|+|||++.+ ..++.++||||||+++|||++|+.||........         ......    ......
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07846         155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF  234 (286)
T ss_pred             cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence            33344567889999998875 4577899999999999999999999853221000         000000    000000


Q ss_pred             cC-CCCCCCChh-----HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          429 DQ-RLPPPVDRK-----VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       429 ~~-~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      .. ..+......     .......+.+++.+||+.+|++||++.++++|+|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            00 000000000     00113457899999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.3e-38  Score=303.84  Aligned_cols=259  Identities=19%  Similarity=0.298  Sum_probs=206.0

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCC-----CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeec-CCeE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPN-----GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH-KKCM  277 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~  277 (496)
                      .++|++.+.||+|+||.||+|.+.+     +..|++|.+...........+.+|+.++++++|+||+++++++.. +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678899999999999999998765     788999998765555556778999999999999999999998776 4678


Q ss_pred             EEEEEecCCCChhhhhhCCCCC-----ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccc
Q 011005          278 FLIYEYMERGSLFCNLHNNEDA-----VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF  352 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Df  352 (496)
                      ++++||+++|+|.+++......     ..+++..+..++.|++.||+|||   +.+++|+||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence            8999999999999998764322     46899999999999999999999   789999999999999999999999999


Q ss_pred             cccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhc
Q 011005          353 GTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLD  429 (496)
Q Consensus       353 g~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  429 (496)
                      |+++.+......  .....++..|+|||++.+..++.++||||||+++||+++ |+.||.....        ........
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~  233 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--------FEMAAYLK  233 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--------HHHHHHHH
Confidence            999865432211  112235667999999998899999999999999999999 9999863221        11122221


Q ss_pred             CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          430 QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       430 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      .........   .....+.+++.+||+.||++|||+.|+++.+....
T Consensus       234 ~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         234 DGYRLAQPI---NCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             cCCCCCCCC---cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            111111111   11235789999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=316.23  Aligned_cols=255  Identities=29%  Similarity=0.395  Sum_probs=207.0

Q ss_pred             CCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          207 FDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      |.-.+.||.|+||.||-|++ .+.+.||||++..+.  ..+....+..|+.++++++|||++.+-|+|......|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            44456799999999999965 578899999997643  234457789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      |- ||-.+++.-...  .+-+-++..|+.+.+.||+|||   +.+.||||||+.|||+++.|.|||+|||.|....+   
T Consensus       108 Cl-GSAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---  178 (948)
T KOG0577|consen  108 CL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---  178 (948)
T ss_pred             Hh-ccHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence            96 477777765432  5778888999999999999999   78999999999999999999999999999987643   


Q ss_pred             Cccccccccccccccccc---cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          364 NRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                       ...++|||.|||||++.   .+.|+-++||||+|++..||...++|+-.++-+       .....+....-|. ..  .
T Consensus       179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-------SALYHIAQNesPt-Lq--s  247 (948)
T KOG0577|consen  179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNESPT-LQ--S  247 (948)
T ss_pred             -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-------HHHHHHHhcCCCC-CC--C
Confidence             34579999999999875   568999999999999999999999995322110       1111222222221 11  2


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCC
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLV  481 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~  481 (496)
                      ..+...+.+|+..||+.-|.+|||.+++++|.|+.+.-|..
T Consensus       248 ~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~t  288 (948)
T KOG0577|consen  248 NEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPT  288 (948)
T ss_pred             chhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCch
Confidence            24455788999999999999999999999999999887653

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=8.4e-39  Score=310.84  Aligned_cols=257  Identities=23%  Similarity=0.340  Sum_probs=187.4

Q ss_pred             ceeeecCCeeEEEEEeC---CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeec--CCeEEEEEEecC
Q 011005          211 YCIGTGGYGSVYKAQLP---NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH--KKCMFLIYEYME  285 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lV~e~~~  285 (496)
                      ..||+|+||+||+|..+   ++..||+|.+.....   ...+.+|+.++++++||||+++++++..  +...++||||+.
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            57999999999999865   457899998875432   2456789999999999999999998854  557899999987


Q ss_pred             CCChhhhhhCC------CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe----cCCCCeEEcccccc
Q 011005          286 RGSLFCNLHNN------EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL----NSKLEAFVADFGTA  355 (496)
Q Consensus       286 ~g~L~~~l~~~------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~----~~~~~~kl~Dfg~~  355 (496)
                      + +|.+.+...      .....+++..+..++.||+.||.|||   +.+++||||||+||++    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 777766422      12235888999999999999999999   7899999999999999    55678999999999


Q ss_pred             ccccCCCC---Ccccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCC--cchhHhhhc
Q 011005          356 RLLHADSS---NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDP--KIMLIDVLD  429 (496)
Q Consensus       356 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~--~~~~~~~~~  429 (496)
                      +.......   ......+|+.|+|||++.+ ..++.++||||+|+++|||+||+.||............  .........
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            87643322   1233568899999999876 45789999999999999999999998633211000000  000000000


Q ss_pred             ----------------------------CCCCCCCC-----hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          430 ----------------------------QRLPPPVD-----RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       430 ----------------------------~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                                                  ........     .........+.+++.+||+.||.+|||+.|+++|+|+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                                        00000000     0000011246789999999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2e-38  Score=298.53  Aligned_cols=245  Identities=22%  Similarity=0.357  Sum_probs=193.0

Q ss_pred             eeecCCeeEEEEEeC---CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCCCh
Q 011005          213 IGTGGYGSVYKAQLP---NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL  289 (496)
Q Consensus       213 lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g~L  289 (496)
                      ||+|+||.||+|.+.   .+..||+|.+.........+.+.+|+.++++++|+||+++++++.. ...++||||+++++|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence            899999999999653   3557999998766544455678999999999999999999998854 468999999999999


Q ss_pred             hhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCc---c
Q 011005          290 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR---T  366 (496)
Q Consensus       290 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~---~  366 (496)
                      .+++....  ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++..........   .
T Consensus        82 ~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          82 NKFLSGKK--DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            99987533  26899999999999999999999   7799999999999999999999999999998654332211   1


Q ss_pred             ccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHH
Q 011005          367 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDIL  445 (496)
Q Consensus       367 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  445 (496)
                      ...+++.|+|||.+....++.++||||||+++|++++ |..||.....        ......+..........   ....
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~---~~~~  225 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--------PEVMSFIEQGKRLDCPA---ECPP  225 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHHHCCCCCCCCC---CCCH
Confidence            1223568999999988889999999999999999996 9999863321        11112222211111111   1123


Q ss_pred             HHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          446 LISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       446 ~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      .+.+++.+||+.||++||++.++.+.+..
T Consensus       226 ~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         226 EMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            57789999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.4e-38  Score=301.37  Aligned_cols=254  Identities=23%  Similarity=0.357  Sum_probs=198.9

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch----hHHHHHHHHHHHHHHHhhcccccccccceeec--CCeE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE----ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH--KKCM  277 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  277 (496)
                      .+|+..+.||+|+||.||+|... .++.|++|.+....    .......+.+|+.++++++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36888999999999999999764 68899999886431    22344568899999999999999999998865  3578


Q ss_pred             EEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          278 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      ++++||+++++|.+.+....   .+++...+.++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            89999999999999987643   5788999999999999999999   78999999999999999999999999999976


Q ss_pred             ccCCC---CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCC
Q 011005          358 LHADS---SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPP  434 (496)
Q Consensus       358 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  434 (496)
                      .....   .......++..|+|||.+.+..++.++||||+|+++|||++|+.||....       ..............+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~-------~~~~~~~~~~~~~~~  228 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE-------AMAAIFKIATQPTNP  228 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc-------hHHHHHHHhcCCCCC
Confidence            53211   11223457889999999999889999999999999999999999986321       111111111111111


Q ss_pred             CCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          435 PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       435 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                      ...   ......+.+++ +||..+|++||+++|+++|+|+.
T Consensus       229 ~~~---~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         229 QLP---SHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             CCc---hhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            111   11122355666 68889999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.2e-38  Score=312.66  Aligned_cols=259  Identities=23%  Similarity=0.348  Sum_probs=199.8

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe------CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecC-C
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHK-K  275 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~  275 (496)
                      .++|.+.+.||+|+||.||+|.+      .+++.||||.++..........+.+|+.++.++ +|+||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            46799999999999999999963      357889999997654444456788999999999 689999999988654 4


Q ss_pred             eEEEEEEecCCCChhhhhhCCCC---------------------------------------------------------
Q 011005          276 CMFLIYEYMERGSLFCNLHNNED---------------------------------------------------------  298 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~---------------------------------------------------------  298 (496)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999998864311                                                         


Q ss_pred             -------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC--ccccc
Q 011005          299 -------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN--RTLLA  369 (496)
Q Consensus       299 -------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~  369 (496)
                             ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++.........  .....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   123678888999999999999999   789999999999999999999999999999765332211  11233


Q ss_pred             cccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHH
Q 011005          370 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLIS  448 (496)
Q Consensus       370 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  448 (496)
                      +++.|+|||.+.+..++.++||||||+++|+|++ |..||.....       .......+...........   ....+.
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~---~~~~~~  312 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-------DEEFCRRLKEGTRMRAPDY---TTPEMY  312 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc-------cHHHHHHHhccCCCCCCCC---CCHHHH
Confidence            5668999999999999999999999999999997 9999863211       1111111111111111110   112467


Q ss_pred             HHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          449 TVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       449 ~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                      +++.+||+.||++|||+.|+++++...
T Consensus       313 ~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         313 QTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            889999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5.8e-39  Score=308.85  Aligned_cols=259  Identities=23%  Similarity=0.338  Sum_probs=202.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCC-----------------CcEEEEEEcccchhHHHHHHHHHHHHHHHhhccccccc
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPN-----------------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK  266 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~  266 (496)
                      .++|++.+.||+|+||.||+|..++                 +..||+|.+.........+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4679999999999999999997542                 24689999887654455678899999999999999999


Q ss_pred             ccceeecCCeEEEEEEecCCCChhhhhhCCC--------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCc
Q 011005          267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNE--------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNN  338 (496)
Q Consensus       267 ~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~N  338 (496)
                      +++++..+...++|||++++++|.+++....        ....+++..++.++.|++.||+|||   +.+++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            9999999999999999999999999987643        1225899999999999999999999   7799999999999


Q ss_pred             eEecCCCCeEEccccccccccCCCC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHh--CCCCCcccccc
Q 011005          339 ILLNSKLEAFVADFGTARLLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM--GKHPRDILSSL  414 (496)
Q Consensus       339 il~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~--g~~p~~~~~~~  414 (496)
                      |+++.++.++|+|||+++.......  ......+++.|+|||.+.+..++.++||||||+++|||++  |..||..... 
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-  239 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-  239 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence            9999999999999999976533221  1223446778999999998889999999999999999998  6777753211 


Q ss_pred             CCCCCCcchhHhhhcC----CCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          415 SSSSDPKIMLIDVLDQ----RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       415 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                            ..........    ........ .......+.+++.+||+.||++|||+.|+++.+.
T Consensus       240 ------~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 ------QQVIENAGHFFRDDGRQIYLPR-PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             ------HHHHHHHHhccccccccccCCC-ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence                  1111111100    00000000 0111235789999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-38  Score=298.77  Aligned_cols=248  Identities=28%  Similarity=0.448  Sum_probs=201.4

Q ss_pred             ceeeecCCeeEEEEEeCC----CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCC
Q 011005          211 YCIGTGGYGSVYKAQLPN----GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMER  286 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~  286 (496)
                      +.||+|+||.||+|....    +..|++|.+.........+.+.+|+++++.++|+|++++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            358999999999997653    7889999998765444467889999999999999999999999999999999999999


Q ss_pred             CChhhhhhCCCC------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          287 GSLFCNLHNNED------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       287 g~L~~~l~~~~~------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      ++|.+++.....      ...+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999987521      247899999999999999999999   78999999999999999999999999999987754


Q ss_pred             CC--CCccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          361 DS--SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       361 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                      ..  .......+++.|+|||.+.+..++.++||||+|+++|+|++ |..||....       ............ .....
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~~~~~~~~~~~-~~~~~  229 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-------NEEVLEYLRKGY-RLPKP  229 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC-------HHHHHHHHHcCC-CCCCC
Confidence            32  12233457789999999998899999999999999999999 699986431       111112221111 11111


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~  472 (496)
                      .   .....+.+++.+||+.+|++|||+.|+++++
T Consensus       230 ~---~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l  261 (262)
T cd00192         230 E---YCPDELYELMLSCWQLDPEDRPTFSELVERL  261 (262)
T ss_pred             c---cCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            1   1133578999999999999999999999876

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.9e-38  Score=303.19  Aligned_cols=258  Identities=26%  Similarity=0.356  Sum_probs=197.8

Q ss_pred             CCCcceeeecCCeeEEEEEe-----CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecC--CeEEE
Q 011005          207 FDIRYCIGTGGYGSVYKAQL-----PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK--KCMFL  279 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  279 (496)
                      |++.+.||+|+||+||++..     .+++.||+|.+...........+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            38889999999999988642     357889999987654334456788999999999999999999988653  46889


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||||+++++|.+++...    .+++..++.++.|++.||.|||   +.+++||||||+||++++++.++|+|||+++...
T Consensus        86 v~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence            99999999999998753    5899999999999999999999   7799999999999999999999999999998764


Q ss_pred             CCCCC---ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccC----CC---CCCcchhHhhhc
Q 011005          360 ADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS----SS---SDPKIMLIDVLD  429 (496)
Q Consensus       360 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~----~~---~~~~~~~~~~~~  429 (496)
                      .....   .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.......    ..   ........+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            33221   112235567999999998899999999999999999999999975322100    00   000001111111


Q ss_pred             CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          430 QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       430 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      .....+...   .....+.+++.+||+.||++|||++++++.+..
T Consensus       239 ~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~  280 (283)
T cd05080         239 RGMRLPCPK---NCPQEVYILMKNCWETEAKFRPTFRSLIPILKE  280 (283)
T ss_pred             cCCCCCCCC---CCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence            111111111   112357899999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-38  Score=300.13  Aligned_cols=253  Identities=28%  Similarity=0.463  Sum_probs=203.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      .++|.+.+.||+|+||.||+|..++++.||+|.+.....  ..+.+.+|+.++++++|+||+++++++......++||||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            467999999999999999999988888999999876432  235688999999999999999999999988899999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+++.... ...+++..+..++.|++.|+.|||   +.+++|+||+|+||++++++.++|+|||++........
T Consensus        83 ~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          83 MSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             cCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            99999999997643 236899999999999999999999   77999999999999999999999999999976643211


Q ss_pred             C-ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          364 N-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       364 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                      . .....++..|+|||.+.+..++.++||||+|+++|++++ |+.||....       ......... .....+....  
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-------~~~~~~~~~-~~~~~~~~~~--  228 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT-------NREVLEQVE-RGYRMPRPPN--  228 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHH-cCCCCCCCCC--
Confidence            1 112234568999999999899999999999999999998 999985321       111222222 2111111111  


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          442 RDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                       ....+.+++.+|++.+|++||+++++.+.+.
T Consensus       229 -~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~  259 (261)
T cd05034         229 -CPEELYDLMLQCWDKDPEERPTFEYLQSFLE  259 (261)
T ss_pred             -CCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence             1235788999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.5e-39  Score=316.06  Aligned_cols=259  Identities=21%  Similarity=0.282  Sum_probs=194.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      ..+|.+.+.||+|+||.||+|... +++.||+|......       ...|+.++++++|+||+++++++......++|+|
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            457999999999999999999765 56789999754322       3468999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      ++. ++|.+++....  ..+++..+..|+.||+.||.|||   .++|+||||||+||+++.++.++|+|||+++..... 
T Consensus       138 ~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  210 (357)
T PHA03209        138 HYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-  210 (357)
T ss_pred             ccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence            995 58888876533  26899999999999999999999   789999999999999999999999999999754322 


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCC-ccccccCCC--CCCcchhHhhhcC------CCC
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPR-DILSSLSSS--SDPKIMLIDVLDQ------RLP  433 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~-~~~~~~~~~--~~~~~~~~~~~~~------~~~  433 (496)
                      .......||+.|+|||++.+..++.++|||||||++|||+++..|+ .........  ..........+..      ..+
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  290 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP  290 (357)
T ss_pred             cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence            2223456899999999999999999999999999999999865553 321100000  0000000000000      000


Q ss_pred             -------------------CCCChh-HH---HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          434 -------------------PPVDRK-VI---RDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       434 -------------------~~~~~~-~~---~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                                         .+.... ..   .......+++.+||+.||++|||+.|+++|+|+..
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                               000000 00   01123456899999999999999999999999864

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-39  Score=305.15  Aligned_cols=258  Identities=28%  Similarity=0.410  Sum_probs=204.1

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCC-----
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKK-----  275 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~-----  275 (496)
                      .+++|++.+.||+|++|.||+|..+ +++.+++|.+.....  ..+.+.+|+.+++++ .|+||+++++++....     
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            4688999999999999999999775 578899999876543  235688999999999 6999999999997644     


Q ss_pred             -eEEEEEEecCCCChhhhhhCCC-CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccc
Q 011005          276 -CMFLIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG  353 (496)
Q Consensus       276 -~~~lV~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  353 (496)
                       ..++||||+++++|.+++.... ....+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence             5899999999999999886532 2236899999999999999999999   7899999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccccccc-----CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhh
Q 011005          354 TARLLHADSSNRTLLAGTYGYIAPELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVL  428 (496)
Q Consensus       354 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  428 (496)
                      ++..............++..|+|||.+..     ..++.++||||+|+++|+|++|+.||.....       ........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~  231 (275)
T cd06608         159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-------MRALFKIP  231 (275)
T ss_pred             cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-------HHHHHHhh
Confidence            99766443333344568889999998754     3467899999999999999999999863221       11122222


Q ss_pred             cCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          429 DQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ....+ .... .......+.+++.+||..||++|||+.|+++|+|.
T Consensus       232 ~~~~~-~~~~-~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         232 RNPPP-TLKS-PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             ccCCC-CCCc-hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            21111 1111 11123357799999999999999999999999874

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.8e-38  Score=300.66  Aligned_cols=253  Identities=26%  Similarity=0.403  Sum_probs=200.9

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC----CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      ++|++.+.||+|+||.||+|...    .+..+|+|.+.........+.+.+|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            56888999999999999999753    23479999987654344456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+++++|.+++....  ..+++.++..++.|++.|++|||   +.+++||||||+||+++.++.++++|||++.....
T Consensus        84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            99999999999997643  25799999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCCCc---cccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCC
Q 011005          361 DSSNR---TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV  436 (496)
Q Consensus       361 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  436 (496)
                      .....   ....++..|+|||.+.+..++.++|+||||+++|++++ |..||.....       .......... ...+.
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~-------~~~~~~~~~~-~~~~~  230 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-------QDVIKAIEEG-YRLPA  230 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH-------HHHHHHHhCC-CcCCC
Confidence            32211   11223467999999998899999999999999999886 9999863321       1111111111 11111


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      ..   ..+..+.+++.+|++.+|++||++.++++.+.
T Consensus       231 ~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  264 (267)
T cd05066         231 PM---DCPAALHQLMLDCWQKDRNERPKFEQIVSILD  264 (267)
T ss_pred             CC---CCCHHHHHHHHHHcccCchhCCCHHHHHHHHH
Confidence            11   11234679999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.9e-38  Score=305.54  Aligned_cols=270  Identities=25%  Similarity=0.297  Sum_probs=206.0

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh----HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE----LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      +|++.+.||+|+||.||+|... +++.||+|.+.....    ......+..|++++++++|+||+++++++...+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778889999999999999764 689999999976432    22334567899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+ +|+|.+++....  ..+++..+..++.||++||.|||   ..+++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899999997643  36899999999999999999999   78999999999999999999999999999987755


Q ss_pred             CCCCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCC---------CCCCcc-----hhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS---------SSDPKI-----MLI  425 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~---------~~~~~~-----~~~  425 (496)
                      .........+++.|+|||.+.+ ..++.++||||+|+++|+|++|..||........         ......     ...
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence            4333333456788999998865 4678899999999999999999887753221100         000000     000


Q ss_pred             hhhcCCC--CCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCC
Q 011005          426 DVLDQRL--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLV  481 (496)
Q Consensus       426 ~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~  481 (496)
                      .......  ..+...........+.+++.+||++||++|||+.|+++|.|+.+.....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence            0000000  0000000111234578999999999999999999999999998865443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.7e-38  Score=306.71  Aligned_cols=262  Identities=23%  Similarity=0.355  Sum_probs=204.8

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC--------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecC
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP--------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHK  274 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  274 (496)
                      .++|.+.+.||+|+||.||+|...        ....+|+|.+...........+.+|+.+++++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            467889999999999999999642        24578999987654444456788999999999 599999999999998


Q ss_pred             CeEEEEEEecCCCChhhhhhCCCC-------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe
Q 011005          275 KCMFLIYEYMERGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL  341 (496)
Q Consensus       275 ~~~~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~  341 (496)
                      ...++||||+++|+|.+++.....             ...+++.++..++.|++.||.|||   +.|++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence            899999999999999999875321             235889999999999999999999   7899999999999999


Q ss_pred             cCCCCeEEccccccccccCCCCCc--cccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCC
Q 011005          342 NSKLEAFVADFGTARLLHADSSNR--TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSS  418 (496)
Q Consensus       342 ~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~  418 (496)
                      +.++.+||+|||+++.........  ....++..|+|||.+.+..++.++||||||+++|+|++ |..||....      
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~------  241 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP------  241 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC------
Confidence            999999999999998664322111  11224467999999999999999999999999999999 888885321      


Q ss_pred             CCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          419 DPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                       . ....+.+.........   ......+.+++.+||+.||++|||+.|+++.+.......
T Consensus       242 -~-~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         242 -V-EELFKLLREGHRMDKP---SNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             -H-HHHHHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence             1 1111221111111111   111224678999999999999999999999988766543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.7e-38  Score=300.93  Aligned_cols=256  Identities=25%  Similarity=0.434  Sum_probs=203.4

Q ss_pred             CCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-----hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-----ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      +|+..+.||+|+||.||+|.. .+++.||+|.+....     .....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477888999999999999965 578999999986532     12345678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC-CeEEccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-EAFVADFGTARLL  358 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  358 (496)
                      |+||+++++|.+++....   .+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++ .++|+|||.+...
T Consensus        81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            999999999999987543   6788999999999999999999   78999999999999998776 5999999999876


Q ss_pred             cCCCCC----ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCC
Q 011005          359 HADSSN----RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPP  434 (496)
Q Consensus       359 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  434 (496)
                      ......    .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||.....    ........+........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~  230 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH----SNHLALIFKIASATTAP  230 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC----cchHHHHHHHhccCCCC
Confidence            543211    1234578899999999988999999999999999999999999863221    11111111111111111


Q ss_pred             CCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          435 PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       435 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ...   ......+.+++.+||..+|++||++.|+++|+|+
T Consensus       231 ~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~  267 (268)
T cd06630         231 SIP---EHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF  267 (268)
T ss_pred             CCc---hhhCHHHHHHHHHHcCCCcccCcCHHHHhcCccc
Confidence            111   1122357789999999999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-40  Score=287.39  Aligned_cols=261  Identities=23%  Similarity=0.312  Sum_probs=208.9

Q ss_pred             CCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-ccccccccceeecCCeEEEEEEec
Q 011005          207 FDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      .+....||.|.-|.||++.+. .|...|||.+....+.+..+++...+.++..-+ +|.||+.+|||..+...++.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            444566999999999999765 589999999998877777788888888887775 899999999999999999999988


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      . .....++.....  .+++.-+-++...+++||.||.+  +++|+|||+||+|||+|+.|++|+||||.+-++.+. ..
T Consensus       174 s-~C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-kA  247 (391)
T KOG0983|consen  174 S-TCAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-KA  247 (391)
T ss_pred             H-HHHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecc-cc
Confidence            4 366666654432  57777777899999999999998  669999999999999999999999999999877543 33


Q ss_pred             ccccccccccccccccccC---CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          365 RTLLAGTYGYIAPELAYTM---VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       365 ~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                      .+...|-+.|||||.+...   .|+.++||||||++++||.||+.||..-      .........+++...+.-...  .
T Consensus       248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c------~tdFe~ltkvln~ePP~L~~~--~  319 (391)
T KOG0983|consen  248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC------KTDFEVLTKVLNEEPPLLPGH--M  319 (391)
T ss_pred             cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC------CccHHHHHHHHhcCCCCCCcc--c
Confidence            4445788899999998754   6888999999999999999999999632      223334444444333211111  1


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCC
Q 011005          442 RDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLV  481 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~  481 (496)
                      .-...+.+++..||.+|+.+||...++++|+|+..+.+.+
T Consensus       320 gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~  359 (391)
T KOG0983|consen  320 GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAE  359 (391)
T ss_pred             CcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhh
Confidence            1223478899999999999999999999999999887765

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.6e-38  Score=301.33  Aligned_cols=249  Identities=25%  Similarity=0.348  Sum_probs=188.5

Q ss_pred             eeeecCCeeEEEEEeCC---CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCCC
Q 011005          212 CIGTGGYGSVYKAQLPN---GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGS  288 (496)
Q Consensus       212 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g~  288 (496)
                      .||+|+||.||+|...+   +..+|+|.+...........+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            58999999999997543   457999998765544444678899999999999999999999999889999999999999


Q ss_pred             hhhhhhCCCC--CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC--C
Q 011005          289 LFCNLHNNED--AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS--N  364 (496)
Q Consensus       289 L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~  364 (496)
                      |.+++.....  ....++..+..++.|++.|++|||   +.+++|+||||+||+++.++.++|+|||++........  .
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            9999875432  224567788889999999999999   78999999999999999999999999999975433221  1


Q ss_pred             ccccccccccccccccccC-------CcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcC--CCCC
Q 011005          365 RTLLAGTYGYIAPELAYTM-------VMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ--RLPP  434 (496)
Q Consensus       365 ~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~  434 (496)
                      .....++..|+|||++.+.       .++.++||||||+++|||++ |+.||.....      ...........  ..+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~  232 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD------EQVLTYTVREQQLKLPK  232 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh------HHHHHHHhhcccCCCCC
Confidence            1234567889999988642       35789999999999999996 9999863221      11111111111  1111


Q ss_pred             CCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 011005          435 PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       435 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~  472 (496)
                      +...  ......+.+++..|+ .+|++|||++|+++.+
T Consensus       233 ~~~~--~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l  267 (269)
T cd05087         233 PRLK--LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL  267 (269)
T ss_pred             CccC--CCCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence            1110  011223667888998 6899999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.1e-38  Score=303.73  Aligned_cols=256  Identities=27%  Similarity=0.426  Sum_probs=202.5

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCM  277 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  277 (496)
                      .++|++.+.||+|+||.||+|..+      ++..||+|.+.........+.+.+|+.++++++||||+++++++..+...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467899999999999999999753      46789999987655444557789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCC-------------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCc
Q 011005          278 FLIYEYMERGSLFCNLHNNE-------------------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNN  338 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~-------------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~N  338 (496)
                      ++||||+++|+|.+++....                   ....+++..++.++.|++.||+|||   ..+++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            99999999999999986421                   1124788889999999999999999   7799999999999


Q ss_pred             eEecCCCCeEEccccccccccCCCC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccC
Q 011005          339 ILLNSKLEAFVADFGTARLLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLS  415 (496)
Q Consensus       339 il~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~  415 (496)
                      |+++.++.++|+|||++........  .......+..|+|||.+.+..++.++||||||+++|||++ |..||....   
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~---  237 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA---  237 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---
Confidence            9999999999999999876533221  1122334667999999998999999999999999999997 888875221   


Q ss_pred             CCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          416 SSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                          ..................    .....+.+++.+||+.||++|||+.|+++.+.
T Consensus       238 ----~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         238 ----HEEVIYYVRDGNVLSCPD----NCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             ----HHHHHHHHhcCCCCCCCC----CCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence                111112222222211111    11235788999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.3e-38  Score=297.73  Aligned_cols=251  Identities=25%  Similarity=0.431  Sum_probs=199.5

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      ++|.+.+.||+|++|.||+|..+.+..+|+|.+.....  ..+.+.+|+.++++++|+|++++++++.. +..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence            56888999999999999999888777899998865432  23567889999999999999999998754 5578999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      ++++|.+++.... ...+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||.+.........
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          83 GKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            9999999997643 235789999999999999999999   779999999999999999999999999999766433221


Q ss_pred             -ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          365 -RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       365 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                       .....++..|+|||...+..++.++||||||+++|+|++ |+.||....       ....... +......+...   .
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-------~~~~~~~-~~~~~~~~~~~---~  227 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV-------NREVLEQ-VERGYRMPCPQ---G  227 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHH-HHcCCCCCCCc---c
Confidence             122345678999999998899999999999999999999 899986321       1111111 22221111111   1


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      ....+.+++.+||..||++||+++++++.+.
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  258 (260)
T cd05069         228 CPESLHELMKLCWKKDPDERPTFEYIQSFLE  258 (260)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence            2345789999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.9e-38  Score=297.56  Aligned_cols=245  Identities=24%  Similarity=0.374  Sum_probs=193.3

Q ss_pred             eeeecCCeeEEEEEe---CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCC
Q 011005          212 CIGTGGYGSVYKAQL---PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERG  287 (496)
Q Consensus       212 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g  287 (496)
                      .||+|+||.||+|.+   ++++.+|+|++.... .....+.+.+|+.+++.++|+||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999964   357889999986543 2334567889999999999999999999875 44678999999999


Q ss_pred             ChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC---
Q 011005          288 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN---  364 (496)
Q Consensus       288 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---  364 (496)
                      +|.+++....   .+++..+..++.|++.||+|||   +++++||||||+||+++.++.++|+|||++.........   
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            9999987543   6889999999999999999999   789999999999999999999999999999876443221   


Q ss_pred             ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHH
Q 011005          365 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD  443 (496)
Q Consensus       365 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  443 (496)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.||.....       . .....+......+...   ..
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~-~~~~~i~~~~~~~~~~---~~  223 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-------N-EVTQMIESGERMECPQ---RC  223 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-------H-HHHHHHHCCCCCCCCC---CC
Confidence            112234578999999988889999999999999999998 9999863221       1 1222222211111111   12


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          444 ILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       444 ~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ...+.+++.+||+.||++||++++|.+.+..
T Consensus       224 ~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         224 PPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            2357799999999999999999999888753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.7e-38  Score=308.39  Aligned_cols=261  Identities=23%  Similarity=0.358  Sum_probs=204.6

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC--------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCC
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP--------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKK  275 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  275 (496)
                      .+|++.+.||+|+||.||+|...        .+..||+|.+.........+.+.+|+.+++++ +|+||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46899999999999999999642        12368999887654444557889999999999 7999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhCCC-------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEec
Q 011005          276 CMFLIYEYMERGSLFCNLHNNE-------------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN  342 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~  342 (496)
                      ..++++||+++|+|.+++....             ....+++..+..++.|++.||+|||   ..+++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence            9999999999999999987532             1235788999999999999999999   78999999999999999


Q ss_pred             CCCCeEEccccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCC
Q 011005          343 SKLEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSD  419 (496)
Q Consensus       343 ~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~  419 (496)
                      .++.++|+|||+++........  .....++..|+|||.+.+..++.++||||||+++|||++ |..||....       
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-------  241 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-------  241 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-------
Confidence            9999999999999765432211  111234567999999999999999999999999999998 888885321       


Q ss_pred             CcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          420 PKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                       .......+..........   .....+.+++.+||+.+|++|||+.|+++++.......
T Consensus       242 -~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         242 -VEELFKLLKEGHRMDKPA---NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             -HHHHHHHHHcCCCCCCCC---CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence             111222121111111111   11224778999999999999999999999998766433

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.9e-38  Score=299.24  Aligned_cols=254  Identities=25%  Similarity=0.369  Sum_probs=194.1

Q ss_pred             CCCcceeeecCCeeEEEEEeCCC-c--EEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecC------Ce
Q 011005          207 FDIRYCIGTGGYGSVYKAQLPNG-K--VFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK------KC  276 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~~~~-~--~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  276 (496)
                      |.+.+.||+|+||.||+|.+.+. .  .||+|.++... .....+.+.+|+.+++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            35678899999999999976543 2  58999886542 233456788999999999999999999987532      24


Q ss_pred             EEEEEEecCCCChhhhhhCCC---CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNE---DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG  353 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  353 (496)
                      .+++|||+++|+|.+++....   ....+++..+..++.|++.||+|||   .++|+||||||+||++++++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence            689999999999988874321   2235789999999999999999999   7899999999999999999999999999


Q ss_pred             ccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcC
Q 011005          354 TARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ  430 (496)
Q Consensus       354 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  430 (496)
                      +++........  .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....       ..........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~  230 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-------SEIYDYLRQG  230 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHcC
Confidence            99876433211  122345678999999999999999999999999999999 8889863211       1111111111


Q ss_pred             CCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          431 RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       431 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      .......    .....+.+++.+||+.||++|||+.++++.+..
T Consensus       231 ~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         231 NRLKQPP----DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             CCCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            1111111    112246799999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.1e-38  Score=306.08  Aligned_cols=266  Identities=23%  Similarity=0.245  Sum_probs=199.0

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++++|.+.+.||+|+||.||+|.. .+++.||+|.+...........+.+|+.+++.++|+||+++++++..++..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            356799999999999999999965 4688999999865443333345678999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+. +++.+.+....  ..+++..+..++.|++.||.|||   ..+++|+||||+||+++.++.++|+|||+++.....
T Consensus        83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9996 67776665432  25678888899999999999999   779999999999999999999999999999765433


Q ss_pred             CCCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCC----------CCCCcc--------
Q 011005          362 SSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS----------SSDPKI--------  422 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~----------~~~~~~--------  422 (496)
                      ........+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||+.......          ......        
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         157 SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence            3333344578899999998764 578899999999999999999999964321000          000000        


Q ss_pred             -hhHhhhcCCCCCCCChh--HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          423 -MLIDVLDQRLPPPVDRK--VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       423 -~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                       ..........+......  .......+.+++.+|+..||++|||++|++.|+|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence             00000000000000000  00112356789999999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=7.3e-39  Score=306.26  Aligned_cols=257  Identities=24%  Similarity=0.308  Sum_probs=198.8

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      +|+..+.||+|++|.||+|..+ +++.||+|.+..... ......+.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999764 689999998875432 22235678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +. ++|.+++.... ...+++..+..++.|++.||+|||   ..+++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            96 58888886543 236899999999999999999999   77999999999999999999999999999976644333


Q ss_pred             CccccccccccccccccccCC-cCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhc-------------
Q 011005          364 NRTLLAGTYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD-------------  429 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------  429 (496)
                      ......+++.|+|||.+.+.. ++.++||||||+++|+|+||+.||......       ........             
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-------DQLFRIFRTLGTPDEVVWPGV  228 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHHHhCCCChhhhhhh
Confidence            333345688999999887654 588999999999999999999998532110       00000000             


Q ss_pred             -------CCCCC----CCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          430 -------QRLPP----PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       430 -------~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                             ...+.    ............+.+++.+||+.||++|||++|+++|+|+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         229 TSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             hHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                   00000    0000000012346789999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.6e-38  Score=299.00  Aligned_cols=255  Identities=31%  Similarity=0.447  Sum_probs=204.0

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      +|++.+.||+|+||.||+|... +++.|++|.++.... ....+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5788899999999999999754 788999999876543 24567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+++....   .+++..+..++.|++.|+.|||   +.+++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            99999999987643   4788899999999999999999   78999999999999999999999999999987654332


Q ss_pred             Ccc----ccccccccccccccccCC---cCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCC
Q 011005          364 NRT----LLAGTYGYIAPELAYTMV---MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV  436 (496)
Q Consensus       364 ~~~----~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  436 (496)
                      ...    ...+++.|+|||++.+..   ++.++||||||+++|++++|+.||....      ..............+ ..
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~-~~  227 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD------NEFQIMFHVGAGHKP-PI  227 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc------chHHHHHHHhcCCCC-CC
Confidence            211    245788999999998776   8899999999999999999999996332      111111111111111 11


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      .. .......+.+++.+||+.+|++|||+.|++.|+|.
T Consensus       228 ~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         228 PD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             Cc-ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            00 11112346789999999999999999999999873

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.5e-38  Score=299.07  Aligned_cols=258  Identities=24%  Similarity=0.380  Sum_probs=205.3

Q ss_pred             CCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeec--CCeEEEEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH--KKCMFLIY  281 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lV~  281 (496)
                      +|++.+.||.|+||.||+|.. .+++.||+|.+.... .....+.+.+|++++++++|+||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            478889999999999999965 468899999886532 23344678899999999999999999998754  45689999


Q ss_pred             EecCCCChhhhhhCC-CCCccCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEeCCCCCceEecCCCCeEEccccccccc
Q 011005          282 EYMERGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHHDC--SPSIIHRDISSNNILLNSKLEAFVADFGTARLL  358 (496)
Q Consensus       282 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  358 (496)
                      ||+++++|.+++... .....+++..++.++.|++.||.|||..+  +.+++|+||+|+||+++.++.++|+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998653 22346899999999999999999999432  468999999999999999999999999999877


Q ss_pred             cCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCCh
Q 011005          359 HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR  438 (496)
Q Consensus       359 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  438 (496)
                      ...........+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....       .. ...+.+..........
T Consensus       161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~-~~~~~~~~~~~~~~~~  232 (265)
T cd08217         161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-------QL-QLASKIKEGKFRRIPY  232 (265)
T ss_pred             cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-------HH-HHHHHHhcCCCCCCcc
Confidence            544432344568999999999999999999999999999999999999986321       11 1222222222111111


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          439 KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       439 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                         .....+.+++.+|++.+|++||++.++++|+|.
T Consensus       233 ---~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         233 ---RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ---ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence               223457799999999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-38  Score=298.96  Aligned_cols=254  Identities=23%  Similarity=0.372  Sum_probs=197.8

Q ss_pred             CCCcceeeecCCeeEEEEEeCC----CcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCe-----
Q 011005          207 FDIRYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKC-----  276 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  276 (496)
                      |.+.+.||+|+||.||+|....    +..||+|.++... .......+.+|+..++.++|+||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999997642    3679999987543 23345678999999999999999999998866554     


Q ss_pred             -EEEEEEecCCCChhhhhhCCC---CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccc
Q 011005          277 -MFLIYEYMERGSLFCNLHNNE---DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF  352 (496)
Q Consensus       277 -~~lV~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Df  352 (496)
                       .++|+||+++|+|..++....   ....+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             789999999999998885432   2236899999999999999999999   779999999999999999999999999


Q ss_pred             cccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhc
Q 011005          353 GTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLD  429 (496)
Q Consensus       353 g~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  429 (496)
                      |+++........  .....++..|+|||.+.+..++.++||||||+++|||++ |..||....       ..........
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~-------~~~~~~~~~~  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-------NHEIYDYLRH  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHc
Confidence            999876433221  112234668999999998899999999999999999999 888885322       1111111121


Q ss_pred             CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          430 QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       430 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      .... ....   .....+.+++.+||+.||++|||+.|+++++..
T Consensus       231 ~~~~-~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         231 GNRL-KQPE---DCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             CCCC-CCCc---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            1111 1111   122357899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2e-38  Score=303.04  Aligned_cols=260  Identities=25%  Similarity=0.368  Sum_probs=199.5

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHH-HHhhcccccccccceeecCCeEEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQV-LSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      ++|++.+.||+|+||.||+|..+ +|+.||+|.+...........+..|+.. ++..+||||+++++++..++..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36888999999999999999765 6999999998765332223455556665 555689999999999999999999999


Q ss_pred             ecCCCChhhhhhCC-CCCccCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          283 YMERGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHHDCSP-SIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       283 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |++ |+|.+.+... .....+++..++.++.||+.||+|||   ++ +++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            997 5887777542 22346899999999999999999999   54 899999999999999999999999999976543


Q ss_pred             CCCCcccccccccccccccccc----CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCC
Q 011005          361 DSSNRTLLAGTYGYIAPELAYT----MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV  436 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  436 (496)
                      .. ......++..|+|||.+.+    ..++.++|+||+|+++|+|++|+.||....      ..............+...
T Consensus       157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~  229 (283)
T cd06617         157 SV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK------TPFQQLKQVVEEPSPQLP  229 (283)
T ss_pred             cc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc------cCHHHHHHHHhcCCCCCC
Confidence            21 2233467889999998865    446889999999999999999999985311      111112222221111111


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ..   .....+.+++.+||..+|++||++.++++|+|+....
T Consensus       230 ~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         230 AE---KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             cc---ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            01   1123477899999999999999999999999998864

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-38  Score=295.43  Aligned_cols=249  Identities=24%  Similarity=0.416  Sum_probs=202.3

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      .++|++.+.||.|+||.||+|... ++.||+|.+.....  ..+.+.+|+.++++++|+||+++++++......++||||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            357889999999999999999874 78899999976653  346789999999999999999999999998899999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+++..... ..+++..+..++.|++.||.|||   ..+++|+||||+||+++.++.++|+|||.++...... 
T Consensus        82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-  156 (256)
T cd05039          82 MAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-  156 (256)
T ss_pred             cCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence            999999999876432 25899999999999999999999   7899999999999999999999999999998763221 


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                        .....+..|+|||.+.+..++.++||||+|+++|++++ |..||....        ..................   .
T Consensus       157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~---~  223 (256)
T cd05039         157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPHVEKGYRMEAPE---G  223 (256)
T ss_pred             --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHhcCCCCCCcc---C
Confidence              12334567999999998889999999999999999997 999985321        111112211111111111   1


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      .+..+.+++.+||..+|++|||+.|+++.+.
T Consensus       224 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  254 (256)
T cd05039         224 CPPEVYKVMKDCWELDPAKRPTFKQLREQLA  254 (256)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHHh
Confidence            1235779999999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-39  Score=286.89  Aligned_cols=269  Identities=25%  Similarity=0.331  Sum_probs=217.5

Q ss_pred             HHhCCCCc-ceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeec----CC
Q 011005          203 ATEDFDIR-YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLH----KK  275 (496)
Q Consensus       203 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~  275 (496)
                      .+++|.+. +.||-|-.|.|-.+.++ .++.+|+|++...      ....+|++..-+. .|||||.+++.++.    ..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk  132 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK  132 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence            46677775 46999999999999654 6889999998654      3457888887666 49999999998865    45


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC---CCCeEEccc
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KLEAFVADF  352 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~---~~~~kl~Df  352 (496)
                      ++.+|||.|+||.|++.++..++. .|++.++..|++||..|+.|||   +.+|.||||||+|+|.+.   +..+||+||
T Consensus       133 cLLiVmE~meGGeLfsriq~~g~~-afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRGDQ-AFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             eeEeeeecccchHHHHHHHHcccc-cchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccc
Confidence            788999999999999999987643 5899999999999999999999   789999999999999965   456999999


Q ss_pred             cccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCC
Q 011005          353 GTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRL  432 (496)
Q Consensus       353 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  432 (496)
                      |+|+.-.. .....+.+.||.|.|||++...+|+..+|+||+||++|-|++|.+||-.....   .....+...+.....
T Consensus       209 GFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~~gqy  284 (400)
T KOG0604|consen  209 GFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIRTGQY  284 (400)
T ss_pred             ccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhhccCc
Confidence            99987643 34456678999999999999999999999999999999999999999754432   222223333333333


Q ss_pred             CCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCcccc
Q 011005          433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAI  486 (496)
Q Consensus       433 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~~~  486 (496)
                      ..+ ...+.+......++|..+|..+|++|.|+.|++.|+|+.....+...+..
T Consensus       285 ~FP-~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~  337 (400)
T KOG0604|consen  285 EFP-EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLS  337 (400)
T ss_pred             cCC-ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCch
Confidence            332 33366666678899999999999999999999999999988776655443

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3e-38  Score=302.03  Aligned_cols=258  Identities=24%  Similarity=0.373  Sum_probs=206.9

Q ss_pred             CCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          206 DFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      .|...+.||+|++|.||+|.. .+++.+++|.+..... ...+.+.+|+.+++.++|+|++++++++..++..++|+||+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~   98 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL   98 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence            455567899999999999975 4688999998865432 22356789999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      ++++|.+++...    .+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.++|+|||.+.........
T Consensus        99 ~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~  171 (285)
T cd06648          99 EGGALTDIVTHT----RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR  171 (285)
T ss_pred             CCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence            999999998762    5788999999999999999999   789999999999999999999999999998765443333


Q ss_pred             ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHH
Q 011005          365 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI  444 (496)
Q Consensus       365 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  444 (496)
                      .....|++.|+|||.+.+..++.++||||+|+++|+|++|+.||.....       ........ ...+..... .....
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-------~~~~~~~~-~~~~~~~~~-~~~~~  242 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-------LQAMKRIR-DNLPPKLKN-LHKVS  242 (285)
T ss_pred             cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-------HHHHHHHH-hcCCCCCcc-cccCC
Confidence            3345688999999999998899999999999999999999999853211       11111111 111111110 11122


Q ss_pred             HHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          445 LLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       445 ~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      ..+.+++.+||+.+|++|||+.++++|.|+....+.
T Consensus       243 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  278 (285)
T cd06648         243 PRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP  278 (285)
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHccCcccccCCCc
Confidence            357899999999999999999999999999776543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.5e-38  Score=304.03  Aligned_cols=265  Identities=22%  Similarity=0.301  Sum_probs=202.0

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      +|++.+.||+|++|.||+|..+ +|+.||+|.+...........+.+|+.++++++|+||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788999999999999999875 688999999876543333456778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      ++ +|.+++........+++..+..++.|++.||.|||   +.+++||||+|+||++++++.++++|||++.........
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~  156 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT  156 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence            85 88888776544446899999999999999999999   779999999999999999999999999999766443333


Q ss_pred             ccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCC-------CCCCcchhHh------hhcC
Q 011005          365 RTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS-------SSDPKIMLID------VLDQ  430 (496)
Q Consensus       365 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~-------~~~~~~~~~~------~~~~  430 (496)
                      .....+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||........       ...+.....+      ....
T Consensus       157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07836         157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP  236 (284)
T ss_pred             cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence            3344578899999988654 568899999999999999999999863221000       0000000000      0000


Q ss_pred             CCCCCCChh----HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          431 RLPPPVDRK----VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       431 ~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ..+......    .......+.+++.+|++.||++||++.|+++++|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            000000000    00112347799999999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.4e-38  Score=305.97  Aligned_cols=253  Identities=24%  Similarity=0.375  Sum_probs=202.5

Q ss_pred             CcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCC
Q 011005          209 IRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERG  287 (496)
Q Consensus       209 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g  287 (496)
                      ....||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.+++.++|||++++++++..++..++|+||++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~  103 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG  103 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence            3456999999999999764 689999999865432 22356789999999999999999999999999999999999999


Q ss_pred             ChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCccc
Q 011005          288 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL  367 (496)
Q Consensus       288 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  367 (496)
                      +|..++...    .+++..++.++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||++............
T Consensus       104 ~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  176 (297)
T cd06659         104 ALTDIVSQT----RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  176 (297)
T ss_pred             CHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence            999877542    5789999999999999999999   789999999999999999999999999999765443333344


Q ss_pred             cccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHH
Q 011005          368 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLI  447 (496)
Q Consensus       368 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  447 (496)
                      ..++..|+|||++.+..++.++||||+|+++|||++|+.||.....       .... ..+........ .........+
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~-~~~~~~~~~~~-~~~~~~~~~l  247 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP-------VQAM-KRLRDSPPPKL-KNAHKISPVL  247 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHH-HHHhccCCCCc-cccCCCCHHH
Confidence            6688999999999998999999999999999999999999863211       1111 11111111110 0011112346


Q ss_pred             HHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          448 STVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       448 ~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      .+++.+||+.+|++||++.++++|+|+....
T Consensus       248 ~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         248 RDFLERMLTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             HHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence            7899999999999999999999999987653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.8e-38  Score=303.49  Aligned_cols=261  Identities=24%  Similarity=0.364  Sum_probs=200.3

Q ss_pred             CCCCcceeeecCCeeEEEEEe-----CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecC--CeEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQL-----PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK--KCMF  278 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  278 (496)
                      .|++.+.||+|+||.||+|.+     .++..||+|.++..........+.+|+.+++.++|||++++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            468889999999999999963     357889999987655445557789999999999999999999998775  5689


Q ss_pred             EEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccc
Q 011005          279 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL  358 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  358 (496)
                      +||||+++++|.+++....  ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||+++..
T Consensus        85 lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             EEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence            9999999999999987543  25799999999999999999999   789999999999999999999999999999876


Q ss_pred             cCCCCC---ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccc-c---CCCCCCcc---hhHhhh
Q 011005          359 HADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSS-L---SSSSDPKI---MLIDVL  428 (496)
Q Consensus       359 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~-~---~~~~~~~~---~~~~~~  428 (496)
                      ......   .....++..|+|||.+.+..++.++||||||+++|+|++++.|...... .   ........   ......
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL  239 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence            433221   1234466789999999988899999999999999999998776421110 0   00000000   011111


Q ss_pred             cCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          429 DQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ......+...   .....+.+++.+||+.+|++|||+.++++.+..
T Consensus       240 ~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         240 EEGKRLPRPP---NCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HcCccCCCCC---CCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            1111111111   122357899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.3e-38  Score=297.67  Aligned_cols=254  Identities=28%  Similarity=0.420  Sum_probs=201.2

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCC-C---cEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPN-G---KVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      .++|+..+.||+|+||.||+|..+. +   ..+|+|.+.........+.+..|++++++++|+|++++++++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            3568888999999999999997652 3   37999998765444445678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||||+++++|.+++....  ..+++..+..++.|++.|++|||   +.+++|+||||+||+++.++.++++|||++....
T Consensus        84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            999999999999987533  36899999999999999999999   7799999999999999999999999999997664


Q ss_pred             CCCCCcc---ccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCC
Q 011005          360 ADSSNRT---LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP  435 (496)
Q Consensus       360 ~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  435 (496)
                      .......   ....++.|+|||++.+..++.++||||||+++||+++ |+.||....       .. .....+......+
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~-------~~-~~~~~i~~~~~~~  230 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS-------NH-EVMKAINDGFRLP  230 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC-------HH-HHHHHHhcCCCCC
Confidence            3322111   1123457999999998889999999999999999997 999985321       11 1111111111111


Q ss_pred             CChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          436 VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       436 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      ...   .....+.+++.+||+.+|++||++.++++.+.
T Consensus       231 ~~~---~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~  265 (268)
T cd05063         231 APM---DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLD  265 (268)
T ss_pred             CCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            111   12235789999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.3e-38  Score=302.08  Aligned_cols=261  Identities=29%  Similarity=0.420  Sum_probs=212.2

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ..+.|+..+.||+|++|.||+|.++ +++.|++|.+.....  ....+.+|+++++.++|+|++++++++......++|+
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            4567888899999999999999776 688999999876543  3466789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++++|.+++....  ..+++..+..++.|++.||.|||   ..|++|+||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            9999999999998654  36899999999999999999999   789999999999999999999999999998766443


Q ss_pred             CCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                      ........+++.|+|||.+.+..++.++||||||+++|+|++|+.||.....       ............+....  ..
T Consensus       170 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~--~~  240 (286)
T cd06614         170 KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP-------LRALFLITTKGIPPLKN--PE  240 (286)
T ss_pred             hhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhcCCCCCcc--hh
Confidence            3333344578899999999988899999999999999999999999863221       11111111111111111  11


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          442 RDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      .....+.+++.+||+.+|.+|||+.+++++.|+.+.-.
T Consensus       241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  278 (286)
T cd06614         241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP  278 (286)
T ss_pred             hCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence            12335789999999999999999999999999988433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.4e-38  Score=298.49  Aligned_cols=253  Identities=23%  Similarity=0.344  Sum_probs=199.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch----hHHHHHHHHHHHHHHHhhcccccccccceeecC--CeE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE----ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK--KCM  277 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  277 (496)
                      .+|++.+.||+|+||.||+|..+ +++.||+|.+....    .....+.+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888999999999999999764 58999999875321    123446788999999999999999999988764  467


Q ss_pred             EEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          278 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      ++||||+++++|.+++....   .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence            89999999999999987543   5788888999999999999999   77999999999999999999999999999976


Q ss_pred             ccCCC---CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCC
Q 011005          358 LHADS---SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPP  434 (496)
Q Consensus       358 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  434 (496)
                      .....   .......++..|+|||.+.+..++.++||||||+++|+|++|+.||....       ..............+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~~~  228 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-------AMAAIFKIATQPTNP  228 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc-------hHHHHHHHhcCCCCC
Confidence            53211   11223457889999999988889999999999999999999999986321       111112211111111


Q ss_pred             CCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          435 PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       435 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ..   +......+.+++.+|+. +|++||+++|+++|+|.
T Consensus       229 ~~---~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~  264 (265)
T cd06652         229 VL---PPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFV  264 (265)
T ss_pred             CC---chhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence            11   11223346788889984 99999999999999886

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.5e-38  Score=300.07  Aligned_cols=253  Identities=25%  Similarity=0.451  Sum_probs=199.3

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMF  278 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  278 (496)
                      .+|...+.||+|+||.||++...      ++..+|+|.+..... .....+.+|+++++.++|+||+++++++..+...+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE-SARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH-HHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            46778899999999999999632      356789998875442 33467899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCC------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCC
Q 011005          279 LIYEYMERGSLFCNLHNNED------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE  346 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~  346 (496)
                      +||||+++++|.+++.....            ...+++..++.++.|++.|++|||   +.+++||||||+||++++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCC
Confidence            99999999999999875432            125789999999999999999999   789999999999999999999


Q ss_pred             eEEccccccccccCCCC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcch
Q 011005          347 AFVADFGTARLLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIM  423 (496)
Q Consensus       347 ~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~  423 (496)
                      ++|+|||++........  ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....       . .
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~-~  232 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN-------T-E  232 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH-------H-H
Confidence            99999999976533221  1122335678999999999999999999999999999998 8999853221       1 1


Q ss_pred             hHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 011005          424 LIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       424 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~  472 (496)
                      ...............   .....+.+++.+||+.||++||++.|+++.+
T Consensus       233 ~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l  278 (280)
T cd05092         233 AIECITQGRELERPR---TCPPEVYAIMQGCWQREPQQRMVIKDIHSRL  278 (280)
T ss_pred             HHHHHHcCccCCCCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence            111111111111111   1123477999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.6e-38  Score=296.96  Aligned_cols=251  Identities=25%  Similarity=0.388  Sum_probs=202.6

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch----hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE----ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      +|+..+.||+|++|.||+|..+ +++.|++|.+....    ..+..+.+.+|+.+++.++|+||+++++++..+...++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4777889999999999999765 78999999886533    123456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      +||+++++|.+++....   .+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999999997653   5788999999999999999999   78999999999999999999999999999876543


Q ss_pred             CCCCccccccccccccccccccCC-cCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhc-CCCCCCCCh
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD-QRLPPPVDR  438 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  438 (496)
                      .. ......+++.|+|||.+.... ++.++|+||+|+++|++++|+.||.....       ......... ...+. .. 
T Consensus       155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~-~~-  224 (258)
T cd06632         155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VAAVFKIGRSKELPP-IP-  224 (258)
T ss_pred             cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-------HHHHHHHHhcccCCC-cC-
Confidence            32 223456888999999987766 88999999999999999999999863221       111111111 11111 10 


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          439 KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       439 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                        ......+.+++.+||+.+|++||++.++++|+|+
T Consensus       225 --~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         225 --DHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             --CCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence              0112346789999999999999999999999873

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.1e-38  Score=305.70  Aligned_cols=262  Identities=24%  Similarity=0.272  Sum_probs=200.0

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-ccccccccceeecCCeEEEEEEe
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      +|+..+.||+|+||.||++... +++.||+|.+...........+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4556678999999999999654 689999999876543344567889999999996 99999999999998899999999


Q ss_pred             cCCCChhhhh---hCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          284 MERGSLFCNL---HNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       284 ~~~g~L~~~l---~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      +.. ++.++.   ... ....+++..+..++.|++.||+|||+  ..+++||||||+||+++.++.++|+|||++.....
T Consensus        85 ~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             ccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            864 554432   221 12368999999999999999999994  35899999999999999999999999999976543


Q ss_pred             CCCCccccccccccccccccccC---CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTM---VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                      .. ......+++.|+|||.+.+.   .++.++||||+|+++|+|++|+.||....      .......+......+....
T Consensus       161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~  233 (288)
T cd06616         161 SI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQLTQVVKGDPPILSN  233 (288)
T ss_pred             CC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHHHhhhcCCCCCcCCC
Confidence            32 22234578899999998876   68899999999999999999999986322      0111111111111111111


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      .........+.+|+.+||+.||++|||++++++|+|+....
T Consensus       234 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            11112233578999999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.4e-38  Score=296.04  Aligned_cols=253  Identities=23%  Similarity=0.388  Sum_probs=203.2

Q ss_pred             CCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          206 DFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      +|+..+.||+|+||.||+|.. .+++.+|+|.+.... .......+.+|++++++++|||++++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            478889999999999999965 468889999986542 233456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC-CCeEEccccccccccCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTARLLHADS  362 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~  362 (496)
                      +++++|.+++.... ...+++..+..++.|++.|+.|||   +++++|+||+|+||+++.+ +.++++|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999999997643 235789999999999999999999   7899999999999999865 457999999998764332


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                       ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||+...       ................. .   .
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~-~---~  224 (256)
T cd08220         157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN-------LPALVLKIMSGTFAPIS-D---R  224 (256)
T ss_pred             -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc-------hHHHHHHHHhcCCCCCC-C---C
Confidence             2233567889999999998889999999999999999999999986321       11122222222111111 1   1


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ....+.+++.+||+.+|++|||+.|+++|+|+
T Consensus       225 ~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         225 YSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            12247789999999999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-38  Score=294.74  Aligned_cols=246  Identities=28%  Similarity=0.402  Sum_probs=194.1

Q ss_pred             ceeeecCCeeEEEEEeCC----CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCC
Q 011005          211 YCIGTGGYGSVYKAQLPN----GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMER  286 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~  286 (496)
                      +.||+|+||.||+|.+..    +..+|+|.+.........+.+.+|+.+++.+.|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999996532    36899999987654344567899999999999999999999876 4567999999999


Q ss_pred             CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCcc
Q 011005          287 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT  366 (496)
Q Consensus       287 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  366 (496)
                      |+|.+++....   .+++..+..++.|++.||+|||   ..+++|+||||+||+++.++.++|+|||+++..........
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            99999998654   6899999999999999999999   77999999999999999999999999999987643332211


Q ss_pred             ---ccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          367 ---LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       367 ---~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                         ...++..|+|||.+.+..++.++||||||+++|++++ |..||.....        ......+......+...   .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~---~  222 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--------AEVIAMLESGERLPRPE---E  222 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHcCCcCCCCC---C
Confidence               1123457999999999999999999999999999998 9999864321        11111111111111111   1


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ....+.+++.+||+.+|++||++.++++.+..
T Consensus       223 ~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~  254 (257)
T cd05060         223 CPQEIYSIMLSCWKYRPEDRPTFSELESTFRR  254 (257)
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            12357799999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.4e-38  Score=300.67  Aligned_cols=256  Identities=25%  Similarity=0.421  Sum_probs=200.1

Q ss_pred             CCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchh---------HHHHHHHHHHHHHHHhhcccccccccceeecCC
Q 011005          206 DFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEE---------LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK  275 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  275 (496)
                      +|.+.+.||+|+||.||+|.. .+++.||+|.+.....         ....+.+.+|+.+++.++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            467788999999999999965 4688999998864211         112346788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccc
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  355 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  355 (496)
                      ..++||||+++++|.+++....   .+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++++|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccc
Confidence            9999999999999999987653   6888999999999999999999   779999999999999999999999999999


Q ss_pred             ccccCCCC--CccccccccccccccccccCC--cCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCC
Q 011005          356 RLLHADSS--NRTLLAGTYGYIAPELAYTMV--MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQR  431 (496)
Q Consensus       356 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  431 (496)
                      ........  ......++..|+|||.+....  ++.++|+||+|+++|++++|..||.....       .....+.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~  228 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-------IAAMFKLGNKR  228 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-------HHHHHHhhccc
Confidence            76543211  122345788999999987654  78899999999999999999999853211       11111111111


Q ss_pred             CCCCC-ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          432 LPPPV-DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       432 ~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ..... ..........+.+++.+||..||++|||++++++|+|+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            11111 11111123457789999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.2e-38  Score=300.33  Aligned_cols=252  Identities=26%  Similarity=0.364  Sum_probs=205.7

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      +|++.+.||+|+||.||+|..+ +++.||+|.+....  .....+.+.+|++++++++||||+++++++..+...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788999999999999999775 68999999987543  22345778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+.+++|.+.+...   ..++...+..++.|++.||.|||   ..+++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999998765   26888999999999999999999   7799999999999999999999999999997764432


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhc-CCCCCCCChhHH
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD-QRLPPPVDRKVI  441 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  441 (496)
                       ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||......     .......... .....+     .
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~-----~  223 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQETADVLYP-----A  223 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhccccccCc-----c
Confidence             223456788999999999888999999999999999999999998743210     1111111111 111111     1


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCH--HHHHHHHHH
Q 011005          442 RDILLISTVSFACLQSNPKSRPTM--QSVSQEFLI  474 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~--~evl~~~~~  474 (496)
                      .....+.+++.+||+.||.+||++  +|+++|+|+
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         224 TWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             cCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            122457799999999999999999  999988774

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5.9e-38  Score=298.53  Aligned_cols=256  Identities=23%  Similarity=0.369  Sum_probs=203.2

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMF  278 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  278 (496)
                      ++|++...||+|+||.||+|..+      +.+.|++|.+.........+.+.+|++++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57889999999999999999754      346799998876554445677899999999999999999999999989999


Q ss_pred             EEEEecCCCChhhhhhCCCCCc------cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccc
Q 011005          279 LIYEYMERGSLFCNLHNNEDAV------ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF  352 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~~~------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Df  352 (496)
                      +||||+++|+|.+++.......      .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999997654222      5899999999999999999999   779999999999999999999999999


Q ss_pred             cccccccCCCC-CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcC
Q 011005          353 GTARLLHADSS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ  430 (496)
Q Consensus       353 g~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  430 (496)
                      |++........ ......++..|+|||.+.+..++.++||||||+++|++++ |..||.....       ..........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-------~~~~~~~~~~  234 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-------EEVLNRLQAG  234 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-------HHHHHHHHcC
Confidence            99875432211 1223346778999999988888999999999999999998 7888853211       1111122112


Q ss_pred             CCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          431 RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       431 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      ........   .....+.+++.+||+.+|++|||+.|+++.+.
T Consensus       235 ~~~~~~~~---~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         235 KLELPVPE---GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CcCCCCCC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            21111111   11235778999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.2e-38  Score=296.39  Aligned_cols=247  Identities=26%  Similarity=0.401  Sum_probs=196.8

Q ss_pred             ceeeecCCeeEEEEEeCC--C--cEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCC
Q 011005          211 YCIGTGGYGSVYKAQLPN--G--KVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMER  286 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~  286 (496)
                      +.||+|++|.||+|.+.+  +  ..||+|.+.........+.+.+|+.++++++|+||+++++.+.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            358999999999997643  3  36899999876543556788999999999999999999999988 889999999999


Q ss_pred             CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC--
Q 011005          287 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN--  364 (496)
Q Consensus       287 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--  364 (496)
                      ++|.+.+..... ..+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++.........  
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999987543 46899999999999999999999   789999999999999999999999999999876543221  


Q ss_pred             -ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          365 -RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       365 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                       .....++..|+|||++.+..++.++||||||+++|+|++ |+.||.....       ................   ...
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~~~~---~~~  225 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-------SQILKKIDKEGERLER---PEA  225 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhcCCcCCC---Ccc
Confidence             112346778999999999999999999999999999998 9999853221       1111111111100000   011


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~  472 (496)
                      .+..+.+++.+||+.+|++|||+.++++.+
T Consensus       226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l  255 (257)
T cd05040         226 CPQDIYNVMLQCWAHNPADRPTFAALREFL  255 (257)
T ss_pred             CCHHHHHHHHHHCCCCcccCCCHHHHHHHh
Confidence            223577899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.4e-38  Score=295.48  Aligned_cols=250  Identities=25%  Similarity=0.423  Sum_probs=199.2

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      .+|++.+.||+|+||.||+|.+.+++.+|+|.+......  ...+.+|++++++++|||++++++++......++||||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC--HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            468888999999999999998877889999998754321  246789999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      ++++|.+++....  ..+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.++|+|||.+.........
T Consensus        82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          82 EHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             CCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence            9999999987543  25788999999999999999999   779999999999999999999999999998765332211


Q ss_pred             -ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          365 -RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       365 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                       .....++..|+|||.+.+..++.++||||+|+++|||++ |+.||....       .. ...+.+..........   .
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-------~~-~~~~~~~~~~~~~~~~---~  225 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-------NS-EVVETINAGFRLYKPR---L  225 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC-------HH-HHHHHHhCCCCCCCCC---C
Confidence             112234568999999998899999999999999999998 999985321       11 1111111111100000   0


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~  472 (496)
                      ....+.+++.+||+.+|++|||+.|+++++
T Consensus       226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         226 ASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            123578899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-38  Score=299.06  Aligned_cols=247  Identities=26%  Similarity=0.395  Sum_probs=191.7

Q ss_pred             eeeecCCeeEEEEEeCC-Cc--EEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEEEEecCCC
Q 011005          212 CIGTGGYGSVYKAQLPN-GK--VFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLIYEYMERG  287 (496)
Q Consensus       212 ~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~g  287 (496)
                      .||+|+||.||+|..++ +.  .+++|.++..........+.+|+++++++ +||||+++++++......++||||+++|
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG   81 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence            58999999999997753 33  46888887544334456788999999999 7999999999999999999999999999


Q ss_pred             ChhhhhhCCC-------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccc
Q 011005          288 SLFCNLHNNE-------------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  354 (496)
Q Consensus       288 ~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  354 (496)
                      +|.+++....             ....+++..+..++.|++.|++|||   +.+++||||||+||++++++.++++|||+
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCCC
Confidence            9999987542             1224789999999999999999999   78999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCC
Q 011005          355 ARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLP  433 (496)
Q Consensus       355 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  433 (496)
                      +...... ........+..|+|||++....++.++||||||+++|||++ |..||.....       .. ....+.....
T Consensus       159 ~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-------~~-~~~~~~~~~~  229 (270)
T cd05047         159 SRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AE-LYEKLPQGYR  229 (270)
T ss_pred             ccccchh-hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-------HH-HHHHHhCCCC
Confidence            8533211 11112234567999999988899999999999999999997 9999853211       11 1111111111


Q ss_pred             CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          434 PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       434 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      .....   .....+.+++.+||+.+|.+|||+.++++.+.
T Consensus       230 ~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  266 (270)
T cd05047         230 LEKPL---NCDDEVYDLMRQCWREKPYERPSFAQILVSLN  266 (270)
T ss_pred             CCCCC---cCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence            11111   11224679999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.2e-38  Score=304.08  Aligned_cols=257  Identities=24%  Similarity=0.310  Sum_probs=203.3

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|+||.||++..+ .++.|++|.+.....  ......+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888999999999999999765 578999998876432  233457789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||++|++|.+++....   .+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.++++|||+++.....
T Consensus        81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            9999999999997643   5788999999999999999999   779999999999999999999999999998642110


Q ss_pred             CC---------------CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHh
Q 011005          362 SS---------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLID  426 (496)
Q Consensus       362 ~~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  426 (496)
                      ..               ......++..|+|||.+.+..++.++||||||+++||+++|..||...       ........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~-------~~~~~~~~  227 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-------TPEELFGQ  227 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHH
Confidence            00               011235678899999999889999999999999999999999998521       11222222


Q ss_pred             hhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCC---HHHHHHHHHHhc
Q 011005          427 VLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPT---MQSVSQEFLITR  476 (496)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~~~~~~~  476 (496)
                      ........+....  .....+.+++.+||+.||++||+   +.++++|+|+..
T Consensus       228 ~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~  278 (305)
T cd05609         228 VISDDIEWPEGDE--ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG  278 (305)
T ss_pred             HHhcccCCCCccc--cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence            2222211111110  12234679999999999999998   799999998744

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2e-38  Score=303.43  Aligned_cols=263  Identities=24%  Similarity=0.287  Sum_probs=201.9

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      +|++.+.||+|+||.||+|.+. +|+.||+|++..... ......+.+|+.++++++||||+++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788899999999999999764 689999999876442 23346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      + +++|.+++....  ..+++..++.++.||+.||+|||   +.+++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999999987543  36899999999999999999999   78999999999999999999999999999987654321


Q ss_pred             -CccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCC-------CCCCcc-hhH-----hhh
Q 011005          364 -NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS-------SSDPKI-MLI-----DVL  428 (496)
Q Consensus       364 -~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~-------~~~~~~-~~~-----~~~  428 (496)
                       ......++..|+|||.+.+. .++.++||||+|+++|+|++|.+||........       ...+.. ...     ...
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence             12335688899999988654 468899999999999999999888753221000       000000 000     000


Q ss_pred             cC-CCCCCCC----hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          429 DQ-RLPPPVD----RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       429 ~~-~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      .. ..+....    .........+.+++.+||+.||++|||++++++|+|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~  285 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF  285 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence            00 0000000    0000112467899999999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1e-37  Score=294.34  Aligned_cols=252  Identities=25%  Similarity=0.436  Sum_probs=201.0

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      .++|.+.+.||+|+||.||+|...++..+|+|.+.....  ....+.+|++++++++|+||+++++.+.. ...+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh--HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            467899999999999999999887888899998876432  23568899999999999999999999887 678999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+++.... ...+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          82 MAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             CCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            99999999997643 236788999999999999999999   77999999999999999999999999999976543221


Q ss_pred             C-ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          364 N-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       364 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                      . .....++..|+|||++.+..++.++|+||||+++|++++ |+.||.....       . .....+......+...   
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-------~-~~~~~~~~~~~~~~~~---  226 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-------P-EVIRALERGYRMPRPE---  226 (260)
T ss_pred             ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH-------H-HHHHHHhCCCCCCCcc---
Confidence            1 122335567999999998889999999999999999998 9999863211       1 1111111211111111   


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          442 RDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      .....+.+++.+|++.+|++||++.++++.+.
T Consensus       227 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~  258 (260)
T cd05073         227 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLD  258 (260)
T ss_pred             cCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence            12235779999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=6.6e-38  Score=297.19  Aligned_cols=251  Identities=30%  Similarity=0.499  Sum_probs=199.4

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCC-C---cEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPN-G---KVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      ++|.+.+.||+|+||.||+|..+. +   ..||+|.+...........+..|+.+++.++||||+++++++..+...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            457888999999999999997643 3   369999987654444557899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+++++|.+++....  ..+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence            99999999999987543  26899999999999999999999   78999999999999999999999999999876543


Q ss_pred             CCCCcc---ccc--cccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcC--CC
Q 011005          361 DSSNRT---LLA--GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ--RL  432 (496)
Q Consensus       361 ~~~~~~---~~~--gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~  432 (496)
                      ......   ...  .+..|+|||.+.+..++.++||||+|+++||+++ |..||.....       . .....+..  ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-------~-~~~~~i~~~~~~  230 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-------Q-DVINAIEQDYRL  230 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-------H-HHHHHHHcCCcC
Confidence            222111   111  2357999999999999999999999999999886 9999863221       1 11111111  11


Q ss_pred             CCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       433 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      +.+.     ..+..+.+++.+||+.+|++||++.++++.+.
T Consensus       231 ~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  266 (269)
T cd05065         231 PPPM-----DCPTALHQLMLDCWQKDRNARPKFGQIVSTLD  266 (269)
T ss_pred             CCcc-----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1111     11234678999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.6e-38  Score=297.07  Aligned_cols=249  Identities=26%  Similarity=0.381  Sum_probs=201.9

Q ss_pred             eeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCCCh
Q 011005          213 IGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL  289 (496)
Q Consensus       213 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g~L  289 (496)
                      ||.|++|.||+|... +++.||+|.+....  .....+.+.+|+.+++.++||||+++++.+.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999775 48899999987543  223456789999999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCccccc
Q 011005          290 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA  369 (496)
Q Consensus       290 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  369 (496)
                      .+++.+..   .++...+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++....... ......
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~  153 (262)
T cd05572          81 WTILRDRG---LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC  153 (262)
T ss_pred             HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence            99997653   5788999999999999999999   7899999999999999999999999999998765432 223346


Q ss_pred             cccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHH
Q 011005          370 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLIST  449 (496)
Q Consensus       370 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  449 (496)
                      +++.|+|||.+.+..++.++|+||+|+++|+|++|..||.....     ......................   ...+.+
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  225 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYNDILKGNGKLEFPNYI---DKAAKD  225 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHHHhccCCCCCCCccc---CHHHHH
Confidence            78899999999888899999999999999999999999863321     1111222222111111111111   335789


Q ss_pred             HHHhcccCCCCCCCC-----HHHHHHHHHHhc
Q 011005          450 VSFACLQSNPKSRPT-----MQSVSQEFLITR  476 (496)
Q Consensus       450 li~~cl~~dP~~Rps-----~~evl~~~~~~~  476 (496)
                      ++.+||+.+|++||+     ++|+++|+|+..
T Consensus       226 ~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~  257 (262)
T cd05572         226 LIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG  257 (262)
T ss_pred             HHHHHccCChhhCcCCcccCHHHHhcChhhhC
Confidence            999999999999999     999999999864

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.2e-38  Score=298.50  Aligned_cols=248  Identities=25%  Similarity=0.344  Sum_probs=186.5

Q ss_pred             eeeecCCeeEEEEEeCC---CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCCC
Q 011005          212 CIGTGGYGSVYKAQLPN---GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGS  288 (496)
Q Consensus       212 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g~  288 (496)
                      .||+|+||.||+|...+   ...+++|.+...........+.+|+.+++.++|+||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999996543   457888887655444445678899999999999999999999999999999999999999


Q ss_pred             hhhhhhCCCC--CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC--C
Q 011005          289 LFCNLHNNED--AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS--N  364 (496)
Q Consensus       289 L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~  364 (496)
                      |.+++.....  ....++.....++.||+.||+|||   +.+|+||||||+||++++++.+||+|||++........  .
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            9999876532  123567788899999999999999   78999999999999999999999999999865432221  1


Q ss_pred             cccccccccccccccccc-------CCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcC---CCC
Q 011005          365 RTLLAGTYGYIAPELAYT-------MVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ---RLP  433 (496)
Q Consensus       365 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~  433 (496)
                      .....+++.|+|||++..       ..++.++||||+|+++|||++ |..||.....       ..........   .++
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------~~~~~~~~~~~~~~~~  231 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-------EQVLKQVVREQDIKLP  231 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH-------HHHHHHHhhccCccCC
Confidence            122345678999998743       456789999999999999999 7888753221       1111111111   111


Q ss_pred             CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 011005          434 PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       434 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~  472 (496)
                      .+.  ........+.+++..|+ .||++|||++||++.+
T Consensus       232 ~~~--~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         232 KPQ--LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             CCc--ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            111  01112233556777888 5999999999998865

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.1e-38  Score=300.41  Aligned_cols=261  Identities=26%  Similarity=0.395  Sum_probs=197.3

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-----CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeec--CCeE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-----PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH--KKCM  277 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  277 (496)
                      .+|++.+.||+|+||.||+|..     .+++.||+|.+..... ...+.+.+|++++++++||||+++++++..  ....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            4688899999999999999964     3578999999876543 334678899999999999999999998754  3468


Q ss_pred             EEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          278 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      ++||||+++|+|.+++....  ..+++..+..++.|++.||+|||   ..+++||||||+||++++++.++|+|||++..
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence            99999999999999997543  25789999999999999999999   78999999999999999999999999999987


Q ss_pred             ccCCCCCc---cccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCcccccc-----CCCCC---CcchhHh
Q 011005          358 LHADSSNR---TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSL-----SSSSD---PKIMLID  426 (496)
Q Consensus       358 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~-----~~~~~---~~~~~~~  426 (496)
                      ........   ....++..|+|||++.+..++.++||||||+++|||++|..|+......     .....   ......+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence            64332211   1112344699999999989999999999999999999987765321110     00000   0000111


Q ss_pred             hhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          427 VLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      .+......+...   .....+.+++.+||+.+|++|||+.|+++.+..
T Consensus       238 ~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         238 LLKNNGRLPAPP---GCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             HHhcCCcCCCCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence            111111111111   112347899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=9.9e-38  Score=293.73  Aligned_cols=247  Identities=23%  Similarity=0.392  Sum_probs=196.6

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceee-cCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL-HKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lV~e~  283 (496)
                      .+|++.+.||+|+||.||+|..+ |..||+|.+.....   .+.+.+|+.++++++|+|++++++++. .+...++||||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCch---HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            47888999999999999999874 77899998865432   356889999999999999999999764 45678999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+++..... ..+++..++.++.|++.||+|||   ..+++||||||+||++++++.+||+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  156 (256)
T cd05082          82 MAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  156 (256)
T ss_pred             CCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence            999999999876432 25789999999999999999999   7899999999999999999999999999987653322 


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                        ....++..|+|||++.+..++.++||||||+++|+|++ |+.||.....       . .....+..........   .
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-------~-~~~~~~~~~~~~~~~~---~  223 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------K-DVVPRVEKGYKMDAPD---G  223 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-------H-HHHHHHhcCCCCCCCC---C
Confidence              22334568999999999899999999999999999997 9999853211       1 1111111111111111   1


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      ....+.+++.+||+.+|++|||+.++++.+.
T Consensus       224 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  254 (256)
T cd05082         224 CPPVVYDVMKQCWHLDAATRPSFLQLREQLE  254 (256)
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHHHHHHh
Confidence            2235778999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.1e-38  Score=296.46  Aligned_cols=254  Identities=23%  Similarity=0.380  Sum_probs=203.9

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      +|.+.+.||+|+||.||+|..+ +|..+|+|.+.... .....+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999765 58889999986542 122345678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCC-eEEccccccccccCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE-AFVADFGTARLLHADS  362 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~  362 (496)
                      +++++|.+++..... ..+++..+..++.|++.||.|||   ..+++|+||+|+||++++++. ++++|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            999999999876432 25789999999999999999999   779999999999999998854 6999999998765433


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                      .......|++.|+|||.+.+..++.++|+||+|+++|++++|+.||....       ..................    .
T Consensus       157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~----~  225 (257)
T cd08225         157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-------LHQLVLKICQGYFAPISP----N  225 (257)
T ss_pred             ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHhcccCCCCCC----C
Confidence            33334568889999999988889999999999999999999999986321       111222222222221111    1


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ....+.+++.+||..+|++|||+.|+++|+|+
T Consensus       226 ~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         226 FSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            12247789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-38  Score=302.31  Aligned_cols=264  Identities=29%  Similarity=0.356  Sum_probs=202.2

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      ++|++.+.||+|+||.||+|..+ +++.||+|.++... .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999765 58899999887543 22334678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |++++.+..+.....   .+++..+..++.||+.|+.|||   ..+++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            999877765554332   5789999999999999999999   7799999999999999999999999999998765443


Q ss_pred             C-CccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCC---------CCCC----cchhHhh
Q 011005          363 S-NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS---------SSDP----KIMLIDV  427 (496)
Q Consensus       363 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~---------~~~~----~~~~~~~  427 (496)
                      . ......++..|+|||++.+. .++.++||||+|+++|+|++|+.||........         ...+    .......
T Consensus       155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07833         155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR  234 (288)
T ss_pred             cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence            2 23345678899999999888 889999999999999999999999863221000         0000    0000000


Q ss_pred             hcC-CCCCCCChhHH------HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          428 LDQ-RLPPPVDRKVI------RDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       428 ~~~-~~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ... ..+........      .....+.+++.+||..+|++|||+++++++.|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            000 00000000000      013457899999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-39  Score=306.36  Aligned_cols=255  Identities=24%  Similarity=0.374  Sum_probs=202.3

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccc-hhHHHHHHHHHHHHHHHhhc-ccccccccceeecCCeEEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      ..|++.+.||.||.+.||++...+.+.||+|++... .+.+....|.+|+..+.+++ |.+|+++++|-..++.+|||||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            458899999999999999999888888999887653 35556788999999999996 9999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      +-+ .+|..+|.+...  ..+...++.+..||+.|+.+.|   ..||||.||||.|+|+-. |.+||+|||.|..+..+.
T Consensus       441 ~Gd-~DL~kiL~k~~~--~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  441 CGD-IDLNKILKKKKS--IDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             ccc-ccHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence            764 589999987543  2232367788999999999999   779999999999999976 589999999999887654


Q ss_pred             CC--ccccccccccccccccccCC-----------cCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhc
Q 011005          363 SN--RTLLAGTYGYIAPELAYTMV-----------MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD  429 (496)
Q Consensus       363 ~~--~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  429 (496)
                      ..  ....+||+.||+||.+....           .+.++||||+|||||+|+.|+.||+.....      ......+.+
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~------~aKl~aI~~  587 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ------IAKLHAITD  587 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH------HHHHHhhcC
Confidence            43  34578999999999886543           456899999999999999999999744311      111222222


Q ss_pred             C--CCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          430 Q--RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       430 ~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      +  .+..+.-.  ...  .+.+++..||.+||.+|||..|+|+|+|...
T Consensus       588 P~~~Iefp~~~--~~~--~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  588 PNHEIEFPDIP--END--ELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             CCccccccCCC--Cch--HHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            2  11111111  111  2778999999999999999999999999876

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-39  Score=308.71  Aligned_cols=253  Identities=28%  Similarity=0.410  Sum_probs=206.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCC---Cc--EEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPN---GK--VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~---~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      +..+..++||.|-||.||+|.+.+   |+  .||||..+.+...+..+.|..|+.+|+.++||||++++|.|.+.. .|+
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-MWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-eeE
Confidence            445556789999999999996532   33  589999988776667889999999999999999999999998764 789


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      |||.++-|.|..+++.+..  .++......++.||..||+|||   +..+|||||..+|||+.....|||+|||+++.+.
T Consensus       468 vmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             EEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            9999999999999997654  6888999999999999999999   7899999999999999999999999999999987


Q ss_pred             CCCCCccc-cccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          360 ADSSNRTL-LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       360 ~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                      ++...... ..-+..|||||.+.-.+++.+||||-||+.+||++. |..||+....      .+....-....++|.+..
T Consensus       543 d~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN------sDVI~~iEnGeRlP~P~n  616 (974)
T KOG4257|consen  543 DDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN------SDVIGHIENGERLPCPPN  616 (974)
T ss_pred             ccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc------cceEEEecCCCCCCCCCC
Confidence            66543322 334568999999999999999999999999999876 9999974432      111111112345554443


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                           .+..+..|+.+||..||.+||++.|+...+-.
T Consensus       617 -----CPp~LYslmskcWayeP~kRPrftei~~~lsd  648 (974)
T KOG4257|consen  617 -----CPPALYSLMSKCWAYEPSKRPRFTEIKAILSD  648 (974)
T ss_pred             -----CChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence                 34457789999999999999999988665443

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-38  Score=309.31  Aligned_cols=268  Identities=23%  Similarity=0.315  Sum_probs=201.8

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecC-----CeE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK-----KCM  277 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  277 (496)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|.+...........+.+|+.++++++|+||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46899999999999999999965 468999999987543334456678899999999999999999987654     357


Q ss_pred             EEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          278 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      ++|+||+.+ ++...+...    .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence            999999964 787777543    6899999999999999999999   78999999999999999999999999999976


Q ss_pred             ccCCCCC---cccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccC---------CCCCCcchh
Q 011005          358 LHADSSN---RTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS---------SSSDPKIML  424 (496)
Q Consensus       358 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~---------~~~~~~~~~  424 (496)
                      .......   .....+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||.......         .... ....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~-~~~~  234 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS-QEDL  234 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC-HHHH
Confidence            5432211   123467889999998754 568899999999999999999999985321100         0000 0000


Q ss_pred             Hhhhc-------CCCCCCCC----hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          425 IDVLD-------QRLPPPVD----RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       425 ~~~~~-------~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      .....       ...+....    .........+.+++.+||+.||++|||+.|+++|+|+......
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence            00000       00000000    0001123357899999999999999999999999999776544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.5e-38  Score=299.60  Aligned_cols=251  Identities=25%  Similarity=0.297  Sum_probs=198.0

Q ss_pred             eeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCCCh
Q 011005          213 IGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL  289 (496)
Q Consensus       213 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g~L  289 (496)
                      ||+|+||+||+|..+ +|+.||+|.+....  .......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999654 68899999986532  122344567899999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCccccc
Q 011005          290 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA  369 (496)
Q Consensus       290 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  369 (496)
                      .+++..... ..+++..+..++.|++.||.|||   ..+++||||+|+||++++++.++|+|||.+...... .......
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~  155 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRA  155 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-Ccccccc
Confidence            999876543 35899999999999999999999   789999999999999999999999999999766432 2223345


Q ss_pred             cccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHH
Q 011005          370 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLIST  449 (496)
Q Consensus       370 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  449 (496)
                      ++..|+|||.+.+..++.++||||+|+++|+|++|+.||......   . ............ +.....   .....+.+
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~-~~~~~~~~~~~~-~~~~~~---~~~~~~~~  227 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK---V-EKEELKRRTLEM-AVEYPD---KFSPEAKD  227 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc---c-cHHHHHhccccc-cccCCc---cCCHHHHH
Confidence            778999999998888999999999999999999999998643210   0 001111111110 111100   11234678


Q ss_pred             HHHhcccCCCCCCC-----CHHHHHHHHHHhc
Q 011005          450 VSFACLQSNPKSRP-----TMQSVSQEFLITR  476 (496)
Q Consensus       450 li~~cl~~dP~~Rp-----s~~evl~~~~~~~  476 (496)
                      ++.+||+.||++||     ++.++++|+|+.+
T Consensus       228 li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~  259 (277)
T cd05577         228 LCEALLQKDPEKRLGCRGGSADEVREHPLFKD  259 (277)
T ss_pred             HHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence            99999999999999     8888999999954

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=6.4e-38  Score=303.44  Aligned_cols=272  Identities=28%  Similarity=0.333  Sum_probs=202.5

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeecC--CeEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK--KCMFL  279 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  279 (496)
                      .++|++.+.||+|+||.||+|..+ +|+.||+|.++.... ......+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467999999999999999999764 689999999865432 11223456899999999999999999998754  46899


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||||+++ +|.+++....  ..+++..+..++.|++.||+|||   ..+++||||||+||+++.++.++|+|||++....
T Consensus        86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999975 7888877543  36899999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCC---------CCCCcc--hhHh-
Q 011005          360 ADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS---------SSDPKI--MLID-  426 (496)
Q Consensus       360 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~---------~~~~~~--~~~~-  426 (496)
                      ..........+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||........         ......  .... 
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence            43333333446788999999875 4578999999999999999999999863321100         000000  0000 


Q ss_pred             -hhc-CCCCC-CCC---hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCC
Q 011005          427 -VLD-QRLPP-PVD---RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLV  481 (496)
Q Consensus       427 -~~~-~~~~~-~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~  481 (496)
                       ... ..... +..   .........+.+++.+||+.||++|||+.|+++|+|+....-..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~  300 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPC  300 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCC
Confidence             000 00000 000   00001123467899999999999999999999999998655443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-37  Score=295.79  Aligned_cols=258  Identities=26%  Similarity=0.429  Sum_probs=203.4

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCC-Cc----EEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPN-GK----VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      .+|++.+.||+|+||.||+|..++ |+    .+|+|.............+.+|+.++++++|+||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            568889999999999999997542 32    5899988766544555778899999999999999999999987 67899


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||||+++|+|.+++.....  .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||.++...
T Consensus        86 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            9999999999999876433  5899999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCCCCcc--ccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCC
Q 011005          360 ADSSNRT--LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV  436 (496)
Q Consensus       360 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  436 (496)
                      .......  ...++..|+|||.+....++.++|+||||+++||+++ |+.||....       .. .....+......+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-------~~-~~~~~~~~~~~~~~  232 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP-------AV-EIPDLLEKGERLPQ  232 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC-------HH-HHHHHHhCCCCCCC
Confidence            3322111  1223567999999988889999999999999999998 999986321       11 11122222111111


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      ..   .....+.+++.+||..||.+||++.++++.+....+.+
T Consensus       233 ~~---~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05057         233 PP---ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP  272 (279)
T ss_pred             CC---CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence            11   01124678899999999999999999999988765543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.5e-38  Score=302.96  Aligned_cols=264  Identities=23%  Similarity=0.289  Sum_probs=199.6

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeecC--CeEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK--KCMFLI  280 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lV  280 (496)
                      ++|++.+.||+|+||.||+|..+ +++.+|+|.++.... ......+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57888999999999999999775 588999999875432 22234567899999999999999999998877  789999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+++ +|.+.+.....  .+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        85 ~e~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999974 89888876432  6899999999999999999999   77999999999999999999999999999987655


Q ss_pred             CCCCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCC---------CCCCcch--hHhh-
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS---------SSDPKIM--LIDV-  427 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~---------~~~~~~~--~~~~-  427 (496)
                      .........+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||........         .......  .... 
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence            43333345578899999988764 468899999999999999999999863321100         0000000  0000 


Q ss_pred             -hc-CC---C-CCCCChhHHH--HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          428 -LD-QR---L-PPPVDRKVIR--DILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       428 -~~-~~---~-~~~~~~~~~~--~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                       .. ..   . ..........  ....+.+++.+||+.||++|||+.|+++|.|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence             00 00   0 0000000000  12346789999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-39  Score=313.07  Aligned_cols=253  Identities=23%  Similarity=0.382  Sum_probs=203.9

Q ss_pred             cceeeecCCeeEEEEEeC-CCcEEEEEEcc---cchhHHHHHHHHHHHHHHHhhcccccccccceeecCC--eEEEEEEe
Q 011005          210 RYCIGTGGYGSVYKAQLP-NGKVFALKKLH---TSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK--CMFLIYEY  283 (496)
Q Consensus       210 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~---~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lV~e~  283 (496)
                      ...||+|+|-+||||.+. +|..||=-.++   ........+.|..|+.+++.|+||||+++|+++.+..  ...+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            456999999999999654 46665532222   2334455688999999999999999999999997754  58899999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC-CCeEEccccccccccCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTARLLHADS  362 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~  362 (496)
                      +..|+|..|+.+.+   ..+.....+|++||++||.|||++ ..+|+|||||-+|||++.+ |.|||+|+|+|+......
T Consensus       125 ~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  125 FTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             ccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            99999999999876   678899999999999999999998 7899999999999999865 899999999999875443


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                      .  ...+|||.|||||... ..|++.+||||||+.++||+|+..||..      -..+......+..+..|.....   -
T Consensus       201 a--ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE------C~n~AQIYKKV~SGiKP~sl~k---V  268 (632)
T KOG0584|consen  201 A--KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE------CTNPAQIYKKVTSGIKPAALSK---V  268 (632)
T ss_pred             c--ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh------hCCHHHHHHHHHcCCCHHHhhc---c
Confidence            2  3378999999999877 7899999999999999999999999852      1222233334444443332221   1


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      ....+.++|.+|+.. .++|||+.|+|++.|+.....
T Consensus       269 ~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g  304 (632)
T KOG0584|consen  269 KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDGG  304 (632)
T ss_pred             CCHHHHHHHHHHhcC-chhccCHHHHhhChhhccccc
Confidence            133578999999999 899999999999999987643

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.4e-37  Score=292.79  Aligned_cols=250  Identities=29%  Similarity=0.454  Sum_probs=200.0

Q ss_pred             CCCcceeeecCCeeEEEEEeCC-----CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          207 FDIRYCIGTGGYGSVYKAQLPN-----GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      |++.+.||.|+||.||+|...+     +..||+|.+.........+.+..|+.+++.++|+||+++++++...+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4567889999999999997653     48899999977654445678899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++++|.+++...... .+++..+..++.|++.||++||   +.+++|+||+|+||++++++.++|+|||++......
T Consensus        81 e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            999999999998764421 2899999999999999999999   789999999999999999999999999999876543


Q ss_pred             CCCcc-ccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          362 SSNRT-LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       362 ~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                      ..... ...+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||....       ................... 
T Consensus       157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~-  228 (258)
T smart00219      157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS-------NEEVLEYLKKGYRLPKPEN-  228 (258)
T ss_pred             cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHhcCCCCCCCCc-
Confidence            22111 2236789999999988889999999999999999998 788875311       1111111111111111111 


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQE  471 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~  471 (496)
                         ....+.+++.+|+..||++|||+.|+++.
T Consensus       229 ---~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  257 (258)
T smart00219      229 ---CPPEIYKLMLQCWAEDPEDRPTFSELVEI  257 (258)
T ss_pred             ---CCHHHHHHHHHHCcCChhhCcCHHHHHhh
Confidence               23357789999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-37  Score=291.72  Aligned_cols=246  Identities=26%  Similarity=0.409  Sum_probs=196.4

Q ss_pred             ceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCCChh
Q 011005          211 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLF  290 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g~L~  290 (496)
                      +.||+|+||.||+|..++++.|++|.+...........+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            36899999999999887799999999876544344567899999999999999999999999999999999999999999


Q ss_pred             hhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCc--ccc
Q 011005          291 CNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR--TLL  368 (496)
Q Consensus       291 ~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~  368 (496)
                      +++.....  .+++..+..++.+++.|++|||   +.+++||||+|+||+++.++.++|+|||.+..........  ...
T Consensus        81 ~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKKKN--RLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            99875432  5788999999999999999999   7799999999999999999999999999997654221111  112


Q ss_pred             ccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHH
Q 011005          369 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLI  447 (496)
Q Consensus       369 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  447 (496)
                      ..+..|+|||.+.+..++.++||||||+++|+|++ |..||.....        .................   .....+
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--------~~~~~~~~~~~~~~~~~---~~~~~~  224 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--------QQTRERIESGYRMPAPQ---LCPEEI  224 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--------HHHHHHHhcCCCCCCCc---cCCHHH
Confidence            23567999999998899999999999999999999 8888853221        11111121111111111   112357


Q ss_pred             HHHHHhcccCCCCCCCCHHHHHHHH
Q 011005          448 STVSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       448 ~~li~~cl~~dP~~Rps~~evl~~~  472 (496)
                      .+++.+||+.+|++|||+.|+++.+
T Consensus       225 ~~li~~~l~~~p~~Rp~~~ell~~l  249 (251)
T cd05041         225 YRLMLQCWAYDPENRPSFSEIYNEL  249 (251)
T ss_pred             HHHHHHHhccChhhCcCHHHHHHHh
Confidence            8899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.4e-37  Score=293.74  Aligned_cols=249  Identities=25%  Similarity=0.369  Sum_probs=190.4

Q ss_pred             ceeeecCCeeEEEEEeC----CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceee-cCCeEEEEEEecC
Q 011005          211 YCIGTGGYGSVYKAQLP----NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL-HKKCMFLIYEYME  285 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lV~e~~~  285 (496)
                      +.||+|+||.||+|.+.    ++..||+|.+.........+.+.+|+.+++.++||||+++++++. .+...++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            35899999999999753    245799999865444444567889999999999999999999775 4556789999999


Q ss_pred             CCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC--
Q 011005          286 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS--  363 (496)
Q Consensus       286 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  363 (496)
                      +|+|.+++.....  ..++..+..++.|++.||+|||   ..+++||||||+||++++++.+||+|||+++.......  
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            9999999875432  4577888899999999999999   77999999999999999999999999999976543211  


Q ss_pred             --CccccccccccccccccccCCcCcccchhhHHHHHHHHHhC-CCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          364 --NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG-KHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       364 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                        ......+++.|+|||.+.+..++.++||||||+++|||++| .+||....       ............... ...  
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-------~~~~~~~~~~~~~~~-~~~--  225 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-------SFDITVYLLQGRRLL-QPE--  225 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHhcCCCCC-CCC--
Confidence              11123456789999999888999999999999999999995 55554211       111111121111111 111  


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                       ..+..+.+++.+||+.+|++||++.|+++.+...
T Consensus       226 -~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         226 -YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             -cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence             1123477899999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.4e-37  Score=300.66  Aligned_cols=256  Identities=28%  Similarity=0.369  Sum_probs=202.4

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ..|.+.+.||+|+||+||+|... +++.||+|.+....  .....+.+.+|+++++.++||||+++++++..++..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            56888899999999999999764 68999999886432  2233467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+. |++.+.+....  ..+++..+..++.|++.||.|||   +.+++||||+|+||++++++.++|+|||++......
T Consensus        95 e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9997 57776665432  25889999999999999999999   779999999999999999999999999998755322


Q ss_pred             CCCccccccccccccccccc---cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCCh
Q 011005          362 SSNRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR  438 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  438 (496)
                          ....+++.|+|||.+.   ...++.++||||||+++|||++|+.||.....       ............+...  
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~-------~~~~~~~~~~~~~~~~--  235 (307)
T cd06607         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNDSPTLS--  235 (307)
T ss_pred             ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH-------HHHHHHHhcCCCCCCC--
Confidence                2346788999999874   45688899999999999999999999853221       1111111111111111  


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          439 KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       439 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                       .......+.+++.+||+.||++||++.++++|+|+.+..+.
T Consensus       236 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  276 (307)
T cd06607         236 -SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPP  276 (307)
T ss_pred             -chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccCCc
Confidence             11123357899999999999999999999999999887653

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.2e-37  Score=293.74  Aligned_cols=255  Identities=27%  Similarity=0.400  Sum_probs=200.6

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCC----CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      .++|.+.+.||+|+||.||+|.+.+    ...|++|...........+.+.+|+.++++++||||+++++++... ..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEE
Confidence            3568889999999999999997543    3468999887655444557789999999999999999999988764 5679


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||||+++|+|.+++.....  .+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||+++...
T Consensus        84 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          84 VMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence            9999999999999976432  5799999999999999999999   7899999999999999999999999999998764


Q ss_pred             CCCCC-ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhc-CCCCCCC
Q 011005          360 ADSSN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLD-QRLPPPV  436 (496)
Q Consensus       360 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  436 (496)
                      ..... .....++..|+|||.+....++.++||||||+++||+++ |+.||.....       ......... ...+.+.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~  231 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-------NDVIGRIENGERLPMPP  231 (270)
T ss_pred             cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHcCCcCCCCC
Confidence            43211 112234568999999988889999999999999999986 9999863321       111111111 1111111


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                           .....+.+++.+|+..+|++|||+.++++.+....
T Consensus       232 -----~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         232 -----NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             -----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                 11235778999999999999999999999886643

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.4e-37  Score=293.57  Aligned_cols=239  Identities=22%  Similarity=0.320  Sum_probs=186.0

Q ss_pred             ceeeecCCeeEEEEEeCC-------------CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeE
Q 011005          211 YCIGTGGYGSVYKAQLPN-------------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCM  277 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  277 (496)
                      +.||+|+||.||+|....             ...|++|.+.... ......+.+|+.+++.++||||+++++++..+...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            358999999999997532             2358888876543 23446788899999999999999999999998889


Q ss_pred             EEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCC-------eEEc
Q 011005          278 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE-------AFVA  350 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~-------~kl~  350 (496)
                      ++||||+++|+|..++....  ..+++..++.++.||+.||+|||   +++++||||||+||+++.++.       ++++
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence            99999999999988886533  25889999999999999999999   789999999999999987654       8999


Q ss_pred             cccccccccCCCCCccccccccccccccccc-cCCcCcccchhhHHHHHHHHH-hCCCCCccccccCCCCCCcchhHhhh
Q 011005          351 DFGTARLLHADSSNRTLLAGTYGYIAPELAY-TMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVL  428 (496)
Q Consensus       351 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~-~g~~p~~~~~~~~~~~~~~~~~~~~~  428 (496)
                      |||++......    ....++..|+|||.+. +..++.++||||||+++|||+ +|..|+.....        .......
T Consensus       155 d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~~~  222 (262)
T cd05077         155 DPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL--------AEKERFY  222 (262)
T ss_pred             CCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch--------hHHHHHH
Confidence            99998655322    2345778899999887 567889999999999999998 58888753211        0111111


Q ss_pred             cCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 011005          429 DQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~  472 (496)
                      .........     ....+.+++.+||+.||++||++.++++++
T Consensus       223 ~~~~~~~~~-----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         223 EGQCMLVTP-----SCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             hcCccCCCC-----ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            111111000     123477899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=8.5e-38  Score=300.67  Aligned_cols=265  Identities=25%  Similarity=0.333  Sum_probs=203.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCC-CcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-ccccccccceeecCCeEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lV~  281 (496)
                      .++|++.+.||+|+||.||+|.+++ ++.||||.++..........+.+|+.++.+.. |+||+++++++..+...++||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3678899999999999999998764 89999999976543333456677787777775 999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+. +++.+.+.....  .+++..+..++.|++.|++|||+  ..+++||||+|+||++++++.++|+|||++......
T Consensus        94 e~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          94 ELMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             eccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            9985 477766654322  68899999999999999999994  258999999999999999999999999999766432


Q ss_pred             CCCccccccccccccccccccCC----cCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMV----MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                      .. .....+++.|+|||.+.+..    ++.++||||||+++|+|++|+.||.....      .............+....
T Consensus       169 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~  241 (296)
T cd06618         169 KA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT------EFEVLTKILQEEPPSLPP  241 (296)
T ss_pred             Cc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh------HHHHHHHHhcCCCCCCCC
Confidence            22 22345778999999987654    78899999999999999999999863211      111122222222111110


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCC
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVK  482 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~  482 (496)
                      .  ......+.+++.+||+.||++||++.++++++|+....+...
T Consensus       242 ~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~  284 (296)
T cd06618         242 N--EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEV  284 (296)
T ss_pred             C--CCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhHH
Confidence            0  012235789999999999999999999999999987655543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=8e-38  Score=299.91  Aligned_cols=255  Identities=24%  Similarity=0.390  Sum_probs=205.0

Q ss_pred             cceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCCC
Q 011005          210 RYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGS  288 (496)
Q Consensus       210 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g~  288 (496)
                      ...||+|+||.||+|.. .+++.||+|++..... .....+.+|+.+++.++|+|++++++++...+..++||||+++++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch-hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            35699999999999976 4789999998865332 234668899999999999999999999999999999999999999


Q ss_pred             hhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCcccc
Q 011005          289 LFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL  368 (496)
Q Consensus       289 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  368 (496)
                      |.+++...    .+++..+..++.|++.|++|||   ..|++||||+|+||+++.++.++|+|||++.............
T Consensus       104 L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~  176 (292)
T cd06657         104 LTDIVTHT----RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  176 (292)
T ss_pred             HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence            99887543    5788999999999999999999   7799999999999999999999999999987665433333445


Q ss_pred             ccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHH
Q 011005          369 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLIS  448 (496)
Q Consensus       369 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  448 (496)
                      .+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.....        ...........+..... .......+.
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--------~~~~~~~~~~~~~~~~~-~~~~~~~l~  247 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIRDNLPPKLKN-LHKVSPSLK  247 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhhCCcccCC-cccCCHHHH
Confidence            688999999999888899999999999999999999999853211        11111111112111111 111223467


Q ss_pred             HHHHhcccCCCCCCCCHHHHHHHHHHhccCCCC
Q 011005          449 TVSFACLQSNPKSRPTMQSVSQEFLITRKTPLV  481 (496)
Q Consensus       449 ~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~  481 (496)
                      +++.+||+.||.+||++.++++|.|+.+..+..
T Consensus       248 ~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~  280 (292)
T cd06657         248 GFLDRLLVRDPAQRATAAELLKHPFLAKAGPPS  280 (292)
T ss_pred             HHHHHHHhCCcccCcCHHHHhcChHHhccCCCc
Confidence            889999999999999999999999999887644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-38  Score=301.20  Aligned_cols=263  Identities=23%  Similarity=0.284  Sum_probs=198.5

Q ss_pred             CCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          207 FDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      |++.+.||.|++|.||+|..+ +|+.||+|++..... ......+.+|++++++++|+|++++++++..++..++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            677889999999999999764 799999999875432 222356788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      + ++|.+++..... ..+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||++.........
T Consensus        81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            5 689988876542 35899999999999999999999   779999999999999999999999999999765433322


Q ss_pred             ccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCC---------CCCCcc-----hhHhhhc
Q 011005          365 RTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS---------SSDPKI-----MLIDVLD  429 (496)
Q Consensus       365 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~---------~~~~~~-----~~~~~~~  429 (496)
                      .....+++.|+|||++.+. .++.++||||+|+++|+|++|+.||........         ......     ...+...
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP  235 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence            3334568899999988764 568899999999999999999999863221000         000000     0000000


Q ss_pred             ---CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          430 ---QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       430 ---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                         .................+.+++.+||+.||++|||++|+++|+|+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence               000000000000111357789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-39  Score=311.47  Aligned_cols=270  Identities=25%  Similarity=0.430  Sum_probs=219.8

Q ss_pred             CCCCcceeeecCCeeEEEEEeC--CCc--EEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP--NGK--VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      +....++||+|.||+|++|.|+  +|+  .||||.++..........|.+|+.+|.+++|+|++++||...+ ....|||
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            4455678999999999999775  344  5899999887655577899999999999999999999999987 5578999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      |.++.|+|.+.|++ .....|.......++.||+.|+.||.   .+++|||||.++|+++-....|||+|||+.+-+...
T Consensus       190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            99999999999998 44557888999999999999999999   789999999999999999999999999999987654


Q ss_pred             CCCccc---cccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhc--CCCCCC
Q 011005          362 SSNRTL---LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLD--QRLPPP  435 (496)
Q Consensus       362 ~~~~~~---~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  435 (496)
                      ...+.+   ..-...|+|||.+.-..++.++|||+|||++|||+| |..||-...        ...+.+.++  .+++.+
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--------g~qIL~~iD~~erLpRP  337 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--------GIQILKNIDAGERLPRP  337 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC--------HHHHHHhccccccCCCC
Confidence            443322   123458999999999999999999999999999998 778875322        222333333  233333


Q ss_pred             CChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCcccccccchhh
Q 011005          436 VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDISISE  493 (496)
Q Consensus       436 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~~~~~i~~~~  493 (496)
                      ..     ....+.+++..||..+|++||||..+.+.++.....+..-.+.-..++.+.
T Consensus       338 k~-----csedIY~imk~cWah~paDRptFsair~~~~l~eaqp~~a~~~~d~~ep~a  390 (1039)
T KOG0199|consen  338 KY-----CSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQPAVARETYDSIEPGA  390 (1039)
T ss_pred             CC-----ChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCCceeeeeccccCCCc
Confidence            22     233578999999999999999999999999988888877666666555543

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.6e-37  Score=292.83  Aligned_cols=237  Identities=27%  Similarity=0.429  Sum_probs=187.6

Q ss_pred             ceeeecCCeeEEEEEeCCCc-----------EEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          211 YCIGTGGYGSVYKAQLPNGK-----------VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      +.||+|+||.||+|.+.+..           .+++|.+......  ...+.+|+.+++.++||||+++++++.. ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            35899999999999775433           5778877654432  4678899999999999999999999988 77899


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC-------CeEEccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-------EAFVADF  352 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~-------~~kl~Df  352 (496)
                      ||||+++|+|.+++.....  .+++..+..++.||+.||+|||   +++++||||||+||+++.++       .++|+||
T Consensus        78 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCC
Confidence            9999999999999886543  5788999999999999999999   78999999999999999887       7999999


Q ss_pred             cccccccCCCCCccccccccccccccccccC--CcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhc
Q 011005          353 GTARLLHADSSNRTLLAGTYGYIAPELAYTM--VMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLD  429 (496)
Q Consensus       353 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  429 (496)
                      |++.....    .....++..|+|||++.+.  .++.++||||+|+++|+|++ |..||.....     ........ ..
T Consensus       153 g~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-----~~~~~~~~-~~  222 (259)
T cd05037         153 GIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-----SEKERFYQ-DQ  222 (259)
T ss_pred             Cccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-----hhHHHHHh-cC
Confidence            99976543    2234566789999999877  78899999999999999999 5777753321     00000111 11


Q ss_pred             CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 011005          430 QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       430 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~  472 (496)
                      ...+.+..       ..+.+++.+||..+|++|||+.++++.+
T Consensus       223 ~~~~~~~~-------~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         223 HRLPMPDC-------AELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             CCCCCCCc-------hHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            11111111       3577999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.5e-37  Score=299.85  Aligned_cols=258  Identities=25%  Similarity=0.407  Sum_probs=200.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCc----EEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGK----VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMF  278 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  278 (496)
                      .++|+..+.||+|+||.||+|.+. ++.    .||+|.+...........+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            356888899999999999999753 343    57889887654444445688999999999999999999998764 467


Q ss_pred             EEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccc
Q 011005          279 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL  358 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  358 (496)
                      +++||+++|+|.+++....  ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+++..
T Consensus        85 ~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccc
Confidence            9999999999999987543  25788999999999999999999   789999999999999999999999999999876


Q ss_pred             cCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCC
Q 011005          359 HADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP  435 (496)
Q Consensus       359 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  435 (496)
                      ......  .....++..|+|||.+.+..++.++||||||+++||+++ |+.||....        .....+.+......+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--------~~~~~~~~~~~~~~~  231 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--------TREIPDLLEKGERLP  231 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHCCCCCC
Confidence            433221  122335678999999999999999999999999999997 899985321        111112222111111


Q ss_pred             CChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          436 VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       436 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ...   .....+.+++.+||..+|++||+++++++.+......
T Consensus       232 ~~~---~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         232 QPP---ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             CCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            111   0122467889999999999999999999998765443

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.5e-37  Score=291.44  Aligned_cols=252  Identities=33%  Similarity=0.475  Sum_probs=205.4

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      +|+..+.||+|++|.||++..+ +++.+++|++..... ...+.+.+|+++++.++|+|++++++.+......++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            4778899999999999999775 688999999977553 34567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      ++++|.+.+....  ..+++..+..++.|++.|+.+||   ..+++||||+|+||++++++.++|+|||.+........ 
T Consensus        80 ~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          80 SGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            9999999987653  36899999999999999999999   78999999999999999999999999999987654332 


Q ss_pred             ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHH
Q 011005          365 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI  444 (496)
Q Consensus       365 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  444 (496)
                      .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||.....       ......... ........ .....
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~-~~~~~~~~-~~~~~  224 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP-------MKALFKIAT-NGPPGLRN-PEKWS  224 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch-------HHHHHHHHh-cCCCCcCc-ccccC
Confidence            3345688899999999988899999999999999999999999863321       111111111 11111111 11112


Q ss_pred             HHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          445 LLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       445 ~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      ..+.+++.+||+.||++|||+.|+++|+|
T Consensus       225 ~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         225 DEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            35788999999999999999999999876

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.9e-37  Score=305.65  Aligned_cols=264  Identities=24%  Similarity=0.294  Sum_probs=200.1

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecC------
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK------  274 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  274 (496)
                      ..++|+..+.||+|+||.||+|... +++.||+|.+.... .......+.+|+.++++++|+||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999754 78999999986532 223345677899999999999999999988643      


Q ss_pred             CeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccc
Q 011005          275 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  354 (496)
Q Consensus       275 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  354 (496)
                      ...++||||+. ++|.+.+..     .++...+..++.|++.||+|||   ..|++||||||+||+++.++.++|+|||+
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCcc
Confidence            35799999996 488877754     2788889999999999999999   77999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCC-------CCCCcch----
Q 011005          355 ARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS-------SSDPKIM----  423 (496)
Q Consensus       355 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~-------~~~~~~~----  423 (496)
                      ++...... ......+++.|+|||.+.+..++.++||||+|+++|+|++|+.||........       ...+...    
T Consensus       165 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
T cd07850         165 ARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR  243 (353)
T ss_pred             ceeCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            98764322 22334578899999999999999999999999999999999999863221000       0000000    


Q ss_pred             ----hHhhhcCCC----------------CCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          424 ----LIDVLDQRL----------------PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       424 ----~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                          .......+.                +.............+.+++.+||+.||++|||+.|+++|+|+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence                000000000                00000001112334679999999999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.2e-38  Score=302.09  Aligned_cols=266  Identities=22%  Similarity=0.253  Sum_probs=197.8

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhc-ccccccccceeecCCe-----
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKC-----  276 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~-----  276 (496)
                      ++|++.+.||+|+||.||+|... +++.||+|.+..... ......+.+|+.+++.+. |+||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999764 689999998865432 122356788999999995 6999999999877655     


Q ss_pred             EEEEEEecCCCChhhhhhCCCC--CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC-CCCeEEcccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNED--AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KLEAFVADFG  353 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg  353 (496)
                      .++||||+++ +|.+++.....  ...+++..++.++.||+.||.|||   ..+++||||+|+||+++. ++.++|+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999986 78888765432  236899999999999999999999   789999999999999998 8899999999


Q ss_pred             ccccccCCCCCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCCC-------CCCc-ch-
Q 011005          354 TARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSS-------SDPK-IM-  423 (496)
Q Consensus       354 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~-------~~~~-~~-  423 (496)
                      ++..+...........+++.|+|||.+.+ ..++.++||||+|+++|+|++|..||.........       ..+. .. 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T cd07837         157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW  236 (295)
T ss_pred             cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence            99866443333333456889999998865 45789999999999999999999998632211000       0000 00 


Q ss_pred             --hHhh-----hcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          424 --LIDV-----LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       424 --~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                        ....     .....+.............+.+++.+||++||.+||++.|++.|+|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~  294 (295)
T cd07837         237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF  294 (295)
T ss_pred             cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCc
Confidence              0000     00000000000001122347789999999999999999999999986

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2e-37  Score=293.86  Aligned_cols=254  Identities=25%  Similarity=0.415  Sum_probs=199.8

Q ss_pred             CCCCcceeeecCCeeEEEEEeCC--CcEEEEEEcccc---------hhHHHHHHHHHHHHHHHh-hcccccccccceeec
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLPN--GKVFALKKLHTS---------EELAFIKSFKNEAQVLSQ-VLHRNIVKLYGYCLH  273 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~---------~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~  273 (496)
                      +|++.+.||+|+||.||+|..+.  ++.+|+|.+...         ........+.+|+.++.+ ++|+||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999998764  788999987532         122334556788888875 689999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhCC-CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccc
Q 011005          274 KKCMFLIYEYMERGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF  352 (496)
Q Consensus       274 ~~~~~lV~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Df  352 (496)
                      ++..++||||+++++|.+++... .....+++..++.++.|++.||.|||+  ..+++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999887542 223368899999999999999999994  358999999999999999999999999


Q ss_pred             cccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCC
Q 011005          353 GTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRL  432 (496)
Q Consensus       353 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  432 (496)
                      |.+....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....       .............
T Consensus       159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-------~~~~~~~~~~~~~  230 (269)
T cd08528         159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-------MLSLATKIVEAVY  230 (269)
T ss_pred             cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-------HHHHHHHHhhccC
Confidence            9998764433 3344568889999999999889999999999999999999999985321       1111112222222


Q ss_pred             CCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 011005          433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       433 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~  472 (496)
                      .+....   .....+.+++.+||+.||++||++.|+.+++
T Consensus       231 ~~~~~~---~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~  267 (269)
T cd08528         231 EPLPEG---MYSEDVTDVITSCLTPDAEARPDIIQVSAMI  267 (269)
T ss_pred             CcCCcc---cCCHHHHHHHHHHCCCCCccCCCHHHHHHHh
Confidence            111110   1123477899999999999999999998876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=314.30  Aligned_cols=255  Identities=26%  Similarity=0.448  Sum_probs=209.4

Q ss_pred             CCCcceeeecCCeeEEEEEe-CCCc----EEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          207 FDIRYCIGTGGYGSVYKAQL-PNGK----VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ....+.||+|+||+||||.+ +.|+    +||+|++......+...++.+|+.+|.+++|||+++++++|.... +.||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            34467899999999999954 4444    689999988776667789999999999999999999999998776 78999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      +|++.|+|.++++.+++  .+.....+.|+.||++|+.|||   .+.++||||.++|||+..-..+||+|||+++....+
T Consensus       777 q~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HhcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999997654  6778889999999999999999   789999999999999999999999999999988776


Q ss_pred             CCCccccc--cccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhc--CCCCCCC
Q 011005          362 SSNRTLLA--GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLD--QRLPPPV  436 (496)
Q Consensus       362 ~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  436 (496)
                      ........  -.+.|||-|.+.-..|+.++|||||||++||++| |..|++....        ..+.+.+.  .+++.+.
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~--------~eI~dlle~geRLsqPp  923 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA--------EEIPDLLEKGERLSQPP  923 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH--------HHhhHHHhccccCCCCC
Confidence            65544333  3468999999999999999999999999999998 8889864321        12222222  2333222


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                           .....+..++.+||..|++.||+++++..++-...+.|.
T Consensus       924 -----iCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq  962 (1177)
T KOG1025|consen  924 -----ICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ  962 (1177)
T ss_pred             -----CccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence                 223346778889999999999999999999877766554

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=9.9e-38  Score=295.94  Aligned_cols=248  Identities=27%  Similarity=0.397  Sum_probs=194.0

Q ss_pred             eeeecCCeeEEEEEeCC-------CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          212 CIGTGGYGSVYKAQLPN-------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       212 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      .||+|+||.||+|..++       ++.+|+|.+...........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            58999999999997643       25789998876543344567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCC----CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC-----CeEEcccccc
Q 011005          285 ERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-----EAFVADFGTA  355 (496)
Q Consensus       285 ~~g~L~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~-----~~kl~Dfg~~  355 (496)
                      ++++|.+++....    ....+++.+++.++.|++.||+|||   +.+++|+||+|+||+++.++     .++++|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            9999999987532    2234788999999999999999999   77999999999999999887     8999999999


Q ss_pred             ccccCCCC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCC
Q 011005          356 RLLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRL  432 (496)
Q Consensus       356 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  432 (496)
                      ........  ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.....       . .....+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-------~-~~~~~~~~~~  230 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-------Q-EVLQHVTAGG  230 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-------H-HHHHHHhcCC
Confidence            76533221  1122345678999999999999999999999999999998 9999863221       1 1111111111


Q ss_pred             CCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       433 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      .....   ......+.+++.+||+.+|.+||+++++++.+.
T Consensus       231 ~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         231 RLQKP---ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ccCCc---ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            11111   112235779999999999999999999988763

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=7.7e-38  Score=306.11  Aligned_cols=272  Identities=24%  Similarity=0.302  Sum_probs=205.6

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeec----CCeE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH----KKCM  277 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~  277 (496)
                      .++|++.+.||+|+||.||+|..+ +++.||+|++..... ....+.+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            478999999999999999999754 689999999876432 2334567789999999999999999998763    3468


Q ss_pred             EEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          278 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      ++||||+. ++|.+.+....   .+++..+..++.||+.||+|||   ..+++||||||+||++++++.++|+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999996 58888886543   5899999999999999999999   77999999999999999999999999999976


Q ss_pred             ccCCCCC----cccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccC---------CCCCC---
Q 011005          358 LHADSSN----RTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS---------SSSDP---  420 (496)
Q Consensus       358 ~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~---------~~~~~---  420 (496)
                      .......    .....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.......         .....   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            5432221    123468889999998765 468899999999999999999999996432100         00000   


Q ss_pred             ----cchhHhhh---cCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCC
Q 011005          421 ----KIMLIDVL---DQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVK  482 (496)
Q Consensus       421 ----~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~  482 (496)
                          .....+..   ......+...........+.+++.+||+.||++|||++++++|+|+.+......
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~  305 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD  305 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcc
Confidence                00000000   001111101101112345889999999999999999999999999977665554

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.4e-37  Score=293.89  Aligned_cols=238  Identities=22%  Similarity=0.347  Sum_probs=184.6

Q ss_pred             eeeecCCeeEEEEEeC-------------------------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhccccccc
Q 011005          212 CIGTGGYGSVYKAQLP-------------------------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK  266 (496)
Q Consensus       212 ~lg~G~~g~Vy~~~~~-------------------------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~  266 (496)
                      .||+|+||.||+|...                         ....|++|.+..... .....+.+|+.+++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence            5899999999999642                         123588888865432 33466888999999999999999


Q ss_pred             ccceeecCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC-
Q 011005          267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-  345 (496)
Q Consensus       267 ~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~-  345 (496)
                      +++++..+...++||||+++|+|..++....  ..+++..+..++.||+.||+|||   .++++||||||+||+++..+ 
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCc
Confidence            9999999999999999999999998886532  26788999999999999999999   78999999999999997643 


Q ss_pred             ------CeEEccccccccccCCCCCcccccccccccccccccc-CCcCcccchhhHHHHHHHHH-hCCCCCccccccCCC
Q 011005          346 ------EAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSS  417 (496)
Q Consensus       346 ------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~-~g~~p~~~~~~~~~~  417 (496)
                            .++++|||.+......    ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||.....    
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----  227 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP----  227 (274)
T ss_pred             ccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh----
Confidence                  3799999988654322    12356778999998875 56889999999999999985 69999863221    


Q ss_pred             CCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 011005          418 SDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~  472 (496)
                         . ............+...     ...+.+++.+||+.+|++|||+.++++++
T Consensus       228 ---~-~~~~~~~~~~~~~~~~-----~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         228 ---S-EKERFYEKKHRLPEPS-----CKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             ---H-HHHHHHHhccCCCCCC-----ChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence               1 1111112111111110     12477899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.2e-37  Score=299.32  Aligned_cols=268  Identities=24%  Similarity=0.297  Sum_probs=199.2

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      ++|++.+.||+|++|+||+|..+ +++.||+|.+..... ....+.+.+|++++++++|+||+++++++..+...++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46889999999999999999765 688999999865432 2233567889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC-CCCeEEccccccccccCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KLEAFVADFGTARLLHAD  361 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~  361 (496)
                      |++ +++.+.+..... ..+++..+..++.||+.||+|||   +++++|+||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 578777765432 24678888899999999999999   779999999999999985 567999999999765433


Q ss_pred             CCCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCC---------CCCCc-----chhHh
Q 011005          362 SSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS---------SSDPK-----IMLID  426 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~---------~~~~~-----~~~~~  426 (496)
                      ........+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||........         .....     .....
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence            3333334678899999988664 578899999999999999999999863221000         00000     00000


Q ss_pred             hhc--CCCCCCC-ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          427 VLD--QRLPPPV-DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       427 ~~~--~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ...  ....... ..........+.+++.+|++.+|++||++.++++|+|+..-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence            000  0000000 00000112346789999999999999999999999998653

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-38  Score=305.86  Aligned_cols=256  Identities=24%  Similarity=0.343  Sum_probs=214.6

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ...|.+...||+|.|+.|..|.+. .+..||||.+.+.. +....+.+.+|+++|+.++|||||+++.+......+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            467889999999999999999654 69999999998754 3334456899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+.+|.+++++.+..   ......+..++.|++.|++|||   .+.|+|||||++|+|++.+.++||+|||++..+. .
T Consensus       135 eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-~  207 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD-Y  207 (596)
T ss_pred             EeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec-c
Confidence            9999999999999876   4455888899999999999999   7899999999999999999999999999999886 3


Q ss_pred             CCCccccccccccccccccccCCcC-cccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcC--CCCCCCCh
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVMT-EKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQ--RLPPPVDR  438 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  438 (496)
                      .....+.+|++.|.|||++.+..|. +++|+||+|+++|-|+.|..||+.-..       .......+..  +++.....
T Consensus       208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-------k~Lr~rvl~gk~rIp~~ms~  280 (596)
T KOG0586|consen  208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-------KELRPRVLRGKYRIPFYMSC  280 (596)
T ss_pred             cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-------ccccchheeeeecccceeec
Confidence            4456678999999999999998875 699999999999999999999984321       1111122222  23332222


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          439 KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       439 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                             .+.+++.+++..+|.+|++.+++.++.|.-.....
T Consensus       281 -------dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  281 -------DCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             -------hhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence                   35578889999999999999999999998766554

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=297.49  Aligned_cols=260  Identities=24%  Similarity=0.296  Sum_probs=208.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      .+.|...+.||+|+||.||-++.+ +|+-||.|++.+..  ......-..+|-.++++++.+.||.+-.+|+.++.+++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            356888899999999999999654 69999999886543  222334568999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      +..|.||+|.-++...+. ..|++..++-++.+|+.||++||   ..+||+||+||+|||+|+.|+++|+|+|+|..+..
T Consensus       264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999887654 47999999999999999999999   77999999999999999999999999999998854


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      .. .....+||.+|||||++.+..|+...|.||+||++|||+.|+.||....        +....+.++.+.........
T Consensus       340 g~-~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K--------eKvk~eEvdrr~~~~~~ey~  410 (591)
T KOG0986|consen  340 GK-PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK--------EKVKREEVDRRTLEDPEEYS  410 (591)
T ss_pred             CC-ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh--------hhhhHHHHHHHHhcchhhcc
Confidence            33 3344589999999999999999999999999999999999999997322        11222222222222211111


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHhc
Q 011005          441 IRDILLISTVSFACLQSNPKSRP-----TMQSVSQEFLITR  476 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~~~~~~  476 (496)
                      ..-......+....|..||++|.     .++++-+|+++..
T Consensus       411 ~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~  451 (591)
T KOG0986|consen  411 DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD  451 (591)
T ss_pred             cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence            12222356777789999999987     4668888877754

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.9e-37  Score=290.71  Aligned_cols=254  Identities=29%  Similarity=0.431  Sum_probs=207.5

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeecC--CeEEEEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK--KCMFLIY  281 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lV~  281 (496)
                      +|...+.||+|++|.||+|... +++.|++|.+..... ....+.+.+|++++++++|+||+++++.+...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4777889999999999999775 789999999876542 23457789999999999999999999999988  8899999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++++|.+++....   .+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            9999999999998654   7899999999999999999999   789999999999999999999999999999877554


Q ss_pred             CC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          362 SS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       362 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                      ..  ......++..|+|||.+.+..++.++||||+|+++|+|++|..||....      .................... 
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~-  227 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG------NPMAALYKIGSSGEPPEIPE-  227 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------chHHHHHhccccCCCcCCCc-
Confidence            32  1334568889999999998889999999999999999999999987432      01111111111111111111 


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                        .....+.+++.+|++.||++||++.|+++|+|+
T Consensus       228 --~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         228 --HLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             --ccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence              113457899999999999999999999999884

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.3e-37  Score=291.19  Aligned_cols=255  Identities=27%  Similarity=0.435  Sum_probs=207.9

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      +|.+.+.||.|+||.||++... +++.+++|.+..... ....+.+.+|+++++.++|+|++++++.+..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4788899999999999999764 688999999876432 24456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCC-CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          284 MERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       284 ~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      +++++|.+.+.... ....+++..+..++.+++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999987642 1247899999999999999999999   7799999999999999999999999999998765443


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                      .......+++.|+|||...+..++.++|+||+|+++|+|++|+.||....       ............... ...   .
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~-~~~---~  226 (258)
T cd08215         158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-------LLELALKILKGQYPP-IPS---Q  226 (258)
T ss_pred             ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-------HHHHHHHHhcCCCCC-CCC---C
Confidence            33344568889999999999899999999999999999999999986321       111222222222211 111   1


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ....+.+++.+||..+|++|||+.|+++++|+
T Consensus       227 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         227 YSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            12347789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.5e-37  Score=293.68  Aligned_cols=248  Identities=27%  Similarity=0.403  Sum_probs=201.2

Q ss_pred             eeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCCCh
Q 011005          213 IGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL  289 (496)
Q Consensus       213 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g~L  289 (496)
                      ||.|+||.||+|... +++.+++|.+.....  ....+.+.+|+.++++++|+||+++++.+..+...++|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999876 489999999865432  23456788999999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC------
Q 011005          290 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS------  363 (496)
Q Consensus       290 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~------  363 (496)
                      .+++.+..   .+++..+..++.||+.||+|||   ..+++|+||+|+||++++++.++|+|||++........      
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            99998644   6899999999999999999999   78999999999999999999999999999876543321      


Q ss_pred             --CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          364 --NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       364 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                        ......++..|+|||...+..++.++||||||+++|++++|+.||....       ...............+...   
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~---  224 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-------PEEIFQNILNGKIEWPEDV---  224 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhcCCcCCCccc---
Confidence              2233457889999999998889999999999999999999999986322       1222222222222221111   


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCH---HHHHHHHHHhc
Q 011005          442 RDILLISTVSFACLQSNPKSRPTM---QSVSQEFLITR  476 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~---~evl~~~~~~~  476 (496)
                      .....+.+++.+||+.+|++|||+   .++++|+|+..
T Consensus       225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence            013457799999999999999999   99999998853

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.8e-37  Score=292.66  Aligned_cols=249  Identities=21%  Similarity=0.294  Sum_probs=184.6

Q ss_pred             eeeecCCeeEEEEEeCCC---cEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCCC
Q 011005          212 CIGTGGYGSVYKAQLPNG---KVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGS  288 (496)
Q Consensus       212 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g~  288 (496)
                      .||+|+||.||+|...++   ..+++|.+.........+.+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999965433   34667776654434445788999999999999999999999999999999999999999


Q ss_pred             hhhhhhCCCC-CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC--CCc
Q 011005          289 LFCNLHNNED-AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS--SNR  365 (496)
Q Consensus       289 L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~  365 (496)
                      |.+++..... ....+...+..++.||+.||+|||   +.+++||||||+||+++.++.++|+|||++.......  ...
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            9999976432 234667778899999999999999   7799999999999999999999999999986432211  112


Q ss_pred             ccccccccccccccccc-------CCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCC---CCC
Q 011005          366 TLLAGTYGYIAPELAYT-------MVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQR---LPP  434 (496)
Q Consensus       366 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~  434 (496)
                      ....++..|+|||++..       ..++.++||||||+++|||++ |..||.....       ...........   +..
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------~~~~~~~~~~~~~~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-------REVLNHVIKDQQVKLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhhcccccCC
Confidence            33567889999998753       245779999999999999997 5667753211       11111111111   111


Q ss_pred             CCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          435 PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       435 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      +....  .....+.+++..|| .+|++||+++|+++.+.
T Consensus       232 ~~~~~--~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQLEL--PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CccCC--CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            10000  01224567888899 67999999999988763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-37  Score=300.48  Aligned_cols=265  Identities=25%  Similarity=0.355  Sum_probs=197.4

Q ss_pred             CCCCcceeeecCCeeEEEEEeC---CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecC--CeEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP---NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK--KCMF  278 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  278 (496)
                      +|.+.+.||+|+||.||+|..+   +++.||+|.+....  .......+.+|+.++++++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999765   47899999987632  112235678899999999999999999999988  7899


Q ss_pred             EEEEecCCCChhhhhhCCCC--CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC----CCCeEEccc
Q 011005          279 LIYEYMERGSLFCNLHNNED--AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS----KLEAFVADF  352 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~----~~~~kl~Df  352 (496)
                      +||||+++ ++.+.+.....  ...++...++.++.|++.||+|||   +.+++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 66666643221  236889999999999999999999   789999999999999999    899999999


Q ss_pred             cccccccCCCC---CccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCC--cchhH-
Q 011005          353 GTARLLHADSS---NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDP--KIMLI-  425 (496)
Q Consensus       353 g~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~--~~~~~-  425 (496)
                      |++........   ......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||...........+  ..... 
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987643322   12234678899999987764 5789999999999999999999998643321100000  00000 


Q ss_pred             --hhh-----------------------cCCCCCCCChhHH------HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          426 --DVL-----------------------DQRLPPPVDRKVI------RDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       426 --~~~-----------------------~~~~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                        +.+                       ......+......      .....+.+++.+||++||++|||+.|+++|+|+
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence              000                       0000000000000      112357889999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-37  Score=303.88  Aligned_cols=268  Identities=24%  Similarity=0.284  Sum_probs=206.0

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeecCC-----eEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK-----CMF  278 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  278 (496)
                      +|++.+.||+|++|.||+|... +++.||+|++..... ....+.+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5888999999999999999765 589999999876432 334567889999999999999999999998775     789


Q ss_pred             EEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccc
Q 011005          279 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL  358 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  358 (496)
                      +||||+. ++|.+.+....   .+++..+..++.|++.||+|||   +.|++||||||+||+++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999997 48888887544   7899999999999999999999   789999999999999999999999999999877


Q ss_pred             cCCCC---CccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccC---------CCCC------
Q 011005          359 HADSS---NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS---------SSSD------  419 (496)
Q Consensus       359 ~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~---------~~~~------  419 (496)
                      .....   ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||.......         ....      
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence            54431   22334578899999999888 78999999999999999999999996432100         0000      


Q ss_pred             -CcchhHhhhcCCCC---CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          420 -PKIMLIDVLDQRLP---PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       420 -~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                       ......+.......   .............+.+++.+||+++|++|||++++++|+|+.+....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence             00000000000000   00000000122357789999999999999999999999999765544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.8e-37  Score=289.42  Aligned_cols=245  Identities=24%  Similarity=0.436  Sum_probs=195.6

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      ++|++.+.||+|+||.||+|.. +++.||+|.+.....   ...+.+|+.++++++|||++++++++.... .++||||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~---~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT---AQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcch---HHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECC
Confidence            5688999999999999999975 678899999865432   256789999999999999999999987654 78999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      ++++|.+++.... ...+++..++.++.|++.|+.|||   +.+++||||||+||+++.++.++|+|||++......   
T Consensus        81 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---  153 (254)
T cd05083          81 SKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---  153 (254)
T ss_pred             CCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence            9999999997643 235789999999999999999999   789999999999999999999999999998754322   


Q ss_pred             ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHH
Q 011005          365 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD  443 (496)
Q Consensus       365 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  443 (496)
                      ......+..|+|||.+.+..++.++|+||+|+++|+|++ |+.||.....       .. ...............   ..
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~-~~~~~~~~~~~~~~~---~~  222 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-------KE-VKECVEKGYRMEPPE---GC  222 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-------HH-HHHHHhCCCCCCCCC---cC
Confidence            112234568999999998899999999999999999997 9999863221       11 111121211111111   12


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 011005          444 ILLISTVSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       444 ~~~l~~li~~cl~~dP~~Rps~~evl~~~  472 (496)
                      +..+.+++.+||+.+|++||+++++++.+
T Consensus       223 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l  251 (254)
T cd05083         223 PADVYVLMTSCWETEPKKRPSFHKLREKL  251 (254)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            23577999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.3e-37  Score=295.83  Aligned_cols=262  Identities=25%  Similarity=0.350  Sum_probs=202.9

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-----CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeec--CCeE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-----NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH--KKCM  277 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  277 (496)
                      .+|++.+.||+|+||.||+|.+.     .++.+|+|.+.........+.+.+|+++++.+.|+||+++++++..  +...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46778899999999999999753     4788999999765543345778999999999999999999999877  5578


Q ss_pred             EEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          278 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      ++||||+++++|.+++.....  .+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||.+..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            999999999999999986532  5899999999999999999999   78999999999999999999999999999987


Q ss_pred             ccCCCCCc---cccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCC----C---CCcchhHhh
Q 011005          358 LHADSSNR---TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSS----S---DPKIMLIDV  427 (496)
Q Consensus       358 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~----~---~~~~~~~~~  427 (496)
                      ........   ....++..|+|||.+.+..++.++||||||+++|||++|+.|+.........    .   .......+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            65332211   1123455799999999889999999999999999999999997532111000    0   001111122


Q ss_pred             hcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          428 LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      +......+...   .....+.+++.+||+.+|++|||+.|+++.+..
T Consensus       239 ~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05038         239 LKEGERLPRPP---SCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR  282 (284)
T ss_pred             HHcCCcCCCCc---cCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence            22211111111   112457899999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.4e-37  Score=304.49  Aligned_cols=268  Identities=22%  Similarity=0.246  Sum_probs=201.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecC-----Ce
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK-----KC  276 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  276 (496)
                      .++|.+.+.||+|+||+||+|.. .+++.||+|.+.... .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            46799999999999999999965 468999999987532 222335667899999999999999999988654     34


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      .++|+||+. ++|.+++....   .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 68888887543   6899999999999999999999   7899999999999999999999999999998


Q ss_pred             cccCCCCCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCcccccc----------CCCCC------
Q 011005          357 LLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSL----------SSSSD------  419 (496)
Q Consensus       357 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~----------~~~~~------  419 (496)
                      .............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......          .....      
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            76443322334567889999998765 46889999999999999999999998632110          00000      


Q ss_pred             CcchhHhhhcCC---CCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          420 PKIMLIDVLDQR---LPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       420 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ............   ...............+.+++.+||+.||++|||++|+++|+|+..-.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence            000000000000   00000000011233577999999999999999999999999996543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-38  Score=304.02  Aligned_cols=263  Identities=25%  Similarity=0.391  Sum_probs=212.8

Q ss_pred             HHHHHHHhCCCCcceeeecCCeeEEEEEeCC-CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCe
Q 011005          198 EDLIEATEDFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKC  276 (496)
Q Consensus       198 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  276 (496)
                      ++++--..+.++.++||-|.||.||.|.|+. .-.||||.++.+.  ....+|..|+.+|+.++|||+|+++|+|.....
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            3333344567788999999999999998864 5679999998754  345889999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      .|||+|||..|+|.++|...... .++.-..+.++.||..|++||.   ++.+|||||.++|+|+.++..||++|||+++
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhh
Confidence            99999999999999999876533 5677777899999999999999   8899999999999999999999999999999


Q ss_pred             cccCCCCCccc-cccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCC
Q 011005          357 LLHADSSNRTL-LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPP  434 (496)
Q Consensus       357 ~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  434 (496)
                      .+..+...... ..-...|.|||.+.-..++.++|||+|||+|||+.| |-.||....        -....+.+.+....
T Consensus       414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid--------lSqVY~LLEkgyRM  485 (1157)
T KOG4278|consen  414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVYGLLEKGYRM  485 (1157)
T ss_pred             hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc--------HHHHHHHHhccccc
Confidence            99766543221 223568999999999999999999999999999998 777875322        11223333333332


Q ss_pred             CCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          435 PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       435 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ....   .++....+|+..||++.|.+||++.|+-+.+...-.
T Consensus       486 ~~Pe---GCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  486 DGPE---GCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             cCCC---CCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            2222   234467899999999999999999999877765433

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.8e-37  Score=294.33  Aligned_cols=249  Identities=22%  Similarity=0.251  Sum_probs=190.9

Q ss_pred             eeeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHHHHHHhh---cccccccccceeecCCeEEEEEEecC
Q 011005          212 CIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQV---LHRNIVKLYGYCLHKKCMFLIYEYME  285 (496)
Q Consensus       212 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lV~e~~~  285 (496)
                      .||+|+||.||++... +++.+|+|.+.....  ......+.+|..+++.+   +|+||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            3899999999999764 688999998865321  11122334454444443   69999999999999999999999999


Q ss_pred             CCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCc
Q 011005          286 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR  365 (496)
Q Consensus       286 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  365 (496)
                      +|+|.+++....   .+++..+..++.|++.||+|||   +.+++||||||+||++++++.++|+|||++......  ..
T Consensus        81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~  152 (279)
T cd05633          81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KP  152 (279)
T ss_pred             CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--Cc
Confidence            999998887544   6899999999999999999999   789999999999999999999999999998755332  22


Q ss_pred             cccccccccccccccc-cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHH
Q 011005          366 TLLAGTYGYIAPELAY-TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI  444 (496)
Q Consensus       366 ~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  444 (496)
                      ....|++.|+|||.+. +..++.++||||+|+++|+|++|+.||.....    . ........ .........   ....
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~-~~~~~~~~-~~~~~~~~~---~~~~  223 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----K-DKHEIDRM-TLTVNVELP---DSFS  223 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC----c-CHHHHHHH-hhcCCcCCc---cccC
Confidence            3346899999999886 45688999999999999999999999964321    0 11111111 111111111   1122


Q ss_pred             HHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHhcc
Q 011005          445 LLISTVSFACLQSNPKSRP-----TMQSVSQEFLITRK  477 (496)
Q Consensus       445 ~~l~~li~~cl~~dP~~Rp-----s~~evl~~~~~~~~  477 (496)
                      ..+.+++.+||+.||++||     |++|+++|+|+...
T Consensus       224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~  261 (279)
T cd05633         224 PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI  261 (279)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence            3577899999999999999     69999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.3e-37  Score=291.85  Aligned_cols=254  Identities=24%  Similarity=0.334  Sum_probs=196.5

Q ss_pred             HHHHHHHhCCCCccee--eecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeec
Q 011005          198 EDLIEATEDFDIRYCI--GTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLH  273 (496)
Q Consensus       198 ~~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  273 (496)
                      .+.....++|++.+.+  |+|+||.||++.. .++..+|+|.+.......      .|+.....+ +|+||+++++++..
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEec
Confidence            4455556788887776  9999999999975 468889999886542111      122222223 69999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC-CeEEccc
Q 011005          274 KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-EAFVADF  352 (496)
Q Consensus       274 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~-~~kl~Df  352 (496)
                      .+..++||||+++++|.+++....   .+++.++..++.|+++||.|||   +.+++||||+|+||+++.++ .++|+||
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~df  154 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDY  154 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecC
Confidence            999999999999999999997654   7899999999999999999999   78999999999999999998 9999999


Q ss_pred             cccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCC
Q 011005          353 GTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRL  432 (496)
Q Consensus       353 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  432 (496)
                      |++......    ....++..|+|||++.+..++.++||||+|+++|+|++|+.||.....      ........... .
T Consensus       155 g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~-~  223 (267)
T PHA03390        155 GLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED------EELDLESLLKR-Q  223 (267)
T ss_pred             ccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc------chhhHHHHHHh-h
Confidence            998765322    234578899999999999999999999999999999999999963211      11111111111 1


Q ss_pred             CCCCChhHHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHHHHHh
Q 011005          433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPT-MQSVSQEFLIT  475 (496)
Q Consensus       433 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~~~~~~  475 (496)
                      ..... ........+.+++.+||+.+|.+||+ ++|+++|+|+.
T Consensus       224 ~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        224 QKKLP-FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             cccCC-cccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence            11110 01122335789999999999999996 69999999975

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.9e-37  Score=296.05  Aligned_cols=260  Identities=22%  Similarity=0.258  Sum_probs=194.1

Q ss_pred             CCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-ccccccccceeecC--CeEEEEEE
Q 011005          207 FDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHK--KCMFLIYE  282 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lV~e  282 (496)
                      |++.+.||+|+||.||+|..+ +++.||+|.++............+|+.+++++. |+|++++++++.++  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567888999999999999754 688999999876432222234457888999885 99999999999887  88999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |++ |++.+.+....  ..+++.++..++.|++.||.|||   ..+++||||+|+||+++. +.++|+|||++.......
T Consensus        81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            997 47877776533  26899999999999999999999   779999999999999999 999999999998764332


Q ss_pred             CCccccccccccccccccc-cCCcCcccchhhHHHHHHHHHhCCCCCccccccCC-------CCCCcchhHhhhcC----
Q 011005          363 SNRTLLAGTYGYIAPELAY-TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS-------SSDPKIMLIDVLDQ----  430 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~----  430 (496)
                      . .....+++.|+|||.+. +..++.++||||+||++|||++|+.||........       ..............    
T Consensus       154 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07831         154 P-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM  232 (282)
T ss_pred             C-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence            2 23345788999999765 45678899999999999999999999964321100       00000000000000    


Q ss_pred             --CCCCCCC----hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          431 --RLPPPVD----RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       431 --~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                        ..+....    .........+.+++.+||+.+|++||+++++++|+|+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence              0000000    0001223568899999999999999999999999885

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.6e-38  Score=326.11  Aligned_cols=258  Identities=27%  Similarity=0.420  Sum_probs=199.8

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeec--------
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH--------  273 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  273 (496)
                      -..+|+..+.||+||||.|||++.+ +|+.||||++....+........+|+.++++++|||||+++..+.+        
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            4567888999999999999999876 8999999999877666666788999999999999999998743311        


Q ss_pred             -----------------------------------------------C--------------------------------
Q 011005          274 -----------------------------------------------K--------------------------------  274 (496)
Q Consensus       274 -----------------------------------------------~--------------------------------  274 (496)
                                                                     .                                
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                           0                                


Q ss_pred             --------------------------------CeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHH
Q 011005          275 --------------------------------KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH  322 (496)
Q Consensus       275 --------------------------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh  322 (496)
                                                      -.+||-||||+..++.+++..+.-..  .....++++++|+.||.|+|
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence                                            12467788888877777777654211  46778899999999999999


Q ss_pred             hCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc------------------CCCCCccccccccccccccccccCC
Q 011005          323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH------------------ADSSNRTLLAGTYGYIAPELAYTMV  384 (496)
Q Consensus       323 ~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~------------------~~~~~~~~~~gt~~y~aPE~~~~~~  384 (496)
                         ++|+|||||||.|||++++..|||+|||+|+...                  ......+..+||..|+|||++.+..
T Consensus       715 ---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  715 ---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             ---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence               7899999999999999999999999999998721                  0011234568999999999998765


Q ss_pred             ---cCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCC
Q 011005          385 ---MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKS  461 (496)
Q Consensus       385 ---~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~  461 (496)
                         |+.|+|+||+|++++||+   .||+.      ..+....+....+..++.+ ..........-..+|.+|+++||.+
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~---yPF~T------sMERa~iL~~LR~g~iP~~-~~f~~~~~~~e~slI~~Ll~hdP~k  861 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEML---YPFGT------SMERASILTNLRKGSIPEP-ADFFDPEHPEEASLIRWLLSHDPSK  861 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHh---ccCCc------hHHHHHHHHhcccCCCCCC-cccccccchHHHHHHHHHhcCCCcc
Confidence               999999999999999998   34542      2333334444444555544 1112222233467889999999999


Q ss_pred             CCCHHHHHHHHHHh
Q 011005          462 RPTMQSVSQEFLIT  475 (496)
Q Consensus       462 Rps~~evl~~~~~~  475 (496)
                      |||+.|+|+.-+.-
T Consensus       862 RPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  862 RPTATELLNSELLP  875 (1351)
T ss_pred             CCCHHHHhhccCCC
Confidence            99999999987664

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.6e-38  Score=280.71  Aligned_cols=272  Identities=24%  Similarity=0.297  Sum_probs=203.7

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC---C--CcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeec-CC
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP---N--GKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH-KK  275 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~  275 (496)
                      -...|+.+..||+|.||.||||..+   +  .+.+|+|+++...+ ........+|+.+++.++|||++.+..++.. +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            3467999999999999999999433   2  33799999987532 2344677999999999999999999999877 77


Q ss_pred             eEEEEEEecCCCChhhhhhCC--CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC----CCeEE
Q 011005          276 CMFLIYEYMERGSLFCNLHNN--EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK----LEAFV  349 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~----~~~kl  349 (496)
                      .+++++||.+. +|.++++..  .....++...+.+|++||+.|+.|||   +.-|+||||||.||++..+    |.|||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEe
Confidence            89999999987 888887643  23347899999999999999999999   6789999999999999877    89999


Q ss_pred             ccccccccccCCCCC---ccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCc----
Q 011005          350 ADFGTARLLHADSSN---RTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPK----  421 (496)
Q Consensus       350 ~Dfg~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~----  421 (496)
                      +|||+++.+...-..   ....+-|.+|+|||.+.|. .||.+.||||+|||+.||+|-++-|.....-.....+.    
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            999999988654332   3346779999999998876 68999999999999999999877664322110000000    


Q ss_pred             -chhHhhhcC------------------------CCCCCCC-hhHHH----HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 011005          422 -IMLIDVLDQ------------------------RLPPPVD-RKVIR----DILLISTVSFACLQSNPKSRPTMQSVSQE  471 (496)
Q Consensus       422 -~~~~~~~~~------------------------~~~~~~~-~~~~~----~~~~l~~li~~cl~~dP~~Rps~~evl~~  471 (496)
                       ..+.+++..                        ......+ .....    ......+|+.++|..||.+|.|+++.++|
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence             000111100                        0000000 00000    01125688999999999999999999999


Q ss_pred             HHHhccC
Q 011005          472 FLITRKT  478 (496)
Q Consensus       472 ~~~~~~~  478 (496)
                      .+++...
T Consensus       338 ~yF~~d~  344 (438)
T KOG0666|consen  338 PYFTEDP  344 (438)
T ss_pred             cccccCC
Confidence            9998763

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.4e-37  Score=294.97  Aligned_cols=252  Identities=27%  Similarity=0.400  Sum_probs=205.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhc-ccccccccceeecCCeEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lV  280 (496)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+....  .....+.+.+|++++++++ |+||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999764 78999999987532  2233467889999999998 99999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      ||++++++|.+++.+..   .+++..+..++.|++.||.+||   +.+++|+||+|+||+++.++.++++|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999999998654   6899999999999999999999   78999999999999999999999999999987644


Q ss_pred             CCC--------------------CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCC
Q 011005          361 DSS--------------------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDP  420 (496)
Q Consensus       361 ~~~--------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~  420 (496)
                      ...                    ......++..|+|||...+..++.++||||+|++++++++|+.||....       .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~  227 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-------E  227 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-------H
Confidence            321                    1222457789999999998889999999999999999999999986332       1


Q ss_pred             cchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCH----HHHHHHHHH
Q 011005          421 KIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTM----QSVSQEFLI  474 (496)
Q Consensus       421 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~----~evl~~~~~  474 (496)
                      ..............+.     .....+.+++.+||+.+|.+|||+    +++++|+|+
T Consensus       228 ~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         228 YLTFQKILKLEYSFPP-----NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHHHHHHhcCCCCCC-----ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            1111122111111111     112347799999999999999999    999999874

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.9e-37  Score=298.04  Aligned_cols=257  Identities=19%  Similarity=0.231  Sum_probs=194.7

Q ss_pred             cceeeecCCeeEEEEEeCCCcEEEEEEcccc-hhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCCC
Q 011005          210 RYCIGTGGYGSVYKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGS  288 (496)
Q Consensus       210 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g~  288 (496)
                      .+.+|.|+++.||++.. +++.||+|++... ......+.+.+|+++++.++|+||+++++++...+..+++|||+++|+
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34455555555555554 6899999998764 233455778999999999999999999999999999999999999999


Q ss_pred             hhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC----
Q 011005          289 LFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN----  364 (496)
Q Consensus       289 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----  364 (496)
                      |.+++..... ..++...+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||.+.........    
T Consensus        86 l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          86 CEDLLKTHFP-EGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             HHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            9999886432 25788999999999999999999   789999999999999999999999999998765332211    


Q ss_pred             ---cccccccccccccccccc--CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCC--------
Q 011005          365 ---RTLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQR--------  431 (496)
Q Consensus       365 ---~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------  431 (496)
                         .....++..|+|||++.+  ..++.++||||+|+++|||++|+.||.......       ...+.....        
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-------~~~~~~~~~~~~~~~~~  234 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-------MLLEKVRGTVPCLLDKS  234 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhccCccccccC
Confidence               122346778999999876  357889999999999999999999996432110       000000000        


Q ss_pred             --------C------------CC-CCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          432 --------L------------PP-PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       432 --------~------------~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                              .            .. ............+.+++.+||+.||++|||++|+++|+|+..-.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                    0            00 00000111123577899999999999999999999999997543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-37  Score=289.41  Aligned_cols=252  Identities=23%  Similarity=0.325  Sum_probs=199.4

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccc----hhHHHHHHHHHHHHHHHhhcccccccccceeecC--CeE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTS----EELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK--KCM  277 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  277 (496)
                      .+|.+.+.||+|+||.||+|.. .+++.||+|.+...    ........+.+|++++++++|+||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4688999999999999999975 46899999987532    1233456788999999999999999999998764  468


Q ss_pred             EEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          278 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      ++|+||+++++|.+++....   .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            89999999999999987543   5788889999999999999999   77999999999999999999999999999986


Q ss_pred             ccCCC---CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCC
Q 011005          358 LHADS---SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPP  434 (496)
Q Consensus       358 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  434 (496)
                      .....   .......++..|+|||.+.+..++.++|+||||+++|++++|+.||....       ...............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~  228 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE-------AMAAIFKIATQPTKP  228 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC-------HHHHHHHHHcCCCCC
Confidence            53211   11223458889999999999889999999999999999999999986321       111222222111111


Q ss_pred             CCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          435 PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       435 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      ...   ......+.+++.+||. +|.+||++.+++.|+|
T Consensus       229 ~~p---~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~  263 (264)
T cd06653         229 MLP---DGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPF  263 (264)
T ss_pred             CCC---cccCHHHHHHHHHHhc-CcccCccHHHHhcCCC
Confidence            111   1122347789999999 5799999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.4e-37  Score=298.85  Aligned_cols=258  Identities=21%  Similarity=0.290  Sum_probs=196.7

Q ss_pred             eeeec--CCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCC
Q 011005          212 CIGTG--GYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERG  287 (496)
Q Consensus       212 ~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g  287 (496)
                      .||+|  +||+||+|.+ ..|+.||+|.+.... .....+.+.+|+.+++.++||||+++++++..++..++|+||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            46666  9999999976 479999999987543 2334577889999999999999999999999999999999999999


Q ss_pred             ChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCc--
Q 011005          288 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR--  365 (496)
Q Consensus       288 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--  365 (496)
                      ++.+++..... ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++||+.+..........  
T Consensus        85 ~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          85 SANSLLKTYFP-EGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            99998876432 25888999999999999999999   7899999999999999999999999998664432211111  


Q ss_pred             -----cccccccccccccccccC--CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcC--------
Q 011005          366 -----TLLAGTYGYIAPELAYTM--VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQ--------  430 (496)
Q Consensus       366 -----~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------  430 (496)
                           ....++..|+|||++.+.  .++.++||||+|+++|+|++|+.||......       ......+..        
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~  233 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT-------QMLLQKLKGPPYSPLDI  233 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH-------HHHHHHhcCCCCCCccc
Confidence                 112345679999998764  4788999999999999999999998643210       000000000        


Q ss_pred             --------------------------------CCCCC--CChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          431 --------------------------------RLPPP--VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       431 --------------------------------~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                                                      .....  ...........+.+|+.+||+.||++|||+.|+++|+|+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~  313 (328)
T cd08226         234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ  313 (328)
T ss_pred             cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence                                            00000  00001123345789999999999999999999999999987


Q ss_pred             cCCC
Q 011005          477 KTPL  480 (496)
Q Consensus       477 ~~~~  480 (496)
                      ....
T Consensus       314 ~~~~  317 (328)
T cd08226         314 VKEQ  317 (328)
T ss_pred             HHHh
Confidence            7654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=7.1e-37  Score=297.05  Aligned_cols=256  Identities=27%  Similarity=0.373  Sum_probs=202.3

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .|...+.||+|+||.||+|... ++..||+|.+....  .......+.+|+.++++++|+|++++++++..+...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3777888999999999999754 68899999986432  22334578899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+.+ ++.+.+....  ..+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.++|+|||++.....  
T Consensus       106 ~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--  177 (317)
T cd06635         106 YCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--  177 (317)
T ss_pred             CCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence            9975 7777765432  25889999999999999999999   78999999999999999999999999999865432  


Q ss_pred             CCccccccccccccccccc---cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          363 SNRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                        .....+++.|+|||.+.   +..++.++||||||+++|+|++|+.||....       .............+..... 
T Consensus       178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~-  247 (317)
T cd06635         178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNESPTLQSN-  247 (317)
T ss_pred             --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHhccCCCCCCc-
Confidence              22346788999999874   4568899999999999999999999985321       1111222222222211111 


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCC
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLV  481 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~  481 (496)
                        .....+.+++.+||+.+|.+||++.++++|+|.....+..
T Consensus       248 --~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  287 (317)
T cd06635         248 --EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET  287 (317)
T ss_pred             --cccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence              1223477899999999999999999999999997766644

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.8e-37  Score=289.57  Aligned_cols=252  Identities=25%  Similarity=0.334  Sum_probs=204.6

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      +|++.+.||+|+||.||++..+ +++.+++|.+.... .......+.+|+++++.++|+||+++++++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999654 68899999987543 223345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCC-CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          284 MERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       284 ~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      +++++|.+++.... ....+++..++.++.|++.||+|||   +.+++|+||+|+||++++++.++++|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999886532 1236889999999999999999999   789999999999999999999999999999876544 


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                       ......+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||....       .............+. ...   .
T Consensus       157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~-~~~---~  224 (256)
T cd08530         157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS-------MQDLRYKVQRGKYPP-IPP---I  224 (256)
T ss_pred             -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhcCCCCC-Cch---h
Confidence             2233467889999999999999999999999999999999999986322       111111222222221 111   2


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      ....+.+++.+||+.+|++|||+.|+++|++
T Consensus       225 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~  255 (256)
T cd08530         225 YSQDLQNFIRSMLQVKPKLRPNCDKILASPA  255 (256)
T ss_pred             hCHHHHHHHHHHcCCCcccCCCHHHHhcCCC
Confidence            3345789999999999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-37  Score=289.56  Aligned_cols=249  Identities=24%  Similarity=0.317  Sum_probs=192.7

Q ss_pred             ceeeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHHHHHH-hhcccccccccceeecCCeEEEEEEecCC
Q 011005          211 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEAQVLS-QVLHRNIVKLYGYCLHKKCMFLIYEYMER  286 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lV~e~~~~  286 (496)
                      +.||+|+||.||+|... +++.||+|.+.....  ......+..|..++. ..+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            45899999999999764 688999999875431  122233445554443 44799999999999999999999999999


Q ss_pred             CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCcc
Q 011005          287 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT  366 (496)
Q Consensus       287 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  366 (496)
                      ++|.+++....   .++...+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||++.....    ..
T Consensus        82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~  151 (260)
T cd05611          82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NK  151 (260)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cc
Confidence            99999987643   5788999999999999999999   77999999999999999999999999999875432    22


Q ss_pred             ccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHH
Q 011005          367 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL  446 (496)
Q Consensus       367 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  446 (496)
                      ...+++.|+|||.+.+..++.++||||+|+++|+|++|..||....       ...............+... .......
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~-~~~~~~~  223 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET-------PDAVFDNILSRRINWPEEV-KEFCSPE  223 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhcccCCCCcc-cccCCHH
Confidence            3467889999999988888999999999999999999999986321       1112222222221111111 1112235


Q ss_pred             HHHHHHhcccCCCCCCCC---HHHHHHHHHHhcc
Q 011005          447 ISTVSFACLQSNPKSRPT---MQSVSQEFLITRK  477 (496)
Q Consensus       447 l~~li~~cl~~dP~~Rps---~~evl~~~~~~~~  477 (496)
                      +.+++.+||+.+|++||+   ++|++.|+|+...
T Consensus       224 ~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~  257 (260)
T cd05611         224 AVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI  257 (260)
T ss_pred             HHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence            789999999999999995   5799999988543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-37  Score=319.13  Aligned_cols=266  Identities=19%  Similarity=0.217  Sum_probs=191.0

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeCC--CcEEEEEE--------------ccc--chhHHHHHHHHHHHHHHHhhccccc
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLPN--GKVFALKK--------------LHT--SEELAFIKSFKNEAQVLSQVLHRNI  264 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~--------------~~~--~~~~~~~~~~~~e~~~l~~l~h~ni  264 (496)
                      ..++|.+.+.||+|+||+||+|..+.  +..++.|.              +..  .........+.+|+.++++++|+||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            45789999999999999999986532  22222221              100  0111234567899999999999999


Q ss_pred             ccccceeecCCeEEEEEEecCCCChhhhhhCCCC--CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEec
Q 011005          265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNED--AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN  342 (496)
Q Consensus       265 v~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~  342 (496)
                      +++++++...+..++|++++. +++.+++.....  ........+..++.||+.||.|||   +++|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence            999999999999999999985 467666653221  123346677889999999999999   78999999999999999


Q ss_pred             CCCCeEEccccccccccCCCCC-ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCC-CccccccCCCCCC
Q 011005          343 SKLEAFVADFGTARLLHADSSN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP-RDILSSLSSSSDP  420 (496)
Q Consensus       343 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p-~~~~~~~~~~~~~  420 (496)
                      .++.+||+|||+++.+...... .....||+.|+|||++.+..++.++|||||||++|||++|..+ +.....     ..
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~-----~~  376 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG-----KP  376 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC-----CH
Confidence            9999999999999876543222 2345799999999999999999999999999999999998764 321110     00


Q ss_pred             cchhHh---------------------hhcCC-CCC---CCChh--HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          421 KIMLID---------------------VLDQR-LPP---PVDRK--VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       421 ~~~~~~---------------------~~~~~-~~~---~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      .....+                     .+... ...   .....  .......+.+++.+||+.||.+|||+.|+++|+|
T Consensus       377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~  456 (501)
T PHA03210        377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL  456 (501)
T ss_pred             HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence            000111                     00000 000   00000  0001123567788999999999999999999999


Q ss_pred             Hhcc
Q 011005          474 ITRK  477 (496)
Q Consensus       474 ~~~~  477 (496)
                      +...
T Consensus       457 f~~~  460 (501)
T PHA03210        457 FSAE  460 (501)
T ss_pred             hhcC
Confidence            8654

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-37  Score=293.27  Aligned_cols=262  Identities=25%  Similarity=0.336  Sum_probs=201.2

Q ss_pred             CCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          207 FDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      |.+.+.||+|++|.||+|..+ +++.+++|.+..... ......+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567788999999999999764 688999999876432 233467788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      ++ ++.+.+....  ..+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP  154 (283)
T ss_pred             CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence            75 8887776543  36899999999999999999999   789999999999999999999999999999877554322


Q ss_pred             ccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCC---------CCCCc--chhHh---h--
Q 011005          365 RTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS---------SSDPK--IMLID---V--  427 (496)
Q Consensus       365 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~---------~~~~~--~~~~~---~--  427 (496)
                      .....++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...+....         .....  .....   .  
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence            3334577889999998876 788999999999999999999999853221100         00000  00000   0  


Q ss_pred             --hcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          428 --LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       428 --~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                        ...................+.+++.+||++||.+||++.+++.|+|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence              00000000011111223467899999999999999999999999884

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-37  Score=287.00  Aligned_cols=252  Identities=28%  Similarity=0.425  Sum_probs=206.0

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      +|++.+.||+|++|.||+|..+ +++.|++|.+..... ......+.+|++++++++|+|++++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788899999999999999765 678999999876542 23456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+++....   .+++..+..++.|++.|+.+||   +.|++||||+|+||+++.++.++|+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            99999999987653   6899999999999999999999   78999999999999999999999999999987755443


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD  443 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  443 (496)
                      ......++..|+|||...+..++.++||||+|+++|+|++|+.||.....       ............+. ...   ..
T Consensus       155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~-~~~---~~  223 (254)
T cd06627         155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-------MAALFRIVQDDHPP-LPE---GI  223 (254)
T ss_pred             cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHhccCCCC-CCC---CC
Confidence            33445688899999999888889999999999999999999999863221       11111111111111 111   11


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          444 ILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       444 ~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ...+.+++.+||..+|++|||+.+++.+.|+
T Consensus       224 ~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         224 SPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             CHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence            2356789999999999999999999998764

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5.3e-37  Score=297.20  Aligned_cols=265  Identities=23%  Similarity=0.324  Sum_probs=195.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCC------
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK------  275 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  275 (496)
                      .++|++.+.||+|+||.||+|... +++.||+|.+.... .......+.+|+.++++++||||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            457999999999999999999764 68999999886532 1222345578999999999999999999886543      


Q ss_pred             --eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccc
Q 011005          276 --CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG  353 (496)
Q Consensus       276 --~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  353 (496)
                        ..++||||+.+ ++.+.+....  ..+++.+++.++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCC
Confidence              45999999964 7877776532  25899999999999999999999   7799999999999999999999999999


Q ss_pred             ccccccCCCCC----ccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccC-------------
Q 011005          354 TARLLHADSSN----RTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS-------------  415 (496)
Q Consensus       354 ~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~-------------  415 (496)
                      ++.........    .....++..|+|||.+.+. .++.++||||+|+++|+|++|+.||.......             
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99866433221    1234567889999988764 46889999999999999999999986332100             


Q ss_pred             CCCCCcchhHhhhcC-CCCCCCChhHH------HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          416 SSSDPKIMLIDVLDQ-RLPPPVDRKVI------RDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       416 ~~~~~~~~~~~~~~~-~~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ....+.......... ..+........      .....+.+++.+||..||++|||++|+++|+|+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            000000000000000 00000000000      011245689999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=291.54  Aligned_cols=262  Identities=25%  Similarity=0.296  Sum_probs=197.5

Q ss_pred             CCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh-HHHHHHHHHHHHHHHhh---cccccccccceeecCCe-----
Q 011005          207 FDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQV---LHRNIVKLYGYCLHKKC-----  276 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~-----  276 (496)
                      |++.+.||+|+||.||+|..+ +++.||+|.+..... ......+.+|+.+++++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567889999999999999876 489999999975432 12234566788887777   49999999999988776     


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      .+++|||+.+ +|.+++..... ..+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999974 88888876432 25899999999999999999999   7799999999999999999999999999997


Q ss_pred             cccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCC----------CC-----CCc
Q 011005          357 LLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS----------SS-----DPK  421 (496)
Q Consensus       357 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~----------~~-----~~~  421 (496)
                      ....... .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||........          ..     ...
T Consensus       156 ~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07838         156 IYSFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV  234 (287)
T ss_pred             eccCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence            7643322 2233578899999999999999999999999999999999999864321100          00     000


Q ss_pred             chhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          422 IMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       422 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      .........................+.+++.+||+.||++||+++|+++|+|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            00000000111111111111223457789999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.5e-37  Score=300.23  Aligned_cols=275  Identities=23%  Similarity=0.262  Sum_probs=205.3

Q ss_pred             HHHHHHHHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecC
Q 011005          197 YEDLIEATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK  274 (496)
Q Consensus       197 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  274 (496)
                      .+++..+.++|++.+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|+.++++++|+||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            456667889999999999999999999964 578999999987543 222345678899999999999999999988543


Q ss_pred             ------CeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeE
Q 011005          275 ------KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF  348 (496)
Q Consensus       275 ------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~k  348 (496)
                            ...+++++++ +++|.+++...    .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEE
Confidence                  3467888876 78998877643    5889999999999999999999   78999999999999999999999


Q ss_pred             EccccccccccCCCCCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCC--------CCC
Q 011005          349 VADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS--------SSD  419 (496)
Q Consensus       349 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~--------~~~  419 (496)
                      |+|||++.....   ......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||........        ...
T Consensus       161 l~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (345)
T cd07877         161 ILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP  237 (345)
T ss_pred             Eecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999999876432   2233467889999998866 5678899999999999999999999853221000        000


Q ss_pred             Ccchh--------Hhh---hcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCC
Q 011005          420 PKIML--------IDV---LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVK  482 (496)
Q Consensus       420 ~~~~~--------~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~  482 (496)
                      .....        ...   ...................+.+++.+|++.||.+||++.++++|+|+........
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~  311 (345)
T cd07877         238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD  311 (345)
T ss_pred             CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCc
Confidence            00000        000   0000000000000011234679999999999999999999999999986554433

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=278.33  Aligned_cols=252  Identities=24%  Similarity=0.347  Sum_probs=209.9

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      -++|+..+.||+|.||.|-+++-+ .++.||+|++++.-  ..++...-..|-.+++..+||.+..+-..|+..+++|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            367889999999999999999654 79999999998753  122334456788999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||..||.|+-++...+   .+++...+-+...|+.||.|||   +++|++||+|.+|.++|.+|++||+|||+++.--.
T Consensus       247 MeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence            99999999999988754   7899999999999999999999   78999999999999999999999999999987766


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhc--CCCCCCCCh
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD--QRLPPPVDR  438 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  438 (496)
                      ......+.||||.|+|||++.+..|..++|.|.+|+++|||++|+.||..       .+......-++-  -+.|...+.
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn-------~dh~kLFeLIl~ed~kFPr~ls~  393 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN-------KDHEKLFELILMEDLKFPRTLSP  393 (516)
T ss_pred             ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc-------cchhHHHHHHHhhhccCCccCCH
Confidence            66677789999999999999999999999999999999999999999852       222222211222  223332222


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHh
Q 011005          439 KVIRDILLISTVSFACLQSNPKSRP-----TMQSVSQEFLIT  475 (496)
Q Consensus       439 ~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~~~~~  475 (496)
                             ....|+...|.+||.+|.     .+.||.+|.|+.
T Consensus       394 -------eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~  428 (516)
T KOG0690|consen  394 -------EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFA  428 (516)
T ss_pred             -------HHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhc
Confidence                   345777899999999997     588888888764

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.3e-37  Score=290.83  Aligned_cols=254  Identities=24%  Similarity=0.342  Sum_probs=197.7

Q ss_pred             CCCCcceeeecCCeeEEEEEeCC-CcEEEEEEcccc---h-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTS---E-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      +|.+.+.||+|+||.||++.... +..+++|.++..   . .......+.+|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            57888999999999999997643 444555554431   1 122334567899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCC-CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          281 YEYMERGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      +||+++++|.+.+... .....+++..++.++.|++.|+.|||   +.+++|+||+|+||+++. +.++|+|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999888642 22346899999999999999999999   789999999999999986 569999999998765


Q ss_pred             CCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          360 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       360 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                      ..........+++.|+|||.+.+..++.++|+||+|+++|+|++|..||....       .............+. ..  
T Consensus       157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-------~~~~~~~~~~~~~~~-~~--  226 (260)
T cd08222         157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------FLSVVLRIVEGPTPS-LP--  226 (260)
T ss_pred             CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHcCCCCC-Cc--
Confidence            44433444567889999999988888999999999999999999999985221       111112222221111 11  


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                       ......+.+++.+||+.+|++||++.|+++|+|+
T Consensus       227 -~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         227 -ETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             -chhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence             1223357789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=289.88  Aligned_cols=262  Identities=23%  Similarity=0.310  Sum_probs=197.9

Q ss_pred             CCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-ccccccccceeecCCeEEEEEEec
Q 011005          207 FDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      |++.+.||+|++|+||+|... +++.|++|.+.............+|+..+++++ |+|++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567889999999999999875 578899999866432222234467899999998 999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                       +|+|.+.+.... ...+++..+..++.|++.+|.|||   +.+++|+||+|+||++++++.++|+|||.+....... .
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~  154 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-P  154 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-C
Confidence             789998887654 236799999999999999999999   7799999999999999999999999999998664322 2


Q ss_pred             ccccccccccccccccc-cCCcCcccchhhHHHHHHHHHhCCCCCccccccCC---------CCCCcc-----hhHhhhc
Q 011005          365 RTLLAGTYGYIAPELAY-TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS---------SSDPKI-----MLIDVLD  429 (496)
Q Consensus       365 ~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~---------~~~~~~-----~~~~~~~  429 (496)
                      .....++..|+|||.+. ...++.++|+||||+++|+|++|+.||........         ......     .......
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            23346788999999875 45578999999999999999999999853321100         000000     0000000


Q ss_pred             CCCCCCC----ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          430 QRLPPPV----DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       430 ~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ...+...    ..........+.+++.+||+.||++|||++|++.++|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            0111000    00000112457899999999999999999999999874

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.2e-37  Score=300.54  Aligned_cols=271  Identities=24%  Similarity=0.279  Sum_probs=200.9

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCC------
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK------  275 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  275 (496)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++.... .......+.+|+.+++.++|+||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999764 68999999987532 2223356789999999999999999999986542      


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccc
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  355 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  355 (496)
                      ..++|+||+.. ++.....     ..+++..+..++.|++.||+|||   ..+++||||||+||+++.++.++|+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            46899999864 6665542     15788999999999999999999   779999999999999999999999999998


Q ss_pred             ccccCCCCCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCCC-------CCCcchh---
Q 011005          356 RLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSS-------SDPKIML---  424 (496)
Q Consensus       356 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~-------~~~~~~~---  424 (496)
                      +....   ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.........       ..+....   
T Consensus       165 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         165 RHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             cCCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            76432   2223467889999999876 46888999999999999999999999642210000       0000000   


Q ss_pred             ------HhhhcC--CCC-CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCcccc
Q 011005          425 ------IDVLDQ--RLP-PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAI  486 (496)
Q Consensus       425 ------~~~~~~--~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~~~  486 (496)
                            ......  ..+ .............+.+++.+||+.||++||+++|+++|+|+....+.......
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~  312 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQ  312 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCC
Confidence                  000000  000 00000000112347799999999999999999999999999887765544443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.6e-36  Score=297.25  Aligned_cols=267  Identities=29%  Similarity=0.343  Sum_probs=199.8

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhh-cccccccccceeecC--CeE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHK--KCM  277 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~  277 (496)
                      ..++|++.+.||+|+||.||+|.+. +++.+|+|++.... .......+.+|+.+++++ +|+||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4678999999999999999999765 68899999885421 222335577899999999 999999999988653  468


Q ss_pred             EEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          278 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      ++||||+. ++|..++...    .+++..+..++.||+.||+|||   +.+++||||||+||+++.++.++|+|||++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 5898888653    5788888999999999999999   78999999999999999999999999999987


Q ss_pred             ccCCCC-----Ccccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCC--------CCCCcch
Q 011005          358 LHADSS-----NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS--------SSDPKIM  423 (496)
Q Consensus       358 ~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~--------~~~~~~~  423 (496)
                      ......     ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||........        .......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            643321     1223467889999998765 4578899999999999999999999863221100        0000000


Q ss_pred             --------hHhhhcCCC---CCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          424 --------LIDVLDQRL---PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       424 --------~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                              ....+....   ..............+.+++.+||+.||++|||+.++++++|+..-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence                    000000000   000000000113457899999999999999999999999988654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=5.5e-37  Score=298.91  Aligned_cols=273  Identities=22%  Similarity=0.289  Sum_probs=204.5

Q ss_pred             HHHHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeec-CCeE
Q 011005          201 IEATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH-KKCM  277 (496)
Q Consensus       201 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~  277 (496)
                      ..++++|++.+.||+|+||.||+|..+ +++.||+|++.... .....+.+.+|+++++.++||||+++++++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            446789999999999999999999654 78999999876432 22234667889999999999999999998865 5578


Q ss_pred             EEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          278 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      ++|+||+ +++|..++...    .++...+..++.|++.||.|||   ..+++||||+|+||++++++.++|+|||.+..
T Consensus        86 ~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          86 YFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence            8999998 56888887643    4678888899999999999999   78999999999999999999999999999975


Q ss_pred             ccCCCCCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCC--------CCCCcch-----
Q 011005          358 LHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS--------SSDPKIM-----  423 (496)
Q Consensus       358 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~--------~~~~~~~-----  423 (496)
                      ....   .....+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||........        ...+...     
T Consensus       158 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd07856         158 QDPQ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC  234 (328)
T ss_pred             cCCC---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            4322   223457889999998766 5688999999999999999999999853221000        0000000     


Q ss_pred             ---hHhhhcC---CCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCcc
Q 011005          424 ---LIDVLDQ---RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHA  484 (496)
Q Consensus       424 ---~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~  484 (496)
                         ..+....   ..+.+...........+.+++.+||+.+|++|||+++++.++|+.........+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~  301 (328)
T cd07856         235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEP  301 (328)
T ss_pred             chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCcccc
Confidence               0000000   000010000011124578999999999999999999999999997766554443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.9e-37  Score=287.92  Aligned_cols=239  Identities=22%  Similarity=0.409  Sum_probs=186.4

Q ss_pred             ceeeecCCeeEEEEEeCC--------CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          211 YCIGTGGYGSVYKAQLPN--------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      +.||+|+||.||+|....        ...|++|.+.... ....+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            358999999999996532        2347888875433 2344678889999999999999999999999889999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCC--------eEEccccc
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE--------AFVADFGT  354 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~--------~kl~Dfg~  354 (496)
                      |+++|+|.+++.....  .+++..++.++.||+.||+|||   +++++||||||+||+++.++.        ++++|||.
T Consensus        80 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          80 YVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             cCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence            9999999999986543  5788999999999999999999   789999999999999987765        68999998


Q ss_pred             cccccCCCCCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCC-CCCccccccCCCCCCcchhHhhhcCCC
Q 011005          355 ARLLHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGK-HPRDILSSLSSSSDPKIMLIDVLDQRL  432 (496)
Q Consensus       355 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~  432 (496)
                      +.....    .....++..|+|||.+.+. .++.++||||||+++|+|++|. .|+.....        ...........
T Consensus       155 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~  222 (258)
T cd05078         155 SITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--------QKKLQFYEDRH  222 (258)
T ss_pred             ccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--------HHHHHHHHccc
Confidence            865432    2234678899999999874 5789999999999999999984 56542211        11111122211


Q ss_pred             CCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 011005          433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       433 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~  472 (496)
                      ..+..     ....+.+++.+||+.||++|||++++++.+
T Consensus       223 ~~~~~-----~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         223 QLPAP-----KWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             cCCCC-----CcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            11111     112467999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-37  Score=292.01  Aligned_cols=262  Identities=28%  Similarity=0.367  Sum_probs=198.4

Q ss_pred             CCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecC--CeEEEEEE
Q 011005          207 FDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK--KCMFLIYE  282 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lV~e  282 (496)
                      |++.+.||+|+||.||+|... +++.+|+|.+.... .......+.+|+.++++++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999765 58899999998653 223345678999999999999999999999888  78999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++ +|.+++....  ..+++..++.++.||+.||+|||   ..+++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9975 8888876542  36899999999999999999999   7799999999999999999999999999998765433


Q ss_pred             C-Ccccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCC---------CCCCcc--hhHh--h
Q 011005          363 S-NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS---------SSDPKI--MLID--V  427 (496)
Q Consensus       363 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~---------~~~~~~--~~~~--~  427 (496)
                      . ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........         ......  ....  .
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence            1 1223456788999998765 4578999999999999999999999863321100         000000  0000  0


Q ss_pred             hc-CCCCCCCCh---hHHH--HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          428 LD-QRLPPPVDR---KVIR--DILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       428 ~~-~~~~~~~~~---~~~~--~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      .. .........   ....  ....+.+++.+||+.+|++||++.++++++|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            00 000000000   0000  13457899999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-38  Score=321.70  Aligned_cols=261  Identities=26%  Similarity=0.340  Sum_probs=212.3

Q ss_pred             HHHHHHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCC
Q 011005          199 DLIEATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK  275 (496)
Q Consensus       199 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  275 (496)
                      ++.-..++|.+.+.||+|+||.|..++++ .++.||.|++.+-.  .......|..|-.+|..-+.+=|+.++-.|.+..
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            33444688999999999999999999876 58889999997732  2234567899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccc
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  355 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  355 (496)
                      ++|+|||||+||+|..++.+..   .+++.-++.++..|+-||..+|   ..|+|||||||+|||+|..|++||+|||.+
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhH
Confidence            9999999999999999999865   6888999999999999999999   789999999999999999999999999999


Q ss_pred             ccccCCCCC-ccccccccccccccccc----c-CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhc
Q 011005          356 RLLHADSSN-RTLLAGTYGYIAPELAY----T-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD  429 (496)
Q Consensus       356 ~~~~~~~~~-~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  429 (496)
                      -.+..++.. ....+|||.|.+||++.    + +.|+..+|.||+||++|||+.|..||-..+       .-.....+++
T Consensus       223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-------lveTY~KIm~  295 (1317)
T KOG0612|consen  223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-------LVETYGKIMN  295 (1317)
T ss_pred             HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-------HHHHHHHHhc
Confidence            988765543 45678999999999986    3 578999999999999999999999995221       1223344444


Q ss_pred             C--CCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCC---HHHHHHHHHHhc
Q 011005          430 Q--RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPT---MQSVSQEFLITR  476 (496)
Q Consensus       430 ~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~~~~~~~  476 (496)
                      .  .+..|....   ......+||.+.+. +|+.|..   ++++-.|+||.+
T Consensus       296 hk~~l~FP~~~~---VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g  343 (1317)
T KOG0612|consen  296 HKESLSFPDETD---VSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEG  343 (1317)
T ss_pred             hhhhcCCCcccc---cCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccC
Confidence            4  333331111   22235677766554 7888888   999999988753

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.1e-36  Score=292.59  Aligned_cols=256  Identities=27%  Similarity=0.379  Sum_probs=200.9

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccc--hhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTS--EELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ..|+..+.||+|+||.||+|... +++.+|+|.+...  ......+.+.+|+++++.++|+|++++++++..+...++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34777788999999999999764 6788999988642  12233456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+. |++.+.+....  ..+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9996 57877765432  25788999999999999999999   779999999999999999999999999998765322


Q ss_pred             CCCccccccccccccccccc---cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCCh
Q 011005          362 SSNRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR  438 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  438 (496)
                          ....+++.|+|||.+.   ...++.++||||||+++|+|++|+.||....       .............+.... 
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~-  236 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNESPALQS-  236 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc-------HHHHHHHHhhcCCCCcCc-
Confidence                2346788999999874   3567889999999999999999999985321       111111112122211111 


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          439 KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       439 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                        ......+.+++.+||+.+|++||++.++++|+|+....+.
T Consensus       237 --~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~  276 (308)
T cd06634         237 --GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP  276 (308)
T ss_pred             --ccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCCh
Confidence              1122347789999999999999999999999999886553

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-37  Score=307.17  Aligned_cols=259  Identities=26%  Similarity=0.420  Sum_probs=222.9

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeec-----CC
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLH-----KK  275 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-----~~  275 (496)
                      .++.|++.+.||.|.+|.||+++. ++++.+|+|+.....+.+  .+...|+++++.. .|||++.++|++..     ++
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d--eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE--EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc--HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            456799999999999999999964 578999999988766544  5677899999988 59999999999864     46


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccc
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  355 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  355 (496)
                      .+|+|||||.|||.-++++... +..+.|+.+..|++.++.|+.|||   ...++|||||-.|||++.++.||++|||.+
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvS  170 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVS  170 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeee
Confidence            8999999999999999999876 668999999999999999999999   778999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccccccC-----CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcC
Q 011005          356 RLLHADSSNRTLLAGTYGYIAPELAYTM-----VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQ  430 (496)
Q Consensus       356 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  430 (496)
                      ..+...-....+.+|||.|||||++...     .|+.++|+||||++..||..|.+|+-.+.+         +..-+...
T Consensus       171 aQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP---------mraLF~Ip  241 (953)
T KOG0587|consen  171 AQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP---------MRALFLIP  241 (953)
T ss_pred             eeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch---------hhhhccCC
Confidence            9887766677788999999999998643     577799999999999999999999764432         23333344


Q ss_pred             CCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          431 RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       431 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      +-|++....+..+...+.++|..||..|-++||++.++++|+|++.
T Consensus       242 RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  242 RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence            5555555667777788999999999999999999999999999983

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.6e-36  Score=287.55  Aligned_cols=249  Identities=21%  Similarity=0.235  Sum_probs=190.4

Q ss_pred             eeeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHHHH---HHhhcccccccccceeecCCeEEEEEEecC
Q 011005          212 CIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEAQV---LSQVLHRNIVKLYGYCLHKKCMFLIYEYME  285 (496)
Q Consensus       212 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~---l~~l~h~niv~~~~~~~~~~~~~lV~e~~~  285 (496)
                      .||+|+||.||+|... +++.||+|.+.....  ......+..|..+   ++...||+|+.+++++...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            3899999999999764 588999998865321  1111223344433   344469999999999999999999999999


Q ss_pred             CCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCc
Q 011005          286 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR  365 (496)
Q Consensus       286 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  365 (496)
                      ||+|..++....   .+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.++|+|||++......  ..
T Consensus        81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~  152 (278)
T cd05606          81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KP  152 (278)
T ss_pred             CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CC
Confidence            999998887543   6899999999999999999999   789999999999999999999999999998765332  22


Q ss_pred             cccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHH
Q 011005          366 TLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI  444 (496)
Q Consensus       366 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  444 (496)
                      ....|+..|+|||.+.+. .++.++||||+|+++|+|++|+.||......     .......... ........   ...
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~-~~~~~~~~---~~s  223 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDRMTL-TMAVELPD---SFS  223 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc-----chHHHHHHhh-ccCCCCCC---cCC
Confidence            334689999999998754 6889999999999999999999999643211     0011111111 11111111   012


Q ss_pred             HHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHhcc
Q 011005          445 LLISTVSFACLQSNPKSRP-----TMQSVSQEFLITRK  477 (496)
Q Consensus       445 ~~l~~li~~cl~~dP~~Rp-----s~~evl~~~~~~~~  477 (496)
                      ..+.+++.+|+..+|.+||     ++.++++|+|+...
T Consensus       224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~  261 (278)
T cd05606         224 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL  261 (278)
T ss_pred             HHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence            3577899999999999999     99999999998664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=7e-37  Score=299.59  Aligned_cols=266  Identities=24%  Similarity=0.244  Sum_probs=199.8

Q ss_pred             HhCCCC-cceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHH-------------HHHHHHHHHHHHHhhccccccccc
Q 011005          204 TEDFDI-RYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELA-------------FIKSFKNEAQVLSQVLHRNIVKLY  268 (496)
Q Consensus       204 ~~~~~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------------~~~~~~~e~~~l~~l~h~niv~~~  268 (496)
                      .++|.. .+.||+|+||+||+|..+ +++.||+|.+.......             ....+.+|+++++.++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            356654 567999999999999754 68999999986543211             012467899999999999999999


Q ss_pred             ceeecCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeE
Q 011005          269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF  348 (496)
Q Consensus       269 ~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~k  348 (496)
                      +++..++..++||||+. |+|.+++....   .+++.....++.|++.||.|||   +.+++|+||+|+||+++.++.++
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEE
Confidence            99999999999999997 58988886543   6889999999999999999999   78999999999999999999999


Q ss_pred             EccccccccccCC--------------CCCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccc
Q 011005          349 VADFGTARLLHAD--------------SSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSS  413 (496)
Q Consensus       349 l~Dfg~~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~  413 (496)
                      |+|||++......              ........+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999999766411              1111223467889999998764 468899999999999999999999863321


Q ss_pred             cCCCCCCcchhHhhhc--------------------CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          414 LSSSSDPKIMLIDVLD--------------------QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       414 ~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      ...    .........                    ...+.............+.+++.+||+.+|++|||++|++.|+|
T Consensus       240 ~~~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~  315 (335)
T PTZ00024        240 IDQ----LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY  315 (335)
T ss_pred             HHH----HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence            100    000000000                    00000000000011234779999999999999999999999999


Q ss_pred             HhccCCC
Q 011005          474 ITRKTPL  480 (496)
Q Consensus       474 ~~~~~~~  480 (496)
                      +......
T Consensus       316 ~~~~~~~  322 (335)
T PTZ00024        316 FKSDPLP  322 (335)
T ss_pred             cCCCCCC
Confidence            9866444

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-36  Score=283.84  Aligned_cols=244  Identities=27%  Similarity=0.378  Sum_probs=199.8

Q ss_pred             eeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCCCh
Q 011005          213 IGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL  289 (496)
Q Consensus       213 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g~L  289 (496)
                      ||+|+||.||++... +++.+|+|.+.....  ......+.+|+++++.++|+|++++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999765 588999999876432  22446788999999999999999999999999999999999999999


Q ss_pred             hhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCccccc
Q 011005          290 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA  369 (496)
Q Consensus       290 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  369 (496)
                      .+++....   .+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||++..............
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG---RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC  154 (250)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence            99997654   5789999999999999999999   78999999999999999999999999999987654433344456


Q ss_pred             cccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHH
Q 011005          370 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLIST  449 (496)
Q Consensus       370 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  449 (496)
                      ++..|+|||...+...+.++|+||||+++|++++|+.||....       ...............+..     ....+.+
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~-----~~~~l~~  222 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED-------RKEIYEKILKDPLRFPEF-----LSPEARD  222 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHhcCCCCCCCC-----CCHHHHH
Confidence            7889999999998888999999999999999999999986322       111222222222221111     1234678


Q ss_pred             HHHhcccCCCCCCCCH---HHHHHHHHH
Q 011005          450 VSFACLQSNPKSRPTM---QSVSQEFLI  474 (496)
Q Consensus       450 li~~cl~~dP~~Rps~---~evl~~~~~  474 (496)
                      ++.+||..||++||++   +++++|+|+
T Consensus       223 ~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         223 LISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            9999999999999999   899998875

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.1e-36  Score=293.14  Aligned_cols=256  Identities=28%  Similarity=0.354  Sum_probs=199.9

Q ss_pred             CCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          207 FDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      |...+.||+|+||+||+|... +++.|++|.+....  .......+.+|+.+++.++|+|++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666778999999999999764 68899999986432  223345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +. |++.+.+....  ..+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||++.....   
T Consensus       103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633         103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            96 57777775432  25889999999999999999999   77999999999999999999999999999864321   


Q ss_pred             Cccccccccccccccccc---cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          364 NRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                       .....++..|+|||.+.   ...++.++||||||+++|+|++|..||.....       ............+.....  
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~--  243 (313)
T cd06633         174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNDSPTLQSN--  243 (313)
T ss_pred             -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhcCCCCCCcc--
Confidence             22356888999999974   45678899999999999999999999853221       111111111111111111  


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCC
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVK  482 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~  482 (496)
                       .....+.+++.+||+.+|.+||++.++++|+|+....+...
T Consensus       244 -~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~~  284 (313)
T cd06633         244 -EWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARV  284 (313)
T ss_pred             -ccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCchhHH
Confidence             11224678999999999999999999999999987655433

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=9.3e-37  Score=294.36  Aligned_cols=263  Identities=29%  Similarity=0.367  Sum_probs=198.4

Q ss_pred             HHHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeecCC----
Q 011005          202 EATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK----  275 (496)
Q Consensus       202 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  275 (496)
                      ...++|++.+.||+|+||.||+|..+ +++.||+|.++.... ......+.+|++++++++|||++++++++....    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            35678999999999999999999775 588999999865432 222346678999999999999999999987654    


Q ss_pred             ------eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEE
Q 011005          276 ------CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFV  349 (496)
Q Consensus       276 ------~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl  349 (496)
                            ..++|+||+++ ++...+...  ...+++..+..++.|++.||+|||   ..+++|+||+|+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEe
Confidence                  78999999986 676666643  236899999999999999999999   779999999999999999999999


Q ss_pred             ccccccccccCCCC-Ccccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhh
Q 011005          350 ADFGTARLLHADSS-NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDV  427 (496)
Q Consensus       350 ~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  427 (496)
                      +|||++........ ......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||........    -......
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~----~~~~~~~  233 (302)
T cd07864         158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ----LELISRL  233 (302)
T ss_pred             CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHH
Confidence            99999987644332 1222345778999998765 4578899999999999999999999864321100    0000000


Q ss_pred             hcCCCC----------------------CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          428 LDQRLP----------------------PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       428 ~~~~~~----------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      .....+                      ..........+..+.+++.+||+.||++|||+.++++++|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            000000                      00000000113457899999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.3e-36  Score=291.60  Aligned_cols=258  Identities=26%  Similarity=0.385  Sum_probs=201.4

Q ss_pred             CCCCcceeeecCCeeEEEEEe----CCCcEEEEEEcccchh---HHHHHHHHHHHHHHHhh-cccccccccceeecCCeE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSEE---LAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCM  277 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  277 (496)
                      +|++.+.||+|+||.||+|..    .+|+.||+|.+.....   ....+.+.+|+.+++++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999975    3688999999875321   12335678899999999 599999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          278 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      ++||||+++++|.+++....   .+++..+..++.|++.||.|||   ..+++||||+|+||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            99999999999999987643   5788899999999999999999   78999999999999999999999999999976


Q ss_pred             ccCCCCC-ccccccccccccccccccC--CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCC
Q 011005          358 LHADSSN-RTLLAGTYGYIAPELAYTM--VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPP  434 (496)
Q Consensus       358 ~~~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  434 (496)
                      ....... .....|+..|+|||.+.+.  .++.++||||+|+++|+|++|+.||.....   ................+.
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~  231 (290)
T cd05613         155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE---KNSQAEISRRILKSEPPY  231 (290)
T ss_pred             cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc---cccHHHHHHHhhccCCCC
Confidence            5433211 2234578899999998753  467899999999999999999999863211   001111111111111111


Q ss_pred             CCChhHHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHhcc
Q 011005          435 PVDRKVIRDILLISTVSFACLQSNPKSRP-----TMQSVSQEFLITRK  477 (496)
Q Consensus       435 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~~~~~~~  477 (496)
                      +.     .....+.+++.+||+.||++||     +.+++++|+|+.+.
T Consensus       232 ~~-----~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  274 (290)
T cd05613         232 PQ-----EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI  274 (290)
T ss_pred             Cc-----cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence            11     1123467899999999999997     89999999998664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-37  Score=291.51  Aligned_cols=262  Identities=26%  Similarity=0.323  Sum_probs=201.0

Q ss_pred             CCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          207 FDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      |+..+.||+|++|.||+|... +++.||+|.+.... .....+.+.+|+.++++++|+|++++++++......++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999765 58999999987653 2233456788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      + ++|.+++....  ..+++..+..++.|++.||.|||   +.+++||||+|+||++++++.++|+|||.+.........
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  154 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT  154 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence            7 58999988653  26899999999999999999999   779999999999999999999999999999876544333


Q ss_pred             ccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCC---------CCCCcch--hHhh--hcC
Q 011005          365 RTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS---------SSDPKIM--LIDV--LDQ  430 (496)
Q Consensus       365 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~---------~~~~~~~--~~~~--~~~  430 (496)
                      .....++..|+|||.+.+. .++.++||||+|+++||+++|+.||........         .......  ....  ...
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            3334567789999998776 788999999999999999999999853221000         0000000  0000  000


Q ss_pred             CCCC----CCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          431 RLPP----PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       431 ~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ..+.    ............+.+++.+||+.||++||++.+++.|+|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            0000    0000000113357899999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-37  Score=303.89  Aligned_cols=203  Identities=31%  Similarity=0.454  Sum_probs=178.3

Q ss_pred             CCCcceeeecCCeeEEEEE-eCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCC------eEEE
Q 011005          207 FDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK------CMFL  279 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~l  279 (496)
                      +...+.||+|+||.||+|+ .+.|+.||||.++........+...+|++++++++|+|||++++.-+...      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            4456779999999999998 45799999999988665556678899999999999999999998776544      5789


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEec--CCCC--eEEcccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN--SKLE--AFVADFGTA  355 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~--~~~~--~kl~Dfg~~  355 (496)
                      |||||.||+|+..+.+-+....+++.+.+.++.+++.||.|||   .+||+||||||.||++-  .+|+  -||+|||+|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999998887788999999999999999999999   78999999999999984  3333  699999999


Q ss_pred             ccccCCCCCccccccccccccccccc-cCCcCcccchhhHHHHHHHHHhCCCCCccccc
Q 011005          356 RLLHADSSNRTLLAGTYGYIAPELAY-TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSS  413 (496)
Q Consensus       356 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~p~~~~~~  413 (496)
                      +...++. .....+||..|.+||... .+.|+..+|.|||||++|+++||..||.+...
T Consensus       172 rel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  172 RELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             ccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            9886544 566789999999999998 58899999999999999999999999975543

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-36  Score=297.51  Aligned_cols=268  Identities=25%  Similarity=0.304  Sum_probs=201.4

Q ss_pred             HHHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCC----
Q 011005          202 EATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK----  275 (496)
Q Consensus       202 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  275 (496)
                      ...++|++.+.||+|+||.||+|.. .+++.||+|.+.... .......+.+|+.++++++|+||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            3567899999999999999999964 478999999986532 2233456789999999999999999999887643    


Q ss_pred             --eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccc
Q 011005          276 --CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG  353 (496)
Q Consensus       276 --~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  353 (496)
                        ..++||||+ +++|.+++...    .+++..+..++.|++.||+|||   ..+++||||||+||+++.++.++++|||
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence              468999998 77888877642    5889999999999999999999   7899999999999999999999999999


Q ss_pred             ccccccCCCCCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCC-------CCCCcchhH
Q 011005          354 TARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS-------SSDPKIMLI  425 (496)
Q Consensus       354 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~-------~~~~~~~~~  425 (496)
                      ++......   .....+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||........       .........
T Consensus       164 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (343)
T cd07880         164 LARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV  240 (343)
T ss_pred             cccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            99765322   223457889999998876 4578899999999999999999999863321000       000000000


Q ss_pred             hhh--------cCCCCCCCCh----hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          426 DVL--------DQRLPPPVDR----KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       426 ~~~--------~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      ..+        ...++.....    ........+.+++.+|++.||++|||+.++++|+|+......
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence            000        0000000000    000112247799999999999999999999999999875443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=5.6e-36  Score=284.60  Aligned_cols=253  Identities=26%  Similarity=0.419  Sum_probs=194.2

Q ss_pred             CCCcceeeecCCeeEEEEEeC----CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCC------
Q 011005          207 FDIRYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK------  275 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  275 (496)
                      |.+.+.||+|+||.||+|.+.    +++.||+|.+.... .....+.+.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567788999999999999653    46889999987643 2233567889999999999999999999886532      


Q ss_pred             eEEEEEEecCCCChhhhhhCCC---CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccc
Q 011005          276 CMFLIYEYMERGSLFCNLHNNE---DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF  352 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Df  352 (496)
                      ..+++++|+.+|+|..++....   ....+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999988765321   2235788999999999999999999   779999999999999999999999999


Q ss_pred             cccccccCCCC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhc
Q 011005          353 GTARLLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLD  429 (496)
Q Consensus       353 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~  429 (496)
                      |+++.......  ......+++.|++||.+.+..++.++||||||+++|+|++ |+.||.....       .........
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-------SEIYNYLIK  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-------HHHHHHHHc
Confidence            99986643221  1122345678999999999899999999999999999999 8888753211       111111111


Q ss_pred             C-CCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          430 Q-RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       430 ~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      . ....+.     .....+.+++.+||+.+|++|||+.|+++.+..
T Consensus       231 ~~~~~~~~-----~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         231 GNRLKQPP-----DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             CCcCCCCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            1 111111     112357899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1e-36  Score=295.36  Aligned_cols=265  Identities=25%  Similarity=0.318  Sum_probs=194.6

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhH-HHHHHHHHHHHHHHhhcccccccccceeecC-------
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEEL-AFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK-------  274 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------  274 (496)
                      .++|++.+.||+|+||.||+|..+ +++.+|+|.+...... .....+.+|++++++++|+||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999764 6889999988653321 1224567899999999999999999987543       


Q ss_pred             -CeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccc
Q 011005          275 -KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG  353 (496)
Q Consensus       275 -~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  353 (496)
                       ...++|+||+.+ ++...+....  ..+++..+..++.|+++||+|||   +.+++|+||||+||++++++.++|+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCc
Confidence             346999999975 6766665432  36899999999999999999999   7899999999999999999999999999


Q ss_pred             ccccccCCCCC-----------ccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCC-----
Q 011005          354 TARLLHADSSN-----------RTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS-----  416 (496)
Q Consensus       354 ~~~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~-----  416 (496)
                      ++.........           .....+++.|+|||.+.+. .++.++||||+|+++|+|++|++||........     
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99765432211           1223567889999987654 578899999999999999999999863322100     


Q ss_pred             ----CCCCcchh-----Hh----hhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          417 ----SSDPKIML-----ID----VLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       417 ----~~~~~~~~-----~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                          ...+....     ..    ......+.............+.+++.+||+.||++|||+.|++.|+|+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence                00000000     00    000000000000001111357899999999999999999999999885

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-38  Score=326.27  Aligned_cols=261  Identities=29%  Similarity=0.380  Sum_probs=207.2

Q ss_pred             HhCCCCcceeeecCCeeEEEEE-eCCCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      +-+++-...||.|.||.||.|. ..+|...|+|-++.... ....+...+|..++..++|||+|+++|+-.+.+..+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            3467778889999999999995 56799999998876432 334566789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      |||++|+|.+.+....   -.++.....+..|++.|++|||   +.|||||||||.||+++.+|.+|++|||.|..+...
T Consensus      1314 EyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             HHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence            9999999999997653   3556666778899999999999   789999999999999999999999999999988654


Q ss_pred             CCC----ccccccccccccccccccCC---cCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCC
Q 011005          362 SSN----RTLLAGTYGYIAPELAYTMV---MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPP  434 (496)
Q Consensus       362 ~~~----~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  434 (496)
                      ...    ....+||+.|||||++.+..   ...++||||+||+..||+||+.||..+..     .-..+..........-
T Consensus      1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-----e~aIMy~V~~gh~Pq~ 1462 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-----EWAIMYHVAAGHKPQI 1462 (1509)
T ss_pred             hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-----hhHHHhHHhccCCCCC
Confidence            321    23467999999999998654   45689999999999999999999974321     1112222222222222


Q ss_pred             CCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          435 PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       435 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      |..     ....-.+++..||..||++|.++.|+++|-|-......
T Consensus      1463 P~~-----ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1463 PER-----LSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDE 1503 (1509)
T ss_pred             chh-----hhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccccc
Confidence            211     12234588999999999999999999999876555433

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-36  Score=296.62  Aligned_cols=269  Identities=22%  Similarity=0.265  Sum_probs=203.0

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCe----
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKC----  276 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----  276 (496)
                      ..++|++.+.||+|++|.||+|... +++.||+|++.... .....+.+.+|+.+++.++|+|++++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4678999999999999999999765 57899999986532 22334567789999999999999999998876554    


Q ss_pred             --EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccc
Q 011005          277 --MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  354 (496)
Q Consensus       277 --~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  354 (496)
                        .++|+||+ +++|.+++...    .+++..+..++.|++.||+|||   +.|++||||+|+||+++.++.++|+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccc
Confidence              89999998 66998888752    6899999999999999999999   78999999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCC--------CCCCcch--
Q 011005          355 ARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS--------SSDPKIM--  423 (496)
Q Consensus       355 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~--------~~~~~~~--  423 (496)
                      +......   .....++..|+|||.+.+ ..++.++||||+|+++|++++|+.||........        .......  
T Consensus       165 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  241 (343)
T cd07851         165 ARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ  241 (343)
T ss_pred             ccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence            9765332   233467889999998865 3678899999999999999999999853221000        0000000  


Q ss_pred             ------hHhhhcCCC---CCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCC
Q 011005          424 ------LIDVLDQRL---PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVK  482 (496)
Q Consensus       424 ------~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~  482 (496)
                            ....+....   ..............+.+++.+||+.||++|||+.|+++|+|+........
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~  309 (343)
T cd07851         242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPED  309 (343)
T ss_pred             hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcc
Confidence                  000000000   00000000011345789999999999999999999999999987655543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-37  Score=298.71  Aligned_cols=244  Identities=24%  Similarity=0.320  Sum_probs=199.9

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV  280 (496)
                      +++.|.+...+|.|+|+.|-.+.+ .+++..++|++....     ....+|+.++.+. +||||+++.+.+.++.+.|+|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeee
Confidence            467888999999999999999954 568889999997762     2345678777777 699999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe-cCCCCeEEcccccccccc
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL-NSKLEAFVADFGTARLLH  359 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~-~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||.+.|+-+.+.+....   .+. .++..|+.+|+.|+.|||   .+|++|||+||+|||+ +..++++|+|||.++...
T Consensus       395 ~e~l~g~ell~ri~~~~---~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKP---EFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             ehhccccHHHHHHHhcc---hhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            99999998888877654   333 677789999999999999   7899999999999999 688999999999998775


Q ss_pred             CCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          360 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       360 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                      .+   ....+-|..|.|||++....|++++|+||||++||+|++|+.||.....       .   .++......+..+. 
T Consensus       468 ~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~-------~---~ei~~~i~~~~~s~-  533 (612)
T KOG0603|consen  468 RS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA-------G---IEIHTRIQMPKFSE-  533 (612)
T ss_pred             hh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc-------h---HHHHHhhcCCcccc-
Confidence            54   3345678899999999999999999999999999999999999973211       1   22222222222221 


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                        .......+|+.+||+.||.+||++.++..|+|+
T Consensus       534 --~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  534 --CVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             --ccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence              122246789999999999999999999999999

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.7e-36  Score=289.09  Aligned_cols=257  Identities=26%  Similarity=0.377  Sum_probs=198.3

Q ss_pred             CCCCcceeeecCCeeEEEEEe----CCCcEEEEEEcccch---hHHHHHHHHHHHHHHHhh-cccccccccceeecCCeE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSE---ELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCM  277 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  277 (496)
                      +|++.+.||+|+||.||++..    .+++.||+|.++...   .....+.+.+|++++.++ +|+||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            477889999999999999964    357889999987532   123345678999999999 599999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          278 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      ++||||+++|+|.+.+....   .+++..+..++.|+++||.|||   ..+++||||+|+||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            99999999999999887543   5788999999999999999999   78999999999999999999999999999876


Q ss_pred             ccCCCCC-ccccccccccccccccccCC--cCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCC
Q 011005          358 LHADSSN-RTLLAGTYGYIAPELAYTMV--MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPP  434 (496)
Q Consensus       358 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  434 (496)
                      ....... .....++..|+|||.+.+..  .+.++||||+|+++|+|++|..||......   ...............+.
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~  231 (288)
T cd05583         155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ---NSQSEISRRILKSKPPF  231 (288)
T ss_pred             cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc---chHHHHHHHHHccCCCC
Confidence            5433221 22345788999999987765  788999999999999999999998632210   01111111122221111


Q ss_pred             CCChhHHHHHHHHHHHHHhcccCCCCCCCCH---HHHHHHHHHhc
Q 011005          435 PVDRKVIRDILLISTVSFACLQSNPKSRPTM---QSVSQEFLITR  476 (496)
Q Consensus       435 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~---~evl~~~~~~~  476 (496)
                      +.     .....+.+++.+||+.||++|||+   .++++|+|+..
T Consensus       232 ~~-----~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~  271 (288)
T cd05583         232 PK-----TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG  271 (288)
T ss_pred             Cc-----ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccccc
Confidence            11     112246789999999999999995   55577776543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.1e-36  Score=296.80  Aligned_cols=265  Identities=22%  Similarity=0.247  Sum_probs=195.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecC--------
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK--------  274 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------  274 (496)
                      ..+|.+.+.||.|+||.||+|.. .+++.||+|++..... ...+.+.+|++++++++||||+++++++...        
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            36799999999999999999965 4688999999866543 3346688999999999999999999876553        


Q ss_pred             ------CeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC-CCCe
Q 011005          275 ------KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KLEA  347 (496)
Q Consensus       275 ------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~-~~~~  347 (496)
                            ...++||||++ ++|.+.+...    .+++..+..++.||+.||.|||   ..+++||||||+||+++. ++.+
T Consensus        83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          83 GSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             ccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceE
Confidence                  35789999997 5888777542    5789999999999999999999   779999999999999974 5678


Q ss_pred             EEccccccccccCCCC---Ccccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCC-------
Q 011005          348 FVADFGTARLLHADSS---NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS-------  416 (496)
Q Consensus       348 kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~-------  416 (496)
                      +++|||.+........   ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........       
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999976533211   1122357889999998654 5678899999999999999999999963321100       


Q ss_pred             CCCCcc-hhH-------hhhc--CCCC-CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          417 SSDPKI-MLI-------DVLD--QRLP-PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       417 ~~~~~~-~~~-------~~~~--~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ...... ...       ....  .... .+...........+.+++.+||+.||++|||+.|+++|+|+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence            000000 000       0000  0000 00000000112346789999999999999999999999999743

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-38  Score=275.71  Aligned_cols=262  Identities=24%  Similarity=0.289  Sum_probs=200.4

Q ss_pred             cceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEEEEecCCC
Q 011005          210 RYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLIYEYMERG  287 (496)
Q Consensus       210 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~g  287 (496)
                      ...||.|+||+|+|..+ +.|+..|||+++......+.+++..|.+...+- ++||||++||.+..++..|+.||.|+- 
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence            34599999999999965 479999999999877666678888888877666 699999999999999999999999953 


Q ss_pred             ChhhhhhC--CCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCc
Q 011005          288 SLFCNLHN--NEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR  365 (496)
Q Consensus       288 ~L~~~l~~--~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  365 (496)
                      |+..+-..  .-....+++.-.-+|....+.||.||..  ...|+|||+||+|||++..|.+||||||.+-.+... ...
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-iAk  224 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-IAK  224 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH-HHh
Confidence            66433221  1122367888777888889999999997  568999999999999999999999999999766433 223


Q ss_pred             ccccccccccccccccc--CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCC-hhHHH
Q 011005          366 TLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD-RKVIR  442 (496)
Q Consensus       366 ~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  442 (496)
                      +..+|-..|||||.+..  ..|+.+|||||+|++|||+.||+.|++.-.      ........+..+..+--.. .....
T Consensus       225 T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~------svfeql~~Vv~gdpp~l~~~~~~~~  298 (361)
T KOG1006|consen  225 TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD------SVFEQLCQVVIGDPPILLFDKECVH  298 (361)
T ss_pred             hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH------HHHHHHHHHHcCCCCeecCcccccc
Confidence            34467778999999864  358899999999999999999999986321      1112222222222221111 11223


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCC
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLV  481 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~  481 (496)
                      ....+..++.-|+.+|-..||++.++.+++|........
T Consensus       299 ~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~  337 (361)
T KOG1006|consen  299 YSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEG  337 (361)
T ss_pred             cCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcC
Confidence            445688999999999999999999999999988775543

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=295.13  Aligned_cols=266  Identities=21%  Similarity=0.271  Sum_probs=211.9

Q ss_pred             HhCCCC--cceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          204 TEDFDI--RYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       204 ~~~~~~--~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      ..-|++  .+.||.|.||+||-|.+ ++|+.||||++.+.. .......+.+|+.+++.+.||+||.+...|+..+..++
T Consensus       561 stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFV  640 (888)
T KOG4236|consen  561 STVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFV  640 (888)
T ss_pred             HHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEE
Confidence            333444  56899999999999954 689999999986632 22233678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC---CCeEEccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK---LEAFVADFGTAR  356 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~  356 (496)
                      |||.+.| ++.+++-..+ ..++++....-++.||+.||.|||   -++|+|+||||+|||+...   -++||||||+|+
T Consensus       641 VMEKl~G-DMLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfAR  715 (888)
T KOG4236|consen  641 VMEKLHG-DMLEMILSSE-KGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFAR  715 (888)
T ss_pred             Eehhhcc-hHHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeecccccee
Confidence            9999965 5555554433 337888888889999999999999   7899999999999999654   469999999999


Q ss_pred             cccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCC
Q 011005          357 LLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV  436 (496)
Q Consensus       357 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  436 (496)
                      .+..... ....+|||.|+|||++..+.|...-|+||.|+|+|--++|..||..          ++.+.+-+...-..-.
T Consensus       716 iIgEksF-RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE----------dEdIndQIQNAaFMyP  784 (888)
T KOG4236|consen  716 IIGEKSF-RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE----------DEDINDQIQNAAFMYP  784 (888)
T ss_pred             ecchhhh-hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC----------ccchhHHhhccccccC
Confidence            8865443 4457899999999999999999999999999999999999999963          2222222222211111


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCccc
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAA  485 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~~  485 (496)
                      ...+........+||...|+..-++|-|.+..+.|+|.+.++-+.+-+.
T Consensus       785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRe  833 (888)
T KOG4236|consen  785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRE  833 (888)
T ss_pred             CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHH
Confidence            2234444455779999999999999999999999999998876655443

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=283.43  Aligned_cols=267  Identities=22%  Similarity=0.327  Sum_probs=205.8

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcc--c----ccccccceeecCC
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLH--R----NIVKLYGYCLHKK  275 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~----niv~~~~~~~~~~  275 (496)
                      .+++|.+...+|+|.||.|-.+.+ +.+..||+|+++.-..  +.+..+-|+++++++.+  |    -+|++.+||...+
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k--YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg  164 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK--YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG  164 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH--HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence            478999999999999999999954 4578999999876542  34566789999999952  2    3788899999999


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC------------
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS------------  343 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~------------  343 (496)
                      +.++|+|.+ |-|+++.+..+. ...++...++.|++|+++++++||   +.+++|.||||+|||+.+            
T Consensus       165 hiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  165 HICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             ceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCc
Confidence            999999988 669999998754 347999999999999999999999   889999999999999932            


Q ss_pred             --------CCCeEEccccccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccC
Q 011005          344 --------KLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS  415 (496)
Q Consensus       344 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~  415 (496)
                              +..++++|||.|+.-...   ....+.|..|+|||++.+-.++.++||||+||||+|+.||..-|+.-....
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                    345899999999865433   356788999999999999999999999999999999999999886432110


Q ss_pred             --------CCCCCcchhHhh------hcCCCC-----------------CCCC---hhHHHHHHHHHHHHHhcccCCCCC
Q 011005          416 --------SSSDPKIMLIDV------LDQRLP-----------------PPVD---RKVIRDILLISTVSFACLQSNPKS  461 (496)
Q Consensus       416 --------~~~~~~~~~~~~------~~~~~~-----------------~~~~---~~~~~~~~~l~~li~~cl~~dP~~  461 (496)
                              ..+.+..++...      ...++.                 .+..   .....+...+.+|+++||..||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence                    001111111100      000111                 0000   001122345899999999999999


Q ss_pred             CCCHHHHHHHHHHhccCC
Q 011005          462 RPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       462 Rps~~evl~~~~~~~~~~  479 (496)
                      |+|+.|++.|+|+.+-.+
T Consensus       397 RiTl~EAL~HpFF~~~~~  414 (415)
T KOG0671|consen  397 RITLREALSHPFFARLTP  414 (415)
T ss_pred             cccHHHHhcCHHhhcCCC
Confidence            999999999999987643

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=250.77  Aligned_cols=266  Identities=22%  Similarity=0.281  Sum_probs=201.7

Q ss_pred             CCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          206 DFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      +|...++||+|.||+||||+. ..++.||+|.++-+++ +..-....+|+.+++.++|+|||++++....++.+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            355567899999999999964 4688999999987553 23345678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      |.. +|..+.....  ..++.+.+.+++.|+++||.++|   ++.+.|||+||.|.+++.+|+.|++|||+++-+.-+-.
T Consensus        83 cdq-dlkkyfdsln--g~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             hhH-HHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            964 7777776543  26888999999999999999999   78999999999999999999999999999998766555


Q ss_pred             CccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCC-Ccccccc----------C-CCCCCcchhHhhhcC
Q 011005          364 NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHP-RDILSSL----------S-SSSDPKIMLIDVLDQ  430 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p-~~~~~~~----------~-~~~~~~~~~~~~~~~  430 (496)
                      ..+..+-|.+|++|.++.+. -|+...|+||.|||+.|+.....| |......          . ...+........-+.
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy  236 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY  236 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence            56667789999999999886 578899999999999999874444 4322110          0 000011111111111


Q ss_pred             CCCCC--CChhHHHHHH----HHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          431 RLPPP--VDRKVIRDIL----LISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       431 ~~~~~--~~~~~~~~~~----~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ...+.  ....+.+...    .=.+++.+.+.-+|.+|.++++.++|+++..-
T Consensus       237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence            11111  1111222222    23578888999999999999999999988654

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=9.1e-36  Score=314.45  Aligned_cols=146  Identities=29%  Similarity=0.460  Sum_probs=130.9

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|.+.+.||+|+||.||+|.+. +++.||+|+++...  .......+.+|+.+++.++|+||+++++++......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57899999999999999999765 68999999987543  2334467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      ||+.+++|.+++....   .+++..++.++.||+.||+|||   ..+|+||||||+|||++.++.++|+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999987543   5788999999999999999999   7799999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.8e-36  Score=286.90  Aligned_cols=256  Identities=20%  Similarity=0.241  Sum_probs=180.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCC----CcEEEEEEcccchhHH--H--------HHHHHHHHHHHHhhcccccccccc
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSEELA--F--------IKSFKNEAQVLSQVLHRNIVKLYG  269 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~--~--------~~~~~~e~~~l~~l~h~niv~~~~  269 (496)
                      .++|.+.+.||+|+||+||+|...+    +..+|+|.........  .        ......+...+..+.|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3679999999999999999997654    3456666543222110  0        011122334455567999999998


Q ss_pred             eeecCC----eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC
Q 011005          270 YCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL  345 (496)
Q Consensus       270 ~~~~~~----~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~  345 (496)
                      ++....    ..+++++++.. ++.+.+....   ..++..+..++.|++.||+|||   +.+++||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCC
Confidence            776543    34678887643 6666655432   3577888999999999999999   78999999999999999999


Q ss_pred             CeEEccccccccccCCCC-------CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCC
Q 011005          346 EAFVADFGTARLLHADSS-------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSS  418 (496)
Q Consensus       346 ~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~  418 (496)
                      .++|+|||+++.+.....       ......||+.|+|||++.+..++.++||||+||++|||++|+.||..........
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            999999999987643221       1223468999999999999999999999999999999999999997442110000


Q ss_pred             C-Ccc-hhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 011005          419 D-PKI-MLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       419 ~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~  472 (496)
                      . ... ............+      .....+.+++..|++.+|++||++.++++.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        244 HAAKCDFIKRLHEGKIKIK------NANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHhHHHHHHHhhhhhhccC------CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            0 000 0111111111111      1124577999999999999999999998754

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=286.98  Aligned_cols=264  Identities=26%  Similarity=0.383  Sum_probs=204.9

Q ss_pred             HHhCCCCcceeeecCCeeEEEE-EeCCCcEEEEEEcccch------hHHHHHHHHHHHHHHHhhcccccccccceeecC-
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSE------ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK-  274 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-  274 (496)
                      ..++|-+.++||+|||+.|||| +....+.||||+-....      ...+.+-..+|..+.+.++||.||++|+|+..+ 
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            4567888899999999999999 45677889999764322      223445678999999999999999999999754 


Q ss_pred             CeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC---CCCeEEcc
Q 011005          275 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KLEAFVAD  351 (496)
Q Consensus       275 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~---~~~~kl~D  351 (496)
                      +..|-|.|||+|.+|.-+|....   .+++.++++|+.||+.||.||... +.+|+|.||||.|||+-+   -|.+||+|
T Consensus       541 dsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence            56889999999999999998776   689999999999999999999977 889999999999999954   47899999


Q ss_pred             ccccccccCCCCC-------ccccccccccccccccccC----CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCC
Q 011005          352 FGTARLLHADSSN-------RTLLAGTYGYIAPELAYTM----VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDP  420 (496)
Q Consensus       352 fg~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~  420 (496)
                      ||+++.+.++...       .+...||.+|++||.+.-+    ..+.++||||+|||+|..+.|+.||............
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe  696 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE  696 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence            9999999776554       2335799999999987533    5678999999999999999999999743221110000


Q ss_pred             cchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          421 KIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       421 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      . .+...-.-..++...     .......+|.+||+..-++|....++..++++..
T Consensus       697 N-TIlkAtEVqFP~KPv-----VsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  697 N-TILKATEVQFPPKPV-----VSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             h-chhcceeccCCCCCc-----cCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            0 000000011111110     1123568899999999999999999999988754

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.3e-35  Score=290.09  Aligned_cols=265  Identities=23%  Similarity=0.290  Sum_probs=195.2

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-C--CcEEEEEEcccch-hHHHHHHHHHHHHHHHhh-cccccccccceeecC----Ce
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-N--GKVFALKKLHTSE-ELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHK----KC  276 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~----~~  276 (496)
                      +|++.+.||+|+||.||++... .  +..||+|.+.... .....+.+.+|+.+++++ .||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999764 3  7789999986532 222345678899999999 599999999875432    45


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      .+++++++. ++|.+.+....   .+++..+..++.||+.||.|||   ..+++||||||+||+++.++.++|+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            788899886 68888886543   6889999999999999999999   7899999999999999999999999999998


Q ss_pred             cccCCCC----Ccccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCC--------CCCCcch
Q 011005          357 LLHADSS----NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS--------SSDPKIM  423 (496)
Q Consensus       357 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~--------~~~~~~~  423 (496)
                      .......    ......|++.|+|||.+.+ ..++.++||||+|+++|++++|+.||........        .......
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            6543221    1123468899999998765 4688999999999999999999999864321000        0000000


Q ss_pred             hHhh-----------hcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          424 LIDV-----------LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       424 ~~~~-----------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ....           ...................+.+++.+||+.||++|||+.|+++|+|+..-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence            0000           00000000000000112357899999999999999999999999999644

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-37  Score=266.29  Aligned_cols=268  Identities=23%  Similarity=0.320  Sum_probs=200.8

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecC--------
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK--------  274 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------  274 (496)
                      +.|.-..++|+|.||.||+|+.+ .|+.||+|++.-.. ....-....+|++++..++|+|++.+++.|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            45666778999999999999765 57788888764422 222334568999999999999999999988542        


Q ss_pred             CeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccc
Q 011005          275 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  354 (496)
Q Consensus       275 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  354 (496)
                      ...++||.+|+. +|.-++...  ...++..++.+++.++..||.|+|   ...|+|||+||.|+|++.++.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccc
Confidence            358999999987 777777654  237899999999999999999999   77999999999999999999999999999


Q ss_pred             cccccCCCC----Ccccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCcccccc-------------CC
Q 011005          355 ARLLHADSS----NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSL-------------SS  416 (496)
Q Consensus       355 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~-------------~~  416 (496)
                      ++.+.....    ..+..+-|.+|++||.+.| ..|+++.|||+.|||+.||+||.+-++.....             ..
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            977654322    2445567999999998876 47899999999999999999999887643221             11


Q ss_pred             CCCCcchhHhhhcCC----CCCCCChhHHHH------HHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          417 SSDPKIMLIDVLDQR----LPPPVDRKVIRD------ILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       417 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~------~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ...+.......+...    ++..........      .....+|+.+++..||.+|+++++++.|.|+.+..
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp  322 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP  322 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence            222222222222211    111110101111      11456899999999999999999999999998764

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-35  Score=302.45  Aligned_cols=260  Identities=28%  Similarity=0.403  Sum_probs=206.5

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC--------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeec
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP--------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLH  273 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  273 (496)
                      ..++..+.+.||+|+||.|++|...        ....||||.++........+.+..|+++|+.+ .|+||+.++|+|..
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            3455566779999999999999642        14579999998876666778899999999999 59999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhCCC-----C------C--ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceE
Q 011005          274 KKCMFLIYEYMERGSLFCNLHNNE-----D------A--VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNIL  340 (496)
Q Consensus       274 ~~~~~lV~e~~~~g~L~~~l~~~~-----~------~--~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil  340 (496)
                      ++..++|+||++.|+|.+++...+     .      .  ..++..+.++++.||+.|++||+   +.+++||||.++|||
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVL  450 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEE
Confidence            999999999999999999998765     0      0  13888999999999999999999   778999999999999


Q ss_pred             ecCCCCeEEccccccccccCCCCCc-cccc--cccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCC
Q 011005          341 LNSKLEAFVADFGTARLLHADSSNR-TLLA--GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSS  416 (496)
Q Consensus       341 ~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~--gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~  416 (496)
                      ++++..+||+|||+|+......... ....  -...|||||.+....|+.++||||||++|||++| |..||...     
T Consensus       451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~-----  525 (609)
T KOG0200|consen  451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI-----  525 (609)
T ss_pred             ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC-----
Confidence            9999999999999998664433322 1112  2457999999999999999999999999999998 78887531     


Q ss_pred             CCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          417 SSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       417 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                        .......+.+...........   ....+.+++..||+.+|++||++.|+.+.+...
T Consensus       526 --~~~~~l~~~l~~G~r~~~P~~---c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  526 --PPTEELLEFLKEGNRMEQPEH---CSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             --CcHHHHHHHHhcCCCCCCCCC---CCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence              111122333333222222121   233577899999999999999999999888763

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=6.6e-35  Score=271.06  Aligned_cols=228  Identities=24%  Similarity=0.247  Sum_probs=181.0

Q ss_pred             cCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCCChhhhhh
Q 011005          216 GGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLH  294 (496)
Q Consensus       216 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g~L~~~l~  294 (496)
                      |.+|.||++.+ .+++.||+|.+.....      ..+|...+....||||+++++++...+..++||||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            88999999966 4788999999876432      2334444555579999999999999999999999999999999987


Q ss_pred             CCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCcccccccccc
Q 011005          295 NNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGY  374 (496)
Q Consensus       295 ~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y  374 (496)
                      ...   .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++|||.+......   .....++..|
T Consensus        78 ~~~---~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y  148 (237)
T cd05576          78 KFL---NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMY  148 (237)
T ss_pred             Hhc---CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccc
Confidence            643   5889999999999999999999   789999999999999999999999999988665432   1223456789


Q ss_pred             ccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhc
Q 011005          375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFAC  454 (496)
Q Consensus       375 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  454 (496)
                      +|||...+..++.++||||+|+++|||++|+.|+.......         .......++..       ....+.+++.+|
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------~~~~~~~~~~~-------~~~~~~~li~~~  212 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------NTHTTLNIPEW-------VSEEARSLLQQL  212 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------ccccccCCccc-------CCHHHHHHHHHH
Confidence            99999988889999999999999999999998875321100         00000011111       122467899999


Q ss_pred             ccCCCCCCCCH-----HHHHHHHHH
Q 011005          455 LQSNPKSRPTM-----QSVSQEFLI  474 (496)
Q Consensus       455 l~~dP~~Rps~-----~evl~~~~~  474 (496)
                      ++.||++||++     +|+++|+|+
T Consensus       213 l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         213 LQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             ccCCHHHhcCCCccchHHHHcCCCC
Confidence            99999999996     888888874

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=272.82  Aligned_cols=254  Identities=23%  Similarity=0.365  Sum_probs=209.0

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV  280 (496)
                      .+|.....||+|+||.|-+|..+ ..+.+|||+++++.  +.+..+--+.|-++++.- +-|.+++++.+|+.-+.+|.|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            46888999999999999999665 46789999998753  112223345667777666 478999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+.||+|--+++..+   .+.+..+.-++..|+-||-+||   ++||++||||.+||+++.+|++||+|||+++.--.
T Consensus       429 MEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             EEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence            99999999988887655   6777888899999999999999   88999999999999999999999999999987766


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      +.....+.+|||.|+|||++...+|...+|.||+|++||||+.|++||+       ..++++....+.++....+.+-  
T Consensus       503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd-------GeDE~elF~aI~ehnvsyPKsl--  573 (683)
T KOG0696|consen  503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD-------GEDEDELFQAIMEHNVSYPKSL--  573 (683)
T ss_pred             CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC-------CCCHHHHHHHHHHccCcCcccc--
Confidence            6666778999999999999999999999999999999999999999997       4445666667777766554322  


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHHHHhc
Q 011005          441 IRDILLISTVSFACLQSNPKSRPT-----MQSVSQEFLITR  476 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~~~~~~  476 (496)
                      .   .+...+....+...|.+|..     -++|.+|+|+++
T Consensus       574 S---kEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~  611 (683)
T KOG0696|consen  574 S---KEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR  611 (683)
T ss_pred             c---HHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence            1   13456677889999999974     356666766643

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.9e-34  Score=297.02  Aligned_cols=270  Identities=20%  Similarity=0.241  Sum_probs=175.8

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-C----CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccce------e
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-N----GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGY------C  271 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~  271 (496)
                      ..++|.+.+.||+|+||.||+|.+. +    +..||+|++......   +....+  .++...+.++..++..      .
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~---e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV---EIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh---HHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            4578999999999999999999765 4    689999987653321   111111  1122222333332222      2


Q ss_pred             ecCCeEEEEEEecCCCChhhhhhCCCCC-----------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCC
Q 011005          272 LHKKCMFLIYEYMERGSLFCNLHNNEDA-----------------VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDI  334 (496)
Q Consensus       272 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~-----------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl  334 (496)
                      ......++|+||+.+++|.+++......                 .......+..++.|++.||.|||   +.+|+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcC
Confidence            3456789999999999999988754211                 01123345679999999999999   789999999


Q ss_pred             CCCceEecC-CCCeEEccccccccccCCC-CCccccccccccccccccccC----------------------CcCcccc
Q 011005          335 SSNNILLNS-KLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTM----------------------VMTEKCD  390 (496)
Q Consensus       335 kp~Nil~~~-~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D  390 (496)
                      ||+|||++. ++.+||+|||+++.+.... .......+++.|+|||.+...                      .++.++|
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            999999986 5799999999998654322 223446789999999965422                      2345679


Q ss_pred             hhhHHHHHHHHHhCCCCCccccc-----cCCCCCCcchhHhhhcCCCCCCCChh---HHHHHHHHHHHHHhcccCCCCCC
Q 011005          391 VYSFGVVTLEVLMGKHPRDILSS-----LSSSSDPKIMLIDVLDQRLPPPVDRK---VIRDILLISTVSFACLQSNPKSR  462 (496)
Q Consensus       391 vwslG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~R  462 (496)
                      |||+||++|||+++..|++....     ..........................   .........+|+.+||+.||++|
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR  441 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR  441 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence            99999999999998777542100     00000000000011111100000000   00011124589999999999999


Q ss_pred             CCHHHHHHHHHHhccCCC
Q 011005          463 PTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       463 ps~~evl~~~~~~~~~~~  480 (496)
                      ||+.|+++|+|+.+....
T Consensus       442 ~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        442 ISAKAALAHPYFDREGLL  459 (566)
T ss_pred             CCHHHHhCCcCcCCCCcc
Confidence            999999999999876554

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.3e-33  Score=283.51  Aligned_cols=268  Identities=16%  Similarity=0.203  Sum_probs=185.2

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-----------------CCCcEEEEEEcccchhHH-------------HHHHHHHHH
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-----------------PNGKVFALKKLHTSEELA-------------FIKSFKNEA  253 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~-------------~~~~~~~e~  253 (496)
                      .++|.+.++||+|+||+||+|..                 ..++.||||++.......             ..+....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            56899999999999999999953                 245689999986543211             012234577


Q ss_pred             HHHHhhcccc-----cccccceeec--------CCeEEEEEEecCCCChhhhhhCCCC---------------------C
Q 011005          254 QVLSQVLHRN-----IVKLYGYCLH--------KKCMFLIYEYMERGSLFCNLHNNED---------------------A  299 (496)
Q Consensus       254 ~~l~~l~h~n-----iv~~~~~~~~--------~~~~~lV~e~~~~g~L~~~l~~~~~---------------------~  299 (496)
                      .++.+++|.+     +++++++|..        ....++||||+++++|.++++....                     .
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            7777786654     4677787753        3468999999999999998874311                     1


Q ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC-cccccccccccccc
Q 011005          300 VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN-RTLLAGTYGYIAPE  378 (496)
Q Consensus       300 ~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE  378 (496)
                      ..+++..+..++.|++.+|.|||   ..+|+||||||+||+++.++.+||+|||++......... .....+++.|+|||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence            13467788899999999999999   779999999999999999999999999999765432211 11233578999999


Q ss_pred             ccccCCc----------------------CcccchhhHHHHHHHHHhCCC-CCccccccCCCCCC-cchhH---hhhcCC
Q 011005          379 LAYTMVM----------------------TEKCDVYSFGVVTLEVLMGKH-PRDILSSLSSSSDP-KIMLI---DVLDQR  431 (496)
Q Consensus       379 ~~~~~~~----------------------~~~~DvwslG~il~el~~g~~-p~~~~~~~~~~~~~-~~~~~---~~~~~~  431 (496)
                      .+.....                      ..+.||||+||++|+|++|.. |+............ .....   ......
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~  460 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK  460 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence            8764321                      124799999999999999986 66432211111000 00000   000111


Q ss_pred             CCCCCChhHHHHHHHHHHHHHhcccCCC---CCCCCHHHHHHHHHHhcc
Q 011005          432 LPPPVDRKVIRDILLISTVSFACLQSNP---KSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       432 ~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~Rps~~evl~~~~~~~~  477 (496)
                      .....   .........+|+.+||..+|   .+|+|++|+++|+|+...
T Consensus       461 ~~~~~---~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~  506 (507)
T PLN03224        461 YDFSL---LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE  506 (507)
T ss_pred             CCccc---ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence            11110   11122346788999999766   789999999999999654

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.6e-33  Score=260.90  Aligned_cols=243  Identities=29%  Similarity=0.395  Sum_probs=195.8

Q ss_pred             CCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCCChhhhhhC
Q 011005          217 GYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN  295 (496)
Q Consensus       217 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~  295 (496)
                      +||.||+|... +++.+|+|.+.........+.+.+|++.+++++|+|++++++++......++++|++++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999876 48999999997755433257889999999999999999999999999999999999999999999876


Q ss_pred             CCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCccccccccccc
Q 011005          296 NEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI  375 (496)
Q Consensus       296 ~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~  375 (496)
                      ..   .+++..+..++.+++.++.+||   ..+++|+||+|+||++++++.++++|||.+....... ......++..|+
T Consensus        81 ~~---~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~  153 (244)
T smart00220       81 RG---RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYM  153 (244)
T ss_pred             cc---CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCC
Confidence            54   3788999999999999999999   7799999999999999999999999999998765432 233456788999


Q ss_pred             cccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcc
Q 011005          376 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACL  455 (496)
Q Consensus       376 aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  455 (496)
                      |||.+.+..++.++||||+|+++|++++|..||...      . ......+............ .......+.+++.+|+
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~------~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l  225 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD------D-QLLELFKKIGKPKPPFPPP-EWKISPEAKDLIRKLL  225 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC------C-cHHHHHHHHhccCCCCccc-cccCCHHHHHHHHHHc
Confidence            999999888999999999999999999999998632      1 1111222222211111100 0002235778999999


Q ss_pred             cCCCCCCCCHHHHHHHHHH
Q 011005          456 QSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       456 ~~dP~~Rps~~evl~~~~~  474 (496)
                      ..+|++||++.++++++|+
T Consensus       226 ~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      226 VKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             cCCchhccCHHHHhhCCCC
Confidence            9999999999999998774

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=254.39  Aligned_cols=261  Identities=23%  Similarity=0.375  Sum_probs=210.3

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccc--hhHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTS--EELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  279 (496)
                      .++|.+...||+|+|+.|-.++++ ..+.||+|++++.  .+.+..+-+..|-.+...- +||.+|-++.+|.....+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            367999999999999999999765 5788999998763  2223344556677776666 69999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      |.||.+||+|--+++.++   .++++.++-+...|.-||.|||   ++||++||+|.+|||++..|++|++|+|+++.--
T Consensus       329 vieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence            999999999987777665   7899999999999999999999   8899999999999999999999999999999877


Q ss_pred             CCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCC-CcchhHhhhcCCCCCCCCh
Q 011005          360 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSD-PKIMLIDVLDQRLPPPVDR  438 (496)
Q Consensus       360 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  438 (496)
                      .+....++.+|||.|.|||++.+..|...+|.|++|++++||+.|+.||++.....+... ++....-++.+.+.-+.+-
T Consensus       403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsl  482 (593)
T KOG0695|consen  403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSL  482 (593)
T ss_pred             CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccccee
Confidence            777778889999999999999999999999999999999999999999998763322222 2222233333433322211


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCC------CHHHHHHHHHHh
Q 011005          439 KVIRDILLISTVSFACLQSNPKSRP------TMQSVSQEFLIT  475 (496)
Q Consensus       439 ~~~~~~~~l~~li~~cl~~dP~~Rp------s~~evl~~~~~~  475 (496)
                           ......++..-|.+||.+|.      .+.++-.|.|+.
T Consensus       483 -----svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr  520 (593)
T KOG0695|consen  483 -----SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFR  520 (593)
T ss_pred             -----ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhh
Confidence                 11234566688999999985      367777777664

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=273.36  Aligned_cols=255  Identities=22%  Similarity=0.318  Sum_probs=206.2

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCc-EEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      .+++.+..||-|+||.|=++..++.. .+|+|.+++..  +....+.+..|-.+|...+.|.||++|..|.+.+..|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            34556677999999999999876544 37888887643  2233456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      |-|-||.+...+.+.+   .|+...+.-++.-+++|++|||   .++||+|||||+|.+++.+|-+||.|||+|+.+...
T Consensus       500 EaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  500 EACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            9999999999998766   7888888999999999999999   889999999999999999999999999999998655


Q ss_pred             CCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                      ... -+++|||.|.|||++.....+.++|.||+|+++|||++|.+||+...++       .....++...-.-....   
T Consensus       574 ~KT-wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm-------ktYn~ILkGid~i~~Pr---  642 (732)
T KOG0614|consen  574 RKT-WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM-------KTYNLILKGIDKIEFPR---  642 (732)
T ss_pred             Cce-eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH-------HHHHHHHhhhhhhhccc---
Confidence            443 3579999999999999999999999999999999999999999743322       12222222111001111   


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHHHHhc
Q 011005          442 RDILLISTVSFACLQSNPKSRPT-----MQSVSQEFLITR  476 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~~~~~~  476 (496)
                      .......+++.+....+|.+|.-     +.++-+|-|+..
T Consensus       643 ~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g  682 (732)
T KOG0614|consen  643 RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG  682 (732)
T ss_pred             ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence            11223568888999999999986     889999998853

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=257.60  Aligned_cols=261  Identities=20%  Similarity=0.299  Sum_probs=208.8

Q ss_pred             HHHHHHHhCCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhccccccccccee
Q 011005          198 EDLIEATEDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC  271 (496)
Q Consensus       198 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  271 (496)
                      .++....++++....+-+|.||.||.|.+.      +.+.|.+|.++...+.-....+..|.-.+..+.|||+.++.+.+
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            455555677888888999999999999543      45668888888777666667788898888889999999999988


Q ss_pred             ecC-CeEEEEEEecCCCChhhhhh-----CCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC
Q 011005          272 LHK-KCMFLIYEYMERGSLFCNLH-----NNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL  345 (496)
Q Consensus       272 ~~~-~~~~lV~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~  345 (496)
                      .+. ...+.++.++.-|+|..++.     +......++..+...++.|++.|++|||   +.+++|.||.++|+++++.-
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhe
Confidence            664 46788899999999999988     3344456777888899999999999999   88999999999999999999


Q ss_pred             CeEEccccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcc
Q 011005          346 EAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKI  422 (496)
Q Consensus       346 ~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~  422 (496)
                      ++||+|=.+++.+-+....  ......+..||+||.+....|+.++||||||+++|||+| |+.|+...+       +.+
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID-------PfE  506 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID-------PFE  506 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC-------HHH
Confidence            9999999999877544332  122335668999999999999999999999999999998 899986432       333


Q ss_pred             hhHhhhcC-CCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          423 MLIDVLDQ-RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       423 ~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      +..-..++ ++..+     .+.+.++..++.-||..+|++||+++|++.-+-
T Consensus       507 m~~ylkdGyRlaQP-----~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs  553 (563)
T KOG1024|consen  507 MEHYLKDGYRLAQP-----FNCPDELFTVMACCWALLPEERPSFSQLVICLS  553 (563)
T ss_pred             HHHHHhccceecCC-----CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence            43333333 33222     234556888999999999999999999987654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=287.81  Aligned_cols=243  Identities=26%  Similarity=0.368  Sum_probs=191.6

Q ss_pred             cceeeecCCe-eEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-ccccccccceeecCCeEEEEEEecCCC
Q 011005          210 RYCIGTGGYG-SVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKCMFLIYEYMERG  287 (496)
Q Consensus       210 ~~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lV~e~~~~g  287 (496)
                      .+.+|.|+.| .||+|.+ +|+.||||++-...    .....+|+..++.-+ |||||++++.-.+....|++.|.|.. 
T Consensus       514 ~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-  587 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-  587 (903)
T ss_pred             HHHcccCCCCcEEEEEee-CCceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence            4568999987 6899998 67899999986543    345689999999984 99999999999999999999999964 


Q ss_pred             ChhhhhhCC-CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC---C--CCeEEccccccccccCC
Q 011005          288 SLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---K--LEAFVADFGTARLLHAD  361 (496)
Q Consensus       288 ~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~---~--~~~kl~Dfg~~~~~~~~  361 (496)
                      +|.+++... .+.........+.+..|++.||+|||   +.+||||||||.||||+.   +  ..++|+|||+++.+..+
T Consensus       588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            999999874 11111222445678999999999999   789999999999999976   2  46899999999998765


Q ss_pred             CCC---ccccccccccccccccccCCcCcccchhhHHHHHHHHHhC-CCCCccccccCCCCCCcchhHhhhcCC-----C
Q 011005          362 SSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG-KHPRDILSSLSSSSDPKIMLIDVLDQR-----L  432 (496)
Q Consensus       362 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~  432 (496)
                      ...   .....||.+|+|||++....-+.++||||+||++|+.++| .+||+.....      +   .+++...     +
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R------~---~NIl~~~~~L~~L  735 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER------Q---ANILTGNYTLVHL  735 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh------h---hhhhcCccceeee
Confidence            433   3446799999999999999989999999999999998886 9999743211      1   1111111     1


Q ss_pred             CCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       433 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      .+..+.       ...+||.+|+.+||..||++.+|+.||++...
T Consensus       736 ~~~~d~-------eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  736 EPLPDC-------EAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             ccCchH-------HHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            111111       46799999999999999999999999998765

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-33  Score=269.58  Aligned_cols=201  Identities=25%  Similarity=0.387  Sum_probs=172.4

Q ss_pred             hCCCCcceeeecCCeeEEEEE-eCCCcEEEEEEcccchh--HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      .-|..++.||-|+||+|.+++ ......||.|.+++.+-  .....-++.|-.||..-+.+=||++|-.|.+++.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            347778889999999999994 44577899999987652  223345688999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      +|++||++-.+|-+.+   -|.+..++.++..++.|+++.|   +.|+|||||||+|||||.+|++||+|||+++.+...
T Consensus       709 dYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceec
Confidence            9999999999887655   6888889999999999999999   889999999999999999999999999999754210


Q ss_pred             ---------CCC---------------------------------ccccccccccccccccccCCcCcccchhhHHHHHH
Q 011005          362 ---------SSN---------------------------------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTL  399 (496)
Q Consensus       362 ---------~~~---------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~  399 (496)
                               ...                                 ....+||+.|+|||++....|+..+|.||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence                     000                                 00136999999999999999999999999999999


Q ss_pred             HHHhCCCCCccc
Q 011005          400 EVLMGKHPRDIL  411 (496)
Q Consensus       400 el~~g~~p~~~~  411 (496)
                      ||+.|++||-..
T Consensus       863 em~~g~~pf~~~  874 (1034)
T KOG0608|consen  863 EMLVGQPPFLAD  874 (1034)
T ss_pred             HHhhCCCCccCC
Confidence            999999999543

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-32  Score=257.66  Aligned_cols=131  Identities=23%  Similarity=0.402  Sum_probs=112.9

Q ss_pred             hCCCCcceeeecCCeeEEEEE-eCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-----c---cccccccceeec--
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-----H---RNIVKLYGYCLH--  273 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~~~--  273 (496)
                      .+|.+.++||.|.|++||+|. ..+.+.||+|+.+...  .+.+....|++++++++     |   ..||++++.|..  
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            689999999999999999995 4578899999998765  34566789999999995     2   479999999975  


Q ss_pred             --CCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe
Q 011005          274 --KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL  341 (496)
Q Consensus       274 --~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~  341 (496)
                        +.+++||+|++ |.+|..++.+.. ...++...+.+|++||+.||.|||..  .||||.||||+|||+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence              45899999998 668888888754 33689999999999999999999985  599999999999999

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=3.2e-33  Score=264.62  Aligned_cols=266  Identities=20%  Similarity=0.217  Sum_probs=207.9

Q ss_pred             HHHHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc------ccccccccceeec
Q 011005          201 IEATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL------HRNIVKLYGYCLH  273 (496)
Q Consensus       201 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~  273 (496)
                      +....+|.+....|+|-|++|..|.+. -|..||||++.......  +.=..|+++|++|+      --|+++++..|..
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~--KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h  505 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH--KTGLKELEILKKLNDADPEDKFHCLRLFRHFKH  505 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh--hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence            345678999999999999999999654 57899999998765332  44578999999996      3589999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC-CeEEccc
Q 011005          274 KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-EAFVADF  352 (496)
Q Consensus       274 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~-~~kl~Df  352 (496)
                      .+++|||+|-+ .-+|.+.|.+.+....+....+..++.|+.-||..|.   ..+|+|.||||+|||+++.. .+|||||
T Consensus       506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDf  581 (752)
T KOG0670|consen  506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDF  581 (752)
T ss_pred             cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccC
Confidence            99999999987 4599999999888888999999999999999999999   77999999999999999874 5799999


Q ss_pred             cccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCcccccc--------CCCCC-----
Q 011005          353 GTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSL--------SSSSD-----  419 (496)
Q Consensus       353 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~--------~~~~~-----  419 (496)
                      |.|.......  .+.+.-+..|.|||++.|..|+...|+||.||+|||+.||+..|.....-        .....     
T Consensus       582 GSA~~~~ene--itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml  659 (752)
T KOG0670|consen  582 GSASFASENE--ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML  659 (752)
T ss_pred             cccccccccc--ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence            9998764332  22233466899999999999999999999999999999999887532110        00000     


Q ss_pred             -------------------------------------CcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCC
Q 011005          420 -------------------------------------PKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSR  462 (496)
Q Consensus       420 -------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  462 (496)
                                                           +...+...+....  ............+.+|+.+|+..||++|
T Consensus       660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q--~~~deq~~~~~~~rdLLdkml~LdP~KR  737 (752)
T KOG0670|consen  660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQ--RLPDEQPKIVQQLRDLLDKMLILDPEKR  737 (752)
T ss_pred             hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccC--CCCchhHHHHHHHHHHHHHHhccChhhc
Confidence                                                 0000000000000  0112223344568899999999999999


Q ss_pred             CCHHHHHHHHHHhc
Q 011005          463 PTMQSVSQEFLITR  476 (496)
Q Consensus       463 ps~~evl~~~~~~~  476 (496)
                      .|..|+|+|+|++.
T Consensus       738 it~nqAL~HpFi~~  751 (752)
T KOG0670|consen  738 ITVNQALKHPFITE  751 (752)
T ss_pred             CCHHHHhcCCcccC
Confidence            99999999999875

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-33  Score=234.48  Aligned_cols=200  Identities=26%  Similarity=0.366  Sum_probs=165.5

Q ss_pred             CCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEEEEe
Q 011005          206 DFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      ...-+..||+|+||.|-+.++ .+|+..|+|.++..-..+..++..+|+.+..+. .+|.+|.++|........++.||.
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~  126 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL  126 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence            344456699999999999865 589999999998876666678888999987776 699999999999999999999999


Q ss_pred             cCCCChhhhhhC-CCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          284 MERGSLFCNLHN-NEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       284 ~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+. ||..+-.+ ...+..+++.-.-+|+..+++||.|||+  ...++|||+||+|||++.+|++|+||||.+-.+.+.-
T Consensus       127 M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi  203 (282)
T KOG0984|consen  127 MDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI  203 (282)
T ss_pred             hhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence            964 66544322 1233468888888999999999999998  5689999999999999999999999999997765432


Q ss_pred             CCcccccccccccccccccc----CCcCcccchhhHHHHHHHHHhCCCCCc
Q 011005          363 SNRTLLAGTYGYIAPELAYT----MVMTEKCDVYSFGVVTLEVLMGKHPRD  409 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~el~~g~~p~~  409 (496)
                       ..+...|-..|||||.+..    ..|+-++||||+|+++.||.+++.||+
T Consensus       204 -Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~  253 (282)
T KOG0984|consen  204 -AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE  253 (282)
T ss_pred             -HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence             2333456678999998764    478899999999999999999999986

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=251.82  Aligned_cols=260  Identities=27%  Similarity=0.306  Sum_probs=196.5

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCC------e
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK------C  276 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~  276 (496)
                      .+|.-.+.+|.|.- .|..|.+ -.++.||+|++.... .....++..+|..++..++|+||++++.++....      .
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46666777888888 6666643 368899999886532 2334567889999999999999999999996543      4


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      .|+|||+|. ++|...+.-     +++..++..|+.|++.|+.|||   +.||+||||||+||++..++.+||.|||+|+
T Consensus        96 ~y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhc
Confidence            789999995 588877772     6788999999999999999999   8899999999999999999999999999998


Q ss_pred             cccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccC---------CCCCC-------
Q 011005          357 LLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS---------SSSDP-------  420 (496)
Q Consensus       357 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~---------~~~~~-------  420 (496)
                      .-..+ ...+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.......         +...+       
T Consensus       167 ~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~  245 (369)
T KOG0665|consen  167 TEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ  245 (369)
T ss_pred             ccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence            76544 34566788999999999999999999999999999999999998875321110         00000       


Q ss_pred             -----------cc---hhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          421 -----------KI---MLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       421 -----------~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                                 ..   ...+.+....-...............+++.+||..||++|.|++++|+|+++.
T Consensus       246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                       00   00011111110111111112223467889999999999999999999999885

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=5.2e-33  Score=237.69  Aligned_cols=263  Identities=20%  Similarity=0.265  Sum_probs=199.6

Q ss_pred             HhCCCCcceeeecCCeeEEEEE-eCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-ccccccccceeecCC--eEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKK--CMFL  279 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~~~l  279 (496)
                      .++|++.+++|+|.|++||.|. ..+.+.++||.++.-..    +.+.+|+++++.+. ||||+++++...++.  ...+
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk----kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK----KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH----HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            4689999999999999999995 56788999999987553    67899999999997 999999999998754  5789


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC-CCeEEccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTARLL  358 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~  358 (496)
                      |+||.++.+...+..      .++.-++...+.+++.||.|||   +.||+|||+||.|++++.. -.++|+|+|+|.++
T Consensus       113 iFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             HhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhc
Confidence            999998866654433      5677788899999999999999   8899999999999999865 56899999999988


Q ss_pred             cCCCCCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCCC--------------------
Q 011005          359 HADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSS--------------------  417 (496)
Q Consensus       359 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~--------------------  417 (496)
                      ... ......+.+..|..||.+.+- .|+..-|+|||||++..|+..+-||-.......+                    
T Consensus       184 Hp~-~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  184 HPG-KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             CCC-ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence            654 344556778889999998764 5788999999999999999999997321110000                    


Q ss_pred             -CCCcchhHhhhcCCCCCCCCh----h-HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          418 -SDPKIMLIDVLDQRLPPPVDR----K-VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       418 -~~~~~~~~~~~~~~~~~~~~~----~-~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                       -..+.....+++.....++..    . ......+..+|+.+.|..|-.+|+|++|.+.|+++......
T Consensus       263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~  331 (338)
T KOG0668|consen  263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA  331 (338)
T ss_pred             ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence             000001111111111111100    0 00112457789999999999999999999999999765444

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3e-33  Score=245.15  Aligned_cols=262  Identities=26%  Similarity=0.305  Sum_probs=193.0

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccc-hhHHHHHHHHHHHHHHHhhcccccccccceeecCC-----eEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK-----CMF  278 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  278 (496)
                      +.+..+.||.|+||.||.+.++ +|+.||.|++..- .+....+.+.+|++++..++|.|++..++......     ..|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            3455677999999999999764 7999999998653 23445678899999999999999999988776543     357


Q ss_pred             EEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccc
Q 011005          279 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL  358 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  358 (496)
                      +++|.|.. +|..++..-.   .++...+.-+.+||++||.|||   +.+|.||||||.|.|++.+..+||||||+++..
T Consensus       134 V~TELmQS-DLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHHHHHh-hhhheeccCC---CCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEeccccccccc
Confidence            88888854 6776665433   5777777788999999999999   889999999999999999999999999999876


Q ss_pred             cCCCCC-ccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccC---------CCCCCcc-----
Q 011005          359 HADSSN-RTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS---------SSSDPKI-----  422 (496)
Q Consensus       359 ~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~---------~~~~~~~-----  422 (496)
                      ..+... .+..+-|..|+|||+++|. .|+.+.||||.|||+.|++..+.-|+..++..         .....+.     
T Consensus       207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC  286 (449)
T ss_pred             chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence            544322 3345678899999999986 68999999999999999999888876443321         0000000     


Q ss_pred             --hhHhhhcCCCCCCCCh------hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          423 --MLIDVLDQRLPPPVDR------KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       423 --~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                        ....+++.....+...      ...........+..+++..||++|.+..+.+.|+..
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence              0111222111111100      000111234567778999999999999999998764

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=257.43  Aligned_cols=198  Identities=24%  Similarity=0.372  Sum_probs=170.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhH--HH-----HHHHHHHHHHHHhhc---ccccccccceee
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEEL--AF-----IKSFKNEAQVLSQVL---HRNIVKLYGYCL  272 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~-----~~~~~~e~~~l~~l~---h~niv~~~~~~~  272 (496)
                      ..+|+..+.+|+|+||.|+.|.++ +...|+||.+.+..-.  .+     ...+--|+.+|+.++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            456899999999999999999776 5667899988765311  11     122456999999997   999999999999


Q ss_pred             cCCeEEEEEEec-CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcc
Q 011005          273 HKKCMFLIYEYM-ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVAD  351 (496)
Q Consensus       273 ~~~~~~lV~e~~-~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~D  351 (496)
                      +++.+|++||-. +|-+|++++....   .+++.++..|++||+.|+++||   +.||+|||||-+||.++.+|.+||+|
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEee
Confidence            999999999985 4568888887655   7889999999999999999999   78999999999999999999999999


Q ss_pred             ccccccccCCCCCccccccccccccccccccCCcC-cccchhhHHHHHHHHHhCCCCCc
Q 011005          352 FGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMT-EKCDVYSFGVVTLEVLMGKHPRD  409 (496)
Q Consensus       352 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~p~~  409 (496)
                      ||.+......  ....++||..|.|||++.|..|- ..-|||++|++||.++....||-
T Consensus       714 fgsaa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  714 FGSAAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             ccchhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999876433  35668999999999999999885 56899999999999999998873

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=5.7e-30  Score=232.76  Aligned_cols=212  Identities=35%  Similarity=0.581  Sum_probs=184.7

Q ss_pred             eeecCCeeEEEEEeCC-CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCCChhh
Q 011005          213 IGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFC  291 (496)
Q Consensus       213 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g~L~~  291 (496)
                      ||+|++|.||++...+ ++.+++|.+...........+.+|+..++.+.|++++++++++......++++|++.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999998754 899999999876543234678999999999999999999999999999999999999999999


Q ss_pred             hhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC-CCCeEEccccccccccCCCCCcccccc
Q 011005          292 NLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KLEAFVADFGTARLLHADSSNRTLLAG  370 (496)
Q Consensus       292 ~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~g  370 (496)
                      ++....  ..++...+..++.+++.++.+||   ..+++|+||+|.||+++. ++.++|+|||.+..............+
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~  155 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG  155 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccC
Confidence            987643  25789999999999999999999   779999999999999999 899999999999876543322333557


Q ss_pred             ccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHH
Q 011005          371 TYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLIST  449 (496)
Q Consensus       371 t~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  449 (496)
                      ...|++||..... .++.++|+|++|++++++                                           ..+.+
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------~~~~~  192 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------PELKD  192 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------HHHHH
Confidence            7899999999887 888999999999999999                                           34778


Q ss_pred             HHHhcccCCCCCCCCHHHHHHHH
Q 011005          450 VSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       450 li~~cl~~dP~~Rps~~evl~~~  472 (496)
                      ++.+|++.+|++||++.++++++
T Consensus       193 ~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         193 LIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHHhhCCcccCcCHHHHhhCC
Confidence            99999999999999999998763

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=4e-32  Score=264.44  Aligned_cols=259  Identities=27%  Similarity=0.411  Sum_probs=211.8

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|+....+|.|.||.||||+++ .++..|+|.++-....+ .+....|+-+++..+|+|||.+++.+...+..|++||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            467999999999999999999764 68899999987654332 3556789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      ||.||+|.+.-+...   .+++.++...++...+|+.|||   +.|-+|||||-.||++++.|.+|+.|||.+-.+...-
T Consensus        93 ycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati  166 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI  166 (829)
T ss_pred             ecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhh
Confidence            999999998887655   7888999999999999999999   7789999999999999999999999999998776555


Q ss_pred             CCccccccccccccccccc---cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCC-CCCCh
Q 011005          363 SNRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLP-PPVDR  438 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  438 (496)
                      .....+.||+.|||||+..   .+.|...+|||+.|++..|+-.-++|.-...++        ...-.+.+... ++.-.
T Consensus       167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm--------r~l~LmTkS~~qpp~lk  238 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM--------RALFLMTKSGFQPPTLK  238 (829)
T ss_pred             hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH--------HHHHHhhccCCCCCccc
Confidence            5566688999999999764   567899999999999999999888884332221        11122222222 22222


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          439 KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       439 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ....+...+-+|++.|+..+|.+||+++.+++|+|....
T Consensus       239 Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            233445568899999999999999999999999887655

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-30  Score=228.08  Aligned_cols=265  Identities=22%  Similarity=0.307  Sum_probs=194.2

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-ccccccccc-eeecCCeEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYG-YCLHKKCMFL  279 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~-~~~~~~~~~l  279 (496)
                      ..+.|.+.+.||+|.||.+-++.++ ..+.+++|-++.....  .++|.+|...--.+. |.||+.-|+ .|+..+.+++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt--~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF   99 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT--QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF   99 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh--HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence            4578999999999999999999775 5678899988876543  377888887766664 899998886 5566778899


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEec--CCCCeEEcccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN--SKLEAFVADFGTARL  357 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~--~~~~~kl~Dfg~~~~  357 (496)
                      ++||++.|+|..-+...    .+.+.....++.|++.|+.|+|   ++.+||||||.+|||+-  +...+|+||||..+.
T Consensus       100 ~qE~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k  172 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRK  172 (378)
T ss_pred             eeccCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccc
Confidence            99999999998877664    4677888899999999999999   88999999999999993  335799999999875


Q ss_pred             ccCCCCCccccccccccccccccccC-----CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCC
Q 011005          358 LHADSSNRTLLAGTYGYIAPELAYTM-----VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRL  432 (496)
Q Consensus       358 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  432 (496)
                      ....-   ...-.+..|.+||.....     ...+.+|||.||+++|.++||+.||+-....    ++.........++.
T Consensus       173 ~g~tV---~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~----d~~Y~~~~~w~~rk  245 (378)
T KOG1345|consen  173 VGTTV---KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM----DKPYWEWEQWLKRK  245 (378)
T ss_pred             cCcee---hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc----CchHHHHHHHhccc
Confidence            43211   112234568999976533     3467899999999999999999999844322    22222222222333


Q ss_pred             CCCCChhHHHHHHHHHHHHHhcccCCCCCC---CCHHHHHHHHHHhccCCCCCc
Q 011005          433 PPPVDRKVIRDILLISTVSFACLQSNPKSR---PTMQSVSQEFLITRKTPLVKH  483 (496)
Q Consensus       433 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---ps~~evl~~~~~~~~~~~~~~  483 (496)
                      .+........-...+..+..+-+.++|++|   .++.......|.-......+.
T Consensus       246 ~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~t~k~  299 (378)
T KOG1345|consen  246 NPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIKTVKR  299 (378)
T ss_pred             CccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhccccC
Confidence            222222222223346678889999999999   566666666776554444333

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=2.8e-30  Score=240.24  Aligned_cols=267  Identities=24%  Similarity=0.297  Sum_probs=198.9

Q ss_pred             HHHHHHhCCCCcceeeecCCeeEEEEEeC----CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-ccccccccceeec
Q 011005          199 DLIEATEDFDIRYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLH  273 (496)
Q Consensus       199 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~  273 (496)
                      +.....+.|...++||+|.|++||+|.+.    .++.||+|.+......   ..+.+|++++..+. +.||+++.+++..
T Consensus        30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            34445678999999999999999999543    4778999999776543   45789999999995 8999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC-CCeEEccc
Q 011005          274 KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADF  352 (496)
Q Consensus       274 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~-~~~kl~Df  352 (496)
                      ++...+|+||++...-.++..      .++..++..+++.+..||.++|   ..|||||||||+|++.+.. +.-.|+||
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDF  177 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDF  177 (418)
T ss_pred             CCeeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEec
Confidence            999999999999988877776      4678899999999999999999   8899999999999999865 66789999


Q ss_pred             cccccccCCC--------------C------------------C------------cccccccccccccccccc-CCcCc
Q 011005          353 GTARLLHADS--------------S------------------N------------RTLLAGTYGYIAPELAYT-MVMTE  387 (496)
Q Consensus       353 g~~~~~~~~~--------------~------------------~------------~~~~~gt~~y~aPE~~~~-~~~~~  387 (496)
                      |+|.......              .                  .            .....||++|+|||++.. ...++
T Consensus       178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt  257 (418)
T KOG1167|consen  178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT  257 (418)
T ss_pred             hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence            9997321100              0                  0            001359999999998764 56788


Q ss_pred             ccchhhHHHHHHHHHhCCCCCcccccc-----------------------CC--CCC--CcchhHhhhcC-------CCC
Q 011005          388 KCDVYSFGVVTLEVLMGKHPRDILSSL-----------------------SS--SSD--PKIMLIDVLDQ-------RLP  433 (496)
Q Consensus       388 ~~DvwslG~il~el~~g~~p~~~~~~~-----------------------~~--~~~--~~~~~~~~~~~-------~~~  433 (496)
                      ++||||.|+|+.-+++++.||-....-                       ..  ..+  ......+....       .+.
T Consensus       258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~  337 (418)
T KOG1167|consen  258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY  337 (418)
T ss_pred             ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence            999999999999999999997311100                       00  000  00000000000       000


Q ss_pred             C-CC---C-hhHH-HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          434 P-PV---D-RKVI-RDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       434 ~-~~---~-~~~~-~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      . ..   . .... .-+..+.+++.+|+..||.+|.|+++.|+|+|+...
T Consensus       338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~  387 (418)
T KOG1167|consen  338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA  387 (418)
T ss_pred             cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence            0 00   0 0001 112357899999999999999999999999999743

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=4.1e-28  Score=223.21  Aligned_cols=198  Identities=34%  Similarity=0.528  Sum_probs=171.4

Q ss_pred             CCCcceeeecCCeeEEEEEeCC-CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecC
Q 011005          207 FDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYME  285 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~  285 (496)
                      |.+.+.||.|++|.||+|...+ ++.+++|.+.........+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5667889999999999998764 889999999875433245778899999999999999999999999899999999999


Q ss_pred             CCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC-CC
Q 011005          286 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-SN  364 (496)
Q Consensus       286 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  364 (496)
                      +++|.+++.....  .+++..+..++.+++.++.+||   ..+++|+|++|+||+++.++.++|+|||.+....... ..
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~  155 (225)
T smart00221       81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL  155 (225)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence            9999999986542  1788999999999999999999   6799999999999999999999999999998775432 12


Q ss_pred             cccccccccccccccc-ccCCcCcccchhhHHHHHHHHHhCCCCCc
Q 011005          365 RTLLAGTYGYIAPELA-YTMVMTEKCDVYSFGVVTLEVLMGKHPRD  409 (496)
Q Consensus       365 ~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~g~~p~~  409 (496)
                      .....++..|++||.+ ....++.++|+|++|+++++|++|+.||.
T Consensus       156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            2334577889999998 66778889999999999999999999995

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=9.4e-29  Score=267.61  Aligned_cols=201  Identities=19%  Similarity=0.255  Sum_probs=145.6

Q ss_pred             hhcc-ccccccccee-------ecCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 011005          258 QVLH-RNIVKLYGYC-------LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI  329 (496)
Q Consensus       258 ~l~h-~niv~~~~~~-------~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i  329 (496)
                      .++| +||++++++|       ......+.++|++ +++|.+++....  ..+++.+++.++.||+.||+|||   ++||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~gI  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAH---SQGI  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            4455 6888888887       2234567788877 569999997532  35899999999999999999999   7899


Q ss_pred             EEeCCCCCceEecC-------------------CCCeEEccccccccccCCC----------------CCcccccccccc
Q 011005          330 IHRDISSNNILLNS-------------------KLEAFVADFGTARLLHADS----------------SNRTLLAGTYGY  374 (496)
Q Consensus       330 ~H~dlkp~Nil~~~-------------------~~~~kl~Dfg~~~~~~~~~----------------~~~~~~~gt~~y  374 (496)
                      +||||||+|||++.                   ++.+|++|||+++......                ......+||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   4456677777765421100                001123578899


Q ss_pred             ccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhc
Q 011005          375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFAC  454 (496)
Q Consensus       375 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  454 (496)
                      ||||++.+..++.++|||||||++|||++|..|+....         ...........++..    .........++.+|
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---------~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~  248 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---------RTMSSLRHRVLPPQI----LLNWPKEASFCLWL  248 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---------HHHHHHHHhhcChhh----hhcCHHHHHHHHHh
Confidence            99999999999999999999999999999988864211         011111111111111    11122345778899


Q ss_pred             ccCCCCCCCCHHHHHHHHHHhcc
Q 011005          455 LQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       455 l~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      |+++|.+||++.|+++|+|+...
T Consensus       249 L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        249 LHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             CCCChhhCcChHHHhhchhhhhh
Confidence            99999999999999999999764

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=6.3e-27  Score=206.98  Aligned_cols=167  Identities=19%  Similarity=0.113  Sum_probs=126.6

Q ss_pred             CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCcc
Q 011005          287 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT  366 (496)
Q Consensus       287 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  366 (496)
                      |+|.+++....  ..+++..++.++.|++.||.|||   ..+      ||+||+++.++.+++  ||++.......    
T Consensus         1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc----
Confidence            68888887543  26899999999999999999999   445      999999999999999  99997664322    


Q ss_pred             ccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCC--ChhHHHHH
Q 011005          367 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV--DRKVIRDI  444 (496)
Q Consensus       367 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  444 (496)
                       ..|++.|+|||++.+..++.++|||||||++|||++|+.||.....      .................  ........
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~  136 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE------LSAILEILLNGMPADDPRDRSNLESVS  136 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch------hcHHHHHHHHHhccCCccccccHHHHH
Confidence             2578999999999999999999999999999999999999863221      11111121111111100  00111111


Q ss_pred             --HHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          445 --LLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       445 --~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                        ..+.+++.+||+.||++||++.|+++|++....
T Consensus       137 ~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      137 AARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             hhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence              258899999999999999999999999998753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=1.6e-25  Score=193.33  Aligned_cols=257  Identities=18%  Similarity=0.255  Sum_probs=205.0

Q ss_pred             HhCCCCcceeeecCCeeEEEE-EeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-ccccccccceeecCCeEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lV~  281 (496)
                      .+.|.++++||.|+||.+|.| ...+|..||||.-.....   ...+..|.++++.++ ..+|..+..+..++.+-.+||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~---hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK---HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC---CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            467999999999999999999 567899999998765432   245678999999997 578999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC---CCeEEccccccccc
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK---LEAFVADFGTARLL  358 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~  358 (496)
                      +.+ |.||.+++.-...  .++..+++-++-|++.-++|+|   .++++||||||+|+|+.-+   ..+.++|||+|+.+
T Consensus        91 dLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhh
Confidence            988 7899998875543  6899999999999999999999   7899999999999999754   35789999999987


Q ss_pred             cCCCCC-------ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCC
Q 011005          359 HADSSN-------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQR  431 (496)
Q Consensus       359 ~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  431 (496)
                      .+....       .....||..|.+-....+.+.+.+.|+=|+|.+|..+..|..||+....    .........+..+.
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka----~tk~QKyEkI~EkK  240 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA----ATKKQKYEKISEKK  240 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch----hhHHHHHHHHHHhh
Confidence            543222       2345799999999999999999999999999999999999999986543    22333444555556


Q ss_pred             CCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          432 LPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       432 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      +..+....+..-+.++.-.+.-|-..--++-|...-+.+-+.
T Consensus       241 ~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  241 MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence            665555555555556667777787777788888776655443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=4e-26  Score=234.46  Aligned_cols=260  Identities=22%  Similarity=0.282  Sum_probs=196.8

Q ss_pred             CcceeeecCCeeEEEEEe-CCCcEEEEEEcc----cch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          209 IRYCIGTGGYGSVYKAQL-PNGKVFALKKLH----TSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       209 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~----~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      ..+.+|.|++|.|+.+.. ...+..+.|.++    ... .......+..|+.+-..+.|+|++..+..+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            456799999998887743 334444444433    222 22333347778888888999999999888887776666699


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      ||++ +|+..+....   .+...++-.+++|+..|++|+|   ..|+.|||+|++|++++.+|.+||+|||.+..+..+.
T Consensus       402 ~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             cccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            9999 9999988753   5777888889999999999999   8899999999999999999999999999998776544


Q ss_pred             CC----ccccccccccccccccccCCcCc-ccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          363 SN----RTLLAGTYGYIAPELAYTMVMTE-KCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       363 ~~----~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                      ..    ....+|+..|+|||.+.+..|++ ..||||.|+++..|.+|+.||..........   .............+..
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~~~~~~~~~~~~~~  551 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---KTNNYSDQRNIFEGPN  551 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---hhhccccccccccChH
Confidence            32    34577999999999999999987 6899999999999999999998654422211   0001111111222222


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ......+.....++.+||++||.+|.|+++|++..|++.-.
T Consensus       552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence            33334444577899999999999999999999999997643

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=1.4e-24  Score=195.99  Aligned_cols=254  Identities=18%  Similarity=0.221  Sum_probs=200.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEE-eCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-ccccccccceeecCCeEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lV~  281 (496)
                      .-.|.+.++||+|.||+++.|. +-+++.||||.-....+   .-++..|+..++.+. .++|...+-+..++.+-.||+
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~---APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE---APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCC---cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            3479999999999999999994 45899999998655432   256788999999995 799999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC-----CeEEccccccc
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-----EAFVADFGTAR  356 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~-----~~kl~Dfg~~~  356 (496)
                      |.+ |.||.+++.-...  .|+..++.-++.|++.-++|+|   ++.+|+|||||+|+||...+     .+.++|||+|+
T Consensus       104 dLL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hhh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            988 7899999886543  7999999999999999999999   78999999999999997543     47899999999


Q ss_pred             cccCCCCC-------ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhc
Q 011005          357 LLHADSSN-------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD  429 (496)
Q Consensus       357 ~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  429 (496)
                      .+.++...       .....||.+||+-....+.+.+.+.|.=|+|-+++.++-|..||+.+.    ..........+=+
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK----A~tnK~kYeKIGe  253 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK----ADTNKEKYEKIGE  253 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc----CcchHHHHHHhcc
Confidence            98765432       233569999999999999999999999999999999999999998653    2222333333333


Q ss_pred             CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 011005          430 QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ  470 (496)
Q Consensus       430 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~  470 (496)
                      ++...+....+..-+..+..-+.-.-..+-.+-|..+-+..
T Consensus       254 ~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~  294 (449)
T KOG1165|consen  254 TKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRK  294 (449)
T ss_pred             ccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            44444444444444555666555566667777888765543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=2.4e-24  Score=208.69  Aligned_cols=260  Identities=21%  Similarity=0.215  Sum_probs=192.5

Q ss_pred             CCCCcceeeecCCeeEEEEEeCCC--cEEEEEEcccchhHHHHHHHHHHHHHHHhhcc----ccccccccee-ecCCeEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLPNG--KVFALKKLHTSEELAFIKSFKNEAQVLSQVLH----RNIVKLYGYC-LHKKCMF  278 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~~  278 (496)
                      +|.+.+.||+|+||.||++.....  ..+|+|........... .+..|..++..+..    +++..+++.. ..+...+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            799999999999999999976553  47888877654322222 57788999988873    6888999988 4777889


Q ss_pred             EEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC-----CCeEEcccc
Q 011005          279 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-----LEAFVADFG  353 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~-----~~~kl~Dfg  353 (496)
                      +||+.+ |.+|.++..... ...++..++..|+.|++.+|.++|   +.|++||||||.|+.+...     ..+.+.|||
T Consensus        98 iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            999977 789999886655 558999999999999999999999   8899999999999999865     358999999


Q ss_pred             ccc--cccCCCC-------C-ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcch
Q 011005          354 TAR--LLHADSS-------N-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIM  423 (496)
Q Consensus       354 ~~~--~~~~~~~-------~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~  423 (496)
                      +++  .+.....       . .....||..|+++....+...+.+.|+||++.++.++..|..||.......    ....
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~----~~~~  248 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD----LKSK  248 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc----hHHH
Confidence            998  3322211       1 223559999999999999999999999999999999999999996433211    1111


Q ss_pred             hHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          424 LIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       424 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      .............   ....+..+.++...+-+.+...+|....+.+.+......
T Consensus       249 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  249 FEKDPRKLLTDRF---GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             HHHHhhhhccccc---cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            1111111111110   001112344555555568999999999998886554443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=9.7e-25  Score=210.49  Aligned_cols=164  Identities=18%  Similarity=0.155  Sum_probs=128.5

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC--CCcEEEEEEcccc----hhHHHHHHHHHHHHHHHhhccccccc-ccceeecCC
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP--NGKVFALKKLHTS----EELAFIKSFKNEAQVLSQVLHRNIVK-LYGYCLHKK  275 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~  275 (496)
                      ..++|.+.+.||+|+||+||+|.++  +++.||||++...    ........+.+|++++++++|+|+++ ++++    +
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~   91 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G   91 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence            4578999999999999999999764  5778899986532    12233466899999999999999985 4432    3


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCC-CCCceEecCCCCeEEccccc
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDI-SSNNILLNSKLEAFVADFGT  354 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl-kp~Nil~~~~~~~kl~Dfg~  354 (496)
                      ..++||||++|++|.. ....      .   ...++.|++++|.|||   .+||+|||| ||+|||++.++.++|+|||+
T Consensus        92 ~~~LVmE~~~G~~L~~-~~~~------~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         92 KDGLVRGWTEGVPLHL-ARPH------G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             CcEEEEEccCCCCHHH-hCcc------c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            5799999999999963 2111      1   1457889999999999   789999999 99999999999999999999


Q ss_pred             cccccCCCCCc--------cccccccccccccccccC
Q 011005          355 ARLLHADSSNR--------TLLAGTYGYIAPELAYTM  383 (496)
Q Consensus       355 ~~~~~~~~~~~--------~~~~gt~~y~aPE~~~~~  383 (496)
                      |+.+.......        ....+++.|+|||.+...
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            99775443211        234577889999988654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=9.7e-26  Score=198.00  Aligned_cols=248  Identities=21%  Similarity=0.372  Sum_probs=187.4

Q ss_pred             CCCcceeeecCCeeEEEEEeCCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecC
Q 011005          207 FDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYME  285 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~  285 (496)
                      ..+.-+|.+...|+.|+|+++ |..+++|++...+ .....+.|..|.-.++.+.||||.++++.|..+..+.++..||+
T Consensus       192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            344556899999999999995 5667778776543 33455778999999999999999999999999999999999999


Q ss_pred             CCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCc
Q 011005          286 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR  365 (496)
Q Consensus       286 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  365 (496)
                      .|+|+..++... ....+..++.+++.+|++|++|||+- ..-|..--+++..|++|++.+.+|.- +-+++    +.+.
T Consensus       271 ~gslynvlhe~t-~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kf----sfqe  343 (448)
T KOG0195|consen  271 FGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKF----SFQE  343 (448)
T ss_pred             chHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-cccee----eeec
Confidence            999999999754 33567888999999999999999974 44444557999999999998877641 11111    1111


Q ss_pred             cccccccccccccccccCCcC---cccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          366 TLLAGTYGYIAPELAYTMVMT---EKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       366 ~~~~gt~~y~aPE~~~~~~~~---~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                      .....+|.||+||.+....-+   .++|+|||++++||+.|...||...+++.-..   ....+.++..+++..+.    
T Consensus       344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm---kialeglrv~ippgis~----  416 (448)
T KOG0195|consen  344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM---KIALEGLRVHIPPGISR----  416 (448)
T ss_pred             cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh---hhhhccccccCCCCccH----
Confidence            223457899999998876543   47999999999999999999998765532211   12233444455554443    


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEF  472 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~  472 (496)
                         .+.+|+.-|+..||.+||.++.++--+
T Consensus       417 ---hm~klm~icmnedpgkrpkfdmivpil  443 (448)
T KOG0195|consen  417 ---HMNKLMNICMNEDPGKRPKFDMIVPIL  443 (448)
T ss_pred             ---HHHHHHHHHhcCCCCcCCCcceehhhH
Confidence               345677789999999999999886544

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.90  E-value=2.1e-22  Score=196.53  Aligned_cols=262  Identities=30%  Similarity=0.406  Sum_probs=200.2

Q ss_pred             CCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHH--HHHHHHHHHHHHHhhccc-ccccccceeecCCeEEEEEEe
Q 011005          207 FDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELA--FIKSFKNEAQVLSQVLHR-NIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lV~e~  283 (496)
                      |.+.+.||.|+||.||++...  ..+++|.+.......  ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667788999999999999876  888999987755332  467889999999999988 799999999877778999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC-CeEEccccccccccCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-EAFVADFGTARLLHADS  362 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~  362 (496)
                      +.++++.+.+........++......++.|++.++.|+|   ..+++|||+||+||+++..+ .++++|||.++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999966665432125788889999999999999999   77899999999999999998 79999999998654433


Q ss_pred             C------Ccccccccccccccccccc---CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCC
Q 011005          363 S------NRTLLAGTYGYIAPELAYT---MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLP  433 (496)
Q Consensus       363 ~------~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  433 (496)
                      .      ......|+..|+|||.+.+   ..+....|+||+|++++++++|..||......    .........+.....
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~~  232 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILELPT  232 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHhcCC
Confidence            2      2355679999999999988   57888999999999999999999996533210    001111111111111


Q ss_pred             C----CCChhH-HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          434 P----PVDRKV-IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       434 ~----~~~~~~-~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      +    ...... ......+.+++.+|+..+|..|.+..+...+.+....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            1    111100 1112346788889999999999999998887544443

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=2.5e-24  Score=221.07  Aligned_cols=246  Identities=20%  Similarity=0.278  Sum_probs=181.6

Q ss_pred             CCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHH---HHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSF---KNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~---~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      ++...+.||.+.|=.|.+|++.+|. |+||++.+....-..+.+   .+|++ ...++|||++++.-+-...+..|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5677888999999999999998887 889998765533223333   34444 445589999999988888888889999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc--C
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH--A  360 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~--~  360 (496)
                      |..+ +|+|.+....   -+...+...|+.|++.|+..+|   ..||+|||||.+|||++.-..+.|+||..-+..-  .
T Consensus       102 yvkh-nLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHhh-hhhhhhccch---HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            9865 8999988654   5778888999999999999999   8899999999999999999999999998765321  1


Q ss_pred             CC-CCcc----ccccccccccccccccC-----------CcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcch
Q 011005          361 DS-SNRT----LLAGTYGYIAPELAYTM-----------VMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIM  423 (496)
Q Consensus       361 ~~-~~~~----~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~  423 (496)
                      ++ ....    +...-.+|.|||.+...           ..+++.||||+||++.||++ |++||.....+.-.......
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~  254 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADD  254 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccC
Confidence            11 1111    11233479999987652           15678999999999999987 78888643322111111111


Q ss_pred             hHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 011005          424 LIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQE  471 (496)
Q Consensus       424 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~  471 (496)
                      ....+.+ +..          ..+.+++..|++.||++|.++++.|+.
T Consensus       255 ~e~~Le~-Ied----------~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  255 PEQLLEK-IED----------VSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHHHh-CcC----------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence            1122111 111          136788999999999999999999987

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=1.3e-22  Score=181.83  Aligned_cols=190  Identities=13%  Similarity=0.173  Sum_probs=143.2

Q ss_pred             ceeeecCCccccHHHHHH--HHhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchh--HHHHHH------HHHHHH
Q 011005          185 VFSIWNYDGRIVYEDLIE--ATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEE--LAFIKS------FKNEAQ  254 (496)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~------~~~e~~  254 (496)
                      .+.++.......|.++..  ..++|...+.+|.|+||.||.+.. ++..+|+|.++....  ......      +.+|+.
T Consensus         9 ~~~~~~~~~~~~~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~   87 (232)
T PRK10359          9 GYTVFYKDNDNKYKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIV   87 (232)
T ss_pred             ceEEEecCCcccHHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHH
Confidence            344555555544554433  468999999999999999999866 577899999975432  222222      679999


Q ss_pred             HHHhhcccccccccceeecC--------CeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCC
Q 011005          255 VLSQVLHRNIVKLYGYCLHK--------KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS  326 (496)
Q Consensus       255 ~l~~l~h~niv~~~~~~~~~--------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~  326 (496)
                      .+.++.|++|..+.+++...        ...++||||++|.+|.+...       ++.    ....+++.++..+|   .
T Consensus        88 ~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH---~  153 (232)
T PRK10359         88 QTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLH---Q  153 (232)
T ss_pred             HHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHH---H
Confidence            99999999999998886543        35789999999999977632       222    24569999999999   7


Q ss_pred             CCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHH
Q 011005          327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL  402 (496)
Q Consensus       327 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~  402 (496)
                      .|++|||++|+||++++++ ++++|||..+....+...            ..+.....+..++|+||||+++..+.
T Consensus       154 ~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        154 HGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             cCCccCCCChHHEEEeCCC-EEEEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence            8999999999999999988 999999988655322111            11344556778999999999987765

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=3.3e-22  Score=177.60  Aligned_cols=140  Identities=20%  Similarity=0.240  Sum_probs=108.9

Q ss_pred             cceeeecCCeeEEEEEeCCCcEEEEEEcccchhH--H-----------------------HHHHHHHHHHHHHhhccccc
Q 011005          210 RYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEEL--A-----------------------FIKSFKNEAQVLSQVLHRNI  264 (496)
Q Consensus       210 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-----------------------~~~~~~~e~~~l~~l~h~ni  264 (496)
                      ...||+|++|.||+|..++|+.||||+++.....  .                       .......|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999998889999999999754210  0                       01123459999999998887


Q ss_pred             ccccceeecCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEeCCCCCceEecC
Q 011005          265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL-HHDCSPSIIHRDISSNNILLNS  343 (496)
Q Consensus       265 v~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l-h~~~~~~i~H~dlkp~Nil~~~  343 (496)
                      .....+...  ..++||||++|+++.......   ..++...+..++.|++.+|.++ |   ..||+||||||+||++++
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~~  153 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYHD  153 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEEC
Confidence            544433222  237999999988775443222   2578899999999999999999 6   679999999999999984


Q ss_pred             CCCeEEccccccccc
Q 011005          344 KLEAFVADFGTARLL  358 (496)
Q Consensus       344 ~~~~kl~Dfg~~~~~  358 (496)
                       +.++|+|||+|...
T Consensus       154 -~~v~LiDFG~a~~~  167 (190)
T cd05147         154 -GKLYIIDVSQSVEH  167 (190)
T ss_pred             -CcEEEEEccccccC
Confidence             78999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=6.4e-21  Score=170.11  Aligned_cols=141  Identities=22%  Similarity=0.296  Sum_probs=110.6

Q ss_pred             cceeeecCCeeEEEEEeCCCcEEEEEEcccchhH-------------------------HHHHHHHHHHHHHHhhccccc
Q 011005          210 RYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEEL-------------------------AFIKSFKNEAQVLSQVLHRNI  264 (496)
Q Consensus       210 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~e~~~l~~l~h~ni  264 (496)
                      ...||+|++|.||+|...+|+.||||.++.....                         .......+|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4679999999999998878999999998764210                         001234678999999999987


Q ss_pred             ccccceeecCCeEEEEEEecCCCChhhh-hhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC
Q 011005          265 VKLYGYCLHKKCMFLIYEYMERGSLFCN-LHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS  343 (496)
Q Consensus       265 v~~~~~~~~~~~~~lV~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~  343 (496)
                      .....+....  .++||||++|+++... +..    ..++..+...++.|++.++.++|+  ..||+||||||+||+++ 
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-
Confidence            5544443332  4799999998865433 322    256778889999999999999993  27999999999999999 


Q ss_pred             CCCeEEcccccccccc
Q 011005          344 KLEAFVADFGTARLLH  359 (496)
Q Consensus       344 ~~~~kl~Dfg~~~~~~  359 (496)
                      ++.++|+|||+++...
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            7899999999998764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.85  E-value=4.5e-21  Score=177.16  Aligned_cols=233  Identities=21%  Similarity=0.258  Sum_probs=147.0

Q ss_pred             CCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhc----------ccccccccceee-
Q 011005          207 FDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVL----------HRNIVKLYGYCL-  272 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~----------h~niv~~~~~~~-  272 (496)
                      +...+.||.|+++.||.+.+. +++.+|+|.+....  .....+.+.+|.-....+.          |-.++-.++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            344667999999999999775 58999999886543  2334566666665554422          223333333221 


Q ss_pred             --------cC---Ce-----EEEEEEecCCCChhhhhhC---C-CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEe
Q 011005          273 --------HK---KC-----MFLIYEYMERGSLFCNLHN---N-EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR  332 (496)
Q Consensus       273 --------~~---~~-----~~lV~e~~~~g~L~~~l~~---~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~  332 (496)
                              ..   ..     .+++|+.+. ++|.+.+..   . .....+....++.+..|+++.+++||   ..|++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence                    11   11     356788774 588776542   1 11223455666788899999999999   7899999


Q ss_pred             CCCCCceEecCCCCeEEccccccccccCCCCCcccccccccccccccccc--------CCcCcccchhhHHHHHHHHHhC
Q 011005          333 DISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT--------MVMTEKCDVYSFGVVTLEVLMG  404 (496)
Q Consensus       333 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~g  404 (496)
                      ||+|+|++++.+|.++|+||+........   ......+..|.+||....        ..++.+.|.|++|+++|.|++|
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR---YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEE---EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCce---eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            99999999999999999999988654321   111334578999997644        2578899999999999999999


Q ss_pred             CCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCC
Q 011005          405 KHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSR  462 (496)
Q Consensus       405 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  462 (496)
                      ..||+..........      ..-.          +...+..+..||..+|+++|++|
T Consensus       247 ~lPf~~~~~~~~~~~------~f~~----------C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPEW------DFSR----------CRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSGG------GGTT----------SS---HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCccccccc------cchh----------cCCcCHHHHHHHHHHccCCcccC
Confidence            999985433211110      1111          11233457899999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=2.6e-20  Score=163.29  Aligned_cols=184  Identities=13%  Similarity=0.094  Sum_probs=138.1

Q ss_pred             CCcceeeecCCeeEEEEEeCCCcEEEEEEcccchh---HHHHHHHHHHHHHHHhhc-ccccccccceeecCCeEEEEEEe
Q 011005          208 DIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEE---LAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       208 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      .+...|+.|+||+||.+.. .+.+++.+.+.....   ......+.+|+++++++. |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3567799999999998877 677888777765432   112235789999999995 5889999886    346899999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCC-CCCceEecCCCCeEEccccccccccCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDI-SSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dl-kp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      +.|.+|......         . ...++.|++.+|.++|   ..||+|||| ||+||+++.++.++|+|||++.......
T Consensus        80 I~G~~L~~~~~~---------~-~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPPR---------G-DLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhhh---------h-hHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            999988644321         1 1347789999999999   789999999 7999999999999999999998654433


Q ss_pred             CC-------------ccccccccccccccccccC-CcC-cccchhhHHHHHHHHHhCCCCCc
Q 011005          363 SN-------------RTLLAGTYGYIAPELAYTM-VMT-EKCDVYSFGVVTLEVLMGKHPRD  409 (496)
Q Consensus       363 ~~-------------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~il~el~~g~~p~~  409 (496)
                      ..             ......++.|++|+...-. ..+ .+.+.++-|.-+|.++|+..|..
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            21             0012256677777754322 223 46788999999999999999854

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.84  E-value=5.7e-22  Score=194.35  Aligned_cols=234  Identities=26%  Similarity=0.338  Sum_probs=182.5

Q ss_pred             eeecCCeeEEEEE----eCCCcEEEEEEcccchhH-HHHHHHHHHHHHHHhhc-ccccccccceeecCCeEEEEEEecCC
Q 011005          213 IGTGGYGSVYKAQ----LPNGKVFALKKLHTSEEL-AFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKCMFLIYEYMER  286 (496)
Q Consensus       213 lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lV~e~~~~  286 (496)
                      +|+|+||.|+.+.    ...|..+|.|..++.... ........|..++..++ ||.+|++...++.+...+++.++..|
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            6899999999873    335778888888764311 11114466888888887 99999999999999999999999999


Q ss_pred             CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCcc
Q 011005          287 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT  366 (496)
Q Consensus       287 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  366 (496)
                      |.+...+....   .+...........++-+++++|   +.+++|||+|++||+++.+|++++.|||+++..-.....  
T Consensus        82 g~lft~l~~~~---~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--  153 (612)
T KOG0603|consen   82 GDLFTRLSKEV---MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--  153 (612)
T ss_pred             chhhhccccCC---chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence            99998887665   5667777778889999999999   889999999999999999999999999999876544322  


Q ss_pred             ccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHH
Q 011005          367 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL  446 (496)
Q Consensus       367 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  446 (496)
                        +||.-|||||++.  .....+|.||||++++||+||..||..           .....+....+..+.     .....
T Consensus       154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~Il~~~~~~p~-----~l~~~  213 (612)
T KOG0603|consen  154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKRILKAELEMPR-----ELSAE  213 (612)
T ss_pred             --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------HHHHHHhhhccCCch-----hhhHH
Confidence              8999999999999  557889999999999999999999973           222333332333222     12223


Q ss_pred             HHHHHHhcccCCCCCCCCH-----HHHHHHHHH
Q 011005          447 ISTVSFACLQSNPKSRPTM-----QSVSQEFLI  474 (496)
Q Consensus       447 l~~li~~cl~~dP~~Rps~-----~evl~~~~~  474 (496)
                      ...++..++..+|..|.-.     .|+.+|.++
T Consensus       214 a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~  246 (612)
T KOG0603|consen  214 ARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFF  246 (612)
T ss_pred             HHHHHHHHHhhCHHHHhccCcchhHHHhccchh
Confidence            5677788999999998754     455555444

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=1.5e-20  Score=173.84  Aligned_cols=246  Identities=25%  Similarity=0.368  Sum_probs=164.2

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCC-C-----------------------------------cEEEEEEcccc----hhHH
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPN-G-----------------------------------KVFALKKLHTS----EELA  244 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~-~-----------------------------------~~vavK~~~~~----~~~~  244 (496)
                      ++|++.+.||+|+...||.|+.++ |                                   -+.|||.+..-    .+..
T Consensus       157 ddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~~  236 (598)
T KOG4158|consen  157 DDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDAH  236 (598)
T ss_pred             hhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchHH
Confidence            568899999999999999997543 0                                   02567766431    2223


Q ss_pred             HHHHHHHHH--------------HHHHh--------hcccccccccceeec---------------------------CC
Q 011005          245 FIKSFKNEA--------------QVLSQ--------VLHRNIVKLYGYCLH---------------------------KK  275 (496)
Q Consensus       245 ~~~~~~~e~--------------~~l~~--------l~h~niv~~~~~~~~---------------------------~~  275 (496)
                      ..+.+.+|.              ...+.        -+|||||++.++|.+                           +.
T Consensus       237 iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~  316 (598)
T KOG4158|consen  237 ILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPK  316 (598)
T ss_pred             HHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCc
Confidence            333333332              11111        249999999987754                           23


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEec--CCC--CeEEcc
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN--SKL--EAFVAD  351 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~--~~~--~~kl~D  351 (496)
                      .+|+||...+. +|..++..+    ..+.....-|+.|+++|+.|||   .+||.|||+|++|||+.  +++  ...++|
T Consensus       317 tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaD  388 (598)
T KOG4158|consen  317 TLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVAD  388 (598)
T ss_pred             eEEEehhcchh-hHHHHHhcC----CCchHHHHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcc
Confidence            57899998864 899888865    3455666778999999999999   88999999999999994  333  467999


Q ss_pred             ccccccccCCC------CCccccccccccccccccccCC------cCcccchhhHHHHHHHHHhCCCCCccccccCCCCC
Q 011005          352 FGTARLLHADS------SNRTLLAGTYGYIAPELAYTMV------MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSD  419 (496)
Q Consensus       352 fg~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~  419 (496)
                      ||++---....      .......|.-.-||||+.....      .-.++|.|+.|.+.||+++...||-.-..+..+. 
T Consensus       389 FGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~-  467 (598)
T KOG4158|consen  389 FGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT-  467 (598)
T ss_pred             cceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech-
Confidence            99984221110      1122345777899999876432      1248999999999999999999986422111110 


Q ss_pred             CcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 011005          420 PKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV  468 (496)
Q Consensus       420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev  468 (496)
                           ...-...++.-.    ...+..+.+++...|++||.+|++..-.
T Consensus       468 -----r~Yqe~qLPalp----~~vpp~~rqlV~~lL~r~pskRvsp~iA  507 (598)
T KOG4158|consen  468 -----RTYQESQLPALP----SRVPPVARQLVFDLLKRDPSKRVSPNIA  507 (598)
T ss_pred             -----hhhhhhhCCCCc----ccCChHHHHHHHHHhcCCccccCCccHH
Confidence                 111111222211    1223346789999999999999986543

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.83  E-value=2.1e-20  Score=183.53  Aligned_cols=214  Identities=27%  Similarity=0.466  Sum_probs=160.8

Q ss_pred             HhhcccccccccceeecCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCC
Q 011005          257 SQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS  336 (496)
Q Consensus       257 ~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp  336 (496)
                      +.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+...  ...+++.-...+.++|+.||+|+|+  +..-.|+.+++
T Consensus         2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s   77 (484)
T KOG1023|consen    2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKS   77 (484)
T ss_pred             cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeecc
Confidence            5678999999999999999999999999999999999873  3478888889999999999999995  33449999999


Q ss_pred             CceEecCCCCeEEccccccccccCC--CCCccccccccccccccccccCC-------cCcccchhhHHHHHHHHHhCCCC
Q 011005          337 NNILLNSKLEAFVADFGTARLLHAD--SSNRTLLAGTYGYIAPELAYTMV-------MTEKCDVYSFGVVTLEVLMGKHP  407 (496)
Q Consensus       337 ~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~il~el~~g~~p  407 (496)
                      .|++++....+|++|||+.......  ........-..-|.|||.+.+..       .+.+.||||+|++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999999999999999999776421  11111122345799999987642       46689999999999999999999


Q ss_pred             CccccccCCCCCCcchhHhhhc-CC--CCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          408 RDILSSLSSSSDPKIMLIDVLD-QR--LPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       408 ~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      |+.......   +.+....+.. ..  ..+...... .....+..++.+||..+|++||+++++-..+....+.
T Consensus       158 ~~~~~~~~~---~~eii~~~~~~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  158 FDLRNLVED---PDEIILRVKKGGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             cccccccCC---hHHHHHHHHhcCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            985432211   1222222222 11  111111111 2223578899999999999999999998877665554

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=6.1e-20  Score=192.54  Aligned_cols=195  Identities=26%  Similarity=0.301  Sum_probs=159.5

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc---ccccccccceeecCCeEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL---HRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l  279 (496)
                      -.+.|.|.+.+|+|+||+||+|...+|+.||+|+-+....-+    |.-=.+++.+|+   -+.|..+..++.-.+.-++
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence            456788899999999999999988889999999987654321    111233344444   3556777777777778899


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC-------CCCeEEccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-------KLEAFVADF  352 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~-------~~~~kl~Df  352 (496)
                      |+||.+.|+|.+++...+   .+++.-++.+..|+++.+++||   ..+||||||||+|+++..       ...++|+||
T Consensus       772 v~ey~~~Gtlld~~N~~~---~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf  845 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLINTNK---VMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF  845 (974)
T ss_pred             eeeccccccHHHhhccCC---CCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEec
Confidence            999999999999998443   7889999999999999999999   889999999999999953       345899999


Q ss_pred             cccccccCC--CCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCC
Q 011005          353 GTARLLHAD--SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP  407 (496)
Q Consensus       353 g~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p  407 (496)
                      |.+..+.--  .......++|-.+-.+|...|..+++.+|-|.++.+++-|+.|+.-
T Consensus       846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            999876533  2334556788999999999999999999999999999999999765

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.79  E-value=5.5e-20  Score=177.11  Aligned_cols=178  Identities=25%  Similarity=0.369  Sum_probs=137.1

Q ss_pred             eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccc
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  355 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  355 (496)
                      +.++.|++|+..+|.+++.........++.....++.|++.|+.|      ++.+|+|+||.||+...+..+||+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999877767778899999999999999999      38999999999999999999999999999


Q ss_pred             ccccCCC------CCccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhh
Q 011005          356 RLLHADS------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVL  428 (496)
Q Consensus       356 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~  428 (496)
                      .......      ...+..+||..||+||.+.+..|+.++||||||++|+|++. =..++.          ......++-
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----------r~~t~~d~r  473 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----------RIATLTDIR  473 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----------HHHhhhhhh
Confidence            8776544      12345679999999999999999999999999999999996 122221          111222233


Q ss_pred             cCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          429 DQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      +..+++..-    .+-..=..|+.+++...|.+||++.+..-+.|
T Consensus       474 ~g~ip~~~~----~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~  514 (516)
T KOG1033|consen  474 DGIIPPEFL----QDYPEEYTLLQQLLSPSPEERPSAIEVALHEF  514 (516)
T ss_pred             cCCCChHHh----hcCcHHHHHHHHhcCCCcccCchHHHHhhhhh
Confidence            333332111    11112347778999999999997766655544

>smart00090 RIO RIO-like kinase

Probab=99.79  E-value=1.3e-18  Score=159.90  Aligned_cols=142  Identities=20%  Similarity=0.224  Sum_probs=110.3

Q ss_pred             CCCCcceeeecCCeeEEEEE--eCCCcEEEEEEcccchhH-----------------------HHHHHHHHHHHHHHhhc
Q 011005          206 DFDIRYCIGTGGYGSVYKAQ--LPNGKVFALKKLHTSEEL-----------------------AFIKSFKNEAQVLSQVL  260 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~  260 (496)
                      -|.+.+.||+|++|.||+|.  ..+|+.||+|.++.....                       .....+.+|+..++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788999999999999997  568999999998753210                       01133578999999997


Q ss_pred             ccc--cccccceeecCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEeCCCCC
Q 011005          261 HRN--IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS-IIHRDISSN  337 (496)
Q Consensus       261 h~n--iv~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~-i~H~dlkp~  337 (496)
                      +.+  +.+++++   . ..++||||++|+++........   .+...+...++.|++.++.+||   ..+ ++||||||+
T Consensus       109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~  178 (237)
T smart00090      109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEY  178 (237)
T ss_pred             hcCCCCCeeeEe---c-CceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChh
Confidence            633  3344432   2 3479999999988876543222   3455667889999999999999   778 999999999


Q ss_pred             ceEecCCCCeEEccccccccc
Q 011005          338 NILLNSKLEAFVADFGTARLL  358 (496)
Q Consensus       338 Nil~~~~~~~kl~Dfg~~~~~  358 (496)
                      ||+++ ++.++++|||.+...
T Consensus       179 NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhcc
Confidence            99999 889999999998754

>PRK10345 hypothetical protein; Provisional

Probab=99.78  E-value=1.6e-18  Score=155.26  Aligned_cols=135  Identities=18%  Similarity=0.211  Sum_probs=104.1

Q ss_pred             CcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-----cccccccccceeecCC---e-EEE
Q 011005          209 IRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-----LHRNIVKLYGYCLHKK---C-MFL  279 (496)
Q Consensus       209 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~-~~l  279 (496)
                      -.+.||+|+||.||.  +++....+||++...... ..+.+.+|+.+++.+     .||||++++|++.++.   . +.+
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~-~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDG-GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCeEEEEEeccccc-hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            356799999999996  544344479988654322 236789999999999     5799999999998864   3 347


Q ss_pred             EEEe--cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEEeCCCCCceEecC----CCCeEEcc-
Q 011005          280 IYEY--MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL-AYLHHDCSPSIIHRDISSNNILLNS----KLEAFVAD-  351 (496)
Q Consensus       280 V~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l-~~lh~~~~~~i~H~dlkp~Nil~~~----~~~~kl~D-  351 (496)
                      |+||  +.+|+|.+++...    .+++.  ..++.+++.++ +|||   +.+|+||||||+||+++.    ++.++|+| 
T Consensus        83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            8999  5579999999653    34444  35677888777 9999   789999999999999974    34799999 


Q ss_pred             cccc
Q 011005          352 FGTA  355 (496)
Q Consensus       352 fg~~  355 (496)
                      ||..
T Consensus       154 ~G~~  157 (210)
T PRK10345        154 IGES  157 (210)
T ss_pred             CCCc
Confidence            5543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=7.3e-18  Score=153.53  Aligned_cols=135  Identities=21%  Similarity=0.336  Sum_probs=112.9

Q ss_pred             ceeeecCCeeEEEEEeCCCcEEEEEEcccch-------hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          211 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-------ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      +.||+|++|.||+|.+ .|..+++|+.....       .......+.+|+.++..+.|+++.....++......++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4689999999999987 67788999765421       011224578899999999999998888777777788999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      ++|++|.+.+....      . .+..++.+++.+|.++|   ..+++|||++|+||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999886432      1 77889999999999999   78999999999999999 78899999998864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=9.1e-18  Score=151.06  Aligned_cols=144  Identities=19%  Similarity=0.223  Sum_probs=110.4

Q ss_pred             HHHHHhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhH---------------------HHHHHHHHHHHHHHh
Q 011005          200 LIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEEL---------------------AFIKSFKNEAQVLSQ  258 (496)
Q Consensus       200 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~e~~~l~~  258 (496)
                      +......|.+.+.||+|+||.||+|..++|+.||||++......                     .......+|+.++..
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            33333347788999999999999998888999999987543200                     011235778999999


Q ss_pred             hcccc--cccccceeecCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCC
Q 011005          259 VLHRN--IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS  336 (496)
Q Consensus       259 l~h~n--iv~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp  336 (496)
                      +.|++  ++..++.    ...++||||++|++|......         .....++.+++.++.++|   ..+++||||+|
T Consensus        90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p  153 (198)
T cd05144          90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAY---KHGIIHGDLSE  153 (198)
T ss_pred             HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCc
Confidence            98874  3444432    345899999999988755321         234568899999999999   78999999999


Q ss_pred             CceEecCCCCeEEcccccccccc
Q 011005          337 NNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       337 ~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      +||++++++.++|+|||.+....
T Consensus       154 ~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         154 FNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             ccEEEcCCCcEEEEECCccccCC
Confidence            99999999999999999996554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.74  E-value=1.2e-18  Score=179.61  Aligned_cols=219  Identities=26%  Similarity=0.329  Sum_probs=148.8

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCC-CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      ..+|..++.+..|+||.||..+++. .+.+|. ++.+...     -+.+   ++.....|.+|                 
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l-----ilRn---ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL-----ILRN---ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhh-cccccch-----hhhc---cccccCCccee-----------------
Confidence            3679999999999999999998864 556777 4433221     0111   22222333333                 


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                          |+=...+...+   .++..        ++.+++|+|   ..||+|||+||+|.+|+.-|++|++|||+++......
T Consensus       136 ----gDc~tllk~~g---~lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 ----GDCATLLKNIG---PLPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             ----chhhhhcccCC---CCcch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence                23233333322   33332        388999999   8899999999999999999999999999997542110


Q ss_pred             ---------------CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhh
Q 011005          363 ---------------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDV  427 (496)
Q Consensus       363 ---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  427 (496)
                                     ......+|||.|.|||++....|...+|.|++|+|+||++-|+.||..       ..+++....+
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG-------dtpeelfg~v  270 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-------DTPEELFGQV  270 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC-------CCHHHHHhhh
Confidence                           112235899999999999999999999999999999999999999862       2233333333


Q ss_pred             hcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCC---CHHHHHHHHHHh
Q 011005          428 LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRP---TMQSVSQEFLIT  475 (496)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~evl~~~~~~  475 (496)
                      +...+..+..  ......+..+++.+.|+.+|..|.   .+-++-+|.+++
T Consensus       271 isd~i~wpE~--dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~  319 (1205)
T KOG0606|consen  271 ISDDIEWPEE--DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQ  319 (1205)
T ss_pred             hhhhcccccc--CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhcccee
Confidence            3333332222  112223467888999999999997   355555555443

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.74  E-value=1.4e-17  Score=150.21  Aligned_cols=131  Identities=20%  Similarity=0.348  Sum_probs=106.5

Q ss_pred             eeeecCCeeEEEEEeCCCcEEEEEEcccch-------hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          212 CIGTGGYGSVYKAQLPNGKVFALKKLHTSE-------ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       212 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      .||+|+||.||+|.+ ++..+++|......       .......+.+|+++++.+.|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999986 56789999864321       1112356778999999999888766666666666678999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      +|++|.+.+....   .       .++.+++.+|.++|   ..+++|||++|+||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~---~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN---D-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH---H-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999998775421   0       68999999999999   78999999999999999 78999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.74  E-value=3.2e-17  Score=169.67  Aligned_cols=139  Identities=19%  Similarity=0.274  Sum_probs=111.8

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEE-cccc------hhHHHHHHHHHHHHHHHhhcccccccccceeecCCe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKK-LHTS------EELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKC  276 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~------~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  276 (496)
                      ...|...+.||+|+||+||+|.+.+.. +++|+ ....      ........+.+|+++++.++|++++....++.....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            445667889999999999999875544 34433 2221      111223567899999999999999988877777777


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      .++||||++|++|.+.+.           ....++.+++.+|.+||   ..+++|||+||+||++ .++.++|+|||+++
T Consensus       411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            889999999999988775           34578999999999999   7899999999999999 57789999999997


Q ss_pred             cc
Q 011005          357 LL  358 (496)
Q Consensus       357 ~~  358 (496)
                      ..
T Consensus       476 ~~  477 (535)
T PRK09605        476 YS  477 (535)
T ss_pred             cC
Confidence            53

>PLN03150 hypothetical protein; Provisional

Probab=99.69  E-value=4.9e-17  Score=170.03  Aligned_cols=152  Identities=31%  Similarity=0.512  Sum_probs=119.7

Q ss_pred             CCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCcccccccccc
Q 011005           16 NLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLS   95 (496)
Q Consensus        16 ~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~l~l~   95 (496)
                      .++.|+|++|.+.|.+|..++.+++|+.|+|++|+|+|.+|..+..+++|+.|+|++|++++.+|..+++|++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            37889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCC-ccccccccCCCCCCCCCCCCCCCCCCCCCCccchhhhhhHHHHHHHHHHHHHHHhHhh
Q 011005           96 SNKLSGPVPFSNNDLS-SMHTVVSLSPNNGLCGNILDLPSCDTTKPATLFVEIFLPLTIVLSVIVFACLLLAKRK  169 (496)
Q Consensus        96 ~n~l~~~~~~~~~~l~-~l~~~~~~~~n~~~c~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~i~~~~~~~~~r~  169 (496)
                      +|+++|.+|..+..+. ++ .-+.+..|+..|+.+ ..+.|.........+.++++++++++++++.++++++||
T Consensus       499 ~N~l~g~iP~~l~~~~~~~-~~l~~~~N~~lc~~p-~l~~C~~~~~~~~~i~~~~~~~~~~l~~~~~~~~~~~~r  571 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHR-ASFNFTDNAGLCGIP-GLRACGPHLSVGAKIGIAFGVSVAFLFLVICAMCWWKRR  571 (623)
T ss_pred             CCcccccCChHHhhccccC-ceEEecCCccccCCC-CCCCCcccCCCceEEEEEhHHHHHHHHHHHHHhhheeeh
Confidence            9999999998887643 33 335688899999853 456776544433334444433333333333333444443

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.67  E-value=5.9e-16  Score=138.11  Aligned_cols=138  Identities=20%  Similarity=0.234  Sum_probs=98.6

Q ss_pred             cceeeecCCeeEEEEEeCCCcEEEEEEcccchhH--HHHH---------------------HHHHHHHHHHhhcccc--c
Q 011005          210 RYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEEL--AFIK---------------------SFKNEAQVLSQVLHRN--I  264 (496)
Q Consensus       210 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~---------------------~~~~e~~~l~~l~h~n--i  264 (496)
                      .+.||+|+||+||+|...+++.||||.+......  ....                     ....|...+.++.+.+  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999998888999999988653211  1001                     1135566666665433  3


Q ss_pred             ccccceeecCCeEEEEEEecCCCChhhh-hhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEEeCCCCCceEec
Q 011005          265 VKLYGYCLHKKCMFLIYEYMERGSLFCN-LHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS-PSIIHRDISSNNILLN  342 (496)
Q Consensus       265 v~~~~~~~~~~~~~lV~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~-~~i~H~dlkp~Nil~~  342 (496)
                      .+.+++    ...++||||++++.+... +....    .. .++..++.+++.++.++|   . .+++|+||||+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE
Confidence            344433    235899999999654321 21111    11 567789999999999999   5 8999999999999999


Q ss_pred             CCCCeEEccccccccccC
Q 011005          343 SKLEAFVADFGTARLLHA  360 (496)
Q Consensus       343 ~~~~~kl~Dfg~~~~~~~  360 (496)
                       ++.++++|||.+.....
T Consensus       150 -~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 -DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             -CCcEEEEECcccccccC
Confidence             88999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.66  E-value=9.6e-16  Score=131.58  Aligned_cols=135  Identities=19%  Similarity=0.174  Sum_probs=113.2

Q ss_pred             CcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcc--cccccccceeecCCeEEEEEEecCC
Q 011005          209 IRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLH--RNIVKLYGYCLHKKCMFLIYEYMER  286 (496)
Q Consensus       209 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lV~e~~~~  286 (496)
                      +.+.||+|.++.||++...+ ..+++|.......   ...+.+|+.+++.+.|  .++++++++...++..+++|||+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            35679999999999998855 7899999866543   3568899999999986  5889999988888889999999998


Q ss_pred             CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          287 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       287 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      +.+...          +......++.+++.++.++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus        78 ~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            776533          4566677899999999999954335799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.64  E-value=3.1e-17  Score=169.07  Aligned_cols=258  Identities=21%  Similarity=0.292  Sum_probs=193.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC--CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhc-ccccccccceeecCCeEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP--NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lV  280 (496)
                      ..|.+.+.||+|+|+.|-.....  ....+|+|.+.... ..........|..+-+.+. |+|++.+++........+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            45777888999999999888653  34456666665542 2333445566888888887 99999999999999999999


Q ss_pred             EEecCCCChhhhh-hCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC-CeEEccccccccc
Q 011005          281 YEYMERGSLFCNL-HNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-EAFVADFGTARLL  358 (496)
Q Consensus       281 ~e~~~~g~L~~~l-~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  358 (496)
                      +++..|+++.+-+ ....  ...+...+..++.|+..++.|+|.  ..++.|+|+||+|.+++..+ ..++.|||+|..+
T Consensus       100 ~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            9999999999888 4322  134445566789999999999995  45899999999999999999 9999999999887


Q ss_pred             cC-CCC--Ccccccc-ccccccccccccCC-cCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCC--
Q 011005          359 HA-DSS--NRTLLAG-TYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQR--  431 (496)
Q Consensus       359 ~~-~~~--~~~~~~g-t~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--  431 (496)
                      .. .+.  .....+| ++.|+|||...+.. ..+..|+||.|+++.-+++|..|++.......      .........  
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~------~~~~~~~~~~~  249 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG------RYSSWKSNKGR  249 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc------cceeecccccc
Confidence            65 222  2334567 99999999998854 45789999999999999999999875433211      111111111  


Q ss_pred             -CCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          432 -LPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       432 -~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                       -..+..    .......++..+++..+|..|.+.+++-.+.|...
T Consensus       250 ~~~~~~~----~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  250 FTQLPWN----SISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cccCccc----cCChhhhhcccccccCCchhccccccccccccccc
Confidence             011111    11123456777899999999999999999999988

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.63  E-value=3.9e-15  Score=137.16  Aligned_cols=137  Identities=20%  Similarity=0.285  Sum_probs=105.4

Q ss_pred             cceee-ecCCeeEEEEEeCCCcEEEEEEcccch------------hHHHHHHHHHHHHHHHhhccccc--ccccceeecC
Q 011005          210 RYCIG-TGGYGSVYKAQLPNGKVFALKKLHTSE------------ELAFIKSFKNEAQVLSQVLHRNI--VKLYGYCLHK  274 (496)
Q Consensus       210 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~  274 (496)
                      ...|| .|+.|+||.+... +..+++|.+....            +......+.+|+.++.++.|+++  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            34688 8999999999884 6788999885421            01223467889999999998875  6667664432


Q ss_pred             C----eEEEEEEecCC-CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEE
Q 011005          275 K----CMFLIYEYMER-GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFV  349 (496)
Q Consensus       275 ~----~~~lV~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl  349 (496)
                      .    ..++|||+++| .+|.+++...    .++..    .+.+++.++.+||   ..||+||||||+|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEE
Confidence            2    23599999997 6888887642    33433    3578999999999   789999999999999999899999


Q ss_pred             ccccccccc
Q 011005          350 ADFGTARLL  358 (496)
Q Consensus       350 ~Dfg~~~~~  358 (496)
                      +|||.+...
T Consensus       184 IDfg~~~~~  192 (239)
T PRK01723        184 IDFDRGELR  192 (239)
T ss_pred             EECCCcccC
Confidence            999998654

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.56  E-value=4e-16  Score=128.63  Aligned_cols=114  Identities=30%  Similarity=0.524  Sum_probs=105.8

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCC-CCC
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQG-SIP   80 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~-~~~   80 (496)
                      |+++.+|+.+..|.+|+.|++++|+|+ .+|..++++++|+.|+++-|++. .+|..|+.+|.|+.|||++|++.. .+|
T Consensus        43 NKl~~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lp  120 (264)
T KOG0617|consen   43 NKLTVVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLP  120 (264)
T ss_pred             CceeecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCC
Confidence            889999999999999999999999998 88999999999999999999999 899999999999999999999963 689


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccccc
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVS  118 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~  118 (496)
                      +.|..|..|+.|+|++|.+. .+|...+++++|+-+..
T Consensus       121 gnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~l  157 (264)
T KOG0617|consen  121 GNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSL  157 (264)
T ss_pred             cchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEee
Confidence            99999999999999999999 78888999999975543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.52  E-value=8.4e-14  Score=139.43  Aligned_cols=141  Identities=21%  Similarity=0.215  Sum_probs=98.6

Q ss_pred             cceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHH---------------------------------------HHHHH
Q 011005          210 RYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAF---------------------------------------IKSFK  250 (496)
Q Consensus       210 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------------------------------~~~~~  250 (496)
                      .+.||.|++|.||+|.+++|+.||||+.+.......                                       .-.+.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            367999999999999999999999999876421100                                       00234


Q ss_pred             HHHHHHHhhc-----cccccccccee-ecCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHH-HHHHHHh
Q 011005          251 NEAQVLSQVL-----HRNIVKLYGYC-LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH-ALAYLHH  323 (496)
Q Consensus       251 ~e~~~l~~l~-----h~niv~~~~~~-~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~-~l~~lh~  323 (496)
                      +|+..+.++.     ++++ .+-..+ ......++||||++|++|.+.......  ..+   ...++.+++. .+..+| 
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~~---~~~ia~~~~~~~l~ql~-  274 (437)
T TIGR01982       202 REAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GLD---RKALAENLARSFLNQVL-  274 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CCC---HHHHHHHHHHHHHHHHH-
Confidence            4555555553     2332 222222 223456899999999999887653211  122   2346666665 467788 


Q ss_pred             CCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       324 ~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                        ..|++|+|++|.||++++++.++++|||++..+.
T Consensus       275 --~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       275 --RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             --hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence              7799999999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.46  E-value=1.5e-13  Score=125.01  Aligned_cols=205  Identities=24%  Similarity=0.329  Sum_probs=142.2

Q ss_pred             HHhhcccccccccceeecCC-----eEEEEEEecCCCChhhhhhCCCC-CccCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 011005          256 LSQVLHRNIVKLYGYCLHKK-----CMFLIYEYMERGSLFCNLHNNED-AVELDWAKRVNIVKAMAHALAYLHHDCSPSI  329 (496)
Q Consensus       256 l~~l~h~niv~~~~~~~~~~-----~~~lV~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i  329 (496)
                      +-.+.|.|+|+++.|+.+.+     ...++.|||..|++...|++... ...+......+|+.||..||.|||+. ...|
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCcc
Confidence            34456999999999997654     47899999999999999886432 22467777789999999999999987 8999


Q ss_pred             EEeCCCCCceEecCCCCeEEccccccccccC----CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCC
Q 011005          330 IHRDISSNNILLNSKLEAFVADFGTARLLHA----DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK  405 (496)
Q Consensus       330 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~  405 (496)
                      +|+++.-+-|++..++-+|++--.-......    .......-.+-++|.|||+-.....+.++|||+||+...||.-|.
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence            9999999999999998888753221111100    000112223567999999877777788999999999999998776


Q ss_pred             CCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          406 HPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       406 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                      .--..   ..+....+......+. .+..+.          -..++.+|++..|..||++.+++.|+...
T Consensus       280 iq~tn---seS~~~~ee~ia~~i~-~len~l----------qr~~i~kcl~~eP~~rp~ar~llfHpllf  335 (458)
T KOG1266|consen  280 IQSTN---SESKVEVEENIANVII-GLENGL----------QRGSITKCLEGEPNGRPDARLLLFHPLLF  335 (458)
T ss_pred             eccCC---Ccceeehhhhhhhhee-eccCcc----------ccCcCcccccCCCCCCcchhhhhcCceee
Confidence            54110   0011111111111111 111111          12456689999999999999999997654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.45  E-value=8.1e-14  Score=137.44  Aligned_cols=253  Identities=26%  Similarity=0.264  Sum_probs=183.2

Q ss_pred             hCCCCcceeee--cCCeeEEEEEe---CCCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhc-ccccccccceeecCCeE
Q 011005          205 EDFDIRYCIGT--GGYGSVYKAQL---PNGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKCM  277 (496)
Q Consensus       205 ~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~  277 (496)
                      ..|.+.+.+|.  |.+|.||.+..   .++..+|+|+-+.... ......=.+|+...++++ |+|.++.+..+...+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            46777888999  99999999965   4678899988433211 111233357777777785 99999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEEeCCCCCceEecCC-CCeEEccc
Q 011005          278 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH----ALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADF  352 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~----~l~~lh~~~~~~i~H~dlkp~Nil~~~~-~~~kl~Df  352 (496)
                      ++-+|++. .++..+.+....  -++....+.+..+..+    |+.++|   ...++|-|+||.||+...+ ...+++||
T Consensus       194 fiqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCc
Confidence            99999885 677766654321  3667777888888888    999999   7899999999999999999 88999999


Q ss_pred             cccccccCCCCCccc-----cccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccc--cccCCCCCCcchhH
Q 011005          353 GTARLLHADSSNRTL-----LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIL--SSLSSSSDPKIMLI  425 (496)
Q Consensus       353 g~~~~~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~--~~~~~~~~~~~~~~  425 (496)
                      |+...+.........     ..|...|++||...+ .++..+|+||+|.++.+..+|-.+....  ..+..       ..
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-------~r  339 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-------LR  339 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-------cc
Confidence            999888665432222     257788999997665 5688999999999999998876664321  11000       00


Q ss_pred             hhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          426 DVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      .   ..++.+...   .....+...+..|++.+|..|++.+.+..+.++...
T Consensus       340 ~---~~ip~e~~~---~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  340 Q---GYIPLEFCE---GGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             c---ccCchhhhc---CcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence            0   001111111   111123347778999999999999999888777643

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.45  E-value=2.7e-13  Score=137.23  Aligned_cols=145  Identities=19%  Similarity=0.199  Sum_probs=92.6

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeCC-CcEEEEEEcccchhH---------------------------------HHHHH
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSEEL---------------------------------AFIKS  248 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---------------------------------~~~~~  248 (496)
                      ....|+. +.||.|++|.||+|.+++ |+.||||+.+..-..                                 +..+.
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            3456776 789999999999999887 999999999754210                                 11122


Q ss_pred             HHHHHHHHHhhcccccccccceeec-------------CCeEEEEEEecCCCChhhh--hhCCC-CCccCCHHHHHHHHH
Q 011005          249 FKNEAQVLSQVLHRNIVKLYGYCLH-------------KKCMFLIYEYMERGSLFCN--LHNNE-DAVELDWAKRVNIVK  312 (496)
Q Consensus       249 ~~~e~~~l~~l~h~niv~~~~~~~~-------------~~~~~lV~e~~~~g~L~~~--l~~~~-~~~~~~~~~~~~i~~  312 (496)
                      +.+|++.....  +|+.++...+..             ....++||||++|+.+.+.  +...+ +...+....+..++.
T Consensus       197 l~~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~  274 (537)
T PRK04750        197 LHDELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT  274 (537)
T ss_pred             HHHhhCHHHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence            23333333333  233333322222             3345799999999999764  22211 111122222223333


Q ss_pred             HHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC----CeEEccccccccccC
Q 011005          313 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKL----EAFVADFGTARLLHA  360 (496)
Q Consensus       313 ~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~  360 (496)
                      |+       .   ..|++|+|++|.||+++.++    .++++|||++..+..
T Consensus       275 Qi-------f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        275 QV-------F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HH-------H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            33       2   45999999999999999888    999999999987743

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.44  E-value=2.8e-12  Score=127.89  Aligned_cols=168  Identities=14%  Similarity=0.150  Sum_probs=128.1

Q ss_pred             EeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCCChhhhhhCCCCCccCCH
Q 011005          225 QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDW  304 (496)
Q Consensus       225 ~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~  304 (496)
                      +..++.+|.|...+.... .......+.++.++.++||||+++++.++..+..|+|+|.+.  .|..++...      ..
T Consensus        33 ~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------~~  103 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------GK  103 (690)
T ss_pred             eeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------HH
Confidence            344677888877766554 444667888999999999999999999999999999999984  566666643      34


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCccccccccccccccccccCC
Q 011005          305 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV  384 (496)
Q Consensus       305 ~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  384 (496)
                      ......++||+.||.+||+  +++++|++|+-+-|+++..|+.||++|.++...............--.|..|+.+....
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc
Confidence            5555678999999999997  56999999999999999999999999999866543332112222223466666544333


Q ss_pred             cCcccchhhHHHHHHHHHhCC
Q 011005          385 MTEKCDVYSFGVVTLEVLMGK  405 (496)
Q Consensus       385 ~~~~~DvwslG~il~el~~g~  405 (496)
                        -..|.|-||++++|++.|.
T Consensus       182 --~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             --cchhhhhHHHHHHHHhCcc
Confidence              3469999999999999993

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.42  E-value=1e-14  Score=120.37  Aligned_cols=115  Identities=31%  Similarity=0.487  Sum_probs=100.4

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCC-CCCchhhcCCcccCeecccccccCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLS-GKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~-~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      .|+|..+|.+++.|++|+.|+++-|++. .+|..|+.++.|+.|||++|++. ..+|..|..|+.|+-|+|+.|.+. .+
T Consensus        65 nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~l  142 (264)
T KOG0617|consen   65 NNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-IL  142 (264)
T ss_pred             cchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cC
Confidence            3789999999999999999999999998 89999999999999999999986 347888888888888888888888 88


Q ss_pred             CccccCcccccccccccccCCCCCCCCCCCCCccccccc
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVS  118 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~  118 (496)
                      |..++.+++|+.|.+..|.+- .+|..++.++.|+.+..
T Consensus       143 p~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhi  180 (264)
T KOG0617|consen  143 PPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHI  180 (264)
T ss_pred             ChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhc
Confidence            888888888888888888887 67888888888877654

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.41  E-value=3.9e-13  Score=150.16  Aligned_cols=113  Identities=42%  Similarity=0.630  Sum_probs=99.1

Q ss_pred             CCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCccccccc
Q 011005           13 NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYL   92 (496)
Q Consensus        13 ~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~l   92 (496)
                      .+++|+.|+|++|++++.+|..|.++++|+.|+|++|++++.+|+.+..+++|+.|+|++|++++.+|..+..+++|+.|
T Consensus       473 ~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  552 (968)
T PLN00113        473 GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQL  552 (968)
T ss_pred             ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEE
Confidence            45678888888888888888889999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCCCCccccccccCCCCCCC
Q 011005           93 NLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLC  126 (496)
Q Consensus        93 ~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c  126 (496)
                      ++++|++++.+|..+..+++|+.+ +++.|+..+
T Consensus       553 ~Ls~N~l~~~~p~~l~~l~~L~~l-~ls~N~l~~  585 (968)
T PLN00113        553 DLSQNQLSGEIPKNLGNVESLVQV-NISHNHLHG  585 (968)
T ss_pred             ECCCCcccccCChhHhcCcccCEE-eccCCccee
Confidence            999999999999999999888654 566666443

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.39  E-value=7e-12  Score=110.29  Aligned_cols=138  Identities=18%  Similarity=0.191  Sum_probs=99.4

Q ss_pred             cceeeecCCeeEEEEEeCC-------CcEEEEEEcccch------------h---------HHHHHH----HHHHHHHHH
Q 011005          210 RYCIGTGGYGSVYKAQLPN-------GKVFALKKLHTSE------------E---------LAFIKS----FKNEAQVLS  257 (496)
Q Consensus       210 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~------------~---------~~~~~~----~~~e~~~l~  257 (496)
                      ...||.|--+.||.|...+       +..+|||..+...            +         ....+.    ..+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3569999999999996543       5799999886421            0         001122    248999999


Q ss_pred             hhcc--cccccccceeecCCeEEEEEEecCCCChhh-hhhCCCCCccCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEeC
Q 011005          258 QVLH--RNIVKLYGYCLHKKCMFLIYEYMERGSLFC-NLHNNEDAVELDWAKRVNIVKAMAHALAYL-HHDCSPSIIHRD  333 (496)
Q Consensus       258 ~l~h--~niv~~~~~~~~~~~~~lV~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l-h~~~~~~i~H~d  333 (496)
                      ++..  -++..++++    ...++||||+.++.+.. .+...    .++..+...+..+++.++..+ |   ..+++|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGD  150 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHAD  150 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence            9964  455666654    34679999997654422 22211    344456677889999999999 7   77999999


Q ss_pred             CCCCceEecCCCCeEEcccccccccc
Q 011005          334 ISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       334 lkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      |++.||++++ +.+.++|||.+....
T Consensus       151 Ls~~NIL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         151 LSEYNMLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCHHHEEEEC-CcEEEEECCCceeCC
Confidence            9999999974 679999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.37  E-value=2.9e-12  Score=112.31  Aligned_cols=127  Identities=23%  Similarity=0.300  Sum_probs=94.6

Q ss_pred             ceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccc-cccceeecCCeEEEEEEecCCCCh
Q 011005          211 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIV-KLYGYCLHKKCMFLIYEYMERGSL  289 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lV~e~~~~g~L  289 (496)
                      +.++.|.++.||++... ++.|++|........  ...+.+|+.+++.+.+.+++ +++.+..  ...++||||++|.++
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~--~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL--LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCccc--ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            56889999999999875 778999987654321  23467899999999765554 4444432  234799999999887


Q ss_pred             hhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          290 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS-----IIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       290 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      .+.    .   . .   ...++.+++++++.||   ..+     ++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~----~---~-~---~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTE----D---F-S---DPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc----c---c-c---CHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            643    0   1 1   1235678999999999   445     59999999999999 66899999998853

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.30  E-value=1.6e-12  Score=128.31  Aligned_cols=250  Identities=20%  Similarity=0.189  Sum_probs=178.3

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEe--CCCcEEEEEEcccchhHHH-HHHHHHHHHHHHhhc-ccccccccceeecCCeEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSEELAF-IKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKCMF  278 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  278 (496)
                      -..+|..+..||.|.|+.|++...  .++..|++|.....-.... ...-..|+.+...+. |.+++.....+......+
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            456788899999999999999843  4688999998866432111 122356777777774 899999888887777778


Q ss_pred             EEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC-CCeEEcccccccc
Q 011005          279 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTARL  357 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~  357 (496)
                      +=-|||+++++.....-   ...++....+.+..|++.++.++|   ++.++|+|++|+||++..+ +..+++|||+++.
T Consensus       343 ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             CchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccc
Confidence            99999999988765522   225677788899999999999999   8899999999999999886 7889999999975


Q ss_pred             ccCCCCCccccccccccc--cccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCC
Q 011005          358 LHADSSNRTLLAGTYGYI--APELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP  435 (496)
Q Consensus       358 ~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  435 (496)
                      +....   ....+.-++.  +|+......+..+.|++|||..+.+.++|..--....          ....+.....+..
T Consensus       417 ~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----------~~~~i~~~~~p~~  483 (524)
T KOG0601|consen  417 LAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----------QSLTIRSGDTPNL  483 (524)
T ss_pred             cceec---ccccccccccccchhhccccccccccccccccccccccccCcccCcccc----------cceeeecccccCC
Confidence            32211   1122233344  5666667788889999999999999998875422111          1111111222211


Q ss_pred             CChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          436 VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       436 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      ...     ...+..+...+..+|+..||.+.++..+..+.+
T Consensus       484 ~~~-----~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  484 PGL-----KLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             Cch-----HHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence            111     123556677899999999999999988766544

>PLN03150 hypothetical protein; Provisional

Probab=99.29  E-value=9.1e-12  Score=130.62  Aligned_cols=95  Identities=33%  Similarity=0.575  Sum_probs=88.6

Q ss_pred             cCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccC
Q 011005            6 IIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITK   85 (496)
Q Consensus         6 ~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~   85 (496)
                      .+|..+++|++|+.|+|++|++.|.+|..++.+++|+.|+|++|+|++.+|+.+.+|++|+.|+|++|++++.+|..+..
T Consensus       433 ~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~  512 (623)
T PLN03150        433 FIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG  512 (623)
T ss_pred             cCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhh
Confidence            58889999999999999999999999999999999999999999999999999999999999999999999999998876


Q ss_pred             c-ccccccccccccCC
Q 011005           86 L-SRLDYLNLSSNKLS  100 (496)
Q Consensus        86 l-~~L~~l~l~~n~l~  100 (496)
                      + .++..+++.+|...
T Consensus       513 ~~~~~~~l~~~~N~~l  528 (623)
T PLN03150        513 RLLHRASFNFTDNAGL  528 (623)
T ss_pred             ccccCceEEecCCccc
Confidence            4 46788999998754

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.26  E-value=4.1e-13  Score=125.13  Aligned_cols=115  Identities=30%  Similarity=0.517  Sum_probs=82.8

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhc-CCcccCeecccccccCCCCC
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIA-SMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~-~l~~L~~l~l~~N~l~~~~~   80 (496)
                      |-++.+|++++.|.+|..|||..|.|. .+| .|+++..|.+|+++.|+|+ .+|.... .+++|..|||..|+++ .+|
T Consensus       193 N~L~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~P  268 (565)
T KOG0472|consen  193 NLLETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVP  268 (565)
T ss_pred             hhhhcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCc
Confidence            556777777777777777777777776 556 6777777777777777777 5666554 7778888888888887 777


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN  123 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~  123 (496)
                      ..++-+++|..||+++|.|+ ..|.+++++ .|.. +.+.+||
T Consensus       269 de~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~-L~leGNP  308 (565)
T KOG0472|consen  269 DEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKF-LALEGNP  308 (565)
T ss_pred             hHHHHhhhhhhhcccCCccc-cCCcccccc-eeee-hhhcCCc
Confidence            77788888888888888887 567777777 5533 3444443

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.24  E-value=1.3e-10  Score=98.66  Aligned_cols=131  Identities=19%  Similarity=0.319  Sum_probs=101.6

Q ss_pred             eeeecCCeeEEEEEeCCCcEEEEEEcccch------h-HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          212 CIGTGGYGSVYKAQLPNGKVFALKKLHTSE------E-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       212 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      .+++|+-+.+|.+.+.+ ..+++|.-....      + .-....-.+|+.++.++.--+|.-.+-+..+.+...|+|||.
T Consensus         3 ~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            47899999999998744 446666432211      1 112234578999999998777776677777777788999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      +|..|.+.+...          ...++..+-.-+.-||   ..||+|+||.++||.++.+. +.++|||++..
T Consensus        82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA----------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc----------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999998888764          1346677788888999   88999999999999999875 89999999964

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.24  E-value=6.5e-11  Score=108.56  Aligned_cols=143  Identities=22%  Similarity=0.283  Sum_probs=109.6

Q ss_pred             ceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhccc--ccccccceeecCC---eEEEEEEecC
Q 011005          211 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR--NIVKLYGYCLHKK---CMFLIYEYME  285 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~---~~~lV~e~~~  285 (496)
                      +.|+.|..+.||++...+|+.+++|.............+.+|+++++.+.+.  .+.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            5689999999999988777899999986643222235678999999999753  4566777766542   5689999999


Q ss_pred             CCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 011005          286 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC----------------------------------------  325 (496)
Q Consensus       286 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~----------------------------------------  325 (496)
                      |.++.+.+..    ..++......++.+++++|..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9888765532    14566777778888888888888521                                        


Q ss_pred             -------------CCCeEEeCCCCCceEecC--CCCeEEcccccccc
Q 011005          326 -------------SPSIIHRDISSNNILLNS--KLEAFVADFGTARL  357 (496)
Q Consensus       326 -------------~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~~~~  357 (496)
                                   ...++|+|+.|.||+++.  ++.+.++||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         256799999999999998  56688999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.22  E-value=3.5e-10  Score=95.42  Aligned_cols=144  Identities=18%  Similarity=0.230  Sum_probs=106.8

Q ss_pred             CcceeeecCCeeEEEEEeCCCcEEEEEEcccch------h-HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          209 IRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE------E-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       209 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ....+.+|+-+.|+++.+ .|+.++||.-....      + .-..++..+|++.+.++.--+|.-..-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            567799999999999998 56777777543321      1 112345678999999998667666666676666678999


Q ss_pred             EecCC-CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCC---eEEcccccccc
Q 011005          282 EYMER-GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE---AFVADFGTARL  357 (496)
Q Consensus       282 e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~~  357 (496)
                      ||++| .++.+++........ .......++.+|-+.+.-||   ..+++||||..+||++..++.   +.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 467777765443322 22233678899999999999   889999999999999976653   57999999854

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.20  E-value=4.7e-12  Score=131.60  Aligned_cols=249  Identities=21%  Similarity=0.275  Sum_probs=167.7

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      ..+.+.+.+-+..|.++.++.+.-. .|...++|.......  ....+....+-.+.-...+|-++...-.+.-....++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            3456777778888999999887432 333334443332211  0011222223333333345656655544444556789


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      |++|..++++...++...   ..+.+........+..++++||   ...+.|+|++|.|.+...+++.+++|||......
T Consensus       882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccc
Confidence            999999999999988765   3444555667778899999999   6668999999999999999999999998433211


Q ss_pred             CC---------------------C----------CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCC
Q 011005          360 AD---------------------S----------SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPR  408 (496)
Q Consensus       360 ~~---------------------~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~  408 (496)
                      --                     .          .......+|+.|.+||...+......+|.|+.|++++|.++|..||
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence            00                     0          0012245899999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHH
Q 011005          409 DILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQ  466 (496)
Q Consensus       409 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  466 (496)
                      ..       ..+......+....++.+..  .........+++.+.+..+|.+|..+.
T Consensus      1036 na-------~tpq~~f~ni~~~~~~~p~g--~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NA-------ETPQQIFENILNRDIPWPEG--PEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CC-------cchhhhhhccccCCCCCCCC--ccccChhhhhhhhhhhccCchhccCcc
Confidence            73       33333334444444433322  222233466788889999999999876

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.16  E-value=2.1e-09  Score=101.83  Aligned_cols=258  Identities=16%  Similarity=0.188  Sum_probs=164.0

Q ss_pred             CCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccce------e-ecCCeEEE
Q 011005          208 DIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGY------C-LHKKCMFL  279 (496)
Q Consensus       208 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~------~-~~~~~~~l  279 (496)
                      .....||+|+.+.+|-.-  .-...+.|+++.......    ...+..|... .||-+-.=+.+      . ..+....+
T Consensus        14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~----aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQ----AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             CCCccccCCccceeeecc--hhhchhheeecCCCchHH----HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            346679999999999752  122336677766432211    1123334333 35543321111      1 11223667


Q ss_pred             EEEecCCCCh-hhhh---hCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccc
Q 011005          280 IYEYMERGSL-FCNL---HNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  355 (496)
Q Consensus       280 V~e~~~~g~L-~~~l---~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  355 (496)
                      .|..+.|.-- .++.   .+..+....+|.-.+..++.++.+.+.||   ..|.+-||++++|+|+++++.|.|.|=..-
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccce
Confidence            7887766422 1111   22334456889999999999999999999   789999999999999999999999874432


Q ss_pred             ccccCCCCCccccccccccccccccc-----cCCcCcccchhhHHHHHHHHHhC-CCCCccccccCCCCCCcc-hh----
Q 011005          356 RLLHADSSNRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMG-KHPRDILSSLSSSSDPKI-ML----  424 (496)
Q Consensus       356 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g-~~p~~~~~~~~~~~~~~~-~~----  424 (496)
                      ... ..+......+|.+.|.+||...     +..-+...|-|.+|+++++++.| ++||...........+.+ .+    
T Consensus       165 qi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~  243 (637)
T COG4248         165 QIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR  243 (637)
T ss_pred             eec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence            221 2222344467899999999754     44556789999999999999886 999976554333222222 11    


Q ss_pred             ----HhhhcCCCCCCCChhHHHHHHHHHHHHHhcccC--CCCCCCCHHHHHHHHHHh
Q 011005          425 ----IDVLDQRLPPPVDRKVIRDILLISTVSFACLQS--NPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       425 ----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--dP~~Rps~~evl~~~~~~  475 (496)
                          .+.-....+.+.+-........+..++.+|+..  .|.-|||++.++.-+-..
T Consensus       244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence                111123344444444555556677788888865  467899999987765443

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.15  E-value=3.5e-12  Score=125.23  Aligned_cols=112  Identities=29%  Similarity=0.459  Sum_probs=72.9

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccC-CCCC
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQ-GSIP   80 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~-~~~~   80 (496)
                      |++..+|+.+.++++|+.|+||+|+|+ .+.-..+...+|++|+||.|+++ .+|+.++.|++|+.|++.+|+++ .-+|
T Consensus       232 N~Lp~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiP  309 (1255)
T KOG0444|consen  232 NNLPIVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIP  309 (1255)
T ss_pred             cCCCcchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCc
Confidence            667777777777777777777777776 44445556666666666777666 56677777777777766666663 1356


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      ++++.|.+|+.+..++|.+. ..|..++.+..|+.|
T Consensus       310 SGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL  344 (1255)
T KOG0444|consen  310 SGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKL  344 (1255)
T ss_pred             cchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHh
Confidence            66666666666666666665 556666665555443

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.11  E-value=1.6e-11  Score=114.73  Aligned_cols=120  Identities=29%  Similarity=0.451  Sum_probs=105.7

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |+++-+|-.++.+++|..|+|++|-+. .+|..++.+..|+.||+|.|++. .+|..+-.+..|+++-.++|++....|.
T Consensus       422 n~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~  499 (565)
T KOG0472|consen  422 NKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPS  499 (565)
T ss_pred             CccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChH
Confidence            566777779999999999999999998 88999999999999999999999 8999888888899999999999966667


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCccccccccCCCCCC
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGL  125 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~  125 (496)
                      .+.+|.+|..|||.+|.|. .+|..++++++|.++ .+++||.-
T Consensus       500 ~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hL-eL~gNpfr  541 (565)
T KOG0472|consen  500 GLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHL-ELDGNPFR  541 (565)
T ss_pred             HhhhhhhcceeccCCCchh-hCChhhccccceeEE-EecCCccC
Confidence            7999999999999999999 778899999999775 45666544

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.11  E-value=6.7e-12  Score=122.40  Aligned_cols=120  Identities=26%  Similarity=0.281  Sum_probs=75.0

Q ss_pred             CCccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            1 MYKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         1 ~n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      +|++..+.+ .+.+|+.|+.|+||+|.|..+-++...-.++|++|+|++|+|+..-+.+|..|..|++|+|++|.++..-
T Consensus       278 ~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~  357 (873)
T KOG4194|consen  278 TNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLA  357 (873)
T ss_pred             cchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHH
Confidence            355666655 5666666666666666666666666666666666666666666544556666666677777777666333


Q ss_pred             CccccCcccccccccccccCCCCCC---CCCCCCCccccccccC
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVP---FSNNDLSSMHTVVSLS  120 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~---~~~~~l~~l~~~~~~~  120 (496)
                      -..|..|++|+.|||++|.|+..+-   ..|++|++|+.|....
T Consensus       358 e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~g  401 (873)
T KOG4194|consen  358 EGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTG  401 (873)
T ss_pred             hhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecC
Confidence            4456666777777777777665443   3355666665554433

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.10  E-value=6.5e-11  Score=102.12  Aligned_cols=114  Identities=33%  Similarity=0.428  Sum_probs=36.0

Q ss_pred             cccCChhccCCCCCCEEeccCCccCCCCCccCC-CCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCcc
Q 011005            4 IGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALG-SLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGE   82 (496)
Q Consensus         4 ~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~-~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~   82 (496)
                      |..+| .+.+..+++.|+|++|.|+. +. .++ .+.+|+.|+|++|+|+. + +.+..++.|++|++++|+|+ .+.+.
T Consensus         9 i~~~~-~~~n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~-l-~~l~~L~~L~~L~L~~N~I~-~i~~~   82 (175)
T PF14580_consen    9 IEQIA-QYNNPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITK-L-EGLPGLPRLKTLDLSNNRIS-SISEG   82 (175)
T ss_dssp             ------------------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS----S-CHH
T ss_pred             ccccc-cccccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCcc-c-cCccChhhhhhcccCCCCCC-ccccc
Confidence            33443 34455678999999999984 43 455 57889999999999984 4 46888899999999999998 45444


Q ss_pred             c-cCcccccccccccccCCCCCC-CCCCCCCccccccccCCCCC
Q 011005           83 I-TKLSRLDYLNLSSNKLSGPVP-FSNNDLSSMHTVVSLSPNNG  124 (496)
Q Consensus        83 ~-~~l~~L~~l~l~~n~l~~~~~-~~~~~l~~l~~~~~~~~n~~  124 (496)
                      + ..+++|+.|++++|+|..... ..+..+++|.. +++.+||.
T Consensus        83 l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~-L~L~~NPv  125 (175)
T PF14580_consen   83 LDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRV-LSLEGNPV  125 (175)
T ss_dssp             HHHH-TT--EEE-TTS---SCCCCGGGGG-TT--E-EE-TT-GG
T ss_pred             hHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcce-eeccCCcc
Confidence            4 468899999999999975433 23445556643 45556654

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.09  E-value=6.8e-12  Score=116.94  Aligned_cols=126  Identities=25%  Similarity=0.335  Sum_probs=101.4

Q ss_pred             CCccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccC-CcCCCCCchhhcCCcccCeecccccccCCC
Q 011005            1 MYKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSS-NKLSGKIPPEIASMKYLTQLDLSNNNIQGS   78 (496)
Q Consensus         1 ~n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~-n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~   78 (496)
                      .|+|+.||+ .|+.+++|+.||||+|+|+.+-|++|..+++|..|-+.+ |+|+....+.|.+|..|+.|.+.-|++.-.
T Consensus        76 qN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Ci  155 (498)
T KOG4237|consen   76 QNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCI  155 (498)
T ss_pred             cCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcch
Confidence            488888888 788888899999999998888888888888887776555 888855556788888888888888888867


Q ss_pred             CCccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCCCCCC
Q 011005           79 IPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCG  127 (496)
Q Consensus        79 ~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~  127 (496)
                      ....|..|++|..|.+..|.+......+|..+..++++.. ..|+..|.
T Consensus       156 r~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhl-A~np~icd  203 (498)
T KOG4237|consen  156 RQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHL-AQNPFICD  203 (498)
T ss_pred             hHHHHHHhhhcchhcccchhhhhhccccccchhccchHhh-hcCccccc
Confidence            7778888888989999999888666668888888877653 45666665

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.07  E-value=2.2e-09  Score=94.29  Aligned_cols=127  Identities=24%  Similarity=0.361  Sum_probs=83.0

Q ss_pred             eEEEEEeCCCcEEEEEEcccch-------------------------hHHHHHHHHHHHHHHHhhccc--ccccccceee
Q 011005          220 SVYKAQLPNGKVFALKKLHTSE-------------------------ELAFIKSFKNEAQVLSQVLHR--NIVKLYGYCL  272 (496)
Q Consensus       220 ~Vy~~~~~~~~~vavK~~~~~~-------------------------~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~  272 (496)
                      .||.|..++|..+|+|..+...                         .........+|++.|.++...  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899999999999999886421                         011223467899999999755  455665442 


Q ss_pred             cCCeEEEEEEecC--CCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEEeCCCCCceEecCCCCeEE
Q 011005          273 HKKCMFLIYEYME--RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY-LHHDCSPSIIHRDISSNNILLNSKLEAFV  349 (496)
Q Consensus       273 ~~~~~~lV~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~-lh~~~~~~i~H~dlkp~Nil~~~~~~~kl  349 (496)
                       +  .++||||++  |..+..+....     ++......++.+++..+.. +|   ..|++|||+++.||+++++ .+.+
T Consensus        80 -~--~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 -R--NVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             -T--TEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE
T ss_pred             -C--CEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEE
Confidence             2  369999998  54454333321     1123345577788885555 57   7899999999999999988 8999


Q ss_pred             cccccccccc
Q 011005          350 ADFGTARLLH  359 (496)
Q Consensus       350 ~Dfg~~~~~~  359 (496)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.07  E-value=5.6e-11  Score=84.37  Aligned_cols=61  Identities=41%  Similarity=0.581  Sum_probs=41.2

Q ss_pred             CCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeeccccccc
Q 011005           15 KNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNI   75 (496)
Q Consensus        15 ~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l   75 (496)
                      ++|+.|+|++|+|+...++.|..+++|++|+|++|+|+...|..|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4567777777777755556667777777777777777655555667777777777777654

...

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.06  E-value=1.7e-11  Score=120.51  Aligned_cols=113  Identities=29%  Similarity=0.465  Sum_probs=102.3

Q ss_pred             cccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccc
Q 011005            4 IGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEI   83 (496)
Q Consensus         4 ~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~   83 (496)
                      +..+|.++..|.+|..+|||.|++. .+|+.+-++++|+.|+||+|+|+ .+.-......+|++|+||.|+++ .+|..+
T Consensus       211 l~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~av  287 (1255)
T KOG0444|consen  211 LDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAV  287 (1255)
T ss_pred             hhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHH
Confidence            3458999999999999999999998 89999999999999999999999 77778888899999999999999 899999


Q ss_pred             cCcccccccccccccCC-CCCCCCCCCCCcccccccc
Q 011005           84 TKLSRLDYLNLSSNKLS-GPVPFSNNDLSSMHTVVSL  119 (496)
Q Consensus        84 ~~l~~L~~l~l~~n~l~-~~~~~~~~~l~~l~~~~~~  119 (496)
                      +.|+.|+.|.+.+|+++ .-+|..++.|..|..+...
T Consensus       288 cKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aa  324 (1255)
T KOG0444|consen  288 CKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAA  324 (1255)
T ss_pred             hhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhh
Confidence            99999999999999997 3478899999999655443

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.06  E-value=3.9e-11  Score=117.19  Aligned_cols=115  Identities=23%  Similarity=0.241  Sum_probs=72.2

Q ss_pred             CccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            2 YKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         2 n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      |+|+.+|. .|.+|++|+.|+|..|+|.-.---.|.+|++|+.|.|..|+|+..-...|..|.++++|+|+.|+++..-.
T Consensus       207 NrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~  286 (873)
T KOG4194|consen  207 NRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNE  286 (873)
T ss_pred             CcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhc
Confidence            56666666 55556666666666666653323445666666666666666664444556666677777777777765455


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      +++.+|..|+.|+|+.|.|....++++...++|+.|
T Consensus       287 g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~L  322 (873)
T KOG4194|consen  287 GWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKEL  322 (873)
T ss_pred             ccccccchhhhhccchhhhheeecchhhhcccceeE
Confidence            566667777777777777766666666666666544

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.04  E-value=5e-09  Score=97.65  Aligned_cols=140  Identities=19%  Similarity=0.155  Sum_probs=100.4

Q ss_pred             eeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHH----------HHHHHHHHHHhhccccc--ccccceeec-----CC
Q 011005          213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIK----------SFKNEAQVLSQVLHRNI--VKLYGYCLH-----KK  275 (496)
Q Consensus       213 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~----------~~~~e~~~l~~l~h~ni--v~~~~~~~~-----~~  275 (496)
                      +-......|.+..+ +|+.|.||......-....+          .+.+|...+.++...+|  +.++++...     ..
T Consensus        30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~  108 (268)
T PRK15123         30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR  108 (268)
T ss_pred             EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence            44444455777776 67889999775433111112          37799999999964444  455556543     23


Q ss_pred             eEEEEEEecCCC-ChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC-------CCCe
Q 011005          276 CMFLIYEYMERG-SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-------KLEA  347 (496)
Q Consensus       276 ~~~lV~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~-------~~~~  347 (496)
                      .-++|+|++++. +|.+++..... ...+...+..++.+++..+.-||   ..||+|+|++++|||++.       +..+
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~  184 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKL  184 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceE
Confidence            468999999886 78888753211 23456677789999999999999   889999999999999975       4678


Q ss_pred             EEcccccccc
Q 011005          348 FVADFGTARL  357 (496)
Q Consensus       348 kl~Dfg~~~~  357 (496)
                      .++||+.+..
T Consensus       185 ~LIDl~r~~~  194 (268)
T PRK15123        185 SVIDLHRAQI  194 (268)
T ss_pred             EEEECCcccc
Confidence            9999998853

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.03  E-value=2.6e-09  Score=96.19  Aligned_cols=137  Identities=22%  Similarity=0.251  Sum_probs=99.2

Q ss_pred             CCCcceeeecCCeeEEEEEeCCCcEEEEEEcccch----------h-----------HHHHHHHHHHHHHHHhhccc--c
Q 011005          207 FDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE----------E-----------LAFIKSFKNEAQVLSQVLHR--N  263 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------~-----------~~~~~~~~~e~~~l~~l~h~--n  263 (496)
                      ..+...||-|--+.||.|..++|.++|||.=+...          +           ........+|.++|.++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            34567899999999999999999999999543211          0           11223467899999999644  6


Q ss_pred             cccccceeecCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC
Q 011005          264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS  343 (496)
Q Consensus       264 iv~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~  343 (496)
                      +.+.+++    +...+|||+.+|-.|...-.        +....-.++..|+.-+.-+-   ..|++|+|+++-||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEec
Confidence            7776664    35679999999866653321        12333345555555555555   468999999999999999


Q ss_pred             CCCeEEccccccccc
Q 011005          344 KLEAFVADFGTARLL  358 (496)
Q Consensus       344 ~~~~kl~Dfg~~~~~  358 (496)
                      +|.+.++||-.+...
T Consensus       238 dg~~~vIDwPQ~v~~  252 (304)
T COG0478         238 DGDIVVIDWPQAVPI  252 (304)
T ss_pred             CCCEEEEeCcccccC
Confidence            999999999877654

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.02  E-value=1.2e-10  Score=100.58  Aligned_cols=98  Identities=31%  Similarity=0.444  Sum_probs=44.9

Q ss_pred             CCccccCChhcc-CCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhh-cCCcccCeecccccccCCC
Q 011005            1 MYKIGIIPPEIG-NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSNNNIQGS   78 (496)
Q Consensus         1 ~n~~~~lp~~~~-~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~-~~l~~L~~l~l~~N~l~~~   78 (496)
                      +|+|..+. .++ .|.+|+.|+|++|+|+. ++ .+..+++|+.|+|++|+|+ .+++.+ ..+++|+.|+|++|+|...
T Consensus        28 ~n~I~~Ie-~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l  103 (175)
T PF14580_consen   28 GNQISTIE-NLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDL  103 (175)
T ss_dssp             ---------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SC
T ss_pred             cccccccc-chhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCCh
Confidence            47777774 566 58999999999999995 43 5889999999999999999 565555 4699999999999999742


Q ss_pred             C-CccccCcccccccccccccCCCC
Q 011005           79 I-PGEITKLSRLDYLNLSSNKLSGP  102 (496)
Q Consensus        79 ~-~~~~~~l~~L~~l~l~~n~l~~~  102 (496)
                      - -..++.+++|+.|++.+|+++..
T Consensus       104 ~~l~~L~~l~~L~~L~L~~NPv~~~  128 (175)
T PF14580_consen  104 NELEPLSSLPKLRVLSLEGNPVCEK  128 (175)
T ss_dssp             CCCGGGGG-TT--EEE-TT-GGGGS
T ss_pred             HHhHHHHcCCCcceeeccCCcccch
Confidence            2 24678899999999999999844

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.00  E-value=1.2e-10  Score=82.68  Aligned_cols=61  Identities=44%  Similarity=0.660  Sum_probs=55.7

Q ss_pred             CCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCcccccccccccccC
Q 011005           39 TNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKL   99 (496)
Q Consensus        39 ~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l   99 (496)
                      |+|++|+|++|+|+...+..|..+++|++|+|++|+++...|..|.++++|+.|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            5799999999999966557899999999999999999977778999999999999999986

...

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.93  E-value=3.3e-08  Score=96.20  Aligned_cols=170  Identities=19%  Similarity=0.316  Sum_probs=127.0

Q ss_pred             CCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeec----CCeEEEEEEecCC-CChh
Q 011005          217 GYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH----KKCMFLIYEYMER-GSLF  290 (496)
Q Consensus       217 ~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lV~e~~~~-g~L~  290 (496)
                      ...+.||+.. -+|..|++|+++...... ...-..-+++.+++.|.|+|++.+++..    ...+++|++|.++ ++|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~-~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQS-TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccC-cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            3468899954 489999999995433211 1122345788999999999999998873    3468999999876 5776


Q ss_pred             hhhhCCC------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccc
Q 011005          291 CNLHNNE------------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL  358 (496)
Q Consensus       291 ~~l~~~~------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  358 (496)
                      ++-....            .+...++...|.++.|++.||.++|   +.|+.-+-|.|.+|+++.+.+++|...|.....
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeee
Confidence            6543221            2234678899999999999999999   789999999999999999999999888877665


Q ss_pred             cCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCC
Q 011005          359 HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP  407 (496)
Q Consensus       359 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p  407 (496)
                      ..+..              |-+.+   -.+-|.=.||.++..|.||..-
T Consensus       444 ~~d~~--------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  444 QEDPT--------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             cCCCC--------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            44431              00111   2367888999999999999543

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.92  E-value=1.8e-10  Score=112.42  Aligned_cols=116  Identities=37%  Similarity=0.525  Sum_probs=88.0

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |.+..+|+.+.+|..|++|||+.|+++ .+|..++.|+ |+.|-+++|+++ .+|+.++.++.|.+||.++|.+. .+|.
T Consensus       108 n~~r~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slps  183 (722)
T KOG0532|consen  108 NCIRTIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPS  183 (722)
T ss_pred             ccceecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchH
Confidence            778888888889999999999999887 7788888887 888888888888 67777777777777777777776 5555


Q ss_pred             cccCccc----------------------ccccccccccCCCCCCCCCCCCCccccccccCCCC
Q 011005           82 EITKLSR----------------------LDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN  123 (496)
Q Consensus        82 ~~~~l~~----------------------L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~  123 (496)
                      .++++.+                      |..||++.|+++ .+|..|..|+.|+.+ .+++||
T Consensus       184 ql~~l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l-~LenNP  245 (722)
T KOG0532|consen  184 QLGYLTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNKIS-YLPVDFRKMRHLQVL-QLENNP  245 (722)
T ss_pred             HhhhHHHHHHHHHhhhhhhhCCHHHhCCceeeeecccCcee-ecchhhhhhhhheee-eeccCC
Confidence            5555544                      455666777777 678888888888654 456665

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.87  E-value=7e-10  Score=111.45  Aligned_cols=155  Identities=20%  Similarity=0.205  Sum_probs=104.5

Q ss_pred             HHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC----Cccc-----ccccccccccccccc
Q 011005          312 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS----NRTL-----LAGTYGYIAPELAYT  382 (496)
Q Consensus       312 ~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~~-----~~gt~~y~aPE~~~~  382 (496)
                      .+++.|+.|+|.  ..++||++|.|++|.++..+..||+.|+.+........    .++.     ......|.|||++.+
T Consensus       106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            455699999997  78999999999999999999999999999876544211    1111     123457999999999


Q ss_pred             CCcCcccchhhHHHHHHHHHhC-CCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCC
Q 011005          383 MVMTEKCDVYSFGVVTLEVLMG-KHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKS  461 (496)
Q Consensus       383 ~~~~~~~DvwslG~il~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~  461 (496)
                      ...+.++|+||+|+++|.+..| +.-+........     .......+..-....   ....+.++.+=+.+++..++..
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-----~~~~~~~~~~~~~~~---s~~~p~el~~~l~k~l~~~~~~  255 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-----YSFSRNLLNAGAFGY---SNNLPSELRESLKKLLNGDSAV  255 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcch-----hhhhhcccccccccc---cccCcHHHHHHHHHHhcCCccc
Confidence            8889999999999999999954 444432211100     000000000000000   0112234556666899999999


Q ss_pred             CCCHHHHHHHHHHhc
Q 011005          462 RPTMQSVSQEFLITR  476 (496)
Q Consensus       462 Rps~~evl~~~~~~~  476 (496)
                      ||++.++...+++..
T Consensus       256 rp~~~~l~~~~ff~D  270 (700)
T KOG2137|consen  256 RPTLDLLLSIPFFSD  270 (700)
T ss_pred             CcchhhhhcccccCC
Confidence            999998888776643

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.85  E-value=4e-10  Score=105.33  Aligned_cols=122  Identities=24%  Similarity=0.316  Sum_probs=102.5

Q ss_pred             cccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccc-cccCCCCCcc
Q 011005            4 IGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSN-NNIQGSIPGE   82 (496)
Q Consensus         4 ~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~-N~l~~~~~~~   82 (496)
                      ++.+|.++.  +....|+|..|+|+.+.|.+|..+++|+.||||+|+|+-+-|++|..+.+|.+|-+.+ |+|+....+.
T Consensus        58 L~eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~  135 (498)
T KOG4237|consen   58 LTEVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGA  135 (498)
T ss_pred             cccCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhH
Confidence            456675543  2578899999999988889999999999999999999988999999999998876555 9999655568


Q ss_pred             ccCcccccccccccccCCCCCCCCCCCCCccccccccCCCC-CCCC
Q 011005           83 ITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN-GLCG  127 (496)
Q Consensus        83 ~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~-~~c~  127 (496)
                      |.+|..|+-|.+.-|++.-.....|..++++..|..+++.. ..|.
T Consensus       136 F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~  181 (498)
T KOG4237|consen  136 FGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICK  181 (498)
T ss_pred             hhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhcc
Confidence            99999999999999999988889999999997666555543 5555

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.85  E-value=2.6e-10  Score=111.23  Aligned_cols=110  Identities=35%  Similarity=0.567  Sum_probs=95.6

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |+++.+|++++.++.|..||.+.|+|. .+|..++++.+|+.|.+..|++. .+|+.+..| .|..||+|+|+++ .+|-
T Consensus       153 Nkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv  228 (722)
T KOG0532|consen  153 NKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPV  228 (722)
T ss_pred             CccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecch
Confidence            788999999999999999999999998 77888999999999999999998 688888854 5999999999999 8999


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      .|.+|+.|++|-|.+|+|+ .+|..++.....|-+
T Consensus       229 ~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIF  262 (722)
T KOG0532|consen  229 DFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIF  262 (722)
T ss_pred             hhhhhhhheeeeeccCCCC-CChHHHHhccceeee
Confidence            9999999999999999999 666666655555433

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.78  E-value=4.7e-10  Score=115.37  Aligned_cols=87  Identities=37%  Similarity=0.515  Sum_probs=49.5

Q ss_pred             ccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCccccc
Q 011005           11 IGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLD   90 (496)
Q Consensus        11 ~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~   90 (496)
                      +.++++|+.|+|++|+|.......+.++..|+.|+||+|+|+ .+|+.+.++..|++|...+|++. .+| .+..++.|+
T Consensus       379 l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~  455 (1081)
T KOG0618|consen  379 LVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLK  455 (1081)
T ss_pred             hccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcce
Confidence            445566666666666665222234556666666666666666 55555555555555555555555 455 455555555


Q ss_pred             ccccccccCC
Q 011005           91 YLNLSSNKLS  100 (496)
Q Consensus        91 ~l~l~~n~l~  100 (496)
                      .+|++.|+|+
T Consensus       456 ~lDlS~N~L~  465 (1081)
T KOG0618|consen  456 VLDLSCNNLS  465 (1081)
T ss_pred             EEecccchhh
Confidence            5555555554

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.75  E-value=7.4e-10  Score=88.50  Aligned_cols=113  Identities=23%  Similarity=0.331  Sum_probs=90.8

Q ss_pred             hccCCCCCCEEeccCCccCCCCCccCC-CCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCccc
Q 011005           10 EIGNLKNLIKLDVGSNSLIGPIPSALG-SLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSR   88 (496)
Q Consensus        10 ~~~~l~~L~~L~l~~n~i~~~~p~~~~-~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~   88 (496)
                      .+.....|+.++|++|.+. .+|..|. .++.++.|+|++|+|+ .+|..+..|+.|+.|+++.|.+. ..|.-+..|.+
T Consensus        48 ~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~  124 (177)
T KOG4579|consen   48 MLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIK  124 (177)
T ss_pred             HHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHh
Confidence            3445566888899999998 5666555 5568999999999999 78999999999999999999999 78888888999


Q ss_pred             ccccccccccCCCCCCCCCCCCCccccccccCCCCCCCC
Q 011005           89 LDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCG  127 (496)
Q Consensus        89 L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~  127 (496)
                      |..|+..+|.+. .+|.. .-.+++..++.+.++++--+
T Consensus       125 l~~Lds~~na~~-eid~d-l~~s~~~al~~lgnepl~~~  161 (177)
T KOG4579|consen  125 LDMLDSPENARA-EIDVD-LFYSSLPALIKLGNEPLGDE  161 (177)
T ss_pred             HHHhcCCCCccc-cCcHH-HhccccHHHHHhcCCccccc
Confidence            999999999998 55654 44556666777766665433

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.74  E-value=1.5e-09  Score=111.69  Aligned_cols=111  Identities=29%  Similarity=0.438  Sum_probs=93.0

Q ss_pred             CCccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCC-
Q 011005            1 MYKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGS-   78 (496)
Q Consensus         1 ~n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~-   78 (496)
                      +|++..+|. .+.+|+.|+.|+||+|.++ .+|+.+..++.|++|...+|+|. .+| .+..+++|+.+|+|.|+++.. 
T Consensus       392 yNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~  468 (1081)
T KOG0618|consen  392 YNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVT  468 (1081)
T ss_pred             ccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhh
Confidence            589999999 7889999999999999998 88999999999999999999999 788 899999999999999999743 


Q ss_pred             CCccccCcccccccccccccCCCCCCCCCCCCCcccc
Q 011005           79 IPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHT  115 (496)
Q Consensus        79 ~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~  115 (496)
                      +|..... ++|++||++||.-.......|..+.+++.
T Consensus       469 l~~~~p~-p~LkyLdlSGN~~l~~d~~~l~~l~~l~~  504 (1081)
T KOG0618|consen  469 LPEALPS-PNLKYLDLSGNTRLVFDHKTLKVLKSLSQ  504 (1081)
T ss_pred             hhhhCCC-cccceeeccCCcccccchhhhHHhhhhhh
Confidence            3444333 89999999999976555666666666643

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.69  E-value=1.2e-07  Score=85.60  Aligned_cols=106  Identities=25%  Similarity=0.336  Sum_probs=84.0

Q ss_pred             HHHHHHHHHHHhhccc--ccccccceeecCC----eEEEEEEecCCC-ChhhhhhCCCCCccCCHHHHHHHHHHHHHHHH
Q 011005          247 KSFKNEAQVLSQVLHR--NIVKLYGYCLHKK----CMFLIYEYMERG-SLFCNLHNNEDAVELDWAKRVNIVKAMAHALA  319 (496)
Q Consensus       247 ~~~~~e~~~l~~l~h~--niv~~~~~~~~~~----~~~lV~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~  319 (496)
                      ....+|...+.++...  .+++.+++.....    ..++|+|++++. +|.+++.....   .+......++.+++..+.
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence            3567888888888643  3456667666532    458999999884 78888876332   455667789999999999


Q ss_pred             HHHhCCCCCeEEeCCCCCceEecCCC---CeEEccccccccc
Q 011005          320 YLHHDCSPSIIHRDISSNNILLNSKL---EAFVADFGTARLL  358 (496)
Q Consensus       320 ~lh~~~~~~i~H~dlkp~Nil~~~~~---~~kl~Dfg~~~~~  358 (496)
                      -||   ..||+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       133 ~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999   88999999999999999887   7999999988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.64  E-value=1.6e-07  Score=94.97  Aligned_cols=143  Identities=17%  Similarity=0.145  Sum_probs=91.0

Q ss_pred             ceeeecCCeeEEEEEeCCCcEEEEEEcccchhHH---------------------------------HH------HHHHH
Q 011005          211 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELA---------------------------------FI------KSFKN  251 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------------------------------~~------~~~~~  251 (496)
                      ..|+.++-|.||+|.+++|+.||||+.+..-...                                 ..      -.+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            5688999999999999999999999987542111                                 00      11234


Q ss_pred             HHHHHHhhc-----ccccccccceeecCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCC
Q 011005          252 EAQVLSQVL-----HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS  326 (496)
Q Consensus       252 e~~~l~~l~-----h~niv~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~  326 (496)
                      |..-+.+++     .+++.-..-|.+......|+|||++|-.+.+...-...  ..+.........++.----+     .
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~ia~~~~~~f~~q~~-----~  283 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRKELAELLVRAFLRQLL-----R  283 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHHHHHHHHHHHHHHHHH-----h
Confidence            444444442     22222111222223456799999999888877432221  34433333222222222222     3


Q ss_pred             CCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       327 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      .|+.|.|..|.||+++.++.+.+.|||+...+..
T Consensus       284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            3899999999999999999999999999977643

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.63  E-value=5e-08  Score=102.95  Aligned_cols=35  Identities=37%  Similarity=0.267  Sum_probs=18.7

Q ss_pred             cccccccccccCCCCCCCCCCCCCccccccccCCCCC
Q 011005           88 RLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNG  124 (496)
Q Consensus        88 ~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~  124 (496)
                      +|+.|++++|+|+ .+|.++.++++|.. +.+++|+.
T Consensus       423 ~L~~L~Ls~NqLt-~LP~sl~~L~~L~~-LdLs~N~L  457 (788)
T PRK15387        423 GLLSLSVYRNQLT-RLPESLIHLSSETT-VNLEGNPL  457 (788)
T ss_pred             hhhhhhhccCccc-ccChHHhhccCCCe-EECCCCCC
Confidence            4455555555555 45555666666643 34555543

>PRK09902 hypothetical protein; Provisional

Probab=98.63  E-value=6.5e-07  Score=79.11  Aligned_cols=139  Identities=17%  Similarity=0.109  Sum_probs=101.2

Q ss_pred             eeecCCeeEEEEEeCCCcEEEEEEcccch--h---HHHHHHHHHHHHHHHhhcccc--cccccceeec-----CCeEEEE
Q 011005          213 IGTGGYGSVYKAQLPNGKVFALKKLHTSE--E---LAFIKSFKNEAQVLSQVLHRN--IVKLYGYCLH-----KKCMFLI  280 (496)
Q Consensus       213 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~---~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~-----~~~~~lV  280 (496)
                      -|+||-+.|++-.+. |+.+-+|.-...-  +   +-....|.+|...++++...+  +.++. ++..     ...-+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            467899999998874 4468888764211  0   113367899999999996433  44444 3321     1246799


Q ss_pred             EEecCC-CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCC--eEEcccccccc
Q 011005          281 YEYMER-GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE--AFVADFGTARL  357 (496)
Q Consensus       281 ~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~  357 (496)
                      +|-+.| -+|.+++..... ...+...+..+..+++.++.-||   ..|+.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            998765 577777755322 24577777899999999999999   889999999999999986666  99999987754

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.63  E-value=1.5e-06  Score=77.97  Aligned_cols=155  Identities=21%  Similarity=0.259  Sum_probs=104.7

Q ss_pred             cccHHHHHHHHhCCCCcce---eeecCCeeEEEEEeCCCcEEEEEEcccchhHH-----------------------HHH
Q 011005          194 RIVYEDLIEATEDFDIRYC---IGTGGYGSVYKAQLPNGKVFALKKLHTSEELA-----------------------FIK  247 (496)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~---lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------------~~~  247 (496)
                      ..+.+.+....++..+...   |++|--+.||+|...++..+|||+++.....-                       ...
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            4566777777787777665   55677789999988889999999997532110                       011


Q ss_pred             HHHHHHHHHHhhc--ccccccccceeecCCeEEEEEEecCCCCh-hhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhC
Q 011005          248 SFKNEAQVLSQVL--HRNIVKLYGYCLHKKCMFLIYEYMERGSL-FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD  324 (496)
Q Consensus       248 ~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lV~e~~~~g~L-~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~  324 (496)
                      -..+|+.-|+++.  +-.+.+.+++.    ...+||||+..... .=.|..    ..+...+...+..++++.+.-|-. 
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~-  184 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYK-  184 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHH-
Confidence            1245666666664  33334444433    24699999855311 111111    122333567788888888888873 


Q ss_pred             CCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       325 ~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                       ..++||+||+.-|||+. ++.+.|+|||.|....
T Consensus       185 -~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         185 -EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             -hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence             47999999999999999 7899999999997664

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.62  E-value=1.6e-08  Score=106.59  Aligned_cols=88  Identities=27%  Similarity=0.357  Sum_probs=66.9

Q ss_pred             CCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCcccccccccc
Q 011005           16 NLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLS   95 (496)
Q Consensus        16 ~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~l~l~   95 (496)
                      +|+.|+|++|+|+ .+|..   .++|+.|+|++|+|+ .+|..+   .+|+.|+|++|+|+ .+|..+.++++|+.|+|+
T Consensus       383 ~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs  453 (788)
T PRK15387        383 GLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE  453 (788)
T ss_pred             ccceEEecCCccc-CCCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence            4666777777776 34432   356788888888887 466533   46888999999999 789999999999999999


Q ss_pred             cccCCCCCCCCCCCCCc
Q 011005           96 SNKLSGPVPFSNNDLSS  112 (496)
Q Consensus        96 ~n~l~~~~~~~~~~l~~  112 (496)
                      +|+|++..+..+..+.+
T Consensus       454 ~N~Ls~~~~~~L~~l~s  470 (788)
T PRK15387        454 GNPLSERTLQALREITS  470 (788)
T ss_pred             CCCCCchHHHHHHHHhc
Confidence            99999877766644443

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.61  E-value=3.9e-09  Score=95.40  Aligned_cols=84  Identities=29%  Similarity=0.402  Sum_probs=56.4

Q ss_pred             CCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCccccccc
Q 011005           13 NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYL   92 (496)
Q Consensus        13 ~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~l   92 (496)
                      ..+.|+.||||+|.|+ .+.++..-+|.++.|++|+|.|+ .+ +++..|++|+.||||+|.++ .+.++-..+.|.+.|
T Consensus       282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL  357 (490)
T KOG1259|consen  282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TV-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL  357 (490)
T ss_pred             hHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-ee-hhhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence            3445777777777776 55666666777777777777777 33 34777777777777777776 455555556666666


Q ss_pred             ccccccCC
Q 011005           93 NLSSNKLS  100 (496)
Q Consensus        93 ~l~~n~l~  100 (496)
                      .|++|.|.
T Consensus       358 ~La~N~iE  365 (490)
T KOG1259|consen  358 KLAQNKIE  365 (490)
T ss_pred             ehhhhhHh
Confidence            66666665

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.60  E-value=7e-09  Score=93.76  Aligned_cols=117  Identities=26%  Similarity=0.278  Sum_probs=88.2

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      .|.|+.+-++..-+|.++.|++|+|+|. .+. .+..|++|+.||||+|.++ .+...=..|-++++|.|+.|.|. .+ 
T Consensus       293 ~N~I~~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE-~L-  367 (490)
T KOG1259|consen  293 GNLITQIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE-TL-  367 (490)
T ss_pred             ccchhhhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHh-hh-
Confidence            4778888888888999999999999998 443 4899999999999999998 45454456778888888888887 33 


Q ss_pred             ccccCcccccccccccccCCCCCC-CCCCCCCccccccccCCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVP-FSNNDLSSMHTVVSLSPNN  123 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~-~~~~~l~~l~~~~~~~~n~  123 (496)
                      .++..+-+|..||+++|+|..... ..+++|+-|+.+ .+.+||
T Consensus       368 SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l-~L~~NP  410 (490)
T KOG1259|consen  368 SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETL-RLTGNP  410 (490)
T ss_pred             hhhHhhhhheeccccccchhhHHHhcccccccHHHHH-hhcCCC
Confidence            457777888888888888874322 346666666443 344444

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.59  E-value=6.1e-08  Score=102.74  Aligned_cols=88  Identities=27%  Similarity=0.540  Sum_probs=45.2

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |+|+.+|..+.  ++|+.|+|++|+++ .+|..+.  ++|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|.
T Consensus       209 N~LtsLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~  279 (754)
T PRK15370        209 NELKSLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPE  279 (754)
T ss_pred             CCCCcCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-cccc
Confidence            55555555443  35666666666655 3443332  24555555555555 4444433  35555666666655 3444


Q ss_pred             cccCcccccccccccccCC
Q 011005           82 EITKLSRLDYLNLSSNKLS  100 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~  100 (496)
                      .+.  ++|+.|++++|+|+
T Consensus       280 ~l~--~sL~~L~Ls~N~Lt  296 (754)
T PRK15370        280 NLP--EELRYLSVYDNSIR  296 (754)
T ss_pred             ccC--CCCcEEECCCCccc
Confidence            432  25555555555555

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.51  E-value=1.7e-06  Score=76.72  Aligned_cols=153  Identities=17%  Similarity=0.211  Sum_probs=99.0

Q ss_pred             eecCCccccHHHHHH--HHhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHH--HHH------HHHHHHHHHH
Q 011005          188 IWNYDGRIVYEDLIE--ATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELA--FIK------SFKNEAQVLS  257 (496)
Q Consensus       188 ~~~~~~~~~~~~~~~--~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~------~~~~e~~~l~  257 (496)
                      ++.......+.++..  ..++|...+.+.......|.+-.. +|+.+++|..+......  ...      ...+++..+.
T Consensus        12 vy~~e~~~~y~~l~~~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~   90 (229)
T PF06176_consen   12 VYYKENDEKYLELGEKILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTD   90 (229)
T ss_pred             EEEecCchHHHHHHHHHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHH
Confidence            333333333444432  457788888888888888888877 57889999887643211  111      1234455455


Q ss_pred             hhcccc---cccccceeec-----CCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 011005          258 QVLHRN---IVKLYGYCLH-----KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI  329 (496)
Q Consensus       258 ~l~h~n---iv~~~~~~~~-----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i  329 (496)
                      +++..+   ...++.+...     ....+++|||++|..|.+...       ++.    .+...+++++.-+|   ..|+
T Consensus        91 ~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH---~~G~  156 (229)
T PF06176_consen   91 KIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLH---KHGF  156 (229)
T ss_pred             HHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHH---HcCC
Confidence            554333   3333333322     234578999999987765432       222    24456788899999   7899


Q ss_pred             EEeCCCCCceEecCCCCeEEccccccc
Q 011005          330 IHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       330 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      +|+|..|.|+++++++ ++++||+..+
T Consensus       157 ~HGD~hpgNFlv~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  157 YHGDPHPGNFLVSNNG-IRIIDTQGKR  182 (229)
T ss_pred             ccCCCCcCcEEEECCc-EEEEECcccc
Confidence            9999999999999765 8999998764

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.51  E-value=2.3e-06  Score=78.24  Aligned_cols=137  Identities=19%  Similarity=0.251  Sum_probs=85.3

Q ss_pred             ceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccc--cccccceeecCCeEEEEEEecCCCC
Q 011005          211 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN--IVKLYGYCLHKKCMFLIYEYMERGS  288 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lV~e~~~~g~  288 (496)
                      ..||+|..+.||+.   .+..+++|..+.....   ....+|.++++.+..-+  +.+.+++....+...+|||+++|.+
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~~---~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFDK---ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCCCH---HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            45899999999984   2446788888764322   34688999999997544  4677888777778889999999963


Q ss_pred             -hhhh---------------------hhCCCCCccCCHHHHH-HHHH----------HHHHH-HHHH--HhCCCCCeEEe
Q 011005          289 -LFCN---------------------LHNNEDAVELDWAKRV-NIVK----------AMAHA-LAYL--HHDCSPSIIHR  332 (496)
Q Consensus       289 -L~~~---------------------l~~~~~~~~~~~~~~~-~i~~----------~i~~~-l~~l--h~~~~~~i~H~  332 (496)
                       +...                     ++..... ..+..... .+..          .+... ..+|  +.. ...++|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~-~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~-~~~~~Hg  158 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCD-TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD-TSTCLHG  158 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC-CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC-CCceEec
Confidence             2111                     1111000 11111100 0000          00011 1111  111 3467899


Q ss_pred             CCCCCceEecCCCCeEEccccccc
Q 011005          333 DISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       333 dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      |+.|.||++++++ +.++||+.+.
T Consensus       159 D~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       159 DFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCCcEEEcCCC-cEEEechhcC
Confidence            9999999999988 9999999874

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.51  E-value=1.2e-07  Score=100.48  Aligned_cols=89  Identities=27%  Similarity=0.502  Sum_probs=53.0

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      +|++..+|..+.  .+|+.|+|++|+++ .+|..+.  ++|+.|+|++|+|+ .+|+.+.  ++|+.|+|++|+|+ .+|
T Consensus       229 ~N~LtsLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP  299 (754)
T PRK15370        229 SNQLTSIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLP  299 (754)
T ss_pred             CCccccCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCc
Confidence            366677776543  35777777777776 5555443  46777777777776 4565543  46677777777666 344


Q ss_pred             ccccCcccccccccccccCC
Q 011005           81 GEITKLSRLDYLNLSSNKLS  100 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~  100 (496)
                      ..+.  ++|+.|++++|.++
T Consensus       300 ~~lp--~sL~~L~Ls~N~Lt  317 (754)
T PRK15370        300 AHLP--SGITHLNVQSNSLT  317 (754)
T ss_pred             ccch--hhHHHHHhcCCccc
Confidence            4332  24555555555555

>PLN03210 Resistant to P

Probab=98.50  E-value=2.5e-07  Score=104.58  Aligned_cols=110  Identities=27%  Similarity=0.401  Sum_probs=70.0

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |.++.+|..| .+.+|+.|+|++|++. .++..+..+++|+.|+|++|...+.+| .+..+++|+.|+|++|.....+|.
T Consensus       599 ~~l~~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~  675 (1153)
T PLN03210        599 YPLRCMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPS  675 (1153)
T ss_pred             CCCCCCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccch
Confidence            4455666655 4567777777777776 556666777777777777665333555 366677777777777654446677


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCcccc
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHT  115 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~  115 (496)
                      .+.++++|+.|++++|...+.+|..+ ++++|+.
T Consensus       676 si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~  708 (1153)
T PLN03210        676 SIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYR  708 (1153)
T ss_pred             hhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCE
Confidence            77777777777777754444555443 4555543

syringae 6; Provisional

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.47  E-value=5.6e-08  Score=97.35  Aligned_cols=94  Identities=48%  Similarity=0.682  Sum_probs=44.3

Q ss_pred             CccccCChhccCCC-CCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            2 YKIGIIPPEIGNLK-NLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         2 n~~~~lp~~~~~l~-~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      |.+..+|+....+. +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|.....++.|+.|++++|+++ .+|
T Consensus       126 n~i~~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~  202 (394)
T COG4886         126 NNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLP  202 (394)
T ss_pred             cccccCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCc
Confidence            34444444444442 5555555555554 33334445555555555555554 34444434455555555555554 344


Q ss_pred             ccccCccccccccccccc
Q 011005           81 GEITKLSRLDYLNLSSNK   98 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~   98 (496)
                      .....+..|+.|.+++|+
T Consensus       203 ~~~~~~~~L~~l~~~~N~  220 (394)
T COG4886         203 PEIELLSALEELDLSNNS  220 (394)
T ss_pred             hhhhhhhhhhhhhhcCCc
Confidence            333333345555555553

>PLN03210 Resistant to P

Probab=98.45  E-value=3.9e-07  Score=102.99  Aligned_cols=108  Identities=26%  Similarity=0.301  Sum_probs=87.4

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      .|++..+|..+..+++|+.|+|++|...+.+|+ +..+++|+.|+|++|.....+|..+..+++|+.|+|++|..-+.+|
T Consensus       620 ~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp  698 (1153)
T PLN03210        620 GSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILP  698 (1153)
T ss_pred             CccccccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccC
Confidence            367888999999999999999998765557774 8889999999999987666899999999999999999865433777


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDL  110 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l  110 (496)
                      ..+ ++++|+.|++++|...+.+|....++
T Consensus       699 ~~i-~l~sL~~L~Lsgc~~L~~~p~~~~nL  727 (1153)
T PLN03210        699 TGI-NLKSLYRLNLSGCSRLKSFPDISTNI  727 (1153)
T ss_pred             CcC-CCCCCCEEeCCCCCCccccccccCCc
Confidence            765 78899999999887665666544333

syringae 6; Provisional

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.42  E-value=2.3e-06  Score=86.37  Aligned_cols=139  Identities=20%  Similarity=0.218  Sum_probs=88.6

Q ss_pred             cceeeecCCeeEEEEEeCCCcEEEEEEcccchhHH------------------------------HHH------HHHHHH
Q 011005          210 RYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELA------------------------------FIK------SFKNEA  253 (496)
Q Consensus       210 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~~~------~~~~e~  253 (496)
                      .+.||.-+.|.||+|+.++|+.||||+-+..-...                              ..+      +|.+|+
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            35699999999999999999999999987542110                              111      123333


Q ss_pred             HHHHhh----cccc------cccccceeecCCeEEEEEEecCCCChhhh--hhCCCCCccCCHHHHHHHHHHHHHHHHHH
Q 011005          254 QVLSQV----LHRN------IVKLYGYCLHKKCMFLIYEYMERGSLFCN--LHNNEDAVELDWAKRVNIVKAMAHALAYL  321 (496)
Q Consensus       254 ~~l~~l----~h~n------iv~~~~~~~~~~~~~lV~e~~~~g~L~~~--l~~~~~~~~~~~~~~~~i~~~i~~~l~~l  321 (496)
                      +-..++    .|-+      |.+++..+  ....+|+||||+|..+.+.  +.+.    .++...+..-+.+...-.-+ 
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~----gi~~~~i~~~l~~~~~~qIf-  318 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR----GISPHDILNKLVEAYLEQIF-  318 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc----CCCHHHHHHHHHHHHHHHHH-
Confidence            333333    2444      33333222  2346899999999877655  3332    34444433333332222222 


Q ss_pred             HhCCCCCeEEeCCCCCceEecC----CCCeEEcccccccccc
Q 011005          322 HHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARLLH  359 (496)
Q Consensus       322 h~~~~~~i~H~dlkp~Nil~~~----~~~~kl~Dfg~~~~~~  359 (496)
                          ..|++|+|-.|.||+++.    ++.+.+.|||+.....
T Consensus       319 ----~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  319 ----KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             ----hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence                448999999999999984    6789999999987664

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.40  E-value=5.6e-06  Score=76.32  Aligned_cols=142  Identities=20%  Similarity=0.259  Sum_probs=83.7

Q ss_pred             ceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccc--cccccceeec---CCeEEEEEEecC
Q 011005          211 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN--IVKLYGYCLH---KKCMFLIYEYME  285 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~---~~~~~lV~e~~~  285 (496)
                      +.++.|..+.||+....+ ..+++|.....   .....+.+|..+++.+...+  +.+++.+...   ....+++|++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            568999999999999877 68999997665   23356778999999986443  4566654422   335789999999


Q ss_pred             CCChhh----------------h---hhCC-CCCccCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 011005          286 RGSLFC----------------N---LHNN-EDAVELDWAK---------RVNI------------VKAMAH-ALAYLHH  323 (496)
Q Consensus       286 ~g~L~~----------------~---l~~~-~~~~~~~~~~---------~~~i------------~~~i~~-~l~~lh~  323 (496)
                      |..+..                .   ++.. .....+....         ....            ...+.. .+..++.
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            987776                0   1111 0000111000         0000            111222 2333331


Q ss_pred             ----CCCCCeEEeCCCCCceEec-CCCCeEEccccccc
Q 011005          324 ----DCSPSIIHRDISSNNILLN-SKLEAFVADFGTAR  356 (496)
Q Consensus       324 ----~~~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~  356 (496)
                          .....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence                1256799999999999999 55666799998774

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.33  E-value=3.5e-07  Score=59.41  Aligned_cols=36  Identities=47%  Similarity=0.826  Sum_probs=16.2

Q ss_pred             CCCEEeccCCcCCCCCchhhcCCcccCeecccccccC
Q 011005           40 NLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQ   76 (496)
Q Consensus        40 ~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~   76 (496)
                      +|++|+|++|+|+ .+|+.+.+|++|+.|++++|+|+
T Consensus         2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred             cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence            3444444444444 34444444455555555544444

...

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.32  E-value=1.5e-08  Score=101.93  Aligned_cols=122  Identities=30%  Similarity=0.356  Sum_probs=93.8

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCch-hhcCCcccCeecccccccCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPP-EIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~-~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      .|++..+-.++.-++.|+.|||++|+++.+  +.+..++.|+.|||++|+|+ .+|. ....+. |+.|.|++|-++ .+
T Consensus       173 yN~L~~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~-tL  247 (1096)
T KOG1859|consen  173 YNRLVLMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALT-TL  247 (1096)
T ss_pred             hhhHHhHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHH-hh
Confidence            377777878888899999999999999855  37999999999999999999 5664 333444 999999999998 44


Q ss_pred             CccccCcccccccccccccCCCCCCCC-CCCCCccccccccCCCCCCCCCC
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVPFS-NNDLSSMHTVVSLSPNNGLCGNI  129 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~~~-~~~l~~l~~~~~~~~n~~~c~~~  129 (496)
                       .++.+|++|..||++.|-|.+---.. +..|..| ..+.+.+||..|..+
T Consensus       248 -~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L-~~L~LeGNPl~c~p~  296 (1096)
T KOG1859|consen  248 -RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSL-IVLWLEGNPLCCAPW  296 (1096)
T ss_pred             -hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHH-HHHhhcCCccccCHH
Confidence             46889999999999999997532111 1223334 235788999888753

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.31  E-value=2.6e-07  Score=92.57  Aligned_cols=112  Identities=44%  Similarity=0.632  Sum_probs=91.7

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      .|++..+|..+.++++|+.|++++|++. .+|...+.+++|+.|++++|+++ .+|.....+..|+.|.+++|++. ..+
T Consensus       149 ~N~i~~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~  225 (394)
T COG4886         149 DNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELL  225 (394)
T ss_pred             ccchhhhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecc
Confidence            4788889888999999999999999998 67766668999999999999999 78887777778999999999655 466


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      ..+..++++..+.+.+|++.. .+.....+++++.+
T Consensus       226 ~~~~~~~~l~~l~l~~n~~~~-~~~~~~~l~~l~~L  260 (394)
T COG4886         226 SSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETL  260 (394)
T ss_pred             hhhhhcccccccccCCceeee-ccchhcccccccee
Confidence            778888888888888888873 35566666666544

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.29  E-value=4.8e-07  Score=90.46  Aligned_cols=254  Identities=19%  Similarity=0.156  Sum_probs=160.2

Q ss_pred             ceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccc-cccccceeecCCeEEEEEEecCCC-C
Q 011005          211 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN-IVKLYGYCLHKKCMFLIYEYMERG-S  288 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lV~e~~~~g-~  288 (496)
                      +-+++|+++.++|.+..-.+....+.+...      ....-+++++.+++||| .+..++-+..+...+++++++.++ +
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs  321 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS  321 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence            447899999999987644444445554433      23456789999999999 777777777778899999999887 2


Q ss_pred             hhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCcccc
Q 011005          289 LFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL  368 (496)
Q Consensus       289 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  368 (496)
                      -......  ....+..-+...+.+.-+++++++|+   -.=+|+|    ||+.++ +..+..||+....+.... .....
T Consensus       322 ~~~~~~~--se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~  390 (829)
T KOG0576|consen  322 SALEMTV--SEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRTA  390 (829)
T ss_pred             ccccCCh--hhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc-ccccC
Confidence            2211111  11123333444566777889999994   3347887    777766 578999999987765432 34456


Q ss_pred             ccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHH
Q 011005          369 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLIS  448 (496)
Q Consensus       369 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  448 (496)
                      .+++.++|||+.....+....|+|+.|.-..++.-|-+|...  +.    ....++..-  ...+....  ...+.....
T Consensus       391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~----~~~~~~g~~--p~s~~L~~--~~aw~~~~~  460 (829)
T KOG0576|consen  391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PP----AVLPMIGNG--PNSPMLTD--KSAWSPVFH  460 (829)
T ss_pred             CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC--Cc----cccCCCCCC--CCccccch--hhhcCcccc
Confidence            789999999999999999999999999988888888777431  00    000000000  00000000  000000011


Q ss_pred             -HHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCcccccccchh
Q 011005          449 -TVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDISIS  492 (496)
Q Consensus       449 -~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~~~~~i~~~  492 (496)
                       ++...|+..-|..|+.....+.+-++-+ -|..-+.+..-|+++
T Consensus       461 ~~~~~~~~~g~P~~pkv~mgacfsKvfng-Cpl~i~~aaswIhp~  504 (829)
T KOG0576|consen  461 RDFPAPCLNGLPPTPKVHMGACFSKVFNG-CPLRIHCAASWIHPS  504 (829)
T ss_pred             cCCcccccCCCCCCCcchhhHHHHHHhcc-CcccceecccccCcc
Confidence             2445799999999999888887766543 334344444444444

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.28  E-value=5.9e-07  Score=58.34  Aligned_cols=37  Identities=43%  Similarity=0.694  Sum_probs=32.5

Q ss_pred             CCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCC
Q 011005           15 KNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLS   52 (496)
Q Consensus        15 ~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~   52 (496)
                      ++|++|+|++|+|+ .+|..+++|++|+.|+|++|+|+
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence            58999999999999 67777999999999999999999

...

>PLN02876 acyl-CoA dehydrogenase

Probab=98.21  E-value=1.7e-05  Score=86.59  Aligned_cols=80  Identities=26%  Similarity=0.411  Sum_probs=57.5

Q ss_pred             cceeeecCCeeEEEEEeCCC---cEEEEEEcccchhHHHHHHHHHHHHHHHhhc-cccc--ccccceeecC---CeEEEE
Q 011005          210 RYCIGTGGYGSVYKAQLPNG---KVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNI--VKLYGYCLHK---KCMFLI  280 (496)
Q Consensus       210 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lV  280 (496)
                      ...++.|.+..+|+....++   ..+++|+............+.+|+++++.+. |.++  .+++.++.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            45688999999999877554   4678887654332122346789999999995 6665  6777777654   357899


Q ss_pred             EEecCCCCh
Q 011005          281 YEYMERGSL  289 (496)
Q Consensus       281 ~e~~~~g~L  289 (496)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998653

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.21  E-value=1.6e-05  Score=73.99  Aligned_cols=139  Identities=15%  Similarity=0.145  Sum_probs=84.9

Q ss_pred             eeecCC-eeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-ccccccccceeecCCeEEEEEEecCCCChh
Q 011005          213 IGTGGY-GSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKCMFLIYEYMERGSLF  290 (496)
Q Consensus       213 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lV~e~~~~g~L~  290 (496)
                      |..|.+ ..||+.... +..+++|......    ...+.+|+++++.+. +--+.+++++....+..++|||+++|.++.
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            445555 789999775 4678888876543    234678999998885 444557777777666788999999998775


Q ss_pred             hhh-------------------hCCCC-CccCC--HHHHHHHHH--------------------HHHHHHHHHHh----C
Q 011005          291 CNL-------------------HNNED-AVELD--WAKRVNIVK--------------------AMAHALAYLHH----D  324 (496)
Q Consensus       291 ~~l-------------------~~~~~-~~~~~--~~~~~~i~~--------------------~i~~~l~~lh~----~  324 (496)
                      ...                   +.... ...+.  .........                    .+......|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            432                   11110 00111  000000000                    01111222211    0


Q ss_pred             CCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          325 CSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       325 ~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      ....++|+|+.|.||+++++..+.|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            13568999999999999998778899999774

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.21  E-value=6.6e-06  Score=72.63  Aligned_cols=105  Identities=23%  Similarity=0.297  Sum_probs=83.9

Q ss_pred             HHHHHHHHhhcc-cccccccceeecCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 011005          250 KNEAQVLSQVLH-RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS  328 (496)
Q Consensus       250 ~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~  328 (496)
                      ..|.-+++.+.+ +++++++|+|-    .++|.||...+++...-.........+|..+.+|+.++++.+.++++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            468888999975 69999999994    3689999987766532111111125699999999999999999999765566


Q ss_pred             eEEeCCCCCceEecCCCCeEEccccccccc
Q 011005          329 IIHRDISSNNILLNSKLEAFVADFGTARLL  358 (496)
Q Consensus       329 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  358 (496)
                      +.-.|++|+|+-+++++.+|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999887654

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.21  E-value=1.9e-07  Score=74.98  Aligned_cols=104  Identities=20%  Similarity=0.238  Sum_probs=85.6

Q ss_pred             CCccccCChhccC-CCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            1 MYKIGIIPPEIGN-LKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         1 ~n~~~~lp~~~~~-l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      +|.+..+|+.|.. ++.++.|+|++|.|. .+|..+..++.|+.|+++.|.|. ..|..+..|.+|-.|+..+|.+. .+
T Consensus        62 ~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-ei  138 (177)
T KOG4579|consen   62 DNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EI  138 (177)
T ss_pred             cchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cC
Confidence            4788889997775 568999999999998 78989999999999999999999 78888888999999999999998 66


Q ss_pred             CccccCcccccccccccccCCCCCCCCC
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVPFSN  107 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~~~~  107 (496)
                      |..+-.-..+-..++.++++.+.-+...
T Consensus       139 d~dl~~s~~~al~~lgnepl~~~~~~kl  166 (177)
T KOG4579|consen  139 DVDLFYSSLPALIKLGNEPLGDETKKKL  166 (177)
T ss_pred             cHHHhccccHHHHHhcCCcccccCcccc
Confidence            6554443455556678888887655443

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	496
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-43
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-42
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-30
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-30
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		9e-29
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-28
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-28
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-28
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-28
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-28
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-28
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-28
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-28
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		7e-28
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-28
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		8e-28
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		9e-28
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-27
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-27
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-27
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-27
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-27
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-27
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-27
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-27
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-27
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-27
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-27
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-27
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-27
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-27
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-27
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-27
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-27
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-27
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-27
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-27
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-26
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-26
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-26
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-26
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-25
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-25
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-24
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-24
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-24
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-22
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-22
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-21
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-21
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-21
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-21
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-21
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-21
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-21
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-21
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-21
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-21
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-21
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-21
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-21
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-21
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-20
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-20
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-20
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-20
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-20
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-20
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-20
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		8e-20
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-20
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		9e-20
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-19
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-19
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-19
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-19
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-19
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-19
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-19
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-19
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-19
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-19
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-19
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-19
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		9e-19
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-18
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-18
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-18
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-18
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-18
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-18
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-18
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-18
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-18
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-18
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-18
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-18
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-18
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-18
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-18
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		9e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		9e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		9e-18
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-17
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-17
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-17
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-17
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		6e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		7e-17
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-17
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		9e-17
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		9e-17
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		9e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		9e-17
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-16
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-16
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-16
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-16
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-16
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-16
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-16
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-16
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-16
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-16
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-16
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-16
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-16
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-16
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-16
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-16
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-16
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-16
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-16
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-16
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-16
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-16
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-16
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		8e-16
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-16
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		9e-16
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-15
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-15
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-15
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-15
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-15
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-15
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-15
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-15
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-15
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-15
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-15
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-15
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-15
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-15
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-15
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-15
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-15
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-15
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-15
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-15
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		8e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		9e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		9e-15
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		9e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		9e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		9e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		9e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-15
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-14
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-14
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-14
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-14
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-14
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-14
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-14
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-14
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-14
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		6e-14
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-14
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		7e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-14
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		7e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-14
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-14
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		7e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-14
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		8e-14
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		8e-14
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-14
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		8e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		9e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		9e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		9e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		9e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		9e-14
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		9e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		9e-14
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		9e-14
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-13
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-13
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-13
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-13
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-13
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-13
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-13
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-13
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-13
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-13
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		7e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		7e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		8e-13
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-13
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		9e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-12
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-12
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-12
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-12
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-12
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-12
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-12
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-12
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-12
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-12
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-12
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-12
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-12
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-12
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-12
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		7e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		7e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		7e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		7e-12
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-12
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		8e-12
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		8e-12
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-12
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		8e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		8e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		8e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-12
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		9e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-12
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-12
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		9e-12
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		9e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		9e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		9e-12
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-12
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-11
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-11
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-11
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-11
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-11
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		9e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		9e-11
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		9e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-10
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-10
3soa_A	444	Full-Length Human Camkii Length = 444		3e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-10
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-10
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		7e-10
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		8e-10
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		8e-10
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		8e-10
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		8e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		9e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-10
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		9e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		9e-10
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		9e-10
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		9e-10
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-09
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-09
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-09
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-09
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-09
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-09
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-09
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-09
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-09
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		6e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		6e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		6e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		6e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-09
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		7e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		8e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		8e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		8e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		9e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		9e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		9e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		9e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		9e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		9e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		9e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		9e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		9e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-08
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		6e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		6e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-08
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-08
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		8e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		8e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		8e-08
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		8e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		9e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		6e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		6e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		6e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		6e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		7e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		5e-06
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		5e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		6e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		6e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-05
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		2e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-05
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-05
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		2e-05
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		2e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-05
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 99/287 (34%), Positives = 152/287 (52%), Gaps = 15/287 (5%)
Query: 194 RIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEA 253
           R    +L  A+++F  +  +G GG+G VYK +L +G + A+K+L           F+ E 
Sbjct: 27  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEV 86
Query: 254 QVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLF-CNLHNNEDAVELDWAKRVNIVK 312
           +++S  +HRN+++L G+C+      L+Y YM  GS+  C     E    LDW KR  I  
Sbjct: 87  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 146
Query: 313 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL-HADSSNRTLLAGT 371
             A  LAYLH  C P IIHRD+ + NILL+ + EA V DFG A+L+ + D      + GT
Sbjct: 147 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGT 206
Query: 372 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVL--- 428
            G+IAPE   T   +EK DV+ +GV+ LE++ G+   D+        D  +ML+D +   
Sbjct: 207 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL---ARLANDDDVMLLDWVKGL 263
Query: 429 --DQRLPPPVDRKVI-----RDILLISTVSFACLQSNPKSRPTMQSV 468
             +++L   VD  +       ++  +  V+  C QS+P  RP M  V
Sbjct: 264 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 310

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  171 bits (432), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 98/287 (34%), Positives = 151/287 (52%), Gaps = 15/287 (5%)
Query: 194 RIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEA 253
           R    +L  A+++F  +  +G GG+G VYK +L +G + A+K+L           F+ E 
Sbjct: 19  RFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEV 78
Query: 254 QVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLF-CNLHNNEDAVELDWAKRVNIVK 312
           +++S  +HRN+++L G+C+      L+Y YM  GS+  C     E    LDW KR  I  
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 313 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL-HADSSNRTLLAGT 371
             A  LAYLH  C P IIHRD+ + NILL+ + EA V DFG A+L+ + D      + G 
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGX 198
Query: 372 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVL--- 428
            G+IAPE   T   +EK DV+ +GV+ LE++ G+   D+        D  +ML+D +   
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL---ARLANDDDVMLLDWVKGL 255
Query: 429 --DQRLPPPVDRKVI-----RDILLISTVSFACLQSNPKSRPTMQSV 468
             +++L   VD  +       ++  +  V+  C QS+P  RP M  V
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 97/286 (33%), Positives = 146/286 (51%), Gaps = 18/286 (6%)
Query: 194 RIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEA 253
           R+   DL EAT +FD ++ IG G +G VYK  L +G   ALK+  T E    I+ F+ E 
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTPESSQGIEEFETEI 86
Query: 254 QVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVK 312
           + LS   H ++V L G+C  +  M LIY+YME G+L  +L+ ++   + + W +R+ I  
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 313 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL-LHADSSN-RTLLAG 370
             A  L YLH   + +IIHRD+ S NILL+      + DFG ++     D ++   ++ G
Sbjct: 147 GAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKG 203
Query: 371 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKH------PRDIXXXXXXXXDP--KI 422
           T GYI PE      +TEK DVYSFGVV  EVL  +       PR++        +     
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263
Query: 423 MLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
            L  ++D  L   +  + +R        +  CL  + + RP+M  V
Sbjct: 264 QLEQIVDPNLADKIRPESLRK---FGDTAVKCLALSSEDRPSMGDV 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 96/286 (33%), Positives = 144/286 (50%), Gaps = 18/286 (6%)
Query: 194 RIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEA 253
           R+   DL EAT +FD ++ IG G +G VYK  L +G   ALK+  T E    I+ F+ E 
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTPESSQGIEEFETEI 86
Query: 254 QVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVK 312
           + LS   H ++V L G+C  +  M LIY+YME G+L  +L+ ++   + + W +R+ I  
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 313 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR--LLHADSSNRTLLAG 370
             A  L YLH   + +IIHRD+ S NILL+      + DFG ++       +    ++ G
Sbjct: 147 GAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKG 203
Query: 371 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKH------PRDIXXXXXXXXDP--KI 422
           T GYI PE      +TEK DVYSFGVV  EVL  +       PR++        +     
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263
Query: 423 MLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
            L  ++D  L   +  + +R        +  CL  + + RP+M  V
Sbjct: 264 QLEQIVDPNLADKIRPESLRK---FGDTAVKCLALSSEDRPSMGDV 306

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  124 bits (312), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 93/276 (33%), Positives = 138/276 (50%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY  RG ++  L   +   + D  +    +  +A+AL+
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELANALS 127
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 182
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 237
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 238 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 266

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 137/276 (49%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY  RG ++  L   +   + D  +    +  +A+AL+
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELANALS 127
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ PE+
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLXGTLDYLPPEM 182
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 237
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 238 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 266

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 138/276 (50%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 148
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 149 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 203
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 258
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 259 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 287

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 138/276 (50%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 122
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTXLCGTLDYLPPEM 177
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 232
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 233 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 261

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 138/276 (50%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+  N K + ALK L  +  E+       + E ++ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 122
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ PE+
Sbjct: 123 YCH---SKKVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEM 177
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKR-----ISRVEFTFPDFVTEG 232
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 233 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 261

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 138/276 (50%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 122
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 177
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 232
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 233 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 261

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 138/276 (50%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 121
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 122 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 176
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 177 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 231
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 232 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 260

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 138/276 (50%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 127
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 182
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 237
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 238 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 266

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  122 bits (305), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 138/276 (50%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 126
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 127 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 181
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 236
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 237 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 265

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 138/276 (50%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 139
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 140 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 194
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 195 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 249
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 250 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 278

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  121 bits (304), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 138/276 (50%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 125
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 180
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 235
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 236 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 264

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  121 bits (304), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 138/276 (50%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 125
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 180
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 235
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 236 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 264

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  121 bits (304), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 138/276 (50%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 123
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +   HA SS RT L+GT  Y+ PE+
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTTLSGTLDYLPPEM 178
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 233
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 234 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 262

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 138/276 (50%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 122
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTELCGTLDYLPPEM 177
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 232
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 233 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 261

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 138/276 (50%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 119
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 120 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 174
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 175 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 229
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 230 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 258

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 138/276 (50%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 122
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 177
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 232
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 233 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 261

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 138/276 (50%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 123
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 178
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 233
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 234 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 262

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 138/276 (50%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 122
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 177
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 232
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 233 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 261

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 138/276 (50%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 127
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 182
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 237
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 238 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 266

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 91/276 (32%), Positives = 138/276 (50%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 125
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +A+FG +  +HA SS RT L GT  Y+ PE+
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPEM 180
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 235
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 236 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 264

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 92/276 (33%), Positives = 136/276 (49%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 127
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE 
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEX 182
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
                  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 183 IEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 237
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 238 A-RD--LISRL----LKHNPSQRPXLREVLEHPWIT 266

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  120 bits (300), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 91/276 (32%), Positives = 137/276 (49%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 122
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ PE+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEM 177
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 232
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 233 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 261

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 91/276 (32%), Positives = 138/276 (50%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 124
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +A+FG +  +HA SS RT L GT  Y+ PE+
Sbjct: 125 YCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPEM 179
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 234
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 235 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 263

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 91/276 (32%), Positives = 137/276 (49%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 125
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ PE+
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEM 180
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 235
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 236 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 264

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 91/276 (32%), Positives = 137/276 (49%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 122
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ PE+
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEM 177
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 232
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 233 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 261

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 91/276 (32%), Positives = 137/276 (49%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 124
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ PE+
Sbjct: 125 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEM 179
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 234
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 235 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 263

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 91/276 (32%), Positives = 137/276 (49%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 125
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ PE+
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEM 180
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 235
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 236 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 264

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 91/276 (32%), Positives = 137/276 (49%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 123
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ PE+
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEM 178
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 233
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 234 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 262

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 75/208 (36%), Positives = 113/208 (54%), Gaps = 11/208 (5%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 148
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ PE+
Sbjct: 149 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPEM 203
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
               +  EK D++S GV+  E L+GK P
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 93/294 (31%), Positives = 142/294 (48%), Gaps = 31/294 (10%)
Query: 197 YEDLIEATEDFDIR------YCIGTGGYGSVYKAQLPNGKVFALKKLH-----TSEELAF 245
           + +L   T +FD R        +G GG+G VYK  + N  V A+KKL      T+EEL  
Sbjct: 17  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEELK- 74
Query: 246 IKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWA 305
            + F  E +V+++  H N+V+L G+      + L+Y YM  GSL   L   +    L W 
Sbjct: 75  -QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 306 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH--ADSS 363
            R  I +  A+ + +LH +     IHRDI S NILL+    A ++DFG AR     A + 
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG-------KHPRDIXXXXXX 416
             + + GT  Y+APE A    +T K D+YSFGVV LE++ G       + P+ +      
Sbjct: 191 MXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 249
Query: 417 XXDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
             D +  + D +D+++       V      + +V+  CL      RP ++ V Q
Sbjct: 250 IEDEEKTIEDYIDKKMNDADSTSV----EAMYSVASQCLHEKKNKRPDIKKVQQ 299

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 91/276 (32%), Positives = 137/276 (49%), Gaps = 23/276 (8%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQV 259
           A EDF+I   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++LYGY      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 125
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ PE+
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPEM 180
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
               +  EK D++S GV+  E L+GK P +               I  ++   P  V   
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-----ISRVEFTFPDFVTEG 235
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
             RD  LIS +    L+ NP  RP ++ V +   IT
Sbjct: 236 A-RD--LISRL----LKHNPSQRPMLREVLEHPWIT 264

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  118 bits (296), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 75/206 (36%), Positives = 111/206 (53%), Gaps = 11/206 (5%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQVLH 261
           EDFDI   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S + H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            NI++LYGY      ++LI EY   G+++  L   +     D  +    +  +A+AL+Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSRFDEQRTATYITELANALSYC 128
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
           H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+  
Sbjct: 129 H---SKRVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIE 183
Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHP 407
             +  EK D++S GV+  E L+G  P
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  118 bits (295), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 93/294 (31%), Positives = 141/294 (47%), Gaps = 31/294 (10%)
Query: 197 YEDLIEATEDFDIRYC------IGTGGYGSVYKAQLPNGKVFALKKLH-----TSEELAF 245
           + +L   T +FD R        +G GG+G VYK  + N  V A+KKL      T+EEL  
Sbjct: 17  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEELK- 74
Query: 246 IKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWA 305
            + F  E +V+++  H N+V+L G+      + L+Y YM  GSL   L   +    L W 
Sbjct: 75  -QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 306 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH--ADSS 363
            R  I +  A+ + +LH +     IHRDI S NILL+    A ++DFG AR     A + 
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG-------KHPRDIXXXXXX 416
               + GT  Y+APE A    +T K D+YSFGVV LE++ G       + P+ +      
Sbjct: 191 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 249
Query: 417 XXDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
             D +  + D +D+++       V      + +V+  CL      RP ++ V Q
Sbjct: 250 IEDEEKTIEDYIDKKMNDADSTSV----EAMYSVASQCLHEKKNKRPDIKKVQQ 299

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 93/294 (31%), Positives = 140/294 (47%), Gaps = 31/294 (10%)
Query: 197 YEDLIEATEDFDIRYC------IGTGGYGSVYKAQLPNGKVFALKKLH-----TSEELAF 245
           + +L   T +FD R        +G GG+G VYK  + N  V A+KKL      T+EEL  
Sbjct: 11  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEELK- 68
Query: 246 IKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWA 305
            + F  E +V+++  H N+V+L G+      + L+Y YM  GSL   L   +    L W 
Sbjct: 69  -QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 306 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH--ADSS 363
            R  I +  A+ + +LH +     IHRDI S NILL+    A ++DFG AR     A   
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG-------KHPRDIXXXXXX 416
               + GT  Y+APE A    +T K D+YSFGVV LE++ G       + P+ +      
Sbjct: 185 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 243
Query: 417 XXDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
             D +  + D +D+++       V      + +V+  CL      RP ++ V Q
Sbjct: 244 IEDEEKTIEDYIDKKMNDADSTSV----EAMYSVASQCLHEKKNKRPDIKKVQQ 293

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 74/206 (35%), Positives = 110/206 (53%), Gaps = 11/206 (5%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQVLH 261
           EDFDI   +G G +G+VY A+    K + ALK L  +  E+       + E ++ S + H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            NI++LYGY      ++LI EY   G+++  L   +     D  +    +  +A+AL+Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSRFDEQRTATYITELANALSYC 128
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
           H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ PE+  
Sbjct: 129 H---SKRVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEMIE 183
Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHP 407
             +  EK D++S GV+  E L+G  P
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 132/265 (49%), Gaps = 19/265 (7%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           ++ ++   +G G +G V KA+    K  A+K++ +  E    K+F  E + LS+V H NI
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER---KAFIVELRQLSRVNHPNI 63
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           VKLYG CL+  C  L+ EY E GSL+  LH  E       A  ++     +  +AYLH  
Sbjct: 64  VKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 325 CSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
              ++IHRD+   N+LL +      + DFGTA  +    +N     G+  ++APE+    
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEVFEGS 178
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIRD 443
             +EKCDV+S+G++  EV+  + P D          P   ++  +     PP+ + + + 
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFD------EIGGPAFRIMWAVHNGTRPPLIKNLPKP 232
Query: 444 ILLISTVSFACLQSNPKSRPTMQSV 468
           I  + T    C   +P  RP+M+ +
Sbjct: 233 IESLMT---RCWSKDPSQRPSMEEI 254

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 132/265 (49%), Gaps = 19/265 (7%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           ++ ++   +G G +G V KA+    K  A+K++ +  E    K+F  E + LS+V H NI
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER---KAFIVELRQLSRVNHPNI 64
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           VKLYG CL+  C  L+ EY E GSL+  LH  E       A  ++     +  +AYLH  
Sbjct: 65  VKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 122
Query: 325 CSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
              ++IHRD+   N+LL +      + DFGTA  +    +N     G+  ++APE+    
Sbjct: 123 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEVFEGS 179
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIRD 443
             +EKCDV+S+G++  EV+  + P D          P   ++  +     PP+ + + + 
Sbjct: 180 NYSEKCDVFSWGIILWEVITRRKPFD------EIGGPAFRIMWAVHNGTRPPLIKNLPKP 233
Query: 444 ILLISTVSFACLQSNPKSRPTMQSV 468
           I  + T    C   +P  RP+M+ +
Sbjct: 234 IESLMT---RCWSKDPSQRPSMEEI 255

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 112/211 (53%), Gaps = 10/211 (4%)
Query: 205 EDFDIRYC-------IGTGGYGSVYKAQLPNGKVFALKKLHTSEELA-FIKSFKNEAQVL 256
           +D DI +C       IG G +G+V++A+  +G   A+K L   +  A  +  F  E  ++
Sbjct: 30  DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIM 88
Query: 257 SQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 316
            ++ H NIV   G       + ++ EY+ RGSL+  LH +    +LD  +R+++   +A 
Sbjct: 89  KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAK 148
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
            + YLH+  +P I+HRD+ S N+L++ K    V DFG +RL  +        AGT  ++A
Sbjct: 149 GMNYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMA 207
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PE+       EK DVYSFGV+  E+   + P
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  112 bits (279), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 113/211 (53%), Gaps = 10/211 (4%)
Query: 205 EDFDIRYC-------IGTGGYGSVYKAQLPNGKVFALKKLHTSEELA-FIKSFKNEAQVL 256
           +D DI +C       IG G +G+V++A+  +G   A+K L   +  A  +  F  E  ++
Sbjct: 30  DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIM 88
Query: 257 SQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 316
            ++ H NIV   G       + ++ EY+ RGSL+  LH +    +LD  +R+++   +A 
Sbjct: 89  KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAK 148
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
            + YLH+  +P I+HR++ S N+L++ K    V DFG +RL  +   +    AGT  ++A
Sbjct: 149 GMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMA 207
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PE+       EK DVYSFGV+  E+   + P
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  111 bits (278), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 92/294 (31%), Positives = 135/294 (45%), Gaps = 31/294 (10%)
Query: 197 YEDLIEATEDFDIR------YCIGTGGYGSVYKAQLPNGKVFALKKLH-----TSEELAF 245
           + +L   T +FD R         G GG+G VYK  + N  V A+KKL      T+EEL  
Sbjct: 8   FYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEELK- 65
Query: 246 IKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWA 305
            + F  E +V ++  H N+V+L G+      + L+Y Y   GSL   L   +    L W 
Sbjct: 66  -QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 306 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH--ADSS 363
            R  I +  A+ + +LH +     IHRDI S NILL+    A ++DFG AR     A   
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG-------KHPRDIXXXXXX 416
             + + GT  Y APE A    +T K D+YSFGVV LE++ G       + P+ +      
Sbjct: 182 XXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 240
Query: 417 XXDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
             D +  + D +D++        V        +V+  CL      RP ++ V Q
Sbjct: 241 IEDEEKTIEDYIDKKXNDADSTSV----EAXYSVASQCLHEKKNKRPDIKKVQQ 290

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQVLH 261
           +DFDI   +G G +G+VY A+    K + ALK L  S  E+       + E ++ S + H
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            NI+++Y Y   +K ++L+ E+  RG L+  L  +      D  +    ++ +A AL Y 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYC 131
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
           H      +IHRDI   N+L+  K E  +ADFG +  +HA S  R  + GT  Y+ PE+  
Sbjct: 132 HER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPEMIE 186
Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
                EK D++  GV+  E L+G  P D
Sbjct: 187 GKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQVLH 261
           +DFDI   +G G +G+VY A+    K + ALK L  S  E+       + E ++ S + H
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            NI+++Y Y   +K ++L+ E+  RG L+  L  +      D  +    ++ +A AL Y 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYC 130
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
           H      +IHRDI   N+L+  K E  +ADFG +  +HA S  R  + GT  Y+ PE+  
Sbjct: 131 HER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPEMIE 185
Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
                EK D++  GV+  E L+G  P D
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKLHTS--EELAFIKSFKNEAQVLSQVLH 261
           +DF+I   +G G +G+VY A+      + ALK L  S  E+       + E ++ + + H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            NI++LY Y   ++ ++LI EY  RG L+  L   + +   D  +   I++ +A AL Y 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKEL---QKSCTFDEQRTATIMEELADALMYC 139
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
           H      +IHRDI   N+LL  K E  +ADFG +  +HA S  R  + GT  Y+ PE+  
Sbjct: 140 H---GKKVIHRDIKPENLLLGLKGELKIADFGWS--VHAPSLRRKTMCGTLDYLPPEMIE 194
Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHP 407
             +  EK D++  GV+  E+L+G  P
Sbjct: 195 GRMHNEKVDLWCIGVLCYELLVGNPP 220

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 134/296 (45%), Gaps = 41/296 (13%)
Query: 195 IVYEDLIEATEDF---------DIRYCIGTGGYGSVYKA--QLPNGK--VFALKKLHTSE 241
             +ED  EA  +F          I   IG G +G V     +LP  +    A+K L +  
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 242 ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE 301
                + F +EA ++ Q  H N++ L G       + +I E+ME GSL   L  N+    
Sbjct: 74  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 133
Query: 302 LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD 361
           +   + V +++ +A  + YL      + +HRD+++ NIL+NS L   V+DFG +R L  D
Sbjct: 134 V--IQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 188
Query: 362 SSNRTLLAGTYG-----YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP-RDIXXXX 414
           +S+ T  +   G     + APE       T   DV+S+G+V  EV+  G+ P  D+    
Sbjct: 189 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 248
Query: 415 XXXXDPKIMLIDVLDQ--RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
                    +I+ ++Q  RLPPP+D       L++      C Q +   RP    +
Sbjct: 249 ---------VINAIEQDYRLPPPMDCPSALHQLMLD-----CWQKDRNHRPKFGQI 290

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           IG GG+G VY+A     +V      H  +E     I++ + EA++ + + H NI+ L G 
Sbjct: 15  IGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74
Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
           CL +  + L+ E+   G L   L       ++     VN    +A  + YLH +    II
Sbjct: 75  CLKEPNLCLVMEFARGGPLNRVLSGKRIPPDI----LVNWAVQIARGMNYLHDEAIVPII 130
Query: 331 HRDISSNNILLNSKLEAF--------VADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
           HRD+ S+NIL+  K+E          + DFG AR  H   + +   AG Y ++APE+   
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAAGAYAWMAPEVIRA 188
Query: 383 MVMTEKCDVYSFGVVTLEVLMGKHP 407
            + ++  DV+S+GV+  E+L G+ P
Sbjct: 189 SMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 136/288 (47%), Gaps = 41/288 (14%)
Query: 201 IEATEDFDIRYC-----IGTGGYGSVYKAQL--PNGK--VFALKKLHTSEELAFIKSFKN 251
           +E  ++ D+ Y      IG G +G V + +L  P  K    A+K L         + F +
Sbjct: 5   MEFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLS 64
Query: 252 EAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVN 309
           EA ++ Q  H NI++L G   +   + ++ E+ME G+L  F  L++ +  V     + V 
Sbjct: 65  EASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV----IQLVG 120
Query: 310 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA 369
           +++ +A  + YL      S +HRD+++ NIL+NS L   V+DFG +R L  +SS+ T  +
Sbjct: 121 MLRGIASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTS 177
Query: 370 GTYG-----YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP-RDIXXXXXXXXDPKI 422
              G     + APE       T   D +S+G+V  EV+  G+ P  D+            
Sbjct: 178 SLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQD-------- 229
Query: 423 MLIDVLDQ--RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
            +I+ ++Q  RLPPP D       L++      C Q +  +RP    V
Sbjct: 230 -VINAIEQDYRLPPPPDCPTSLHQLMLD-----CWQKDRNARPRFPQV 271

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 114/204 (55%), Gaps = 20/204 (9%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG+G +G+VYK +  +G V A+K L+ T+     +++FKNE  VL +  H NI+   GY 
Sbjct: 21  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
             K  + ++ ++ E  SL+ +LH  E   E+   K ++I +  A  + YLH   + SIIH
Sbjct: 79  T-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSIIH 132
Query: 332 RDISSNNILLNSKLEAFVADFG--TARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEK- 388
           RD+ SNNI L+  L   + DFG  T +   + S     L+G+  ++APE+   + M +K 
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDKN 189
Query: 389 -----CDVYSFGVVTLEVLMGKHP 407
                 DVY+FG+V  E++ G+ P
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 114/204 (55%), Gaps = 20/204 (9%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG+G +G+VYK +  +G V A+K L+ T+     +++FKNE  VL +  H NI+   GY 
Sbjct: 16  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
             K  + ++ ++ E  SL+ +LH  E   E+   K ++I +  A  + YLH   + SIIH
Sbjct: 74  T-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSIIH 127
Query: 332 RDISSNNILLNSKLEAFVADFG--TARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEK- 388
           RD+ SNNI L+  L   + DFG  T +   + S     L+G+  ++APE+   + M +K 
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDKN 184
Query: 389 -----CDVYSFGVVTLEVLMGKHP 407
                 DVY+FG+V  E++ G+ P
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 114/204 (55%), Gaps = 20/204 (9%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG+G +G+VYK +  +G V A+K L+ T+     +++FKNE  VL +  H NI+   GY 
Sbjct: 36  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
             K  + ++ ++ E  SL+ +LH  E   E+   K ++I +  A  + YLH   + SIIH
Sbjct: 94  T-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSIIH 147
Query: 332 RDISSNNILLNSKLEAFVADFG--TARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEK- 388
           RD+ SNNI L+  L   + DFG  T +   + S     L+G+  ++APE+   + M +K 
Sbjct: 148 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV---IRMQDKN 204
Query: 389 -----CDVYSFGVVTLEVLMGKHP 407
                 DVY+FG+V  E++ G+ P
Sbjct: 205 PYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 114/204 (55%), Gaps = 20/204 (9%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG+G +G+VYK +  +G V A+K L+ T+     +++FKNE  VL +  H NI+   GY 
Sbjct: 43  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
             K  + ++ ++ E  SL+ +LH  E   E+   K ++I +  A  + YLH   + SIIH
Sbjct: 101 T-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSIIH 154
Query: 332 RDISSNNILLNSKLEAFVADFG--TARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEK- 388
           RD+ SNNI L+  L   + DFG  T +   + S     L+G+  ++APE+   + M +K 
Sbjct: 155 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDKN 211
Query: 389 -----CDVYSFGVVTLEVLMGKHP 407
                 DVY+FG+V  E++ G+ P
Sbjct: 212 PYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 114/204 (55%), Gaps = 20/204 (9%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG+G +G+VYK +  +G V A+K L+ T+     +++FKNE  VL +  H NI+   GY 
Sbjct: 18  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
             K  + ++ ++ E  SL+ +LH  E   E+   K ++I +  A  + YLH   + SIIH
Sbjct: 76  T-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSIIH 129
Query: 332 RDISSNNILLNSKLEAFVADFG--TARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEK- 388
           RD+ SNNI L+  L   + DFG  T +   + S     L+G+  ++APE+   + M +K 
Sbjct: 130 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDKN 186
Query: 389 -----CDVYSFGVVTLEVLMGKHP 407
                 DVY+FG+V  E++ G+ P
Sbjct: 187 PYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 114/204 (55%), Gaps = 20/204 (9%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG+G +G+VYK +  +G V A+K L+ T+     +++FKNE  VL +  H NI+   GY 
Sbjct: 16  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
             K  + ++ ++ E  SL+ +LH  E   E+   K ++I +  A  + YLH   + SIIH
Sbjct: 74  T-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSIIH 127
Query: 332 RDISSNNILLNSKLEAFVADFG--TARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEK- 388
           RD+ SNNI L+  L   + DFG  T +   + S     L+G+  ++APE+   + M +K 
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV---IRMQDKN 184
Query: 389 -----CDVYSFGVVTLEVLMGKHP 407
                 DVY+FG+V  E++ G+ P
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 114/204 (55%), Gaps = 20/204 (9%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG+G +G+VYK +  +G V A+K L+ T+     +++FKNE  VL +  H NI+   GY 
Sbjct: 44  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
             K  + ++ ++ E  SL+ +LH  E   E+   K ++I +  A  + YLH   + SIIH
Sbjct: 102 T-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSIIH 155
Query: 332 RDISSNNILLNSKLEAFVADFG--TARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEK- 388
           RD+ SNNI L+  L   + DFG  T +   + S     L+G+  ++APE+   + M +K 
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDKN 212
Query: 389 -----CDVYSFGVVTLEVLMGKHP 407
                 DVY+FG+V  E++ G+ P
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 114/204 (55%), Gaps = 20/204 (9%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG+G +G+VYK +  +G V A+K L+ T+     +++FKNE  VL +  H NI+   GY 
Sbjct: 21  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
             K  + ++ ++ E  SL+ +LH  E   E+   K ++I +  A  + YLH   + SIIH
Sbjct: 79  T-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSIIH 132
Query: 332 RDISSNNILLNSKLEAFVADFG--TARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEK- 388
           RD+ SNNI L+  L   + DFG  T +   + S     L+G+  ++APE+   + M +K 
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDKN 189
Query: 389 -----CDVYSFGVVTLEVLMGKHP 407
                 DVY+FG+V  E++ G+ P
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 114/204 (55%), Gaps = 20/204 (9%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG+G +G+VYK +  +G V A+K L+ T+     +++FKNE  VL +  H NI+   GY 
Sbjct: 44  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
             K  + ++ ++ E  SL+ +LH  E   E+   K ++I +  A  + YLH   + SIIH
Sbjct: 102 T-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSIIH 155
Query: 332 RDISSNNILLNSKLEAFVADFG--TARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEK- 388
           RD+ SNNI L+  L   + DFG  T +   + S     L+G+  ++APE+   + M +K 
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV---IRMQDKN 212
Query: 389 -----CDVYSFGVVTLEVLMGKHP 407
                 DVY+FG+V  E++ G+ P
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 137/291 (47%), Gaps = 41/291 (14%)
Query: 198 EDLIEATEDFDIRYC-----IGTGGYGSVYKAQL--PNGK--VFALKKLHTSEELAFIKS 248
           E + E  ++ D+ Y      IG G +G V + +L  P  K    A+K L         + 
Sbjct: 4   EAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRRE 63
Query: 249 FKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAK 306
           F +EA ++ Q  H NI++L G   +   + ++ E+ME G+L  F  L++ +  V     +
Sbjct: 64  FLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV----IQ 119
Query: 307 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT 366
            V +++ +A  + YL      S +HRD+++ NIL+NS L   V+DFG +R L  +SS+ T
Sbjct: 120 LVGMLRGIASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPT 176
Query: 367 LLAGTYG-----YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP-RDIXXXXXXXXD 419
             +   G     + APE       T   D +S+G+V  EV+  G+ P  D+         
Sbjct: 177 ETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQD----- 231
Query: 420 PKIMLIDVLDQ--RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
               +I+ ++Q  RLPPP D       L++      C Q +  +RP    V
Sbjct: 232 ----VINAIEQDYRLPPPPDCPTSLHQLMLD-----CWQKDRNARPRFPQV 273

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 113/201 (56%), Gaps = 14/201 (6%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG+G +G+VYK +  +G V A+K L+ T+     +++FKNE  VL +  H NI+   GY 
Sbjct: 20  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
             K  + ++ ++ E  SL+ +LH +E   E+   K ++I +  A  + YLH   + SIIH
Sbjct: 78  T-KPQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLH---AKSIIH 131
Query: 332 RDISSNNILLNSKLEAFVADFG--TARLLHADSSNRTLLAGTYGYIAPE---LAYTMVMT 386
           RD+ SNNI L+      + DFG  T +   + S     L+G+  ++APE   +  +   +
Sbjct: 132 RDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 191
Query: 387 EKCDVYSFGVVTLEVLMGKHP 407
            + DVY+FG+V  E++ G+ P
Sbjct: 192 FQSDVYAFGIVLYELMTGQLP 212

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 114/204 (55%), Gaps = 20/204 (9%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG+G +G+VYK +  +G V A+K L+ T+     +++FKNE  VL +  H NI+   GY 
Sbjct: 16  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
              + + ++ ++ E  SL+ +LH  E   E+   K ++I +  A  + YLH   + SIIH
Sbjct: 74  TAPQ-LAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSIIH 127
Query: 332 RDISSNNILLNSKLEAFVADFG--TARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEK- 388
           RD+ SNNI L+  L   + DFG  T +   + S     L+G+  ++APE+   + M +K 
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDKN 184
Query: 389 -----CDVYSFGVVTLEVLMGKHP 407
                 DVY+FG+V  E++ G+ P
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 113/201 (56%), Gaps = 14/201 (6%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG+G +G+VYK +  +G V A+K L+ T+     +++FKNE  VL +  H NI+   GY 
Sbjct: 32  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
             K  + ++ ++ E  SL+ +LH +E   E+   K ++I +  A  + YLH   + SIIH
Sbjct: 90  T-KPQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLH---AKSIIH 143
Query: 332 RDISSNNILLNSKLEAFVADFG--TARLLHADSSNRTLLAGTYGYIAPE---LAYTMVMT 386
           RD+ SNNI L+      + DFG  T +   + S     L+G+  ++APE   +  +   +
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 387 EKCDVYSFGVVTLEVLMGKHP 407
            + DVY+FG+V  E++ G+ P
Sbjct: 204 FQSDVYAFGIVLYELMTGQLP 224

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 113/201 (56%), Gaps = 14/201 (6%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG+G +G+VYK +  +G V A+K L+ T+     +++FKNE  VL +  H NI+   GY 
Sbjct: 32  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
              + + ++ ++ E  SL+ +LH +E   E+   K ++I +  A  + YLH   + SIIH
Sbjct: 90  TAPQ-LAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLH---AKSIIH 143
Query: 332 RDISSNNILLNSKLEAFVADFG--TARLLHADSSNRTLLAGTYGYIAPE---LAYTMVMT 386
           RD+ SNNI L+      + DFG  T +   + S     L+G+  ++APE   +  +   +
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 387 EKCDVYSFGVVTLEVLMGKHP 407
            + DVY+FG+V  E++ G+ P
Sbjct: 204 FQSDVYAFGIVLYELMTGQLP 224

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 122/270 (45%), Gaps = 26/270 (9%)
Query: 209 IRYCIGTGGYGSVYKA--QLPNGK--VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           I   IG G +G V     +LP  +    A+K L +       + F +EA ++ Q  H N+
Sbjct: 11  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 70
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           + L G       + +I E+ME GSL   L  N+    +   + V +++ +A  + YL   
Sbjct: 71  IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL--- 125
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG-----YIAPEL 379
              + +HR +++ NIL+NS L   V+DFG +R L  D+S+ T  +   G     + APE 
Sbjct: 126 ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 185
Query: 380 AYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDR 438
                 T   DV+S+G+V  EV+  G+ P           +  ++     D RLPPP+D 
Sbjct: 186 IQYRKFTSASDVWSYGIVMWEVMSYGERP------YWDMTNQDVINAIEQDYRLPPPMDC 239
Query: 439 KVIRDILLISTVSFACLQSNPKSRPTMQSV 468
                 L++      C Q +   RP    +
Sbjct: 240 PSALHQLMLD-----CWQKDRNHRPKFGQI 264

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 131/294 (44%), Gaps = 41/294 (13%)
Query: 196 VYEDLIEATEDF---------DIRYCIGTGGYGSV--YKAQLPNGKVF--ALKKLHTSEE 242
            YED  +   +F          I   +G G +G V   + +LP+ K    A+K L     
Sbjct: 27  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 243 LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAV 300
               + F  EA ++ Q  H NI++L G     K + ++ EYME GSL  F   H+ +  V
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 301 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA 360
                + V +++ +A  + YL        +HRD+++ NIL+NS L   V+DFG +R+L  
Sbjct: 147 ----IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 361 DSSNRTLLAGT---YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXX 416
           D        G      + +PE       T   DV+S+G+V  EV+  G+ P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----YWEMS 255
Query: 417 XXDPKIMLIDVLDQ--RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
             D    +I  +D+  RLPPP+D       L++      C Q +  +RP  + +
Sbjct: 256 NQD----VIKAVDEGYRLPPPMDCPAALYQLMLD-----CWQKDRNNRPKFEQI 300

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 131/294 (44%), Gaps = 41/294 (13%)
Query: 196 VYEDLIEATEDF---------DIRYCIGTGGYGSV--YKAQLPNGKVF--ALKKLHTSEE 242
            YED  +   +F          I   +G G +G V   + +LP+ K    A+K L     
Sbjct: 25  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 84
Query: 243 LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAV 300
               + F  EA ++ Q  H NI++L G     K + ++ EYME GSL  F   H+ +  V
Sbjct: 85  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 144
Query: 301 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA 360
                + V +++ +A  + YL        +HRD+++ NIL+NS L   V+DFG +R+L  
Sbjct: 145 ----IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 197
Query: 361 DSSNRTLLAGT---YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXX 416
           D        G      + +PE       T   DV+S+G+V  EV+  G+ P         
Sbjct: 198 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----YWEMS 253
Query: 417 XXDPKIMLIDVLDQ--RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
             D    +I  +D+  RLPPP+D       L++      C Q +  +RP  + +
Sbjct: 254 NQD----VIKAVDEGYRLPPPMDCPAALYQLMLD-----CWQKDRNNRPKFEQI 298

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 131/294 (44%), Gaps = 41/294 (13%)
Query: 196 VYEDLIEATEDF---------DIRYCIGTGGYGSV--YKAQLPNGKVF--ALKKLHTSEE 242
            +ED  +   +F          I   +G G +G V   + +LP+ K    A+K L     
Sbjct: 27  TFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 243 LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAV 300
               + F  EA ++ Q  H NI++L G     K + ++ EYME GSL  F   H+ +  V
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 301 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA 360
                + V +++ +A  + YL        +HRD+++ NIL+NS L   V+DFG AR+L  
Sbjct: 147 ----IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLED 199
Query: 361 DSSNRTLLAGT---YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXX 416
           D        G      + +PE       T   DV+S+G+V  EV+  G+ P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----YWEMS 255
Query: 417 XXDPKIMLIDVLDQ--RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
             D    +I  +D+  RLPPP+D       L++      C Q +  +RP  + +
Sbjct: 256 NQD----VIKAVDEGYRLPPPMDCPAALYQLMLD-----CWQKDRNNRPKFEQI 300

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 131/294 (44%), Gaps = 41/294 (13%)
Query: 196 VYEDLIEATEDF---------DIRYCIGTGGYGSV--YKAQLPNGKVF--ALKKLHTSEE 242
            YED  +   +F          I   +G G +G V   + +LP+ K    A+K L     
Sbjct: 27  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 243 LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAV 300
               + F  EA ++ Q  H NI++L G     K + ++ EYME GSL  F   H+ +  V
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 301 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA 360
                + V +++ +A  + YL        +HRD+++ NIL+NS L   V+DFG +R+L  
Sbjct: 147 ----IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 361 DSSNRTLLAGT---YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXX 416
           D        G      + +PE       T   DV+S+G+V  EV+  G+ P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----YWEMS 255
Query: 417 XXDPKIMLIDVLDQ--RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
             D    +I  +D+  RLPPP+D       L++      C Q +  +RP  + +
Sbjct: 256 NQD----VIKAVDEGYRLPPPMDCPAALYQLMLD-----CWQKDRNNRPKFEQI 300

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 131/294 (44%), Gaps = 41/294 (13%)
Query: 196 VYEDLIEATEDF---------DIRYCIGTGGYGSV--YKAQLPNGKVF--ALKKLHTSEE 242
            +ED  +   +F          I   +G G +G V   + +LP+ K    A+K L     
Sbjct: 27  TFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 243 LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAV 300
               + F  EA ++ Q  H NI++L G     K + ++ EYME GSL  F   H+ +  V
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 301 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA 360
                + V +++ +A  + YL        +HRD+++ NIL+NS L   V+DFG +R+L  
Sbjct: 147 ----IQLVGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 361 DSSNRTLLAGT---YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXX 416
           D        G      + +PE       T   DV+S+G+V  EV+  G+ P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----YWEMS 255
Query: 417 XXDPKIMLIDVLDQ--RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
             D    +I  +D+  RLPPP+D       L++      C Q +  +RP  + +
Sbjct: 256 NQD----VIKAVDEGYRLPPPMDCPAALYQLMLD-----CWQKDRNNRPKFEQI 300

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 138/293 (47%), Gaps = 48/293 (16%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKL------HTSEELAFIKSFKNEAQV 255
           A  + +    IG GG+G V+K +L   K V A+K L        +E +   + F+ E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 315
           +S + H NIVKLYG   +   M  + E++  G L+  L +   A  + W+ ++ ++  +A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIA 132
Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLE-----AFVADFGTARL-LHADSSNRTLLA 369
             + Y+ +  +P I+HRD+ S NI L S  E     A VADFGT++  +H+ S     L 
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSG----LL 187
Query: 370 GTYGYIAPEL--AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDV 427
           G + ++APE   A     TEK D YSF ++   +L G+ P D           KI  I++
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG------KIKFINM 241
Query: 428 LDQR-----LP---PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           + +      +P   PP  R VI            C   +PK RP    + +E 
Sbjct: 242 IREEGLRPTIPEDCPPRLRNVIE----------LCWSGDPKKRPHFSYIVKEL 284

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 128/294 (43%), Gaps = 39/294 (13%)
Query: 195 IVYEDLIEATEDF---------DIRYCIGTGGYGSVYKAQL--PNGK--VFALKKLHTSE 241
             +ED  +A  +F          I   IG G +G V   +L  P  +    A+K L    
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 242 ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE 301
                + F +EA ++ Q  H NI+ L G     K + +I EYME GSL   L  N+    
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT 129
Query: 302 LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD 361
           +   + V +++ +   + YL      S +HRD+++ NIL+NS L   V+DFG +R+L  D
Sbjct: 130 V--IQLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 184
Query: 362 SSNRTLLAGT---YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP-RDIXXXXXX 416
                   G      + APE       T   DV+S+G+V  EV+  G+ P  D+      
Sbjct: 185 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-- 242
Query: 417 XXDPKIMLIDVLDQ--RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
                  +I  +++  RLPPP+D  +    L++      C Q     RP    +
Sbjct: 243 -------VIKAIEEGYRLPPPMDCPIALHQLMLD-----CWQKERSDRPKFGQI 284

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 130/280 (46%), Gaps = 33/280 (11%)
Query: 201 IEATEDFDIRYCIGTGGYGSV--YKAQLPNGKVF--ALKKLHTSEELAFIKSFKNEAQVL 256
           ++AT +  I   +G G +G V   + +LP+ K    A+K L         + F  EA ++
Sbjct: 30  LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 88
Query: 257 SQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAM 314
            Q  H NI++L G     K + ++ EYME GSL  F   H+ +  V     + V +++ +
Sbjct: 89  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV----IQLVGMLRGI 144
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT--- 371
           A  + YL        +HRD+++ NIL+NS L   V+DFG +R+L  D        G    
Sbjct: 145 ASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 201
Query: 372 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQ 430
             + +PE       T   DV+S+G+V  EV+  G+ P           D    +I  +D+
Sbjct: 202 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----YWEMSNQD----VIKAVDE 253
Query: 431 --RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
             RLPPP+D       L++      C Q +  +RP  + +
Sbjct: 254 GYRLPPPMDCPAALYQLMLD-----CWQKDRNNRPKFEQI 288

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 124/268 (46%), Gaps = 32/268 (11%)
Query: 213 IGTGGYGSVY--KAQLPNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           +G G +G V   + +LP+ K    A+K L         + F  EA ++ Q  H NI++L 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 269 GYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
           G     K + ++ EYME GSL  F   H+ +  V     + V +++ +A  + YL     
Sbjct: 84  GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV----IQLVGMLRGIASGMKYL---SD 136
Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIAPELAYTM 383
              +HRD+++ NIL+NS L   V+DFG +R+L  D        G      + +PE     
Sbjct: 137 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 196
Query: 384 VMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQ--RLPPPVDRKV 440
             T   DV+S+G+V  EV+  G+ P           D    +I  +D+  RLPPP+D   
Sbjct: 197 KFTSASDVWSYGIVLWEVMSYGERP----YWEMSNQD----VIKAVDEGYRLPPPMDCPA 248
Query: 441 IRDILLISTVSFACLQSNPKSRPTMQSV 468
               L++      C Q +  +RP  + +
Sbjct: 249 ALYQLMLD-----CWQKDRNNRPKFEQI 271

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 130/294 (44%), Gaps = 41/294 (13%)
Query: 196 VYEDLIEATEDF---------DIRYCIGTGGYGSV--YKAQLPNGKVF--ALKKLHTSEE 242
            +ED  +   +F          I   +G G +G V   + +LP+ K    A+K L     
Sbjct: 27  TFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 243 LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAV 300
               + F  EA ++ Q  H NI++L G     K + ++ EYME GSL  F   H+ +  V
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 301 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA 360
                + V +++ +A  + YL        +HRD+++ NIL+NS L   V+DFG  R+L  
Sbjct: 147 ----IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199
Query: 361 DSSNRTLLAGT---YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXX 416
           D        G      + +PE       T   DV+S+G+V  EV+  G+ P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----YWEMS 255
Query: 417 XXDPKIMLIDVLDQ--RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
             D    +I  +D+  RLPPP+D       L++      C Q +  +RP  + +
Sbjct: 256 NQD----VIKAVDEGYRLPPPMDCPAALYQLMLD-----CWQKDRNNRPKFEQI 300

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 100/204 (49%), Gaps = 14/204 (6%)
Query: 213 IGTGGYGSVYKAQL--PNGKV---FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           IG G +G VYK  L   +GK     A+K L           F  EA ++ Q  H NI++L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
            G     K M +I EYME G+L   L   +   E    + V +++ +A  + YL    + 
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIAPELAYTMV 384
           + +HRD+++ NIL+NS L   V+DFG +R+L  D       +G      + APE      
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226
Query: 385 MTEKCDVYSFGVVTLEVLM-GKHP 407
            T   DV+SFG+V  EV+  G+ P
Sbjct: 227 FTSASDVWSFGIVMWEVMTYGERP 250

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 125/272 (45%), Gaps = 32/272 (11%)
Query: 209 IRYCIGTGGYGSV--YKAQLPNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           I   +G G +G V   + +LP+ K    A+K L         + F  EA ++ Q  H NI
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
           ++L G     K + ++ EYME GSL  F   H+ +  V     + V +++ +A  + YL 
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV----IQLVGMLRGIASGMKYL- 163
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIAPEL 379
                  +HRD+++ NIL+NS L   V+DFG +R+L  D        G      + +PE 
Sbjct: 164 --SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 380 AYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQ--RLPPPV 436
                 T   DV+S+G+V  EV+  G+ P           D    +I  +D+  RLPPP+
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERP----YWEMSNQD----VIKAVDEGYRLPPPM 273
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
           D       L++      C Q +  +RP  + +
Sbjct: 274 DCPAALYQLMLD-----CWQKDRNNRPKFEQI 300

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 131/294 (44%), Gaps = 41/294 (13%)
Query: 196 VYEDLIEATEDF---------DIRYCIGTGGYGSV--YKAQLPNGKVF--ALKKLHTSEE 242
            +ED  +   +F          I   +G G +G V   + +LP+ K    A+K L     
Sbjct: 27  TFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 243 LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAV 300
               + F  EA ++ Q  H NI++L G     K + ++ EYME GSL  F   H+ +  V
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 301 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA 360
                + V +++ +A  + YL        +HRD+++ NIL+NS L   V+DFG +R+L  
Sbjct: 147 ----IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 361 DSSNRTLLAGT---YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXX 416
           D        G      + +PE       T   DV+S+G+V  EV+  G+ P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----YWEMS 255
Query: 417 XXDPKIMLIDVLDQ--RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
             D    +I  +D+  RLPPP+D       L++      C Q +  +RP  + +
Sbjct: 256 NQD----VIKAVDEGYRLPPPMDCPAALYQLMLD-----CWQKDRNNRPKFEQI 300

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 121/271 (44%), Gaps = 30/271 (11%)
Query: 209 IRYCIGTGGYGSVYKAQL--PNGK--VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           I   IG G +G V   +L  P  +    A+K L         + F +EA ++ Q  H NI
Sbjct: 12  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNI 71
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           + L G     K + +I EYME GSL   L  N+    +   + V +++ +   + YL   
Sbjct: 72  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLS-- 127
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIAPELAY 381
              S +HRD+++ NIL+NS L   V+DFG +R+L  D        G      + APE   
Sbjct: 128 -DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 186
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHP-RDIXXXXXXXXDPKIMLIDVLDQ--RLPPPVD 437
               T   DV+S+G+V  EV+  G+ P  D+             +I  +++  RLPPP+D
Sbjct: 187 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---------VIKAIEEGYRLPPPMD 237
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
             +    L++      C Q     RP    +
Sbjct: 238 CPIALHQLMLD-----CWQKERSDRPKFGQI 263

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 121/271 (44%), Gaps = 30/271 (11%)
Query: 209 IRYCIGTGGYGSVYKAQL--PNGK--VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           I   IG G +G V   +L  P  +    A+K L         + F +EA ++ Q  H NI
Sbjct: 18  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNI 77
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           + L G     K + +I EYME GSL   L  N+    +   + V +++ +   + YL   
Sbjct: 78  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLS-- 133
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIAPELAY 381
              S +HRD+++ NIL+NS L   V+DFG +R+L  D        G      + APE   
Sbjct: 134 -DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 192
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHP-RDIXXXXXXXXDPKIMLIDVLDQ--RLPPPVD 437
               T   DV+S+G+V  EV+  G+ P  D+             +I  +++  RLPPP+D
Sbjct: 193 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---------VIKAIEEGYRLPPPMD 243
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
             +    L++      C Q     RP    +
Sbjct: 244 CPIALHQLMLD-----CWQKERSDRPKFGQI 269

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 21/205 (10%)
Query: 213 IGTGGYGSVYK-AQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           +G G +G   K      G+V  +K+L   +E    ++F  E +V+  + H N++K  G  
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEET-QRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
              K +  I EY++ G+L   + + +   +  W++RV+  K +A  +AYLH   S +IIH
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLH---SMNIIH 131
Query: 332 RDISSNNILLNSKLEAFVADFGTARLL--------------HADSSNRTLLAGTYGYIAP 377
           RD++S+N L+       VADFG ARL+                D   R  + G   ++AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVL 402
           E+       EK DV+SFG+V  E++
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 202 EATEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           +  E FD+   +G G YGSVYKA     G++ A+K++    +L   +    E  ++ Q  
Sbjct: 26  QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL---QEIIKEISIMQQCD 82
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSL--FCNLHNN---EDAVELDWAKRVNIVKAMA 315
             ++VK YG       ++++ EY   GS+     L N    ED +         I+++  
Sbjct: 83  SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEI-------ATILQSTL 135
Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI 375
             L YLH       IHRDI + NILLN++  A +ADFG A  L    + R  + GT  ++
Sbjct: 136 KGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWM 192
Query: 376 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           APE+   +      D++S G+  +E+  GK P
Sbjct: 193 APEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 137/293 (46%), Gaps = 48/293 (16%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKL------HTSEELAFIKSFKNEAQV 255
           A  + +    IG GG+G V+K +L   K V A+K L        +E +   + F+ E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 315
           +S + H NIVKLYG   +   M  + E++  G L+  L +   A  + W+ ++ ++  +A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIA 132
Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLE-----AFVADFG-TARLLHADSSNRTLLA 369
             + Y+ +  +P I+HRD+ S NI L S  E     A VADFG + + +H+ S     L 
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSG----LL 187
Query: 370 GTYGYIAPEL--AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDV 427
           G + ++APE   A     TEK D YSF ++   +L G+ P D           KI  I++
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG------KIKFINM 241
Query: 428 LDQR-----LP---PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           + +      +P   PP  R VI            C   +PK RP    + +E 
Sbjct: 242 IREEGLRPTIPEDCPPRLRNVIE----------LCWSGDPKKRPHFSYIVKEL 284

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 130/294 (44%), Gaps = 41/294 (13%)
Query: 196 VYEDLIEATEDF---------DIRYCIGTGGYGSV--YKAQLPNGKVF--ALKKLHTSEE 242
            YED  +   +F          I   +G G +G V   + +LP+ K    A+K L     
Sbjct: 27  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 243 LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAV 300
               + F  EA ++ Q  H NI++L G     K + ++ E ME GSL  F   H+ +  V
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV 146
Query: 301 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA 360
                + V +++ +A  + YL        +HRD+++ NIL+NS L   V+DFG +R+L  
Sbjct: 147 ----IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 361 DSSNRTLLAGT---YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXX 416
           D        G      + +PE       T   DV+S+G+V  EV+  G+ P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----YWEMS 255
Query: 417 XXDPKIMLIDVLDQ--RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
             D    +I  +D+  RLPPP+D       L++      C Q +  +RP  + +
Sbjct: 256 NQD----VIKAVDEGYRLPPPMDCPAALYQLMLD-----CWQKDRNNRPKFEQI 300

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 128/268 (47%), Gaps = 31/268 (11%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL 272
           +G G +G V+          A+K L         +SF  EAQ++ ++ H  +V+LY   +
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPG--TMSPESFLEEAQIMKKLKHDKLVQLYA-VV 73
Query: 273 HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR 332
            ++ ++++ EYM +GSL   L + E    L     V++   +A  +AY+      + IHR
Sbjct: 74  SEEPIYIVTEYMNKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIER---MNYIHR 129
Query: 333 DISSNNILLNSKLEAFVADFGTARLLHA-DSSNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           D+ S NIL+ + L   +ADFG ARL+   + + R        + APE A     T K DV
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 392 YSFGVVTLE-VLMGKHPRDIXXXXXXXXDPKIMLIDVLDQ-----RLPPPVDRKVIRDIL 445
           +SFG++  E V  G+ P            P +   +VL+Q     R+P P D  +    L
Sbjct: 190 WSFGILLTELVTKGRVPY-----------PGMNNREVLEQVERGYRMPCPQDCPISLHEL 238
Query: 446 LISTVSFACLQSNPKSRPTMQSVSQEFL 473
           +I      C + +P+ RPT + + Q FL
Sbjct: 239 MIH-----CWKKDPEERPTFEYL-QSFL 260

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 118/216 (54%), Gaps = 21/216 (9%)
Query: 201 IEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLH----TSEELAFIKSFKNEAQVL 256
           IEA+E   +   IG+G +G+VYK +  +G V A+K L     T E+    ++F+NE  VL
Sbjct: 33  IEASEVM-LSTRIGSGSFGTVYKGKW-HGDV-AVKILKVVDPTPEQF---QAFRNEVAVL 86
Query: 257 SQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 316
            +  H NI+   GY + K  + ++ ++ E  SL+ +LH  E   ++   + ++I +  A 
Sbjct: 87  RKTRHVNILLFMGY-MTKDNLAIVTQWCEGSSLYKHLHVQETKFQM--FQLIDIARQTAQ 143
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL--AGTYGY 374
            + YLH   + +IIHRD+ SNNI L+  L   + DFG A +    S ++ +    G+  +
Sbjct: 144 GMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLW 200
Query: 375 IAPELAYTM---VMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+         + + DVYS+G+V  E++ G+ P
Sbjct: 201 MAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 130/294 (44%), Gaps = 41/294 (13%)
Query: 196 VYEDLIEATEDF---------DIRYCIGTGGYGSV--YKAQLPNGKVF--ALKKLHTSEE 242
            +ED  +   +F          I   +G G +G V   + +LP+ K    A+K L     
Sbjct: 27  TFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 243 LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAV 300
               + F  EA ++ Q  H NI++L G     K + ++ E ME GSL  F   H+ +  V
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV 146
Query: 301 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA 360
                + V +++ +A  + YL        +HRD+++ NIL+NS L   V+DFG +R+L  
Sbjct: 147 ----IQLVGMLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 361 DSSNRTLLAGT---YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXX 416
           D        G      + +PE       T   DV+S+G+V  EV+  G+ P         
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----YWEMS 255
Query: 417 XXDPKIMLIDVLDQ--RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
             D    +I  +D+  RLPPP+D       L++      C Q +  +RP  + +
Sbjct: 256 NQD----VIKAVDEGYRLPPPMDCPAALYQLMLD-----CWQKDRNNRPKFEQI 300

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 129/280 (46%), Gaps = 33/280 (11%)
Query: 201 IEATEDFDIRYCIGTGGYGSVY--KAQLPNGKVF--ALKKLHTSEELAFIKSFKNEAQVL 256
           ++AT +  I   +G G +G V   + +LP+ K    A+K L         + F  EA ++
Sbjct: 13  LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 257 SQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAM 314
            Q  H NI++L G     K + ++ E ME GSL  F   H+ +  V     + V +++ +
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV----IQLVGMLRGI 127
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT--- 371
           A  + YL        +HRD+++ NIL+NS L   V+DFG +R+L  D        G    
Sbjct: 128 ASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 184
Query: 372 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQ 430
             + +PE       T   DV+S+G+V  EV+  G+ P           D    +I  +D+
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP----YWEMSNQD----VIKAVDE 236
Query: 431 --RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
             RLPPP+D       L++      C Q +  +RP  + +
Sbjct: 237 GYRLPPPMDCPAALYQLMLD-----CWQKDRNNRPKFEQI 271

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 123/290 (42%), Gaps = 33/290 (11%)
Query: 196 VYEDLIEATEDF---------DIRYCIGTGGYGSVY--KAQLPNGKVF--ALKKLHTSEE 242
            YED  +A  +F          I   IG G +G V   + +LP  +    A+K L     
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 243 LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVEL 302
               + F  EA ++ Q  H NI+ L G     K + ++ EYME GSL   L  N+    +
Sbjct: 64  EKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV 123
Query: 303 DWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS 362
              + V +++ ++  + YL        +HRD+++ NIL+NS L   V+DFG +R+L  D 
Sbjct: 124 --IQLVGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 178
Query: 363 SNRTLLAGT---YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXX 418
                  G      + APE       T   DV+S+G+V  EV+  G+ P           
Sbjct: 179 EAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP------YWEMT 232
Query: 419 DPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
           +  ++       RLP P+D       L++      C Q    SRP    +
Sbjct: 233 NQDVIKAVEEGYRLPSPMDCPAALYQLMLD-----CWQKERNSRPKFDEI 277

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 132/277 (47%), Gaps = 33/277 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E   +   +G G +G V+          A+K L         ++F  EAQV+ ++ H  +
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKL 75
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+LY   + ++ ++++ EYM +GSL  +    E    L   + V++   +A  +AY+   
Sbjct: 76  VQLYA-VVSEEPIYIVTEYMSKGSLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTM 383
              + +HRD+++ NIL+   L   VADFG ARL+  +  + R        + APE A   
Sbjct: 134 ---NYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQ-----RLP-PPV 436
             T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P PP 
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCPPE 239
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
             + + D++        C + +P+ RPT + + Q FL
Sbjct: 240 CPESLHDLMC------QCWRKDPEERPTFEYL-QAFL 269

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 131/277 (47%), Gaps = 33/277 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E   +   +G G +G V+          A+K L         ++F  EAQV+ ++ H  +
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKIRHEKL 75
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+LY   + ++ ++++ EYM +GSL  +    E    L   + V++   +A  +AY+   
Sbjct: 76  VQLYA-VVSEEPIYIVTEYMSKGSLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTM 383
              + +HRD+ + NIL+   L   VADFG ARL+  +  + R        + APE A   
Sbjct: 134 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQ-----RLP-PPV 436
             T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P PP 
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCPPE 239
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
             + + D++        C + +P+ RPT + + Q FL
Sbjct: 240 CPESLHDLMC------QCWRKDPEERPTFEYL-QAFL 269

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 130/277 (46%), Gaps = 33/277 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E   +   +G G +G V+          A+K L         ++F  EAQV+ ++ H  +
Sbjct: 11  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKL 68
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+LY   + ++ ++++ EYM +GSL  +    E    L   + V++   +A  +AY+   
Sbjct: 69  VQLYA-VVSEEPIYIVTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 126
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTM 383
              + +HRD+ + NIL+   L   VADFG ARL+  +  + R        + APE A   
Sbjct: 127 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 183
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQ-----RLP-PPV 436
             T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P PP 
Sbjct: 184 RFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCPPE 232
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
             + + D++        C +  P+ RPT + + Q FL
Sbjct: 233 CPESLHDLMC------QCWRKEPEERPTFEYL-QAFL 262

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 130/277 (46%), Gaps = 33/277 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E   +   +G G +G V+          A+K L         ++F  EAQV+ ++ H  +
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKL 324
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+LY   + ++ ++++ EYM +GSL  +    E    L   + V++   +A  +AY+   
Sbjct: 325 VQLYA-VVSEEPIYIVTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTM 383
              + +HRD+ + NIL+   L   VADFG ARL+  +  + R        + APE A   
Sbjct: 383 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 439
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQ-----RLP-PPV 436
             T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P PP 
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCPPE 488
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
             + + D++        C +  P+ RPT + + Q FL
Sbjct: 489 CPESLHDLMC------QCWRKEPEERPTFEYL-QAFL 518

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 131/277 (47%), Gaps = 33/277 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E   +   +G G +G V+          A+K L         ++F  EAQV+ ++ H  +
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKL 64
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+LY   + ++ ++++ EYM +GSL  +    E    L   + V++   +A  +AY+   
Sbjct: 65  VQLYA-VVSEEPIYIVTEYMSKGSLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 122
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTM 383
              + +HRD+ + NIL+   L   VADFG ARL+  +  + R        + APE A   
Sbjct: 123 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 179
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQ-----RLP-PPV 436
             T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P PP 
Sbjct: 180 RFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCPPE 228
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
             + + D++        C + +P+ RPT + + Q FL
Sbjct: 229 CPESLHDLMC------QCWRKDPEERPTFEYL-QAFL 258

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 131/277 (47%), Gaps = 33/277 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E   +   +G G +G V+          A+K L         ++F  EAQV+ ++ H  +
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKL 75
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+LY   + ++ ++++ EYM +GSL  +    E    L   + V++   +A  +AY+   
Sbjct: 76  VQLYA-VVSEEPIYIVIEYMSKGSLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA-DSSNRTLLAGTYGYIAPELAYTM 383
              + +HRD+ + NIL+   L   VADFG ARL+   + + R        + APE A   
Sbjct: 134 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYG 190
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQ-----RLP-PPV 436
             T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P PP 
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCPPE 239
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
             + + D++        C + +P+ RPT + + Q FL
Sbjct: 240 CPESLHDLMC------QCWRKDPEERPTFEYL-QAFL 269

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 130/277 (46%), Gaps = 33/277 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E   +   +G G +G V+          A+K L         ++F  EAQV+ ++ H  +
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKL 241
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+LY   + ++ ++++ EYM +GSL  +    E    L   + V++   +A  +AY+   
Sbjct: 242 VQLYA-VVSEEPIYIVTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVER- 298
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTM 383
              + +HRD+ + NIL+   L   VADFG ARL+  +  + R        + APE A   
Sbjct: 299 --MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQ-----RLP-PPV 436
             T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P PP 
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCPPE 405
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
             + + D++        C +  P+ RPT + + Q FL
Sbjct: 406 CPESLHDLMC------QCWRKEPEERPTFEYL-QAFL 435

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 136/293 (46%), Gaps = 48/293 (16%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK-VFALKKL------HTSEELAFIKSFKNEAQV 255
           A  + +    IG GG+G V+K +L   K V A+K L        +E +   + F+ E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 315
           +S + H NIVKLYG   +   M  + E++  G L+  L +   A  + W+ ++ ++  +A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIA 132
Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLE-----AFVADFG-TARLLHADSSNRTLLA 369
             + Y+ +  +P I+HRD+ S NI L S  E     A VADF  + + +H+ S     L 
Sbjct: 133 LGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSG----LL 187
Query: 370 GTYGYIAPEL--AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDV 427
           G + ++APE   A     TEK D YSF ++   +L G+ P D           KI  I++
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG------KIKFINM 241
Query: 428 LDQR-----LP---PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           + +      +P   PP  R VI            C   +PK RP    + +E 
Sbjct: 242 IREEGLRPTIPEDCPPRLRNVIE----------LCWSGDPKKRPHFSYIVKEL 284

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 130/277 (46%), Gaps = 33/277 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E   +   +G G +G V+          A+K L         ++F  EAQV+ ++ H  +
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKL 241
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+LY   + ++ ++++ EYM +GSL  +    E    L   + V++   +A  +AY+   
Sbjct: 242 VQLYA-VVSEEPIYIVTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVER- 298
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTM 383
              + +HRD+ + NIL+   L   VADFG ARL+  +  + R        + APE A   
Sbjct: 299 --MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQ-----RLP-PPV 436
             T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P PP 
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCPPE 405
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
             + + D++        C +  P+ RPT + + Q FL
Sbjct: 406 CPESLHDLMC------QCWRKEPEERPTFEYL-QAFL 435

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 131/277 (47%), Gaps = 33/277 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E   +   +G G +G V+          A+K L         ++F  EAQV+ ++ H  +
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKL 66
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+LY   + ++ ++++ EYM +GSL  +    E    L   + V++   +A  +AY+   
Sbjct: 67  VQLYA-VVSEEPIYIVTEYMSKGSLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 124
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTM 383
              + +HRD+ + NIL+   L   VADFG ARL+  +  + R        + APE A   
Sbjct: 125 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 181
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQ-----RLP-PPV 436
             T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P PP 
Sbjct: 182 RFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCPPE 230
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
             + + D++        C + +P+ RPT + + Q FL
Sbjct: 231 CPESLHDLMC------QCWRKDPEERPTFEYL-QAFL 260

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHR 262
           ED+++ Y IGTG YG   K +   +GK+   K+L + S   A  +   +E  +L ++ H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 263 NIVKLYGYCLHKK--CMFLIYEYMERGSLFCNL-HNNEDAVELDWAKRVNIVKAMAHALA 319
           NIV+ Y   + +    ++++ EY E G L   +    ++   LD    + ++  +  AL 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 320 YLHH--DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
             H   D   +++HRD+   N+ L+ K    + DFG AR+L+ D+S      GT  Y++P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEV 401
           E    M   EK D++S G +  E+
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 131/277 (47%), Gaps = 33/277 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E   +   +G G +G V+          A+K L         ++F  EAQV+ ++ H  +
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKL 75
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+LY   + ++ ++++ EYM +GSL  +    E    L   + V++   +A  +AY+   
Sbjct: 76  VQLYA-VVSEEPIYIVTEYMSKGSLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTM 383
              + +HRD+ + NIL+   L   VADFG ARL+  +  + R        + APE A   
Sbjct: 134 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQ-----RLP-PPV 436
             T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P PP 
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCPPE 239
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
             + + D++        C + +P+ RPT + + Q FL
Sbjct: 240 CPESLHDLMC------QCWRKDPEERPTFEYL-QAFL 269

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 131/277 (47%), Gaps = 33/277 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E   +   +G G +G V+          A+K L         ++F  EAQV+ ++ H  +
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKL 75
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+LY   + ++ ++++ EYM +GSL  +    E    L   + V++   +A  +AY+   
Sbjct: 76  VQLYA-VVSEEPIYIVIEYMSKGSLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTM 383
              + +HRD+ + NIL+   L   VADFG ARL+  +  + R        + APE A   
Sbjct: 134 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQ-----RLP-PPV 436
             T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P PP 
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCPPE 239
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
             + + D++        C + +P+ RPT + + Q FL
Sbjct: 240 CPESLHDLMC------QCWRKDPEERPTFEYL-QAFL 269

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 130/277 (46%), Gaps = 33/277 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E   +   +G G +G V+          A+K L         ++F  EAQV+ ++ H  +
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKL 72
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+LY   + ++ ++++ EYM +GSL  +    E    L   + V++   +A  +AY+   
Sbjct: 73  VQLYA-VVSEEPIYIVTEYMNKGSLL-DFLKGETGKYLRLPQLVDMSAQIASGMAYVERM 130
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTM 383
              + +HRD+ + NIL+   L   VADFG ARL+  +  + R        + APE A   
Sbjct: 131 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYG 187
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQ-----RLP-PPV 436
             T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P PP 
Sbjct: 188 RFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCPPE 236
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
             + + D++        C +  P+ RPT + + Q FL
Sbjct: 237 CPESLHDLMC------QCWRKEPEERPTFEYL-QAFL 266

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHR 262
           ED+++ Y IGTG YG   K +   +GK+   K+L + S   A  +   +E  +L ++ H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 263 NIVKLYGYCLHKK--CMFLIYEYMERGSLFCNL-HNNEDAVELDWAKRVNIVKAMAHALA 319
           NIV+ Y   + +    ++++ EY E G L   +    ++   LD    + ++  +  AL 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 320 YLHH--DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
             H   D   +++HRD+   N+ L+ K    + DFG AR+L+ D+S      GT  Y++P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 185
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEV 401
           E    M   EK D++S G +  E+
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 130/277 (46%), Gaps = 33/277 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E   +   +G G +G V+          A+K L         ++F  EAQV+ ++ H  +
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKL 72
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+LY   + ++ ++++ EYM +GSL  +    E    L   + V++   +A  +AY+   
Sbjct: 73  VQLYA-VVSEEPIYIVTEYMNKGSLL-DFLKGETGKYLRLPQLVDMSAQIASGMAYVERM 130
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTM 383
              + +HRD+ + NIL+   L   VADFG ARL+  +  + R        + APE A   
Sbjct: 131 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 187
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQ-----RLP-PPV 436
             T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P PP 
Sbjct: 188 RFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCPPE 236
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
             + + D++        C +  P+ RPT + + Q FL
Sbjct: 237 CPESLHDLMC------QCWRKEPEERPTFEYL-QAFL 266

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 130/277 (46%), Gaps = 33/277 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E   +   +G G +G V+          A+K L         ++F  EAQV+ ++ H  +
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKL 241
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+LY   + ++ ++++ EYM +GSL  +    E    L   + V++   +A  +AY+   
Sbjct: 242 VQLYA-VVSEEPIYIVGEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVER- 298
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTM 383
              + +HRD+ + NIL+   L   VADFG ARL+  +  + R        + APE A   
Sbjct: 299 --MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQ-----RLP-PPV 436
             T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P PP 
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCPPE 405
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
             + + D++        C +  P+ RPT + + Q FL
Sbjct: 406 CPESLHDLMC------QCWRKEPEERPTFEYL-QAFL 435

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 131/277 (47%), Gaps = 33/277 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E   +   +G G +G V+          A+K L         ++F  EAQV+ ++ H  +
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKL 75
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+LY   + ++ ++++ EYM +GSL  +    E    L   + V++   +A  +AY+   
Sbjct: 76  VQLYA-VVSEEPIYIVCEYMSKGSLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTM 383
              + +HRD+ + NIL+   L   VADFG ARL+  +  + R        + APE A   
Sbjct: 134 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQ-----RLP-PPV 436
             T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P PP 
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCPPE 239
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
             + + D++        C + +P+ RPT + + Q FL
Sbjct: 240 CPESLHDLMC------QCWRKDPEERPTFEYL-QAFL 269

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 129/277 (46%), Gaps = 33/277 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E   +   +G G +G V+          A+K L         ++F  EAQV+ ++ H  +
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKL 65
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+LY   + ++ + ++ EYM +GSL  +    E    L   + V++   +A  +AY+   
Sbjct: 66  VQLYA-VVSEEPIXIVTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 123
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA-DSSNRTLLAGTYGYIAPELAYTM 383
              + +HRD+ + NIL+   L   VADFG ARL+   + + R        + APE A   
Sbjct: 124 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYG 180
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQ-----RLP-PPV 436
             T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P PP 
Sbjct: 181 RFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCPPE 229
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
             + + D++        C +  P+ RPT + + Q FL
Sbjct: 230 CPESLHDLMC------QCWRKEPEERPTFEYL-QAFL 259

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 115/265 (43%), Gaps = 19/265 (7%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G +G V+K       KV A+K +   E    I+  + E  VLSQ     + K YG  
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
           L    +++I EY+  GS    L        LD  +   I++ +   L YLH   S   IH
Sbjct: 95  LKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLH---SEKKIH 147
Query: 332 RDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           RDI + N+LL+   E  +ADFG A  L      R    GT  ++APE+        K D+
Sbjct: 148 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 207
Query: 392 YSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVS 451
           +S G+  +E+  G+ P            P  +L  ++ +  PP ++    +    +    
Sbjct: 208 WSLGITAIELARGEPPHS-------ELHPMKVLF-LIPKNNPPTLEGNYSKP---LKEFV 256
Query: 452 FACLQSNPKSRPTMQSVSQEFLITR 476
            ACL   P  RPT + + +   I R
Sbjct: 257 EACLNKEPSFRPTAKELLKHKFILR 281

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 116/265 (43%), Gaps = 19/265 (7%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G +G V+K       KV A+K +   E    I+  + E  VLSQ     + K YG  
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
           L    +++I EY+  GS    L    +   LD  +   I++ +   L YLH   S   IH
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH---SEKKIH 142
Query: 332 RDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           RDI + N+LL+   E  +ADFG A  L      R    GT  ++APE+        K D+
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADI 202
Query: 392 YSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVS 451
           +S G+  +E+  G+ P            P  +L  ++ +  PP ++    +    +    
Sbjct: 203 WSLGITAIELARGEPPHS-------ELHPMKVLF-LIPKNNPPTLEGNYSKP---LKEFV 251
Query: 452 FACLQSNPKSRPTMQSVSQEFLITR 476
            ACL   P  RPT + + +   I R
Sbjct: 252 EACLNKEPSFRPTAKELLKHKFILR 276

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 116/265 (43%), Gaps = 19/265 (7%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G +G V+K       KV A+K +   E    I+  + E  VLSQ     + K YG  
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
           L    +++I EY+  GS    L    +   LD  +   I++ +   L YLH   S   IH
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH---SEKKIH 127
Query: 332 RDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           RDI + N+LL+   E  +ADFG A  L      R    GT  ++APE+        K D+
Sbjct: 128 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADI 187
Query: 392 YSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVS 451
           +S G+  +E+  G+ P            P  +L  ++ +  PP ++    +    +    
Sbjct: 188 WSLGITAIELARGEPPHS-------ELHPMKVLF-LIPKNNPPTLEGNYSKP---LKEFV 236
Query: 452 FACLQSNPKSRPTMQSVSQEFLITR 476
            ACL   P  RPT + + +   I R
Sbjct: 237 EACLNKEPSFRPTAKELLKHKFILR 261

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 73/211 (34%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 213 IGTGGYGSVYKAQLPNG---------KVFALKKLHTSEELAFIKSFK----NEAQVLSQV 259
           +G+G YG V   +  NG         K     K   S++   I+ F     NE  +L  +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI+KL+     KK  +L+ E+ E G LF  + N     E D A   NI+K +   + 
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA---NIMKQILSGIC 160
Query: 320 YLHHDCSPSIIHRDISSNNILL---NSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           YLH     +I+HRDI   NILL   NS L   + DFG +     D   R  L   Y YIA
Sbjct: 161 YLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAY-YIA 216
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PE+       EKCDV+S GV+   +L G  P
Sbjct: 217 PEVL-KKKYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 116/265 (43%), Gaps = 19/265 (7%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G +G V+K       KV A+K +   E    I+  + E  VLSQ     + K YG  
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
           L    +++I EY+  GS    L    +   LD  +   I++ +   L YLH   S   IH
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH---SEKKIH 127
Query: 332 RDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           RDI + N+LL+   E  +ADFG A  L      R    GT  ++APE+        K D+
Sbjct: 128 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 187
Query: 392 YSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVS 451
           +S G+  +E+  G+ P            P  +L  ++ +  PP ++    +    +    
Sbjct: 188 WSLGITAIELARGEPPHS-------ELHPMKVLF-LIPKNNPPTLEGNYSKP---LKEFV 236
Query: 452 FACLQSNPKSRPTMQSVSQEFLITR 476
            ACL   P  RPT + + +   I R
Sbjct: 237 EACLNKEPSFRPTAKELLKHKFILR 261

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 130/277 (46%), Gaps = 33/277 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E   +   +G G +G V+          A+K L         ++F  EAQV+ ++ H  +
Sbjct: 185 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGN--MSPEAFLQEAQVMKKLRHEKL 242
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+LY   + ++ ++++ EYM +GSL  +    E    L   + V++   +A  +AY+   
Sbjct: 243 VQLYA-VVSEEPIYIVTEYMSKGSLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVER- 299
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTM 383
              + +HRD+ + NIL+   L   VADFG  RL+  +  + R        + APE A   
Sbjct: 300 --MNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYG 357
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQ-----RLP-PPV 436
             T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P PP 
Sbjct: 358 RFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCPPE 406
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
             + + D++        C + +P+ RPT + + Q FL
Sbjct: 407 CPESLHDLMC------QCWRKDPEERPTFEYL-QAFL 436

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 119/272 (43%), Gaps = 29/272 (10%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G +G V+K       +V A+K +   E    I+  + E  VLSQ     + K YG  
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
           L    +++I EY+  GS    L     A   D  +   ++K +   L YLH   S   IH
Sbjct: 91  LKGSKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLH---SEKKIH 143
Query: 332 RDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           RDI + N+LL+ + +  +ADFG A  L      R    GT  ++APE+        K D+
Sbjct: 144 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 203
Query: 392 YSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVS 451
           +S G+  +E+  G+ P           D   M +  L  +  PP    ++ D     T S
Sbjct: 204 WSLGITAIELAKGEPPN---------SDMHPMRVLFLIPKNNPPT---LVGDF----TKS 247
Query: 452 F-----ACLQSNPKSRPTMQSVSQEFLITRKT 478
           F     ACL  +P  RPT + + +   I + +
Sbjct: 248 FKEFIDACLNKDPSFRPTAKELLKHKFIVKNS 279

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTS--EELAFIKSFKNEAQVLSQVLH 261
           +DF I   +GTG +G V+  +   NG+ +A+K L       L  ++   +E  +LS V H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNE---DAVELDWAKRVNIVKAMAHAL 318
             I++++G     + +F+I +Y+E G LF  L  ++   + V   +A  V +      AL
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL------AL 119
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
            YLH   S  II+RD+   NILL+      + DFG A+ +         L GT  YIAPE
Sbjct: 120 EYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYXLCGTPDYIAPE 173
Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +  T    +  D +SFG++  E+L G  P
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 130/277 (46%), Gaps = 33/277 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E   +   +G G +G V+          A+K L         ++F  EAQV+ ++ H  +
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKL 75
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+LY   + ++ ++++ EYM +G L  +    E    L   + V++   +A  +AY+   
Sbjct: 76  VQLYA-VVSEEPIYIVMEYMSKGCLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTM 383
              + +HRD+ + NIL+   L   VADFG ARL+  +  + R        + APE A   
Sbjct: 134 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQ-----RLP-PPV 436
             T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P PP 
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCPPE 239
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
             + + D++        C + +P+ RPT + + Q FL
Sbjct: 240 CPESLHDLMC------QCWRKDPEERPTFEYL-QAFL 269

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 130/277 (46%), Gaps = 33/277 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E   +   +G G +G V+          A+K L         ++F  EAQV+ ++ H  +
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKL 75
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+LY   + ++ ++++ EYM +G L  +    E    L   + V++   +A  +AY+   
Sbjct: 76  VQLYA-VVSEEPIYIVTEYMSKGCLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTM 383
              + +HRD+ + NIL+   L   VADFG ARL+  +  + R        + APE A   
Sbjct: 134 ---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQ-----RLP-PPV 436
             T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+P PP 
Sbjct: 191 RFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCPPE 239
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
             + + D++        C + +P+ RPT + + Q FL
Sbjct: 240 CPESLHDLMC------QCWRKDPEERPTFEYL-QAFL 269

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 131/282 (46%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K L+ +        F +EA +++ + H ++V+L
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL    + L+ + M  G L   +H ++D +     L+W   V I K M     YL  
Sbjct: 106 LGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWC--VQIAKGMM----YLEE 158
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ S     + DFG ARLL  D        G     ++A E  +
Sbjct: 159 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 215
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
               T + DV+S+GV   E++  G  P D          P   + D+L+  +RLP PP+ 
Sbjct: 216 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGI--------PTREIPDLLEKGERLPQPPI- 266
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +   V   C   +  SRP  + ++ EF    + P
Sbjct: 267 --CTIDVYM---VMVKCWMIDADSRPKFKELAAEFSRMARDP 303

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 131/282 (46%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K L+ +        F +EA +++ + H ++V+L
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL    + L+ + M  G L   +H ++D +     L+W   V I K M     YL  
Sbjct: 83  LGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWC--VQIAKGMM----YLEE 135
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ S     + DFG ARLL  D        G     ++A E  +
Sbjct: 136 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
               T + DV+S+GV   E++  G  P D          P   + D+L+  +RLP PP+ 
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGI--------PTREIPDLLEKGERLPQPPI- 243
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +   V   C   +  SRP  + ++ EF    + P
Sbjct: 244 --CTIDVYM---VMVKCWMIDADSRPKFKELAAEFSRMARDP 280

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 7/205 (3%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLH 261
            ED+++ Y IGTG YG   K +   +GK+   K+L + S   A  +   +E  +L ++ H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 262 RNIVKLYGYCLHKK--CMFLIYEYMERGSLFCNL-HNNEDAVELDWAKRVNIVKAMAHAL 318
            NIV+ Y   + +    ++++ EY E G L   +    ++   LD    + ++  +  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 319 AYLHH--DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
              H   D   +++HRD+   N+ L+ K    + DFG AR+L+ D        GT  Y++
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMS 184
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEV 401
           PE    M   EK D++S G +  E+
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 128/287 (44%), Gaps = 39/287 (13%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPN-----GKVFALKKLHTSEELAFIKSFKNEAQVLSQV 259
            D  ++  +G G +G V+ A+  N      K+    K      LA  K F+ EA++L+ +
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAV-----------ELDWAK 306
            H +IVK YG C     + +++EYM+ G L  F   H  +  +           EL  ++
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 307 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR- 365
            ++I   +A  + YL    S   +HRD+++ N L+ + L   + DFG +R +++    R 
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 366 ---TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPK 421
              T+L     ++ PE       T + DV+SFGV+  E+   GK P              
Sbjct: 192 GGHTMLP--IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--WFQLSNTEVIEC 247
Query: 422 IMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
           I    VL++   P V  K + D++L       C Q  P+ R  ++ +
Sbjct: 248 ITQGRVLER---PRVCPKEVYDVML------GCWQREPQQRLNIKEI 285

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 105/220 (47%), Gaps = 24/220 (10%)
Query: 201 IEATEDFDIRYCIGTGGYGSVYKAQL--PNGK-----VFALKKLHTSEELAFIKSFKNEA 253
           IEA+    I   IG+G  G V   +L  P  +     + ALK  +T  +    + F +EA
Sbjct: 46  IEASR-IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR---RDFLSEA 101
Query: 254 QVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIV 311
            ++ Q  H NI++L G     +   ++ EYME GSL  F   H+ +  +     + V ++
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI----MQLVGML 157
Query: 312 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT 371
           + +   + YL        +HRD+++ N+L++S L   V+DFG +R+L  D        G 
Sbjct: 158 RGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGG 214
Query: 372 ---YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP 407
                + APE       +   DV+SFGVV  EVL  G+ P
Sbjct: 215 KIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 8/211 (3%)
Query: 202 EATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQ 258
           E  EDF +   +G G +  VY+A+ +  G   A+K +      +   ++  +NE ++  Q
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
           + H +I++LY Y      ++L+ E    G +   L N       + A+  + +  +   +
Sbjct: 68  LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR--HFMHQIITGM 125
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
            YLH   S  I+HRD++ +N+LL   +   +ADFG A  L         L GT  YI+PE
Sbjct: 126 LYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE 182
Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
           +A       + DV+S G +   +L+G+ P D
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 120/267 (44%), Gaps = 19/267 (7%)
Query: 213 IGTGGYGSVYKAQLPNGK-VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G +G VYK    + K V A+K +   E    I+  + E  VLSQ     I + +G  
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
           L    +++I EY+  GS    L        L+      I++ +   L YLH   S   IH
Sbjct: 87  LKSTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLH---SERKIH 139
Query: 332 RDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           RDI + N+LL+ + +  +ADFG A  L      R    GT  ++APE+        K D+
Sbjct: 140 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADI 199
Query: 392 YSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVS 451
           +S G+  +E+  G+ P            P  +L  ++ +  PP ++ +  +         
Sbjct: 200 WSLGITAIELAKGEPPNS-------DLHPMRVLF-LIPKNSPPTLEGQHSKP---FKEFV 248
Query: 452 FACLQSNPKSRPTMQSVSQEFLITRKT 478
            ACL  +P+ RPT + + +   ITR T
Sbjct: 249 EACLNKDPRFRPTAKELLKHKFITRYT 275

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 105/220 (47%), Gaps = 24/220 (10%)
Query: 201 IEATEDFDIRYCIGTGGYGSVYKAQL--PNGK-----VFALKKLHTSEELAFIKSFKNEA 253
           IEA+    I   IG+G  G V   +L  P  +     + ALK  +T  +    + F +EA
Sbjct: 46  IEASR-IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR---RDFLSEA 101
Query: 254 QVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIV 311
            ++ Q  H NI++L G     +   ++ EYME GSL  F   H+ +  +     + V ++
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI----MQLVGML 157
Query: 312 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT 371
           + +   + YL        +HRD+++ N+L++S L   V+DFG +R+L  D        G 
Sbjct: 158 RGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGG 214
Query: 372 ---YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP 407
                + APE       +   DV+SFGVV  EVL  G+ P
Sbjct: 215 KIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 128/283 (45%), Gaps = 46/283 (16%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           D  +++ +G G YG VY+       +  A+K L   E+   ++ F  EA V+ ++ H N+
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 69
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           V+L G C  +   ++I E+M  G+L      CN       V L  A ++      + A+ 
Sbjct: 70  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI------SSAME 123
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIA 376
           YL      + IHRD+++ N L+       VADFG +RL+  D+   T  AG      + A
Sbjct: 124 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTA 178
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVL---MGKHPRDIXXXXXXXXDP-KIMLIDVLDQR 431
           PE LAY    + K DV++FGV+  E+    M  +P           DP ++  +   D R
Sbjct: 179 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYP---------GIDPSQVYELLEKDYR 228
Query: 432 L--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           +  P     KV         +  AC Q NP  RP+   + Q F
Sbjct: 229 MERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 264

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 128/299 (42%), Gaps = 40/299 (13%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQV 259
           D  +++ +G G +G V+ A+  N        + A+K L  + E A  + F+ EA++L+ +
Sbjct: 42  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA-RQDFQREAELLTML 100
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSL--FCNLH--------NNEDAV--ELDWAKR 307
            H++IV+ +G C   + + +++EYM  G L  F   H          ED     L   + 
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 308 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS----S 363
           + +   +A  + YL        +HRD+++ N L+   L   + DFG +R +++       
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKI 422
            RT+L     ++ PE       T + DV+SFGVV  E+   GK P           D   
Sbjct: 218 GRTML--PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW-YQLSNTEAIDCIT 274
Query: 423 MLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLV 481
              ++   R  PP    ++R           C Q  P+ R +++ V        + P V
Sbjct: 275 QGRELERPRACPPEVYAIMR----------GCWQREPQQRHSIKDVHARLQALAQAPPV 323

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 126/294 (42%), Gaps = 43/294 (14%)
Query: 197 YEDLIEATEDF---------DIRYCIGTGGYGSVY--KAQLPNGK--VFALKKLHTSEEL 243
           YED   A   F          I   IG G +G V   + +LP  +    A+K L      
Sbjct: 26  YEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTE 85
Query: 244 AFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAVE 301
              + F  EA ++ Q  H N+V L G     K + ++ E+ME G+L  F   H+ +  V 
Sbjct: 86  KQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV- 144
Query: 302 LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD 361
               + V +++ +A  + YL        +HRD+++ NIL+NS L   V+DFG +R++  D
Sbjct: 145 ---IQLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDD 198
Query: 362 SSNRTLLAGT---YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP-RDIXXXXXX 416
                   G      + APE       T   DV+S+G+V  EV+  G+ P  D+      
Sbjct: 199 PEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-- 256
Query: 417 XXDPKIMLIDVLDQ--RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
                  +I  +++  RLP P+D       L++      C Q     RP  + +
Sbjct: 257 -------VIKAIEEGYRLPAPMDCPAGLHQLMLD-----CWQKERAERPKFEQI 298

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSEELAFIKSFKNEAQVLSQV 259
            ED+D+   +G G YG V   QL   +V     A+K +     +   ++ K E  +   +
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 62
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H N+VK YG+       +L  EY   G LF  +  +    E D A+R      +   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAGVV 119
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 377
           YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176
Query: 378 E-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
           E L       E  DV+S G+V   +L G+ P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 126/285 (44%), Gaps = 50/285 (17%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           D  +++ +G G YG VY+       +  A+K L   E+   ++ F  EA V+ ++ H N+
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 72
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           V+L G C  +   ++I E+M  G+L      CN       V L  A ++      + A+ 
Sbjct: 73  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAME 126
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIA 376
           YL      + IHRD+++ N L+       VADFG +RL+  D+   T  AG      + A
Sbjct: 127 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTA 181
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVL-----D 429
           PE LAY    + K DV++FGV+  E+   G  P            P I L  V      D
Sbjct: 182 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKD 229
Query: 430 QRL--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            R+  P     KV         +  AC Q NP  RP+   + Q F
Sbjct: 230 YRMERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 267

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 128/299 (42%), Gaps = 40/299 (13%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQV 259
           D  +++ +G G +G V+ A+  N        + A+K L  + E A  + F+ EA++L+ +
Sbjct: 13  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA-RQDFQREAELLTML 71
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSL--FCNLH--------NNEDAV--ELDWAKR 307
            H++IV+ +G C   + + +++EYM  G L  F   H          ED     L   + 
Sbjct: 72  QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 131
Query: 308 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS----S 363
           + +   +A  + YL        +HRD+++ N L+   L   + DFG +R +++       
Sbjct: 132 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 188
Query: 364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKI 422
            RT+L     ++ PE       T + DV+SFGVV  E+   GK P           D   
Sbjct: 189 GRTML--PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW-YQLSNTEAIDCIT 245
Query: 423 MLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLV 481
              ++   R  PP    ++R           C Q  P+ R +++ V        + P V
Sbjct: 246 QGRELERPRACPPEVYAIMR----------GCWQREPQQRHSIKDVHARLQALAQAPPV 294

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSEELAFIKSFKNEAQVLSQV 259
            ED+D+   +G G YG V   QL   +V     A+K +     +   ++ K E  +   +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 61
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H N+VK YG+       +L  EY   G LF  +  +    E D A+R      +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAGVV 118
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 377
           YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 378 E-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
           E L       E  DV+S G+V   +L G+ P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSEELAFIKSFKNEAQVLSQV 259
            ED+D+   +G G YG V   QL   +V     A+K +     +   ++ K E  +   +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 61
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H N+VK YG+       +L  EY   G LF  +  +    E D A+R      +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAGVV 118
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 377
           YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 378 E-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
           E L       E  DV+S G+V   +L G+ P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 126/285 (44%), Gaps = 50/285 (17%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           D  +++ +G G YG VY+       +  A+K L   E+   ++ F  EA V+ ++ H N+
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 76
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           V+L G C  +   ++I E+M  G+L      CN       V L  A ++      + A+ 
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAME 130
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIA 376
           YL      + IHRD+++ N L+       VADFG +RL+  D+   T  AG      + A
Sbjct: 131 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTA 185
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDIXXXXXXXXDPKIMLIDVL-----D 429
           PE LAY    + K DV++FGV+  E+   G  P            P I L  V      D
Sbjct: 186 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKD 233
Query: 430 QRL--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            R+  P     KV         +  AC Q NP  RP+   + Q F
Sbjct: 234 YRMERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 271

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 128/299 (42%), Gaps = 40/299 (13%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQV 259
           D  +++ +G G +G V+ A+  N        + A+K L  + E A  + F+ EA++L+ +
Sbjct: 19  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA-RQDFQREAELLTML 77
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSL--FCNLH--------NNEDAV--ELDWAKR 307
            H++IV+ +G C   + + +++EYM  G L  F   H          ED     L   + 
Sbjct: 78  QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 137
Query: 308 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS----S 363
           + +   +A  + YL        +HRD+++ N L+   L   + DFG +R +++       
Sbjct: 138 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 194
Query: 364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKI 422
            RT+L     ++ PE       T + DV+SFGVV  E+   GK P           D   
Sbjct: 195 GRTML--PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW-YQLSNTEAIDCIT 251
Query: 423 MLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLV 481
              ++   R  PP    ++R           C Q  P+ R +++ V        + P V
Sbjct: 252 QGRELERPRACPPEVYAIMR----------GCWQREPQQRHSIKDVHARLQALAQAPPV 300

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 126/285 (44%), Gaps = 50/285 (17%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           D  +++ +G G YG VY+       +  A+K L   E+   ++ F  EA V+ ++ H N+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           V+L G C  +   ++I E+M  G+L      CN       V L  A ++      + A+ 
Sbjct: 72  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI------SSAME 125
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIA 376
           YL      + IHRD+++ N L+       VADFG +RL+  D+   T  AG      + A
Sbjct: 126 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTA 180
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDIXXXXXXXXDPKIMLIDVL-----D 429
           PE LAY    + K DV++FGV+  E+   G  P            P I L  V      D
Sbjct: 181 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKD 228
Query: 430 QRL--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            R+  P     KV         +  AC Q NP  RP+   + Q F
Sbjct: 229 YRMERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 266

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 126/285 (44%), Gaps = 50/285 (17%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           D  +++ +G G YG VY+       +  A+K L   E+   ++ F  EA V+ ++ H N+
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 76
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           V+L G C  +   ++I E+M  G+L      CN       V L  A ++      + A+ 
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAME 130
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIA 376
           YL      + IHRD+++ N L+       VADFG +RL+  D+   T  AG      + A
Sbjct: 131 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTA 185
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVL-----D 429
           PE LAY    + K DV++FGV+  E+   G  P            P I L  V      D
Sbjct: 186 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKD 233
Query: 430 QRL--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            R+  P     KV         +  AC Q NP  RP+   + Q F
Sbjct: 234 YRMERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 271

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 128/283 (45%), Gaps = 46/283 (16%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           D  +++ +G G YG VY+       +  A+K L   E+   ++ F  EA V+ ++ H N+
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 69
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           V+L G C  +   ++I E+M  G+L      CN       V L  A ++      + A+ 
Sbjct: 70  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI------SSAME 123
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIA 376
           YL      + IHRD+++ N L+       VADFG +RL+  D+   T  AG      + A
Sbjct: 124 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTF--TAHAGAKFPIKWTA 178
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVL---MGKHPRDIXXXXXXXXDP-KIMLIDVLDQR 431
           PE LAY    + K DV++FGV+  E+    M  +P           DP ++  +   D R
Sbjct: 179 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYP---------GIDPSQVYELLEKDYR 228
Query: 432 L--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           +  P     KV         +  AC Q NP  RP+   + Q F
Sbjct: 229 MERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 264

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 126/285 (44%), Gaps = 50/285 (17%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           D  +++ +G G YG VY+       +  A+K L   E+   ++ F  EA V+ ++ H N+
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 76
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           V+L G C  +   ++I E+M  G+L      CN       V L  A ++      + A+ 
Sbjct: 77  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAME 130
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIA 376
           YL      + IHRD+++ N L+       VADFG +RL+  D+   T  AG      + A
Sbjct: 131 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTA 185
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDIXXXXXXXXDPKIMLIDVL-----D 429
           PE LAY    + K DV++FGV+  E+   G  P            P I L  V      D
Sbjct: 186 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKD 233
Query: 430 QRL--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            R+  P     KV         +  AC Q NP  RP+   + Q F
Sbjct: 234 YRMERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 271

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 108/217 (49%), Gaps = 29/217 (13%)
Query: 213 IGTGGYGSVYKAQLPN-----GKVF-ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G V+ A+  N      K+  A+K L  + + A  K F  EA++L+ + H +IVK
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR-KDFHREAELLTNLQHEHIVK 79
Query: 267 LYGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAV---------ELDWAKRVNIVKAMA 315
            YG C+    + +++EYM+ G L  F   H   DAV         EL  ++ ++I + +A
Sbjct: 80  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAH-GPDAVLMAEGNPPTELTQSQMLHIAQQIA 138
Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR----TLLAGT 371
             + YL    S   +HRD+++ N L+   L   + DFG +R +++    R    T+L   
Sbjct: 139 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP-- 193
Query: 372 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP 407
             ++ PE       T + DV+S GVV  E+   GK P
Sbjct: 194 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 126/285 (44%), Gaps = 50/285 (17%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           D  +++ +G G YG VY+       +  A+K L   E+   ++ F  EA V+ ++ H N+
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 73
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           V+L G C  +   ++I E+M  G+L      CN       V L  A ++      + A+ 
Sbjct: 74  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAME 127
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIA 376
           YL      + IHRD+++ N L+       VADFG +RL+  D+   T  AG      + A
Sbjct: 128 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTA 182
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDIXXXXXXXXDPKIMLIDVL-----D 429
           PE LAY    + K DV++FGV+  E+   G  P            P I L  V      D
Sbjct: 183 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKD 230
Query: 430 QRL--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            R+  P     KV         +  AC Q NP  RP+   + Q F
Sbjct: 231 YRMERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 268

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 126/285 (44%), Gaps = 50/285 (17%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           D  +++ +G G YG VY+       +  A+K L   E+   ++ F  EA V+ ++ H N+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           V+L G C  +   ++I E+M  G+L      CN       V L  A ++      + A+ 
Sbjct: 72  VQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI------SSAME 125
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIA 376
           YL      + IHRD+++ N L+       VADFG +RL+  D+   T  AG      + A
Sbjct: 126 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTA 180
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDIXXXXXXXXDPKIMLIDVL-----D 429
           PE LAY    + K DV++FGV+  E+   G  P            P I L  V      D
Sbjct: 181 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKD 228
Query: 430 QRL--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            R+  P     KV         +  AC Q NP  RP+   + Q F
Sbjct: 229 YRMERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 266

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 126/285 (44%), Gaps = 50/285 (17%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           D  +++ +G G YG VY+       +  A+K L   E+   ++ F  EA V+ ++ H N+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           V+L G C  +   ++I E+M  G+L      CN       V L  A ++      + A+ 
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI------SSAME 125
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIA 376
           YL      + IHRD+++ N L+       VADFG +RL+  D+   T  AG      + A
Sbjct: 126 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTA 180
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDIXXXXXXXXDPKIMLIDVL-----D 429
           PE LAY    + K DV++FGV+  E+   G  P            P I L  V      D
Sbjct: 181 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKD 228
Query: 430 QRL--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            R+  P     KV         +  AC Q NP  RP+   + Q F
Sbjct: 229 YRMERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 266

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 126/285 (44%), Gaps = 50/285 (17%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           D  +++ +G G YG VY+       +  A+K L   E+   ++ F  EA V+ ++ H N+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           V+L G C  +   ++I E+M  G+L      CN       V L  A ++      + A+ 
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI------SSAME 125
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIA 376
           YL      + IHRD+++ N L+       VADFG +RL+  D+   T  AG      + A
Sbjct: 126 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTA 180
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDIXXXXXXXXDPKIMLIDVL-----D 429
           PE LAY    + K DV++FGV+  E+   G  P            P I L  V      D
Sbjct: 181 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKD 228
Query: 430 QRL--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            R+  P     KV         +  AC Q NP  RP+   + Q F
Sbjct: 229 YRMERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 266

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 126/285 (44%), Gaps = 50/285 (17%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           D  +++ +G G YG VY+       +  A+K L   E+   ++ F  EA V+ ++ H N+
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 76
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           V+L G C  +   ++I E+M  G+L      CN       V L  A ++      + A+ 
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI------SSAME 130
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIA 376
           YL      + IHRD+++ N L+       VADFG +RL+  D+   T  AG      + A
Sbjct: 131 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTA 185
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVL-----D 429
           PE LAY    + K DV++FGV+  E+   G  P            P I L  V      D
Sbjct: 186 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKD 233
Query: 430 QRL--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            R+  P     KV         +  AC Q NP  RP+   + Q F
Sbjct: 234 YRMERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 271

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 126/285 (44%), Gaps = 50/285 (17%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           D  +++ +G G YG VY+       +  A+K L   E+   ++ F  EA V+ ++ H N+
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 76
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           V+L G C  +   ++I E+M  G+L      CN       V L  A ++      + A+ 
Sbjct: 77  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAME 130
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIA 376
           YL      + IHRD+++ N L+       VADFG +RL+  D+   T  AG      + A
Sbjct: 131 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTA 185
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDIXXXXXXXXDPKIMLIDVL-----D 429
           PE LAY    + K DV++FGV+  E+   G  P            P I L  V      D
Sbjct: 186 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKD 233
Query: 430 QRL--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            R+  P     KV         +  AC Q NP  RP+   + Q F
Sbjct: 234 YRMERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 271

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 126/285 (44%), Gaps = 50/285 (17%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           D  +++ +G G YG VY+       +  A+K L   E+   ++ F  EA V+ ++ H N+
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 72
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           V+L G C  +   ++I E+M  G+L      CN       V L  A ++      + A+ 
Sbjct: 73  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAME 126
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIA 376
           YL      + IHRD+++ N L+       VADFG +RL+  D+   T  AG      + A
Sbjct: 127 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAPAGAKFPIKWTA 181
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDIXXXXXXXXDPKIMLIDVL-----D 429
           PE LAY    + K DV++FGV+  E+   G  P            P I L  V      D
Sbjct: 182 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKD 229
Query: 430 QRL--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            R+  P     KV         +  AC Q NP  RP+   + Q F
Sbjct: 230 YRMERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 267

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 126/285 (44%), Gaps = 50/285 (17%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           D  +++ +G G YG VY+       +  A+K L   E+   ++ F  EA V+ ++ H N+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           V+L G C  +   ++I E+M  G+L      CN       V L  A ++      + A+ 
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAME 125
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIA 376
           YL      + IHRD+++ N L+       VADFG +RL+  D+   T  AG      + A
Sbjct: 126 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTA 180
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDIXXXXXXXXDPKIMLIDVL-----D 429
           PE LAY    + K DV++FGV+  E+   G  P            P I L  V      D
Sbjct: 181 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKD 228
Query: 430 QRL--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            R+  P     KV         +  AC Q NP  RP+   + Q F
Sbjct: 229 YRMERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 266

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 126/285 (44%), Gaps = 50/285 (17%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           D  +++ +G G YG VY+       +  A+K L   E+   ++ F  EA V+ ++ H N+
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           V+L G C  +   ++I E+M  G+L      CN       V L  A ++      + A+ 
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAME 125
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIA 376
           YL      + IHRD+++ N L+       VADFG +RL+  D+   T  AG      + A
Sbjct: 126 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTA 180
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDIXXXXXXXXDPKIMLIDVL-----D 429
           PE LAY    + K DV++FGV+  E+   G  P            P I L  V      D
Sbjct: 181 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKD 228
Query: 430 QRL--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            R+  P     KV         +  AC Q NP  RP+   + Q F
Sbjct: 229 YRMERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 266

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 126/285 (44%), Gaps = 50/285 (17%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           D  +++ +G G YG VY+       +  A+K L   E+   ++ F  EA V+ ++ H N+
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 75
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           V+L G C  +   ++I E+M  G+L      CN       V L  A ++      + A+ 
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAME 129
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIA 376
           YL      + IHRD+++ N L+       VADFG +RL+  D+   T  AG      + A
Sbjct: 130 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTA 184
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDIXXXXXXXXDPKIMLIDVL-----D 429
           PE LAY    + K DV++FGV+  E+   G  P            P I L  V      D
Sbjct: 185 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKD 232
Query: 430 QRL--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            R+  P     KV         +  AC Q NP  RP+   + Q F
Sbjct: 233 YRMERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 270

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 126/285 (44%), Gaps = 50/285 (17%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           D  +++ +G G YG VY+       +  A+K L   E+   ++ F  EA V+ ++ H N+
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 73
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           V+L G C  +   ++I E+M  G+L      CN       V L  A ++      + A+ 
Sbjct: 74  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAME 127
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIA 376
           YL      + IHRD+++ N L+       VADFG +RL+  D+   T  AG      + A
Sbjct: 128 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTA 182
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDIXXXXXXXXDPKIMLIDVL-----D 429
           PE LAY    + K DV++FGV+  E+   G  P            P I L  V      D
Sbjct: 183 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKD 230
Query: 430 QRL--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            R+  P     KV         +  AC Q NP  RP+   + Q F
Sbjct: 231 YRMERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 268

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 126/285 (44%), Gaps = 50/285 (17%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           D  +++ +G G YG VY+       +  A+K L   E+   ++ F  EA V+ ++ H N+
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 73
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           V+L G C  +   ++I E+M  G+L      CN       V L  A ++      + A+ 
Sbjct: 74  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAME 127
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIA 376
           YL      + IHRD+++ N L+       VADFG +RL+  D+   T  AG      + A
Sbjct: 128 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAPAGAKFPIKWTA 182
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDIXXXXXXXXDPKIMLIDVL-----D 429
           PE LAY    + K DV++FGV+  E+   G  P            P I L  V      D
Sbjct: 183 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKD 230
Query: 430 QRL--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            R+  P     KV         +  AC Q NP  RP+   + Q F
Sbjct: 231 YRMERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 268

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSEELAFIKSFKNEAQVLSQV 259
            ED+D+   +G G YG V   QL   +V     A+K +     +   ++ K E  + + +
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAML 62
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H N+VK YG+       +L  EY   G LF  +  +    E D A+R      +   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAGVV 119
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 377
           YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 378 E-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
           E L       E  DV+S G+V   +L G+ P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 126/285 (44%), Gaps = 50/285 (17%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           D  +++ +G G YG VY+       +  A+K L   E+   ++ F  EA V+ ++ H N+
Sbjct: 27  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 84
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           V+L G C  +   ++I E+M  G+L      CN       V L  A ++      + A+ 
Sbjct: 85  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAME 138
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIA 376
           YL      + IHRD+++ N L+       VADFG +RL+  D+   T  AG      + A
Sbjct: 139 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTA 193
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDIXXXXXXXXDPKIMLIDVL-----D 429
           PE LAY    + K DV++FGV+  E+   G  P            P I L  V      D
Sbjct: 194 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKD 241
Query: 430 QRL--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            R+  P     KV         +  AC Q NP  RP+   + Q F
Sbjct: 242 YRMERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 279

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 8/197 (4%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL 272
           +G G +G V+     N    A+K L        +++F  EA ++  + H  +V+LY    
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPG--TMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 273 HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR 332
            ++ +++I EYM +GSL   L ++E    L   K ++    +A  +AY+      + IHR
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERK---NYIHR 134
Query: 333 DISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           D+ + N+L++  L   +ADFG AR++  +  + R        + APE       T K DV
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDV 194
Query: 392 YSFGVVTLEVLM-GKHP 407
           +SFG++  E++  GK P
Sbjct: 195 WSFGILLYEIVTYGKIP 211

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSEELAFIKSFKNEAQVLSQV 259
            ED+D+   +G G YG V   QL   +V     A+K +     +   ++ K E  +   +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H N+VK YG+       +L  EY   G LF  +  +    E D A+R      +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAGVV 118
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 377
           YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 378 E-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
           E L       E  DV+S G+V   +L G+ P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSEELAFIKSFKNEAQVLSQV 259
            ED+D+   +G G YG V   QL   +V     A+K +     +   ++ K E  +   +
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H N+VK YG+       +L  EY   G LF  +  +    E D A+R      +   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAGVV 119
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 377
           YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 378 E-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
           E L       E  DV+S G+V   +L G+ P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSEELAFIKSFKNEAQVLSQV 259
            ED+D+   +G G YG V   QL   +V     A+K +     +   ++ K E  +   +
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H N+VK YG+       +L  EY   G LF  +  +    E D A+R      +   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAGVV 119
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 377
           YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 378 E-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
           E L       E  DV+S G+V   +L G+ P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSEELAFIKSFKNEAQVLSQV 259
            ED+D+   +G G YG V   QL   +V     A+K +     +   ++ K E  +   +
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H N+VK YG+       +L  EY   G LF  +  +    E D A+R      +   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAGVV 119
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 377
           YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 378 E-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
           E L       E  DV+S G+V   +L G+ P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSEELAFIKSFKNEAQVLSQV 259
            ED+D+   +G G YG V   QL   +V     A+K +     +   ++ K E  +   +
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H N+VK YG+       +L  EY   G LF  +  +    E D A+R      +   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAGVV 119
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 377
           YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 378 E-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
           E L       E  DV+S G+V   +L G+ P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 128/283 (45%), Gaps = 46/283 (16%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           D  +++ +G G +G VY+       +  A+K L   E+   ++ F  EA V+ ++ H N+
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 69
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           V+L G C  +   ++I E+M  G+L      CN       V L  A ++      + A+ 
Sbjct: 70  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI------SSAME 123
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIA 376
           YL      + IHRD+++ N L+       VADFG +RL+  D+   T  AG      + A
Sbjct: 124 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTA 178
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVL---MGKHPRDIXXXXXXXXDP-KIMLIDVLDQR 431
           PE LAY    + K DV++FGV+  E+    M  +P           DP ++  +   D R
Sbjct: 179 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYP---------GIDPSQVYELLEKDYR 228
Query: 432 L--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           +  P     KV         +  AC Q NP  RP+   + Q F
Sbjct: 229 MERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 264

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSEELAFIKSFKNEAQVLSQV 259
            ED+D+   +G G YG V   QL   +V     A+K +     +   ++ K E  +   +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H N+VK YG+       +L  EY   G LF  +  +    E D A+R      +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAGVV 118
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 377
           YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 378 E-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
           E L       E  DV+S G+V   +L G+ P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSEELAFIKSFKNEAQVLSQV 259
            ED+D+   +G G YG V   QL   +V     A+K +     +   ++ K E  +   +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H N+VK YG+       +L  EY   G LF  +  +    E D A+R      +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAGVV 118
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 377
           YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 378 E-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
           E L       E  DV+S G+V   +L G+ P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSEELAFIKSFKNEAQVLSQV 259
            ED+D+   +G G YG V   QL   +V     A+K +     +   ++ K E  +   +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H N+VK YG+       +L  EY   G LF  +  +    E D A+R      +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAGVV 118
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 377
           YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 378 E-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
           E L       E  DV+S G+V   +L G+ P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 16/212 (7%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           ED+D+   +G G YG V   QL   +V     A+K +     +   ++ K E  +   + 
Sbjct: 6   EDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H N+VK YG+       +L  EY   G LF  +  +    E D A+R      +   + Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAGVVY 119
Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAPE 378
           LH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+APE
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 379 -LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
            L       E  DV+S G+V   +L G+ P D
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSEELAFIKSFKNEAQVLSQV 259
            ED+D+   +G G YG V   QL   +V     A+K +     +   ++ K E  +   +
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H N+VK YG+       +L  EY   G LF  +  +    E D A+R      +   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAGVV 119
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 377
           YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 378 E-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
           E L       E  DV+S G+V   +L G+ P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 16/212 (7%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           ED+D+   +G G YG V   QL   +V     A+K +     +   ++ K E  +   + 
Sbjct: 7   EDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H N+VK YG+       +L  EY   G LF  +  +    E D A+R      +   + Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAGVVY 120
Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAPE 378
           LH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+APE
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 379 -LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
            L       E  DV+S G+V   +L G+ P D
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSEELAFIKSFKNEAQVLSQV 259
            ED+D+   +G G YG V   QL   +V     A+K +     +   ++ K E  +   +
Sbjct: 4   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 60
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H N+VK YG+       +L  EY   G LF  +  +    E D A+R      +   + 
Sbjct: 61  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAGVV 117
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 377
           YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+AP
Sbjct: 118 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
Query: 378 E-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
           E L       E  DV+S G+V   +L G+ P D
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSEELAFIKSFKNEAQVLSQV 259
            ED+D+   +G G YG V   QL   +V     A+K +     +   ++ K E  +   +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H N+VK YG+       +L  EY   G LF  +  +    E D A+R      +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAGVV 118
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 377
           YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 378 E-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
           E L       E  DV+S G+V   +L G+ P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSEELAFIKSFKNEAQVLSQV 259
            ED+D+   +G G YG V   QL   +V     A+K +     +   ++ K E  +   +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H N+VK YG+       +L  EY   G LF  +  +    E D A+R      +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAGVV 118
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 377
           YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 378 E-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
           E L       E  DV+S G+V   +L G+ P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSEELAFIKSFKNEAQVLSQV 259
            ED+D+   +G G YG V   QL   +V     A+K +     +   ++ K E  +   +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H N+VK YG+       +L  EY   G LF  +  +    E D A+R      +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAGVV 118
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 377
           YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 378 E-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
           E L       E  DV+S G+V   +L G+ P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 16/213 (7%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSEELAFIKSFKNEAQVLSQV 259
            ED+D+   +G G YG V   QL   +V     A+K +     +   ++ K E  +   +
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H N+VK YG+       +L  EY   G LF  +  +    E D A+R      +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAGVV 118
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 377
           YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 378 E-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
           E L       E  DV+S G+V   +L G+ P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 135/274 (49%), Gaps = 25/274 (9%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E   +   +G G +G V+ A        A+K +        +++F  EA V+  + H  +
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKL 72
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           VKL+   + K+ +++I E+M +GSL   L ++E + +    K ++    +A  +A++   
Sbjct: 73  VKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQR 130
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTM 383
              + IHRD+ + NIL+++ L   +ADFG AR++  +  + R        + APE     
Sbjct: 131 ---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 187
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVD-RKVI 441
             T K DV+SFG++ +E++  G+ P           +P+++       R+P P +  + +
Sbjct: 188 SFTIKSDVWSFGILLMEIVTYGRIP------YPGMSNPEVIRALERGYRMPRPENCPEEL 241
Query: 442 RDILLISTVSFACLQSNPKSRPT---MQSVSQEF 472
            +I++       C ++ P+ RPT   +QSV  +F
Sbjct: 242 YNIMM------RCWKNRPEERPTFEYIQSVLDDF 269

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 125/269 (46%), Gaps = 36/269 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           IG G  G V  A +   GK  A+KK+        EL F     NE  ++    H N+V +
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-----NEVVIMRDYHHDNVVDM 107
Query: 268 YGYCLHKKCMFLIYEYMERGSL---FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           Y   L    ++++ E++E G+L     +   NE+ +         +  ++  AL+YLH+ 
Sbjct: 108 YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-------ATVCLSVLRALSYLHNQ 160
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
               +IHRDI S++ILL S     ++DFG    +  +   R  L GT  ++APE+   + 
Sbjct: 161 ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLP 217
Query: 385 MTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIRDI 444
              + D++S G++ +E++ G+ P           +P +  +  +   LPP V     +D+
Sbjct: 218 YGTEVDIWSLGIMVIEMIDGEPP--------YFNEPPLQAMRRIRDSLPPRV-----KDL 264
Query: 445 LLISTVSFACLQSNPKSRPTMQSVSQEFL 473
             +S+V    L       P+ ++ +QE L
Sbjct: 265 HKVSSVLRGFLDLMLVREPSQRATAQELL 293

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/194 (33%), Positives = 99/194 (51%), Gaps = 8/194 (4%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHRNIVKLYGYC 271
           IG G YG VYKAQ   G+ FALKK+   +E   I S    E  +L ++ H NIVKLY   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
             KK + L++E++++  L   L   E  +E   AK  + +  + + +AY H      ++H
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK--SFLLQLLNGIAYCH---DRRVLH 123
Query: 332 RDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAYTMVMTEKCD 390
           RD+   N+L+N + E  +ADFG AR         T    T  Y AP+ L  +   +   D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTID 183
Query: 391 VYSFGVVTLEVLMG 404
           ++S G +  E++ G
Sbjct: 184 IWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/194 (33%), Positives = 99/194 (51%), Gaps = 8/194 (4%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHRNIVKLYGYC 271
           IG G YG VYKAQ   G+ FALKK+   +E   I S    E  +L ++ H NIVKLY   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
             KK + L++E++++  L   L   E  +E   AK  + +  + + +AY H      ++H
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK--SFLLQLLNGIAYCH---DRRVLH 123
Query: 332 RDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAYTMVMTEKCD 390
           RD+   N+L+N + E  +ADFG AR         T    T  Y AP+ L  +   +   D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTID 183
Query: 391 VYSFGVVTLEVLMG 404
           ++S G +  E++ G
Sbjct: 184 IWSVGCIFAEMVNG 197

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 109/227 (48%), Gaps = 38/227 (16%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHRN 263
           DF+    +G G +G V KA+   + + +A+KK+ HT E+L+ I S   E  +L+ + H+ 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS---EVMLLASLNHQY 63
Query: 264 IVKLYGYCLHKK-------------CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNI 310
           +V+ Y   L ++              +F+  EY E G+L+  +H+     + D   R  +
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR--L 121
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH----------- 359
            + +  AL+Y+H   S  IIHRD+   NI ++      + DFG A+ +H           
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 360 ---ADSSNRTLLAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVL 402
                S N T   GT  Y+A E L  T    EK D+YS G++  E++
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 12/208 (5%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ--LPNGKVFALKKLHT--SEELAFIKSFKNEAQVLSQVL 260
           E + I   +G GG  +VY A+  + N KV A+K +     E+   +K F+ E    SQ+ 
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKV-AIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H+NIV +        C +L+ EY+E G        +   + +D A  +N    +   + +
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIE-GPTLSEYIESHGPLSVDTA--INFTNQILDGIKH 126
Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT-LLAGTYGYIAPEL 379
            H      I+HRDI   NIL++S     + DFG A+ L   S  +T  + GT  Y +PE 
Sbjct: 127 AH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           A      E  D+YS G+V  E+L+G+ P
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/194 (33%), Positives = 99/194 (51%), Gaps = 8/194 (4%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHRNIVKLYGYC 271
           IG G YG VYKAQ   G+ FALKK+   +E   I S    E  +L ++ H NIVKLY   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
             KK + L++E++++  L   L   E  +E   AK  + +  + + +AY H      ++H
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK--SFLLQLLNGIAYCH---DRRVLH 123
Query: 332 RDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAYTMVMTEKCD 390
           RD+   N+L+N + E  +ADFG AR         T    T  Y AP+ L  +   +   D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 391 VYSFGVVTLEVLMG 404
           ++S G +  E++ G
Sbjct: 184 IWSVGCIFAEMVNG 197

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 27/277 (9%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +D++++  IG+G    V  A   P  +  A+K+++  +    +     E Q +SQ  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN-----NEDAVELDWAKRVNIVKAMAHAL 318
           IV  Y   + K  ++L+ + +  GS+   + +        +  LD +    I++ +   L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD-----SSNRTLLAGTYG 373
            YLH +     IHRD+ + NILL       +ADFG +  L        +  R    GT  
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 374 YIAPELAYTMVMTE-KCDVYSFGVVTLEVLMG-----KHPRDIXXXXXXXXDPKIMLIDV 427
           ++APE+   +   + K D++SFG+  +E+  G     K+P           DP  +   V
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV 251
Query: 428 LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPT 464
            D+ +     +   + I L       CLQ +P+ RPT
Sbjct: 252 QDKEMLKKYGKSFRKMISL-------CLQKDPEKRPT 281

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 121/277 (43%), Gaps = 27/277 (9%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +D++++  IG+G    V  A   P  +  A+K+++  +    +     E Q +SQ  H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN-----NEDAVELDWAKRVNIVKAMAHAL 318
           IV  Y   + K  ++L+ + +  GS+   + +        +  LD +    I++ +   L
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-----SNRTLLAGTYG 373
            YLH +     IHRD+ + NILL       +ADFG +  L           R    GT  
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 374 YIAPELAYTMVMTE-KCDVYSFGVVTLEVLMG-----KHPRDIXXXXXXXXDPKIMLIDV 427
           ++APE+   +   + K D++SFG+  +E+  G     K+P           DP  +   V
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV 246
Query: 428 LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPT 464
            D+ +     +   + I L       CLQ +P+ RPT
Sbjct: 247 QDKEMLKKYGKSFRKMISL-------CLQKDPEKRPT 276

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 135/274 (49%), Gaps = 25/274 (9%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E   +   +G G +G V+ A        A+K +        +++F  EA V+  + H  +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKL 245
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           VKL+   + K+ +++I E+M +GSL   L ++E + +    K ++    +A  +A++   
Sbjct: 246 VKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQR 303
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTM 383
              + IHRD+ + NIL+++ L   +ADFG AR++  +  + R        + APE     
Sbjct: 304 ---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 360
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVD-RKVI 441
             T K DV+SFG++ +E++  G+ P           +P+++       R+P P +  + +
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIP------YPGMSNPEVIRALERGYRMPRPENCPEEL 414
Query: 442 RDILLISTVSFACLQSNPKSRPT---MQSVSQEF 472
            +I++       C ++ P+ RPT   +QSV  +F
Sbjct: 415 YNIMM------RCWKNRPEERPTFEYIQSVLDDF 442

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 126/285 (44%), Gaps = 50/285 (17%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           D  +++ +G G YG VY+       +  A+K L   E+   ++ F  EA V+ ++ H N+
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           V+L G C  +   ++I E+M  G+L      CN       V L  A ++      + A+ 
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI------SSAME 332
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY---GYIA 376
           YL      + IHR++++ N L+       VADFG +RL+  D+   T  AG      + A
Sbjct: 333 YLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTA 387
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVL-----D 429
           PE LAY    + K DV++FGV+  E+   G  P            P I L  V      D
Sbjct: 388 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKD 435
Query: 430 QRL--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            R+  P     KV         +  AC Q NP  RP+   + Q F
Sbjct: 436 YRMERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 473

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 126/285 (44%), Gaps = 50/285 (17%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           D  +++ +G G YG VY+       +  A+K L   E+   ++ F  EA V+ ++ H N+
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 317
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           V+L G C  +   ++I E+M  G+L      CN       V L  A ++      + A+ 
Sbjct: 318 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAME 371
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY---GYIA 376
           YL      + IHR++++ N L+       VADFG +RL+  D+   T  AG      + A
Sbjct: 372 YLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTA 426
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVL-----D 429
           PE LAY    + K DV++FGV+  E+   G  P            P I L  V      D
Sbjct: 427 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKD 474
Query: 430 QRL--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            R+  P     KV         +  AC Q NP  RP+   + Q F
Sbjct: 475 YRMERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAF 512

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 125/277 (45%), Gaps = 26/277 (9%)
Query: 205 EDFDIRYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +DF+    +G G  G V+K +  P+G V A K +H   + A       E QVL +     
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           IV  YG       + +  E+M+ GSL   L       E    K V+I  A+   L YL  
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKGLTYLRE 125
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
                I+HRD+  +NIL+NS+ E  + DFG +  L  + +N     GT  Y++PE     
Sbjct: 126 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANE--FVGTRSYMSPERLQGT 181
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRL--PPPVDRKVI 441
             + + D++S G+  +E+ +G++PR           P + + ++LD  +  PPP   K+ 
Sbjct: 182 HYSVQSDIWSMGLSLVEMAVGRYPR-----------PPMAIFELLDYIVNEPPP---KLP 227
Query: 442 RDILLISTVSFA--CLQSNPKSRPTMQSVSQEFLITR 476
             +  +    F   CL  NP  R  ++ +     I R
Sbjct: 228 SAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 264

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 213 IGTGGYGSVYKAQLPNGK-VFALK--------KLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +G GG+   ++    + K VFA K        K H  E+++       E  +   + H++
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM------EISIHRSLAHQH 102
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           +V  +G+      +F++ E   R SL   LH    A+    A+    ++ +     YLH 
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLL-ELHKRRKALTEPEARYY--LRQIVLGCQYLHR 159
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
           +    +IHRD+   N+ LN  LE  + DFG A  +  D   + +L GT  YIAPE+    
Sbjct: 160 N---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 216
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             + + DV+S G +   +L+GK P
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPP 240

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 213 IGTGGYGSVYKAQLPNGK-VFALK--------KLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +G GG+   ++    + K VFA K        K H  E+++       E  +   + H++
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM------EISIHRSLAHQH 100
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           +V  +G+      +F++ E   R SL   LH    A+    A+    ++ +     YLH 
Sbjct: 101 VVGFHGFFEDNDFVFVVLELCRRRSLL-ELHKRRKALTEPEAR--YYLRQIVLGCQYLHR 157
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
           +    +IHRD+   N+ LN  LE  + DFG A  +  D   + +L GT  YIAPE+    
Sbjct: 158 N---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 214
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             + + DV+S G +   +L+GK P
Sbjct: 215 GHSFEVDVWSIGCIMYTLLVGKPP 238

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 23/203 (11%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           IG G  G V  A +  +GK+ A+KK+        EL F     NE  ++    H N+V++
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 91
Query: 268 YGYCLHKKCMFLIYEYMERGSL---FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           Y   L    ++++ E++E G+L     +   NE+ +         +  A+  AL+ LH  
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-------AAVCLAVLQALSVLH-- 142
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
            +  +IHRDI S++ILL       ++DFG    +  +   R  L GT  ++APEL   + 
Sbjct: 143 -AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP 201
Query: 385 MTEKCDVYSFGVVTLEVLMGKHP 407
              + D++S G++ +E++ G+ P
Sbjct: 202 YGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 23/203 (11%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           IG G  G V  A +  +GK+ A+KK+        EL F     NE  ++    H N+V++
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 213
Query: 268 YGYCLHKKCMFLIYEYMERGSL---FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           Y   L    ++++ E++E G+L     +   NE+ +         +  A+  AL+ LH  
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-------AAVCLAVLQALSVLH-- 264
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
            +  +IHRDI S++ILL       ++DFG    +  +   R  L GT  ++APEL   + 
Sbjct: 265 -AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP 323
Query: 385 MTEKCDVYSFGVVTLEVLMGKHP 407
              + D++S G++ +E++ G+ P
Sbjct: 324 YGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 23/203 (11%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           IG G  G V  A +  +GK+ A+KK+        EL F     NE  ++    H N+V++
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 93
Query: 268 YGYCLHKKCMFLIYEYMERGSL---FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           Y   L    ++++ E++E G+L     +   NE+ +         +  A+  AL+ LH  
Sbjct: 94  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-------AAVCLAVLQALSVLH-- 144
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
            +  +IHRDI S++ILL       ++DFG    +  +   R  L GT  ++APEL   + 
Sbjct: 145 -AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP 203
Query: 385 MTEKCDVYSFGVVTLEVLMGKHP 407
              + D++S G++ +E++ G+ P
Sbjct: 204 YGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 127/264 (48%), Gaps = 32/264 (12%)
Query: 213 IGTGGYGSV----YKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           +G+G +G V    +K Q  +  V  +K+   SE+      F  EAQ + ++ H  +VK Y
Sbjct: 16  LGSGQFGVVKLGKWKGQY-DVAVKMIKEGSMSED-----EFFQEAQTMMKLSHPKLVKFY 69
Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
           G C  +  ++++ EY+  G L   L ++   +E   ++ + +   +   +A+L    S  
Sbjct: 70  GVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP--SQLLEMCYDVCEGMAFLE---SHQ 124
Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIAPELAYTMVM 385
            IHRD+++ N L++  L   V+DFG  R +  D    ++  GT     + APE+ +    
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV--GTKFPVKWSAPEVFHYFKY 182
Query: 386 TEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIRDI 444
           + K DV++FG++  EV  +GK P D+        + +++L      RL  P    +  D 
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKMPYDL------YTNSEVVLKVSQGHRLYRP---HLASDT 233
Query: 445 LLISTVSFACLQSNPKSRPTMQSV 468
             I  + ++C    P+ RPT Q +
Sbjct: 234 --IYQIMYSCWHELPEKRPTFQQL 255

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 23/203 (11%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           IG G  G V  A +  +GK+ A+KK+        EL F     NE  ++    H N+V++
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 82
Query: 268 YGYCLHKKCMFLIYEYMERGSL---FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           Y   L    ++++ E++E G+L     +   NE+ +         +  A+  AL+ LH  
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-------AAVCLAVLQALSVLH-- 133
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
            +  +IHRDI S++ILL       ++DFG    +  +   R  L GT  ++APEL   + 
Sbjct: 134 -AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP 192
Query: 385 MTEKCDVYSFGVVTLEVLMGKHP 407
              + D++S G++ +E++ G+ P
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 10/214 (4%)
Query: 197 YEDLIEA-TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQV 255
           +ED  E   E   +   +G G  G V+          A+K L          +F  EA +
Sbjct: 4   WEDAWEVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANL 61
Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 315
           + Q+ H+ +V+LY   + ++ +++I EYME GSL  +       ++L   K +++   +A
Sbjct: 62  MKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH-ADSSNRTLLAGTYGY 374
             +A++      + IHRD+ + NIL++  L   +ADFG ARL+  A+ + R        +
Sbjct: 120 EGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKW 176
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP 407
            APE       T K DV+SFG++  E++  G+ P
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 123/280 (43%), Gaps = 40/280 (14%)
Query: 213 IGTGGYGSVYKAQLPNGK-VFALK--------KLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +G GG+   ++    + K VFA K        K H  E+++       E  +   + H++
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM------EISIHRSLAHQH 76
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           +V  +G+      +F++ E   R SL   LH    A+    A+    ++ +     YLH 
Sbjct: 77  VVGFHGFFEDNDFVFVVLELCRRRSLL-ELHKRRKALTEPEAR--YYLRQIVLGCQYLHR 133
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
           +    +IHRD+   N+ LN  LE  + DFG A  +  D   + +L GT  YIAPE+    
Sbjct: 134 N---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 190
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPP---PVDRKV 440
             + + DV+S G +   +L+GK P +             + I   +  +P    PV   +
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-----LRIKKNEYSIPKHINPVAASL 245
Query: 441 IRDILLISTVSFACLQSNPKSRPTMQS-VSQEFLITRKTP 479
           I+ +          LQ++P +RPT+   ++ EF  +   P
Sbjct: 246 IQKM----------LQTDPTARPTINELLNDEFFTSGYIP 275

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 213 IGTGGYGSVYKAQLPNGK-VFALK--------KLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +G GG+   ++    + K VFA K        K H  E+++       E  +   + H++
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM------EISIHRSLAHQH 78
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           +V  +G+      +F++ E   R SL   LH    A+    A+    ++ +     YLH 
Sbjct: 79  VVGFHGFFEDNDFVFVVLELCRRRSLL-ELHKRRKALTEPEARYY--LRQIVLGCQYLHR 135
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
           +    +IHRD+   N+ LN  LE  + DFG A  +  D   +  L GT  YIAPE+    
Sbjct: 136 N---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKK 192
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             + + DV+S G +   +L+GK P
Sbjct: 193 GHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 23/203 (11%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           IG G  G V  A +  +GK+ A+KK+        EL F     NE  ++    H N+V++
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 86
Query: 268 YGYCLHKKCMFLIYEYMERGSL---FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           Y   L    ++++ E++E G+L     +   NE+ +         +  A+  AL+ LH  
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-------AAVCLAVLQALSVLH-- 137
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
            +  +IHRDI S++ILL       ++DFG    +  +   R  L GT  ++APEL   + 
Sbjct: 138 -AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP 196
Query: 385 MTEKCDVYSFGVVTLEVLMGKHP 407
              + D++S G++ +E++ G+ P
Sbjct: 197 YGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 97/213 (45%), Gaps = 16/213 (7%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSEELAFIKSFKNEAQVLSQV 259
            ED+D+   +G G  G V   QL   +V     A+K +     +   ++ K E  +   +
Sbjct: 5   VEDWDLVQTLGEGAAGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H N+VK YG+       +L  EY   G LF  +  +    E D A+R      +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAGVV 118
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 377
           YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+AP
Sbjct: 119 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 378 E-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
           E L       E  DV+S G+V   +L G+ P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 213 IGTGGYGSVYKAQLPNGK-VFALK--------KLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +G GG+   ++    + K VFA K        K H  E+++       E  +   + H++
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM------EISIHRSLAHQH 78
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           +V  +G+      +F++ E   R SL   LH    A+    A+    ++ +     YLH 
Sbjct: 79  VVGFHGFFEDNDFVFVVLELCRRRSLL-ELHKRRKALTEPEARYY--LRQIVLGCQYLHR 135
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
           +    +IHRD+   N+ LN  LE  + DFG A  +  D   +  L GT  YIAPE+    
Sbjct: 136 N---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKK 192
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             + + DV+S G +   +L+GK P
Sbjct: 193 GHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 23/203 (11%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           IG G  G V  A +  +GK+ A+KK+        EL F     NE  ++    H N+V++
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 136
Query: 268 YGYCLHKKCMFLIYEYMERGSL---FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           Y   L    ++++ E++E G+L     +   NE+ +         +  A+  AL+ LH  
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-------AAVCLAVLQALSVLH-- 187
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
            +  +IHRDI S++ILL       ++DFG    +  +   R  L GT  ++APEL   + 
Sbjct: 188 -AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP 246
Query: 385 MTEKCDVYSFGVVTLEVLMGKHP 407
              + D++S G++ +E++ G+ P
Sbjct: 247 YGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 102/200 (51%), Gaps = 17/200 (8%)
Query: 213 IGTGGYGSVYKAQLPN-GKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           IG G  G V  A+  + G+  A+K +        EL F     NE  ++    H N+V++
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF-----NEVVIMRDYQHFNVVEM 107
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
           Y   L  + ++++ E+++ G+L     +    V L+  +   + +A+  ALAYLH   + 
Sbjct: 108 YKSYLVGEELWVLMEFLQGGAL----TDIVSQVRLNEEQIATVCEAVLQALAYLH---AQ 160
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTE 387
            +IHRDI S++ILL       ++DFG    +  D   R  L GT  ++APE+    +   
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYAT 220
Query: 388 KCDVYSFGVVTLEVLMGKHP 407
           + D++S G++ +E++ G+ P
Sbjct: 221 EVDIWSLGIMVIEMVDGEPP 240

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 8/195 (4%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHRNIVKLYGYC 271
           +G G YG VYKA+   G++ ALK++    E   I S    E  +L ++ H NIV L    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
             ++C+ L++E+ME+  L   L  N+  ++ D   ++ + + +   +A+ H      I+H
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTGLQ-DSQIKIYLYQLL-RGVAHCHQH---RILH 142
Query: 332 RDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAYTMVMTEKCD 390
           RD+   N+L+NS     +ADFG AR       + T    T  Y AP+ L  +   +   D
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVD 202
Query: 391 VYSFGVVTLEVLMGK 405
           ++S G +  E++ GK
Sbjct: 203 IWSIGCIFAEMITGK 217

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 213 IGTGGYGSVYKAQLPNGK-VFALK--------KLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +G GG+   ++    + K VFA K        K H  E+++       E  +   + H++
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM------EISIHRSLAHQH 82
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           +V  +G+      +F++ E   R SL   LH    A+    A+    ++ +     YLH 
Sbjct: 83  VVGFHGFFEDNDFVFVVLELCRRRSLL-ELHKRRKALTEPEARYY--LRQIVLGCQYLHR 139
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
           +    +IHRD+   N+ LN  LE  + DFG A  +  D   +  L GT  YIAPE+    
Sbjct: 140 N---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKK 196
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             + + DV+S G +   +L+GK P
Sbjct: 197 GHSFEVDVWSIGCIMYTLLVGKPP 220

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHRNIVKLYGYC 271
           +G G YG VYKA+   G++ ALK++    E   I S    E  +L ++ H NIV L    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK--RVNIVKAMAHALAYLHHDCSPSI 329
             ++C+ L++E+ME+  L   L  N+  ++    K     +++ +AH   +        I
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH-------RI 140
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAYTMVMTEK 388
           +HRD+   N+L+NS     +ADFG AR       + T    T  Y AP+ L  +   +  
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTS 200
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E++ GK
Sbjct: 201 VDIWSIGCIFAEMITGK 217

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 9/208 (4%)
Query: 197 YEDLIEA-TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQV 255
           +ED  E   E   +   +G G +G V+          A+K L          +F  EA +
Sbjct: 13  WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANL 70
Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 315
           + Q+ H+ +V+LY   + ++ +++I EYME GSL  +       ++L   K +++   +A
Sbjct: 71  MKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIA 128
Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA-DSSNRTLLAGTYGY 374
             +A++      + IHRD+ + NIL++  L   +ADFG ARL+   + + R        +
Sbjct: 129 EGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 185
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVL 402
            APE       T K DV+SFG++  E++
Sbjct: 186 TAPEAINYGTFTIKSDVWSFGILLTEIV 213

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 9/208 (4%)
Query: 197 YEDLIEA-TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQV 255
           +ED  E   E   +   +G G +G V+          A+K L          +F  EA +
Sbjct: 10  WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANL 67
Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 315
           + Q+ H+ +V+LY   + ++ +++I EYME GSL  +       ++L   K +++   +A
Sbjct: 68  MKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIA 125
Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA-DSSNRTLLAGTYGY 374
             +A++      + IHRD+ + NIL++  L   +ADFG ARL+   + + R        +
Sbjct: 126 EGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 182
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVL 402
            APE       T K DV+SFG++  E++
Sbjct: 183 TAPEAINYGTFTIKSDVWSFGILLTEIV 210

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 9/208 (4%)
Query: 197 YEDLIEA-TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQV 255
           +ED  E   E   +   +G G +G V+          A+K L          +F  EA +
Sbjct: 12  WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANL 69
Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 315
           + Q+ H+ +V+LY   + ++ +++I EYME GSL  +       ++L   K +++   +A
Sbjct: 70  MKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIA 127
Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA-DSSNRTLLAGTYGY 374
             +A++      + IHRD+ + NIL++  L   +ADFG ARL+   + + R        +
Sbjct: 128 EGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 184
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVL 402
            APE       T K DV+SFG++  E++
Sbjct: 185 TAPEAINYGTFTIKSDVWSFGILLTEIV 212

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 99/197 (50%), Gaps = 8/197 (4%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL 272
           +G G +G V+     N    A+K L        +++F  EA ++  + H  +V+LY    
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPG--TMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 273 HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR 332
            ++ +++I E+M +GSL   L ++E    L   K ++    +A  +AY+      + IHR
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERK---NYIHR 133
Query: 333 DISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           D+ + N+L++  L   +ADFG AR++  +  + R        + APE       T K +V
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNV 193
Query: 392 YSFGVVTLEVLM-GKHP 407
           +SFG++  E++  GK P
Sbjct: 194 WSFGILLYEIVTYGKIP 210

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 10/214 (4%)
Query: 197 YEDLIEA-TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQV 255
           +ED  E   E   +   +G G +G V+          A+K L          +F  EA +
Sbjct: 6   WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANL 63
Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 315
           + Q+ H+ +V+LY   + ++ +++I EYME GSL  +       ++L   K +++   +A
Sbjct: 64  MKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIA 121
Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA-DSSNRTLLAGTYGY 374
             +A++      + IHRD+ + NIL++  L   +ADFG ARL+   + + R        +
Sbjct: 122 EGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 178
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP 407
            APE       T K DV+SFG++  E++  G+ P
Sbjct: 179 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 212

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 9/208 (4%)
Query: 197 YEDLIEA-TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQV 255
           +ED  E   E   +   +G G +G V+          A+K L          +F  EA +
Sbjct: 4   WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANL 61
Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 315
           + Q+ H+ +V+LY   + ++ +++I EYME GSL  +       ++L   K +++   +A
Sbjct: 62  MKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA-DSSNRTLLAGTYGY 374
             +A++      + IHRD+ + NIL++  L   +ADFG ARL+   + + R        +
Sbjct: 120 EGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 176
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVL 402
            APE       T K DV+SFG++  E++
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIV 204

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 108/227 (47%), Gaps = 38/227 (16%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHRN 263
           DF+    +G G +G V KA+   + + +A+KK+ HT E+L+ I S   E  +L+ + H+ 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS---EVMLLASLNHQY 63
Query: 264 IVKLYGYCLHKK-------------CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNI 310
           +V+ Y   L ++              +F+  EY E  +L+  +H+     + D   R  +
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR--L 121
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH----------- 359
            + +  AL+Y+H   S  IIHRD+   NI ++      + DFG A+ +H           
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 360 ---ADSSNRTLLAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVL 402
                S N T   GT  Y+A E L  T    EK D+YS G++  E++
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL 272
           +G G +G V+          A+K L          +F  EA ++ Q+ H+ +V+LY   +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLYA-VV 77
Query: 273 HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR 332
            ++ +++I EYME GSL  +       ++L   K +++   +A  +A++      + IHR
Sbjct: 78  TQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 333 DISSNNILLNSKLEAFVADFGTARLLHA-DSSNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           D+ + NIL++  L   +ADFG ARL+   + + R        + APE       T K DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 392 YSFGVVTLEVLM-GKHP 407
           +SFG++  E++  G+ P
Sbjct: 194 WSFGILLTEIVTHGRIP 210

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL 272
           +G G +G V+          A+K L          +F  EA ++ Q+ H+ +V+LY   +
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLYA-VV 82
Query: 273 HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR 332
            ++ +++I EYME GSL  +       ++L   K +++   +A  +A++      + IHR
Sbjct: 83  TQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 138
Query: 333 DISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           D+ + NIL++  L   +ADFG ARL+  +  + R        + APE       T K DV
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 198
Query: 392 YSFGVVTLEVLM-GKHP 407
           +SFG++  E++  G+ P
Sbjct: 199 WSFGILLTEIVTHGRIP 215

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHT---SEELAFIKSFKNEAQVLSQVLHRNIVKLYG 269
           IG+G +G V+     N    A+K +     SEE      F  EA+V+ ++ H  +V+LYG
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-----DFIEEAEVMMKLSHPKLVQLYG 69
Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
            CL +  + L++E+ME G L   L         +    + +   +   +AYL   C   +
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---V 124
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTMVMTEK 388
           IHRD+++ N L+       V+DFG  R +  D  ++ T       + +PE+      + K
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 389 CDVYSFGVVTLEVLM-GKHPRD 409
            DV+SFGV+  EV   GK P +
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYE 206

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 10/214 (4%)
Query: 197 YEDLIEA-TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQV 255
           +ED  E   E   +   +G G +G V+          A+K L          +F  EA +
Sbjct: 10  WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANL 67
Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 315
           + Q+ H+ +V+LY   + ++ +++I EYME GSL  +       ++L   K +++   +A
Sbjct: 68  MKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIA 125
Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGY 374
             +A++      + IHRD+ + NIL++  L   +ADFG ARL+  +  + R        +
Sbjct: 126 EGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 182
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP 407
            APE       T K DV+SFG++  E++  G+ P
Sbjct: 183 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL 272
           +G G +G V+          A+K L          +F  EA ++ Q+ H+ +V+LY   +
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLYA-VV 78
Query: 273 HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR 332
            ++ +++I EYME GSL  +       ++L   K +++   +A  +A++      + IHR
Sbjct: 79  TQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 134
Query: 333 DISSNNILLNSKLEAFVADFGTARLLHA-DSSNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           D+ + NIL++  L   +ADFG ARL+   + + R        + APE       T K DV
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 194
Query: 392 YSFGVVTLEVLM-GKHP 407
           +SFG++  E++  G+ P
Sbjct: 195 WSFGILLTEIVTHGRIP 211

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 9/208 (4%)
Query: 197 YEDLIEA-TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQV 255
           +ED  E   E   +   +G G +G V+          A+K L          +F  EA +
Sbjct: 14  WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANL 71
Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 315
           + Q+ H+ +V+LY   + ++ +++I EYME GSL  +       ++L   K +++   +A
Sbjct: 72  MKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIA 129
Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGY 374
             +A++      + IHRD+ + NIL++  L   +ADFG ARL+  +  + R        +
Sbjct: 130 EGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 186
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVL 402
            APE       T K DV+SFG++  E++
Sbjct: 187 TAPEAINYGTFTIKSDVWSFGILLTEIV 214

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHT---SEELAFIKSFKNEAQVLSQVLHRNIVKLYG 269
           IG+G +G V+     N    A+K +     SEE      F  EA+V+ ++ H  +V+LYG
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-----DFIEEAEVMMKLSHPKLVQLYG 67
Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
            CL +  + L++E+ME G L   L         +    + +   +   +AYL   C   +
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---V 122
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTMVMTEK 388
           IHRD+++ N L+       V+DFG  R +  D  ++ T       + +PE+      + K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 389 CDVYSFGVVTLEVLM-GKHPRD 409
            DV+SFGV+  EV   GK P +
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYE 204

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 126/291 (43%), Gaps = 62/291 (21%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           D  +++ +G G YG VY        +  A+K L   E+   ++ F  EA V+ ++ H N+
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 90
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+L G C  +   +++ EYM  G+L            LD+ +  N  +  A  L Y+   
Sbjct: 91  VQLLGVCTLEPPFYIVTEYMPYGNL------------LDYLRECNREEVTAVVLLYMATQ 138
Query: 325 CSPSI--------IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YG 373
            S ++        IHRD+++ N L+       VADFG +RL+  D+   T  AG      
Sbjct: 139 ISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDT--YTAHAGAKFPIK 196
Query: 374 YIAPE-LAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDIXXXXXXXXDPKIMLIDVLD-- 429
           + APE LAY    + K DV++FGV+  E+   G  P            P I L  V D  
Sbjct: 197 WTAPESLAYN-TFSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYDLL 244
Query: 430 ---QRLP-----PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
               R+      PP   +++R          AC + +P  RP+     Q F
Sbjct: 245 EKGYRMEQPEGCPPKVYELMR----------ACWKWSPADRPSFAETHQAF 285

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHT---SEELAFIKSFKNEAQVLSQVLHRNIVKLYG 269
           IG+G +G V+     N    A+K +     SEE      F  EA+V+ ++ H  +V+LYG
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-----DFIEEAEVMMKLSHPKLVQLYG 72
Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
            CL +  + L++E+ME G L   L         +    + +   +   +AYL   C   +
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---V 127
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTMVMTEK 388
           IHRD+++ N L+       V+DFG  R +  D  ++ T       + +PE+      + K
Sbjct: 128 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 187
Query: 389 CDVYSFGVVTLEVLM-GKHPRD 409
            DV+SFGV+  EV   GK P +
Sbjct: 188 SDVWSFGVLMWEVFSEGKIPYE 209

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL 272
           +G G +G V+          A+K L          +F  EA ++ Q+ H+ +V+LY   +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLYA-VV 77
Query: 273 HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR 332
            ++ +++I EYME GSL  +       ++L   K +++   +A  +A++      + IHR
Sbjct: 78  TQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 333 DISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           D+ + NIL++  L   +ADFG ARL+  +  + R        + APE       T K DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 392 YSFGVVTLEVLM-GKHP 407
           +SFG++  E++  G+ P
Sbjct: 194 WSFGILLTEIVTHGRIP 210

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL 272
           +G G +G V+          A+K L          +F  EA ++ Q+ H+ +V+LY   +
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLYA-VV 72
Query: 273 HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR 332
            ++ +++I EYME GSL  +       ++L   K +++   +A  +A++      + IHR
Sbjct: 73  TQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 128
Query: 333 DISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           D+ + NIL++  L   +ADFG ARL+  +  + R        + APE       T K DV
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 188
Query: 392 YSFGVVTLEVLM-GKHP 407
           +SFG++  E++  G+ P
Sbjct: 189 WSFGILLTEIVTHGRIP 205

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 102/206 (49%), Gaps = 29/206 (14%)
Query: 216 GGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLS--QVLHRNIVKLYGYCLH 273
           G +G V+KAQL N  V A+K     ++    +S++NE +V S   + H NI++  G    
Sbjct: 35  GRFGCVWKAQLLNEYV-AVKIFPIQDK----QSWQNEYEVYSLPGMKHENILQFIGAEKR 89
Query: 274 KKC----MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC---- 325
                  ++LI  + E+GSL   L  N     + W +  +I + MA  LAYLH D     
Sbjct: 90  GTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGLK 145
Query: 326 ---SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NRTLLAGTYGYIAPELA 380
               P+I HRDI S N+LL + L A +ADFG A    A  S  +     GT  Y+APE+ 
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL 205
Query: 381 YTMVMTE-----KCDVYSFGVVTLEV 401
              +  +     + D+Y+ G+V  E+
Sbjct: 206 EGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 107/219 (48%), Gaps = 32/219 (14%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL--HR 262
            D  +  C+G G YG V++     G+  A+K   + +E    KS+  E ++ + V+  H 
Sbjct: 8   RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE----KSWFRETELYNTVMLRHE 62
Query: 263 NIVKLYGYCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
           NI+      +  +     ++LI  Y E GSL+  L        LD    + IV ++A  L
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGL 118
Query: 319 AYLHHDC-----SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA---- 369
           A+LH +       P+I HRD+ S NIL+    +  +AD G A ++H+ S+N+  +     
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPR 177
Query: 370 -GTYGYIAPELAYTMVMTE------KCDVYSFGVVTLEV 401
            GT  Y+APE+    +  +      + D+++FG+V  EV
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 124/273 (45%), Gaps = 29/273 (10%)
Query: 213 IGTGGYG-SVYKAQLPNGKVFALKKLHTSEELAFIKS-FKNEAQVLSQVLHRNIVKLYGY 270
           IG G +G ++      +G+ + +K+++ S   +  +   + E  VL+ + H NIV+    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNN------EDAVELDWAKRVNIVKAMAHALAYLHHD 324
                 ++++ +Y E G LF  ++        ED + LDW   V I  A+ H      HD
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI-LDWF--VQICLALKHV-----HD 143
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
               I+HRDI S NI L       + DFG AR+L++         GT  Y++PE+     
Sbjct: 144 --RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 385 MTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIRDI 444
              K D+++ G V  E+   KH  +           K +++ ++     PPV      D+
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSM-------KNLVLKIISGSF-PPVSLHYSYDL 253
Query: 445 LLISTVSFACLQSNPKSRPTMQSVSQEFLITRK 477
             + +  F   + NP+ RP++ S+ ++  I ++
Sbjct: 254 RSLVSQLF---KRNPRDRPSVNSILEKGFIAKR 283

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 32/212 (15%)
Query: 212 CIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL--HRNIVKLYG 269
           C+G G YG V++     G+  A+K   + +E    KS+  E ++ + V+  H NI+    
Sbjct: 44  CVGKGRYGEVWRGSW-QGENVAVKIFSSRDE----KSWFRETELYNTVMLRHENILGFIA 98
Query: 270 YCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
             +  +     ++LI  Y E GSL+  L        LD    + IV ++A  LA+LH + 
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEI 154
Query: 326 -----SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA-----GTYGYI 375
                 P+I HRD+ S NIL+    +  +AD G A ++H+ S+N+  +      GT  Y+
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYM 213
Query: 376 APELAYTMVMTE------KCDVYSFGVVTLEV 401
           APE+    +  +      + D+++FG+V  EV
Sbjct: 214 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 15/199 (7%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G  G+VY A  +  G+  A+++++  ++    +   NE  V+ +  + NIV      
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYLHHDCSPS 328
           L    ++++ EY+  GSL        D V    +D  +   + +    AL +LH   S  
Sbjct: 87  LVGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQ 136
Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 388
           +IHRDI S+NILL       + DFG    +  + S R+ + GT  ++APE+        K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 389 CDVYSFGVVTLEVLMGKHP 407
            D++S G++ +E++ G+ P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 15/199 (7%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G  G+VY A  +  G+  A+++++  ++    +   NE  V+ +  + NIV      
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYLHHDCSPS 328
           L    ++++ EY+  GSL        D V    +D  +   + +    AL +LH   S  
Sbjct: 88  LVGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQ 137
Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 388
           +IHRDI S+NILL       + DFG    +  + S R+ + GT  ++APE+        K
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPK 197
Query: 389 CDVYSFGVVTLEVLMGKHP 407
            D++S G++ +E++ G+ P
Sbjct: 198 VDIWSLGIMAIEMIEGEPP 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 15/199 (7%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G  G+VY A  +  G+  A+++++  ++    +   NE  V+ +  + NIV      
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYLHHDCSPS 328
           L    ++++ EY+  GSL        D V    +D  +   + +    AL +LH   S  
Sbjct: 87  LVGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQ 136
Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 388
           +IHRDI S+NILL       + DFG    +  + S R+ + GT  ++APE+        K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPK 196
Query: 389 CDVYSFGVVTLEVLMGKHP 407
            D++S G++ +E++ G+ P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSEEL--AFIKSFKNEAQVLSQVLH 261
           EDF+I   IG G +G V   +L N  KVFA+K L+  E L  A    F+ E  VL     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK----RVNIVKAMAHA 317
           + I  L+        ++L+ +Y   G L   L   ED +  + A+     + I     H 
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA-GTYGYIA 376
           L Y         +HRDI  +NIL++      +ADFG+   L  D + ++ +A GT  YI+
Sbjct: 194 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 377 PELAYTMVMTE-----KCDVYSFGVVTLEVLMGKHP 407
           PE+   M   +     +CD +S GV   E+L G+ P
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 32/212 (15%)
Query: 212 CIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL--HRNIVKLYG 269
           C+G G YG V++     G+  A+K   + +E    KS+  E ++ + V+  H NI+    
Sbjct: 15  CVGKGRYGEVWRGSW-QGENVAVKIFSSRDE----KSWFRETELYNTVMLRHENILGFIA 69
Query: 270 YCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
             +  +     ++LI  Y E GSL+  L        LD    + IV ++A  LA+LH + 
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 326 -----SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA-----GTYGYI 375
                 P+I HRD+ S NIL+    +  +AD G A ++H+ S+N+  +      GT  Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 376 APELAYTMVMTE------KCDVYSFGVVTLEV 401
           APE+    +  +      + D+++FG+V  EV
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 133/293 (45%), Gaps = 37/293 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ----LPNGKVFALKKL------HTSEELAFIKSFKNEAQ 254
           E F++   +G GGYG V++ +       GK+FA+K L        +++ A  K+ +N   
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN--- 73
Query: 255 VLSQVLHRNIVKL-YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 313
           +L +V H  IV L Y +    K ++LI EY+  G LF  L      +E D A     +  
Sbjct: 74  ILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFME-DTA--CFYLAE 129
Query: 314 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG 373
           ++ AL +LH      II+RD+   NI+LN +    + DFG  +    D +      GT  
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIE 186
Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLP 433
           Y+APE+          D +S G +  ++L G  P           + K  +  +L  +L 
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP-------FTGENRKKTIDKILKCKLN 239
Query: 434 -PPVDRKVIRDIL--LISTVSFACLQSNP------KSRPTMQSVSQEFLITRK 477
            PP   +  RD+L  L+   + + L + P      ++ P  + ++ E L+ RK
Sbjct: 240 LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARK 292

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 213 IGTGGYGSVYKA-----QLPNGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +GSV        Q   G+V A+KKL H++EE   ++ F+ E ++L  + H NIVK
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 73
Query: 267 LYGYCLH--KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
             G C    ++ + LI EY+  GSL   L  +++ +  D  K +     +   + YL   
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 128
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG---YIAPELAY 381
            +   IHRD+++ NIL+ ++    + DFG  ++L  D     +         + APE   
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 382 TMVMTEKCDVYSFGVVTLEVL 402
               +   DV+SFGVV  E+ 
Sbjct: 189 ESKFSVASDVWSFGVVLYELF 209

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 15/199 (7%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G  G+VY A  +  G+  A+++++  ++    +   NE  V+ +  + NIV      
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYLHHDCSPS 328
           L    ++++ EY+  GSL        D V    +D  +   + +    AL +LH   S  
Sbjct: 87  LVGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQ 136
Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 388
           +IHRDI S+NILL       + DFG    +  + S R+ + GT  ++APE+        K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPK 196
Query: 389 CDVYSFGVVTLEVLMGKHP 407
            D++S G++ +E++ G+ P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 213 IGTGGYGSVYKA-----QLPNGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +GSV        Q   G+V A+KKL H++EE   ++ F+ E ++L  + H NIVK
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 79
Query: 267 LYGYCLH--KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
             G C    ++ + LI EY+  GSL   L  +++ +  D  K +     +   + YL   
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 134
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG---YIAPELAY 381
            +   IHRD+++ NIL+ ++    + DFG  ++L  D     +         + APE   
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 382 TMVMTEKCDVYSFGVVTLEVL 402
               +   DV+SFGVV  E+ 
Sbjct: 195 ESKFSVASDVWSFGVVLYELF 215

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHT---SEELAFIKSFKNEAQVLSQVLHRNIVKLYG 269
           IG+G +G V+     N    A+K +     SEE      F  EA+V+ ++ H  +V+LYG
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-----DFIEEAEVMMKLSHPKLVQLYG 69
Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
            CL +  + L++E+ME G L   L         +    + +   +   +AYL      S+
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEE---ASV 124
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTMVMTEK 388
           IHRD+++ N L+       V+DFG  R +  D  ++ T       + +PE+      + K
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 389 CDVYSFGVVTLEVLM-GKHPRD 409
            DV+SFGV+  EV   GK P +
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYE 206

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 133/293 (45%), Gaps = 37/293 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ----LPNGKVFALKKL------HTSEELAFIKSFKNEAQ 254
           E F++   +G GGYG V++ +       GK+FA+K L        +++ A  K+ +N   
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN--- 73
Query: 255 VLSQVLHRNIVKL-YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 313
           +L +V H  IV L Y +    K ++LI EY+  G LF  L      +E D A     +  
Sbjct: 74  ILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFME-DTA--CFYLAE 129
Query: 314 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG 373
           ++ AL +LH      II+RD+   NI+LN +    + DFG  +    D +      GT  
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE 186
Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLP 433
           Y+APE+          D +S G +  ++L G  P           + K  +  +L  +L 
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP-------FTGENRKKTIDKILKCKLN 239
Query: 434 -PPVDRKVIRDIL--LISTVSFACLQSNP------KSRPTMQSVSQEFLITRK 477
            PP   +  RD+L  L+   + + L + P      ++ P  + ++ E L+ RK
Sbjct: 240 LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARK 292

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 9/199 (4%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL 272
           IG+G +G V+     N    A+K +   E       F  EA+V+ ++ H  +V+LYG CL
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTI--KEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 273 HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR 332
            +  + L++E+ME G L   L         +    + +   +   +AYL   C   +IHR
Sbjct: 93  EQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---VIHR 147
Query: 333 DISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           D+++ N L+       V+DFG  R +  D  ++ T       + +PE+      + K DV
Sbjct: 148 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 207
Query: 392 YSFGVVTLEVLM-GKHPRD 409
           +SFGV+  EV   GK P +
Sbjct: 208 WSFGVLMWEVFSEGKIPYE 226

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 213 IGTGGYGSVYKA-----QLPNGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +GSV        Q   G+V A+KKL H++EE   ++ F+ E ++L  + H NIVK
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 74
Query: 267 LYGYCLH--KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
             G C    ++ + LI EY+  GSL   L  +++ +  D  K +     +   + YL   
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 129
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG---YIAPELAY 381
            +   IHRD+++ NIL+ ++    + DFG  ++L  D     +         + APE   
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 189
Query: 382 TMVMTEKCDVYSFGVVTLEVL 402
               +   DV+SFGVV  E+ 
Sbjct: 190 ESKFSVASDVWSFGVVLYELF 210

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 213 IGTGGYGSVYKA-----QLPNGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +GSV        Q   G+V A+KKL H++EE   ++ F+ E ++L  + H NIVK
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 75
Query: 267 LYGYCLH--KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
             G C    ++ + LI EY+  GSL   L  +++ +  D  K +     +   + YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 130
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG---YIAPELAY 381
            +   IHRD+++ NIL+ ++    + DFG  ++L  D     +         + APE   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 382 TMVMTEKCDVYSFGVVTLEVL 402
               +   DV+SFGVV  E+ 
Sbjct: 191 ESKFSVASDVWSFGVVLYELF 211

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 213 IGTGGYGSVYKA-----QLPNGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +GSV        Q   G+V A+KKL H++EE   ++ F+ E ++L  + H NIVK
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 78
Query: 267 LYGYCLH--KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
             G C    ++ + LI EY+  GSL   L  +++ +  D  K +     +   + YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 133
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG---YIAPELAY 381
            +   IHRD+++ NIL+ ++    + DFG  ++L  D     +         + APE   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 382 TMVMTEKCDVYSFGVVTLEVL 402
               +   DV+SFGVV  E+ 
Sbjct: 194 ESKFSVASDVWSFGVVLYELF 214

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 201 IEATEDFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAFIKSFK-NEAQVLSQ 258
            ++ E ++    +G G YG V K +  + G++ A+KK   S++   +K     E ++L Q
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVEL-----DWAKRVNIVKA 313
           + H N+V L   C  KK  +L++E+++        H   D +EL     D+      +  
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVD--------HTILDDLELFPNGLDYQVVQKYLFQ 132
Query: 314 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG 373
           + + + + H   S +IIHRDI   NIL++      + DFG AR L A          T  
Sbjct: 133 IINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRW 189
Query: 374 YIAPELAYTMVMTEKC-DVYSFGVVTLEVLMGK 405
           Y APEL    V   K  DV++ G +  E+ MG+
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 213 IGTGGYGSVYKA-----QLPNGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +GSV        Q   G+V A+KKL H++EE   ++ F+ E ++L  + H NIVK
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 106
Query: 267 LYGYCLH--KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
             G C    ++ + LI EY+  GSL   L  +++ +  D  K +     +   + YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 161
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG---YIAPELAY 381
            +   IHRD+++ NIL+ ++    + DFG  ++L  D     +         + APE   
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 382 TMVMTEKCDVYSFGVVTLEVL 402
               +   DV+SFGVV  E+ 
Sbjct: 222 ESKFSVASDVWSFGVVLYELF 242

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 213 IGTGGYGSVYKA-----QLPNGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +GSV        Q   G+V A+KKL H++EE   ++ F+ E ++L  + H NIVK
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 75
Query: 267 LYGYCLH--KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
             G C    ++ + LI EY+  GSL   L  +++ +  D  K +     +   + YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 130
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG---YIAPELAY 381
            +   IHRD+++ NIL+ ++    + DFG  ++L  D     +         + APE   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 382 TMVMTEKCDVYSFGVVTLEVL 402
               +   DV+SFGVV  E+ 
Sbjct: 191 ESKFSVASDVWSFGVVLYELF 211

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +DF+    +G G  G V K Q  P+G + A K +H   + A       E QVL +     
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV------NIVKAMAHA 317
           IV  YG       + +  E+M+ GSL        D V L  AKR+       +  A+   
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSL--------DQV-LKEAKRIPEEILGKVSIAVLRG 126
Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           LAYL       I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y+AP
Sbjct: 127 LAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMAP 182
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           E       + + D++S G+  +E+ +G++P
Sbjct: 183 ERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 213 IGTGGYGSVYKA-----QLPNGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +GSV        Q   G+V A+KKL H++EE   ++ F+ E ++L  + H NIVK
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 80
Query: 267 LYGYCLH--KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
             G C    ++ + LI EY+  GSL   L  +++ +  D  K +     +   + YL   
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 135
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG---YIAPELAY 381
            +   IHRD+++ NIL+ ++    + DFG  ++L  D     +         + APE   
Sbjct: 136 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 195
Query: 382 TMVMTEKCDVYSFGVVTLEVL 402
               +   DV+SFGVV  E+ 
Sbjct: 196 ESKFSVASDVWSFGVVLYELF 216

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHT---SEELAFIKSFKNEAQVLSQVLHRNIVKLYG 269
           IG+G +G V+     N    A+K +     SEE      F  EA+V+ ++ H  +V+LYG
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-----DFIEEAEVMMKLSHPKLVQLYG 70
Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
            CL +  + L+ E+ME G L   L         +    + +   +   +AYL   C   +
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---V 125
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTMVMTEK 388
           IHRD+++ N L+       V+DFG  R +  D  ++ T       + +PE+      + K
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 389 CDVYSFGVVTLEVLM-GKHPRD 409
            DV+SFGV+  EV   GK P +
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYE 207

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 213 IGTGGYGSVYKA-----QLPNGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +GSV        Q   G+V A+KKL H++EE   ++ F+ E ++L  + H NIVK
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 82
Query: 267 LYGYCLH--KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
             G C    ++ + LI EY+  GSL   L  +++ +  D  K +     +   + YL   
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 137
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG---YIAPELAY 381
            +   IHRD+++ NIL+ ++    + DFG  ++L  D     +         + APE   
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 197
Query: 382 TMVMTEKCDVYSFGVVTLEVL 402
               +   DV+SFGVV  E+ 
Sbjct: 198 ESKFSVASDVWSFGVVLYELF 218

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 213 IGTGGYGSVYKA-----QLPNGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +GSV        Q   G+V A+KKL H++EE   ++ F+ E ++L  + H NIVK
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 81
Query: 267 LYGYCLH--KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
             G C    ++ + LI EY+  GSL   L  +++ +  D  K +     +   + YL   
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 136
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG---YIAPELAY 381
            +   IHRD+++ NIL+ ++    + DFG  ++L  D     +         + APE   
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 196
Query: 382 TMVMTEKCDVYSFGVVTLEVL 402
               +   DV+SFGVV  E+ 
Sbjct: 197 ESKFSVASDVWSFGVVLYELF 217

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL 272
           +G G +G V+          A+K L          +F  EA ++ Q+ H+ +V+LY   +
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLYA-VV 73
Query: 273 HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR 332
            ++ +++I EYME GSL  +       ++L   K +++   +A  +A++      + IHR
Sbjct: 74  TQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHR 129
Query: 333 DISSNNILLNSKLEAFVADFGTARLLHADS-SNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           ++ + NIL++  L   +ADFG ARL+  +  + R        + APE       T K DV
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 189
Query: 392 YSFGVVTLEVLM-GKHP 407
           +SFG++  E++  G+ P
Sbjct: 190 WSFGILLTEIVTHGRIP 206

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 106/227 (46%), Gaps = 38/227 (16%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHRN 263
           DF+    +G G +G V KA+   + + +A+KK+ HT E+L+ I S   E  +L+ + H+ 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS---EVXLLASLNHQY 63
Query: 264 IVKLYGYCLHKK-------------CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNI 310
           +V+ Y   L ++              +F+  EY E  +L+  +H+     + D   R  +
Sbjct: 64  VVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR--L 121
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH----------- 359
            + +  AL+Y+H   S  IIHR++   NI ++      + DFG A+ +H           
Sbjct: 122 FRQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 360 ---ADSSNRTLLAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVL 402
                S N T   GT  Y+A E L  T    EK D YS G++  E +
Sbjct: 179 NLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 213 IGTGGYGSVYKA-----QLPNGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +GSV        Q   G+V A+KKL H++EE   ++ F+ E ++L  + H NIVK
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 93
Query: 267 LYGYCLH--KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
             G C    ++ + LI EY+  GSL   L  +++ +  D  K +     +   + YL   
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 148
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG---YIAPELAY 381
            +   IHRD+++ NIL+ ++    + DFG  ++L  D     +         + APE   
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 382 TMVMTEKCDVYSFGVVTLEVL 402
               +   DV+SFGVV  E+ 
Sbjct: 209 ESKFSVASDVWSFGVVLYELF 229

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 213 IGTGGYGSVYKA-----QLPNGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +GSV        Q   G+V A+KKL H++EE   ++ F+ E ++L  + H NIVK
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 93
Query: 267 LYGYCLH--KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
             G C    ++ + LI EY+  GSL   L  +++ +  D  K +     +   + YL   
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 148
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG---YIAPELAY 381
            +   IHRD+++ NIL+ ++    + DFG  ++L  D     +         + APE   
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 382 TMVMTEKCDVYSFGVVTLEVL 402
               +   DV+SFGVV  E+ 
Sbjct: 209 ESKFSVASDVWSFGVVLYELF 229

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 40/223 (17%)
Query: 213 IGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           IG G +G V++A+ P         + A+K L           F+ EA ++++  + NIVK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 267 LYGYCLHKKCMFLIYEYMERGSL-----------FCNLHNNEDAVE----------LDWA 305
           L G C   K M L++EYM  G L            C+L +++ +            L  A
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 306 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH------ 359
           +++ I + +A  +AYL        +HRD+++ N L+   +   +ADFG +R ++      
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 360 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL 402
           AD ++    A    ++ PE  +    T + DV+++GVV  E+ 
Sbjct: 232 ADGND----AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 123/277 (44%), Gaps = 16/277 (5%)
Query: 205 EDFDIRYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +DF+    +G G  G V+K +  P+G V A K +H   + A       E QVL +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           IV  YG       + +  E+M+ GSL   L       E    K V+I  A+   L YL  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKGLTYLRE 122
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
                I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y++PE     
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSPERLQGT 178
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRL--PPPVDRKVI 441
             + + D++S G+  +E+ +G++P            P + + ++LD  +  PPP   K+ 
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIP-PPDAKEDSRPPMAIFELLDYIVNEPPP---KLP 234
Query: 442 RDILLISTVSFA--CLQSNPKSRPTMQSVSQEFLITR 476
             +  +    F   CL  NP  R  ++ +     I R
Sbjct: 235 SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 271

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 213 IGTGGYGSVYKA-----QLPNGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +GSV        Q   G+V A+KKL H++EE   ++ F+ E ++L  + H NIVK
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 78
Query: 267 LYGYCLH--KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
             G C    ++ + LI EY+  GSL   L  +  A  +D  K +     +   + YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAH--AERIDHIKLLQYTSQICKGMEYL--- 133
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG---YIAPELAY 381
            +   IHRD+++ NIL+ ++    + DFG  ++L  D     +         + APE   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 382 TMVMTEKCDVYSFGVVTLEVL 402
               +   DV+SFGVV  E+ 
Sbjct: 194 ESKFSVASDVWSFGVVLYELF 214

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 118/278 (42%), Gaps = 22/278 (7%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           ED  +   IG G +G V+  +L  +  + A+K    +        F  EA++L Q  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           IV+L G C  K+ ++++ E ++ G     L    +   L     + +V   A  + YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD---SSNRTLLAGTYGYIAPELA 380
            C    IHRD+++ N L+  K    ++DFG +R   AD   +++  L      + APE  
Sbjct: 232 KC---CIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVXAASGGLRQVPVKWTAPEAL 287
Query: 381 YTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
                + + DV+SFG++  E   +G  P           + +         RLP P   +
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASP------YPNLSNQQTREFVEKGGRLPCP---E 338
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK 477
           +  D +    +   C    P  RP+  ++ QE    RK
Sbjct: 339 LCPDAVF--RLMEQCWAYEPGQRPSFSTIYQELQSIRK 374

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 15/201 (7%)
Query: 213 IGTGGYGSVYK-AQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR-----NIVK 266
           +G GG+   Y+   +   +VFA K +  S     +K  + E       +H+     ++V 
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKS---MLLKPHQKEKMSTEIAIHKSLDNPHVVG 106
Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
            +G+      ++++ E   R SL   LH    AV    A+    ++     + YLH++  
Sbjct: 107 FHGFFEDDDFVYVVLEICRRRSLL-ELHKRRKAVTEPEAR--YFMRQTIQGVQYLHNN-- 161
Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMT 386
             +IHRD+   N+ LN  ++  + DFG A  +  D   +  L GT  YIAPE+      +
Sbjct: 162 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHS 220
Query: 387 EKCDVYSFGVVTLEVLMGKHP 407
            + D++S G +   +L+GK P
Sbjct: 221 FEVDIWSLGCILYTLLVGKPP 241

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/273 (25%), Positives = 131/273 (47%), Gaps = 33/273 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E   +   +G G +G V+ A        A+K +        +++F  EA V+  + H  +
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKL 239
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           VKL+   + K+ +++I E+M +GSL   L ++E + +    K ++    +A  +A++   
Sbjct: 240 VKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQR 297
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
              + IHRD+ + NIL+++ L   +ADFG AR+                + APE      
Sbjct: 298 ---NYIHRDLRAANILVSASLVCKIADFGLARV---------GAKFPIKWTAPEAINFGS 345
Query: 385 MTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVD-RKVIR 442
            T K DV+SFG++ +E++  G+ P           +P+++       R+P P +  + + 
Sbjct: 346 FTIKSDVWSFGILLMEIVTYGRIP------YPGMSNPEVIRALERGYRMPRPENCPEELY 399
Query: 443 DILLISTVSFACLQSNPKSRPT---MQSVSQEF 472
           +I++       C ++ P+ RPT   +QSV  +F
Sbjct: 400 NIMM------RCWKNRPEERPTFEYIQSVLDDF 426

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 114/258 (44%), Gaps = 24/258 (9%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALK--KLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +GTG +G V   +       A+K  K  +  E  FI+    EA+V+  + H  +V+LYG 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 87
Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
           C  ++ +F+I EYM  G L   L       +    + + + K +  A+ YL    S   +
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 142
Query: 331 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG-TYGYIAPELAYTMVMTEKC 389
           HRD+++ N L+N +    V+DFG +R +  D    ++ +     +  PE+      + K 
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 390 DVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIRDILLIS 448
           D+++FGV+  E+  +GK P +         +    +   L    P     KV        
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYE----RFTNSETAEHIAQGLRLYRPHLASEKVY------- 251
Query: 449 TVSFACLQSNPKSRPTMQ 466
           T+ ++C       RPT +
Sbjct: 252 TIMYSCWHEKADERPTFK 269

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 118/278 (42%), Gaps = 22/278 (7%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           ED  +   IG G +G V+  +L  +  + A+K    +        F  EA++L Q  H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           IV+L G C  K+ ++++ E ++ G     L    +   L     + +V   A  + YL  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD---SSNRTLLAGTYGYIAPELA 380
            C    IHRD+++ N L+  K    ++DFG +R   AD   +++  L      + APE  
Sbjct: 232 KC---CIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWTAPEAL 287
Query: 381 YTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
                + + DV+SFG++  E   +G  P           + +         RLP P   +
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASP------YPNLSNQQTREFVEKGGRLPCP---E 338
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK 477
           +  D +    +   C    P  RP+  ++ QE    RK
Sbjct: 339 LCPDAVF--RLMEQCWAYEPGQRPSFSTIYQELQSIRK 374

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 15/201 (7%)
Query: 213 IGTGGYGSVYK-AQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR-----NIVK 266
           +G GG+   Y+   +   +VFA K +  S     +K  + E       +H+     ++V 
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKS---MLLKPHQKEKMSTEIAIHKSLDNPHVVG 106
Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
            +G+      ++++ E   R SL   LH    AV    A+    ++     + YLH++  
Sbjct: 107 FHGFFEDDDFVYVVLEICRRRSLL-ELHKRRKAVTEPEAR--YFMRQTIQGVQYLHNN-- 161
Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMT 386
             +IHRD+   N+ LN  ++  + DFG A  +  D   +  L GT  YIAPE+      +
Sbjct: 162 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHS 220
Query: 387 EKCDVYSFGVVTLEVLMGKHP 407
            + D++S G +   +L+GK P
Sbjct: 221 FEVDIWSLGCILYTLLVGKPP 241

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 15/201 (7%)
Query: 213 IGTGGYGSVYK-AQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR-----NIVK 266
           +G GG+   Y+   +   +VFA K +  S     +K  + E       +H+     ++V 
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKS---MLLKPHQKEKMSTEIAIHKSLDNPHVVG 90
Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
            +G+      ++++ E   R SL   LH    AV    A+    ++     + YLH++  
Sbjct: 91  FHGFFEDDDFVYVVLEICRRRSLL-ELHKRRKAVTEPEAR--YFMRQTIQGVQYLHNN-- 145
Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMT 386
             +IHRD+   N+ LN  ++  + DFG A  +  D   +  L GT  YIAPE+      +
Sbjct: 146 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHS 204
Query: 387 EKCDVYSFGVVTLEVLMGKHP 407
            + D++S G +   +L+GK P
Sbjct: 205 FEVDIWSLGCILYTLLVGKPP 225

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 15/199 (7%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G  G+VY A  +  G+  A+++++  ++    +   NE  V+ +  + NIV      
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYLHHDCSPS 328
           L    ++++ EY+  GSL        D V    +D  +   + +    AL +LH   S  
Sbjct: 88  LVGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQ 137
Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEK 388
           +IHR+I S+NILL       + DFG    +  + S R+ + GT  ++APE+        K
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 197
Query: 389 CDVYSFGVVTLEVLMGKHP 407
            D++S G++ +E++ G+ P
Sbjct: 198 VDIWSLGIMAIEMIEGEPP 216

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 106/220 (48%), Gaps = 31/220 (14%)
Query: 204 TEDFDIRYCIGTGGYGSV----YKAQLPNGKVFALKKLHTSEELAFIKS--FKNEAQVLS 257
            ED+D+   IG G +G V    +KA   + KV+A+K L   E +    S  F  E  +++
Sbjct: 74  AEDYDVVKVIGRGAFGEVQLVRHKA---SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 130
Query: 258 QVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 317
                 +V+L+      K ++++ EYM  G L  NL +N D  E  WAK       +  A
Sbjct: 131 FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPE-KWAKFY--TAEVVLA 186
Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT------ARLLHADSSNRTLLAGT 371
           L  +H   S  +IHRD+  +N+LL+      +ADFGT        ++H D++      GT
Sbjct: 187 LDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA-----VGT 238
Query: 372 YGYIAPELAYTM----VMTEKCDVYSFGVVTLEVLMGKHP 407
             YI+PE+  +         +CD +S GV   E+L+G  P
Sbjct: 239 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 213 IGTGGYGSVYKA-----QLPNGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +GSV        Q   G+V A+KKL H++EE   ++ F+ E ++L  + H NIVK
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 78
Query: 267 LYGYCLH--KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
             G C    ++ + LI E++  GSL   L  +++ +  D  K +     +   + YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 133
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG---YIAPELAY 381
            +   IHRD+++ NIL+ ++    + DFG  ++L  D     +         + APE   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 382 TMVMTEKCDVYSFGVVTLEVL 402
               +   DV+SFGVV  E+ 
Sbjct: 194 ESKFSVASDVWSFGVVLYELF 214

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 15/201 (7%)
Query: 213 IGTGGYGSVYK-AQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR-----NIVK 266
           +G GG+   Y+   +   +VFA K +  S     +K  + E       +H+     ++V 
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKS---MLLKPHQKEKMSTEIAIHKSLDNPHVVG 106
Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
            +G+      ++++ E   R SL   LH    AV    A+    ++     + YLH++  
Sbjct: 107 FHGFFEDDDFVYVVLEICRRRSLL-ELHKRRKAVTEPEAR--YFMRQTIQGVQYLHNN-- 161
Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMT 386
             +IHRD+   N+ LN  ++  + DFG A  +  D   +  L GT  YIAPE+      +
Sbjct: 162 -RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHS 220
Query: 387 EKCDVYSFGVVTLEVLMGKHP 407
            + D++S G +   +L+GK P
Sbjct: 221 FEVDIWSLGCILYTLLVGKPP 241

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 114/258 (44%), Gaps = 24/258 (9%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALK--KLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +GTG +G V   +       A+K  K  +  E  FI+    EA+V+  + H  +V+LYG 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 87
Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
           C  ++ +F+I EYM  G L   L       +    + + + K +  A+ YL    S   +
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 142
Query: 331 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG-TYGYIAPELAYTMVMTEKC 389
           HRD+++ N L+N +    V+DFG +R +  D    ++ +     +  PE+      + K 
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 390 DVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIRDILLIS 448
           D+++FGV+  E+  +GK P +         +    +   L    P     KV        
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYE----RFTNSETAEHIAQGLRLYRPHLASEKVY------- 251
Query: 449 TVSFACLQSNPKSRPTMQ 466
           T+ ++C       RPT +
Sbjct: 252 TIMYSCWHEKADERPTFK 269

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 213 IGTGGYGSVYKA-----QLPNGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +GSV        Q   G+V A+KKL H++EE   ++ F+ E ++L  + H NIVK
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 75
Query: 267 LYGYCLH--KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
             G C    ++ + LI EY+  GSL   L  +++ +  D  K +     +   + YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 130
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG---YIAPELAY 381
            +   IHRD+++ NIL+ ++    + DFG  ++L  D     +         + APE   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 382 TMVMTEKCDVYSFGVVTLEVL 402
               +   DV+SFGVV  E+ 
Sbjct: 191 ESKFSVASDVWSFGVVLYELF 211

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 114/258 (44%), Gaps = 24/258 (9%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALK--KLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +GTG +G V   +       A+K  K  +  E  FI+    EA+V+  + H  +V+LYG 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 71
Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
           C  ++ +F+I EYM  G L   L       +    + + + K +  A+ YL    S   +
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 126
Query: 331 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT-YGYIAPELAYTMVMTEKC 389
           HRD+++ N L+N +    V+DFG +R +  D    ++ +     +  PE+      + K 
Sbjct: 127 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 186
Query: 390 DVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIRDILLIS 448
           D+++FGV+  E+  +GK P +         +    +   L    P     KV        
Sbjct: 187 DIWAFGVLMWEIYSLGKMPYE----RFTNSETAEHIAQGLRLYRPHLASEKVY------- 235
Query: 449 TVSFACLQSNPKSRPTMQ 466
           T+ ++C       RPT +
Sbjct: 236 TIMYSCWHEKADERPTFK 253

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 114/258 (44%), Gaps = 24/258 (9%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALK--KLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +GTG +G V   +       A+K  K  +  E  FI+    EA+V+  + H  +V+LYG 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 72
Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
           C  ++ +F+I EYM  G L   L       +    + + + K +  A+ YL    S   +
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 127
Query: 331 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT-YGYIAPELAYTMVMTEKC 389
           HRD+++ N L+N +    V+DFG +R +  D    ++ +     +  PE+      + K 
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 390 DVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIRDILLIS 448
           D+++FGV+  E+  +GK P +         +    +   L    P     KV        
Sbjct: 188 DIWAFGVLMWEIYSLGKMPYE----RFTNSETAEHIAQGLRLYRPHLASEKVY------- 236
Query: 449 TVSFACLQSNPKSRPTMQ 466
           T+ ++C       RPT +
Sbjct: 237 TIMYSCWHEKADERPTFK 254

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 114/258 (44%), Gaps = 24/258 (9%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALK--KLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +GTG +G V   +       A+K  K  +  E  FI+    EA+V+  + H  +V+LYG 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 78
Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
           C  ++ +F+I EYM  G L   L       +    + + + K +  A+ YL    S   +
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 133
Query: 331 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT-YGYIAPELAYTMVMTEKC 389
           HRD+++ N L+N +    V+DFG +R +  D    ++ +     +  PE+      + K 
Sbjct: 134 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 193
Query: 390 DVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIRDILLIS 448
           D+++FGV+  E+  +GK P +         +    +   L    P     KV        
Sbjct: 194 DIWAFGVLMWEIYSLGKMPYE----RFTNSETAEHIAQGLRLYRPHLASEKVY------- 242
Query: 449 TVSFACLQSNPKSRPTMQ 466
           T+ ++C       RPT +
Sbjct: 243 TIMYSCWHEKADERPTFK 260

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 24/218 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSEEL--AFIKSFKNEAQVLSQVLH 261
           +DF+I   IG G +  V   ++   G+V+A+K ++  + L    +  F+ E  VL     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK--RVNIVKAM--AHA 317
           R I +L+     +  ++L+ EY   G L   L    + +  + A+     IV A+   H 
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR 180
Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA-GTYGYIA 376
           L Y         +HRDI  +NILL+      +ADFG+   L AD + R+L+A GT  Y++
Sbjct: 181 LGY---------VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLS 231
Query: 377 PELAYTMVMTE-------KCDVYSFGVVTLEVLMGKHP 407
           PE+   +           +CD ++ GV   E+  G+ P
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 114/258 (44%), Gaps = 24/258 (9%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALK--KLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +GTG +G V   +       A+K  K  +  E  FI+    EA+V+  + H  +V+LYG 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 67
Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
           C  ++ +F+I EYM  G L   L       +    + + + K +  A+ YL    S   +
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 122
Query: 331 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT-YGYIAPELAYTMVMTEKC 389
           HRD+++ N L+N +    V+DFG +R +  D    ++ +     +  PE+      + K 
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 390 DVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIRDILLIS 448
           D+++FGV+  E+  +GK P +         +    +   L    P     KV        
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYE----RFTNSETAEHIAQGLRLYRPHLASEKVY------- 231
Query: 449 TVSFACLQSNPKSRPTMQ 466
           T+ ++C       RPT +
Sbjct: 232 TIMYSCWHEKADERPTFK 249

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 124/279 (44%), Gaps = 39/279 (13%)
Query: 201 IEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           ++  E ++I   +G G +G VYKA+       A  K+  ++    ++ +  E ++L+   
Sbjct: 7   LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD 66
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN------IVKAM 314
           H  IVKL G   H   ++++ E+   G++        DA+ L+  + +       + + M
Sbjct: 67  HPYIVKLLGAYYHDGKLWIMIEFCPGGAV--------DAIMLELDRGLTEPQIQVVCRQM 118
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGY 374
             AL +LH   S  IIHRD+ + N+L+  + +  +ADFG +         R    GT  +
Sbjct: 119 LEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYW 175
Query: 375 IAPELAYTMVMTE-----KCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLD 429
           +APE+     M +     K D++S G+  +E+   + P           +P  +L+ +  
Sbjct: 176 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH-------HELNPMRVLLKIAK 228
Query: 430 QRLP----PPVDRKVIRDILLISTVSFACLQSNPKSRPT 464
              P    P       RD L I+      L  NP++RP+
Sbjct: 229 SDPPTLLTPSKWSVEFRDFLKIA------LDKNPETRPS 261

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 87  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLED 139
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 140 R---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 196
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 197 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 247
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 248 --CTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 284

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 123/278 (44%), Gaps = 31/278 (11%)
Query: 213 IGTGGYGSVYKA-QLPNGK----VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P+G+      A+K L  +      K   +EA V++ V    + +L
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
            G CL      L+ + M  G L    H  E+   L     +N    +A  ++YL      
Sbjct: 85  LGICLTSTVQ-LVTQLMPYGCLLD--HVRENRGRLGSQDLLNWCMQIAKGMSYLE---DV 138
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAYTMVM 385
            ++HRD+++ N+L+ S     + DFG ARLL  D +      G     ++A E       
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRF 198
Query: 386 TEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVDRKVI 441
           T + DV+S+GV   E++  G  P D          P   + D+L+  +RLP PP+     
Sbjct: 199 THQSDVWSYGVTVWELMTFGAKPYDGI--------PAREIPDLLEKGERLPQPPI---CT 247
Query: 442 RDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
            D+ +I      C   + + RP  + +  EF    + P
Sbjct: 248 IDVYMIMV---KCWMIDSECRPRFRELVSEFSRMARDP 282

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLED 137
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 138 R---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 245
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 246 --CTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 282

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 86  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLED 138
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 139 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 246
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 247 --CTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 283

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 84  LGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLED 136
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 137 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 193
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 194 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 244
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 245 --CTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 281

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLED 137
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 138 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 245
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 246 --CTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 282

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 10/207 (4%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAF--IKSFKNEAQVLSQVL- 260
           EDF++   +G G +G V+ A+     + FA+K L     L    ++    E +VLS    
Sbjct: 18  EDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 77
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H  +  ++     K+ +F + EY+  G L   +++ +   + D ++       +   L +
Sbjct: 78  HPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQF 134
Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELA 380
           LH   S  I++RD+  +NILL+      +ADFG  +      +      GT  YIAPE+ 
Sbjct: 135 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEIL 191
Query: 381 YTMVMTEKCDVYSFGVVTLEVLMGKHP 407
                    D +SFGV+  E+L+G+ P
Sbjct: 192 LGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 87  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLED 139
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 140 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 196
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 197 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 247
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 248 --CTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 284

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 83  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLE- 134
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 243
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 244 --CTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 280

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 84  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLED 136
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 137 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 193
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 194 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 244
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 245 --CTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 281

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLED 142
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 143 R---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 250
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 251 --CTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 287

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLED 137
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 138 R---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 245
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 246 --CTIDVYMIMR---KCWMIDADSRPKFRELIIEFSKMARDP 282

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLE- 134
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 243
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 244 --CTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 280

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 124/279 (44%), Gaps = 39/279 (13%)
Query: 201 IEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           ++  E ++I   +G G +G VYKA+       A  K+  ++    ++ +  E ++L+   
Sbjct: 15  LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD 74
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN------IVKAM 314
           H  IVKL G   H   ++++ E+   G++        DA+ L+  + +       + + M
Sbjct: 75  HPYIVKLLGAYYHDGKLWIMIEFCPGGAV--------DAIMLELDRGLTEPQIQVVCRQM 126
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGY 374
             AL +LH   S  IIHRD+ + N+L+  + +  +ADFG +         R    GT  +
Sbjct: 127 LEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYW 183
Query: 375 IAPELAYTMVMTE-----KCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLD 429
           +APE+     M +     K D++S G+  +E+   + P           +P  +L+ +  
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH-------HELNPMRVLLKIAK 236
Query: 430 QRLP----PPVDRKVIRDILLISTVSFACLQSNPKSRPT 464
              P    P       RD L I+      L  NP++RP+
Sbjct: 237 SDPPTLLTPSKWSVEFRDFLKIA------LDKNPETRPS 269

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 85  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLED 137
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 138 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 245
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 246 --CTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 282

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 128/282 (45%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL    + LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 85  LGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLED 137
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 138 R---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 245
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 246 --CTIDVYMIMR---KCWMIDADSRPKFRELIIEFSKMARDP 282

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLED 138
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 139 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 246
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 247 --CTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 283

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 32/212 (15%)
Query: 212 CIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL--HRNIVKLYG 269
           C+G G YG V++  L +G+  A+K   + +E    +S+  E ++ + VL  H NI+    
Sbjct: 15  CVGKGRYGEVWRG-LWHGESVAVKIFSSRDE----QSWFRETEIYNTVLLRHDNILGFIA 69
Query: 270 YCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
             +  +     ++LI  Y E GSL+  L      +E   A R+ +  + A  LA+LH + 
Sbjct: 70  SDMTSRNSSTQLWLITHYHEHGSLYDFLQRQ--TLEPHLALRLAV--SAACGLAHLHVEI 125
Query: 326 -----SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA-----GTYGYI 375
                 P+I HRD  S N+L+ S L+  +AD G A ++H+  S+   +      GT  Y+
Sbjct: 126 FGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA-VMHSQGSDYLDIGNNPRVGTKRYM 184
Query: 376 APELAYTMVMTE------KCDVYSFGVVTLEV 401
           APE+    + T+        D+++FG+V  E+
Sbjct: 185 APEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 83  LGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLE- 134
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 243
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 244 --CTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 280

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLED 138
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 139 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 246
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 247 --CTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 283

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 110/238 (46%), Gaps = 15/238 (6%)
Query: 178 RATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNG-KVFALKK 236
           R   NID F     D      DL    ED+++   IG G +G V   +  +  KV+A+K 
Sbjct: 47  RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 106
Query: 237 LHTSEELAFIKS--FKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLH 294
           L   E +    S  F  E  +++      +V+L+      + ++++ EYM  G L  NL 
Sbjct: 107 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLM 165
Query: 295 NNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT 354
           +N D  E  WA+       +  AL  +H   S   IHRD+  +N+LL+      +ADFGT
Sbjct: 166 SNYDVPE-KWARF--YTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGT 219
Query: 355 ARLLHADSSNRTLLA-GTYGYIAPELAYTM----VMTEKCDVYSFGVVTLEVLMGKHP 407
              ++ +   R   A GT  YI+PE+  +         +CD +S GV   E+L+G  P
Sbjct: 220 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLED 142
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 143 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 250
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 251 --CTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 287

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 110/238 (46%), Gaps = 15/238 (6%)
Query: 178 RATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNG-KVFALKK 236
           R   NID F     D      DL    ED+++   IG G +G V   +  +  KV+A+K 
Sbjct: 42  RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 101
Query: 237 LHTSEELAFIKS--FKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLH 294
           L   E +    S  F  E  +++      +V+L+      + ++++ EYM  G L  NL 
Sbjct: 102 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLM 160
Query: 295 NNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT 354
           +N D  E  WA+       +  AL  +H   S   IHRD+  +N+LL+      +ADFGT
Sbjct: 161 SNYDVPE-KWARF--YTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGT 214
Query: 355 ARLLHADSSNRTLLA-GTYGYIAPELAYTM----VMTEKCDVYSFGVVTLEVLMGKHP 407
              ++ +   R   A GT  YI+PE+  +         +CD +S GV   E+L+G  P
Sbjct: 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 126/278 (45%), Gaps = 31/278 (11%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
            G CL      LI + M  G L   +  ++D +   +   +N    +A  + YL      
Sbjct: 80  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQIAEGMNYLE---DR 133
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAYTMVM 385
            ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E     + 
Sbjct: 134 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 193
Query: 386 TEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVDRKVI 441
           T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+     
Sbjct: 194 THQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI---CT 242
Query: 442 RDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
            D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 243 IDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 277

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLE- 134
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 243
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 244 --CTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 280

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 113/258 (43%), Gaps = 24/258 (9%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALK--KLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +GTG +G V   +       A+K  K  +  E  FI+    EA+V+  + H  +V+LYG 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 72
Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
           C  ++ +F+I EYM  G L   L       +    + + + K +  A+ YL    S   +
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 127
Query: 331 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT-YGYIAPELAYTMVMTEKC 389
           HRD+++ N L+N +    V+DFG +R +  D    +  +     +  PE+      + K 
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 390 DVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIRDILLIS 448
           D+++FGV+  E+  +GK P +         +    +   L    P     KV        
Sbjct: 188 DIWAFGVLMWEIYSLGKMPYE----RFTNSETAEHIAQGLRLYRPHLASEKVY------- 236
Query: 449 TVSFACLQSNPKSRPTMQ 466
           T+ ++C       RPT +
Sbjct: 237 TIMYSCWHEKADERPTFK 254

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 207 FDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQVLHRNI 264
           F++   +G G YG VYK + +  G++ A+K +  T +E   IK   N  +  S   HRNI
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH--HRNI 83
Query: 265 VKLYGYCLHKK------CMFLIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHA 317
              YG  + K        ++L+ E+   GS+   + N + + ++ +W     I + +   
Sbjct: 84  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREILRG 141
Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           L++LH      +IHRDI   N+LL    E  + DFG +  L      R    GT  ++AP
Sbjct: 142 LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198
Query: 378 ELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHP 407
           E+             K D++S G+  +E+  G  P
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 14/212 (6%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSEEL--AFIKSFKNEAQVLSQVLH 261
           EDF+I   IG G +G V   ++ N  +++A+K L+  E L  A    F+ E  VL     
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
           + I  L+     +  ++L+ +Y   G L   L   ED +  D A+    +  M  A+  +
Sbjct: 134 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFY--IGEMVLAIDSI 191
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA-GTYGYIAPELA 380
           H       +HRDI  +N+LL+      +ADFG+   ++ D + ++ +A GT  YI+PE+ 
Sbjct: 192 HQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEIL 248
Query: 381 YTMV-----MTEKCDVYSFGVVTLEVLMGKHP 407
             M         +CD +S GV   E+L G+ P
Sbjct: 249 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 108 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLE- 159
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 160 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 217
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 218 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 268
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 269 --CTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 305

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 19/215 (8%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQL----PNGKVFALKKLHTS---EELAFIKSFKNEAQVLS 257
           E+F++   +GTG YG V+  +       GK++A+K L  +   ++    +  + E QVL 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 258 QVLHRNIVKLYGYCLHKKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNI-VKAMA 315
            +     +    Y    +  + LI +Y+  G LF +L   E   E      V I V  + 
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE----HEVQIYVGEIV 169
Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
            AL +LH      II+RDI   NILL+S     + DFG ++   AD + R     GT  Y
Sbjct: 170 LALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 226
Query: 375 IAPEL--AYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +AP++         +  D +S GV+  E+L G  P
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 84/164 (51%), Gaps = 11/164 (6%)
Query: 247 KSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK 306
           +S   E Q+L Q+ H NI+KLY +   K   +L+ E    G LF  + + +   E+D A+
Sbjct: 77  ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR 136
Query: 307 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSS 363
              I++ +   + Y+H +    I+HRD+   N+LL SK +     + DFG +    A   
Sbjct: 137 ---IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 190
Query: 364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            +  +   Y YIAPE+ +     EKCDV+S GV+   +L G  P
Sbjct: 191 MKDKIGTAY-YIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPP 232

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 110/238 (46%), Gaps = 15/238 (6%)
Query: 178 RATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNG-KVFALKK 236
           R   NID F     D      DL    ED+++   IG G +G V   +  +  KV+A+K 
Sbjct: 47  RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 106
Query: 237 LHTSEELAFIKS--FKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLH 294
           L   E +    S  F  E  +++      +V+L+      + ++++ EYM  G L  NL 
Sbjct: 107 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLM 165
Query: 295 NNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT 354
           +N D  E  WA+       +  AL  +H   S   IHRD+  +N+LL+      +ADFGT
Sbjct: 166 SNYDVPE-KWARF--YTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGT 219
Query: 355 ARLLHADSSNRTLLA-GTYGYIAPELAYTM----VMTEKCDVYSFGVVTLEVLMGKHP 407
              ++ +   R   A GT  YI+PE+  +         +CD +S GV   E+L+G  P
Sbjct: 220 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLED 135
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYD--------GIPASEISSILEKGERLPQPPI- 243
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 244 --CTIDVYMIMR---KCWMIDADSRPKFRELIIEFSKMARDP 280

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 93  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLE- 144
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 145 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 202
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 203 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 253
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 254 --CTIDVYMIMR---KCWMIDADSRPKFRELIIEFSKMARDP 290

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLED 138
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 139 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 246
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 247 --CTIDVYMIMR---KCWMIDADSRPKFRELIIEFSKMARDP 283

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 128/282 (45%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL    + LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 89  LGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLE- 140
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 141 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 198
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 199 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 249
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 250 --CTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 286

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 124/282 (43%), Gaps = 48/282 (17%)
Query: 213 IGTGGYGSVYKA-QLPNGKV-----FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIV 265
           +G G +G V +A     GK       A+K L ++      ++  +E +++S +  H NIV
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLH-------NNEDAVELDWAKRVNIVKAMAHAL 318
            L G C H   + +I EY   G L   L        + ED   L+    ++    +A  +
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 165
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT----YGY 374
           A+L    S + IHRD+++ N+LL +   A + DFG AR +  DS+   ++ G       +
Sbjct: 166 AFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN--YIVKGNARLPVKW 220
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIM-------LID 426
           +APE  +  V T + DV+S+G++  E+  +G +P            P I+       L+ 
Sbjct: 221 MAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY-----------PGILVNSKFYKLVK 269
Query: 427 VLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
              Q   P    K I  I+       AC    P  RPT Q +
Sbjct: 270 DGYQMAQPAFAPKNIYSIMQ------ACWALEPTHRPTFQQI 305

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 83/161 (51%), Gaps = 11/161 (6%)
Query: 247 KSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK 306
           +S   E Q+L Q+ H NI+KLY +   K   +L+ E    G LF  + + +   E+D A+
Sbjct: 94  ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR 153
Query: 307 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSS 363
              I++ +   + Y+H +    I+HRD+   N+LL SK +     + DFG +    A   
Sbjct: 154 ---IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 207
Query: 364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG 404
            +  +   Y YIAPE+ +     EKCDV+S GV+   +L G
Sbjct: 208 MKDKIGTAY-YIAPEVLHG-TYDEKCDVWSTGVILYILLSG 246

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 77  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLE- 128
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 129 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 237
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 238 --CTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 274

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 83/161 (51%), Gaps = 11/161 (6%)
Query: 247 KSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK 306
           +S   E Q+L Q+ H NI+KLY +   K   +L+ E    G LF  + + +   E+D A+
Sbjct: 95  ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR 154
Query: 307 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSS 363
              I++ +   + Y+H +    I+HRD+   N+LL SK +     + DFG +    A   
Sbjct: 155 ---IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 208
Query: 364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG 404
            +  +   Y YIAPE+ +     EKCDV+S GV+   +L G
Sbjct: 209 MKDKIGTAY-YIAPEVLHG-TYDEKCDVWSTGVILYILLSG 247

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 83/161 (51%), Gaps = 11/161 (6%)
Query: 247 KSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK 306
           +S   E Q+L Q+ H NI+KLY +   K   +L+ E    G LF  + + +   E+D A+
Sbjct: 71  ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR 130
Query: 307 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSS 363
              I++ +   + Y+H +    I+HRD+   N+LL SK +     + DFG +    A   
Sbjct: 131 ---IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184
Query: 364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG 404
            +  +   Y YIAPE+ +     EKCDV+S GV+   +L G
Sbjct: 185 MKDKIGTAY-YIAPEVLHG-TYDEKCDVWSTGVILYILLSG 223

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 14/212 (6%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSEEL--AFIKSFKNEAQVLSQVLH 261
           EDF+I   IG G +G V   ++ N  +++A+K L+  E L  A    F+ E  VL     
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
           + I  L+     +  ++L+ +Y   G L   L   ED +  D A+    +  M  A+  +
Sbjct: 150 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFY--IGEMVLAIDSI 207
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA-GTYGYIAPELA 380
           H       +HRDI  +N+LL+      +ADFG+   ++ D + ++ +A GT  YI+PE+ 
Sbjct: 208 HQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEIL 264
Query: 381 YTMV-----MTEKCDVYSFGVVTLEVLMGKHP 407
             M         +CD +S GV   E+L G+ P
Sbjct: 265 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 213 IGTGGYGSVYKA-----QLPNGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +GSV        Q   G+V A+KKL H++EE   ++ F+ E ++L  + H NIVK
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIEILKSLQHDNIVK 76
Query: 267 LYGYCLH--KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
             G C    ++ + LI EY+  GSL   L  +++ +  D  K +     +   + YL   
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL--- 131
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG---YIAPELAY 381
            +   IHR++++ NIL+ ++    + DFG  ++L  D     +         + APE   
Sbjct: 132 GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 191
Query: 382 TMVMTEKCDVYSFGVVTLEVL 402
               +   DV+SFGVV  E+ 
Sbjct: 192 ESKFSVASDVWSFGVVLYELF 212

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 122/277 (44%), Gaps = 22/277 (7%)
Query: 205 EDFDIRYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +DF+    +G G  G V+K +  P+G V A K +H   + A       E QVL +     
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           IV  YG       + +  E+M+ GSL   L       E    K V+I  A+   L YL  
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKGLTYLRE 141
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
                I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y++PE     
Sbjct: 142 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSPERLQGT 197
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRL--PPPVDRKVI 441
             + + D++S G+  +E+ +G++P              + + ++LD  +  PPP   K+ 
Sbjct: 198 HYSVQSDIWSMGLSLVEMAVGRYP-------IGSGSGSMAIFELLDYIVNEPPP---KLP 247
Query: 442 RDILLISTVSFA--CLQSNPKSRPTMQSVSQEFLITR 476
             +  +    F   CL  NP  R  ++ +     I R
Sbjct: 248 SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 284

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 124/292 (42%), Gaps = 45/292 (15%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           DF     IG+GG+G V+KA+   +GK + +K++  + E A     + E + L+++ H NI
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA-----EREVKALAKLDHVNI 66
Query: 265 VKLYGYCL-----------------HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR 307
           V  Y  C                    KC+F+  E+ ++G+L   +       +LD    
Sbjct: 67  VH-YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLA 124
Query: 308 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL 367
           + + + +   + Y+H   S  +I+RD+  +NI L    +  + DFG    L  D   R  
Sbjct: 125 LELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKRXR 180
Query: 368 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDV 427
             GT  Y++PE   +    ++ D+Y+ G++  E+L   H  D                D+
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---HVCDTAFETSK------FFTDL 231
Query: 428 LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
            D  +    D+K         T+    L   P+ RP    + +   + +K+P
Sbjct: 232 RDGIISDIFDKKE-------KTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 124/282 (43%), Gaps = 48/282 (17%)
Query: 213 IGTGGYGSVYKAQLPN-GKV-----FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIV 265
           +G G +G V +A     GK       A+K L ++      ++  +E +++S +  H NIV
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLH-------NNEDAVELDWAKRVNIVKAMAHAL 318
            L G C H   + +I EY   G L   L        + ED   L+    ++    +A  +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 173
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT----YGY 374
           A+L    S + IHRD+++ N+LL +   A + DFG AR +  DS+   ++ G       +
Sbjct: 174 AFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN--YIVKGNARLPVKW 228
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIM-------LID 426
           +APE  +  V T + DV+S+G++  E+  +G +P            P I+       L+ 
Sbjct: 229 MAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY-----------PGILVNSKFYKLVK 277
Query: 427 VLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
              Q   P    K I  I+       AC    P  RPT Q +
Sbjct: 278 DGYQMAQPAFAPKNIYSIMQ------ACWALEPTHRPTFQQI 313

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 19/231 (8%)
Query: 185 VFSIWNYDGRIVYEDLIEATED-----FDIRYCIGTGGYGSVYK-AQLPNGKVFALKKLH 238
           VF IW    +  Y   +E   D     +DI   +GTG +G V++  +   G  FA K + 
Sbjct: 136 VFDIW----KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM 191
Query: 239 TSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNED 298
           T  E +  ++ + E Q +S + H  +V L+        M +IYE+M  G LF  + +  +
Sbjct: 192 TPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN 250
Query: 299 AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL--EAFVADFGTAR 356
            +  D A  V  ++ +   L ++H +   + +H D+   NI+  +K   E  + DFG   
Sbjct: 251 KMSEDEA--VEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305
Query: 357 LLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            L    S + +  GT  + APE+A    +    D++S GV++  +L G  P
Sbjct: 306 HLDPKQSVK-VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 10/207 (4%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAF--IKSFKNEAQVLSQVL- 260
           EDF +   +G G +G V+ A+     + FA+K L     L    ++    E +VLS    
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H  +  ++     K+ +F + EY+  G L   +++ +   + D ++       +   L +
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQF 133
Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELA 380
           LH   S  I++RD+  +NILL+      +ADFG  +      +      GT  YIAPE+ 
Sbjct: 134 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEIL 190
Query: 381 YTMVMTEKCDVYSFGVVTLEVLMGKHP 407
                    D +SFGV+  E+L+G+ P
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 8/204 (3%)
Query: 205 EDFDIRYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +DF+    +G G  G V+K +  P+G V A K +H   + A       E QVL +     
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           IV  YG       + +  E+M+ GSL   L       E    K V+I  A+   L YL  
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKGLTYLRE 184
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
                I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y++PE     
Sbjct: 185 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSPERLQGT 240
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             + + D++S G+  +E+ +G++P
Sbjct: 241 HYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 19/231 (8%)
Query: 185 VFSIWNYDGRIVYEDLIEATED-----FDIRYCIGTGGYGSVYK-AQLPNGKVFALKKLH 238
           VF IW    +  Y   +E   D     +DI   +GTG +G V++  +   G  FA K + 
Sbjct: 30  VFDIW----KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM 85
Query: 239 TSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNED 298
           T  E +  ++ + E Q +S + H  +V L+        M +IYE+M  G LF  + +  +
Sbjct: 86  TPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN 144
Query: 299 AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL--EAFVADFGTAR 356
            +  D A  V  ++ +   L ++H +   + +H D+   NI+  +K   E  + DFG   
Sbjct: 145 KMSEDEA--VEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTA 199
Query: 357 LLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            L    S + +  GT  + APE+A    +    D++S GV++  +L G  P
Sbjct: 200 HLDPKQSVK-VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 110/209 (52%), Gaps = 12/209 (5%)
Query: 204 TEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAF-IKSFKNEAQVLSQVLH 261
           ++++D++  +G G +  V +      G  FA K ++T +  A   +  + EA++  ++ H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            NIV+L+     +   +L+++ +  G LF ++   E   E D +   + ++ +  ++AY 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAYC 144
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAGTYGYIAPE 378
           H   S  I+HR++   N+LL SK +     +ADFG A  ++ DS      AGT GY++PE
Sbjct: 145 H---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPE 200
Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +      ++  D+++ GV+   +L+G  P
Sbjct: 201 VLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 110/209 (52%), Gaps = 12/209 (5%)
Query: 204 TEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAF-IKSFKNEAQVLSQVLH 261
           ++++D++  +G G +  V +      G  FA K ++T +  A   +  + EA++  ++ H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            NIV+L+     +   +L+++ +  G LF ++   E   E D +   + ++ +  ++AY 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAYC 121
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAGTYGYIAPE 378
           H   S  I+HR++   N+LL SK +     +ADFG A  ++ DS      AGT GY++PE
Sbjct: 122 H---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPE 177
Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +      ++  D+++ GV+   +L+G  P
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHT--SEELAFIKSFKNEAQVLSQVL 260
           ++ +++   +G GG   V+ A+ L + +  A+K L    + + +F   F+ EAQ  + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 261 HRNIVKLYGYCLHKKCM----FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 316
           H  IV +Y     +       +++ EY++  +L   +H       +   + + ++     
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 127
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR----TLLAGTY 372
           AL + H +    IIHRD+   NIL+++     V DFG AR + ADS N       + GT 
Sbjct: 128 ALNFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAI-ADSGNSVXQTAAVIGTA 183
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            Y++PE A    +  + DVYS G V  EVL G+ P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 81/161 (50%), Gaps = 11/161 (6%)
Query: 247 KSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK 306
           +S   E Q+L Q+ H NI KLY +   K   +L+ E    G LF  + + +   E+D A+
Sbjct: 71  ESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR 130
Query: 307 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSS 363
              I++ +   + Y H +    I+HRD+   N+LL SK +     + DFG +    A   
Sbjct: 131 ---IIRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184
Query: 364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG 404
            +  +   Y YIAPE+ +     EKCDV+S GV+   +L G
Sbjct: 185 XKDKIGTAY-YIAPEVLHG-TYDEKCDVWSTGVILYILLSG 223

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 110/209 (52%), Gaps = 12/209 (5%)
Query: 204 TEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAF-IKSFKNEAQVLSQVLH 261
           ++++D++  +G G +  V +      G  FA K ++T +  A   +  + EA++  ++ H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            NIV+L+     +   +L+++ +  G LF ++   E   E D +   + ++ +  ++AY 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAYC 121
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAGTYGYIAPE 378
           H   S  I+HR++   N+LL SK +     +ADFG A  ++ DS      AGT GY++PE
Sbjct: 122 H---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPE 177
Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +      ++  D+++ GV+   +L+G  P
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 205 EDF-DIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           EDF +I   +G G +G VYKAQ     V A  K+  ++    ++ +  E  +L+   H N
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 95
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK-----RVNIV-KAMAHA 317
           IVKL     ++  ++++ E+   G++        DAV L+  +     ++ +V K    A
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAV--------DAVMLELERPLTESQIQVVCKQTLDA 147
Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           L YLH +    IIHRD+ + NIL     +  +ADFG +         R    GT  ++AP
Sbjct: 148 LNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAP 204
Query: 378 ELAYTMVMTE-----KCDVYSFGVVTLEV 401
           E+       +     K DV+S G+  +E+
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 125/305 (40%), Gaps = 58/305 (19%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           DF     IG+GG+G V+KA+   +GK + ++++  + E A     + E + L+++ H NI
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKA-----EREVKALAKLDHVNI 67
Query: 265 VKLYGYCL------------------------------HKKCMFLIYEYMERGSLFCNLH 294
           V  Y  C                                 KC+F+  E+ ++G+L   + 
Sbjct: 68  VH-YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 126
Query: 295 NNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT 354
                 +LD    + + + +   + Y+H   S  +IHRD+  +NI L    +  + DFG 
Sbjct: 127 KRR-GEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGL 182
Query: 355 ARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXX 414
              L  D   RT   GT  Y++PE   +    ++ D+Y+ G++  E+L   H  D     
Sbjct: 183 VTSLKND-GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---HVCDTAFET 238
Query: 415 XXXXDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI 474
                      D+ D  +    D+K         T+    L   P+ RP    + +   +
Sbjct: 239 SK------FFTDLRDGIISDIFDKKE-------KTLLQKLLSKKPEDRPNTSEILRTLTV 285
Query: 475 TRKTP 479
            +K+P
Sbjct: 286 WKKSP 290

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 110/209 (52%), Gaps = 12/209 (5%)
Query: 204 TEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAF-IKSFKNEAQVLSQVLH 261
           ++++D++  +G G +  V +      G  FA K ++T +  A   +  + EA++  ++ H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            NIV+L+     +   +L+++ +  G LF ++   E   E D +   + ++ +  ++AY 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAYC 120
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAGTYGYIAPE 378
           H   S  I+HR++   N+LL SK +     +ADFG A  ++ DS      AGT GY++PE
Sbjct: 121 H---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPE 176
Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +      ++  D+++ GV+   +L+G  P
Sbjct: 177 VLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 8/204 (3%)
Query: 205 EDFDIRYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +DF+    +G G  G V+K +  P+G V A K +H   + A       E QVL +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           IV  YG       + +  E+M+ GSL   L       E    K V+I  A+   L YL  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKGLTYLRE 122
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
                I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y++PE     
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSPERLQGT 178
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             + + D++S G+  +E+ +G++P
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 118/288 (40%), Gaps = 29/288 (10%)
Query: 213 IGTGGYGSVYKAQL--PNGKVFALK----KLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G V + +   P+GK  ++     K     +   +  F  E   +  + HRN+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
           LYG  L    M ++ E    GSL   L  ++    L    R  +   +A  + YL    S
Sbjct: 80  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 133
Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIAPELAYTM 383
              IHRD+++ N+LL ++    + DFG  R L  +  +  +       + + APE   T 
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIR 442
             +   D + FGV   E+   G+ P              +  ID   +RLP P D    +
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEP-----WIGLNGSQILHKIDKEGERLPRPED--CPQ 246
Query: 443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDIS 490
           DI     V   C    P+ RPT  ++    L  + T +    A+QD  
Sbjct: 247 DIY---NVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM---RALQDFE 288

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 111/221 (50%), Gaps = 22/221 (9%)
Query: 202 EATEDFDIRYCIGTGGYGSVYK-AQLPNGKVFALKKLHTS------EELAFIK-SFKNEA 253
           E  + +D +  IG G    V +      G  FA+K +  +      E+L  ++ + + E 
Sbjct: 91  EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRET 150
Query: 254 QVLSQVL-HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK 312
            +L QV  H +I+ L         MFL+++ M +G LF  L    + V L   +  +I++
Sbjct: 151 HILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVALSEKETRSIMR 207
Query: 313 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY 372
           ++  A+++LH +   +I+HRD+   NILL+  ++  ++DFG +  L      R  L GT 
Sbjct: 208 SLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE-LCGTP 263
Query: 373 GYIAPE-LAYTMVMT-----EKCDVYSFGVVTLEVLMGKHP 407
           GY+APE L  +M  T     ++ D+++ GV+   +L G  P
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 8/204 (3%)
Query: 205 EDFDIRYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +DF+    +G G  G V+K +  P+G V A K +H   + A       E QVL +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           IV  YG       + +  E+M+ GSL   L       E    K V+I  A+   L YL  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKGLTYLRE 122
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
                I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y++PE     
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSPERLQGT 178
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             + + D++S G+  +E+ +G++P
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 8/204 (3%)
Query: 205 EDFDIRYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +DF+    +G G  G V+K +  P+G V A K +H   + A       E QVL +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           IV  YG       + +  E+M+ GSL   L       E    K V+I  A+   L YL  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKGLTYLRE 122
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
                I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y++PE     
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSPERLQGT 178
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             + + D++S G+  +E+ +G++P
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 8/204 (3%)
Query: 205 EDFDIRYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +DF+    +G G  G V+K +  P+G V A K +H   + A       E QVL +     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           IV  YG       + +  E+M+ GSL   L       E    K V+I  A+   L YL  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKGLTYLRE 122
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
                I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y++PE     
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSPERLQGT 178
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             + + D++S G+  +E+ +G++P
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 205 EDF-DIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           EDF +I   +G G +G VYKAQ     V A  K+  ++    ++ +  E  +L+   H N
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 95
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK-----RVNIV-KAMAHA 317
           IVKL     ++  ++++ E+   G++        DAV L+  +     ++ +V K    A
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAV--------DAVMLELERPLTESQIQVVCKQTLDA 147
Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           L YLH +    IIHRD+ + NIL     +  +ADFG +         R    GT  ++AP
Sbjct: 148 LNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 204
Query: 378 ELAYTMVMTE-----KCDVYSFGVVTLEV 401
           E+       +     K DV+S G+  +E+
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 205 EDF-DIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           EDF +I   +G G +G VYKAQ     V A  K+  ++    ++ +  E  +L+   H N
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 95
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK-----RVNIV-KAMAHA 317
           IVKL     ++  ++++ E+   G++        DAV L+  +     ++ +V K    A
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAV--------DAVMLELERPLTESQIQVVCKQTLDA 147
Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           L YLH +    IIHRD+ + NIL     +  +ADFG +         R    GT  ++AP
Sbjct: 148 LNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAP 204
Query: 378 ELAYTMVMTE-----KCDVYSFGVVTLEV 401
           E+       +     K DV+S G+  +E+
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 8/204 (3%)
Query: 205 EDFDIRYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +DF+    +G G  G V+K +  P+G V A K +H   + A       E QVL +     
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           IV  YG       + +  E+M+ GSL   L       E    K V+I  A+   L YL  
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKGLTYLRE 149
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
                I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y++PE     
Sbjct: 150 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSPERLQGT 205
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             + + D++S G+  +E+ +G++P
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 32/222 (14%)
Query: 213 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN 263
           +G G +G V  A+        PN     A+K L +      +    +E +++  +  H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSL---------------FCNLHNNEDAVELDWAKRV 308
           I+ L G C     +++I EY  +G+L               F   HN E+  +L     V
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEE--QLSSKDLV 153
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H     +   
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTT 210
Query: 369 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
            G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 115/272 (42%), Gaps = 27/272 (9%)
Query: 213 IGTGGYGSVYKAQL--PNGKVFALK----KLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G V + +   P+GK  ++     K     +   +  F  E   +  + HRN+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
           LYG  L    M ++ E    GSL   L  ++    L    R  +   +A  + YL    S
Sbjct: 86  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 139
Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIAPELAYTM 383
              IHRD+++ N+LL ++    + DFG  R L  +  +  +       + + APE   T 
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 199
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIR 442
             +   D + FGV   E+   G+ P              +  ID   +RLP P D    +
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP-----WIGLNGSQILHKIDKEGERLPRPED--CPQ 252
Query: 443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLI 474
           DI     V   C    P+ RPT  ++ ++FL+
Sbjct: 253 DIY---NVMVQCWAHKPEDRPTFVAL-RDFLL 280

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 29/218 (13%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRN 263
           F+I   IG G +G V   Q  +  K++A+K ++  +  E   +++   E Q++  + H  
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNN----EDAVELDWAKRVNIVKAMAHALA 319
           +V L+     ++ MF++ + +  G L  +L  N    E+ V+L        +  +  AL 
Sbjct: 77  LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-------FICELVMALD 129
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           YL +     IIHRD+  +NILL+      + DF  A +L  ++   T +AGT  Y+APE+
Sbjct: 130 YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ-ITTMAGTKPYMAPEM 185
Query: 380 -------AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDI 410
                   Y+  +    D +S GV   E+L G+ P  I
Sbjct: 186 FSSRKGAGYSFAV----DWWSLGVTAYELLRGRRPYHI 219

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 115/272 (42%), Gaps = 27/272 (9%)
Query: 213 IGTGGYGSVYKAQL--PNGKVFALK----KLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G V + +   P+GK  ++     K     +   +  F  E   +  + HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
           LYG  L    M ++ E    GSL   L  ++    L    R  +   +A  + YL    S
Sbjct: 76  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 129
Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIAPELAYTM 383
              IHRD+++ N+LL ++    + DFG  R L  +  +  +       + + APE   T 
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 189
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIR 442
             +   D + FGV   E+   G+ P              +  ID   +RLP P D    +
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP-----WIGLNGSQILHKIDKEGERLPRPED--CPQ 242
Query: 443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLI 474
           DI     V   C    P+ RPT  ++ ++FL+
Sbjct: 243 DIY---NVMVQCWAHKPEDRPTFVAL-RDFLL 270

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 33/226 (14%)
Query: 212 CIGTGGYGSVYKAQLPNGK------VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIV 265
            +G G +G V KA   + K        A+K L  +   + ++   +E  VL QV H +++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNE---------------------DAVELDW 304
           KLYG C     + LI EY + GSL   L  +                      D   L  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 305 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 364
              ++    ++  + YL      S++HRD+++ NIL+    +  ++DFG +R ++ + S 
Sbjct: 150 GDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 365 RTLLAGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
                G     ++A E  +  + T + DV+SFGV+  E++ +G +P
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 103/209 (49%), Gaps = 11/209 (5%)
Query: 204 TEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFI-KSFKNEAQVLSQVLH 261
           T+++ +   +G G +  V +  ++P G+ +A K ++T +  A   +  + EA++   + H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            NIV+L+     +   +L+++ +  G LF      ED V  ++    +    +   L  +
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELF------EDIVAREYYSEADASHCIQQILESV 116
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAGTYGYIAPE 378
           +H     I+HRD+   N+LL SK +     +ADFG A  +  D       AGT GY++PE
Sbjct: 117 NHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPE 176
Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +       +  D+++ GV+   +L+G  P
Sbjct: 177 VLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 126/282 (44%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           + +G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 90  LGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLED 142
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 143 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 250
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 251 --CTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 287

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 126/282 (44%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           + +G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLED 135
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 136 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 243
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 244 --CTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 280

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHT--SEELAFIKSFKNEAQVLSQVL 260
           ++ +++   +G GG   V+ A+ L + +  A+K L    + + +F   F+ EAQ  + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 261 HRNIVKLYGYCLHKKCM----FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 316
           H  IV +Y     +       +++ EY++  +L   +H       +   + + ++     
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 127
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR----TLLAGTY 372
           AL + H +    IIHRD+   NI++++     V DFG AR + ADS N       + GT 
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI-ADSGNSVTQTAAVIGTA 183
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            Y++PE A    +  + DVYS G V  EVL G+ P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHT--SEELAFIKSFKNEAQVLSQVL 260
           ++ +++   +G GG   V+ A+ L + +  A+K L    + + +F   F+ EAQ  + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 261 HRNIVKLYGYCLHKKCM----FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 316
           H  IV +Y     +       +++ EY++  +L   +H       +   + + ++     
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 127
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR----TLLAGTY 372
           AL + H +    IIHRD+   NI++++     V DFG AR + ADS N       + GT 
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI-ADSGNSVTQTAAVIGTA 183
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            Y++PE A    +  + DVYS G V  EVL G+ P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 126/282 (44%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           + +G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLED 142
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 143 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 250
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 251 --CTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 287

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 79/327 (24%), Positives = 143/327 (43%), Gaps = 38/327 (11%)
Query: 163 LLLAKRKYKKPKLEERATNNID---VFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYG 219
           L + K  +++P+       ++D     SI N +  +  +DL    E       +G G YG
Sbjct: 13  LKIPKEAFEQPQTSSTPPRDLDSKACISIGNQNFEVKADDLEPIME-------LGRGAYG 65
Query: 220 SVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQV-LSQVLHRNIVKLYGYCLHKKCM 277
            V K + +P+G++ A+K++  +      K    +  + +  V     V  YG    +  +
Sbjct: 66  VVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 125
Query: 278 FLIYEYMERG--SLFCNLHNNEDAVELDWAKR--VNIVKAMAHALAYLHHDCSPSIIHRD 333
           ++  E M+      +  + +    +  D   +  V+IVKA+ H  + L      S+IHRD
Sbjct: 126 WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL------SVIHRD 179
Query: 334 ISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTE----KC 389
           +  +N+L+N+  +  + DFG +  L  DS  +T+ AG   Y+APE     +  +    K 
Sbjct: 180 VKPSNVLINALGQVKMCDFGISGYL-VDSVAKTIDAGCKPYMAPERINPELNQKGYSVKS 238
Query: 390 DVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPP-PVDRKVIRDILLIS 448
           D++S G+  +E+ + + P D          P   L  V+++  P  P D+     +   S
Sbjct: 239 DIWSLGITMIELAILRFPYD------SWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTS 292
Query: 449 TVSFACLQSNPKSRPTMQSVSQEFLIT 475
                CL+ N K RPT   + Q    T
Sbjct: 293 Q----CLKKNSKERPTYPELMQHPFFT 315

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 115/272 (42%), Gaps = 27/272 (9%)
Query: 213 IGTGGYGSVYKAQL--PNGKVFALK----KLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G V + +   P+GK  ++     K     +   +  F  E   +  + HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
           LYG  L    M ++ E    GSL   L  ++    L    R  +   +A  + YL    S
Sbjct: 76  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 129
Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIAPELAYTM 383
              IHRD+++ N+LL ++    + DFG  R L  +  +  +       + + APE   T 
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIR 442
             +   D + FGV   E+   G+ P              +  ID   +RLP P D    +
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP-----WIGLNGSQILHKIDKEGERLPRPED--CPQ 242
Query: 443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLI 474
           DI     V   C    P+ RPT  ++ ++FL+
Sbjct: 243 DIY---NVMVQCWAHKPEDRPTFVAL-RDFLL 270

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 126/282 (44%), Gaps = 39/282 (13%)
Query: 213 IGTGGYGSVYKA-QLPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK   +P G+      A+ +L  +      K   +EA V++ V + ++ +L
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL      LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 117 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLED 169
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPELAY 381
                ++HRD+++ N+L+ +     + DFG A+LL A+        G     ++A E   
Sbjct: 170 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 226
Query: 382 TMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLD--QRLP-PPVD 437
             + T + DV+S+GV   E++  G  P D          P   +  +L+  +RLP PP+ 
Sbjct: 227 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI--------PASEISSILEKGERLPQPPI- 277
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 278 --CTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 314

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 115/272 (42%), Gaps = 27/272 (9%)
Query: 213 IGTGGYGSVYKAQL--PNGKVFALK----KLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G V + +   P+GK  ++     K     +   +  F  E   +  + HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
           LYG  L    M ++ E    GSL   L  ++    L    R  +   +A  + YL    S
Sbjct: 76  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 129
Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIAPELAYTM 383
              IHRD+++ N+LL ++    + DFG  R L  +  +  +       + + APE   T 
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIR 442
             +   D + FGV   E+   G+ P              +  ID   +RLP P D    +
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP-----WIGLNGSQILHKIDKEGERLPRPED--CPQ 242
Query: 443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLI 474
           DI     V   C    P+ RPT  ++ ++FL+
Sbjct: 243 DIY---NVMVQCWAHKPEDRPTFVAL-RDFLL 270

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 103/209 (49%), Gaps = 11/209 (5%)
Query: 204 TEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAF-IKSFKNEAQVLSQVLH 261
           T+++ +   +G G +  V +  ++P G+ +A K ++T +  A   +  + EA++   + H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            NIV+L+     +   +L+++ +  G LF      ED V  ++    +    +   L  +
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELF------EDIVAREYYSEADASHCIQQILESV 116
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAGTYGYIAPE 378
           +H     I+HRD+   N+LL SK +     +ADFG A  +  D       AGT GY++PE
Sbjct: 117 NHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPE 176
Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +       +  D+++ GV+   +L+G  P
Sbjct: 177 VLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 123/286 (43%), Gaps = 52/286 (18%)
Query: 213 IGTGGYGSVYKAQLPN-GK-----VFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIV 265
           +G G +G V +A     GK       A+K L ++      ++  +E +++S +  H NIV
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV-----------NIVKAM 314
            L G C H   + +I EY   G L   L      +E D A  +           +    +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT--- 371
           A  +A+L    S + IHRD+++ N+LL +   A + DFG AR +  DS+   ++ G    
Sbjct: 174 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN--YIVKGNARL 228
Query: 372 -YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIM------ 423
              ++APE  +  V T + DV+S+G++  E+  +G +P            P I+      
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY-----------PGILVNSKFY 277
Query: 424 -LIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
            L+    Q   P    K I  I+       AC    P  RPT Q +
Sbjct: 278 KLVKDGYQMAQPAFAPKNIYSIMQ------ACWALEPTHRPTFQQI 317

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 115/272 (42%), Gaps = 27/272 (9%)
Query: 213 IGTGGYGSVYKAQL--PNGKVFALK----KLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G V + +   P+GK  ++     K     +   +  F  E   +  + HRN+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
           LYG  L    M ++ E    GSL   L  ++    L    R  +   +A  + YL    S
Sbjct: 86  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 139
Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIAPELAYTM 383
              IHRD+++ N+LL ++    + DFG  R L  +  +  +       + + APE   T 
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIR 442
             +   D + FGV   E+   G+ P              +  ID   +RLP P D    +
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP-----WIGLNGSQILHKIDKEGERLPRPED--CPQ 252
Query: 443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLI 474
           DI     V   C    P+ RPT  ++ ++FL+
Sbjct: 253 DIY---NVMVQCWAHKPEDRPTFVAL-RDFLL 280

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 123/286 (43%), Gaps = 52/286 (18%)
Query: 213 IGTGGYGSVYKAQLPN-GK-----VFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIV 265
           +G G +G V +A     GK       A+K L ++      ++  +E +++S +  H NIV
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV-----------NIVKAM 314
            L G C H   + +I EY   G L   L      +E D A  +           +    +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQV 173
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT--- 371
           A  +A+L    S + IHRD+++ N+LL +   A + DFG AR +  DS+   ++ G    
Sbjct: 174 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN--YIVKGNARL 228
Query: 372 -YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIM------ 423
              ++APE  +  V T + DV+S+G++  E+  +G +P            P I+      
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY-----------PGILVNSKFY 277
Query: 424 -LIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
            L+    Q   P    K I  I+       AC    P  RPT Q +
Sbjct: 278 KLVKDGYQMAQPAFAPKNIYSIMQ------ACWALEPTHRPTFQQI 317

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 115/272 (42%), Gaps = 27/272 (9%)
Query: 213 IGTGGYGSVYKAQL--PNGKVFALK----KLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G V + +   P+GK  ++     K     +   +  F  E   +  + HRN+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
           LYG  L    M ++ E    GSL   L  ++    L    R  +   +A  + YL    S
Sbjct: 80  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 133
Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT---YGYIAPELAYTM 383
              IHRD+++ N+LL ++    + DFG  R L  +  +  +       + + APE   T 
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIR 442
             +   D + FGV   E+   G+ P              +  ID   +RLP P D    +
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEP-----WIGLNGSQILHKIDKEGERLPRPED--CPQ 246
Query: 443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLI 474
           DI     V   C    P+ RPT  ++ ++FL+
Sbjct: 247 DIY---NVMVQCWAHKPEDRPTFVAL-RDFLL 274

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 213 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG G +G VY   L   +GK    A+K L+   ++  +  F  E  ++    H N++ L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 269 GYCLHKKCM-FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
           G CL  +    ++  YM+ G L   + N      +     +     +A  + YL    S 
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 151
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS----NRTLLAGTYGYIAPELAYTM 383
             +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E   T 
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQ 211
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             T K DV+SFGV+  E++    P
Sbjct: 212 KFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 213 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG G +G VY   L   +GK    A+K L+   ++  +  F  E  ++    H N++ L 
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 269 GYCLHKKCM-FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
           G CL  +    ++  YM+ G L   + N      +     +     +A  + YL    S 
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 170
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADS----SNRTLLAGTYGYIAPELAYTM 383
             +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E   T 
Sbjct: 171 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 230
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             T K DV+SFGV+  E++    P
Sbjct: 231 KFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 207 FDIRYCIGTGGYGSVY-KAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIV 265
           F  +  +G+G +G V+   +  +G    +K ++       ++  + E +VL  + H NI+
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHD 324
           K++        M+++ E  E G L   + + +     L       ++K M +ALAY H  
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH-- 141
Query: 325 CSPSIIHRDISSNNILL-----NSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
            S  ++H+D+   NIL      +S ++  + DFG A L  +D  + T  AGT  Y+APE+
Sbjct: 142 -SQHVVHKDLKPENILFQDTSPHSPIK--IIDFGLAELFKSD-EHSTNAAGTALYMAPEV 197
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMG 404
            +   +T KCD++S GVV   +L G
Sbjct: 198 -FKRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 11/205 (5%)
Query: 207 FDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIV 265
           F+ +  +GTG +  V  A+    GK+FA+K +          S +NE  VL ++ H NIV
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
            L         ++L+ + +  G LF  +       E D +    +++ +  A+ YLH   
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAS---TLIRQVLDAVYYLHR-- 138
Query: 326 SPSIIHRDISSNNILLNSKLEA---FVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              I+HRD+   N+L  S+ E     ++DFG +++        +   GT GY+APE+   
Sbjct: 139 -MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM-EGKGDVMSTACGTPGYVAPEVLAQ 196
Query: 383 MVMTEKCDVYSFGVVTLEVLMGKHP 407
              ++  D +S GV+   +L G  P
Sbjct: 197 KPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 213 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG G +G VY   L   +GK    A+K L+   ++  +  F  E  ++    H N++ L 
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 269 GYCLHKKCM-FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
           G CL  +    ++  YM+ G L   + N      +     +     +A  + YL    S 
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 171
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADS----SNRTLLAGTYGYIAPELAYTM 383
             +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E   T 
Sbjct: 172 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 231
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             T K DV+SFGV+  E++    P
Sbjct: 232 KFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 94/203 (46%), Gaps = 25/203 (12%)
Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHRNIVKLYGY 270
           IG G YG V+K +    G++ A+KK   SE+   IK     E ++L Q+ H N+V L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR---VNIVKAMA----HALAYLH- 322
              K+ + L++EY +   L           ELD  +R    ++VK++      A+ + H 
Sbjct: 71  FRRKRRLHLVFEYCDHTVLH----------ELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAY 381
           H+C    IHRD+   NIL+       + DFG ARLL   S        T  Y +PE L  
Sbjct: 121 HNC----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG 176
Query: 382 TMVMTEKCDVYSFGVVTLEVLMG 404
                   DV++ G V  E+L G
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 213 IGTGGYGSVY--KAQLPNGKVFALKKLHTSEELAFIKS--FKNEAQVLSQVLHRNIVKLY 268
           +G+G YG V   K +L  G   A+K +  S       S    +E  VL Q+ H NI+KLY
Sbjct: 29  LGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 87
Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
            +   K+  +L+ E    G LF  +   +   E+D A    I+K +     YLH     +
Sbjct: 88  EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAA---VIMKQVLSGTTYLH---KHN 141
Query: 329 IIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVM 385
           I+HRD+   N+LL SK       + DFG +         +  L   Y YIAPE+      
Sbjct: 142 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAY-YIAPEVLRKK-Y 199
Query: 386 TEKCDVYSFGVVTLEVLMGKHP 407
            EKCDV+S GV+   +L G  P
Sbjct: 200 DEKCDVWSCGVILYILLCGYPP 221

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 213 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG G +G VY   L   +GK    A+K L+   ++  +  F  E  ++    H N++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 269 GYCLHKKCM-FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
           G CL  +    ++  YM+ G L   + N      +     +     +A  + YL    S 
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 152
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADS----SNRTLLAGTYGYIAPELAYTM 383
             +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E   T 
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             T K DV+SFGV+  E++    P
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKL-----HTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G YG V    L   KV  +++       TS   +       E  VL  + H NI+KL
Sbjct: 45  LGSGAYGEVL---LCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
           Y +   K+  +L+ E  + G LF  + +     E+D A    I+K +   + YLH     
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV---IIKQVLSGVTYLH---KH 155
Query: 328 SIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
           +I+HRD+   N+LL SK +     + DFG + +       +  L GT  YIAPE+     
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL-GTAYYIAPEVLRKKY 214
Query: 385 MTEKCDVYSFGVVTLEVLMGKHP 407
             EKCDV+S GV+   +L G  P
Sbjct: 215 -DEKCDVWSIGVILFILLAGYPP 236

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 213 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG G +G VY   L   +GK    A+K L+   ++  +  F  E  ++    H N++ L 
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 269 GYCLHKKCM-FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
           G CL  +    ++  YM+ G L   + N      +     +     +A  + YL    S 
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 144
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADS----SNRTLLAGTYGYIAPELAYTM 383
             +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E   T 
Sbjct: 145 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 204
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             T K DV+SFGV+  E++    P
Sbjct: 205 KFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 213 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG G +G VY   L   +GK    A+K L+   ++  +  F  E  ++    H N++ L 
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 269 GYCLHKKCM-FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
           G CL  +    ++  YM+ G L   + N      +     +     +A  + YL    S 
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 149
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADS----SNRTLLAGTYGYIAPELAYTM 383
             +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E   T 
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 209
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             T K DV+SFGV+  E++    P
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 46/216 (21%)
Query: 216 GGYGSVYKAQLPNG----KVFALKKLHTSEELAFIKSFKNEAQVLSQ--VLHRNIVKL-- 267
           G +G V+KAQL N     K+F L+           +S+++E ++ S   + H N+++   
Sbjct: 26  GRFGCVWKAQLMNDFVAVKIFPLQDK---------QSWQSEREIFSTPGMKHENLLQFIA 76
Query: 268 ---YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
               G  L  + ++LI  + ++GSL   L  N     + W +  ++ + M+  L+YLH D
Sbjct: 77  AEKRGSNLEVE-LWLITAFHDKGSLTDYLKGNI----ITWNELCHVAETMSRGLSYLHED 131
Query: 325 C--------SPSIIHRDISSNNILLNSKLEAFVADFGTARLLH-----ADSSNRTLLAGT 371
                     PSI HRD  S N+LL S L A +ADFG A          D+  +    GT
Sbjct: 132 VPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV---GT 188
Query: 372 YGYIAPELAYTMVMTE-----KCDVYSFGVVTLEVL 402
             Y+APE+    +  +     + D+Y+ G+V  E++
Sbjct: 189 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 213 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG G +G VY   L   +GK    A+K L+   ++  +  F  E  ++    H N++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 269 GYCLHKKCM-FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
           G CL  +    ++  YM+ G L   + N      +     +     +A  + YL    S 
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 152
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADS----SNRTLLAGTYGYIAPELAYTM 383
             +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E   T 
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             T K DV+SFGV+  E++    P
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFK-----NEAQVLSQ 258
           EDF     +G G + +V  A +L   + +A+K L   E+   IK  K      E  V+S+
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYVTRERDVMSR 88
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
           + H   VKLY      + ++    Y + G   C L         D          +  AL
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNG---CLLKYIRKIGSFDETCTRFYTAEIVSAL 145
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS--SNRTLLAGTYGYIA 376
            YLH      IIHRD+   NILLN  +   + DFGTA++L  +S  +      GT  Y++
Sbjct: 146 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 202
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PEL      ++  D+++ G +  +++ G  P
Sbjct: 203 PELLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 101/226 (44%), Gaps = 33/226 (14%)
Query: 212 CIGTGGYGSVYKAQLPNGK------VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIV 265
            +G G +G V KA   + K        A+K L  +   + ++   +E  VL QV H +++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNE---------------------DAVELDW 304
           KLYG C     + LI EY + GSL   L  +                      D   L  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 305 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 364
              ++    ++  + YL       ++HRD+++ NIL+    +  ++DFG +R ++ + S 
Sbjct: 150 GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 365 RTLLAGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
                G     ++A E  +  + T + DV+SFGV+  E++ +G +P
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 213 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG G +G VY   L   +GK    A+K L+   ++  +  F  E  ++    H N++ L 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 269 GYCLHKKCM-FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
           G CL  +    ++  YM+ G L   + N      +     +     +A  + YL    S 
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 150
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADS----SNRTLLAGTYGYIAPELAYTM 383
             +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E   T 
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 210
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             T K DV+SFGV+  E++    P
Sbjct: 211 KFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 213 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG G +G VY   L   +GK    A+K L+   ++  +  F  E  ++    H N++ L 
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 269 GYCLHKKCM-FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
           G CL  +    ++  YM+ G L   + N      +     +     +A  + YL    S 
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 147
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADS----SNRTLLAGTYGYIAPELAYTM 383
             +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E   T 
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             T K DV+SFGV+  E++    P
Sbjct: 208 KFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 213 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG G +G VY   L   +GK    A+K L+   ++  +  F  E  ++    H N++ L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 269 GYCLHKKCM-FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
           G CL  +    ++  YM+ G L   + N      +     +     +A  + YL    S 
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 151
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADS----SNRTLLAGTYGYIAPELAYTM 383
             +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E   T 
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 211
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             T K DV+SFGV+  E++    P
Sbjct: 212 KFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 213 IGTGGYGSVY--KAQLPNGKVFALKKLHTSEELAFIKS--FKNEAQVLSQVLHRNIVKLY 268
           +G+G YG V   K +L  G   A+K +  S       S    +E  VL Q+ H NI+KLY
Sbjct: 12  LGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 70
Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
            +   K+  +L+ E    G LF  +   +   E+D A    I+K +     YLH     +
Sbjct: 71  EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAA---VIMKQVLSGTTYLH---KHN 124
Query: 329 IIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVM 385
           I+HRD+   N+LL SK       + DFG +         +  L   Y YIAPE+      
Sbjct: 125 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAY-YIAPEVLRKK-Y 182
Query: 386 TEKCDVYSFGVVTLEVLMGKHP 407
            EKCDV+S GV+   +L G  P
Sbjct: 183 DEKCDVWSCGVILYILLCGYPP 204

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHT--SEELAFIKSFKNEAQVLSQVL 260
           ++ +++   +G GG   V+ A+ L   +  A+K L    + + +F   F+ EAQ  + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 261 HRNIVKLYGYCLHKKCM----FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 316
           H  IV +Y     +       +++ EY++  +L   +H       +   + + ++     
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 127
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR----TLLAGTY 372
           AL + H +    IIHRD+   NI++++     V DFG AR + ADS N       + GT 
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI-ADSGNSVTQTAAVIGTA 183
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            Y++PE A    +  + DVYS G V  EVL G+ P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 202 EATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQV 259
           E  E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MA 315
            H NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    + 
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLL 120
Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI 375
             LA+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y 
Sbjct: 121 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 177
Query: 376 APE-LAYTMVMTEKCDVYSFGVVTLEVL 402
           APE L      +   D++S G +  E++
Sbjct: 178 APEILLGXKYYSTAVDIWSLGCIFAEMV 205

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPNG----KVFALK--KLHTSEELAFIKSFKNEAQVLSQVL 260
           F++   +G G +G V+  +  +G    +++A+K  K  T +    +++ K E  +L +V 
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVN 84
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALA 319
           H  IVKL+     +  ++LI +++  G LF  L       E D    V    A +A AL 
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED----VKFYLAELALALD 140
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           +LH   S  II+RD+   NILL+ +    + DFG ++             GT  Y+APE+
Sbjct: 141 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
                 T+  D +SFGV+  E+L G  P
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 100/209 (47%), Gaps = 11/209 (5%)
Query: 204 TEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAF-IKSFKNEAQVLSQVLH 261
           T+++ +   IG G +  V +  +L  G  +A K ++T +  A   +  + EA++   + H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            NIV+L+     +   +L+++ +  G LF      ED V  ++    +    +   L  +
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELF------EDIVAREYYSEADASHCIQQILEAV 116
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAGTYGYIAPE 378
            H     ++HRD+   N+LL SK +     +ADFG A  +  D       AGT GY++PE
Sbjct: 117 LHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPE 176
Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +       +  D+++ GV+   +L+G  P
Sbjct: 177 VLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFK-----NEAQVLSQ 258
           EDF     +G G + +V  A +L   + +A+K L   E+   IK  K      E  V+S+
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYVTRERDVMSR 66
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 314
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 67  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 121
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS--SNRTLLAGTY 372
             AL YLH      IIHRD+   NILLN  +   + DFGTA++L  +S  +      GT 
Sbjct: 122 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 176
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            Y++PEL       +  D+++ G +  +++ G  P
Sbjct: 177 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 102/226 (45%), Gaps = 33/226 (14%)
Query: 212 CIGTGGYGSVYKAQLPNGK------VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIV 265
            +G G +G V KA   + K        A+K L  +   + ++   +E  VL QV H +++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNE---------------------DAVELDW 304
           KLYG C     + LI EY + GSL   L  +                      D   L  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 305 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS- 363
              ++    ++  + YL       ++HRD+++ NIL+    +  ++DFG +R ++ + S 
Sbjct: 150 GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 364 -NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
             R+       ++A E  +  + T + DV+SFGV+  E++ +G +P
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKVF-ALKKLHTSEELAFIKSFKNEAQVLSQ--VLHR 262
           DF     IG G +G V  A+    +VF A+K L   ++ A +K  K E  ++S+  VL +
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL---QKKAILKK-KEEKHIMSERNVLLK 94
Query: 263 NIVKLYGYCLH-----KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAH 316
           N+   +   LH        ++ + +Y+  G LF +L      +E     R     A +A 
Sbjct: 95  NVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE----PRARFYAAEIAS 150
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           AL YLH   S +I++RD+   NILL+S+    + DFG  +     +S  +   GT  Y+A
Sbjct: 151 ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLA 207
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PE+ +        D +  G V  E+L G  P
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFK-----NEAQVLSQ 258
           EDF     +G G + +V  A +L   + +A+K L   E+   IK  K      E  V+S+
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYVTRERDVMSR 65
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 314
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 66  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 120
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS--SNRTLLAGTY 372
             AL YLH      IIHRD+   NILLN  +   + DFGTA++L  +S  +      GT 
Sbjct: 121 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 175
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            Y++PEL       +  D+++ G +  +++ G  P
Sbjct: 176 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 13/207 (6%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPNG----KVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLH 261
           F++   +G G +G V+  +  +G    +++A+K L  +  ++      K E  +L +V H
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAY 320
             IVKL+     +  ++LI +++  G LF  L       E D    V    A +A AL +
Sbjct: 86  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED----VKFYLAELALALDH 141
Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELA 380
           LH   S  II+RD+   NILL+ +    + DFG ++             GT  Y+APE+ 
Sbjct: 142 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 381 YTMVMTEKCDVYSFGVVTLEVLMGKHP 407
                T+  D +SFGV+  E+L G  P
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 13/207 (6%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPNG----KVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLH 261
           F++   +G G +G V+  +  +G    +++A+K L  +  ++      K E  +L +V H
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 86
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAY 320
             IVKL+     +  ++LI +++  G LF  L       E D    V    A +A AL +
Sbjct: 87  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED----VKFYLAELALALDH 142
Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELA 380
           LH   S  II+RD+   NILL+ +    + DFG ++             GT  Y+APE+ 
Sbjct: 143 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 199
Query: 381 YTMVMTEKCDVYSFGVVTLEVLMGKHP 407
                T+  D +SFGV+  E+L G  P
Sbjct: 200 NRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 125/292 (42%), Gaps = 32/292 (10%)
Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFK-----NEAQVLSQ 258
           EDF     +G G + +V  A +L   + +A+K L   E+   IK  K      E  V+S+
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYVTRERDVMSR 88
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 314
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 143
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS--SNRTLLAGTY 372
             AL YLH      IIHRD+   NILLN  +   + DFGTA++L  +S  +      GT 
Sbjct: 144 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDV-LDQR 431
            Y++PEL       +  D+++ G +  +++ G  P             KI+ ++    ++
Sbjct: 199 QYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPP--FRAGNEGLIFAKIIKLEYDFPEK 256
Query: 432 LPPPVDRKVIRDILLISTVSFACLQSNP----KSRPTMQSVSQEFLITRKTP 479
             P     V + ++L +T    C +       K+ P  +SV+ E L  +  P
Sbjct: 257 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPP 308

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIK--SFKNEAQVLSQVLHRNIVKLYG 269
           IG G +G+VY A+ + N +V A+KK+  S + +  K      E + L ++ H N ++  G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 270 YCLHKKCMFLIYEY-MERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
             L +   +L+ EY +   S    +H      VE+       +       LAYLH   S 
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAVTHGALQGLAYLH---SH 173
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTE 387
           ++IHRD+ + NILL+      + DFG+A ++    +      GT  ++APE+   M   +
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANXFVGTPYWMAPEVILAMDEGQ 229
Query: 388 ---KCDVYSFGVVTLEVLMGKHP 407
              K DV+S G+  +E+   K P
Sbjct: 230 YDGKVDVWSLGITCIELAERKPP 252

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 32/222 (14%)
Query: 213 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN 263
           +G G +G V  A+        PN     A+K L +      +    +E +++  +  H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSL-------------FC--NLHNNEDAVELDWAKRV 308
           I+ L G C     +++I EY  +G+L             +C    HN E+  +L     V
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEE--QLSSKDLV 138
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H     +   
Sbjct: 139 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 369 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
            G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 127/293 (43%), Gaps = 34/293 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFK-----NEAQVLSQ 258
           EDF     +G G + +V  A +L   + +A+K L   E+   IK  K      E  V+S+
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYVTRERDVMSR 93
Query: 259 VLHRNIVKLYGYCLHK-KCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKA 313
           + H   VKLY +C    + ++    Y + G L   +      +E       A+ V+    
Sbjct: 94  LDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS---- 148
Query: 314 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS--SNRTLLAGT 371
              AL YLH      IIHRD+   NILLN  +   + DFGTA++L  +S  +      GT
Sbjct: 149 ---ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202
Query: 372 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDV-LDQ 430
             Y++PEL       +  D+++ G +  +++ G  P             KI+ ++    +
Sbjct: 203 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPE 260
Query: 431 RLPPPVDRKVIRDILLISTVSFACLQSNP----KSRPTMQSVSQEFLITRKTP 479
           +  P     V + ++L +T    C +       K+ P  +SV+ E L  +  P
Sbjct: 261 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPP 313

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 202 EATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQV 259
           E  E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MA 315
            H NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    + 
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLL 120
Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI 375
             LA+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y 
Sbjct: 121 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 177
Query: 376 APE-LAYTMVMTEKCDVYSFGVVTLEVL 402
           APE L      +   D++S G +  E++
Sbjct: 178 APEILLGCKYYSTAVDIWSLGCIFAEMV 205

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFK-----NEAQVLSQ 258
           EDF     +G G + +V  A +L   + +A+K L   E+   IK  K      E  V+S+
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYVTRERDVMSR 64
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 314
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 119
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS--SNRTLLAGTY 372
             AL YLH      IIHRD+   NILLN  +   + DFGTA++L  +S  +      GT 
Sbjct: 120 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 174
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            Y++PEL       +  D+++ G +  +++ G  P
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFK-----NEAQVLSQ 258
           EDF     +G G + +V  A +L   + +A+K L   E+   IK  K      E  V+S+
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYVTRERDVMSR 63
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 314
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 64  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 118
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS--SNRTLLAGTY 372
             AL YLH      IIHRD+   NILLN  +   + DFGTA++L  +S  +      GT 
Sbjct: 119 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 173
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            Y++PEL       +  D+++ G +  +++ G  P
Sbjct: 174 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 125/292 (42%), Gaps = 32/292 (10%)
Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFK-----NEAQVLSQ 258
           EDF     +G G + +V  A +L   + +A+K L   E+   IK  K      E  V+S+
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYVTRERDVMSR 88
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 314
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 143
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS--SNRTLLAGTY 372
             AL YLH      IIHRD+   NILLN  +   + DFGTA++L  +S  +      GT 
Sbjct: 144 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDV-LDQR 431
            Y++PEL       +  D+++ G +  +++ G  P             KI+ ++    ++
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEGLIFAKIIKLEYDFPEK 256
Query: 432 LPPPVDRKVIRDILLISTVSFACLQSNP----KSRPTMQSVSQEFLITRKTP 479
             P     V + ++L +T    C +       K+ P  +SV+ E L  +  P
Sbjct: 257 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPP 308

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 125/292 (42%), Gaps = 32/292 (10%)
Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFK-----NEAQVLSQ 258
           EDF     +G G + +V  A +L   + +A+K L   E+   IK  K      E  V+S+
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYVTRERDVMSR 88
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 314
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 143
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS--SNRTLLAGTY 372
             AL YLH      IIHRD+   NILLN  +   + DFGTA++L  +S  +      GT 
Sbjct: 144 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDV-LDQR 431
            Y++PEL       +  D+++ G +  +++ G  P             KI+ ++    ++
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPEK 256
Query: 432 LPPPVDRKVIRDILLISTVSFACLQSNP----KSRPTMQSVSQEFLITRKTP 479
             P     V + ++L +T    C +       K+ P  +SV+ E L  +  P
Sbjct: 257 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPP 308

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 32/222 (14%)
Query: 213 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN 263
           +G G +G V  A+        PN     A+K L +      +    +E +++  +  H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSL-------------FCN--LHNNEDAVELDWAKRV 308
           I+ L G C     +++I EY  +G+L             +C    HN E+  +L     V
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEE--QLSSKDLV 153
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H     +   
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 369 AGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
            G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 125/292 (42%), Gaps = 32/292 (10%)
Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFK-----NEAQVLSQ 258
           EDF     +G G + +V  A +L   + +A+K L   E+   IK  K      E  V+S+
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYVTRERDVMSR 89
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 314
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 90  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 144
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS--SNRTLLAGTY 372
             AL YLH      IIHRD+   NILLN  +   + DFGTA++L  +S  +      GT 
Sbjct: 145 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 199
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDV-LDQR 431
            Y++PEL       +  D+++ G +  +++ G  P             KI+ ++    ++
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPEK 257
Query: 432 LPPPVDRKVIRDILLISTVSFACLQSNP----KSRPTMQSVSQEFLITRKTP 479
             P     V + ++L +T    C +       K+ P  +SV+ E L  +  P
Sbjct: 258 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPP 309

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHT--SEELAFIKSFKNEAQVLSQVL 260
           ++ +++   +G GG   V+ A+ L   +  A+K L    + + +F   F+ EAQ  + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 261 HRNIVKLYGYCLHKKCM----FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 316
           H  IV +Y     +       +++ EY++  +L   +H       +   + + ++     
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 127
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR----TLLAGTY 372
           AL + H +    IIHRD+   NI++++     V DFG AR + ADS N       + GT 
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI-ADSGNSVTQTAAVIGTA 183
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            Y++PE A    +  + DVYS G V  EVL G+ P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 125/292 (42%), Gaps = 32/292 (10%)
Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFK-----NEAQVLSQ 258
           EDF     +G G + +V  A +L   + +A+K L   E+   IK  K      E  V+S+
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYVTRERDVMSR 86
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 314
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 141
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS--SNRTLLAGTY 372
             AL YLH      IIHRD+   NILLN  +   + DFGTA++L  +S  +      GT 
Sbjct: 142 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDV-LDQR 431
            Y++PEL       +  D+++ G +  +++ G  P             KI+ ++    ++
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPEK 254
Query: 432 LPPPVDRKVIRDILLISTVSFACLQSNP----KSRPTMQSVSQEFLITRKTP 479
             P     V + ++L +T    C +       K+ P  +SV+ E L  +  P
Sbjct: 255 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPP 306

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 125/292 (42%), Gaps = 32/292 (10%)
Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFK-----NEAQVLSQ 258
           EDF     +G G + +V  A +L   + +A+K L   E+   IK  K      E  V+S+
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYVTRERDVMSR 88
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 314
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 143
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS--SNRTLLAGTY 372
             AL YLH      IIHRD+   NILLN  +   + DFGTA++L  +S  +      GT 
Sbjct: 144 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDV-LDQR 431
            Y++PEL       +  D+++ G +  +++ G  P             KI+ ++    ++
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPEK 256
Query: 432 LPPPVDRKVIRDILLISTVSFACLQSNP----KSRPTMQSVSQEFLITRKTP 479
             P     V + ++L +T    C +       K+ P  +SV+ E L  +  P
Sbjct: 257 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPP 308

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 125/292 (42%), Gaps = 32/292 (10%)
Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFK-----NEAQVLSQ 258
           EDF     +G G + +V  A +L   + +A+K L   E+   IK  K      E  V+S+
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYVTRERDVMSR 86
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 314
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 141
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS--SNRTLLAGTY 372
             AL YLH      IIHRD+   NILLN  +   + DFGTA++L  +S  +      GT 
Sbjct: 142 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDV-LDQR 431
            Y++PEL       +  D+++ G +  +++ G  P             KI+ ++    ++
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPEK 254
Query: 432 LPPPVDRKVIRDILLISTVSFACLQSNP----KSRPTMQSVSQEFLITRKTP 479
             P     V + ++L +T    C +       K+ P  +SV+ E L  +  P
Sbjct: 255 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPP 306

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIK--SFKNEAQVLSQVLHRNIVKLYG 269
           IG G +G+VY A+ + N +V A+KK+  S + +  K      E + L ++ H N ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 270 YCLHKKCMFLIYEY-MERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
             L +   +L+ EY +   S    +H      VE+       +       LAYLH   S 
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAVTHGALQGLAYLH---SH 134
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTE 387
           ++IHRD+ + NILL+      + DFG+A ++    +      GT  ++APE+   M   +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANXFVGTPYWMAPEVILAMDEGQ 190
Query: 388 ---KCDVYSFGVVTLEVLMGKHP 407
              K DV+S G+  +E+   K P
Sbjct: 191 YDGKVDVWSLGITCIELAERKPP 213

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 95/190 (50%), Gaps = 12/190 (6%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL 272
           IG G +G V        KV A+K +      A  ++F  EA V++Q+ H N+V+L G  +
Sbjct: 20  IGKGEFGDVMLGDYRGNKV-AVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIV 75
Query: 273 HKKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
            +K  ++++ EYM +GSL   L +   +V L     +     +  A+ YL  +   + +H
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NFVH 131
Query: 332 RDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           RD+++ N+L++    A V+DFG   L    SS +        + APE       + K DV
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFG---LTKEASSTQDTGKLPVKWTAPEALREAAFSTKSDV 188
Query: 392 YSFGVVTLEV 401
           +SFG++  E+
Sbjct: 189 WSFGILLWEI 198

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 124/295 (42%), Gaps = 61/295 (20%)
Query: 213 IGTGGYGSVYKAQLPN-GKV-----FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIV 265
           +G G +G V +A     GK       A+K L ++      ++  +E +++S +  H NIV
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLH--------------------NNEDAVELDWA 305
            L G C H   + +I EY   G L   L                     + ED   L+  
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 306 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR 365
             ++    +A  +A+L    S + IHRD+++ N+LL +   A + DFG AR +  DS+  
Sbjct: 159 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN-- 213
Query: 366 TLLAGT----YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDP 420
            ++ G       ++APE  +  V T + DV+S+G++  E+  +G +P            P
Sbjct: 214 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY-----------P 262
Query: 421 KIM-------LIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
            I+       L+    Q   P    K I  I+       AC    P  RPT Q +
Sbjct: 263 GILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQ------ACWALEPTHRPTFQQI 311

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 125/292 (42%), Gaps = 32/292 (10%)
Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFK-----NEAQVLSQ 258
           EDF     +G G + +V  A +L   + +A+K L   E+   IK  K      E  V+S+
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYVTRERDVMSR 88
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 314
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 143
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS--SNRTLLAGTY 372
             AL YLH      IIHRD+   NILLN  +   + DFGTA++L  +S  +      GT 
Sbjct: 144 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDV-LDQR 431
            Y++PEL       +  D+++ G +  +++ G  P             KI+ ++    ++
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPEK 256
Query: 432 LPPPVDRKVIRDILLISTVSFACLQSNP----KSRPTMQSVSQEFLITRKTP 479
             P     V + ++L +T    C +       K+ P  +SV+ E L  +  P
Sbjct: 257 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPP 308

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 213 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG G +G VY   L   +GK    A+K L+   ++  +  F  E  ++    H N++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 269 GYCLHKKCM-FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
           G CL  +    ++  YM+ G L   + N      +     +     +A  + +L    S 
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 152
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADS----SNRTLLAGTYGYIAPELAYTM 383
             +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E   T 
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             T K DV+SFGV+  E++    P
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 213 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG G +G VY   L   +GK    A+K L+   ++  +  F  E  ++    H N++ L 
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 269 GYCLHKKCM-FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
           G CL  +    ++  YM+ G L   + N      +     +     +A  + +L    S 
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKFL---ASK 211
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADS----SNRTLLAGTYGYIAPELAYTM 383
             +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E   T 
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             T K DV+SFGV+  E++    P
Sbjct: 272 KFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 32/222 (14%)
Query: 213 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN 263
           +G G +G V  A+        PN     A+K L +      +    +E +++  +  H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNL---------------HNNEDAVELDWAKRV 308
           I+ L G C     +++I EY  +G+L   L               HN E+  +L     V
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE--QLSSKDLV 146
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H     +   
Sbjct: 147 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 203
Query: 369 AGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
            G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 204 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 245

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 125/292 (42%), Gaps = 32/292 (10%)
Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFK-----NEAQVLSQ 258
           EDF     +G G + +V  A +L   + +A+K L   E+   IK  K      E  V+S+
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYVTRERDVMSR 86
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 314
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 141
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS--SNRTLLAGTY 372
             AL YLH      IIHRD+   NILLN  +   + DFGTA++L  +S  +      GT 
Sbjct: 142 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTA 196
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDV-LDQR 431
            Y++PEL       +  D+++ G +  +++ G  P             KI+ ++    ++
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPEK 254
Query: 432 LPPPVDRKVIRDILLISTVSFACLQSNP----KSRPTMQSVSQEFLITRKTP 479
             P     V + ++L +T    C +       K+ P  +SV+ E L  +  P
Sbjct: 255 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPP 306

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 116/279 (41%), Gaps = 32/279 (11%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKA-------QLPNGKVFALKKLHTSEELAFIKSFKNEAQV 255
           A E   +   +G G +G VY+          P  +V A+K ++ +  +     F NEA V
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFLNEASV 66
Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERG-------SLFCNLHNNEDAVELDWAKRV 308
           + +    ++V+L G     +   +I E M RG       SL   + NN        +K +
Sbjct: 67  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 126
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
            +   +A  +AYL+ +     +HRD+++ N ++       + DFG  R +      R   
Sbjct: 127 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 183
Query: 369 AG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDIXXXXXXXXDPKIMLI 425
            G     +++PE     V T   DV+SFGVV  E+  + + P              +M  
Sbjct: 184 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR--FVMEG 241
Query: 426 DVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPT 464
            +LD+    P       D+LL   +   C Q NPK RP+
Sbjct: 242 GLLDKPDNCP-------DMLL--ELMRMCWQYNPKMRPS 271

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFK-----NEAQVLSQ 258
           EDF     +G G + +V  A +L   + +A+K L   E+   IK  K      E  V+S+
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYVTRERDVMSR 91
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 314
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 92  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 146
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS--SNRTLLAGTY 372
             AL YLH      IIHRD+   NILLN  +   + DFGTA++L  +S  +      GT 
Sbjct: 147 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 201
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            Y++PEL       +  D+++ G +  +++ G  P
Sbjct: 202 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 213 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG G +G VY   L   +GK    A+K L+   ++  +  F  E  ++    H N++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 269 GYCLHKKCM-FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
           G CL  +    ++  YM+ G L   + N      +     +     +A  + +L    S 
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 152
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADS----SNRTLLAGTYGYIAPELAYTM 383
             +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E   T 
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             T K DV+SFGV+  E++    P
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 125/292 (42%), Gaps = 32/292 (10%)
Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFK-----NEAQVLSQ 258
           EDF     +G G + +V  A +L   + +A+K L   E+   IK  K      E  V+S+
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYVTRERDVMSR 70
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 314
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 71  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 125
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS--SNRTLLAGTY 372
             AL YLH      IIHRD+   NILLN  +   + DFGTA++L  +S  +      GT 
Sbjct: 126 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 180
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDV-LDQR 431
            Y++PEL       +  D+++ G +  +++ G  P             KI+ ++    ++
Sbjct: 181 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPEK 238
Query: 432 LPPPVDRKVIRDILLISTVSFACLQSNP----KSRPTMQSVSQEFLITRKTP 479
             P     V + ++L +T    C +       K+ P  +SV+ E L  +  P
Sbjct: 239 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPP 290

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +GT G   V K +L   KV A+K L+  +   L  +   + E Q L    H +I+KLY  
Sbjct: 26  VGTFGKVKVGKHELTGHKV-AVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84
Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
                 +F++ EY+  G LF  +  N     LD  +   + + +   + Y H      ++
Sbjct: 85  ISTPSDIFMVMEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRHM---VV 138
Query: 331 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAYTMVMTEKC 389
           HRD+   N+LL++ + A +ADFG + ++ +D        G+  Y APE ++  +    + 
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRXSCGSPNYAAPEVISGRLYAGPEV 197
Query: 390 DVYSFGVVTLEVLMGKHPRD 409
           D++S GV+   +L G  P D
Sbjct: 198 DIWSSGVILYALLCGTLPFD 217

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 213 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG G +G VY   L   +GK    A+K L+   ++  +  F  E  ++    H N++ L 
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 269 GYCLHKKCM-FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
           G CL  +    ++  YM+ G L   + N      +     +     +A  + +L    S 
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 157
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADS----SNRTLLAGTYGYIAPELAYTM 383
             +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E   T 
Sbjct: 158 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 217
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             T K DV+SFGV+  E++    P
Sbjct: 218 KFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 213 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG G +G VY   L   +GK    A+K L+   ++  +  F  E  ++    H N++ L 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 269 GYCLHKKCM-FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
           G CL  +    ++  YM+ G L   + N      +     +     +A  + +L    S 
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 153
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADS----SNRTLLAGTYGYIAPELAYTM 383
             +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E   T 
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             T K DV+SFGV+  E++    P
Sbjct: 214 KFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 213 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG G +G VY   L   +GK    A+K L+   ++  +  F  E  ++    H N++ L 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 269 GYCLHKKCM-FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
           G CL  +    ++  YM+ G L   + N      +     +     +A  + +L    S 
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 150
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADS----SNRTLLAGTYGYIAPELAYTM 383
             +HRD+++ N +L+ K    VADFG AR ++        N+T       ++A E   T 
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 210
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             T K DV+SFGV+  E++    P
Sbjct: 211 KFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 32/222 (14%)
Query: 213 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN 263
           +G G +G V  A+        PN     A+K L +      +    +E +++  +  H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNL---------------HNNEDAVELDWAKRV 308
           I+ L G C     +++I EY  +G+L   L               HN E+  +L     V
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE--QLSSKDLV 153
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H     +   
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 369 AGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
            G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 32/222 (14%)
Query: 213 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN 263
           +G G +G V  A+        PN     A+K L +      +    +E +++  +  H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNL---------------HNNEDAVELDWAKRV 308
           I+ L G C     +++I EY  +G+L   L               HN E+  +L     V
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE--QLSSKDLV 145
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H     +   
Sbjct: 146 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 202
Query: 369 AGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
            G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 203 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 244

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 32/222 (14%)
Query: 213 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN 263
           +G G +G V  A+        PN     A+K L +      +    +E +++  +  H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNL---------------HNNEDAVELDWAKRV 308
           I+ L G C     +++I EY  +G+L   L               HN E+  +L     V
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE--QLSSKDLV 142
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H     +   
Sbjct: 143 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 199
Query: 369 AGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
            G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 200 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 241

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 32/222 (14%)
Query: 213 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN 263
           +G G +G V  A+        PN     A+K L +      +    +E +++  +  H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNL---------------HNNEDAVELDWAKRV 308
           I+ L G C     +++I EY  +G+L   L               HN E+  +L     V
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEE--QLSSKDLV 153
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H     +   
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 369 AGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
            G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 252

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 213 IGTGGYGSVY-KAQLPNGKVFALKKLHTSEELAFI-KSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G +  V+   Q   GK+FALK +  S   AF   S +NE  VL ++ H NIV L   
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
                  +L+ + +  G LF  +       E D +    +++ +  A+ YLH +    I+
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL---VIQQVLSAVKYLHEN---GIV 128
Query: 331 HRDISSNNILL-----NSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVM 385
           HRD+   N+L      NSK+   + DFG +++    +   +   GT GY+APE+      
Sbjct: 129 HRDLKPENLLYLTPEENSKI--MITDFGLSKM--EQNGIMSTACGTPGYVAPEVLAQKPY 184
Query: 386 TEKCDVYSFGVVTLEVLMGKHP 407
           ++  D +S GV+T  +L G  P
Sbjct: 185 SKAVDCWSIGVITYILLCGYPP 206

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 13/208 (6%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQVLHR 262
           E ++I   +G G +G V K +     + +A+K ++  S +     +   E ++L ++ H 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
           NI+KL+         +++ E    G LF  +   +   E D A+   I+K +   + Y+H
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMH 138
Query: 323 HDCSPSIIHRDISSNNILLNSK---LEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
                +I+HRD+   NILL SK    +  + DFG +     ++  +  + GT  YIAPE+
Sbjct: 139 ---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-GTAYYIAPEV 194
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
                  EKCDV+S GV+   +L G  P
Sbjct: 195 LRG-TYDEKCDVWSAGVILYILLSGTPP 221

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 125/292 (42%), Gaps = 32/292 (10%)
Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFK-----NEAQVLSQ 258
           EDF     +G G + +V  A +L   + +A+K L   E+   IK  K      E  V+S+
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYVTRERDVMSR 89
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 314
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 90  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 144
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS--SNRTLLAGTY 372
             AL YLH      IIHRD+   NILLN  +   + DFGTA++L  +S  +      GT 
Sbjct: 145 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 199
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDV-LDQR 431
            Y++PEL       +  D+++ G +  +++ G  P             KI+ ++    ++
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPEK 257
Query: 432 LPPPVDRKVIRDILLISTVSFACLQSNP----KSRPTMQSVSQEFLITRKTP 479
             P     V + ++L +T    C +       K+ P  +SV+ E L  +  P
Sbjct: 258 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPP 309

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 125/292 (42%), Gaps = 32/292 (10%)
Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFK-----NEAQVLSQ 258
           EDF     +G G + +V  A +L   + +A+K L   E+   IK  K      E  V+S+
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYVTRERDVMSR 85
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 314
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 86  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 140
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS--SNRTLLAGTY 372
             AL YLH      IIHRD+   NILLN  +   + DFGTA++L  +S  +      GT 
Sbjct: 141 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 195
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDV-LDQR 431
            Y++PEL       +  D+++ G +  +++ G  P             KI+ ++    ++
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPEK 253
Query: 432 LPPPVDRKVIRDILLISTVSFACLQSNP----KSRPTMQSVSQEFLITRKTP 479
             P     V + ++L +T    C +       K+ P  +SV+ E L  +  P
Sbjct: 254 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPP 305

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHR 262
           E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHAL 318
           NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +   L
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQGL 116
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
           A+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE
Sbjct: 117 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 379 -LAYTMVMTEKCDVYSFGVVTLEVL 402
            L      +   D++S G +  E++
Sbjct: 174 ILLGXKYYSTAVDIWSLGCIFAEMV 198

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHR 262
           E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHAL 318
           NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +   L
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQGL 120
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
           A+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE
Sbjct: 121 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 177
Query: 379 -LAYTMVMTEKCDVYSFGVVTLEVL 402
            L      +   D++S G +  E++
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMV 202

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVL 260
           + E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAH 316
           H NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +  
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQ 115
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
            LA+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y A
Sbjct: 116 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 172
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVL 402
           PE L      +   D++S G +  E++
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHT--SEELAFIKSFKNEAQVLSQVL 260
           ++ +++   +G GG   V+ A+ L   +  A+K L    + + +F   F+ EAQ  + + 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 261 HRNIVKLYGYCLHKKCM----FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 316
           H  IV +Y     +       +++ EY++  +L   +H       +   + + ++     
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 144
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR----TLLAGTY 372
           AL + H +    IIHRD+   NI++++     V DFG AR + ADS N       + GT 
Sbjct: 145 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI-ADSGNSVTQTAAVIGTA 200
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            Y++PE A    +  + DVYS G V  EVL G+ P
Sbjct: 201 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 32/222 (14%)
Query: 213 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN 263
           +G G +G V  A+        PN     A+K L +      +    +E +++  +  H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNL---------------HNNEDAVELDWAKRV 308
           I+ L G C     +++I EY  +G+L   L               HN E+  +L     V
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE--QLSSKDLV 194
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H     +   
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 369 AGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
            G     ++APE  +  + T + DV+SFGV+  E+  +G  P
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 125/290 (43%), Gaps = 58/290 (20%)
Query: 213 IGTGGYGSVYKAQLPN-GK-----VFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIV 265
           +G G +G V +A     GK       A+K L ++      ++  +E +++S +  H NIV
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNL---------------HNNEDAVELDWAKRVNI 310
            L G C H   + +I EY   G L   L               HN E+  +L     ++ 
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEE--QLSSRDLLHF 171
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG 370
              +A  +A+L    S + IHRD+++ N+LL +   A + DFG AR +  DS+   ++ G
Sbjct: 172 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN--YIVKG 226
Query: 371 T----YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIM-- 423
                  ++APE  +  V T + DV+S+G++  E+  +G +P            P I+  
Sbjct: 227 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY-----------PGILVN 275
Query: 424 -----LIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
                L+    Q   P    K I  I+       AC    P  RPT Q +
Sbjct: 276 SKFYKLVKDGYQMAQPAFAPKNIYSIMQ------ACWALEPTHRPTFQQI 319

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHR 262
           E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHAL 318
           NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +   L
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQGL 116
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
           A+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE
Sbjct: 117 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 379 -LAYTMVMTEKCDVYSFGVVTLEVL 402
            L      +   D++S G +  E++
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 213 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG G +G VY   L   +GK    A+K L+   ++  +  F  E  ++    H N++ L 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 269 GYCLHKKCM-FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
           G CL  +    ++  YM+ G L   + N      +     +     +A  + +L    S 
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 153
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLL---HADS-SNRTLLAGTYGYIAPELAYTM 383
             +HRD+++ N +L+ K    VADFG AR +     DS  N+T       ++A E   T 
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             T K DV+SFGV+  E++    P
Sbjct: 214 KFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKA-------QLPNGKVFALKKLHTSEELAFIKSFKNEAQV 255
           A E   +   +G G +G VY+          P  +V A+K ++ +  +     F NEA V
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFLNEASV 81
Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERG-------SLFCNLHNNEDAVELDWAKRV 308
           + +    ++V+L G     +   +I E M RG       SL   + NN        +K +
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 141
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
            +   +A  +AYL+ +     +HRD+++ N ++       + DFG  R ++     R   
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 369 AG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEV 401
            G     +++PE     V T   DV+SFGVV  E+
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHR 262
           E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHAL 318
           NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +   L
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQGL 116
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
           A+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE
Sbjct: 117 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 379 -LAYTMVMTEKCDVYSFGVVTLEVL 402
            L      +   D++S G +  E++
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHR 262
           E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHAL 318
           NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +   L
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQGL 115
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
           A+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE
Sbjct: 116 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 379 -LAYTMVMTEKCDVYSFGVVTLEVL 402
            L      +   D++S G +  E++
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHR 262
           E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHAL 318
           NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +   L
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQGL 115
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
           A+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE
Sbjct: 116 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 379 -LAYTMVMTEKCDVYSFGVVTLEVL 402
            L      +   D++S G +  E++
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 125/292 (42%), Gaps = 32/292 (10%)
Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFK-----NEAQVLSQ 258
           EDF     +G G + +V  A +L   + +A+K L   E+   IK  K      E  V+S+
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYVTRERDVMSR 85
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 314
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 86  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 140
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS--SNRTLLAGTY 372
             AL YLH      IIHRD+   NILLN  +   + DFGTA++L  +S  +      GT 
Sbjct: 141 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 195
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDV-LDQR 431
            Y++PEL       +  D+++ G +  +++ G  P             KI+ ++    ++
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPEK 253
Query: 432 LPPPVDRKVIRDILLISTVSFACLQSNP----KSRPTMQSVSQEFLITRKTP 479
             P     V + ++L +T    C +       K+ P  +SV+ E L  +  P
Sbjct: 254 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPP 305

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 121/267 (45%), Gaps = 34/267 (12%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL 272
           IG G +G V        KV A+K +      A  ++F  EA V++Q+ H N+V+L G  +
Sbjct: 201 IGKGEFGDVMLGDYRGNKV-AVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 273 HKKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
            +K  ++++ EYM +GSL   L +   +V L     +     +  A+ YL  +   + +H
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NFVH 312
Query: 332 RDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           RD+++ N+L++    A V+DFG   L    SS +        + APE       + K DV
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFG---LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369
Query: 392 YSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIRDI-----L 445
           +SFG++  E+   G+ P            P+I L DV+     P V++    D       
Sbjct: 370 WSFGILLWEIYSFGRVPY-----------PRIPLKDVV-----PRVEKGYKMDAPDGCPP 413
Query: 446 LISTVSFACLQSNPKSRPTMQSVSQEF 472
            +  V   C   +  +RPT   + ++ 
Sbjct: 414 AVYDVMKNCWHLDAATRPTFLQLREQL 440

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 20/215 (9%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKA-------QLPNGKVFALKKLHTSEELAFIKSFKNEAQV 255
           A E   +   +G G +G VY+          P  +V A+K ++ +  +     F NEA V
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFLNEASV 75
Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERG-------SLFCNLHNNEDAVELDWAKRV 308
           + +    ++V+L G     +   +I E M RG       SL   + NN        +K +
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
            +   +A  +AYL+ +     +HRD+++ N ++       + DFG  R +      R   
Sbjct: 136 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 192
Query: 369 AG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEV 401
            G     +++PE     V T   DV+SFGVV  E+
Sbjct: 193 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKA-------QLPNGKVFALKKLHTSEELAFIKSFKNEAQV 255
           A E   +   +G G +G VY+          P  +V A+K ++ +  +     F NEA V
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFLNEASV 74
Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERG-------SLFCNLHNNEDAVELDWAKRV 308
           + +    ++V+L G     +   +I E M RG       SL   + NN        +K +
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
            +   +A  +AYL+ +     +HRD+++ N ++       + DFG  R ++     R   
Sbjct: 135 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 369 AG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEV 401
            G     +++PE     V T   DV+SFGVV  E+
Sbjct: 192 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 13/208 (6%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQVLHR 262
           E ++I   +G G +G V K +     + +A+K ++  S +     +   E ++L ++ H 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
           NI+KL+         +++ E    G LF  +   +   E D A+   I+K +   + Y+H
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMH 138
Query: 323 HDCSPSIIHRDISSNNILLNSK---LEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
                +I+HRD+   NILL SK    +  + DFG +     ++  +  + GT  YIAPE+
Sbjct: 139 ---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-GTAYYIAPEV 194
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
                  EKCDV+S GV+   +L G  P
Sbjct: 195 L-RGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 13/208 (6%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQVLHR 262
           E ++I   +G G +G V K +     + +A+K ++  S +     +   E ++L ++ H 
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
           NI+KL+         +++ E    G LF  +   +   E D A+   I+K +   + Y+H
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMH 138
Query: 323 HDCSPSIIHRDISSNNILLNSK---LEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
                +I+HRD+   NILL SK    +  + DFG +     ++  +  + GT  YIAPE+
Sbjct: 139 ---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-GTAYYIAPEV 194
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
                  EKCDV+S GV+   +L G  P
Sbjct: 195 L-RGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 120/294 (40%), Gaps = 38/294 (12%)
Query: 213 IGTGGYGSVYKAQL------PNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHR 262
           +G G +G VY+ Q+      P+    A+K L       +EL F+     EA ++S++ H+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKLNHQ 94
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 318
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARLLHADSSNRTLLAGT--YG 373
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R          
Sbjct: 155 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 211
Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRL 432
           ++ PE     + T K D +SFGV+  E+  +G  P           + +++       R+
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP------YPSKSNQEVLEFVTSGGRM 265
Query: 433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAI 486
            PP  +     +  I T    C Q  P+ RP    + +      + P V + A+
Sbjct: 266 DPP--KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 314

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 124/292 (42%), Gaps = 32/292 (10%)
Query: 205 EDFDIRYCIGTGGYGS-VYKAQLPNGKVFALKKLHTSEELAFIKSFK-----NEAQVLSQ 258
           EDF     +G G + + V   +L   + +A+K L   E+   IK  K      E  V+S+
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKIL---EKRHIIKENKVPYVTRERDVMSR 86
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 314
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 141
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS--SNRTLLAGTY 372
             AL YLH      IIHRD+   NILLN  +   + DFGTA++L  +S  +      GT 
Sbjct: 142 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDV-LDQR 431
            Y++PEL       +  D+++ G +  +++ G  P             KI+ ++    ++
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLIFQKIIKLEYDFPEK 254
Query: 432 LPPPVDRKVIRDILLISTVSFACLQSNP----KSRPTMQSVSQEFLITRKTP 479
             P     V + ++L +T    C +       K+ P  +SV+ E L  +  P
Sbjct: 255 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPP 306

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 95/190 (50%), Gaps = 12/190 (6%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL 272
           IG G +G V        KV A+K +      A  ++F  EA V++Q+ H N+V+L G  +
Sbjct: 14  IGKGEFGDVMLGDYRGNKV-AVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 273 HKKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
            +K  ++++ EYM +GSL   L +   +V L     +     +  A+ YL  +   + +H
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NFVH 125
Query: 332 RDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           RD+++ N+L++    A V+DFG   L    SS +        + APE       + K DV
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFG---LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 392 YSFGVVTLEV 401
           +SFG++  E+
Sbjct: 183 WSFGILLWEI 192

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 120/294 (40%), Gaps = 38/294 (12%)
Query: 213 IGTGGYGSVYKAQL------PNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHR 262
           +G G +G VY+ Q+      P+    A+K L       +EL F+     EA ++S++ H+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKLNHQ 108
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 318
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 109 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARLLHADSSNRTLLAGTY--G 373
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R          
Sbjct: 169 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 225
Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRL 432
           ++ PE     + T K D +SFGV+  E+  +G  P           + +++       R+
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP------YPSKSNQEVLEFVTSGGRM 279
Query: 433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAI 486
            PP  +     +  I T    C Q  P+ RP    + +      + P V + A+
Sbjct: 280 DPP--KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 328

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 205 EDFDIRYCIGTGGYGSVYKA-----QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV 259
           E  ++  CIG G +G V++      + P   V A+K        +  + F  EA  + Q 
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAV-AIKTCKNCTSDSVREKFLQEALTMRQF 68
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H +IVKL G  + +  +++I E    G L   L   +    LD A  +     ++ ALA
Sbjct: 69  DHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALA 125
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAP 377
           YL    S   +HRDI++ N+L++S     + DFG +R +  DS+      G     ++AP
Sbjct: 126 YLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTXXKASKGKLPIKWMAP 181
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLM 403
           E       T   DV+ FGV   E+LM
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEILM 207

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 213 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN 263
           +G G +G V  A+        P   V  A+K L        +    +E +++  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRVNI 310
           I+ L G C     +++I EY  +G+L   L              N     ++ +   V+ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG 370
              +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +    G
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 371 T--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
                ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKN-EAQVLSQVLHRNIVKL--- 267
           IG G +G VY+A+L  +G++ A+KK+         K FKN E Q++ ++ H NIV+L   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 268 -YGYCLHKKCMF--LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            Y     K  ++  L+ +Y+         H +     L        +  +  +LAY+H  
Sbjct: 82  FYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 139
Query: 325 CSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
            S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y APEL +  
Sbjct: 140 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGA 197
Query: 384 V-MTEKCDVYSFGVVTLEVLMGK 405
              T   DV+S G V  E+L+G+
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKA-------QLPNGKVFALKKLHTSEELAFIKSFKNEAQV 255
           A E   +   +G G +G VY+          P  +V A+K ++ +  +     F NEA V
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFLNEASV 68
Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERG-------SLFCNLHNNEDAVELDWAKRV 308
           + +    ++V+L G     +   +I E M RG       SL   + NN        +K +
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
            +   +A  +AYL+ +     +HRD+++ N ++       + DFG  R ++     R   
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 369 AG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEV 401
            G     +++PE     V T   DV+SFGVV  E+
Sbjct: 186 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKA-------QLPNGKVFALKKLHTSEELAFIKSFKNEAQV 255
           A E   +   +G G +G VY+          P  +V A+K ++ +  +     F NEA V
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFLNEASV 72
Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERG-------SLFCNLHNNEDAVELDWAKRV 308
           + +    ++V+L G     +   +I E M RG       SL   + NN        +K +
Sbjct: 73  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 132
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
            +   +A  +AYL+ +     +HRD+++ N ++       + DFG  R ++     R   
Sbjct: 133 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 189
Query: 369 AG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEV 401
            G     +++PE     V T   DV+SFGVV  E+
Sbjct: 190 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 213 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN 263
           +G G +G V  A+        P   V  A+K L        +    +E +++  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRVNI 310
           I+ L G C     +++I EY  +G+L   L              N     ++ +   V+ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG 370
              +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +    G
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 371 T--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
                ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKA-------QLPNGKVFALKKLHTSEELAFIKSFKNEAQV 255
           A E   +   +G G +G VY+          P  +V A+K ++ +  +     F NEA V
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFLNEASV 74
Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERG-------SLFCNLHNNEDAVELDWAKRV 308
           + +    ++V+L G     +   +I E M RG       SL   + NN        +K +
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
            +   +A  +AYL+ +     +HRD+++ N ++       + DFG  R ++     R   
Sbjct: 135 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 369 AG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEV 401
            G     +++PE     V T   DV+SFGVV  E+
Sbjct: 192 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKA-------QLPNGKVFALKKLHTSEELAFIKSFKNEAQV 255
           A E   +   +G G +G VY+          P  +V A+K ++ +  +     F NEA V
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFLNEASV 75
Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERG-------SLFCNLHNNEDAVELDWAKRV 308
           + +    ++V+L G     +   +I E M RG       SL   + NN        +K +
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
            +   +A  +AYL+ +     +HRD+++ N ++       + DFG  R ++     R   
Sbjct: 136 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 192
Query: 369 AG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEV 401
            G     +++PE     V T   DV+SFGVV  E+
Sbjct: 193 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 38/294 (12%)
Query: 213 IGTGGYGSVYKAQL------PNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHR 262
           +G G +G VY+ Q+      P+    A+K L       +EL F+     EA ++S+  H+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 94
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 318
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARLLHADSSNRTLLAGT--YG 373
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R          
Sbjct: 155 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 211
Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRL 432
           ++ PE     + T K D +SFGV+  E+  +G  P           + +++       R+
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP------YPSKSNQEVLEFVTSGGRM 265
Query: 433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAI 486
            PP  +     +  I T    C Q  P+ RP    + +      + P V + A+
Sbjct: 266 DPP--KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 314

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 38/294 (12%)
Query: 213 IGTGGYGSVYKAQL------PNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHR 262
           +G G +G VY+ Q+      P+    A+K L       +EL F+     EA ++S+  H+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 108
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 318
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 109 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARLLHADSSNRTLLAGT--YG 373
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R          
Sbjct: 169 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 225
Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRL 432
           ++ PE     + T K D +SFGV+  E+  +G  P           + +++       R+
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP------YPSKSNQEVLEFVTSGGRM 279
Query: 433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAI 486
            PP  +     +  I T    C Q  P+ RP    + +      + P V + A+
Sbjct: 280 DPP--KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 328

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 95/190 (50%), Gaps = 12/190 (6%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL 272
           IG G +G V        KV A+K +      A  ++F  EA V++Q+ H N+V+L G  +
Sbjct: 29  IGKGEFGDVMLGDYRGNKV-AVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 273 HKKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
            +K  ++++ EYM +GSL   L +   +V L     +     +  A+ YL  +   + +H
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NFVH 140
Query: 332 RDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDV 391
           RD+++ N+L++    A V+DFG   L    SS +        + APE       + K DV
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFG---LTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 197
Query: 392 YSFGVVTLEV 401
           +SFG++  E+
Sbjct: 198 WSFGILLWEI 207

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 38/294 (12%)
Query: 213 IGTGGYGSVYKAQL------PNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHR 262
           +G G +G VY+ Q+      P+    A+K L       +EL F+     EA ++S+  H+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 85
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 318
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 86  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 145
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARLLHADSSNRTLLAGT--YG 373
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R          
Sbjct: 146 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 202
Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRL 432
           ++ PE     + T K D +SFGV+  E+  +G  P           + +++       R+
Sbjct: 203 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP------YPSKSNQEVLEFVTSGGRM 256
Query: 433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAI 486
            PP  +     +  I T    C Q  P+ RP    + +      + P V + A+
Sbjct: 257 DPP--KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 305

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 38/294 (12%)
Query: 213 IGTGGYGSVYKAQL------PNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHR 262
           +G G +G VY+ Q+      P+    A+K L       +EL F+     EA ++S+  H+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 93
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 318
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARLLHADSSNRTLLAGT--YG 373
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R          
Sbjct: 154 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210
Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRL 432
           ++ PE     + T K D +SFGV+  E+  +G  P           + +++       R+
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP------YPSKSNQEVLEFVTSGGRM 264
Query: 433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAI 486
            PP  +     +  I T    C Q  P+ RP    + +      + P V + A+
Sbjct: 265 DPP--KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 313

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 38/294 (12%)
Query: 213 IGTGGYGSVYKAQL------PNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHR 262
           +G G +G VY+ Q+      P+    A+K L       +EL F+     EA ++S+  H+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 93
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 318
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 94  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARLLHADSSNRTLLAGT--YG 373
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R          
Sbjct: 154 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210
Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRL 432
           ++ PE     + T K D +SFGV+  E+  +G  P           + +++       R+
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP------YPSKSNQEVLEFVTSGGRM 264
Query: 433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAI 486
            PP  +     +  I T    C Q  P+ RP    + +      + P V + A+
Sbjct: 265 DPP--KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 313

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 38/294 (12%)
Query: 213 IGTGGYGSVYKAQL------PNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHR 262
           +G G +G VY+ Q+      P+    A+K L       +EL F+     EA ++S+  H+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLM----EALIISKFNHQ 108
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 318
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 109 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARLLHADSSNRTLLAGTY--G 373
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R          
Sbjct: 169 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 225
Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRL 432
           ++ PE     + T K D +SFGV+  E+  +G  P           + +++       R+
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP------YPSKSNQEVLEFVTSGGRM 279
Query: 433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAI 486
            PP  +     +  I T    C Q  P+ RP    + +      + P V + A+
Sbjct: 280 DPP--KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 328

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKL-----HTSEELAFIKSFKNEAQVLSQ 258
           +DFD+   IG G Y  V   +L    +++A+K +     +  E++ ++++   E  V  Q
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT---EKHVFEQ 61
Query: 259 VL-HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAH 316
              H  +V L+     +  +F + EY+  G L  ++       E    +      A ++ 
Sbjct: 62  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEISL 117
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           AL YLH      II+RD+  +N+LL+S+    + D+G  +         +   GT  YIA
Sbjct: 118 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIA 174
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDI 410
           PE+          D ++ GV+  E++ G+ P DI
Sbjct: 175 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 208

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 99/200 (49%), Gaps = 11/200 (5%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +GT G   + + QL   KV A+K L+  +   L  +   K E Q L    H +I+KLY  
Sbjct: 21  VGTFGKVKIGEHQLTGHKV-AVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
                  F++ EY+  G LF  +  +    E++ A+R  + + +  A+ Y H      ++
Sbjct: 80  ISTPTDFFMVMEYVSGGELFDYICKHGRVEEME-ARR--LFQQILSAVDYCHRHM---VV 133
Query: 331 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAYTMVMTEKC 389
           HRD+   N+LL++ + A +ADFG + ++      RT   G+  Y APE ++  +    + 
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVISGRLYAGPEV 192
Query: 390 DVYSFGVVTLEVLMGKHPRD 409
           D++S GV+   +L G  P D
Sbjct: 193 DIWSCGVILYALLCGTLPFD 212

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKN-EAQVLSQVLHRNIVKL--Y 268
           IG G +G VY+A+L  +G++ A+KK+         K+FKN E Q++ ++ H NIV+L  +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQG------KAFKNRELQIMRKLDHCNIVRLRYF 81
Query: 269 GYCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            Y   +K     + L+ +Y+         H +     L        +  +  +LAY+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 139
Query: 325 CSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
            S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y APEL +  
Sbjct: 140 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFGA 197
Query: 384 V-MTEKCDVYSFGVVTLEVLMGK 405
              T   DV+S G V  E+L+G+
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 25/223 (11%)
Query: 199 DLIEATEDFDI---RYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQ 254
           DL+E   ++D    R  +G G YG VY  + L N    A+K++    +  + +    E  
Sbjct: 13  DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI-PERDSRYSQPLHEEIA 71
Query: 255 VLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL-------FCNLHNNEDAVELDWAKR 307
           +   + H+NIV+  G       + +  E +  GSL       +  L +NE  +       
Sbjct: 72  LHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF----- 126
Query: 308 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRT 366
               K +   L YLH +    I+HRDI  +N+L+N+      ++DFGT++ L   +    
Sbjct: 127 --YTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE 181
Query: 367 LLAGTYGYIAPEL--AYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
              GT  Y+APE+         +  D++S G   +E+  GK P
Sbjct: 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 92/201 (45%), Gaps = 8/201 (3%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHR 262
           E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
           NIVKL      +  ++L++E++ +     +L    DA  L       I   +   L  L 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALTGIPLPLIKSYLFQLLQGLS 117
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAY 381
              S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE L  
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 382 TMVMTEKCDVYSFGVVTLEVL 402
               +   D++S G +  E++
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMV 198

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 38/294 (12%)
Query: 213 IGTGGYGSVYKAQL------PNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHR 262
           +G G +G VY+ Q+      P+    A+K L       +EL F+     EA ++S+  H+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 100
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 318
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 101 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 160
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARLLHADSSNRTLLAGTY--G 373
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R          
Sbjct: 161 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 217
Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRL 432
           ++ PE     + T K D +SFGV+  E+  +G  P           + +++       R+
Sbjct: 218 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP------YPSKSNQEVLEFVTSGGRM 271
Query: 433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAI 486
            PP  +     +  I T    C Q  P+ RP    + +      + P V + A+
Sbjct: 272 DPP--KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 320

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 38/294 (12%)
Query: 213 IGTGGYGSVYKAQL------PNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHR 262
           +G G +G VY+ Q+      P+    A+K L       +EL F+     EA ++S+  H+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 110
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 318
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 111 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 170
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARLLHADSSNRTLLAGTY--G 373
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R          
Sbjct: 171 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 227
Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRL 432
           ++ PE     + T K D +SFGV+  E+  +G  P           + +++       R+
Sbjct: 228 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP------YPSKSNQEVLEFVTSGGRM 281
Query: 433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAI 486
            PP  +     +  I T    C Q  P+ RP    + +      + P V + A+
Sbjct: 282 DPP--KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 330

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 14/205 (6%)
Query: 207 FDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIV 265
           F++   +G G    VY+  Q    K +ALK L  + +   +++   E  VL ++ H NI+
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT---EIGVLLRLSHPNII 111
Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
           KL         + L+ E +  G LF  +       E D A   + VK +  A+AYLH + 
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA---DAVKQILEAVAYLHEN- 167
Query: 326 SPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              I+HRD+   N+L  +        +ADFG ++++      +T+  GT GY APE+   
Sbjct: 168 --GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV-CGTPGYCAPEILRG 224
Query: 383 MVMTEKCDVYSFGVVTLEVLMGKHP 407
                + D++S G++T  +L G  P
Sbjct: 225 CAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKL-----HTSEELAFIKSFKNEAQVLSQ 258
           +DFD+   IG G Y  V   +L    +++A+K +     +  E++ ++++   E  V  Q
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT---EKHVFEQ 65
Query: 259 VL-HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAH 316
              H  +V L+     +  +F + EY+  G L  ++       E    +      A ++ 
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEISL 121
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           AL YLH      II+RD+  +N+LL+S+    + D+G  +         +   GT  YIA
Sbjct: 122 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIA 178
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDI 410
           PE+          D ++ GV+  E++ G+ P DI
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKN-EAQVLSQVLHRNIVKL--Y 268
           IG G +G VY+A+L  +G++ A+KK+         K+FKN E Q++ ++ H NIV+L  +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQG------KAFKNRELQIMRKLDHCNIVRLRYF 81
Query: 269 GYCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            Y   +K     + L+ +Y+         H +     L        +  +  +LAY+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 139
Query: 325 CSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
            S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y APEL +  
Sbjct: 140 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFGA 197
Query: 384 V-MTEKCDVYSFGVVTLEVLMGK 405
              T   DV+S G V  E+L+G+
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 92/215 (42%), Gaps = 30/215 (13%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPNGKV------FALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           FDI   IG G + +VYK       V         +KL  SE     + FK EA+ L  + 
Sbjct: 30  FDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER----QRFKEEAEXLKGLQ 83
Query: 261 HRNIVKLY----GYCLHKKCMFLIYEYMERGSLFCNLHN---NEDAVELDWAKRVNIVKA 313
           H NIV+ Y         KKC+ L+ E    G+L   L      +  V   W +++     
Sbjct: 84  HPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI----- 138
Query: 314 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTY 372
               L +LH   +P IIHRD+  +NI +     +  + D G A L  A  +   +  GT 
Sbjct: 139 -LKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI--GTP 194
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            + APE  Y     E  DVY+FG   LE    ++P
Sbjct: 195 EFXAPE-XYEEKYDESVDVYAFGXCXLEXATSEYP 228

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 127/293 (43%), Gaps = 33/293 (11%)
Query: 198 EDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALK---KLHTSEELAF--IKSFKNE 252
           ED++   + F +   +G G +GSV +AQL       +K   K+  ++ +A   I+ F  E
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 253 AQVLSQVLHRNIVKLYGYCLHKKCM------FLIYEYMERGSLFCNL---HNNEDAVELD 303
           A  + +  H ++ KL G  L  +         +I  +M+ G L   L      E+   L 
Sbjct: 76  AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 304 WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS 363
               V  +  +A  + YL    S + IHRD+++ N +L   +   VADFG +R +++   
Sbjct: 136 LQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 364 NRTLLAGTY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDIXXXXXXXXDP 420
            R   A      ++A E     + T   DV++FGV   E++  G+ P           + 
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP------YAGIENA 246
Query: 421 KIMLIDVLDQRL-PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           +I    +   RL  PP   + + D++      + C  ++PK RP+   +  E 
Sbjct: 247 EIYNYLIGGNRLKQPPECMEEVYDLM------YQCWSADPKQRPSFTCLRMEL 293

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 207 FDIRYCIGTGGYGSVY---KAQLPN-GKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLH 261
           F++   +G G +G V+   K   P+ G ++A+K L  +  ++      K E  +L+ V H
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNH 89
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAY 320
             +VKL+     +  ++LI +++  G LF  L       E D    V    A +A  L +
Sbjct: 90  PFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED----VKFYLAELALGLDH 145
Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELA 380
           LH   S  II+RD+   NILL+ +    + DFG ++             GT  Y+APE+ 
Sbjct: 146 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVV 202
Query: 381 YTMVMTEKCDVYSFGVVTLEVLMGKHP 407
                +   D +S+GV+  E+L G  P
Sbjct: 203 NRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 115/245 (46%), Gaps = 18/245 (7%)
Query: 169 KYKKPKLEERATNNIDVF--SIWN-YDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYK-A 224
           KY  PK+     N+ D F   IW  Y  + V        + +DI   +G+G +G V++  
Sbjct: 17  KYDGPKI-----NDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71
Query: 225 QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM 284
           +   G+VF  K ++T   L    + KNE  +++Q+ H  ++ L+     K  M LI E++
Sbjct: 72  EKATGRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130
Query: 285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK 344
             G LF  +   +   ++  A+ +N ++     L ++H     SI+H DI   NI+  +K
Sbjct: 131 SGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETK 185
Query: 345 LEAFVA--DFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL 402
             + V   DFG A  L+ D   +   A T  + APE+     +    D+++ GV+   +L
Sbjct: 186 KASSVKIIDFGLATKLNPDEIVKVTTA-TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 244
Query: 403 MGKHP 407
            G  P
Sbjct: 245 SGLSP 249

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 116/279 (41%), Gaps = 32/279 (11%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKA-------QLPNGKVFALKKLHTSEELAFIKSFKNEAQV 255
           A E   +   +G G +G VY+          P  +V A+K ++ +  +     F NEA V
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFLNEASV 68
Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERG-------SLFCNLHNNEDAVELDWAKRV 308
           + +    ++V+L G     +   +I E M RG       SL   + NN        +K +
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
            +   +A  +AYL+ +     +HRD+++ N  +       + DFG  R ++     R   
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 369 AG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEV-LMGKHPRDIXXXXXXXXDPKIMLI 425
            G     +++PE     V T   DV+SFGVV  E+  + + P              +M  
Sbjct: 186 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR--FVMEG 243
Query: 426 DVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPT 464
            +LD+    P       D+LL   +   C Q NPK RP+
Sbjct: 244 GLLDKPDNCP-------DMLL--ELMRMCWQYNPKMRPS 273

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHR 262
           E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHAL 318
           NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +   L
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQ-----DLKTFMDASALT-GIPLPLIKSYLFQLLQGL 115
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
           A+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE
Sbjct: 116 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 379 -LAYTMVMTEKCDVYSFGVVTLEVL 402
            L      +   D++S G +  E++
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKA-------QLPNGKVFALKKLHTSEELAFIKSFKNEAQV 255
           A E   +   +G G +G VY+          P  +V A+K ++ +  +     F NEA V
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFLNEASV 103
Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERG-------SLFCNLHNNEDAVELDWAKRV 308
           + +    ++V+L G     +   +I E M RG       SL   + NN        +K +
Sbjct: 104 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 163
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
            +   +A  +AYL+ +     +HRD+++ N ++       + DFG  R ++     R   
Sbjct: 164 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 220
Query: 369 AG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEV 401
            G     +++PE     V T   DV+SFGVV  E+
Sbjct: 221 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 204 TEDFDIRYCIGTGGYGSVYK------AQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLS 257
           T+D+ +   +G G +  V +       Q    K+   KKL   +     +  + EA++  
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDH----QKLEREARICR 85
Query: 258 QVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 317
            + H NIV+L+     +   +L+++ +  G LF      ED V  ++    +    +   
Sbjct: 86  LLKHPNIVRLHDSISEEGFHYLVFDLVTGGELF------EDIVAREYYSEADASHCIHQI 139
Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAGTYGY 374
           L  ++H     I+HRD+   N+LL SK +     +ADFG A  +  +       AGT GY
Sbjct: 140 LESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGY 199
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           ++PE+       +  D+++ GV+   +L+G  P
Sbjct: 200 LSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 213 IGTGGYGSVYKA--QLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYG 269
           +G G +GSV +   ++   ++  A+K L    E A  +    EAQ++ Q+ +  IV+L G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
            C   + + L+ E    G L   L    + + +  +    ++  ++  + YL      + 
Sbjct: 78  VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPV--SNVAELLHQVSMGMKYLEEK---NF 131
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL-AGTY--GYIAPELAYTMVMT 386
           +HRD+++ N+LL ++  A ++DFG ++ L AD S  T   AG +   + APE       +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 387 EKCDVYSFGVVTLEVL-MGKHP 407
            + DV+S+GV   E L  G+ P
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKP 213

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 206 DFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLH-----TSEELAFIKSFKNEAQVLSQV 259
           DFD    +G G +G V    +   G+ +A+K L        +E+A   +   E++VL   
Sbjct: 11  DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT---ESRVLQNT 67
Query: 260 LHRNIVKL-YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHA 317
            H  +  L Y +  H +  F++ EY   G LF +L       E    +R     A +  A
Sbjct: 68  RHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSA 122
Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           L YLH   S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+AP
Sbjct: 123 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAP 179
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           E+          D +  GVV  E++ G+ P
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKL-----HTSEELAFIKSFKNEAQVLSQ 258
           +DFD+   IG G Y  V   +L    +++A+K +     +  E++ ++++   E  V  Q
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT---EKHVFEQ 76
Query: 259 VL-HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAH 316
              H  +V L+     +  +F + EY+  G L  ++       E    +      A ++ 
Sbjct: 77  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEISL 132
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           AL YLH      II+RD+  +N+LL+S+    + D+G  +         +   GT  YIA
Sbjct: 133 ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIA 189
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDI 410
           PE+          D ++ GV+  E++ G+ P DI
Sbjct: 190 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 223

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKN-EAQVLSQVLHRNIVKL--Y 268
           IG G +G VY+A+L  +G++ A+KK+         K+FKN E Q++ ++ H NIV+L  +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQG------KAFKNRELQIMRKLDHCNIVRLRYF 81
Query: 269 GYCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            Y   +K     + L+ +Y+         H +     L        +  +  +LAY+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 139
Query: 325 CSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
            S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y APEL +  
Sbjct: 140 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGA 197
Query: 384 V-MTEKCDVYSFGVVTLEVLMGK 405
              T   DV+S G V  E+L+G+
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKA-------QLPNGKVFALKKLHTSEELAFIKSFKNEAQV 255
           A E   +   +G G +G VY+          P  +V A+K ++ +  +     F NEA V
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFLNEASV 81
Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERG-------SLFCNLHNNEDAVELDWAKRV 308
           + +    ++V+L G     +   +I E M RG       SL   + NN        +K +
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
            +   +A  +AYL+ +     +HRD+++ N ++       + DFG  R ++     R   
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 369 AG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEV 401
            G     +++PE     V T   DV+SFGVV  E+
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 213 IGTGGYGSV----YKAQLPN-GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G G +G V    Y  +  N G+  A+K L        I   K E ++L  + H NIVK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 268 YGYCLHK--KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
            G C       + LI E++  GSL   L  N++ + L   +++     +   + YL    
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL--KQQLKYAVQICKGMDYLG--- 143
Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG---YIAPELAYT 382
           S   +HRD+++ N+L+ S+ +  + DFG  + +  D    T+         + APE    
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 203
Query: 383 MVMTEKCDVYSFGVVTLEVL 402
                  DV+SFGV   E+L
Sbjct: 204 SKFYIASDVWSFGVTLHELL 223

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 206 DFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLH-----TSEELAFIKSFKNEAQVLSQV 259
           DFD    +G G +G V    +   G+ +A+K L        +E+A   +   E++VL   
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT---ESRVLQNT 62
Query: 260 LHRNIVKL-YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHA 317
            H  +  L Y +  H +  F++ EY   G LF +L       E    +R     A +  A
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSA 117
Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           L YLH   S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+AP
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAP 174
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           E+          D +  GVV  E++ G+ P
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKN-EAQVLSQVLHRNIVKL--Y 268
           IG G +G VY+A+L  +G++ A+KK+         K FKN E Q++ ++ H NIV+L  +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 269 GYCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            Y   +K     + L+ +Y+         H +     L        +  +  +LAY+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 139
Query: 325 CSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
            S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y APEL +  
Sbjct: 140 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGA 197
Query: 384 V-MTEKCDVYSFGVVTLEVLMGK 405
              T   DV+S G V  E+L+G+
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 206 DFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLH-----TSEELAFIKSFKNEAQVLSQV 259
           DFD    +G G +G V    +   G+ +A+K L        +E+A   +   E++VL   
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT---ESRVLQNT 62
Query: 260 LHRNIVKL-YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHA 317
            H  +  L Y +  H +  F++ EY   G LF +L       E    +R     A +  A
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSA 117
Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           L YLH   S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+AP
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAP 174
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           E+          D +  GVV  E++ G+ P
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKN-EAQVLSQVLHRNIVKL--Y 268
           IG G +G VY+A+L  +G++ A+KK+         K FKN E Q++ ++ H NIV+L  +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 269 GYCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            Y   +K     + L+ +Y+         H +     L        +  +  +LAY+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 139
Query: 325 CSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
            S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y APEL +  
Sbjct: 140 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGA 197
Query: 384 V-MTEKCDVYSFGVVTLEVLMGK 405
              T   DV+S G V  E+L+G+
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKN-EAQVLSQVLHRNIVKL--Y 268
           IG G +G VY+A+L  +G++ A+KK+         K FKN E Q++ ++ H NIV+L  +
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCNIVRLRYF 89
Query: 269 GYCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            Y   +K     + L+ +Y+         H +     L        +  +  +LAY+H  
Sbjct: 90  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 147
Query: 325 CSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
            S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y APEL +  
Sbjct: 148 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGA 205
Query: 384 V-MTEKCDVYSFGVVTLEVLMGK 405
              T   DV+S G V  E+L+G+
Sbjct: 206 TDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 206 DFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLH-----TSEELAFIKSFKNEAQVLSQV 259
           DFD    +G G +G V    +   G+ +A+K L        +E+A   +   E++VL   
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT---ESRVLQNT 62
Query: 260 LHRNIVKL-YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHA 317
            H  +  L Y +  H +  F++ EY   G LF +L       E    +R     A +  A
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSA 117
Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           L YLH   S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+AP
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 174
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           E+          D +  GVV  E++ G+ P
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKN-EAQVLSQVLHRNIVKL--Y 268
           IG G +G VY+A+L  +G++ A+KK+         K FKN E Q++ ++ H NIV+L  +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 269 GYCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            Y   +K     + L+ +Y+         H +     L        +  +  +LAY+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 139
Query: 325 CSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
            S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y APEL +  
Sbjct: 140 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFGA 197
Query: 384 V-MTEKCDVYSFGVVTLEVLMGK 405
              T   DV+S G V  E+L+G+
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 206 DFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLH-----TSEELAFIKSFKNEAQVLSQV 259
           DFD    +G G +G V    +   G+ +A+K L        +E+A   +   E++VL   
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT---ESRVLQNT 62
Query: 260 LHRNIVKL-YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHA 317
            H  +  L Y +  H +  F++ EY   G LF +L       E    +R     A +  A
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSA 117
Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           L YLH   S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+AP
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAP 174
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           E+          D +  GVV  E++ G+ P
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVL 260
           + E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAH 316
           H NIVKL      +  ++L++E++       +L +  DA  L     + ++K+    +  
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLS-----MDLKDFMDASALT-GIPLPLIKSYLFQLLQ 117
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
            LA+ H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y A
Sbjct: 118 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVL 402
           PE L      +   D++S G +  E++
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKN-EAQVLSQVLHRNIVKL--Y 268
           IG G +G VY+A+L  +G++ A+KK+         K FKN E Q++ ++ H NIV+L  +
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCNIVRLRYF 100
Query: 269 GYCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            Y   +K     + L+ +Y+         H +     L        +  +  +LAY+H  
Sbjct: 101 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 158
Query: 325 CSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
            S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y APEL +  
Sbjct: 159 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGA 216
Query: 384 V-MTEKCDVYSFGVVTLEVLMGK 405
              T   DV+S G V  E+L+G+
Sbjct: 217 TDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 32/222 (14%)
Query: 213 IGTGGYGSVYKAQL-------PNGKVFA----LKKLHTSEELAFIKSFKNEAQVLSQVLH 261
           +G G +G V  A+        P   V      LK   T E+L+ + S     +++ +  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGK--H 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRV 308
           +NI+ L G C     +++I EY  +G+L   L              N     ++ +   V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +   
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 369 AGT--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
            G     ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKN-EAQVLSQVLHRNIVKL--Y 268
           IG G +G VY+A+L  +G++ A+KK+         K FKN E Q++ ++ H NIV+L  +
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCNIVRLRYF 82
Query: 269 GYCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            Y   +K     + L+ +Y+         H +     L        +  +  +LAY+H  
Sbjct: 83  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 140
Query: 325 CSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
            S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y APEL +  
Sbjct: 141 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGA 198
Query: 384 V-MTEKCDVYSFGVVTLEVLMGK 405
              T   DV+S G V  E+L+G+
Sbjct: 199 TDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVL 260
           + E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAH 316
           H NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +  
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKTFMDASALT-GIPLPLIKSYLFQLLQ 117
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
            LA+ H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y A
Sbjct: 118 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVL 402
           PE L      +   D++S G +  E++
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKN-EAQVLSQVLHRNIVKL--Y 268
           IG G +G VY+A+L  +G++ A+KK+         K FKN E Q++ ++ H NIV+L  +
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCNIVRLRYF 94
Query: 269 GYCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            Y   +K     + L+ +Y+         H +     L        +  +  +LAY+H  
Sbjct: 95  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 152
Query: 325 CSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
            S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y APEL +  
Sbjct: 153 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFGA 210
Query: 384 V-MTEKCDVYSFGVVTLEVLMGK 405
              T   DV+S G V  E+L+G+
Sbjct: 211 TDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVL 260
           + E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAH 316
           H NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +  
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQ 117
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
            LA+ H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y A
Sbjct: 118 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVL 402
           PE L      +   D++S G +  E++
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVL 260
           + E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAH 316
           H NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +  
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQ 116
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
            LA+ H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y A
Sbjct: 117 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 173
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVL 402
           PE L      +   D++S G +  E++
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVL 260
           + E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAH 316
           H NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +  
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQ 118
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
            LA+ H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y A
Sbjct: 119 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 175
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVL 402
           PE L      +   D++S G +  E++
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMV 202

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVL 260
           + E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAH 316
           H NIVKL      +  ++L++E++ +     +L +  DA  L     + ++K+    +  
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKDFMDASALT-GIPLPLIKSYLFQLLQ 114
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
            LA+ H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y A
Sbjct: 115 GLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 171
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVL 402
           PE L      +   D++S G +  E++
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKN-EAQVLSQVLHRNIVKL--Y 268
           IG G +G VY+A+L  +G++ A+KK+         K FKN E Q++ ++ H NIV+L  +
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCNIVRLRYF 93
Query: 269 GYCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            Y   +K     + L+ +Y+         H +     L        +  +  +LAY+H  
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 151
Query: 325 CSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
            S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y APEL +  
Sbjct: 152 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGA 209
Query: 384 V-MTEKCDVYSFGVVTLEVLMGK 405
              T   DV+S G V  E+L+G+
Sbjct: 210 TDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 206 DFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLH-----TSEELAFIKSFKNEAQVLSQV 259
           DFD    +G G +G V    +   G+ +A+K L        +E+A   +   E++VL   
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT---ESRVLQNT 62
Query: 260 LHRNIVKL-YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHA 317
            H  +  L Y +  H +  F++ EY   G LF +L       E    +R     A +  A
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSA 117
Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           L YLH   S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+AP
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 174
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           E+          D +  GVV  E++ G+ P
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 38/294 (12%)
Query: 213 IGTGGYGSVYKAQL------PNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHR 262
           +G G +G VY+ Q+      P+    A+K L       +EL F+     EA ++S+  H+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 120
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 318
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 121 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 180
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARLLHADSSNRTLLAGTY--G 373
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R          
Sbjct: 181 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 237
Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRL 432
           ++ PE     + T K D +SFGV+  E+  +G  P           + +++       R+
Sbjct: 238 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP------YPSKSNQEVLEFVTSGGRM 291
Query: 433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAI 486
            PP  +     +  I T    C Q  P+ RP    + +      + P V + A+
Sbjct: 292 DPP--KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 340

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 32/225 (14%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV---FALKKLHTSEELAFIKSFKNEAQVLSQVLHR 262
           D   +  IG G +G V KA++    +    A+K++         + F  E +VL ++ H 
Sbjct: 16  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 75
Query: 263 -NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN-------------NEDAVELDWAKRV 308
            NI+ L G C H+  ++L  EY   G+L   L               N  A  L   + +
Sbjct: 76  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 135
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
           +    +A  + YL        IHRD+++ NIL+     A +ADFG +R           +
Sbjct: 136 HFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYV 186
Query: 369 AGTYG-----YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
             T G     ++A E     V T   DV+S+GV+  E++ +G  P
Sbjct: 187 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 231

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVL 260
           + E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAH 316
           H NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +  
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQ 117
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
            LA+ H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y A
Sbjct: 118 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVL 402
           PE L      +   D++S G +  E++
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVL 260
           + E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAH 316
           H NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +  
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQ 116
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
            LA+ H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y A
Sbjct: 117 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 173
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVL 402
           PE L      +   D++S G +  E++
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKN-EAQVLSQVLHRNIVKL--Y 268
           IG G +G VY+A+L  +G++ A+KK+         K FKN E Q++ ++ H NIV+L  +
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCNIVRLRYF 85
Query: 269 GYCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            Y   +K     + L+ +Y+         H +     L        +  +  +LAY+H  
Sbjct: 86  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 143
Query: 325 CSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
            S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y APEL +  
Sbjct: 144 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGA 201
Query: 384 V-MTEKCDVYSFGVVTLEVLMGK 405
              T   DV+S G V  E+L+G+
Sbjct: 202 TDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 20/215 (9%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKA-------QLPNGKVFALKKLHTSEELAFIKSFKNEAQV 255
           A E   +   +G G +G VY+          P  +V A+K ++ +  +     F NEA V
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFLNEASV 71
Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLH-------NNEDAVELDWAKRV 308
           + +    ++V+L G     +   +I E M RG L   L        NN        +K +
Sbjct: 72  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 131
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
            +   +A  +AYL+ +     +HRD+++ N ++       + DFG  R ++     R   
Sbjct: 132 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 188
Query: 369 AG--TYGYIAPELAYTMVMTEKCDVYSFGVVTLEV 401
            G     +++PE     V T   DV+SFGVV  E+
Sbjct: 189 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 213 IGTGGYGSV----YKAQLPN-GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G G +G V    Y  +  N G+  A+K L        I   K E ++L  + H NIVK 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 268 YGYCLHK--KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
            G C       + LI E++  GSL   L  N++ + L   +++     +   + YL    
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL--KQQLKYAVQICKGMDYLG--- 131
Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG---YIAPELAYT 382
           S   +HRD+++ N+L+ S+ +  + DFG  + +  D    T+         + APE    
Sbjct: 132 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 191
Query: 383 MVMTEKCDVYSFGVVTLEVL 402
                  DV+SFGV   E+L
Sbjct: 192 SKFYIASDVWSFGVTLHELL 211

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 203 ATEDFDIRY-------CIGTGGYGSVYKA-----QLPNGKVFALKKLHTSEELAFIKSFK 250
           +T D++I+        CIG G +G V++      + P   V A+K        +  + F 
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAV-AIKTCKNCTSDSVREKFL 59
Query: 251 NEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNI 310
            EA  + Q  H +IVKL G  + +  +++I E    G L   L   +    LD A  +  
Sbjct: 60  QEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILY 116
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG 370
              ++ ALAYL    S   +HRDI++ N+L++S     + DFG +R +  DS+      G
Sbjct: 117 AYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKG 172
Query: 371 TY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVLM 403
                ++APE       T   DV+ FGV   E+LM
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 207

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 213 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN 263
           +G G +G V  A+        P   V  A+K L        +    +E +++  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRVNI 310
           I+ L G C     +++I EY  +G+L   L              N     ++ +   V+ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG 370
              +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +    G
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 371 T--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
                ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVL 260
           + E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAH 316
           H NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +  
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQ 115
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
            LA+ H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y A
Sbjct: 116 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 172
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVL 402
           PE L      +   D++S G +  E++
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 11/200 (5%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +GT G   + + QL   KV A+K L+  +   L  +   K E Q L    H +I+KLY  
Sbjct: 21  VGTFGKVKIGEHQLTGHKV-AVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
                  F++ EY+  G LF  +  +    E++ A+R  + + +  A+ Y H      ++
Sbjct: 80  ISTPTDFFMVMEYVSGGELFDYICKHGRVEEME-ARR--LFQQILSAVDYCHRHM---VV 133
Query: 331 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAYTMVMTEKC 389
           HRD+   N+LL++ + A +ADFG + ++ +D        G+  Y APE ++  +    + 
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRDSCGSPNYAAPEVISGRLYAGPEV 192
Query: 390 DVYSFGVVTLEVLMGKHPRD 409
           D++S GV+   +L G  P D
Sbjct: 193 DIWSCGVILYALLCGTLPFD 212

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVL 260
           + E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAH 316
           H NIVKL      +  ++L++E++       +L +  DA  L     + ++K+    +  
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLS-----MDLKDFMDASALT-GIPLPLIKSYLFQLLQ 116
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
            LA+ H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y A
Sbjct: 117 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 173
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVL 402
           PE L      +   D++S G +  E++
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 206 DFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLH-----TSEELAFIKSFKNEAQVLSQV 259
           DFD    +G G +G V    +   G+ +A+K L        +E+A   +   E++VL   
Sbjct: 9   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT---ESRVLQNT 65
Query: 260 LHRNIVKL-YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHA 317
            H  +  L Y +  H +  F++ EY   G LF +L       E    +R     A +  A
Sbjct: 66  RHPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSA 120
Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           L YLH   S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+AP
Sbjct: 121 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 177
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           E+          D +  GVV  E++ G+ P
Sbjct: 178 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKN-EAQVLSQVLHRNIVKL--Y 268
           IG G +G VY+A+L  +G++ A+KK+         K FKN E Q++ ++ H NIV+L  +
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCNIVRLRYF 93
Query: 269 GYCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            Y   +K     + L+ +Y+         H +     L        +  +  +LAY+H  
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 151
Query: 325 CSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
            S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y APEL +  
Sbjct: 152 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGA 209
Query: 384 V-MTEKCDVYSFGVVTLEVLMGK 405
              T   DV+S G V  E+L+G+
Sbjct: 210 TDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 213 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN 263
           +G G +G V  A+        P   V  A+K L        +    +E +++  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRVNI 310
           I+ L G C     +++I EY  +G+L   L              N     ++ +   V+ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG 370
              +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +    G
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 371 T--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
                ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 32/225 (14%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV---FALKKLHTSEELAFIKSFKNEAQVLSQVLHR 262
           D   +  IG G +G V KA++    +    A+K++         + F  E +VL ++ H 
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 85
Query: 263 -NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN-------------NEDAVELDWAKRV 308
            NI+ L G C H+  ++L  EY   G+L   L               N  A  L   + +
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
           +    +A  + YL        IHRD+++ NIL+     A +ADFG +R           +
Sbjct: 146 HFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYV 196
Query: 369 AGTYG-----YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
             T G     ++A E     V T   DV+S+GV+  E++ +G  P
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 101/227 (44%), Gaps = 36/227 (15%)
Query: 191 YDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHT--SEELAFIK 247
           ++ R VY DL            +G+G YG+V  A     G   A+KKL+     EL F K
Sbjct: 21  WEVRAVYRDL----------QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL-FAK 69
Query: 248 SFKNEAQVLSQVLHRNIVKLYGYCLHKKCM------FLIYEYM--ERGSLFCNLHNNEDA 299
               E ++L  + H N++ L       + +      +L+  +M  + G L  +    ED 
Sbjct: 70  RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR 129
Query: 300 VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH 359
           ++        +V  M   L Y+H   +  IIHRD+   N+ +N   E  + DFG AR   
Sbjct: 130 IQF-------LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--Q 177
Query: 360 ADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGK 405
           ADS     +  T  Y APE+    M  T+  D++S G +  E++ GK
Sbjct: 178 ADSEMXGXVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVL 260
           + E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAH 316
           H NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +  
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQ 116
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
            LA+ H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y A
Sbjct: 117 GLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 173
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVL 402
           PE L      +   D++S G +  E++
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 203 ATEDFDIRY-------CIGTGGYGSVYKA-----QLPNGKVFALKKLHTSEELAFIKSFK 250
           +T D++I+        CIG G +G V++      + P   V A+K        +  + F 
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAV-AIKTCKNCTSDSVREKFL 439
Query: 251 NEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNI 310
            EA  + Q  H +IVKL G  + +  +++I E    G L   L   +    LD A  +  
Sbjct: 440 QEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILY 496
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG 370
              ++ ALAYL    S   +HRDI++ N+L++S     + DFG +R +  DS+      G
Sbjct: 497 AYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKG 552
Query: 371 TY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVLM 403
                ++APE       T   DV+ FGV   E+LM
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVL 260
           + E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAH 316
           H NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +  
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQ 114
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
            LA+ H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y A
Sbjct: 115 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 171
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVL 402
           PE L      +   D++S G +  E++
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKN-EAQVLSQVLHRNIVKL--Y 268
           IG G +G VY+A+L  +G++ A+KK+         K FKN E Q++ ++ H NIV+L  +
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCNIVRLRYF 86
Query: 269 GYCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            Y   +K     + L+ +Y+         H +     L        +  +  +LAY+H  
Sbjct: 87  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 144
Query: 325 CSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
            S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y APEL +  
Sbjct: 145 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFGA 202
Query: 384 V-MTEKCDVYSFGVVTLEVLMGK 405
              T   DV+S G V  E+L+G+
Sbjct: 203 TDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVL 260
           + E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAH 316
           H NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +  
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQ 114
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
            LA+ H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y A
Sbjct: 115 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 171
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVL 402
           PE L      +   D++S G +  E++
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKN-EAQVLSQVLHRNIVKL--- 267
           IG G +G VY+A+L  +G++ A+KK+         K FKN E Q++ ++ H NIV+L   
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 268 -YGYCLHKKCMF--LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            Y     K  ++  L+ +Y+         H +     L        +  +  +LAY+H  
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 173
Query: 325 CSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
            S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y APEL +  
Sbjct: 174 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGA 231
Query: 384 V-MTEKCDVYSFGVVTLEVLMGK 405
              T   DV+S G V  E+L+G+
Sbjct: 232 TDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 203 ATEDFDIRY-------CIGTGGYGSVYKA--QLPNGKVFA--LKKLHTSEELAFIKSFKN 251
           +T D++I+        CIG G +G V++     P     A  +K        +  + F  
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 60
Query: 252 EAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIV 311
           EA  + Q  H +IVKL G  + +  +++I E    G L   L   +    LD A  +   
Sbjct: 61  EALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYA 117
Query: 312 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT 371
             ++ ALAYL    S   +HRDI++ N+L++S     + DFG +R +  DS+      G 
Sbjct: 118 YQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGK 173
Query: 372 Y--GYIAPELAYTMVMTEKCDVYSFGVVTLEVLM 403
               ++APE       T   DV+ FGV   E+LM
Sbjct: 174 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 207

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKN-EAQVLSQVLHRNIVKL--Y 268
           IG G +G VY+A+L  +G++ A+KK+         K FKN E Q++ ++ H NIV+L  +
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCNIVRLRYF 109
Query: 269 GYCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            Y   +K     + L+ +Y+         H +     L        +  +  +LAY+H  
Sbjct: 110 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 167
Query: 325 CSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
            S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y APEL +  
Sbjct: 168 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFGA 225
Query: 384 V-MTEKCDVYSFGVVTLEVLMGK 405
              T   DV+S G V  E+L+G+
Sbjct: 226 TDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKN-EAQVLSQVLHRNIVKL--Y 268
           IG G +G VY+A+L  +G++ A+KK+         K FKN E Q++ ++ H NIV+L  +
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCNIVRLRYF 117
Query: 269 GYCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            Y   +K     + L+ +Y+         H +     L        +  +  +LAY+H  
Sbjct: 118 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 175
Query: 325 CSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
            S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y APEL +  
Sbjct: 176 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFGA 233
Query: 384 V-MTEKCDVYSFGVVTLEVLMGK 405
              T   DV+S G V  E+L+G+
Sbjct: 234 TDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVL 260
           + E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAH 316
           H NIVKL      +  ++L++E++++     +L    DA  L     + ++K+    +  
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQ 117
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
            LA+ H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y A
Sbjct: 118 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVL 402
           PE L      +   D++S G +  E++
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 205 EDFDIRYCIGTGGYGSVYKA--QLPNGKVFA--LKKLHTSEELAFIKSFKNEAQVLSQVL 260
           E  ++  CIG G +G V++     P     A  +K        +  + F  EA  + Q  
Sbjct: 38  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 97
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H +IVKL G  + +  +++I E    G L   L   +    LD A  +     ++ ALAY
Sbjct: 98  HPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAY 154
Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPE 378
           L    S   +HRDI++ N+L++S     + DFG +R +  DS+      G     ++APE
Sbjct: 155 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 210
Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLM 403
                  T   DV+ FGV   E+LM
Sbjct: 211 SINFRRFTSASDVWMFGVCMWEILM 235

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVL 260
           + E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAH 316
           H NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +  
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQ 114
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
            LA+ H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y A
Sbjct: 115 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 171
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVL 402
           PE L      +   D++S G +  E++
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKN-EAQVLSQVLHRNIVKL--Y 268
           IG G +G VY+A+L  +G++ A+KK+         K FKN E Q++ ++ H NIV+L  +
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCNIVRLRYF 119
Query: 269 GYCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            Y   +K     + L+ +Y+         H +     L        +  +  +LAY+H  
Sbjct: 120 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 177
Query: 325 CSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
            S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y APEL +  
Sbjct: 178 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFGA 235
Query: 384 V-MTEKCDVYSFGVVTLEVLMGK 405
              T   DV+S G V  E+L+G+
Sbjct: 236 TDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 16/205 (7%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHR 262
           E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHAL 318
           NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +   L
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQGL 115
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
           A+ H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y APE
Sbjct: 116 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 172
Query: 379 -LAYTMVMTEKCDVYSFGVVTLEVL 402
            L      +   D++S G +  E++
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 16/205 (7%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHR 262
           E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHAL 318
           NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +   L
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQGL 115
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
           A+ H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y APE
Sbjct: 116 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 172
Query: 379 -LAYTMVMTEKCDVYSFGVVTLEVL 402
            L      +   D++S G +  E++
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKN-EAQVLSQVLHRNIVKL--Y 268
           IG G +G VY+A+L  +G++ A+KK+         K FKN E Q++ ++ H NIV+L  +
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 269 GYCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            Y   +K     + L+ +Y+         H +     L        +  +  +LAY+H  
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 173
Query: 325 CSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
            S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y APEL +  
Sbjct: 174 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFGA 231
Query: 384 V-MTEKCDVYSFGVVTLEVLMGK 405
              T   DV+S G V  E+L+G+
Sbjct: 232 TDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 213 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN 263
           +G G +G V  A+        P   V  A+K L        +    +E +++  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRVNI 310
           I+ L G C     +++I EY  +G+L   L              N     ++ +   V+ 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG 370
              +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +    G
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 371 T--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
                ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 16/205 (7%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHR 262
           E+F     IG G YG VYKA+    G+V AL K+    E   + S    E  +L ++ H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHAL 318
           NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +   L
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQGL 116
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
           A+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE
Sbjct: 117 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 379 -LAYTMVMTEKCDVYSFGVVTLEVL 402
            L      +   D++S G +  E++
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 16/205 (7%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHR 262
           E+F     IG G YG VYKA+    G+V AL K+    E   + S    E  +L ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHAL 318
           NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +   L
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQGL 115
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
           A+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE
Sbjct: 116 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 379 -LAYTMVMTEKCDVYSFGVVTLEVL 402
            L      +   D++S G +  E++
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 118/294 (40%), Gaps = 38/294 (12%)
Query: 213 IGTGGYGSVYKAQL------PNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHR 262
           +G G +G VY+ Q+      P+    A+K L       +EL F+     EA ++S+  H+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 134
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 318
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARLLHADSSNRTLLAGTY--G 373
            YL  +     IHRDI++ N LL       VA   DFG AR ++     R          
Sbjct: 195 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251
Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRL 432
           ++ PE     + T K D +SFGV+  E+  +G  P           + +++       R+
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP------YPSKSNQEVLEFVTSGGRM 305
Query: 433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAI 486
            PP  +     +  I T    C Q  P+ RP    + +      + P V + A+
Sbjct: 306 DPP--KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 354

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 118/294 (40%), Gaps = 38/294 (12%)
Query: 213 IGTGGYGSVYKAQL------PNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHR 262
           +G G +G VY+ Q+      P+    A+K L       +EL F+     EA ++S+  H+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 111
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 318
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 112 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 171
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARLLHADSSNRTLLAGT--YG 373
            YL  +     IHRDI++ N LL       VA   DFG AR ++     R          
Sbjct: 172 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 228
Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRL 432
           ++ PE     + T K D +SFGV+  E+  +G  P           + +++       R+
Sbjct: 229 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP------YPSKSNQEVLEFVTSGGRM 282
Query: 433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAI 486
            PP  +     +  I T    C Q  P+ RP    + +      + P V + A+
Sbjct: 283 DPP--KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 331

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 205 EDFDIRYCIGTGGYGSVYKA--QLPNGKVFA--LKKLHTSEELAFIKSFKNEAQVLSQVL 260
           E  ++  CIG G +G V++     P     A  +K        +  + F  EA  + Q  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H +IVKL G  + +  +++I E    G L   L   +    LD A  +     ++ ALAY
Sbjct: 67  HPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAY 123
Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPE 378
           L    S   +HRDI++ N+L++S     + DFG +R +  DS+      G     ++APE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 179
Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLM 403
                  T   DV+ FGV   E+LM
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILM 204

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 205 EDFDIRYCIGTGGYGSVYKA--QLPNGKVFA--LKKLHTSEELAFIKSFKNEAQVLSQVL 260
           E  ++  CIG G +G V++     P     A  +K        +  + F  EA  + Q  
Sbjct: 13  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 72
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H +IVKL G  + +  +++I E    G L   L   +    LD A  +     ++ ALAY
Sbjct: 73  HPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAY 129
Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPE 378
           L    S   +HRDI++ N+L++S     + DFG +R +  DS+      G     ++APE
Sbjct: 130 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 185
Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLM 403
                  T   DV+ FGV   E+LM
Sbjct: 186 SINFRRFTSASDVWMFGVCMWEILM 210

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVL 260
           + E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAH 316
           H NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +  
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQ 114
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
            LA+ H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y A
Sbjct: 115 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 171
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVL 402
           PE L      +   D++S G +  E++
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 205 EDFDIRYCIGTGGYGSVYKA--QLPNGKVFA--LKKLHTSEELAFIKSFKNEAQVLSQVL 260
           E  ++  CIG G +G V++     P     A  +K        +  + F  EA  + Q  
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H +IVKL G  + +  +++I E    G L   L   +    LD A  +     ++ ALAY
Sbjct: 75  HPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAY 131
Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPE 378
           L    S   +HRDI++ N+L++S     + DFG +R +  DS+      G     ++APE
Sbjct: 132 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 187
Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLM 403
                  T   DV+ FGV   E+LM
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILM 212

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 124/290 (42%), Gaps = 55/290 (18%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKK-LHTSEELAFIKSFK---NEAQVLSQVLHRNIVKL 267
           +G+G +G+V+K   +P G+   +   +   E+ +  +SF+   +    +  + H +IV+L
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G C     + L+ +Y+  GSL  ++  +  A+     L+W   V I K M     YL  
Sbjct: 99  LGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG--VQIAKGMY----YLEE 151
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT----YGYIAPEL 379
                ++HR++++ N+LL S  +  VADFG A LL  D  ++ LL         ++A E 
Sbjct: 152 H---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD--DKQLLYSEAKTPIKWMALES 206
Query: 380 AYTMVMTEKCDVYSFGVVTLEVL-MGKHPR---------DIXXXXXXXXDPKIMLIDVLD 429
            +    T + DV+S+GV   E++  G  P          D+         P+I  IDV  
Sbjct: 207 IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVY- 265
Query: 430 QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                               V   C   +   RPT + ++ EF    + P
Sbjct: 266 -------------------MVMVKCWMIDENIRPTFKELANEFTRMARDP 296

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 205 EDFDIRYCIGTGGYGSVYKA--QLPNGKVFA--LKKLHTSEELAFIKSFKNEAQVLSQVL 260
           E  ++  CIG G +G V++     P     A  +K        +  + F  EA  + Q  
Sbjct: 12  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 71
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H +IVKL G  + +  +++I E    G L   L   +    LD A  +     ++ ALAY
Sbjct: 72  HPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAY 128
Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAPE 378
           L    S   +HRDI++ N+L++S     + DFG +R +  DS+      G     ++APE
Sbjct: 129 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 184
Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLM 403
                  T   DV+ FGV   E+LM
Sbjct: 185 SINFRRFTSASDVWMFGVCMWEILM 209

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 16/205 (7%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHR 262
           E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHAL 318
           NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +   L
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQGL 117
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
           A+ H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y APE
Sbjct: 118 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 379 -LAYTMVMTEKCDVYSFGVVTLEVL 402
            L      +   D++S G +  E++
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKL-----HTSEELAFIKSFKNEAQVLSQ 258
           +DFD+   IG G Y  V   +L    +++A++ +     +  E++ ++++   E  V  Q
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQT---EKHVFEQ 108
Query: 259 VL-HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAH 316
              H  +V L+     +  +F + EY+  G L  ++       E    +      A ++ 
Sbjct: 109 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEISL 164
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           AL YLH      II+RD+  +N+LL+S+    + D+G  +         +   GT  YIA
Sbjct: 165 ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 221
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDI 410
           PE+          D ++ GV+  E++ G+ P DI
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVL 260
           + E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAH 316
           H NIVKL      +  ++L++E++ +     +L    DA  L     + ++K+    +  
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQ 115
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
            LA+ H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y A
Sbjct: 116 GLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 172
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVL 402
           PE L      +   D++S G +  E++
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 213 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN 263
           +G G +G V  A+        P   V  A+K L        +    +E +++  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRVNI 310
           I+ L G C     +++I EY  +G+L   L              N     ++ +   V+ 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG 370
              +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +    G
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 371 T--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
                ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 40/215 (18%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL--HRNIV----- 265
           IG G +G V++ +   G+  A+K   + EE    +S+  EA++   V+  H NI+     
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAA 104
Query: 266 --KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
             K  G       ++L+ +Y E GSLF  L+     VE      + +  + A  LA+LH 
Sbjct: 105 DNKDNGTWTQ---LWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHM 157
Query: 324 DC-----SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL------LAGTY 372
           +       P+I HRD+ S NIL+       +AD G A  +  DS+  T+        GT 
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTK 215
Query: 373 GYIAPEL---AYTMVMTE---KCDVYSFGVVTLEV 401
            Y+APE+   +  M   E   + D+Y+ G+V  E+
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVL 260
           + E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAH 316
           H NIVKL      +  ++L++E++       +L    DA  L     + ++K+    +  
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLS-----MDLKKFMDASALT-GIPLPLIKSYLFQLLQ 117
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
            LA+ H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y A
Sbjct: 118 GLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVL 402
           PE L      +   D++S G +  E++
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKN-EAQVLSQVLHRNIVKL--Y 268
           IG G +G VY+A+L  +G++ A+KK+         K FKN E Q++ ++ H NIV+L  +
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCNIVRLRYF 160
Query: 269 GYCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
            Y   +K     + L+ +Y+         H +     L        +  +  +LAY+H  
Sbjct: 161 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 218
Query: 325 CSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
            S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y APEL +  
Sbjct: 219 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELIFGA 276
Query: 384 V-MTEKCDVYSFGVVTLEVLMGK 405
              T   DV+S G V  E+L+G+
Sbjct: 277 TDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 213 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN 263
           +G G +G V  A+        P   V  A+K L        +    +E +++  +  H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRVNI 310
           I+ L G C     +++I EY  +G+L   L              N     ++ +   V+ 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG 370
              +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +    G
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 371 T--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
                ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKN-EAQVLSQVLHRNIVKLYGYC 271
           IG G +G V++A+L      A+KK+         K FKN E Q++  V H N+V L  + 
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQD------KRFKNRELQIMRIVKHPNVVDLKAFF 101
Query: 272 L----HKKCMF--LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK----AMAHALAYL 321
                 K  +F  L+ EY+       + H      +L     + ++K     +  +LAY+
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPETVYRASRH----YAKLKQTMPMLLIKLYMYQLLRSLAYI 157
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELA 380
           H   S  I HRDI   N+LL+       + DFG+A++L A   N + +   Y Y APEL 
Sbjct: 158 H---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY-YRAPELI 213
Query: 381 YTMV-MTEKCDVYSFGVVTLEVLMGK 405
           +     T   D++S G V  E++ G+
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 213 IGTGGYGSVYKA--QLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYG 269
           +G G +GSV +   ++   ++  A+K L    E A  +    EAQ++ Q+ +  IV+L G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
            C   + + L+ E    G L   L    + + +  +    ++  ++  + YL      + 
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPV--SNVAELLHQVSMGMKYLEEK---NF 457
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL-AGTY--GYIAPELAYTMVMT 386
           +HR++++ N+LL ++  A ++DFG ++ L AD S  T   AG +   + APE       +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 387 EKCDVYSFGVVTLEVL-MGKHP 407
            + DV+S+GV   E L  G+ P
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKP 539

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 119/294 (40%), Gaps = 38/294 (12%)
Query: 213 IGTGGYGSVYKAQL------PNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQVLHR 262
           +G G +G VY+ Q+      P+    A+K L       +EL F+     EA ++S+  H+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 94
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 318
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA---DFGTARLLHADSSNRTLLAGT--YG 373
            YL  +     IHRDI++ N LL       VA   DFG A+ ++  S  R          
Sbjct: 155 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVK 211
Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRL 432
           ++ PE     + T K D +SFGV+  E+  +G  P           + +++       R+
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP------YPSKSNQEVLEFVTSGGRM 265
Query: 433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAI 486
            PP  +     +  I T    C Q  P+ RP    + +      + P V + A+
Sbjct: 266 DPP--KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 314

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 29/229 (12%)
Query: 194 RIVYEDLIEATEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNE 252
           RIVY      + DF ++  +G G YG V  A   P G++ A+KK+   ++  F      E
Sbjct: 4   RIVYN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE 59
Query: 253 AQVLSQVLHRNIVKLYGYCLHKKC-----MFLIYEYMERGSLFCNLHNNEDAVELDWAKR 307
            ++L    H NI+ ++             +++I E M+      +LH       L     
Sbjct: 60  IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-----TDLHRVISTQMLSDDHI 114
Query: 308 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH---ADSSN 364
              +     A+  LH     ++IHRD+  +N+L+NS  +  V DFG AR++    AD+S 
Sbjct: 115 QYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 365 RT-------LLAGTYGYIAPELAYTMVMTEKC-DVYSFGVVTLEVLMGK 405
            T           T  Y APE+  T     +  DV+S G +  E+ + +
Sbjct: 172 PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 205 EDFDIRYCIGTGGYGSVYKA-----QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV 259
           E  ++  CIG G +G V++      + P   V A+K        +  + F  EA  + Q 
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAV-AIKTCKNCTSDSVREKFLQEALTMRQF 68
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H +IVKL G  + +  +++I E    G L   L   +    LD A  +     ++ ALA
Sbjct: 69  DHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALA 125
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY--GYIAP 377
           YL    S   +HRDI++ N+L+++     + DFG +R +  DS+      G     ++AP
Sbjct: 126 YLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAP 181
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLM 403
           E       T   DV+ FGV   E+LM
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEILM 207

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 126/289 (43%), Gaps = 53/289 (18%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV----FALKKLH-TSEELAFIKSFKNEAQVLSQVL 260
           DF+   C+G GG+G V++A+    KV    +A+K++   + ELA  K  + E + L+++ 
Sbjct: 6   DFEPIQCLGRGGFGVVFEAK---NKVDDCNYAIKRIRLPNRELAREKVMR-EVKALAKLE 61
Query: 261 HRNIVKLYGYCLHKKCMFL-------IYEYMERGSLFCNLHNNEDAV-------ELDWAK 306
           H  IV+ +   L K            +Y Y++     C   N +D +       E + + 
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQ--LCRKENLKDWMNGRCTIEERERSV 119
Query: 307 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT 366
            ++I   +A A+ +LH   S  ++HRD+  +NI         V DFG    +  D   +T
Sbjct: 120 CLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 367 LLA------------GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXX 414
           +L             GT  Y++PE  +    + K D++S G++  E+L   +P       
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMER 233
Query: 415 XXXXDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRP 463
                    L DV + + PP   +K   + +++  +    L  +P  RP
Sbjct: 234 VRT------LTDVRNLKFPPLFTQKYPCEYVMVQDM----LSPSPMERP 272

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVL 260
           + E+F     IG G YG VYKA+    G+V ALKK+    E   + S    E  +L ++ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAH 316
           H NIVKL      +  ++L++E++       +L    DA  L     + ++K+    +  
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLS-----MDLKKFMDASALT-GIPLPLIKSYLFQLLQ 115
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
            LA+ H   S  ++HRD+   N+L+N++    +ADFG AR              T  Y A
Sbjct: 116 GLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 172
Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVL 402
           PE L      +   D++S G +  E++
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 29/229 (12%)
Query: 194 RIVYEDLIEATEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNE 252
           RIVY      + DF ++  +G G YG V  A   P G++ A+KK+   ++  F      E
Sbjct: 4   RIVYN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE 59
Query: 253 AQVLSQVLHRNIVKLYGYCLHKKC-----MFLIYEYMERGSLFCNLHNNEDAVELDWAKR 307
            ++L    H NI+ ++             +++I E M+      +LH       L     
Sbjct: 60  IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-----TDLHRVISTQMLSDDHI 114
Query: 308 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL 367
              +     A+  LH     ++IHRD+  +N+L+NS  +  V DFG AR++   +++ + 
Sbjct: 115 QYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 368 LAG----------TYGYIAPELAYTMVMTEKC-DVYSFGVVTLEVLMGK 405
             G          T  Y APE+  T     +  DV+S G +  E+ + +
Sbjct: 172 PTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 124/290 (42%), Gaps = 55/290 (18%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKK-LHTSEELAFIKSFK---NEAQVLSQVLHRNIVKL 267
           +G+G +G+V+K   +P G+   +   +   E+ +  +SF+   +    +  + H +IV+L
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G C     + L+ +Y+  GSL  ++  +  A+     L+W   V I K M     YL  
Sbjct: 81  LGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG--VQIAKGMY----YLEE 133
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT----YGYIAPEL 379
                ++HR++++ N+LL S  +  VADFG A LL  D  ++ LL         ++A E 
Sbjct: 134 H---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD--DKQLLYSEAKTPIKWMALES 188
Query: 380 AYTMVMTEKCDVYSFGVVTLEVL-MGKHPR---------DIXXXXXXXXDPKIMLIDVLD 429
            +    T + DV+S+GV   E++  G  P          D+         P+I  IDV  
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVY- 247
Query: 430 QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                               V   C   +   RPT + ++ EF    + P
Sbjct: 248 -------------------MVMVKCWMIDENIRPTFKELANEFTRMARDP 278

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 194 RIVYEDLIEATEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNE 252
           RIVY      + DF ++  +G G YG V  A   P G++ A+KK+   ++  F      E
Sbjct: 4   RIVYN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE 59
Query: 253 AQVLSQVLHRNIVKLYGYCLHKKC-----MFLIYEYMERGSLFCNLHNNEDAVELDWAKR 307
            ++L    H NI+ ++             +++I E M+      +LH       L     
Sbjct: 60  IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-----TDLHRVISTQMLSDDHI 114
Query: 308 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH-------- 359
              +     A+  LH     ++IHRD+  +N+L+NS  +  V DFG AR++         
Sbjct: 115 QYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 360 --ADSSNRTLLAGTYGYIAPELAYTMVMTEKC-DVYSFGVVTLEVLMGK 405
                S  T    T  Y APE+  T     +  DV+S G +  E+ + +
Sbjct: 172 PTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 125/288 (43%), Gaps = 48/288 (16%)
Query: 213 IGTGGYGSVYKAQLP-----NGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +GSV   +        G + A+K+L H+  +    + F+ E Q+L  +    IVK
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ--RDFQREIQILKALHSDFIVK 75
Query: 267 LYG--YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
             G  Y   ++ + L+ EY+  G L   L  +     LD ++ +     +   + YL   
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLG-- 131
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN---RTLLAGTYGYIAPELAY 381
            S   +HRD+++ NIL+ S+    +ADFG A+LL  D      R        + APE   
Sbjct: 132 -SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 190
Query: 382 TMVMTEKCDVYSFGVVTLEV----------------LMGKHPRDIXXXXXXXXDPKIMLI 425
             + + + DV+SFGVV  E+                +MG   RD+          +++ +
Sbjct: 191 DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSE-RDVPALS------RLLEL 243
Query: 426 DVLDQRLP-PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
               QRLP PP     + +++ +      C   +P+ RP+  ++  + 
Sbjct: 244 LEEGQRLPAPPACPAEVHELMKL------CWAPSPQDRPSFSALGPQL 285

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 128/288 (44%), Gaps = 50/288 (17%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL--HRNIV----- 265
           IG G +G V++ +   G+  A+K   + EE    +S+  EA++   V+  H NI+     
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAA 65
Query: 266 --KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
             K  G       ++L+ +Y E GSLF  L+     VE      + +  + A  LA+LH 
Sbjct: 66  DNKDNGTWTQ---LWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHM 118
Query: 324 DC-----SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL------LAGTY 372
           +       P+I HRD+ S NIL+       +AD G A  +  DS+  T+        GT 
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTK 176
Query: 373 GYIAPEL---AYTMVMTE---KCDVYSFGVVTLEV-----LMGKHPR-DIXXXXXXXXDP 420
            Y+APE+   +  M   E   + D+Y+ G+V  E+     + G H    +        DP
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 421 KI--MLIDVLDQRLPP--PVDRKVIRDILLISTVSFACLQSNPKSRPT 464
            +  M   V +Q+L P  P   +    + +++ +   C  +N  +R T
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 284

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 40/215 (18%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL--HRNIV----- 265
           IG G +G V++ +   G+  A+K   + EE    +S+  EA++   V+  H NI+     
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAA 91
Query: 266 --KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
             K  G       ++L+ +Y E GSLF  L+     VE      + +  + A  LA+LH 
Sbjct: 92  DNKDNGTWTQ---LWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHM 144
Query: 324 DC-----SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL------LAGTY 372
           +       P+I HRD+ S NIL+       +AD G A  +  DS+  T+        GT 
Sbjct: 145 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTK 202
Query: 373 GYIAPEL---AYTMVMTE---KCDVYSFGVVTLEV 401
            Y+APE+   +  M   E   + D+Y+ G+V  E+
Sbjct: 203 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPN-GKVFALK--KLHTSEELAFIKSFKNEA--QVLS 257
           AT  ++    IG G YG+VYKA+ P+ G   ALK  ++   EE   I + +  A  + L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 258 QVLHRNIVKLYGYCLHKKC-----MFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVN 309
              H N+V+L   C   +      + L++E++++     +L    D      L      +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-----DLRTYLDKAPPPGLPAETIKD 116
Query: 310 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA 369
           +++     L +LH +C   I+HRD+   NIL+ S     +ADFG AR+     +   ++ 
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV 173
Query: 370 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK 405
            T  Y APE+          D++S G +  E+   K
Sbjct: 174 -TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 128/288 (44%), Gaps = 50/288 (17%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL--HRNIV----- 265
           IG G +G V++ +   G+  A+K   + EE    +S+  EA++   V+  H NI+     
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAA 68
Query: 266 --KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
             K  G       ++L+ +Y E GSLF  L+     VE      + +  + A  LA+LH 
Sbjct: 69  DNKDNGTWTQ---LWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHM 121
Query: 324 DC-----SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL------LAGTY 372
           +       P+I HRD+ S NIL+       +AD G A  +  DS+  T+        GT 
Sbjct: 122 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTK 179
Query: 373 GYIAPEL---AYTMVMTE---KCDVYSFGVVTLEV-----LMGKHPR-DIXXXXXXXXDP 420
            Y+APE+   +  M   E   + D+Y+ G+V  E+     + G H    +        DP
Sbjct: 180 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 239
Query: 421 KI--MLIDVLDQRLPP--PVDRKVIRDILLISTVSFACLQSNPKSRPT 464
            +  M   V +Q+L P  P   +    + +++ +   C  +N  +R T
Sbjct: 240 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 287

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 203 ATEDFDIRY-------CIGTGGYGSVYKA-----QLPNGKVFALKKLHTSEELAFIKSFK 250
           +T D++I+        CIG G +G V++      + P   V A+K        +  + F 
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAV-AIKTCKNCTSDSVREKFL 439
Query: 251 NEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNI 310
            EA  + Q  H +IVKL G  + +  +++I E    G L   L   +    LD A  +  
Sbjct: 440 QEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILY 496
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG 370
              ++ ALAYL    S   +HRDI++ N+L+++     + DFG +R +  DS+      G
Sbjct: 497 AYQLSTALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKG 552
Query: 371 TY--GYIAPELAYTMVMTEKCDVYSFGVVTLEVLM 403
                ++APE       T   DV+ FGV   E+LM
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 17/214 (7%)
Query: 201 IEATEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV 259
           + ++  F     +G G Y +VYK      G   ALK++    E     +   E  ++ ++
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR---VNIVK---- 312
            H NIV+LY     +  + L++E+M+      +L    D+  +    R   +N+VK    
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDN-----DLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 313 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY 372
            +   LA+ H +    I+HRD+   N+L+N + +  + DFG AR      +  +    T 
Sbjct: 116 QLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL 172
Query: 373 GYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGK 405
            Y AP+ L  +   +   D++S G +  E++ GK
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 128/288 (44%), Gaps = 50/288 (17%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL--HRNIV----- 265
           IG G +G V++ +   G+  A+K   + EE    +S+  EA++   V+  H NI+     
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAA 71
Query: 266 --KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
             K  G       ++L+ +Y E GSLF  L+     VE      + +  + A  LA+LH 
Sbjct: 72  DNKDNGTWTQ---LWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHM 124
Query: 324 DC-----SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL------LAGTY 372
           +       P+I HRD+ S NIL+       +AD G A  +  DS+  T+        GT 
Sbjct: 125 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTK 182
Query: 373 GYIAPEL---AYTMVMTE---KCDVYSFGVVTLEV-----LMGKHPR-DIXXXXXXXXDP 420
            Y+APE+   +  M   E   + D+Y+ G+V  E+     + G H    +        DP
Sbjct: 183 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 242
Query: 421 KI--MLIDVLDQRLPP--PVDRKVIRDILLISTVSFACLQSNPKSRPT 464
            +  M   V +Q+L P  P   +    + +++ +   C  +N  +R T
Sbjct: 243 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 290

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 213 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN 263
           +G G +G V  A+        P   V  A+K L        +    +E +++  +  H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRVNI 310
           I+ L G C     +++I EY  +G+L   L              N     ++ +   V+ 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG 370
              +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +    G
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 371 T--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
                ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 248

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPN-GKVFALK--KLHTSEELAFIKSFKNEA--QVLS 257
           AT  ++    IG G YG+VYKA+ P+ G   ALK  ++   EE   I + +  A  + L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 258 QVLHRNIVKLYGYCLHKKC-----MFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVN 309
              H N+V+L   C   +      + L++E++++     +L    D      L      +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-----DLRTYLDKAPPPGLPAETIKD 116
Query: 310 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA 369
           +++     L +LH +C   I+HRD+   NIL+ S     +ADFG AR+     +   ++ 
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVV 173
Query: 370 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK 405
            T  Y APE+          D++S G +  E+   K
Sbjct: 174 -TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 213 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN 263
           +G G +G V  A+        P   V  A+K L        +    +E +++  +  H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRVNI 310
           I+ L G C     +++I EY  +G+L   L              N     ++ +   V+ 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG 370
              +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +    G
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 371 T--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
                ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 246

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 128/288 (44%), Gaps = 50/288 (17%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL--HRNIV----- 265
           IG G +G V++ +   G+  A+K   + EE    +S+  EA++   V+  H NI+     
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAA 66
Query: 266 --KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
             K  G       ++L+ +Y E GSLF  L+     VE      + +  + A  LA+LH 
Sbjct: 67  DNKDNGTWTQ---LWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHM 119
Query: 324 DC-----SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL------LAGTY 372
           +       P+I HRD+ S NIL+       +AD G A  +  DS+  T+        GT 
Sbjct: 120 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTK 177
Query: 373 GYIAPEL---AYTMVMTE---KCDVYSFGVVTLEV-----LMGKHPR-DIXXXXXXXXDP 420
            Y+APE+   +  M   E   + D+Y+ G+V  E+     + G H    +        DP
Sbjct: 178 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 237
Query: 421 KI--MLIDVLDQRLPP--PVDRKVIRDILLISTVSFACLQSNPKSRPT 464
            +  M   V +Q+L P  P   +    + +++ +   C  +N  +R T
Sbjct: 238 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 285

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 213 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN 263
           +G G +G V  A+        P   V  A+K L        +    +E +++  +  H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRVNI 310
           I+ L G C     +++I EY  +G+L   L              N     ++ +   V+ 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG 370
              +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +    G
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 371 T--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
                ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 251

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 14/211 (6%)
Query: 207 FDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIV 265
           ++++  +GTGG+G V +      G+  A+K+          + +  E Q++ ++ H N+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 266 KLYGY--CLHK----KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
                   L K        L  EY E G L   L+  E+   L       ++  ++ AL 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 320 YLHHDCSPSIIHRDISSNNILLN---SKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           YLH +    IIHRD+   NI+L     +L   + D G A+ L       T   GT  Y+A
Sbjct: 136 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC-TEFVGTLQYLA 191
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PEL      T   D +SFG +  E + G  P
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 8/202 (3%)
Query: 210 RYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           R  +G G YG VY  + L N    A+K++    +  + +    E  +   + H+NIV+  
Sbjct: 13  RVVLGKGTYGIVYAGRDLSNQVRIAIKEI-PERDSRYSQPLHEEIALHKHLKHKNIVQYL 71
Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
           G       + +  E +  GSL   L +    ++ +        K +   L YLH +    
Sbjct: 72  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---Q 128
Query: 329 IIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPEL--AYTMVM 385
           I+HRDI  +N+L+N+      ++DFGT++ L   +       GT  Y+APE+        
Sbjct: 129 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 188
Query: 386 TEKCDVYSFGVVTLEVLMGKHP 407
            +  D++S G   +E+  GK P
Sbjct: 189 GKAADIWSLGCTIIEMATGKPP 210

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 14/211 (6%)
Query: 207 FDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIV 265
           ++++  +GTGG+G V +      G+  A+K+          + +  E Q++ ++ H N+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 266 KLYGY--CLHK----KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
                   L K        L  EY E G L   L+  E+   L       ++  ++ AL 
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 136
Query: 320 YLHHDCSPSIIHRDISSNNILLN---SKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           YLH +    IIHRD+   NI+L     +L   + D G A+ L       T   GT  Y+A
Sbjct: 137 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC-TEFVGTLQYLA 192
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PEL      T   D +SFG +  E + G  P
Sbjct: 193 PELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 11/205 (5%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIK-SFKNEAQVLSQVLHRNIV 265
           +D R  +GTG +  V  A+    +     K    E L   + S +NE  VL ++ H NIV
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
            L         ++LI + +  G LF  +       E D ++   ++  +  A+ YLH   
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLH--- 133
Query: 326 SPSIIHRDISSNNIL---LNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              I+HRD+   N+L   L+   +  ++DFG +++    S   T   GT GY+APE+   
Sbjct: 134 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CGTPGYVAPEVLAQ 192
Query: 383 MVMTEKCDVYSFGVVTLEVLMGKHP 407
              ++  D +S GV+   +L G  P
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPN-GKVFALK--KLHTSEELAFIKSFKNEA--QVLS 257
           AT  ++    IG G YG+VYKA+ P+ G   ALK  ++   EE   I + +  A  + L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 258 QVLHRNIVKLYGYCLHKKC-----MFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVN 309
              H N+V+L   C   +      + L++E++++     +L    D      L      +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-----DLRTYLDKAPPPGLPAETIKD 116
Query: 310 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA 369
           +++     L +LH +C   I+HRD+   NIL+ S     +ADFG AR+     +   ++ 
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV 173
Query: 370 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK 405
            T  Y APE+          D++S G +  E+   K
Sbjct: 174 -TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 32/225 (14%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKV---FALKKLHTSEELAFIKSFKNEAQVLSQVLHR 262
           D   +  IG G +G V KA++    +    A+K++         + F  E +VL ++ H 
Sbjct: 23  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 82
Query: 263 -NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN-------------NEDAVELDWAKRV 308
            NI+ L G C H+  ++L  EY   G+L   L               N  A  L   + +
Sbjct: 83  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 142
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
           +    +A  + YL        IHR++++ NIL+     A +ADFG +R           +
Sbjct: 143 HFAADVARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGLSR------GQEVYV 193
Query: 369 AGTYG-----YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
             T G     ++A E     V T   DV+S+GV+  E++ +G  P
Sbjct: 194 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 238

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 213 IGTGGYGSVYKAQLP-----NGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +GSV   +        G + A+K+L H+  +    + F+ E Q+L  +    IVK
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ--RDFQREIQILKALHSDFIVK 76
Query: 267 LYG--YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
             G  Y   ++ + L+ EY+  G L   L  +     LD ++ +     +   + YL   
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLG-- 132
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN---RTLLAGTYGYIAPELAY 381
            S   +HRD+++ NIL+ S+    +ADFG A+LL  D      R        + APE   
Sbjct: 133 -SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 191
Query: 382 TMVMTEKCDVYSFGVVTLEVL 402
             + + + DV+SFGVV  E+ 
Sbjct: 192 DNIFSRQSDVWSFGVVLYELF 212

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 213 IGTGGYGSVYKAQLP-----NGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +GSV   +        G + A+K+L H+  +    + F+ E Q+L  +    IVK
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ--RDFQREIQILKALHSDFIVK 72
Query: 267 LYG--YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
             G  Y   +  + L+ EY+  G L   L  +     LD ++ +     +   + YL   
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLG-- 128
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN---RTLLAGTYGYIAPELAY 381
            S   +HRD+++ NIL+ S+    +ADFG A+LL  D      R        + APE   
Sbjct: 129 -SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLS 187
Query: 382 TMVMTEKCDVYSFGVVTLEVL 402
             + + + DV+SFGVV  E+ 
Sbjct: 188 DNIFSRQSDVWSFGVVLYELF 208

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 207 FDIRYCIGTGGYGSVYKAQ------LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           +D R  +GTG +  V  A+      L   K  A K L   E      S +NE  VL ++ 
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-----GSMENEIAVLHKIK 74
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H NIV L         ++LI + +  G LF  +       E D ++   ++  +  A+ Y
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKY 131
Query: 321 LHHDCSPSIIHRDISSNNIL---LNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           LH      I+HRD+   N+L   L+   +  ++DFG +++    S   T   GT GY+AP
Sbjct: 132 LH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CGTPGYVAP 187
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           E+      ++  D +S GV+   +L G  P
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 213 IGTGGYGSVYKAQLP-----NGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +GSV   +        G + A+K+L H+  +    + F+ E Q+L  +    IVK
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ--RDFQREIQILKALHSDFIVK 88
Query: 267 LYG--YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
             G  Y   ++ + L+ EY+  G L   L  +     LD ++ +     +   + YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLG-- 144
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN---RTLLAGTYGYIAPELAY 381
            S   +HRD+++ NIL+ S+    +ADFG A+LL  D      R        + APE   
Sbjct: 145 -SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203
Query: 382 TMVMTEKCDVYSFGVVTLEVL 402
             + + + DV+SFGVV  E+ 
Sbjct: 204 DNIFSRQSDVWSFGVVLYELF 224

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 111/269 (41%), Gaps = 30/269 (11%)
Query: 213 IGTGGYGSVYKAQLPN---GKV---FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G VY+    +   G+     A+K ++ S  L     F NEA V+      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNL-------HNNEDAVELDWAKRVNIVKAMAHALA 319
           L G     +   ++ E M  G L   L        NN         + + +   +A  +A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG--TYGYIAP 377
           YL+   +   +HRD+++ N ++       + DFG  R ++  +  R    G     ++AP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPV 436
           E     V T   D++SFGVV  E+  + + P              +M    LDQ   P  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK--FVMDGGYLDQ---PDN 256
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTM 465
             + + D++ +      C Q NPK RPT 
Sbjct: 257 CPERVTDLMRM------CWQFNPKMRPTF 279

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 11/205 (5%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIK-SFKNEAQVLSQVLHRNIV 265
           +D R  +GTG +  V  A+    +     K    E L   + S +NE  VL ++ H NIV
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
            L         ++LI + +  G LF  +       E D ++   ++  +  A+ YLH   
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLH--- 133
Query: 326 SPSIIHRDISSNNIL---LNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              I+HRD+   N+L   L+   +  ++DFG +++    S   T   GT GY+APE+   
Sbjct: 134 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CGTPGYVAPEVLAQ 192
Query: 383 MVMTEKCDVYSFGVVTLEVLMGKHP 407
              ++  D +S GV+   +L G  P
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 125/289 (43%), Gaps = 28/289 (9%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFI--KSFKNEAQVLSQVLHRNIVKLYG 269
           +G GG+G V+  Q+   GK++A KKL+          +    E ++L++V  R IV L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-A 251
Query: 270 YCLHKKC-MFLIYEYMERGSLFCNLHN-NEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
           Y    K  + L+   M  G +  +++N +ED       + +     +   L +LH     
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR--- 308
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTE 387
           +II+RD+   N+LL+      ++D G A  L A  +     AGT G++APEL        
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368
Query: 388 KCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRKVIRDILLI 447
             D ++ GV   E++  + P           + K +   VL+Q +  P       D    
Sbjct: 369 SVDYFALGVTLYEMIAARGP---FRARGEKVENKELKQRVLEQAVTYP-------DKFSP 418
Query: 448 STVSF--ACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDISISEL 494
           ++  F  A LQ +P+ R   +  S + L T       H   +DIS  +L
Sbjct: 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRT-------HPLFRDISWRQL 460

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 122/278 (43%), Gaps = 36/278 (12%)
Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQV-LSQVLHRNIVKLYGY 270
           +G G YG V K + +P+G++ A+K++  +      K    +  + +  V     V  YG 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 271 CLHKKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKR--VNIVKAMAHALAYLHHDCS 326
              +  +++  E M+      +  + +    +  D   +  V+IVKA+ H  + L     
Sbjct: 75  LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL----- 129
Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL------- 379
            S+IHRD+  +N+L+N+  +  + DFG +  L  D   + + AG   Y+APE        
Sbjct: 130 -SVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 380 -AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPP-PVD 437
             Y++    K D++S G+  +E+ + + P D          P   L  V+++  P  P D
Sbjct: 188 KGYSV----KSDIWSLGITMIELAILRFPYD------SWGTPFQQLKQVVEEPSPQLPAD 237
Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
           +     +   S     CL+ N K RPT   + Q    T
Sbjct: 238 KFSAEFVDFTSQ----CLKKNSKERPTYPELMQHPFFT 271

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 11/205 (5%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIK-SFKNEAQVLSQVLHRNIV 265
           +D R  +GTG +  V  A+    +     K    E L   + S +NE  VL ++ H NIV
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
            L         ++LI + +  G LF  +       E D ++   ++  +  A+ YLH   
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLH--- 133
Query: 326 SPSIIHRDISSNNIL---LNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              I+HRD+   N+L   L+   +  ++DFG +++    S   T   GT GY+APE+   
Sbjct: 134 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CGTPGYVAPEVLAQ 192
Query: 383 MVMTEKCDVYSFGVVTLEVLMGKHP 407
              ++  D +S GV+   +L G  P
Sbjct: 193 KPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 130/299 (43%), Gaps = 31/299 (10%)
Query: 205 EDF--DIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFI--KSFKNEAQVLSQV 259
           ED+  D R  +G GG+G V+  Q+   GK++A KKL+          +    E ++L++V
Sbjct: 184 EDWFLDFR-VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV 242
Query: 260 LHRNIVKLYGYCLHKKC-MFLIYEYMERGSLFCNLHN-NEDAVELDWAKRVNIVKAMAHA 317
             R IV L  Y    K  + L+   M  G +  +++N +ED       + +     +   
Sbjct: 243 HSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           L +LH     +II+RD+   N+LL+      ++D G A  L A  +     AGT G++AP
Sbjct: 302 LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAP 358
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVD 437
           EL          D ++ GV   E++  + P           + K +   VL+Q +  P  
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAARGP---FRARGEKVENKELKQRVLEQAVTYP-- 413
Query: 438 RKVIRDILLISTVSF--ACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDISISEL 494
                D    ++  F  A LQ +P+ R   +  S + L T       H   +DIS  +L
Sbjct: 414 -----DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT-------HPLFRDISWRQL 460

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 130/299 (43%), Gaps = 31/299 (10%)
Query: 205 EDF--DIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFI--KSFKNEAQVLSQV 259
           ED+  D R  +G GG+G V+  Q+   GK++A KKL+          +    E ++L++V
Sbjct: 184 EDWFLDFR-VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV 242
Query: 260 LHRNIVKLYGYCLHKKC-MFLIYEYMERGSLFCNLHN-NEDAVELDWAKRVNIVKAMAHA 317
             R IV L  Y    K  + L+   M  G +  +++N +ED       + +     +   
Sbjct: 243 HSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           L +LH     +II+RD+   N+LL+      ++D G A  L A  +     AGT G++AP
Sbjct: 302 LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAP 358
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVD 437
           EL          D ++ GV   E++  + P           + K +   VL+Q +  P  
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAARGP---FRARGEKVENKELKQRVLEQAVTYP-- 413
Query: 438 RKVIRDILLISTVSF--ACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDISISEL 494
                D    ++  F  A LQ +P+ R   +  S + L T       H   +DIS  +L
Sbjct: 414 -----DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT-------HPLFRDISWRQL 460

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 97/200 (48%), Gaps = 11/200 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAF-IKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G G +  V +  ++  G+ +A K ++T +  A   +  + EA++   + H NIV+L+  
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
              +   +LI++ +  G LF      ED V  ++    +    +   L  + H     ++
Sbjct: 90  ISEEGHHYLIFDLVTGGELF------EDIVAREYYSEADASHCIQQILEAVLHCHQMGVV 143
Query: 331 HRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTE 387
           HRD+   N+LL SKL+     +ADFG A  +  +       AGT GY++PE+       +
Sbjct: 144 HRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGK 203
Query: 388 KCDVYSFGVVTLEVLMGKHP 407
             D+++ GV+   +L+G  P
Sbjct: 204 PVDLWACGVILYILLVGYPP 223

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 9/150 (6%)
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H NIVKL+     +   FL+ E +  G LF  +   +   E + +    I++ +  A+++
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS---YIMRKLVSAVSH 121
Query: 321 LHHDCSPSIIHRDISSNNILL---NSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           +H      ++HRD+   N+L    N  LE  + DFG ARL   D+        T  Y AP
Sbjct: 122 MH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           EL       E CD++S GV+   +L G+ P
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 130/299 (43%), Gaps = 31/299 (10%)
Query: 205 EDF--DIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFI--KSFKNEAQVLSQV 259
           ED+  D R  +G GG+G V+  Q+   GK++A KKL+          +    E ++L++V
Sbjct: 184 EDWFLDFR-VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV 242
Query: 260 LHRNIVKLYGYCLHKKC-MFLIYEYMERGSLFCNLHN-NEDAVELDWAKRVNIVKAMAHA 317
             R IV L  Y    K  + L+   M  G +  +++N +ED       + +     +   
Sbjct: 243 HSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           L +LH     +II+RD+   N+LL+      ++D G A  L A  +     AGT G++AP
Sbjct: 302 LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAP 358
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVD 437
           EL          D ++ GV   E++  + P           + K +   VL+Q +  P  
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAARGP---FRARGEKVENKELKQRVLEQAVTYP-- 413
Query: 438 RKVIRDILLISTVSF--ACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDISISEL 494
                D    ++  F  A LQ +P+ R   +  S + L T       H   +DIS  +L
Sbjct: 414 -----DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT-------HPLFRDISWRQL 460

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 28/220 (12%)
Query: 213 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN 263
           +G G +G V  A+        P   V  A+K L        +    +E +++  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRVNI 310
           I+ L G C     +++I  Y  +G+L   L              N     ++ +   V+ 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG 370
              +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +    G
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 371 T--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
                ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 40/215 (18%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL--HRNIVKLYGY 270
           IG G YG V+  +    KV A+K   T+EE ++ +    E ++   VL  H NI+     
Sbjct: 45  IGKGRYGEVWMGKWRGEKV-AVKVFFTTEEASWFR----ETEIYQTVLMRHENILGFIAA 99
Query: 271 CLHKKC----MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC- 325
            +        ++LI +Y E GSL+  L     +  LD    + +  +    L +LH +  
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 326 ----SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL----LAGTYGYIAP 377
                P+I HRD+ S NIL+       +AD G A    +D++   +      GT  Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 378 EL-----------AYTMVMTEKCDVYSFGVVTLEV 401
           E+           +Y M      D+YSFG++  EV
Sbjct: 216 EVLDESLNRNHFQSYIMA-----DMYSFGLILWEV 245

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 202 EATED-FDIRYCIGTGGYGSVYK-AQLPNGKVFALK-----KLHTSEELAFIKSFKNEAQ 254
           E  ED +++   +G+G +  V K  Q   GK +A K     +L +S      +  + E  
Sbjct: 8   EDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 67
Query: 255 VLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM 314
           +L ++ H NI+ L+    +K  + LI E +  G LF  L   E   E    +    +K +
Sbjct: 68  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE---DEATQFLKQI 124
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILL------NSKLEAFVADFGTARLLHADSSNRTLL 368
              + YLH   S  I H D+   NI+L      N +++  + DFG A  + A +  + + 
Sbjct: 125 LDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIK--LIDFGIAHKIEAGNEFKNIF 179
Query: 369 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            GT  ++APE+     +  + D++S GV+T  +L G  P
Sbjct: 180 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 109/268 (40%), Gaps = 30/268 (11%)
Query: 213 IGTGGYGSVYKAQLPN---GKV---FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G VY+    +   G+     A+K ++ S  L     F NEA V+      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNL-------HNNEDAVELDWAKRVNIVKAMAHALA 319
           L G     +   ++ E M  G L   L        NN         + + +   +A  +A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG--TYGYIAP 377
           YL+   +   +HRD+++ N ++       + DFG  R +      R    G     ++AP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPV 436
           E     V T   D++SFGVV  E+  + + P              +M    LDQ   P  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK--FVMDGGYLDQ---PDN 256
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPT 464
             + + D++ +      C Q NPK RPT
Sbjct: 257 CPERVTDLMRM------CWQFNPKMRPT 278

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 213 IGTGGYGSVYKAQL------PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G   +G VYK  L         +  A+K L    E    + F++EA + +++ H N+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNL-----HNNEDAVELDWAKR--------VNIVKA 313
           L G     + + +I+ Y   G L   L     H++  + + D   +        V++V  
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 314 MAHALAYL--HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT 371
           +A  + YL  HH     ++H+D+++ N+L+  KL   ++D G  R ++A +    LL  +
Sbjct: 154 IAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYA-ADYYKLLGNS 207
Query: 372 Y---GYIAPELAYTMVMTEKCDVYSFGVVTLEVL 402
                ++APE       +   D++S+GVV  EV 
Sbjct: 208 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 241

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 41/221 (18%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL--HRNIVKL--- 267
           IG G YG+VYK  L    V A+K    +    FI    NE  +    L  H NI +    
Sbjct: 21  IGRGRYGAVYKGSLDERPV-AVKVFSFANRQNFI----NEKNIYRVPLMEHDNIARFIVG 75
Query: 268 --YGYCLHKKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
                   +    L+ EY   GSL  + +LH +      DW     +  ++   LAYLH 
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS------DWVSSCRLAHSVTRGLAYLHT 129
Query: 324 DC------SPSIIHRDISSNNILLNSKLEAFVADFGTA------RLLHADSSNRTLLA-- 369
           +        P+I HRD++S N+L+ +     ++DFG +      RL+     +   ++  
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 370 GTYGYIAPELAYTMV-------MTEKCDVYSFGVVTLEVLM 403
           GT  Y+APE+    V         ++ D+Y+ G++  E+ M
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 109/268 (40%), Gaps = 30/268 (11%)
Query: 213 IGTGGYGSVYKAQLPN---GKV---FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G VY+    +   G+     A+K ++ S  L     F NEA V+      ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNL-------HNNEDAVELDWAKRVNIVKAMAHALA 319
           L G     +   ++ E M  G L   L        NN         + + +   +A  +A
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG--TYGYIAP 377
           YL+   +   +HRD+++ N ++       + DFG  R +      R    G     ++AP
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPV 436
           E     V T   D++SFGVV  E+  + + P              +M    LDQ   P  
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK--FVMDGGYLDQ---PDN 253
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPT 464
             + + D++ +      C Q NPK RPT
Sbjct: 254 CPERVTDLMRM------CWQFNPKMRPT 275

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAF--IKSFKNEAQVLSQV 259
             ++F+    +G G +G V  A++   G ++A+K L     L    ++    E ++LS  
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS-- 78
Query: 260 LHRN---IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 316
           L RN   + +L+        +F + E++  G L  ++  +      D A+       +  
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIIS 135
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           AL +LH      II+RD+  +N+LL+ +    +ADFG  +    +        GT  YIA
Sbjct: 136 ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIA 192
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PE+   M+     D ++ GV+  E+L G  P
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 213 IGTGGYGSVYKAQL------PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G   +G VYK  L         +  A+K L    E    + F++EA + +++ H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNL-----HNNEDAVELDWAKR--------VNIVKA 313
           L G     + + +I+ Y   G L   L     H++  + + D   +        V++V  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 314 MAHALAYL--HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT 371
           +A  + YL  HH     ++H+D+++ N+L+  KL   ++D G  R ++A +    LL  +
Sbjct: 137 IAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYA-ADYYKLLGNS 190
Query: 372 Y---GYIAPELAYTMVMTEKCDVYSFGVVTLEVL 402
                ++APE       +   D++S+GVV  EV 
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 110/269 (40%), Gaps = 30/269 (11%)
Query: 213 IGTGGYGSVYKAQLPN---GKV---FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G VY+    +   G+     A+K ++ S  L     F NEA V+      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNL-------HNNEDAVELDWAKRVNIVKAMAHALA 319
           L G     +   ++ E M  G L   L        NN         + + +   +A  +A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG--TYGYIAP 377
           YL+   +   +HRD+++ N ++       + DFG  R ++     R    G     ++AP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPV 436
           E     V T   D++SFGVV  E+  + + P              +M    LDQ   P  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK--FVMDGGYLDQ---PDN 256
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTM 465
             + + D++ +      C Q NPK RPT 
Sbjct: 257 CPERVTDLMRM------CWQFNPKMRPTF 279

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 17/219 (7%)
Query: 198 EDLIEATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVF-ALKKL--HTSEELAFIKSFKNEA 253
           + L  A + ++    IG G YG V+KA+ L NG  F ALK++   T EE   + + +  A
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 254 --QVLSQVLHRNIVKLYGYCLHKKC-----MFLIYEYMERGSLFCNLHNNEDAVELDWAK 306
             + L    H N+V+L+  C   +      + L++E++++          E  V  +  K
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 123
Query: 307 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT 366
             +++  +   L +LH   S  ++HRD+   NIL+ S  +  +ADFG AR +++     T
Sbjct: 124 --DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALT 177
Query: 367 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK 405
            +  T  Y APE+          D++S G +  E+   K
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 28/220 (12%)
Query: 213 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN 263
           +G G +G V  A+        P   V  A+K L        +    +E +++  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRVNI 310
           I+ L G C     +++I  Y  +G+L   L              N     ++ +   V+ 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG 370
              +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +    G
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 371 T--YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
                ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 213 IGTGGYGSVYK-AQLPNGKVFALK-----KLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G+G +  V K  Q   GK +A K     +L +S      +  + E  +L ++ H NI+ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
           L+    +K  + LI E +  G LF  L   E   E D A     +K +   + YLH   S
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTE-DEA--TQFLKQILDGVHYLH---S 126
Query: 327 PSIIHRDISSNNILL------NSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELA 380
             I H D+   NI+L      N +++  + DFG A  + A +  + +  GT  ++APE+ 
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIK--LIDFGIAHKIEAGNEFKNIF-GTPEFVAPEIV 183
Query: 381 YTMVMTEKCDVYSFGVVTLEVLMGKHP 407
               +  + D++S GV+T  +L G  P
Sbjct: 184 NYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 110/268 (41%), Gaps = 30/268 (11%)
Query: 213 IGTGGYGSVYKAQLPN---GKV---FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G VY+    +   G+     A+K ++ S  L     F NEA V+      ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNL-------HNNEDAVELDWAKRVNIVKAMAHALA 319
           L G     +   ++ E M  G L   L        NN         + + +   +A  +A
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG--TYGYIAP 377
           YL+   +   +HRD+++ N ++       + DFG  R ++     R    G     ++AP
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPV 436
           E     V T   D++SFGVV  E+  + + P              +M    LDQ   P  
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK--FVMDGGYLDQ---PDN 255
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPT 464
             + + D++ +      C Q NPK RPT
Sbjct: 256 CPERVTDLMRM------CWQFNPKMRPT 277

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 17/219 (7%)
Query: 198 EDLIEATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVF-ALKKL--HTSEELAFIKSFKNEA 253
           + L  A + ++    IG G YG V+KA+ L NG  F ALK++   T EE   + + +  A
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 254 --QVLSQVLHRNIVKLYGYCLHKKC-----MFLIYEYMERGSLFCNLHNNEDAVELDWAK 306
             + L    H N+V+L+  C   +      + L++E++++          E  V  +  K
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 123
Query: 307 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT 366
             +++  +   L +LH   S  ++HRD+   NIL+ S  +  +ADFG AR +++     T
Sbjct: 124 --DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALT 177
Query: 367 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK 405
            +  T  Y APE+          D++S G +  E+   K
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 107/225 (47%), Gaps = 23/225 (10%)
Query: 195 IVYEDLIEATEDFDIRYCIGTGGYGSVYK-AQLPNGKVFALK-----KLHTSEELAFIKS 248
           + ++ ++E  + +++   +G+G +  V K  Q   GK +A K     +L +S      + 
Sbjct: 18  LYFQSMVE--DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREE 75
Query: 249 FKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV 308
            + E  +L ++ H NI+ L+    +K  + LI E +  G LF  L   E   E D A   
Sbjct: 76  IEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE-DEA--T 132
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILL------NSKLEAFVADFGTARLLHADS 362
             +K +   + YLH   S  I H D+   NI+L      N +++  + DFG A  + A +
Sbjct: 133 QFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIK--LIDFGIAHKIEAGN 187
Query: 363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
             + +  GT  ++APE+     +  + D++S GV+T  +L G  P
Sbjct: 188 EFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 17/219 (7%)
Query: 198 EDLIEATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVF-ALKKL--HTSEELAFIKSFKNEA 253
           + L  A + ++    IG G YG V+KA+ L NG  F ALK++   T EE   + + +  A
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 254 --QVLSQVLHRNIVKLYGYCLHKKC-----MFLIYEYMERGSLFCNLHNNEDAVELDWAK 306
             + L    H N+V+L+  C   +      + L++E++++          E  V  +  K
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 123
Query: 307 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT 366
             +++  +   L +LH   S  ++HRD+   NIL+ S  +  +ADFG AR +++     T
Sbjct: 124 --DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALT 177
Query: 367 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK 405
            +  T  Y APE+          D++S G +  E+   K
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 39/226 (17%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLH--------------TSEELAFIK 247
           AT  ++    IG G YG+VYKA+ P+ G   ALK +               T  E+A ++
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 248 SFKNEAQVLSQVLHRNIVKLYGYCLHKKC-----MFLIYEYMERGSLFCNLHNNEDAVE- 301
                   L    H N+V+L   C   +      + L++E++++     +L    D    
Sbjct: 67  R-------LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-----DLRTYLDKAPP 114
Query: 302 --LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH 359
             L      ++++     L +LH +C   I+HRD+   NIL+ S     +ADFG AR ++
Sbjct: 115 PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR-IY 170
Query: 360 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK 405
           +     T +  T  Y APE+          D++S G +  E+   K
Sbjct: 171 SYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 11/209 (5%)
Query: 204 TEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAF-IKSFKNEAQVLSQVLH 261
           TE++ +   +G G +  V +  ++  G+ +A   ++T +  A   +  + EA++   + H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            NIV+L+     +   +LI++ +  G LF      ED V  ++    +    +   L  +
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELF------EDIVAREYYSEADASHCIQQILEAV 123
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAGTYGYIAPE 378
            H     ++HR++   N+LL SKL+     +ADFG A  +  +       AGT GY++PE
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE 183
Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +       +  D+++ GV+   +L+G  P
Sbjct: 184 VLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 108/239 (45%), Gaps = 45/239 (18%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEA----------- 253
           E+ +    +G+G +G V      N   + + K   S ++A +K  K +A           
Sbjct: 45  ENLEFGKVLGSGAFGKV-----MNATAYGISKTGVSIQVA-VKMLKEKADSSEREALMSE 98
Query: 254 -QVLSQV-LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN-----NEDAVELDWAK 306
            ++++Q+  H NIV L G C     ++LI+EY   G L   L +     +ED +E +  K
Sbjct: 99  LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158
Query: 307 RVN---------------IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVAD 351
           R+                    +A  + +L      S +HRD+++ N+L+       + D
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICD 215
Query: 352 FGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
           FG AR + +DS+   R        ++APE  +  + T K DV+S+G++  E+  +G +P
Sbjct: 216 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 86/196 (43%), Gaps = 9/196 (4%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A    +G+  A+KKL    +   F K    E  +L  + H N++ L   
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
                 +   Y++                +E    K   +V  M   L Y+H   S  ++
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIH---SAGVV 166
Query: 331 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKC 389
           HRD+   N+ +N   E  + DFG AR  HAD +  T    T  Y APE+  + M   +  
Sbjct: 167 HRDLKPGNLAVNEDCELKILDFGLAR--HAD-AEMTGYVVTRWYRAPEVILSWMHYNQTV 223
Query: 390 DVYSFGVVTLEVLMGK 405
           D++S G +  E+L GK
Sbjct: 224 DIWSVGCIMAEMLTGK 239

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 37/221 (16%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAF--IKSFKNEAQVLSQVL-HRNIVKLY 268
           +G G YG V+K+     G+V A+KK+  + + +    ++F+ E  +L+++  H NIV L 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLL 75
Query: 269 GYCL--HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
                 + + ++L+++YME      +LH    A  L+   +  +V  +   + YLH   S
Sbjct: 76  NVLRADNDRDVYLVFDYME-----TDLHAVIRANILEPVHKQYVVYQLIKVIKYLH---S 127
Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARL---------------------LHADSSNR 365
             ++HRD+  +NILLN++    VADFG +R                         D    
Sbjct: 128 GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 366 TLLAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGK 405
           T    T  Y APE L  +   T+  D++S G +  E+L GK
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 213 IGTGGYGSVYKAQLPN-GKVFALKKL---HTSEELAFI-KSFKNEAQVLSQVLHRNIVKL 267
           +G G + +VYKA+  N  ++ A+KK+   H SE    I ++   E ++L ++ H NI+ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
                HK  + L++++ME   L   + +N   +     K   ++      L YLH     
Sbjct: 78  LDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM--TLQGLEYLHQHW-- 132
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTE 387
            I+HRD+  NN+LL+      +ADFG A+   + +        T  Y APEL +   M  
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYG 191
Query: 388 -KCDVYSFGVVTLEVLM 403
              D+++ G +  E+L+
Sbjct: 192 VGVDMWAVGCILAELLL 208

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 18/204 (8%)
Query: 213 IGTGGYGSVYKAQLPN---GKV---FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G VY+    +   G+     A+K ++ S  L     F NEA V+      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNL-------HNNEDAVELDWAKRVNIVKAMAHALA 319
           L G     +   ++ E M  G L   L        NN         + + +   +A  +A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG--TYGYIAP 377
           YL+   +   +HRD+++ N ++       + DFG  R +      R    G     ++AP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEV 401
           E     V T   D++SFGVV  E+
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 125/291 (42%), Gaps = 35/291 (12%)
Query: 203 ATEDFDIR-------YCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQ 254
           A E+F+++         +G G YG V K + +P+G++ A+K++  +      K    +  
Sbjct: 25  AXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLD 84
Query: 255 VLSQVLHRNI-VKLYGYCLHKKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKR--VN 309
           +  + +     V  YG    +  +++  E  +      +  + +    +  D   +  V+
Sbjct: 85  ISXRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVS 144
Query: 310 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA 369
           IVKA+ H  + L      S+IHRD+  +N+L+N+  +    DFG +  L  D   + + A
Sbjct: 145 IVKALEHLHSKL------SVIHRDVKPSNVLINALGQVKXCDFGISGYL-VDDVAKDIDA 197
Query: 370 GTYGYIAPELAYTMVMTE----KCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLI 425
           G   Y APE     +  +    K D++S G+  +E+ + + P D          P   L 
Sbjct: 198 GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYD------SWGTPFQQLK 251
Query: 426 DVLDQRLPP-PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT 475
            V+++  P  P D+     +   S     CL+ N K RPT   + Q    T
Sbjct: 252 QVVEEPSPQLPADKFSAEFVDFTSQ----CLKKNSKERPTYPELXQHPFFT 298

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 15/162 (9%)
Query: 252 EAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIV 311
           EA V+ Q+ +  IV++ G C  +  M L+ E  E G L   L  N    + +    + +V
Sbjct: 420 EANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELV 475
Query: 312 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT 371
             ++  + YL      + +HRD+++ N+LL ++  A ++DFG ++ L AD +     A T
Sbjct: 476 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQT 530
Query: 372 YG-----YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
           +G     + APE       + K DV+SFGV+  E    G+ P
Sbjct: 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 15/162 (9%)
Query: 252 EAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIV 311
           EA V+ Q+ +  IV++ G C  +  M L+ E  E G L   L  N    + +    + +V
Sbjct: 421 EANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELV 476
Query: 312 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT 371
             ++  + YL      + +HRD+++ N+LL ++  A ++DFG ++ L AD +     A T
Sbjct: 477 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQT 531
Query: 372 YG-----YIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
           +G     + APE       + K DV+SFGV+  E    G+ P
Sbjct: 532 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 213 IGTGGYGSVYKA--QLPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
           G C  +  M L+ E  E G L   L  N    + +    + +V  ++  + YL      +
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 147
Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG-----YIAPELAYTM 383
            +HRD+++ N+LL ++  A ++DFG ++ L AD +     A T+G     + APE     
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPECINYY 205
Query: 384 VMTEKCDVYSFGVVTLEVL-MGKHP 407
             + K DV+SFGV+  E    G+ P
Sbjct: 206 KFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 213 IGTGGYGSVYKA--QLPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
           G C  +  M L+ E  E G L   L  N    + +    + +V  ++  + YL      +
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 147
Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG-----YIAPELAYTM 383
            +HRD+++ N+LL ++  A ++DFG ++ L AD +     A T+G     + APE     
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPECINYY 205
Query: 384 VMTEKCDVYSFGVVTLEVL-MGKHP 407
             + K DV+SFGV+  E    G+ P
Sbjct: 206 KFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 213 IGTGGYGSVYKA--QLPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
           G C  +  M L+ E  E G L   L  N    + +    + +V  ++  + YL      +
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 131
Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG-----YIAPELAYTM 383
            +HRD+++ N+LL ++  A ++DFG ++ L AD +     A T+G     + APE     
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYK--AQTHGKWPVKWYAPECINYY 189
Query: 384 VMTEKCDVYSFGVVTLEVL-MGKHP 407
             + K DV+SFGV+  E    G+ P
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSEELAFIKSFKNEAQVLSQ 258
           A ED  +   +G G +G VY+    N K      A+K       L   + F +EA ++  
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
           + H +IVKL G  + ++  ++I E    G L   L  N++++++     V     +  A+
Sbjct: 82  LDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAM 138
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH-ADSSNRTLLAGTYGYIAP 377
           AYL    S + +HRDI+  NIL+ S     + DFG +R +   D    ++      +++P
Sbjct: 139 AYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSP 195
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
           E       T   DV+ F V   E+L  GK P
Sbjct: 196 ESINFRRFTTASDVWMFAVCMWEILSFGKQP 226

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 119/271 (43%), Gaps = 31/271 (11%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSEELAFIKSFKNEAQVLSQ 258
           A ED  +   +G G +G VY+    N K      A+K       L   + F +EA ++  
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
           + H +IVKL G  + ++  ++I E    G L   L  N++++++     V     +  A+
Sbjct: 66  LDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAM 122
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH-ADSSNRTLLAGTYGYIAP 377
           AYL    S + +HRDI+  NIL+ S     + DFG +R +   D    ++      +++P
Sbjct: 123 AYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSP 179
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQ--RLPP 434
           E       T   DV+ F V   E+L  GK P           D    +I VL++  RLP 
Sbjct: 180 ESINFRRFTTASDVWMFAVCMWEILSFGKQP----FFWLENKD----VIGVLEKGDRLPK 231
Query: 435 PVDRKVIRDIL--LISTVSFACLQSNPKSRP 463
           P       D+   ++ T+   C   +P  RP
Sbjct: 232 P-------DLCPPVLYTLMTRCWDYDPSDRP 255

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A    +G+  A+KKL    +   F K    E  +L  + H N++ L   
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 271 CLHKKCM------FLIYEYMERG-SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
                 +      +L+  +M+        L  +E+ ++        +V  M   L Y+H 
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY-------LVYQMLKGLKYIH- 143
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT- 382
             S  ++HRD+   N+ +N   E  + DFG AR  HAD +  T    T  Y APE+  + 
Sbjct: 144 --SAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HAD-AEMTGYVVTRWYRAPEVILSW 198
Query: 383 MVMTEKCDVYSFGVVTLEVLMGK 405
           M   +  D++S G +  E+L GK
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 16/204 (7%)
Query: 212 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYG 269
            IG G +  V  A+ +  GK  A+K +  ++   + ++    E +++  + H NIVKL+ 
Sbjct: 14  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 73
Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNI---VKAMAHALAYLHHDCS 326
               +K ++L+ EY   G +F  L      V   W K        + +  A+ Y H    
Sbjct: 74  VIETEKTLYLVMEYASGGEVFDYL------VAHGWMKEKEARAKFRQIVSAVQYCHQKF- 126
Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMT 386
             I+HRD+ + N+LL++ +   +ADFG +      +   T   G+  Y APEL       
Sbjct: 127 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT-FCGSPPYAAPELFQGKKYD 183
Query: 387 E-KCDVYSFGVVTLEVLMGKHPRD 409
             + DV+S GV+   ++ G  P D
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 213 IGTGGYGSVYKA--QLPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
           G C  +  M L+ E  E G L   L  N    + +    + +V  ++  + YL      +
Sbjct: 93  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 145
Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG-----YIAPELAYTM 383
            +HRD+++ N+LL ++  A ++DFG ++ L AD +     A T+G     + APE     
Sbjct: 146 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPECINYY 203
Query: 384 VMTEKCDVYSFGVVTLEVL-MGKHP 407
             + K DV+SFGV+  E    G+ P
Sbjct: 204 KFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 119/271 (43%), Gaps = 31/271 (11%)
Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSEELAFIKSFKNEAQVLSQ 258
           A ED  +   +G G +G VY+    N K      A+K       L   + F +EA ++  
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
           + H +IVKL G  + ++  ++I E    G L   L  N++++++     V     +  A+
Sbjct: 70  LDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAM 126
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH-ADSSNRTLLAGTYGYIAP 377
           AYL    S + +HRDI+  NIL+ S     + DFG +R +   D    ++      +++P
Sbjct: 127 AYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSP 183
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQ--RLPP 434
           E       T   DV+ F V   E+L  GK P           D    +I VL++  RLP 
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILSFGKQP----FFWLENKD----VIGVLEKGDRLPK 235
Query: 435 PVDRKVIRDIL--LISTVSFACLQSNPKSRP 463
           P       D+   ++ T+   C   +P  RP
Sbjct: 236 P-------DLCPPVLYTLMTRCWDYDPSDRP 259

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 20/194 (10%)
Query: 228 NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN---------IVKLY-GYCLHKKC 276
           NGKV  +    T E+ A +K  ++  +   +V LH           IV +Y      +KC
Sbjct: 37  NGKVLQIFNKRTQEKFA-LKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 95
Query: 277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 336
           + ++ E ++ G LF  + +  D    +  +   I+K++  A+ YLH   S +I HRD+  
Sbjct: 96  LLIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH---SINIAHRDVKP 151
Query: 337 NNILLNSKLEAFV---ADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 393
            N+L  SK    +    DFG A+   + +S  T     Y Y+APE+       + CD++S
Sbjct: 152 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 210
Query: 394 FGVVTLEVLMGKHP 407
            GV+   +L G  P
Sbjct: 211 LGVIMYILLCGYPP 224

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/89 (47%), Positives = 56/89 (62%), Gaps = 2/89 (2%)
Query: 53  GKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSS 112
           G IP EI SM YL  L+L +N+I GSIP E+  L  L+ L+LSSNKL G +P + + L +
Sbjct: 643 GYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSAL-T 701
Query: 113 MHTVVSLSPNNGLCGNILDLPSCDTTKPA 141
           M T + LS NN L G I ++   +T  PA
Sbjct: 702 MLTEIDLS-NNNLSGPIPEMGQFETFPPA 729

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/89 (47%), Positives = 56/89 (62%), Gaps = 2/89 (2%)
Query: 53  GKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSS 112
           G IP EI SM YL  L+L +N+I GSIP E+  L  L+ L+LSSNKL G +P + + L +
Sbjct: 646 GYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSAL-T 704
Query: 113 MHTVVSLSPNNGLCGNILDLPSCDTTKPA 141
           M T + LS NN L G I ++   +T  PA
Sbjct: 705 MLTEIDLS-NNNLSGPIPEMGQFETFPPA 732

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 20/194 (10%)
Query: 228 NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN---------IVKLY-GYCLHKKC 276
           NGKV  +    T E+ A +K  ++  +   +V LH           IV +Y      +KC
Sbjct: 35  NGKVLQIFNKRTQEKFA-LKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 93
Query: 277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 336
           + ++ E ++ G LF  + +  D    +  +   I+K++  A+ YLH   S +I HRD+  
Sbjct: 94  LLIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH---SINIAHRDVKP 149
Query: 337 NNILLNSKLEAFV---ADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 393
            N+L  SK    +    DFG A+   + +S  T     Y Y+APE+       + CD++S
Sbjct: 150 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 208
Query: 394 FGVVTLEVLMGKHP 407
            GV+   +L G  P
Sbjct: 209 LGVIMYILLCGYPP 222

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 20/194 (10%)
Query: 228 NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN---------IVKLY-GYCLHKKC 276
           NGKV  +    T E+ A +K  ++  +   +V LH           IV +Y      +KC
Sbjct: 36  NGKVLQIFNKRTQEKFA-LKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 94
Query: 277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 336
           + ++ E ++ G LF  + +  D    +  +   I+K++  A+ YLH   S +I HRD+  
Sbjct: 95  LLIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH---SINIAHRDVKP 150
Query: 337 NNILLNSKLEAFV---ADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 393
            N+L  SK    +    DFG A+   + +S  T     Y Y+APE+       + CD++S
Sbjct: 151 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 209
Query: 394 FGVVTLEVLMGKHP 407
            GV+   +L G  P
Sbjct: 210 LGVIMYILLCGYPP 223

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 213 IGTGGYGSVYKA--QLPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
           G C  +  M L+ E  E G L   L  N    + +    + +V  ++  + YL      +
Sbjct: 85  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 137
Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG-----YIAPELAYTM 383
            +HRD+++ N+LL ++  A ++DFG ++ L AD +     A T+G     + APE     
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPECINYY 195
Query: 384 VMTEKCDVYSFGVVTLEVL-MGKHP 407
             + K DV+SFGV+  E    G+ P
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 213 IGTGGYGSVYKA--QLPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
           G C  +  M L+ E  E G L   L  N    + +    + +V  ++  + YL      +
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 131
Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG-----YIAPELAYTM 383
            +HRD+++ N+LL ++  A ++DFG ++ L AD +     A T+G     + APE     
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPECINYY 189
Query: 384 VMTEKCDVYSFGVVTLEVL-MGKHP 407
             + K DV+SFGV+  E    G+ P
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 20/194 (10%)
Query: 228 NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN---------IVKLY-GYCLHKKC 276
           NGKV  +    T E+ A +K  ++  +   +V LH           IV +Y      +KC
Sbjct: 45  NGKVLQIFNKRTQEKFA-LKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 103
Query: 277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 336
           + ++ E ++ G LF  + +  D    +  +   I+K++  A+ YLH   S +I HRD+  
Sbjct: 104 LLIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH---SINIAHRDVKP 159
Query: 337 NNILLNSKLEAFV---ADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 393
            N+L  SK    +    DFG A+   + +S  T     Y Y+APE+       + CD++S
Sbjct: 160 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 218
Query: 394 FGVVTLEVLMGKHP 407
            GV+   +L G  P
Sbjct: 219 LGVIMYILLCGYPP 232

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 213 IGTGGYGSVYKA--QLPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
           G C  +  M L+ E  E G L   L  N    + +    + +V  ++  + YL      +
Sbjct: 73  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLE---ESN 125
Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG-----YIAPELAYTM 383
            +HRD+++ N+LL ++  A ++DFG ++ L AD +     A T+G     + APE     
Sbjct: 126 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--YYKAQTHGKWPVKWYAPECINYY 183
Query: 384 VMTEKCDVYSFGVVTLEVL-MGKHP 407
             + K DV+SFGV+  E    G+ P
Sbjct: 184 KFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 12/202 (5%)
Query: 212 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLY 268
            IG G +  V  A+ +  G+  A+K +  ++    +  K F+ E +++  + H NIVKL+
Sbjct: 19  TIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLF 77
Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
                +K ++LI EY   G +F  L  +    E +   +    + +  A+ Y H      
Sbjct: 78  EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF---RQIVSAVQYCHQ---KR 131
Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTE- 387
           I+HRD+ + N+LL++ +   +ADFG +          T   G+  Y APEL         
Sbjct: 132 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT-FCGSPPYAAPELFQGKKYDGP 190
Query: 388 KCDVYSFGVVTLEVLMGKHPRD 409
           + DV+S GV+   ++ G  P D
Sbjct: 191 EVDVWSLGVILYTLVSGSLPFD 212

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 20/194 (10%)
Query: 228 NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN---------IVKLY-GYCLHKKC 276
           NGKV  +    T E+ A +K  ++  +   +V LH           IV +Y      +KC
Sbjct: 75  NGKVLQIFNKRTQEKFA-LKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133
Query: 277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 336
           + ++ E ++ G LF  + +  D    +  +   I+K++  A+ YLH   S +I HRD+  
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH---SINIAHRDVKP 189
Query: 337 NNILLNSKLEAFV---ADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 393
            N+L  SK    +    DFG A+   + +S  T     Y Y+APE+       + CD++S
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 248
Query: 394 FGVVTLEVLMGKHP 407
            GV+   +L G  P
Sbjct: 249 LGVIMYILLCGYPP 262

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 20/194 (10%)
Query: 228 NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN---------IVKLY-GYCLHKKC 276
           NGKV  +    T E+ A +K  ++  +   +V LH           IV +Y      +KC
Sbjct: 31  NGKVLQIFNKRTQEKFA-LKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89
Query: 277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 336
           + ++ E ++ G LF  + +  D    +  +   I+K++  A+ YLH   S +I HRD+  
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH---SINIAHRDVKP 145
Query: 337 NNILLNSKLEAFV---ADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 393
            N+L  SK    +    DFG A+   + +S  T     Y Y+APE+       + CD++S
Sbjct: 146 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 204
Query: 394 FGVVTLEVLMGKHP 407
            GV+   +L G  P
Sbjct: 205 LGVIMYILLCGYPP 218

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 20/194 (10%)
Query: 228 NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN---------IVKLY-GYCLHKKC 276
           NGKV  +    T E+ A +K  ++  +   +V LH           IV +Y      +KC
Sbjct: 29  NGKVLQIFNKRTQEKFA-LKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 87
Query: 277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 336
           + ++ E ++ G LF  + +  D    +  +   I+K++  A+ YLH   S +I HRD+  
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH---SINIAHRDVKP 143
Query: 337 NNILLNSKLEAFV---ADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 393
            N+L  SK    +    DFG A+   + +S  T     Y Y+APE+       + CD++S
Sbjct: 144 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 202
Query: 394 FGVVTLEVLMGKHP 407
            GV+   +L G  P
Sbjct: 203 LGVIMYILLCGYPP 216

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 20/194 (10%)
Query: 228 NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN---------IVKLY-GYCLHKKC 276
           NGKV  +    T E+ A +K  ++  +   +V LH           IV +Y      +KC
Sbjct: 30  NGKVLQIFNKRTQEKFA-LKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 88
Query: 277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 336
           + ++ E ++ G LF  + +  D    +  +   I+K++  A+ YLH   S +I HRD+  
Sbjct: 89  LLIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH---SINIAHRDVKP 144
Query: 337 NNILLNSKLEAFV---ADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 393
            N+L  SK    +    DFG A+   + +S  T     Y Y+APE+       + CD++S
Sbjct: 145 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 203
Query: 394 FGVVTLEVLMGKHP 407
            GV+   +L G  P
Sbjct: 204 LGVIMYILLCGYPP 217

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 89/194 (45%), Gaps = 20/194 (10%)
Query: 228 NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN---------IVKLY-GYCLHKKC 276
           NGKV  +    T E+ A +K  ++  +   +V LH           IV +Y      +KC
Sbjct: 75  NGKVLQIFNKRTQEKFA-LKXLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133
Query: 277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 336
           + ++ E ++ G LF  + +  D    +  +   I K++  A+ YLH   S +I HRD+  
Sbjct: 134 LLIVXECLDGGELFSRIQDRGDQAFTE-REASEIXKSIGEAIQYLH---SINIAHRDVKP 189
Query: 337 NNILLNSKLEAFV---ADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 393
            N+L  SK    +    DFG A+   + +S  T     Y Y+APE+       + CD +S
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDXWS 248
Query: 394 FGVVTLEVLMGKHP 407
            GV+   +L G  P
Sbjct: 249 LGVIXYILLCGYPP 262

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 20/194 (10%)
Query: 228 NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN---------IVKLY-GYCLHKKC 276
           NGKV  +    T E+ A +K  ++  +   +V LH           IV +Y      +KC
Sbjct: 31  NGKVLQIFNKRTQEKFA-LKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89
Query: 277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 336
           + ++ E ++ G LF  + +  D    +  +   I+K++  A+ YLH   S +I HRD+  
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH---SINIAHRDVKP 145
Query: 337 NNILLNSKLEAFV---ADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 393
            N+L  SK    +    DFG A+   + +S  T     Y Y+APE+       + CD++S
Sbjct: 146 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 204
Query: 394 FGVVTLEVLMGKHP 407
            GV+   +L G  P
Sbjct: 205 LGVIMYILLCGYPP 218

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 213 IGTGGYGSVYKA--QLPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
           G C  +  M L+ E  E G L   L  N    + +    + +V  ++  + YL      +
Sbjct: 75  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLE---ESN 127
Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG-----YIAPELAYTM 383
            +HRD+++ N+LL ++  A ++DFG ++ L AD +     A T+G     + APE     
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHGKWPVKWYAPECINYY 185
Query: 384 VMTEKCDVYSFGVVTLEVL-MGKHP 407
             + K DV+SFGV+  E    G+ P
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 20/194 (10%)
Query: 228 NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN---------IVKLY-GYCLHKKC 276
           NGKV  +    T E+ A +K  ++  +   +V LH           IV +Y      +KC
Sbjct: 81  NGKVLQIFNKRTQEKFA-LKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 139
Query: 277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 336
           + ++ E ++ G LF  + +  D    +  +   I+K++  A+ YLH   S +I HRD+  
Sbjct: 140 LLIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH---SINIAHRDVKP 195
Query: 337 NNILLNSKLEAFV---ADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 393
            N+L  SK    +    DFG A+   + +S  T     Y Y+APE+       + CD++S
Sbjct: 196 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWS 254
Query: 394 FGVVTLEVLMGKHP 407
            GV+   +L G  P
Sbjct: 255 LGVIMYILLCGYPP 268

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 109/228 (47%), Gaps = 29/228 (12%)
Query: 197 YEDLIEATEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQV 255
           +ED+ + T +      +G G Y  V  A  L NGK +A+K +      +  + F+ E + 
Sbjct: 10  FEDMYKLTSEL-----LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFR-EVET 63
Query: 256 LSQVL-HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM 314
           L Q   ++NI++L  +       +L++E ++ GS+  ++   +   E + ++   +V+ +
Sbjct: 64  LYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASR---VVRDV 120
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSS-------N 364
           A AL +LH   +  I HRD+   NIL  S  +     + DF     +  ++S        
Sbjct: 121 AAALDFLH---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPE 177
Query: 365 RTLLAGTYGYIAPELA--YTMVMT---EKCDVYSFGVVTLEVLMGKHP 407
            T   G+  Y+APE+   +T   T   ++CD++S GVV   +L G  P
Sbjct: 178 LTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 209 IRYCIGTGGYGSV-----YKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           IR  +G G +G V     YK Q      F  ++L    ++      + E   L  + H +
Sbjct: 13  IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHM--RVEREISYLKLLRHPH 70
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           I+KLY        + ++ EY   G LF  +   +   E D  +R    + +  A+ Y H 
Sbjct: 71  IIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTE-DEGRR--FFQQIICAIEYCHR 126
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAYT 382
                I+HRD+   N+LL+  L   +ADFG + ++  D +      G+  Y APE +   
Sbjct: 127 H---KIVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAPEVINGK 182
Query: 383 MVMTEKCDVYSFGVVTLEVLMGKHPRD 409
           +    + DV+S G+V   +L+G+ P D
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           +G GG+  V   + L +G  +ALK++   E+    ++ + EA +     H NI++L  YC
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEA-QREADMHRLFNHPNILRLVAYC 95
Query: 272 LHKKCM----FLIYEYMERGSLFCNLHNNEDAVE-LDWAKRVNIVKAMAHALAYLHHDCS 326
           L ++      +L+  + +RG+L+  +   +D    L   + + ++  +   L  +H   +
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTAR--LLHADSSNRTLLAGTYG-------YIAP 377
               HRD+   NILL  + +  + D G+     +H + S + L    +        Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 378 ELAYTM---VMTEKCDVYSFGVVTLEVLMGKHPRDI 410
           EL       V+ E+ DV+S G V   ++ G+ P D+
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 18/217 (8%)
Query: 202 EATEDF-DIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIK-----SFKNEAQ 254
           +  EDF DI   +G+G +  V K  +   G  +A K +   +  A  +       + E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 255 VLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM 314
           +L QVLH N++ L+    ++  + LI E +  G LF  L   E   E    +  + +K +
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATSFIKQI 124
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSK----LEAFVADFGTARLLHADSSNRTLLAG 370
              + YLH   +  I H D+   NI+L  K        + DFG A  +      + +  G
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-G 180
Query: 371 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           T  ++APE+     +  + D++S GV+T  +L G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 24/196 (12%)
Query: 228 NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN---------IVKLY-GYCLHKKC 276
           NGKV  +    T E+ A +K  ++  +   +V LH           IV +Y      +KC
Sbjct: 29  NGKVLQIFNKRTQEKFA-LKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 87
Query: 277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 336
           + ++ E ++ G LF  + +  D    +  +   I+K++  A+ YLH   S +I HRD+  
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH---SINIAHRDVKP 143
Query: 337 NNILLNSKLEAFV---ADFGTARLLHADSSNRTLLAGTYG--YIAPELAYTMVMTEKCDV 391
            N+L  SK    +    DFG A+     +S+ +L    Y   Y+APE+       + CD+
Sbjct: 144 ENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDM 200
Query: 392 YSFGVVTLEVLMGKHP 407
           +S GV+   +L G  P
Sbjct: 201 WSLGVIMYILLCGYPP 216

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 108/258 (41%), Gaps = 53/258 (20%)
Query: 200 LIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFI-----KSFKNEAQ 254
           L+E  + + ++  IG G YG V  A     +     K+    ++  I     +  K E +
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80
Query: 255 VLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLH-------------------- 294
           ++ ++ H NI +LY     ++ + L+ E    G L   L+                    
Sbjct: 81  LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 295 ----NNEDAV---------ELDWAKR----VNIVKAMAHALAYLHHDCSPSIIHRDISSN 337
                NE+A+          LD+ +R     NI++ +  AL YLH+     I HRDI   
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPE 197
Query: 338 NILL--NSKLEAFVADFGTA----RLLHADSSNRTLLAGTYGYIAPELAYTMVMT--EKC 389
           N L   N   E  + DFG +    +L + +    T  AGT  ++APE+  T   +   KC
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 390 DVYSFGVVTLEVLMGKHP 407
           D +S GV+   +LMG  P
Sbjct: 258 DAWSAGVLLHLLLMGAVP 275

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 206 DFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHR 262
           ++ ++  IG G +  V  A+ +  G+  A+K +  ++    +  K F+ E +++  + H 
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR-EVRIMKILNHP 74
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
           NIVKL+     +K ++L+ EY   G +F  L  +    E +   +    + +  A+ Y H
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCH 131
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
                 I+HRD+ + N+LL+  +   +ADFG +      +   T   G+  Y APEL   
Sbjct: 132 QKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT-FCGSPPYAAPELFQG 187
Query: 383 MVMTE-KCDVYSFGVVTLEVLMGKHPRD 409
                 + DV+S GV+   ++ G  P D
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 18/217 (8%)
Query: 202 EATEDF-DIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIK-----SFKNEAQ 254
           +  EDF DI   +G+G +  V K  +   G  +A K +   +  A  +       + E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 255 VLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM 314
           +L QVLH N++ L+    ++  + LI E +  G LF  L   E   E    +  + +K +
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATSFIKQI 124
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSK----LEAFVADFGTARLLHADSSNRTLLAG 370
              + YLH   +  I H D+   NI+L  K        + DFG A  +      + +  G
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-G 180
Query: 371 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           T  ++APE+     +  + D++S GV+T  +L G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHRNIVKLYGY 270
           IG G YG+V+KA+     ++ ALK++   ++   + S    E  +L ++ H+NIV+L+  
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV--NIVKAMAHALAYLHHDCSPS 328
               K + L++E+ ++     +L    D+   D    +  + +  +   L + H   S +
Sbjct: 70  LHSDKKLTLVFEFCDQ-----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRN 121
Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY-TMVMTE 387
           ++HRD+   N+L+N   E  +ADFG AR         +    T  Y  P++ +   + + 
Sbjct: 122 VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 388 KCDVYSFGVVTLEVLMGKHP 407
             D++S G +  E+     P
Sbjct: 182 SIDMWSAGCIFAELANAARP 201

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 10/201 (4%)
Query: 212 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYG 269
            IG G +  V  A+ +  GK  A+K +  ++   + ++    E +++  + H NIVKL+ 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               +K ++L+ EY   G +F  L  +    E +   +    + +  A+ Y H      I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQKF---I 134
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTE-K 388
           +HRD+ + N+LL++ +   +ADFG +      +   T   G+  Y APEL         +
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT-FCGSPPYAAPELFQGKKYDGPE 193
Query: 389 CDVYSFGVVTLEVLMGKHPRD 409
            DV+S GV+   ++ G  P D
Sbjct: 194 VDVWSLGVILYTLVSGSLPFD 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 18/217 (8%)
Query: 202 EATEDF-DIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIK-----SFKNEAQ 254
           +  EDF DI   +G+G +  V K  +   G  +A K +   +  A  +       + E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 255 VLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM 314
           +L QVLH N++ L+    ++  + LI E +  G LF  L   E   E    +  + +K +
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATSFIKQI 124
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSK----LEAFVADFGTARLLHADSSNRTLLAG 370
              + YLH   +  I H D+   NI+L  K        + DFG A  +      + +  G
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-G 180
Query: 371 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           T  ++APE+     +  + D++S GV+T  +L G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 10/201 (4%)
Query: 212 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYG 269
            IG G +  V  A+ +  GK  A+K +  ++   + ++    E +++  + H NIVKL+ 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               +K ++L+ EY   G +F  L  +    E +   +    + +  A+ Y H      I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQKF---I 134
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTE-K 388
           +HRD+ + N+LL++ +   +ADFG +      +   T   G+  Y APEL         +
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT-FCGSPPYAAPELFQGKKYDGPE 193
Query: 389 CDVYSFGVVTLEVLMGKHPRD 409
            DV+S GV+   ++ G  P D
Sbjct: 194 VDVWSLGVILYTLVSGSLPFD 214

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 118/286 (41%), Gaps = 44/286 (15%)
Query: 213 IGTGGYGSVYKA------QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIV 265
           +G G +G V +A      +       A+K L  S  L   ++  +E +VLS +  H NIV
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAV---------------ELDWAKRVNI 310
            L G C       +I EY   G L   L    D+                 LD    ++ 
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG 370
              +A  +A+L    S + IHRD+++ NILL       + DFG AR +  DS+   ++ G
Sbjct: 174 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSN--YVVKG 228
Query: 371 T----YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIM-L 424
                  ++APE  +  V T + DV+S+G+   E+  +G  P           D K   +
Sbjct: 229 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-----YPGMPVDSKFYKM 283
Query: 425 IDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
           I    + L P      + DI+        C  ++P  RPT + + Q
Sbjct: 284 IKEGFRMLSPEHAPAEMYDIMK------TCWDADPLKRPTFKQIVQ 323

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 18/217 (8%)
Query: 202 EATEDF-DIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIK-----SFKNEAQ 254
           +  EDF DI   +G+G +  V K  +   G  +A K +   +  A  +       + E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 255 VLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM 314
           +L QVLH N++ L+    ++  + LI E +  G LF  L   E   E    +  + +K +
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATSFIKQI 124
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSK----LEAFVADFGTARLLHADSSNRTLLAG 370
              + YLH   +  I H D+   NI+L  K        + DFG A  +      + +  G
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-G 180
Query: 371 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           T  ++APE+     +  + D++S GV+T  +L G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 20/226 (8%)
Query: 192 DGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALK-----KLHTSEELAF 245
           D  +++ED+ E  E       IG G +  V +      G+ FA+K     K  +S  L+ 
Sbjct: 17  DDDVLFEDVYELCE------VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLS- 69
Query: 246 IKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDA-VELDW 304
            +  K EA +   + H +IV+L         +++++E+M+   L   +    DA      
Sbjct: 70  TEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE 129
Query: 305 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHAD 361
           A   + ++ +  AL Y H +   +IIHRD+   N+LL SK  +    + DFG A  L   
Sbjct: 130 AVASHYMRQILEALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGES 186
Query: 362 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
                   GT  ++APE+       +  DV+  GV+   +L G  P
Sbjct: 187 GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 118/286 (41%), Gaps = 44/286 (15%)
Query: 213 IGTGGYGSVYKA------QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIV 265
           +G G +G V +A      +       A+K L  S  L   ++  +E +VLS +  H NIV
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAV---------------ELDWAKRVNI 310
            L G C       +I EY   G L   L    D+                 LD    ++ 
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG 370
              +A  +A+L    S + IHRD+++ NILL       + DFG AR +  DS+   ++ G
Sbjct: 174 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN--YVVKG 228
Query: 371 T----YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIM-L 424
                  ++APE  +  V T + DV+S+G+   E+  +G  P           D K   +
Sbjct: 229 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-----YPGMPVDSKFYKM 283
Query: 425 IDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
           I    + L P      + DI+        C  ++P  RPT + + Q
Sbjct: 284 IKEGFRMLSPEHAPAEMYDIMK------TCWDADPLKRPTFKQIVQ 323

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 18/217 (8%)
Query: 202 EATEDF-DIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIK-----SFKNEAQ 254
           +  EDF DI   +G+G +  V K  +   G  +A K +   +  A  +       + E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 255 VLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM 314
           +L QVLH N++ L+    ++  + LI E +  G LF  L   E   E    +  + +K +
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATSFIKQI 124
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSK----LEAFVADFGTARLLHADSSNRTLLAG 370
              + YLH   +  I H D+   NI+L  K        + DFG A  +      + +  G
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-G 180
Query: 371 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           T  ++APE+     +  + D++S GV+T  +L G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 118/286 (41%), Gaps = 44/286 (15%)
Query: 213 IGTGGYGSVYKA------QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIV 265
           +G G +G V +A      +       A+K L  S  L   ++  +E +VLS +  H NIV
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAV---------------ELDWAKRVNI 310
            L G C       +I EY   G L   L    D+                 LD    ++ 
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG 370
              +A  +A+L    S + IHRD+++ NILL       + DFG AR +  DS+   ++ G
Sbjct: 167 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN--YVVKG 221
Query: 371 T----YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIM-L 424
                  ++APE  +  V T + DV+S+G+   E+  +G  P           D K   +
Sbjct: 222 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-----YPGMPVDSKFYKM 276
Query: 425 IDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
           I    + L P      + DI+        C  ++P  RPT + + Q
Sbjct: 277 IKEGFRMLSPEHAPAEMYDIMK------TCWDADPLKRPTFKQIVQ 316

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 118/286 (41%), Gaps = 44/286 (15%)
Query: 213 IGTGGYGSVYKA------QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIV 265
           +G G +G V +A      +       A+K L  S  L   ++  +E +VLS +  H NIV
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAV---------------ELDWAKRVNI 310
            L G C       +I EY   G L   L    D+                 LD    ++ 
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG 370
              +A  +A+L    S + IHRD+++ NILL       + DFG AR +  DS+   ++ G
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN--YVVKG 205
Query: 371 T----YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIM-L 424
                  ++APE  +  V T + DV+S+G+   E+  +G  P           D K   +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-----YPGMPVDSKFYKM 260
Query: 425 IDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
           I    + L P      + DI+        C  ++P  RPT + + Q
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMK------TCWDADPLKRPTFKQIVQ 300

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 109/269 (40%), Gaps = 30/269 (11%)
Query: 213 IGTGGYGSVYKAQLPN---GKV---FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G VY+    +   G+     A+K ++ S  L     F NEA V+      ++V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNL-------HNNEDAVELDWAKRVNIVKAMAHALA 319
           L G     +   ++ E M  G L   L        NN         + + +   +A  +A
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG--TYGYIAP 377
           YL+   +   +HR++++ N ++       + DFG  R ++     R    G     ++AP
Sbjct: 146 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPV 436
           E     V T   D++SFGVV  E+  + + P              +M    LDQ   P  
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK--FVMDGGYLDQ---PDN 257
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTM 465
             + + D++ +      C Q NP  RPT 
Sbjct: 258 CPERVTDLMRM------CWQFNPNMRPTF 280

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 13/139 (9%)
Query: 274 KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRD 333
           K+C+ +I E ME G LF  +    D    +  +   I++ +  A+ +LH   S +I HRD
Sbjct: 79  KRCLLIIMECMEGGELFSRIQERGDQAFTE-REAAEIMRDIGTAIQFLH---SHNIAHRD 134
Query: 334 ISSNNILLNSKLEAFV---ADFGTARLLHADSSNRTLLAGTYG--YIAPELAYTMVMTEK 388
           +   N+L  SK +  V    DFG A+    +++   L    Y   Y+APE+       + 
Sbjct: 135 VKPENLLYTSKEKDAVLKLTDFGFAK----ETTQNALQTPCYTPYYVAPEVLGPEKYDKS 190
Query: 389 CDVYSFGVVTLEVLMGKHP 407
           CD++S GV+   +L G  P
Sbjct: 191 CDMWSLGVIMYILLCGFPP 209

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 30/212 (14%)
Query: 213 IGTGGYGSVYK-AQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQ--VLHRN-----I 264
           IG G YGSV K    P+G++ A+K++ ++ +       K + Q+L    V+ R+     I
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE------KEQKQLLMDLDVVMRSSDCPYI 83
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNN-----EDAVELDWAKRVNIVKAMAHALA 319
           V+ YG    +   ++  E M   + F   +       +D +  +   ++ +  A   AL 
Sbjct: 84  VQFYGALFREGDCWICMELM--STSFDKFYKYVYSVLDDVIPEEILGKITL--ATVKALN 139
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           +L  +    IIHRDI  +NILL+      + DFG +  L  DS  +T  AG   Y+APE 
Sbjct: 140 HLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDAGCRPYMAPER 196
Query: 380 ----AYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
               A       + DV+S G+   E+  G+ P
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 13/139 (9%)
Query: 274 KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRD 333
           K+C+ +I E ME G LF  +    D    +  +   I++ +  A+ +LH   S +I HRD
Sbjct: 98  KRCLLIIMECMEGGELFSRIQERGDQAFTE-REAAEIMRDIGTAIQFLH---SHNIAHRD 153
Query: 334 ISSNNILLNSKLEAFV---ADFGTARLLHADSSNRTLLAGTYG--YIAPELAYTMVMTEK 388
           +   N+L  SK +  V    DFG A+    +++   L    Y   Y+APE+       + 
Sbjct: 154 VKPENLLYTSKEKDAVLKLTDFGFAK----ETTQNALQTPCYTPYYVAPEVLGPEKYDKS 209
Query: 389 CDVYSFGVVTLEVLMGKHP 407
           CD++S GV+   +L G  P
Sbjct: 210 CDMWSLGVIMYILLCGFPP 228

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALK------KLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +GSV +  L      +LK      KL  S +   I+ F +EA  +    H N+++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE-IEEFLSEAACMKDFSHPNVIR 100
Query: 267 LYGYCLHKKCM-----FLIYEYMERGSL-----FCNLHNNEDAVELDWAKRVNIVKAMAH 316
           L G C+           +I  +M+ G L     +  L      + L       ++K M  
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ-----TLLKFMVD 155
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT--LLAGTYGY 374
               + +  + + +HRD+++ N +L   +   VADFG ++ +++    R   +      +
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEV 401
           IA E     V T K DV++FGV   E+
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEI 242

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 109/269 (40%), Gaps = 30/269 (11%)
Query: 213 IGTGGYGSVYKAQLPN---GKV---FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G VY+    +   G+     A+K ++ S  L     F NEA V+      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNL-------HNNEDAVELDWAKRVNIVKAMAHALA 319
           L G     +   ++ E M  G L   L        NN         + + +   +A  +A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG--TYGYIAP 377
           YL+   +   +HR++++ N ++       + DFG  R ++     R    G     ++AP
Sbjct: 145 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPV 436
           E     V T   D++SFGVV  E+  + + P              +M    LDQ   P  
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK--FVMDGGYLDQ---PDN 256
Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTM 465
             + + D++ +      C Q NP  RPT 
Sbjct: 257 CPERVTDLMRM------CWQFNPNMRPTF 279

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 118/286 (41%), Gaps = 44/286 (15%)
Query: 213 IGTGGYGSVYKA------QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIV 265
           +G G +G V +A      +       A+K L  S  L   ++  +E +VLS +  H NIV
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAV---------------ELDWAKRVNI 310
            L G C       +I EY   G L   L    D+                 LD    ++ 
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG 370
              +A  +A+L    S + IHRD+++ NILL       + DFG AR +  DS+   ++ G
Sbjct: 169 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN--YVVKG 223
Query: 371 T----YGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDIXXXXXXXXDPKIM-L 424
                  ++APE  +  V T + DV+S+G+   E+  +G  P           D K   +
Sbjct: 224 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP-----YPGMPVDSKFYKM 278
Query: 425 IDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
           I    + L P      + DI+        C  ++P  RPT + + Q
Sbjct: 279 IKEGFRMLSPEHAPAEMYDIMK------TCWDADPLKRPTFKQIVQ 318

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 18/217 (8%)
Query: 202 EATEDF-DIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIK-----SFKNEAQ 254
           +  EDF DI   +G+G +  V K  +   G  +A K +   +  A  +       + E  
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 255 VLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM 314
           +L QVLH NI+ L+    ++  + LI E +  G LF  L   E   E    +  + +K +
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATSFIKQI 124
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSK----LEAFVADFGTARLLHADSSNRTLLAG 370
              + YLH   +  I H D+   NI+L  K        + DFG A  +      + +  G
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-G 180
Query: 371 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           T  ++APE+     +  + D++S GV+T  +L G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    IGTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EYM  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    VADFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEY 204
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    IGTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EYM  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    VADFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEY 204
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 94/198 (47%), Gaps = 10/198 (5%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL 272
           +G G +G V+K +     +    K+  +  +   +  KNE  V++Q+ H N+++LY    
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 273 HKKCMFLIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
            K  + L+ EY++ G LF  + +   +  ELD    +  +K +   + ++H      I+H
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELD---TILFMKQICEGIRHMHQ---MYILH 210
Query: 332 RDISSNNIL-LNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKC 389
            D+   NIL +N   +   + DFG AR        +    GT  ++APE+     ++   
Sbjct: 211 LDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEFLAPEVVNYDFVSFPT 269
Query: 390 DVYSFGVVTLEVLMGKHP 407
           D++S GV+   +L G  P
Sbjct: 270 DMWSVGVIAYMLLSGLSP 287

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 80/171 (46%), Gaps = 25/171 (14%)
Query: 250 KNEAQVLSQVLHRNIVKLYG--YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR 307
           K E Q+L ++ H+N+++L    Y   K+ M+++ EY       C +    D+V     KR
Sbjct: 54  KKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY-----CVCGMQEMLDSVP---EKR 105
Query: 308 VNIVKAMAH------ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH-- 359
             + +A  +       L YLH   S  I+H+DI   N+LL +     ++  G A  LH  
Sbjct: 106 FPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162
Query: 360 -ADSSNRTLLAGTYGYIAPELAYTMVMTE--KCDVYSFGVVTLEVLMGKHP 407
            AD + RT   G+  +  PE+A  +      K D++S GV    +  G +P
Sbjct: 163 AADDTCRT-SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 95/201 (47%), Gaps = 10/201 (4%)
Query: 212 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYG 269
            IG G +  V  A+ +  GK  A++ +  ++   + ++    E +++  + H NIVKL+ 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               +K ++L+ EY   G +F  L  +    E +   +    + +  A+ Y H      I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQKF---I 134
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTE-K 388
           +HRD+ + N+LL++ +   +ADFG +      +   T   G+  Y APEL         +
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT-FCGSPPYAAPELFQGKKYDGPE 193
Query: 389 CDVYSFGVVTLEVLMGKHPRD 409
            DV+S GV+   ++ G  P D
Sbjct: 194 VDVWSLGVILYTLVSGSLPFD 214

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYG 269
           IG G +  V  A+ +  G+  A+K +  ++    +  K F+ E +++  + H NIVKL+ 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 81
Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               +K ++LI EY   G +F  L  +    E +   +    + +  A+ Y H      I
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF---RQIVSAVQYCHQ---KRI 135
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTE-K 388
           +HRD+ + N+LL++ +   +ADFG +              G   Y APEL         +
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDAFCGAPPYAAPELFQGKKYDGPE 194
Query: 389 CDVYSFGVVTLEVLMGKHPRD 409
            DV+S GV+   ++ G  P D
Sbjct: 195 VDVWSLGVILYTLVSGSLPFD 215

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIH---SADI 142
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 199
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 200 VDIWSVGCIMAELLTGR 216

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 146
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGFVA-TRWYRAPEIMLNWMHYNQT 203
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 116/273 (42%), Gaps = 34/273 (12%)
Query: 213 IGTGGYGSVYKA----QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG G +G VY      Q  N    A+K L    E+  +++F  E  ++  + H N++ L 
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 269 GYCLHKKCM-FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
           G  L  + +  ++  YM  G L   + + +    +     ++    +A  + YL      
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYL---AEQ 143
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG-----YIAPELAYT 382
             +HRD+++ N +L+      VADFG AR +  D    ++    +      + A E   T
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQQHRHARLPVKWTALESLQT 202
Query: 383 MVMTEKCDVYSFGVVTLEVLMGKHP--RDIXXXXXXXXDPKIMLIDVLDQ--RLPPPVDR 438
              T K DV+SFGV+  E+L    P  R I        DP   L   L Q  RLP P   
Sbjct: 203 YRFTTKSDVWSFGVLLWELLTRGAPPYRHI--------DP-FDLTHFLAQGRRLPQP--- 250
Query: 439 KVIRDILLISTVSFACLQSNPKSRPTMQSVSQE 471
           +   D L    V   C +++P  RPT + +  E
Sbjct: 251 EYCPDSLY--QVMQQCWEADPAVRPTFRVLVGE 281

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 146
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGFVA-TRWYRAPEIMLNWMHYNQT 203
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 14/164 (8%)
Query: 250 KNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN 309
           + E ++L ++ H  I+K+  +    +  +++ E ME G LF  +  N+    L  A    
Sbjct: 63  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK---RLKEATCKL 118
Query: 310 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRT 366
               M  A+ YLH +    IIHRD+   N+LL+S+ E     + DFG +++L   S  RT
Sbjct: 119 YFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 175
Query: 367 LLAGTYGYIAPEL---AYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            L GT  Y+APE+     T       D +S GV+    L G  P
Sbjct: 176 -LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 14/164 (8%)
Query: 250 KNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN 309
           + E ++L ++ H  I+K+  +    +  +++ E ME G LF  +  N+    L  A    
Sbjct: 62  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK---RLKEATCKL 117
Query: 310 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRT 366
               M  A+ YLH +    IIHRD+   N+LL+S+ E     + DFG +++L   S  RT
Sbjct: 118 YFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 174
Query: 367 LLAGTYGYIAPEL---AYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            L GT  Y+APE+     T       D +S GV+    L G  P
Sbjct: 175 -LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 217

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 142
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y APE+    M   + 
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGFVA-TRWYRAPEIMLNWMHYNQT 199
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 200 VDIWSVGCIMAELLTGR 216

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 14/164 (8%)
Query: 250 KNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN 309
           + E ++L ++ H  I+K+  +    +  +++ E ME G LF  +  N+    L  A    
Sbjct: 69  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK---RLKEATCKL 124
Query: 310 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRT 366
               M  A+ YLH +    IIHRD+   N+LL+S+ E     + DFG +++L   S  RT
Sbjct: 125 YFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 181
Query: 367 LLAGTYGYIAPEL---AYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            L GT  Y+APE+     T       D +S GV+    L G  P
Sbjct: 182 -LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 224

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 14/164 (8%)
Query: 250 KNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN 309
           + E ++L ++ H  I+K+  +    +  +++ E ME G LF  +  N+    L  A    
Sbjct: 63  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK---RLKEATCKL 118
Query: 310 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRT 366
               M  A+ YLH +    IIHRD+   N+LL+S+ E     + DFG +++L   S  RT
Sbjct: 119 YFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 175
Query: 367 LLAGTYGYIAPEL---AYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            L GT  Y+APE+     T       D +S GV+    L G  P
Sbjct: 176 -LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 14/164 (8%)
Query: 250 KNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN 309
           + E ++L ++ H  I+K+  +    +  +++ E ME G LF  +  N+    L  A    
Sbjct: 63  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNK---RLKEATCKL 118
Query: 310 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRT 366
               M  A+ YLH +    IIHRD+   N+LL+S+ E     + DFG +++L   S  RT
Sbjct: 119 YFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 175
Query: 367 LLAGTYGYIAPEL---AYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            L GT  Y+APE+     T       D +S GV+    L G  P
Sbjct: 176 -LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 166
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y APE+    M   + 
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMXGXVA-TRWYRAPEIMLNWMHYNQT 223
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 224 VDIWSVGCIMAELLTGR 240

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           DF +   IG GG+G VY  +  + GK++A+K L        IK  + E   L++ +  ++
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR----IKMKQGETLALNERIMLSL 245
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY---- 320
           V   G C    CM   +   ++ S   +L N  D   L +    + V + A    Y    
Sbjct: 246 VST-GDCPFIVCMSYAFHTPDKLSFILDLMNGGD---LHYHLSQHGVFSEADMRFYAAEI 301
Query: 321 ---LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA--GTYGYI 375
              L H  +  +++RD+   NILL+      ++D G A     D S +   A  GT+GY+
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYM 357
Query: 376 APE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           APE L   +      D +S G +  ++L G  P
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           DF +   IG GG+G VY  +  + GK++A+K L        IK  + E   L++ +  ++
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR----IKMKQGETLALNERIMLSL 245
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY---- 320
           V   G C    CM   +   ++ S   +L N  D   L +    + V + A    Y    
Sbjct: 246 VST-GDCPFIVCMSYAFHTPDKLSFILDLMNGGD---LHYHLSQHGVFSEADMRFYAAEI 301
Query: 321 ---LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA--GTYGYI 375
              L H  +  +++RD+   NILL+      ++D G A     D S +   A  GT+GY+
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYM 357
Query: 376 APE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           APE L   +      D +S G +  ++L G  P
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 100 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 156
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 157 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 213
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 214 VDIWSVGCIMAELLTGR 230

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 14/164 (8%)
Query: 250 KNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN 309
           + E ++L ++ H  I+K+  +    +  +++ E ME G LF  +  N+   E   A    
Sbjct: 188 ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKE---ATCKL 243
Query: 310 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRT 366
               M  A+ YLH +    IIHRD+   N+LL+S+ E     + DFG +++L   S  RT
Sbjct: 244 YFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 300
Query: 367 LLAGTYGYIAPEL---AYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            L GT  Y+APE+     T       D +S GV+    L G  P
Sbjct: 301 -LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 146
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 142
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 199
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 200 VDIWSVGCIMAELLTGR 216

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 21/203 (10%)
Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEA-QVLSQVLHRNIVKLYGY 270
           +G G +G V++ +    G   A+KK+        ++ F+ E     + +    IV LYG 
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVR-------LEVFRAEELMACAGLTSPRIVPLYGA 153
Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
                 + +  E +E GSL   L   +  +  D  + +  +      L YLH   S  I+
Sbjct: 154 VREGPWVNIFMELLEGGSLG-QLVKEQGCLPED--RALYYLGQALEGLEYLH---SRRIL 207
Query: 331 HRDISSNNILLNS-KLEAFVADFGTARLLHADSSNRTLLAGTY-----GYIAPELAYTMV 384
           H D+ ++N+LL+S    A + DFG A  L  D   ++LL G Y      ++APE+     
Sbjct: 208 HGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS 267
Query: 385 MTEKCDVYSFGVVTLEVLMGKHP 407
              K DV+S   + L +L G HP
Sbjct: 268 CDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 166
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y APE+    M   + 
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 223
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 224 VDIWSVGCIMAELLTGR 240

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           DF +   IG GG+G VY  +  + GK++A+K L        IK  + E   L++ +  ++
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR----IKMKQGETLALNERIMLSL 245
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY---- 320
           V   G C    CM   +   ++ S   +L N  D   L +    + V + A    Y    
Sbjct: 246 VST-GDCPFIVCMSYAFHTPDKLSFILDLMNGGD---LHYHLSQHGVFSEADMRFYAAEI 301
Query: 321 ---LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA--GTYGYI 375
              L H  +  +++RD+   NILL+      ++D G A     D S +   A  GT+GY+
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYM 357
Query: 376 APE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           APE L   +      D +S G +  ++L G  P
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 212 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYG 269
            IG G +  V  A+ +  GK  A+K +  ++   + ++    E +++  + H NIVKL+ 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               +K ++L+ EY   G +F  L  +    E +   +    + +  A+ Y H      I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQKF---I 134
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTE-K 388
           +HRD+ + N+LL++ +   +ADFG +       +      G   Y APEL         +
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 389 CDVYSFGVVTLEVLMGKHPRD 409
            DV+S GV+   ++ G  P D
Sbjct: 194 VDVWSLGVILYTLVSGSLPFD 214

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 165
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y APE+    M   + 
Sbjct: 166 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 222
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 223 VDIWSVGCIMAELLTGR 239

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKL-----------HTSEELAFIKSFKNE 252
           ++++I   IG G YG V  A+    G+  A+KK+            T  EL  +K FK++
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 114
Query: 253 AQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK 312
             +  + + R  V  YG     K ++++ + ME   L   +H+++  + L+  +    + 
Sbjct: 115 NIIAIKDILRPTVP-YG---EFKSVYVVLDLME-SDLHQIIHSSQ-PLTLEHVR--YFLY 166
Query: 313 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR----TLL 368
            +   L Y+H   S  +IHRD+  +N+L+N   E  + DFG AR L    +      T  
Sbjct: 167 QLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEY 223
Query: 369 AGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKH 406
             T  Y APEL  ++   T+  D++S G +  E+L  + 
Sbjct: 224 VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 14/164 (8%)
Query: 250 KNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN 309
           + E ++L ++ H  I+K+  +    +  +++ E ME G LF  +  N+   E   A    
Sbjct: 202 ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKE---ATCKL 257
Query: 310 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRT 366
               M  A+ YLH +    IIHRD+   N+LL+S+ E     + DFG +++L   S  RT
Sbjct: 258 YFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 314
Query: 367 LLAGTYGYIAPEL---AYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            L GT  Y+APE+     T       D +S GV+    L G  P
Sbjct: 315 -LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 357

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           DF +   IG GG+G VY  +  + GK++A+K L        IK  + E   L++ +  ++
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR----IKMKQGETLALNERIMLSL 244
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY---- 320
           V   G C    CM   +   ++ S   +L N  D   L +    + V + A    Y    
Sbjct: 245 VST-GDCPFIVCMSYAFHTPDKLSFILDLMNGGD---LHYHLSQHGVFSEADMRFYAAEI 300
Query: 321 ---LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA--GTYGYI 375
              L H  +  +++RD+   NILL+      ++D G A     D S +   A  GT+GY+
Sbjct: 301 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYM 356
Query: 376 APE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           APE L   +      D +S G +  ++L G  P
Sbjct: 357 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 213 IGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G YG V  A     KV  A+KK+   E   + +    E ++L +  H NI+ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 272 L-----HKKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
                   K ++++ + ME     L    H + D +          +  +   L Y+H  
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH-- 149
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPELAY 381
            S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y APE+  
Sbjct: 150 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 382 -TMVMTEKCDVYSFGVVTLEVLMGK 405
            +   T+  D++S G +  E+L  +
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 213 IGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G YG V  A     KV  A+KK+   E   + +    E ++L +  H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 272 L-----HKKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
                   K ++++ + ME     L    H + D +          +  +   L Y+H  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH-- 141
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPELAY 381
            S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y APE+  
Sbjct: 142 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 382 -TMVMTEKCDVYSFGVVTLEVLMGK 405
            +   T+  D++S G +  E+L  +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 213 IGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G YG V  A     KV  A+KK+   E   + +    E ++L +  H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 272 L-----HKKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
                   K ++++ + ME     L    H + D +          +  +   L Y+H  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH-- 141
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPELAY 381
            S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y APE+  
Sbjct: 142 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 382 -TMVMTEKCDVYSFGVVTLEVLMGK 405
            +   T+  D++S G +  E+L  +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           + +   IG G +G V  A     ++    K      +  +  FK E +++  + H NI++
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
           LY        ++L+ E    G LF  + +     E D A+   I+K +  A+AY H    
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR---IMKDVLSAVAYCH---K 124
Query: 327 PSIIHRDISSNNILL-----NSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
            ++ HRD+   N L      +S L+  + DFG A         RT + GT  Y++P++  
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLK--LIDFGLAARFKPGKMMRTKV-GTPYYVSPQVLE 181
Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHP 407
            +   E CD +S GV+   +L G  P
Sbjct: 182 GLYGPE-CDEWSAGVMMYVLLCGYPP 206

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           IG+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 151
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 152 IHRDLKPSNLAVNEDXELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 208
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 209 VDIWSVGCIMAELLTGR 225

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 213 IGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G YG V  A     KV  A+KK+   E   + +    E ++L +  H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 272 L-----HKKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
                   K ++++ + ME     L    H + D +          +  +   L Y+H  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH-- 141
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPELAY 381
            S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y APE+  
Sbjct: 142 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 382 -TMVMTEKCDVYSFGVVTLEVLMGK 405
            +   T+  D++S G +  E+L  +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 213 IGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G YG V  A     KV  A+KK+   E   + +    E ++L +  H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 272 L-----HKKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
                   K ++++ + ME     L    H + D +          +  +   L Y+H  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH-- 141
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPELAY 381
            S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y APE+  
Sbjct: 142 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 382 -TMVMTEKCDVYSFGVVTLEVLMGK 405
            +   T+  D++S G +  E+L  +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 213 IGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G YG V  A     KV  A+KK+   E   + +    E ++L +  H NI+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 272 L-----HKKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
                   K ++++ + ME     L    H + D +          +  +   L Y+H  
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH-- 143
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPELAY 381
            S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y APE+  
Sbjct: 144 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 382 -TMVMTEKCDVYSFGVVTLEVLMGK 405
            +   T+  D++S G +  E+L  +
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 202 EATEDFDIRYCIGTGGYGSVYK-AQLPNGKVFALK--KLHTSEELAFIKSFKNEAQVLSQ 258
           E  E + I   +G G +G V++  +  + K +  K  K+  ++++      K E  +L+ 
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV----KKEISILNI 57
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
             HRNI+ L+      + + +I+E++    +F  +  N  A EL+  + V+ V  +  AL
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEAL 115
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVA--DFGTARLLHADSSNRTLLAGTYGYIA 376
            +LH   S +I H DI   NI+  ++  + +   +FG AR L    + R L      Y A
Sbjct: 116 QFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP-EYYA 171
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PE+    V++   D++S G +   +L G +P
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 213 IGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G YG V  A     KV  A+KK+   E   + +    E ++L +  H NI+ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 272 L-----HKKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
                   K ++++ + ME     L    H + D +          +  +   L Y+H  
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH-- 139
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPELAY 381
            S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y APE+  
Sbjct: 140 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 382 -TMVMTEKCDVYSFGVVTLEVLMGK 405
            +   T+  D++S G +  E+L  +
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 213 IGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G YG V  A     KV  A+KK+   E   + +    E ++L +  H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 272 L-----HKKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
                   K ++++ + ME     L    H + D +          +  +   L Y+H  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH-- 145
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPELAY 381
            S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y APE+  
Sbjct: 146 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 382 -TMVMTEKCDVYSFGVVTLEVLMGK 405
            +   T+  D++S G +  E+L  +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 146
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGXVATRWYRAPEIMLNWMHYNQT 203
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKL-----------HTSEELAFIKSFKNE 252
           ++++I   IG G YG V  A+    G+  A+KK+            T  EL  +K FK++
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 113
Query: 253 AQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK 312
             +  + + R  V  YG     K ++++ + ME   L   +H+++  + L+  +    + 
Sbjct: 114 NIIAIKDILRPTVP-YGEF---KSVYVVLDLME-SDLHQIIHSSQ-PLTLEHVR--YFLY 165
Query: 313 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR----TLL 368
            +   L Y+H   S  +IHRD+  +N+L+N   E  + DFG AR L    +      T  
Sbjct: 166 QLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEY 222
Query: 369 AGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKH 406
             T  Y APEL  ++   T+  D++S G +  E+L  + 
Sbjct: 223 VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 213 IGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G YG V  A     KV  A+KK+   E   + +    E ++L +  H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 272 L-----HKKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
                   K ++++ + ME     L    H + D +          +  +   L Y+H  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH-- 145
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL---AGTYGYIAPELAY 381
            S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y APE+  
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 382 -TMVMTEKCDVYSFGVVTLEVLMGK 405
            +   T+  D++S G +  E+L  +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 213 IGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G YG V  A     KV  A+KK+   E   + +    E ++L +  H NI+ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 272 L-----HKKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
                   K ++++ + ME     L    H + D +          +  +   L Y+H  
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH-- 146
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL---AGTYGYIAPELAY 381
            S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y APE+  
Sbjct: 147 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 382 -TMVMTEKCDVYSFGVVTLEVLMGK 405
            +   T+  D++S G +  E+L  +
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 213 IGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G YG V  A     KV  A+KK+   E   + +    E ++L +  H NI+ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 272 L-----HKKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
                   K ++++ + ME     L    H + D +          +  +   L Y+H  
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH-- 146
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPELAY 381
            S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y APE+  
Sbjct: 147 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 382 -TMVMTEKCDVYSFGVVTLEVLMGK 405
            +   T+  D++S G +  E+L  +
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 213 IGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G YG V  A     KV  A+KK+   E   + +    E ++L +  H NI+ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 272 L-----HKKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
                   K ++++ + ME     L    H + D +          +  +   L Y+H  
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH-- 147
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPELAY 381
            S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y APE+  
Sbjct: 148 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 382 -TMVMTEKCDVYSFGVVTLEVLMGK 405
            +   T+  D++S G +  E+L  +
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 213 IGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G YG V  A     KV  A+KK+   E   + +    E ++L +  H NI+ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 272 L-----HKKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
                   K ++++ + ME     L    H + D +          +  +   L Y+H  
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH-- 138
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPELAY 381
            S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y APE+  
Sbjct: 139 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 382 -TMVMTEKCDVYSFGVVTLEVLMGK 405
            +   T+  D++S G +  E+L  +
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 213 IGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G YG V  A     KV  A+KK+   E   + +    E ++L +  H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 272 L-----HKKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
                   K ++++ + ME     L    H + D +          +  +   L Y+H  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH-- 145
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPELAY 381
            S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y APE+  
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 382 -TMVMTEKCDVYSFGVVTLEVLMGK 405
            +   T+  D++S G +  E+L  +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 92/199 (46%), Gaps = 14/199 (7%)
Query: 213 IGTGGYGSV---YKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           +G+G YGSV   Y A+L   KV A+KKL    + L   +    E ++L  + H N++ L 
Sbjct: 36  VGSGAYGSVCSAYDARL-RQKV-AVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 269 GYCLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
                   +    E Y+    +  +L+N   +  L       +V  +   L Y+H   S 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIH---SA 150
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMT 386
            IIHRD+  +N+ +N   E  + DFG AR   AD      +A T  Y APE+    M   
Sbjct: 151 GIIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEMTGYVA-TRWYRAPEIMLNWMHYN 207
Query: 387 EKCDVYSFGVVTLEVLMGK 405
           +  D++S G +  E+L GK
Sbjct: 208 QTVDIWSVGCIMAELLQGK 226

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 213 IGTGGYGSV---YKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           +G+G YGSV   Y A+L   KV A+KKL    + L   +    E ++L  + H N++ L 
Sbjct: 28  VGSGAYGSVCSAYDARL-RQKV-AVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 269 GYCLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
                   +    E Y+    +  +L+N      L       +V  +   L Y+H   S 
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH---SA 142
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMT 386
            IIHRD+  +N+ +N   E  + DFG AR   AD      +A T  Y APE+    M   
Sbjct: 143 GIIHRDLKPSNVAVNEDCELRILDFGLAR--QADEEMTGYVA-TRWYRAPEIMLNWMHYN 199
Query: 387 EKCDVYSFGVVTLEVLMGK 405
           +  D++S G +  E+L GK
Sbjct: 200 QTVDIWSVGCIMAELLQGK 218

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 213 IGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G YG V  A     KV  A+KK+   E   + +    E ++L +  H NI+ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 272 L-----HKKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
                   K ++++ + ME     L    H + D +          +  +   L Y+H  
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH-- 161
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPELAY 381
            S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y APE+  
Sbjct: 162 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 382 -TMVMTEKCDVYSFGVVTLEVLMGK 405
            +   T+  D++S G +  E+L  +
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIH---SADI 146
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDXELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 213 IGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G YG V  A     KV  A+KK+   E   + +    E ++L +  H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 272 L-----HKKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
                   K ++++ + ME     L    H + D +          +  +   L Y+H  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH-- 145
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPELAY 381
            S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y APE+  
Sbjct: 146 -SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 382 -TMVMTEKCDVYSFGVVTLEVLMGK 405
            +   T+  D++S G +  E+L  +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 146
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 213 IGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G YG V  A     KV  A+KK+   E   + +    E ++L +  H NI+ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 272 L-----HKKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
                   K ++++ + ME     L    H + D +          +  +   L Y+H  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH-- 141
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPELAY 381
            S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y APE+  
Sbjct: 142 -SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 382 -TMVMTEKCDVYSFGVVTLEVLMGK 405
            +   T+  D++S G +  E+L  +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 7/206 (3%)
Query: 206 DFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKN---EAQVLSQVLH 261
           +F I   IG G +  VY+A  L +G   ALKK+   + L   K+  +   E  +L Q+ H
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD-LMDAKARADCIKEIDLLKQLNH 91
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            N++K Y   +    + ++ E  + G L   + + +    L       + K      + L
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL--IPERTVWKYFVQLCSAL 149
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
            H  S  ++HRDI   N+ + +     + D G  R   + ++    L GT  Y++PE  +
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHP 407
                 K D++S G +  E+   + P
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSP 235

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 213 IGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G YG V  A     KV  A+KK+   E   + +    E ++L +  H NI+ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 272 L-----HKKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
                   K ++++ + ME     L    H + D +          +  +   L Y+H  
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH-- 139
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPELAY 381
            S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y APE+  
Sbjct: 140 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 382 -TMVMTEKCDVYSFGVVTLEVLMGK 405
            +   T+  D++S G +  E+L  +
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 146
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHRNIVKLYGY 270
           IG G YG+V+KA+     ++ ALK++   ++   + S    E  +L ++ H+NIV+L+  
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV--NIVKAMAHALAYLHHDCSPS 328
               K + L++E+ ++     +L    D+   D    +  + +  +   L + H   S +
Sbjct: 70  LHSDKKLTLVFEFCDQ-----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRN 121
Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY-TMVMTE 387
           ++HRD+   N+L+N   E  +A+FG AR         +    T  Y  P++ +   + + 
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 388 KCDVYSFGVVTLEVLMGKHP 407
             D++S G +  E+     P
Sbjct: 182 SIDMWSAGCIFAELANAGRP 201

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 142
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 199
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 200 VDIWSVGCIMAELLTGR 216

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 146
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 143
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 144 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 200
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 201 VDIWSVGCIMAELLTGR 217

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 17/200 (8%)
Query: 213 IGTGGYG--SVYKAQLPN---GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G G +G  S+Y     N   G++ A+K L           +K E  +L  + H +I+K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 268 YGYCLHK--KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
            G C  +  K + L+ EY+  GSL   L  +   +    A+ +   + +   +AYLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGL----AQLLLFAQQICEGMAYLH--- 134
Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLL---HADSSNRTLLAGTYGYIAPELAYT 382
           S   IHR++++ N+LL++     + DFG A+ +   H     R        + APE    
Sbjct: 135 SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 194
Query: 383 MVMTEKCDVYSFGVVTLEVL 402
                  DV+SFGV   E+L
Sbjct: 195 YKFYYASDVWSFGVTLYELL 214

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 146
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY-TMVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNAMHYNQT 203
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 146
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 157
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 158 IHRDLKPSNLAVNEDXELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 214
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 215 VDIWSVGCIMAELLTGR 231

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 148
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 205
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 206 VDIWSVGCIMAELLTGR 222

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           + +   IG G +G V  A     ++    K      +  +  FK E +++  + H NI++
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
           LY        ++L+ E    G LF  + +     E D A+   I+K +  A+AY H    
Sbjct: 88  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR---IMKDVLSAVAYCH---K 141
Query: 327 PSIIHRDISSNNILL-----NSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
            ++ HRD+   N L      +S L+  + DFG A         RT + GT  Y++P++  
Sbjct: 142 LNVAHRDLKPENFLFLTDSPDSPLK--LIDFGLAARFKPGKMMRTKV-GTPYYVSPQVLE 198
Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHP 407
            +   E CD +S GV+   +L G  P
Sbjct: 199 GLYGPE-CDEWSAGVMMYVLLCGYPP 223

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 151
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 152 IHRDLKPSNLAVNEDXELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 208
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 209 VDIWSVGCIMAELLTGR 225

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 146
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 151
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 152 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 208
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 209 VDIWSVGCIMAELLTGR 225

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 151
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 152 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 208
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 209 VDIWSVGCIMAELLTGR 225

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 166
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y APE+    M   + 
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 223
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 224 VDIWSVGCIMAELLTGR 240

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 89  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 145
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 146 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 202
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 203 VDIWSVGCIMAELLTGR 219

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 88  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 144
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 145 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 201
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 202 VDIWSVGCIMAELLTGR 218

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 165
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y APE+    M   + 
Sbjct: 166 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 222
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 223 VDIWSVGCIMAELLTGR 239

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 143
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 144 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 200
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 201 VDIWSVGCIMAELLTGR 217

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIH---SADI 146
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 146
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 206 DFDIRYCIGTGGYGSV-YKAQLPNGKVFALKKLH-----TSEELAFIKSFKNEAQVLSQV 259
           +F+    +G G +G V    +   G+ +A+K L        +E+A   +   E +VL   
Sbjct: 11  EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT---ENRVLQNS 67
Query: 260 LHRNIVKL-YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
            H  +  L Y +  H +  F++ EY   G LF +L + E     D A+       +  AL
Sbjct: 68  RHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHL-SRERVFSEDRARFYGA--EIVSAL 123
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
            YLH +   ++++RD+   N++L+      + DFG  +    D +      GT  Y+APE
Sbjct: 124 DYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPE 181
Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +          D +  GVV  E++ G+ P
Sbjct: 182 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 169
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y APE+    M   + 
Sbjct: 170 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 226
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 227 VDIWSVGCIMAELLTGR 243

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 148
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 205
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 206 VDIWSVGCIMAELLTGR 222

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  LAGT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLAGTPEY 204
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 158
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y APE+    M   + 
Sbjct: 159 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 215
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 216 VDIWSVGCIMAELLTGR 232

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 146
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 153
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 210
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 211 VDIWSVGCIMAELLTGR 227

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 10/201 (4%)
Query: 212 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYG 269
            IG G +  V  A+ +  GK  A++ +  ++   + ++    E +++  + H NIVKL+ 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               +K ++L+ EY   G +F  L  +    E +   +    + +  A+ Y H      I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---RQIVSAVQYCHQKF---I 134
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTE-K 388
           +HRD+ + N+LL++ +   +ADFG +       +      G+  Y APEL         +
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDEFCGSPPYAAPELFQGKKYDGPE 193
Query: 389 CDVYSFGVVTLEVLMGKHPRD 409
            DV+S GV+   ++ G  P D
Sbjct: 194 VDVWSLGVILYTLVSGSLPFD 214

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 148
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 205
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 206 VDIWSVGCIMAELLTGR 222

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 158
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y APE+    M   + 
Sbjct: 159 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 215
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 216 VDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 158
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y APE+    M   + 
Sbjct: 159 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIMLNWMHYNQT 215
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 216 VDIWSVGCIMAELLTGR 232

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 206 DFDIRYCIGTGGYGSV-YKAQLPNGKVFALKKLH-----TSEELAFIKSFKNEAQVLSQV 259
           +F+    +G G +G V    +   G+ +A+K L        +E+A   +   E +VL   
Sbjct: 9   EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT---ENRVLQNS 65
Query: 260 LHRNIVKL-YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
            H  +  L Y +  H +  F++ EY   G LF +L + E     D A+       +  AL
Sbjct: 66  RHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHL-SRERVFSEDRARFYGA--EIVSAL 121
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
            YLH +   ++++RD+   N++L+      + DFG  +    D +      GT  Y+APE
Sbjct: 122 DYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPE 179
Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +          D +  GVV  E++ G+ P
Sbjct: 180 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 152
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 210 VDIWSVGCIMAELLTGR 226

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 152
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 210 VDIWSVGCIMAELLTGR 226

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 213 IGTGGYG--SVYKAQLPN---GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G G +G  S+Y     N   G++ A+K L           +K E  +L  + H +I+K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 268 YGYC--LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
            G C       + L+ EY+  GSL   L  +   +    A+ +   + +   +AYLH   
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGL----AQLLLFAQQICEGMAYLH--- 151
Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLL---HADSSNRTLLAGTYGYIAPELAYT 382
           +   IHRD+++ N+LL++     + DFG A+ +   H     R        + APE    
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKE 211
Query: 383 MVMTEKCDVYSFGVVTLEVL 402
                  DV+SFGV   E+L
Sbjct: 212 YKFYYASDVWSFGVTLYELL 231

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    IGTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    VADFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEY 204
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 157
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 158 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 214
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 215 VDIWSVGCIMAELLTGR 231

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 206 DFDIRYCIGTGGYGSV-YKAQLPNGKVFALKKLH-----TSEELAFIKSFKNEAQVLSQV 259
           +F+    +G G +G V    +   G+ +A+K L        +E+A   +   E +VL   
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT---ENRVLQNS 205
Query: 260 LHRNIVKL-YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
            H  +  L Y +  H +  F++ EY   G LF +L + E     D A+       +  AL
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHL-SRERVFSEDRARFYGA--EIVSAL 261
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
            YLH +   ++++RD+   N++L+      + DFG  +    D +      GT  Y+APE
Sbjct: 262 DYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 319
Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +          D +  GVV  E++ G+ P
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 169
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y APE+    M   + 
Sbjct: 170 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMXGYVA-TRWYRAPEIMLNWMHYNQT 226
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 227 VDIWSVGCIMAELLTGR 243

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 206 DFDIRYCIGTGGYGSV-YKAQLPNGKVFALKKLH-----TSEELAFIKSFKNEAQVLSQV 259
           +F+    +G G +G V    +   G+ +A+K L        +E+A   +   E +VL   
Sbjct: 152 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT---ENRVLQNS 208
Query: 260 LHRNIVKL-YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
            H  +  L Y +  H +  F++ EY   G LF +L + E     D A+       +  AL
Sbjct: 209 RHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHL-SRERVFSEDRARFYGA--EIVSAL 264
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
            YLH +   ++++RD+   N++L+      + DFG  +    D +      GT  Y+APE
Sbjct: 265 DYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 322
Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +          D +  GVV  E++ G+ P
Sbjct: 323 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 32/219 (14%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIV 265
           DF+    +G G +G V            L     +EEL  IK  K +  +    +   +V
Sbjct: 20  DFNFLMVLGKGSFGKV-----------MLADRKGTEELYAIKILKKDVVIQDDDVECTMV 68
Query: 266 KLYGYCLHKKCMFL---------------IYEYMERGSLFCNLHNNEDAVELDWAKRVNI 310
           +     L  K  FL               + EY+  G L   +++ +   +    + V  
Sbjct: 69  EKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFY 125
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG 370
              ++  L +LH      II+RD+  +N++L+S+    +ADFG  +    D        G
Sbjct: 126 AAEISIGLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCG 182
Query: 371 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
           T  YIAPE+       +  D +++GV+  E+L G+ P D
Sbjct: 183 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 21/203 (10%)
Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHRNIVKLYGY 270
           +G G +G V++ +    G   A+KK+        ++ F+  E    + +    IV LYG 
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVR-------LEVFRAEELMACAGLTSPRIVPLYGA 134
Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
                 + +  E +E GSL   L   +  +  D  + +  +      L YLH   S  I+
Sbjct: 135 VREGPWVNIFMELLEGGSLG-QLVKEQGCLPED--RALYYLGQALEGLEYLH---SRRIL 188
Query: 331 HRDISSNNILLNS-KLEAFVADFGTARLLHADSSNRTLLAGTY-----GYIAPELAYTMV 384
           H D+ ++N+LL+S    A + DFG A  L  D   + LL G Y      ++APE+     
Sbjct: 189 HGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS 248
Query: 385 MTEKCDVYSFGVVTLEVLMGKHP 407
              K DV+S   + L +L G HP
Sbjct: 249 CDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 206 DFDIRYCIGTGGYGSV-YKAQLPNGKVFALKKLH-----TSEELAFIKSFKNEAQVLSQV 259
           +F+    +G G +G V    +   G+ +A+K L        +E+A   +   E +VL   
Sbjct: 10  EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT---ENRVLQNS 66
Query: 260 LHRNIVKL-YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
            H  +  L Y +  H +  F++ EY   G LF +L + E     D A+       +  AL
Sbjct: 67  RHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHL-SRERVFSEDRARFYGA--EIVSAL 122
Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
            YLH +   ++++RD+   N++L+      + DFG  +    D +      GT  Y+APE
Sbjct: 123 DYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPE 180
Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +          D +  GVV  E++ G+ P
Sbjct: 181 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 19/213 (8%)
Query: 213 IGTGGYGSVYKA------QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR-NIV 265
           +G G +G V +A      +    +  A+K L      +  ++  +E ++L  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 266 KLYGYCLHKKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY---- 320
            L G C      + +I E+ + G+L   L +  +   + +         + H + Y    
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-VPYKDLYKDFLTLEHLIXYSFQV 153
Query: 321 ---LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NRTLLAGTYGYI 375
              +    S   IHRD+++ NILL+ K    + DFG AR ++ D     +        ++
Sbjct: 154 AKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWM 213
Query: 376 APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
           APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 214 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 19/213 (8%)
Query: 213 IGTGGYGSVYKA------QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR-NIV 265
           +G G +G V +A      +    +  A+K L      +  ++  +E ++L  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 266 KLYGYCLHKKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY---- 320
            L G C      + +I E+ + G+L   L +  +   + +         + H + Y    
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-VPYKDLYKDFLTLEHLICYSFQV 153
Query: 321 ---LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NRTLLAGTYGYI 375
              +    S   IHRD+++ NILL+ K    + DFG AR ++ D     +        ++
Sbjct: 154 AKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 213
Query: 376 APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
           APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 214 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 213 IGTGGYGSV---YKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           +G+G YGSV   Y A+L   KV A+KKL    + L   +    E ++L  + H N++ L 
Sbjct: 36  VGSGAYGSVCSAYDARL-RQKV-AVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 269 GYCLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
                   +    E Y+    +  +L+N      L       +V  +   L Y+H   S 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH---SA 150
Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMT 386
            IIHRD+  +N+ +N   E  + DFG AR   AD      +A T  Y APE+    M   
Sbjct: 151 GIIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEMTGYVA-TRWYRAPEIMLNWMHYN 207
Query: 387 EKCDVYSFGVVTLEVLMGK 405
           +  D++S G +  E+L GK
Sbjct: 208 QTVDIWSVGCIMAELLQGK 226

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 213 IGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G YG V  A     KV  A+KK+   E   + +    E ++L    H NI+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 272 L-----HKKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
                   K ++++ + ME     L    H + D +          +  +   L Y+H  
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH-- 143
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPELAY 381
            S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y APE+  
Sbjct: 144 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 382 -TMVMTEKCDVYSFGVVTLEVLMGK 405
            +   T+  D++S G +  E+L  +
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 148
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 149 IHRDLKPSNLAVNEDSELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 205
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 206 VDIWSVGCIMAELLTGR 222

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/279 (22%), Positives = 110/279 (39%), Gaps = 39/279 (13%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E  +I   IG G +G VY  +        L  +    E   +K+FK E     Q  H N+
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQ-LKAFKREVMAYRQTRHENV 91
Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V   G C+    + +I    +  +L+  + + +  + LD  K   I + +   + YLH  
Sbjct: 92  VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLH-- 147
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFG---TARLLHADSSNRTLLA--GTYGYIAPEL 379
            +  I+H+D+ S N+  ++  +  + DFG    + +L A      L    G   ++APE+
Sbjct: 148 -AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 380 AYTMV---------MTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQ 430
              +           ++  DV++ G +  E+   + P            P   +I  +  
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP--------FKTQPAEAIIWQMGT 257
Query: 431 RLPPPVDR----KVIRDILLISTVSFACLQSNPKSRPTM 465
            + P + +    K I DILL       C     + RPT 
Sbjct: 258 GMKPNLSQIGMGKEISDILLF------CWAFEQEERPTF 290

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 213 IGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G YG V  A     KV  A++K+   E   + +    E ++L +  H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 272 L-----HKKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
                   K ++++ + ME     L    H + D +          +  +   L Y+H  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH-- 145
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPELAY 381
            S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y APE+  
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 382 -TMVMTEKCDVYSFGVVTLEVLMGK 405
            +   T+  D++S G +  E+L  +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 213 IGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G YG V  A     KV  A+KK+   E   + +    E ++L +  H NI+ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 272 L-----HKKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
                   K ++++ + ME     L    H + D +          +  +   L Y+H  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHI-------CYFLYQILRGLKYIH-- 145
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPELAY 381
            S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y APE+  
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 382 -TMVMTEKCDVYSFGVVTLEVLMGK 405
            +   T+  D++S G +  E+L  +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 110/235 (46%), Gaps = 31/235 (13%)
Query: 190 NYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKS 248
           ++ GR  +ED+ +  ED      +G G +  V     L   + +A+K +         + 
Sbjct: 5   SFSGR--FEDVYQLQEDV-----LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV 57
Query: 249 FKNEAQVLSQVL-HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR 307
           F+ E ++L Q   HRN+++L  +   +   +L++E M  GS+  ++H      EL+ +  
Sbjct: 58  FR-EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV- 115
Query: 308 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN-----SKLEAFVADFGTARLLHADS 362
             +V+ +A AL +LH+     I HRD+   NIL       S ++    D G+   L+ D 
Sbjct: 116 --VVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170
Query: 363 ---SNRTLL--AGTYGYIAPELAYTM-----VMTEKCDVYSFGVVTLEVLMGKHP 407
              S   LL   G+  Y+APE+         +  ++CD++S GV+   +L G  P
Sbjct: 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 26/204 (12%)
Query: 213 IGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           +G G Y +VYK +      + ALK++    E     +   E  +L  + H NIV L+   
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 272 LHKKCMFLIYEYMER---------GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
             +K + L++EY+++         G++  N+HN    V+L        +  +   LAY H
Sbjct: 70  HTEKSLTLVFEYLDKDLKQYLDDCGNII-NMHN----VKL-------FLFQLLRGLAYCH 117
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAY 381
                 ++HRD+   N+L+N + E  +ADFG AR     +        T  Y  P+ L  
Sbjct: 118 RQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLG 174
Query: 382 TMVMTEKCDVYSFGVVTLEVLMGK 405
           +   + + D++  G +  E+  G+
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGR 198

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 152
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 153 IHRDLKPSNLAVNEDSELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 210 VDIWSVGCIMAELLTGR 226

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 152
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y APE+    M   + 
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 210 VDIWSVGCIMAELLTGR 226

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 17/200 (8%)
Query: 213 IGTGGYG--SVYKAQLPN---GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G G +G  S+Y     N   G++ A+K L           +K E  +L  + H +I+K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 268 YGYCLHK--KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
            G C  +  K + L+ EY+  GSL   L  +   +    A+ +   + +   +AYLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGL----AQLLLFAQQICEGMAYLH--- 134
Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLL---HADSSNRTLLAGTYGYIAPELAYT 382
           +   IHR++++ N+LL++     + DFG A+ +   H     R        + APE    
Sbjct: 135 AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 194
Query: 383 MVMTEKCDVYSFGVVTLEVL 402
                  DV+SFGV   E+L
Sbjct: 195 YKFYYASDVWSFGVTLYELL 214

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           +D    +G+G +  V K +  +       K    ++  +S      +  + E  +L ++ 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H N++ L+    +K  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 129
Query: 321 LHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPAFVA 185
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PE+     +  + D++S GV+T  +L G  P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 23/219 (10%)
Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKL-------HTSEELAFIKSFK-NEAQV 255
           E+++ +  +G G    V +    P  K +A+K +        ++EE+  ++     E  +
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 256 LSQVL-HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM 314
           L +V  H NI++L          FL+++ M++G LF  L    + V L   +   I++A+
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 133
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGY 374
              +  LH     +I+HRD+   NILL+  +   + DFG +  L      R+ + GT  Y
Sbjct: 134 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS-VCGTPSY 189
Query: 375 IAPELAYTMV------MTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+    +        ++ D++S GV+   +L G  P
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 213 IGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G YG V  A     KV  A+KK+   E   + +    E ++L    H NI+ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 272 L-----HKKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
                   K ++++ + ME     L    H + D +          +  +   L Y+H  
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH-- 143
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPELAY 381
            S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y APE+  
Sbjct: 144 -SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 382 -TMVMTEKCDVYSFGVVTLEVLMGK 405
            +   T+  D++S G +  E+L  +
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 91/201 (45%), Gaps = 10/201 (4%)
Query: 212 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYG 269
            IG G +  V  A+ +  GK  A+K +  ++   + ++    E ++   + H NIVKL+ 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFE 80
Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               +K ++L+ EY   G +F  L  +    E +   +    + +  A+ Y H      I
Sbjct: 81  VIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKF---RQIVSAVQYCHQKF---I 134
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTE-K 388
           +HRD+ + N+LL++     +ADFG +       +      G   Y APEL         +
Sbjct: 135 VHRDLKAENLLLDADXNIKIADFGFSNEF-TFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 389 CDVYSFGVVTLEVLMGKHPRD 409
            DV+S GV+   ++ G  P D
Sbjct: 194 VDVWSLGVILYTLVSGSLPFD 214

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 146
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + D+G AR  H D    T    T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDYGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 23/219 (10%)
Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKL-------HTSEELAFIKSFK-NEAQV 255
           E+++ +  +G G    V +    P  K +A+K +        ++EE+  ++     E  +
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 256 LSQVL-HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM 314
           L +V  H NI++L          FL+++ M++G LF  L    + V L   +   I++A+
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 120
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGY 374
              +  LH     +I+HRD+   NILL+  +   + DFG +  L      R  + GT  Y
Sbjct: 121 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-VCGTPSY 176
Query: 375 IAPELAYTMV------MTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+    +        ++ D++S GV+   +L G  P
Sbjct: 177 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 213 IGTGGYGSVYKA------QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR-NIV 265
           +G G +G V +A      +    +  A+K L      +  ++  +E ++L  + H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 266 KLYGYCLHKKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK---AMAHALAY- 320
            L G C      + +I E+ + G+L   L +  +  E    K  ++ K    + H + Y 
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN--EFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 321 ------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NRTLLAGTY 372
                 +    S   IHRD+++ NILL+ K    + DFG AR +  D     +       
Sbjct: 155 FQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
            ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 31/235 (13%)
Query: 190 NYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKS 248
           ++ GR  +ED+ +  ED      +G G +  V     L   + +A+K +         + 
Sbjct: 5   SFSGR--FEDVYQLQEDV-----LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV 57
Query: 249 FKNEAQVLSQVL-HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR 307
           F+ E ++L Q   HRN+++L  +   +   +L++E M  GS+  ++H      EL+ +  
Sbjct: 58  FR-EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV- 115
Query: 308 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKLEAFVADF--GTARLLHADS 362
             +V+ +A AL +LH+     I HRD+   NIL    N      + DF  G+   L+ D 
Sbjct: 116 --VVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDC 170
Query: 363 ---SNRTLL--AGTYGYIAPELAYTM-----VMTEKCDVYSFGVVTLEVLMGKHP 407
              S   LL   G+  Y+APE+         +  ++CD++S GV+   +L G  P
Sbjct: 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHT-------SEELAFIKSFKNEAQVLSQVLHRNI 264
           +G GG+G V   Q+   GK++A KKL          E +A      NE Q+L +V  R +
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-----NEKQILEKVNSRFV 246
Query: 265 VKL-YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           V L Y Y   K  + L+   M  G L  ++++   A     A+ V     +   L  LH 
Sbjct: 247 VSLAYAY-ETKDALCLVLTLMNGGDLKFHIYHMGQAG-FPEARAVFYAAEICCGLEDLHR 304
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
           +    I++RD+   NILL+      ++D G A  +    + +  + GT GY+APE+    
Sbjct: 305 E---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNE 360
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             T   D ++ G +  E++ G+ P
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 110/263 (41%), Gaps = 46/263 (17%)
Query: 167 KRKYKKPKL-------EERATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYG 219
           ++K+++ K+       EE+  N I  F   N   R    D ++ T DF+    +G G +G
Sbjct: 303 RQKFERAKIGQGTKAPEEKTANTISKFD--NNGNR----DRMKLT-DFNFLMVLGKGSFG 355
Query: 220 SVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEA-----QVLSQVLHRNIVKLYGY---- 270
            V            L +   ++EL  +K  K +       V   ++ + ++ L G     
Sbjct: 356 KV-----------MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 404
Query: 271 -----CLHK-KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
                C      ++ + EY+  G L   +++ +          V     +A  L +L   
Sbjct: 405 TQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ-- 459
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
            S  II+RD+  +N++L+S+    +ADFG  +    D        GT  YIAPE+     
Sbjct: 460 -SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP 518
Query: 385 MTEKCDVYSFGVVTLEVLMGKHP 407
             +  D ++FGV+  E+L G+ P
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQAP 541

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 213 IGTGGYGSVYKA------QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR-NIV 265
           +G G +G V +A      +    +  A+K L      +  ++  +E ++L  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 266 KLYGYCLHKKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK---AMAHALAY- 320
            L G C      + +I E+ + G+L   L +  +          ++ K    + H + Y 
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 321 ------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NRTLLAGTY 372
                 +    S   IHRD+++ NILL+ K    + DFG AR ++ D     +       
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPL 214
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
            ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           +D    +G+G +  V K +  +       K    ++  +S      +  + E  +L ++ 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H N++ L+    +K  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 129
Query: 321 LHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 185
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PE+     +  + D++S GV+T  +L G  P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N   + +L       ++  +   L Y+H   S  I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIH---SADI 146
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG  R  H D    T    T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDSELKILDFGLCR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHT-------SEELAFIKSFKNEAQVLSQVLHRNI 264
           +G GG+G V   Q+   GK++A KKL          E +A      NE Q+L +V  R +
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-----NEKQILEKVNSRFV 246
Query: 265 VKL-YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           V L Y Y   K  + L+   M  G L  ++++   A     A+ V     +   L  LH 
Sbjct: 247 VSLAYAY-ETKDALCLVLTLMNGGDLKFHIYHMGQAG-FPEARAVFYAAEICCGLEDLHR 304
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
           +    I++RD+   NILL+      ++D G A  +    + +  + GT GY+APE+    
Sbjct: 305 E---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAPEVVKNE 360
Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP 407
             T   D ++ G +  E++ G+ P
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           +D    +G+G +  V K +  +       K    ++  +S      +  + E  +L ++ 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H N++ L+    +K  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 129
Query: 321 LHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 185
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PE+     +  + D++S GV+T  +L G  P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           +D    +G+G +  V K +  +       K    ++  +S      +  + E  +L ++ 
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H N++ L+    +K  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 129
Query: 321 LHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 185
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PE+     +  + D++S GV+T  +L G  P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           +D    +G+G +  V K +  +       K    ++  +S      +  + E  +L ++ 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H N++ L+    +K  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 129
Query: 321 LHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 185
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PE+     +  + D++S GV+T  +L G  P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           +D    +G+G +  V K +  +       K    ++  +S      +  + E  +L ++ 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H N++ L+    +K  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 129
Query: 321 LHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 185
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PE+     +  + D++S GV+T  +L G  P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           +D    +G+G +  V K +  +       K    ++  +S      +  + E  +L ++ 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H N++ L+    +K  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 128
Query: 321 LHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 184
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PE+     +  + D++S GV+T  +L G  P
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           +D    +G+G +  V K +  +       K    ++  +S      +  + E  +L ++ 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H N++ L+    +K  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 129
Query: 321 LHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 185
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PE+     +  + D++S GV+T  +L G  P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 213 IGTGGYGSVYKA------QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR-NIV 265
           +G G +G V +A      +    +  A+K L      +  ++  +E ++L  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 266 KLYGYCLHKKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK---AMAHALAY- 320
            L G C      + +I E+ + G+L   L +  +          ++ K    + H + Y 
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 321 ------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NRTLLAGTY 372
                 +    S   IHRD+++ NILL+ K    + DFG AR ++ D     +       
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 214
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
            ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 213 IGTGGYGSVYKA------QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR-NIV 265
           +G G +G V +A      +    +  A+K L      +  ++  +E ++L  + H  N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 266 KLYGYCLHKKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK---AMAHALAY- 320
            L G C      + +I E+ + G+L   L +  +          ++ K    + H + Y 
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 321 ------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NRTLLAGTY 372
                 +    S   IHRD+++ NILL+ K    + DFG AR ++ D     +       
Sbjct: 192 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 251
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
            ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 252 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 138
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI 375
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+
Sbjct: 139 LTFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRT---WXLCGTPEYL 192
Query: 376 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 193 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 87/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 153
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR     +   T    T  Y APE+    M   + 
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVATRWYRAPEIMLNWMHYNQT 210
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 211 VDIWSVGCIMAELLTGR 227

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           +D    +G+G +  V K +  +       K    ++  +S      +  + E  +L ++ 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H N++ L+    +K  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 128
Query: 321 LHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 184
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PE+     +  + D++S GV+T  +L G  P
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 204
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 87/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 153
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR     +   T    T  Y APE+    M   + 
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVATRWYRAPEIMLNWMHYNQT 210
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 211 VDIWSVGCIMAELLTGR 227

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLXGTPEY 204
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           +D    +G+G +  V K +  +       K    ++  +S      +  + E  +L ++ 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H N++ L+    +K  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 129
Query: 321 LHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 185
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PE+     +  + D++S GV+T  +L G  P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 87/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 153
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DFG AR     +   T    T  Y APE+    M   + 
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVATRWYRAPEIMLNWMHYNQT 210
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 211 VDIWSVGCIMAELLTGR 227

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 204
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 20/217 (9%)
Query: 207 FDI--RYC----IGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQV 259
           FD+  RY     IG G YG V  A     K   A+KK+   E   + +    E Q+L + 
Sbjct: 39  FDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRF 98
Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H N++ +           +   Y+ +  +  +L+    + +L        +  +   L 
Sbjct: 99  RHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLK 158
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL---HADSSNRTLLAGTYGYIA 376
           Y+H   S +++HRD+  +N+L+N+  +  + DFG AR+    H  +   T    T  Y A
Sbjct: 159 YIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRA 215
Query: 377 PELAY-TMVMTEKCDVYSFGVVTLEVLM------GKH 406
           PE+   +   T+  D++S G +  E+L       GKH
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 252

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 23/219 (10%)
Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKL-------HTSEELAFIKSFK-NEAQV 255
           E+++ +  +G G    V +    P  K +A+K +        ++EE+  ++     E  +
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 256 LSQVL-HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM 314
           L +V  H NI++L          FL+++ M++G LF  L    + V L   +   I++A+
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 133
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGY 374
              +  LH     +I+HRD+   NILL+  +   + DFG +  L      R  + GT  Y
Sbjct: 134 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-VCGTPSY 189
Query: 375 IAPELAYTMV------MTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+    +        ++ D++S GV+   +L G  P
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 152
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 205
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 213 IGTGGYGSVYKA------QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR-NIV 265
           +G G +G V +A      +    +  A+K L      +  ++  +E ++L  + H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 266 KLYGYCLHKKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK---AMAHALAY- 320
            L G C      + +I E+ + G+L   L +  +          ++ K    + H + Y 
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 321 ------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NRTLLAGTY 372
                 +    S   IHRD+++ NILL+ K    + DFG AR ++ D     +       
Sbjct: 157 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 216
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
            ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 217 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 252

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 62/131 (47%), Gaps = 6/131 (4%)
Query: 277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 336
           ++ + EY+  G L   +++ +          V     +A  L +L    S  II+RD+  
Sbjct: 96  LYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKL 149
Query: 337 NNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGV 396
           +N++L+S+    +ADFG  +    D        GT  YIAPE+       +  D ++FGV
Sbjct: 150 DNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 209
Query: 397 VTLEVLMGKHP 407
           +  E+L G+ P
Sbjct: 210 LLYEMLAGQAP 220

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIV 137
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI 375
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+
Sbjct: 138 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT---LCGTPEYL 191
Query: 376 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 192 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 223

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 204
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 204
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 172
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI 375
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+
Sbjct: 173 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWT---LCGTPEYL 226
Query: 376 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
             +VKL         ++++ EY+  G +F +L       E            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAE---PHARFYAAQIVLTFEYL 157
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGYIAPELA 380
           H   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+APE+ 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEII 210
Query: 381 YTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            +    +  D ++ GV+  E+  G  P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 204
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 8/198 (4%)
Query: 213 IGTGGYGSVYKAQLPNGKV-FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG G YG V  A     KV  A+KK+   E   + +    E ++L +  H NI+ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 331
                  +   Y+    +  +L+       L        +  +   L Y+H   S +++H
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 167
Query: 332 RDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPELAY-TMVMTE 387
           RD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y APE+   +   T+
Sbjct: 168 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 227
Query: 388 KCDVYSFGVVTLEVLMGK 405
             D++S G +  E+L  +
Sbjct: 228 SIDIWSVGCILAEMLSNR 245

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 213 IGTGGYGSVYKA------QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR-NIV 265
           +G G +G V +A      +    +  A+K L      +  ++  +E ++L  + H  N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 266 KLYGYCLHKKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK---AMAHALAY- 320
            L G C      + +I E+ + G+L   L +  +   + +    ++ K    + H + Y 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-VPYKTPEDLYKDFLTLEHLICYS 154
Query: 321 ------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NRTLLAGTY 372
                 +    S   IHRD+++ NILL+ K    + DFG AR +  D     +       
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
            ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 12/206 (5%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
             +VKL         ++++ EY+  G +F +L       E            +     YL
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 152
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
           H   S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+APE+  
Sbjct: 153 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 206
Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +    +  D ++ GV+  E+  G  P
Sbjct: 207 SKGYNKAVDWWALGVLIYEMAAGYPP 232

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           +D    +G+G +  V K +  +       K    ++  +S      +  + E  +L ++ 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H N++ L+    +K  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 129
Query: 321 LHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 185
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PE+     +  + D++S GV+T  +L G  P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
             +VKL         ++++ EY+  G +F +L       E            +     YL
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 178
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGYIAPELA 380
           H   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+APE+ 
Sbjct: 179 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEII 231
Query: 381 YTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            +    +  D ++ GV+  E+  G  P
Sbjct: 232 LSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 12/208 (5%)
Query: 206 DFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTS--EELAFIKSFKNEAQVLSQVLHR 262
           ++ I   +G G +G V  A     G+  ALK ++     +       + E   L  + H 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
           +I+KLY     K  + ++ EY   G+   +     D +    A+R    + +  A+ Y H
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYA--GNELFDYIVQRDKMSEQEARR--FFQQIISAVEYCH 120
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAY 381
                 I+HRD+   N+LL+  L   +ADFG + ++  D +      G+  Y APE ++ 
Sbjct: 121 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAPEVISG 176
Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
            +    + DV+S GV+   +L  + P D
Sbjct: 177 KLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIV 152
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI 375
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT---LCGTPEYL 206
Query: 376 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           +D    +G+G +  V K +  +       K    ++  +S      +  + E  +L ++ 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H N++ L+    +K  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 129
Query: 321 LHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 185
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PE+     +  + D++S GV+T  +L G  P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           +D    +G+G +  V K +  +       K    ++  +S      +  + E  +L ++ 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H N++ L+    +K  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 129
Query: 321 LHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 185
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PE+     +  + D++S GV+T  +L G  P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
             +VKL         ++++ EY+  G +F +L       E            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 157
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGYIAPELA 380
           H   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+APE+ 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEII 210
Query: 381 YTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            +    +  D ++ GV+  E+  G  P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 12/208 (5%)
Query: 206 DFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTS--EELAFIKSFKNEAQVLSQVLHR 262
           ++ I   +G G +G V  A     G+  ALK ++     +       + E   L  + H 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
           +I+KLY     K  + ++ EY   G+   +     D +    A+R    + +  A+ Y H
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYA--GNELFDYIVQRDKMSEQEARR--FFQQIISAVEYCH 124
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAY 381
                 I+HRD+   N+LL+  L   +ADFG + ++  D +      G+  Y APE ++ 
Sbjct: 125 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAPEVISG 180
Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
            +    + DV+S GV+   +L  + P D
Sbjct: 181 KLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 213 IGTGGYGSVYKA------QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR-NIV 265
           +G G +G V +A      +    +  A+K L      +  ++  +E ++L  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 266 KLYGYCLHKKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK---AMAHALAY- 320
            L G C      + +I E+ + G+L   L +  +          ++ K    + H + Y 
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 321 ------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NRTLLAGTY 372
                 +    S   IHRD+++ NILL+ K    + DFG AR +  D     +       
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
            ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
             +VKL         ++++ EY+  G +F +L       E            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 157
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGYIAPELA 380
           H   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+APE+ 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEII 210
Query: 381 YTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            +    +  D ++ GV+  E+  G  P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 76/333 (22%), Positives = 137/333 (41%), Gaps = 72/333 (21%)
Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTS---EELAFIKS-------------F 249
           D+ I   +  G +  +   +  N K +ALKK   S   ++  F KS             F
Sbjct: 32  DYRIIRTLNQGKFNKIILCEKDN-KFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 250 KNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN 309
           KNE Q+++ + +   +   G   +   +++IYEYME  S+   L  +E    LD      
Sbjct: 91  KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSI---LKFDEYFFVLDKNYTCF 147
Query: 310 --------IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD 361
                   I+K++ ++ +Y+H++   +I HRD+  +NIL++      ++DFG +  +   
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 362 SSNRTLLAGTYGYIAPEL--AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXD 419
               +   GTY ++ PE     +     K D++S G+    +     P  +         
Sbjct: 206 KIKGS--RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL--------- 254
Query: 420 PKIMLIDVLD----QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQE---- 471
            KI L+++ +    + +  P+DR             F    +N KS  +   +S E    
Sbjct: 255 -KISLVELFNNIRTKNIEYPLDRN-----------HFLYPLTNKKSTCSNNFLSNEDIDF 302
Query: 472 -FLITRKTP--------LVKHAAIQDISISELR 495
             L  RK P         +KH  + D +I +LR
Sbjct: 303 LKLFLRKNPAERITSEDALKHEWLADTNIEDLR 335

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 213 IGTGGYGSVYKA------QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR-NIV 265
           +G G +G V +A      +    +  A+K L      +  ++  +E ++L  + H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 266 KLYGYCLHKKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK---AMAHALAY- 320
            L G C      + +I E+ + G+L   L +  +          ++ K    + H + Y 
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 321 ------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NRTLLAGTY 372
                 +    S   IHRD+++ NILL+ K    + DFG AR ++ D     +       
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 205
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
            ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIV 152
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 205
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
             +VKL         ++++ EY+  G +F +L       E            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 157
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGYIAPELA 380
           H   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+APE+ 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEYLAPEII 210
Query: 381 YTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            +    +  D ++ GV+  E+  G  P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 21/203 (10%)
Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR-NIVKLYGY 270
           +G G +G V++ +    G   A+KK+        ++ F+ E  V    L    IV LYG 
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVR-------LEVFRVEELVACAGLSSPRIVPLYGA 118
Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
                 + +  E +E GSL   L      +  D  + +  +      L YLH   +  I+
Sbjct: 119 VREGPWVNIFMELLEGGSLG-QLIKQMGCLPED--RALYYLGQALEGLEYLH---TRRIL 172
Query: 331 HRDISSNNILLNS-KLEAFVADFGTARLLHADSSNRTLLAGTY-----GYIAPELAYTMV 384
           H D+ ++N+LL+S    A + DFG A  L  D   ++LL G Y      ++APE+     
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232
Query: 385 MTEKCDVYSFGVVTLEVLMGKHP 407
              K D++S   + L +L G HP
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/272 (22%), Positives = 119/272 (43%), Gaps = 33/272 (12%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRN-- 263
           + I   IG+GG   V++      +++A+K ++  E +   + S++NE   L+++   +  
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 73
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           I++LY Y +  + ++++   ME G++  N    +    +D  +R +  K M  A+  +H 
Sbjct: 74  IIRLYDYEITDQYIYMV---MECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ 129
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAY 381
                I+H D+   N L+   +   + DFG A  +  D+++  +    GT  Y+ PE   
Sbjct: 130 H---GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 185
Query: 382 TMVMTEK-----------CDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQ 430
            M  + +            DV+S G +   +  GK P                +ID   +
Sbjct: 186 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH---AIIDPNHE 242
Query: 431 RLPPPVDRKVIRDILLISTVSFACLQSNPKSR 462
              P +  K ++D+L        CL+ +PK R
Sbjct: 243 IEFPDIPEKDLQDVLK------CCLKRDPKQR 268

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 21/203 (10%)
Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR-NIVKLYGY 270
           +G G +G V++ +    G   A+KK+        ++ F+ E  V    L    IV LYG 
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVR-------LEVFRVEELVACAGLSSPRIVPLYGA 134
Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
                 + +  E +E GSL   L      +  D  + +  +      L YLH   +  I+
Sbjct: 135 VREGPWVNIFMELLEGGSLG-QLIKQMGCLPED--RALYYLGQALEGLEYLH---TRRIL 188
Query: 331 HRDISSNNILLNS-KLEAFVADFGTARLLHADSSNRTLLAGTY-----GYIAPELAYTMV 384
           H D+ ++N+LL+S    A + DFG A  L  D   ++LL G Y      ++APE+     
Sbjct: 189 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 248
Query: 385 MTEKCDVYSFGVVTLEVLMGKHP 407
              K D++S   + L +L G HP
Sbjct: 249 CDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           +D    +G+G +  V K +  +       K    ++  +S      +  + E  +L ++ 
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H N++ L+    +K  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 129
Query: 321 LHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 185
Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           PE+     +  + D++S GV+T  +L G  P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 213 IGTGGYGSVYKA------QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR-NIV 265
           +G G +G V +A      +    +  A+K L      +  ++  +E ++L  + H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 266 KLYGYCLHKKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK---AMAHALAY- 320
            L G C      + +I E+ + G+L   L +  +          ++ K    + H + Y 
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 321 ------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NRTLLAGTY 372
                 +    S   IHRD+++ NILL+ K    + DFG AR ++ D     +       
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 205
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
            ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 146
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + DF  AR  H D    T    T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFYLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 117/275 (42%), Gaps = 31/275 (11%)
Query: 213 IGTGGYG--SVYKAQLPN---GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G G +G  S+Y     N   G++ A+K L           ++ E ++L  + H +IVK 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 268 YGYCLHK--KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
            G C  +  K + L+ EY+  GSL   L  +   V L  A+ +   + +   +AYLH   
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH--CVGL--AQLLLFAQQICEGMAYLH--- 128
Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLL---HADSSNRTLLAGTYGYIAPELAYT 382
           +   IHR +++ N+LL++     + DFG A+ +   H     R        + APE    
Sbjct: 129 AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 188
Query: 383 MVMTEKCDVYSFGVVTLEVLM----GKHPRDIXXXXXXXXDPKIMLIDVLD-----QRLP 433
                  DV+SFGV   E+L      + P             ++ ++ + +     +RLP
Sbjct: 189 CKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLP 248
Query: 434 PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
            P DR       L+      C ++    RPT Q++
Sbjct: 249 RP-DRCPCEIYHLMKN----CWETEASFRPTFQNL 278

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 12/208 (5%)
Query: 206 DFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTS--EELAFIKSFKNEAQVLSQVLHR 262
           ++ I   +G G +G V  A     G+  ALK ++     +       + E   L  + H 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
           +I+KLY     K  + ++ EY   G+   +     D +    A+R    + +  A+ Y H
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYA--GNELFDYIVQRDKMSEQEARR--FFQQIISAVEYCH 129
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAY 381
                 I+HRD+   N+LL+  L   +ADFG + ++  D +      G+  Y APE ++ 
Sbjct: 130 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAPEVISG 185
Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
            +    + DV+S GV+   +L  + P D
Sbjct: 186 KLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 10/210 (4%)
Query: 200 LIEATEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLS 257
           + E  E +     +G+G YGSV  +  + +G   A+KKL    + +   K    E ++L 
Sbjct: 46  IWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLK 105
Query: 258 QVLHRNIVKLYGYCLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 316
            + H N++ L         +    + Y+    +  +L+N     +L       ++  +  
Sbjct: 106 HMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 165
Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
            L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y A
Sbjct: 166 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTD-DEMTGYVATRWYRA 219
Query: 377 PELAYT-MVMTEKCDVYSFGVVTLEVLMGK 405
           PE+    M      D++S G +  E+L G+
Sbjct: 220 PEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 117/275 (42%), Gaps = 31/275 (11%)
Query: 213 IGTGGYG--SVYKAQLPN---GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G G +G  S+Y     N   G++ A+K L           ++ E ++L  + H +IVK 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 268 YGYCLHK--KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
            G C  +  K + L+ EY+  GSL   L  +   V L  A+ +   + +   +AYLH   
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH--CVGL--AQLLLFAQQICEGMAYLH--- 129
Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLL---HADSSNRTLLAGTYGYIAPELAYT 382
           +   IHR +++ N+LL++     + DFG A+ +   H     R        + APE    
Sbjct: 130 AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 189
Query: 383 MVMTEKCDVYSFGVVTLEVLM----GKHPRDIXXXXXXXXDPKIMLIDVLD-----QRLP 433
                  DV+SFGV   E+L      + P             ++ ++ + +     +RLP
Sbjct: 190 CKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLP 249
Query: 434 PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
            P DR       L+      C ++    RPT Q++
Sbjct: 250 RP-DRCPCEIYHLMKN----CWETEASFRPTFQNL 279

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
             +VKL         ++++ EY+  G +F +L       E            +     YL
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 158
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGYIAPELA 380
           H   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+APE+ 
Sbjct: 159 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEII 211
Query: 381 YTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            +    +  D ++ GV+  E+  G  P
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 64/178 (35%), Gaps = 51/178 (28%)
Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIP-SAXXXXXXXXXXXXXXXXXXGKIPPEIASM- 62
           G +PP I +L NL+ +    N + G IP S                   GKIPP  A++ 
Sbjct: 139 GTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN 198
Query: 63  ---------------------------------------------KYLTQLDLSNNNIQG 77
                                                        K L  LDL NN I G
Sbjct: 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYG 258
Query: 78  SIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGNILDLPSC 135
           ++P  +T+L  L  LN+S N L G +P   N       V + + N  LCG+   LP+C
Sbjct: 259 TLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN--LQRFDVSAYANNKCLCGS--PLPAC 312

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 12/208 (5%)
Query: 206 DFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTS--EELAFIKSFKNEAQVLSQVLHR 262
           ++ I   +G G +G V  A     G+  ALK ++     +       + E   L  + H 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
           +I+KLY     K  + ++ EY   G+   +     D +    A+R    + +  A+ Y H
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYA--GNELFDYIVQRDKMSEQEARR--FFQQIISAVEYCH 130
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAY 381
                 I+HRD+   N+LL+  L   +ADFG + ++  D +      G+  Y APE ++ 
Sbjct: 131 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAPEVISG 186
Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
            +    + DV+S GV+   +L  + P D
Sbjct: 187 KLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 146
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  +  FG AR  H D    T    T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILGFGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
             +VKL         ++++ EY+  G +F +L       E            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 157
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGYIAPELA 380
           H   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+APE+ 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEII 210
Query: 381 YTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            +    +  D ++ GV+  E+  G  P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   +    G  FA+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   +    G  FA+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N++++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 204
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 205 LAPEIIISKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
             +VKL         ++++ EY+  G +F +L       E            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 157
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGYIAPELA 380
           H   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+APE+ 
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEII 210
Query: 381 YTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            +    +  D ++ GV+  E+  G  P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   +    G  FA+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 204
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 21/196 (10%)
Query: 207 FDIRYCIGTGGYGSVYKA--QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           ++++ CI  GG G +Y A  +  NG+   LK L  S +         E Q L++V+H +I
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 265 VKLYGYCLHKK-----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           V+++ +  H         +++ EY+   SL           +L  A+ +  +  +  AL+
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-----KRSKGQKLPVAEAIAYLLEILPALS 196
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           YLH   S  +++ D+   NI+L  +    + D G    +++       L GT G+ APE+
Sbjct: 197 YLH---SIGLVYNDLKPENIMLTEEQLKLI-DLGAVSRINSFG----YLYGTPGFQAPEI 248
Query: 380 AYTMVMTEKCDVYSFG 395
             T   T   D+Y+ G
Sbjct: 249 VRTG-PTVATDIYTVG 263

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/272 (22%), Positives = 119/272 (43%), Gaps = 33/272 (12%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRN-- 263
           + I   IG+GG   V++      +++A+K ++  E +   + S++NE   L+++   +  
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 69
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           I++LY Y +  + ++++   ME G++  N    +    +D  +R +  K M  A+  +H 
Sbjct: 70  IIRLYDYEITDQYIYMV---MECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ 125
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAY 381
                I+H D+   N L+   +   + DFG A  +  D+++  +    GT  Y+ PE   
Sbjct: 126 H---GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 181
Query: 382 TMVMTEK-----------CDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQ 430
            M  + +            DV+S G +   +  GK P                +ID   +
Sbjct: 182 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA---IIDPNHE 238
Query: 431 RLPPPVDRKVIRDILLISTVSFACLQSNPKSR 462
              P +  K ++D+L        CL+ +PK R
Sbjct: 239 IEFPDIPEKDLQDVLK------CCLKRDPKQR 264

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 21/203 (10%)
Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR-NIVKLYGY 270
           +G G +G V++ +    G   A+KK+        ++ F+ E  V    L    IV LYG 
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVR-------LEVFRVEELVACAGLSSPRIVPLYGA 132
Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
                 + +  E +E GSL   L      +  D  + +  +      L YLH   +  I+
Sbjct: 133 VREGPWVNIFMELLEGGSLG-QLIKQMGCLPED--RALYYLGQALEGLEYLH---TRRIL 186
Query: 331 HRDISSNNILLNS-KLEAFVADFGTARLLHADSSNRTLLAGTY-----GYIAPELAYTMV 384
           H D+ ++N+LL+S    A + DFG A  L  D   ++LL G Y      ++APE+     
Sbjct: 187 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 246
Query: 385 MTEKCDVYSFGVVTLEVLMGKHP 407
              K D++S   + L +L G HP
Sbjct: 247 CDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 213 IGTGGYGSVYKA------QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR-NIV 265
           +G G +G V +A      +    +  A+K L      +  ++  +E ++L  + H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 266 KLYGYCLHKKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK---AMAHALAY- 320
            L G C      + +I E+ + G+L   L +  +          ++ K    + H + Y 
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 321 ------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NRTLLAGTY 372
                 +    S   IHRD+++ NILL+ K    + DFG AR +  D     +       
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 205
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
            ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 204
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  ++  G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYQMAAGYPP 237

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/272 (22%), Positives = 119/272 (43%), Gaps = 33/272 (12%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRN-- 263
           + I   IG+GG   V++      +++A+K ++  E +   + S++NE   L+++   +  
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           I++LY Y +  + ++++   ME G++  N    +    +D  +R +  K M  A+  +H 
Sbjct: 90  IIRLYDYEITDQYIYMV---MECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ 145
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAY 381
                I+H D+   N L+   +   + DFG A  +  D+++  +    GT  Y+ PE   
Sbjct: 146 H---GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 382 TMVMTEK-----------CDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQ 430
            M  + +            DV+S G +   +  GK P                +ID   +
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA---IIDPNHE 258
Query: 431 RLPPPVDRKVIRDILLISTVSFACLQSNPKSR 462
              P +  K ++D+L        CL+ +PK R
Sbjct: 259 IEFPDIPEKDLQDVLK------CCLKRDPKQR 284

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 79/156 (50%), Gaps = 20/156 (12%)
Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKK-LHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           IG G +G V+KA+    G+  ALKK L  +E+  F  +   E ++L  + H N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 271 CLHK-----KC---MFLIYEYMER--GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           C  K     +C   ++L++++ E     L  N+      V+   ++   +++ + + L Y
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYY 140
Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR 356
           +H +    I+HRD+ + N+L+       +ADFG AR
Sbjct: 141 IHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 146
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + D G AR  H D    T    T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDAGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 79/156 (50%), Gaps = 20/156 (12%)
Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKK-LHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           IG G +G V+KA+    G+  ALKK L  +E+  F  +   E ++L  + H N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 271 CLHK-----KC---MFLIYEYMER--GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           C  K     +C   ++L++++ E     L  N+      V+   ++   +++ + + L Y
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYY 140
Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR 356
           +H +    I+HRD+ + N+L+       +ADFG AR
Sbjct: 141 IHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 79/156 (50%), Gaps = 20/156 (12%)
Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKK-LHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           IG G +G V+KA+    G+  ALKK L  +E+  F  +   E ++L  + H N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 271 CLHK-----KC---MFLIYEYMER--GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           C  K     +C   ++L++++ E     L  N+      V+   ++   +++ + + L Y
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYY 140
Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR 356
           +H +    I+HRD+ + N+L+       +ADFG AR
Sbjct: 141 IHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 146
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + D G AR  H D    T    T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDRGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 79/156 (50%), Gaps = 20/156 (12%)
Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKK-LHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           IG G +G V+KA+    G+  ALKK L  +E+  F  +   E ++L  + H N+V L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 271 CLHK-----KC---MFLIYEYMER--GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           C  K     +C   ++L++++ E     L  N+      V+   ++   +++ + + L Y
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYY 139
Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR 356
           +H +    I+HRD+ + N+L+       +ADFG AR
Sbjct: 140 IHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/272 (22%), Positives = 119/272 (43%), Gaps = 33/272 (12%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRN-- 263
           + I   IG+GG   V++      +++A+K ++  E +   + S++NE   L+++   +  
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           I++LY Y +  + ++++   ME G++  N    +    +D  +R +  K M  A+  +H 
Sbjct: 71  IIRLYDYEITDQYIYMV---MECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ 126
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAY 381
                I+H D+   N L+   +   + DFG A  +  D+++  +    GT  Y+ PE   
Sbjct: 127 H---GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 382 TMVMTEK-----------CDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQ 430
            M  + +            DV+S G +   +  GK P                +ID   +
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA---IIDPNHE 239
Query: 431 RLPPPVDRKVIRDILLISTVSFACLQSNPKSR 462
              P +  K ++D+L        CL+ +PK R
Sbjct: 240 IEFPDIPEKDLQDVLK------CCLKRDPKQR 265

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 213 IGTGGYGSVYKA------QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR-NIV 265
           +G G +G V +A      +    +  A+K L      +  ++  +E ++L  + H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 266 KLYGYCLHKKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK---AMAHALAY- 320
            L G C      + +I E+ + G+L   L +  +          ++ K    + H + Y 
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 321 ------LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NRTLLAGTY 372
                 +    S   IHRD+++ NILL+ K    + DFG AR +  D     +       
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 205
Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
            ++APE  +  V T + DV+SFGV+  E+  +G  P
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 10/197 (5%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G+G YGSV  A     G   A+KKL    + +   K    E ++L  + H N++ L   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 271 CLHKKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
               + +    + Y+    +  +L+N     +L       ++  +   L Y+H   S  I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADI 146
Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEK 388
           IHRD+  +N+ +N   E  + D G AR  H D    T    T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDGGLAR--HTDDE-MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 389 CDVYSFGVVTLEVLMGK 405
            D++S G +  E+L G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/273 (22%), Positives = 121/273 (44%), Gaps = 35/273 (12%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRN-- 263
           + I   IG+GG   V++      +++A+K ++  E +   + S++NE   L+++   +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           I++LY Y +  + ++++   ME G++  N    +    +D  +R +  K M  A+  +H 
Sbjct: 118 IIRLYDYEITDQYIYMV---MECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ 173
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAY 381
                I+H D+   N L+   +   + DFG A  +  D+++  +    GT  Y+ PE   
Sbjct: 174 H---GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 229
Query: 382 TMVMTEK-----------CDVYSFGVVTLEVLMGKHP-RDIXXXXXXXXDPKIMLIDVLD 429
            M  + +            DV+S G +   +  GK P + I             +ID   
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH----AIIDPNH 285
Query: 430 QRLPPPVDRKVIRDILLISTVSFACLQSNPKSR 462
           +   P +  K ++D+L        CL+ +PK R
Sbjct: 286 EIEFPDIPEKDLQDVLK------CCLKRDPKQR 312

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY   G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N++++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRV----KGRTWXLCGTPEY 204
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   +    G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIV 144
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 145 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 197
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 198 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 47/226 (20%)
Query: 209 IRYC----IGTGGYGS-VYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHR 262
           I +C    +G G  G+ VY+    N  V A+K++   E  +F      E Q+L +   H 
Sbjct: 24  ISFCPKDVLGHGAEGTIVYRGMFDNRDV-AVKRI-LPECFSFAD---REVQLLRESDEHP 78
Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWA----KRVNIVKAMAHAL 318
           N+++ +  C  K   F  Y  +E     C     E   + D+A    + + +++     L
Sbjct: 79  NVIRYF--CTEKDRQFQ-YIAIE----LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGL 131
Query: 319 AYLHHDCSPSIIHRDISSNNILL-----NSKLEAFVADFGTARLLHADS---SNRTLLAG 370
           A+LH   S +I+HRD+  +NIL+     + K++A ++DFG  + L       S R+ + G
Sbjct: 132 AHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188
Query: 371 TYGYIAPELAYTMVMTEKC--------DVYSFGVVTLEVLM-GKHP 407
           T G+IAPE+     ++E C        D++S G V   V+  G HP
Sbjct: 189 TEGWIAPEM-----LSEDCKENPTYTVDIFSAGCVFYYVISEGSHP 229

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY   G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N++++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRV----KGRTWXLCGTPEY 204
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY   G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N++++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 87/200 (43%), Gaps = 17/200 (8%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           +G G YG VYKA      +  A+K++    EE     +   E  +L ++ HRNI++L   
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC-SPSI 329
             H   + LI+EY E   L   +  N D         + ++K+  + L    + C S   
Sbjct: 102 IHHNHRLHLIFEYAE-NDLKKYMDKNPDV-------SMRVIKSFLYQLINGVNFCHSRRC 153
Query: 330 IHRDISSNNILLN----SKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPE-LAYTM 383
           +HRD+   N+LL+    S+     + DFG AR         T    T  Y  PE L  + 
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSR 213
Query: 384 VMTEKCDVYSFGVVTLEVLM 403
             +   D++S   +  E+LM
Sbjct: 214 HYSTSVDIWSIACIWAEMLM 233

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 90/202 (44%), Gaps = 22/202 (10%)
Query: 213 IGTGGYGSV---YKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G V   Y A L      A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +++ E M+      NL +    +ELD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMD-----ANL-SQVIQMELDHERMSYLLYQMLVGIKHLH 143
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 199
Query: 383 MVMTEKCDVYSFGVVTLEVLMG 404
           M   E  D++S GV+  E++ G
Sbjct: 200 MGYKENVDIWSVGVIMGEMIKG 221

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/272 (22%), Positives = 119/272 (43%), Gaps = 33/272 (12%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRN-- 263
           + I   IG+GG   V++      +++A+K ++  E +   + S++NE   L+++   +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           I++LY Y +  + ++++   ME G++  N    +    +D  +R +  K M  A+  +H 
Sbjct: 118 IIRLYDYEITDQYIYMV---MECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ 173
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAY 381
                I+H D+   N L+   +   + DFG A  +  D+++  +    GT  Y+ PE   
Sbjct: 174 H---GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 229
Query: 382 TMVMTEK-----------CDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQ 430
            M  + +            DV+S G +   +  GK P                +ID   +
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH---AIIDPNHE 286
Query: 431 RLPPPVDRKVIRDILLISTVSFACLQSNPKSR 462
              P +  K ++D+L        CL+ +PK R
Sbjct: 287 IEFPDIPEKDLQDVLK------CCLKRDPKQR 312

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 90/202 (44%), Gaps = 22/202 (10%)
Query: 213 IGTGGYGSV---YKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G V   Y A L      A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 32  IGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +++ E M+      NL +    +ELD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMD-----ANL-SQVIQMELDHERMSYLLYQMLVGIKHLH 143
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 199
Query: 383 MVMTEKCDVYSFGVVTLEVLMG 404
           M   E  D++S GV+  E++ G
Sbjct: 200 MGYKENVDIWSVGVIMGEMIKG 221

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY   G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N++++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 14/207 (6%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   +    G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
             +VKL         ++++ EY+  G +F +L       E            +     YL
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 150
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGYIAPELA 380
           H   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+APE+ 
Sbjct: 151 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEII 203
Query: 381 YTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            +    +  D ++ GV+  E+  G  P
Sbjct: 204 LSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 20/226 (8%)
Query: 192 DGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALK-----KLHTSEELAF 245
           D  +++ED+ E  E       IG G +  V +      G+ FA+K     K  +S  L+ 
Sbjct: 19  DDDVLFEDVYELCE------VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLS- 71
Query: 246 IKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDA-VELDW 304
            +  K EA +   + H +IV+L         +++++E+M+   L   +    DA      
Sbjct: 72  TEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE 131
Query: 305 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHAD 361
           A   + ++ +  AL Y H +   +IIHRD+  + +LL SK  +    +  FG A  L   
Sbjct: 132 AVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES 188
Query: 362 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
                   GT  ++APE+       +  DV+  GV+   +L G  P
Sbjct: 189 GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 234

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 20/226 (8%)
Query: 192 DGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALK-----KLHTSEELAF 245
           D  +++ED+ E  E       IG G +  V +      G+ FA+K     K  +S  L+ 
Sbjct: 17  DDDVLFEDVYELCE------VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLS- 69
Query: 246 IKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDA-VELDW 304
            +  K EA +   + H +IV+L         +++++E+M+   L   +    DA      
Sbjct: 70  TEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE 129
Query: 305 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHAD 361
           A   + ++ +  AL Y H +   +IIHRD+  + +LL SK  +    +  FG A  L   
Sbjct: 130 AVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES 186
Query: 362 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
                   GT  ++APE+       +  DV+  GV+   +L G  P
Sbjct: 187 GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   +    G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIV 152
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 205
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   +    G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIV 152
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 205
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   +    G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIV 172
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 173 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 225
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 226 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   +    G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIV 152
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 205
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 100/229 (43%), Gaps = 38/229 (16%)
Query: 209 IRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL------- 260
           +R  +  GG+  VY+AQ + +G+ +ALK+L ++EE       KN A ++ +V        
Sbjct: 32  VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE------KNRA-IIQEVCFMKKLSG 84
Query: 261 HRNIVKLYGYCLHKK-------CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 313
           H NIV+        K         FL+   + +G L   L   E    L     + I   
Sbjct: 85  HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 314 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL-----HADSSNRTLL 368
              A+ ++H    P IIHRD+   N+LL+++    + DFG+A  +     ++ S+ R  L
Sbjct: 145 TCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203
Query: 369 A-------GTYGYIAPE---LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
                    T  Y  PE   L     + EK D+++ G +   +   +HP
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 14/207 (6%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
             +VKL         ++++ EY   G +F +L       E            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 157
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGYIAPELA 380
           H   S  +I+RD+   N++++ +    V DFG A+ +      RT  L GT  Y+APE+ 
Sbjct: 158 H---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEII 210
Query: 381 YTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            +    +  D ++ GV+  E+  G  P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 25/214 (11%)
Query: 204 TEDFDIRYCIGTGGYGS----VYKAQLPNG--KVFALKKLHTSEELAFIKSFKNEAQVLS 257
           ++ + ++  IG G Y      V+KA       KV    K   SEE+  +  +        
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQ------ 79
Query: 258 QVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 317
              H NI+ L       K ++L+ E M  G L   +   +   E + +    ++  +   
Sbjct: 80  ---HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREAS---FVLHTIGKT 133
Query: 318 LAYLHHDCSPSIIHRDISSNNILL---NSKLEAF-VADFGTARLLHADSSNRTLLAGTYG 373
           + YLH   S  ++HRD+  +NIL    +   E   + DFG A+ L A++        T  
Sbjct: 134 VEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN 190
Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           ++APE+       E CD++S G++   +L G  P
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 213 IGTGGYGSV---YKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G V   Y A L   +  A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +L+ E M+      NL      +ELD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMD-----ANL-XQVIQMELDHERMSYLLYQMLXGIKHLH 143
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 199
Query: 383 MVMTEKCDVYSFGVVTLEVLMGK 405
           M   E  D++S G +  E++  K
Sbjct: 200 MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +AP +  +    +  D ++ GV+  E+  G  P
Sbjct: 205 LAPAIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 25/213 (11%)
Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYG-- 269
           +G G   +V++ +    G +FA+K  +    L  +     E +VL ++ H+NIVKL+   
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 270 ---YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
                 HK    LI E+   GSL+  L    +A  L  ++ + +++ +   + +L  +  
Sbjct: 77  EETTTRHK---VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 327 PSIIHRDISSNNILL----NSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
             I+HR+I   NI+     + +    + DFG AR L  D      L GT  Y+ P++   
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVXLYGTEEYLHPDMYER 189
Query: 383 MVMTEK--------CDVYSFGVVTLEVLMGKHP 407
            V+ +          D++S GV       G  P
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 89/200 (44%), Gaps = 18/200 (9%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           IG+G  G V  A     G   A+KKL    +     K    E  +L  V H+NI+ L   
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 271 CLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
              +K +      +L+ E M+  +L   +H     +ELD  +   ++  M   + +LH  
Sbjct: 90  FTPQKTLEEFQDVYLVMELMD-ANLCQVIH-----MELDHERMSYLLYQMLCGIKHLH-- 141
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
            S  IIHRD+  +NI++ S     + DFG AR    +      +   Y Y APE+   M 
Sbjct: 142 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRY-YRAPEVILGMG 199
Query: 385 MTEKCDVYSFGVVTLEVLMG 404
             E  D++S G +  E++ G
Sbjct: 200 YKENVDIWSVGCIMGELVKG 219

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 88/203 (43%), Gaps = 22/203 (10%)
Query: 213 IGTGGYGSV---YKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G V   Y A L      A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +L+ E M+     C +      +ELD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHLH 143
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 199
Query: 383 MVMTEKCDVYSFGVVTLEVLMGK 405
           M   E  D++S G +  E++  K
Sbjct: 200 MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 213 IGTGGYGSV---YKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G V   Y A L   +  A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +L+ E M+     C +      +ELD  +   ++  M   + +LH
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHLH 144
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 145 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 200
Query: 383 MVMTEKCDVYSFGVVTLEVLMGK 405
           M   E  D++S G +  E++  K
Sbjct: 201 MGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 213 IGTGGYGSV---YKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G V   Y A L   +  A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +L+ E M+     C +      +ELD  +   ++  M   + +LH
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHLH 137
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 138 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 193
Query: 383 MVMTEKCDVYSFGVVTLEVLMGK 405
           M   E  D++S G +  E++  K
Sbjct: 194 MGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 213 IGTGGYGSV---YKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G V   Y A L   +  A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +L+ E M+     C +      +ELD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHLH 143
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 199
Query: 383 MVMTEKCDVYSFGVVTLEVLMGK 405
           M   E  D++S G +  E++  K
Sbjct: 200 MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/272 (22%), Positives = 116/272 (42%), Gaps = 33/272 (12%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRN-- 263
           + I   IG+GG   V++      +++A+K ++  E +   + S++NE   L+++   +  
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           I++LY Y +  + ++++   ME G++  N    +    +D  +R +  K M  A+  +H 
Sbjct: 90  IIRLYDYEITDQYIYMV---MECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ 145
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAY 381
                I+H D+   N L+   +   + DFG A  +  D     +    GT  Y+ PE   
Sbjct: 146 H---GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIK 201
Query: 382 TMVMTEK-----------CDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQ 430
            M  + +            DV+S G +   +  GK P                +ID   +
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA---IIDPNHE 258
Query: 431 RLPPPVDRKVIRDILLISTVSFACLQSNPKSR 462
              P +  K ++D+L        CL+ +PK R
Sbjct: 259 IEFPDIPEKDLQDVLK------CCLKRDPKQR 284

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 213 IGTGGYGSV---YKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G V   Y A L   +  A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +L+ E M+     C +      +ELD  +   ++  M   + +LH
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHLH 136
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 137 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 192
Query: 383 MVMTEKCDVYSFGVVTLEVLMGK 405
           M   E  D++S G +  E++  K
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 213 IGTGGYGSV---YKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G V   Y A L   +  A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 31  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 88
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +L+ E M+     C +      +ELD  +   ++  M   + +LH
Sbjct: 89  NVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHLH 142
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 143 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 198
Query: 383 MVMTEKCDVYSFGVVTLEVLMGK 405
           M   E  D++S G +  E++  K
Sbjct: 199 MGYKENVDIWSVGCIMGEMVRHK 221

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 213 IGTGGYGSV---YKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G V   Y A L   +  A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +L+ E M+     C +      +ELD  +   ++  M   + +LH
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHLH 144
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 145 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 200
Query: 383 MVMTEKCDVYSFGVVTLEVLMGK 405
           M   E  D++S G +  E++  K
Sbjct: 201 MGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 213 IGTGGYG---SVYKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G   + Y A L   +  A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +L+ E M+     C +      +ELD  +   ++  M   + +LH
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHLH 181
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 182 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 237
Query: 383 MVMTEKCDVYSFGVVTLEVLMGK 405
           M   E  D++S G +  E++  K
Sbjct: 238 MGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 25/214 (11%)
Query: 204 TEDFDIRYCIGTGGYGS----VYKAQLPNG--KVFALKKLHTSEELAFIKSFKNEAQVLS 257
           ++ + ++  IG G Y      V+KA       KV    K   SEE+  +  +        
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQ------ 79
Query: 258 QVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 317
              H NI+ L       K ++L+ E M  G L   +   +   E + +    ++  +   
Sbjct: 80  ---HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREAS---FVLHTIGKT 133
Query: 318 LAYLHHDCSPSIIHRDISSNNILL---NSKLEAF-VADFGTARLLHADSSNRTLLAGTYG 373
           + YLH   S  ++HRD+  +NIL    +   E   + DFG A+ L A++        T  
Sbjct: 134 VEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN 190
Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           ++APE+       E CD++S G++   +L G  P
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 213 IGTGGYGSV---YKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G V   Y A L   +  A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +L+ E M+     C +      +ELD  +   ++  M   + +LH
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHLH 137
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 138 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 193
Query: 383 MVMTEKCDVYSFGVVTLEVLMGK 405
           M   E  D++S G +  E++  K
Sbjct: 194 MGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 213 IGTGGYGSV---YKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G V   Y A L   +  A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +L+ E M+     C +      +ELD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHLH 143
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 199
Query: 383 MVMTEKCDVYSFGVVTLEVLMGK 405
           M   E  D++S G +  E++  K
Sbjct: 200 MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             + KL         ++++ EY   G +F +L             R +   A  +A    
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR---------IGRFSEPHARFYAAQIV 152
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N++++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEY 205
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 213 IGTGGYG---SVYKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G   + Y A L      A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +++ E M+     C +      +ELD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHLH 143
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 199
Query: 383 MVMTEKCDVYSFGVVTLEVLMG 404
           M   E  D++S G +  E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             + KL         ++++ EY   G +F +L             R +   A  +A    
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR---------IGRFSEPHARFYAAQIV 152
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N++++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEY 205
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT   
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEA 204
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   +    G  +A+K L   +  +L  I+   NE ++   V  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY   G +F +L             R +   A  +A    
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRR---------IGRFSEPHARFYAAQIV 152
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N+L++ +    VADFG A+ +      RT  L GT  Y
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEY 205
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 25/213 (11%)
Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYG-- 269
           +G G   +V++ +    G +FA+K  +    L  +     E +VL ++ H+NIVKL+   
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 270 ---YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
                 HK    LI E+   GSL+  L    +A  L  ++ + +++ +   + +L  +  
Sbjct: 77  EETTTRHK---VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 327 PSIIHRDISSNNILL----NSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
             I+HR+I   NI+     + +    + DFG AR L  D    +L  GT  Y+ P++   
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYLHPDMYER 189
Query: 383 MVMTE--------KCDVYSFGVVTLEVLMGKHP 407
            V+ +          D++S GV       G  P
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 213 IGTGGYG---SVYKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G   + Y A L      A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 33  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +++ E M+     C +      +ELD  +   ++  M   + +LH
Sbjct: 91  NVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHLH 144
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 145 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 200
Query: 383 MVMTEKCDVYSFGVVTLEVLMG 404
           M   E  D++S G +  E++ G
Sbjct: 201 MGYKENVDIWSVGCIMGEMIKG 222

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 213 IGTGGYG---SVYKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G   + Y A L      A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +++ E M+     C +      +ELD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHLH 143
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 199
Query: 383 MVMTEKCDVYSFGVVTLEVLMG 404
           M   E  D++S G +  E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 73/147 (49%), Gaps = 16/147 (10%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEEL---------AFIKSFKNEAQ 254
            ED      +G G +  ++K      +V    +LH +E L          + +SF   A 
Sbjct: 7   NEDLIFNESLGQGTFTKIFKGV--RREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAAS 64
Query: 255 VLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM 314
           ++S++ H+++V  YG C       L+ E+++ GSL   L  N++ + + W  ++ + K +
Sbjct: 65  MMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQL 122
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILL 341
           A A+ +L  +   ++IH ++ + NILL
Sbjct: 123 AWAMHFLEEN---TLIHGNVCAKNILL 146

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 213 IGTGGYG---SVYKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G   + Y A L      A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +++ E M+     C +      +ELD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHLH 143
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPEVVTRYYRAPEVILG 199
Query: 383 MVMTEKCDVYSFGVVTLEVLMG 404
           M   E  D++S G +  E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 74/147 (50%), Gaps = 16/147 (10%)
Query: 204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEEL---------AFIKSFKNEAQ 254
            ED      +G G +  ++K      +V    +LH +E L          + +SF   A 
Sbjct: 7   NEDLIFNESLGQGTFTKIFKGV--RREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAAS 64
Query: 255 VLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM 314
           ++S++ H+++V  YG C+      L+ E+++ GSL   L  N++ + + W  ++ + K +
Sbjct: 65  MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQL 122
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILL 341
           A A+ +L  +   ++IH ++ + NILL
Sbjct: 123 AAAMHFLEEN---TLIHGNVCAKNILL 146

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 213 IGTGGYG---SVYKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G   + Y A L   +  A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +L+ E M+     C +      +ELD  +   ++  M   + +LH
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHLH 181
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 182 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 237
Query: 383 MVMTEKCDVYSFGVVTLEVLMGK 405
           M   E  D++S G +  E++  K
Sbjct: 238 MGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 213 IGTGGYGSV---YKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G V   Y A L   +  A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +L+ E M+      NL      +ELD  +   ++  M   + +LH
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMD-----ANL-XQVIQMELDHERMSYLLYQMLXGIKHLH 136
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 137 ---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 192
Query: 383 MVMTEKCDVYSFGVVTLEVLMGK 405
           M   E  D++S G +  E++  K
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 87/202 (43%), Gaps = 22/202 (10%)
Query: 213 IGTGGYG---SVYKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G   + Y A L      A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 34  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 91
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +++ E M+     C +      +ELD  +   ++  M   + +LH
Sbjct: 92  NVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHLH 145
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR           +   Y Y APE+   
Sbjct: 146 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRY-YRAPEVILG 201
Query: 383 MVMTEKCDVYSFGVVTLEVLMG 404
           M   E  D++S G +  E++ G
Sbjct: 202 MGYKENVDIWSVGCIMGEMIKG 223

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 14/207 (6%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
             + KL         ++++ EY   G +F +L       E            +     YL
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 158
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGYIAPELA 380
           H   S  +I+RD+   N++++ +    V DFG A+ +      RT  L GT  Y+APE+ 
Sbjct: 159 H---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEYLAPEII 211
Query: 381 YTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            +    +  D ++ GV+  E+  G  P
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 26/213 (12%)
Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+    +GTG +G V   +    G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 317
             +VKL         ++++ EY   G +F +L             R +   A  +A    
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR---------IGRFSEPHARFYAAQIV 152
Query: 318 --LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGY 374
               YLH   S  +I+RD+   N++++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----KGRTWXLCGTPEY 205
Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 213 IGTGGYGSV---YKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G V   Y A L   +  A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +L+ E M+      NL      +ELD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMD-----ANL-XQVIQMELDHERMSYLLYQMLXGIKHLH 143
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 199
Query: 383 MVMTEKCDVYSFGVVTLEVLMGK 405
           M   E  D++S G +  E++  K
Sbjct: 200 MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/272 (22%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRN-- 263
           + I   IG+GG   V++      +++A+K ++  E +   + S++NE   L+++   +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           I++LY Y +  + ++++   ME G++  N    +    +D  +R +  K M  A+  +H 
Sbjct: 118 IIRLYDYEITDQYIYMV---MECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ 173
Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAY 381
                I+H D+   N L+   +   + DFG A  +  D+++  +    G   Y+ PE   
Sbjct: 174 H---GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 382 TMVMTEK-----------CDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQ 430
            M  + +            DV+S G +   +  GK P                +ID   +
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH---AIIDPNHE 286
Query: 431 RLPPPVDRKVIRDILLISTVSFACLQSNPKSR 462
              P +  K ++D+L        CL+ +PK R
Sbjct: 287 IEFPDIPEKDLQDVLK------CCLKRDPKQR 312

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 196 VYEDLIEATEDFDIRYCIGTGGYG----SVYKAQLPNGKVFALK-----KLHTSEELAFI 246
           ++ + I+ T+ ++++  IG G Y      ++KA       FA+K     K   +EE+  +
Sbjct: 13  LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKA---TNMEFAVKIIDKSKRDPTEEIEIL 69
Query: 247 KSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK 306
             +           H NI+ L       K ++++ E M+ G L   +   +   E + + 
Sbjct: 70  LRYGQ---------HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA 120
Query: 307 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKLEAF-VADFGTARLLHADS 362
              ++  +   + YLH   +  ++HRD+  +NIL    +   E+  + DFG A+ L A++
Sbjct: 121 ---VLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
                   T  ++APE+         CD++S GV+   +L G  P
Sbjct: 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 22/202 (10%)
Query: 213 IGTGGYGSV---YKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G V   Y A L      A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +++ E M+      NL +    +ELD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMD-----ANL-SQVIQMELDHERMSYLLYQMLVGIKHLH 143
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 199
Query: 383 MVMTEKCDVYSFGVVTLEVLMG 404
           M   E  D++S G +  E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 89/202 (44%), Gaps = 22/202 (10%)
Query: 213 IGTGGYG---SVYKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G   + Y A L      A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +++ E M+      NL +    +ELD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMD-----ANL-SQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 199
Query: 383 MVMTEKCDVYSFGVVTLEVLMG 404
           M   E  D++S G +  E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 103/232 (44%), Gaps = 52/232 (22%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYC 271
           +G G  G+V       G+  A+K++     + F      E ++L++   H N+++ Y   
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRML----IDFCDIALMEIKLLTESDDHPNVIRYYCSE 78
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVE--------LDWAKRVN---IVKAMAHALAY 320
              + +++  E        CNL N +D VE        L   K  N   +++ +A  +A+
Sbjct: 79  TTDRFLYIALE-------LCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 321 LHHDCSPSIIHRDISSNNILLNS-------------KLEAFVADFGTARLLHA-DSSNRT 366
           LH   S  IIHRD+   NIL+++              L   ++DFG  + L +  SS RT
Sbjct: 131 LH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 367 LL---AGTYGYIAPE-------LAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
            L   +GT G+ APE       L     +T   D++S G V   +L  GKHP
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 213 IGTGGYGSV---YKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G V   Y A L   +  A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +L+ E M+      NL      +ELD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMD-----ANL-XQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 199
Query: 383 MVMTEKCDVYSFGVVTLEVLMGK 405
           M   E  D++S G +  E++  K
Sbjct: 200 MGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 89/202 (44%), Gaps = 22/202 (10%)
Query: 213 IGTGGYG---SVYKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G   + Y A L      A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +++ E M+      NL +    +ELD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMD-----ANL-SQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 199
Query: 383 MVMTEKCDVYSFGVVTLEVLMG 404
           M   E  D++S G +  E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 87/200 (43%), Gaps = 27/200 (13%)
Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGY 270
           +G G YG V+K +   +G+++A+K+      ++  +  K+ A+ L++V  H  + +    
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKR-----SMSPFRGPKDRARKLAEVGSHEKVGQ---- 115
Query: 271 CLHKKCMFLIYEYMERGSLFCNL---------HNNEDAVELDWAKRVNIVKAMAHALAYL 321
             H  C+ L   + E G L+            H       L  A+    ++    ALA+L
Sbjct: 116 --HPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
           H   S  ++H D+   NI L  +    + DFG    L    +   +  G   Y+APEL  
Sbjct: 174 H---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE-VQEGDPRYMAPELLQ 229
Query: 382 TMVMTEKCDVYSFGVVTLEV 401
               T   DV+S G+  LEV
Sbjct: 230 GSYGT-AADVFSLGLTILEV 248

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 89/202 (44%), Gaps = 22/202 (10%)
Query: 213 IGTGGYG---SVYKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G   + Y A L      A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +++ E M+      NL +    +ELD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMD-----ANL-SQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 199
Query: 383 MVMTEKCDVYSFGVVTLEVLMG 404
           M   E  D++S G +  E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG 221

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 96/231 (41%), Gaps = 42/231 (18%)
Query: 207 FDIRYCIGTGGYGSVYKA-QLPNGKVFALKK-LHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           ++IR+ IGTG YG V +A      +V A+KK L   E+L   K    E  +L+++ H ++
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 265 VKLYGYCLHKKC-----MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           VK+    + K       ++++ E  +  S F  L      V L       ++  +   + 
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIAD--SDFKKLFRT--PVYLTELHIKTLLYNLLVGVK 170
Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL--------------------- 358
           Y+H   S  I+HRD+   N L+N      V DFG AR +                     
Sbjct: 171 YVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 359 ----HADSSNRTLLAG--TYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVL 402
               H  +  R L     T  Y APEL       TE  DV+S G +  E+L
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 25/208 (12%)
Query: 213 IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN----IVKL 267
           +G+G  G V+K +    G V A+K++  S      K    +  V   VL  +    IV+ 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDV---VLKSHDCPYIVQC 89
Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV--NIVKAMAHALAYLHHDC 325
           +G  +    +F+  E M  G+    L      ++    +R+   +  A+  AL YL    
Sbjct: 90  FGTFITNTDVFIAMELM--GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKE-- 142
Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFG-TARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
              +IHRD+  +NILL+ + +  + DFG + RL+   + +R+  AG   Y+APE      
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS--AGCAAYMAPERIDPPD 200
Query: 385 MTE-----KCDVYSFGVVTLEVLMGKHP 407
            T+     + DV+S G+  +E+  G+ P
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 46/85 (54%), Gaps = 3/85 (3%)
Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NRTLLAGTYGYIAPELAYTM 383
           S   IHRD+++ NILL+ K    + DFG AR ++ D     +        ++APE  +  
Sbjct: 216 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 275
Query: 384 VMTEKCDVYSFGVVTLEVL-MGKHP 407
           V T + DV+SFGV+  E+  +G  P
Sbjct: 276 VYTIQSDVWSFGVLLWEIFSLGASP 300

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 103/221 (46%), Gaps = 31/221 (14%)
Query: 200 LIEATEDFDIRYCIGTGGYG--SVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLS 257
           ++  ++ +++   IG G +G   + + +  N ++ A+K +   E++   ++ K E     
Sbjct: 14  IMHDSDRYELVKDIGAGNFGVARLMRDKQAN-ELVAVKYIERGEKID--ENVKREIINHR 70
Query: 258 QVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLF---CNLHN-NEDAVELDWAKRVNIVKA 313
            + H NIV+     L    + ++ EY   G LF   CN    +ED     + + ++ V +
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV-S 129
Query: 314 MAHALAYLHHDCSPSIIHRDISSNNILLNS----KLEAFVADFG--TARLLHADSSNRTL 367
            AHA+          + HRD+   N LL+     +L+  +ADFG   A +LH+   +   
Sbjct: 130 YAHAM---------QVAHRDLKLENTLLDGSPAPRLK--IADFGYSKASVLHSQPKS--- 175
Query: 368 LAGTYGYIAPELAYTMVMTEK-CDVYSFGVVTLEVLMGKHP 407
             GT  YIAPE+        K  DV+S GV    +L+G +P
Sbjct: 176 AVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 46/85 (54%), Gaps = 3/85 (3%)
Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NRTLLAGTYGYIAPELAYTM 383
           S   IHRD+++ NILL+ K    + DFG AR ++ D     +        ++APE  +  
Sbjct: 218 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 277
Query: 384 VMTEKCDVYSFGVVTLEVL-MGKHP 407
           V T + DV+SFGV+  E+  +G  P
Sbjct: 278 VYTIQSDVWSFGVLLWEIFSLGASP 302

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 46/85 (54%), Gaps = 3/85 (3%)
Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NRTLLAGTYGYIAPELAYTM 383
           S   IHRD+++ NILL+ K    + DFG AR ++ D     +        ++APE  +  
Sbjct: 211 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 270
Query: 384 VMTEKCDVYSFGVVTLEVL-MGKHP 407
           V T + DV+SFGV+  E+  +G  P
Sbjct: 271 VYTIQSDVWSFGVLLWEIFSLGASP 295

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/85 (35%), Positives = 46/85 (54%), Gaps = 3/85 (3%)
Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NRTLLAGTYGYIAPELAYTM 383
           S   IHRD+++ NILL+ K    + DFG AR ++ D     +        ++APE  +  
Sbjct: 209 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 268
Query: 384 VMTEKCDVYSFGVVTLEVL-MGKHP 407
           V T + DV+SFGV+  E+  +G  P
Sbjct: 269 VYTIQSDVWSFGVLLWEIFSLGASP 293

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 18/200 (9%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           IG+G  G V  A     G   A+KKL    +     K    E  +L  V H+NI+ L   
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 271 CLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
              +K +      +L+ E M+  +L   +H     +ELD  +   ++  M   + +LH  
Sbjct: 92  FTPQKTLEEFQDVYLVMELMD-ANLCQVIH-----MELDHERMSYLLYQMLCGIKHLH-- 143
Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
            S  IIHRD+  +NI++ S     + DFG AR    +      +   Y Y APE+   M 
Sbjct: 144 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY-YRAPEVILGMG 201
Query: 385 MTEKCDVYSFGVVTLEVLMG 404
                D++S G +  E++ G
Sbjct: 202 YAANVDIWSVGCIMGELVKG 221

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 56/124 (45%), Gaps = 21/124 (16%)
Query: 291 CNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVA 350
           C+L + E  V L      +I   +A A+ +LH   S  ++HRD+  +NI         V 
Sbjct: 156 CSLEDREHGVCL------HIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVG 206
Query: 351 DFGTARLLHADSSNRTLLA------------GTYGYIAPELAYTMVMTEKCDVYSFGVVT 398
           DFG    +  D   +T+L             GT  Y++PE  +    + K D++S G++ 
Sbjct: 207 DFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLIL 266
Query: 399 LEVL 402
            E+L
Sbjct: 267 FELL 270

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 107/225 (47%), Gaps = 35/225 (15%)
Query: 206 DFDIRYC----IGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           D   RY     +G GG G V+ A   +  K  A+KK+  ++  + +K    E +++ ++ 
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS-VKHALREIKIIRRLD 66
Query: 261 HRNIVKLY--------------GYCLHKKCMFLIYEYMERGSLFCNLHNN-EDAVELDWA 305
           H NIVK++              G       ++++ EYME      +L N  E    L+  
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-----TDLANVLEQGPLLEEH 121
Query: 306 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTARLLHADSSN 364
            R+ + + +   L Y+H   S +++HRD+   N+ +N++ L   + DFG AR++    S+
Sbjct: 122 ARLFMYQLL-RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
Query: 365 RTLLAG---TYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGK 405
           +  L+    T  Y +P L  +    T+  D+++ G +  E+L GK
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 88/203 (43%), Gaps = 22/203 (10%)
Query: 213 IGTGGYGSV---YKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G V   Y A L      A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 26  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 83
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +++ E M+     C +      +ELD  +   ++  M   + +LH
Sbjct: 84  NVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHLH 137
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 138 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 193
Query: 383 MVMTEKCDVYSFGVVTLEVLMGK 405
           M   E  D++S G +  E++  K
Sbjct: 194 MGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 22/203 (10%)
Query: 213 IGTGGYG---SVYKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G   + Y A L      A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 37  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 94
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +++ E M+     C +      +ELD  +   ++  M   + +LH
Sbjct: 95  NVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHLH 148
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR     S   T    T  Y APE+   
Sbjct: 149 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILG 204
Query: 383 MVMTEKCDVYSFGVVTLEVLMGK 405
           M   E  D++S G +  E++  K
Sbjct: 205 MGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 213 IGTGGYG---SVYKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G   + Y A L      A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +++ E M+     C +      +ELD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHLH 143
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR           +   Y Y APE+   
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRY-YRAPEVILG 199
Query: 383 MVMTEKCDVYSFGVVTLEVLMGK 405
           M   E  D++S G +  E++  K
Sbjct: 200 MGYKENVDIWSVGCIMGEMVCHK 222

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 106/247 (42%), Gaps = 47/247 (19%)
Query: 196 VYEDLIEATEDFDIRYCIGTGGYGSVY--KAQLPNG--KVFALKKLHTSEELAFIKSFKN 251
           +YE + + +  F I   IG G + SVY   AQL  G  +  ALK L  +     I +   
Sbjct: 12  LYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAA--- 68
Query: 252 EAQVLSQVLHRNIVKLYGYCLHKKCMFLI-YEYMERGSLFCNLHNNEDAVELDWAKRVNI 310
           E Q L+    ++ V    YC  K    +I   Y+E  S F ++ N+    E+     +N+
Sbjct: 69  ELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHES-FLDILNSLSFQEVR-EYMLNL 126
Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHAD-------- 361
            KA+     +        I+HRD+  +N L N +L+ + + DFG A+  H          
Sbjct: 127 FKALKRIHQF-------GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFV 179
Query: 362 ---------SSNRTLL-----------AGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLE 400
                    S N+  +           AGT G+ APE L      T   D++S GV+ L 
Sbjct: 180 QSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLS 239
Query: 401 VLMGKHP 407
           +L G++P
Sbjct: 240 LLSGRYP 246

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 48/228 (21%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYC 271
           +G G  G+V       G+  A+K++     + F      E ++L++   H N+++ Y   
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRML----IDFCDIALMEIKLLTESDDHPNVIRYYCSE 96
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVE--------LDWAKRVN---IVKAMAHALAY 320
              + +++  E        CNL N +D VE        L   K  N   +++ +A  +A+
Sbjct: 97  TTDRFLYIALE-------LCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 148
Query: 321 LHHDCSPSIIHRDISSNNILLNS-------------KLEAFVADFGTARLLHADS----S 363
           LH   S  IIHRD+   NIL+++              L   ++DFG  + L +       
Sbjct: 149 LH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRX 205
Query: 364 NRTLLAGTYGYIAPEL---AYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
           N    +GT G+ APEL   +    +T   D++S G V   +L  GKHP
Sbjct: 206 NLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHP 253

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 48/228 (21%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYC 271
           +G G  G+V       G+  A+K++     + F      E ++L++   H N+++ Y   
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRML----IDFCDIALMEIKLLTESDDHPNVIRYYCSE 96
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVE--------LDWAKRVN---IVKAMAHALAY 320
              + +++  E        CNL N +D VE        L   K  N   +++ +A  +A+
Sbjct: 97  TTDRFLYIALE-------LCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 148
Query: 321 LHHDCSPSIIHRDISSNNILLNSK-------------LEAFVADFGTARLLHADS----S 363
           LH   S  IIHRD+   NIL+++              L   ++DFG  + L +       
Sbjct: 149 LH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRX 205
Query: 364 NRTLLAGTYGYIAPEL---AYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
           N    +GT G+ APEL   +    +T   D++S G V   +L  GKHP
Sbjct: 206 NLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHP 253

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 98/225 (43%), Gaps = 31/225 (13%)
Query: 196 VYEDLIEATEDFDIRYCIGTGGYG----SVYKAQLPNGKVFALK-----KLHTSEELAFI 246
           ++ + I+ T+ ++++  IG G Y      ++KA       FA+K     K   +EE+  +
Sbjct: 13  LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKA---TNXEFAVKIIDKSKRDPTEEIEIL 69
Query: 247 KSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK 306
             +           H NI+ L       K ++++ E  + G L   +   +   E + + 
Sbjct: 70  LRYGQ---------HPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASA 120
Query: 307 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKLEAF-VADFGTARLLHADS 362
              ++  +   + YLH   +  ++HRD+  +NIL    +   E+  + DFG A+ L A++
Sbjct: 121 ---VLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174
Query: 363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
                   T  ++APE+         CD++S GV+    L G  P
Sbjct: 175 GLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 213 IGTGGYG---SVYKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           IG+G  G   + Y A L      A+KKL    +     K    E  ++  V H+NI+ L 
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 269 GYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
                +K +      +++ E M+     C +      +ELD  +   ++  M   + +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHLH 143
Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  IIHRD+  +NI++ S     + DFG AR           +   Y Y APE+   
Sbjct: 144 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRY-YRAPEVILG 199
Query: 383 MVMTEKCDVYSFGVVTLEVLMGK 405
           M   E  D++S G +  E++  K
Sbjct: 200 MGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 83/194 (42%), Gaps = 41/194 (21%)
Query: 228 NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRN---------IVKLY-GYCLHKKC 276
           NGKV  +    T E+ A +K  ++  +   +V LH           IV +Y      +KC
Sbjct: 31  NGKVLQIFNKRTQEKFA-LKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89
Query: 277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 336
           + ++ E ++ G LF  + +  D    +  +   I+K++  A+ YLH   S +I HRD+  
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH---SINIAHRDVKP 145
Query: 337 NNILLNSKLEAFV---ADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYS 393
            N+L  SK    +    DFG A+    +  +++                      CD++S
Sbjct: 146 ENLLYTSKRPNAILKLTDFGFAKETTGEKYDKS----------------------CDMWS 183
Query: 394 FGVVTLEVLMGKHP 407
            GV+   +L G  P
Sbjct: 184 LGVIMYILLCGYPP 197

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/284 (22%), Positives = 120/284 (42%), Gaps = 46/284 (16%)
Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL--------HRN 263
           +G+GG+GSVY   ++ +    A+K +   + ++      N  +V  +V+           
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHV-EKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV--NIVKAMAHALAYL 321
           +++L  +        LI E ME      +      A++ + A+     +++A+ H     
Sbjct: 75  VIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC---- 130
Query: 322 HHDCSPSIIHRDISSNNILLN-SKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-L 379
            H+C   ++HRDI   NIL++ ++ E  + DFG+  LL    +  T   GT  Y  PE +
Sbjct: 131 -HNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWI 185
Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIXXXXXXXXDPKIMLIDVLDQRLPPPVDRK 439
            Y         V+S G++  +++ G  P +         D +I+   V  ++      + 
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE--------HDEEIIRGQVFFRQRVSSECQH 237
Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVS-----QEFLITRKT 478
           +IR           CL   P  RPT + +      Q+ L+ ++T
Sbjct: 238 LIR----------WCLALRPSDRPTFEEIQNHPWMQDVLLPQET 271

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 25/218 (11%)
Query: 200 LIEATEDFDIRYCIGTGGYG-SVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQ 258
           ++  ++ +++   IG+G +G +       + ++ A+K +   E++A   + K E      
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIA--ANVKREIINHRS 71
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLF---CNLHN-NEDAVELDWAKRVNIVKAM 314
           + H NIV+     L    + ++ EY   G LF   CN    +ED     + + ++ V + 
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV-SY 130
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF--VADFGTAR--LLHADSSNRTLLAG 370
            HA+          + HRD+   N LL+        + DFG ++  +LH+   +     G
Sbjct: 131 CHAM---------QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVG 178
Query: 371 TYGYIAPELAYTMVMTEK-CDVYSFGVVTLEVLMGKHP 407
           T  YIAPE+        K  DV+S GV    +L+G +P
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 92/227 (40%), Gaps = 43/227 (18%)
Query: 200 LIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV 259
           ++  ++ +D    IG+G +G           V  L +   ++EL  +K  +  A +   V
Sbjct: 15  IMHDSDRYDFVKDIGSGNFG-----------VARLMRDKLTKELVAVKYIERGAAIDENV 63
Query: 260 L----------HRNIVKLYGYCLHKKCMFLIYEYMERGSLF---CNLHN-NEDAVELDWA 305
                      H NIV+     L    + +I EY   G L+   CN    +ED       
Sbjct: 64  QREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARF--- 120
Query: 306 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF--VADFGTAR--LLHAD 361
                 + +   ++Y H   S  I HRD+   N LL+        + DFG ++  +LH+ 
Sbjct: 121 ----FFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173
Query: 362 SSNRTLLAGTYGYIAPELAYTMVMTEK-CDVYSFGVVTLEVLMGKHP 407
             +     GT  YIAPE+        K  DV+S GV    +L+G +P
Sbjct: 174 PKS---TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 103/231 (44%), Gaps = 22/231 (9%)
Query: 190 NYDGRIVYEDLIEATED-FDIRYC-IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIK 247
           +YD ++      E  ED F+   C +G G YG VYKA+  +GK      L   E      
Sbjct: 4   DYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM 63
Query: 248 SFKNEAQVLSQVLHRNIVKLYGYCLHK--KCMFLIYEYMERGSL-FCNLHNNEDAVELDW 304
           S   E  +L ++ H N++ L    L    + ++L+++Y E         H    A +   
Sbjct: 64  SACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANK--- 120
Query: 305 AKRVNIVKAMAHALAY-----LHHDCSPSIIHRDISSNNILL----NSKLEAFVADFGTA 355
            K V + + M  +L Y     +H+  +  ++HRD+   NIL+      +    +AD G A
Sbjct: 121 -KPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179
Query: 356 RLLHA---DSSNRTLLAGTYGYIAPELAY-TMVMTEKCDVYSFGVVTLEVL 402
           RL ++     ++   +  T+ Y APEL       T+  D+++ G +  E+L
Sbjct: 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 230

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 48/115 (41%), Gaps = 25/115 (21%)
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILL-NSKLEAF------------------V 349
           ++   + HAL +LH +    + H D+   NIL  NS+ E                    V
Sbjct: 127 HMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 350 ADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG 404
           ADFG+A     D  + T +  T  Y  PE+   +   + CDV+S G +  E   G
Sbjct: 184 ADFGSATF---DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 99/232 (42%), Gaps = 52/232 (22%)
Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYC 271
           +G G  G+V       G+  A+K++     + F      E ++L++   H N+++ Y   
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRML----IDFCDIALMEIKLLTESDDHPNVIRYYCSE 78
Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVE--------LDWAKRVN---IVKAMAHALAY 320
              + +++  E        CNL N +D VE        L   K  N   +++ +A  +A+
Sbjct: 79  TTDRFLYIALE-------LCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 321 LHHDCSPSIIHRDISSNNILLNS-------------KLEAFVADFGTARLLHADS----S 363
           LH   S  IIHRD+   NIL+++              L   ++DFG  + L +       
Sbjct: 131 LH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRX 187
Query: 364 NRTLLAGTYGYIAPE-------LAYTMVMTEKCDVYSFGVVTLEVL-MGKHP 407
           N    +GT G+ APE       L     +T   D++S G V   +L  GKHP
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 23/215 (10%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTS----------EELAFIKSFKNEAQVL 256
           + ++  I +G YG+V       G   A+K++  +           +    K    E ++L
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 257 SQVLHRNIVKLYGYCLHKK-----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIV 311
           +   H NI+ L    +H +      ++L+ E M R  L   +H+    +        +I 
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQ-----HIQ 137
Query: 312 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT 371
             M H L  LH      ++HRD+   NILL    +  + DF  AR   AD +N+T     
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD-ANKTHYVTH 196
Query: 372 YGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGK 405
             Y APEL       T+  D++S G V  E+   K
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 23/215 (10%)
Query: 207 FDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTS----------EELAFIKSFKNEAQVL 256
           + ++  I +G YG+V       G   A+K++  +           +    K    E ++L
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 257 SQVLHRNIVKLYGYCLHKK-----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIV 311
           +   H NI+ L    +H +      ++L+ E M R  L   +H+    +        +I 
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQ-----HIQ 137
Query: 312 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT 371
             M H L  LH      ++HRD+   NILL    +  + DF  AR   AD +N+T     
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD-ANKTHYVTH 196
Query: 372 YGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGK 405
             Y APEL       T+  D++S G V  E+   K
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 48/115 (41%), Gaps = 25/115 (21%)
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILL-NSKLEAF------------------V 349
           ++   + HAL +LH +    + H D+   NIL  NS+ E                    V
Sbjct: 136 HMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 192
Query: 350 ADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG 404
           ADFG+A     D  + T +  T  Y  PE+   +   + CDV+S G +  E   G
Sbjct: 193 ADFGSATF---DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 244

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 48/115 (41%), Gaps = 25/115 (21%)
Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILL-NSKLEAF------------------V 349
           ++   + HAL +LH +    + H D+   NIL  NS+ E                    V
Sbjct: 159 HMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 215
Query: 350 ADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG 404
           ADFG+A     D  + T +  T  Y  PE+   +   + CDV+S G +  E   G
Sbjct: 216 ADFGSATF---DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 267

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 200 LIEATEDFDIRYCIGTGGYG-SVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQ 258
           ++  ++ +++   IG+G +G +       + ++ A+K +   E++   ++ K E      
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKID--ENVKREIINHRS 71
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLF---CNLHN-NEDAVELDWAKRVNIVKAM 314
           + H NIV+     L    + ++ EY   G LF   CN    +ED     + + ++ V + 
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV-SY 130
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNRTLLAG 370
            HA+          + HRD+   N LL+     +L+     +  + +LH+   +     G
Sbjct: 131 CHAM---------QVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKD---TVG 178
Query: 371 TYGYIAPELAYTMVMTEK-CDVYSFGVVTLEVLMGKHP 407
           T  YIAPE+        K  DV+S GV    +L+G +P
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 200 LIEATEDFDIRYCIGTGGYG-SVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQ 258
           ++  ++ +++   IG+G +G +       + ++ A+K +   E++   ++ K E      
Sbjct: 13  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKID--ENVKREIINHRS 70
Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLF---CNLHN-NEDAVELDWAKRVNIVKAM 314
           + H NIV+     L    + ++ EY   G LF   CN    +ED     + + ++ V + 
Sbjct: 71  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV-SY 129
Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTAR--LLHADSSNRTLL 368
            HA+          + HRD+   N LL+     +L+  + DFG ++  +LH+   +    
Sbjct: 130 CHAM---------QVCHRDLKLENTLLDGSPAPRLK--ICDFGYSKSSVLHSQPKS---T 175
Query: 369 AGTYGYIAPELAYTMVMTEK-CDVYSFGVVTLEVLMGKHP 407
            GT  YIAPE+        K  DV+S GV    +L+G +P
Sbjct: 176 VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 215
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	496
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	7e-94
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-82
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-77
3soc_A	322	Activin receptor type-2A; structural genomics cons	7e-71
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-66
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-65
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-62
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-61
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	8e-59
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-57
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-56
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-55
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-55
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-55
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-54
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-54
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-54
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-53
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-42
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-41
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-34
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-25
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-42
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-41
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-41
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-41
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-40
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-39
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-38
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-38
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-38
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-36
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-35
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-33
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-32
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-32
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-32
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-29
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-29
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-28
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-26
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-22
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-14
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-38
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-38
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-37
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-37
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-36
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-36
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-36
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-36
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-36
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-36
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-36
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-36
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-36
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-35
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-35
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-35
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-35
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-35
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-35
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-35
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-34
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-34
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-34
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-34
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-34
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-34
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-34
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-34
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-34
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-34
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-34
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-34
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	7e-34
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-34
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	8e-34
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-33
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-33
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-33
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-33
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-33
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-33
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-33
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-33
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-33
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-33
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-33
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-33
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-33
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-32
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-32
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-32
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-32
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-32
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-32
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-32
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-31
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-31
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-31
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-31
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-31
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-31
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-31
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-31
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	9e-31
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-30
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-30
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-30
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-30
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	8e-30
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-30
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-29
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-29
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-29
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-29
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-29
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-29
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-29
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-28
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-28
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-28
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-28
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-28
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-28
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-28
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-28
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-28
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-28
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	7e-28
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-28
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-28
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-27
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-27
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-27
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-27
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-27
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-27
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-27
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-27
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-26
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-26
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-26
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-26
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-23
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-23
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-22
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-22
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-22
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-21
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-20
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-19
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-15
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-14
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-26
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-26
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-26
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-26
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-26
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-26
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-26
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	8e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	9e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-25
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-24
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-22
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-12
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-26
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-25
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-25
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-25
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-25
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-25
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-25
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-25
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	7e-25
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-24
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-24
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-22
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-22
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-22
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-21
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-19
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-15
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-13
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-12
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-24
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-24
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-20
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-20
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-20
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-19
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-19
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-19
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-18
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-09
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-23
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-23
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-23
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-23
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-21
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-21
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-21
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-21
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-20
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-18
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-17
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-13
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-11
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-11
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-10
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-21
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-21
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-19
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-19
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-19
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-17
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-11
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	8e-21
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-20
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-20
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-19
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-19
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-18
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-11
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-20
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-20
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-19
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-19
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-19
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-19
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-19
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-17
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-17
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-17
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-16
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-16
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-12
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-11
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-19
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-19
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-19
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-19
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-19
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-18
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-17
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-17
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-15
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-15
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-10
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-19
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	8e-19
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-17
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-16
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-16
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-16
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-13
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-11
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-18
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-18
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-18
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-18
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-18
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-18
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-18
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-05
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-18
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-18
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-17
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-17
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-16
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-15
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-05
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-05
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-17
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-17
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-17
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-16
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-16
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-16
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-16
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-15
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-15
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-11
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-10
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-17
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-17
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-16
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-16
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-16
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-16
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-14
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-13
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	9e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-05
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-16
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-16
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-16
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-16
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-14
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-13
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-11
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-11
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-09
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	9e-16
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-12
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-09
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-08
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-15
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-15
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-14
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-13
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-12
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-11
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-11
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-10
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-05
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-15
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-14
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-14
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-13
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-11
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-14
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-14
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-13
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-12
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-12
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-05
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	8e-11
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-09
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-06
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-05
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	8e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-08
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-14
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-14
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-11
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-11
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-10
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-10
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-08
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-08
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-14
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-14
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-14
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-14
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-12
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-12
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-11
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-11
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-11
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	7e-10
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-07
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-14
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-14
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-11
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-04
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	7e-14
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	8e-14
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-12
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-12
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-12
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-11
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-11
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-08
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	8e-04
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	8e-14
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-14
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	9e-11
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-10
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-10
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-09
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-07
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-13
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-13
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-13
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-11
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-10
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-07
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-13
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-13
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-12
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-12
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-12
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	9e-12
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-10
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-07
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	6e-12
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	8e-06
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-13
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-11
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-10
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-10
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-10
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-07
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	6e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-04
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-13
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-13
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-12
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-12
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-12
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-11
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-13
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-11
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-04
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-13
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-12
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-12
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-11
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-10
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-04
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	7e-13
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-10
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-05
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-12
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-08
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-08
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	9e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-06
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-11
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-11
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-10
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-07
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-12
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-09
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-09
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-04
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-08
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-11
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-08
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-08
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-07
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-11
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-11
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	8e-11
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	8e-11
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	9e-09
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-10
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-10
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-08
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-07
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-06
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	6e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	5e-08
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-10
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-07
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-06
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-10
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-09
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-09
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-07
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	9e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-06
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-09
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	6e-09
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-09
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-08
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	8e-08
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	6e-06
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-04
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	4e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	7e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	5e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	6e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	6e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	7e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-04
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-06
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-05
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-04
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-04
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-04
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-04
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-04
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	7e-04
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	6e-06
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-04
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-04
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-05
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	2e-05
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	8e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-05
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	4e-05
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	7e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-04
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	6e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  287 bits (736), Expect = 7e-94
 Identities = 101/312 (32%), Positives = 156/312 (50%), Gaps = 32/312 (10%)

Query: 173 PKLEERATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVF 232
            +  E     +  FS           +L  A+++F  +  +G GG+G VYK +L +G + 
Sbjct: 7   EEDPEVHLGQLKRFS---------LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLV 57

Query: 233 ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCN 292
           A+K+L           F+ E +++S  +HRN+++L G+C+      L+Y YM  GS+   
Sbjct: 58  AVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASC 117

Query: 293 LHNNEDAVE-LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVAD 351
           L    ++   LDW KR  I    A  LAYLH  C P IIHRD+ + NILL+ + EA V D
Sbjct: 118 LRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177

Query: 352 FGTARLLHADSSN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDI 410
           FG A+L+    ++  T + GT G+IAPE   T   +EK DV+ +GV+ LE++ G+   D 
Sbjct: 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD- 236

Query: 411 LSSLSSSSDPKIMLID-------------VLDQRLPPPVDRK-VIRDILLISTVSFACLQ 456
                 ++D  +ML+D             ++D  L      + V + I     V+  C Q
Sbjct: 237 --LARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQ----VALLCTQ 290

Query: 457 SNPKSRPTMQSV 468
           S+P  RP M  V
Sbjct: 291 SSPMERPKMSEV 302

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  257 bits (658), Expect = 3e-82
 Identities = 93/286 (32%), Positives = 136/286 (47%), Gaps = 18/286 (6%)

Query: 194 RIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEA 253
           R+   DL EAT +FD ++ IG G +G VYK  L +G   ALK+         I+ F+ E 
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG-IEEFETEI 86

Query: 254 QVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLH-NNEDAVELDWAKRVNIVK 312
           + LS   H ++V L G+C  +  M LIY+YME G+L  +L+ ++   + + W +R+ I  
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146

Query: 313 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR--TLLAG 370
             A  L YLH      IIHRD+ S NILL+      + DFG ++           T++ G
Sbjct: 147 GAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKG 203

Query: 371 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSS--------DPKI 422
           T GYI PE      +TEK DVYSFGVV  EVL  +            +            
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263

Query: 423 MLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
            L  ++D  L   +  + +R        +  CL  + + RP+M  V
Sbjct: 264 QLEQIVDPNLADKIRPESLRKFGDT---AVKCLALSSEDRPSMGDV 306

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  243 bits (623), Expect = 2e-77
 Identities = 90/315 (28%), Positives = 143/315 (45%), Gaps = 46/315 (14%)

Query: 177 ERATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYC------IGTGGYGSVYKAQLPNGK 230
           E +      FS         + +L   T +FD R        +G GG+G VYK  + N  
Sbjct: 6   EVSDTRFHSFS---------FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNT 55

Query: 231 VFALKKLHTSEELAFI---KSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERG 287
             A+KKL    ++      + F  E +V+++  H N+V+L G+      + L+Y YM  G
Sbjct: 56  TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNG 115

Query: 288 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEA 347
           SL   L   +    L W  R  I +  A+ + +LH +     IHRDI S NILL+    A
Sbjct: 116 SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTA 172

Query: 348 FVADFGTARLLHADS----SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM 403
            ++DFG AR     +    ++R  + GT  Y+APE A    +T K D+YSFGVV LE++ 
Sbjct: 173 KISDFGLARASEKFAQTVMTSR--IVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIIT 229

Query: 404 GKHPRDILSSLSSSSDPKIMLID----VL--DQRLPPPVDRKV----IRDILLISTVSFA 453
           G    D             +L+D    +   ++ +   +D+K+       +  + +V+  
Sbjct: 230 GLPAVD-------EHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQ 282

Query: 454 CLQSNPKSRPTMQSV 468
           CL      RP ++ V
Sbjct: 283 CLHEKKNKRPDIKKV 297

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  227 bits (581), Expect = 7e-71
 Identities = 78/303 (25%), Positives = 126/303 (41%), Gaps = 40/303 (13%)

Query: 197 YEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQV- 255
            E+L   +    +      G +G V+KAQL N  V A+K     ++    +S++NE +V 
Sbjct: 16  TENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYV-AVKIFPIQDK----QSWQNEYEVY 70

Query: 256 -LSQVLHRNIVKLYGYCLH----KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNI 310
            L  + H NI++  G           ++LI  + E+GSL   L  N     + W +  +I
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHI 126

Query: 311 VKAMAHALAYLHHD-------CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS 363
            + MA  LAYLH D         P+I HRDI S N+LL + L A +ADFG A    A  S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 364 --NRTLLAGTYGYIAPELA-----YTMVMTEKCDVYSFGVVTLEVLMGKHPRDILS---- 412
             +     GT  Y+APE+      +      + D+Y+ G+V  E+       D       
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246

Query: 413 ---SLSSSSDPKI--MLIDVLDQRLPPPVDRKVIRDILL--ISTVSFACLQSNPKSRPTM 465
                     P +  M   V+ ++  P +     +   +  +      C   + ++R + 
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306

Query: 466 QSV 468
             V
Sbjct: 307 GCV 309

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  214 bits (548), Expect = 3e-66
 Identities = 79/271 (29%), Positives = 135/271 (49%), Gaps = 23/271 (8%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           ++ ++   +G G +G V KA+    K  A+K++ +  E    K+F  E + LS+V H NI
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER---KAFIVELRQLSRVNHPNI 63

Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           VKLYG CL+  C+  + EY E GSL+  LH  E       A  ++     +  +AYLH  
Sbjct: 64  VKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 325 CSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
              ++IHRD+   N+LL +      + DFGTA  +    +N     G+  ++APE+    
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEVFEGS 178

Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP-RDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR 442
             +EKCDV+S+G++  EV+  + P  +I         P   ++  +     PP+ + + +
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEI-------GGPAFRIMWAVHNGTRPPLIKNLPK 231

Query: 443 DI-LLISTVSFACLQSNPKSRPTMQSVSQEF 472
            I  L++     C   +P  RP+M+ + +  
Sbjct: 232 PIESLMT----RCWSKDPSQRPSMEEIVKIM 258

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  213 bits (544), Expect = 1e-65
 Identities = 78/294 (26%), Positives = 135/294 (45%), Gaps = 33/294 (11%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELA-FIKSFKNEAQVLSQVLHRN 263
            D +I+  IG G +G+V++A+  +G   A+K L   +  A  +  F  E  ++ ++ H N
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           IV   G       + ++ EY+ RGSL+  LH +    +LD  +R+++   +A  + YLH+
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL---- 379
             +P I+HR++ S N+L++ K    V DFG +RL  +   +    AGT  ++APE+    
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE 214

Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD-- 437
                  EK DVYSFGV+  E+   + P   L+         +  +    +RL  P +  
Sbjct: 215 PS----NEKSDVYSFGVILWELATLQQPWGNLNPAQV-----VAAVGFKCKRLEIPRNLN 265

Query: 438 ---RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ--EFLITRKTPLVKHAAI 486
                +I            C  + P  RP+  ++      LI    P    + +
Sbjct: 266 PQVAAIIEG----------CWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  204 bits (521), Expect = 2e-62
 Identities = 79/290 (27%), Positives = 127/290 (43%), Gaps = 48/290 (16%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHT------SEELAFIKSFKNEAQVLS 257
            + +    IG GG+G V+K + + +  V A+K L        +E +   + F+ E  ++S
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 258 QVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 317
            + H NIVKLYG   +   M  + E++  G L+  L +      + W+ ++ ++  +A  
Sbjct: 79  NLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALG 134

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAF-----VADFGTARLLHADSSNRTLLAGTY 372
           + Y+ +  +P I+HRD+ S NI L S  E       VADFG ++      S      G +
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL---GNF 190

Query: 373 GYIAPEL------AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLID 426
            ++APE       +Y    TEK D YSF ++   +L G+ P D  S         I +I 
Sbjct: 191 QWMAPETIGAEEESY----TEKADTYSFAMILYTILTGEGPFDEYSYGKIK---FINMIR 243

Query: 427 VLDQRLPPPVD-----RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQE 471
               R   P D     R VI            C   +PK RP    + +E
Sbjct: 244 EEGLRPTIPEDCPPRLRNVIEL----------CWSGDPKKRPHFSYIVKE 283

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  200 bits (512), Expect = 2e-61
 Identities = 73/281 (25%), Positives = 126/281 (44%), Gaps = 34/281 (12%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTS---EELAFIKSFKNEAQVLSQVLH 261
            +  +   IG GG+G VY+A    G   A+K        +    I++ + EA++ + + H
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            NI+ L G CL +  + L+ E+   G L   L        +     VN    +A  + YL
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYL 121

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAF--------VADFGTARLLHADSSNRTLLAGTYG 373
           H +    IIHRD+ S+NIL+  K+E          + DFG AR  H   + +   AG Y 
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAAGAYA 179

Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLP 433
           ++APE+    + ++  DV+S+GV+  E+L G+ P   +  L+       +   V   +L 
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-------VAYGVAMNKLA 232

Query: 434 PPVDR---KVIRDILLISTVSFACLQSNPKSRPTMQSVSQE 471
            P+     +    ++        C   +P SRP+  ++  +
Sbjct: 233 LPIPSTCPEPFAKLME------DCWNPDPHSRPSFTNILDQ 267

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  196 bits (500), Expect = 8e-59
 Identities = 66/314 (21%), Positives = 118/314 (37%), Gaps = 51/314 (16%)

Query: 197 YEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQV- 255
             +     ++  +   IG G YG+VYK  L + +  A+K    +      ++F NE  + 
Sbjct: 5   ASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR----QNFINEKNIY 59

Query: 256 -LSQVLHRNIVKLYGYCLHKKC-----MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN 309
            +  + H NI +                 L+ EY   GSL   L  +      DW     
Sbjct: 60  RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCR 115

Query: 310 IVKAMAHALAYLHHD------CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS 363
           +  ++   LAYLH +        P+I HRD++S N+L+ +     ++DFG +  L  +  
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175

Query: 364 NR--------TLLAGTYGYIAPELAYTMV-------MTEKCDVYSFGVVTLEVLMGKHPR 408
            R            GT  Y+APE+    V         ++ D+Y+ G++  E+ M     
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235

Query: 409 DILSSLSS---------SSDPKI--MLIDVLDQRLPPPVDRKVIRDILLISTVS---FAC 454
               S+            + P    M + V  ++  P        + L + ++      C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295

Query: 455 LQSNPKSRPTMQSV 468
              + ++R T Q  
Sbjct: 296 WDQDAEARLTAQXA 309

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  189 bits (482), Expect = 7e-57
 Identities = 51/275 (18%), Positives = 100/275 (36%), Gaps = 34/275 (12%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELA-FIKSFKNEAQVLSQVLHRN 263
           +  +    +     G ++K +   G    +K L   +      + F  E   L    H N
Sbjct: 10  KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 264 IVKLYGYCLH--KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
           ++ + G C         LI  +M  GSL+  LH   + V +D ++ V     MA  +A+L
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFL 127

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL-- 379
           H    P I    ++S +++++  + A ++         +             ++APE   
Sbjct: 128 HT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-----MYAPAWVAPEALQ 181

Query: 380 -AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD- 437
                      D++SF V+  E++  + P   LS++        M + +   R   P   
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-----GMKVALEGLRPTIPPGI 236

Query: 438 ----RKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
                K+++           C+  +P  RP    +
Sbjct: 237 SPHVSKLMKI----------CMNEDPAKRPKFDMI 261

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  189 bits (483), Expect = 1e-56
 Identities = 72/300 (24%), Positives = 122/300 (40%), Gaps = 40/300 (13%)

Query: 204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQV--LSQVLH 261
             D  +  C+G G YG V++     G+  A+K   + +E    KS+  E ++     + H
Sbjct: 7   ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE----KSWFRETELYNTVMLRH 61

Query: 262 RNIVKLYGYCLHKKC----MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 317
            NI+      +  +     ++LI  Y E GSL+  L        LD    + IV ++A  
Sbjct: 62  ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASG 117

Query: 318 LAYLHHD-----CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS----NRTLL 368
           LA+LH +       P+I HRD+ S NIL+    +  +AD G A +    ++         
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177

Query: 369 AGTYGYIAPEL------AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS------S 416
            GT  Y+APE+             ++ D+++FG+V  EV        I+           
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237

Query: 417 SSDPKI--MLIDVLDQRLPPPVDRKVIRDILL--ISTVSFACLQSNPKSRPTMQSVSQEF 472
            +DP    M   V   +  P +  +   D  L  ++ +   C   NP +R T   + +  
Sbjct: 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  187 bits (478), Expect = 1e-55
 Identities = 59/281 (20%), Positives = 112/281 (39%), Gaps = 37/281 (13%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELA-FIKSFKNEAQVLSQVLHRN 263
           E  +I   IG G +G VY  +  +G+V A++ +    +    +K+FK E     Q  H N
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           +V   G C+    + +I    +  +L+  + + +    LD  K   I + +   + YLH 
Sbjct: 91  VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLH- 147

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR-----TLLAGTYGYIAPE 378
             +  I+H+D+ S N+  ++  +  + DFG   +     + R      +  G   ++APE
Sbjct: 148 --AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204

Query: 379 L---------AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD 429
           +            +  ++  DV++ G +  E+   + P     + +      I+      
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA------IIWQMGTG 258

Query: 430 QRLPPPVDR--KVIRDILLISTVSFACLQSNPKSRPTMQSV 468
            +         K I DILL       C     + RPT   +
Sbjct: 259 MKPNLSQIGMGKEISDILL------FCWAFEQEERPTFTKL 293

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  186 bits (475), Expect = 2e-55
 Identities = 70/288 (24%), Positives = 118/288 (40%), Gaps = 40/288 (13%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
            D      +G G +G   K      G+V  +K+L   +E    ++F  E +V+  + H N
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET-QRTFLKEVKVMRCLEHPN 68

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           ++K  G     K +  I EY++ G+L   + + +   +  W++RV+  K +A  +AYLH 
Sbjct: 69  VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLH- 125

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL--------------HADSSNRTLLA 369
             S +IIHRD++S+N L+       VADFG ARL+                D   R  + 
Sbjct: 126 --SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183

Query: 370 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD 429
           G   ++APE+       EK DV+SFG+V  E++   +        +        L     
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT----MDFGLNVRGF 239

Query: 430 QRLPPPVD-----RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
                P +       +             C   +P+ RP+   +    
Sbjct: 240 LDRYCPPNCPPSFFPITVR----------CCDLDPEKRPSFVKLEHWL 277

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  186 bits (475), Expect = 4e-55
 Identities = 74/295 (25%), Positives = 116/295 (39%), Gaps = 40/295 (13%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQV--LSQVLHR 262
           +   +   IG G YG V+  +   G+  A+K   T+EE     S+  E ++     + H 
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE----ASWFRETEIYQTVLMRHE 91

Query: 263 NIVKLYGYCLHKKC----MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
           NI+      +        ++LI +Y E GSL+  L +      LD    + +  +    L
Sbjct: 92  NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGL 147

Query: 319 AYLH-----HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL----A 369
            +LH         P+I HRD+ S NIL+       +AD G A    +D++   +      
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207

Query: 370 GTYGYIAPE-LAYTMVM-----TEKCDVYSFGVVTLEVLMGKHPRDILSSLS------SS 417
           GT  Y+ PE L  ++           D+YSFG++  EV        I+            
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267

Query: 418 SDPKI--MLIDVLDQRLPPPVDRKVIRDILL--ISTVSFACLQSNPKSRPTMQSV 468
           SDP    M   V  ++L P    +   D  L  +  +   C   NP SR T   V
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  183 bits (466), Expect = 3e-54
 Identities = 73/276 (26%), Positives = 133/276 (48%), Gaps = 32/276 (11%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRN 263
               +   IG+G +G+VYK +  +G V A+K L+ +      +++FKNE  VL +  H N
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           I+   GY      + ++ ++ E  SL+ +LH +E   + +  K ++I +  A  + YLH 
Sbjct: 82  ILLFMGYST-APQLAIVTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLH- 137

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH--ADSSNRTLLAGTYGYIAPEL-- 379
             + SIIHRD+ SNNI L+      + DFG A      + S     L+G+  ++APE+  
Sbjct: 138 --AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195

Query: 380 -AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR 438
              +   + + DVY+FG+V  E++ G+ P   +++         ++  V    L P + +
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIEMVGRGSLSPDLSK 249

Query: 439 ------KVIRDILLISTVSFACLQSNPKSRPTMQSV 468
                 K ++ ++        CL+     RP+   +
Sbjct: 250 VRSNCPKRMKRLMA------ECLKKKRDERPSFPRI 279

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  182 bits (463), Expect = 3e-53
 Identities = 69/295 (23%), Positives = 122/295 (41%), Gaps = 40/295 (13%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQV--LSQVLHR 262
               ++  IG G +G V++ +   G+  A+K   + EE    +S+  EA++     + H 
Sbjct: 42  RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHE 96

Query: 263 NIVKLYGYCLHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
           NI+               ++L+ +Y E GSLF  L+       +     + +  + A  L
Sbjct: 97  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGL 152

Query: 319 AYLHHD-----CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL----A 369
           A+LH +       P+I HRD+ S NIL+       +AD G A    + +    +      
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212

Query: 370 GTYGYIAPE-LAYTMVM-----TEKCDVYSFGVVTLEVLMGKHPRDILS------SLSSS 417
           GT  Y+APE L  ++ M      ++ D+Y+ G+V  E+        I             
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272

Query: 418 SDPKI--MLIDVLDQRLPPPVDRKVIRDILL--ISTVSFACLQSNPKSRPTMQSV 468
           SDP +  M   V +Q+L P +  +      L  ++ +   C  +N  +R T   +
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  152 bits (387), Expect = 1e-42
 Identities = 48/131 (36%), Positives = 66/131 (50%), Gaps = 6/131 (4%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
           G IPP   NL NL  +D+  N L G      GS  N   + L+ N L+  +  ++   K 
Sbjct: 188 GKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKN 245

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNG 124
           L  LDL NN I G++P  +T+L  L  LN+S N L G +P   N L     V + + N  
Sbjct: 246 LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN-LQRF-DVSAYANNKC 303

Query: 125 LCGNILDLPSC 135
           LCG+   LP+C
Sbjct: 304 LCGSP--LPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  149 bits (379), Expect = 2e-41
 Identities = 45/126 (35%), Positives = 68/126 (53%), Gaps = 2/126 (1%)

Query: 5   GIIPPEIGNLKNLIKLDV-GSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMK 63
             IP  + NL  L  L + G N+L+GPIP A+  LT L  L ++   +SG IP  ++ +K
Sbjct: 66  YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125

Query: 64  YLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
            L  LD S N + G++P  I+ L  L  +    N++SG +P S    S + T +++S  N
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS-RN 184

Query: 124 GLCGNI 129
            L G I
Sbjct: 185 RLTGKI 190

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  130 bits (330), Expect = 2e-34
 Identities = 39/128 (30%), Positives = 66/128 (51%), Gaps = 5/128 (3%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIG--PIPSALGSLTNLSNLDLSS-NKLSGKIPPEIAS 61
           G++         +  LD+   +L    PIPS+L +L  L+ L +   N L G IPP IA 
Sbjct: 40  GVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAK 99

Query: 62  MKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSP 121
           +  L  L +++ N+ G+IP  ++++  L  L+ S N LSG +P S + L ++   ++   
Sbjct: 100 LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL-VGITFD- 157

Query: 122 NNGLCGNI 129
            N + G I
Sbjct: 158 GNRISGAI 165

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  104 bits (261), Expect = 4e-25
 Identities = 36/130 (27%), Positives = 61/130 (46%), Gaps = 9/130 (6%)

Query: 7   IPPEIGNLKNL----IKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSG--KIPPEIA 60
           I  ++GN   L       D  + + +G +         ++NLDLS   L     IP  +A
Sbjct: 14  IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73

Query: 61  SMKYLTQLDLSN-NNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSL 119
           ++ YL  L +   NN+ G IP  I KL++L YL ++   +SG +P   + + ++   +  
Sbjct: 74  NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL-VTLDF 132

Query: 120 SPNNGLCGNI 129
           S  N L G +
Sbjct: 133 S-YNALSGTL 141

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  151 bits (384), Expect = 2e-42
 Identities = 66/263 (25%), Positives = 110/263 (41%), Gaps = 29/263 (11%)

Query: 212 CIGTGGYGSVYKA-QLPNGKVFALKKLHTSEEL-AFIKSFKNEAQVLSQVLHRNIVKLYG 269
            IG G + +VYK          A  +L   +   +  + FK EA++L  + H NIV+ Y 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 270 YCL----HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
                   KKC+ L+ E M  G+L   L   +    +      +  + +   L +LH   
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH-TR 148

Query: 326 SPSIIHRDISSNNILLNSKL-EAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV 384
           +P IIHRD+  +NI +        + D G A L    +S    + GT  ++APE+ Y   
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTPEFMAPEM-YEEK 205

Query: 385 MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR---KVI 441
             E  DVY+FG+  LE+   ++P     + +      I    V     P   D+     +
Sbjct: 206 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRR-VTSGVKPASFDKVAIPEV 259

Query: 442 RDILLISTVSFACLQSNPKSRPT 464
           ++I+        C++ N   R +
Sbjct: 260 KEIIE------GCIRQNKDERYS 276

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  149 bits (378), Expect = 1e-41
 Identities = 65/293 (22%), Positives = 122/293 (41%), Gaps = 45/293 (15%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
            DF     IG+GG+G V+KA+   +GK + +K++  + E A     + E + L+++ H N
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA-----EREVKALAKLDHVN 65

Query: 264 IVKLYGY----------------CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR 307
           IV   G                     KC+F+  E+ ++G+L           +LD    
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE-QWIEKRRGEKLDKVLA 124

Query: 308 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL 367
           + + + +   + Y+H   S  +I+RD+  +NI L    +  + DFG    L  D      
Sbjct: 125 LELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR- 180

Query: 368 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLID 426
             GT  Y++PE   +    ++ D+Y+ G++  E+L +     +                D
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK----------FFTD 230

Query: 427 VLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
           + D  +    D+K  +   L+       L   P+ RP    + +   + +K+P
Sbjct: 231 LRDGIISDIFDKK-EKT--LLQ----KLLSKKPEDRPNTSEILRTLTVWKKSP 276

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  147 bits (373), Expect = 8e-41
 Identities = 61/301 (20%), Positives = 121/301 (40%), Gaps = 42/301 (13%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
            DF+   C+G GG+G V++A+   +   +A+K++         +    E + L+++ H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 264 IVKLYGYCLHKKCM------------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIV 311
           IV+ +   L K               ++  +   + +L   ++      E + +  ++I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 312 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS--------- 362
             +A A+ +LH   S  ++HRD+  +NI         V DFG    +  D          
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 363 ---SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSD 419
              +  T   GT  Y++PE  +    + K D++S G++  E+L   +P       S+  +
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP------FSTQME 232

Query: 420 PKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV-SQEFLITRKT 478
               L DV + + PP   +K   + +++       L  +P  RP   ++           
Sbjct: 233 RVRTLTDVRNLKFPPLFTQKYPCEYVMVQ----DMLSPSPMERPEAINIIENAVFEDLDF 288

Query: 479 P 479
           P
Sbjct: 289 P 289

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  149 bits (379), Expect = 9e-41
 Identities = 67/282 (23%), Positives = 110/282 (39%), Gaps = 40/282 (14%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR 262
           ED  +   IG G +G V+  +L   N  V A+K    +        F  EA++L Q  H 
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLV-AVKSCRETLPPDLKAKFLQEARILKQYSHP 172

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
           NIV+L G C  K+ ++++ E ++ G     L      + +     + +V   A  + YL 
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVK--TLLQMVGDAAAGMEYLE 230

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI-----AP 377
              S   IHRD+++ N L+  K    ++DFG +R            +G    +     AP
Sbjct: 231 ---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA---SGGLRQVPVKWTAP 284

Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ-----R 431
           E       + + DV+SFG++  E    G  P            P +      +      R
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPY-----------PNLSNQQTREFVEKGGR 333

Query: 432 LPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           LP P      +  ++        C    P  RP+  ++ QE 
Sbjct: 334 LPCPELCPDAVFRLME------QCWAYEPGQRPSFSTIYQEL 369

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  146 bits (371), Expect = 5e-40
 Identities = 64/278 (23%), Positives = 118/278 (42%), Gaps = 41/278 (14%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLH----TSEELAFIKSFKNEAQVLSQV 259
           E +     IG G +G     +   +G+ + +K+++    +S+E    +  + E  VL+ +
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER---EESRREVAVLANM 80

Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNN------EDAVELDWAKRVNIVKA 313
            H NIV+          ++++ +Y E G LF  ++        ED + LDW  +      
Sbjct: 81  KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI-LDWFVQ------ 133

Query: 314 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG 373
           +  AL ++H      I+HRDI S NI L       + DFG AR+L++         GT  
Sbjct: 134 ICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPY 190

Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP---RDILSSLSSSSDPKIMLIDVLDQ 430
           Y++PE+        K D+++ G V  E+   KH      + + +      KI+       
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL-----KIISGSF--P 243

Query: 431 RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
            +        +R ++          + NP+ RP++ S+
Sbjct: 244 PVSLHYSYD-LRSLVS------QLFKRNPRDRPSVNSI 274

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  143 bits (363), Expect = 3e-39
 Identities = 70/300 (23%), Positives = 124/300 (41%), Gaps = 58/300 (19%)

Query: 204 TEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR 262
             DF+    +G G +G V KA+   + + +A+KK+  +EE   + +  +E  +L+ + H+
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK--LSTILSEVMLLASLNHQ 62

Query: 263 NIVKLYG-------------YCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDW 304
            +V+ Y                  K  +F+  EY E G+L+      NL+   D      
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY---- 118

Query: 305 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD--- 361
                + + +  AL+Y+H   S  IIHRD+   NI ++      + DFG A+ +H     
Sbjct: 119 ---WRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172

Query: 362 -----------SSNRTLLAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRD 409
                      S N T   GT  Y+A E L  T    EK D+YS G++  E++       
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGM 232

Query: 410 ILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD-ILLISTVSFACLQSNPKSRPTMQSV 468
              ++      K+  + +     PP  D   ++    +I       +  +P  RP  +++
Sbjct: 233 ERVNILK----KLRSVSI---EFPPDFDDNKMKVEKKIIR----LLIDHDPNKRPGARTL 281

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  140 bits (356), Expect = 3e-38
 Identities = 60/280 (21%), Positives = 108/280 (38%), Gaps = 35/280 (12%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKK--LHTSEELAFIKSFKNEAQVLSQVLH 261
            +F I   IG G +  VY+A  L +G   ALKK  +    +         E  +L Q+ H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNN--------EDAVELDWAKRVNIVKA 313
            N++K Y   +    + ++ E  + G L   + +         E  V             
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTV-------WKYFVQ 144

Query: 314 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG 373
           +  AL ++H   S  ++HRDI   N+ + +     + D G  R   + ++    L GT  
Sbjct: 145 LCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 201

Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLP 433
           Y++PE  +      K D++S G +  E+   + P           +   +   +     P
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY-----GDKMNLYSLCKKIEQCDYP 256

Query: 434 P-PVDR--KVIRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
           P P D   + +R ++        C+  +P+ RP +  V  
Sbjct: 257 PLPSDHYSEELRQLVN------MCINPDPEKRPDVTYVYD 290

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  147 bits (374), Expect = 3e-38
 Identities = 47/142 (33%), Positives = 69/142 (48%), Gaps = 11/142 (7%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
           G   P   N  +++ LD+  N L G IP  +GS+  L  L+L  N +SG IP E+  ++ 
Sbjct: 622 GHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRG 681

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVP----FSNNDLSSMHTVVSLS 120
           L  LDLS+N + G IP  ++ L+ L  ++LS+N LSGP+P    F     +         
Sbjct: 682 LNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPA------KFL 735

Query: 121 PNNGLCGNILDLPSCDTTKPAT 142
            N GLCG  L      +     
Sbjct: 736 NNPGLCGYPL-PRCDPSNADGY 756

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  146 bits (371), Expect = 9e-38
 Identities = 46/131 (35%), Positives = 64/131 (48%), Gaps = 5/131 (3%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
           G IP  +G+L  L  L +  N L G IP  L  +  L  L L  N L+G+IP  +++   
Sbjct: 432 GTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTN 491

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNG 124
           L  + LSNN + G IP  I +L  L  L LS+N  SG +P    D  S+   + L+  N 
Sbjct: 492 LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSL-IWLDLN-TNL 549

Query: 125 LCGNILDLPSC 135
             G I   P+ 
Sbjct: 550 FNGTI---PAA 557

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  141 bits (358), Expect = 4e-36
 Identities = 49/125 (39%), Positives = 75/125 (60%), Gaps = 2/125 (1%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
           G IPP + N   L+ L +  N L G IPS+LGSL+ L +L L  N L G+IP E+  +K 
Sbjct: 408 GKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKT 467

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNG 124
           L  L L  N++ G IP  ++  + L++++LS+N+L+G +P     L ++  ++ LS NN 
Sbjct: 468 LETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENL-AILKLS-NNS 525

Query: 125 LCGNI 129
             GNI
Sbjct: 526 FSGNI 530

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  138 bits (349), Expect = 5e-35
 Identities = 44/127 (34%), Positives = 66/127 (51%), Gaps = 4/127 (3%)

Query: 5   GIIPPEIGN--LKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           G I P +       L +L + +N   G IP  L + + L +L LS N LSG IP  + S+
Sbjct: 382 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL 441

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN 122
             L  L L  N ++G IP E+  +  L+ L L  N L+G +P   ++ +++   +SLS N
Sbjct: 442 SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNL-NWISLS-N 499

Query: 123 NGLCGNI 129
           N L G I
Sbjct: 500 NRLTGEI 506

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  133 bits (337), Expect = 2e-33
 Identities = 42/116 (36%), Positives = 66/116 (56%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
           G IP E+  +K L  L +  N L G IPS L + TNL+ + LS+N+L+G+IP  I  ++ 
Sbjct: 456 GEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLEN 515

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLS 120
           L  L LSNN+  G+IP E+     L +L+L++N  +G +P +    S       ++
Sbjct: 516 LAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIA 571

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  130 bits (329), Expect = 2e-32
 Identities = 49/127 (38%), Positives = 66/127 (51%), Gaps = 5/127 (3%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSAL-GSLTNLSNLDLSSNKLSGKIPPEIASMK 63
           G IPP    LK+L  L +  N   G IP  L G+   L+ LDLS N   G +PP   S  
Sbjct: 261 GPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCS 318

Query: 64  YLTQLDLSNNNIQGSIPGE-ITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN 122
            L  L LS+NN  G +P + + K+  L  L+LS N+ SG +P S  +LS+    + LS +
Sbjct: 319 LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLS-S 377

Query: 123 NGLCGNI 129
           N   G I
Sbjct: 378 NNFSGPI 384

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  130 bits (329), Expect = 2e-32
 Identities = 47/129 (36%), Positives = 66/129 (51%), Gaps = 6/129 (4%)

Query: 5   GIIPPE-IGNLKNLIKLDVGSNSLIGPIPSALGSLT-NLSNLDLSSNKLSGKIPPEI--A 60
           G +P + +  ++ L  LD+  N   G +P +L +L+ +L  LDLSSN  SG I P +   
Sbjct: 332 GELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQN 391

Query: 61  SMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLS 120
               L +L L NN   G IP  ++  S L  L+LS N LSG +P S   LS +   + L 
Sbjct: 392 PKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKL-RDLKLW 450

Query: 121 PNNGLCGNI 129
             N L G I
Sbjct: 451 -LNMLEGEI 458

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  129 bits (327), Expect = 3e-32
 Identities = 40/122 (32%), Positives = 58/122 (47%), Gaps = 5/122 (4%)

Query: 9   PEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQL 68
           P +G+   L  LD+  N L G    A+ + T L  L++SSN+  G IPP    +K L  L
Sbjct: 217 PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYL 274

Query: 69  DLSNNNIQGSIPGEIT-KLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCG 127
            L+ N   G IP  ++     L  L+LS N   G VP      S +   ++LS +N   G
Sbjct: 275 SLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLL-ESLALS-SNNFSG 332

Query: 128 NI 129
            +
Sbjct: 333 EL 334

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  121 bits (307), Expect = 1e-29
 Identities = 33/129 (25%), Positives = 49/129 (37%), Gaps = 8/129 (6%)

Query: 5   GIIPPEIGNLKNLIKLDVGSN--SLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           G     I N     +     N     G     L  L+  +  +++S    G   P   + 
Sbjct: 572 GKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNN 631

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSL--S 120
             +  LD+S N + G IP EI  +  L  LNL  N +SG +P     +  +  +  L  S
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDE---VGDLRGLNILDLS 688

Query: 121 PNNGLCGNI 129
            N  L G I
Sbjct: 689 SNK-LDGRI 696

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  119 bits (301), Expect = 9e-29
 Identities = 30/130 (23%), Positives = 57/130 (43%), Gaps = 5/130 (3%)

Query: 4   IGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPP--EIAS 61
              +   + +L  L  L + ++ + G +        +L++LDLS N LSG +     + S
Sbjct: 66  FSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLTSLGS 124

Query: 62  MKYLTQLDLSNNNIQGSIP-GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLS 120
              L  L++S+N +          KL+ L+ L+LS+N +SG              +  L+
Sbjct: 125 CSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLA 184

Query: 121 -PNNGLCGNI 129
              N + G++
Sbjct: 185 ISGNKISGDV 194

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  117 bits (296), Expect = 3e-28
 Identities = 38/131 (29%), Positives = 62/131 (47%), Gaps = 11/131 (8%)

Query: 5   GIIPP--EIGNLKNLIKLDVGSNSLIGPIP-SALGSLTNLSNLDLSSNKLSGKIPPEIA- 60
           G +     +G+   L  L+V SN+L  P   S    L +L  LDLS+N +SG        
Sbjct: 114 GPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVL 173

Query: 61  --SMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVS 118
                 L  L +S N I G +   +++   L++L++SSN  S  +PF  +  S++   + 
Sbjct: 174 SDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGD-CSAL-QHLD 229

Query: 119 LSPNNGLCGNI 129
           +S  N L G+ 
Sbjct: 230 IS-GNKLSGDF 239

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  112 bits (282), Expect = 2e-26
 Identities = 33/121 (27%), Positives = 51/121 (42%), Gaps = 7/121 (5%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
           G IP  IG L+NL  L + +NS  G IP+ LG   +L  LDL++N  +G IP  +     
Sbjct: 504 GEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ-- 561

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSN--KLSGPVPFSNNDLSSMHTVVSLSPN 122
                ++ N I G     I         + + N  +  G      N LS+     +++  
Sbjct: 562 --SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTR-NPCNITSR 618

Query: 123 N 123
            
Sbjct: 619 V 619

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 99.6 bits (249), Expect = 3e-22
 Identities = 38/123 (30%), Positives = 59/123 (47%), Gaps = 9/123 (7%)

Query: 13  NLKNLIKLDVGSNSL---IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLD 69
               +  +D+ S  L      + S+L SLT L +L LS++ ++G +         LT LD
Sbjct: 48  RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSV-SGFKCSASLTSLD 106

Query: 70  LSNNNIQGSIP--GEITKLSRLDYLNLSSNKLSGPVPFSN-NDLSSMHTVVSLSPNNGLC 126
           LS N++ G +     +   S L +LN+SSN L  P   S    L+S+  V+ LS  N + 
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSL-EVLDLS-ANSIS 164

Query: 127 GNI 129
           G  
Sbjct: 165 GAN 167

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 74.9 bits (185), Expect = 2e-14
 Identities = 28/53 (52%), Positives = 37/53 (69%)

Query: 4   IGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIP 56
            G IP E+G+L+ L  LD+ SN L G IP A+ +LT L+ +DLS+N LSG IP
Sbjct: 669 SGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  139 bits (352), Expect = 5e-38
 Identities = 87/269 (32%), Positives = 133/269 (49%), Gaps = 27/269 (10%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           EDF+I   +G G +G+VY A+   +  + ALK L  ++  +       + E ++ S + H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            NI++LYGY      ++LI EY   G+++  L       E         +  +A+AL+Y 
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-QRTAT--YITELANALSYC 125

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
           H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ PE+  
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIE 180

Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIML--IDVLDQRLPPPVDRK 439
             +  EK D++S GV+  E L+GK P +       ++  +     I  ++   P  V   
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFE-------ANTYQETYKRISRVEFTFPDFVTEG 233

Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSV 468
             RD  LIS      L+ NP  RP ++ V
Sbjct: 234 A-RD--LIS----RLLKHNPSQRPMLREV 255

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  139 bits (353), Expect = 6e-38
 Identities = 63/272 (23%), Positives = 105/272 (38%), Gaps = 43/272 (15%)

Query: 210 RYCIGTGGYGSVYKA-QLPNGKVFALK--KLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           R  +G G YG VY    L N    A+K      S      +    E  +   + H+NIV+
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY---SQPLHEEIALHKHLKHKNIVQ 83

Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
             G       + +  E +  GSL   L +    ++ +        K +   L YLH    
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---D 140

Query: 327 PSIIHRDISSNNILLNS-----KLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL-- 379
             I+HRDI  +N+L+N+     K+    +DFGT++ L   +       GT  Y+APE+  
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKI----SDFGTSKRLAGINPCTETFTGTLQYMAPEIID 196

Query: 380 ----AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP 435
                Y        D++S G   +E+  GK P           +P+  +  V   ++ P 
Sbjct: 197 KGPRGYGK----AADIWSLGCTIIEMATGKPP------FYELGEPQAAMFKVGMFKVHPE 246

Query: 436 VDRKV---IRDILLISTVSFACLQSNPKSRPT 464
           +   +    +  +L       C + +P  R  
Sbjct: 247 IPESMSAEAKAFIL------KCFEPDPDKRAC 272

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  138 bits (350), Expect = 1e-37
 Identities = 66/277 (23%), Positives = 119/277 (42%), Gaps = 30/277 (10%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLH----TSEELAFIKSFKNEAQVLSQV 259
           ED+++ Y IGTG YG   K +   +GK+   K+L     T  E    +   +E  +L ++
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK---QMLVSEVNLLREL 62

Query: 260 LHRNIVKLYGYCLHK--KCMFLIYEYMERGSLFCNL-HNNEDAVELDWAKRVNIVKAMAH 316
            H NIV+ Y   + +    ++++ EY E G L   +    ++   LD    + ++  +  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122

Query: 317 ALAYLH--HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGY 374
           AL   H   D   +++HRD+   N+ L+ K    + DFG AR+L+ D+S      GT  Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYY 182

Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP---RDILSSLSSSSDPKIMLIDVLDQR 431
           ++PE    M   EK D++S G +  E+     P                   L   + + 
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-----------LAGKIREG 231

Query: 432 LPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
               +  +   +  L   ++   L      RP+++ +
Sbjct: 232 KFRRIPYRYSDE--LNEIIT-RMLNLKDYHRPSVEEI 265

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  139 bits (353), Expect = 2e-37
 Identities = 75/294 (25%), Positives = 117/294 (39%), Gaps = 42/294 (14%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +DF+    +G G  G V+K    P+G V A K +H   + A       E QVL +     
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           IV  YG       + +  E+M+ GSL   L       E    K   +  A+   L YL  
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLTYLRE 149

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
                I+HRD+  +NIL+NS+ E  + DFG +  L  DS   +   GT  Y++PE     
Sbjct: 150 KH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANS-FVGTRSYMSPERLQGT 205

Query: 384 VMTEKCDVYSFGVVTLEVLMGKHP-------------------------------RDILS 412
             + + D++S G+  +E+ +G++P                                  L+
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265

Query: 413 SLSSSSDPKIMLIDVLDQ--RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPT 464
                S P + + ++LD     PPP     +  +     V+  CL  NP  R  
Sbjct: 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN-KCLIKNPAERAD 318

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  140 bits (355), Expect = 4e-37
 Identities = 61/283 (21%), Positives = 115/283 (40%), Gaps = 46/283 (16%)

Query: 206 DFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNI 264
            F  +  +G G  G++    + + +  A+K++              E Q+L +   H N+
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL----PECFSFADREVQLLRESDEHPNV 80

Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLF------CNLHNNEDAVELDWAKRVNIVKAMAHAL 318
           ++ +     ++  ++  E     +L          H   +         + +++     L
Sbjct: 81  IRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEP--------ITLLQQTTSGL 131

Query: 319 AYLHHDCSPSIIHRDISSNNILL-----NSKLEAFVADFGTARLLHADSSNRTLL---AG 370
           A+LH   S +I+HRD+  +NIL+     + K++A ++DFG  + L     + +      G
Sbjct: 132 AHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188

Query: 371 TYGYIAPEL---AYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLID 426
           T G+IAPE+         T   D++S G V   V+  G HP       S      I+L  
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK----SLQRQANILLGA 244

Query: 427 V-LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
             LD   P   +  + R+  LI       +  +P+ RP+ + V
Sbjct: 245 CSLDCLHPEKHEDVIARE--LIE----KMIAMDPQKRPSAKHV 281

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  137 bits (346), Expect = 1e-36
 Identities = 62/300 (20%), Positives = 120/300 (40%), Gaps = 37/300 (12%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           + +     +G GG+  V   + L +G  +ALK++   E+    +  + EA +     H N
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD-REEAQREADMHRLFNHPN 87

Query: 264 IVKLYGYCL----HKKCMFLIYEYMERGSLFCNLHNNEDAVE-LDWAKRVNIVKAMAHAL 318
           I++L  YCL     K   +L+  + +RG+L+  +   +D    L   + + ++  +   L
Sbjct: 88  ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA--------- 369
             +H   +    HRD+   NILL  + +  + D G+                        
Sbjct: 148 EAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204

Query: 370 GTYGYIAPEL----AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLI 425
            T  Y APEL    ++ ++  E+ DV+S G V   ++ G+ P D    +       + L 
Sbjct: 205 CTISYRAPELFSVQSHCVI-DERTDVWSLGCVLYAMMFGEGPYD----MVFQKGDSVALA 259

Query: 426 DVLDQRLPPPVDR--KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKH 483
            V +Q   P   R    +    L++    + +  +P  RP +  +  +    +     +H
Sbjct: 260 -VQNQLSIPQSPRHSSALWQ--LLN----SMMTVDPHQRPHIPLLLSQLEALQPPAPGQH 312

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  136 bits (346), Expect = 1e-36
 Identities = 72/283 (25%), Positives = 117/283 (41%), Gaps = 55/283 (19%)

Query: 213 IGTGGYGSVYKAQL--PNGKVF---ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+VYK        KV    A+K+L  +      K   +EA V++ V + ++ +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G CL    + LI + M  G L   +  ++D +     L+W   V I K M     YL  
Sbjct: 83  LGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN----YLE- 134

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG------TYGYIAP 377
                ++HRD+++ N+L+ +     + DFG A+LL A+        G           A 
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----AL 188

Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP------RDILSSLSSSSDPKIMLIDVLDQ 430
           E     + T + DV+S+GV   E++  G  P       +I S L               +
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK------------GE 236

Query: 431 RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           RLP P      +  I+        C   +  SRP  + +  EF
Sbjct: 237 RLPQPPICTIDVYMIMR------KCWMIDADSRPKFRELIIEF 273

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  137 bits (347), Expect = 2e-36
 Identities = 32/340 (9%), Positives = 83/340 (24%), Gaps = 54/340 (15%)

Query: 170 YKKPKLEERATNNIDVFS--IWNYDGRIVYEDLI-EATEDFDIRYCIGTGGYGSVYKA-Q 225
           Y + +  +     ++  +  +W  +     + L+ +      +   +  G    V+    
Sbjct: 24  YCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRD 83

Query: 226 LPNGKVFALKKLHTSEEL--AFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCM------ 277
           +   + FALK      E   + ++         +++L  +  +                 
Sbjct: 84  VERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143

Query: 278 --------------------FLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKA 313
                                L+        L       +                +   
Sbjct: 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQ 202

Query: 314 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG 373
           +    A L    S  ++H   + +N+ +       + D           +     +    
Sbjct: 203 LIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW---KVGTRGPASSVPVT 256

Query: 374 YIAPEL--AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQR 431
           Y   E   A T   T   + +  G+    V     P  +++     S  +  L       
Sbjct: 257 YAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDS 316

Query: 432 LPPPVDRKV---IRDILLISTVSFACLQSNPKSRPTMQSV 468
           L       +   ++ ++         L  + + R      
Sbjct: 317 LAFGSCTPLPDFVKTLIG------RFLNFDRRRRLLPLEA 350

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  135 bits (343), Expect = 3e-36
 Identities = 62/267 (23%), Positives = 105/267 (39%), Gaps = 21/267 (7%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVL-SQVLHR 262
            D +    +G+G  G V+K +    G V A+K++  S      K    +  V+       
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
            IV+ +G  +    +F+  E M   +            E    K   +  A+  AL YL 
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK---MTVAIVKALYYLK 141

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
                 +IHRD+  +NILL+ + +  + DFG +  L  D   +   AG   Y+APE    
Sbjct: 142 EK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRL-VDDKAKDRSAGCAAYMAPERIDP 198

Query: 383 MVMTE-----KCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD 437
              T+     + DV+S G+  +E+  G+ P         +      ++  + Q  PP + 
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFPY-------KNCKTDFEVLTKVLQEEPPLLP 251

Query: 438 RKVIRDILLISTVSFACLQSNPKSRPT 464
             +       S V   CL  + + RP 
Sbjct: 252 GHMGFSGDFQSFVK-DCLTKDHRKRPK 277

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  135 bits (342), Expect = 3e-36
 Identities = 63/301 (20%), Positives = 128/301 (42%), Gaps = 42/301 (13%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRN 263
             + I   IG+GG   V++      +++A+K ++  E +   + S++NE   L+++   +
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 264 --IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
             I++LY Y +  + ++++ E      L   L   + +++    K     K M  A+  +
Sbjct: 88  DKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKK-SIDPWERKS--YWKNMLEAVHTI 143

Query: 322 HHDCSPSIIHRDISSNNILLNS---KLEAFVADFGTARLLHADSSN--RTLLAGTYGYIA 376
           H      I+H D+   N L+     KL     DFG A  +  D+++  +    GT  Y+ 
Sbjct: 144 H---QHGIVHSDLKPANFLIVDGMLKL----IDFGIANQMQPDTTSVVKDSQVGTVNYMP 196

Query: 377 PEL-----------AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLI 425
           PE                 ++ K DV+S G +   +  GK P   +     +   K+  I
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI----INQISKLHAI 252

Query: 426 DVLDQRLP-PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ-EFLITRKTPLVKH 483
              +  +  P +  K ++D+L        CL+ +PK R ++  +    ++  +  P+ + 
Sbjct: 253 IDPNHEIEFPDIPEKDLQDVLK------CCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 306

Query: 484 A 484
           A
Sbjct: 307 A 307

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  135 bits (341), Expect = 3e-36
 Identities = 84/301 (27%), Positives = 125/301 (41%), Gaps = 44/301 (14%)

Query: 204 TEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR 262
            E F     IG G +G V+K       KV A+K +   E    I+  + E  VLSQ    
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN---NEDAVELDWAKRVNIVKAMAHALA 319
            + K YG  L    +++I EY+  GS    L     +E  +         I++ +   L 
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-------ILREILKGLD 133

Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           YLH   S   IHRDI + N+LL+   E  +ADFG A  L      R    GT  ++APE+
Sbjct: 134 YLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 190

Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDP--KIMLIDVLDQRLPPPVD 437
                   K D++S G+  +E+  G+ P        S   P   + LI     +  PP  
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPPH-------SELHPMKVLFLI----PKNNPPTL 239

Query: 438 R----KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDISISE 493
                K +++ +       ACL   P  RPT    ++E L   K   +   A +   ++E
Sbjct: 240 EGNYSKPLKEFVE------ACLNKEPSFRPT----AKELL---KHKFILRNAKKTSYLTE 286

Query: 494 L 494
           L
Sbjct: 287 L 287

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  135 bits (343), Expect = 3e-36
 Identities = 72/276 (26%), Positives = 107/276 (38%), Gaps = 34/276 (12%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQV-LSQVLHR 262
           ED      IG G YGSV K    P+G++ A+K++ ++ +    K    +  V +      
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN------IVKAMAH 316
            IV+ YG    +   ++  E M   S           V       +       I  A   
Sbjct: 82  YIVQFYGALFREGDCWICMELMS-TSFDKFY----KYVYSVLDDVIPEEILGKITLATVK 136

Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           AL +L  +    IIHRDI  +NILL+      + DFG +  L  DS  +T  AG   Y+A
Sbjct: 137 ALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDAGCRPYMA 193

Query: 377 PE----LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQ-- 430
           PE     A       + DV+S G+   E+  G+ P    +S          + D L Q  
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS----------VFDQLTQVV 243

Query: 431 RLPPPVDRKVIRDILLISTVSF--ACLQSNPKSRPT 464
           +  PP            S ++F   CL  +   RP 
Sbjct: 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPK 279

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  133 bits (338), Expect = 5e-36
 Identities = 71/292 (24%), Positives = 117/292 (40%), Gaps = 48/292 (16%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLH--TSEELAFIKSFKNEAQVLSQVLH 261
            +      IG+G +G V+        KV A+K +      E  FI+    EA+V+ ++ H
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----EAEVMMKLSH 62

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
             +V+LYG CL +  + L+ E+ME G L   L              + +   +   +AYL
Sbjct: 63  PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYL 120

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD---SSNRTLLAGTYGYI--- 375
                  +IHRD+++ N L+       V+DFG  R +  D   SS  T        +   
Sbjct: 121 ---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP-----VKWA 172

Query: 376 APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ---- 430
           +PE+      + K DV+SFGV+  EV   GK P                  +V++     
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY-----------ENRSNSEVVEDISTG 221

Query: 431 -RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL 480
            RL  P      +  I+        C +  P+ RP    + ++     ++ L
Sbjct: 222 FRLYKPRLASTHVYQIMN------HCWRERPEDRPAFSRLLRQLAEIAESGL 267

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  133 bits (338), Expect = 1e-35
 Identities = 74/306 (24%), Positives = 123/306 (40%), Gaps = 52/306 (16%)

Query: 205 EDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +D++++  IG+G    V  A   P  +  A+K+++  +    +     E Q +SQ  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSL-----FCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
           IV  Y   + K  ++L+ + +  GS+              +  LD +    I++ +   L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG-----TARLLHADSSNRTLLAGTYG 373
            YLH       IHRD+ + NILL       +ADFG             +  R    GT  
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 374 YIAPELAYTMVMTE------KCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDP--KIMLI 425
           ++APE     VM +      K D++SFG+  +E+  G  P            P   +ML 
Sbjct: 192 WMAPE-----VMEQVRGYDFKADIWSFGITAIELATGAAPY-------HKYPPMKVLMLT 239

Query: 426 DVLDQRLPPPVDRKVIRDILLISTVS--F-----ACLQSNPKSRPTMQSVSQEFLITRKT 478
                +  PP     ++D  ++      F      CLQ +P+ RPT    + E L   + 
Sbjct: 240 ----LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT----AAELL---RH 288

Query: 479 PLVKHA 484
              + A
Sbjct: 289 KFFQKA 294

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  134 bits (340), Expect = 1e-35
 Identities = 64/301 (21%), Positives = 128/301 (42%), Gaps = 42/301 (13%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLH-- 261
             + I   IG+GG   V++      +++A+K ++  E +   + S++NE   L+++    
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
             I++LY Y +  + ++++ E      L   L   +    +D  +R +  K M  A+  +
Sbjct: 69  DKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTI 124

Query: 322 HHDCSPSIIHRDISSNNILLNS---KLEAFVADFGTARLLHADSSN--RTLLAGTYGYIA 376
           H      I+H D+   N L+     KL     DFG A  +  D+++  +    GT  Y+ 
Sbjct: 125 H---QHGIVHSDLKPANFLIVDGMLKL----IDFGIANQMQPDTTSVVKDSQVGTVNYMP 177

Query: 377 PEL-----------AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLI 425
           PE                 ++ K DV+S G +   +  GK P   +     +   K+  I
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI----INQISKLHAI 233

Query: 426 DVLDQRLP-PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ-EFLITRKTPLVKH 483
              +  +  P +  K ++D+L        CL+ +PK R ++  +    ++  +  P+ + 
Sbjct: 234 IDPNHEIEFPDIPEKDLQDVLK------CCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 287

Query: 484 A 484
           A
Sbjct: 288 A 288

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  137 bits (346), Expect = 2e-35
 Identities = 74/282 (26%), Positives = 122/282 (43%), Gaps = 42/282 (14%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL--PNGKVFALK--KLHTSEELAFIKSFKNEAQVLSQVL 260
            D  +++ +G G YG VY+      +  V A+K  K  T E   F+K    EA V+ ++ 
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTV-AVKTLKEDTMEVEEFLK----EAAVMKEIK 274

Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H N+V+L G C  +   ++I E+M  G+L   L       E+     + +   ++ A+ Y
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEY 333

Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD---SSNRTLLAGTYGYIAP 377
           L      + IHR++++ N L+       VADFG +RL+  D   +           + AP
Sbjct: 334 LE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAP 388

Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ-----R 431
           E       + K DV++FGV+  E+   G  P            P I L  V +      R
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKDYR 437

Query: 432 LPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           +  P    + + +++       AC Q NP  RP+   + Q F
Sbjct: 438 MERPEGCPEKVYELMR------ACWQWNPSDRPSFAEIHQAF 473

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  132 bits (334), Expect = 3e-35
 Identities = 68/277 (24%), Positives = 120/277 (43%), Gaps = 40/277 (14%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQV-LSQVLHR 262
           +D +    +G G YG V K + +P+G++ A+K++  +      K    +  + +  V   
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSL---FCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
             V  YG    +  +++  E M+  SL   +  + +    +  D   +  I  ++  AL 
Sbjct: 67  FTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALE 123

Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE- 378
           +LH   S  +IHRD+  +N+L+N+  +  + DFG +  L  D   + + AG   Y+APE 
Sbjct: 124 HLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDIDAGCKPYMAPER 180

Query: 379 -------LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQ- 430
                    Y++    K D++S G+  +E+ + + P        S   P       L Q 
Sbjct: 181 INPELNQKGYSV----KSDIWSLGITMIELAILRFP------YDSWGTP----FQQLKQV 226

Query: 431 -RLPPPVDRKVIRDILLISTVSF--ACLQSNPKSRPT 464
              P P   ++  D      V F   CL+ N K RPT
Sbjct: 227 VEEPSP---QLPADKFSAEFVDFTSQCLKKNSKERPT 260

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  131 bits (331), Expect = 7e-35
 Identities = 63/286 (22%), Positives = 112/286 (39%), Gaps = 43/286 (15%)

Query: 213 IGTGGYGSVYKAQLP-----NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G G +G V   +        G+  A+K L        I   K E ++L  + H NIVK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 268 YGYCLHKKC--MFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYL 321
            G C       + LI E++  GSL   L  N++ +     L +A ++         + YL
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI------CKGMDYL 142

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI-----A 376
               S   +HRD+++ N+L+ S+ +  + DFG  + +  D    T              A
Sbjct: 143 G---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT--VKDDRDSPVFWYA 197

Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSD---PKIMLIDVLDQ-- 430
           PE           DV+SFGV   E+L         ++           ++ +  +++   
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257

Query: 431 ---RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
              RLP P +    +  ++        C +  P +R + Q++ + F
Sbjct: 258 EGKRLPCPPNCPDEVYQLMR------KCWEFQPSNRTSFQNLIEGF 297

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  130 bits (330), Expect = 8e-35
 Identities = 61/278 (21%), Positives = 116/278 (41%), Gaps = 38/278 (13%)

Query: 209 IRYCIGTGGYGSVYKAQL--PNGKVF-ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIV 265
               +G G +GSV +        ++  A+K L    E A  +    EAQ++ Q+ +  IV
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73

Query: 266 KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
           +L G C   + + L+ E    G L   L    +  E+  +    ++  ++  + YL    
Sbjct: 74  RLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYL---E 127

Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI---APELAYT 382
             + +HRD+++ N+LL ++  A ++DFG ++ L AD S  T  +     +   APE    
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187

Query: 383 MVMTEKCDVYSFGVVTLEVLM-GKHP------RDILSSLSSSSDPKIMLIDVLDQRLPPP 435
              + + DV+S+GV   E L  G+ P       ++++ +               +R+  P
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ------------GKRMECP 235

Query: 436 VD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            +    +  ++        C     + RP   +V Q  
Sbjct: 236 PECPPELYALMS------DCWIYKWEDRPDFLTVEQRM 267

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  130 bits (330), Expect = 9e-35
 Identities = 76/283 (26%), Positives = 121/283 (42%), Gaps = 44/283 (15%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVF-ALK--KLHTSEELAFIKSFKNEAQVLSQVLH 261
            D  +++ +G G YG VY+       +  A+K  K  T E   F+K    EA V+ ++ H
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKH 68

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            N+V+L G C  +   ++I E+M  G+L   L       E+     + +   ++ A+ YL
Sbjct: 69  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL 127

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI-----A 376
                 + IHRD+++ N L+       VADFG +RL+  D    T  A           A
Sbjct: 128 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTA 180

Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ----- 430
           PE       + K DV++FGV+  E+   G  P            P I L  V +      
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-----------PGIDLSQVYELLEKDY 229

Query: 431 RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           R+  P    + + +++       AC Q NP  RP+   + Q F
Sbjct: 230 RMERPEGCPEKVYELMR------ACWQWNPSDRPSFAEIHQAF 266

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  130 bits (328), Expect = 1e-34
 Identities = 67/275 (24%), Positives = 113/275 (41%), Gaps = 46/275 (16%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALK--KLHTSEELAFIKSFKNEAQVLSQVLHR 262
           +D      +GTG +G V   +       A+K  K  +  E  FI+    EA+V+  + H 
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHE 79

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
            +V+LYG C  ++ +F+I EYM  G L   L            + + + K +  A+ YL 
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE 137

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD---SSNRTLLAGTYGYI---A 376
              S   +HRD+++ N L+N +    V+DFG +R +  D   SS  +        +    
Sbjct: 138 ---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-----VRWSP 189

Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ----- 430
           PE+      + K D+++FGV+  E+   GK P             +    +  +      
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY-----------ERFTNSETAEHIAQGL 238

Query: 431 RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPT 464
           RL  P    + +  I+       +C       RPT
Sbjct: 239 RLYRPHLASEKVYTIMY------SCWHEKADERPT 267

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  136 bits (343), Expect = 2e-34
 Identities = 59/271 (21%), Positives = 105/271 (38%), Gaps = 55/271 (20%)

Query: 210 RY----CIGTGGYGSVYKA---QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR 262
           +Y    CI  GG G +Y A    + NG+   LK L  S +         E Q L++V+H 
Sbjct: 81  QYEVKGCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHP 139

Query: 263 NIVKLYGYCLH-----KKCMFLIYEYMERGSLFCNLHNNEDAVE--LDWAKRVNIVKAMA 315
           +IV+++ +  H         +++ EY+   SL       + +    L  A+ +  +  + 
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-------KRSKGQKLPVAEAIAYLLEIL 192

Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNS---KLEAFVADFGTARLLHADSSNRTLLAGTY 372
            AL+YLH   S  +++ D+   NI+L     K    + D G    +++       L GT 
Sbjct: 193 PALSYLH---SIGLVYNDLKPENIMLTEEQLK----LIDLGAVSRINSFGY----LYGTP 241

Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRL 432
           G+ APE+  T   T   D+Y+ G     + +    R+             +  D    + 
Sbjct: 242 GFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRN-------GRYVDGLPEDDPVLKT 293

Query: 433 PPPVDRKVIRDILLISTVSFACLQSNPKSRP 463
                R + R            +  +P+ R 
Sbjct: 294 YDSYGRLLRR-----------AIDPDPRQRF 313

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  133 bits (336), Expect = 2e-34
 Identities = 64/306 (20%), Positives = 119/306 (38%), Gaps = 51/306 (16%)

Query: 198 EDLIEATEDFDIRYC----IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEA 253
            ++    +           +G G  G+V       G+  A+K++     + F      E 
Sbjct: 4   ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM----LIDFCDIALMEI 59

Query: 254 QVLSQVL-HRNIVKLYGYCLHKKCMFLIYEYMERGSLF----CNLHNNEDAVELDWAKRV 308
           ++L++   H N+++ Y      + +++  E     +L         ++E+         +
Sbjct: 60  KLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPI 118

Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF-------------VADFGTA 355
           ++++ +A  +A+LH   S  IIHRD+   NIL+++                  ++DFG  
Sbjct: 119 SLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175

Query: 356 RLLHADSSNRTL----LAGTYGYIAPEL-------AYTMVMTEKCDVYSFGVVTLEVL-M 403
           + L +  S+        +GT G+ APEL            +T   D++S G V   +L  
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

Query: 404 GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD-ILLISTVSFACLQSNPKSR 462
           GKHP         S +  I+        +    DR +I +   LIS      +  +P  R
Sbjct: 236 GKHPFGD----KYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLIS----QMIDHDPLKR 287

Query: 463 PTMQSV 468
           PT   V
Sbjct: 288 PTAMKV 293

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  132 bits (333), Expect = 2e-34
 Identities = 63/301 (20%), Positives = 126/301 (41%), Gaps = 42/301 (13%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLH-- 261
             + I   IG+GG   V++      +++A+K ++  E +   + S++NE   L+++    
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
             I++LY Y +  + ++++ E      L   L   +    +D  +R +  K M  A+  +
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTI 171

Query: 322 HHDCSPSIIHRDISSNNILLNS---KLEAFVADFGTARLLHADSSNRTL--LAGTYGYIA 376
           H      I+H D+   N L+     KL     DFG A  +  D+++       G   Y+ 
Sbjct: 172 H---QHGIVHSDLKPANFLIVDGMLKL----IDFGIANQMQPDTTSVVKDSQVGAVNYMP 224

Query: 377 PEL-----------AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLI 425
           PE                 ++ K DV+S G +   +  GK P   +     +   K+  I
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI----INQISKLHAI 280

Query: 426 DVLDQRLP-PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ-EFLITRKTPLVKH 483
              +  +  P +  K ++D+L        CL+ +PK R ++  +    ++  +  P+ + 
Sbjct: 281 IDPNHEIEFPDIPEKDLQDVLK------CCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 334

Query: 484 A 484
           A
Sbjct: 335 A 335

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  130 bits (329), Expect = 3e-34
 Identities = 59/281 (20%), Positives = 101/281 (35%), Gaps = 50/281 (17%)

Query: 202 EATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           E       +  +G G +G V++ +    G   A+K      ++        E    + + 
Sbjct: 55  EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK------KVRLEVFRVEELVACAGLS 108

Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAH 316
              IV LYG       + +  E +E GSL   +       ED         +  +     
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA-------LYYLGQALE 161

Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTARLLHADSSNRTL-----LAG 370
            L YLH   +  I+H D+ ++N+LL+S    A + DFG A  L  D   ++L     + G
Sbjct: 162 GLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218

Query: 371 TYGYIAPELAYTMVM----TEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLID 426
           T  ++APE    +VM      K D++S   + L +L G HP       +      + L  
Sbjct: 219 TETHMAPE----VVMGKPCDAKVDIWSSCCMMLHMLNGCHP------WTQYFRGPLCLKI 268

Query: 427 VLDQRLPPPVDRKV---IRDILLISTVSFACLQSNPKSRPT 464
             +      +           +         L+  P  R +
Sbjct: 269 ASEPPPIREIPPSCAPLTAQAIQ------EGLRKEPVHRAS 303

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  129 bits (326), Expect = 3e-34
 Identities = 81/269 (30%), Positives = 129/269 (47%), Gaps = 27/269 (10%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           +DFDI   +G G +G+VY A+   N  + ALK L  S+  +       + E ++ S + H
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            NI+++Y Y   +K ++L+ E+  RG L+  L  +    E   +     ++ +A AL Y 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE-QRSAT--FMEELADALHYC 130

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
           H      +IHRDI   N+L+  K E  +ADFG +  +HA S  R  + GT  Y+ PE+  
Sbjct: 131 H---ERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRTMCGTLDYLPPEMIE 185

Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIML--IDVLDQRLPPPVDRK 439
                EK D++  GV+  E L+G  P D       S         I  +D + PP +   
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFD-------SPSHTETHRRIVNVDLKFPPFLSDG 238

Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSV 468
             +D  LIS +    L+ +P  R  ++ V
Sbjct: 239 S-KD--LISKL----LRYHPPQRLPLKGV 260

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  129 bits (326), Expect = 3e-34
 Identities = 70/289 (24%), Positives = 117/289 (40%), Gaps = 48/289 (16%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL--PNGKVF--ALK--KLHTSEELAFIKSFKNEAQVLSQ 258
           +D  +   +G G +G V + +   P+GK    A+K  K     +   +  F  E   +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAM 314
           + HRN+++LYG  L    M ++ E    GSL   L  ++          +A  V + + M
Sbjct: 78  LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA--VQVAEGM 134

Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT--- 371
                YL    S   IHRD+++ N+LL ++    + DFG  R L  +  +  +       
Sbjct: 135 G----YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187

Query: 372 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP------RDILSSLSSSSDPKIML 424
           + + APE   T   +   D + FGV   E+   G+ P        IL             
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH-----------K 236

Query: 425 IDVLDQRLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           ID   +RLP P D  + I ++++       C    P+ RPT  ++    
Sbjct: 237 IDKEGERLPRPEDCPQDIYNVMV------QCWAHKPEDRPTFVALRDFL 279

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  129 bits (327), Expect = 4e-34
 Identities = 77/288 (26%), Positives = 127/288 (44%), Gaps = 37/288 (12%)

Query: 204 TEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR 262
            E FD+   +G G YGSVYKA     G++ A+K++    +   ++    E  ++ Q    
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSP 84

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
           ++VK YG       ++++ EY   GS+   +      +  D      I+++    L YLH
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT--ILQSTLKGLEYLH 142

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
                  IHRDI + NILLN++  A +ADFG A  L    + R  + GT  ++APE+   
Sbjct: 143 ---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 199

Query: 383 MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR---- 438
           +      D++S G+  +E+  GK P   +  + +     I +I       PPP  R    
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA-----IFMI----PTNPPPTFRKPEL 250

Query: 439 --KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHA 484
                 D +        CL  +P+ R T    + + L   + P V+ A
Sbjct: 251 WSDNFTDFVK------QCLVKSPEQRAT----ATQLL---QHPFVRSA 285

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  129 bits (327), Expect = 5e-34
 Identities = 73/290 (25%), Positives = 121/290 (41%), Gaps = 53/290 (18%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL--PNGKVF---ALKKLHTSEELAFIKSFKNEAQVLSQV 259
            +F     +G+G +G+VYK        KV    A+K+L  +      K   +EA V++ V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMA 315
            + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V I K M 
Sbjct: 75  DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN 131

Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI 375
               YL       ++HRD+++ N+L+ +     + DFG A+LL A+           G +
Sbjct: 132 ----YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH---AEGGKV 181

Query: 376 -----APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP------RDILSSLSSSSDPKIM 423
                A E     + T + DV+S+GV   E++  G  P       +I S L         
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK------- 234

Query: 424 LIDVLDQRLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
                 +RLP P      +  I++       C   +  SRP  + +  EF
Sbjct: 235 -----GERLPQPPICTIDVYMIMV------KCWMIDADSRPKFRELIIEF 273

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  129 bits (327), Expect = 5e-34
 Identities = 70/303 (23%), Positives = 116/303 (38%), Gaps = 52/303 (17%)

Query: 213 IGTGGYGSVYKAQLP-----NGKVFALKKL---HTSEELAFIKSFKNEAQVLSQVLHRNI 264
           +G G +GSV   +        G + A+K+L      ++  F +    E Q+L  +    I
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR----EIQILKALHSDFI 86

Query: 265 VKLYGYCLHKKC--MFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHAL 318
           VK  G         + L+ EY+  G L   L  +   ++    L ++    I K M    
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS--SQICKGME--- 141

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI--- 375
            YL    S   +HRD+++ NIL+ S+    +ADFG A+LL  D           G     
Sbjct: 142 -YLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV--VREPGQSPIF 195

Query: 376 --APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP---RDILSSLSSSSDPKIMLIDVLD 429
             APE     + + + DV+SFGVV  E+                +         L  +L+
Sbjct: 196 WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255

Query: 430 Q-----RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF--LITRKTPLV 481
                 RLP P      + +++        C   +P+ RP+  ++  +   L +      
Sbjct: 256 LLEEGQRLPAPPACPAEVHELMK------LCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309

Query: 482 KHA 484
            HA
Sbjct: 310 THA 312

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  128 bits (323), Expect = 5e-34
 Identities = 68/280 (24%), Positives = 120/280 (42%), Gaps = 40/280 (14%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALK--KLHTSEELAFIKSFKNEAQVLSQVLHR 262
           E+  +   +G+G +G V   +       A+K  K  +  E  F +    EAQ + ++ H 
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ----EAQTMMKLSHP 63

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
            +VK YG C  +  ++++ EY+  G L   L ++     L+ ++ + +   +   +A+L 
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLE 121

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI---APEL 379
              S   IHRD+++ N L++  L   V+DFG  R +  D    +   GT   +   APE+
Sbjct: 122 ---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS--VGTKFPVKWSAPEV 176

Query: 380 AYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ-----RLP 433
            +    + K DV++FG++  EV   GK P                  +V+ +     RL 
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMPY-----------DLYTNSEVVLKVSQGHRLY 225

Query: 434 PPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            P      I  I+       +C    P+ RPT Q +    
Sbjct: 226 RPHLASDTIYQIMY------SCWHELPEKRPTFQQLLSSI 259

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  130 bits (328), Expect = 6e-34
 Identities = 38/225 (16%), Positives = 72/225 (32%), Gaps = 25/225 (11%)

Query: 204 TEDFDIRYCIGTGGYGSVYKAQ------LPNGKVFALKKLHTSEELAFIKSFKNEAQVLS 257
           ++   + + +G G +  VY+A         N + F LK    +    F        + L 
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF-YIGTQLMERLK 122

Query: 258 QVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLF--CNLHNNEDAVELDWAKRVNIVKAMA 315
             +    +K Y   L +    L+ E    G+L    NL+ N     +     ++    M 
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182

Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAF-----------VADFGTARLLHADSSN 364
           + +  +H      IIH DI  +N +L +                + D G +  +      
Sbjct: 183 YMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239

Query: 365 RTL--LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
                   T G+   E+        + D +        +L G + 
Sbjct: 240 TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  129 bits (327), Expect = 7e-34
 Identities = 80/286 (27%), Positives = 125/286 (43%), Gaps = 43/286 (15%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL--PNGKVF---ALKKLH--TSEELAFIKSFKNEAQVLS 257
                +  IG G +G VYK  L   +GK     A+K L    +E+      F  EA ++ 
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMG 101

Query: 258 QVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 317
           Q  H NI++L G     K M +I EYME G+L   L   +   E    + V +++ +A  
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAG 159

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI-- 375
           + YL    + + +HRD+++ NIL+NS L   V+DFG +R+L  D       +G    I  
Sbjct: 160 MKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 216

Query: 376 -APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP------RDILSSLSSSSDPKIMLIDV 427
            APE       T   DV+SFG+V  EV+  G+ P       +++ +++            
Sbjct: 217 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND----------- 265

Query: 428 LDQRLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
              RLP P+D    I  +++       C Q     RP    +    
Sbjct: 266 -GFRLPTPMDCPSAIYQLMM------QCWQQERARRPKFADIVSIL 304

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  129 bits (326), Expect = 7e-34
 Identities = 73/284 (25%), Positives = 115/284 (40%), Gaps = 40/284 (14%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL---PNGKVF-ALKKLHTSEELAFIKSFKNEAQVLSQVL 260
               I   IG+G  G V   +L       V  A+K L         + F +EA ++ Q  
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108

Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H NI++L G     +   ++ EYME GSL   L  ++   +    + V +++ +   + Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRY 166

Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI----- 375
           L        +HRD+++ N+L++S L   V+DFG +R+L  D         T G I     
Sbjct: 167 LS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD--AAYTTTGGKIPIRWT 221

Query: 376 APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ---- 430
           APE       +   DV+SFGVV  EVL  G+ P              +   DV+      
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY-----------WNMTNRDVISSVEEG 270

Query: 431 -RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            RLP P+     +  ++L       C   +   RP    +    
Sbjct: 271 YRLPAPMGCPHALHQLML------DCWHKDRAQRPRFSQIVSVL 308

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  130 bits (328), Expect = 8e-34
 Identities = 74/277 (26%), Positives = 121/277 (43%), Gaps = 42/277 (15%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGK-------VFALKKLHTSEELAFIKSFKNEAQVLS 257
            +  I   +G G +G V   +L           +  LK  +T ++    + F  EA ++ 
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR---RDFLGEASIMG 101

Query: 258 QVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 317
           Q  H NI++L G     K + ++ EYME GSL   L  ++   +    + V +++ +A  
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASG 159

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI-- 375
           + YL        +HRD+++ NIL+NS L   V+DFG  R+L  D        G    I  
Sbjct: 160 MKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW 216

Query: 376 -APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ--- 430
            +PE       T   DV+S+G+V  EV+  G+ P             ++   DV+     
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY-----------WEMSNQDVIKAVDE 265

Query: 431 --RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPT 464
             RLPPP+D    +  ++L       C Q +  +RP 
Sbjct: 266 GYRLPPPMDCPAALYQLML------DCWQKDRNNRPK 296

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  127 bits (321), Expect = 1e-33
 Identities = 71/290 (24%), Positives = 126/290 (43%), Gaps = 31/290 (10%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           EDF +   +G G +  VY+A+ +  G   A+K +      +   ++  +NE ++  Q+ H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            +I++LY Y      ++L+ E    G +   L N       + A+    +  +   + YL
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH--FMHQIITGMLYL 128

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
           H   S  I+HRD++ +N+LL   +   +ADFG A  L         L GT  YI+PE+A 
Sbjct: 129 H---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT 185

Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIML--IDVLDQRLPPPVD-- 437
                 + DV+S G +   +L+G+ P D       +   K  L  + + D  +P  +   
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPPFD-------TDTVKNTLNKVVLADYEMPSFLSIE 238

Query: 438 -RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ-EFLITRKTPLVKHAA 485
            + +I  +          L+ NP  R ++ SV    F+    +   K   
Sbjct: 239 AKDLIHQL----------LRRNPADRLSLSSVLDHPFMSRNSSTKSKDEG 278

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  128 bits (323), Expect = 2e-33
 Identities = 63/282 (22%), Positives = 114/282 (40%), Gaps = 53/282 (18%)

Query: 213 IGTGGYGSVYKAQL----PNGKVF-ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G+G +G+V+K        + K+   +K +         ++  +    +  + H +IV+L
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHH 323
            G C     + L+ +Y+  GSL  ++  +  A+     L+W   V I K M     YL  
Sbjct: 81  LGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG--VQIAKGMY----YLE- 132

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI-----APE 378
                ++HR++++ N+LL S  +  VADFG A LL  D         +         A E
Sbjct: 133 --EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL---LYSEAKTPIKWMALE 187

Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLM-GKHP------RDILSSLSSSSDPKIMLIDVLDQR 431
             +    T + DV+S+GV   E++  G  P       ++   L               +R
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK------------GER 235

Query: 432 LPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           L  P      +  +++       C   +   RPT + ++ EF
Sbjct: 236 LAQPQICTIDVYMVMV------KCWMIDENIRPTFKELANEF 271

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  128 bits (323), Expect = 2e-33
 Identities = 70/316 (22%), Positives = 127/316 (40%), Gaps = 58/316 (18%)

Query: 204 TEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-H 261
              F++   +G G YG VYK + +  G++ A+K +  + +    +  K E  +L +   H
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHH 80

Query: 262 RNIVKLYGYCLHKKC------MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN------ 309
           RNI   YG  + K        ++L+ E+   GS+        D ++      +       
Sbjct: 81  RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-------TDLIKNTKGNTLKEEWIAY 133

Query: 310 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA 369
           I + +   L++LH      +IHRDI   N+LL    E  + DFG +  L      R    
Sbjct: 134 ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI 190

Query: 370 GTYGYIAPELAYTMVMTE-----KCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIML 424
           GT  ++APE+       +     K D++S G+  +E+  G  P   +  + +     + L
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFL 245

Query: 425 IDVLDQRLPPPVDR-----KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
           I     R P P  +     K  +  +       +CL  N   RP     +++ +   K P
Sbjct: 246 I----PRNPAPRLKSKKWSKKFQSFIE------SCLVKNHSQRPA----TEQLM---KHP 288

Query: 480 LVKHAAIQDISISELR 495
            ++    +     +L+
Sbjct: 289 FIRDQPNERQVRIQLK 304

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  126 bits (320), Expect = 2e-33
 Identities = 64/273 (23%), Positives = 118/273 (43%), Gaps = 46/273 (16%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           ++  +   IG G +G V        KV A+K +      A  ++F  EA V++Q+ H N+
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIK---NDATAQAFLAEASVMTQLRHSNL 76

Query: 265 VKLYGYCLHKK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           V+L G  + +K  ++++ EYM +GSL   L +   +  L     +     +  A+ YL  
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE- 134

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI-----APE 378
               + +HRD+++ N+L++    A V+DFG  +   +            G +     APE
Sbjct: 135 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT--------GKLPVKWTAPE 184

Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ-----RL 432
                  + K DV+SFG++  E+   G+ P            P+I L DV+ +     ++
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPY-----------PRIPLKDVVPRVEKGYKM 233

Query: 433 PPPVD-RKVIRDILLISTVSFACLQSNPKSRPT 464
             P      + +++        C   +   RP+
Sbjct: 234 DAPDGCPPAVYEVMK------NCWHLDAAMRPS 260

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  132 bits (334), Expect = 2e-33
 Identities = 62/273 (22%), Positives = 115/273 (42%), Gaps = 36/273 (13%)

Query: 213 IGTGGYGSVYKAQL--PNGKVF-ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYG 269
           +G G +GSV +        ++  A+K L    E A  +    EAQ++ Q+ +  IV+L G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
            C   + + L+ E    G L   L    +  E+  +    ++  ++  + YL      + 
Sbjct: 404 VCQ-AEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYL---EEKNF 457

Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI---APELAYTMVMT 386
           +HR++++ N+LL ++  A ++DFG ++ L AD S  T  +     +   APE       +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517

Query: 387 EKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ-----RLPPPVD-RK 439
            + DV+S+GV   E L  G+ P             K+   +V+       R+  P +   
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPY-----------KKMKGPEVMAFIEQGKRMECPPECPP 566

Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            +  ++        C     + RP   +V Q  
Sbjct: 567 ELYALMS------DCWIYKWEDRPDFLTVEQRM 593

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  127 bits (321), Expect = 2e-33
 Identities = 67/276 (24%), Positives = 113/276 (40%), Gaps = 49/276 (17%)

Query: 210 RY----CIGTGGYGSVYKAQ-LPNGKVFALKKLHT--SEELAFIKSFKNEAQVLSQVLHR 262
           RY     +G GG  +VY A+        A+K +     E+   +K F+ E    SQ+ H+
Sbjct: 12  RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQ 71

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
           NIV +        C +L+ EY+E  +L   + ++     L     +N    +   + + H
Sbjct: 72  NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH 128

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT-LLAGTYGYIAPELAY 381
                 I+HRDI   NIL++S     + DFG A+ L   S  +T  + GT  Y +PE A 
Sbjct: 129 DM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185

Query: 382 TMVMTEKCDVYSFGVVTLEVLMG--------------KHPRDILSSLSSSSDPKIMLIDV 427
                E  D+YS G+V  E+L+G              KH +D + ++++     I     
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDI----- 240

Query: 428 LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRP 463
                P  +   ++R             + +  +R 
Sbjct: 241 -----PQSLSNVILR-----------ATEKDKANRY 260

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  127 bits (321), Expect = 2e-33
 Identities = 58/272 (21%), Positives = 98/272 (36%), Gaps = 42/272 (15%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKL----HTSEELAFIKSFKNEAQVLSQV 259
           + F     +G G YG V+K +   +G+++A+K+        ++         E     +V
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR---ARKLAEVGSHEKV 113

Query: 260 L-HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
             H   V+L         ++L  E     SL  +      ++          ++    AL
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVW--GYLRDTLLAL 170

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
           A+LH   S  ++H D+   NI L  +    + DFG    L    +      G   Y+APE
Sbjct: 171 AHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-GDPRYMAPE 226

Query: 379 L---AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP 435
           L   +Y        DV+S G+  LEV                   ++         LPP 
Sbjct: 227 LLQGSY----GTAADVFSLGLTILEVACNMELPHGGEGW-----QQLR-----QGYLPPE 272

Query: 436 VDRKV---IRDILLISTVSFACLQSNPKSRPT 464
               +   +R +L+        L+ +PK R T
Sbjct: 273 FTAGLSSELRSVLV------MMLEPDPKLRAT 298

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  130 bits (329), Expect = 3e-33
 Identities = 75/281 (26%), Positives = 128/281 (45%), Gaps = 42/281 (14%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLH--TSEELAFIKSFKNEAQVLSQVLH 261
           E   +   +G G +G V+        +V A+K L   T    AF++    EAQV+ ++ H
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQ----EAQVMKKLRH 238

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
             +V+LY     ++ ++++ EYM +GSL   L        L   + V++   +A  +AY+
Sbjct: 239 EKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV 296

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD---SSNRTLLAGTYGYIAPE 378
                 + +HRD+ + NIL+   L   VADFG ARL+  +   +           + APE
Sbjct: 297 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPE 351

Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ-----RL 432
            A     T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRM 400

Query: 433 PPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           P P +  + + D++        C +  P+ RPT + +    
Sbjct: 401 PCPPECPESLHDLMC------QCWRKEPEERPTFEYLQAFL 435

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  126 bits (318), Expect = 4e-33
 Identities = 72/287 (25%), Positives = 122/287 (42%), Gaps = 45/287 (15%)

Query: 213 IGTGGYGSVYKAQLP-----NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G G +GSV   +        G+V A+KKL  S E   ++ F+ E ++L  + H NIVK 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH-LRDFEREIEILKSLQHDNIVKY 76

Query: 268 YGYCLH--KKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYL 321
            G C    ++ + LI EY+  GSL   L  +++ ++    L +     I K M     YL
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT--SQICKGME----YL 130

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI-----A 376
               +   IHRD+++ NIL+ ++    + DFG  ++L  D           G       A
Sbjct: 131 G---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK--VKEPGESPIFWYA 185

Query: 377 PELAYTMVMTEKCDVYSFGVV-----TLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQ- 430
           PE       +   DV+SFGVV     T        P + +  + +    ++++  +++  
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245

Query: 431 ----RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
               RLP P      I  I+        C  +N   RP+ + ++   
Sbjct: 246 KNNGRLPRPDGCPDEIYMIMT------ECWNNNVNQRPSFRDLALRV 286

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  126 bits (318), Expect = 5e-33
 Identities = 66/276 (23%), Positives = 115/276 (41%), Gaps = 42/276 (15%)

Query: 213 IGTGGYGSVYKAQLPNGKVF---ALKKLHT-SEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           +G+G +G+V K      KV    A+K L   + + A       EA V+ Q+ +  IV++ 
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
           G C   +   L+ E  E G L   L  N     +     + +V  ++  + YL      +
Sbjct: 85  GICE-AESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLE---ESN 137

Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI-----APELAYTM 383
            +HRD+++ N+LL ++  A ++DFG ++ L AD +     A T+G       APE     
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHGKWPVKWYAPECINYY 195

Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ-----RLPPPVD 437
             + K DV+SFGV+  E    G+ P              +   +V        R+  P  
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKPY-----------RGMKGSEVTAMLEKGERMGCPAG 244

Query: 438 -RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
             + + D++        C   + ++RP   +V    
Sbjct: 245 CPREMYDLMN------LCWTYDVENRPGFAAVELRL 274

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  125 bits (317), Expect = 5e-33
 Identities = 68/275 (24%), Positives = 120/275 (43%), Gaps = 46/275 (16%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALK--KLHTSEELAFIKSFKNEAQVLSQVLHR 262
           E   +   +G G +G V+          A+K  K  +    AF+     EA ++ Q+ H+
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQ 68

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
            +V+LY     ++ +++I EYME GSL   L       +L   K +++   +A  +A++ 
Sbjct: 69  RLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIE 126

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD---SSNRTLLAGTYGYI---A 376
                + IHRD+ + NIL++  L   +ADFG ARL+  +   +            I   A
Sbjct: 127 ---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-----IKWTA 178

Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ----- 430
           PE       T K DV+SFG++  E++  G+ P            P +   +V+       
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-----------PGMTNPEVIQNLERGY 227

Query: 431 RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPT 464
           R+  P +  + +  ++        C +  P+ RPT
Sbjct: 228 RMVRPDNCPEELYQLMR------LCWKERPEDRPT 256

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  130 bits (329), Expect = 5e-33
 Identities = 75/281 (26%), Positives = 128/281 (45%), Gaps = 42/281 (14%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLH--TSEELAFIKSFKNEAQVLSQVLH 261
           E   +   +G G +G V+        +V A+K L   T    AF++    EAQV+ ++ H
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQ----EAQVMKKLRH 321

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
             +V+LY     ++ ++++ EYM +GSL   L        L   + V++   +A  +AY+
Sbjct: 322 EKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV 379

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD---SSNRTLLAGTYGYIAPE 378
                 + +HRD+ + NIL+   L   VADFG ARL+  +   +           + APE
Sbjct: 380 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPE 434

Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ-----RL 432
            A     T K DV+SFG++  E+   G+ P            P ++  +VLDQ     R+
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRM 483

Query: 433 PPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           P P +  + + D++        C +  P+ RPT + +    
Sbjct: 484 PCPPECPESLHDLMC------QCWRKEPEERPTFEYLQAFL 518

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  126 bits (318), Expect = 6e-33
 Identities = 69/280 (24%), Positives = 119/280 (42%), Gaps = 47/280 (16%)

Query: 204 TEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKK--LHTSEELAFIKSFKNEAQVLSQVL 260
            E ++I   +G G +G VYKA+    G + A K     + EEL        E ++L+   
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI---VEIEILATCD 74

Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSL-----FCNLHNNEDAVELDWAKRVNIVKAMA 315
           H  IVKL G   H   ++++ E+   G++       +    E  +++       + + M 
Sbjct: 75  HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-------VCRQML 127

Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI 375
            AL +LH   S  IIHRD+ + N+L+  + +  +ADFG +         R    GT  ++
Sbjct: 128 EALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWM 184

Query: 376 APELAYTMVMTE-----KCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQ 430
           APE+     M +     K D++S G+  +E+   + P   L+ +       ++ I     
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----LLKI----A 235

Query: 431 RLPPPVDR------KVIRDILLISTVSFACLQSNPKSRPT 464
           +  PP            RD L         L  NP++RP+
Sbjct: 236 KSDPPTLLTPSKWSVEFRDFLK------IALDKNPETRPS 269

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  129 bits (326), Expect = 6e-33
 Identities = 66/276 (23%), Positives = 122/276 (44%), Gaps = 36/276 (13%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           ++  +   IG G +G V        KV A+K +      A  ++F  EA V++Q+ H N+
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIKND---ATAQAFLAEASVMTQLRHSNL 248

Query: 265 VKLYGYCLHKK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           V+L G  + +K  ++++ EYM +GSL   L +   +  L     +     +  A+ YL  
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE- 306

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
               + +HRD+++ N+L++    A V+DFG  +   +      L      + APE     
Sbjct: 307 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---PVKWTAPEALREK 361

Query: 384 VMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ-----RLPPPVD 437
             + K DV+SFG++  E+   G+ P            P+I L DV+ +     ++  P  
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVPY-----------PRIPLKDVVPRVEKGYKMDAPDG 410

Query: 438 -RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
               + D++        C   +  +RPT   + ++ 
Sbjct: 411 CPPAVYDVMK------NCWHLDAATRPTFLQLREQL 440

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  125 bits (316), Expect = 1e-32
 Identities = 66/271 (24%), Positives = 115/271 (42%), Gaps = 25/271 (9%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTS--EELAFIKSFKNEAQVLSQVLH 261
             +     +G GG+   ++       +VFA K +  S   +    +    E  +   + H
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
           +++V  +G+      +F++ E   R SL   LH    A+    A+    ++ +     YL
Sbjct: 75  QHVVGFHGFFEDNDFVFVVLELCRRRSLL-ELHKRRKALTEPEARY--YLRQIVLGCQYL 131

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
           H      +IHRD+   N+ LN  LE  + DFG A  +  D   + +L GT  YIAPE+  
Sbjct: 132 H---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 188

Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIML--IDVLDQRLPPPVDRK 439
               + + DV+S G +   +L+GK P +       +S  K     I   +  +P  ++  
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFE-------TSCLKETYLRIKKNEYSIPKHINPV 241

Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
                 LI       LQ++P +RPT+  +  
Sbjct: 242 A-AS--LIQ----KMLQTDPTARPTINELLN 265

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  125 bits (316), Expect = 1e-32
 Identities = 65/268 (24%), Positives = 118/268 (44%), Gaps = 30/268 (11%)

Query: 204 TEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKK--LHTSEELAFIKSFKNEAQVLSQVL 260
            + +     IG G  G+VY A  +  G+  A+++  L    +   I    NE  V+ +  
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII---NEILVMRENK 75

Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           + NIV      L    ++++ EY+  GSL   +        +D  +   + +    AL +
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEF 131

Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELA 380
           LH   S  +IHRDI S+NILL       + DFG    +  + S R+ + GT  ++APE+ 
Sbjct: 132 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188

Query: 381 YTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV 440
                  K D++S G++ +E++ G+ P    + L +     + LI         P     
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----LYLI----ATNGTP----E 235

Query: 441 IRDILLISTV--SF--ACLQSNPKSRPT 464
           +++   +S +   F   CL+ + + R +
Sbjct: 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGS 263

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  126 bits (318), Expect = 1e-32
 Identities = 66/271 (24%), Positives = 115/271 (42%), Gaps = 25/271 (9%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
             +     +G GG+   ++       +VFA K +  S   +    +    E  +   + H
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
           +++V  +G+      +F++ E   R SL   LH    A+    A+    ++ +     YL
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLL-ELHKRRKALTEPEARY--YLRQIVLGCQYL 157

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
           H      +IHRD+   N+ LN  LE  + DFG A  +  D   + +L GT  YIAPE+  
Sbjct: 158 H---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 214

Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIML--IDVLDQRLPPPVDRK 439
               + + DV+S G +   +L+GK P +       +S  K     I   +  +P  ++  
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPPFE-------TSCLKETYLRIKKNEYSIPKHINPV 267

Query: 440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
                 LI       LQ++P +RPT+  +  
Sbjct: 268 A-AS--LIQ----KMLQTDPTARPTINELLN 291

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  128 bits (324), Expect = 1e-32
 Identities = 70/280 (25%), Positives = 130/280 (46%), Gaps = 40/280 (14%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLH--TSEELAFIKSFKNEAQVLSQVLHR 262
           E   +   +G G +G V+ A        A+K +   +    AF+     EA V+  + H 
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQHD 243

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
            +VKL+     K+ +++I E+M +GSL   L ++E + +    K ++    +A  +A++ 
Sbjct: 244 KLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIE 301

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI---APEL 379
                + IHRD+ + NIL+++ L   +ADFG AR++  +    T   G    I   APE 
Sbjct: 302 ---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEA 356

Query: 380 AYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ-----RLP 433
                 T K DV+SFG++ +E++  G+ P            P +   +V+       R+P
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRIPY-----------PGMSNPEVIRALERGYRMP 405

Query: 434 PPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            P +  + + +I++       C ++ P+ RPT + +    
Sbjct: 406 RPENCPEELYNIMM------RCWKNRPEERPTFEYIQSVL 439

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  124 bits (314), Expect = 1e-32
 Identities = 57/299 (19%), Positives = 115/299 (38%), Gaps = 67/299 (22%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFA-----------LKKLHTSEELAFIKSFKNEA 253
           ED      +G G +  ++K        +            L K H +   +F +     A
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE----AA 63

Query: 254 QVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 313
            ++S++ H+++V  YG C+      L+ E+++ GSL   L  N++ + + W  ++ + K 
Sbjct: 64  SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQ 121

Query: 314 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF--------VADFGTARLLHADSSNR 365
           +A A+ +L      ++IH ++ + NILL  + +          ++D G +  +       
Sbjct: 122 LAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD--- 175

Query: 366 TLLAGTYGYI-----APE-LAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSS 418
                           PE +     +    D +SFG    E+   G  P   LS+L S  
Sbjct: 176 ------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP---LSALDSQ- 225

Query: 419 DPKIMLIDVLDQ-----RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
                    L       +LP P     + +++        C+   P  RP+ +++ ++ 
Sbjct: 226 -------RKLQFYEDRHQLPAP-KAAELANLIN------NCMDYEPDHRPSFRAIIRDL 270

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  125 bits (315), Expect = 2e-32
 Identities = 67/268 (25%), Positives = 124/268 (46%), Gaps = 30/268 (11%)

Query: 204 TEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKK--LHTSEELAFIKSFKNEAQVLSQVL 260
               D    IG G  G V  A+   +G+  A+K   L   +    +    NE  ++    
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF---NEVVIMRDYQ 100

Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H N+V++Y   L  + ++++ E+++ G+L  ++ +     E   A    + +A+  ALAY
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGAL-TDIVSQVRLNEEQIAT---VCEAVLQALAY 156

Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELA 380
           LH   +  +IHRDI S++ILL       ++DFG    +  D   R  L GT  ++APE+ 
Sbjct: 157 LH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI 213

Query: 381 YTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV 440
              +   + D++S G++ +E++ G+ P    S + +     +  +    +  PPP     
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-----MKRL----RDSPPPK---- 260

Query: 441 IRDILLISTV--SF--ACLQSNPKSRPT 464
           +++   +S V   F    L  +P+ R T
Sbjct: 261 LKNSHKVSPVLRDFLERMLVRDPQERAT 288

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  125 bits (315), Expect = 2e-32
 Identities = 72/287 (25%), Positives = 120/287 (41%), Gaps = 45/287 (15%)

Query: 213 IGTGGYGSVYKAQLP-----NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G G +GSV   +        G+V A+KKL  S E   ++ F+ E ++L  + H NIVK 
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH-LRDFEREIEILKSLQHDNIVKY 107

Query: 268 YGYCLHKKC--MFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYL 321
            G C       + LI EY+  GSL   L  +++ ++    L +     I K M     YL
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT--SQICKGME----YL 161

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI-----A 376
               +   IHRD+++ NIL+ ++    + DFG  ++L  D           G       A
Sbjct: 162 G---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYK--VKEPGESPIFWYA 216

Query: 377 PELAYTMVMTEKCDVYSFGVV-----TLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQ- 430
           PE       +   DV+SFGVV     T        P + +  + +    ++++  +++  
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276

Query: 431 ----RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
               RLP P      I  I+        C  +N   RP+ + ++   
Sbjct: 277 KNNGRLPRPDGCPDEIYMIMT------ECWNNNVNQRPSFRDLALRV 317

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  123 bits (312), Expect = 3e-32
 Identities = 68/302 (22%), Positives = 113/302 (37%), Gaps = 51/302 (16%)

Query: 198 EDLIEATEDFDIRY---------CIGTGGYGSVYKAQL--PNGKVF--ALKKLHTSEELA 244
            +L++A +   I            IG G +G VY   L   +GK    A+K L+   ++ 
Sbjct: 9   PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 68

Query: 245 FIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKC-MFLIYEYMERGSLFCNLHNNEDAVELD 303
            +  F  E  ++    H N++ L G CL  +    ++  YM+ G L   + N        
Sbjct: 69  EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPT 126

Query: 304 WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS 363
               +     +A  + YL    S   +HRD+++ N +L+ K    VADFG AR ++    
Sbjct: 127 VKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183

Query: 364 NRTLLAGTYGYI-----APELAYTMVMTEKCDVYSFGVVTLEVLM-------GKHPRDIL 411
                  T   +     A E   T   T K DV+SFGV+  E++          +  DI 
Sbjct: 184 YSV-HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 242

Query: 412 SSLSSSSDPKIMLIDVLDQRLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
             L               +RL  P      + +++L       C     + RP+   +  
Sbjct: 243 VYLLQ------------GRRLLQPEYCPDPLYEVML------KCWHPKAEMRPSFSELVS 284

Query: 471 EF 472
             
Sbjct: 285 RI 286

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  123 bits (311), Expect = 7e-32
 Identities = 62/284 (21%), Positives = 108/284 (38%), Gaps = 41/284 (14%)

Query: 213 IGTGGYGSVYKAQLPN-----GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G G +G V            G++ A+K L           +K E  +L  + H +I+K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 268 YGYCLHKKC--MFLIYEYMERGSLFCNLHNNEDAVE--LDWAKRVNIVKAMAHALAYLHH 323
            G C       + L+ EY+  GSL   L  +   +   L +A    I + MA    YLH 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFA--QQICEGMA----YLH- 151

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI-----APE 378
             +   IHRD+++ N+LL++     + DFG A+ +              G       APE
Sbjct: 152 --AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR--VREDGDSPVFWYAPE 207

Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSD---PKIMLIDVLD----- 429
                      DV+SFGV   E+L      +   +           ++ ++ + +     
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267

Query: 430 QRLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           +RLP P      +  ++        C ++    RPT +++    
Sbjct: 268 ERLPRPDKCPAEVYHLMK------NCWETEASFRPTFENLIPIL 305

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  122 bits (309), Expect = 1e-31
 Identities = 58/259 (22%), Positives = 101/259 (38%), Gaps = 27/259 (10%)

Query: 213 IGTGGYGSVYKAQLPN-GKVFALKKLHT--SEELAFIKSFKNEAQVLSQVLHRNIVKLYG 269
           +G GG G VY+A+     ++ ALK +    S +  F    + EA+   ++   ++V ++ 
Sbjct: 42  VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101

Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 329
           +      +++    +    L   L        L   + V IV+ +  AL   H       
Sbjct: 102 FGEIDGQLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA---GA 155

Query: 330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT-LLAGTYGYIAPELAYTMVMTEK 388
            HRD+   NIL+++   A++ DFG A     +   +     GT  Y+APE       T +
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYR 215

Query: 389 CDVYSFGVVTLEVLMGKHP--RDILSSLSS--SSDPKIMLIDVLDQRLPPPVDRKVIRDI 444
            D+Y+   V  E L G  P   D LS + +  +          +   +P   D  + R  
Sbjct: 216 ADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIP--RPSTVRPGIPVAFDAVIAR-- 271

Query: 445 LLISTVSFACLQSNPKSRP 463
                     +  NP+ R 
Sbjct: 272 ---------GMAKNPEDRY 281

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  121 bits (307), Expect = 1e-31
 Identities = 69/277 (24%), Positives = 112/277 (40%), Gaps = 45/277 (16%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL--PNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           E  ++  CIG G +G V++     P       A+K        +  + F  EA  + Q  
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74

Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H +IVKL G    +  +++I E    G L   L   +    LD A  +     ++ ALAY
Sbjct: 75  HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAY 131

Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI----- 375
           L    S   +HRDI++ N+L++S     + DFG +R +   +  +     + G +     
Sbjct: 132 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA----SKGKLPIKWM 184

Query: 376 APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP------RDILSSLSSSSDPKIMLIDVL 428
           APE       T   DV+ FGV   E+LM G  P       D++  + +            
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN------------ 232

Query: 429 DQRLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPT 464
            +RLP P +    +  ++        C   +P  RP 
Sbjct: 233 GERLPMPPNCPPTLYSLMT------KCWAYDPSRRPR 263

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  124 bits (312), Expect = 1e-31
 Identities = 71/328 (21%), Positives = 123/328 (37%), Gaps = 43/328 (13%)

Query: 164 LLAKRKYKKPKLEERATNNIDVFSIWNYDGRIVYEDLIEATEDF-DIRYCIGTGGYGSVY 222
           L  K   +    +   T +ID+ ++     + V   +I  +         IG G +G VY
Sbjct: 47  LYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVY 106

Query: 223 KAQL--PNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKC-M 277
              L   +GK    A+K L+   ++  +  F  E  ++    H N++ L G CL  +   
Sbjct: 107 HGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166

Query: 278 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSN 337
            ++  YM+ G L   + N            +     +A  + +L    S   +HRD+++ 
Sbjct: 167 LVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAAR 221

Query: 338 NILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI-----APELAYTMVMTEKCDVY 392
           N +L+ K    VADFG AR ++    +      T   +     A E   T   T K DV+
Sbjct: 222 NCMLDEKFTVKVADFGLARDMYDKEFDSV-HNKTGAKLPVKWMALESLQTQKFTTKSDVW 280

Query: 393 SFGVVTLEVLM-------GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD-RKVIRDI 444
           SFGV+  E++          +  DI   L               +RL  P      + ++
Sbjct: 281 SFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------------GRRLLQPEYCPDPLYEV 328

Query: 445 LLISTVSFACLQSNPKSRPTMQSVSQEF 472
           +L       C     + RP+   +    
Sbjct: 329 ML------KCWHPKAEMRPSFSELVSRI 350

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  120 bits (304), Expect = 4e-31
 Identities = 69/282 (24%), Positives = 116/282 (41%), Gaps = 55/282 (19%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL--PNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           ED  +   +G G +G VY+       G+    A+K       L   + F +EA ++  + 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAH 316
           H +IVKL G    ++  ++I E    G L   L  N+++++    + ++ ++        
Sbjct: 72  HPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI------CK 124

Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD---SSNRTLLAGTYG 373
           A+AYL    S + +HRDI+  NIL+ S     + DFG +R +  +    ++ T L     
Sbjct: 125 AMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP---- 177

Query: 374 YI---APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP------RDILSSLSSSSDPKIM 423
            I   +PE       T   DV+ F V   E+L  GK P      +D++  L         
Sbjct: 178 -IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK------- 229

Query: 424 LIDVLDQRLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPT 464
                  RLP P     V+  ++        C   +P  RP 
Sbjct: 230 -----GDRLPKPDLCPPVLYTLMT------RCWDYDPSDRPR 260

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  121 bits (305), Expect = 5e-31
 Identities = 52/218 (23%), Positives = 93/218 (42%), Gaps = 19/218 (8%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
             + +   +G G   +V++ +    G +FA+K  +    L  +     E +VL ++ H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 264 IVKLYGY--CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
           IVKL+        +   LI E+   GSL+  L    +A  L  ++ + +++ +   + +L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAF----VADFGTARLLHADSSNRTLLAGTYGYIAP 377
                  I+HR+I   NI+     +      + DFG AR L  D    +L  GT  Y+ P
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYLHP 184

Query: 378 ELAYTMVM--------TEKCDVYSFGVVTLEVLMGKHP 407
           ++    V+            D++S GV       G  P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  124 bits (313), Expect = 5e-31
 Identities = 66/224 (29%), Positives = 102/224 (45%), Gaps = 30/224 (13%)

Query: 200 LIEATEDFDIRYCI----GTGGYGSVYKA-QLPNGKVFALK-----KLHTSEELAFIKSF 249
           +  +T  F  RY      G G +G V        G+  A+K     ++    +    +S 
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD---KESL 73

Query: 250 KNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN 309
             E Q+L Q+ H NI+KLY +   K   +L+ E    G LF  + + +   E+D A+   
Sbjct: 74  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--- 130

Query: 310 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRT 366
           I++ +   + Y+H      I+HRD+   N+LL SK +     + DFG +    A    + 
Sbjct: 131 IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 187

Query: 367 LLAGTYGYIAPEL---AYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
              GT  YIAPE+    Y     EKCDV+S GV+   +L G  P
Sbjct: 188 -KIGTAYYIAPEVLHGTY----DEKCDVWSTGVILYILLSGCPP 226

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  121 bits (305), Expect = 5e-31
 Identities = 67/282 (23%), Positives = 116/282 (41%), Gaps = 56/282 (19%)

Query: 210 RY----CIGTGGYGSVYKAQ-LPNGKVFALKKLHT--SEELAFIKSFKNEAQVLSQVLHR 262
           RY     +G GG   V+ A+ L + +  A+K L    + + +F   F+ EAQ  + + H 
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72

Query: 263 NIVKLYGY----CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
            IV +Y             +++ EY++  +L   +H       +   + + ++     AL
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQAL 129

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT---LLAGTYGYI 375
            + H +    IIHRD+   NI++++     V DFG AR +    ++ T    + GT  Y+
Sbjct: 130 NFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186

Query: 376 APELAYTMVMTEKCDVYSFGVVTLEVLMG--------------KHPRDILSSLSSSSDPK 421
           +PE A    +  + DVYS G V  EVL G              +H R+     S+     
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----- 241

Query: 422 IMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRP 463
                   + L   +D  V++            L  NP++R 
Sbjct: 242 ------RHEGLSADLDAVVLK-----------ALAKNPENRY 266

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  124 bits (312), Expect = 7e-31
 Identities = 62/220 (28%), Positives = 94/220 (42%), Gaps = 23/220 (10%)

Query: 200 LIEATEDFDIRYCI----GTGGYGSVYKA-QLPNGKVFALKKLHTSE-ELAFIKSFKNEA 253
           +          Y      G+G YG V            A+K +  +    +       E 
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87

Query: 254 QVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 313
            VL  + H NI+KLY +   K+  +L+ E  + G LF  + +     E+D A    I+K 
Sbjct: 88  AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV---IIKQ 144

Query: 314 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAG 370
           +   + YLH     +I+HRD+   N+LL SK +     + DFG + +   +        G
Sbjct: 145 VLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKERLG 200

Query: 371 TYGYIAPEL---AYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           T  YIAPE+    Y     EKCDV+S GV+   +L G  P
Sbjct: 201 TAYYIAPEVLRKKY----DEKCDVWSIGVILFILLAGYPP 236

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  121 bits (305), Expect = 7e-31
 Identities = 71/293 (24%), Positives = 120/293 (40%), Gaps = 45/293 (15%)

Query: 204 TEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKK--LHTSEELAFIKSFKNEAQVLSQVL 260
            + F     IG G +G+VY A+ + N +V A+KK      +     +    E + L ++ 
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H N ++  G  L +   +L+ EY   GS    L  ++  ++        +       LAY
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA--VTHGALQGLAY 169

Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELA 380
           LH   S ++IHRD+ + NILL+      + DFG+A    +  +      GT  ++APE+ 
Sbjct: 170 LH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANSFVGTPYWMAPEVI 222

Query: 381 YTMVMTE---KCDVYSFGVVTLEVLMGK------HPRDILSSLSSSSDPKIMLIDVLDQR 431
             M   +   K DV+S G+  +E+   K      +    L  ++ +  P           
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP----------A 272

Query: 432 LPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHA 484
           L      +  R+ +       +CLQ  P+ RPT    S+  L   K   V   
Sbjct: 273 LQSGHWSEYFRNFVD------SCLQKIPQDRPT----SEVLL---KHRFVLRE 312

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  121 bits (306), Expect = 9e-31
 Identities = 47/313 (15%), Positives = 114/313 (36%), Gaps = 61/313 (19%)

Query: 204 TEDFDIRYCIGTG--GYGSVYKAQ-LPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQV 259
              +++   IG G     +V  A+  P G+   +++++  +     +   + E  V    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NIV      +    ++++  +M  GS   +L        ++      I++ +  AL 
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAK-DLICTHFMDGMNELAIAYILQGVLKALD 142

Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL-------AGTY 372
           Y+HH      +HR + +++IL++   + +++   +   + +    + ++           
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199

Query: 373 GYIAPELAYTMVMTE-------KCDVYSFGVVTLEVLMGK------HPRDILSSLSSSSD 419
            +++PE     V+ +       K D+YS G+   E+  G           +L    + + 
Sbjct: 200 PWLSPE-----VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254

Query: 420 PKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFA-------------------------- 453
           P ++    +          + + +  L  +++ +                          
Sbjct: 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFV 314

Query: 454 --CLQSNPKSRPT 464
             CLQ NP +RP+
Sbjct: 315 EQCLQRNPDARPS 327

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  119 bits (301), Expect = 1e-30
 Identities = 61/271 (22%), Positives = 107/271 (39%), Gaps = 44/271 (16%)

Query: 213 IGTGGYGSVYKAQLPNG-----KVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           IG G +G VY  +  +      +  A+K L    E+  +++F  E  ++  + H N++ L
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQC-AIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87

Query: 268 YGYCLHKKCM-FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
            G  L  + +  ++  YM  G L   + + +          ++    +A  + YL     
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLA---E 142

Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI-----APELAY 381
              +HRD+++ N +L+      VADFG AR +             +  +     A E   
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV-QQHRHARLPVKWTALESLQ 201

Query: 382 TMVMTEKCDVYSFGVVTLEVLM-------GKHPRDILSSLSSSSDPKIMLIDVLDQRLPP 434
           T   T K DV+SFGV+  E+L           P D+   L+              +RLP 
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ------------GRRLPQ 249

Query: 435 PVD-RKVIRDILLISTVSFACLQSNPKSRPT 464
           P      +  ++        C +++P  RPT
Sbjct: 250 PEYCPDSLYQVMQ------QCWEADPAVRPT 274

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  123 bits (309), Expect = 4e-30
 Identities = 63/294 (21%), Positives = 105/294 (35%), Gaps = 40/294 (13%)

Query: 206 DFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
            ++++  +GTGG+G V +      G+  A+K+          + +  E Q++ ++ H N+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 265 VKLY------GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
           V                   L  EY E G L   L+  E+   L       ++  ++ AL
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAGTYGYI 375
            YLH      IIHRD+   NI+L    +     + D G A+ L         + GT  Y+
Sbjct: 135 RYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV-GTLQYL 190

Query: 376 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHP-------------------RDILSSLSS 416
           APEL      T   D +SFG +  E + G  P                     I+     
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250

Query: 417 SSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
           +   K   +      L   +  K+ R +  +       L  + + R T      
Sbjct: 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCM-------LMWHQRQRGTDPQNPN 297

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  117 bits (296), Expect = 5e-30
 Identities = 55/313 (17%), Positives = 108/313 (34%), Gaps = 61/313 (19%)

Query: 204 TEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKL-HTSEELAFIKSFKNEAQVLSQVL- 260
           T +F     IG+G +GSV+K     +G ++A+K+           ++   E    + +  
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNL-HNNEDAVELDWAKRVNIVKAMAHALA 319
           H ++V+ +        M +  EY   GSL   +  N         A+  +++  +   L 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFV-------------------ADFGTARLLHA 360
           Y+H   S S++H DI  +NI ++                           D G    +  
Sbjct: 130 YIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184

Query: 361 DSSNRTLLAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSD 419
             S+  +  G   ++A E L        K D+++  +  +     +            + 
Sbjct: 185 --SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL--------PRNG 234

Query: 420 PKIMLIDVLDQRLPPPVDR--KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK 477
            +   I     RLP       +   ++L         +  +P+ RP+  +          
Sbjct: 235 DQWHEI--RQGRLPRIPQVLSQEFTELLK------VMIHPDPERRPSAMA---------- 276

Query: 478 TPLVKHAAIQDIS 490
             LVKH+ +   S
Sbjct: 277 --LVKHSVLLSAS 287

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  118 bits (298), Expect = 5e-30
 Identities = 69/289 (23%), Positives = 109/289 (37%), Gaps = 56/289 (19%)

Query: 213 IGTGGYGSVYKAQLPNGK---------VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +G G +G VY+ Q+             V  L ++ + ++      F  EA ++S+  H+N
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE---LDFLMEALIISKFNHQN 94

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSL--F--CNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           IV+  G  L     F++ E M  G L  F             L     +++ + +A    
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFV---ADFGTARLLHADSSNRTLLAGTYGYI- 375
           YL        IHRDI++ N LL       V    DFG AR ++  S  R    G    + 
Sbjct: 155 YLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR---KGGCAMLP 208

Query: 376 ----APE-LAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLD 429
                PE      + T K D +SFGV+  E+  +G  P            P     +VL+
Sbjct: 209 VKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPY-----------PSKSNQEVLE 256

Query: 430 Q-----RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
                 R+ PP +    +  I+        C Q  P+ RP    + +  
Sbjct: 257 FVTSGGRMDPPKNCPGPVYRIMT------QCWQHQPEDRPNFAIILERI 299

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  119 bits (300), Expect = 8e-30
 Identities = 52/218 (23%), Positives = 93/218 (42%), Gaps = 19/218 (8%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
             + +   +G G   +V++ +    G +FA+K  +    L  +     E +VL ++ H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 264 IVKLYGY--CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
           IVKL+        +   LI E+   GSL+  L    +A  L  ++ + +++ +   + +L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAF----VADFGTARLLHADSSNRTLLAGTYGYIAP 377
                  I+HR+I   NI+     +      + DFG AR L  D    +L  GT  Y+ P
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYLHP 184

Query: 378 ELAYTMVM--------TEKCDVYSFGVVTLEVLMGKHP 407
           ++    V+            D++S GV       G  P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  120 bits (304), Expect = 8e-30
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 19/212 (8%)

Query: 204 TEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLH 261
            E ++I   +G G +G V K       + +A+K ++ +  +     +   E ++L ++ H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            NI+KL+         +++ E    G LF  +   +   E D A+   I+K +   + Y+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYM 137

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAGTYGYIAPE 378
           H     +I+HRD+   NILL SK +     + DFG +     ++  +    GT  YIAPE
Sbjct: 138 H---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD-RIGTAYYIAPE 193

Query: 379 L---AYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +    Y     EKCDV+S GV+   +L G  P
Sbjct: 194 VLRGTY----DEKCDVWSAGVILYILLSGTPP 221

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  121 bits (306), Expect = 1e-29
 Identities = 69/285 (24%), Positives = 114/285 (40%), Gaps = 45/285 (15%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL--PNGKVF--ALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           E  ++  CIG G +G V++     P       A+K        +  + F  EA  + Q  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449

Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H +IVKL G    +  +++I E    G L   L   +    LD A  +     ++ ALAY
Sbjct: 450 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTALAY 506

Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI----- 375
           L    S   +HRDI++ N+L++S     + DFG +R +   +  +     + G +     
Sbjct: 507 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA----SKGKLPIKWM 559

Query: 376 APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP------RDILSSLSSSSDPKIMLIDVL 428
           APE       T   DV+ FGV   E+LM G  P       D++  + +            
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN------------ 607

Query: 429 DQRLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            +RLP P +    +  ++        C   +P  RP    +  + 
Sbjct: 608 GERLPMPPNCPPTLYSLMT------KCWAYDPSRRPRFTELKAQL 646

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  118 bits (297), Expect = 2e-29
 Identities = 69/296 (23%), Positives = 110/296 (37%), Gaps = 56/296 (18%)

Query: 213 IGTGGYGSVYKAQLPNGK---------VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +G G +G VY+ Q+             V  L ++ + ++      F  EA ++S+  H+N
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE---LDFLMEALIISKFNHQN 135

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSL--F--CNLHNNEDAVELDWAKRVNIVKAMAHALA 319
           IV+  G  L     F++ E M  G L  F             L     +++ + +A    
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFV---ADFGTARLLHADSSNRTLLAGTYGYI- 375
           YL        IHRDI++ N LL       V    DFG AR ++     R    G    + 
Sbjct: 196 YLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR---KGGCAMLP 249

Query: 376 ----APE-LAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLD 429
                PE      + T K D +SFGV+  E+  +G  P            P     +VL+
Sbjct: 250 VKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPY-----------PSKSNQEVLE 297

Query: 430 Q-----RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                 R+ PP +    +  I+        C Q  P+ RP    + +      + P
Sbjct: 298 FVTSGGRMDPPKNCPGPVYRIMT------QCWQHQPEDRPNFAIILERIEYCTQDP 347

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  117 bits (295), Expect = 2e-29
 Identities = 49/201 (24%), Positives = 83/201 (41%), Gaps = 24/201 (11%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALK----KLHTSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           IG G +  V +      G+ FA+K       TS      +  K EA +   + H +IV+L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV-------NIVKAMAHALAY 320
                    +++++E+M+   L        + V+   A  V       + ++ +  AL Y
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLC------FEIVKRADAGFVYSEAVASHYMRQILEALRY 145

Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAGTYGYIAP 377
            H     +IIHRD+  + +LL SK  +    +  FG A  L           GT  ++AP
Sbjct: 146 CH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202

Query: 378 ELAYTMVMTEKCDVYSFGVVT 398
           E+       +  DV+  GV+ 
Sbjct: 203 EVVKREPYGKPVDVWGCGVIL 223

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  119 bits (299), Expect = 4e-29
 Identities = 68/231 (29%), Positives = 95/231 (41%), Gaps = 34/231 (14%)

Query: 200 LIEATEDFDIRYCI----GTGGYGSVYKA-QLPNGKVFALK-----KLHTSEELAFIKS- 248
           + +        Y      G+G YG V    +       A+K     +          K+ 
Sbjct: 27  VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86

Query: 249 ------FKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVEL 302
                   NE  +L  + H NI+KL+     KK  +L+ E+ E G LF  + N     E 
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146

Query: 303 DWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLH 359
           D A    I+K +   + YLH     +I+HRDI   NILL +K       + DFG +    
Sbjct: 147 DAAN---IMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200

Query: 360 ADSSNRTLLAGTYGYIAPEL---AYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            D   R    GT  YIAPE+    Y     EKCDV+S GV+   +L G  P
Sbjct: 201 KDYKLRD-RLGTAYYIAPEVLKKKY----NEKCDVWSCGVIMYILLCGYPP 246

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  116 bits (292), Expect = 4e-29
 Identities = 64/292 (21%), Positives = 112/292 (38%), Gaps = 42/292 (14%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGY 270
           +  GG+  VY+AQ + +G+ +ALK+L ++EE    ++   E   + ++  H NIV+    
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEK-NRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 271 CL-------HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
                      +  FL+   + +G L   L   E    L     + I      A+ ++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA------------GT 371
              P IIHRD+   N+LL+++    + DFG+A  +                        T
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 372 YGYIAPELAYTM---VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVL 428
             Y  PE+        + EK D+++ G +   +   +HP +         D   + I   
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE---------DGAKLRIVNG 264

Query: 429 DQRLPPPVDR-KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
              +PP   +  V     LI       LQ NP+ R ++  V  +        
Sbjct: 265 KYSIPPHDTQYTVFHS--LIRA----MLQVNPEERLSIAEVVHQLQEIAAAR 310

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  114 bits (288), Expect = 5e-29
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 23/207 (11%)

Query: 204 TEDFDIRYCI----GTGGYGSVYKA-QLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLS 257
              F  RY I    G G +G V K       + +A+K ++ +  +     +   E ++L 
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 258 QVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 317
           ++ H NI+KL+         +++ E    G LF  +   +   E D A+   I+K +   
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSG 133

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAGTYGY 374
           + Y+H     +I+HRD+   NILL SK +     + DFG +     ++  +    GT  Y
Sbjct: 134 ITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD-RIGTAYY 189

Query: 375 IAPEL---AYTMVMTEKCDVYSFGVVT 398
           IAPE+    Y     EKCDV+S GV+ 
Sbjct: 190 IAPEVLRGTY----DEKCDVWSAGVIL 212

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  115 bits (290), Expect = 6e-29
 Identities = 62/288 (21%), Positives = 108/288 (37%), Gaps = 54/288 (18%)

Query: 213 IGTGGYGSVYKAQLPNGK---------VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +G G +G VY+                +  + +  +  E      F NEA V+ +    +
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER---IEFLNEASVMKEFNCHH 89

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSL--F-----CNLHNNEDAVELDWAKRVNIVKAMAH 316
           +V+L G     +   +I E M RG L  +       + NN        +K + +   +A 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI- 375
            +AYL+   +   +HRD+++ N ++       + DFG  R ++     R    G  G + 
Sbjct: 150 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR---KGGKGLLP 203

Query: 376 ----APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ 430
               +PE     V T   DV+SFGVV  E+    + P              +    VL  
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-----------QGLSNEQVLRF 252

Query: 431 -----RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
                 L  P +   ++ +++        C Q NPK RP+   +    
Sbjct: 253 VMEGGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSI 294

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  113 bits (285), Expect = 2e-28
 Identities = 60/296 (20%), Positives = 110/296 (37%), Gaps = 63/296 (21%)

Query: 213 IGTGGYGSVYKAQLPNGK---------VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +G   +G VYK  L             +  LK           + F++EA + +++ H N
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR---EEFRHEAMLRARLQHPN 73

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSL-------------FCNLHNNEDAVELDWAKRVNI 310
           +V L G     + + +I+ Y   G L                  +      L+    V++
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG 370
           V  +A  + YL    S  ++H+D+++ N+L+  KL   ++D G  R ++A    +     
Sbjct: 134 VAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK---LL 187

Query: 371 TYGYI-----APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHP------RDILSSLSSSS 418
               +     APE       +   D++S+GVV  EV   G  P      +D++  + +  
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN-- 245

Query: 419 DPKIMLIDVLDQRLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
                      Q LP P D    +  +++       C    P  RP  + +    L
Sbjct: 246 ----------RQVLPCPDDCPAWVYALMI------ECWNEFPSRRPRFKDI-HSRL 284

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  115 bits (290), Expect = 2e-28
 Identities = 42/299 (14%), Positives = 86/299 (28%), Gaps = 66/299 (22%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELA--FIKSFKNEAQVLSQ----------- 258
           +G     +  +A     G+ F +   + +E      IK  K E   L             
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 259 -----------VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAV------- 300
                      V      K+    L ++ M+++  +     +  NL    + +       
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 301 -ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH 359
             L    R+ +   +   LA LH      ++H  +   +I+L+ +   F+  F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--R 260

Query: 360 ADSSNRTLLAGTYG---YIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHP--RD 409
             +S  + +   +      A  +         +MT   D ++ G+    +     P   D
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320

Query: 410 ILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
                          I    + +P PV R ++             L+   + R      
Sbjct: 321 AALGG-------SEWIFRSCKNIPQPV-RALLE----------GFLRYPKEDRLLPLQA 361

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  115 bits (289), Expect = 2e-28
 Identities = 62/245 (25%), Positives = 112/245 (45%), Gaps = 14/245 (5%)

Query: 167 KRKYKKPKLEERATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKA-Q 225
           + KY  PK+ +      D++    Y  + V        + +DI   +G+G +G V++  +
Sbjct: 15  RGKYDGPKINDYDKFYEDIWK--KYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVE 72

Query: 226 LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYME 285
              G+VF  K ++T        + KNE  +++Q+ H  ++ L+     K  M LI E++ 
Sbjct: 73  KATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131

Query: 286 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL 345
            G LF  +    +  ++  A+ +N ++     L ++H     SI+H DI   NI+  +K 
Sbjct: 132 GGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKK 186

Query: 346 EAFV--ADFGTARLLHADSSNRTLLAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVL 402
            + V   DFG A  L+ D   +     T  + APE +    V     D+++ GV+   +L
Sbjct: 187 ASSVKIIDFGLATKLNPDEIVKV-TTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLL 244

Query: 403 MGKHP 407
            G  P
Sbjct: 245 SGLSP 249

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  115 bits (290), Expect = 3e-28
 Identities = 76/310 (24%), Positives = 122/310 (39%), Gaps = 45/310 (14%)

Query: 180 TNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLH 238
            N + VF     D + VY   +   +++ +   +G+G  G V  A +    K  A++ + 
Sbjct: 112 RNKVFVFFDLTVDDQSVYPKALR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS 169

Query: 239 TS-------EELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLF- 290
                     E     + + E ++L ++ H  I+K+  +    +  +++ E ME G LF 
Sbjct: 170 KRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFD 228

Query: 291 ---CNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEA 347
               N    E        K       M  A+ YLH      IIHRD+   N+LL+S+ E 
Sbjct: 229 KVVGNKRLKEAT-----CKL--YFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEED 278

Query: 348 F---VADFGTARLLHADSSNRTLLAGTYGYIAPE-LAYTMVM--TEKCDVYSFGVVTLEV 401
               + DFG +++L   S  RT L GT  Y+APE L            D +S GV+    
Sbjct: 279 CLIKITDFGHSKILGETSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 337

Query: 402 LMGKHPRDILSSLSSSSDPKIMLIDVLDQRL--PPPVDRKVIRDIL-LISTVSFACLQSN 458
           L G  P       S       +   +   +    P V  +V    L L+       L  +
Sbjct: 338 LSGYPP------FSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVK----KLLVVD 387

Query: 459 PKSRPTMQSV 468
           PK+R T +  
Sbjct: 388 PKARFTTEEA 397

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  112 bits (283), Expect = 3e-28
 Identities = 53/212 (25%), Positives = 98/212 (46%), Gaps = 32/212 (15%)

Query: 204 TEDFDIRYCI----GTGGYGSVYKA-QLPNGKVFALK-----KLHTSEELAFIKSFKNEA 253
           +  F   Y +    G G +  V +      G  FA K     KL   +     +  + EA
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQKLEREA 56

Query: 254 QVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 313
           ++  ++ H NIV+L+     +   +L+++ +  G LF ++   E   E D +     ++ 
Sbjct: 57  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQ 113

Query: 314 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAG 370
           +  ++AY H   S  I+HR++   N+LL SK +     +ADFG A  ++   +     AG
Sbjct: 114 ILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG-FAG 169

Query: 371 TYGYIAPEL----AYTMVMTEKCDVYSFGVVT 398
           T GY++PE+     Y    ++  D+++ GV+ 
Sbjct: 170 TPGYLSPEVLKKDPY----SKPVDIWACGVIL 197

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  114 bits (287), Expect = 3e-28
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 23/210 (10%)

Query: 204 TEDFDIRYCI----GTGGYGSVYKA-QLPNGKVFALK-----KLHTSEELAFIKSFKNEA 253
            +  +  Y I    G+G +  V K  +   G  +A K     +   S      +  + E 
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66

Query: 254 QVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 313
            +L QVLH NI+ L+    ++  + LI E +  G LF  L   E   E +     + +K 
Sbjct: 67  SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---SFIKQ 123

Query: 314 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF----VADFGTARLLHADSSNRTLLA 369
           +   + YLH   +  I H D+   NI+L  K        + DFG A  +      +  + 
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-IF 179

Query: 370 GTYGYIAPE-LAYTMVMTEKCDVYSFGVVT 398
           GT  ++APE + Y  +   + D++S GV+T
Sbjct: 180 GTPEFVAPEIVNYEPL-GLEADMWSIGVIT 208

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  113 bits (284), Expect = 4e-28
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 19/206 (9%)

Query: 204 TEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALK-----KLHTSEELAFIKSFKNEAQVLS 257
            + +DI   +G+G +  V K  +   G  +A K     +   S      +  + E  +L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 258 QVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 317
           QVLH N++ L+    ++  + LI E +  G LF  L   E   E +     + +K +   
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---SFIKQILDG 127

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAF----VADFGTARLLHADSSNRTLLAGTYG 373
           + YLH   +  I H D+   NI+L  K        + DFG A  +      +  + GT  
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-IFGTPE 183

Query: 374 YIAPE-LAYTMVMTEKCDVYSFGVVT 398
           ++APE + Y  +   + D++S GV+T
Sbjct: 184 FVAPEIVNYEPL-GLEADMWSIGVIT 208

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  115 bits (289), Expect = 5e-28
 Identities = 49/215 (22%), Positives = 96/215 (44%), Gaps = 37/215 (17%)

Query: 204 TEDFDIRYC----IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAF-IKSFKNEAQVLS 257
              F   Y     +G G +  V +  ++  G+ +A   ++T +  A   +  + EA++  
Sbjct: 6   CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65

Query: 258 QVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAV-------ELDWAKRVNI 310
            + H NIV+L+     +   +LI++ +  G LF       + +       E D +     
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELF-------EDIVAREYYSEADASH---C 115

Query: 311 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTL 367
           ++ +  A+ + H      ++HR++   N+LL SKL+     +ADFG A  +  +      
Sbjct: 116 IQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG 172

Query: 368 LAGTYGYIAPEL----AYTMVMTEKCDVYSFGVVT 398
            AGT GY++PE+     Y     +  D+++ GV+ 
Sbjct: 173 FAGTPGYLSPEVLRKDPY----GKPVDLWACGVIL 203

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  112 bits (283), Expect = 6e-28
 Identities = 68/288 (23%), Positives = 114/288 (39%), Gaps = 53/288 (18%)

Query: 213 IGTGGYGSVYKAQLPNGK-------VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIV 265
           +G G +GSV +AQL           V  LK    +     I+ F  EA  + +  H ++ 
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD--IEEFLREAACMKEFDHPHVA 88

Query: 266 KLYGYCL------HKKCMFLIYEYMERGSLFCNLHNN---EDAVELDWAKRVNIVKAMAH 316
           KL G  L            +I  +M+ G L   L  +   E+   L     V  +  +A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI- 375
            + YL    S + IHRD+++ N +L   +   VADFG +R +++    R    G    + 
Sbjct: 149 GMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR---QGCASKLP 202

Query: 376 ----APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ 430
               A E     + T   DV++FGV   E++  G+ P              I   ++ + 
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY-----------AGIENAEIYNY 251

Query: 431 -----RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
                RL  P +  + + D++        C  ++PK RP+   +  E 
Sbjct: 252 LIGGNRLKQPPECMEEVYDLMY------QCWSADPKQRPSFTCLRMEL 293

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  112 bits (283), Expect = 6e-28
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 23/210 (10%)

Query: 204 TEDFDIRYCI----GTGGYGSVYKA-QLPNGKVFALK-----KLHTSEELAFIKSFKNEA 253
            E+ D  Y      G+G +  V K  +   G  +A K     +  +S      +  + E 
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 254 QVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 313
            +L ++ H N++ L+    +K  + LI E +  G LF  L   E   E +       +K 
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT---EFLKQ 122

Query: 314 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF----VADFGTARLLHADSSNRTLLA 369
           + + + YLH   S  I H D+   NI+L  +        + DFG A  +   +  +  + 
Sbjct: 123 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-IF 178

Query: 370 GTYGYIAPE-LAYTMVMTEKCDVYSFGVVT 398
           GT  ++APE + Y  +   + D++S GV+T
Sbjct: 179 GTPEFVAPEIVNYEPL-GLEADMWSIGVIT 207

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  111 bits (281), Expect = 6e-28
 Identities = 73/302 (24%), Positives = 130/302 (43%), Gaps = 62/302 (20%)

Query: 213 IGTGGYGSVYKAQLPNG-------KVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIV 265
           +G G +G V+ A+  N         V A+K L      A    F+ EA++L+ + H +IV
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLV-AVKALKDPTLAARKD-FQREAELLTNLQHEHIV 80

Query: 266 KLYGYCLHKKCMFLIYEYMERGSL-------------FCNLHNNEDAVELDWAKRVNIVK 312
           K YG C     + +++EYM+ G L               +    +   EL  ++ ++I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 313 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY 372
            +A  + YL    S   +HRD+++ N L+ + L   + DFG +R +++    R    G +
Sbjct: 141 QIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR---VGGH 194

Query: 373 GYI-----APE-LAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLI 425
             +      PE + Y    T + DV+SFGV+  E+   GK P             ++   
Sbjct: 195 TMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPW-----------FQLSNT 242

Query: 426 DVLDQ-----RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL--ITRK 477
           +V++       L  P    K + D++L       C Q  P+ R  ++ +  + L  + + 
Sbjct: 243 EVIECITQGRVLERPRVCPKEVYDVML------GCWQREPQQRLNIKEI-YKILHALGKA 295

Query: 478 TP 479
           TP
Sbjct: 296 TP 297

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  112 bits (283), Expect = 7e-28
 Identities = 68/294 (23%), Positives = 116/294 (39%), Gaps = 65/294 (22%)

Query: 213 IGTGGYGSVYKAQLPNGKVF------ALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIV 265
           IG G +G V KA++    +        +K+  + ++    + F  E +VL ++  H NI+
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH---RDFAGELEVLCKLGHHPNII 89

Query: 266 KLYGYCLHKKCMFLIYEYMERGSL-------------FCNLHNNEDAVELDWAKRVNIVK 312
            L G C H+  ++L  EY   G+L                   N  A  L   + ++   
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 313 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY 372
            +A  + YL        IHRD+++ NIL+     A +ADFG +R           +  T 
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTM 200

Query: 373 GYI-----APE-LAYTMVMTEKCDVYSFGVVTLEVL-MGKHP------RDILSSLSSSSD 419
           G +     A E L Y+ V T   DV+S+GV+  E++ +G  P       ++   L     
Sbjct: 201 GRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ--- 256

Query: 420 PKIMLIDVLDQRLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
                      RL  P++    + D++        C +  P  RP+   +    
Sbjct: 257 ---------GYRLEKPLNCDDEVYDLMR------QCWREKPYERPSFAQILVSL 295

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  113 bits (284), Expect = 7e-28
 Identities = 55/308 (17%), Positives = 110/308 (35%), Gaps = 58/308 (18%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE----------------ELAFIKS 248
            D+ I   +  G +  +   +  + K +ALKK   S                   +    
Sbjct: 31  NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 249 FKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV 308
           FKNE Q+++ + +   +   G   +   +++IYEYME  S+           + ++   +
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFI 148

Query: 309 NIVKA------MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS 362
            I         + ++ +Y+H+    +I HRD+  +NIL++      ++DFG +   +   
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESE--YMVD 204

Query: 363 SNRTLLAGTYGYIAPELAYTMVMTE------KCDVYSFGVVTLEVLMGKHPRDILSSLSS 416
                  GTY ++ PE        E      K D++S G+    +     P         
Sbjct: 205 KKIKGSRGTYEFMPPE----FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS------L 254

Query: 417 SSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFAC--------------LQSNPKSR 462
                 +  ++  + +  P+DR      L     + +               L+ NP  R
Sbjct: 255 KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAER 314

Query: 463 PTMQSVSQ 470
            T +   +
Sbjct: 315 ITSEDALK 322

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  111 bits (280), Expect = 7e-28
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 19/206 (9%)

Query: 204 TEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALK-----KLHTSEELAFIKSFKNEAQVLS 257
            + +++   +G+G +  V K  Q   GK +A K     +L +S      +  + E  +L 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 258 QVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 317
           ++ H NI+ L+    +K  + LI E +  G LF  L   E   E +       +K +   
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT---QFLKQILDG 120

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAF----VADFGTARLLHADSSNRTLLAGTYG 373
           + YLH   S  I H D+   NI+L  K        + DFG A  + A +  +  + GT  
Sbjct: 121 VHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN-IFGTPE 176

Query: 374 YIAPE-LAYTMVMTEKCDVYSFGVVT 398
           ++APE + Y  +   + D++S GV+T
Sbjct: 177 FVAPEIVNYEPL-GLEADMWSIGVIT 201

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  113 bits (284), Expect = 7e-28
 Identities = 55/218 (25%), Positives = 103/218 (47%), Gaps = 32/218 (14%)

Query: 198 EDLIEATEDFDIRY----CIGTGGYGSVYKA-QLPNGKVFALK-----KLHTSEELAFIK 247
           E ++ A+  F   Y     +G G +  V +      G  FA K     KL   +     +
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD----FQ 73

Query: 248 SFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR 307
             + EA++  ++ H NIV+L+     +   +L+++ +  G LF ++   E   E D +  
Sbjct: 74  KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-- 131

Query: 308 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSN 364
            + ++ +  ++AY H   S  I+HR++   N+LL SK +     +ADFG A  ++   + 
Sbjct: 132 -HCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187

Query: 365 RTLLAGTYGYIAPEL----AYTMVMTEKCDVYSFGVVT 398
               AGT GY++PE+     Y    ++  D+++ GV+ 
Sbjct: 188 HG-FAGTPGYLSPEVLKKDPY----SKPVDIWACGVIL 220

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  112 bits (281), Expect = 1e-27
 Identities = 64/294 (21%), Positives = 116/294 (39%), Gaps = 62/294 (21%)

Query: 213 IGTGGYGSVYKAQLPNG-------KVFALKKL--HTSEELAFIKSFKNEAQVLSQVLHRN 263
           +G G +G V+ A+  N         V A+K L   +       + F+ EA++L+ + H++
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLV-AVKALKEASESAR---QDFQREAELLTMLQHQH 104

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSL------------FCNLHNNEDAVELDWAKRVNIV 311
           IV+ +G C   + + +++EYM  G L                  +     L   + + + 
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 312 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT 371
             +A  + YL        +HRD+++ N L+   L   + DFG +R +++    R    G 
Sbjct: 165 SQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR---VGG 218

Query: 372 YGYI-----APE-LAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIML 424
              +      PE + Y    T + DV+SFGVV  E+   GK P             ++  
Sbjct: 219 RTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPW-----------YQLSN 266

Query: 425 IDVLDQ-----RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            + +D       L  P      +  I+        C Q  P+ R +++ V    
Sbjct: 267 TEAIDCITQGRELERPRACPPEVYAIMR------GCWQREPQQRHSIKDVHARL 314

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  112 bits (281), Expect = 1e-27
 Identities = 54/340 (15%), Positives = 115/340 (33%), Gaps = 87/340 (25%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFA----------------------LKKLHTSE 241
            DF+   C+G GG+G V++A+   +   +A                      L KL    
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 242 ELAFIKSFKN-----------------------------------EAQVLSQVLHRNIVK 266
            + +  ++                                     + + +     +N V 
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
                  K  +++  +   + +L   ++      + +    ++I   +A A+ +LH   S
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---S 182

Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS------------NRTLLAGTYGY 374
             ++HRD+  +NI         V DFG    +  D                T   GT  Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPP 434
           ++PE  +    + K D++S G++  E+L   +        S+  +   ++ DV + + P 
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELL---YS------FSTQMERVRIITDVRNLKFPL 293

Query: 435 PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ-EFL 473
              +K  ++ +++       L  +P  RP    + +    
Sbjct: 294 LFTQKYPQEHMMVQ----DMLSPSPTERPEATDIIENAIF 329

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  112 bits (282), Expect = 1e-27
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 32/210 (15%)

Query: 204 TEDFDIRYCI----GTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQ 258
            +     + +    G G    VY+  Q    K +ALK L  + +    K  + E  VL +
Sbjct: 48  RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD---KKIVRTEIGVLLR 104

Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAV-------ELDWAKRVNIV 311
           + H NI+KL         + L+ E +  G LF       D +       E D A     V
Sbjct: 105 LSHPNIIKLKEIFETPTEISLVLELVTGGELF-------DRIVEKGYYSERDAAD---AV 154

Query: 312 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLL 368
           K +  A+AYLH      I+HRD+   N+L  +        +ADFG ++++      +T +
Sbjct: 155 KQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT-V 210

Query: 369 AGTYGYIAPELAYTMVMTEKCDVYSFGVVT 398
            GT GY APE+        + D++S G++T
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  110 bits (277), Expect = 2e-27
 Identities = 54/206 (26%), Positives = 87/206 (42%), Gaps = 23/206 (11%)

Query: 204 TEDFDIRYCI----GTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQ 258
             D +  Y +    G G +G V  A Q       A KK+     +  +  FK E +++  
Sbjct: 4   KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-VEDVDRFKQEIEIMKS 62

Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
           + H NI++LY        ++L+ E    G LF  + +     E D A+   I+K +  A+
Sbjct: 63  LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR---IMKDVLSAV 119

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAGTYGYI 375
           AY H     ++ HRD+   N L  +        + DFG A         RT   GT  Y+
Sbjct: 120 AYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT-KVGTPYYV 175

Query: 376 APEL---AYTMVMTEKCDVYSFGVVT 398
           +P++    Y      +CD +S GV+ 
Sbjct: 176 SPQVLEGLY----GPECDEWSAGVMM 197

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  112 bits (282), Expect = 2e-27
 Identities = 50/197 (25%), Positives = 90/197 (45%), Gaps = 12/197 (6%)

Query: 206 DFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
                  +G G +G V+K  +   G   A K + T   +   +  KNE  V++Q+ H N+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANL 148

Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           ++LY     K  + L+ EY++ G LF  +   +++  L     +  +K +   + ++H  
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRI--IDESYNLTELDTILFMKQICEGIRHMH-- 204

Query: 325 CSPSIIHRDISSNNILLNSKLEAFV--ADFGTARLLHADSSNRTLLAGTYGYIAPE-LAY 381
               I+H D+   NIL  ++    +   DFG AR        +    GT  ++APE + Y
Sbjct: 205 -QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEFLAPEVVNY 262

Query: 382 TMVMTEKCDVYSFGVVT 398
             V +   D++S GV+ 
Sbjct: 263 DFV-SFPTDMWSVGVIA 278

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  110 bits (276), Expect = 2e-27
 Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 22/206 (10%)

Query: 204 TEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR 262
            + F  +  +G+G +G V+   +  +G    +K ++       ++  + E +VL  + H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAV----ELDWAKRVNIVKAMAHAL 318
           NI+K++        M+++ E  E G L   + + +       E   A+   ++K M +AL
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAE---LMKQMMNAL 137

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAGTYGYI 375
           AY H   S  ++H+D+   NIL           + DFG A L  +D  +    AGT  Y+
Sbjct: 138 AYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN-AAGTALYM 193

Query: 376 APEL---AYTMVMTEKCDVYSFGVVT 398
           APE+         T KCD++S GVV 
Sbjct: 194 APEVFKRDV----TFKCDIWSAGVVM 215

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  110 bits (277), Expect = 4e-27
 Identities = 63/287 (21%), Positives = 115/287 (40%), Gaps = 52/287 (18%)

Query: 213 IGTGGYGSVYKAQLPNGK-------VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIV 265
           +G G +GSV +  L           V  +K  ++S+    I+ F +EA  +    H N++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE--IEEFLSEAACMKDFSHPNVI 99

Query: 266 KLYGYCL-----HKKCMFLIYEYMERGSLFCNLHNN---EDAVELDWAKRVNIVKAMAHA 317
           +L G C+           +I  +M+ G L   L  +        +     +  +  +A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI-- 375
           + YL    + + +HRD+++ N +L   +   VADFG ++ +++    R    G    +  
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR---QGRIAKMPV 213

Query: 376 ---APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ- 430
              A E     V T K DV++FGV   E+   G  P            P +   ++ D  
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY-----------PGVQNHEMYDYL 262

Query: 431 ----RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
               RL  P D    + +I+       +C +++P  RPT   +  + 
Sbjct: 263 LHGHRLKQPEDCLDELYEIMY------SCWRTDPLDRPTFSVLRLQL 303

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  109 bits (276), Expect = 4e-27
 Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 31/210 (14%)

Query: 204 TEDFDIRYCI----GTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQ 258
           T +    +      G+G +  V+   Q   GK+FALK +  S       S +NE  VL +
Sbjct: 4   TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-AFRDSSLENEIAVLKK 62

Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAV-------ELDWAKRVNIV 311
           + H NIV L          +L+ + +  G LF       D +       E D +    ++
Sbjct: 63  IKHENIVTLEDIYESTTHYYLVMQLVSGGELF-------DRILERGVYTEKDASL---VI 112

Query: 312 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLL 368
           + +  A+ YLH      I+HRD+   N+L  +  E     + DFG +++    +   +  
Sbjct: 113 QQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTA 167

Query: 369 AGTYGYIAPELAYTMVMTEKCDVYSFGVVT 398
            GT GY+APE+      ++  D +S GV+T
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  110 bits (277), Expect = 4e-27
 Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 23/213 (10%)

Query: 204 TEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR 262
            E + I   +G G +G V++  +  + K +  K +            K E  +L+   HR
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHR 61

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHA 317
           NI+ L+      + + +I+E++    +F          NE  +       V+ V  +  A
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREI-------VSYVHQVCEA 114

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFV--ADFGTARLLHADSSNRTLLAGTYGYI 375
           L +LH   S +I H DI   NI+  ++  + +   +FG AR L    + R  L     Y 
Sbjct: 115 LQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYY 170

Query: 376 APE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           APE   + +V +   D++S G +   +L G +P
Sbjct: 171 APEVHQHDVV-STATDMWSLGTLVYVLLSGINP 202

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  109 bits (275), Expect = 9e-27
 Identities = 65/297 (21%), Positives = 118/297 (39%), Gaps = 63/297 (21%)

Query: 213 IGTGGYGSVYKAQLPNGK-----------VFALKKLHTSEELAFIKSFKNEAQVLSQVL- 260
           +G G +G V  A+                V  LK   T ++L       +E +++  +  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL---SDLVSEMEMMKMIGK 99

Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSL-------------FCNLHNNEDAVELDWAKR 307
           H+NI+ L G C     +++I EY  +G+L             +    N     ++ +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 308 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL 367
           V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +  
Sbjct: 160 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK-- 214

Query: 368 LAGTYGYI-----APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPK 421
              T G +     APE  +  V T + DV+SFGV+  E+  +G  P            P 
Sbjct: 215 -KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-----------PG 262

Query: 422 IMLIDVLDQ-----RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           I + ++        R+  P +    +  ++        C  + P  RPT + + ++ 
Sbjct: 263 IPVEELFKLLKEGHRMDKPANCTNELYMMMR------DCWHAVPSQRPTFKQLVEDL 313

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  110 bits (276), Expect = 1e-26
 Identities = 43/301 (14%), Positives = 92/301 (30%), Gaps = 69/301 (22%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELA--FIKSFKNEAQ--------------- 254
           +G     +  +A     G+ F +   + +E      IK  K E                 
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 255 ----------VLSQVLHRNIVKLYGYCLHKKCM--FLIYEYME--RGSLFCNLHNNEDAV 300
                     ++     + ++++         +  F +Y  M+    +    L ++    
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 301 E-LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH 359
           + L    R+ +   +   LA LH      ++H  +   +I+L+ +   F+  F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256

Query: 360 ADSSNRTLLAGTYGYIAPEL-----------AYTMVMTEKCDVYSFGVVTLEVLMGKHPR 408
                R + + + G+  PEL               +MT   D ++ G+V   +     P 
Sbjct: 257 ---GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP- 312

Query: 409 DILSSLSSSSDPKIM-LIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQS 467
                ++  +       I    + +P PV     R   L+       L+   + R     
Sbjct: 313 -----ITKDAALGGSEWIFRSCKNIPQPV-----RA--LLE----GFLRYPKEDRLLPLQ 356

Query: 468 V 468
            
Sbjct: 357 A 357

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  108 bits (273), Expect = 1e-26
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 30/213 (14%)

Query: 204 TEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTS-------EELAFIKSFKNEAQV 255
            +++ +   +G+G  G V  A +    K  A+K +           E     + + E ++
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLF----CNLHNNEDAVELDWAKRVNIV 311
           L ++ H  I+K+  +    +  +++ E ME G LF     N    E        K     
Sbjct: 69  LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEAT-----CKL--YF 120

Query: 312 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLL 368
             M  A+ YLH      IIHRD+   N+LL+S+ E     + DFG +++L   S  RT L
Sbjct: 121 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-L 176

Query: 369 AGTYGYIAPE-LAYTMVM--TEKCDVYSFGVVT 398
            GT  Y+APE L            D +S GV+ 
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  109 bits (274), Expect = 1e-26
 Identities = 46/205 (22%), Positives = 88/205 (42%), Gaps = 25/205 (12%)

Query: 204 TEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-H 261
           T+ ++++  IG G Y    +         FA+K +  S+          E ++L +   H
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQH 75

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            NI+ L       K ++++ E M+ G L   +   +   E + +    ++  +   + YL
Sbjct: 76  PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA---VLFTITKTVEYL 132

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAF----VADFGTARLLHADSSNRTLLAGTYGYIAP 377
           H   +  ++HRD+  +NIL   +        + DFG A+ L A++        T  ++AP
Sbjct: 133 H---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAP 189

Query: 378 EL----AYTMVMTEKCDVYSFGVVT 398
           E+     Y       CD++S GV+ 
Sbjct: 190 EVLERQGY----DAACDIWSLGVLL 210

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  112 bits (282), Expect = 2e-26
 Identities = 21/132 (15%), Positives = 56/132 (42%), Gaps = 13/132 (9%)

Query: 2   YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKL--------SG 53
            +      +  NLK+L  ++V +   +  +P+ L +L  +  ++++ N+           
Sbjct: 236 QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDW 295

Query: 54  KIPPEIASMKYLTQLDLSNNNIQ-GSIPGEITKLSRLDYLNLSSNKLSGPVP-FSNNDLS 111
           +   +    + +  + +  NN++   +   + K+ +L  L    N+L G +P F +    
Sbjct: 296 QALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGS--EI 353

Query: 112 SMHTVVSLSPNN 123
            +   ++L+ N 
Sbjct: 354 KL-ASLNLAYNQ 364

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  103 bits (259), Expect = 1e-23
 Identities = 28/130 (21%), Positives = 51/130 (39%), Gaps = 12/130 (9%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPP--EIASMKY 64
             P  G+   L  L++  N +     +  G    + NL  + NKL   IP   +  S+  
Sbjct: 345 KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSV 403

Query: 65  LTQLDLSNNNIQG-------SIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVV 117
           ++ +D S N I          +     K   +  +NLS+N++S       +  S + + +
Sbjct: 404 MSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPL-SSI 462

Query: 118 SLSPNNGLCG 127
           +L   N L  
Sbjct: 463 NLM-GNMLTE 471

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  102 bits (257), Expect = 2e-23
 Identities = 24/133 (18%), Positives = 48/133 (36%), Gaps = 12/133 (9%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSG-------KIPPEI 59
           + P      N+  +++ +N +         + + LS+++L  N L+              
Sbjct: 425 LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENF 484

Query: 60  ASMKYLTQLDLSNNNIQGSIPGEI--TKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVV 117
            +   LT +DL  N +   +  +   T L  L  ++LS N  S   P    + S++    
Sbjct: 485 KNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTL-KGF 541

Query: 118 SLSPNNGLCGNIL 130
            +       GN  
Sbjct: 542 GIRNQRDAQGNRT 554

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  100 bits (250), Expect = 1e-22
 Identities = 25/138 (18%), Positives = 45/138 (32%), Gaps = 12/138 (8%)

Query: 4   IGIIPPEIGNLKNLIKLDVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           +        N   L  +D+  N L          +L  L  +DLS N  S   P +  + 
Sbjct: 477 LKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNS 535

Query: 63  KYLTQLDLSN------NNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV 116
             L    + N      N      P  IT    L  L + SN +      +     ++ +V
Sbjct: 536 STLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK---VNEKITPNI-SV 591

Query: 117 VSLSPNNGLCGNILDLPS 134
           + +  N  +  ++  +  
Sbjct: 592 LDIKDNPNISIDLSYVCP 609

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 99.7 bits (249), Expect = 2e-22
 Identities = 24/141 (17%), Positives = 54/141 (38%), Gaps = 14/141 (9%)

Query: 3   KIGIIPPEI--GNLKNLIKLDVGSNSLIGPIPSALGSLTNL------SNLDLSSNKLSGK 54
           K+  +  +     L  L+ +D+  NS     P+   + + L      +  D   N+   +
Sbjct: 499 KLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLRE 557

Query: 55  IPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSG-PVPFSNNDLSSM 113
            P  I     LTQL + +N+I+  +  +I     +  L++  N      + +    + + 
Sbjct: 558 WPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAG 614

Query: 114 HTVVSLSPNNGLCG-NILDLP 133
             ++       + G + LD+ 
Sbjct: 615 MYMLFYDKTQDIRGCDALDIK 635

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 98.6 bits (246), Expect = 4e-22
 Identities = 14/119 (11%), Positives = 37/119 (31%), Gaps = 7/119 (5%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
            I  +   +  L  L +  +G++  +           N                 +  ++
Sbjct: 194 NITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT-----EDLKWDNL 248

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSG--PVPFSNNDLSSMHTVVSL 119
           K LT +++ N      +P  +  L  +  +N++ N+      +      L+       +
Sbjct: 249 KDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKI 307

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 97.0 bits (242), Expect = 1e-21
 Identities = 22/136 (16%), Positives = 43/136 (31%), Gaps = 30/136 (22%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSL-------IGPIPSALGSLTNLSNLDLSSNKLSGKIPP 57
                       L  +++  N L       +        +   L+++DL  NKL+  +  
Sbjct: 447 KFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSD 505

Query: 58  EIA--SMKYLTQLDLSNNNIQGSIPGEITKLSRL------DYLNLSSNKLSGPVP----- 104
           +    ++ YL  +DLS N+     P +    S L      +  +   N+     P     
Sbjct: 506 DFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITL 564

Query: 105 --------FSNNDLSS 112
                     +ND+  
Sbjct: 565 CPSLTQLQIGSNDIRK 580

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 93.2 bits (232), Expect = 3e-20
 Identities = 12/111 (10%), Positives = 31/111 (27%), Gaps = 3/111 (2%)

Query: 4   IGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALG--SLTNLSNLDLSSNKLSGKIPPEIAS 61
               P  I    +  +                     ++L    ++S+     I      
Sbjct: 122 RLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI 181

Query: 62  MKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSS 112
               TQ+   +NNI   +   + +L++L    + ++           +  +
Sbjct: 182 TLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENEN 231

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 91.3 bits (227), Expect = 1e-19
 Identities = 22/120 (18%), Positives = 42/120 (35%), Gaps = 7/120 (5%)

Query: 10  EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSG----KIPPEIASMKYL 65
            + +   +  L +      G +P A+G LT L  L L S+          P  I++    
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135

Query: 66  TQLDLSNNNIQGSIPGEITKL--SRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
            Q      + Q +      +   S L    ++S+     +  S+  ++   T +    NN
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR-ITLKDTQIGQLSNN 194

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 19/142 (13%), Positives = 39/142 (27%), Gaps = 18/142 (12%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
           G       N     +LD            +L S   ++ L L     SG++P  I  +  
Sbjct: 51  GFGTQPGANWNFNKELD----MWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTE 106

Query: 65  LTQLDLSNNNIQG----SIPGEITKLSRLDYLNLSSNKLSGPVP----------FSNNDL 110
           L  L L ++  +       P  I+     +                           + +
Sbjct: 107 LEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCI 166

Query: 111 SSMHTVVSLSPNNGLCGNILDL 132
           +S     S+  ++ +      +
Sbjct: 167 NSDPQQKSIKKSSRITLKDTQI 188

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 73.5 bits (181), Expect = 5e-14
 Identities = 15/85 (17%), Positives = 28/85 (32%), Gaps = 3/85 (3%)

Query: 4   IGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMK 63
           +   P  I    +L +L +GSN +   +   +    N+S LD+  N         +    
Sbjct: 555 LREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYI 611

Query: 64  YLTQLDLSNNNIQGSIPGEITKLSR 88
                 L  +  Q     +   + R
Sbjct: 612 EAGMYMLFYDKTQDIRGCDALDIKR 636

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  111 bits (280), Expect = 2e-26
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 22/213 (10%)

Query: 204 TEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR 262
            + +DI   +GTG +G V++  +   G  FA K + T    +  ++ + E Q +S + H 
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHP 214

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNL-----HNNEDAVELDWAKRVNIVKAMAHA 317
            +V L+        M +IYE+M  G LF  +       +ED         V  ++ +   
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA-------VEYMRQVCKG 267

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFV--ADFGTARLLHADSSNRTLLAGTYGYI 375
           L ++H     + +H D+   NI+  +K    +   DFG    L    S +    GT  + 
Sbjct: 268 LCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-GTAEFA 323

Query: 376 APE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           APE      V     D++S GV++  +L G  P
Sbjct: 324 APEVAEGKPV-GYYTDMWSVGVLSYILLSGLSP 355

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  107 bits (269), Expect = 5e-26
 Identities = 49/191 (25%), Positives = 83/191 (43%), Gaps = 15/191 (7%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGY 270
           +G G +    K     + + FA+K +    E     + + E   L     H NIVKL+  
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRME----ANTQKEITALKLCEGHPNIVKLHEV 74

Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
              +   FL+ E +  G LF  +   +   E + +    I++ +  A++++H      ++
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY---IMRKLVSAVSHMH---DVGVV 128

Query: 331 HRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTE 387
           HRD+   N+L   + +     + DFG ARL   D+        T  Y APEL       E
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDE 188

Query: 388 KCDVYSFGVVT 398
            CD++S GV+ 
Sbjct: 189 SCDLWSLGVIL 199

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  106 bits (267), Expect = 6e-26
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 27/217 (12%)

Query: 202 EATEDFDIRY----CIGTGGYGSVYKA-QLPNGKVFALK-------KLHTSEELAFIK-S 248
            +T  F   Y     +G G    V +    P  K +A+K          ++EE+  ++ +
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 249 FKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR 307
              E  +L +V  H NI++L          FL+++ M++G LF  L       E +  K 
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK- 128

Query: 308 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL 367
             I++A+   +  LH     +I+HRD+   NILL+  +   + DFG +  L      R  
Sbjct: 129 --IMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE- 182

Query: 368 LAGTYGYIAPE-LAYTMVM-----TEKCDVYSFGVVT 398
           + GT  Y+APE +  +M        ++ D++S GV+ 
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  109 bits (273), Expect = 6e-26
 Identities = 68/218 (31%), Positives = 101/218 (46%), Gaps = 26/218 (11%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAF--IKSFKNEAQVLSQVLH 261
           EDF+I   IG G +G V   +L    KVFA+K L+  E L       F+ E  VL     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 262 RNIVKLYGYCLH-KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALA 319
           + I  L+ Y       ++L+ +Y   G L   L   ED +  + A+      A M  A+ 
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMAR---FYLAEMVIAID 189

Query: 320 YLHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNRTLLA-GTYGY 374
            +H       +HRDI  +NIL++     +L    ADFG+   L  D + ++ +A GT  Y
Sbjct: 190 SVH---QLHYVHRDIKPDNILMDMNGHIRL----ADFGSCLKLMEDGTVQSSVAVGTPDY 242

Query: 375 IAPELAYTMVMTEK-----CDVYSFGVVTLEVLMGKHP 407
           I+PE+   M   +      CD +S GV   E+L G+ P
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  107 bits (270), Expect = 6e-26
 Identities = 65/297 (21%), Positives = 118/297 (39%), Gaps = 63/297 (21%)

Query: 213 IGTGGYGSVYKAQLPNGK-----------VFALKKLHTSEELAFIKSFKNEAQVLSQVL- 260
           +G G +G V  A+                V  LK   T ++L       +E +++  +  
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL---SDLVSEMEMMKMIGK 145

Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSL-------------FCNLHNNEDAVELDWAKR 307
           H+NI+ L G C     +++I EY  +G+L             +    N     ++ +   
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 308 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL 367
           V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++     +  
Sbjct: 206 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK-- 260

Query: 368 LAGTYGYI-----APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPK 421
              T G +     APE  +  V T + DV+SFGV+  E+  +G  P            P 
Sbjct: 261 -KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-----------PG 308

Query: 422 IMLIDVLDQ-----RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           I + ++        R+  P +    +  ++        C  + P  RPT + + ++ 
Sbjct: 309 IPVEELFKLLKEGHRMDKPANCTNELYMMMR------DCWHAVPSQRPTFKQLVEDL 359

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  107 bits (270), Expect = 7e-26
 Identities = 64/297 (21%), Positives = 118/297 (39%), Gaps = 63/297 (21%)

Query: 213 IGTGGYGSVYKAQLPNGK-----------VFALKKLHTSEELAFIKSFKNEAQVLSQVL- 260
           +G G +G V  A+                V  LK   T ++L       +E +++  +  
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL---SDLISEMEMMKMIGK 133

Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSL-------------FCNLHNNEDAVELDWAKR 307
           H+NI+ L G C     +++I EY  +G+L             +    ++    +L     
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 308 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL 367
           V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H     +  
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK-- 248

Query: 368 LAGTYGYI-----APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPK 421
              T G +     APE  +  + T + DV+SFGV+  E+  +G  P            P 
Sbjct: 249 -KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-----------PG 296

Query: 422 IMLIDVLDQ-----RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           + + ++        R+  P +    +  ++        C  + P  RPT + + ++ 
Sbjct: 297 VPVEELFKLLKEGHRMDKPSNCTNELYMMMR------DCWHAVPSQRPTFKQLVEDL 347

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  106 bits (267), Expect = 7e-26
 Identities = 69/294 (23%), Positives = 108/294 (36%), Gaps = 56/294 (19%)

Query: 213 IGTGGYGSVYKAQLPNGK---------VFALKKLHTSEELAFIKSFKNEAQVLSQVL-HR 262
           +G G +G V +A               V  LK      E    ++  +E +VLS +  H 
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER---EALMSELKVLSYLGNHM 87

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM-------- 314
           NIV L G C       +I EY   G L   L    D+          +            
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 315 -------AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL 367
                  A  +A+L    S + IHRD+++ NILL       + DFG AR +  DS+    
Sbjct: 148 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV-- 202

Query: 368 LAGTYGYI-----APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPK 421
                  +     APE  +  V T + DV+S+G+   E+  +G  P      +   S   
Sbjct: 203 -VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP---YPGMPVDSK-- 256

Query: 422 IMLIDVLDQ--RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
                ++ +  R+  P      + DI+        C  ++P  RPT + + Q  
Sbjct: 257 --FYKMIKEGFRMLSPEHAPAEMYDIMK------TCWDADPLKRPTFKQIVQLI 302

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  106 bits (267), Expect = 8e-26
 Identities = 69/302 (22%), Positives = 124/302 (41%), Gaps = 68/302 (22%)

Query: 213 IGTGGYGSVYKAQLPNGK---------VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           +G G +G V KA   + K         V  LK+  +  EL   +   +E  VL QV H +
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL---RDLLSEFNVLKQVNHPH 87

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSL---------------------FCNLHNNEDAVEL 302
           ++KLYG C     + LI EY + GSL                       +  ++ D   L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 303 DWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS 362
                ++    ++  + YL       ++HRD+++ NIL+    +  ++DFG +R ++ + 
Sbjct: 148 TMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 363 SNRTLLAGTYGYI-----APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSS 416
           S       + G I     A E  +  + T + DV+SFGV+  E++ +G +P         
Sbjct: 205 SYV---KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY-------- 253

Query: 417 SSDPKIMLIDVLDQ-----RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
              P I    + +      R+  P +  + +  ++L       C +  P  RP    +S+
Sbjct: 254 ---PGIPPERLFNLLKTGHRMERPDNCSEEMYRLML------QCWKQEPDKRPVFADISK 304

Query: 471 EF 472
           + 
Sbjct: 305 DL 306

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  107 bits (268), Expect = 9e-26
 Identities = 61/299 (20%), Positives = 118/299 (39%), Gaps = 61/299 (20%)

Query: 213 IGTGGYGSVYKAQLPNGK---------VFALKKLHTSEELAFIKSFKNEAQVLSQVL-HR 262
           +G+G +G V  A               V  LK+   S E    ++  +E ++++Q+  H 
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER---EALMSELKMMTQLGSHE 109

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM-------- 314
           NIV L G C     ++LI+EY   G L   L +  +    D  +  N  +          
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 315 ------------AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS 362
                       A  + +L      S +HRD+++ N+L+       + DFG AR + +DS
Sbjct: 170 TFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226

Query: 363 SNRTLLAGTYGYI-----APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSS 416
           +           +     APE  +  + T K DV+S+G++  E+  +G +P      +  
Sbjct: 227 NYV---VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP---YPGIPV 280

Query: 417 SSDPKIMLIDVLDQ--RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            ++       ++    ++  P    + I  I+       +C   + + RP+  +++   
Sbjct: 281 DAN----FYKLIQNGFKMDQPFYATEEIYIIMQ------SCWAFDSRKRPSFPNLTSFL 329

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  106 bits (267), Expect = 1e-25
 Identities = 72/294 (24%), Positives = 118/294 (40%), Gaps = 60/294 (20%)

Query: 213 IGTGGYGSVYKAQLPNGK---------VFALKKLHTSEELAFIKSFKNEAQVLSQVL-HR 262
           +G G +G V +A               V  LK    ++E    ++  +E +++S +  H 
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK---EALMSELKIMSHLGQHE 110

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR-----------VNIV 311
           NIV L G C H   + +I EY   G L   L      +E D A             ++  
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 312 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT 371
             +A  +A+L    S + IHRD+++ N+LL +   A + DFG AR +  DS+        
Sbjct: 171 SQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI---VKG 224

Query: 372 YGYI-----APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIM-- 423
              +     APE  +  V T + DV+S+G++  E+  +G +P            P I+  
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY-----------PGILVN 273

Query: 424 --LIDVLDQ--RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
                ++    ++  P    K I  I+       AC    P  RPT Q +    
Sbjct: 274 SKFYKLVKDGYQMAQPAFAPKNIYSIMQ------ACWALEPTHRPTFQQICSFL 321

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  107 bits (268), Expect = 1e-25
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 40/222 (18%)

Query: 203 ATEDFDIRY----CIGTGGYGSVYKA-QLPNGKVFALK-----KLHTSEELA--FIKSFK 250
           A ++F  +Y     IG G    V +      G  FA+K         S E      ++ +
Sbjct: 88  AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147

Query: 251 NEAQVLSQVL-HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAV-------EL 302
            E  +L QV  H +I+ L         MFL+++ M +G LF       D +       E 
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELF-------DYLTEKVALSEK 200

Query: 303 DWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS 362
           +      I++++  A+++LH   + +I+HRD+   NILL+  ++  ++DFG +  L    
Sbjct: 201 ETRS---IMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE 254

Query: 363 SNRTLLAGTYGYIAPE-LAYTMVMTEK-----CDVYSFGVVT 398
             R  L GT GY+APE L  +M  T        D+++ GV+ 
Sbjct: 255 KLRE-LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  107 bits (270), Expect = 1e-25
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 28/220 (12%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           +DF+I   IG G +  V   ++   G+V+A+K ++  +  +   +  F+ E  VL     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 262 RNIVKLYGYCLH-KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALA 319
           R I +L+ +    +  ++L+ EY   G L   L    + +  + A+      A +  A+ 
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMAR---FYLAEIVMAID 176

Query: 320 YLHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNRTLLA-GTYGY 374
            +H       +HRDI  +NILL+     +L    ADFG+   L AD + R+L+A GT  Y
Sbjct: 177 SVH---RLGYVHRDIKPDNILLDRCGHIRL----ADFGSCLKLRADGTVRSLVAVGTPDY 229

Query: 375 IAPELAYTMVMTEK-------CDVYSFGVVTLEVLMGKHP 407
           ++PE+   +            CD ++ GV   E+  G+ P
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  105 bits (265), Expect = 1e-25
 Identities = 46/203 (22%), Positives = 86/203 (42%), Gaps = 24/203 (11%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGY 270
           +G G +  V     L   + +A+K +              E ++L Q   HRN+++L  +
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
              +   +L++E M  GS+  ++H      EL+ +    +V+ +A AL +LH   +  I 
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLH---NKGIA 133

Query: 331 HRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTL-------LAGTYGYIAPELA 380
           HRD+   NIL     +     + DF     +  +     +         G+  Y+APE+ 
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193

Query: 381 YTMVMT-----EKCDVYSFGVVT 398
                      ++CD++S GV+ 
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVIL 216

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  105 bits (265), Expect = 2e-25
 Identities = 65/293 (22%), Positives = 109/293 (37%), Gaps = 55/293 (18%)

Query: 213 IGTGGYGSVYKAQLPNGK---------VFALKKLHTSEELAFIKSFKNEAQVLSQVL-HR 262
           +G G +G V +A               V  LK+  T  E    ++  +E ++L  +  H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH---RALMSELKILIHIGHHL 91

Query: 263 NIVKLYGYCLHKKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM------- 314
           N+V L G C      + +I E+ + G+L   L +  +          ++ K         
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 315 ------AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
                 A  + +L    S   IHRD+++ NILL+ K    + DFG AR ++ D       
Sbjct: 152 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV--- 205

Query: 369 AGTYGYI-----APELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKI 422
                 +     APE  +  V T + DV+SFGV+  E+  +G  P      +    +   
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP---YPGVKIDEE--- 259

Query: 423 MLIDVLDQ--RLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
                L +  R+  P      +   +L       C    P  RPT   + +  
Sbjct: 260 -FCRRLKEGTRMRAPDYTTPEMYQTML------DCWHGEPSQRPTFSELVEHL 305

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  105 bits (265), Expect = 2e-25
 Identities = 50/219 (22%), Positives = 91/219 (41%), Gaps = 34/219 (15%)

Query: 200 LIEATEDFDIRYCI-----GTGGYGSVYKA-QLPNGKVFALK---KLHTSEELAFIKSFK 250
             ++ E+F+  Y +     G G +  V +      G+ +A K   K    ++        
Sbjct: 19  YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC--RAEIL 76

Query: 251 NEAQVLSQVLHR-NIVKLYGYCLHKKCMFLIYEYMERGSLF------CNLHNNEDAVELD 303
           +E  VL        ++ L+    +   + LI EY   G +F           +E+ V   
Sbjct: 77  HEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDV--- 133

Query: 304 WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHA 360
               + ++K +   + YLH     +I+H D+   NILL+S        + DFG +R +  
Sbjct: 134 ----IRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186

Query: 361 DSSNRTLLAGTYGYIAPE-LAYTMVMTEKCDVYSFGVVT 398
               R ++ GT  Y+APE L Y  + T   D+++ G++ 
Sbjct: 187 ACELREIM-GTPEYLAPEILNYDPI-TTATDMWNIGIIA 223

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  106 bits (267), Expect = 2e-25
 Identities = 72/274 (26%), Positives = 121/274 (44%), Gaps = 42/274 (15%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + F+I   IG G +G V   Q     K++A+K ++  +  E   +++   E Q++  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 262 RNIVKLYGYCLH-KKCMFLIYEYMERGSLFCNLHNN----EDAVELDWAKRVNIVKAMAH 316
             +V L+ Y    ++ MF++ + +  G L  +L  N    E+ V+L   +       +  
Sbjct: 75  PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICE-------LVM 126

Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           AL YL    +  IIHRD+  +NILL+      + DF  A +L  ++   T +AGT  Y+A
Sbjct: 127 ALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MAGTKPYMA 182

Query: 377 PELAYTMVMTEKCDVY-------SFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD 429
           PE    M  + K   Y       S GV   E+L G+ P  I     SS+  K ++     
Sbjct: 183 PE----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI----RSSTSSKEIVHTFET 234

Query: 430 QRLP-PPVDRKVIRDILLISTVSFACLQSNPKSR 462
             +  P    + +  +L         L+ NP  R
Sbjct: 235 TVVTYPSAWSQEMVSLLK------KLLEPNPDQR 262

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  104 bits (262), Expect = 5e-25
 Identities = 66/303 (21%), Positives = 115/303 (37%), Gaps = 70/303 (23%)

Query: 213 IGTGGYGSVYKAQLPNGK---------VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           IG G +G V++A+ P            V  LK+  +++       F+ EA ++++  + N
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ---ADFQREAALMAEFDNPN 111

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM--------- 314
           IVKL G C   K M L++EYM  G L   L +         +      +A          
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 315 ------------AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS 362
                       A  +AYL        +HRD+++ N L+   +   +ADFG +R +++  
Sbjct: 172 SCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 363 SNRTLLAGTYGYI-----APE-LAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLS 415
             +   A     I      PE + Y    T + DV+++GVV  E+   G  P        
Sbjct: 229 YYK---ADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPY------- 277

Query: 416 SSSDPKIMLIDVLD-----QRLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVS 469
                 +   +V+        L  P +    + +++        C    P  RP+  S+ 
Sbjct: 278 ----YGMAHEEVIYYVRDGNILACPENCPLELYNLMR------LCWSKLPADRPSFCSIH 327

Query: 470 QEF 472
           +  
Sbjct: 328 RIL 330

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  104 bits (261), Expect = 7e-25
 Identities = 59/254 (23%), Positives = 101/254 (39%), Gaps = 53/254 (20%)

Query: 204 TEDFDIRYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAF----IKSFKNEAQVLSQ 258
            + + ++  IG G YG V  A +     + A+K ++ ++        ++  K E +++ +
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV---------- 308
           + H NI +LY     ++ + L+ E    G L   L+   D      A  V          
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 309 ---------------------------NIVKAMAHALAYLHHDCSPSIIHRDISSNNILL 341
                                      NI++ +  AL YLH   +  I HRDI   N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLF 201

Query: 342 NSKLEAFV--ADFGTARLLHADSSNR----TLLAGTYGYIAPELAYTMVM--TEKCDVYS 393
           ++     +   DFG ++  +  ++      T  AGT  ++APE+  T       KCD +S
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 394 FGVVTLEVLMGKHP 407
            GV+   +LMG  P
Sbjct: 262 AGVLLHLLLMGAVP 275

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  106 bits (266), Expect = 2e-24
 Identities = 26/120 (21%), Positives = 48/120 (40%), Gaps = 2/120 (1%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
            +      +   L  LD+    +      A  SL++LS L L+ N +        + +  
Sbjct: 42  HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSS 101

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKL-SGPVPFSNNDLSSMHTVVSLSPNN 123
           L +L     N+       I  L  L  LN++ N + S  +P   ++L+++   + LS N 
Sbjct: 102 LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL-EHLDLSSNK 160

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  105 bits (263), Expect = 4e-24
 Identities = 30/123 (24%), Positives = 45/123 (36%), Gaps = 1/123 (0%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPI-PSALGSLTNLSNLDLSSNKLSGKIPPEIASMK 63
                    L +L  L +  NS      P     L NL+ LDLS  +L    P    S+ 
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 494

Query: 64  YLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
            L  L++S+NN           L+ L  L+ S N +            S    ++L+ N+
Sbjct: 495 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 554

Query: 124 GLC 126
             C
Sbjct: 555 FAC 557

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  100 bits (251), Expect = 1e-22
 Identities = 31/132 (23%), Positives = 58/132 (43%), Gaps = 8/132 (6%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKL-SGKIPPEIASMK 63
            +       L +L KL     +L       +G L  L  L+++ N + S K+P   +++ 
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 64  YLTQLDLSNNNIQGSIPGEITKLSRLDY----LNLSSNKLSGPVPFSNNDLSSMHTVVSL 119
            L  LDLS+N IQ     ++  L ++      L+LS N ++   P +  ++      ++L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRL--HKLTL 207

Query: 120 SPNNGLCGNILD 131
             NN    N++ 
Sbjct: 208 R-NNFDSLNVMK 218

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  100 bits (251), Expect = 1e-22
 Identities = 23/105 (21%), Positives = 41/105 (39%), Gaps = 2/105 (1%)

Query: 1   MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI- 59
           +   G          +L  LD+  N +I  + S    L  L +LD   + L       + 
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417

Query: 60  ASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVP 104
            S++ L  LD+S+ + + +  G    LS L+ L ++ N       
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 97.8 bits (244), Expect = 8e-22
 Identities = 33/129 (25%), Positives = 54/129 (41%), Gaps = 4/129 (3%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIP-SALGSLTNLSNLDLSSNKLSGKIPPEIAS 61
            +  +      L+ L  LD   ++L      S   SL NL  LD+S              
Sbjct: 384 GVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 443

Query: 62  MKYLTQLDLSNNNIQGSI-PGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLS 120
           +  L  L ++ N+ Q +  P   T+L  L +L+LS  +L    P + N LSS+  V+++S
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL-QVLNMS 502

Query: 121 PNNGLCGNI 129
            +N      
Sbjct: 503 -HNNFFSLD 510

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 96.6 bits (241), Expect = 2e-21
 Identities = 28/117 (23%), Positives = 46/117 (39%), Gaps = 3/117 (2%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLT 66
           IP  +    +   LD+  N L      +  S   L  LDLS  ++         S+ +L+
Sbjct: 22  IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79

Query: 67  QLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
            L L+ N IQ    G  + LS L  L      L+    F    L ++   ++++ N 
Sbjct: 80  TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL-KELNVAHNL 135

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 90.1 bits (224), Expect = 2e-19
 Identities = 32/129 (24%), Positives = 52/129 (40%), Gaps = 6/129 (4%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSL--IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           G       +L +L  LD+  N L   G    +    T+L  LDLS N +   +      +
Sbjct: 337 GGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGL 395

Query: 63  KYLTQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSP 121
           + L  LD  ++N++      +   L  L YL++S            N LSS+  V+ ++ 
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL-EVLKMA- 453

Query: 122 NNGLCGNIL 130
            N    N L
Sbjct: 454 GNSFQENFL 462

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 78.9 bits (195), Expect = 1e-15
 Identities = 19/116 (16%), Positives = 41/116 (35%), Gaps = 5/116 (4%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM-K 63
            + P    +L +L  L++  N+           L +L  LD S N +      E+     
Sbjct: 484 QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPS 543

Query: 64  YLTQLDLSNNNIQGSIPGE--ITKLSRLDYLNLSSNKLSG--PVPFSNNDLSSMHT 115
            L  L+L+ N+   +   +  +  +     L +   ++    P       + S++ 
Sbjct: 544 SLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSLNI 599

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 69.7 bits (171), Expect = 7e-13
 Identities = 18/116 (15%), Positives = 36/116 (31%), Gaps = 10/116 (8%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPS-ALGSLTNLSNLDLSSNKLSGKI---PPE 58
            +  I P       L KL + +N     +    +  L  L    L   +   +      +
Sbjct: 188 PMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247

Query: 59  IASMKYLTQLDLSNNNIQ------GSIPGEITKLSRLDYLNLSSNKLSGPVPFSNN 108
            ++++ L  L +    +         I      L+ +   +L S  +     FS N
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN 303

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 67.7 bits (166), Expect = 3e-12
 Identities = 23/146 (15%), Positives = 42/146 (28%), Gaps = 26/146 (17%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLS------------ 52
             I      L N+    + S ++      +        +L+L + K              
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFGQFPTLKLKSLKR 329

Query: 53  -------GKIPPEIASMKYLTQLDLSNNNIQ--GSIPGEITKLSRLDYLNLSSNKLSGPV 103
                  G        +  L  LDLS N +   G         + L YL+LS N +   +
Sbjct: 330 LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-M 388

Query: 104 PFSNNDLSSMHTVVSLSPNNGLCGNI 129
             +   L  +   +    ++ L    
Sbjct: 389 SSNFLGLEQLEH-LDFQ-HSNLKQMS 412

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 66.6 bits (163), Expect = 8e-12
 Identities = 32/158 (20%), Positives = 52/158 (32%), Gaps = 32/158 (20%)

Query: 6   IIPPEIGNLKNLIKLDVGSNSL------IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI 59
           +   +   L+ L  L +    L      +  I      LTN+S+  L S  +      + 
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDF 300

Query: 60  ASMKYLTQLDLSNNNI-------------------QGSIPGEITKLSRLDYLNLSSNKLS 100
           +       L+L N                      +G        L  L++L+LS N LS
Sbjct: 301 SYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLS 360

Query: 101 --GPVPFSNNDLSSMHTVVSLSPNN--GLCGNILDLPS 134
             G    S+   +S+   + LS N    +  N L L  
Sbjct: 361 FKGCCSQSDFGTTSL-KYLDLSFNGVITMSSNFLGLEQ 397

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  104 bits (261), Expect = 6e-24
 Identities = 33/121 (27%), Positives = 46/121 (38%), Gaps = 3/121 (2%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
            + P     L  L  L++  N L           TNL+ L L SN +           K 
Sbjct: 63  KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSG--PVPFSNNDLSSMHTVVSLSPN 122
           L  LDLS+N +  +  G   +L  L  L LS+NK+             SS+   + LS N
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSL-KKLELSSN 181

Query: 123 N 123
            
Sbjct: 182 Q 182

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  104 bits (261), Expect = 7e-24
 Identities = 34/119 (28%), Positives = 47/119 (39%), Gaps = 1/119 (0%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
            +          L  LDVG N++    P     L  L  L+L  N+LS       A    
Sbjct: 39  RLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTN 98

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
           LT+L L +N+IQ        K   L  L+LS N LS     +   L ++   + LS N 
Sbjct: 99  LTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENL-QELLLSNNK 156

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 93.9 bits (234), Expect = 1e-20
 Identities = 23/117 (19%), Positives = 45/117 (38%), Gaps = 3/117 (2%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLT 66
           +P ++    N+  L++  N L     +     + L++LD+  N +S   P     +  L 
Sbjct: 19  VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLK 76

Query: 67  QLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
            L+L +N +           + L  L+L SN +            ++   + LS N 
Sbjct: 77  VLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL-ITLDLSHNG 132

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 93.9 bits (234), Expect = 2e-20
 Identities = 29/128 (22%), Positives = 48/128 (37%), Gaps = 9/128 (7%)

Query: 4   IGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLS--------GKI 55
           +   P     L+NL  LD+ +N++       L  L  L  LDL  N L+        G  
Sbjct: 469 VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGP 528

Query: 56  PPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHT 115
              +  + +L  L+L +N            L  L  ++L  N L+       N+  S+  
Sbjct: 529 IYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSL-K 587

Query: 116 VVSLSPNN 123
            ++L  N 
Sbjct: 588 SLNLQKNL 595

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 93.5 bits (233), Expect = 2e-20
 Identities = 29/140 (20%), Positives = 45/140 (32%), Gaps = 10/140 (7%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSL--------IGPIPSALGSLTNLSNLDLSSNKLSGKIP 56
            I    +  L+ L  LD+  N+L         G     L  L++L  L+L SN       
Sbjct: 494 NINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPV 553

Query: 57  PEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV 116
                +  L  +DL  NN+             L  LNL  N ++              T 
Sbjct: 554 EVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTE 613

Query: 117 VSLSPNN--GLCGNILDLPS 134
           + +  N     C +I    +
Sbjct: 614 LDMRFNPFDCTCESIAWFVN 633

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 90.1 bits (224), Expect = 3e-19
 Identities = 27/116 (23%), Positives = 45/116 (38%), Gaps = 8/116 (6%)

Query: 13  NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPP-EIASMKYLTQLDLS 71
               L  L++  N +      A   L +L  LDL  N++  ++   E   ++ + ++ LS
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438

Query: 72  NNNIQGSIPGEITKLSRLDYLNLSSNKLSG----PVPFSNNDLSSMHTVVSLSPNN 123
            N            +  L  L L    L      P PF    L ++ T++ LS NN
Sbjct: 439 YNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP--LRNL-TILDLSNNN 491

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 89.3 bits (222), Expect = 6e-19
 Identities = 33/133 (24%), Positives = 53/133 (39%), Gaps = 12/133 (9%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSL--IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
            +       + +L +L +   +L  +   PS    L NL+ LDLS+N ++      +  +
Sbjct: 444 QLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGL 503

Query: 63  KYLTQLDLSNNNIQ--------GSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMH 114
           + L  LDL +NN+         G     +  LS L  LNL SN           DL  + 
Sbjct: 504 EKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL- 562

Query: 115 TVVSLSPNNGLCG 127
            ++ L   N L  
Sbjct: 563 KIIDLG-LNNLNT 574

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 88.9 bits (221), Expect = 7e-19
 Identities = 28/126 (22%), Positives = 50/126 (39%), Gaps = 8/126 (6%)

Query: 5   GIIPPEIGNLKN--LIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIA-- 60
            +   E+    N  L KL++ SN +    P    ++  L  L L++ +L   +  ++   
Sbjct: 159 ALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLE 218

Query: 61  -SMKYLTQLDLSNNNIQGSIPGEIT--KLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVV 117
            +   +  L LSN+ +  +        K + L  L+LS N L+     S   L  +    
Sbjct: 219 LANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEY-F 277

Query: 118 SLSPNN 123
            L  NN
Sbjct: 278 FLEYNN 283

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 87.0 bits (216), Expect = 2e-18
 Identities = 28/132 (21%), Positives = 49/132 (37%), Gaps = 14/132 (10%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSN---------KLSGKI 55
            +       L  L    +  N++      +L  L N+  L+L  +          L    
Sbjct: 262 VVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKID 321

Query: 56  PPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSG----PVPFSNNDLS 111
                 +K L  L++ +N+I G      T L  L YL+LS++  S        F +   S
Sbjct: 322 DFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHS 381

Query: 112 SMHTVVSLSPNN 123
            +H  ++L+ N 
Sbjct: 382 PLHI-LNLTKNK 392

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 83.5 bits (207), Expect = 4e-17
 Identities = 29/133 (21%), Positives = 49/133 (36%), Gaps = 15/133 (11%)

Query: 5   GIIPPEIG---NLKNLIKLDVGSNSLIGPIPSALGSL--TNLSNLDLSSNKLSGKIPPEI 59
             +  ++       ++  L + ++ L     +    L  TNL+ LDLS N L+       
Sbjct: 209 PSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF 268

Query: 60  ASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSN---------KLSGPVPFSNNDL 110
           A +  L    L  NNIQ      +  L  + YLNL  +          L     FS   L
Sbjct: 269 AWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWL 328

Query: 111 SSMHTVVSLSPNN 123
             +   +++  N+
Sbjct: 329 KCLEH-LNMEDND 340

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 59.6 bits (145), Expect = 1e-09
 Identities = 20/85 (23%), Positives = 41/85 (48%), Gaps = 4/85 (4%)

Query: 39  TNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNK 98
            +    D S  KL+ ++P ++ +   +T L+L++N ++       T+ S+L  L++  N 
Sbjct: 4   VSHEVADCSHLKLT-QVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 99  LSGPVPFSNNDLSSMHTVVSLSPNN 123
           +S   P     L  +  V++L  N 
Sbjct: 61  ISKLEPELCQKLPML-KVLNLQHNE 84

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =   99 bits (250), Expect = 1e-23
 Identities = 54/214 (25%), Positives = 89/214 (41%), Gaps = 23/214 (10%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           EDF     +G G + +V  A+     + +A+K L      +   +     E  V+S++ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA------MA 315
              VKLY      + ++    Y + G L   +               +          + 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---------IGSFDETCTRFYTAEIV 140

Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN-RTL-LAGTYG 373
            AL YLH      IIHRD+   NILLN  +   + DFGTA++L  +S   R     GT  
Sbjct: 141 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197

Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           Y++PEL       +  D+++ G +  +++ G  P
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  101 bits (253), Expect = 2e-23
 Identities = 51/197 (25%), Positives = 89/197 (45%), Gaps = 24/197 (12%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGY 270
           +G G  G V +       + FALK L    +       + E ++  +     +IV++   
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKA------RREVELHWRASQCPHIVRIVDV 123

Query: 271 C----LHKKCMFLIYEYMERGSLFCNLHNNEDAV--ELDWAKRVNIVKAMAHALAYLHHD 324
                  +KC+ ++ E ++ G LF  + +  D    E + +    I+K++  A+ YLH  
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS---EIMKSIGEAIQYLH-- 178

Query: 325 CSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
            S +I HRD+   N+L  SK       + DFG A+   + +S  T    T  Y+APE+  
Sbjct: 179 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYVAPEVLG 236

Query: 382 TMVMTEKCDVYSFGVVT 398
                + CD++S GV+ 
Sbjct: 237 PEKYDKSCDMWSLGVIM 253

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  100 bits (252), Expect = 2e-23
 Identities = 68/242 (28%), Positives = 107/242 (44%), Gaps = 19/242 (7%)

Query: 176 EERATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFAL 234
             R   NID F     D      DL    ED+++   IG G +G V   +     KV+A+
Sbjct: 40  ALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAM 99

Query: 235 KKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH-KKCMFLIYEYMERGSLFC 291
           K L   E  + +    F  E  +++      +V+L+ Y     + ++++ EYM  G L  
Sbjct: 100 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVN 158

Query: 292 NLHNNEDAVELDWAKRVNIVKA-MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVA 350
            + N +  V   WA+      A +  AL  +H   S   IHRD+  +N+LL+      +A
Sbjct: 159 LMSNYD--VPEKWAR---FYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLA 210

Query: 351 DFGTARLLHADSSNRT-LLAGTYGYIAPEL----AYTMVMTEKCDVYSFGVVTLEVLMGK 405
           DFGT   ++ +   R     GT  YI+PE+            +CD +S GV   E+L+G 
Sbjct: 211 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

Query: 406 HP 407
            P
Sbjct: 271 TP 272

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 26/207 (12%)

Query: 204 TEDFDI-RYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL- 260
           T+D+ + +  +G G  G V +      G+  ALK L+ S         + E     Q   
Sbjct: 27  TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PKARQEVDHHWQASG 80

Query: 261 HRNIVKLYGYC----LHKKCMFLIYEYMERGSLFCNLHNNEDAV--ELDWAKRVNIVKAM 314
             +IV +          K+C+ +I E ME G LF  +    D    E + A+   I++ +
Sbjct: 81  GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAE---IMRDI 137

Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAGT 371
             A+ +LH   S +I HRD+   N+L  SK +     + DFG A+      +       T
Sbjct: 138 GTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQTPCYT 192

Query: 372 YGYIAPELAYTMVMTEKCDVYSFGVVT 398
             Y+APE+       + CD++S GV+ 
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 97.6 bits (243), Expect = 1e-21
 Identities = 29/131 (22%), Positives = 49/131 (37%), Gaps = 8/131 (6%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYL 65
           +  +      +    +G N+L   P  ++L  +  L  LD   NK+         +   L
Sbjct: 540 LADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKL 597

Query: 66  TQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLSG-PVPFSNNDLSSMHTVVSLSPNN 123
           T L L  N I+  IP +      +++ L  S NKL   P  F+   +  M   V  S  N
Sbjct: 598 TDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVM-GSVDFS-YN 654

Query: 124 GLCGNILDLPS 134
            +     ++  
Sbjct: 655 KIGSEGRNISC 665

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 96.9 bits (241), Expect = 2e-21
 Identities = 25/141 (17%), Positives = 53/141 (37%), Gaps = 14/141 (9%)

Query: 3   KIGIIPPEI--GNLKNLIKLDVGSNSLIGPIPSALGSLTNL------SNLDLSSNKLSGK 54
           K+  +  +     L  L  +DV  N      P+   + + L         D   N++  +
Sbjct: 739 KLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQ 797

Query: 55  IPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKL-SGPVPFSNNDLSSM 113
            P  I +   L QL + +N+I+  +  ++    +L  L+++ N   S  V      + + 
Sbjct: 798 WPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAG 854

Query: 114 HTVVSLSPNNGLCG-NILDLP 133
             V+       + G + L + 
Sbjct: 855 MYVLLYDKTQDIRGCDALGIE 875

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 96.9 bits (241), Expect = 3e-21
 Identities = 17/106 (16%), Positives = 36/106 (33%), Gaps = 5/106 (4%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           +I  I   I  L  L  +   ++       +      +  + +    K         +++
Sbjct: 436 RITFISKAIQRLTKLQIIYFANSPFTYDNIA-----VDWEDANSDYAKQYENEELSWSNL 490

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNN 108
           K LT ++L N      +P  +  L  L  LN++ N+         +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKAD 536

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 95.3 bits (237), Expect = 8e-21
 Identities = 25/138 (18%), Positives = 45/138 (32%), Gaps = 12/138 (8%)

Query: 4   IGIIPPEIGNLKNLIKLDVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           +        N   L  +D+  N L          +L  LSN+D+S N  S   P +  + 
Sbjct: 717 LKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNS 775

Query: 63  KYLTQLDL------SNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV 116
             L    +        N I    P  IT    L  L + SN +             +  +
Sbjct: 776 SQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK---VDEKLTPQL-YI 831

Query: 117 VSLSPNNGLCGNILDLPS 134
           + ++ N  +  ++  +  
Sbjct: 832 LDIADNPNISIDVTSVCP 849

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 92.2 bits (229), Expect = 7e-20
 Identities = 21/134 (15%), Positives = 42/134 (31%), Gaps = 16/134 (11%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGP---------IPSALGSLTNLSNLDLSSNKLSG 53
            +  +P  + +L  L  L++  N  I           +     +   +    +  N L  
Sbjct: 503 NMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE 562

Query: 54  KIPPE--IASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLS 111
             P    +  M  L  LD  +N ++  +        +L  L L  N++            
Sbjct: 563 -FPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEEIPEDFCAFTD 619

Query: 112 SMHTVVSLSPNNGL 125
            +   +  S +N L
Sbjct: 620 QV-EGLGFS-HNKL 631

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 86.1 bits (213), Expect = 6e-18
 Identities = 26/136 (19%), Positives = 46/136 (33%), Gaps = 17/136 (12%)

Query: 3   KIGIIPPEIG-NLKNLIKLDVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPPEIA 60
           +I  IP +       +  L    N L   P      S+  + ++D S NK+       I+
Sbjct: 606 QIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGS-EGRNIS 664

Query: 61  S------MKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS-------GPVPFSN 107
                      + + LS N IQ          S +  + LS+N ++        P   + 
Sbjct: 665 CSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNY 724

Query: 108 NDLSSMHTVVSLSPNN 123
            +   + T + L  N 
Sbjct: 725 KNTYLLTT-IDLRFNK 739

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 84.5 bits (209), Expect = 2e-17
 Identities = 25/124 (20%), Positives = 38/124 (30%), Gaps = 9/124 (7%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPP--EIASMKY 64
                G    L  L +  N +             +  L  S NKL   IP      S+  
Sbjct: 587 HLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYV 645

Query: 65  LTQLDLSNNNIQG-----SIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSL 119
           +  +D S N I       S   +  K      + LS N++           S + + + L
Sbjct: 646 MGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPI-STIIL 704

Query: 120 SPNN 123
           S N 
Sbjct: 705 SNNL 708

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 72.2 bits (177), Expect = 2e-13
 Identities = 18/125 (14%), Positives = 38/125 (30%), Gaps = 4/125 (3%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
                ++ N   +  L +      G +P A+G LT L  L   ++  +            
Sbjct: 313 DQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELT 372

Query: 65  LTQLDLSNNNIQGSIP----GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLS 120
               +   + I+            +L+  D L  + N+     P   +   S+      +
Sbjct: 373 PDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGN 432

Query: 121 PNNGL 125
             N +
Sbjct: 433 LTNRI 437

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 18/137 (13%), Positives = 45/137 (32%), Gaps = 21/137 (15%)

Query: 6   IIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYL 65
           +   +  NL +L++  +  N  + PI          + +   +N+++  I   I  +  L
Sbjct: 392 LDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKL 450

Query: 66  TQLDLSNNNIQG-------------------SIPGEITKLSRLDYLNLSSNKLSGPVPFS 106
             +  +N+                       +     + L  L  + L +      +P  
Sbjct: 451 QIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDF 510

Query: 107 NNDLSSMHTVVSLSPNN 123
             DL  +   ++++ N 
Sbjct: 511 LYDLPEL-QSLNIACNR 526

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 64.1 bits (156), Expect = 5e-11
 Identities = 10/128 (7%), Positives = 34/128 (26%), Gaps = 14/128 (10%)

Query: 19  KLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGS 78
             +   +         L +   ++ L L+     G++P  I  +  L  L    ++   S
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362

Query: 79  IPGEITKLSRLDYLNLSSNKLSGPVP--------------FSNNDLSSMHTVVSLSPNNG 124
                 +    D      +++                      + ++    +  +  ++ 
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422

Query: 125 LCGNILDL 132
           +      +
Sbjct: 423 ISLKDTQI 430

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 16/84 (19%), Positives = 27/84 (32%), Gaps = 3/84 (3%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
              P  I    +LI+L +GSN +   +   L     L  LD++ N         +     
Sbjct: 796 RQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIE 852

Query: 65  LTQLDLSNNNIQGSIPGEITKLSR 88
                L  +  Q     +   + R
Sbjct: 853 AGMYVLLYDKTQDIRGCDALGIER 876

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 92.1 bits (229), Expect = 5e-21
 Identities = 33/266 (12%), Positives = 74/266 (27%), Gaps = 57/266 (21%)

Query: 210 RY----CIGTGGYGSVYKA---QLPNGKVFALKKLHT--SEELAFIKSFKNEAQVLSQVL 260
           RY      G       ++A    L   +  AL  +          ++   +    LS++ 
Sbjct: 32  RYRLLIFHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID 89

Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVE--LDWAKRVNIVKAMAHAL 318
              + ++      +    ++ E++  GSL       ++  +        +  ++++A A 
Sbjct: 90  KPGVARVLDVVHTRAGGLVVAEWIRGGSL-------QEVADTSPSPVGAIRAMQSLAAAA 142

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
              H      +       + +         V+  G   L                 +   
Sbjct: 143 DAAHRA---GVALSIDHPSRVR--------VSIDGDVVL------------AYPATMPDA 179

Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR 438
                    + D+   G     +L+ + P       S  +            +   P   
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA----PAERDTAGQPIEP--A 226

Query: 439 KVIRDI-LLISTVSFACLQSNPKSRP 463
            + RDI   IS V+   +Q +   R 
Sbjct: 227 DIDRDIPFQISAVAARSVQGDGGIRS 252

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 92.7 bits (231), Expect = 5e-21
 Identities = 29/120 (24%), Positives = 53/120 (44%), Gaps = 2/120 (1%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
            I  +P  I NL+NL  L + ++ L   +  A+  L  L  LDL         PP     
Sbjct: 194 GIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGR 252

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN 122
             L +L L + +   ++P +I +L++L+ L+L        +P     L +   ++ + P+
Sbjct: 253 APLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN-CIILVPPH 311

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 21/107 (19%), Positives = 38/107 (35%), Gaps = 11/107 (10%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
            +   P +   L +L  + + +  L+  +P  +     L  L L+ N L   +P  IAS+
Sbjct: 92  PLPQFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASL 149

Query: 63  KYLTQLDLSNNNIQGSIPGEI---------TKLSRLDYLNLSSNKLS 100
             L +L +        +P  +           L  L  L L    + 
Sbjct: 150 NRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR 196

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 87.3 bits (217), Expect = 3e-19
 Identities = 27/132 (20%), Positives = 53/132 (40%), Gaps = 12/132 (9%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGS---------LTNLSNLDLSSNKLSG 53
            +  +P  I +L  L +L + +   +  +P  L S         L NL +L L    +  
Sbjct: 138 PLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR- 196

Query: 54  KIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSM 113
            +P  IA+++ L  L + N+ +  ++   I  L +L+ L+L         P      + +
Sbjct: 197 SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPL 255

Query: 114 HTVVSLSPNNGL 125
              + L   + L
Sbjct: 256 -KRLILKDCSNL 266

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 87.3 bits (217), Expect = 5e-19
 Identities = 20/98 (20%), Positives = 37/98 (37%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
            +  + P I +L  L +LD+   + +   P   G    L  L L        +P +I  +
Sbjct: 217 PLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRL 276

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
             L +LDL        +P  I +L     + +  +  +
Sbjct: 277 TQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 20/116 (17%), Positives = 45/116 (38%), Gaps = 5/116 (4%)

Query: 7   IPPEIGNLK--NLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
               + +      + L++ S  L    P     L++L ++ + +  L  ++P  +     
Sbjct: 71  TADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAG 128

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLS 120
           L  L L+ N ++ ++P  I  L+RL  L++ +      +P       +      L 
Sbjct: 129 LETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLV 183

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 63.0 bits (154), Expect = 5e-11
 Identities = 15/118 (12%), Positives = 33/118 (27%), Gaps = 22/118 (18%)

Query: 4   IGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIP------- 56
           +G       +      L    ++ + P    L       N D +    + +         
Sbjct: 1   MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQI 60

Query: 57  --------------PEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
                          E A+      L+L +  +    P +  +LS L ++ + +  L 
Sbjct: 61  ETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM 117

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 95.0 bits (236), Expect = 8e-21
 Identities = 59/250 (23%), Positives = 99/250 (39%), Gaps = 31/250 (12%)

Query: 171 KKPKLEERATNNIDVFSIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQL-PNG 229
                +   ++    F  W      ++  +     DF +   IG GG+G VY  +    G
Sbjct: 159 GDVFQKFIESDKFTRFCQWKNVELNIHLTM----NDFSVHRIIGRGGFGEVYGCRKADTG 214

Query: 230 KVFALKKLHTSEELAFIKSFK------NEAQVLSQV---LHRNIVKLYGYCLH-KKCMFL 279
           K++A+K L    +   IK  +      NE  +LS V       IV +  Y  H    +  
Sbjct: 215 KMYAMKCL----DKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFHTPDKLSF 269

Query: 280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYLHHDCSPSIIHRDISSNN 338
           I + M  G L  +L  +    E      +    A +   L ++H   +  +++RD+   N
Sbjct: 270 ILDLMNGGDLHYHLSQHGVFSE----ADMRFYAAEIILGLEHMH---NRFVVYRDLKPAN 322

Query: 339 ILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAYTMVMTEKCDVYSFGVV 397
           ILL+      ++D G A        +     GT+GY+APE L   +      D +S G +
Sbjct: 323 ILLDEHGHVRISDLGLACDFSKKKPHA--SVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 380

Query: 398 TLEVLMGKHP 407
             ++L G  P
Sbjct: 381 LFKLLRGHSP 390

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 93.6 bits (233), Expect = 8e-21
 Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 54/227 (23%)

Query: 208 DIRYC----IGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKN-EAQVLSQVLH 261
           ++ Y     IG G +G VY+A+L  +G++ A+KK+   +       FKN E Q++ ++ H
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDH 106

Query: 262 RNIVKLYGYCLH-------KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM 314
            NIV+L  Y  +       +  + L+ +Y+        ++            R      +
Sbjct: 107 CNIVRLR-YFFYSSGEKKDEVYLNLVLDYVP-----ETVYR-----VARHYSRAKQTLPV 155

Query: 315 AH----------ALAYLHHDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSS 363
            +          +LAY+H   S  I HRDI   N+LL+       + DFG+A+ L     
Sbjct: 156 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212

Query: 364 NRTLLAGTYGYIAPEL-----AYTMVMTEKCDVYSFGVVTLEVLMGK 405
           N + +   Y Y APEL      YT  +    DV+S G V  E+L+G+
Sbjct: 213 NVSYICSRY-YRAPELIFGATDYTSSI----DVWSAGCVLAELLLGQ 254

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 94.1 bits (234), Expect = 1e-20
 Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 24/214 (11%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFK------NEAQVLS 257
             F     +G GG+G V   Q+   GK++A KKL    E   IK  K      NE Q+L 
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKL----EKKRIKKRKGEAMALNEKQILE 239

Query: 258 QVLHRNIVKLYGYCLH-KKCMFLIYEYMERGSLFCNLHNNEDAV--ELDWAKRVNIVKA- 313
           +V  R +V L  Y    K  + L+   M  G L  ++++   A   E     R     A 
Sbjct: 240 KVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE----ARAVFYAAE 294

Query: 314 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG 373
           +   L  LH      I++RD+   NILL+      ++D G A  +    + +    GT G
Sbjct: 295 ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-RVGTVG 350

Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           Y+APE+      T   D ++ G +  E++ G+ P
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 93.2 bits (232), Expect = 3e-20
 Identities = 24/119 (20%), Positives = 35/119 (29%), Gaps = 1/119 (0%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
            I       L NL  LD+    +         S   L  L L++N L       ++  K 
Sbjct: 47  TIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKA 106

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
           L  L      I       +     L+ L L SN +S            +  V+    N 
Sbjct: 107 LKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKL-KVLDFQNNA 164

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 90.8 bits (226), Expect = 2e-19
 Identities = 28/128 (21%), Positives = 48/128 (37%), Gaps = 4/128 (3%)

Query: 1   MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI- 59
           +        ++ NL +L  L++  N  +     A      L  LDL+  +L  K      
Sbjct: 362 IETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPF 421

Query: 60  ASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMH--TVV 117
            ++  L  L+LS++ +  S       L  L +LNL  N          N L ++    ++
Sbjct: 422 QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEIL 481

Query: 118 SLSPNNGL 125
            LS    L
Sbjct: 482 VLS-FCDL 488

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 88.9 bits (221), Expect = 5e-19
 Identities = 23/120 (19%), Positives = 43/120 (35%), Gaps = 1/120 (0%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
            I      +   L  L + +N LI    +AL     L +L      +S      + + K 
Sbjct: 71  WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVV-SLSPNN 123
           L  L L +N+I      +     +L  L+  +N +        + L     +  +L+ N+
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND 190

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 87.0 bits (216), Expect = 2e-18
 Identities = 26/129 (20%), Positives = 45/129 (34%), Gaps = 2/129 (1%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
            +    +   K L  L      +       L +   L +L L SN +S    P+    + 
Sbjct: 95  FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK 154

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLD--YLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN 122
           L  LD  NN I      +++ L +     LNL+ N ++G  P + +           + N
Sbjct: 155 LKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQN 214

Query: 123 NGLCGNILD 131
             +    L 
Sbjct: 215 LLVIFKGLK 223

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 82.0 bits (203), Expect = 1e-16
 Identities = 32/122 (26%), Positives = 50/122 (40%), Gaps = 5/122 (4%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPI---PSALGSLTNLSNLDLSSNKLSGKIPPEIAS 61
                    L  L  L++  N          ++L +L  L  L LS   LS        S
Sbjct: 439 ISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTS 498

Query: 62  MKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSP 121
           +K +  +DLS+N +  S    ++ L  + YLNL+SN +S  +P     LS     ++L  
Sbjct: 499 LKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQ-RTINLRQ 556

Query: 122 NN 123
           N 
Sbjct: 557 NP 558

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 80.8 bits (200), Expect = 2e-16
 Identities = 21/117 (17%), Positives = 42/117 (35%), Gaps = 3/117 (2%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLT 66
           IP  +    +   L+   N L     +    L NL+ LDL+  ++         S   L 
Sbjct: 27  IPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLD 84

Query: 67  QLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
            L L+ N +       ++    L +L      +S       ++  ++ + + L  N+
Sbjct: 85  TLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES-LYLGSNH 140

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 80.4 bits (199), Expect = 3e-16
 Identities = 27/132 (20%), Positives = 51/132 (38%), Gaps = 5/132 (3%)

Query: 6   IIPPEIGNLKNLIKLDVGSNSL--IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMK 63
           +    + NL+NL +LD+  + +         L +L++L +L+LS N+             
Sbjct: 341 LGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECP 400

Query: 64  YLTQLDLSNNNIQGSIP-GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN 122
            L  LDL+   ++          L  L  LNLS + L        + L ++   ++L   
Sbjct: 401 QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPAL-QHLNLQ-G 458

Query: 123 NGLCGNILDLPS 134
           N      +   +
Sbjct: 459 NHFPKGNIQKTN 470

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 79.7 bits (197), Expect = 5e-16
 Identities = 30/126 (23%), Positives = 42/126 (33%), Gaps = 6/126 (4%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPPEIA 60
           +   +  E       L  LD+    L      S   +L  L  L+LS + L         
Sbjct: 387 EPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFD 446

Query: 61  SMKYLTQLDLSNNNIQGSI---PGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVV 117
            +  L  L+L  N+           +  L RL+ L LS   LS     +   L  M   V
Sbjct: 447 GLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMM-NHV 505

Query: 118 SLSPNN 123
            LS N 
Sbjct: 506 DLSHNR 511

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 79.3 bits (196), Expect = 6e-16
 Identities = 30/122 (24%), Positives = 49/122 (40%), Gaps = 5/122 (4%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
            I          L +LD+ +  L   +PS L  L+ L  L LS+NK         ++   
Sbjct: 268 NISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPS 326

Query: 65  LTQLDLSNNNIQGSI-PGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMH--TVVSLSP 121
           LT L +  N  +  +  G +  L  L  L+LS + +       N  L ++     ++LS 
Sbjct: 327 LTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET-SDCCNLQLRNLSHLQSLNLSY 385

Query: 122 NN 123
           N 
Sbjct: 386 NE 387

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 71.6 bits (176), Expect = 2e-13
 Identities = 17/110 (15%), Positives = 31/110 (28%), Gaps = 5/110 (4%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALG--SLTNLSNLDLSSNKLSGKIPPEIA 60
            I  I P   +      L+ G    +  I   L   ++ +L              P    
Sbjct: 190 DIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE 249

Query: 61  SMK--YLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSG-PVPFSN 107
            +    +  ++L  +             S L  L+L++  LS  P     
Sbjct: 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVG 299

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 14/125 (11%), Positives = 41/125 (32%), Gaps = 8/125 (6%)

Query: 5   GIIPPEIGNLKNL--IKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIA-- 60
            +   ++ +L+    + L++  N  I  I           +L+    +    I   +   
Sbjct: 167 YLSKEDMSSLQQATNLSLNLNGND-IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNS 225

Query: 61  SMKYLTQLDLSNNNIQGSIPGEITKLSRLD--YLNLSSNKLSGPVPFSNNDLSSMHTVVS 118
           +++ L      + + +   P     L  +    +NL  +        + +  S +   + 
Sbjct: 226 TIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQE-LD 284

Query: 119 LSPNN 123
           L+  +
Sbjct: 285 LTATH 289

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 92.5 bits (230), Expect = 4e-20
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 17/212 (8%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFK------NEAQVLS 257
           + F     +G GG+G V+  Q+   GK++A KKL        +K  K       E ++L+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKL----NKKRLKKRKGYQGAMVEKKILA 240

Query: 258 QVLHRNIVKLYGYCLH-KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MA 315
           +V  R IV L  Y    K  + L+   M  G +  +++N ++        R     A + 
Sbjct: 241 KVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299

Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI 375
             L +LH     +II+RD+   N+LL+      ++D G A  L A  +     AGT G++
Sbjct: 300 SGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFM 356

Query: 376 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           APEL          D ++ GV   E++  + P
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 90.4 bits (225), Expect = 4e-20
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 17/200 (8%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHRNIVKLYGY 270
           +G G YG V K +    G++ A+KK   S++   +K     E ++L Q+ H N+V L   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92

Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 330
           C  KK  +L++E+++  ++  +L    + ++    +    +  + + + + H   S +II
Sbjct: 93  CKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQ--KYLFQIINGIGFCH---SHNII 146

Query: 331 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL-----AYTMVM 385
           HRDI   NIL++      + DFG AR L A          T  Y APEL      Y   +
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAV 206

Query: 386 TEKCDVYSFGVVTLEVLMGK 405
               DV++ G +  E+ MG+
Sbjct: 207 ----DVWAIGCLVTEMFMGE 222

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 90.0 bits (224), Expect = 7e-20
 Identities = 54/237 (22%), Positives = 90/237 (37%), Gaps = 60/237 (25%)

Query: 202 EATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKN----EAQVL 256
           +  + F +    G G +G+V   +    G   A+KK+           F+N      Q L
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD------PRFRNRELQIMQDL 73

Query: 257 SQVLHRNIVKLYGYCLHKK--------CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV 308
           + + H NIV+L     +           + ++ EY+        LH            R 
Sbjct: 74  AVLHHPNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVP-----DTLHR-----CCRNYYRR 122

Query: 309 NIVKAMAH----------ALAYLHHDCSPSIIHRDISSNNILLNS-----KLEAFVADFG 353
            +                ++  LH   S ++ HRDI  +N+L+N      KL     DFG
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKL----CDFG 177

Query: 354 TARLLHADSSNRTLLAGTYGYIAPEL-----AYTMVMTEKCDVYSFGVVTLEVLMGK 405
           +A+ L     N   +   Y Y APEL      YT  +    D++S G +  E+++G+
Sbjct: 178 SAKKLSPSEPNVAYICSRY-YRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLGE 229

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 73/290 (25%), Positives = 111/290 (38%), Gaps = 44/290 (15%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFK-NEAQVLSQVLHR 262
           E ++    IG G YG V+K +    G++ A+KK   SE+   IK     E ++L Q+ H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
           N+V L      K+ + L++EY +  ++   L   +  V     K  +I      A+ + H
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK--SITWQTLQAVNFCH 119

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL--- 379
                + IHRD+   NIL+       + DFG ARLL   S        T  Y +PEL   
Sbjct: 120 ---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG 176

Query: 380 --AYTMVMTEKCDVYSFGVVTLEVLMGK-------------HPRDILSSLSSSSDPKIM- 423
              Y   +    DV++ G V  E+L G                R  L  L          
Sbjct: 177 DTQYGPPV----DVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232

Query: 424 LIDVLDQRLPPPVDRKVIRDIL---------LISTVSFACLQSNPKSRPT 464
                  ++P P D + +             L+      CL  +P  R T
Sbjct: 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLK----GCLHMDPTERLT 278

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 88.4 bits (220), Expect = 2e-19
 Identities = 42/182 (23%), Positives = 77/182 (42%), Gaps = 6/182 (3%)

Query: 201 IEATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV 259
           + ++  F     +G G Y +VYK      G   ALK++    E     +   E  ++ ++
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60

Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMER--GSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 317
            H NIV+LY     +  + L++E+M+        +         L+          +   
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           LA+ H +    I+HRD+   N+L+N + +  + DFG AR      +  +    T  Y AP
Sbjct: 121 LAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAP 177

Query: 378 EL 379
           ++
Sbjct: 178 DV 179

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 62/230 (26%), Positives = 97/230 (42%), Gaps = 61/230 (26%)

Query: 208 DIRYC----IGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKN-EAQVLSQVLHR 262
           +I Y     IG G +G V++A+L      A+KK+   +       FKN E Q++  V H 
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHP 92

Query: 263 NIVKLYGYCLH-------KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 315
           N+V L     +       +  + L+ EY+        ++            ++     M 
Sbjct: 93  NVVDLK-AFFYSNGDKKDEVFLNLVLEYVP-----ETVYR-----ASRHYAKLKQTMPML 141

Query: 316 H----------ALAYLHHDCSPSIIHRDISSNNILLNS-----KLEAFVADFGTARLLHA 360
                      +LAY+H   S  I HRDI   N+LL+      KL     DFG+A++L A
Sbjct: 142 LIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKL----IDFGSAKILIA 194

Query: 361 DSSNRTLLAGTYGYIAPEL-----AYTMVMTEKCDVYSFGVVTLEVLMGK 405
              N + +   Y Y APEL      YT  +    D++S G V  E++ G+
Sbjct: 195 GEPNVSYICSRY-YRAPELIFGATNYTTNI----DIWSTGCVMAELMQGQ 239

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 89.7 bits (223), Expect = 3e-19
 Identities = 25/106 (23%), Positives = 38/106 (35%), Gaps = 3/106 (2%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
            +      N   L  LD+    +      A   L +LSNL L+ N +    P   + +  
Sbjct: 46  ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTS 105

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSG---PVPFSN 107
           L  L      +       I +L  L  LN++ N +     P  FSN
Sbjct: 106 LENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 88.9 bits (221), Expect = 6e-19
 Identities = 28/123 (22%), Positives = 48/123 (39%), Gaps = 2/123 (1%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPS-ALGSLTNLSNLDLSSNKLSGKIPPEIASMK 63
                    L +L  L +  NS      S    + TNL+ LDLS  +L         ++ 
Sbjct: 438 IDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLH 497

Query: 64  YLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
            L  L++S+NN+         +L  L  L+ S N++        +   S+    +L+ N+
Sbjct: 498 RLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSL-AFFNLTNNS 556

Query: 124 GLC 126
             C
Sbjct: 557 VAC 559

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 83.5 bits (207), Expect = 3e-17
 Identities = 26/117 (22%), Positives = 51/117 (43%), Gaps = 3/117 (2%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLT 66
           +P +I +  +   +D+  N L      +  + + L  LDLS  ++          + +L+
Sbjct: 26  VPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83

Query: 67  QLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
            L L+ N IQ   PG  + L+ L+ L     KL+    F    L ++   ++++ N 
Sbjct: 84  NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL-KKLNVAHNF 139

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 83.2 bits (206), Expect = 4e-17
 Identities = 25/120 (20%), Positives = 45/120 (37%), Gaps = 5/120 (4%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIP-SALGSLTNLSNLDLSSNKLSGKIPPEIAS 61
              I+      L+ L  LD   ++L      SA  SL  L  LD+S              
Sbjct: 387 GAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLG 446

Query: 62  MKYLTQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLS 120
           +  L  L ++ N+ + +    +    + L +L+LS  +L      S     ++H +  L+
Sbjct: 447 LTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ---ISWGVFDTLHRLQLLN 503

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 82.8 bits (205), Expect = 5e-17
 Identities = 23/98 (23%), Positives = 36/98 (36%), Gaps = 1/98 (1%)

Query: 4   IGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
                  +  N  NL  LD+    L         +L  L  L++S N L          +
Sbjct: 461 KDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQL 520

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
             L+ LD S N I+ S          L + NL++N ++
Sbjct: 521 YSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 81.2 bits (201), Expect = 2e-16
 Identities = 34/139 (24%), Positives = 57/139 (41%), Gaps = 8/139 (5%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMK 63
            +    IG L  L KL+V  N +    +P+   +LTNL ++DLS N +      ++  ++
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177

Query: 64  YLTQ----LDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVP-FSNNDLSSMHTVVS 118
              Q    LD+S N I   I  +  +  +L  L L  N  S  +      +L+ +H V  
Sbjct: 178 ENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLH-VHR 235

Query: 119 LSPNNGLCGNILDLPSCDT 137
           L          L++     
Sbjct: 236 LILGEFKDERNLEIFEPSI 254

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 80.5 bits (199), Expect = 3e-16
 Identities = 22/104 (21%), Positives = 36/104 (34%), Gaps = 2/104 (1%)

Query: 2   YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPE-IA 60
              G          +L  LD+  N  I  + +    L  L +LD   + L          
Sbjct: 363 SFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFL 421

Query: 61  SMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVP 104
           S++ L  LD+S  N +    G    L+ L+ L ++ N       
Sbjct: 422 SLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 465

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 27/97 (27%), Positives = 35/97 (36%), Gaps = 5/97 (5%)

Query: 12  GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIP--PEIASMKYLTQLD 69
            +L  L  L +  N     I     +L +LS LDLS N LS              L  LD
Sbjct: 325 LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLD 382

Query: 70  LSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFS 106
           LS N     +      L  L +L+   + L     FS
Sbjct: 383 LSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFS 418

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 63.9 bits (156), Expect = 6e-11
 Identities = 16/115 (13%), Positives = 33/115 (28%), Gaps = 9/115 (7%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPS-ALGSLTNLSNLDLSSNKLSGKIPPEIAS 61
            I  I  +      L +L +  N     I    L +L  L    L   +   +   EI  
Sbjct: 192 PIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFE 251

Query: 62  MKYL--------TQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNN 108
              +         +  L+  N       +   L+ +  ++L+   +        +
Sbjct: 252 PSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKH 306

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 61/275 (22%), Positives = 107/275 (38%), Gaps = 47/275 (17%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALK-----KLHTSEELAFIKSFKNEAQVLSQV----LHR 262
           +G GG+G+V+    L +    A+K     ++     L+   +   E  +L +V     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGS-LFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            +++L  +   ++   L+ E       LF  +       E   ++       +  A+ + 
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGE-GPSRC--FFGQVVAAIQHC 155

Query: 322 HHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL- 379
           H   S  ++HRDI   NIL++ +   A + DFG+  LLH D        GT  Y  PE  
Sbjct: 156 H---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTD-FDGTRVYSPPEWI 210

Query: 380 ---AYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP 435
               Y         V+S G++ L  ++ G  P +         D +I+  ++     P  
Sbjct: 211 SRHQYH---ALPATVWSLGIL-LYDMVCGDIPFE--------RDQEILEAEL---HFPAH 255

Query: 436 VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
           V         LI      CL   P SRP+++ +  
Sbjct: 256 VSPDCCA---LIR----RCLAPKPSSRPSLEEILL 283

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 32/216 (14%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NED-----AVELDWAKRVNIVK 312
             +VKL         ++++ EY+  G +F +L      +E      A ++          
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI---------- 150

Query: 313 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGT 371
                  YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT
Sbjct: 151 --VLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGT 201

Query: 372 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
              +APE+  +    +  D ++ GV+  E+  G  P
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 87.3 bits (217), Expect = 4e-19
 Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 7/176 (3%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           E +     +G G Y +VYK +      + ALK++    E     +   E  +L  + H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           IV L+     +K + L++EY+++  L   L +  + + +   K    +  +   LAY H 
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVK--LFLFQLLRGLAYCH- 117

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
                ++HRD+   N+L+N + E  +ADFG AR     +        T  Y  P++
Sbjct: 118 --RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDI 171

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 86.4 bits (215), Expect = 4e-19
 Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 16/207 (7%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHT-SEELAFIKSFKNEAQVLSQVLHRN 263
           E +     IG G YG VYKAQ   G+ FALKK+    E+     +   E  +L ++ H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           IVKLY     KK + L++E++++  L   L   E  +E   AK  + +  + + +AY H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK--SFLLQLLNGIAYCHD 118

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL---- 379
                ++HRD+   N+L+N + E  +ADFG AR         T    T  Y AP++    
Sbjct: 119 RR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 380 -AYTMVMTEKCDVYSFGVVTLEVLMGK 405
             Y    +   D++S G +  E++ G 
Sbjct: 176 KKY----STTIDIWSVGCIFAEMVNGT 198

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 86.8 bits (216), Expect = 5e-19
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 30/214 (14%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKN--------EAQVL 256
           E +     +G G YG VYKA+   G++ ALK++    E                 E  +L
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE-------DEGIPSTAIREISLL 73

Query: 257 SQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 316
            ++ H NIV L      ++C+ L++E+ME+  L   L  N+  ++    K    +  +  
Sbjct: 74  KELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIK--IYLYQLLR 130

Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
            +A+ H      I+HRD+   N+L+NS     +ADFG AR       + T    T  Y A
Sbjct: 131 GVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187

Query: 377 PEL-----AYTMVMTEKCDVYSFGVVTLEVLMGK 405
           P++      Y    +   D++S G +  E++ GK
Sbjct: 188 PDVLMGSKKY----STSVDIWSIGCIFAEMITGK 217

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 86.8 bits (216), Expect = 6e-19
 Identities = 27/99 (27%), Positives = 48/99 (48%), Gaps = 4/99 (4%)

Query: 9   PEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQL 68
             + NL  L  L++G+N +     +A+  LT L  L++ SN++S      + ++  L  L
Sbjct: 237 SPLANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSL 292

Query: 69  DLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSN 107
            L+NN +       I  L+ L  L LS N ++   P ++
Sbjct: 293 FLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLAS 331

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 84.1 bits (209), Expect = 7e-18
 Identities = 27/93 (29%), Positives = 48/93 (51%), Gaps = 4/93 (4%)

Query: 8   PPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQ 67
              + +L  L  L+VGSN +     S L +L+ L++L L++N+L  +    I  +  LT 
Sbjct: 258 INAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTT 315

Query: 68  LDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
           L LS N+I    P  +  LS++D  + ++  + 
Sbjct: 316 LFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 82.2 bits (204), Expect = 2e-17
 Identities = 29/105 (27%), Positives = 55/105 (52%), Gaps = 6/105 (5%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           +I  I P + NL  L  L +G+N +     SAL +LTNL  L L+ + +S      +A++
Sbjct: 77  QITDISP-LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD--ISPLANL 131

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSN 107
             +  L+L  N+    +   ++ ++ L+YL ++ +K+    P +N
Sbjct: 132 TKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTPIAN 175

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 81.8 bits (203), Expect = 3e-17
 Identities = 30/106 (28%), Positives = 50/106 (47%), Gaps = 7/106 (6%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           K+  + P I NL +L  L +  N +    P  L SLT+L       N+++   P  +A+M
Sbjct: 166 KVKDVTP-IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANM 220

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNN 108
             L  L + NN I    P  +  LS+L +L + +N++S      + 
Sbjct: 221 TRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINAVKDL 264

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 75.3 bits (186), Expect = 5e-15
 Identities = 22/105 (20%), Positives = 44/105 (41%), Gaps = 7/105 (6%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
            I  I P   +L   I+  +   S+   +      L +++ L ++  K++      I  +
Sbjct: 11  PINQIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYL 65

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSN 107
             L  L+L+ N I    P  ++ L +L  L + +NK++      N
Sbjct: 66  TNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISALQN 108

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 75.3 bits (186), Expect = 5e-15
 Identities = 24/100 (24%), Positives = 46/100 (46%), Gaps = 6/100 (6%)

Query: 8   PPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQ 67
                 L+++ KL V    +       +  LTNL  L+L+ N+++   P  ++++  LT 
Sbjct: 37  VVTQEELESITKLVVAGEKVASI--QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTN 92

Query: 68  LDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSN 107
           L +  N I  +    +  L+ L  L L+ + +S   P +N
Sbjct: 93  LYIGTNKI--TDISALQNLTNLRELYLNEDNISDISPLAN 130

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 60.6 bits (148), Expect = 3e-10
 Identities = 21/91 (23%), Positives = 36/91 (39%), Gaps = 6/91 (6%)

Query: 17  LIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQ 76
              L       I  I      L       L    ++         ++ +T+L ++   + 
Sbjct: 2   AATLATLPAP-INQI-FPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57

Query: 77  GSIPGEITKLSRLDYLNLSSNKLSGPVPFSN 107
            SI G I  L+ L+YLNL+ N+++   P SN
Sbjct: 58  -SIQG-IEYLTNLEYLNLNGNQITDISPLSN 86

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 87.5 bits (217), Expect = 6e-19
 Identities = 50/189 (26%), Positives = 83/189 (43%), Gaps = 25/189 (13%)

Query: 209 IRYCIGTGGYGSVYKAQ---LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIV 265
               +G G YG VYKA+     + K +ALK++   E      S   E  +L ++ H N++
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI---EGTGISMSACREIALLRELKHPNVI 81

Query: 266 KLYGYCLHK--KCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAH----A 317
            L    L    + ++L+++Y E   L      H    A +        +VK++ +     
Sbjct: 82  SLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAF----VADFGTARLLHADSSNRTLLAG--- 370
           + YLH +    ++HRD+   NIL+  +        +AD G ARL ++       L     
Sbjct: 141 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197

Query: 371 TYGYIAPEL 379
           T+ Y APEL
Sbjct: 198 TFWYRAPEL 206

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 86.2 bits (214), Expect = 8e-19
 Identities = 27/132 (20%), Positives = 53/132 (40%), Gaps = 7/132 (5%)

Query: 3   KIGIIPP-EIGNLKNLIKLDVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPPEIA 60
           KI ++   + G    +  LD+  N +          S   L +L+L  N +   +  ++ 
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV- 188

Query: 61  SMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLS 120
               L  LDLS+N +   +  E    + + +++L +NKL   +  +     ++     L 
Sbjct: 189 VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNL-EHFDLR 245

Query: 121 PNNGLCGNILDL 132
            N   CG + D 
Sbjct: 246 GNGFHCGTLRDF 257

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 26/124 (20%), Positives = 42/124 (33%), Gaps = 4/124 (3%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLT 66
                 +   L  L++  N +   +         L  LDLSSNKL+  + PE  S   +T
Sbjct: 161 FAELAASSDTLEHLNLQYNFIYD-VK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVT 217

Query: 67  QLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLC 126
            + L NN +   I   +     L++ +L  N             +     V+      L 
Sbjct: 218 WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLT 276

Query: 127 GNIL 130
           G   
Sbjct: 277 GQNE 280

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 78.9 bits (195), Expect = 3e-16
 Identities = 19/93 (20%), Positives = 40/93 (43%), Gaps = 8/93 (8%)

Query: 8   PPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQ 67
             ++ +L  L  LD+ +N +       L    ++  L  ++N +S ++       +    
Sbjct: 73  TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSR--GQGKKN 124

Query: 68  LDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
           + L+NN I      +    SR+ YL+L  N++ 
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 26/99 (26%), Positives = 46/99 (46%), Gaps = 8/99 (8%)

Query: 3   KIGIIPPEIG-NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAS 61
            +      +  +  N+ +LD+  N L     + L   T L  L+LSSN L      ++ S
Sbjct: 21  SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLES 78

Query: 62  MKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
           +  L  LDL+NN +Q     E+     ++ L+ ++N +S
Sbjct: 79  LSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 27/94 (28%), Positives = 41/94 (43%), Gaps = 2/94 (2%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLT 66
           I     N        V  +SL   + S   S  N+  LDLS N LS     ++A    L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 67  QLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
            L+LS+N +      ++  LS L  L+L++N + 
Sbjct: 62  LLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ 93

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 16/77 (20%), Positives = 31/77 (40%)

Query: 31  IPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLD 90
           I     +        ++ + L   +     S   + +LDLS N +      ++   ++L+
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 91  YLNLSSNKLSGPVPFSN 107
            LNLSSN L   +   +
Sbjct: 62  LLNLSSNVLYETLDLES 78

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 62.7 bits (153), Expect = 5e-11
 Identities = 16/95 (16%), Positives = 33/95 (34%), Gaps = 3/95 (3%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           K+  + PE  +   +  + + +N L+  I  AL    NL + DL  N             
Sbjct: 202 KLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC-GTLRDFFS 259

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSN 97
           K      ++   ++  + G+  +   +  L     
Sbjct: 260 KNQRVQTVAKQTVK-KLTGQNEEECTVPTLGHYGA 293

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 87.1 bits (216), Expect = 1e-18
 Identities = 51/208 (24%), Positives = 85/208 (40%), Gaps = 12/208 (5%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAF--IKSFKNEAQVLSQVLH 261
            +F+    +G G +G V   +    G+ +A+K L     +A   +     E +VL    H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 262 RNIVKLYGYCLH-KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALA 319
             +  L  Y       +  + EY   G LF +L       E     R     A +  AL 
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSE----DRARFYGAEIVSALD 262

Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
           YLH + +  +++RD+   N++L+      + DFG  +    D +      GT  Y+APE+
Sbjct: 263 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 320

Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
                     D +  GVV  E++ G+ P
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 63/273 (23%), Positives = 103/273 (37%), Gaps = 45/273 (16%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALK-----KLHTSEELAFIKSFKNEAQVLSQVLHR--NI 264
           +G+GG+GSVY    + +    A+K     ++    EL        E  +L +V      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 265 VKLYGYCLHKKCMFLIYEYME-RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           ++L  +        LI E  E    LF  +       E + A+       +  A+ + H 
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE-ELARS--FFWQVLEAVRHCH- 166

Query: 324 DCSPSIIHRDISSNNILLNS-KLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL--- 379
             +  ++HRDI   NIL++  + E  + DFG+  LL  D+       GT  Y  PE    
Sbjct: 167 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD-FDGTRVYSPPEWIRY 222

Query: 380 -AYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD 437
             Y         V+S G++ L  ++ G  P +         D +I+   V        V 
Sbjct: 223 HRYH---GRSAAVWSLGIL-LYDMVCGDIPFE--------HDEEIIRGQV---FFRQRVS 267

Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
            +      LI      CL   P  RPT + +  
Sbjct: 268 SECQH---LIR----WCLALRPSDRPTFEEIQN 293

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 51/222 (22%), Positives = 94/222 (42%), Gaps = 58/222 (26%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKK--LHTSEELAFIKSFKN----EAQVLS 257
             ++    IG G +G V+KA+    G+  ALKK  +   +E      F      E ++L 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-----GFPITALREIKILQ 71

Query: 258 QVLHRNIVKLYG--------YCLHKKCMFLIYEYMER--GSLFCNLHNNEDAVELDWAKR 307
            + H N+V L          Y   K  ++L++++ E     L  N+      V+   ++ 
Sbjct: 72  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-----VKFTLSEI 126

Query: 308 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL 367
             +++ + + L Y+H +    I+HRD+ + N+L+       +ADFG AR           
Sbjct: 127 KRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR----------- 172

Query: 368 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTL-----EVLMG 404
                       A+++    + + Y+  VVTL     E+L+G
Sbjct: 173 ------------AFSLAKNSQPNRYTNRVVTLWYRPPELLLG 202

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 84.9 bits (211), Expect = 2e-18
 Identities = 40/184 (21%), Positives = 82/184 (44%), Gaps = 22/184 (11%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKN--------EAQV 255
           + ++    IG G YG+V+KA+     ++ ALK++   ++                 E  +
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-------DEGVPSSALREICL 54

Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 315
           L ++ H+NIV+L+      K + L++E+ ++  L     +    ++ +  K  + +  + 
Sbjct: 55  LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVK--SFLFQLL 111

Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI 375
             L + H      ++HRD+   N+L+N   E  +A+FG AR         +    T  Y 
Sbjct: 112 KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR 168

Query: 376 APEL 379
            P++
Sbjct: 169 PPDV 172

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 84.9 bits (211), Expect = 2e-18
 Identities = 51/191 (26%), Positives = 82/191 (42%), Gaps = 35/191 (18%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKN--------EAQV 255
           E+F     IG G YG VYKA+    G+V ALKK+    E                 E  +
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-------TEGVPSTAIREISL 55

Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLH---NNEDAVELDWAKRVNIVK 312
           L ++ H NIVKL      +  ++L++E++       +L    +      +     + ++K
Sbjct: 56  LKELNHPNIVKLLDVIHTENKLYLVFEFLH-----QDLKKFMDASALTGIP----LPLIK 106

Query: 313 AMAH----ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
           +        LA+ H      ++HRD+   N+L+N++    +ADFG AR         T  
Sbjct: 107 SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 163

Query: 369 AGTYGYIAPEL 379
             T  Y APE+
Sbjct: 164 VVTLWYRAPEI 174

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 85.3 bits (212), Expect = 2e-18
 Identities = 51/202 (25%), Positives = 84/202 (41%), Gaps = 43/202 (21%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKN----EAQVLSQVLHRNIVKL 267
           +G G + +VYKA+     ++ A+KK+                  E ++L ++ H NI+ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
                HK  + L++++ME   L   + +N   +     K    +      L YLH     
Sbjct: 78  LDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIK--AYMLMTLQGLEYLHQH--- 131

Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTE 387
            I+HRD+  NN+LL+      +ADFG A+              ++G  +P  AYT    +
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAK--------------SFG--SPNRAYT---HQ 172

Query: 388 KCDVYSFGVVTL-----EVLMG 404
                   VVT      E+L G
Sbjct: 173 --------VVTRWYRAPELLFG 186

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 82.3 bits (204), Expect = 2e-18
 Identities = 23/97 (23%), Positives = 40/97 (41%), Gaps = 1/97 (1%)

Query: 11  IGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDL 70
           I  L NL +L +    +       L  LT+L+ LD+S +     I  +I ++  +  +DL
Sbjct: 84  ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143

Query: 71  SNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSN 107
           S N     I   +  L  L  LN+  + +       +
Sbjct: 144 SYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRGIED 179

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 76.2 bits (188), Expect = 3e-16
 Identities = 21/99 (21%), Positives = 45/99 (45%), Gaps = 3/99 (3%)

Query: 11  IGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDL 70
           I    N+  L + +        + +  L+NL  L +    ++    P ++ +  LT LD+
Sbjct: 62  IEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119

Query: 71  SNNNIQGSIPGEITKLSRLDYLNLSSN-KLSGPVPFSNN 108
           S++    SI  +I  L +++ ++LS N  ++  +P    
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTL 158

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 75.4 bits (186), Expect = 5e-16
 Identities = 20/96 (20%), Positives = 42/96 (43%), Gaps = 3/96 (3%)

Query: 6   IIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYL 65
              P +  L +L  LD+  ++    I + + +L  ++++DLS N     I P + ++  L
Sbjct: 103 DKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPEL 161

Query: 66  TQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSG 101
             L++  + +       I    +L+ L   S  + G
Sbjct: 162 KSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 71.5 bits (176), Expect = 1e-14
 Identities = 16/123 (13%), Positives = 49/123 (39%), Gaps = 5/123 (4%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           +          + +L  + + + + +  + + +    N+ +L +++   +    P I+ +
Sbjct: 32  QSSTANITEAQMNSLTYITLANIN-VTDL-TGIEYAHNIKDLTINNIHAT-NYNP-ISGL 87

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN 122
             L +L +   ++       ++ L+ L  L++S +     +    N L  +   + LS N
Sbjct: 88  SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKV-NSIDLSYN 146

Query: 123 NGL 125
             +
Sbjct: 147 GAI 149

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 44.6 bits (106), Expect = 2e-05
 Identities = 14/71 (19%), Positives = 26/71 (36%), Gaps = 5/71 (7%)

Query: 37  SLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSS 96
           +     N  L  +  +       A M  LT + L+N N+   + G I     +  L +++
Sbjct: 21  TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINN 75

Query: 97  NKLSGPVPFSN 107
              +   P S 
Sbjct: 76  IHATNYNPISG 86

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 84.3 bits (209), Expect = 3e-18
 Identities = 46/202 (22%), Positives = 78/202 (38%), Gaps = 55/202 (27%)

Query: 213 IGTGGYGSVYKA-QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGY 270
           +G G  G V +       + FALK L    +       + E ++  +     +IV++   
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKA------RREVELHWRASQCPHIVRIVDV 79

Query: 271 C----LHKKCMFLIYEYMERGSLF------CNLHNNE-DAVELDWAKRVNIVKAMAHALA 319
                  +KC+ ++ E ++ G LF       +    E +A E        I+K++  A+ 
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE--------IMKSIGEAIQ 131

Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAGTYGYIA 376
           YLH   S +I HRD+   N+L  SK       + DFG A         +      Y    
Sbjct: 132 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---------KETTGEKYD--- 176

Query: 377 PELAYTMVMTEKCDVYSFGVVT 398
                     + CD++S GV+ 
Sbjct: 177 ----------KSCDMWSLGVIM 188

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 84.2 bits (209), Expect = 4e-18
 Identities = 46/220 (20%), Positives = 83/220 (37%), Gaps = 62/220 (28%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKN--------EAQV 255
           + +     +G G YG VYKA      +  A+K++    E       +         E  +
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-------EEGVPGTAIREVSL 86

Query: 256 LSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNN-EDAVELDWAKRVNIVKAM 314
           L ++ HRNI++L     H   + LI+EY E      +L    +   ++      + +  +
Sbjct: 87  LKELQHRNIIELKSVIHHNHRLHLIFEYAE-----NDLKKYMDKNPDVSMRVIKSFLYQL 141

Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF-----VADFGTARLLHADSSNRTLLA 369
            + + + H   S   +HRD+   N+LL+    +      + DFG AR             
Sbjct: 142 INGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR------------- 185

Query: 370 GTYGYIAPELAYTMVMTEKCDVYSFGVVTL-----EVLMG 404
             +G   P   +T             ++TL     E+L+G
Sbjct: 186 -AFG--IPIRQFTHE-----------IITLWYRPPEILLG 211

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 82.2 bits (204), Expect = 2e-17
 Identities = 68/226 (30%), Positives = 101/226 (44%), Gaps = 52/226 (23%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKL------------HTSEELAFIKSFKN 251
           +DF I   +GTG +G V+  +   NG+ +A+K L            HT           +
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT----------ND 55

Query: 252 EAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN----NED-----AVEL 302
           E  +LS V H  I++++G     + +F+I +Y+E G LF  L              A E+
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 115

Query: 303 DWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS 362
                         AL YLH   S  II+RD+   NILL+      + DFG A+ +    
Sbjct: 116 ------------CLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---- 156

Query: 363 SNRTL-LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
            + T  L GT  YIAPE+  T    +  D +SFG++  E+L G  P
Sbjct: 157 PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 83.4 bits (206), Expect = 3e-17
 Identities = 27/132 (20%), Positives = 53/132 (40%), Gaps = 7/132 (5%)

Query: 3   KIGIIPP-EIGNLKNLIKLDVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPPEIA 60
           KI ++   + G    +  LD+  N +          S   L +L+L  N +   +  ++ 
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV- 188

Query: 61  SMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLS 120
               L  LDLS+N +   +  E    + + +++L +NKL   +  +     ++     L 
Sbjct: 189 VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEH-FDLR 245

Query: 121 PNNGLCGNILDL 132
            N   CG + D 
Sbjct: 246 GNGFHCGTLRDF 257

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 79.1 bits (195), Expect = 6e-16
 Identities = 26/99 (26%), Positives = 46/99 (46%), Gaps = 8/99 (8%)

Query: 3   KIGIIPPEIG-NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAS 61
            +      +  +  N+ +LD+  N L     + L   T L  L+LSSN L      ++ S
Sbjct: 21  SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLES 78

Query: 62  MKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
           +  L  LDL+NN +Q     E+     ++ L+ ++N +S
Sbjct: 79  LSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 77.2 bits (190), Expect = 3e-15
 Identities = 26/90 (28%), Positives = 40/90 (44%), Gaps = 2/90 (2%)

Query: 11  IGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDL 70
             N        V  +SL   + S   S  N+  LDLS N LS     ++A    L  L+L
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 71  SNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
           S+N +      ++  LS L  L+L++N + 
Sbjct: 66  SSNVLY-ETL-DLESLSTLRTLDLNNNYVQ 93

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 26/118 (22%), Positives = 45/118 (38%), Gaps = 11/118 (9%)

Query: 6   IIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYL 65
           I   ++     L  L++ SN L       L SL+ L  LDL++N +      E+     +
Sbjct: 49  ISAADLAPFTKLELLNLSSNVLYET--LDLESLSTLRTLDLNNNYVQ-----ELLVGPSI 101

Query: 66  TQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
             L  +NNNI   +            + L++NK++          S +   + L  N 
Sbjct: 102 ETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRV-QYLDLKLNE 155

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 69.9 bits (171), Expect = 6e-13
 Identities = 18/92 (19%), Positives = 35/92 (38%), Gaps = 4/92 (4%)

Query: 10  EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLD 69
           E+    ++  L   +N+ I  +           N+ L++NK++     +      +  LD
Sbjct: 94  ELLVGPSIETLHAANNN-ISRVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150

Query: 70  LSNNNIQG-SIPGEITKLSRLDYLNLSSNKLS 100
           L  N I   +          L++LNL  N + 
Sbjct: 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 69.5 bits (170), Expect = 6e-13
 Identities = 20/93 (21%), Positives = 39/93 (41%), Gaps = 3/93 (3%)

Query: 31  IPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLD 90
           I     +        ++ + L   +     S   + +LDLS N +      ++   ++L+
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 91  YLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
            LNLSSN L   +   +  LS++   + L+ N 
Sbjct: 62  LLNLSSNVLYETLDLES--LSTL-RTLDLNNNY 91

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 64.1 bits (156), Expect = 4e-11
 Identities = 18/141 (12%), Positives = 41/141 (29%), Gaps = 4/141 (2%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           K+  + PE  +   +  + + +N L+  I  AL    NL + DL  N             
Sbjct: 202 KLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC-GTLRDFFS 259

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN 122
           K      ++   ++        + +     +  +           + L ++         
Sbjct: 260 KNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKR--KEHAL 317

Query: 123 NGLCGNILDLPSCDTTKPATL 143
               G+  +   C+    A  
Sbjct: 318 LSGQGSETERLECERENQARQ 338

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 10/114 (8%), Positives = 23/114 (20%), Gaps = 4/114 (3%)

Query: 6   IIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSG----KIPPEIAS 61
           +                G+             L  L   + +     G    ++  E  +
Sbjct: 275 LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECEREN 334

Query: 62  MKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHT 115
                ++D      +  I     +      L      L   V       + +  
Sbjct: 335 QARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDG 388

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 44.8 bits (106), Expect = 5e-05
 Identities = 8/102 (7%), Positives = 23/102 (22%), Gaps = 9/102 (8%)

Query: 6   IIPPEIGNLKNLIKLDVGSNSL-------IGPIPSALGSLTNLSNLDLSSNKLSGKIPPE 58
                      LI L    ++L          +     +      +D    +    +  +
Sbjct: 296 CEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYR-TVIDQ 354

Query: 59  I-ASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKL 99
           +    +    L+     +   +       + LD     +   
Sbjct: 355 VTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ 396

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 81.5 bits (202), Expect = 3e-17
 Identities = 51/212 (24%), Positives = 81/212 (38%), Gaps = 55/212 (25%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEA-------QVLSQVLHRNI 264
           IG G YG+VYKA+   +G   ALK +                       + L    H N+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 265 VKLYGYCLHKKC-----MFLIYEYMER--GSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 317
           V+L   C   +      + L++E++++   +      +      L      ++++     
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYL----DKAPPPGLPAETIKDLMRQFLRG 132

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           L +LH +C   I+HRD+   NIL+ S     +ADFG AR               Y     
Sbjct: 133 LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR--------------IYS---Y 172

Query: 378 ELAYTMVMTEKCDVYSFGVVTL-----EVLMG 404
           ++A T V           VVTL     EVL+ 
Sbjct: 173 QMALTPV-----------VVTLWYRAPEVLLQ 193

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 68/276 (24%), Positives = 113/276 (40%), Gaps = 52/276 (18%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALK-----KLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           IG G +  V  A+ +  G+  A+K     +L+ +     ++    E +++  + H NIVK
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS----LQKLFREVRIMKILNHPNIVK 78

Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
           L+     +K ++LI EY   G +F  L  +    E   A+     + +  A+ Y H    
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE-KEARS--KFRQIVSAVQYCHQKR- 134

Query: 327 PSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL----AYT 382
             I+HRD+ + N+LL++ +   +ADFG +              G   Y APEL     Y 
Sbjct: 135 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-FCGAPPYAAPELFQGKKYD 191

Query: 383 MVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI 441
                + DV+S GV+ L  L+ G  P D         + K +   VL  +   P      
Sbjct: 192 ---GPEVDVWSLGVI-LYTLVSGSLPFD-------GQNLKELRERVLRGKYRIP------ 234

Query: 442 RDILLISTVSFAC-------LQSNPKSRPTMQSVSQ 470
                   +S  C       L  NP  R T++ + +
Sbjct: 235 ------FYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 82.3 bits (204), Expect = 5e-17
 Identities = 32/126 (25%), Positives = 54/126 (42%), Gaps = 6/126 (4%)

Query: 9   PEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQL 68
             I NLKNL  L +  N++    P  + SLT L  L   +NK+S      +A++  +  L
Sbjct: 303 SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWL 358

Query: 69  DLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGN 128
              +N I    P  +  L+R+  L L+    +        ++S  +TV +++        
Sbjct: 359 SAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPAT 416

Query: 129 ILDLPS 134
           I D  S
Sbjct: 417 ISDGGS 422

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 80.8 bits (200), Expect = 2e-16
 Identities = 35/100 (35%), Positives = 52/100 (52%), Gaps = 6/100 (6%)

Query: 9   PEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQL 68
             +G L NL +L +  N L       L SLTNL++LDL++N++S   P  ++ +  LT+L
Sbjct: 215 TPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 270

Query: 69  DLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNN 108
            L  N I    P  +  L+ L  L L+ N+L    P SN 
Sbjct: 271 KLGANQISNISP--LAGLTALTNLELNENQLEDISPISNL 308

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 79.6 bits (197), Expect = 4e-16
 Identities = 35/116 (30%), Positives = 60/116 (51%), Gaps = 9/116 (7%)

Query: 8   PPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQ 67
              + NL  L +LD+ SN +     S L  LTNL +L  ++N++S  I P +  +  L +
Sbjct: 170 LKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISD-ITP-LGILTNLDE 225

Query: 68  LDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
           L L+ N ++    G +  L+ L  L+L++N++S   P S   L+ + T + L  N 
Sbjct: 226 LSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSG--LTKL-TELKLGANQ 276

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 78.5 bits (194), Expect = 8e-16
 Identities = 19/105 (18%), Positives = 43/105 (40%), Gaps = 7/105 (6%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
            I  I      L   +K  +G  ++   +      L  ++ L      +       +  +
Sbjct: 13  PINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYL 67

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSN 107
             LTQ++ SNN +    P  +  L++L  + +++N+++   P +N
Sbjct: 68  NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLAN 110

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 78.5 bits (194), Expect = 9e-16
 Identities = 26/99 (26%), Positives = 47/99 (47%), Gaps = 6/99 (6%)

Query: 9   PEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQL 68
             +  L  L  L++  N L    P  + +L NL+ L L  N +S   P  ++S+  L +L
Sbjct: 281 SPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 336

Query: 69  DLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSN 107
              NN +  S    +  L+ +++L+   N++S   P +N
Sbjct: 337 FFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTPLAN 373

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 31/99 (31%), Positives = 50/99 (50%), Gaps = 7/99 (7%)

Query: 9   PEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQL 68
             + NL NL  L + +N +    P  L +LTNL+ L+LSSN +S      ++ +  L QL
Sbjct: 106 TPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQL 161

Query: 69  DLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSN 107
              N  +    P  +  L+ L+ L++SSNK+S     + 
Sbjct: 162 SFGNQ-VTDLKP--LANLTTLERLDISSNKVSDISVLAK 197

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 76.5 bits (189), Expect = 4e-15
 Identities = 25/116 (21%), Positives = 51/116 (43%), Gaps = 9/116 (7%)

Query: 8   PPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQ 67
                +L  +  L      +       +  L NL+ ++ S+N+L+   P  + ++  L  
Sbjct: 39  TVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVD 94

Query: 68  LDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
           + ++NN I    P  +  L+ L  L L +N+++   P  N  L+++   + LS N 
Sbjct: 95  ILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPLKN--LTNL-NRLELSSNT 145

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 64.2 bits (157), Expect = 3e-11
 Identities = 17/95 (17%), Positives = 33/95 (34%), Gaps = 4/95 (4%)

Query: 8   PPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQ 67
              + NL N+  L  G N +    P  L +LT ++ L L+    +       A++     
Sbjct: 346 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNT 403

Query: 68  LDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGP 102
           +      +    P  I+        +++ N  S  
Sbjct: 404 VKNVTGAL--IAPATISDGGSYTEPDITWNLPSYT 436

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 60.4 bits (147), Expect = 6e-10
 Identities = 19/91 (20%), Positives = 35/91 (38%), Gaps = 5/91 (5%)

Query: 17  LIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQ 76
           L    +  ++ I  I     +L       L    ++  +      +  +T L      I+
Sbjct: 3   LGSATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK 59

Query: 77  GSIPGEITKLSRLDYLNLSSNKLSGPVPFSN 107
            SI G +  L+ L  +N S+N+L+   P  N
Sbjct: 60  -SIDG-VEYLNNLTQINFSNNQLTDITPLKN 88

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 80.7 bits (200), Expect = 7e-17
 Identities = 65/218 (29%), Positives = 93/218 (42%), Gaps = 29/218 (13%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGK----VFA---LKKLHTSEELAFIKSFKNEAQVLS 257
           E F++   +G GGYG V++ +   G     +FA   LKK             K E  +L 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 258 QVLHRNIVKLYGYCL--HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-M 314
           +V H  IV L  Y      K ++LI EY+  G LF  L      +E           A +
Sbjct: 77  EVKHPFIVDLI-YAFQTGGK-LYLILEYLSGGELFMQLEREGIFME----DTACFYLAEI 130

Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARL-LHADSSNRTLLA 369
           + AL +LH      II+RD+   NI+LN     KL     DFG  +  +H  +   T   
Sbjct: 131 SMALGHLH---QKGIIYRDLKPENIMLNHQGHVKL----TDFGLCKESIHDGTVTHTFC- 182

Query: 370 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           GT  Y+APE+          D +S G +  ++L G  P
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 80.8 bits (200), Expect = 8e-17
 Identities = 51/222 (22%), Positives = 92/222 (41%), Gaps = 18/222 (8%)

Query: 194 RIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNE 252
            +V   + +    +     IG G YG V  A    N    A+KK+   E   + +    E
Sbjct: 16  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE 75

Query: 253 AQVLSQVLHRNIVKLYGYCLHKKC-----MFLIYEYMERGSLFCNLHNNEDAVELDWAKR 307
            ++L +  H NI+ +              ++++ + ME      +L+       L     
Sbjct: 76  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLLKTQHLSNDHI 130

Query: 308 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL 367
              +  +   L Y+H   S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   
Sbjct: 131 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187

Query: 368 LAG---TYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGK 405
           L     T  Y APE+       T+  D++S G +  E+L  +
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 80.3 bits (199), Expect = 9e-17
 Identities = 64/226 (28%), Positives = 99/226 (43%), Gaps = 47/226 (20%)

Query: 205 EDFDIRYCIGTGGYGSVY----KAQLPNGKVFALKKL-----------HTSEELAFIKSF 249
             F++   +G G +G V+     +     +++A+K L            T          
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT---------- 73

Query: 250 KNEAQVLSQVLHRNIVKLYGYCL--HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR 307
           K E  +L +V H  IVKL+ Y      K ++LI +++  G LF  L       E    + 
Sbjct: 74  KMERDILVEVNHPFIVKLH-YAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTE----ED 127

Query: 308 VNIVKA-MAHALAYLHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARL-LHAD 361
           V    A +A AL +LH   S  II+RD+   NILL+     KL     DFG ++  +  +
Sbjct: 128 VKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKL----TDFGLSKESIDHE 180

Query: 362 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
               +   GT  Y+APE+      T+  D +SFGV+  E+L G  P
Sbjct: 181 KKAYSFC-GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 64/279 (22%), Positives = 108/279 (38%), Gaps = 43/279 (15%)

Query: 206 DFDIRYCIGTGGYGSVYKAQ-LPNGKVFALK-------KLHTSEELAFIKSFKNEAQVLS 257
            +     +G+G +G V+ A      K   +K             E   +     E  +LS
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 258 QVLHRNIVKLYGYCLHKKCMFLIYEYMERGS-LFCNLHNNEDAVELDWAKRVNIVKAMAH 316
           +V H NI+K+     ++    L+ E    G  LF  +  +    E   A    I + +  
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE-PLASY--IFRQLVS 141

Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           A+ YL       IIHRDI   NI++       + DFG+A  L       T   GT  Y A
Sbjct: 142 AVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIEYCA 197

Query: 377 PEL----AYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQR 431
           PE+     Y      + +++S GV  L  L+  ++P   L         + +   +    
Sbjct: 198 PEVLMGNPYR---GPELEMWSLGVT-LYTLVFEENPFCELE--------ETVEAAI---H 242

Query: 432 LPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
            P  V ++++    L+S +    LQ  P+ R T++ +  
Sbjct: 243 PPYLVSKELMS---LVSGL----LQPVPERRTTLEKLVT 274

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 79.9 bits (198), Expect = 1e-16
 Identities = 54/230 (23%), Positives = 89/230 (38%), Gaps = 75/230 (32%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ--LPNGKVFALKK--LHTSEE------LAFIKSFKNEAQ 254
           + ++    IG G YG V+KA+     G+  ALK+  + T EE      +  +   ++   
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH--- 67

Query: 255 VLSQVLHRNIVKLY-----GYCLHKKCMFLIYEYMERGSLFCNLHNNED-AVELDWAKRV 308
            L    H N+V+L+          +  + L++E++++           D    LD     
Sbjct: 68  -LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-----------DLTTYLDKVPEP 115

Query: 309 NI----VKAMAH----ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA 360
            +    +K M       L +LH      ++HRD+   NIL+ S  +  +ADFG AR    
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR---- 168

Query: 361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTL-----EVLMGK 405
                      Y     ++A T V           VVTL     EVL+  
Sbjct: 169 ----------IYS---FQMALTSV-----------VVTLWYRAPEVLLQS 194

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 68/225 (30%), Positives = 100/225 (44%), Gaps = 39/225 (17%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLP----NGKVFA---LKKLHTSEELAFIKSFKNEAQVLS 257
           E+F++   +GTG YG V+  +       GK++A   LKK    ++    +  + E QVL 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 258 QVLHRN-IVKLYGYCL--HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA- 313
            +     +V L+ Y      K + LI +Y+  G LF +L   E   E      V I    
Sbjct: 114 HIRQSPFLVTLH-YAFQTETK-LHLILDYINGGELFTHLSQRERFTE----HEVQIYVGE 167

Query: 314 MAHALAYLHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNRTL-L 368
           +  AL +LH      II+RDI   NILL+S     L     DFG ++   AD + R    
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVL----TDFGLSKEFVADETERAYDF 220

Query: 369 AGTYGYIAPELAYTMVMTEK------CDVYSFGVVTLEVLMGKHP 407
            GT  Y+AP+    +V           D +S GV+  E+L G  P
Sbjct: 221 CGTIEYMAPD----IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 51/228 (22%), Positives = 91/228 (39%), Gaps = 27/228 (11%)

Query: 196 VYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLH-TSEELAFIKSFKN--- 251
           +  +L      + ++  I +G YG+V       G   A+K++  T  +   +    +   
Sbjct: 13  LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFL 72

Query: 252 ------EAQVLSQVLHRNIVKLYGYCLHKKC-----MFLIYEYMERGSLFCNLHN--NED 298
                 E ++L+   H NI+ L    +H +      ++L+ E M       +L    ++ 
Sbjct: 73  CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-----TDLAQVIHDQ 127

Query: 299 AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL 358
            + +        +  +   L  LH      ++HRD+   NILL    +  + DF  AR  
Sbjct: 128 RIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLARED 184

Query: 359 HADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGK 405
            AD +N+T       Y APEL       T+  D++S G V  E+   K
Sbjct: 185 TAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 80.9 bits (200), Expect = 2e-16
 Identities = 33/124 (26%), Positives = 55/124 (44%), Gaps = 5/124 (4%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPPEI-A 60
            +  +      L+ L  LD   ++L      S   SL NL  LD+S           I  
Sbjct: 384 GVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFN 442

Query: 61  SMKYLTQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSL 119
            +  L  L ++ N+ Q +   +I T+L  L +L+LS  +L    P + N LSS+  V+++
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL-QVLNM 501

Query: 120 SPNN 123
           + N 
Sbjct: 502 ASNQ 505

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 79.4 bits (196), Expect = 7e-16
 Identities = 26/124 (20%), Positives = 50/124 (40%), Gaps = 5/124 (4%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-A 60
            +  +      +   L  LD+    +      A  SL++LS L L+ N +   +     +
Sbjct: 39  PLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFS 97

Query: 61  SMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKL-SGPVPFSNNDLSSMHTVVSL 119
            +  L +L     N+       I  L  L  LN++ N + S  +P   ++L+++   + L
Sbjct: 98  GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL-EHLDL 156

Query: 120 SPNN 123
           S N 
Sbjct: 157 SSNK 160

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 32/129 (24%), Positives = 54/129 (41%), Gaps = 12/129 (9%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKL-SGKIPPEIA 60
            I  +       L +L KL     +L       +G L  L  L+++ N + S K+P   +
Sbjct: 87  PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146

Query: 61  SMKYLTQLDLSNNNIQGSIPGEITKLSRLDY----LNLSSNKLSG--PVPFSNNDLSSMH 114
           ++  L  LDLS+N IQ     ++  L ++      L+LS N ++   P  F    L    
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRL---- 202

Query: 115 TVVSLSPNN 123
             ++L  N 
Sbjct: 203 HKLTLRNNF 211

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 28/117 (23%), Positives = 46/117 (39%), Gaps = 3/117 (2%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLT 66
           IP  +    +   LD+  N L      +  S   L  LDLS  ++         S+ +L+
Sbjct: 22  IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79

Query: 67  QLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
            L L+ N IQ    G  + LS L  L      L+    F    L ++   ++++ N 
Sbjct: 80  TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL-KELNVAHNL 135

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 34/141 (24%), Positives = 56/141 (39%), Gaps = 13/141 (9%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSN----LDLSSNKLSGKIPPEIASM 62
           +P    NL NL  LD+ SN +     + L  L  +      LDLS N ++  I P     
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKE 199

Query: 63  KYLTQLDLSNNNIQGSIP-GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSL-- 119
             L +L L NN    ++    I  L+ L+   L   +          D S++  + +L  
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259

Query: 120 -----SPNNGLCGNILDLPSC 135
                +  +    +I+DL +C
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNC 280

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 66.3 bits (162), Expect = 9e-12
 Identities = 26/90 (28%), Positives = 38/90 (42%), Gaps = 5/90 (5%)

Query: 13  NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLS--GKIPPEIASMKYLTQLDL 70
            LK+L +L   SN        +   L +L  LDLS N LS  G           L  LDL
Sbjct: 323 KLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380

Query: 71  SNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
           S N +  ++      L +L++L+   + L 
Sbjct: 381 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLK 409

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 22/108 (20%), Positives = 35/108 (32%), Gaps = 11/108 (10%)

Query: 6   IIPPEIGNLKNLIKLDVGSNSL------IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI 59
           +   +   L+ L  L +    L      +  I      LTN+S+  L S  +      + 
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDF 300

Query: 60  ASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSN 107
           +       L+L N       P    KL  L  L  +SNK        +
Sbjct: 301 SYNFGWQHLELVNCKFG-QFPTL--KLKSLKRLTFTSNKGGNAFSEVD 345

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 79.2 bits (196), Expect = 3e-16
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 15/209 (7%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAF--IKSFKNEAQVLSQVLH 261
            DFD    +G G +G V   +    G+ +A+K L     +A   +     E++VL    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 262 RNIVKLYGYCLH-KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALA 319
             +  L  Y       +  + EY   G LF +L       E    +R     A +  AL 
Sbjct: 65  PFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTE----ERARFYGAEIVSALE 119

Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL-LHADSSNRTLLAGTYGYIAPE 378
           YLH   S  +++RDI   N++L+      + DFG  +  +   ++ +T   GT  Y+APE
Sbjct: 120 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPE 175

Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           +          D +  GVV  E++ G+ P
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 59/252 (23%), Positives = 94/252 (37%), Gaps = 72/252 (28%)

Query: 208 DIRYC----IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKN-EAQVLSQVLH 261
             +Y     +GTG +G V +   + +GK FALKK+           +KN E  ++  + H
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDH 59

Query: 262 RNIVKLYGY---CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR----VNIV--- 311
            NI+KL  Y      ++                N   N     +         +N++   
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 312 ------KAMAH----------------------ALAYLHHDCSPSIIHRDISSNNILLNS 343
                 K +                        A+ ++H   S  I HRDI   N+L+NS
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNS 176

Query: 344 -----KLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL-----AYTMVMTEKCDVYS 393
                KL     DFG+A+ L     +   +   + Y APEL      YT  +    D++S
Sbjct: 177 KDNTLKL----CDFGSAKKLIPSEPSVAYICSRF-YRAPELMLGATEYTPSI----DLWS 227

Query: 394 FGVVTLEVLMGK 405
            G V  E+++GK
Sbjct: 228 IGCVFGELILGK 239

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 55/237 (23%), Positives = 95/237 (40%), Gaps = 55/237 (23%)

Query: 202 EATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKL---------HTSEELAFIKSFKN 251
           +    +     +G GG G V+ A      K  A+KK+         H   E+  I+    
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLD- 66

Query: 252 EAQVLSQVLHRNIVKLY--------------GYCLHKKCMFLIYEYMERGSLFCNLHNNE 297
                    H NIVK++              G       ++++ EYME      +L N  
Sbjct: 67  ---------HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-----TDLANVL 112

Query: 298 DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTAR 356
           +   L        +  +   L Y+H   S +++HRD+   N+ +N++ L   + DFG AR
Sbjct: 113 EQGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLAR 169

Query: 357 LLHADSSNRTLLAG---TYGYIAPEL-----AYTMVMTEKCDVYSFGVVTLEVLMGK 405
           ++    S++  L+    T  Y +P L      YT  +    D+++ G +  E+L GK
Sbjct: 170 IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 222

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 78.0 bits (192), Expect = 7e-16
 Identities = 58/337 (17%), Positives = 107/337 (31%), Gaps = 93/337 (27%)

Query: 213 IGTGGYGSVYKAQL------PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIV 265
           +G G +G V +A           +  A+K L      +  ++  +E ++L  +  H N+V
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 266 KLYGYCLHKKC-MFLIYEYMERGSLFCNLHNN--------------------EDAVELDW 304
            L G C      + +I E+ + G+L   L +                       A+ +D 
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149

Query: 305 AKRVNIVKAMAHA----------------LAYLHHDCSPSIIHRD--------------I 334
            +R++ + +   +                           +                  +
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209

Query: 335 SSNN----------ILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYI-----APEL 379
           +S            ILL+ K    + DFG AR ++ D             +     APE 
Sbjct: 210 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV---RKGDARLPLKWMAPET 266

Query: 380 AYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLDQ--RLPPPV 436
            +  V T + DV+SFGV+  E+  +G  P      +    +        L +  R+  P 
Sbjct: 267 IFDRVYTIQSDVWSFGVLLWEIFSLGASP---YPGVKIDEE----FCRRLKEGTRMRAPD 319

Query: 437 D-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
                +   +L       C    P  RPT   + +  
Sbjct: 320 YTTPEMYQTML------DCWHGEPSQRPTFSELVEHL 350

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 76.9 bits (190), Expect = 7e-16
 Identities = 68/275 (24%), Positives = 105/275 (38%), Gaps = 53/275 (19%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           +G G YG V  A      +  A+K +     +   ++ K E  +   + H N+VK YG+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA------MAHALAYLHHDC 325
                 +L  EY   G LF  +  +           +    A      +   + YLH   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPD---------IGMPEPDAQRFFHQLMAGVVYLH--- 122

Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAPEL---- 379
              I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+APEL    
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 380 AYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVL--DQRLPPPV 436
            +     E  DV+S G+V L  ++ G+ P D        SD      D       L P  
Sbjct: 183 EFH---AEPVDVWSCGIV-LTAMLAGELPWD------QPSDSCQEYSDWKEKKTYLNPWK 232

Query: 437 D-----RKVIRDILLISTVSFACLQSNPKSRPTMQ 466
                   ++  I          L  NP +R T+ 
Sbjct: 233 KIDSAPLALLHKI----------LVENPSARITIP 257

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 76.5 bits (189), Expect = 9e-16
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 30/204 (14%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTS--EELAFIKSFKNEAQVLSQVLHRNIVKLYG 269
           +G G +G V   +    G   A+K L+      L  +   K E Q L    H +I+KLY 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA------MAHALAYLHH 323
                   F++ EY+  G LF  +  +          RV  ++A      +  A+ Y H 
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKH---------GRVEEMEARRLFQQILSAVDYCH- 128

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL---- 379
                ++HRD+   N+LL++ + A +ADFG + ++      RT   G+  Y APE+    
Sbjct: 129 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVISGR 185

Query: 380 AYTMVMTEKCDVYSFGVVTLEVLM 403
            Y      + D++S GV+ L  L+
Sbjct: 186 LYA---GPEVDIWSCGVI-LYALL 205

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 78.2 bits (193), Expect = 9e-16
 Identities = 27/127 (21%), Positives = 54/127 (42%), Gaps = 6/127 (4%)

Query: 8   PPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQ 67
              + N   L+++D+  N L   +      +  L  L +S+N+L   +      +  L  
Sbjct: 241 TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 299

Query: 68  LDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCG 127
           LDLS+N++   +     +  RL+ L L  N +   +  S     ++   ++LS N+  C 
Sbjct: 300 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKN-LTLSHNDWDCN 354

Query: 128 NILDLPS 134
           ++  L  
Sbjct: 355 SLRALFR 361

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 72.4 bits (178), Expect = 7e-14
 Identities = 22/99 (22%), Positives = 37/99 (37%), Gaps = 6/99 (6%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAS 61
           ++  I       ++ L +L + +N L+  +      +  L  LDLS N L   +      
Sbjct: 259 ELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 316

Query: 62  MKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
              L  L L +N+I  ++         L  L LS N   
Sbjct: 317 FDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 20/101 (19%), Positives = 43/101 (42%), Gaps = 5/101 (4%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-A 60
            +  +P  +  + + +  L++    +      A      +  L +  N +   +PP +  
Sbjct: 56  TMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQ 114

Query: 61  SMKYLTQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLS 100
           ++  LT L L  N++  S+P  I     +L  L++S+N L 
Sbjct: 115 NVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE 154

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 29/123 (23%), Positives = 47/123 (38%), Gaps = 22/123 (17%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPP---- 57
            +  +P  I  N   L  L + +N+L         + T+L NL LSSN+L+  +      
Sbjct: 128 DLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIP 186

Query: 58  -------------EIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVP 104
                         +A    + +LD S+N+I   + G +     L  L L  N L+    
Sbjct: 187 SLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTDTAW 243

Query: 105 FSN 107
             N
Sbjct: 244 LLN 246

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 62.4 bits (152), Expect = 9e-11
 Identities = 27/115 (23%), Positives = 50/115 (43%), Gaps = 9/115 (7%)

Query: 10  EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLD 69
            +     + +LD   NS I  +         L+ L L  N L+      + +   L ++D
Sbjct: 200 TLAIPIAVEELDASHNS-INVVRG--PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVD 254

Query: 70  LSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
           LS N ++  I      K+ RL+ L +S+N+L   +      + ++  V+ LS N+
Sbjct: 255 LSYNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTL-KVLDLSHNH 306

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 12/96 (12%), Positives = 32/96 (33%), Gaps = 4/96 (4%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYL 65
           I   +        + +   +          +L N   +   ++ +  K+P  +  S + +
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71

Query: 66  TQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLS 100
             L+L++  I+  I          +  L +  N + 
Sbjct: 72  ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR 106

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 78.8 bits (194), Expect = 9e-16
 Identities = 27/127 (21%), Positives = 54/127 (42%), Gaps = 6/127 (4%)

Query: 8   PPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQ 67
              + N   L+++D+  N L   +      +  L  L +S+N+L   +      +  L  
Sbjct: 247 TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 305

Query: 68  LDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCG 127
           LDLS+N++   +     +  RL+ L L  N +   +  S     ++   ++LS N+  C 
Sbjct: 306 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTL-KNLTLSHNDWDCN 360

Query: 128 NILDLPS 134
           ++  L  
Sbjct: 361 SLRALFR 367

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 69.2 bits (169), Expect = 1e-12
 Identities = 35/131 (26%), Positives = 57/131 (43%), Gaps = 17/131 (12%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-A 60
           +I  I          + KL +G N++    P    ++  L+ L L  N LS  +P  I  
Sbjct: 86  QIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFH 144

Query: 61  SMKYLTQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLSGPVPF-----------SNN 108
           +   LT L +SNNN++  I  +     + L  L LSSN+L+  V             S N
Sbjct: 145 NTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH-VDLSLIPSLFHANVSYN 202

Query: 109 DLSSMHTVVSL 119
            LS++   +++
Sbjct: 203 LLSTLAIPIAV 213

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 33/139 (23%), Positives = 52/139 (37%), Gaps = 25/139 (17%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPP---- 57
            +  +P  I  N   L  L + +N+L         + T+L NL LSSN+L+  +      
Sbjct: 134 DLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIP 192

Query: 58  -------------EIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVP 104
                         +A    + +LD S+N+I   + G +     L  L L  N L+    
Sbjct: 193 SLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTDTAW 249

Query: 105 FSNNDLSSMHTVVSLSPNN 123
             N     +   V LS N 
Sbjct: 250 LLN--YPGL-VEVDLSYNE 265

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 27/115 (23%), Positives = 50/115 (43%), Gaps = 9/115 (7%)

Query: 10  EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLD 69
            +     + +LD   NS I  +         L+ L L  N L+      + +   L ++D
Sbjct: 206 TLAIPIAVEELDASHNS-INVVRG--PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVD 260

Query: 70  LSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
           LS N ++  I      K+ RL+ L +S+N+L   +      + ++  V+ LS N+
Sbjct: 261 LSYNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTL-KVLDLSHNH 312

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 21/129 (16%), Positives = 41/129 (31%), Gaps = 11/129 (8%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           ++  +      +  L  LD+  N L+  +         L NL L  N +   +     + 
Sbjct: 289 RLVALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKLS--TH 344

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN 122
             L  L LS+N+   +    +  L R    N++   +         D    H +     +
Sbjct: 345 HTLKNLTLSHNDWDCN---SLRALFR----NVARPAVDDADQHCKIDYQLEHGLCCKESD 397

Query: 123 NGLCGNILD 131
                 +L 
Sbjct: 398 KPYLDRLLQ 406

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 12/96 (12%), Positives = 32/96 (33%), Gaps = 4/96 (4%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYL 65
           I   +        + +   +          +L N   +   ++ +  K+P  +  S + +
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77

Query: 66  TQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLS 100
             L+L++  I+  I          +  L +  N + 
Sbjct: 78  ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR 112

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 57/223 (25%), Positives = 90/223 (40%), Gaps = 40/223 (17%)

Query: 202 EATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKN--------- 251
              + +     IG+G  G V  A      +  A+KKL         + F+N         
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS--------RPFQNQTHAKRAYR 73

Query: 252 EAQVLSQVLHRNIVKLY------GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAV---EL 302
           E  ++  V H+NI+ L             + ++++ E M+      NL      V   EL
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-----ANLCQ----VIQMEL 124

Query: 303 DWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS 362
           D  +   ++  M   + +LH   S  IIHRD+  +NI++ S     + DFG AR     S
Sbjct: 125 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTS 180

Query: 363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK 405
              T    T  Y APE+   M   E  D++S G +  E++ G 
Sbjct: 181 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 25/221 (11%)

Query: 202 EATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL 260
             + DF ++  +G G YG V  A   P G++ A+KK+   ++  F      E ++L    
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK 67

Query: 261 HRNIVKLY-----GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 315
           H NI+ ++         +   +++I E M+      +LH       L        +    
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQ-----TDLHRVISTQMLSDDHIQYFIYQTL 122

Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG-- 373
            A+  LH     ++IHRD+  +N+L+NS  +  V DFG AR++   +++ +   G     
Sbjct: 123 RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179

Query: 374 --------YIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGK 405
                   Y APE+  T    +   DV+S G +  E+ + +
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 75.8 bits (187), Expect = 3e-15
 Identities = 56/213 (26%), Positives = 88/213 (41%), Gaps = 20/213 (9%)

Query: 202 EATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQV 259
           E    +     +G+G YG+V  A     G   A+KKL+   +   F K    E ++L  +
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 81

Query: 260 LHRNIVKLY------GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 313
            H N++ L                +L+  +M       +L       +L   +   +V  
Sbjct: 82  RHENVIGLLDVFTPDETLDDFTDFYLVMPFMG-----TDLGKLMKHEKLGEDRIQFLVYQ 136

Query: 314 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG 373
           M   L Y+H   +  IIHRD+   N+ +N   E  + DFG AR      S  T    T  
Sbjct: 137 MLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVVTRW 190

Query: 374 YIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGK 405
           Y APE+    M  T+  D++S G +  E++ GK
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 76.2 bits (188), Expect = 5e-15
 Identities = 22/92 (23%), Positives = 41/92 (44%), Gaps = 7/92 (7%)

Query: 9   PEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQL 68
           PE+ NL  L  +   +NSL   +P       +L ++   +N L     PE+ ++ +LT +
Sbjct: 189 PELQNLPFLTAIYADNNSLKK-LPD---LPLSLESIVAGNNILE--ELPELQNLPFLTTI 242

Query: 69  DLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
              NN ++ ++P     L  L+  +     L 
Sbjct: 243 YADNNLLK-TLPDLPPSLEALNVRDNYLTDLP 273

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 24/99 (24%), Positives = 43/99 (43%), Gaps = 10/99 (10%)

Query: 9   PEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQL 68
           PE+ N   L  +DV +NSL   +P       +L  +   +N+L     PE+ ++ +LT +
Sbjct: 147 PELQNSSFLKIIDVDNNSLKK-LPD---LPPSLEFIAAGNNQLE--ELPELQNLPFLTAI 200

Query: 69  DLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSN 107
              NN+++  +P     L  +      +N L       N
Sbjct: 201 YADNNSLK-KLPDLPLSLESIV---AGNNILEELPELQN 235

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 24/120 (20%), Positives = 44/120 (36%), Gaps = 23/120 (19%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIP------ 56
            +  +P    +L+    L    NSL   +P    SL +L   + +   LS   P      
Sbjct: 82  GLSSLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLG 137

Query: 57  ---------PEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSN 107
                    PE+ +  +L  +D+ NN+++  +P     L  +      +N+L       N
Sbjct: 138 VSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIA---AGNNQLEELPELQN 193

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 25/116 (21%), Positives = 47/116 (40%), Gaps = 16/116 (13%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
            +  +P    +L++   +  G+N L       L +L  L+ +   +N L   +P    S 
Sbjct: 206 SLKKLPDLPLSLES---IVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPS- 258

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVP------FSNNDLSS 112
             L  L++ +N +   +P     L+ LD      + LS   P       S+N++ S
Sbjct: 259 --LEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRS 311

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 18/107 (16%), Positives = 37/107 (34%), Gaps = 18/107 (16%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY-- 64
           I P   +   L +    S++L   +P    ++ + +    + ++     PP     +   
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 65  -----------LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
                        +L+L+N  +  S+P     L     L  S N L+
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT 104

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 23/126 (18%), Positives = 42/126 (33%), Gaps = 28/126 (22%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           K+  +P     L+   +L    N L   +P       NL  L +  N L  + P    S+
Sbjct: 328 KLIELPALPPRLE---RLIASFNHLAE-VPE---LPQNLKQLHVEYNPLR-EFPDIPESV 379

Query: 63  KY----------------LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFS 106
           +                 L QL +  N ++   P     +  L    ++S ++  P  F+
Sbjct: 380 EDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVEDLR---MNSERVVDPYEFA 435

Query: 107 NNDLSS 112
           +     
Sbjct: 436 HETTDK 441

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 23/114 (20%), Positives = 34/114 (29%), Gaps = 22/114 (19%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
              PP  G  + +    +                     L+L++  LS  +P        
Sbjct: 48  RNAPPGNGEQREMAVSRLRDC-----------LDRQAHELELNNLGLS-SLPELPPH--- 92

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVP------FSNNDLSS 112
           L  L  S N++   +P     L  L   N +   LS   P       SNN L  
Sbjct: 93  LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK 145

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 34/159 (21%), Positives = 58/159 (36%), Gaps = 40/159 (25%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLT-----------------NLSNLD 45
            +  +P    +L+    L+V  N L   +P    SLT                 NL  L+
Sbjct: 248 LLKTLPDLPPSLEA---LNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPPNLYYLN 303

Query: 46  LSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVP- 104
            SSN++   +     S   L +L++SNN +   +P    +L RL     S N L+  VP 
Sbjct: 304 ASSNEIR-SLCDLPPS---LEELNVSNNKLI-ELPALPPRLERLI---ASFNHLAE-VPE 354

Query: 105 ---------FSNNDLSSMHTVVSLSPNNGLCGNILDLPS 134
                       N L     +     +  +  ++ ++P 
Sbjct: 355 LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPE 393

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 19/114 (16%), Positives = 34/114 (29%), Gaps = 24/114 (21%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLT----------------NLSNLDL 46
            +  +P    NLK   +L V  N L    P    S+                 NL  L +
Sbjct: 348 HLAEVPELPQNLK---QLHVEYNPLRE-FPDIPESVEDLRMNSHLAEVPELPQNLKQLHV 403

Query: 47  SSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
            +N L  + P    S   +  L +++  +            +L+      +   
Sbjct: 404 ETNPLR-EFPDIPES---VEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 15/78 (19%), Positives = 30/78 (38%), Gaps = 3/78 (3%)

Query: 37  SLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSS 96
           S T L      S+ L+ ++P E  ++K  T+   + +  + + P    +   +    L  
Sbjct: 9   SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67

Query: 97  NKLSG--PVPFSNNDLSS 112
                   +  +N  LSS
Sbjct: 68  CLDRQAHELELNNLGLSS 85

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 46.1 bits (110), Expect = 2e-05
 Identities = 10/59 (16%), Positives = 21/59 (35%), Gaps = 1/59 (1%)

Query: 55  IPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSM 113
           I P   S  +L +    ++N+   +P E   +        + ++     P  N +   M
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 74.7 bits (184), Expect = 6e-15
 Identities = 66/273 (24%), Positives = 104/273 (38%), Gaps = 49/273 (17%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           +G G YG V  A      +  A+K +     +   ++ K E  +   + H N+VK YG+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA------MAHALAYLHHDC 325
                 +L  EY   G LF  +  +           +    A      +   + YLH   
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPD---------IGMPEPDAQRFFHQLMAGVVYLH--- 122

Query: 326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAPEL---- 379
              I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+APEL    
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 380 AYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD- 437
            +     E  DV+S G+V L  ++ G+ P D  S        +          L P    
Sbjct: 183 EFH---AEPVDVWSCGIV-LTAMLAGELPWDQPSDSC----QEYSDWKEKKTYLNPWKKI 234

Query: 438 ----RKVIRDILLISTVSFACLQSNPKSRPTMQ 466
                 ++  I          L  NP +R T+ 
Sbjct: 235 DSAPLALLHKI----------LVENPSARITIP 257

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 74.2 bits (183), Expect = 8e-15
 Identities = 50/233 (21%), Positives = 89/233 (38%), Gaps = 52/233 (22%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALK-------------------------KLHTSEELAFI 246
           IG G YG V  A    +   +A+K                              +    I
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 247 KSFKNEAQVLSQVLHRNIVKLYG--YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDW 304
           +    E  +L ++ H N+VKL       ++  +++++E + +G +           E+  
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVM----------EVPT 130

Query: 305 AKRVNIVKA------MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL 358
            K ++  +A      +   + YLH      IIHRDI  +N+L+       +ADFG +   
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187

Query: 359 HADSSNRTLLAGTYGYIAPELAYTMVMT---EKCDVYSFGVVTLEVLM-GKHP 407
               +  +   GT  ++APE           +  DV++ G VTL   + G+ P
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMG-VTLYCFVFGQCP 239

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 75.7 bits (186), Expect = 8e-15
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 34/226 (15%)

Query: 196 VYEDLIEATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKN--- 251
           V +      + +     IG+G  G V  A      +  A+KKL         + F+N   
Sbjct: 53  VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--------RPFQNQTH 104

Query: 252 ------EAQVLSQVLHRNIVKLY------GYCLHKKCMFLIYEYMERGSLFCNLHNNEDA 299
                 E  ++  V H+NI+ L             + ++L+ E M+      NL      
Sbjct: 105 AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-----ANLCQVIQM 159

Query: 300 VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH 359
            ELD  +   ++  M   + +LH   S  IIHRD+  +NI++ S     + DFG AR   
Sbjct: 160 -ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 214

Query: 360 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK 405
             S   T    T  Y APE+   M   E  D++S G +  E++  K
Sbjct: 215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 20/213 (9%)

Query: 202 EATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQV 259
           E  E +     +G+G YGSV  A     G   A+KKL    + +   K    E ++L  +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85

Query: 260 LHRNIVKLY------GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 313
            H N++ L               ++L+   M       +L+N     +L       ++  
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLIYQ 140

Query: 314 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYG 373
           +   L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR     +   T    T  
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT---ADEMTGYVATRW 194

Query: 374 YIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGK 405
           Y APE+    M   +  D++S G +  E+L G+
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 75.0 bits (184), Expect = 1e-14
 Identities = 27/137 (19%), Positives = 46/137 (33%), Gaps = 15/137 (10%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           ++ ++P    +L+    L V +N L   +P    SL  L   D+S+N L   +P      
Sbjct: 151 QLTMLPELPTSLE---VLSVRNNQLTF-LPELPESLEAL---DVSTNLLES-LPAVPVRN 202

Query: 63  KYLTQ----LDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVS 118
            +  +         N I   IP  I  L     + L  N LS  +  S +  +       
Sbjct: 203 HHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT--AQPDY 259

Query: 119 LSPNNGLCGNILDLPSC 135
             P      +     + 
Sbjct: 260 HGPRIYFSMSDGQQNTL 276

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 71.5 bits (175), Expect = 2e-13
 Identities = 30/140 (21%), Positives = 49/140 (35%), Gaps = 31/140 (22%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
            +  +P    +L+    LD   N L   +P    SL +L   D+ +N+L+  +P   A  
Sbjct: 91  ALISLPELPASLE---YLDACDNRLST-LPELPASLKHL---DVDNNQLT-MLPELPAL- 141

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLD-----------------YLNLSSNKLSG--PV 103
             L  ++  NN +   +P   T L  L                   L++S+N L     V
Sbjct: 142 --LEYINADNNQLT-MLPELPTSLEVLSVRNNQLTFLPELPESLEALDVSTNLLESLPAV 198

Query: 104 PFSNNDLSSMHTVVSLSPNN 123
           P  N+             N 
Sbjct: 199 PVRNHHSEETEIFFRCRENR 218

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 19/94 (20%), Positives = 33/94 (35%), Gaps = 9/94 (9%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLT 66
                   +         N  +  +   L  +   S L L+   LS  +P  +     +T
Sbjct: 29  YFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLS-SLPDNLP--PQIT 83

Query: 67  QLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
            L+++ N +  S+P     L  LD      N+LS
Sbjct: 84  VLEITQNALI-SLPELPASLEYLD---ACDNRLS 113

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 63/281 (22%), Positives = 110/281 (39%), Gaps = 53/281 (18%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALK---KLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           +G G YG V +          A+K   K           + K E Q+L ++ H+N+++L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 269 G--YCLHKKCMFLIYEYMERGS--LFCNLHNNEDAVELDWAKRVNIVKA------MAHAL 318
              Y   K+ M+++ EY   G   +        D+V     KR  + +A      +   L
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEML-------DSVP---EKRFPVCQAHGYFCQLIDGL 122

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIA 376
            YLH   S  I+H+DI   N+LL +     ++  G A  LH  +++ T     G+  +  
Sbjct: 123 EYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179

Query: 377 PELAYTMVMTE--KCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIML----IDVLD 429
           PE+A  +      K D++S GV  L  +  G +P +            I      I    
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVT-LYNITTGLYPFE---------GDNIYKLFENIGKGS 229

Query: 430 QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
             +P      +     L+  +    L+  P  R +++ + Q
Sbjct: 230 YAIPGDCGPPLSD---LLKGM----LEYEPAKRFSIRQIRQ 263

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 30/134 (22%), Positives = 48/134 (35%), Gaps = 5/134 (3%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPS-ALGSLTNLSNLDLSSNKLSGKIPPEI- 59
              +    I   L +L  L +  NS            L NL+ LDLS  +L  ++ P   
Sbjct: 137 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAF 195

Query: 60  ASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSL 119
            S+  L  L++S+NN           L+ L  L+ S N +            S    ++L
Sbjct: 196 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 255

Query: 120 SPNNGLCG-NILDL 132
           + N+  C       
Sbjct: 256 TQNDFACTCEHQSF 269

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 68.5 bits (168), Expect = 6e-13
 Identities = 26/102 (25%), Positives = 43/102 (42%), Gaps = 5/102 (4%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSL--IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI 59
           K+  +P  +   L  L KL + SN L   G    +    T+L  LDLS N +   +    
Sbjct: 39  KLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNF 97

Query: 60  ASMKYLTQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLS 100
             ++ L  LD  ++N++      +   L  L YL++S     
Sbjct: 98  LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 139

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 23/100 (23%), Positives = 41/100 (41%), Gaps = 4/100 (4%)

Query: 2   YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIA- 60
              G          +L  LD+  N +I  + S    L  L +LD   + L  ++      
Sbjct: 65  SFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVF 122

Query: 61  -SMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKL 99
            S++ L  LD+S+ + + +  G    LS L+ L ++ N  
Sbjct: 123 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 162

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 27/96 (28%), Positives = 42/96 (43%), Gaps = 5/96 (5%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIA--SMKY 64
           +P  I    +  +L++ SN L          LT L+ L LSSN LS K     +      
Sbjct: 22  VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
           L  LDLS N +  ++      L +L++L+   + L 
Sbjct: 80  LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK 114

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 11/97 (11%)

Query: 40  NLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKL 99
           + + +  +S  L+  +P  I S    T+L+L +N +Q    G   KL++L  L+LSSN L
Sbjct: 8   SGTEIRCNSKGLT-SVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64

Query: 100 S--GPVPFSNNDLSSMHTVVSLSPNNGLCGNILDLPS 134
           S  G    S+   +S+   + LS N      ++ + S
Sbjct: 65  SFKGCCSQSDFGTTSL-KYLDLSFN-----GVITMSS 95

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 73.4 bits (180), Expect = 2e-14
 Identities = 24/99 (24%), Positives = 41/99 (41%), Gaps = 6/99 (6%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMK 63
           G+          L  LD+  NSL       +    + L++L+LS   L  ++P  + +  
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAK- 275

Query: 64  YLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGP 102
            L+ LDLS N +    P    +L ++  L+L  N     
Sbjct: 276 -LSVLDLSYNRLD-RNP-SPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 66.5 bits (162), Expect = 3e-12
 Identities = 23/97 (23%), Positives = 39/97 (40%), Gaps = 4/97 (4%)

Query: 6   IIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAS-MKY 64
           + P +   L+ L   + G  +  G   +   +   L  LDLS N L              
Sbjct: 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSG 101
           L  L+LS   ++  +P  +   ++L  L+LS N+L  
Sbjct: 255 LNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDR 288

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 62.2 bits (151), Expect = 8e-11
 Identities = 28/119 (23%), Positives = 37/119 (31%), Gaps = 8/119 (6%)

Query: 14  LKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIA----SMKYLTQLD 69
              L  L +     +      +     LS LDLS N   G+     A        L  L 
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207

Query: 70  LSNNN---IQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGL 125
           L N       G          +L  L+LS N L       + D  S    ++LS   GL
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLS-FTGL 265

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 23/131 (17%), Positives = 41/131 (31%), Gaps = 12/131 (9%)

Query: 5   GIIPPEIGNL--KNLIKLDVGSNSLIGPIPSALG----SLTNLSNLDLSSNKLSGKIPPE 58
           G  PP +      +L  L++ + S                  L  L ++          +
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168

Query: 59  IASMKYLTQLDLSNNNIQGSIPGEIT----KLSRLDYLNLSSNKLSGPVPFSNNDLSSMH 114
           +     L+ LDLS+N   G           K   L  L L +  +  P    +   ++  
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228

Query: 115 --TVVSLSPNN 123
               + LS N+
Sbjct: 229 QLQGLDLSHNS 239

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 23/142 (16%), Positives = 46/142 (32%), Gaps = 19/142 (13%)

Query: 8   PPEIGNLKNLIKLDVGSNSLIGPIPS---ALGSLTNLSNLDLSSNKLSGKIPPEIA--SM 62
             +I    +L +L V +  +   I      +  ++ L  L L + +++G  PP +   + 
Sbjct: 61  FTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATG 120

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLS-----RLDYLNLSSNKLSG-PVPFSNN-------D 109
             L  L+L N +        + +L       L  L+++                     D
Sbjct: 121 PDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLD 179

Query: 110 LSSMHTVVSLSPNNGLCGNILD 131
           LS    +      + LC     
Sbjct: 180 LSDNPELGERGLISALCPLKFP 201

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 44.1 bits (104), Expect = 6e-05
 Identities = 16/110 (14%), Positives = 38/110 (34%), Gaps = 6/110 (5%)

Query: 12  GNLKNLIKLDVGSNSLIGPIPSA-LGSLTNLSNLDLSSNKLSGKIPPEIA---SMKYLTQ 67
           G  ++L  L    ++         +    +L  L + + ++  +I         +  L +
Sbjct: 40  GGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQE 99

Query: 68  LDLSNNNIQGSIPGEITKL--SRLDYLNLSSNKLSGPVPFSNNDLSSMHT 115
           L L N  + G+ P  + +     L+ LNL +   +    +       +  
Sbjct: 100 LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKP 149

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 74.5 bits (183), Expect = 2e-14
 Identities = 43/242 (17%), Positives = 79/242 (32%), Gaps = 69/242 (28%)

Query: 202 EATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLH-----------TSEELAFIKSF 249
           +  + ++IR+ IGTG YG V +A      +V A+KK+               E+A +   
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109

Query: 250 KNEAQVLSQVLHRNIVKLY-----GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDW 304
                      H ++VK+              ++++ E  +      +            
Sbjct: 110 N----------HDHVVKVLDIVIPKDVEKFDELYVVLEIAD-----SDFKK--------- 145

Query: 305 AKRVNIVKA-----MAH----------ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFV 349
                + +        H           + Y+H   S  I+HRD+   N L+N      V
Sbjct: 146 -----LFRTPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKV 197

Query: 350 ADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTL-----EVLMG 404
            DFG AR +    +  + L  +       L             +  VVT      E+++ 
Sbjct: 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL 257

Query: 405 KH 406
           + 
Sbjct: 258 QE 259

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 65/271 (23%), Positives = 118/271 (43%), Gaps = 31/271 (11%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKL-----HTSEELAFIKSFKNEAQVLSQ 258
           +DFD+   IG G Y  V   +L    +++A+K +     +  E++ ++++   E  V  Q
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT---EKHVFEQ 65

Query: 259 VL-HRNIVKLYGYCLH-KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MA 315
              H  +V L+  C   +  +F + EY+  G L  ++       E    +      A ++
Sbjct: 66  ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEIS 120

Query: 316 HALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL-LHADSSNRTLLAGTYGY 374
            AL YLH      II+RD+  +N+LL+S+    + D+G  +  L    +  T   GT  Y
Sbjct: 121 LALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNY 176

Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP--RDILSSLSSSSDPKIMLIDVLDQRL 432
           IAPE+          D ++ GV+  E++ G+ P      S     +    +   +L++++
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 236

Query: 433 PPPVDRKV-IRDILLISTVSFACLQSNPKSR 462
             P    V    +L       + L  +PK R
Sbjct: 237 RIPRSLSVKAASVLK------SFLNKDPKER 261

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 34/129 (26%), Positives = 55/129 (42%), Gaps = 12/129 (9%)

Query: 3   KIGIIPPEI--GNLKNLIKLDVGSNSLIGPIPS-ALGSLTNLSNLDLSSNKLSGKIPPEI 59
            +  +  E     L NL  L +  N  +  I S A   + NL  LDLSSN L   +   +
Sbjct: 50  NLSRLRAEWTPTRLTNLHSLLLSHNH-LNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFL 107

Query: 60  -ASMKYLTQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLSGPVP---FSNNDLSSMH 114
            + ++ L  L L NN+I   +       +++L  L LS N++S   P     + +     
Sbjct: 108 FSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKL 165

Query: 115 TVVSLSPNN 123
            ++ LS N 
Sbjct: 166 MLLDLSSNK 174

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 68.7 bits (168), Expect = 8e-13
 Identities = 37/131 (28%), Positives = 49/131 (37%), Gaps = 9/131 (6%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-A 60
            +  I  E    + NL  LD+ SN L          L  L  L L +N +   +      
Sbjct: 75  HLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFE 133

Query: 61  SMKYLTQLDLSNNNIQGSIPGEI----TKLSRLDYLNLSSNKLSGPVPFSNNDLSSM-HT 115
            M  L +L LS N I    P E+     KL +L  L+LSSNKL          L +    
Sbjct: 134 DMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKN 192

Query: 116 VVSLSPNNGLC 126
            + L  N   C
Sbjct: 193 GLYLHNNPLEC 203

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 54.1 bits (130), Expect = 4e-08
 Identities = 23/65 (35%), Positives = 33/65 (50%), Gaps = 5/65 (7%)

Query: 39  TNLSNLDLSSNKLSGKIPPEIA--SMKYLTQLDLSNNNIQGSIPGEI-TKLSRLDYLNLS 95
           +  + LDLS N LS ++  E     +  L  L LS+N++   I  E    +  L YL+LS
Sbjct: 39  SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLS 96

Query: 96  SNKLS 100
           SN L 
Sbjct: 97  SNHLH 101

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 20/212 (9%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAF--IKSFKNEAQVLSQVL- 260
           EDF +   +G G +G V+ A+     + FA+K L     L    ++    E +VLS    
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76

Query: 261 HRNIVKLYGYCLH-KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHAL 318
           H  +  ++      K+ +F + EY+  G L  ++  +    +L  A       A +   L
Sbjct: 77  HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRAT---FYAAEIILGL 131

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFV--ADFGTARL-LHADSSNRTLLAGTYGYI 375
            +LH   S  I++RD+  +NILL+   +  +  ADFG  +  +  D+   T   GT  YI
Sbjct: 132 QFLH---SKGIVYRDLKLDNILLDK--DGHIKIADFGMCKENMLGDAKTNT-FCGTPDYI 185

Query: 376 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           APE+          D +SFGV+  E+L+G+ P
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 74.1 bits (182), Expect = 4e-14
 Identities = 40/141 (28%), Positives = 61/141 (43%), Gaps = 9/141 (6%)

Query: 13  NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPE--IASMKYLTQLDL 70
           NL NL  LD+GS+ +    P A   L +L  L L    LS  +  +    ++K LT+LDL
Sbjct: 71  NLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDL 130

Query: 71  SNNNIQG-SIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMH-TVVSLSPNNGLCGN 128
           S N I+   +     KL+ L  ++ SSN++          L     +  SL+ N     +
Sbjct: 131 SKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAAN-----S 185

Query: 129 ILDLPSCDTTKPATLFVEIFL 149
           +    S D  K    F  + L
Sbjct: 186 LYSRVSVDWGKCMNPFRNMVL 206

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 71.0 bits (174), Expect = 4e-13
 Identities = 28/117 (23%), Positives = 49/117 (41%), Gaps = 9/117 (7%)

Query: 13  NLKNLIKLDVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPPEI-----ASMKYLT 66
            + +L  L +  N               +L  L L  N L      E+       + +L 
Sbjct: 424 RVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQ 483

Query: 67  QLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
            L L++N +    PG  + L+ L  L+L+SN+L+     S+NDL +   ++ +S N 
Sbjct: 484 VLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV---LSHNDLPANLEILDISRNQ 537

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 71.0 bits (174), Expect = 4e-13
 Identities = 31/136 (22%), Positives = 44/136 (32%), Gaps = 18/136 (13%)

Query: 13  NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLS 71
            L    +L +  N +     S+   L  L  L+L S      I  E   ++  L  LDL 
Sbjct: 22  VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81

Query: 72  NNNIQGSIPGEITKLSRLDYLNLSSNKLSG----PVPF-----------SNNDLSSMHTV 116
           ++ I    P     L  L  L L    LS        F           S N + S++  
Sbjct: 82  SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH 141

Query: 117 VSLSPNNGLCGNILDL 132
            S    N L    +D 
Sbjct: 142 PSFGKLNSL--KSIDF 155

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 67.1 bits (164), Expect = 6e-12
 Identities = 28/132 (21%), Positives = 54/132 (40%), Gaps = 15/132 (11%)

Query: 3   KIGIIPPE--IGNLKNLIKLDVGSNSLIGPI-----PSALGSLTNLSNLDLSSNKLSGKI 55
           +      +       +L +L +G N L               L++L  L L+ N L+  +
Sbjct: 437 RFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SL 495

Query: 56  PPEI-ASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMH 114
           PP + + +  L  L L++N +   +       + L+ L++S N+L  P P     LS + 
Sbjct: 496 PPGVFSHLTALRGLSLNSNRLT-VLSHN-DLPANLEILDISRNQLLAPNPDVFVSLSVLD 553

Query: 115 TVVSLSPNNGLC 126
               ++ N  +C
Sbjct: 554 ----ITHNKFIC 561

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 63.7 bits (155), Expect = 7e-11
 Identities = 26/135 (19%), Positives = 54/135 (40%), Gaps = 15/135 (11%)

Query: 16  NLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSNNN 74
           ++  LD+    +         +L +L  L+L+ NK++ KI  E    +  L  L+LS N 
Sbjct: 267 SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNL 325

Query: 75  IQGSIPGEITKLSRLDYLNLSSNKLSGPVP-------------FSNNDLSSMHTVVSLSP 121
           +          L ++ Y++L  N ++                   +N L+++H + S+  
Sbjct: 326 LGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPD 385

Query: 122 NNGLCGNILDLPSCD 136
                  ++ LP  +
Sbjct: 386 IFLSGNKLVTLPKIN 400

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 63.7 bits (155), Expect = 7e-11
 Identities = 27/139 (19%), Positives = 55/139 (39%), Gaps = 11/139 (7%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPPEI-- 59
              +      NLK L +LD+  N +    +  + G L +L ++D SSN++   +      
Sbjct: 111 DAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELE 169

Query: 60  -ASMKYLTQLDLSNNNIQGSIPGEITKLS------RLDYLNLSSNKLSGPVPFSNNDLSS 112
               K L+   L+ N++   +  +  K         L+ L++S N  +  +  + ++  S
Sbjct: 170 PLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAIS 229

Query: 113 MHTVVSLSPNNGLCGNILD 131
                SL   + + G    
Sbjct: 230 KSQAFSLILAHHIMGAGFG 248

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 28/117 (23%), Positives = 46/117 (39%), Gaps = 10/117 (8%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-A 60
           KI  I  E    L NL  L++  N L     S    L  ++ +DL  N ++  I  +   
Sbjct: 301 KINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFK 359

Query: 61  SMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSG--PVPFSNNDLSSMHT 115
            ++ L  LDL +N +       I  +  +  + LS NKL     +  + N +     
Sbjct: 360 FLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSEN 411

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 60.6 bits (147), Expect = 7e-10
 Identities = 34/180 (18%), Positives = 58/180 (32%), Gaps = 17/180 (9%)

Query: 1   MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIA 60
            ++  +       L +L  L +  N L    P     LT L  L L+SN+L+  +     
Sbjct: 466 AWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDL 524

Query: 61  SMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSN--NDLSSMHTVVS 118
               L  LD+S N +    P        L  L+++ NK       S   N L+  +  ++
Sbjct: 525 P-ANLEILDISRNQLLAPNPDV---FVSLSVLDITHNKFICECELSTFINWLNHTNVTIA 580

Query: 119 LSPNNGLCGN----------ILDLPSCDTTKPATLFVEIFLPLTIVLSVIVFACLLLAKR 168
             P +  C             L    CD  +           +  V   +    +L   +
Sbjct: 581 GPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTK 640

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 21/114 (18%), Positives = 41/114 (35%), Gaps = 3/114 (2%)

Query: 12  GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMK--YLTQLD 69
           GN   +      SN++      +L    ++       + +        A +    +  LD
Sbjct: 213 GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLD 272

Query: 70  LSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
           LS+  +          L  L  LNL+ NK++     +   L ++   ++LS N 
Sbjct: 273 LSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQV-LNLSYNL 325

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 30/126 (23%), Positives = 52/126 (41%), Gaps = 17/126 (13%)

Query: 13  NLKNLIKLDVGSNSLI--------GPIPSALGSLTNLSNLDLSSNKLSGKIPPE--IASM 62
            L  L K+++ +N +           I   L  + +L  L L+ N+ S     +   +  
Sbjct: 392 KLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS-SCSGDQTPSEN 450

Query: 63  KYLTQLDLSNNNIQGSIPGEITK-----LSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVV 117
             L QL L  N +Q +   E+       LS L  L L+ N L+   P   + L+++   +
Sbjct: 451 PSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTAL-RGL 509

Query: 118 SLSPNN 123
           SL+ N 
Sbjct: 510 SLNSNR 515

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 72.7 bits (179), Expect = 4e-14
 Identities = 56/225 (24%), Positives = 95/225 (42%), Gaps = 33/225 (14%)

Query: 196 VYEDLIEATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTS-EELAFIKSFKNEA 253
           V +   E  + +     +G+G YGSV  A    +G+  A+KKL    +   F K    E 
Sbjct: 15  VNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYREL 74

Query: 254 QVLSQVLHRNIVKLY------GYCLHKKCMFLIYEYMERGSLFCNLHN------NEDAVE 301
            +L  + H N++ L           +    +L+  +M+      +L        +E+ ++
Sbjct: 75  LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-----TDLQKIMGLKFSEEKIQ 129

Query: 302 LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD 361
                   +V  M   L Y+H   S  ++HRD+   N+ +N   E  + DFG AR     
Sbjct: 130 Y-------LVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHA--- 176

Query: 362 SSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGK 405
            +  T    T  Y APE+  + M   +  D++S G +  E+L GK
Sbjct: 177 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 73.3 bits (180), Expect = 4e-14
 Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 36/207 (17%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALK-----KLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
           +G G +G V   +    G   A+K     K+ + + +  I+    E Q L    H +I+K
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR---REIQNLKLFRHPHIIK 80

Query: 267 LYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA------MAHALAY 320
           LY        +F++ EY+  G LF  +  N          R++  ++      +   + Y
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGELFDYICKN---------GRLDEKESRRLFQQILSGVDY 131

Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL- 379
            H      ++HRD+   N+LL++ + A +ADFG + ++      RT   G+  Y APE+ 
Sbjct: 132 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVI 187

Query: 380 ---AYTMVMTEKCDVYSFGVVTLEVLM 403
               Y      + D++S GV+ L  L+
Sbjct: 188 SGRLYA---GPEVDIWSSGVI-LYALL 210

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 73.9 bits (181), Expect = 5e-14
 Identities = 51/210 (24%), Positives = 95/210 (45%), Gaps = 16/210 (7%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAF--IKSFKNEAQVLSQVL- 260
            DF+    +G G +G V  ++     +++A+K L     +    ++    E +VL+    
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 261 HRNIVKLYGYCLH-KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHAL 318
              + +L+  C      ++ + EY+  G L  ++       E           A +A  L
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE----PHAVFYAAEIAIGL 455

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL-LHADSSNRTLLAGTYGYIAP 377
            +L    S  II+RD+  +N++L+S+    +ADFG  +  +    + +T   GT  YIAP
Sbjct: 456 FFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAP 511

Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           E+       +  D ++FGV+  E+L G+ P
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 72.4 bits (178), Expect = 6e-14
 Identities = 49/212 (23%), Positives = 85/212 (40%), Gaps = 39/212 (18%)

Query: 202 EATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLH-----------TSEELAFIKSF 249
                +++   +G G YG V+K+     G+V A+KK+            T  E+  +   
Sbjct: 6   HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTEL 65

Query: 250 KNEAQVLSQVLHRNIVKLYGYCL--HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR 307
                      H NIV L       + + ++L+++YME      +LH    A  L+   +
Sbjct: 66  SG---------HENIVNLLNVLRADNDRDVYLVFDYME-----TDLHAVIRANILEPVHK 111

Query: 308 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL 367
             +V  +   + YLH   S  ++HRD+  +NILLN++    VADFG +R           
Sbjct: 112 QYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168

Query: 368 LAGTYGYIAPELAYTM-VMTEKCDVYSFGVVT 398
           +  +             ++T+    Y   V T
Sbjct: 169 IPLSINENTENFDDDQPILTD----Y---VAT 193

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 72.0 bits (177), Expect = 6e-14
 Identities = 33/105 (31%), Positives = 49/105 (46%), Gaps = 8/105 (7%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAS 61
           KI  +       L NL KL +  NS+      +L +  +L  L L++NKL  K+P  +A 
Sbjct: 203 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261

Query: 62  MKYLTQLDLSNNNIQG------SIPGEITKLSRLDYLNLSSNKLS 100
            KY+  + L NNNI          PG  TK +    ++L SN + 
Sbjct: 262 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 28/100 (28%), Positives = 48/100 (48%), Gaps = 7/100 (7%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPS-ALGSLTNLSNLDLSSNKLSGKIPPEI-A 60
            I  IP   G   +L +L +  N  I  + + +L  L NL+ L LS N +S  +     A
Sbjct: 182 NITTIPQ--GLPPSLTELHLDGNK-ITKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLA 237

Query: 61  SMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
           +  +L +L L+NN +   +PG +     +  + L +N +S
Sbjct: 238 NTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 276

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 65.8 bits (161), Expect = 6e-12
 Identities = 29/100 (29%), Positives = 46/100 (46%), Gaps = 6/100 (6%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAS 61
           KI  I      NLKNL  L + +N +    P A   L  L  L LS N+L  ++P ++  
Sbjct: 63  KITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP- 120

Query: 62  MKYLTQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLS 100
            K L +L +  N I   +   +   L+++  + L +N L 
Sbjct: 121 -KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLK 158

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 31/112 (27%), Positives = 49/112 (43%), Gaps = 7/112 (6%)

Query: 13  NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLS 71
            +K L  + +   ++   IP   G   +L+ L L  NK++ K+       +  L +L LS
Sbjct: 169 GMKKLSYIRIADTNITT-IPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLS 224

Query: 72  NNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
            N+I     G +     L  L+L++NKL   VP    D   +   V L  NN
Sbjct: 225 FNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQV-VYLHNNN 274

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 18/106 (16%), Positives = 36/106 (33%), Gaps = 12/106 (11%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPE--- 58
            I  +      N  +L +L + +N L+  +P  L     +  + L +N +S  I      
Sbjct: 227 SISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS-AIGSNDFC 284

Query: 59  ----IASMKYLTQLDLSNNNIQGSI--PGEITKLSRLDYLNLSSNK 98
                      + + L +N +Q     P     +     + L + K
Sbjct: 285 PPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 20/102 (19%), Positives = 43/102 (42%), Gaps = 8/102 (7%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-A 60
           KI  I P     L  L +L +  N L   +P  +     L  L +  N+++ K+   +  
Sbjct: 87  KISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEIT-KVRKSVFN 142

Query: 61  SMKYLTQLDLSNNNIQGSI--PGEITKLSRLDYLNLSSNKLS 100
            +  +  ++L  N ++ S    G    + +L Y+ ++   ++
Sbjct: 143 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 59.2 bits (144), Expect = 7e-10
 Identities = 25/100 (25%), Positives = 46/100 (46%), Gaps = 7/100 (7%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKL-SGKIPPEI-A 60
           ++  +P ++   K L +L V  N +     S    L  +  ++L +N L S  I      
Sbjct: 111 QLKELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168

Query: 61  SMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
            MK L+ + +++ NI  +IP  +     L  L+L  NK++
Sbjct: 169 GMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT 205

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 24/71 (33%), Positives = 36/71 (50%), Gaps = 4/71 (5%)

Query: 31  IPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSNNNIQGSIPGEITKLSRL 89
           +P  L    + + LDL +NK++ +I      ++K L  L L NN I    PG    L +L
Sbjct: 46  VPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102

Query: 90  DYLNLSSNKLS 100
           + L LS N+L 
Sbjct: 103 ERLYLSKNQLK 113

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 72.4 bits (178), Expect = 6e-14
 Identities = 67/273 (24%), Positives = 113/273 (41%), Gaps = 35/273 (12%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAF--IKSFKNEAQVLSQVL- 260
           +DFD+   IG G Y  V   +L    +++A++ +          I   + E  V  Q   
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111

Query: 261 HRNIVKLYGYCLH-KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHAL 318
           H  +V L+  C   +  +F + EY+  G L  ++       E    +      A ++ AL
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEISLAL 166

Query: 319 AYLHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARL-LHADSSNRTLLAGTYG 373
            YLH      II+RD+  +N+LL+S    KL     D+G  +  L    +  T   GT  
Sbjct: 167 NYLH---ERGIIYRDLKLDNVLLDSEGHIKL----TDYGMCKEGLRPGDTTST-FCGTPN 218

Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP--RDILSSLSSSSDPKIMLIDVLDQ- 430
           YIAPE+          D ++ GV+  E++ G+ P      S     +    +   +L++ 
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 278

Query: 431 -RLPPPVDRKVIRDILLISTVSFACLQSNPKSR 462
            R+P  +  K    +L       + L  +PK R
Sbjct: 279 IRIPRSLSVKA-ASVLK------SFLNKDPKER 304

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 73.2 bits (180), Expect = 6e-14
 Identities = 20/117 (17%), Positives = 49/117 (41%), Gaps = 3/117 (2%)

Query: 3   KIGIIPPE-IGNLKNLIKLDVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPPE-I 59
            +  +     G L +L  L++  N      + S   +LTNL  L + + +   +I     
Sbjct: 85  HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDF 144

Query: 60  ASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV 116
           A +  L +L++   +++      +  +  + +L L  ++ +  +    + LSS+  +
Sbjct: 145 AGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYL 201

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 69.4 bits (170), Expect = 9e-13
 Identities = 30/121 (24%), Positives = 50/121 (41%), Gaps = 6/121 (4%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYL 65
           IP  +     +  LD+  N +       L +  NL  L L S++++  I  +   S+  L
Sbjct: 20  IPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSL 76

Query: 66  TQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSG-PVPFSNNDLSSMHTVVSLSPNNG 124
             LDLS+N++          LS L YLNL  N      V     +L+++ T + +     
Sbjct: 77  EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT-LRIGNVET 135

Query: 125 L 125
            
Sbjct: 136 F 136

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 29/125 (23%), Positives = 47/125 (37%), Gaps = 6/125 (4%)

Query: 3   KIGIIPPE-IGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPE-IA 60
           KI  I    +    NL  L + S+ +      A  SL +L +LDLS N LS  +      
Sbjct: 37  KITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFG 95

Query: 61  SMKYLTQLDLSNNNIQG-SIPGEITKLSRLDYLNLSS-NKLSGPVPFSNNDLSSMHTVVS 118
            +  L  L+L  N  Q   +      L+ L  L + +    S         L+S+   + 
Sbjct: 96  PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSL-NELE 154

Query: 119 LSPNN 123
           +   +
Sbjct: 155 IKALS 159

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 25/132 (18%), Positives = 49/132 (37%), Gaps = 3/132 (2%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIP-SALGSLTNLSNLDLSSNKLSGKIPPEIASMKYL 65
           +     NL NL  L +G+      I       LT+L+ L++ +  L       + S++ +
Sbjct: 115 VTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDI 174

Query: 66  TQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSG--PVPFSNNDLSSMHTVVSLSPNN 123
             L L  +     +      LS + YL L    L+     P   +++SS    ++   + 
Sbjct: 175 HHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV 234

Query: 124 GLCGNILDLPSC 135
               +  +L   
Sbjct: 235 LTDESFNELLKL 246

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 66.7 bits (163), Expect = 7e-12
 Identities = 24/92 (26%), Positives = 42/92 (45%), Gaps = 6/92 (6%)

Query: 11  IGNLKNLIKLDVGSNSL--IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQL 68
            G   +L  L +  N L  +      L +L NL++LD+S N     +P      + +  L
Sbjct: 357 KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFL 415

Query: 69  DLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
           +LS+  I+  +   I     L+ L++S+N L 
Sbjct: 416 NLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD 444

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 64.0 bits (156), Expect = 4e-11
 Identities = 22/121 (18%), Positives = 48/121 (39%), Gaps = 10/121 (8%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
               +P      + +  L++ S  +   + +       L  LD+S+N L       +   
Sbjct: 398 TFHPMPDSCQWPEKMRFLNLSSTGI-RVVKT--CIPQTLEVLDVSNNNLD-SFSLFLPR- 452

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN 122
             L +L +S N ++ ++P + +    L  + +S N+L        + L+S+   + L  N
Sbjct: 453 --LQELYISRNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSL-QKIWLHTN 507

Query: 123 N 123
            
Sbjct: 508 P 508

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 20/104 (19%), Positives = 39/104 (37%), Gaps = 6/104 (5%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPE--- 58
            +      +   L+ + ++ V ++ +     S    L +L  LDLS N +  +       
Sbjct: 297 YLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSAC 356

Query: 59  IASMKYLTQLDLSNNNIQ--GSIPGEITKLSRLDYLNLSSNKLS 100
             +   L  L LS N+++        +  L  L  L++S N   
Sbjct: 357 KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH 400

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 17/113 (15%), Positives = 42/113 (37%), Gaps = 1/113 (0%)

Query: 3   KIGIIPPE-IGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAS 61
               I       L +L +L++ + SL      +L S+ ++ +L L  ++ +  +      
Sbjct: 135 TFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADI 194

Query: 62  MKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMH 114
           +  +  L+L + N+       +        +   + + S     S N+L  + 
Sbjct: 195 LSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLL 247

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 57.8 bits (140), Expect = 4e-09
 Identities = 12/107 (11%), Positives = 39/107 (36%), Gaps = 2/107 (1%)

Query: 13  NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSN 72
            L  L   +   + ++  +         +  L +    L   +    + ++ + ++ + N
Sbjct: 262 TLNGLGDFNPSESDVVSELGKV--ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVEN 319

Query: 73  NNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSL 119
           + +          L  L++L+LS N +      ++    +  ++ +L
Sbjct: 320 SKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTL 366

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 16/65 (24%), Positives = 26/65 (40%), Gaps = 4/65 (6%)

Query: 13  NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLS 71
            L  L +L +  N L   +P A      L  + +S N+L   +P  I   +  L ++ L 
Sbjct: 449 FLPRLQELYISRNKLKT-LPDA-SLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLH 505

Query: 72  NNNIQ 76
            N   
Sbjct: 506 TNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 40.9 bits (96), Expect = 7e-04
 Identities = 9/43 (20%), Positives = 16/43 (37%)

Query: 9   PEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKL 51
           P+      L+ + +  N L          LT+L  + L +N  
Sbjct: 467 PDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 73.0 bits (179), Expect = 8e-14
 Identities = 25/108 (23%), Positives = 40/108 (37%), Gaps = 23/108 (21%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSL--------------TNLSNLDLSSNKLS 52
           +P     L  L         L   +PS L  L                L  L +S N+L+
Sbjct: 96  LPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLA 154

Query: 53  GKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
             +P   +    L +L   NN +  S+P   + L     L++S N+L+
Sbjct: 155 -SLPALPSE---LCKLWAYNNQLT-SLPMLPSGLQE---LSVSDNQLA 194

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 68.4 bits (167), Expect = 2e-12
 Identities = 17/98 (17%), Positives = 38/98 (38%), Gaps = 14/98 (14%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
            +  +P  +    ++  L +  N+L   +P+       L  L++S N+L+  +P     +
Sbjct: 51  GLTTLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVLPPGL 103

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
             L+       ++     G       L  L +  N+L+
Sbjct: 104 LELSIFSNPLTHLPALPSG-------LCKLWIFGNQLT 134

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 68.4 bits (167), Expect = 2e-12
 Identities = 22/97 (22%), Positives = 41/97 (42%), Gaps = 12/97 (12%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           ++  +P     L+    L V  N L   +P+    L     L   +N+L+  +P   +  
Sbjct: 132 QLTSLPVLPPGLQE---LSVSDNQLAS-LPALPSELC---KLWAYNNQLT-SLPMLPSG- 182

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKL 99
             L +L +S+N +  S+P   ++L +L   N     L
Sbjct: 183 --LQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSL 216

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 67.2 bits (164), Expect = 5e-12
 Identities = 23/98 (23%), Positives = 44/98 (44%), Gaps = 15/98 (15%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           ++  +P     L+   +L V  N L   +P+    L  L      +N+L+  +P   +  
Sbjct: 172 QLTSLPMLPSGLQ---ELSVSDNQLAS-LPTLPSELYKL---WAYNNRLT-SLPALPSG- 222

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
             L +L +S N +  S+P   ++L     L +S N+L+
Sbjct: 223 --LKELIVSGNRLT-SLPVLPSELK---ELMVSGNRLT 254

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 65.7 bits (160), Expect = 1e-11
 Identities = 18/130 (13%), Positives = 44/130 (33%), Gaps = 8/130 (6%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           ++  +P     LK L    V  N L   +P     L +L    +  N+L+ ++P  +  +
Sbjct: 232 RLTSLPVLPSELKEL---MVSGNRLTS-LPMLPSGLLSL---SVYRNQLT-RLPESLIHL 283

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN 122
              T ++L  N +       + +++     +    +       +  +  ++H   +    
Sbjct: 284 SSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLV 343

Query: 123 NGLCGNILDL 132
               G     
Sbjct: 344 PAREGEPAPA 353

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 23/98 (23%), Positives = 41/98 (41%), Gaps = 15/98 (15%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           ++  +P     L  L      +N L   +P      + L  L +S N+L+  +P   +  
Sbjct: 152 QLASLPALPSELCKL---WAYNNQLTS-LPM---LPSGLQELSVSDNQLA-SLPTLPSE- 202

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
             L +L   NN +  S+P   + L  L    +S N+L+
Sbjct: 203 --LYKLWAYNNRLT-SLPALPSGLKELI---VSGNRLT 234

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 14/63 (22%), Positives = 31/63 (49%), Gaps = 7/63 (11%)

Query: 38  LTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSN 97
               + L++  + L+  +P  +    ++T L + +NN+  S+P    +L     L +S N
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELR---TLEVSGN 91

Query: 98  KLS 100
           +L+
Sbjct: 92  QLT 94

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 41.0 bits (96), Expect = 8e-04
 Identities = 11/90 (12%), Positives = 28/90 (31%), Gaps = 2/90 (2%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           ++  +P  + +L +   +++  N L      AL  +T+         +            
Sbjct: 272 QLTRLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRET 331

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYL 92
           + L     + + +  +  GE     R    
Sbjct: 332 RALH--LAAADWLVPAREGEPAPADRWHMF 359

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 71.9 bits (177), Expect = 8e-14
 Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 24/214 (11%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAF--IKSFKNEAQVLSQVL- 260
            DF+    +G G +G V  ++     +++A+K L     +    ++    E +VL+    
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79

Query: 261 HRNIVKLYGYCLH-KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHAL 318
              + +L+  C      ++ + EY+  G L  ++       +   A       A +A  L
Sbjct: 80  PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPHAV---FYAAEIAIGL 134

Query: 319 AYLHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARL-LHADSSNRTLLAGTYG 373
            +L    S  II+RD+  +N++L+S    K+    ADFG  +  +    + +T   GT  
Sbjct: 135 FFLQ---SKGIIYRDLKLDNVMLDSEGHIKI----ADFGMCKENIWDGVTTKT-FCGTPD 186

Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           YIAPE+       +  D ++FGV+  E+L G+ P
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 71.5 bits (176), Expect = 8e-14
 Identities = 42/234 (17%), Positives = 89/234 (38%), Gaps = 41/234 (17%)

Query: 189 WNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLH------TSE 241
           W+Y+    +       +D+ +   +G G Y  V++A  + N +   +K L          
Sbjct: 23  WDYE---SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR 79

Query: 242 ELAFIKSFKNEAQVLSQVLHRNIVKLYG--YCLHKKCMFLIYEYMERGSLFCNLHNNEDA 299
           E+  +++ +            NI+ L         +   L++E++       +       
Sbjct: 80  EIKILENLRG---------GPNIITLADIVKDPVSRTPALVFEHVNN----TDFKQLYQT 126

Query: 300 VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-EAFVADFGTARLL 358
           +     +    +  +  AL Y H   S  I+HRD+  +N++++ +  +  + D+G A   
Sbjct: 127 LTDYDIRF--YMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181

Query: 359 HADSSNRTLLAGTYGYIAPEL-----AYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           H        +A  Y +  PEL      Y   +    D++S G +   ++  K P
Sbjct: 182 HPGQEYNVRVASRY-FKGPELLVDYQMYDYSL----DMWSLGCMLASMIFRKEP 230

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 35/136 (25%), Positives = 51/136 (37%), Gaps = 6/136 (4%)

Query: 6   IIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYL 65
           +   +I +L  L  L +  N +     S       L  LDLS NKL  KI         L
Sbjct: 36  LWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNL 92

Query: 66  TQLDLSNNNIQGSIP--GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
             LDLS N    ++P   E   +S+L +L LS+  L          L+    ++ L    
Sbjct: 93  KHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY 151

Query: 124 GLCGNILDLPSCDTTK 139
           G   +   L   +T  
Sbjct: 152 GEKEDPEGLQDFNTES 167

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 69.9 bits (171), Expect = 6e-13
 Identities = 29/119 (24%), Positives = 45/119 (37%), Gaps = 16/119 (13%)

Query: 9   PEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI---ASMKYL 65
                +   + LD  +N L   +    G LT L  L L  N+L  ++         MK L
Sbjct: 318 LCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSL 376

Query: 66  TQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLSGPVPF-----------SNNDLSS 112
            QLD+S N++         +    L  LN+SSN L+  +              +N + S
Sbjct: 377 QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKS 435

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 4/89 (4%)

Query: 13  NLKNLIKLDVGSNSL-IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLS 71
            +K+L +LD+  NS+             +L +L++SSN L+  I   +     +  LDL 
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR--IKVLDLH 429

Query: 72  NNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
           +N I+ SIP ++ KL  L  LN++SN+L 
Sbjct: 430 SNKIK-SIPKQVVKLEALQELNVASNQLK 457

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 63.0 bits (153), Expect = 9e-11
 Identities = 22/95 (23%), Positives = 41/95 (43%), Gaps = 7/95 (7%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYL 65
           +P ++   +    L++  N +     S + SL+ L  L +S N++   +   +    + L
Sbjct: 15  VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQEL 71

Query: 66  TQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
             LDLS+N +   I         L +L+LS N   
Sbjct: 72  EYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFD 103

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 30/131 (22%), Positives = 47/131 (35%), Gaps = 5/131 (3%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKL-SGKIPPEIA 60
           +I  +   +    + L  LD+  N L   I        NL +LDLS N   +  I  E  
Sbjct: 56  RIQYLDISVFKFNQELEYLDLSHNKL-VKISC--HPTVNLKHLDLSFNAFDALPICKEFG 112

Query: 61  SMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLS 120
           +M  L  L LS  +++ S    I  L+    L +                 +  ++  + 
Sbjct: 113 NMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVF 172

Query: 121 PNNGLCGNILD 131
           P N     ILD
Sbjct: 173 PTNKEFHFILD 183

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 60.6 bits (147), Expect = 6e-10
 Identities = 18/88 (20%), Positives = 34/88 (38%)

Query: 13  NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSN 72
           +LK L    V S+    P        +N++  + + +          + +     LD SN
Sbjct: 274 SLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSN 333

Query: 73  NNIQGSIPGEITKLSRLDYLNLSSNKLS 100
           N +  ++      L+ L+ L L  N+L 
Sbjct: 334 NLLTDTVFENCGHLTELETLILQMNQLK 361

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 58.0 bits (140), Expect = 4e-09
 Identities = 28/105 (26%), Positives = 43/105 (40%), Gaps = 15/105 (14%)

Query: 20  LDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI 79
           +D   N LI  +P  L      + L++S N +S     +I S+  L  L +S+N IQ   
Sbjct: 5   VDRSKNGLIH-VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61

Query: 80  PGEITKLSRLDYLNLSSNKLSGPVPF-----------SNNDLSSM 113
                    L+YL+LS NKL   +             S N   ++
Sbjct: 62  ISVFKFNQELEYLDLSHNKLVK-ISCHPTVNLKHLDLSFNAFDAL 105

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 25/113 (22%), Positives = 39/113 (34%), Gaps = 4/113 (3%)

Query: 12  GNLKNLIKLDVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDL 70
               NL  LD+  N+    PI    G+++ L  L LS+  L       IA +     L +
Sbjct: 87  HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLV 146

Query: 71  SNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
                      E   L   +  +L     +    F      S+ TV +L  +N
Sbjct: 147 LGETYGEKEDPE--GLQDFNTESLHIVFPTNK-EFHFILDVSVKTVANLELSN 196

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAF--IKSFKNEAQVLSQVL- 260
           ++F+    +G G +G V  A++   G ++A+K L     L    ++    E ++LS    
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82

Query: 261 HRNIVKLYGYCLH-KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHAL 318
           H  + +L+  C      +F + E++  G L  ++  +    E     R     A +  AL
Sbjct: 83  HPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE----ARARFYAAEIISAL 137

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL-LHADSSNRTLLAGTYGYIAP 377
            +LH      II+RD+  +N+LL+ +    +ADFG  +  +    +  T   GT  YIAP
Sbjct: 138 MFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIAP 193

Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           E+   M+     D ++ GV+  E+L G  P
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 26/100 (26%), Positives = 45/100 (45%), Gaps = 4/100 (4%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPS-ALGSLTNLSNLDLSSNKLSGKIPPEIA 60
            I  IP      + +L++LD+G    +  I   A   L NL  L+L    +     P + 
Sbjct: 158 PIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD--MPNLT 215

Query: 61  SMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
            +  L +L++S N+     PG    LS L  L + ++++S
Sbjct: 216 PLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS 255

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 69.8 bits (171), Expect = 5e-13
 Identities = 27/100 (27%), Positives = 43/100 (43%), Gaps = 5/100 (5%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPE-IA 60
           K+  I       L NL  L++G  ++   +P  L  L  L  L++S N    +I P    
Sbjct: 183 KLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFP-EIRPGSFH 239

Query: 61  SMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
            +  L +L + N+ +          L+ L  LNL+ N LS
Sbjct: 240 GLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 24/91 (26%), Positives = 46/91 (50%), Gaps = 4/91 (4%)

Query: 9   PEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPE-IASMKYLTQ 67
           P +  L  L +L++  N      P +   L++L  L + ++++S  I       +  L +
Sbjct: 212 PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVE 270

Query: 68  LDLSNNNIQGSIPGEI-TKLSRLDYLNLSSN 97
           L+L++NN+  S+P ++ T L  L  L+L  N
Sbjct: 271 LNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 23/96 (23%), Positives = 38/96 (39%), Gaps = 6/96 (6%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYL 65
           +P  I    N   L++  N++          L +L  L L  N +  +I       +  L
Sbjct: 69  VPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASL 125

Query: 66  TQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLS 100
             L+L +N +   IP      LS+L  L L +N + 
Sbjct: 126 NTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE 160

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 21/76 (27%), Positives = 36/76 (47%), Gaps = 3/76 (3%)

Query: 3   KIGIIPPE-IGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-A 60
               I P     L +L KL V ++ +     +A   L +L  L+L+ N LS  +P ++  
Sbjct: 229 HFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFT 287

Query: 61  SMKYLTQLDLSNNNIQ 76
            ++YL +L L +N   
Sbjct: 288 PLRYLVELHLHHNPWN 303

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 24/214 (11%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAF--IKSFKNEAQVLSQVL- 260
            DF     IG G +G V  A+       +A+K L     L     K   +E  VL + + 
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97

Query: 261 HRNIVKLYGYCLH-KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHAL 318
           H  +V L+ +       ++ + +Y+  G LF +L      +E     R     A +A AL
Sbjct: 98  HPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLE----PRARFYAAEIASAL 152

Query: 319 AYLHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARL-LHADSSNRTLLAGTYG 373
            YLH   S +I++RD+   NILL+S     L     DFG  +  +  +S+  T   GT  
Sbjct: 153 GYLH---SLNIVYRDLKPENILLDSQGHIVL----TDFGLCKENIEHNSTTST-FCGTPE 204

Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP 407
           Y+APE+ +        D +  G V  E+L G  P
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 35/129 (27%), Positives = 58/129 (44%), Gaps = 7/129 (5%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           +I  I P +  L NL  L +G+  +     + L +L+ L+ L    NK+S  I P +AS+
Sbjct: 140 QITNISP-LAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKIS-DISP-LASL 194

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN 122
             L ++ L NN I   +   +   S L  + L++  ++    F NN+L   + V   S  
Sbjct: 195 PNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGA 252

Query: 123 NGLCGNILD 131
                 I D
Sbjct: 253 PIAPATISD 261

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 29/105 (27%), Positives = 55/105 (52%), Gaps = 7/105 (6%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           +I  + P + NL  + +L++  N L     SA+  L ++  LDL+S +++  + P +A +
Sbjct: 74  QITDLAP-LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQIT-DVTP-LAGL 128

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSN 107
             L  L L  N I  +I   +  L+ L YL++ + ++S   P +N
Sbjct: 129 SNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDLTPLAN 171

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 19/95 (20%), Positives = 38/95 (40%), Gaps = 6/95 (6%)

Query: 13  NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSN 72
            L N IK+  G +++   +      L  ++ L      ++  I   +  +  L  L+L +
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72

Query: 73  NNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSN 107
           N I   +   +  L+++  L LS N L      + 
Sbjct: 73  NQIT-DLAP-LKNLTKITELELSGNPLKNVSAIAG 105

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 66.3 bits (162), Expect = 4e-12
 Identities = 30/106 (28%), Positives = 51/106 (48%), Gaps = 7/106 (6%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           +I  + P +  L NL  L +  N +     S L  LTNL  L + + ++S  + P +A++
Sbjct: 118 QITDVTP-LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS-DLTP-LANL 172

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNN 108
             LT L   +N I   I   +  L  L  ++L +N++S   P +N 
Sbjct: 173 SKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSPLANT 216

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 65.1 bits (159), Expect = 9e-12
 Identities = 21/100 (21%), Positives = 47/100 (47%), Gaps = 6/100 (6%)

Query: 8   PPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQ 67
                +L  +  L       +  I   +  L NL  L+L  N+++  + P + ++  +T+
Sbjct: 34  TVTQADLDGITTLSAFGT-GVTTI-EGVQYLNNLIGLELKDNQIT-DLAP-LKNLTKITE 89

Query: 68  LDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSN 107
           L+LS N ++ ++   I  L  +  L+L+S +++   P + 
Sbjct: 90  LELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTPLAG 127

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 26/106 (24%), Positives = 43/106 (40%), Gaps = 5/106 (4%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           ++  + P + NL  L  L    N +     S L SL NL  + L +N++S  + P +A+ 
Sbjct: 162 QVSDLTP-LANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQIS-DVSP-LANT 216

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNN 108
             L  + L+N  I          L   + +   S     P   S+N
Sbjct: 217 SNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDN 262

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 14/75 (18%), Positives = 28/75 (37%), Gaps = 4/75 (5%)

Query: 33  SALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYL 92
               +L N   +    + ++       A +  +T L      +  +I G +  L+ L  L
Sbjct: 13  FPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGL 68

Query: 93  NLSSNKLSGPVPFSN 107
            L  N+++   P  N
Sbjct: 69  ELKDNQITDLAPLKN 83

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 35/118 (29%), Positives = 46/118 (38%), Gaps = 6/118 (5%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYL 65
           +P     L  L  LDV  N L      AL  L  L  L L  N+L   +PP +      L
Sbjct: 92  LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKL 150

Query: 66  TQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN 122
            +L L+NNN+   +P  +   L  LD L L  N L   +P        +     L  N
Sbjct: 151 EKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLL-PFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 65.1 bits (159), Expect = 6e-12
 Identities = 27/94 (28%), Positives = 46/94 (48%), Gaps = 5/94 (5%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLT 66
           +PP++   K+   L +  N L     + L   T L+ L+L   +L+        ++  L 
Sbjct: 25  LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT--KLQVDGTLPVLG 80

Query: 67  QLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
            LDLS+N +Q S+P     L  L  L++S N+L+
Sbjct: 81  TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT 113

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 46.6 bits (111), Expect = 8e-06
 Identities = 14/70 (20%), Positives = 27/70 (38%), Gaps = 3/70 (4%)

Query: 38  LTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSN 97
           + +   ++     L+  +PP++      T L LS N +       +   +RL  LNL   
Sbjct: 9   VASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65

Query: 98  KLSGPVPFSN 107
           +L+       
Sbjct: 66  ELTKLQVDGT 75

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 28/106 (26%), Positives = 45/106 (42%), Gaps = 10/106 (9%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAS 61
           KI  I  E       L +L +G N +      +L  L  L  L L +NKLS ++P  +  
Sbjct: 204 KIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPD 262

Query: 62  MKYLTQLDLSNNNIQGSIP-------GEITKLSRLDYLNLSSNKLS 100
           +K L  + L  NNI   +        G   K +  + ++L +N + 
Sbjct: 263 LKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 25/124 (20%), Positives = 49/124 (39%), Gaps = 8/124 (6%)

Query: 3   KIGIIPPE-IGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAS 61
            I  +  +    L++L  L + +N +      A   L  L  L +S N L  +IPP +  
Sbjct: 65  DISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL-- 121

Query: 62  MKYLTQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLSGPVPFSNNDLSSMH-TVVSL 119
              L +L + +N I+  +P  + + L  ++ + +  N L     F       +    + +
Sbjct: 122 PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLE-NSGFEPGAFDGLKLNYLRI 179

Query: 120 SPNN 123
           S   
Sbjct: 180 SEAK 183

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 20/106 (18%), Positives = 38/106 (35%), Gaps = 12/106 (11%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-- 59
           +I +I       L  L +L + +N L   +P+ L  L  L  + L +N ++ K+      
Sbjct: 228 QIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFC 285

Query: 60  -----ASMKYLTQLDLSNNNIQGSI--PGEITKLSRLDYLNLSSNK 98
                    Y   + L NN +      P     ++    +   + K
Sbjct: 286 PVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 36/145 (24%), Positives = 54/145 (37%), Gaps = 27/145 (18%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSL-IGPIPSAL---------------------GSLT 39
           +I  +P  +   L+N+  +++G N L                                  
Sbjct: 134 RIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPE 193

Query: 40  NLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNK 98
            L+ L L  NK+   I  E       L +L L +N I+    G ++ L  L  L+L +NK
Sbjct: 194 TLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNK 252

Query: 99  LSGPVPFSNNDLSSMHTVVSLSPNN 123
           LS  VP    DL  +   V L  NN
Sbjct: 253 LSR-VPAGLPDLKLLQV-VYLHTNN 275

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 60.0 bits (146), Expect = 4e-10
 Identities = 23/101 (22%), Positives = 47/101 (46%), Gaps = 7/101 (6%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-A 60
           KI  I  +    L+ L KL +  N L+  IP      ++L  L +  N++  K+P  + +
Sbjct: 89  KISKIHEKAFSPLRKLQKLYISKNHLVE-IPP--NLPSSLVELRIHDNRIR-KVPKGVFS 144

Query: 61  SMKYLTQLDLSNNNIQ-GSIPGEITKLSRLDYLNLSSNKLS 100
            ++ +  +++  N ++            +L+YL +S  KL+
Sbjct: 145 GLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT 185

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 18/71 (25%), Positives = 33/71 (46%), Gaps = 4/71 (5%)

Query: 31  IPSALGSLTNLSNLDLSSNKLSGKIPPE-IASMKYLTQLDLSNNNIQGSIPGEITKLSRL 89
           +P  +    + + LDL +N +S ++  +    +++L  L L NN I        + L +L
Sbjct: 48  VPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104

Query: 90  DYLNLSSNKLS 100
             L +S N L 
Sbjct: 105 QKLYISKNHLV 115

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 44/231 (19%), Positives = 72/231 (31%), Gaps = 73/231 (31%)

Query: 202 EATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLH-----------TSEELAFIKSF 249
              +++ I++ IG G YG VY A      K  A+KK++              E+  +   
Sbjct: 23  HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL 82

Query: 250 KNEAQVLSQVLHRNIVKLY-----GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDW 304
           K             I++LY        L    ++++ E  +      +L           
Sbjct: 83  K----------SDYIIRLYDLIIPDDLLKFDELYIVLEIAD-----SDLKK--------- 118

Query: 305 AKRVNIVKAMAH---------------ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFV 349
                + K                      ++H      IIHRD+   N LLN      V
Sbjct: 119 -----LFKTPIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKV 170

Query: 350 ADFGTARLLH--ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVT 398
            DFG AR ++   D++    L                +T     +   VVT
Sbjct: 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS----H---VVT 214

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 70.6 bits (172), Expect = 4e-13
 Identities = 28/93 (30%), Positives = 41/93 (44%), Gaps = 4/93 (4%)

Query: 9   PEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQL 68
             +  L  +  LD+  N L   +P AL +L  L  L  S N L   +   +A++  L +L
Sbjct: 457 CHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQEL 513

Query: 69  DLSNNNIQG-SIPGEITKLSRLDYLNLSSNKLS 100
            L NN +Q  +    +    RL  LNL  N L 
Sbjct: 514 LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 60.5 bits (146), Expect = 6e-10
 Identities = 20/88 (22%), Positives = 38/88 (43%), Gaps = 4/88 (4%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSG-KIPPEIAS 61
           ++  +PP +  L+ L  L    N+L   +   + +L  L  L L +N+L        + S
Sbjct: 474 RLRALPPALAALRCLEVLQASDNALEN-VDG-VANLPRLQELLLCNNRLQQSAAIQPLVS 531

Query: 62  MKYLTQLDLSNNNIQGSIPGEITKLSRL 89
              L  L+L  N++     G   +L+ +
Sbjct: 532 CPRLVLLNLQGNSLC-QEEGIQERLAEM 558

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 42.4 bits (99), Expect = 3e-04
 Identities = 17/119 (14%), Positives = 41/119 (34%), Gaps = 23/119 (19%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSG--------- 53
           K  ++  E+ + K L +L+  +   +  I   + +L  L     +    S          
Sbjct: 360 KSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRA 419

Query: 54  ------------KIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
                       +          +  L L++ ++   +   + +L  + +L+LS N+L 
Sbjct: 420 AYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR 476

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 31/204 (15%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTS--EELAFIKSFKNEAQVLSQVLHRNIVKLYG 269
           +G G +G V  A      +  ALK +     ++       + E   L  + H +I+KLY 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA------MAHALAYLHH 323
                  + ++ EY   G LF  +            KR+   +       +  A+ Y H 
Sbjct: 77  VITTPTDIVMVIEYAG-GELFDYIVEK---------KRMTEDEGRRFFQQIICAIEYCH- 125

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPEL---- 379
                I+HRD+   N+LL+  L   +ADFG + ++   +  +T   G+  Y APE+    
Sbjct: 126 --RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAAPEVINGK 182

Query: 380 AYTMVMTEKCDVYSFGVVTLEVLM 403
            Y      + DV+S G+V L V++
Sbjct: 183 LYA---GPEVDVWSCGIV-LYVML 202

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 25/100 (25%), Positives = 43/100 (43%), Gaps = 3/100 (3%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAS 61
            +  IP E   +L  LI L +   ++      +   L  L  L++S       + P    
Sbjct: 163 NLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY 222

Query: 62  MKYLTQLDLSNNNIQGSIP-GEITKLSRLDYLNLSSNKLS 100
              LT L +++ N+  ++P   +  L  L +LNLS N +S
Sbjct: 223 GLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS 261

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 33/128 (25%), Positives = 53/128 (41%), Gaps = 10/128 (7%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-A 60
           ++ +IP  +   L NL KLD+  N ++  +      L NL +L++  N L   I     +
Sbjct: 91  RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFS 149

Query: 61  SMKYLTQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLS--GPVPFSNNDLSSMHTVV 117
            +  L QL L   N+  SIP E  + L  L  L L    ++      F    L  +   +
Sbjct: 150 GLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKR--LYRLKV-L 205

Query: 118 SLSPNNGL 125
            +S    L
Sbjct: 206 EISHWPYL 213

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 28/125 (22%), Positives = 51/125 (40%), Gaps = 8/125 (6%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPE-IA 60
            I  I       L  L  L++     +  +        NL++L ++   L+  +P   + 
Sbjct: 187 NINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVR 245

Query: 61  SMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS--GPVPFSNNDLSSMHTVVS 118
            + YL  L+LS N I       + +L RL  + L   +L+   P  F    L+ +  V++
Sbjct: 246 HLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRG--LNYLR-VLN 302

Query: 119 LSPNN 123
           +S N 
Sbjct: 303 VSGNQ 307

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 66.7 bits (163), Expect = 6e-12
 Identities = 24/99 (24%), Positives = 40/99 (40%), Gaps = 2/99 (2%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-AS 61
            +  + P      NL  L +   +L      A+  L  L  L+LS N +S  I   +   
Sbjct: 212 YLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHE 270

Query: 62  MKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
           +  L ++ L    +    P     L+ L  LN+S N+L+
Sbjct: 271 LLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT 309

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 63.2 bits (154), Expect = 7e-11
 Identities = 27/96 (28%), Positives = 44/96 (45%), Gaps = 6/96 (6%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYL 65
           +P  I        LD+G N +         S  +L  L+L+ N +S  + P    ++  L
Sbjct: 26  VPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNL 82

Query: 66  TQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLS 100
             L L +N ++  IP  + T LS L  L++S NK+ 
Sbjct: 83  RTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV 117

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 68.5 bits (168), Expect = 5e-13
 Identities = 26/102 (25%), Positives = 43/102 (42%), Gaps = 7/102 (6%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPS-ALGSLTNLSNLDLSSNKLSGKIPPEI- 59
            +  + P +   L  L  L +  N+ +  +P      L NL++L L  N++S  +P    
Sbjct: 116 GLQELGPGLFRGLAALQYLYLQDNA-LQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAF 173

Query: 60  ASMKYLTQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLS 100
             +  L +L L  N +   +       L RL  L L +N LS
Sbjct: 174 RGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS 214

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 25/96 (26%), Positives = 40/96 (41%), Gaps = 5/96 (5%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYL 65
           +P  I       ++ +  N +     ++  +  NL+ L L SN L+ +I       +  L
Sbjct: 26  VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALL 82

Query: 66  TQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLS 100
            QLDLS+N    S+       L RL  L+L    L 
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ 118

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 40.7 bits (96), Expect = 6e-04
 Identities = 12/57 (21%), Positives = 16/57 (28%), Gaps = 3/57 (5%)

Query: 44  LDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
                  L   +P  I       ++ L  N I             L  L L SN L+
Sbjct: 16  TSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA 69

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 69.8 bits (170), Expect = 7e-13
 Identities = 36/106 (33%), Positives = 54/106 (50%), Gaps = 7/106 (6%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           K+  I P + NLKNL  L +  N  I  + S+L  L  L +L L  N +S  I   +  +
Sbjct: 76  KLTDIKP-LTNLKNLGWLFLDENK-IKDL-SSLKDLKKLKSLSLEHNGIS-DING-LVHL 130

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNN 108
             L  L L NN I   I   +++L++LD L+L  N++S  VP +  
Sbjct: 131 PQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDIVPLAGL 174

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 68.2 bits (166), Expect = 2e-12
 Identities = 20/105 (19%), Positives = 41/105 (39%), Gaps = 7/105 (6%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
            I  I P        IK ++   S+   +      L ++  +  +++ +   +   I  +
Sbjct: 10  PIKQIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYL 64

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSN 107
             +T+L L+ N +   I   +T L  L +L L  NK+       +
Sbjct: 65  PNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIKDLSSLKD 107

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 67.8 bits (165), Expect = 3e-12
 Identities = 35/137 (25%), Positives = 55/137 (40%), Gaps = 7/137 (5%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
            I  I   + +L  L  L +G+N +     + L  LT L  L L  N++S  I P +A +
Sbjct: 120 GISDING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVP-LAGL 174

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN 122
             L  L LS N+I   +   +  L  LD L L S +         ++L   +TV +   +
Sbjct: 175 TKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGS 232

Query: 123 NGLCGNILDLPSCDTTK 139
                 I D    +   
Sbjct: 233 LVTPEIISDDGDYEKPN 249

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 64.4 bits (156), Expect = 4e-11
 Identities = 23/92 (25%), Positives = 44/92 (47%), Gaps = 6/92 (6%)

Query: 9   PEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQL 68
                L ++ ++   ++  I  +   +  L N++ L L+ NKL+  I P + ++K L  L
Sbjct: 37  VTQNELNSIDQIIANNSD-IKSV-QGIQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWL 92

Query: 69  DLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
            L  N I+  +   +  L +L  L+L  N +S
Sbjct: 93  FLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS 122

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 29/122 (23%), Positives = 44/122 (36%), Gaps = 9/122 (7%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSL--IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIA 60
           KI  I   +  L  L  L +  N +  I      L  LT L NL LS N +S  +   +A
Sbjct: 142 KITDITV-LSRLTKLDTLSLEDNQISDI----VPLAGLTKLQNLYLSKNHIS-DLRA-LA 194

Query: 61  SMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLS 120
            +K L  L+L +           + L   + +  +   L  P   S++       V    
Sbjct: 195 GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHL 254

Query: 121 PN 122
           P 
Sbjct: 255 PE 256

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 43.2 bits (101), Expect = 2e-04
 Identities = 17/98 (17%), Positives = 34/98 (34%), Gaps = 4/98 (4%)

Query: 9   PEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQL 68
             +  L  L  L +  N +      AL  L NL  L+L S +   K     +++     +
Sbjct: 169 VPLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 226

Query: 69  DLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFS 106
             ++ ++    P  I+     +  N+  +        S
Sbjct: 227 KNTDGSLV--TPEIISDDGDYEKPNVKWHLPEFTNEVS 262

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 69.4 bits (170), Expect = 7e-13
 Identities = 27/100 (27%), Positives = 44/100 (44%), Gaps = 4/100 (4%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPS-ALGSLTNLSNLDLSSNKLSGKIPPEIA 60
            I  IP      + +L +LD+G    +  I   A   L+NL  L+L+   L     P + 
Sbjct: 147 PIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE--IPNLT 204

Query: 61  SMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
            +  L +LDLS N++    PG    L  L  L +  +++ 
Sbjct: 205 PLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ 244

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 28/121 (23%), Positives = 49/121 (40%), Gaps = 7/121 (5%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYL 65
           +P  I    N   L++  N +     ++   L +L  L LS N +   I       +  L
Sbjct: 58  VPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANL 114

Query: 66  TQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNG 124
             L+L +N +  +IP      LS+L  L L +N +     ++ N + S+   + L     
Sbjct: 115 NTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRR-LDLGELKR 172

Query: 125 L 125
           L
Sbjct: 173 L 173

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 44.4 bits (105), Expect = 6e-05
 Identities = 20/84 (23%), Positives = 34/84 (40%), Gaps = 4/84 (4%)

Query: 40  NLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKL 99
             S +      L  ++P  I++      L+L  N IQ         L  L+ L LS N +
Sbjct: 44  QFSKVICVRKNLR-EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100

Query: 100 SGPVPFSNNDLSSMHTVVSLSPNN 123
                 + N L++++T + L  N 
Sbjct: 101 RTIEIGAFNGLANLNT-LELFDNR 123

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 28/101 (27%), Positives = 48/101 (47%), Gaps = 5/101 (4%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-A 60
           KI  +   +  +  +L +L +  N +     +A   LT+L  L+LS N L   I   +  
Sbjct: 286 KIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFE 344

Query: 61  SMKYLTQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLS 100
           ++  L  LDLS N+I+ ++  +    L  L  L L +N+L 
Sbjct: 345 NLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK 384

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 18/90 (20%), Positives = 32/90 (35%), Gaps = 3/90 (3%)

Query: 16  NLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSNNN 74
           ++  +D+  NS+     ++   L +L  L +        I       +  L  L L  N 
Sbjct: 31  HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 75  IQGSIPGEI-TKLSRLDYLNLSSNKLSGPV 103
               +       L+ L+ L L+   L G V
Sbjct: 91  FL-QLETGAFNGLANLEVLTLTQCNLDGAV 119

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 22/87 (25%), Positives = 42/87 (48%), Gaps = 4/87 (4%)

Query: 16  NLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSNNN 74
            +   D+  + +   + S     T+L  L L+ N+++ KI       + +L +L+LS N 
Sbjct: 276 GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNF 334

Query: 75  IQGSIPGEI-TKLSRLDYLNLSSNKLS 100
           +  SI   +   L +L+ L+LS N + 
Sbjct: 335 LG-SIDSRMFENLDKLEVLDLSYNHIR 360

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 26/98 (26%), Positives = 44/98 (44%), Gaps = 5/98 (5%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-A 60
           +I  I       L +L+KL++  N L         +L  L  LDLS N +   +  +   
Sbjct: 310 EINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFL 368

Query: 61  SMKYLTQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSN 97
            +  L +L L  N ++ S+P  I  +L+ L  + L +N
Sbjct: 369 GLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 22/92 (23%), Positives = 34/92 (36%), Gaps = 6/92 (6%)

Query: 13  NLKNLIKLDVGSNSLIGPIPSALGSL--TNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLD 69
           +    +    G  +   P       L  + +   DLS +K+   +   + +    L QL 
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLT 305

Query: 70  LSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLS 100
           L+ N I   I       L+ L  LNLS N L 
Sbjct: 306 LAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG 336

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 54.0 bits (130), Expect = 6e-08
 Identities = 13/64 (20%), Positives = 26/64 (40%), Gaps = 3/64 (4%)

Query: 39  TNLSNLDLSSNKLSGKIPPE-IASMKYLTQLDLSNNNIQGSIP-GEITKLSRLDYLNLSS 96
            +++ +DLS N ++ ++     + ++ L  L +        I       LS L  L L  
Sbjct: 30  AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88

Query: 97  NKLS 100
           N+  
Sbjct: 89  NQFL 92

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 32/143 (22%), Positives = 51/143 (35%), Gaps = 22/143 (15%)

Query: 13  NLKNLIKLDVGSNSL--IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI---ASMKYLTQ 67
            L +L  L +  N++  I P  S   ++     LDL+ NK+   I  E       K+ T 
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPA-SFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTL 184

Query: 68  LDLSNNNIQ--------GSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSL 119
           L LS+  +Q            G   K + +  L+LS N     +     D  +   + SL
Sbjct: 185 LRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSL 244

Query: 120 SPNNGL-------CGNILDLPSC 135
             +N           N  D  + 
Sbjct: 245 ILSNSYNMGSSFGHTNFKDPDNF 267

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 64.7 bits (158), Expect = 4e-12
 Identities = 19/102 (18%), Positives = 45/102 (44%), Gaps = 6/102 (5%)

Query: 3   KIGIIPPEIG--NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI- 59
           +  ++        L  L K++  +N +      A    + ++ + L+SN+L   +  ++ 
Sbjct: 43  EFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN-VQHKMF 101

Query: 60  ASMKYLTQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLS 100
             ++ L  L L +N I   +  +    LS +  L+L  N+++
Sbjct: 102 KGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT 142

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 54.7 bits (132), Expect = 9e-09
 Identities = 20/86 (23%), Positives = 36/86 (41%), Gaps = 4/86 (4%)

Query: 14  LKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSN 72
              + ++ + SN L          L +L  L L SN+++  +  +    +  +  L L +
Sbjct: 80  ASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYD 138

Query: 73  NNIQGSIP-GEITKLSRLDYLNLSSN 97
           N I  ++  G    L  L  LNL +N
Sbjct: 139 NQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 14/64 (21%), Positives = 29/64 (45%), Gaps = 3/64 (4%)

Query: 39  TNLSNLDLSSNKLSGKIPPEIA--SMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSS 96
              + L L++N+ +  +        +  L +++ SNN I     G     S ++ + L+S
Sbjct: 32  QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90

Query: 97  NKLS 100
           N+L 
Sbjct: 91  NRLE 94

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 35/106 (33%), Positives = 54/106 (50%), Gaps = 7/106 (6%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           K+  I P + NLKNL  L +  N  +  + S+L  L  L +L L  N +S  I   +  +
Sbjct: 79  KLTDIKP-LANLKNLGWLFLDENK-VKDL-SSLKDLKKLKSLSLEHNGIS-DING-LVHL 133

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNN 108
             L  L L NN I   I   +++L++LD L+L  N++S  VP +  
Sbjct: 134 PQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDIVPLAGL 177

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 33/114 (28%), Positives = 50/114 (43%), Gaps = 7/114 (6%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
            I  I   + +L  L  L +G+N +     + L  LT L  L L  N++S  I P +A +
Sbjct: 123 GISDING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGL 177

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV 116
             L  L LS N+I   +   +  L  LD L L S +         ++L   +TV
Sbjct: 178 TKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 229

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 18/105 (17%), Positives = 39/105 (37%), Gaps = 7/105 (6%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
            I  I          IK ++   S+   +      L ++  +  +++ +   +   I  +
Sbjct: 13  PIKQIFS-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYL 67

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSN 107
             +T+L L+ N +   I   +  L  L +L L  NK+       +
Sbjct: 68  PNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVKDLSSLKD 110

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 23/100 (23%), Positives = 46/100 (46%), Gaps = 6/100 (6%)

Query: 9   PEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQL 68
                L ++ ++   ++  I  +   +  L N++ L L+ NKL+  I P +A++K L  L
Sbjct: 40  VTQNELNSIDQIIANNSD-IKSV-QGIQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWL 95

Query: 69  DLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNN 108
            L  N ++  +   +  L +L  L+L  N +S      + 
Sbjct: 96  FLDENKVK-DLSS-LKDLKKLKSLSLEHNGISDINGLVHL 133

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 27/108 (25%), Positives = 42/108 (38%), Gaps = 9/108 (8%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSL--IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIA 60
           KI  I   +  L  L  L +  N +  I      L  LT L NL LS N +S  +   +A
Sbjct: 145 KITDITV-LSRLTKLDTLSLEDNQISDI----VPLAGLTKLQNLYLSKNHIS-DLRA-LA 197

Query: 61  SMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNN 108
            +K L  L+L +           + L   + +  +   L  P   S++
Sbjct: 198 GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDD 245

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 64.3 bits (157), Expect = 6e-12
 Identities = 31/117 (26%), Positives = 55/117 (47%), Gaps = 5/117 (4%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-A 60
            I +IPP      K L ++D+ +N +    P A   L +L++L L  NK++ ++P  +  
Sbjct: 43  TIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFE 101

Query: 61  SMKYLTQLDLSNNNIQGSIP-GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV 116
            +  L  L L+ N I   +       L  L+ L+L  NKL      + + L ++ T+
Sbjct: 102 GLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTM 157

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 58.1 bits (141), Expect = 6e-10
 Identities = 22/84 (26%), Positives = 42/84 (50%), Gaps = 4/84 (4%)

Query: 19  KLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSNNNIQG 77
           ++ +  N++    P A      L  +DLS+N++S ++ P+    ++ L  L L  N I  
Sbjct: 36  EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT- 93

Query: 78  SIPGEI-TKLSRLDYLNLSSNKLS 100
            +P  +   L  L  L L++NK++
Sbjct: 94  ELPKSLFEGLFSLQLLLLNANKIN 117

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 50.0 bits (120), Expect = 4e-07
 Identities = 20/63 (31%), Positives = 30/63 (47%), Gaps = 2/63 (3%)

Query: 39  TNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSN 97
             ++ + L  N +   IPP   +  K L ++DLSNN I    P     L  L+ L L  N
Sbjct: 32  ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90

Query: 98  KLS 100
           K++
Sbjct: 91  KIT 93

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 65.8 bits (161), Expect = 6e-12
 Identities = 57/279 (20%), Positives = 105/279 (37%), Gaps = 53/279 (18%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC 271
           IG+G +G     +     ++ A+K +     +   ++ + E      + H NIV+     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAID--ENVQREIINHRSLRHPNIVRFKEVI 85

Query: 272 LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA------HALAYLHHDC 325
           L    + +I EY   G L+  + N           R +  +A          ++Y H   
Sbjct: 86  LTPTHLAIIMEYASGGELYERICNA---------GRFSEDEARFFFQQLLSGVSYCH--- 133

Query: 326 SPSIIHRDISSNNILLNSKLEAF--VADFGTARLLHADSSNRTLLAGTYGYIAPEL---- 379
           S  I HRD+   N LL+        + DFG ++     S  ++ + GT  YIAPE+    
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRQ 192

Query: 380 AYTMVMTEKCDVYSFGVVTLEVLM-GKHP--RDILSSLSSSSDPKIMLIDVLDQRLPPPV 436
            Y     +  DV+S GV  L V++ G +P            +  +I+ +      +P  +
Sbjct: 193 EYD---GKIADVWSCGVT-LYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY---SIPDDI 245

Query: 437 D-----RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
                   +I  I            ++P +R ++  +  
Sbjct: 246 RISPECCHLISRI----------FVADPATRISIPEIKT 274

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 26/127 (20%), Positives = 48/127 (37%), Gaps = 17/127 (13%)

Query: 6   IIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYL 65
           I   ++     L  LD   N +   +   +     L+ L+  +N ++     ++     L
Sbjct: 161 ITKLDVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITK---LDLNQNIQL 214

Query: 66  TQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNN------DLSSMH-TVVS 118
           T LD S+N +   I   +T L++L Y + S N L+  +  S                 + 
Sbjct: 215 TFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVSTLSKLTTLHCIQTDLLEID 270

Query: 119 LSPNNGL 125
           L+ N  L
Sbjct: 271 LTHNTQL 277

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 22/132 (16%), Positives = 51/132 (38%), Gaps = 12/132 (9%)

Query: 6   IIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYL 65
           I   ++ +   L  LD  +  +   +   L     L  L L++ +L+ ++   ++    L
Sbjct: 288 IKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKL 341

Query: 66  TQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN-G 124
             L   N +IQ      + K+  L+    +  +           L++    +++SP+   
Sbjct: 342 KSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTIT---MPKETLTNNSLTIAVSPDLLD 396

Query: 125 LCGNILDLPSCD 136
             GN +++   D
Sbjct: 397 QFGNPMNIEPGD 408

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 26/98 (26%), Positives = 48/98 (48%), Gaps = 9/98 (9%)

Query: 11  IGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDL 70
              L  L  LD  ++S+     + +  LT L+ L  +SN ++     +++    LT L  
Sbjct: 38  EEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNITT---LDLSQNTNLTYLAC 92

Query: 71  SNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNN 108
            +N +  ++   +T L++L YLN  +NKL+  +  S N
Sbjct: 93  DSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVSQN 126

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 59.7 bits (145), Expect = 9e-10
 Identities = 30/117 (25%), Positives = 51/117 (43%), Gaps = 13/117 (11%)

Query: 9   PEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQL 68
             I  L  L KL   SN++   +   L   TNL+ L   SNKL+  +   +  +  LT L
Sbjct: 58  TGIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYL 111

Query: 69  DLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGL 125
           +   N +   +   +++   L YLN + N L+  +  S+N   +  T +    N  +
Sbjct: 112 NCDTNKLT-KLD--VSQNPLLTYLNCARNTLT-EIDVSHN---TQLTELDCHLNKKI 161

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 19/96 (19%), Positives = 42/96 (43%), Gaps = 9/96 (9%)

Query: 13  NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSN 72
           N  + +       +       +   L  L++LD  ++ ++      I  +  LT+L  ++
Sbjct: 19  NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTS 73

Query: 73  NNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNN 108
           NNI  ++   +++ + L YL   SNKL+  +  +  
Sbjct: 74  NNIT-TLD--LSQNTNLTYLACDSNKLTN-LDVTPL 105

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 57.0 bits (138), Expect = 6e-09
 Identities = 23/98 (23%), Positives = 40/98 (40%), Gaps = 9/98 (9%)

Query: 11  IGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDL 70
           +     L  L+   N+L   I   +   T L+ LD   NK       ++     LT LD 
Sbjct: 123 VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDC 177

Query: 71  SNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNN 108
           S N I   +   +++   L+ LN  +N ++  +  + N
Sbjct: 178 SFNKIT-ELD--VSQNKLLNRLNCDTNNITK-LDLNQN 211

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 32/159 (20%), Positives = 56/159 (35%), Gaps = 34/159 (21%)

Query: 10  EIGNLKNLIKLDVGSNSLIGPIPSALGSLT-------NLSNLDLSSNKLSGKI------- 55
           ++  L  L   D   N L     S L  LT       +L  +DL+ N             
Sbjct: 228 DVTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRK 287

Query: 56  --PPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNN----- 108
               ++     L  LD     I   +   +++  +L YL L++ +L+  +  S+N     
Sbjct: 288 IKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE-LDVSHNTKLKS 343

Query: 109 ---------DLSSMHTVVSLSPNNGLCGNILDLPSCDTT 138
                    D SS+  + +L+ N    G  + +P    T
Sbjct: 344 LSCVNAHIQDFSSVGKIPALNNNFEAEGQTITMPKETLT 382

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 50.5 bits (121), Expect = 8e-07
 Identities = 14/121 (11%), Positives = 36/121 (29%), Gaps = 13/121 (10%)

Query: 10  EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLD 69
           ++     L+ L + +  L   +   +   T L +L   +  +       +  +  L    
Sbjct: 313 DLSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNF 367

Query: 70  LSNNNIQGSIPGEITKLSRL------DYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN 123
            +      ++P E    + L      D L+   N ++   P            ++    +
Sbjct: 368 EAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMN-IEPGDGGVYDQATNTITWENLS 425

Query: 124 G 124
            
Sbjct: 426 T 426

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 22/95 (23%), Positives = 41/95 (43%), Gaps = 4/95 (4%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPS-ALGSLTNLSNLDLSSNKLSGKIPPEIAS-MKY 64
               +   +NL +L + +   +  +    L  L  L NL +  + L   + P+       
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKL 99
           L++L+LS N ++ S+  +  +   L  L LS N L
Sbjct: 82  LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 63.6 bits (154), Expect = 3e-11
 Identities = 19/100 (19%), Positives = 33/100 (33%), Gaps = 9/100 (9%)

Query: 31  IPSALGSLTNLSNLDLSSNKLSGKIPPE-IASMKYLTQLDLSNNNIQGSIPGEI-TKLSR 88
               L    NL+ L + + +    +    +  +  L  L +  + ++  +  +      R
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81

Query: 89  LDYLNLSSNKLSG--PVPFSNNDLSSMHTVVSLSPNNGLC 126
           L  LNLS N L            L  +     LS N   C
Sbjct: 82  LSRLNLSFNALESLSWKTVQGLSLQELV----LSGNPLHC 117

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 43.2 bits (101), Expect = 1e-04
 Identities = 12/77 (15%), Positives = 29/77 (37%), Gaps = 2/77 (2%)

Query: 48  SNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP-GEITKLSRLDYLNLSSNKLSGPVPFS 106
           +   +      +   + LT+L + N      +   ++  L  L  L +  + L    P +
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 107 NNDLSSMHTVVSLSPNN 123
            +    + + ++LS N 
Sbjct: 76  FHFTPRL-SRLNLSFNA 91

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 62.7 bits (153), Expect = 3e-11
 Identities = 18/90 (20%), Positives = 42/90 (46%), Gaps = 6/90 (6%)

Query: 11  IGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDL 70
              L N +K ++G  S+   +      L+ + N +  ++ +   +   +     L +L L
Sbjct: 15  DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHL 70

Query: 71  SNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
           S+N I   +   +  L++L+ L+++ N+L 
Sbjct: 71  SHNQIS-DLSP-LKDLTKLEELSVNRNRLK 98

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 27/108 (25%), Positives = 47/108 (43%), Gaps = 6/108 (5%)

Query: 13  NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSN 72
               L +L + +N L      +L  L NL  L + +NKL   I   +  +  L  LDL  
Sbjct: 104 PSACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHG 159

Query: 73  NNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLS 120
           N I  +  G +T+L ++++++L+  K          +L   +TV    
Sbjct: 160 NEIT-NTGG-LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPD 205

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 59.7 bits (145), Expect = 3e-10
 Identities = 25/98 (25%), Positives = 42/98 (42%), Gaps = 7/98 (7%)

Query: 11  IGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDL 70
           +    NL +L +  N  I  + S L  LT L  L ++ N+L   +         L++L L
Sbjct: 59  MQFFTNLKELHLSHNQ-ISDL-SPLKDLTKLEELSVNRNRLK-NLNGI--PSACLSRLFL 113

Query: 71  SNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNN 108
            NN ++      +  L  L+ L++ +NKL   V     
Sbjct: 114 DNNELR-DTDS-LIHLKNLEILSIRNNKLKSIVMLGFL 149

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 23/100 (23%), Positives = 40/100 (40%), Gaps = 8/100 (8%)

Query: 11  IGNLKNLIKLDVGSNSL--IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQL 68
           + +LKNL  L + +N L  I      LG L+ L  LDL  N+++      +  +K +  +
Sbjct: 124 LIHLKNLEILSIRNNKLKSI----VMLGFLSKLEVLDLHGNEIT-NTGG-LTRLKKVNWI 177

Query: 69  DLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNN 108
           DL+             +L   + +     +   P   SN 
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNG 217

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 64.1 bits (156), Expect = 4e-11
 Identities = 32/88 (36%), Positives = 46/88 (52%), Gaps = 4/88 (4%)

Query: 13  NLKNLIKLDVGSNSL-IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLS 71
           N+ +L  LDV  NSL             ++  L+LSSN L+G +   +     +  LDL 
Sbjct: 401 NMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLH 458

Query: 72  NNNIQGSIPGEITKLSRLDYLNLSSNKL 99
           NN I  SIP ++T L  L  LN++SN+L
Sbjct: 459 NNRIM-SIPKDVTHLQALQELNVASNQL 485

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 22/95 (23%), Positives = 42/95 (44%), Gaps = 7/95 (7%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYL 65
           +P ++        L +  NS+       +  L+ L  L LS N++   +   +    + L
Sbjct: 46  VPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDL 102

Query: 66  TQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
             LD+S+N +Q +I      ++ L +L+LS N   
Sbjct: 103 EYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFD 134

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 54.5 bits (131), Expect = 5e-08
 Identities = 18/88 (20%), Positives = 30/88 (34%)

Query: 13  NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSN 72
            LK+L+   V +   +    +       ++   LS +           S    T L+ + 
Sbjct: 303 ALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQ 362

Query: 73  NNIQGSIPGEITKLSRLDYLNLSSNKLS 100
           N    S+    + L RL  L L  N L 
Sbjct: 363 NVFTDSVFQGCSTLKRLQTLILQRNGLK 390

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 27/115 (23%), Positives = 40/115 (34%), Gaps = 14/115 (12%)

Query: 12  GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLS--GKIPPEIASMKYLTQLD 69
            +  +   L+   N     +     +L  L  L L  N L    K+     +M  L  LD
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLD 409

Query: 70  LSNNNIQGSIPGEITKL-SRLDYLNLSSNKLSGPVP-----------FSNNDLSS 112
           +S N++              +  LNLSSN L+G V              NN + S
Sbjct: 410 VSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMS 464

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 34/199 (17%), Positives = 70/199 (35%), Gaps = 18/199 (9%)

Query: 12  GNLKNLIKLDVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMK-YLTQLD 69
             + +L  LD+  N     P+    G+LT L+ L LS+ K        +A +      LD
Sbjct: 118 CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLD 177

Query: 70  LSNNNIQGSIPGEITKLSRLD-YLNLSSNKLSGPVPF-----------SNNDLSSMHTVV 117
           L + +I+G     +   +    +L    N L                 SN  L+  +   
Sbjct: 178 LVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQR 237

Query: 118 SLSPNNGLCGNI----LDLPSCDTTKPATLFVEIFLPLTIVLSVIVFACLLLAKRKYKKP 173
            ++  + L        + L   +TT   ++ +  F     V  + ++   +  +   ++ 
Sbjct: 238 LMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEF 297

Query: 174 KLEERATNNIDVFSIWNYD 192
              E A  ++ +  + N  
Sbjct: 298 TYSETALKSLMIEHVKNQV 316

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 44.5 bits (105), Expect = 6e-05
 Identities = 22/72 (30%), Positives = 35/72 (48%), Gaps = 8/72 (11%)

Query: 34  ALGSLTNLSN-----LDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSR 88
            +GS+T  SN     +D S+  L+  +P ++        L LS N+I      +I+ LS 
Sbjct: 21  IVGSMTPFSNELESMVDYSNRNLT-HVPKDLPPR--TKALSLSQNSISELRMPDISFLSE 77

Query: 89  LDYLNLSSNKLS 100
           L  L LS N++ 
Sbjct: 78  LRVLRLSHNRIR 89

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 61.2 bits (149), Expect = 4e-11
 Identities = 32/98 (32%), Positives = 46/98 (46%), Gaps = 5/98 (5%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
            I  +   +  LK    L + +N  I  I S+L  + NL  L L  N +  KI    A  
Sbjct: 36  PIEKMDATLSTLKACKHLALSTN-NIEKI-SSLSGMENLRILSLGRNLIK-KIENLDAVA 92

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
             L +L +S N I  S+ G I KL  L  L +S+NK++
Sbjct: 93  DTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKIT 128

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.8 bits (127), Expect = 4e-08
 Identities = 21/84 (25%), Positives = 38/84 (45%), Gaps = 4/84 (4%)

Query: 17  LIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQ 76
            ++L       I  + + L +L    +L LS+N +  KI   ++ M+ L  L L  N I+
Sbjct: 27  KVELHGMIPP-IEKMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK 83

Query: 77  GSIPGEITKLSRLDYLNLSSNKLS 100
             I         L+ L +S N+++
Sbjct: 84  -KIENLDAVADTLEELWISYNQIA 106

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 51.2 bits (123), Expect = 1e-07
 Identities = 34/115 (29%), Positives = 50/115 (43%), Gaps = 8/115 (6%)

Query: 11  IGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDL 70
           +  ++NL  L +G N LI  I +       L  L +S N+++  +   I  +  L  L +
Sbjct: 66  LSGMENLRILSLGRN-LIKKIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYM 122

Query: 71  SNNNIQGSIPGEITKLSR---LDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN 122
           SNN I     GEI KL+    L+ L L+ N L      +N        VV   PN
Sbjct: 123 SNNKITN--WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPN 175

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 63.2 bits (154), Expect = 5e-11
 Identities = 47/235 (20%), Positives = 91/235 (38%), Gaps = 55/235 (23%)

Query: 208 DIRYCI----GTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV--- 259
           D RY +    G G + +V+ A+ + N    A+K +   +   + ++ ++E ++L +V   
Sbjct: 18  DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDA 75

Query: 260 --------LHRNIVKLYGYCLHKKC----MFLIYEYMERGSLFCNLHNNEDAVELDWAKR 307
                      +I+KL  +  HK      + +++E +   +L   +   E        + 
Sbjct: 76  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH-------RG 127

Query: 308 VNI--VKAMAH----ALAYLHHDCSPSIIHRDISSNNILLNSKLEAF------VADFGTA 355
           + +  VK ++      L Y+H  C   IIH DI   N+L+             +AD G A
Sbjct: 128 IPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

Query: 356 RLLHADSSNRTLLAGTYGYIAPE----LAYTMVMTEKCDVYSFGVVTLEVLMGKH 406
                   + T    T  Y +PE      +        D++S   +  E++ G  
Sbjct: 186 CWYD---EHYTNSIQTREYRSPEVLLGAPWGC----GADIWSTACLIFELITGDF 233

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 61.9 bits (151), Expect = 8e-11
 Identities = 35/105 (33%), Positives = 48/105 (45%), Gaps = 9/105 (8%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPPEI- 59
            +  +     G+LK L +L+V  N +    +P    +LTNL +LDLSSNK+   I     
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDL 169

Query: 60  ---ASMKYLT-QLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
                M  L   LDLS N +   I     K  RL  L L +N+L 
Sbjct: 170 RVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK 213

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 61.9 bits (151), Expect = 8e-11
 Identities = 27/105 (25%), Positives = 41/105 (39%), Gaps = 8/105 (7%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYL 65
           IP  +    +   LD+  N L      +  S   L  LDLS  ++   I      S+ +L
Sbjct: 22  IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78

Query: 66  TQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLSG--PVPFSN 107
           + L L+ N IQ S+     + LS L  L      L+     P  +
Sbjct: 79  STLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 55.4 bits (134), Expect = 9e-09
 Identities = 28/90 (31%), Positives = 43/90 (47%), Gaps = 7/90 (7%)

Query: 13  NLKNLIKLDVGSNSLIGPIPSALGSLTNL----SNLDLSSNKLSGKIPPEIASMKYLTQL 68
           NL NL  LD+ SN +     + L  L  +     +LDLS N ++  I P       L +L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKEL 205

Query: 69  DLSNNNIQGSIPGEI-TKLSRLDYLNLSSN 97
            L  N ++ S+P  I  +L+ L  + L +N
Sbjct: 206 ALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 28/96 (29%), Positives = 44/96 (45%), Gaps = 6/96 (6%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYL 65
           IP  +   + +  LD+ +N +     S L    NL  L L+SN ++  I  +  +S+  L
Sbjct: 46  IPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSL 102

Query: 66  TQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLS 100
             LDLS N +  ++       LS L +LNL  N   
Sbjct: 103 EHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK 137

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 24/145 (16%), Positives = 55/145 (37%), Gaps = 6/145 (4%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSL--IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI 59
            +  +       L +L  L++  N    +G   S    LT L  L + +     KI  + 
Sbjct: 111 YLSNLSSSWFKPLSSLTFLNLLGNPYKTLGE-TSLFSHLTKLQILRVGNMDTFTKIQRKD 169

Query: 60  -ASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVS 118
            A + +L +L++  +++Q   P  +  +  + +L L   +    +    +  SS+   + 
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSV-ECLE 228

Query: 119 LSPNNGLCGNILDLPSCDTTKPATL 143
           L   +    +  +L + +T      
Sbjct: 229 LRDTDLDTFHFSELSTGETNSLIKK 253

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 21/133 (15%), Positives = 51/133 (38%), Gaps = 17/133 (12%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAS 61
            +    P+   +++N+  L +     I  +   +   +++  L+L    L      E+++
Sbjct: 185 DLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST 244

Query: 62  --------MKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVP---FSNNDL 110
                         + +++ ++   +   + ++S L  L  S N+L   VP   F    L
Sbjct: 245 GETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDR--L 300

Query: 111 SSMHTVVSLSPNN 123
           +S+   + L  N 
Sbjct: 301 TSLQK-IWLHTNP 312

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 17/107 (15%), Positives = 41/107 (38%), Gaps = 12/107 (11%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGS--------LTNLSNLDLSSNKLSG 53
           +  ++         ++  L++    L     S L +             N+ ++   L  
Sbjct: 209 QHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF- 267

Query: 54  KIPPEIASMKYLTQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKL 99
           ++   +  +  L +L+ S N ++ S+P  I  +L+ L  + L +N  
Sbjct: 268 QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 47.4 bits (113), Expect = 5e-06
 Identities = 13/65 (20%), Positives = 24/65 (36%), Gaps = 3/65 (4%)

Query: 13  NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLS 71
                  + +   SL   +   L  ++ L  L+ S N+L   +P  I   +  L ++ L 
Sbjct: 252 KKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLH 309

Query: 72  NNNIQ 76
            N   
Sbjct: 310 TNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 17/56 (30%), Positives = 26/56 (46%), Gaps = 3/56 (5%)

Query: 45  DLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
             SS  L+  IP  +     +  LDLSNN I      ++ +   L  L L+SN ++
Sbjct: 37  KGSSGSLN-SIPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN 89

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 61.8 bits (149), Expect = 1e-10
 Identities = 31/252 (12%), Positives = 67/252 (26%), Gaps = 64/252 (25%)

Query: 203 ATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLH-------TSEELAFIKSFKNEAQV 255
            TE       IG G +G V++    +  V A+K +                +    E  +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIADHTPV-AIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 256 LSQVL---------HRNIVKLYGYCLHKKC------------------------------ 276
             ++              + L      +                                
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 336
           +F++ E+   G     +           A   +I+  +  +LA      S    HRD+  
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190

Query: 337 NNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM--VMTEKCDVYSF 394
            N+LL       +             + ++    + G     + YT+  +  +   V+  
Sbjct: 191 GNVLLKKTSLKKLHYTL---------NGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCD 241

Query: 395 GVVTLEVLMGKH 406
             +  ++  G  
Sbjct: 242 VSMDEDLFTGDG 253

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 4/87 (4%)

Query: 16  NLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSNNN 74
           +  KLD+ SN L      A   LT L  L L+ NKL   +P  I   +K L  L +++N 
Sbjct: 38  DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK 96

Query: 75  IQGSIPGEI-TKLSRLDYLNLSSNKLS 100
           +Q ++P  +  +L  L  L L  N+L 
Sbjct: 97  LQ-ALPIGVFDQLVNLAELRLDRNQLK 122

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 59.2 bits (144), Expect = 6e-10
 Identities = 33/119 (27%), Positives = 54/119 (45%), Gaps = 6/119 (5%)

Query: 7   IPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKY 64
           +P  +   L NL +L +  N L    P    SLT L+ L L  N+L   +P  +   +  
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTS 158

Query: 65  LTQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN 122
           L +L L NN ++  +P     KL+ L  L L +N+L      + + L  +  ++ L  N
Sbjct: 159 LKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKL-KMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 22/64 (34%), Positives = 35/64 (54%), Gaps = 4/64 (6%)

Query: 39  TNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSS 96
            +   LDL SNKLS  +P +    +  L  L L++N +Q ++P  I  +L  L+ L ++ 
Sbjct: 37  ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTD 94

Query: 97  NKLS 100
           NKL 
Sbjct: 95  NKLQ 98

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 58.8 bits (143), Expect = 2e-10
 Identities = 24/84 (28%), Positives = 42/84 (50%), Gaps = 5/84 (5%)

Query: 19  KLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSNNNIQG 77
           +L +  N     +P  L +  +L+ +DLS+N++S  +  +  ++M  L  L LS N ++ 
Sbjct: 35  ELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR- 91

Query: 78  SIP-GEITKLSRLDYLNLSSNKLS 100
            IP      L  L  L+L  N +S
Sbjct: 92  CIPPRTFDGLKSLRLLSLHGNDIS 115

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 52.3 bits (126), Expect = 5e-08
 Identities = 20/62 (32%), Positives = 36/62 (58%), Gaps = 1/62 (1%)

Query: 39  TNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNK 98
            +++ L L  N+ +  +P E+++ K+LT +DLSNN I        + +++L  L LS N+
Sbjct: 31  RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89

Query: 99  LS 100
           L 
Sbjct: 90  LR 91

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 21/121 (17%), Positives = 45/121 (37%), Gaps = 5/121 (4%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYL 65
           IP ++   +N I+L      L      A     +L  +++S N +   I  ++ +++  L
Sbjct: 24  IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81

Query: 66  TQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNG 124
            ++ +   N    I  E    L  L YL +S+  +                ++ +  N  
Sbjct: 82  HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK-VLLDIQDNIN 140

Query: 125 L 125
           +
Sbjct: 141 I 141

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 50.6 bits (121), Expect = 5e-07
 Identities = 25/125 (20%), Positives = 50/125 (40%), Gaps = 8/125 (6%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPS-ALGSLT-NLSNLDLSSNKLSGKIPPEI 59
            I  +P     +    + LD+  N  I  I   +   L+     L L+ N +  +I    
Sbjct: 115 GIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSA 173

Query: 60  ASMKYLTQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVS 118
            +   L +L+LS+NN    +P ++    S    L++S  ++       +  L ++  + +
Sbjct: 174 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH---SLPSYGLENLKKLRA 230

Query: 119 LSPNN 123
            S  N
Sbjct: 231 RSTYN 235

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 47.5 bits (113), Expect = 5e-06
 Identities = 19/100 (19%), Positives = 32/100 (32%), Gaps = 6/100 (6%)

Query: 3   KIGIIPPEI--GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI- 59
            I  I      G     + L +  N +     SA             +N L  ++P ++ 
Sbjct: 140 NIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVF 198

Query: 60  ASMKYLTQLDLSNNNIQGSIPGEI-TKLSRLDYLNLSSNK 98
                   LD+S   I  S+P      L +L   +  + K
Sbjct: 199 HGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK 237

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 49/225 (21%), Positives = 82/225 (36%), Gaps = 45/225 (20%)

Query: 205 EDFDIRY----CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV 259
           +    RY     IG G +G V KA      +  ALK +   +   F +    E ++L  +
Sbjct: 93  DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHL 150

Query: 260 LHR------NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLH-----NNEDAVELDWAKRV 308
             +      N++ +      +  + + +E +       NL+     N      L   ++ 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFELLS-----MNLYELIKKNKFQGFSLPLVRK- 204

Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF--VADFGTARLLHADSSNRT 366
               ++   L  LH      IIH D+   NILL  +  +   V DFG++   H       
Sbjct: 205 -FAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR----- 255

Query: 367 LLAGTYGYI------APELAYTMVMTEKCDVYSFGVVTLEVLMGK 405
                Y YI      APE+          D++S G +  E+L G 
Sbjct: 256 ----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 57.3 bits (139), Expect = 1e-09
 Identities = 20/104 (19%), Positives = 37/104 (35%), Gaps = 7/104 (6%)

Query: 3   KIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPS-ALGSLTNLSNLDLSSNKLSGKIPPEIA 60
            +  +      NL  +  +++ +   +  I   AL  L  L  L + +  L    P    
Sbjct: 67  TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTK 125

Query: 61  --SMKYLTQLDLSNNNIQGSIP-GEITKL-SRLDYLNLSSNKLS 100
             S      L++++N    SIP      L +    L L +N  +
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 55.4 bits (134), Expect = 6e-09
 Identities = 15/112 (13%), Positives = 43/112 (38%), Gaps = 2/112 (1%)

Query: 16  NLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSNNN 74
           +   L +    L      A  +L N+S + +S +    ++      ++  +T +++ N  
Sbjct: 32  STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91

Query: 75  IQGSIPGEI-TKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGL 125
               I  +   +L  L +L + +  L      +    + +  ++ ++ N  +
Sbjct: 92  NLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYM 143

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 18/104 (17%), Positives = 38/104 (36%), Gaps = 7/104 (6%)

Query: 3   KIGIIPPE--IGNLKNLIKLDVGSNSLIGPIPS-ALGSLTNLS-NLDLSSNKLSGKIPPE 58
            + + P    + +      L++  N  +  IP  A   L N +  L L +N  +  +   
Sbjct: 116 GLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGY 174

Query: 59  IASMKYLTQLDLSNNNIQGSIPGEI-TKL-SRLDYLNLSSNKLS 100
             +   L  + L+ N     I  +    + S    L++S   ++
Sbjct: 175 AFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 19/97 (19%), Positives = 35/97 (36%), Gaps = 7/97 (7%)

Query: 3   KIGIIPPEI-GNLKN-LIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIA 60
            +  IP      L N  + L + +N     +     + T L  + L+ NK    I  +  
Sbjct: 142 YMTSIPVNAFQGLCNETLTLKLYNNG-FTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAF 200

Query: 61  S--MKYLTQLDLSNNNIQGSIPGEI-TKLSRLDYLNL 94
                  + LD+S  ++  ++P +    L  L   N 
Sbjct: 201 GGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 26/90 (28%), Positives = 45/90 (50%), Gaps = 4/90 (4%)

Query: 13  NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLS 71
            L  L  L++  N L          LT L  L L++N+L+  +P  +   +  L +L L 
Sbjct: 57  GLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLG 115

Query: 72  NNNIQGSIP-GEITKLSRLDYLNLSSNKLS 100
            N ++ S+P G   +L++L  L L++N+L 
Sbjct: 116 GNQLK-SLPSGVFDRLTKLKELRLNTNQLQ 144

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 55.5 bits (134), Expect = 9e-09
 Identities = 32/105 (30%), Positives = 49/105 (46%), Gaps = 4/105 (3%)

Query: 14  LKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSN 72
           L  L  L + +N L          LT L  L L  N+L   +P  +   +  L +L L+ 
Sbjct: 82  LTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNT 140

Query: 73  NNIQGSIP-GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV 116
           N +Q SIP G   KL+ L  L+LS+N+L      + + L  + T+
Sbjct: 141 NQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTI 184

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 26/83 (31%), Positives = 41/83 (49%), Gaps = 4/83 (4%)

Query: 19  KLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSNNNIQG 77
           KLD+ S  L     +    LT L+ L+L  N+L   +   +   +  L  L L+NN +  
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA- 96

Query: 78  SIPGEI-TKLSRLDYLNLSSNKL 99
           S+P  +   L++LD L L  N+L
Sbjct: 97  SLPLGVFDHLTQLDKLYLGGNQL 119

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 29/87 (33%), Positives = 40/87 (45%), Gaps = 4/87 (4%)

Query: 13  NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLS 71
           +L  L KL +G N L          LT L  L L++N+L   IP      +  L  L LS
Sbjct: 105 HLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLS 163

Query: 72  NNNIQGSIP-GEITKLSRLDYLNLSSN 97
            N +Q S+P G   +L +L  + L  N
Sbjct: 164 TNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 18/62 (29%), Positives = 28/62 (45%)

Query: 39  TNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNK 98
            +   LDL S  L+         +  LT L+L  N +Q    G    L+ L  L L++N+
Sbjct: 35  ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94

Query: 99  LS 100
           L+
Sbjct: 95  LA 96

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 55.9 bits (135), Expect = 2e-09
 Identities = 28/88 (31%), Positives = 39/88 (44%), Gaps = 4/88 (4%)

Query: 13  NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSN 72
            ++ L+ LD    S  G I        NL  L L +  L   +   +  +  L +L+LS 
Sbjct: 25  AVRELV-LD-NCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSE 80

Query: 73  NNIQGSIPGEITKLSRLDYLNLSSNKLS 100
           N I G +     KL  L +LNLS NKL 
Sbjct: 81  NRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 51.3 bits (123), Expect = 6e-08
 Identities = 24/101 (23%), Positives = 40/101 (39%), Gaps = 11/101 (10%)

Query: 2   YKIGIIPPEIGNLKNLIKLDVGSNSL--IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI 59
              G I        NL  L + +  L  +  +P     L  L  L+LS N++ G +    
Sbjct: 36  SNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPK----LPKLKKLELSENRIFGGLDMLA 91

Query: 60  ASMKYLTQLDLSNNNIQGSIPGEITKLSR---LDYLNLSSN 97
             +  LT L+LS N ++      +  L +   L  L+L + 
Sbjct: 92  EKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLKSLDLFNC 130

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 54.7 bits (132), Expect = 3e-09
 Identities = 25/88 (28%), Positives = 40/88 (45%), Gaps = 4/88 (4%)

Query: 13  NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSN 72
           ++K L+ LD  S S  G +         L  L   +  L+  I   +  +  L +L+LS+
Sbjct: 18  DVKELV-LD-NSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSD 73

Query: 73  NNIQGSIPGEITKLSRLDYLNLSSNKLS 100
           N + G +     K   L +LNLS NK+ 
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 48.9 bits (117), Expect = 3e-07
 Identities = 27/99 (27%), Positives = 40/99 (40%), Gaps = 7/99 (7%)

Query: 2   YKIGIIPPEIGNLKNLIKLDVGSNSL--IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI 59
              G +       + L  L   +  L  I  +P     L  L  L+LS N++SG +    
Sbjct: 29  SNEGKLEGLTDEFEELEFLSTINVGLTSIANLPK----LNKLKKLELSDNRVSGGLEVLA 84

Query: 60  ASMKYLTQLDLSNNNIQG-SIPGEITKLSRLDYLNLSSN 97
                LT L+LS N I+  S    + KL  L  L+L + 
Sbjct: 85  EKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.8 bits (96), Expect = 2e-04
 Identities = 18/66 (27%), Positives = 31/66 (46%), Gaps = 1/66 (1%)

Query: 11  IGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSG-KIPPEIASMKYLTQLD 69
           +  L  L KL++  N + G +        NL++L+LS NK+        +  ++ L  LD
Sbjct: 60  LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119

Query: 70  LSNNNI 75
           L N  +
Sbjct: 120 LFNCEV 125

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 57.6 bits (139), Expect = 4e-09
 Identities = 57/304 (18%), Positives = 103/304 (33%), Gaps = 86/304 (28%)

Query: 205 EDFDIRYCI----GTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV 259
           + F+ RY +    G G + +V+ +  +   K  A+K +  S E  + ++  +E ++L  V
Sbjct: 33  DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAE-HYTETALDEIRLLKSV 90

Query: 260 L--------HRNIVKLYGYCLHK------KCMFLIYEYMERGSLFCNLHNNED-AVELDW 304
                       +V+L              CM  ++E +    L   +  +    + L  
Sbjct: 91  RNSDPNDPNREMVVQLLDDFKISGVNGTHICM--VFEVL-GHHLLKWIIKSNYQGLPLPC 147

Query: 305 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN---------------------- 342
            K+  I++ +   L YLH  C   IIH DI   NILL+                      
Sbjct: 148 VKK--IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAP 203

Query: 343 ---------------------------SKLEAFVADFGTARLLHADSSNRTLLAGTYGYI 375
                                       KL+  +AD G A  +H    + T    T  Y 
Sbjct: 204 PPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH---KHFTEDIQTRQYR 260

Query: 376 APELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKI--MLIDVLDQRLP 433
           + E+          D++S   +  E+  G +  +  S    + D     ++I++L     
Sbjct: 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG---K 317

Query: 434 PPVD 437
            P  
Sbjct: 318 VPRK 321

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 55.0 bits (133), Expect = 6e-09
 Identities = 25/85 (29%), Positives = 38/85 (44%), Gaps = 5/85 (5%)

Query: 19  KLDVGSNSLIGPIPSAL-GSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSNNNIQ 76
           +L +  N L       L G L +L  L+L  N+L+  I P       ++ +L L  N I+
Sbjct: 33  ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91

Query: 77  GSIP-GEITKLSRLDYLNLSSNKLS 100
             I       L +L  LNL  N++S
Sbjct: 92  -EISNKMFLGLHQLKTLNLYDNQIS 115

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 53.5 bits (129), Expect = 2e-08
 Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 6/99 (6%)

Query: 3   KIGIIPPE--IGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI- 59
           ++G I  +   G L +L+KL++  N L G  P+A    +++  L L  NK+  +I  ++ 
Sbjct: 40  ELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKMF 98

Query: 60  ASMKYLTQLDLSNNNIQGSIP-GEITKLSRLDYLNLSSN 97
             +  L  L+L +N I   +  G    L+ L  LNL+SN
Sbjct: 99  LGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 47.3 bits (113), Expect = 2e-06
 Identities = 16/64 (25%), Positives = 29/64 (45%), Gaps = 3/64 (4%)

Query: 39  TNLSNLDLSSNKLSGKIPPEIA--SMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSS 96
            + + L L+ N+L  +I  +     + +L +L+L  N + G  P      S +  L L  
Sbjct: 29  LHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87

Query: 97  NKLS 100
           NK+ 
Sbjct: 88  NKIK 91

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 53/223 (23%), Positives = 93/223 (41%), Gaps = 39/223 (17%)

Query: 205 EDFDIRYCI----GTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV 259
           E +  RY I    G G +G V KA      +  A+K +   +  AF+   + E ++L  +
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELM 107

Query: 260 LHR------NIVKLYGYCLHKKCMFLIYEYMERGSLFCNL-HNNEDAVELDWAKRVNIVK 312
                     IV L  + + +  + L++E +   +L+  L + N   V L+  ++    +
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRK--FAQ 164

Query: 313 AMAHALAYLHHDCSPSIIHRDISSNNILL--NSKLEAFVADFGTARLLHADSSNRTLLAG 370
            M  AL +L      SIIH D+   NILL    +    + DFG++  L            
Sbjct: 165 QMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY------- 216

Query: 371 TY----GYIAPE----LAYTMVMTEKCDVYSFGVVTLEVLMGK 405
            Y     Y +PE    + Y +      D++S G + +E+  G+
Sbjct: 217 QYIQSRFYRSPEVLLGMPYDL----AIDMWSLGCILVEMHTGE 255

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 30/88 (34%), Positives = 42/88 (47%), Gaps = 2/88 (2%)

Query: 13  NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLS 71
            L NL  L +  N L          LTNL  L L  N+L   +P  +   +  LT L+L+
Sbjct: 83  ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLA 141

Query: 72  NNNIQGSIPGEITKLSRLDYLNLSSNKL 99
           +N +Q    G   KL+ L  L+LS N+L
Sbjct: 142 HNQLQSLPKGVFDKLTNLTELDLSYNQL 169

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 52.7 bits (127), Expect = 8e-08
 Identities = 33/88 (37%), Positives = 48/88 (54%), Gaps = 4/88 (4%)

Query: 14  LKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSN 72
           L NL +L +  N L          LTNL+ L+L+ N+L   +P  +   +  LT+LDLS 
Sbjct: 108 LTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSY 166

Query: 73  NNIQGSIP-GEITKLSRLDYLNLSSNKL 99
           N +Q S+P G   KL++L  L L  N+L
Sbjct: 167 NQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 46.9 bits (112), Expect = 6e-06
 Identities = 24/93 (25%), Positives = 39/93 (41%), Gaps = 8/93 (8%)

Query: 9   PEIGNLKNLIKLDVGSNSL--IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLT 66
                L ++ ++   ++ +  +  I      L N+  L L  NKL   I   +  +  LT
Sbjct: 35  VTQNELNSIDQIIANNSDIKSVQGIQY----LPNVRYLALGGNKLH-DISA-LKELTNLT 88

Query: 67  QLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKL 99
            L L+ N +Q    G   KL+ L  L L  N+L
Sbjct: 89  YLILTGNQLQSLPNGVFDKLTNLKELVLVENQL 121

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 29/86 (33%), Positives = 42/86 (48%), Gaps = 4/86 (4%)

Query: 14  LKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSN 72
           L NL  L++  N L          LTNL+ LDLS N+L   +P  +   +  L  L L  
Sbjct: 132 LTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQ 190

Query: 73  NNIQGSIP-GEITKLSRLDYLNLSSN 97
           N ++ S+P G   +L+ L Y+ L  N
Sbjct: 191 NQLK-SVPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 16/82 (19%), Positives = 34/82 (41%), Gaps = 6/82 (7%)

Query: 19  KLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGS 78
           K ++   S+          L ++  +  +++ +  K    I  +  +  L L  N +   
Sbjct: 23  KANLKKKSVTDA--VTQNELNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNKLH-D 77

Query: 79  IPGEITKLSRLDYLNLSSNKLS 100
           I   + +L+ L YL L+ N+L 
Sbjct: 78  I-SALKELTNLTYLILTGNQLQ 98

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 53.1 bits (128), Expect = 2e-08
 Identities = 22/92 (23%), Positives = 37/92 (40%), Gaps = 3/92 (3%)

Query: 9   PEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQL 68
            +  N     +LD+     I  I +   +L     +D S N++  K+      ++ L  L
Sbjct: 13  AQYTNAVRDRELDLRGY-KIPVIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTL 69

Query: 69  DLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
            ++NN I     G    L  L  L L++N L 
Sbjct: 70  LVNNNRICRIGEGLDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 46.6 bits (111), Expect = 3e-06
 Identities = 24/99 (24%), Positives = 42/99 (42%), Gaps = 7/99 (7%)

Query: 2   YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAS 61
           YKI +I      L     +D   N  I  +      L  L  L +++N++         +
Sbjct: 29  YKIPVIENLGATLDQFDAIDFSDNE-IRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQA 86

Query: 62  MKYLTQLDLSNNNIQGSIPGEITKLS---RLDYLNLSSN 97
           +  LT+L L+NN++     G++  L+    L YL +  N
Sbjct: 87  LPDLTELILTNNSL--VELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 40.4 bits (95), Expect = 3e-04
 Identities = 18/67 (26%), Positives = 30/67 (44%), Gaps = 1/67 (1%)

Query: 11  IGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSG-KIPPEIASMKYLTQLD 69
              L+ L  L V +N +         +L +L+ L L++N L        +AS+K LT L 
Sbjct: 60  FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLC 119

Query: 70  LSNNNIQ 76
           +  N + 
Sbjct: 120 ILRNPVT 126

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 52.8 bits (127), Expect = 4e-08
 Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 2/82 (2%)

Query: 19  KLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSNNNIQG 77
            LD+ +NSL          LT+L+ L L  NKL   +P  +   +  LT L+LS N +Q 
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQS 90

Query: 78  SIPGEITKLSRLDYLNLSSNKL 99
              G   KL++L  L L++N+L
Sbjct: 91  LPNGVFDKLTQLKELALNTNQL 112

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 52.0 bits (125), Expect = 7e-08
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 4/89 (4%)

Query: 13  NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLS 71
            L +L +L +G N L          LT+L+ L+LS+N+L   +P  +   +  L +L L+
Sbjct: 50  ELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALN 108

Query: 72  NNNIQGSIP-GEITKLSRLDYLNLSSNKL 99
            N +Q S+P G   KL++L  L L  N+L
Sbjct: 109 TNQLQ-SLPDGVFDKLTQLKDLRLYQNQL 136

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 43.5 bits (103), Expect = 5e-05
 Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)

Query: 14  LKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSN 72
           L +L  L++ +N L          LT L  L L++N+L   +P  +   +  L  L L  
Sbjct: 75  LTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQ 133

Query: 73  NNIQGSIP-GEITKLSRLDYLNLSSN 97
           N ++ S+P G   +L+ L Y+ L  N
Sbjct: 134 NQLK-SVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 25/69 (36%), Positives = 34/69 (49%), Gaps = 2/69 (2%)

Query: 31 IPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLD 90
          +P+  G     + LDL +N L          +  LTQL L  N +Q    G   KL+ L 
Sbjct: 22 VPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLT 79

Query: 91 YLNLSSNKL 99
          YLNLS+N+L
Sbjct: 80 YLNLSTNQL 88

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 52.4 bits (126), Expect = 6e-08
 Identities = 26/82 (31%), Positives = 35/82 (42%), Gaps = 2/82 (2%)

Query: 19  KLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSNNNIQG 77
            L +  N +    P    SL NL  L L SN+L   +P  +  S+  LT LDL  N +  
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTV 102

Query: 78  SIPGEITKLSRLDYLNLSSNKL 99
                  +L  L  L +  NKL
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKL 124

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 52.4 bits (126), Expect = 6e-08
 Identities = 29/88 (32%), Positives = 48/88 (54%), Gaps = 3/88 (3%)

Query: 13  NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLS 71
           +L NL +L +GSN L         SLT L+ LDL +N+L+  +P  +   + +L +L + 
Sbjct: 62  SLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMC 120

Query: 72  NNNIQGSIPGEITKLSRLDYLNLSSNKL 99
            N +   +P  I +L+ L +L L  N+L
Sbjct: 121 CNKLT-ELPRGIERLTHLTHLALDQNQL 147

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 46.2 bits (110), Expect = 7e-06
 Identities = 26/84 (30%), Positives = 40/84 (47%), Gaps = 1/84 (1%)

Query: 14  LKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNN 73
           L  L  LD+G+N L     +    L +L  L +  NKL+ ++P  I  + +LT L L  N
Sbjct: 87  LTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145

Query: 74  NIQGSIPGEITKLSRLDYLNLSSN 97
            ++    G   +LS L +  L  N
Sbjct: 146 QLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 20/70 (28%), Positives = 35/70 (50%), Gaps = 2/70 (2%)

Query: 31  IPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLD 90
           +P+  G  TN   L L  N+++   P    S+  L +L L +N +     G    L++L 
Sbjct: 34  VPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT 91

Query: 91  YLNLSSNKLS 100
            L+L +N+L+
Sbjct: 92  VLDLGTNQLT 101

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 50.3 bits (121), Expect = 1e-07
 Identities = 28/83 (33%), Positives = 43/83 (51%), Gaps = 4/83 (4%)

Query: 19  KLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSNNNIQG 77
           +L++ SN L          LT L+ L LS N++   +P  +   +  LT L L  N +Q 
Sbjct: 32  RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ- 89

Query: 78  SIP-GEITKLSRLDYLNLSSNKL 99
           S+P G   KL++L  L L +N+L
Sbjct: 90  SLPNGVFDKLTQLKELALDTNQL 112

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 44.2 bits (105), Expect = 2e-05
 Identities = 25/86 (29%), Positives = 39/86 (45%), Gaps = 4/86 (4%)

Query: 14  LKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSN 72
           L  L KL +  N +          LT L+ L L  NKL   +P  +   +  L +L L  
Sbjct: 51  LTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDT 109

Query: 73  NNIQGSIP-GEITKLSRLDYLNLSSN 97
           N ++ S+P G   +L+ L  + L +N
Sbjct: 110 NQLK-SVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 43.8 bits (104), Expect = 3e-05
 Identities = 24/62 (38%), Positives = 34/62 (54%), Gaps = 2/62 (3%)

Query: 39 TNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSN 97
          ++ + L+L SNKL   +P  +   +  LT+L LS N IQ    G   KL++L  L L  N
Sbjct: 28 SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86

Query: 98 KL 99
          KL
Sbjct: 87 KL 88

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.0 bits (121), Expect = 6e-07
 Identities = 68/450 (15%), Positives = 133/450 (29%), Gaps = 140/450 (31%)

Query: 14  LKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQL----D 69
           L+ L KL       I P  ++     + SN+ L  + +  ++   + S  Y   L    +
Sbjct: 199 LEMLQKL----LYQIDPNWTSRSD--HSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLN 252

Query: 70  LSNNNIQGSIPGEITKLSRLDYLNLSS------------NKLSGPVPFSNNDLSSMHTVV 117
           + N                 +  NLS             + LS         +S  H  +
Sbjct: 253 VQNAKA-------------WNAFNLSCKILLTTRFKQVTDFLSAATTT---HISLDHHSM 296

Query: 118 SLSPNN--GLCGNIL-----DLPS--CDTTKPATLFVEIFLPLTIVL---SVIVFACLLL 165
           +L+P+    L    L     DLP     T            P  + +   S+        
Sbjct: 297 TLTPDEVKSLLLKYLDCRPQDLPREVLTT-----------NPRRLSIIAESIRDGLATWD 345

Query: 166 AKRKYKKPKLEERATNNIDV------------FSIWNYDGRI-------VYEDLIEATED 206
             +     KL     ++++V             S++     I       ++ D+I++   
Sbjct: 346 NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVM 405

Query: 207 FDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK 266
             +          S+ + Q     +     +  S  L      +NE       LHR+IV 
Sbjct: 406 VVVNKLHKY----SLVEKQPKESTIS----IP-SIYLELKVKLENEYA-----LHRSIVD 451

Query: 267 LY----GYCLHKK---------CMFLIY-----EYMERGSLFCNLHNNEDAVELDWAKR- 307
            Y     +                 + +     E+ ER +LF  +  +       + ++ 
Sbjct: 452 HYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLD-----FRFLEQK 506

Query: 308 -------VNIVKAMAHALA----YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR 356
                   N   ++ + L     Y  +      I  +      L+N+ +  F+       
Sbjct: 507 IRHDSTAWNASGSILNTLQQLKFYKPY------ICDNDPKYERLVNA-ILDFLPKIEE-N 558

Query: 357 LLHADSSN--RTLLAGTYGYIAPELAYTMV 384
           L+ +  ++  R  L      I  E A+  V
Sbjct: 559 LICSKYTDLLRIALMAEDEAIFEE-AHKQV 587

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 50.0 bits (118), Expect = 1e-06
 Identities = 18/105 (17%), Positives = 35/105 (33%), Gaps = 16/105 (15%)

Query: 12  GNLKNLIKLDV-------GSNSLIGPIPSAL--GSLTNLSNLDLSSNKLSGKIPPEIAS- 61
            +L NL KL +       G +  +             NL  L +   +    +       
Sbjct: 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLES 275

Query: 62  --MKYLTQLDLSNNNIQGS----IPGEITKLSRLDYLNLSSNKLS 100
             +  L  +D+S   +       +   + K+  L ++N+  N LS
Sbjct: 276 DILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 41.5 bits (96), Expect = 4e-04
 Identities = 17/101 (16%), Positives = 33/101 (32%), Gaps = 14/101 (13%)

Query: 14  LKNLIKLDVGSNSLIGPIPSALGS--LTNLSNLDL---SSNKLSGKIPPEIA------SM 62
             NL  L++ S  L   +   +    L NL  L L     +                   
Sbjct: 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRF 251

Query: 63  KYLTQLDLSNNNIQGSIPGEITK---LSRLDYLNLSSNKLS 100
             L  L + +   Q  +     +   L +L+ +++S+  L+
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLT 292

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 23/100 (23%), Positives = 36/100 (36%), Gaps = 13/100 (13%)

Query: 14  LKNLIKLDVGSNSL----IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM-----KY 64
           L+    + +    L       I SAL     L+ L+L SN+L       +          
Sbjct: 27  LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 86

Query: 65  LTQLDLSNNNIQ----GSIPGEITKLSRLDYLNLSSNKLS 100
           + +L L N  +     G +   +  L  L  L+LS N L 
Sbjct: 87  IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 126

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 45.3 bits (108), Expect = 3e-05
 Identities = 19/98 (19%), Positives = 34/98 (34%), Gaps = 13/98 (13%)

Query: 16  NLIKLDVGSNSL----IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM-----KYLT 66
            + KL + +  L     G + S L +L  L  L LS N L       +          L 
Sbjct: 86  KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLE 145

Query: 67  QLDLSNNNIQ----GSIPGEITKLSRLDYLNLSSNKLS 100
           +L L   ++       +   +        L +S+N ++
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 43.4 bits (103), Expect = 1e-04
 Identities = 21/101 (20%), Positives = 34/101 (33%), Gaps = 13/101 (12%)

Query: 13  NLKNLIKLDVGSNSL----IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM-----K 63
           +   L  L + S  +       +   + S  +L  L L SNKL      E+         
Sbjct: 197 SPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSS 256

Query: 64  YLTQLDLSNNNIQ----GSIPGEITKLSRLDYLNLSSNKLS 100
            L  L +    I     G +   +     L  L+L+ N+L 
Sbjct: 257 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG 297

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 43.4 bits (103), Expect = 1e-04
 Identities = 22/102 (21%), Positives = 36/102 (35%), Gaps = 14/102 (13%)

Query: 13  NLKNLIKLDVGSNSLIGPIPSALGSL-----TNLSNLDLSSNKLSGKIPPEIASM----K 63
            L  L +L +  N L       L          L  L L    LS      +AS+     
Sbjct: 111 TLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKP 170

Query: 64  YLTQLDLSNNNIQGSIPGEITKL-----SRLDYLNLSSNKLS 100
              +L +SNN+I  +    + +       +L+ L L S  ++
Sbjct: 171 DFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVT 212

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 42.6 bits (101), Expect = 2e-04
 Identities = 16/96 (16%), Positives = 34/96 (35%), Gaps = 10/96 (10%)

Query: 15  KNLIKLDVGSNSLIGP-IPSALGSLTNLSNLDLSSNKLSGKIPPEIASM----KYLTQLD 69
            ++  LD+    L        L  L     + L    L+     +I+S       L +L+
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 70  LSNNNIQGSIPGEITKL-----SRLDYLNLSSNKLS 100
           L +N +       + +       ++  L+L +  L+
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 98

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 16/99 (16%), Positives = 33/99 (33%), Gaps = 13/99 (13%)

Query: 15  KNLIKLDVGSNSL----IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM-----KYL 65
             L  L +    +     G +   L +  +L  L L+ N+L  +    +          L
Sbjct: 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQL 315

Query: 66  TQLDLSNNNIQG----SIPGEITKLSRLDYLNLSSNKLS 100
             L + + +            + +   L  L +S+N+L 
Sbjct: 316 ESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE 354

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 23/101 (22%), Positives = 35/101 (34%), Gaps = 13/101 (12%)

Query: 13  NLKNLIKLDVGSNSL----IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM-----K 63
               L  L V S S          S L     L  L +S+N+L      E+         
Sbjct: 311 PGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGS 370

Query: 64  YLTQLDLSNNNIQ----GSIPGEITKLSRLDYLNLSSNKLS 100
            L  L L++ ++      S+   +     L  L+LS+N L 
Sbjct: 371 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 41.1 bits (97), Expect = 7e-04
 Identities = 22/104 (21%), Positives = 42/104 (40%), Gaps = 14/104 (13%)

Query: 11  IGNLKNLIKLDVGSNSL----IGPIPSALGS-LTNLSNLDLSSNKLSGKIPPEIASM--- 62
           +   + L++L + +N L    +  +   LG   + L  L L+   +S      +A+    
Sbjct: 337 LAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLA 396

Query: 63  -KYLTQLDLSNNNIQGSIPGEITKL-----SRLDYLNLSSNKLS 100
              L +LDLSNN +  +   ++ +        L+ L L     S
Sbjct: 397 NHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 47.4 bits (113), Expect = 6e-06
 Identities = 24/102 (23%), Positives = 37/102 (36%), Gaps = 17/102 (16%)

Query: 15  KNLIKLDVGSNSLIGP-----IPSALGSLTNLSNLDLSSNKLSGKIPPEIASM------K 63
           + L  LD+  N+         +  AL S  NL  L L+   LS +    +          
Sbjct: 216 QELKVLDLQDNT-FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENI 274

Query: 64  YLTQLDLSNNNIQGSIPGEI-----TKLSRLDYLNLSSNKLS 100
            L  L L  N I+      +      K+  L +L L+ N+ S
Sbjct: 275 GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 17/116 (14%), Positives = 33/116 (28%), Gaps = 27/116 (23%)

Query: 11  IGNLKNLIKLDVGSNSL----------IGPIPSALGSLTNLSNLDLSSNKLSGK----IP 56
           I + K+L   +                +  +  AL     L  + LS N         + 
Sbjct: 56  IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLI 115

Query: 57  PEIASMKYLTQLDLSNNNI-------------QGSIPGEITKLSRLDYLNLSSNKL 99
             ++    L  L L NN +             + ++  +      L  +    N+L
Sbjct: 116 DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 19/110 (17%), Positives = 41/110 (37%), Gaps = 22/110 (20%)

Query: 11  IGNLKNLIKLDVGSNSLIGP-----IPSALGSLTNLSNLDLSSNKLSGKIPPEIAS---- 61
           +    ++ ++ +  N+ IG      +   + S  +L   + S     G++  EI      
Sbjct: 28  LLEDDSVKEIVLSGNT-IGTEAARWLSENIASKKDLEIAEFSDIFT-GRVKDEIPEALRL 85

Query: 62  -------MKYLTQLDLSNNNI--QG--SIPGEITKLSRLDYLNLSSNKLS 100
                     L  + LS+N         +   ++K + L++L L +N L 
Sbjct: 86  LLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG 135

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 18/103 (17%), Positives = 36/103 (34%), Gaps = 20/103 (19%)

Query: 17  LIKLDVGSNSL----IGPIPSALGSLTNLSNLDLSSNKLSGK----IPPEIASMKYLTQL 68
           +    +  +++       + + L    ++  + LS N +  +    +   IAS K L   
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 69  DLSNNNIQGSIPGEIT-----------KLSRLDYLNLSSNKLS 100
           + S+    G +  EI            K  +L  + LS N   
Sbjct: 66  EFSDIFT-GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG 107

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 19/105 (18%), Positives = 34/105 (32%), Gaps = 15/105 (14%)

Query: 10  EIGNLKNLIKLDVGSNSLIGP-----IPSALGSLTNLSNLDLSSNKLSGK-----IPPEI 59
           +  N   L  +  G N  +             S   L  + +  N +  +     +   +
Sbjct: 154 KAKNAPPLRSIICGRNR-LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGL 212

Query: 60  ASMKYLTQLDLSNNNI--QG--SIPGEITKLSRLDYLNLSSNKLS 100
           A  + L  LDL +N     G  ++   +     L  L L+   LS
Sbjct: 213 AYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 19/108 (17%), Positives = 33/108 (30%), Gaps = 21/108 (19%)

Query: 11  IGNLKNLIKLDVGSNSLIGP------IPSALGSLTNLSNLDLSSNKLSGKIPPEIASM-- 62
             + + L  + +  N  I P      +   L     L  LDL  N  +      +A    
Sbjct: 183 FQSHRLLHTVKMVQNG-IRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 241

Query: 63  --KYLTQLDLSNNNIQGSIPG--------EITKLSRLDYLNLSSNKLS 100
               L +L L++  +     G           +   L  L L  N++ 
Sbjct: 242 SWPNLRELGLNDCLLSAR--GAAAVVDAFSKLENIGLQTLRLQYNEIE 287

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 46.6 bits (111), Expect = 8e-06
 Identities = 30/154 (19%), Positives = 59/154 (38%), Gaps = 24/154 (15%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLH-RNIVKLYGY 270
           IG+G +G +Y    +  G+  A+K      +         E+++   +     I  +   
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWC 73

Query: 271 CLHKKCMFLIYEYMERGSL-----FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
                   ++ E +   SL     FC+   +   V       + +   M   + Y+H   
Sbjct: 74  GAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTV-------LLLADQMISRIEYIH--- 122

Query: 326 SPSIIHRDISSNNILLNSKLEA---FVADFGTAR 356
           S + IHRD+  +N L+    +    ++ DFG A+
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 30/157 (19%), Positives = 58/157 (36%), Gaps = 28/157 (17%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLH-RNIVKLYGY 270
           IG G +G +++   L N +  A+K      +       ++E +    +     I  +Y +
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYF 74

Query: 271 CLHKKCMFLIYEYMERGSL-----FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 325
                   L+ + +   SL      C    +   V           K M   +  +H   
Sbjct: 75  GQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTV-------AMAAKQMLARVQSIH--- 123

Query: 326 SPSIIHRDISSNNILL------NSKLEAFVADFGTAR 356
             S+++RDI  +N L+      N+ +  +V DFG  +
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMI-YVVDFGMVK 159

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 36/180 (20%), Positives = 69/180 (38%), Gaps = 33/180 (18%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLH--RNIVKLYG 269
           IG+G +G +Y    +   +  A+K  +   +         E+++  ++L     I  +  
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIY-RILQGGTGIPNVRW 70

Query: 270 YCLHKKCMFLIYEYMERGSL-----FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           + +      L+ + +   SL     FC+   +   V       + +   M + + ++H  
Sbjct: 71  FGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTV-------LMLADQMINRVEFVH-- 120

Query: 325 CSPSIIHRDISSNNILLNSKLEA---FVADFGTARL-------LHADSSNRTLLAGTYGY 374
            S S +HRDI  +N L+     A   ++ DFG A+         H        L GT  Y
Sbjct: 121 -SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 44.1 bits (105), Expect = 2e-05
 Identities = 24/71 (33%), Positives = 40/71 (56%), Gaps = 6/71 (8%)

Query: 31 IPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSNNNIQGSIP-GEITKLSR 88
          +P+  G  T    L L  N+++ K+ P +   +  LT+LDL NN +   +P G   KL++
Sbjct: 24 VPT--GIPTTTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQ 79

Query: 89 LDYLNLSSNKL 99
          L  L+L+ N+L
Sbjct: 80 LTQLSLNDNQL 90

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 42.2 bits (100), Expect = 8e-05
 Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 6/93 (6%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYL 65
           +P  I        L +  N +    P     LT L+ LDL +N+L+  +P  +   +  L
Sbjct: 24  VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQL 80

Query: 66  TQLDLSNNNIQGSIP-GEITKLSRLDYLNLSSN 97
           TQL L++N ++ SIP G    L  L ++ L +N
Sbjct: 81  TQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 31/158 (19%), Positives = 57/158 (36%), Gaps = 30/158 (18%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLH-RNIVKLYGY 270
           IG G +G +   + L   +  A+K                E +   Q+     I ++Y +
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA---PQLHLEYRFYKQLGSGDGIPQVYYF 73

Query: 271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR-------VNIVKAMAHALAYLHH 323
               K   ++ E +   SL       ED    D   R       + I   +   + Y+H 
Sbjct: 74  GPCGKYNAMVLELLGP-SL-------EDL--FDLCDRTFSLKTVLMIAIQLISRMEYVH- 122

Query: 324 DCSPSIIHRDISSNNILL-----NSKLEAFVADFGTAR 356
             S ++I+RD+   N L+      ++    + DF  A+
Sbjct: 123 --SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 50/248 (20%), Positives = 83/248 (33%), Gaps = 69/248 (27%)

Query: 205 EDFDIRY----CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV 259
              +  +     +G G +G V   Q + N K +A+K +   +   + +S K EA +L ++
Sbjct: 31  MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKI 88

Query: 260 LHR-----NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR------- 307
            +      NIVK +G  ++   M LI+E +   SL+            +   R       
Sbjct: 89  QNDDINNNNIVKYHGKFMYYDHMCLIFEPLGP-SLY------------EIITRNNYNGFH 135

Query: 308 VNIVKAMAH----ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS 363
           +  +K        AL YL    S  + H D+   NILL+                     
Sbjct: 136 IEDIKLYCIEILKALNYLR-KMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192

Query: 364 NRTLLAGT----------------YGYI------APE----LAYTMVMTEKCDVYSFGVV 397
                +                     I      APE    L + +      D++SFG V
Sbjct: 193 IYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDV----SSDMWSFGCV 248

Query: 398 TLEVLMGK 405
             E+  G 
Sbjct: 249 LAELYTGS 256

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 38/173 (21%), Positives = 67/173 (38%), Gaps = 42/173 (24%)

Query: 213 IGTGGYGSVYKAQLPNGKVFALK-----KLHTSE------ELAFIKSFKNEAQVLSQVLH 261
           IG GG+G +Y A + + +          K+  S+      EL F +      Q+   +  
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 262 RN-----IVKLYGYCLHKKCM----FLIYEYMERGSLFCNLHNNEDAVELDWAKR----- 307
           R      + K +G  LH K      F+I   M+R     +L   +     +   +     
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMI---MDR--FGSDL---QKI--YEANAKRFSRK 152

Query: 308 --VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE--AFVADFGTAR 356
             + +   +   L Y+H       +H DI ++N+LLN K     ++ D+G A 
Sbjct: 153 TVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 43.0 bits (102), Expect = 4e-05
 Identities = 22/71 (30%), Positives = 41/71 (57%), Gaps = 6/71 (8%)

Query: 31 IPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYLTQLDLSNNNIQGSIP-GEITKLSR 88
          +P+  G  T+   L L++N+++ K+ P +   +  L QL  ++N +  +IP G   KL++
Sbjct: 27 VPA--GIPTDKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82

Query: 89 LDYLNLSSNKL 99
          L  L+L+ N L
Sbjct: 83 LTQLDLNDNHL 93

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 42.6 bits (101), Expect = 7e-05
 Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 6/93 (6%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEI-ASMKYL 65
           +P  I    +  +L + +N +    P     L NL  L  +SNKL+  IP  +   +  L
Sbjct: 27  VPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQL 83

Query: 66  TQLDLSNNNIQGSIP-GEITKLSRLDYLNLSSN 97
           TQLDL++N+++ SIP G    L  L ++ L +N
Sbjct: 84  TQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 47/245 (19%), Positives = 87/245 (35%), Gaps = 67/245 (27%)

Query: 205 EDFDIRY----CIGTGGYGSVYKAQ--LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQ 258
           +    RY     +G G +G V +       G+  A+K +   +   + ++ ++E QVL  
Sbjct: 10  DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEH 67

Query: 259 VLHR------NIVKLYGYCLHKKCMFLIYEYMERGSLFCNL-HNNEDAVELDWAKRVNIV 311
           +           V++  +  H   + +++E +   S +  +  N      L      + +
Sbjct: 68  LNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRL------DHI 120

Query: 312 KAMAH----ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVA----------------- 350
           + MA+    ++ +LH   S  + H D+   NIL                           
Sbjct: 121 RKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177

Query: 351 --DFGTARLLHADSSNRTLLAGTY----GYIAPE----LAYTMVMTEKCDVYSFGVVTLE 400
             DFG+A       S       T      Y APE    L ++      CDV+S G + +E
Sbjct: 178 VVDFGSATYDDEHHS-------TLVSTRHYRAPEVILALGWSQ----PCDVWSIGCILIE 226

Query: 401 VLMGK 405
             +G 
Sbjct: 227 YYLGF 231

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 25/104 (24%), Positives = 43/104 (41%), Gaps = 17/104 (16%)

Query: 13  NLKNLIKLDVGSNSLIGP-----IPSALGSL-TNLSNLDLSSNKLSGKIPPEIASM---- 62
              ++  L++  NS +G      +   L ++  N+++L+LS N LS K   E+       
Sbjct: 49  TPASVTSLNLSGNS-LGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAI 107

Query: 63  -KYLTQLDLSNNNIQGSIPGEITKL-----SRLDYLNLSSNKLS 100
              +T LDL  N+       E  +      + +  LNL  N L 
Sbjct: 108 PFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG 151

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 20/80 (25%), Positives = 34/80 (42%), Gaps = 10/80 (12%)

Query: 31  IPSALGSLTNLSNLDLSSNKLSGKIPPEIASM-----KYLTQLDLSNNNIQGSIPGEITK 85
           +         +++LDLS N L      E+          +T L+LS N++      E+ +
Sbjct: 14  VEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQ 73

Query: 86  L-----SRLDYLNLSSNKLS 100
           +     + +  LNLS N LS
Sbjct: 74  ILAAIPANVTSLNLSGNFLS 93

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 21/100 (21%), Positives = 43/100 (43%), Gaps = 16/100 (16%)

Query: 15  KNLIKLDVGSNSLIGP-----IPSALGSL-TNLSNLDLSSNKLSGKIPPEIASM-----K 63
            N+  L++  N+ +       +   L S+  ++++LDLS+N L  K   E+A +      
Sbjct: 167 ANVNSLNLRGNN-LASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPN 225

Query: 64  YLTQLDLSNNNIQGS----IPGEITKLSRLDYLNLSSNKL 99
           ++  L+L  N + G     +      L  L  + L  + +
Sbjct: 226 HVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIV 265

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 33/173 (19%), Positives = 63/173 (36%), Gaps = 42/173 (24%)

Query: 213 IGTGGYGSVYKAQ---------LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL--- 260
                 G +Y+A           P  + F+LK       L   ++F   A    QV    
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 261 ------HRNIVKLYGYCLH-KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR------ 307
                    I    G+ +H  K  FL+   +    L  +L   + A  LD + +      
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLV---LPS--LGRSL---QSA--LDVSPKHVLSER 159

Query: 308 --VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEA--FVADFGTAR 356
             + +   +  AL +LH       +H ++++ NI ++ + ++   +A +G A 
Sbjct: 160 SVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 49/249 (19%), Positives = 77/249 (30%), Gaps = 75/249 (30%)

Query: 205 EDFDIRY----CIGTGGYGSVYKA--QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQ 258
           +    RY     +G G +G V +           ALK +       + ++ + E  VL +
Sbjct: 15  DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKK 72

Query: 259 VLHR------NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLH-----NNEDAVELDWAKR 307
           +  +        V +  +      M + +E      L  N       NN     L     
Sbjct: 73  IKEKDKENKFLCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPL----- 122

Query: 308 VNIVKAMAH----ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVA------------- 350
              V+ MA+    AL +LH      + H D+   NIL  +     +              
Sbjct: 123 -PHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKN 178

Query: 351 ------DFGTARLLHADSSNRTLLAGTY----GYIAPE----LAYTMVMTEKCDVYSFGV 396
                 DFG+A   H   +       T      Y  PE    L +       CDV+S G 
Sbjct: 179 TSIRVADFGSATFDHEHHT-------TIVATRHYRPPEVILELGWAQ----PCDVWSIGC 227

Query: 397 VTLEVLMGK 405
           +  E   G 
Sbjct: 228 ILFEYYRGF 236

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 40.9 bits (96), Expect = 6e-04
 Identities = 14/102 (13%), Positives = 29/102 (28%), Gaps = 17/102 (16%)

Query: 15  KNLIKLDVGSNSLIGP-----IPSALGSLTNLSNLDLSSNKLSGKIPPEIASM----KYL 65
            ++  L +     +G      + + L     L  L+++ N         +A        L
Sbjct: 183 TSVTHLSLLHTG-LGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSL 241

Query: 66  TQLDLSNNNIQ-------GSIPGEITKLSRLDYLNLSSNKLS 100
             L L  N +          + G     +R+         +S
Sbjct: 242 ELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 40.5 bits (95), Expect = 8e-04
 Identities = 38/170 (22%), Positives = 62/170 (36%), Gaps = 39/170 (22%)

Query: 213 IGTGGYGSVYKAQ-LPNGKVFALK--KLHTSE------ELAFIK-----SFKNEAQVLSQ 258
           IG+GG+G +Y A      +  A    K+   E      EL F +         +     Q
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 259 VLHRNIVKLYGYCLH----KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR------V 308
           + +  I   YG  L     +   F++   MER  L  +L   +                +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMV---MER--LGIDL---QKI--SGQNGTFKKSTVL 154

Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE--AFVADFGTAR 356
            +   M   L Y+H       +H DI + N+LL  K     ++AD+G + 
Sbjct: 155 QLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	496
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.81
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.73
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.72
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.71
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.7
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.7
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.67
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.66
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.65
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.65
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.64
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.64
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.63
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.62
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.61
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.59
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.59
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.58
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.58
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.58
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.58
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.58
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.58
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.57
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.57
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.56
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.56
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.56
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.55
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.55
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.54
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.54
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.54
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.53
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.53
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.53
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.52
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.52
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.52
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.51
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.51
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.51
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.51
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.5
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.49
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.48
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.48
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.47
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.46
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.46
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.46
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.46
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.45
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.45
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.45
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.44
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.44
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.44
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.44
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.43
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.42
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.42
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.42
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.42
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.4
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.4
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.4
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.4
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.39
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.39
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.39
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.39
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.39
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.39
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.39
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.38
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.38
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.38
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.38
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.38
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.38
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.37
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.37
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.37
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.37
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.36
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.35
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.35
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.35
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.35
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.34
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.34
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.34
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.34
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.33
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.33
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.32
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.32
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.32
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.32
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.3
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.3
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.29
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.28
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.28
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.28
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.26
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.26
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.26
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.24
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.24
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.23
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.22
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.22
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.22
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.21
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.19
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.15
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.14
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.14
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.14
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.11
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.1
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.1
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.08
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.05
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.0
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	98.99
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.97
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	98.94
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	98.94
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	98.89
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	98.88
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	98.86
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	98.85
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	98.85
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	98.78
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	98.74
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.72
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.64
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.63
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	98.6
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.59
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.5
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.5
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.49
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.39
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.39
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.26
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.25
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	98.19
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.18
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.17
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.13
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.06
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	97.98
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.97
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	97.97
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	97.97
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.95
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.89
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	97.81
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.65
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.63
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.6
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	97.58
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	97.56
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.53
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.42
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.4
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.39
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.37
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.3
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	97.3
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	97.3
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	97.28
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.25
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	97.2
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	97.2
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	97.08
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	96.93
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	96.91
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.84
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.79
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.74
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.65
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.55
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.14
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	95.25
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.05
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.3
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	94.13
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	93.52
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	91.89
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	91.73
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	86.95
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	85.3

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6.7e-58  Score=441.06  Aligned_cols=259  Identities=23%  Similarity=0.391  Sum_probs=211.7

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      ++|++.+.||+|+||+||+|.+ .+|+.||||++.... .....+.+.+|+.++++++|||||++++++.+++.+|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            6899999999999999999976 469999999997643 33445778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      ||+||+|.+++.... ...+++..++.|+.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+......
T Consensus       104 y~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            999999999997543 235789999999999999999999   7899999999999999999999999999998765433


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                      ......+||+.|||||++.+..|+.++||||+||++|||++|+.||...       ........+.....++....    
T Consensus       180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~-------~~~~~~~~i~~~~~~~~~~~----  248 (350)
T 4b9d_A          180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG-------SMKNLVLKIISGSFPPVSLH----  248 (350)
T ss_dssp             HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-------SHHHHHHHHHHTCCCCCCTT----
T ss_pred             ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-------CHHHHHHHHHcCCCCCCCcc----
Confidence            3334568999999999999999999999999999999999999999632       22233344444443322211    


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ....+.+|+.+||+.||++|||++|+++|+|+.+..
T Consensus       249 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  284 (350)
T 4b9d_A          249 YSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI  284 (350)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence            122477899999999999999999999999997653

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=8.2e-58  Score=433.23  Aligned_cols=267  Identities=22%  Similarity=0.355  Sum_probs=223.7

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|+||+||+|.+ .+|+.||||++....  .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999976 479999999997643  2234567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      |||+||+|.+++.+..   .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            9999999999998654   6899999999999999999999   779999999999999999999999999999987543


Q ss_pred             CC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          362 SS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       362 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                      ..  .....+||+.|||||++.+..|+.++||||+||++|||++|+.||...       ........+.......+..  
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-------~~~~~~~~i~~~~~~~p~~--  256 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-------NEGLIFAKIIKLEYDFPEK--  256 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHTCCCCCTT--
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHcCCCCCCcc--
Confidence            32  344578999999999999999999999999999999999999999632       2222333344433322211  


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCcccccccchhhhc
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDISISELR  495 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~~~~~i~~~~~~  495 (496)
                      .   ...+.+|+.+||+.||++|||++|++.+.|+.      .++++++|.|+.++
T Consensus       257 ~---s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~------~Hp~F~~idw~~l~  303 (311)
T 4aw0_A          257 F---FPKARDLVEKLLVLDATKRLGCEEMEGYGPLK------AHPFFESVTWENLH  303 (311)
T ss_dssp             C---CHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHH------TSGGGTTCCCTTGG
T ss_pred             c---CHHHHHHHHHHccCCHhHCcChHHHcCCHHHH------CCCCcCCCCHHHhc
Confidence            1   12467899999999999999999987777764      46777888888765

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.9e-57  Score=437.25  Aligned_cols=259  Identities=25%  Similarity=0.383  Sum_probs=217.0

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      +.|++.+.||+|+||+||+|.++ +|+.||||++..... ...+.+.+|+.+++.++|||||++++++.+++.+||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            56889999999999999999765 699999999965432 2235578999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      |+||+|.+++...    .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus       153 ~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  225 (346)
T 4fih_A          153 LEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  225 (346)
T ss_dssp             CTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             CCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence            9999999999753    5899999999999999999999   77999999999999999999999999999998866655


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD  443 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  443 (496)
                      .....+||+.|||||++.+..|+.++||||+||++|||++|+.||....       .......+... .++.... ....
T Consensus       226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-------~~~~~~~i~~~-~~~~~~~-~~~~  296 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-------PLKAMKMIRDN-LPPRLKN-LHKV  296 (346)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHS-SCCCCSC-GGGS
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-------HHHHHHHHHcC-CCCCCCc-cccC
Confidence            5667899999999999999999999999999999999999999996321       11222222222 2111111 1112


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          444 ILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       444 ~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      ...+.+|+.+||+.||++|||++|+++|+|+.+..+.
T Consensus       297 s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p  333 (346)
T 4fih_A          297 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP  333 (346)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence            2357799999999999999999999999999876554

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.8e-56  Score=415.55  Aligned_cols=255  Identities=22%  Similarity=0.343  Sum_probs=199.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|+||+||+|.++ +|+.||+|++....  .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999764 69999999997543  2233467899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+ +|+|.+++.+..   .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 679999987654   6899999999999999999999   779999999999999999999999999999876443


Q ss_pred             CCCccccccccccccccccccCCc-CcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      . .....+||+.|||||++.+..+ +.++||||+||++|+|++|+.||...       ........+.......+..   
T Consensus       166 ~-~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-------~~~~~~~~i~~~~~~~p~~---  234 (275)
T 3hyh_A          166 N-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-------SIPVLFKNISNGVYTLPKF---  234 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHTCCCCCTT---
T ss_pred             C-ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-------CHHHHHHHHHcCCCCCCCC---
Confidence            2 3345789999999999998886 57999999999999999999999632       1222223333333322211   


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                        ....+.+|+.+||+.||++|||++|+++|+|++...|
T Consensus       235 --~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~~p  271 (275)
T 3hyh_A          235 --LSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLP  271 (275)
T ss_dssp             --SCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTTCC
T ss_pred             --CCHHHHHHHHHHccCChhHCcCHHHHHcCcccccCCC
Confidence              1124678999999999999999999999999976654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5e-56  Score=419.16  Aligned_cols=251  Identities=25%  Similarity=0.393  Sum_probs=201.8

Q ss_pred             CCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeec----CCeEEEEE
Q 011005          208 DIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH----KKCMFLIY  281 (496)
Q Consensus       208 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lV~  281 (496)
                      .+.+.||+|+||+||+|.+. +++.||+|++.... .....+.+.+|+.++++++|||||++++++..    +..+++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            55678999999999999764 68899999997543 33345778999999999999999999999865    35689999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEeCCCCCceEecC-CCCeEEccccccccc
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS--IIHRDISSNNILLNS-KLEAFVADFGTARLL  358 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~  358 (496)
                      |||+||+|.+++.+..   .+++..+..++.||+.||+|||   +++  |+||||||+|||++. ++.+||+|||+|+..
T Consensus       109 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            9999999999998644   6899999999999999999999   556  999999999999984 789999999999864


Q ss_pred             cCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCC-CCCCCC
Q 011005          359 HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQR-LPPPVD  437 (496)
Q Consensus       359 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  437 (496)
                      .  .......+||+.|||||++.+ .|+.++|||||||++|||+||+.||....       ........+... .+....
T Consensus       183 ~--~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~-------~~~~~~~~i~~~~~~~~~~  252 (290)
T 3fpq_A          183 R--ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQIYRRVTSGVKPASFD  252 (290)
T ss_dssp             C--TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHHHHHHHTTTCCCGGGG
T ss_pred             C--CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC-------cHHHHHHHHHcCCCCCCCC
Confidence            3  233455789999999998865 69999999999999999999999996321       111222222222 221111


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      .   .....+.+|+.+||+.||++|||++|+++|+|+..+
T Consensus       253 ~---~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~  289 (290)
T 3fpq_A          253 K---VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             G---CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             c---cCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence            1   112247789999999999999999999999999764

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.5e-56  Score=438.07  Aligned_cols=259  Identities=25%  Similarity=0.381  Sum_probs=216.6

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      +.|++.+.||+|+||+||+|.++ +|+.||||++...... ..+.+.+|+.+|+.++|||||++++++.+++.+||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS-SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            56999999999999999999764 6999999999754322 235678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      |+||+|.+++...    .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus       230 ~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~  302 (423)
T 4fie_A          230 LEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  302 (423)
T ss_dssp             CTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred             CCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence            9999999999753    5899999999999999999999   77999999999999999999999999999998866655


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD  443 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  443 (496)
                      .....+||+.|||||++.+..|+.++||||+||++|||++|+.||....       .......+... .+..... ....
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-------~~~~~~~i~~~-~~~~~~~-~~~~  373 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-------PLKAMKMIRDN-LPPRLKN-LHKV  373 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHS-CCCCCSC-TTSS
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-------HHHHHHHHHcC-CCCCCcc-cccC
Confidence            5667899999999999999999999999999999999999999996321       11122222222 1111110 0111


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          444 ILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       444 ~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      ...+.+|+.+||+.||++|||++|+++|+|+.+..+.
T Consensus       374 s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p  410 (423)
T 4fie_A          374 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP  410 (423)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence            2247789999999999999999999999999876554

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-55  Score=419.84  Aligned_cols=258  Identities=25%  Similarity=0.439  Sum_probs=203.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      +++.+.+.||+|+||+||+|.+++  .||||+++... +.+..+.|.+|+.++++++|||||++++++.+ +..+|||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            578889999999999999998753  69999987533 34456789999999999999999999998865 457899999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      |+||+|.+++....  ..+++.+++.|+.||+.||+|||   +++|+||||||+|||+++++.+||+|||+|+.......
T Consensus       113 ~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          113 CEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             CSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             CCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            99999999997643  26899999999999999999999   67999999999999999999999999999987643322


Q ss_pred             --Ccccccccccccccccccc---CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCC-CCCCCC
Q 011005          364 --NRTLLAGTYGYIAPELAYT---MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQR-LPPPVD  437 (496)
Q Consensus       364 --~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  437 (496)
                        .....+||+.|||||++.+   ..|+.++|||||||++|||+||+.||....       ........+... ..+...
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~-------~~~~~~~~~~~~~~~p~~~  260 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN-------NRDQIIFMVGRGYASPDLS  260 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-------CHHHHHHHHHTTCCCCCST
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC-------hHHHHHHHHhcCCCCCCcc
Confidence              2345689999999999864   358999999999999999999999996322       111222222222 121111


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ......+..+.+|+.+||+.||++|||+.|+++++...+.
T Consensus       261 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          261 KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            1111223457899999999999999999999999876543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=8.2e-56  Score=422.56  Aligned_cols=256  Identities=23%  Similarity=0.351  Sum_probs=208.7

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMF  278 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  278 (496)
                      +++++.+.||+|+||+||+|.+.      +++.||||+++........+.|.+|+.++++++|||||+++|+|.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            45667889999999999999863      468899999987654455578999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCC-------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC
Q 011005          279 LIYEYMERGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL  345 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~  345 (496)
                      +|||||++|+|.+++.....             ...+++.+++.|+.||+.||+|||   +++|+||||||+|||+++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence            99999999999999975421             235899999999999999999999   67999999999999999999


Q ss_pred             CeEEccccccccccCCCC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcc
Q 011005          346 EAFVADFGTARLLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKI  422 (496)
Q Consensus       346 ~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~  422 (496)
                      .+||+|||+++.......  .....+||+.|||||++.+..|+.++|||||||++|||+| |+.||....       ...
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~-------~~~  255 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-------NQD  255 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC-------HHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC-------HHH
Confidence            999999999987644322  2344679999999999999999999999999999999998 899996332       122


Q ss_pred             hhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          423 MLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       423 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ....+......+ ....   .+..+.+|+.+||+.||++|||+.||++++.-
T Consensus       256 ~~~~i~~~~~~~-~p~~---~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          256 VVEMIRNRQVLP-CPDD---CPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             HHHHHHTTCCCC-CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHHHHHcCCCCC-Cccc---chHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            222222222222 1111   22357799999999999999999999999854

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.6e-55  Score=421.33  Aligned_cols=259  Identities=24%  Similarity=0.432  Sum_probs=206.2

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMF  278 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  278 (496)
                      ++|.+.+.||+|+||+||+|.++      +++.||||+++... ....+.|.+|++++++++|||||+++++|.+++..+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            46778889999999999999864      47889999997654 344578999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCC------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCC
Q 011005          279 LIYEYMERGSLFCNLHNNED------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE  346 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~  346 (496)
                      +|||||++|+|.++++....            ...+++.+++.|+.||+.||+|||   +++|+||||||+|||+++++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCc
Confidence            99999999999999976432            235899999999999999999999   679999999999999999999


Q ss_pred             eEEccccccccccCCCC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcch
Q 011005          347 AFVADFGTARLLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIM  423 (496)
Q Consensus       347 ~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~  423 (496)
                      +||+|||+|+.......  .....+||+.|||||++.+..|+.++|||||||++|||+| |+.||....       ....
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~-------~~~~  269 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS-------NTEA  269 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC-------HHHH
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC-------HHHH
Confidence            99999999987644332  2234679999999999999999999999999999999999 899996332       1222


Q ss_pred             hHhhhcCC-CCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          424 LIDVLDQR-LPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       424 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      ...+.... ++.+..     .+..+.+|+.+||+.||++|||++||++++....+.|
T Consensus       270 ~~~i~~g~~~~~p~~-----~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p  321 (329)
T 4aoj_A          270 IDCITQGRELERPRA-----CPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP  321 (329)
T ss_dssp             HHHHHHTCCCCCCTT-----CCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred             HHHHHcCCCCCCccc-----ccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence            22222222 222111     1235779999999999999999999999998776654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.3e-55  Score=419.28  Aligned_cols=258  Identities=25%  Similarity=0.420  Sum_probs=209.8

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMF  278 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  278 (496)
                      ++|.+.+.||+|+||+||+|.+.      +++.||||+++.... ...+.|.+|++++++++|||||+++|+|.+++..+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh-HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            56888999999999999999764      478899999986543 34578999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCC----------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeE
Q 011005          279 LIYEYMERGSLFCNLHNNE----------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF  348 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~k  348 (496)
                      +|||||++|+|.+++....          ....+++.+++.|+.||+.||+|||   +++|+||||||+|||++.++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEE
Confidence            9999999999999997542          2346999999999999999999999   67999999999999999999999


Q ss_pred             EccccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhH
Q 011005          349 VADFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLI  425 (496)
Q Consensus       349 l~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~  425 (496)
                      |+|||+|+........  .....||+.|||||++.+..|+.++|||||||++|||+| |+.||....       ......
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~-------~~~~~~  241 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-------NNEVIE  241 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-------HHHHHH
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHH
Confidence            9999999876443322  223468999999999999999999999999999999998 899996432       222233


Q ss_pred             hhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          426 DVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      .+.....+.....    .+..+.+|+.+||+.||++|||++|+.+.+....+
T Consensus       242 ~i~~~~~~~~p~~----~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          242 CITQGRVLQRPRT----CPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             HHHHTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCcc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            3333332221111    12357799999999999999999999887765443

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.3e-56  Score=423.48  Aligned_cols=254  Identities=25%  Similarity=0.349  Sum_probs=205.0

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC----CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      ++|++.+.||+|+||+||+|+..    .++.||+|+++... .......+.+|++++++++|||||++++++.+++..++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999752    47899999997542 11122457889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      |||||+||+|.+++.+..   .+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            999999999999998654   6899999999999999999999   7799999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          360 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       360 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                      .........+||+.|||||++.+..|+.++||||+||++|||++|+.||...       ........+.......+..  
T Consensus       178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~-------~~~~~~~~i~~~~~~~p~~--  248 (304)
T 3ubd_A          178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK-------DRKETMTMILKAKLGMPQF--  248 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHCCCCCCTT--
T ss_pred             CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc-------CHHHHHHHHHcCCCCCCCc--
Confidence            5555556678999999999999999999999999999999999999999632       2222333344443332211  


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHHHHhc
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPT-----MQSVSQEFLITR  476 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~~~~~~  476 (496)
                         ....+.+|+.+||+.||++|||     ++|+++|+|+..
T Consensus       249 ---~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~  287 (304)
T 3ubd_A          249 ---LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST  287 (304)
T ss_dssp             ---SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred             ---CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence               1224678999999999999998     579999998743

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=8.4e-55  Score=417.63  Aligned_cols=265  Identities=22%  Similarity=0.240  Sum_probs=210.5

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      +.|++.++||+|+||+||+|.++ +|+.||||+++....      ..+|+.+++.++|||||++++++.+++.+||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            46778889999999999999764 699999999975431      24799999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC-CeEEccccccccccCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-EAFVADFGTARLLHADS  362 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~  362 (496)
                      |+||+|.+++....   .+++..+..++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+|+.+....
T Consensus       132 ~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            99999999998654   6899999999999999999999   78999999999999999987 69999999998775432


Q ss_pred             CC-----ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          363 SN-----RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       363 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                      ..     ....+||+.|||||++.+..|+.++||||+||++|||++|+.||....       .......+.....+..  
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-------~~~~~~~i~~~~~~~~--  276 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF-------RGPLCLKIASEPPPIR--  276 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC-------CSCCHHHHHHSCCGGG--
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC-------HHHHHHHHHcCCCCch--
Confidence            21     233579999999999999999999999999999999999999996322       1222233333222110  


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc-CCCCCcccccccc
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK-TPLVKHAAIQDIS  490 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~-~~~~~~~~~~~i~  490 (496)
                      ..+......+.+++.+||+.||++|||+.|+++++...-. .....+++++++.
T Consensus       277 ~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~  330 (336)
T 4g3f_A          277 EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK  330 (336)
T ss_dssp             GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred             hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence            0011112347789999999999999999999999765433 2334556665543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.4e-54  Score=413.10  Aligned_cols=257  Identities=22%  Similarity=0.376  Sum_probs=199.9

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCC-------
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK-------  275 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------  275 (496)
                      .++|++.+.||+|+||+||+|.++ +|+.||||+++........+.+.+|+.++++++|||||++++++.+.+       
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            356999999999999999999764 789999999976655555678899999999999999999999987544       


Q ss_pred             -----eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEc
Q 011005          276 -----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVA  350 (496)
Q Consensus       276 -----~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~  350 (496)
                           ..|+|||||++|+|.+++.........++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEc
Confidence                 37899999999999999987765556777888999999999999999   7799999999999999999999999


Q ss_pred             cccccccccCCCCC------------ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCC
Q 011005          351 DFGTARLLHADSSN------------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSS  418 (496)
Q Consensus       351 Dfg~~~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~  418 (496)
                      |||+|+........            ....+||+.|||||++.+..|+.++||||+||++|||++   ||....      
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~------  231 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM------  231 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH------
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc------
Confidence            99999877543221            233579999999999999999999999999999999996   664211      


Q ss_pred             CCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          419 DPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      ..............+    ...........+|+.+||+.||++|||+.|+++|+|+..
T Consensus       232 ~~~~~~~~~~~~~~p----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~  285 (299)
T 4g31_A          232 ERVRTLTDVRNLKFP----PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED  285 (299)
T ss_dssp             HHHHHHHHHHTTCCC----HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred             HHHHHHHHHhcCCCC----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence            011111222222222    122223334678999999999999999999999999854

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=9.9e-54  Score=415.27  Aligned_cols=260  Identities=24%  Similarity=0.355  Sum_probs=210.7

Q ss_pred             HHHHhCCCCcceeeecCCeeEEEEEeCC------CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcc-cccccccceeec
Q 011005          201 IEATEDFDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLH-RNIVKLYGYCLH  273 (496)
Q Consensus       201 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~  273 (496)
                      +...++|++.+.||+|+||+||+|.+..      ++.||||++.........+.+.+|++++++++| ||||+++|+|.+
T Consensus        60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~  139 (353)
T 4ase_A           60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK  139 (353)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence            3345789999999999999999997542      468999999876655556789999999999975 899999999876


Q ss_pred             C-CeEEEEEEecCCCChhhhhhCCCC-------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCce
Q 011005          274 K-KCMFLIYEYMERGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  339 (496)
Q Consensus       274 ~-~~~~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Ni  339 (496)
                      . +.+++|||||++|+|.++++....             ...+++..++.++.||+.||+|||   +++|+||||||+||
T Consensus       140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NI  216 (353)
T 4ase_A          140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNI  216 (353)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred             cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccce
Confidence            4 568999999999999999975321             235899999999999999999999   77999999999999


Q ss_pred             EecCCCCeEEccccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCC
Q 011005          340 LLNSKLEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSS  416 (496)
Q Consensus       340 l~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~  416 (496)
                      |+++++.+||+|||+|+........  ....+||+.|||||++.+..|+.++|||||||++|||+| |+.||....    
T Consensus       217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~----  292 (353)
T 4ase_A          217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK----  292 (353)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC----
T ss_pred             eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC----
Confidence            9999999999999999876544332  334678999999999999999999999999999999998 999996322    


Q ss_pred             CCCCcchhHhhh-cC-CCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          417 SSDPKIMLIDVL-DQ-RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       417 ~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                         ........+ .. +++.+..     ....+.+++.+||+.||++|||+.|+++|+...
T Consensus       293 ---~~~~~~~~i~~g~~~~~p~~-----~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          293 ---IDEEFCRRLKEGTRMRAPDY-----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             ---CSHHHHHHHHHTCCCCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHHHHHHHcCCCCCCCcc-----CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence               112222222 22 2222211     123477899999999999999999999998654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7e-53  Score=403.31  Aligned_cols=267  Identities=23%  Similarity=0.330  Sum_probs=203.0

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCC----eEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK----CMFLI  280 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lV  280 (496)
                      .+|.+.+.||+|+||+||+|.+ +|+.||||++.......  .....|+..+.+++|||||++++++.+++    .++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~--~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS--WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHH--HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhh--HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            4577889999999999999998 58999999997654322  22345666667889999999999998653    58999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEeCCCCCceEecCCCCeEEcccccc
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD-----CSPSIIHRDISSNNILLNSKLEAFVADFGTA  355 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-----~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  355 (496)
                      ||||++|+|.++++..    .+++..+.+++.|++.||+|||+.     +..+|+||||||+|||++.++++||+|||+|
T Consensus        80 ~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            9999999999999864    589999999999999999999943     1239999999999999999999999999999


Q ss_pred             ccccCCCCC----ccccccccccccccccccC------CcCcccchhhHHHHHHHHHhCCCCCccccccCCCC-------
Q 011005          356 RLLHADSSN----RTLLAGTYGYIAPELAYTM------VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSS-------  418 (496)
Q Consensus       356 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~-------  418 (496)
                      +........    ....+||+.|||||++.+.      .++.++|||||||++|||+||+.|+..........       
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            877544322    2235799999999998764      46789999999999999999998875433211110       


Q ss_pred             -CCcchhHhhhcCCCCCCCChh--HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          419 -DPKIMLIDVLDQRLPPPVDRK--VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       419 -~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                       ...............+.....  .......+.+|+.+||+.||++|||+.|+++.+....+.
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence             011112222333333332221  223445678999999999999999999999998766543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-51  Score=406.22  Aligned_cols=267  Identities=23%  Similarity=0.325  Sum_probs=205.4

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeec------CCe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH------KKC  276 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  276 (496)
                      ++|++.+.||+|+||+||+|.+ .+|+.||||+++... .....+.+.+|+++|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5799999999999999999976 479999999997643 23345678899999999999999999998754      357


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      +|+|||||+ |+|.+++....   .+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||+|+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceee
Confidence            899999996 67999997654   7999999999999999999999   7899999999999999999999999999998


Q ss_pred             cccCCC----CCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccC---------CCCCC--
Q 011005          357 LLHADS----SNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS---------SSSDP--  420 (496)
Q Consensus       357 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~---------~~~~~--  420 (496)
                      .+....    ......+||+.|||||++.+. .++.++||||+||++|||++|++||...+...         .....  
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            764322    223457899999999998875 46899999999999999999999996432100         00000  


Q ss_pred             -----cchhHhhhc---CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          421 -----KIMLIDVLD---QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       421 -----~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                           .........   ...+.+...........+.+|+.+||..||++|||++|+++|+|+....
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH  352 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence                 000000000   1111110000001123467899999999999999999999999998653

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.4e-50  Score=394.22  Aligned_cols=264  Identities=25%  Similarity=0.260  Sum_probs=201.2

Q ss_pred             HHHHhCCCCcceeeecCCeeEEEEEeC----CCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCC
Q 011005          201 IEATEDFDIRYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKK  275 (496)
Q Consensus       201 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  275 (496)
                      .+..++|++.+.||+|+||+||+|..+    .++.||+|++.....   ...+.+|+++++.+ +||||+++++++.+++
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            345678999999999999999999653    468899999876543   24578999999998 6999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC-CCeEEccccc
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGT  354 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~  354 (496)
                      +.++||||++||+|.+++.      .+++.++..++.||+.||+|||   ++||+||||||+|||++.+ +.+||+|||+
T Consensus        94 ~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGl  164 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGL  164 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence            9999999999999999984      4789999999999999999999   7899999999999999877 7999999999


Q ss_pred             cccccCCCC----------------------------CccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCC
Q 011005          355 ARLLHADSS----------------------------NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGK  405 (496)
Q Consensus       355 ~~~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~  405 (496)
                      |+.......                            .....+||+.|+|||++.+. .|+.++||||+||++|||++|+
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~  244 (361)
T 4f9c_A          165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR  244 (361)
T ss_dssp             CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence            976543211                            12235799999999999875 5899999999999999999999


Q ss_pred             CCCccccccC----------------------------CCCCCcch---hHhhhc---CCCCCCCC---------hhHHH
Q 011005          406 HPRDILSSLS----------------------------SSSDPKIM---LIDVLD---QRLPPPVD---------RKVIR  442 (496)
Q Consensus       406 ~p~~~~~~~~----------------------------~~~~~~~~---~~~~~~---~~~~~~~~---------~~~~~  442 (496)
                      .||.......                            ....+...   ..+...   ...+....         .....
T Consensus       245 ~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  324 (361)
T 4f9c_A          245 YPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE  324 (361)
T ss_dssp             SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence            9994321100                            00000000   000000   00000000         00000


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      ....+.+|+.+||+.||++|||++|+++|+|+..
T Consensus       325 is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          325 VPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence            1124679999999999999999999999999853

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.5e-49  Score=408.80  Aligned_cols=261  Identities=23%  Similarity=0.303  Sum_probs=214.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|++.+.||+|+||+||+|.++ +|+.||+|.+..... ...+.+.+|+.+|+.++|||||++++++.+++.+++|||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch-hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            368999999999999999999764 799999999876543 234678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC--CCeEEccccccccccC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK--LEAFVADFGTARLLHA  360 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~--~~~kl~Dfg~~~~~~~  360 (496)
                      ||+||+|.+++....  ..+++.++..++.||+.||+|||   +++|+||||||+|||++.+  +.+||+|||+|+.+..
T Consensus       235 ~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          235 FMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             CCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             ecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            999999999987532  26899999999999999999999   7799999999999999854  8999999999988754


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      . ......+||+.|||||++.+..|+.++||||+||++|||++|+.||....       .......+.......+. ...
T Consensus       310 ~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~-~~~  380 (573)
T 3uto_A          310 K-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-------DDETLRNVKSCDWNMDD-SAF  380 (573)
T ss_dssp             T-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHHHHHTTCCCCCS-GGG
T ss_pred             C-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-------HHHHHHHHHhCCCCCCc-ccc
Confidence            3 33445689999999999999999999999999999999999999996322       22222333322222111 111


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      ......+.+|+.+||+.||++|||+.|+++|+|+.....
T Consensus       381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          381 SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence            111234678999999999999999999999999976543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.5e-49  Score=405.18  Aligned_cols=255  Identities=22%  Similarity=0.256  Sum_probs=205.4

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHH---HHHHHHHhhcccccccccceeecCCeEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFK---NEAQVLSQVLHRNIVKLYGYCLHKKCMF  278 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~~  278 (496)
                      ++|++.+.||+|+||+||+|..+ +|+.||+|++.+..-  ........   +++.+++.++|||||++++++.+++.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            67999999999999999999765 699999999975421  11112233   3456666778999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccc
Q 011005          279 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL  358 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  358 (496)
                      +|||||+||+|.+++.+..   .+++..+..++.||+.||+|||   ++||+||||||+|||++.+|++||+|||+|+.+
T Consensus       269 lVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence            9999999999999998654   6899999999999999999999   889999999999999999999999999999877


Q ss_pred             cCCCCCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          359 HADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       359 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                      ...  .....+||+.|||||++.+ ..|+.++||||+||++|||++|++||.....    .................+..
T Consensus       343 ~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~----~~~~~i~~~i~~~~~~~p~~  416 (689)
T 3v5w_A          343 SKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----KDKHEIDRMTLTMAVELPDS  416 (689)
T ss_dssp             SSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC----CCHHHHHHHHHHCCCCCCTT
T ss_pred             CCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhhcCCCCCCCcc
Confidence            543  2345689999999999974 5799999999999999999999999964321    11111222222332222211


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHHHHhc
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPT-----MQSVSQEFLITR  476 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~~~~~~  476 (496)
                           ....+.+|+.+||+.||++|++     ++|+++|+|+..
T Consensus       417 -----~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          417 -----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             -----SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             -----CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence                 1124678999999999999998     799999999864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.9e-47  Score=363.56  Aligned_cols=261  Identities=24%  Similarity=0.357  Sum_probs=215.8

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|++.+.||+|+||+||+|.+ .+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            46899999999999999999975 57899999998754422 23568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++|+|.+++...    .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        98 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           98 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             CCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            99999999999764    5889999999999999999999   6799999999999999999999999999998876655


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                      .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.....       ............+....  ...
T Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~--~~~  241 (297)
T 3fxz_A          171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATNGTPELQN--PEK  241 (297)
T ss_dssp             CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHHCSCCCSC--GGG
T ss_pred             cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCCC--ccc
Confidence            555667899999999999999999999999999999999999999963221       11111111111111100  011


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCC
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLV  481 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~  481 (496)
                      ....+.+++.+||+.||++|||++|+++|+|+....+..
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~  280 (297)
T 3fxz_A          242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLS  280 (297)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGG
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCccc
Confidence            123477899999999999999999999999998776553

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=7.7e-47  Score=366.66  Aligned_cols=256  Identities=24%  Similarity=0.363  Sum_probs=214.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      .++|++.+.||+|+||.||+|.+ .+|+.||||++.... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46799999999999999999976 579999999997643 3344567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            9999999999997654   6899999999999999999999   779999999999999999999999999999876543


Q ss_pred             CCCccccccccccccccccccCCcC-cccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVMT-EKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                       ......+||+.|+|||++.+..++ .++||||+|+++|+|++|+.||....       ...............+..   
T Consensus       168 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~p~~---  236 (328)
T 3fe3_A          168 -GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-------LKELRERVLRGKYRIPFY---  236 (328)
T ss_dssp             -CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTT---
T ss_pred             -CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCCC---
Confidence             334556899999999999988875 79999999999999999999996321       222233333333322211   


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                        ....+.+++.+||+.||++|||++|+++|+|+....
T Consensus       237 --~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          237 --MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             --SCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             --CCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence              112467899999999999999999999999997654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-46  Score=362.59  Aligned_cols=262  Identities=23%  Similarity=0.295  Sum_probs=215.8

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|++.+.||+|+||+||+|.++ +++.||+|.+.....  ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH--HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc--cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            468999999999999999999765 688999999876543  23568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC--CCCeEEccccccccccC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS--KLEAFVADFGTARLLHA  360 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~  360 (496)
                      |+++|+|.+++....  ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.  ++.+||+|||+++....
T Consensus        82 ~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           82 FISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             eCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            999999999997543  26899999999999999999999   779999999999999987  78999999999987653


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      . .......||+.|+|||++.+..++.++||||+|+++|+|++|..||....       .......+.......+ ....
T Consensus       157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~~~~~~-~~~~  227 (321)
T 1tki_A          157 G-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-------NQQIIENIMNAEYTFD-EEAF  227 (321)
T ss_dssp             T-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHTCCCCC-HHHH
T ss_pred             C-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC-------HHHHHHHHHcCCCCCC-hhhh
Confidence            3 23345679999999999999989999999999999999999999996321       2222333333333221 1111


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCC
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLV  481 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~  481 (496)
                      ......+.+++.+||+.||++|||+.|+++|+|+.......
T Consensus       228 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~  268 (321)
T 1tki_A          228 KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERV  268 (321)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGGS
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCcccc
Confidence            12234578999999999999999999999999998765443

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=7e-46  Score=359.51  Aligned_cols=269  Identities=25%  Similarity=0.359  Sum_probs=219.8

Q ss_pred             ccccHHHHHHHHhC----------CCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcc
Q 011005          193 GRIVYEDLIEATED----------FDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLH  261 (496)
Q Consensus       193 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h  261 (496)
                      +.++++++..+++.          |...+.||+|+||.||+|..+ +|+.||||++..... ...+.+.+|+.++++++|
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CSHHHHHHHHHHHTTCCC
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-hHHHHHHHHHHHHHhCCC
Confidence            45677888777764          667789999999999999876 799999999875432 224568899999999999


Q ss_pred             cccccccceeecCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe
Q 011005          262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL  341 (496)
Q Consensus       262 ~niv~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~  341 (496)
                      |||+++++++...+..++||||+++|+|.+++...    .+++..+..++.|++.||.|||   +.+|+||||||+||++
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll  174 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILL  174 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEE
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEE
Confidence            99999999999999999999999999999998753    5899999999999999999999   6799999999999999


Q ss_pred             cCCCCeEEccccccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCc
Q 011005          342 NSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPK  421 (496)
Q Consensus       342 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~  421 (496)
                      +.++.+||+|||++..............||+.|+|||++.+..++.++||||||+++|+|++|+.||....       ..
T Consensus       175 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~-------~~  247 (321)
T 2c30_A          175 TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS-------PV  247 (321)
T ss_dssp             CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HH
T ss_pred             CCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HH
Confidence            99999999999999877655444455689999999999999999999999999999999999999986321       11


Q ss_pred             chhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          422 IMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       422 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ...........+....  .......+.+++.+||+.||++|||+.|+++|+|+....
T Consensus       248 ~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          248 QAMKRLRDSPPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             HHHHHHHHSSCCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             HHHHHHhcCCCCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence            1122222221111111  111123477899999999999999999999999998654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.8e-46  Score=362.11  Aligned_cols=254  Identities=23%  Similarity=0.317  Sum_probs=212.8

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|+||.||+|..+ +|+.||+|.++...  .......+.+|+.+++.++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            67999999999999999999765 68999999997643  2233466889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||++||+|.+++....   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        85 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            9999999999987643   6899999999999999999999   779999999999999999999999999999875544


Q ss_pred             CCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                      .......+||+.|+|||++.+..++.++||||+|+++|||++|+.||...       ........+.......+..    
T Consensus       159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-------~~~~~~~~i~~~~~~~p~~----  227 (337)
T 1o6l_A          159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-------DHERLFELILMEEIRFPRT----  227 (337)
T ss_dssp             TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHCCCCCCTT----
T ss_pred             CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC-------CHHHHHHHHHcCCCCCCCC----
Confidence            44455678999999999999999999999999999999999999999632       1222222333332222111    


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHhc
Q 011005          442 RDILLISTVSFACLQSNPKSRP-----TMQSVSQEFLITR  476 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~~~~~~  476 (496)
                       ....+.+++.+||+.||++||     +++|+++|+|+..
T Consensus       228 -~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~  266 (337)
T 1o6l_A          228 -LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             -SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             -CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence             112467899999999999999     9999999999854

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.2e-46  Score=363.06  Aligned_cols=282  Identities=33%  Similarity=0.576  Sum_probs=224.7

Q ss_pred             ccccHHHHHHHHhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceee
Q 011005          193 GRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL  272 (496)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  272 (496)
                      ..+++.++....++|.+.+.||+|+||.||+|..++++.||||++...........+.+|+++++.++||||+++++++.
T Consensus        18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   97 (326)
T 3uim_A           18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM   97 (326)
T ss_dssp             EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred             ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence            45678899999999999999999999999999988899999999987554333346889999999999999999999999


Q ss_pred             cCCeEEEEEEecCCCChhhhhhCCCC-CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcc
Q 011005          273 HKKCMFLIYEYMERGSLFCNLHNNED-AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVAD  351 (496)
Q Consensus       273 ~~~~~~lV~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~D  351 (496)
                      ..+..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.+..+|+||||||+||+++.++.+||+|
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D  177 (326)
T 3uim_A           98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD  177 (326)
T ss_dssp             CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred             cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence            99999999999999999999987542 33589999999999999999999953333999999999999999999999999


Q ss_pred             ccccccccCCCCC-ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCC----------
Q 011005          352 FGTARLLHADSSN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDP----------  420 (496)
Q Consensus       352 fg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~----------  420 (496)
                      ||+++........ .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||+...........          
T Consensus       178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  257 (326)
T 3uim_A          178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK  257 (326)
T ss_dssp             CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred             CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence            9999876543322 33456999999999999999999999999999999999999999643221111000          


Q ss_pred             cchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          421 KIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       421 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ........+.......   .......+.+++.+||+.||++|||+.|+++++.....
T Consensus       258 ~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          258 EKKLEALVDVDLQGNY---KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             SCCSTTSSCTTCTTSC---CHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             chhhhhhcChhhcccc---CHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            0011111111222222   23344568899999999999999999999999986443

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=7.2e-46  Score=357.88  Aligned_cols=266  Identities=24%  Similarity=0.325  Sum_probs=208.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|++.+.||+|+||+||+|.+.+++.||+|++..... ......+.+|++++++++||||+++++++..+...++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            478999999999999999999998899999999976432 2334678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++ +|.+.+....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus       100 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A          100 FMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             CCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             CCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            9985 8888877543  25899999999999999999999   7799999999999999999999999999998776554


Q ss_pred             CCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCC------
Q 011005          363 SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP------  435 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  435 (496)
                      .......+|+.|+|||++.+ ..++.++||||+|+++|+|++|+.||......    ..............+..      
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~  249 (311)
T 3niz_A          174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD----DQLPKIFSILGTPNPREWPQVQE  249 (311)
T ss_dssp             C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT----THHHHHHHHHCCCCTTTSGGGTT
T ss_pred             ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHHCCCChHHhhhhhc
Confidence            44555678999999999876 56899999999999999999999999643211    00001111111100000      


Q ss_pred             -----------CChhH-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          436 -----------VDRKV-----IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       436 -----------~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                                 .....     ......+.+|+.+||+.||++|||++|+++|+|+..-.+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence                       00000     001124678999999999999999999999999976543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.1e-46  Score=376.17  Aligned_cols=261  Identities=21%  Similarity=0.276  Sum_probs=214.2

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      ..++|++.+.||+|+||+||+|.. .+|+.||+|.+.... .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            567899999999999999999965 478999999987643 333456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEec---CCCCeEEcccccccc
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN---SKLEAFVADFGTARL  357 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~  357 (496)
                      |||++||+|.+.+....   .+++..+..++.||+.||.|||   +.+|+||||||+|||++   .++.+||+|||++..
T Consensus        89 ~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            99999999999988654   6899999999999999999999   77999999999999998   467899999999987


Q ss_pred             ccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          358 LHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       358 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                      ............||+.|+|||++.+..++.++||||+|+++|+|++|+.||....       .......+.......+..
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~~  235 (444)
T 3soa_A          163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED-------QHRLYQQIKAGAYDFPSP  235 (444)
T ss_dssp             CCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHTCCCCCTT
T ss_pred             ecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHhCCCCCCcc
Confidence            7655544456789999999999999999999999999999999999999996321       222223333332221111


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      . .......+.+++.+||+.||++|||+.|+++|+|+...
T Consensus       236 ~-~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          236 E-WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             T-TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             c-cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            0 11112347799999999999999999999999999754

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.8e-46  Score=360.87  Aligned_cols=260  Identities=25%  Similarity=0.354  Sum_probs=209.3

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|++.+.||+|+||+||+|.+. +++.||+|++.........+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999765 7899999999765544444678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++|+|.+++....   .+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+....
T Consensus        86 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            999999999997653   6899999999999999999999   7799999999999999999999999999998664332


Q ss_pred             --CCccccccccccccccccccCCc-CcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          363 --SNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       363 --~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                        .......||+.|+|||++.+..+ +.++||||+|+++|+|++|+.||.....      ................... 
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~-  232 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD------SCQEYSDWKEKKTYLNPWK-  232 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT------TSHHHHHHHTTCTTSTTGG-
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch------HHHHHHHHhcccccCCccc-
Confidence              12334679999999999988776 7799999999999999999999963221      1112222222222111111 


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                        .....+.+|+.+||+.||++|||++|+++|+|+....
T Consensus       233 --~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          233 --KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             --GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             --cCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence              1123467899999999999999999999999997654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.7e-46  Score=364.83  Aligned_cols=259  Identities=24%  Similarity=0.313  Sum_probs=212.5

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhH-----HHHHHHHHHHHHHHhhcccccccccceeecCCe
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEEL-----AFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKC  276 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  276 (496)
                      ..++|++.+.||+|+||+||+|..+ +|+.||+|.+......     ...+.+.+|+.+++.++||||+++++++.....
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            3467999999999999999999765 6899999999764321     124678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC----CeEEccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL----EAFVADF  352 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~----~~kl~Df  352 (496)
                      .++||||++||+|.+++....   .+++..+..++.||+.||.|||   +.||+||||||+||+++.++    .+||+||
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            999999999999999997643   6899999999999999999999   67999999999999998877    7999999


Q ss_pred             cccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCC
Q 011005          353 GTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRL  432 (496)
Q Consensus       353 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  432 (496)
                      |+++...... .....+||+.|+|||++.+..++.++||||+|+++|+|++|..||....       .......+.....
T Consensus       164 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~-------~~~~~~~i~~~~~  235 (361)
T 2yab_A          164 GLAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-------KQETLANITAVSY  235 (361)
T ss_dssp             SSCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHHHHHTTCC
T ss_pred             CCceEcCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhcCC
Confidence            9998765432 3345679999999999999999999999999999999999999996321       1222222222222


Q ss_pred             CCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       433 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      ..+ ..........+.+|+.+||..||++|||+.|+++|+|+..
T Consensus       236 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  278 (361)
T 2yab_A          236 DFD-EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (361)
T ss_dssp             CCC-HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred             CCC-chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence            211 1111122235779999999999999999999999999864

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3e-46  Score=364.03  Aligned_cols=258  Identities=20%  Similarity=0.342  Sum_probs=209.6

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCC------
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK------  275 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  275 (496)
                      ..++|++.+.||+|+||.||+|.++ +++.||||++.........+.+.+|+.++++++||||+++++++.+..      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            4578999999999999999999875 799999999976554445578899999999999999999999885533      


Q ss_pred             ---------------------------------------------------eEEEEEEecCCCChhhhhhCCCCCccCCH
Q 011005          276 ---------------------------------------------------CMFLIYEYMERGSLFCNLHNNEDAVELDW  304 (496)
Q Consensus       276 ---------------------------------------------------~~~lV~e~~~~g~L~~~l~~~~~~~~~~~  304 (496)
                                                                         ..++||||+++|+|.+++.........++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               37999999999999999998776667788


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC------------Ccccccccc
Q 011005          305 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS------------NRTLLAGTY  372 (496)
Q Consensus       305 ~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~gt~  372 (496)
                      ..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......            ......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            889999999999999999   77999999999999999999999999999987754421            123356999


Q ss_pred             ccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHH
Q 011005          373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSF  452 (496)
Q Consensus       373 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  452 (496)
                      .|+|||++.+..++.++||||+|+++|+|++|..|+....         ..........    ...........+.+++.
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~---------~~~~~~~~~~----~~~~~~~~~~~~~~li~  307 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV---------RIITDVRNLK----FPLLFTQKYPQEHMMVQ  307 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH---------HHHHHHHTTC----CCHHHHHHCHHHHHHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH---------HHHHHhhccC----CCcccccCChhHHHHHH
Confidence            9999999999999999999999999999999988753211         1111111111    11222333345688999


Q ss_pred             hcccCCCCCCCCHHHHHHHHHHhc
Q 011005          453 ACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       453 ~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      +||+.||++|||++|+++|+|+..
T Consensus       308 ~~l~~~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          308 DMLSPSPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             HHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred             HHccCCCCcCCCHHHHhhchhhhc
Confidence            999999999999999999999753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.2e-46  Score=366.87  Aligned_cols=255  Identities=22%  Similarity=0.371  Sum_probs=209.0

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  279 (496)
                      .++|++.+.||+|+||+||+|.++ +++.||+|+++...  .......+.+|..+++.+ +||||+++++++...+..++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            478999999999999999999765 68999999997643  223346678999999988 69999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||||++||+|.+++....   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       102 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            999999999999997654   6899999999999999999999   7799999999999999999999999999998654


Q ss_pred             CCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          360 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       360 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                      .........+||+.|+|||++.+..++.++||||+||++|||++|+.||...       ........+.......+..  
T Consensus       176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-------~~~~~~~~i~~~~~~~p~~--  246 (353)
T 3txo_A          176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE-------NEDDLFEAILNDEVVYPTW--  246 (353)
T ss_dssp             C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHCCCCCCTT--
T ss_pred             cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC-------CHHHHHHHHHcCCCCCCCC--
Confidence            4444455678999999999999999999999999999999999999999632       2223334444443332211  


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCH------HHHHHHHHHhc
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTM------QSVSQEFLITR  476 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~~~~~~  476 (496)
                         ....+.+++.+||+.||++||++      +|+++|+|+..
T Consensus       247 ---~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~  286 (353)
T 3txo_A          247 ---LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE  286 (353)
T ss_dssp             ---SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred             ---CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence               11246789999999999999998      89999999864

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=8.4e-46  Score=356.88  Aligned_cols=260  Identities=28%  Similarity=0.434  Sum_probs=202.5

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|++.+.||+|+||+||+|.+ +++.||||++.... .....+.+.+|++++++++||||+++++++......++|||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            56899999999999999999987 68899999987643 33445678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS--IIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |+++|+|.+++........+++..++.++.|++.||+|||   +.+  |+||||||+||+++.++.+||+|||+++....
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            9999999999987654445899999999999999999999   678  99999999999999999999999999986654


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      .........||+.|+|||++.+..++.++||||||+++|+|++|+.||....       ...................  
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~-------~~~~~~~~~~~~~~~~~~~--  262 (309)
T 3p86_A          192 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN-------PAQVVAAVGFKCKRLEIPR--  262 (309)
T ss_dssp             ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC-------HHHHHHHHHHSCCCCCCCT--
T ss_pred             cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhcCCCCCCCc--
Confidence            4334455679999999999999999999999999999999999999996322       1111111111111111111  


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                       .....+.+++.+||+.||++|||++|+++.+...-+
T Consensus       263 -~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          263 -NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             -TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             -cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence             111247789999999999999999999997765544

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=354.68  Aligned_cols=256  Identities=22%  Similarity=0.309  Sum_probs=202.6

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhH-------------------------HHHHHHHHHHHHHH
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEEL-------------------------AFIKSFKNEAQVLS  257 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~e~~~l~  257 (496)
                      .++|++.+.||+|+||.||+|.. .+++.||+|.+......                         ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            36799999999999999999976 46889999998654311                         12356889999999


Q ss_pred             hhcccccccccceeec--CCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCC
Q 011005          258 QVLHRNIVKLYGYCLH--KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDIS  335 (496)
Q Consensus       258 ~l~h~niv~~~~~~~~--~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk  335 (496)
                      +++||||+++++++..  ....++||||+++++|.+++..    ..+++..++.++.||+.||+|||   +.+|+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCC
Confidence            9999999999999986  5689999999999999876543    26899999999999999999999   6799999999


Q ss_pred             CCceEecCCCCeEEccccccccccCCCCCccccccccccccccccccCC---cCcccchhhHHHHHHHHHhCCCCCcccc
Q 011005          336 SNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV---MTEKCDVYSFGVVTLEVLMGKHPRDILS  412 (496)
Q Consensus       336 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~el~~g~~p~~~~~  412 (496)
                      |+||+++.++.+||+|||+++.............||+.|+|||++.+..   ++.++||||||+++|+|++|+.||....
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            9999999999999999999987765444445567999999999998765   4778999999999999999999986321


Q ss_pred             ccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          413 SLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       413 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                             ...............+....   ....+.+++.+||+.||++|||+.|+++|+|+.+
T Consensus       245 -------~~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          245 -------IMCLHSKIKSQALEFPDQPD---IAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             -------HHHHHHHHHHCCCCCCSSSC---CCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             -------HHHHHHHHhcccCCCCCccc---cCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence                   11111222222222111111   1124778999999999999999999999999864

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.3e-45  Score=363.20  Aligned_cols=260  Identities=23%  Similarity=0.343  Sum_probs=213.5

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      ..++|++.+.||+|+||.||+|.++ +++.||+|.+.... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4678999999999999999999764 68999999997643 233456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC---CCeEEcccccccc
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK---LEAFVADFGTARL  357 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~  357 (496)
                      |||+++|+|.+.+....   .+++..+..++.||+.||.|||   +.+|+||||||+||+++.+   +.+||+|||++..
T Consensus       107 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          107 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             ECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            99999999999987653   6899999999999999999999   6799999999999999865   4599999999987


Q ss_pred             ccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          358 LHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       358 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                      .... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||....       .......+.......+..
T Consensus       181 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-------~~~~~~~i~~~~~~~~~~  252 (362)
T 2bdw_A          181 VNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-------QHRLYAQIKAGAYDYPSP  252 (362)
T ss_dssp             CTTC-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCCCCCTT
T ss_pred             ecCC-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhCCCCCCcc
Confidence            6533 23345679999999999999999999999999999999999999986321       122222233332222211


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      . .......+.+++.+||+.||++|||+.|+++|+|+...
T Consensus       253 ~-~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          253 E-WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             G-GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             c-ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            1 11122357799999999999999999999999999754

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=9.2e-46  Score=366.61  Aligned_cols=262  Identities=23%  Similarity=0.378  Sum_probs=211.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  279 (496)
                      .++|++.+.||+|+||+||+|..+ +++.||+|+++...  .....+.+.+|..+++++ +||||+++++++..++..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            367999999999999999999765 58899999997643  222334578899999887 79999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||||++||+|..++....   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            999999999999998643   6899999999999999999999   7799999999999999999999999999998754


Q ss_pred             CCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCC--CCcchhHhhhcCCCCCCCC
Q 011005          360 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSS--DPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       360 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  437 (496)
                      .........+||+.|+|||++.+..++.++||||+||++|||++|+.||..........  ........+.......+..
T Consensus       205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~  284 (396)
T 4dc2_A          205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS  284 (396)
T ss_dssp             CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred             cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence            44455566789999999999999999999999999999999999999996432211111  1111222333333322211


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCH------HHHHHHHHHhc
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTM------QSVSQEFLITR  476 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~~~~~~  476 (496)
                           ....+.+|+.+||+.||++||++      +|+++|+|+..
T Consensus       285 -----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~  324 (396)
T 4dc2_A          285 -----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  324 (396)
T ss_dssp             -----SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred             -----CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence                 11246789999999999999985      89999999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=7.3e-46  Score=359.91  Aligned_cols=262  Identities=21%  Similarity=0.300  Sum_probs=191.2

Q ss_pred             cceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-ccccccccceeecCCeEEEEEEecCCC
Q 011005          210 RYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKCMFLIYEYMERG  287 (496)
Q Consensus       210 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lV~e~~~~g  287 (496)
                      .+.||+|+||+||+|.++ +++.||||++....    ...+.+|+.+++.+. ||||+++++++.++...++||||+++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhh----hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence            378999999999999765 68999999986543    255678999999997 999999999999999999999999999


Q ss_pred             ChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC---CeEEccccccccccCCCCC
Q 011005          288 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL---EAFVADFGTARLLHADSSN  364 (496)
Q Consensus       288 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~  364 (496)
                      +|.+++....   .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++   .+||+|||+++........
T Consensus        92 ~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  165 (325)
T 3kn6_A           92 ELFERIKKKK---HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP  165 (325)
T ss_dssp             BHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence            9999998754   6899999999999999999999   77999999999999998765   7999999999876555444


Q ss_pred             ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHH
Q 011005          365 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI  444 (496)
Q Consensus       365 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  444 (496)
                      ....+||+.|+|||++.+..++.++||||+|+++|+|++|+.||..................+....... .........
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~s  244 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF-EGEAWKNVS  244 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC-CSHHHHTSC
T ss_pred             ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC-CcccccCCC
Confidence            5566789999999999999999999999999999999999999975432111111111222222222222 222222233


Q ss_pred             HHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCC
Q 011005          445 LLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVK  482 (496)
Q Consensus       445 ~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~  482 (496)
                      ..+.+|+.+||+.||++|||++|+++|+|+........
T Consensus       245 ~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~  282 (325)
T 3kn6_A          245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSS  282 (325)
T ss_dssp             HHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCC
T ss_pred             HHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCC
Confidence            45789999999999999999999999999987655443

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1e-45  Score=362.76  Aligned_cols=263  Identities=20%  Similarity=0.275  Sum_probs=212.8

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhH----HHHHHHHHHHHHHHhhcccccccccceeecCCeE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEEL----AFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCM  277 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  277 (496)
                      ..++|++.+.||+|+||+||+|..+ +++.||+|++......    ...+.+.+|+.+++.++||||+++++++...+..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            3567999999999999999999764 6899999998653311    1246789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCC-CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCC---eEEcccc
Q 011005          278 FLIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE---AFVADFG  353 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg  353 (496)
                      ++||||+++|+|.+.+.... ....+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.   +||+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence            99999999999988776432 2235899999999999999999999   779999999999999987654   9999999


Q ss_pred             ccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCC
Q 011005          354 TARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLP  433 (496)
Q Consensus       354 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  433 (496)
                      ++.............+||+.|+|||++.+..++.++||||+|+++|+|++|+.||....        .............
T Consensus       179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~i~~~~~~  250 (351)
T 3c0i_A          179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--------ERLFEGIIKGKYK  250 (351)
T ss_dssp             TCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--------HHHHHHHHHTCCC
T ss_pred             ceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--------HHHHHHHHcCCCC
Confidence            99887654444455679999999999999999999999999999999999999996321        1222222223222


Q ss_pred             CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          434 PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       434 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ... .........+.+++.+||+.||++|||+.|+++|+|+...
T Consensus       251 ~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          251 MNP-RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             CCH-HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             CCc-cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            111 1111123357899999999999999999999999999764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.5e-46  Score=377.15  Aligned_cols=264  Identities=25%  Similarity=0.318  Sum_probs=212.3

Q ss_pred             HHHHHHHHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHHHHHHhhcccccccccceeec
Q 011005          197 YEDLIEATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH  273 (496)
Q Consensus       197 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  273 (496)
                      +.++....++|++.+.||+|+||+||+|.++ +++.||+|++.....  ......+.+|..++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            3444445689999999999999999999876 478999999976432  1122347899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccc
Q 011005          274 KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG  353 (496)
Q Consensus       274 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  353 (496)
                      ++..++||||++||+|.+++....  ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFG  220 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFG  220 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchh
Confidence            999999999999999999998632  26899999999999999999999   7799999999999999999999999999


Q ss_pred             ccccccCCCCC-ccccccccccccccccc-----cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhh
Q 011005          354 TARLLHADSSN-RTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDV  427 (496)
Q Consensus       354 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  427 (496)
                      +++........ ....+||+.|+|||++.     ...++.++||||+||++|||++|+.||....       .......+
T Consensus       221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~-------~~~~~~~i  293 (437)
T 4aw2_A          221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-------LVETYGKI  293 (437)
T ss_dssp             TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHH
T ss_pred             hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC-------hhHHHHhh
Confidence            99876544332 23468999999999987     5678999999999999999999999996321       11222222


Q ss_pred             hc----CCCCCCCChhHHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHHHHHhc
Q 011005          428 LD----QRLPPPVDRKVIRDILLISTVSFACLQSNPKS--RPTMQSVSQEFLITR  476 (496)
Q Consensus       428 ~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~~~~~~  476 (496)
                      +.    ...+.....    ....+.+|+.+||..+|++  ||+++|+++|+|+..
T Consensus       294 ~~~~~~~~~p~~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~  344 (437)
T 4aw2_A          294 MNHKERFQFPTQVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG  344 (437)
T ss_dssp             HTHHHHCCCCSSCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred             hhccccccCCccccc----CCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence            21    122221111    1124678999999988888  999999999999964

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.2e-45  Score=358.84  Aligned_cols=253  Identities=23%  Similarity=0.350  Sum_probs=208.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|.+.+.||+|+||.||+|.+ .+++.||+|++....  .......+.+|+.+++.++||||+++++++..++..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            6799999999999999999976 578999999987542  1122356889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+ +|+|.+++....   .+++..++.++.|++.||.|||   +.||+||||||+||+++.++.+||+|||++......
T Consensus        89 E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             CCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             ECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            999 789988887543   6899999999999999999999   679999999999999999999999999999876443


Q ss_pred             CCCccccccccccccccccccCCc-CcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcC--CCCCCCCh
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQ--RLPPPVDR  438 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  438 (496)
                      . .....+||+.|+|||++.+..+ +.++||||+|+++|+|++|+.||+......       ........  ..+...  
T Consensus       162 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-------~~~~i~~~~~~~p~~~--  231 (336)
T 3h4j_B          162 N-FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-------LFKKVNSCVYVMPDFL--  231 (336)
T ss_dssp             B-TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-------CBCCCCSSCCCCCTTS--
T ss_pred             c-ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-------HHHHHHcCCCCCcccC--
Confidence            2 2344679999999999998876 689999999999999999999997432110       00001111  111111  


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          439 KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       439 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                           ...+.+++.+||+.||.+|||++|+++|+|+....+
T Consensus       232 -----s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  267 (336)
T 3h4j_B          232 -----SPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLP  267 (336)
T ss_dssp             -----CHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred             -----CHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCCc
Confidence                 124678999999999999999999999999987654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=356.86  Aligned_cols=260  Identities=25%  Similarity=0.312  Sum_probs=211.6

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhH-----HHHHHHHHHHHHHHhhcccccccccceeecCCe
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEEL-----AFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKC  276 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  276 (496)
                      ..++|.+.+.||+|+||.||+|..+ +++.||+|.+......     ...+.+.+|+.++++++||||+++++++..+..
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            3467999999999999999999765 6899999998754311     124678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC----CeEEccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL----EAFVADF  352 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~----~~kl~Df  352 (496)
                      .++||||+++|+|.+++....   .+++..++.++.||+.||.|||   +.+|+||||||+||+++.++    .+||+||
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            999999999999999997543   6899999999999999999999   77999999999999999887    7999999


Q ss_pred             cccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCC
Q 011005          353 GTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRL  432 (496)
Q Consensus       353 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  432 (496)
                      |+++...... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||....       .............
T Consensus       163 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~~~~~~~  234 (326)
T 2y0a_A          163 GLAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-------KQETLANVSAVNY  234 (326)
T ss_dssp             TTCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHHHHHHTCC
T ss_pred             CCCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC-------HHHHHHHHHhcCC
Confidence            9998765332 2334579999999999999999999999999999999999999985321       1112222222221


Q ss_pred             CCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       433 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ..+ ..........+.+++.+||+.||++|||+.|+++|+|+...
T Consensus       235 ~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          235 EFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             CCC-HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             CcC-ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            111 11111122357799999999999999999999999999754

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.9e-45  Score=358.09  Aligned_cols=261  Identities=24%  Similarity=0.383  Sum_probs=212.4

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV  280 (496)
                      ++|++.+.||+|+||.||+|..+ +++.||+|++....  .....+.+.+|..+++++ +||||+++++++...+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            57999999999999999999765 68899999997643  233456788999999988 899999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+++|+|.+++....   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        89 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            99999999999997643   6899999999999999999999   77999999999999999999999999999986544


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCC--CCCcchhHhhhcCCCCCCCCh
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSS--SDPKIMLIDVLDQRLPPPVDR  438 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  438 (496)
                      ........+||+.|+|||++.+..++.++||||+||++|||++|+.||.........  .........+.......+.. 
T Consensus       163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~-  241 (345)
T 3a8x_A          163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS-  241 (345)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT-
T ss_pred             CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC-
Confidence            444455678999999999999999999999999999999999999999643221111  11111222223333222211 


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCCH------HHHHHHHHHhc
Q 011005          439 KVIRDILLISTVSFACLQSNPKSRPTM------QSVSQEFLITR  476 (496)
Q Consensus       439 ~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~~~~~~  476 (496)
                          ....+.+++.+||+.||++||++      +|+++|+|+..
T Consensus       242 ----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~  281 (345)
T 3a8x_A          242 ----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  281 (345)
T ss_dssp             ----SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred             ----CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence                12246789999999999999995      89999999864

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-45  Score=351.72  Aligned_cols=251  Identities=27%  Similarity=0.386  Sum_probs=211.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|+||.||+|..+ +|+.||+|.+.....  ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            67999999999999999999765 689999999976431  223466789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||++||+|.+++....   .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.... 
T Consensus        86 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-  158 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-  158 (318)
T ss_dssp             CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence            9999999999998654   6899999999999999999999   78999999999999999999999999999987543 


Q ss_pred             CCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                        .....+||+.|+|||++.+..++.++||||+|+++|||++|+.||...       ........+.......+..    
T Consensus       159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-------~~~~~~~~i~~~~~~~p~~----  225 (318)
T 1fot_A          159 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-------NTMKTYEKILNAELRFPPF----  225 (318)
T ss_dssp             --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-------SHHHHHHHHHHCCCCCCTT----
T ss_pred             --ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC-------CHHHHHHHHHhCCCCCCCC----
Confidence              233467999999999999999999999999999999999999999632       1222333333333322211    


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHhc
Q 011005          442 RDILLISTVSFACLQSNPKSRP-----TMQSVSQEFLITR  476 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~~~~~~  476 (496)
                       ....+.+++.+||+.||++||     +++|+++|+|+..
T Consensus       226 -~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          226 -FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             -SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             -CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence             112467899999999999999     9999999999864

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.9e-45  Score=356.79  Aligned_cols=273  Identities=33%  Similarity=0.515  Sum_probs=218.4

Q ss_pred             HHHHHHHhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeE
Q 011005          198 EDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCM  277 (496)
Q Consensus       198 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  277 (496)
                      .++..++++|++.+.||+|+||+||+|.+++++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus        32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  110 (321)
T 2qkw_B           32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS-QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM  110 (321)
T ss_dssp             SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS-SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred             HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            344456789999999999999999999988899999999876542 2346789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCC-CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          278 FLIYEYMERGSLFCNLHNNED-AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      ++||||+++|+|.+++..... ...+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  187 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK  187 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred             EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            999999999999999976532 235899999999999999999999   6799999999999999999999999999998


Q ss_pred             cccCCCC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchh--------Hh
Q 011005          357 LLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIML--------ID  426 (496)
Q Consensus       357 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~--------~~  426 (496)
                      .......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||................        ..
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (321)
T 2qkw_B          188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ  267 (321)
T ss_dssp             ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence            6543222  2234568999999999999999999999999999999999999986433211100000000        00


Q ss_pred             hhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          427 VLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ..+......   ........+.+++.+||+.||++|||+.|+++++....+
T Consensus       268 ~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          268 IVDPNLADK---IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             SSSSSCTTC---SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcChhhccc---cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            111111111   123445568899999999999999999999999987654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.3e-45  Score=360.09  Aligned_cols=256  Identities=23%  Similarity=0.361  Sum_probs=211.7

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHHHHHHhh-cccccccccceeecCCeEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMF  278 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  278 (496)
                      ..++|.+.+.||+|+||.||+|.++ +++.||+|.++....  ......+..|..+++.+ +||||+++++++...+..+
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            4578999999999999999999875 689999999976431  22345678899999887 8999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccc
Q 011005          279 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL  358 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  358 (496)
                      +||||++||+|.+++....   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        95 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            9999999999999997643   6899999999999999999999   779999999999999999999999999999865


Q ss_pred             cCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCCh
Q 011005          359 HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR  438 (496)
Q Consensus       359 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  438 (496)
                      ..........+||+.|+|||++.+..++.++||||+|+++|||++|+.||....       .......+.......+.. 
T Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-------~~~~~~~i~~~~~~~p~~-  240 (345)
T 1xjd_A          169 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-------EEELFHSIRMDNPFYPRW-  240 (345)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTT-
T ss_pred             ccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC-------HHHHHHHHHhCCCCCCcc-
Confidence            444444556789999999999999999999999999999999999999996321       122222222222221110 


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCCHH-HHHHHHHHhc
Q 011005          439 KVIRDILLISTVSFACLQSNPKSRPTMQ-SVSQEFLITR  476 (496)
Q Consensus       439 ~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~~~~~~~  476 (496)
                          ....+.+++.+||+.||++||++. |+++|+|+..
T Consensus       241 ----~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~  275 (345)
T 1xjd_A          241 ----LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE  275 (345)
T ss_dssp             ----SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             ----cCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccC
Confidence                112467899999999999999998 9999999864

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.1e-45  Score=352.84  Aligned_cols=266  Identities=26%  Similarity=0.324  Sum_probs=202.6

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      ++|++.+.||+|+||+||+|...+++.||+|++..... ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            47889999999999999999888899999999865432 22335678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++ +|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            985 8988887643  26889999999999999999999   67999999999999999999999999999987754444


Q ss_pred             CccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccC----------C---CCCCcchhHhhhc
Q 011005          364 NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS----------S---SSDPKIMLIDVLD  429 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~----------~---~~~~~~~~~~~~~  429 (496)
                      ......+|+.|+|||++.+. .++.++||||+|+++|+|++|+.||.......          .   ...+........+
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence            44456789999999998764 58999999999999999999999996432100          0   0000000000000


Q ss_pred             CCCC----CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          430 QRLP----PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       430 ~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      ....    .+...........+.+++.+||+.||++|||++|+++|+|+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence            0000    0000000011234678999999999999999999999999864

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=8.9e-45  Score=351.75  Aligned_cols=265  Identities=22%  Similarity=0.296  Sum_probs=212.2

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCC--eEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK--CMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lV~  281 (496)
                      ++|.+.+.||+|+||+||+|.+. +++.||||++.........+.+.+|++++++++||||+++++++....  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            57899999999999999999775 589999999987554444567789999999999999999999987755  789999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe----cCCCCeEEcccccccc
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL----NSKLEAFVADFGTARL  357 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~----~~~~~~kl~Dfg~~~~  357 (496)
                      ||+++|+|.+++........+++..++.++.||+.||+|||   +.+|+||||||+||++    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999987654445899999999999999999999   7799999999999999    7788899999999987


Q ss_pred             ccCCCCCccccccccccccccccc--------cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhc
Q 011005          358 LHADSSNRTLLAGTYGYIAPELAY--------TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD  429 (496)
Q Consensus       358 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  429 (496)
                      ..... ......||+.|+|||++.        +..++.++||||||+++|||++|+.||.......   ...........
T Consensus       166 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~  241 (319)
T 4euu_A          166 LEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR---RNKEVMYKIIT  241 (319)
T ss_dssp             CCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG---GCHHHHHHHHH
T ss_pred             cCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc---hhHHHHHHHhc
Confidence            65433 233457999999999986        5788999999999999999999999997432211   11111111111


Q ss_pred             CC---------------------CCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          430 QR---------------------LPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       430 ~~---------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ..                     .+.. ..........+.+++.+||+.||++|||++|+++|+.....
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVS-CSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTT-CSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             CCCcccchhhhcccCCccccCccCCcc-cccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            11                     1111 11123344467899999999999999999999999986544

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.8e-45  Score=353.86  Aligned_cols=274  Identities=20%  Similarity=0.259  Sum_probs=196.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|++.+.||+|+||+||+|..+ +++.||+|.+.........+.+.+|+.++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            468999999999999999999765 6899999999765433334667899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCC---CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          283 YMERGSLFCNLHNNE---DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      |++ |+|.+++....   ....+++..+..++.||+.||.|||   +.||+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 59988876431   2235899999999999999999999   7799999999999999999999999999998775


Q ss_pred             CCCCCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccC----------CCCC-CcchhHh-
Q 011005          360 ADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS----------SSSD-PKIMLID-  426 (496)
Q Consensus       360 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~----------~~~~-~~~~~~~-  426 (496)
                      ..........||+.|+|||++.+. .++.++||||+|+++|+|++|+.||.......          .... ....... 
T Consensus       160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (317)
T 2pmi_A          160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL  239 (317)
T ss_dssp             SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred             CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence            544444556789999999998764 68999999999999999999999996432100          0000 0000000 


Q ss_pred             -hhcCCC----CCCCChh-----HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCC
Q 011005          427 -VLDQRL----PPPVDRK-----VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLV  481 (496)
Q Consensus       427 -~~~~~~----~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~  481 (496)
                       ......    +......     .......+.+|+.+||+.||++|||++|+++|+|+.......
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  304 (317)
T 2pmi_A          240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHA  304 (317)
T ss_dssp             TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC--
T ss_pred             hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchh
Confidence             000000    0000000     000122578999999999999999999999999998765543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.9e-45  Score=358.94  Aligned_cols=259  Identities=21%  Similarity=0.307  Sum_probs=209.4

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV  280 (496)
                      ..++|++.+.||+|+||.||+|.++ +++.||+|.+.....     ...+|++++.++ +||||+++++++.+++..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence            5678999999999999999999765 688999999976542     235788888888 799999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC----CCeEEccccccc
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK----LEAFVADFGTAR  356 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~----~~~kl~Dfg~~~  356 (496)
                      |||++||+|.+.+....   .+++..+..++.||+.||+|||   +.||+||||||+||++.++    +.+||+|||+++
T Consensus        95 ~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           95 TELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             ECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            99999999999998654   6899999999999999999999   7799999999999998543    359999999998


Q ss_pred             cccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCC
Q 011005          357 LLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV  436 (496)
Q Consensus       357 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  436 (496)
                      ............+||+.|+|||++.+..++.++||||+|+++|+|++|+.||....    ..........+.........
T Consensus       169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~~~~~i~~~~~~~~~  244 (342)
T 2qr7_A          169 QLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP----DDTPEEILARIGSGKFSLSG  244 (342)
T ss_dssp             ECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST----TSCHHHHHHHHHHCCCCCCS
T ss_pred             cCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC----cCCHHHHHHHHccCCcccCc
Confidence            87655545556789999999999998889999999999999999999999996321    11112222222222222111


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                       ..+......+.+|+.+||+.||++|||+.|+++|+|+...
T Consensus       245 -~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          245 -GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             -TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             -cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence             0011112347789999999999999999999999999754

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.1e-45  Score=355.08  Aligned_cols=255  Identities=26%  Similarity=0.354  Sum_probs=201.5

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe----CCCcEEEEEEcccch---hHHHHHHHHHHHHHHHhhcccccccccceeecCCe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSE---ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKC  276 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  276 (496)
                      .++|++.+.||+|+||.||+|..    .+++.||+|+++...   .......+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46799999999999999999976    478999999997643   22234567899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      .++||||+++|+|.+++....   .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            999999999999999997643   6889999999999999999999   6799999999999999999999999999998


Q ss_pred             cccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCC
Q 011005          357 LLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV  436 (496)
Q Consensus       357 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  436 (496)
                      ............+||+.|+|||++.+..++.++||||+|+++|+|++|+.||....       .......+.......+.
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~i~~~~~~~p~  242 (327)
T 3a62_A          170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN-------RKKTIDKILKCKLNLPP  242 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHTCCCCCT
T ss_pred             ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhCCCCCCC
Confidence            65444444445679999999999999999999999999999999999999996321       22222333333322211


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHhc
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRP-----TMQSVSQEFLITR  476 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~~~~~~  476 (496)
                      .     ....+.+++.+||+.||++||     ++.|+++|+|+..
T Consensus       243 ~-----~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~  282 (327)
T 3a62_A          243 Y-----LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH  282 (327)
T ss_dssp             T-----SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred             C-----CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence            1     112467899999999999999     8899999999864

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.8e-45  Score=359.92  Aligned_cols=262  Identities=21%  Similarity=0.310  Sum_probs=201.8

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|++.+.||+|+||+||+|... +++.||+|++......  .+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            468999999999999999999775 7899999999764422  2567899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCC--eEEccccccccccC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE--AFVADFGTARLLHA  360 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~  360 (496)
                      |+++|+|.+++....   .+++..++.++.|++.||+|||   ++||+||||||+||+++.++.  +||+|||+++....
T Consensus        97 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           97 YASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred             eCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence            999999999987543   6899999999999999999999   779999999999999987765  99999999975432


Q ss_pred             CCCCccccccccccccccccccCCcCcc-cchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEK-CDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                      . ......+||+.|+|||++.+..++.+ +||||+|+++|+|++|+.||.....   ..................+....
T Consensus       171 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  246 (361)
T 3uc3_A          171 H-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE---PRDYRKTIQRILSVKYSIPDDIR  246 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-------CCCHHHHHHHHHTTCCCCCTTSC
T ss_pred             c-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc---HHHHHHHHHHHhcCCCCCCCcCC
Confidence            2 22334579999999999988888765 8999999999999999999974321   11111122222222222111110


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                         ....+.+|+.+||+.||++|||+.|+++|+|+.+..+.
T Consensus       247 ---~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  284 (361)
T 3uc3_A          247 ---ISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPA  284 (361)
T ss_dssp             ---CCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCCC
T ss_pred             ---CCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCch
Confidence               11246789999999999999999999999999776544

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.3e-44  Score=357.36  Aligned_cols=258  Identities=22%  Similarity=0.362  Sum_probs=209.8

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe--------CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecC
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL--------PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHK  274 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  274 (496)
                      .++|++.+.||+|+||.||+|.+        .++..||||.++........+.+.+|+.+++++ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            36789999999999999999975        245679999998765555667899999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhCCCC-------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe
Q 011005          275 KCMFLIYEYMERGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL  341 (496)
Q Consensus       275 ~~~~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~  341 (496)
                      +..++||||+++|+|.+++.....             ...+++..++.++.||+.||+|||   .++|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            999999999999999999976432             235899999999999999999999   7799999999999999


Q ss_pred             cCCCCeEEccccccccccCCCC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCC
Q 011005          342 NSKLEAFVADFGTARLLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSS  418 (496)
Q Consensus       342 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~  418 (496)
                      +.++.+||+|||+++.......  ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....      
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~------  310 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------  310 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC------
Confidence            9999999999999987654322  1233457789999999999999999999999999999999 999986321      


Q ss_pred             CCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          419 DPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                       .............. ....   .....+.+++.+||+.||++|||+.|+++++...
T Consensus       311 -~~~~~~~~~~~~~~-~~~~---~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          311 -VEELFKLLKEGHRM-DKPA---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             -GGGHHHHHHTTCCC-CCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHHHHHHhcCCCC-CCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             11122222222111 1111   1122477899999999999999999999998654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.8e-45  Score=352.79  Aligned_cols=261  Identities=25%  Similarity=0.383  Sum_probs=209.3

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC----CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      ++|.+.+.||+|+||+||+|.+.    .+..||||.++........+.+.+|+.++++++||||+++++++..++..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            57888999999999999999874    45569999998765555567899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+++|+|.+++....  ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       129 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             EECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             eeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            99999999999997543  26899999999999999999999   77999999999999999999999999999987754


Q ss_pred             CCCC---ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCC
Q 011005          361 DSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV  436 (496)
Q Consensus       361 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  436 (496)
                      ....   .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....       ........... ...+.
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-------~~~~~~~~~~~-~~~~~  275 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT-------NRDVISSVEEG-YRLPA  275 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC-------HHHHHHHHHTT-CCCCC
T ss_pred             CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC-------HHHHHHHHHcC-CCCCC
Confidence            3322   122345778999999999999999999999999999999 999986321       11122222222 11111


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCC
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLV  481 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~  481 (496)
                      ..   .....+.+++.+||+.||++|||+.|+++.+....+.+..
T Consensus       276 ~~---~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~  317 (325)
T 3kul_A          276 PM---GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES  317 (325)
T ss_dssp             CT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred             CC---CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence            11   1123477899999999999999999999999887665543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.4e-45  Score=358.17  Aligned_cols=255  Identities=21%  Similarity=0.328  Sum_probs=212.6

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  279 (496)
                      .++|++.+.||+|+||.||+|..+ +++.||+|+++...  .......+.+|..+++.+ +||+|+++++++...+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            468999999999999999999876 47899999997643  223345678899999888 79999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||||++||+|.+++....   .+++..++.++.||+.||+|||   +.||+||||||+|||++.++.+||+|||+++...
T Consensus        99 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            999999999999997643   6899999999999999999999   7799999999999999999999999999998654


Q ss_pred             CCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          360 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       360 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                      .........+||+.|+|||++.+..++.++||||+|+++|||++|+.||...       ........+.......+..  
T Consensus       173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~-------~~~~~~~~i~~~~~~~p~~--  243 (353)
T 2i0e_A          173 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-------DEDELFQSIMEHNVAYPKS--  243 (353)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHCCCCCCTT--
T ss_pred             cCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC-------CHHHHHHHHHhCCCCCCCC--
Confidence            4444455678999999999999999999999999999999999999999632       2222333333333332211  


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHHHHhc
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPT-----MQSVSQEFLITR  476 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~~~~~~  476 (496)
                         ....+.+++.+||+.||++||+     ++|+++|+|+..
T Consensus       244 ---~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          244 ---MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             ---SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             ---CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence               1224678999999999999994     699999999853

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=347.79  Aligned_cols=259  Identities=27%  Similarity=0.447  Sum_probs=210.0

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|.+.+.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            367889999999999999999764 68999999886543 3345778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++|+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        88 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           88 YIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             CCTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             ecCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            999999999998643  26899999999999999999999   7799999999999999999999999999998764332


Q ss_pred             CCc--------------cccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhh
Q 011005          363 SNR--------------TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVL  428 (496)
Q Consensus       363 ~~~--------------~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  428 (496)
                      ...              ....||+.|+|||++.+..++.++||||||+++|+|++|..|+........  ..........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~--~~~~~~~~~~  240 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM--DFGLNVRGFL  240 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT--TSSBCHHHHH
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH--HHhhhhhccc
Confidence            211              145799999999999999999999999999999999999999864332111  1111222222


Q ss_pred             cCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          429 DQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ....+....       ..+.+++.+||+.||++|||+.|+++.+...+.
T Consensus       241 ~~~~~~~~~-------~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          241 DRYCPPNCP-------PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             HHTCCTTCC-------TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccCCCCCC-------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            222222222       136789999999999999999999998776543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.1e-44  Score=345.04  Aligned_cols=267  Identities=22%  Similarity=0.336  Sum_probs=216.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      .++|++.+.||+|+||.||+|.++ +++.||+|++.... .....+.+.+|+.++++++||||+++++++..+...++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            578999999999999999999764 68999999987643 3344567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCC---eEEccccccccc
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE---AFVADFGTARLL  358 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~~~  358 (496)
                      ||+++++|.+.+....   .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            9999999988887643   6899999999999999999999   779999999999999986655   999999999776


Q ss_pred             cCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCCh
Q 011005          359 HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR  438 (496)
Q Consensus       359 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  438 (496)
                      .... ......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||....       ...............+...
T Consensus       159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~  230 (284)
T 3kk8_A          159 NDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-------QHRLYAQIKAGAYDYPSPE  230 (284)
T ss_dssp             CSSC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCCCCCTTT
T ss_pred             ccCc-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc-------hhHHHHHHHhccccCCchh
Confidence            4332 2344678999999999999999999999999999999999999986321       1222222222222211110


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCccc
Q 011005          439 KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAA  485 (496)
Q Consensus       439 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~~  485 (496)
                       .......+.+++.+||+.||++|||++|+++|+|+...........
T Consensus       231 -~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~~~  276 (284)
T 3kk8_A          231 -WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIH  276 (284)
T ss_dssp             -TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGSCC
T ss_pred             -hcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhHhh
Confidence             0111234778999999999999999999999999988766654433

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.4e-45  Score=351.24  Aligned_cols=262  Identities=21%  Similarity=0.275  Sum_probs=204.6

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      ++|++.+.||+|+||+||+|.+. +++.||+|++.... .......+.+|+.++++++||||+++++++..++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            47899999999999999999765 68999999997543 23344678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++ ++.+.+....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        82 ~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            9986 5555554322  26899999999999999999999   6799999999999999999999999999998776555


Q ss_pred             CCccccccccccccccccccCC-cCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhc------------
Q 011005          363 SNRTLLAGTYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD------------  429 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------  429 (496)
                      .......||+.|+|||++.+.. ++.++||||+|+++|+|++|..|+-....      .......+..            
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~------~~~~~~~i~~~~~~~~~~~~~~  229 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND------VDDQLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS------HHHHHHHHHHHHCCCCTTTCTT
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC------HHHHHHHHHHHhCCCChhhhhh
Confidence            5555667899999999998765 79999999999999999999888532111      0000000000            


Q ss_pred             -----CCCC-------CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          430 -----QRLP-------PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       430 -----~~~~-------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                           ...+       .............+.+|+.+||+.||++|||++|+++|+|+....
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                 0000       000000001123467899999999999999999999999997643

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3e-44  Score=364.03  Aligned_cols=256  Identities=23%  Similarity=0.383  Sum_probs=213.9

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|.+.+.||+|+||.||+|.+. +|+.||||++.....  ......+.+|+.+++.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57999999999999999999775 799999999976432  223467899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++|+|.+++....   .+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        96 E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            9999999999997643   6899999999999999999999   789999999999999999999999999999876543


Q ss_pred             CCCccccccccccccccccccCCc-CcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                       ......+||+.|+|||++.+..+ +.++||||+|+++|+|++|+.||...       ........+.......+..   
T Consensus       170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~-------~~~~~~~~i~~~~~~~p~~---  238 (476)
T 2y94_A          170 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD-------HVPTLFKKICDGIFYTPQY---  238 (476)
T ss_dssp             -CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS-------SSHHHHHHHHTTCCCCCTT---
T ss_pred             -ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC-------CHHHHHHHHhcCCcCCCcc---
Confidence             23345679999999999998776 68999999999999999999999632       1222233333333222211   


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                        ....+.+|+.+||+.||++|||++|+++|+|+....+
T Consensus       239 --~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  275 (476)
T 2y94_A          239 --LNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLP  275 (476)
T ss_dssp             --CCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred             --CCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence              1124678999999999999999999999999987654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=6.2e-45  Score=356.83  Aligned_cols=261  Identities=25%  Similarity=0.320  Sum_probs=197.7

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ..++|++.+.||+|+||.||+|.++ +++.||||.+.....   .+.+.+|+.++++++||||+++++++..+...++||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD---KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh---HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            3567999999999999999999876 588999999976542   356789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC---CCCeEEccccccccc
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KLEAFVADFGTARLL  358 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg~~~~~  358 (496)
                      ||+++|+|.+++....   .+++..++.++.|++.||.|||   +.+|+||||||+||+++.   ++.+||+|||+++..
T Consensus       128 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          128 ELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             CCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             EeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            9999999999997643   6899999999999999999999   679999999999999975   889999999999876


Q ss_pred             cCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCCh
Q 011005          359 HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR  438 (496)
Q Consensus       359 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  438 (496)
                      .... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....      ........+......... .
T Consensus       202 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~~i~~~~~~~~~-~  273 (349)
T 2w4o_A          202 EHQV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER------GDQFMFRRILNCEYYFIS-P  273 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT------CHHHHHHHHHTTCCCCCT-T
T ss_pred             Cccc-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc------ccHHHHHHHHhCCCccCC-c
Confidence            4322 2334678999999999999999999999999999999999999985321      111122223322221111 0


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          439 KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       439 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      ........+.+++.+||+.||++|||+.|+++|+|+......
T Consensus       274 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  315 (349)
T 2w4o_A          274 WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN  315 (349)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred             hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence            011122347799999999999999999999999999876554

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.2e-44  Score=354.38  Aligned_cols=252  Identities=22%  Similarity=0.316  Sum_probs=212.0

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      .++|++.+.||+|+||.||+|..+ +|+.||+|.+....  .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            367999999999999999999765 68999999997643  223346788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||++||+|.+++....   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence            99999999999998643   6899999999999999999999   77999999999999999999999999999987643


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      .   ....+||+.|+|||++.+..++.++||||+|+++|||++|+.||...       ........+.......+..   
T Consensus       194 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~-------~~~~~~~~i~~~~~~~p~~---  260 (350)
T 1rdq_E          194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-------QPIQIYEKIVSGKVRFPSH---  260 (350)
T ss_dssp             C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHCCCCCCTT---
T ss_pred             C---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC-------CHHHHHHHHHcCCCCCCCC---
Confidence            2   33467999999999999999999999999999999999999999632       1222333333333322211   


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHHHHhc
Q 011005          441 IRDILLISTVSFACLQSNPKSRPT-----MQSVSQEFLITR  476 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~~~~~~  476 (496)
                        ....+.+++.+||+.||++||+     ++|+++|+|+..
T Consensus       261 --~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          261 --FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             --CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             --CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence              1224778999999999999998     999999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=8.6e-45  Score=347.52  Aligned_cols=259  Identities=25%  Similarity=0.371  Sum_probs=202.8

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.+....  .....+.+.+|+.++++++||||+++++++..++..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            467999999999999999999754 68999999985432  334457789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+++++|.+++....   .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            99999999999997654   6899999999999999999999   77999999999999999999999999999987654


Q ss_pred             CCC-CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          361 DSS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       361 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                      ... ......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||....       .............+......
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~  236 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET-------AVSIAIKHIQDSVPNVTTDV  236 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC-------HHHHHHHHHSSCCCCHHHHS
T ss_pred             ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHhhccCCCcchhc
Confidence            322 2334568999999999999999999999999999999999999996322       11112222222222111000


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHHHh
Q 011005          440 VIRDILLISTVSFACLQSNPKSRP-TMQSVSQEFLIT  475 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~~~~~  475 (496)
                      ....+..+.+++.+||+.||++|| +++++.+.+...
T Consensus       237 ~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~  273 (294)
T 4eqm_A          237 RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV  273 (294)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred             ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence            111223577899999999999999 666666666543

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.2e-44  Score=351.27  Aligned_cols=264  Identities=26%  Similarity=0.344  Sum_probs=206.9

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCC----eEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK----CMFL  279 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~l  279 (496)
                      .++|++.+.||+|+||+||+|.+. ++.||||++......  .....+|+.++++++||||+++++++....    ..++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ--SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH--HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            367999999999999999999885 789999999765432  244567899999999999999999998743    4799


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCC----------CeEEeCCCCCceEecCCCCeEE
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP----------SIIHRDISSNNILLNSKLEAFV  349 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~----------~i~H~dlkp~Nil~~~~~~~kl  349 (496)
                      ||||+++|+|.+++...    .+++..++.++.|++.||+|||   +.          +|+||||||+|||++.++.+||
T Consensus       100 v~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL  172 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI  172 (322)
T ss_dssp             EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred             EEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence            99999999999999764    5899999999999999999999   67          9999999999999999999999


Q ss_pred             ccccccccccCCCCC--cccccccccccccccccc-----CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCC----
Q 011005          350 ADFGTARLLHADSSN--RTLLAGTYGYIAPELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSS----  418 (496)
Q Consensus       350 ~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~----  418 (496)
                      +|||+++........  .....||+.|+|||++.+     ..++.++||||||+++|||++|+.||..........    
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            999999876543322  233578999999999987     456678999999999999999999987432211100    


Q ss_pred             -----CCcchhHhhhcCCCCCCCCh--hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          419 -----DPKIMLIDVLDQRLPPPVDR--KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       419 -----~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                           ...............+....  ........+.+++.+||+.||++|||+.|+++.+....+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                 01111111222222222222  112334458899999999999999999999999876554

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.2e-44  Score=357.53  Aligned_cols=264  Identities=17%  Similarity=0.282  Sum_probs=209.0

Q ss_pred             HhCCCCcceeeec--CCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          204 TEDFDIRYCIGTG--GYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       204 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      .++|++.+.||+|  +||+||+|.++ +++.||||++.... .....+.+.+|+.+++.++||||+++++++..++..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4679999999999  99999999775 79999999997653 23445678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||||+++|+|.+++..... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||.+....
T Consensus       104 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            9999999999999976532 25899999999999999999999   7799999999999999999999999999986543


Q ss_pred             CCC-------CCcccccccccccccccccc--CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcC
Q 011005          360 ADS-------SNRTLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQ  430 (496)
Q Consensus       360 ~~~-------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  430 (496)
                      ...       .......||+.|+|||++.+  ..++.++||||+||++|+|++|+.||......       .........
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~~~~~  252 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT-------QMLLEKLNG  252 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST-------THHHHC---
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHhcC
Confidence            221       11223478899999999987  67899999999999999999999999643211       111111100


Q ss_pred             CCCC-----------------------------------------CCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 011005          431 RLPP-----------------------------------------PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVS  469 (496)
Q Consensus       431 ~~~~-----------------------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl  469 (496)
                      ..+.                                         +...........+.+|+.+||+.||++|||++|++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell  332 (389)
T 3gni_B          253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL  332 (389)
T ss_dssp             -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred             CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence            0000                                         00000011123478899999999999999999999


Q ss_pred             HHHHHhccC
Q 011005          470 QEFLITRKT  478 (496)
Q Consensus       470 ~~~~~~~~~  478 (496)
                      +|+|+....
T Consensus       333 ~hp~f~~~~  341 (389)
T 3gni_B          333 NHSFFKQIK  341 (389)
T ss_dssp             TSGGGGGC-
T ss_pred             cCHHHHHHh
Confidence            999997654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-44  Score=354.78  Aligned_cols=268  Identities=25%  Similarity=0.310  Sum_probs=210.7

Q ss_pred             HHHHHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch----hHHHHHHHHHHHHHHHhhcccccccccceeecC
Q 011005          200 LIEATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE----ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK  274 (496)
Q Consensus       200 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  274 (496)
                      +....++|++.+.||+|+||+||+|.. .+++.||+|.+....    .....+.+.+|+.++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            345678999999999999999999976 468899999987542    223456789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhCCC-------------------------------------CCccCCHHHHHHHHHHHHHH
Q 011005          275 KCMFLIYEYMERGSLFCNLHNNE-------------------------------------DAVELDWAKRVNIVKAMAHA  317 (496)
Q Consensus       275 ~~~~lV~e~~~~g~L~~~l~~~~-------------------------------------~~~~~~~~~~~~i~~~i~~~  317 (496)
                      +..++||||+++|+|.+++....                                     ....+++..++.++.||+.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            99999999999999999885210                                     01124677788999999999


Q ss_pred             HHHHHhCCCCCeEEeCCCCCceEecCCC--CeEEccccccccccCCCC----Ccccccccccccccccccc--CCcCccc
Q 011005          318 LAYLHHDCSPSIIHRDISSNNILLNSKL--EAFVADFGTARLLHADSS----NRTLLAGTYGYIAPELAYT--MVMTEKC  389 (496)
Q Consensus       318 l~~lh~~~~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~  389 (496)
                      |+|||   +.+|+||||||+||+++.++  .+||+|||+++.+.....    ......||+.|+|||++.+  ..++.++
T Consensus       181 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999   67999999999999998776  899999999987643222    1234579999999999875  6788999


Q ss_pred             chhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 011005          390 DVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVS  469 (496)
Q Consensus       390 DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl  469 (496)
                      ||||||+++|+|++|+.||....       ...............+... .......+.+++.+||+.||++|||+.|++
T Consensus       258 DiwslG~il~el~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~~l  329 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVN-------DADTISQVLNKKLCFENPN-YNVLSPLARDLLSNLLNRNVDERFDAMRAL  329 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCTTSGG-GGGSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCC-------hHHHHHHHHhcccccCCcc-cccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence            99999999999999999996322       2223333333333322211 111223577999999999999999999999


Q ss_pred             HHHHHhccC
Q 011005          470 QEFLITRKT  478 (496)
Q Consensus       470 ~~~~~~~~~  478 (496)
                      +|+|+....
T Consensus       330 ~hp~~~~~~  338 (345)
T 3hko_A          330 QHPWISQFS  338 (345)
T ss_dssp             HSHHHHTTS
T ss_pred             cChhhccCh
Confidence            999997653

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-44  Score=356.69  Aligned_cols=261  Identities=23%  Similarity=0.297  Sum_probs=211.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|++.+.||+|+||.||+|..+ +++.||+|.+...... ....+.+|+.+++.++||||+++++++......++|||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh-hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            467999999999999999999765 6889999998765432 23568899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC--CCCeEEccccccccccC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS--KLEAFVADFGTARLLHA  360 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~  360 (496)
                      |+++|+|.+++....  ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.  ++.+||+|||+++....
T Consensus       129 ~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          129 FLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             CCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             cCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            999999999987543  26899999999999999999999   779999999999999974  47799999999987654


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      .. ......||+.|+|||++.+..++.++||||+||++|+|++|+.||....       .......+.......+... .
T Consensus       204 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~-~  274 (387)
T 1kob_A          204 DE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-------DLETLQNVKRCDWEFDEDA-F  274 (387)
T ss_dssp             TS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHHHHHHCCCCCCSST-T
T ss_pred             Cc-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCccc-c
Confidence            32 2344579999999999999999999999999999999999999996322       1112222222221111100 1


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      ......+.+++.+||+.||++|||+.|+++|+|+.....
T Consensus       275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  313 (387)
T 1kob_A          275 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  313 (387)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence            111234779999999999999999999999999976543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=354.97  Aligned_cols=257  Identities=26%  Similarity=0.381  Sum_probs=210.0

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      .++|++.+.||+|+||.||+|..+ +++.||+|.+....  .....+.+.+|+.+++.++||||+++++++......++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            367999999999999999999765 58899999987643  223346788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+.||+|.+++....   .+++..+..++.||+.||.|||   +.||+||||||+|||++.++.+||+|||+++....
T Consensus        94 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             ECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            99999999999998654   6899999999999999999999   77999999999999999999999999999987643


Q ss_pred             CCCCcccccccccccccccccc---CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          361 DSSNRTLLAGTYGYIAPELAYT---MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                      . ......+||+.|+|||++.+   ..++.++||||+||++|+|++|+.||.....    .................+..
T Consensus       168 ~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~----~~~~~~~~~~~~~~~~~p~~  242 (384)
T 4fr4_A          168 E-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS----TSSKEIVHTFETTVVTYPSA  242 (384)
T ss_dssp             T-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT----SCHHHHHHHHHHCCCCCCTT
T ss_pred             C-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC----ccHHHHHHHHhhcccCCCCc
Confidence            3 33455689999999999874   4589999999999999999999999963221    11111122222222221111


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHHHHHhc
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPT-MQSVSQEFLITR  476 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~~~~~~~  476 (496)
                           ....+.+++.+||+.||++||+ ++++++|+|+..
T Consensus       243 -----~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~  277 (384)
T 4fr4_A          243 -----WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND  277 (384)
T ss_dssp             -----SCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred             -----CCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence                 1124778999999999999998 999999999854

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=347.22  Aligned_cols=266  Identities=25%  Similarity=0.319  Sum_probs=203.8

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      ++|++.+.||+|+||+||+|.+. +|+.||+|++.... .....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            67999999999999999999775 58999999986643 33345678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++++|.+++....   .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......
T Consensus        83 ~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           83 YCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             eCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            999999998887543   6899999999999999999999   7799999999999999999999999999998776544


Q ss_pred             CCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhh-------------
Q 011005          363 SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVL-------------  428 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------  428 (496)
                      .......||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||........    ........             
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~  232 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ----LYLIRKTLGDLIPRHQQVFST  232 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCSCCHHHHHHHHT
T ss_pred             cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhccccccccccccc
Confidence            44455678999999999876 6789999999999999999999999964321100    00000000             


Q ss_pred             -----cCCCCCCCChhH-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          429 -----DQRLPPPVDRKV-----IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       429 -----~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                           ....+.+.....     ......+.+++.+||+.||++|||++|+++|+|+......
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  294 (311)
T 4agu_A          233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI  294 (311)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred             ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence                 001111110000     0112347789999999999999999999999999875444

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.8e-44  Score=339.19  Aligned_cols=263  Identities=24%  Similarity=0.341  Sum_probs=213.1

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ..++|++.+.||+|+||.||+|... +++.||+|.+.........+.+.+|+.+++.++||||+++++++..++..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            4578999999999999999999765 789999999876554445577899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++++|.+++....   .+++..++.++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++......
T Consensus        85 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           85 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            9999999999987543   6899999999999999999999   779999999999999999999999999999866432


Q ss_pred             C--CCccccccccccccccccccCCc-CcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCCh
Q 011005          362 S--SNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR  438 (496)
Q Consensus       362 ~--~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  438 (496)
                      .  .......|++.|+|||.+.+..+ +.++||||+|+++|+|++|+.||.....      .................  
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~--  230 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD------SCQEYSDWKEKKTYLNP--  230 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT------TSHHHHHHHTTCTTSTT--
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch------HHHHHHHhhhcccccCc--
Confidence            2  12334578999999999988765 7799999999999999999999964221      11112222222111111  


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          439 KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       439 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                       .......+.+++.+||+.||++|||++|+++|+|+......
T Consensus       231 -~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  271 (276)
T 2yex_A          231 -WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK  271 (276)
T ss_dssp             -GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC-
T ss_pred             -hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhhc
Confidence             11112346789999999999999999999999999766443

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=342.64  Aligned_cols=259  Identities=26%  Similarity=0.426  Sum_probs=187.8

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchh--HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|.+.....  ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35799999999999999999976 5789999999975432  22346788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+++++|.+++....  ..+++..++.++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            99999999999998643  36899999999999999999999   67999999999999999999999999999987654


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      .........||+.|+|||.+.+..++.++||||+|+++|+|++|+.||......       .............+.    
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~----  233 (278)
T 3cok_A          165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK-------NTLNKVVLADYEMPS----  233 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSSCCCCCT----
T ss_pred             CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH-------HHHHHHhhcccCCcc----
Confidence            443344567899999999999999999999999999999999999999643211       111111111111110    


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                       .....+.+++.+||+.||++|||++|+++|+|+.....
T Consensus       234 -~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  271 (278)
T 3cok_A          234 -FLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSS  271 (278)
T ss_dssp             -TSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred             -ccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCCC
Confidence             01124678999999999999999999999999976543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1e-43  Score=342.32  Aligned_cols=275  Identities=31%  Similarity=0.500  Sum_probs=221.0

Q ss_pred             ccccHHHHHHHHhCCCCc------ceeeecCCeeEEEEEeCCCcEEEEEEcccch---hHHHHHHHHHHHHHHHhhcccc
Q 011005          193 GRIVYEDLIEATEDFDIR------YCIGTGGYGSVYKAQLPNGKVFALKKLHTSE---ELAFIKSFKNEAQVLSQVLHRN  263 (496)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~n  263 (496)
                      ..+++.++..++++|...      +.||+|+||.||+|.. +++.||+|++....   .....+.+.+|+.++++++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            357789999999998877      8999999999999987 68899999987532   2334567899999999999999


Q ss_pred             cccccceeecCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC
Q 011005          264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS  343 (496)
Q Consensus       264 iv~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~  343 (496)
                      |+++++++...+..++||||+++|+|.+++........+++..++.++.|++.||.|||   +.+++||||||+||+++.
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~  168 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDE  168 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECT
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEcC
Confidence            99999999999999999999999999999986544456899999999999999999999   679999999999999999


Q ss_pred             CCCeEEccccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCC--
Q 011005          344 KLEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSD--  419 (496)
Q Consensus       344 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~--  419 (496)
                      ++.+||+|||++.........  .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...........  
T Consensus       169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~  247 (307)
T 2nru_A          169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK  247 (307)
T ss_dssp             TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred             CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence            999999999999876543222  233568999999998875 588999999999999999999999974332110000  


Q ss_pred             -----CcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          420 -----PKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       420 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                           ........+...+..    ........+.+++.+||+.||++|||+.++++++....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          248 EEIEDEEKTIEDYIDKKMND----ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHTTSCCHHHHSCSSCSC----CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHhhhhhhhhhhhccccccc----cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence                 000112222222221    12234456889999999999999999999999987653

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.7e-44  Score=340.57  Aligned_cols=257  Identities=30%  Similarity=0.460  Sum_probs=208.3

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      .++|++.+.||+|+||+||+|.+. +++.||+|.+.....  ......+.+|+.++++++||||+++++++......++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467999999999999999999664 577999999866432  22346788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+++|+|.+.+....   .+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            99999999999987643   6899999999999999999999   78999999999999999999999999999865432


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      .  ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||....       ...............+..   
T Consensus       162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~---  229 (279)
T 3fdn_A          162 S--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-------YQETYKRISRVEFTFPDF---  229 (279)
T ss_dssp             --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHTCCCCCTT---
T ss_pred             c--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc-------HHHHHHHHHhCCCCCCCc---
Confidence            2  2344578999999999999999999999999999999999999986321       111222222222211111   


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                        ....+.+++.+||+.||++|||++|+++|+|+......
T Consensus       230 --~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~  267 (279)
T 3fdn_A          230 --VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSK  267 (279)
T ss_dssp             --SCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred             --CCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccC
Confidence              11246789999999999999999999999999876543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.5e-44  Score=338.64  Aligned_cols=256  Identities=24%  Similarity=0.395  Sum_probs=209.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      .++|++.+.||+|+||.||+|.++++..||+|++......  .+.+.+|++++++++||||+++++++......++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            4678999999999999999999988889999999765432  25688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+++....  ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++........
T Consensus        85 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           85 ISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             CTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred             cCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence            99999999997642  25899999999999999999999   77999999999999999999999999999987644322


Q ss_pred             C-ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          364 N-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       364 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                      . .....+|+.|+|||.+.+..++.++||||+|+++|+|++ |+.||....       ...................   
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~---  229 (268)
T 3sxs_A          160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT-------NSEVVLKVSQGHRLYRPHL---  229 (268)
T ss_dssp             EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC-------HHHHHHHHHTTCCCCCCTT---
T ss_pred             hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC-------hHHHHHHHHcCCCCCCCCc---
Confidence            1 222346678999999999999999999999999999999 999986322       1112222222211111111   


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          442 RDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                       ....+.+++.+||+.||++|||+.|+++++...++
T Consensus       230 -~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          230 -ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             -SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             -ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence             11247789999999999999999999999977654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.3e-45  Score=370.16  Aligned_cols=256  Identities=21%  Similarity=0.294  Sum_probs=202.3

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++....  .......+.+|+.+++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            46799999999999999999975 468999999997642  223345678899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+++|+|.+++....   .+++..+..++.||+.||+|||+  ..||+||||||+|||++.++.+||+|||+++....
T Consensus       227 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            99999999999997644   68999999999999999999993  17999999999999999999999999999987554


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      ........+||+.|+|||++.+..++.++||||||+++|||++|+.||....       .......+.......+..   
T Consensus       302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-------~~~~~~~i~~~~~~~p~~---  371 (446)
T 4ejn_A          302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HEKLFELILMEEIRFPRT---  371 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTT---
T ss_pred             CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-------HHHHHHHHHhCCCCCCcc---
Confidence            4444556789999999999999999999999999999999999999996321       222222333332222111   


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHhc
Q 011005          441 IRDILLISTVSFACLQSNPKSRP-----TMQSVSQEFLITR  476 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~~~~~~  476 (496)
                        ....+.+|+.+||+.||++||     |++|+++|+|+..
T Consensus       372 --~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~  410 (446)
T 4ejn_A          372 --LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG  410 (446)
T ss_dssp             --SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             --CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence              112467899999999999999     9999999999875

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-45  Score=365.51  Aligned_cols=265  Identities=23%  Similarity=0.304  Sum_probs=210.8

Q ss_pred             HHHHHHHHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeec
Q 011005          197 YEDLIEATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH  273 (496)
Q Consensus       197 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  273 (496)
                      +++.....++|++.+.||+|+||+||+|..+ +++.||+|++....  .......+.+|..++..++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3444445688999999999999999999775 79999999997643  12223457899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccc
Q 011005          274 KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG  353 (496)
Q Consensus       274 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  353 (496)
                      .+..++||||++||+|.+++.+..  ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++++||+|||
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeech
Confidence            999999999999999999997542  26899999999999999999999   7799999999999999999999999999


Q ss_pred             ccccccCCCCC-ccccccccccccccccc-------cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhH
Q 011005          354 TARLLHADSSN-RTLLAGTYGYIAPELAY-------TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLI  425 (496)
Q Consensus       354 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  425 (496)
                      +++........ ....+||+.|+|||++.       +..++.++|||||||++|||++|+.||....       ......
T Consensus       208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-------~~~~~~  280 (412)
T 2vd5_A          208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-------TAETYG  280 (412)
T ss_dssp             TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHH
T ss_pred             hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC-------HHHHHH
Confidence            99877544332 23468999999999987       4578999999999999999999999996321       112222


Q ss_pred             hhhcC--CCCCCCChhHHHHHHHHHHHHHhcccCCCCCC---CCHHHHHHHHHHhc
Q 011005          426 DVLDQ--RLPPPVDRKVIRDILLISTVSFACLQSNPKSR---PTMQSVSQEFLITR  476 (496)
Q Consensus       426 ~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---ps~~evl~~~~~~~  476 (496)
                      .+...  ....+..  .......+.+|+.+||. +|++|   |+++|+++|+|+..
T Consensus       281 ~i~~~~~~~~~p~~--~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~  333 (412)
T 2vd5_A          281 KIVHYKEHLSLPLV--DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG  333 (412)
T ss_dssp             HHHTHHHHCCCC------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred             HHHhcccCcCCCcc--ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence            22211  1111100  00112247789999999 99998   59999999999864

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=352.93  Aligned_cols=258  Identities=22%  Similarity=0.366  Sum_probs=203.5

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcc--cccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLH--RNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|+||.||+|...+++.||||++.... .....+.+.+|+.++++++|  +||+++++++..+...++||
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~   88 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM   88 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence            5689999999999999999998899999999987543 33445778999999999986  99999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      | +.+++|.+++....   .+++..+..++.||+.||.|||   +.+|+||||||+|||++ ++.+||+|||+++.....
T Consensus        89 e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           89 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             C-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             e-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            9 56889999998654   6899999999999999999999   67999999999999997 578999999999876543


Q ss_pred             CCC--cccccccccccccccccc-----------CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhh
Q 011005          362 SSN--RTLLAGTYGYIAPELAYT-----------MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVL  428 (496)
Q Consensus       362 ~~~--~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  428 (496)
                      ...  ....+||+.|+|||++.+           ..++.++||||||+++|+|++|+.||....      ..........
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~~~~  234 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------NQISKLHAII  234 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC------SHHHHHHHHH
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh------hHHHHHHHHh
Confidence            321  234679999999999865           678899999999999999999999996321      1111222222


Q ss_pred             cCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          429 DQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      ............   ...+.+++.+||+.||++|||+.|+++|+|+.....
T Consensus       235 ~~~~~~~~~~~~---~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  282 (343)
T 3dbq_A          235 DPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  282 (343)
T ss_dssp             CTTSCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred             cCCcccCCcccC---CHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence            222221111111   124678999999999999999999999999986544

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.2e-44  Score=340.20  Aligned_cols=255  Identities=25%  Similarity=0.386  Sum_probs=208.7

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      ++|++.+.||+|+||+||+|.+.+++.||+|++......  .+.+.+|++++++++||||+++++++.+....++||||+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            578899999999999999999988999999999865432  256889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC-
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS-  363 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  363 (496)
                      ++++|.+++....  ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||+++....... 
T Consensus        88 ~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  162 (269)
T 4hcu_A           88 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  162 (269)
T ss_dssp             TTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             CCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence            9999999997643  25899999999999999999999   77999999999999999999999999999986643211 


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                      ......+|+.|+|||.+.+..++.++||||+|+++|+|++ |+.||....       ........... ........   
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~-------~~~~~~~~~~~-~~~~~~~~---  231 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDISTG-FRLYKPRL---  231 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHTT-CCCCCCTT---
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC-------HHHHHHHHhcC-ccCCCCCc---
Confidence            1223456778999999999999999999999999999999 999986321       12222222222 11111111   


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ....+.+++.+||+.||++|||+.|+++++....+
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          232 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            12247789999999999999999999999977654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.1e-44  Score=340.73  Aligned_cols=262  Identities=21%  Similarity=0.304  Sum_probs=213.3

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ..++|++.+.||+|+||.||+|.++ ++..||+|++...... ..+.+.+|++++++++||||+++++++..+...++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            4578999999999999999999765 5778999998764322 2467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe---cCCCCeEEccccccccc
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKLEAFVADFGTARLL  358 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~  358 (496)
                      ||+++++|.+++....   .+++..++.++.|++.||+|||   +.+++||||||+||++   +.++.++|+|||++...
T Consensus        86 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           86 ELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             eccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            9999999999887643   6899999999999999999999   7799999999999999   78899999999999876


Q ss_pred             cCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCCh
Q 011005          359 HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR  438 (496)
Q Consensus       359 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  438 (496)
                      .... ......||+.|+|||.+.+. ++.++||||+|+++|+|++|+.||....       ...............+. .
T Consensus       160 ~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~-~  229 (277)
T 3f3z_A          160 KPGK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT-------DSEVMLKIREGTFTFPE-K  229 (277)
T ss_dssp             CTTS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCH-H
T ss_pred             cCcc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhCCCCCCc-h
Confidence            5432 33445799999999998765 8999999999999999999999996321       22222233333222211 1


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCC
Q 011005          439 KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLV  481 (496)
Q Consensus       439 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~  481 (496)
                      ........+.+++.+||+.||++|||+.|+++|+|+.......
T Consensus       230 ~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~  272 (277)
T 3f3z_A          230 DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS  272 (277)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCS
T ss_pred             hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccccc
Confidence            1112234578999999999999999999999999998765543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.4e-44  Score=361.25  Aligned_cols=260  Identities=24%  Similarity=0.309  Sum_probs=198.0

Q ss_pred             HHHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-------hHHHHHHHHHHHHHHHhhcccccccccceeec
Q 011005          202 EATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-------ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH  273 (496)
Q Consensus       202 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  273 (496)
                      ...++|.+.+.||+|+||+||+|.. .+++.||+|++....       .......+.+|+.++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3568999999999999999999965 468999999987542       11222357899999999999999999999854


Q ss_pred             CCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC---CeEEc
Q 011005          274 KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL---EAFVA  350 (496)
Q Consensus       274 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~---~~kl~  350 (496)
                       +..++||||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++   .+||+
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             -CceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEe
Confidence             45789999999999999887654   6899999999999999999999   67999999999999997544   59999


Q ss_pred             cccccccccCCCCCcccccccccccccccccc---CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhh
Q 011005          351 DFGTARLLHADSSNRTLLAGTYGYIAPELAYT---MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDV  427 (496)
Q Consensus       351 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  427 (496)
                      |||+++..... ......+||+.|+|||++.+   ..++.++||||+|+++|+|++|+.||....       ........
T Consensus       285 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-------~~~~~~~~  356 (419)
T 3i6u_A          285 DFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR-------TQVSLKDQ  356 (419)
T ss_dssp             CSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS-------SSCCHHHH
T ss_pred             ecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc-------chHHHHHH
Confidence            99999876433 22345679999999999864   567889999999999999999999996321       11112222


Q ss_pred             hcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          428 LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      +..................+.+++.+||+.||++|||++|+++|+|+..
T Consensus       357 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          357 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             HhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            2222111111111122345789999999999999999999999999864

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.7e-44  Score=352.73  Aligned_cols=263  Identities=25%  Similarity=0.335  Sum_probs=205.7

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-----ccccccccceeecCCe
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-----HRNIVKLYGYCLHKKC  276 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~~~~~~~~~  276 (496)
                      ..++|.+.+.||+|+||+||+|.+ .+++.||||++.....  ....+..|+.+++.+.     ||||+++++++...+.
T Consensus        33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~  110 (360)
T 3llt_A           33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK--YTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH  110 (360)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHH--HHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred             ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchh--hhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence            467899999999999999999976 4789999999975432  3356788999999996     9999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC-------------
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-------------  343 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~-------------  343 (496)
                      .++||||+ +++|.+++...... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.             
T Consensus       111 ~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          111 MCLIFEPL-GPSLYEIITRNNYN-GFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             EEEEECCC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             eEEEEcCC-CCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccchhcc
Confidence            99999999 89999999865432 5899999999999999999999   779999999999999975             


Q ss_pred             ------------CCCeEEccccccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccc
Q 011005          344 ------------KLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIL  411 (496)
Q Consensus       344 ------------~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~  411 (496)
                                  ++.+||+|||+++.....   .....||+.|+|||++.+..++.++||||+||++|+|++|+.||...
T Consensus       186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  262 (360)
T 3llt_A          186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH  262 (360)
T ss_dssp             TTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence                        788999999999865432   23457899999999999999999999999999999999999999642


Q ss_pred             cccC--------CCCCCcchhHhhh-------------cCCCCCCCChhH-H------------HHHHHHHHHHHhcccC
Q 011005          412 SSLS--------SSSDPKIMLIDVL-------------DQRLPPPVDRKV-I------------RDILLISTVSFACLQS  457 (496)
Q Consensus       412 ~~~~--------~~~~~~~~~~~~~-------------~~~~~~~~~~~~-~------------~~~~~l~~li~~cl~~  457 (496)
                      ....        ....+........             ....+....... .            .....+.+|+.+||+.
T Consensus       263 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  342 (360)
T 3llt_A          263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI  342 (360)
T ss_dssp             SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred             cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence            2110        0000000000000             000010000000 0            0013467999999999


Q ss_pred             CCCCCCCHHHHHHHHHHh
Q 011005          458 NPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       458 dP~~Rps~~evl~~~~~~  475 (496)
                      ||++|||++|+++|+|+.
T Consensus       343 dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          343 DPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             SGGGSCCHHHHTTSGGGC
T ss_pred             ChhhCCCHHHHhcCcccC
Confidence            999999999999999973

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.4e-44  Score=347.95  Aligned_cols=259  Identities=24%  Similarity=0.311  Sum_probs=211.3

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhH-----HHHHHHHHHHHHHHhhcccccccccceeecCCe
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEEL-----AFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKC  276 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  276 (496)
                      ..++|++.+.||+|+||.||+|..+ +|+.||+|.+......     ...+.+.+|+.+++.++||||+++++++.....
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            3567999999999999999999765 6899999998764321     124678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC----CeEEccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL----EAFVADF  352 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~----~~kl~Df  352 (496)
                      .++||||+++++|.+++....   .+++..++.++.|++.||+|||   +.+++||||||+||+++.++    .++|+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            999999999999999998643   6899999999999999999999   67999999999999999887    7999999


Q ss_pred             cccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCC
Q 011005          353 GTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRL  432 (496)
Q Consensus       353 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  432 (496)
                      |++....... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||....       .............
T Consensus       164 g~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~i~~~~~  235 (321)
T 2a2a_A          164 GLAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-------KQETLANITSVSY  235 (321)
T ss_dssp             TTCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHHHHHTTCC
T ss_pred             ccceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHhccc
Confidence            9998765432 2344578999999999999999999999999999999999999996321       1112222222221


Q ss_pred             CCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       433 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      ..+ ..........+.+++.+||+.||++|||+.|+++|+|+..
T Consensus       236 ~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~  278 (321)
T 2a2a_A          236 DFD-EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (321)
T ss_dssp             CCC-HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred             ccC-hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence            111 1111112235789999999999999999999999999864

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.5e-45  Score=364.44  Aligned_cols=260  Identities=24%  Similarity=0.338  Sum_probs=210.7

Q ss_pred             HHHHHHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHHHHHHhhcccccccccceeecCC
Q 011005          199 DLIEATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK  275 (496)
Q Consensus       199 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  275 (496)
                      ++....++|++.+.||+|+||+||+|.++ +++.||+|++.....  ......+.+|+.+++.++||||+++++++.+..
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            33445678999999999999999999775 588999999876331  112234789999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccc
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  355 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  355 (496)
                      ..++||||++||+|.+++...    .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEecccee
Confidence            999999999999999999753    5899999999999999999999   779999999999999999999999999999


Q ss_pred             ccccCCCC-CccccccccccccccccccCC----cCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcC
Q 011005          356 RLLHADSS-NRTLLAGTYGYIAPELAYTMV----MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQ  430 (496)
Q Consensus       356 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  430 (496)
                      +....... .....+||+.|+|||++.+..    ++.++|||||||++|||++|+.||....       .......+...
T Consensus       216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-------~~~~~~~i~~~  288 (410)
T 3v8s_A          216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-------LVGTYSKIMNH  288 (410)
T ss_dssp             EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHTH
T ss_pred             EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC-------hhhHHHHHHhc
Confidence            87654332 233568999999999998765    8899999999999999999999996321       12222222221


Q ss_pred             ----CCCCCCChhHHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHHHHHhcc
Q 011005          431 ----RLPPPVDRKVIRDILLISTVSFACLQSNPKS--RPTMQSVSQEFLITRK  477 (496)
Q Consensus       431 ----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~~~~~~~  477 (496)
                          ..+....     ....+.+|+.+||+.+|.+  ||+++|+++|+|+...
T Consensus       289 ~~~~~~p~~~~-----~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          289 KNSLTFPDDND-----ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             HHHCCCCTTCC-----CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             cccccCCCccc-----ccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence                1221100     1124678999999999988  9999999999999753

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=346.21  Aligned_cols=252  Identities=23%  Similarity=0.253  Sum_probs=198.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV  280 (496)
                      .++|++.+.||+|+||+||+|.+. +++.||||++.... ..........|+..+.++ +||||+++++++.+++..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            467999999999999999999776 79999999986532 222334455666666666 899999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+ +++|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.....
T Consensus       136 ~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             Eecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            9999 679988887543  26899999999999999999999   67999999999999999999999999999987643


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      .. ......||+.|+|||++.+ .++.++||||||+++|||++|..|+....          ..........+.   ...
T Consensus       210 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~~~~~~~~~~~---~~~  274 (311)
T 3p1a_A          210 AG-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GWQQLRQGYLPP---EFT  274 (311)
T ss_dssp             ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HHHHHTTTCCCH---HHH
T ss_pred             CC-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HHHHHhccCCCc---ccc
Confidence            32 2344569999999999876 78999999999999999999976653211          111111111111   001


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      ......+.+++.+||+.||++|||++|+++|+|+..
T Consensus       275 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          275 AGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             cCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            112235789999999999999999999999999864

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.4e-44  Score=343.24  Aligned_cols=259  Identities=26%  Similarity=0.405  Sum_probs=199.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHh--hcccccccccceeec----CCeE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQ--VLHRNIVKLYGYCLH----KKCM  277 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~~~~  277 (496)
                      .++|++.+.||+|+||+||+|.+ +++.||||++.....    ..+.+|.+++..  ++||||+++++++..    ....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~----~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE----KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGH----HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccc----hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            46899999999999999999988 689999999876542    445667777766  789999999998654    3468


Q ss_pred             EEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEeCCCCCceEecCCCCeEEccc
Q 011005          278 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC-----SPSIIHRDISSNNILLNSKLEAFVADF  352 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-----~~~i~H~dlkp~Nil~~~~~~~kl~Df  352 (496)
                      ++||||+++|+|.+++...    .+++..++.++.|++.||+|||+..     +++|+||||||+|||++.++.+||+||
T Consensus        82 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             EEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence            9999999999999999643    6899999999999999999999321     458999999999999999999999999


Q ss_pred             cccccccCCCCC----ccccccccccccccccccC------CcCcccchhhHHHHHHHHHhC----------CCCCcccc
Q 011005          353 GTARLLHADSSN----RTLLAGTYGYIAPELAYTM------VMTEKCDVYSFGVVTLEVLMG----------KHPRDILS  412 (496)
Q Consensus       353 g~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~el~~g----------~~p~~~~~  412 (496)
                      |+++........    .....||+.|+|||++.+.      .++.++||||||+++|||++|          +.||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            999876543322    2234799999999999877      556799999999999999999          66664322


Q ss_pred             ccCCCCCCcchhHhhh-cCCCCCCCCh--hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          413 SLSSSSDPKIMLIDVL-DQRLPPPVDR--KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       413 ~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ..   ........... .....+....  ........+.+++.+||+.||++|||+.|+++.+..
T Consensus       238 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          238 PN---DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             CS---SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             CC---CcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            11   11111111111 1111111111  122344568899999999999999999999998864

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5.2e-44  Score=355.36  Aligned_cols=258  Identities=22%  Similarity=0.357  Sum_probs=204.8

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhc--ccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVL--HRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lV~  281 (496)
                      .+|.+.+.||+|+||.||+|...+++.||||++.... .....+.+.+|+.++++++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4599999999999999999998889999999986543 3344577899999999996  599999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      | +.+++|.+++....   .+++..+..++.||+.||.|||   +.+|+||||||+|||++ ++.+||+|||+++.....
T Consensus       136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            9 66889999998654   6788999999999999999999   78999999999999996 578999999999876543


Q ss_pred             CC--Ccccccccccccccccccc-----------CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhh
Q 011005          362 SS--NRTLLAGTYGYIAPELAYT-----------MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVL  428 (496)
Q Consensus       362 ~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  428 (496)
                      ..  .....+||+.|+|||++.+           ..++.++|||||||++|||++|+.||....      ..........
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~------~~~~~~~~~~  281 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------NQISKLHAII  281 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC------CHHHHHHHHH
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh------HHHHHHHHHh
Confidence            22  1234679999999999875           468899999999999999999999996321      1112223333


Q ss_pred             cCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          429 DQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      ............   ...+.+++.+||+.||++|||+.|+++|+|+.....
T Consensus       282 ~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~  329 (390)
T 2zmd_A          282 DPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  329 (390)
T ss_dssp             CTTSCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred             CccccCCCCccc---hHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence            322221111111   124678999999999999999999999999986543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=356.19  Aligned_cols=262  Identities=25%  Similarity=0.341  Sum_probs=210.6

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCM  277 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  277 (496)
                      .++|++.+.||+|+||+||+|.+.      +++.||||++...........+.+|+.++++++||||+++++++......
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467899999999999999999843      46789999997654445556788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCC----CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC---CeEEc
Q 011005          278 FLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL---EAFVA  350 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~---~~kl~  350 (496)
                      ++||||+++|+|.+++....    ....+++..++.++.||+.||+|||   +.+|+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999997543    2235899999999999999999999   77999999999999999554   59999


Q ss_pred             cccccccccCCC--CCccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhh
Q 011005          351 DFGTARLLHADS--SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDV  427 (496)
Q Consensus       351 Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~  427 (496)
                      |||+++......  .......+|+.|+|||++.+..++.++|||||||++|||++ |..||....       ........
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~-------~~~~~~~i  299 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------NQEVLEFV  299 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHHHHHHH
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHH
Confidence            999998653322  22334567899999999999999999999999999999998 999986321       11122222


Q ss_pred             hcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          428 LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      ......... ..   ....+.+++.+||+.||++|||+.|++++++.....+
T Consensus       300 ~~~~~~~~~-~~---~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          300 TSGGRMDPP-KN---CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             HTTCCCCCC-TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HcCCCCCCC-cc---CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            222211111 11   1224778999999999999999999999999876643

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4e-45  Score=354.81  Aligned_cols=269  Identities=20%  Similarity=0.237  Sum_probs=199.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      ++|.+.+.||+|+||+||+|... +++.||+|++...........+.+|+.++++++||||+++++++..++..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57889999999999999999765 78999999997654333223456899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      ++ |+|.+++.....  .+++..+..++.||+.||.|||   +.||+||||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             CS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            97 588888876432  5899999999999999999999   77999999999999999999999999999987654444


Q ss_pred             Ccccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccC-------------CCCCCcc-hhHhhh
Q 011005          364 NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS-------------SSSDPKI-MLIDVL  428 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~-------------~~~~~~~-~~~~~~  428 (496)
                      ......||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||.......             ....+.. ......
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  235 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence            4455678999999999876 568999999999999999999999996432100             0000000 000000


Q ss_pred             cCCCCCCCCh----hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          429 DQRLPPPVDR----KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       429 ~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      ....+.....    ........+.+|+.+||+.||++|||++|+++|+|+.....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence            0000000000    00011234679999999999999999999999999987643

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-44  Score=343.77  Aligned_cols=259  Identities=25%  Similarity=0.354  Sum_probs=202.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|.+.+.||+|+||+||+|... +++.||+|++.........+.+.+|++++++++||||+++++++......++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            467999999999999999999764 6889999999776544445778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCC-CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe---cCCCCeEEccccccccc
Q 011005          283 YMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKLEAFVADFGTARLL  358 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~  358 (496)
                      |+++|+|.+.+.... ....+++..++.++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            999999999885431 1236899999999999999999999   7799999999999999   45678999999999866


Q ss_pred             cCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCCh
Q 011005          359 HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR  438 (496)
Q Consensus       359 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  438 (496)
                      .... ......||+.|+|||++. ..++.++||||+|+++|+|++|+.||....       ...................
T Consensus       178 ~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~~  248 (285)
T 3is5_A          178 KSDE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS-------LEEVQQKATYKEPNYAVEC  248 (285)
T ss_dssp             ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCC--
T ss_pred             CCcc-cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC-------HHHHHhhhccCCccccccc
Confidence            4432 234457899999999876 468899999999999999999999996322       1111111111111111100


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          439 KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       439 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      .  .....+.+++.+||+.||++|||+.|+++|+|+.+
T Consensus       249 ~--~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          249 R--PLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             C--CCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             C--cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            0  01224678999999999999999999999999875

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.2e-44  Score=354.60  Aligned_cols=253  Identities=22%  Similarity=0.274  Sum_probs=202.0

Q ss_pred             cceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCCCC
Q 011005          210 RYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGS  288 (496)
Q Consensus       210 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g~  288 (496)
                      .+.||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            56799999999999976 4689999999976542 234678999999999999999999999999999999999999999


Q ss_pred             hhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe--cCCCCeEEccccccccccCCCCCcc
Q 011005          289 LFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL--NSKLEAFVADFGTARLLHADSSNRT  366 (496)
Q Consensus       289 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~~  366 (496)
                      |.+++....  ..+++..++.++.||+.||+|||   +.+|+||||||+|||+  +.++.+||+|||+++...... ...
T Consensus       173 L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~~  246 (373)
T 2x4f_A          173 LFDRIIDES--YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLK  246 (373)
T ss_dssp             EHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BCC
T ss_pred             HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-ccc
Confidence            999887532  36899999999999999999999   6799999999999999  567889999999998765432 233


Q ss_pred             ccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHH
Q 011005          367 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILL  446 (496)
Q Consensus       367 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  446 (496)
                      ...||+.|+|||++.+..++.++||||||+++|||++|+.||....       .......+.......+.. ........
T Consensus       247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-------~~~~~~~i~~~~~~~~~~-~~~~~~~~  318 (373)
T 2x4f_A          247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN-------DAETLNNILACRWDLEDE-EFQDISEE  318 (373)
T ss_dssp             CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHTCCCSCSG-GGTTSCHH
T ss_pred             cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhccCCCChh-hhccCCHH
Confidence            4579999999999999999999999999999999999999996322       122233333333222111 11112235


Q ss_pred             HHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          447 ISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       447 l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      +.+|+.+||+.||++|||+.|+++|+|+...
T Consensus       319 ~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          319 AKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            7899999999999999999999999998754

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1e-43  Score=360.58  Aligned_cols=263  Identities=24%  Similarity=0.251  Sum_probs=199.9

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecC------C
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK------K  275 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  275 (496)
                      .++|++.+.||+|+||+||+|.+. +++.||||++.... .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            468999999999999999999654 68999999997642 334456788999999999999999999999654      4


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccc
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  355 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  355 (496)
                      ..++||||+++ ++.+.+..     .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence            67999999976 46666643     4789999999999999999999   779999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccC---------CCCC------C
Q 011005          356 RLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS---------SSSD------P  420 (496)
Q Consensus       356 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~---------~~~~------~  420 (496)
                      +..... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.......         ....      .
T Consensus       212 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          212 RTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             -----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred             eecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence            876433 23345689999999999999999999999999999999999999996432100         0000      0


Q ss_pred             cchhHhhhcCC---------------CCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          421 KIMLIDVLDQR---------------LPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       421 ~~~~~~~~~~~---------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      ...........               ..+............+.+|+.+||+.||++|||++|+++|+|+..
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  361 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence            00000111110               011111112222445789999999999999999999999999975

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=7.7e-44  Score=355.18  Aligned_cols=261  Identities=23%  Similarity=0.328  Sum_probs=198.6

Q ss_pred             HhCCCCc-ceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeec----CCe
Q 011005          204 TEDFDIR-YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLH----KKC  276 (496)
Q Consensus       204 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~  276 (496)
                      .++|.+. +.||+|+||+||+|.++ +++.||||++...      ..+.+|+.++.++ +||||+++++++..    ...
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            3567666 68999999999999765 6899999998643      3456788887555 79999999998875    567


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC---CCCeEEcccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KLEAFVADFG  353 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg  353 (496)
                      .++||||++||+|.+++.... ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.   ++.+||+|||
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecc
Confidence            899999999999999998643 235899999999999999999999   679999999999999998   7889999999


Q ss_pred             ccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCC
Q 011005          354 TARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLP  433 (496)
Q Consensus       354 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  433 (496)
                      +++..... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||........   .......+......
T Consensus       210 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~i~~~~~~  285 (400)
T 1nxk_A          210 FAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMGQYE  285 (400)
T ss_dssp             TCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS---CCSHHHHHHHTCCC
T ss_pred             cccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc---cHHHHHHHHcCccc
Confidence            99876432 223456789999999999999999999999999999999999999974332111   11112222222221


Q ss_pred             CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          434 PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       434 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      .+... .......+.+|+.+||+.||++|||+.|+++|+|+.....
T Consensus       286 ~~~~~-~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  330 (400)
T 1nxk_A          286 FPNPE-WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  330 (400)
T ss_dssp             CCTTT-TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred             CCCcc-cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence            11100 0111234779999999999999999999999999987544

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.6e-44  Score=355.82  Aligned_cols=264  Identities=23%  Similarity=0.338  Sum_probs=209.6

Q ss_pred             HHHHHHhCCCCcceeeecCCeeEEEEEe------CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-ccccccccccee
Q 011005          199 DLIEATEDFDIRYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYC  271 (496)
Q Consensus       199 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  271 (496)
                      +.....++|.+.+.||+|+||.||+|.+      .+++.||||+++........+.+.+|+++++++ +||||+++++++
T Consensus        16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~   95 (359)
T 3vhe_A           16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC   95 (359)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence            3334568899999999999999999963      346899999998765555567899999999999 799999999998


Q ss_pred             ecCC-eEEEEEEecCCCChhhhhhCCCC----------------------------------------------------
Q 011005          272 LHKK-CMFLIYEYMERGSLFCNLHNNED----------------------------------------------------  298 (496)
Q Consensus       272 ~~~~-~~~lV~e~~~~g~L~~~l~~~~~----------------------------------------------------  298 (496)
                      ...+ ..++||||+++|+|.+++.....                                                    
T Consensus        96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A           96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence            8755 48999999999999999986542                                                    


Q ss_pred             -----------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC--Cc
Q 011005          299 -----------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS--NR  365 (496)
Q Consensus       299 -----------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~  365 (496)
                                 ...+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......  ..
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK  252 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence                       112899999999999999999999   67999999999999999999999999999987644332  23


Q ss_pred             cccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHH
Q 011005          366 TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDI  444 (496)
Q Consensus       366 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  444 (496)
                      ....||+.|+|||++.+..++.++||||||+++|||++ |+.||....       ........+...........   ..
T Consensus       253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~---~~  322 (359)
T 3vhe_A          253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-------IDEEFCRRLKEGTRMRAPDY---TT  322 (359)
T ss_dssp             --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC-------CSHHHHHHHHHTCCCCCCTT---CC
T ss_pred             cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc-------hhHHHHHHHHcCCCCCCCCC---CC
Confidence            34568889999999999999999999999999999998 999986321       11112111111111111111   11


Q ss_pred             HHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          445 LLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       445 ~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                      ..+.+++.+||+.||++|||+.|+++++...
T Consensus       323 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          323 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            2477899999999999999999999998654

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=7.7e-44  Score=342.61  Aligned_cols=259  Identities=30%  Similarity=0.433  Sum_probs=214.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .+.|++.+.||+|+||.||+|.. .+++.||+|.+.........+.+.+|+.+++.++||||+++++++......++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            45789999999999999999975 46899999999765544445778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++++|.+++...    .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++.......
T Consensus       101 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          101 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            99999999998753    6899999999999999999999   6799999999999999999999999999998776544


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                      .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.....       ............+. ....   
T Consensus       174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~-~~~~---  242 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-------MKVLFLIPKNNPPT-LEGN---  242 (303)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCCCC-CCSS---
T ss_pred             cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-------HHHHHHhhcCCCCC-Cccc---
Confidence            444556789999999999999999999999999999999999999863221       11111111111111 1110   


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      ....+.+++.+||+.||++|||+.|+++|+|+.+....
T Consensus       243 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  280 (303)
T 3a7i_A          243 YSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKK  280 (303)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCCC
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCCc
Confidence            11247789999999999999999999999999876543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5e-44  Score=349.99  Aligned_cols=258  Identities=27%  Similarity=0.377  Sum_probs=208.6

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      .+.|...+.||+|+||+||+|.. .+++.||||++....  .....+.+.+|++++++++||||+++++++..++..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            35688899999999999999975 578999999986532  334456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+. |++.+.+....  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       133 ~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            99997 58887775432  26899999999999999999999   67999999999999999999999999999976543


Q ss_pred             CCCCccccccccccccccccc---cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          361 DSSNRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                      .    ....||+.|+|||++.   +..++.++||||||+++|||++|+.||.....       ............+....
T Consensus       207 ~----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~  275 (348)
T 1u5q_A          207 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNESPALQS  275 (348)
T ss_dssp             B----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCCCCCCC
T ss_pred             C----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhcCCCCCCC
Confidence            2    3457899999999985   56789999999999999999999999863221       11122222222221111


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCC
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLV  481 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~  481 (496)
                      ..   ....+.+++.+||+.||++|||++|+++|+|+.+..+..
T Consensus       276 ~~---~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~~  316 (348)
T 1u5q_A          276 GH---WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT  316 (348)
T ss_dssp             TT---SCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTT
T ss_pred             CC---CCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCcc
Confidence            11   122467899999999999999999999999998876543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-44  Score=349.01  Aligned_cols=263  Identities=22%  Similarity=0.364  Sum_probs=209.1

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEe------CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCC
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKK  275 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  275 (496)
                      ..++|.+.+.||+|+||.||+|.+      .+++.||+|.+.........+.+.+|+.+++++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            357899999999999999999975      246689999998655444557789999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCC--------------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCC
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDA--------------------VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDIS  335 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~--------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk  335 (496)
                      ..++||||+++|+|.+++......                    ..+++..++.++.||+.||+|||   +.||+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence            999999999999999999865421                    24789999999999999999999   7799999999


Q ss_pred             CCceEecCCCCeEEccccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCcccc
Q 011005          336 SNNILLNSKLEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILS  412 (496)
Q Consensus       336 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~  412 (496)
                      |+||+++.++.+||+|||++.........  .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            99999999999999999999876544322  223457889999999999999999999999999999998 999996322


Q ss_pred             ccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          413 SLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       413 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                             ........+...........   ....+.+++.+||+.||++|||+.|+++++......
T Consensus       280 -------~~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          280 -------VDANFYKLIQNGFKMDQPFY---ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             -------CSHHHHHHHHTTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             -------cHHHHHHHHhcCCCCCCCCC---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence                   12222222222222211111   123477899999999999999999999999876554

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2e-44  Score=357.18  Aligned_cols=257  Identities=25%  Similarity=0.384  Sum_probs=208.0

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|.+.+.||+|+||.||+|.++ +++.||||.++..........+.+|+.++++++||||+++++++..++..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            467889999999999999999876 7899999999865444445678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++......
T Consensus       193 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             CCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            999999999997532  25899999999999999999999   7799999999999999999999999999997653321


Q ss_pred             CC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          363 SN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       363 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                      ..  .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.....        ....+.+......+....
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~  339 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--------QQTREFVEKGGRLPCPEL  339 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--------HHHHHHHHTTCCCCCCTT
T ss_pred             eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCCCC
Confidence            11  112235678999999999999999999999999999998 9999864321        112222222111111111


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                         .+..+.+++.+||+.||++|||++++++.+....
T Consensus       340 ---~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          340 ---CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence               1234778999999999999999999999887654

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=351.94  Aligned_cols=251  Identities=23%  Similarity=0.343  Sum_probs=208.6

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchh-------HHHHHHHHHHHHHHHhhcccccccccceeecC
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEE-------LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK  274 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  274 (496)
                      ..++|++.+.||+|+||+||+|.+ .+++.||||.+.....       ......+.+|+.++++++||||+++++++...
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            467899999999999999999975 5789999999876431       11223567899999999999999999999999


Q ss_pred             CeEEEEEEecCCC-ChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccc
Q 011005          275 KCMFLIYEYMERG-SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG  353 (496)
Q Consensus       275 ~~~~lV~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  353 (496)
                      +..++||||+.+| +|.+++....   .+++..+..++.||+.||.|||   ..+|+||||||+||+++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999777 9999998654   6899999999999999999999   7799999999999999999999999999


Q ss_pred             ccccccCCCCCccccccccccccccccccCCc-CcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCC
Q 011005          354 TARLLHADSSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRL  432 (496)
Q Consensus       354 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  432 (496)
                      +++...... ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||......             .....
T Consensus       176 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------~~~~~  241 (335)
T 3dls_A          176 SAAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------VEAAI  241 (335)
T ss_dssp             TCEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------TTTCC
T ss_pred             cceECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------Hhhcc
Confidence            998765433 3344679999999999998877 78999999999999999999999643221             11111


Q ss_pred             CCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       433 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ..+..     ....+.+++.+||+.||++|||+.|+++|+|+....
T Consensus       242 ~~~~~-----~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          242 HPPYL-----VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             CCSSC-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             CCCcc-----cCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence            11111     112477899999999999999999999999997643

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.5e-43  Score=339.06  Aligned_cols=258  Identities=23%  Similarity=0.364  Sum_probs=214.2

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      .++|.+.+.||+|+||.||+|.++ +++.||+|.+....  .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            367899999999999999999775 58899999986542  234456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+++++|.+++....   .+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            99999999999887543   6899999999999999999999   67999999999999999999999999999987755


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      .........||+.|+|||.+.+..++.++||||+|+++|+|++|+.||....       ...............+..   
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~---  237 (294)
T 2rku_A          168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-------LKETYLRIKKNEYSIPKH---  237 (294)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHTTCCCCCTT---
T ss_pred             CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhhccCCCccc---
Confidence            4444555679999999999999999999999999999999999999986322       111122222222211111   


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                        ....+.+++.+||+.||++|||++|+++|+|+.....
T Consensus       238 --~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  274 (294)
T 2rku_A          238 --INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI  274 (294)
T ss_dssp             --SCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             --cCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence              1124678999999999999999999999999987643

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.3e-43  Score=337.70  Aligned_cols=264  Identities=28%  Similarity=0.415  Sum_probs=215.3

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      .++|++.+.||+|+||.||+|... +++.||+|.+.....  ......+.+|+.++++++||||+++++++...+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            367999999999999999999765 678899999865432  22346788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+++|+|.+++....   .+++..++.++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            99999999999987643   6899999999999999999999   78999999999999999999999999999976543


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      .  ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||....       ...............+..   
T Consensus       167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~---  234 (284)
T 2vgo_A          167 L--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS-------HTETHRRIVNVDLKFPPF---  234 (284)
T ss_dssp             S--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHTTCCCCCTT---
T ss_pred             c--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC-------HhHHHHHHhccccCCCCc---
Confidence            2  2334578999999999999999999999999999999999999996321       111222222222211110   


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCccccc
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQ  487 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~~~~  487 (496)
                        ....+.+++.+||+.||++|||++|+++|+|+........++..+
T Consensus       235 --~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~~~~  279 (284)
T 2vgo_A          235 --LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQ  279 (284)
T ss_dssp             --SCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCCCC-
T ss_pred             --CCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCCCccc
Confidence              112467899999999999999999999999998876655544433

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.3e-43  Score=349.54  Aligned_cols=265  Identities=25%  Similarity=0.377  Sum_probs=213.3

Q ss_pred             HHHHHHHHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-------hHHHHHHHHHHHHHHHhh-cccccccc
Q 011005          197 YEDLIEATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-------ELAFIKSFKNEAQVLSQV-LHRNIVKL  267 (496)
Q Consensus       197 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l-~h~niv~~  267 (496)
                      .+......++|.+.+.||+|+||.||+|.++ +|+.||||++....       .....+.+.+|+.+++++ +||||+++
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            3444556788999999999999999999875 79999999986532       122345678999999999 79999999


Q ss_pred             cceeecCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCe
Q 011005          268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEA  347 (496)
Q Consensus       268 ~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~  347 (496)
                      ++++......++||||+++++|.+++....   .+++..+..++.||+.||.|||   +.|++||||||+||+++.++.+
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~i  239 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQI  239 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCE
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCE
Confidence            999999999999999999999999987543   6899999999999999999999   6799999999999999999999


Q ss_pred             EEccccccccccCCCCCcccccccccccccccccc------CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCc
Q 011005          348 FVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT------MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPK  421 (496)
Q Consensus       348 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~  421 (496)
                      +|+|||++....... ......||+.|+|||++.+      ..++.++||||||+++|+|++|+.||....       ..
T Consensus       240 kl~DfG~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-------~~  311 (365)
T 2y7j_A          240 RLSDFGFSCHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR-------QI  311 (365)
T ss_dssp             EECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-------HH
T ss_pred             EEEecCcccccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC-------HH
Confidence            999999998765432 3345679999999999864      358889999999999999999999986321       11


Q ss_pred             chhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          422 IMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       422 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      .....+......... .........+.+++.+||+.||++|||+.|+++|+|+.+
T Consensus       312 ~~~~~i~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          312 LMLRMIMEGQYQFSS-PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHHHHHHHTCCCCCH-HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             HHHHHHHhCCCCCCC-cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            122222222222111 111112234779999999999999999999999999853

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.8e-44  Score=354.20  Aligned_cols=258  Identities=26%  Similarity=0.404  Sum_probs=198.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC----CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      .++|++.+.||+|+||.||+|.++    ++..||||.++........+.+.+|+.++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357999999999999999999764    5778999999876544556789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||||+++|+|.+++....  ..+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus       124 v~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            999999999999998643  36899999999999999999999   6799999999999999999999999999998765


Q ss_pred             CCCCCc---cccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCC
Q 011005          360 ADSSNR---TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP  435 (496)
Q Consensus       360 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  435 (496)
                      ......   ....+++.|+|||++.+..++.++||||||+++|||++ |+.||....       . ......+......+
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~-------~-~~~~~~i~~~~~~~  270 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS-------N-QDVIKAVDEGYRLP  270 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC-------H-HHHHHHHHTTEECC
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC-------H-HHHHHHHHcCCCCC
Confidence            432211   12235678999999999999999999999999999998 999986321       1 11222222221111


Q ss_pred             CChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          436 VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       436 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ...   .....+.+++.+||+.||++||++.|+++.+.....
T Consensus       271 ~~~---~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          271 PPM---DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             CCT---TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCc---cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence            111   112347789999999999999999999998876543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.5e-44  Score=354.50  Aligned_cols=255  Identities=24%  Similarity=0.327  Sum_probs=202.5

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHH-HHhhcccccccccceeecCCeEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQV-LSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      .++|++.+.||+|+||.||+|..+ +++.||+|++....  .......+.+|..+ ++.++||||+++++++...+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            367999999999999999999775 58899999997653  22233456667766 466799999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||||++||+|.+++....   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            999999999999997643   6889999999999999999999   7799999999999999999999999999998755


Q ss_pred             CCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          360 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       360 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                      .........+||+.|+|||++.+..++.++|||||||++|||++|+.||....       .......+.......+..  
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~~--  261 (373)
T 2r5t_A          191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-------TAEMYDNILNKPLQLKPN--  261 (373)
T ss_dssp             CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB-------HHHHHHHHHHSCCCCCSS--
T ss_pred             cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHhcccCCCCC--
Confidence            44445556789999999999999999999999999999999999999996321       222333333333322211  


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCH----HHHHHHHHHhc
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTM----QSVSQEFLITR  476 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~----~evl~~~~~~~  476 (496)
                         ....+.+++.+||+.||++||++    .|+++|+|+..
T Consensus       262 ---~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          262 ---ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             ---SCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             ---CCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence               11246789999999999999987    68888888753

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=8e-44  Score=364.81  Aligned_cols=262  Identities=23%  Similarity=0.326  Sum_probs=211.7

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      ..++|++.+.||+|+||+||+|..+ +++.||||++.... .......+.+|++++++++||||+++++++......++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            4578999999999999999999765 78999999986532 122346788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEec---CCCCeEEcccccccc
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN---SKLEAFVADFGTARL  357 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~  357 (496)
                      |||+++|+|.+.+....   .+++..+..++.||+.||.|||   +.+|+||||||+||+++   .++.+||+|||+++.
T Consensus       100 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            99999999999887643   6899999999999999999999   77999999999999995   456799999999987


Q ss_pred             ccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          358 LHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       358 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                      ..... .....+||+.|+|||++.+ .++.++||||+||++|+|++|+.||....       .......+..........
T Consensus       174 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~  244 (486)
T 3mwu_A          174 FQQNT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN-------EYDILKRVETGKYAFDLP  244 (486)
T ss_dssp             BCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCCCSCSG
T ss_pred             CCCCC-ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCCc
Confidence            64432 2344679999999999876 58999999999999999999999996321       222223333333322211


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      . +......+.+++.+||+.||++|||+.|+++|+|+......
T Consensus       245 ~-~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~  286 (486)
T 3mwu_A          245 Q-WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE  286 (486)
T ss_dssp             G-GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCC
T ss_pred             c-cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCccc
Confidence            1 11223357799999999999999999999999999876544

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=351.34  Aligned_cols=261  Identities=23%  Similarity=0.355  Sum_probs=211.9

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC--------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecC
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP--------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHK  274 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  274 (496)
                      .++|.+.+.||+|+||+||+|.+.        .+..||+|++.........+.+.+|+++++++ +||||+++++++..+
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            467899999999999999999752        34679999998765555667889999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhCCCC-------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe
Q 011005          275 KCMFLIYEYMERGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL  341 (496)
Q Consensus       275 ~~~~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~  341 (496)
                      +..++||||+++|+|.+++.....             ...+++..++.++.||+.||+|||   +.+|+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence            999999999999999999976532             235899999999999999999999   6799999999999999


Q ss_pred             cCCCCeEEccccccccccCCCC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCC
Q 011005          342 NSKLEAFVADFGTARLLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSS  418 (496)
Q Consensus       342 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~  418 (496)
                      +.++.+||+|||+++.......  ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||....      
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~------  298 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------  298 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC------
Confidence            9999999999999987654322  2233457889999999999999999999999999999999 999986321      


Q ss_pred             CCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          419 DPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                       .. .....+...........   ....+.+++.+||+.||++|||++|+++++......
T Consensus       299 -~~-~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  353 (382)
T 3tt0_A          299 -VE-ELFKLLKEGHRMDKPSN---CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  353 (382)
T ss_dssp             -HH-HHHHHHHTTCCCCCCSS---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -HH-HHHHHHHcCCCCCCCcc---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence             11 12222222211111111   122477899999999999999999999998776543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.3e-43  Score=363.42  Aligned_cols=261  Identities=25%  Similarity=0.315  Sum_probs=214.0

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|.+.+.||+|+||.||+|.++ +|+.||+|++.....  ......+.+|+.++++++||||+++++++......++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            67889999999999999999875 699999999976432  223467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCC-CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          282 EYMERGSLFCNLHNNED-AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      ||++||+|.+++..... ...+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            99999999999876432 336899999999999999999999   77999999999999999999999999999988755


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      ........+||+.|+|||++.+..++.++||||+||++|||++|+.||.....   ..........+.......+..   
T Consensus       342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~---~~~~~~~~~~i~~~~~~~p~~---  415 (543)
T 3c4z_A          342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE---KVENKELKQRVLEQAVTYPDK---  415 (543)
T ss_dssp             TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC---CCCHHHHHHHHHHCCCCCCTT---
T ss_pred             CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc---chhHHHHHHHHhhcccCCCcc---
Confidence            44444456899999999999999999999999999999999999999974321   111122222233332222211   


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHHHHhc
Q 011005          441 IRDILLISTVSFACLQSNPKSRPT-----MQSVSQEFLITR  476 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~~~~~~  476 (496)
                        ....+.+++.+||+.||++||+     ++++++|+|+..
T Consensus       416 --~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~  454 (543)
T 3c4z_A          416 --FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD  454 (543)
T ss_dssp             --SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred             --cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence              1224678999999999999996     489999999875

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.5e-43  Score=345.44  Aligned_cols=258  Identities=23%  Similarity=0.364  Sum_probs=214.3

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|.+....  .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467999999999999999999765 57899999987542  234456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+++++|.+++....   .+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||++.....
T Consensus       120 ~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            99999999999887543   6899999999999999999999   67999999999999999999999999999987765


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      .........||+.|+|||++.+..++.++||||||+++|+|++|+.||....       ...............+..   
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~---  263 (335)
T 2owb_A          194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-------LKETYLRIKKNEYSIPKH---  263 (335)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHHTCCCCCTT---
T ss_pred             CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC-------HHHHHHHHhcCCCCCCcc---
Confidence            4444555679999999999999999999999999999999999999996321       111122222222211110   


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                        ....+.+++.+||+.||++|||++|+++|+|+.....
T Consensus       264 --~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~  300 (335)
T 2owb_A          264 --INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI  300 (335)
T ss_dssp             --SCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             --CCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence              1124678999999999999999999999999987643

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=7.9e-44  Score=339.01  Aligned_cols=260  Identities=24%  Similarity=0.311  Sum_probs=207.9

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhH-----HHHHHHHHHHHHHHhhcccccccccceeecCCeE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEEL-----AFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCM  277 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  277 (496)
                      .++|++.+.||+|+||.||+|..+ +++.||+|.+......     ...+.+.+|+.++++++||||+++++++..+...
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            467999999999999999999776 6899999998754211     1246789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC----CeEEcccc
Q 011005          278 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL----EAFVADFG  353 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~----~~kl~Dfg  353 (496)
                      ++||||+++++|.+++....   .+++..+..++.|++.||.|||   +.+++||||||+||+++.++    .++|+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            99999999999999997543   6899999999999999999999   77999999999999998877    79999999


Q ss_pred             ccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCC
Q 011005          354 TARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLP  433 (496)
Q Consensus       354 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  433 (496)
                      ++....... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||....       ..............
T Consensus       158 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~  229 (283)
T 3bhy_A          158 IAHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET-------KQETLTNISAVNYD  229 (283)
T ss_dssp             TCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHTTCCC
T ss_pred             cceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc-------hHHHHHHhHhcccC
Confidence            998764332 2334568999999999999999999999999999999999999986321       11111222111111


Q ss_pred             CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          434 PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       434 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      . ...........+.+++.+||+.||++|||+.|+++|+|+....
T Consensus       230 ~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          230 F-DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             C-CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             C-cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            1 1111112233578999999999999999999999999987653

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.8e-44  Score=344.27  Aligned_cols=263  Identities=26%  Similarity=0.328  Sum_probs=200.9

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchh----HHHHHHHHHHHHHHHhhc---ccccccccceeecC
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEE----LAFIKSFKNEAQVLSQVL---HRNIVKLYGYCLHK  274 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~  274 (496)
                      ..++|++.+.||+|+||+||+|.+ .+++.||+|++.....    ......+.+|+.++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            467899999999999999999986 4789999999864321    111235667888877775   99999999999775


Q ss_pred             C-----eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEE
Q 011005          275 K-----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFV  349 (496)
Q Consensus       275 ~-----~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl  349 (496)
                      .     ..++||||+. |+|.+++..... ..+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEE
Confidence            4     5899999997 599999987543 24899999999999999999999   679999999999999999999999


Q ss_pred             ccccccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhc
Q 011005          350 ADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD  429 (496)
Q Consensus       350 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  429 (496)
                      +|||+++...... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||......       .....+..
T Consensus       162 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-------~~~~~i~~  233 (308)
T 3g33_A          162 ADFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-------DQLGKIFD  233 (308)
T ss_dssp             CSCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-------HHHHHHHH
T ss_pred             eeCccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHH
Confidence            9999998764332 334567899999999999999999999999999999999999999632210       00000000


Q ss_pred             ----------------------CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          430 ----------------------QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       430 ----------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                                            ...+.+...........+.+++.+||+.||++|||+.|+++|+|+.+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence                                  0000000000001123577899999999999999999999999998653

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=9.6e-44  Score=348.09  Aligned_cols=261  Identities=25%  Similarity=0.391  Sum_probs=211.8

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCe
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKC  276 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  276 (496)
                      ..++|++.+.||+|+||.||+|.+.      +++.||+|.++........+.+.+|+.++++++||||+++++++...+.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            3578999999999999999999764      3488999999876555556789999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhCCCC---------------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCC
Q 011005          277 MFLIYEYMERGSLFCNLHNNED---------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDIS  335 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk  335 (496)
                      .++||||+++|+|.+++.....                     ...+++.+++.++.||+.||.|||   +.+|+|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence            9999999999999999976421                     146899999999999999999999   7799999999


Q ss_pred             CCceEecCCCCeEEccccccccccCCC--CCccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCcccc
Q 011005          336 SNNILLNSKLEAFVADFGTARLLHADS--SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILS  412 (496)
Q Consensus       336 p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~  412 (496)
                      |+||+++.++.+||+|||+++......  .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            999999999999999999998764332  12233567889999999999999999999999999999999 999986321


Q ss_pred             ccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          413 SLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       413 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                             ...................    ....+.+++.+||+.||++|||+.|+++++.....
T Consensus       282 -------~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          282 -------HEEVIYYVRDGNILACPEN----CPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             -------HHHHHHHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             -------hHHHHHHHhCCCcCCCCCC----CCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence                   1222222222222211111    12247789999999999999999999999877554

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.1e-43  Score=341.62  Aligned_cols=262  Identities=23%  Similarity=0.329  Sum_probs=210.8

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ..++|.+.+.||+|+||.||+|... +|+.||+|.+...... ....+.+|+.++++++||||+++++++......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF-RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            4578999999999999999999765 7899999999765422 2356889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe---cCCCCeEEccccccccc
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKLEAFVADFGTARLL  358 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~  358 (496)
                      ||+++++|.+++....   .+++..+..++.|++.||.|||   +.+++||||||+||++   +.++.++|+|||++...
T Consensus        86 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           86 QLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             CCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             EcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            9999999999887543   6899999999999999999999   6799999999999999   78899999999999754


Q ss_pred             cCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCCh
Q 011005          359 HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR  438 (496)
Q Consensus       359 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  438 (496)
                      ...  ......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||....       .......+.......+.. 
T Consensus       160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~-  229 (304)
T 2jam_A          160 QNG--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET-------ESKLFEKIKEGYYEFESP-  229 (304)
T ss_dssp             CCB--TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHCCCCCCTT-
T ss_pred             CCC--ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHcCCCCCCcc-
Confidence            322  2334568999999999999999999999999999999999999986321       111222222222211110 


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCC
Q 011005          439 KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLV  481 (496)
Q Consensus       439 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~  481 (496)
                      ........+.+++.+||+.||++|||++|+++|+|+....+..
T Consensus       230 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  272 (304)
T 2jam_A          230 FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALH  272 (304)
T ss_dssp             TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCSCC
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCccc
Confidence            0011123577999999999999999999999999998876543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3e-44  Score=357.63  Aligned_cols=261  Identities=25%  Similarity=0.318  Sum_probs=194.8

Q ss_pred             HHHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhc-ccccccccceeecCC--e
Q 011005          202 EATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKK--C  276 (496)
Q Consensus       202 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~  276 (496)
                      ...++|++.+.||+|+||.||+|.+ .+|+.||||++.... .....+.+.+|+.+++++. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3567899999999999999999975 478999999986532 2334567789999999997 999999999997544  7


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      .++||||++ |+|..++...    .++...+..++.||+.||+|||   +.||+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            899999997 5898888753    6889999999999999999999   7799999999999999999999999999998


Q ss_pred             cccCC---------------------CCCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCcccccc
Q 011005          357 LLHAD---------------------SSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSL  414 (496)
Q Consensus       357 ~~~~~---------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~  414 (496)
                      .....                     .......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            65321                     111233579999999999987 67899999999999999999999999643211


Q ss_pred             CCCCCCcchhHhhhcC-------------------------------CC-CCCCChhHH----------HHHHHHHHHHH
Q 011005          415 SSSSDPKIMLIDVLDQ-------------------------------RL-PPPVDRKVI----------RDILLISTVSF  452 (496)
Q Consensus       415 ~~~~~~~~~~~~~~~~-------------------------------~~-~~~~~~~~~----------~~~~~l~~li~  452 (496)
                             .....+...                               .. .........          .....+.+|+.
T Consensus       238 -------~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~  310 (388)
T 3oz6_A          238 -------NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLD  310 (388)
T ss_dssp             -------HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHH
T ss_pred             -------HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHH
Confidence                   000000000                               00 000000000          01234779999


Q ss_pred             hcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          453 ACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       453 ~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      +||+.||++|||++|+++|+|+..-
T Consensus       311 ~~L~~dP~~R~t~~e~l~Hp~~~~~  335 (388)
T 3oz6_A          311 KLLQFNPNKRISANDALKHPFVSIF  335 (388)
T ss_dssp             HHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred             HhhccCcccCCCHHHHhCCHHHHHh
Confidence            9999999999999999999998653

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.5e-43  Score=342.20  Aligned_cols=258  Identities=24%  Similarity=0.406  Sum_probs=209.8

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe------CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCM  277 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  277 (496)
                      .++|.+.+.||+|+||.||+|.+      .+++.||+|.+.........+.+.+|+.++++++||||+++++++...+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            46789999999999999999975      345889999998765555667889999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCC---------------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCC
Q 011005          278 FLIYEYMERGSLFCNLHNNED---------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS  336 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp  336 (496)
                      ++||||+++|+|.+++.....                     ...+++..++.++.||+.||.|||   +.+++||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence            999999999999999986532                     124899999999999999999999   67999999999


Q ss_pred             CceEecCCCCeEEccccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccc
Q 011005          337 NNILLNSKLEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSS  413 (496)
Q Consensus       337 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~  413 (496)
                      +||+++.++.+||+|||+++........  .....+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||.... 
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-  257 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP-  257 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC-
Confidence            9999999999999999999876443322  223456788999999999999999999999999999999 999986322 


Q ss_pred             cCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          414 LSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       414 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                            ... ....+..........   .....+.+++.+||+.||++|||+.|+++++...
T Consensus       258 ------~~~-~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          258 ------PER-LFNLLKTGHRMERPD---NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             ------GGG-HHHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------HHH-HHHHhhcCCcCCCCc---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                  111 222222211111111   1123477899999999999999999999998654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.6e-44  Score=351.35  Aligned_cols=261  Identities=22%  Similarity=0.276  Sum_probs=197.8

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      ..++|++.+.||+|+||+||+|.+ .+++.||+|++..... ....+.+.+|+.++++++||||+++++++..+...++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            457899999999999999999975 4789999999976432 23345678999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEec-----CCCCeEEcccccc
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN-----SKLEAFVADFGTA  355 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~-----~~~~~kl~Dfg~~  355 (496)
                      |||+++ +|.+++....   .+++..++.++.||+.||+|||   +.+|+||||||+|||++     ..+.+||+|||++
T Consensus       112 ~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          112 FEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            999985 9999988654   5899999999999999999999   67999999999999994     4556999999999


Q ss_pred             ccccCCCCCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhh------
Q 011005          356 RLLHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVL------  428 (496)
Q Consensus       356 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------  428 (496)
                      +.............+|+.|+|||++.+. .++.++||||+|+++|+|++|+.||......       .......      
T Consensus       185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~~~~~~~~  257 (329)
T 3gbz_A          185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI-------DQLFKIFEVLGLP  257 (329)
T ss_dssp             HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHHHCCC
T ss_pred             cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH-------HHHHHHHHHhCCC
Confidence            8876544445556789999999999875 4899999999999999999999999633210       0000000      


Q ss_pred             --------------cCCCCCCCChhHH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          429 --------------DQRLPPPVDRKVI-----RDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       429 --------------~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                                    ....+........     .....+.+|+.+||+.||++|||++|+++|+|+...
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence                          0000000000000     012357799999999999999999999999999754

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.6e-44  Score=366.01  Aligned_cols=261  Identities=24%  Similarity=0.341  Sum_probs=214.1

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      ..++|.+.+.||+|+||.||+|..+ +++.||||++....  .......+.+|+.++++++||||+++++++......++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3568999999999999999999765 78999999986532  12234678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe---cCCCCeEEccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKLEAFVADFGTAR  356 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~  356 (496)
                      ||||+.+|+|.+.+....   .+++..+..++.||+.||.|||   +.+|+||||||+||++   +.++.+||+|||+++
T Consensus       104 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            999999999999987654   6899999999999999999999   7799999999999999   567899999999998


Q ss_pred             cccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCC
Q 011005          357 LLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV  436 (496)
Q Consensus       357 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  436 (496)
                      ...... .....+||+.|+|||++.+ .++.++||||+|+++|+|++|+.||....       .......+.......+.
T Consensus       178 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~~~~~~~  248 (484)
T 3nyv_A          178 HFEASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN-------EYDILKKVEKGKYTFEL  248 (484)
T ss_dssp             HBCCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCS
T ss_pred             Eccccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHcCCCCCCC
Confidence            775432 3344679999999999876 68999999999999999999999996322       22222333333332221


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      .. +......+.+|+.+||+.||++|||+.|+++|+|+.....
T Consensus       249 ~~-~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          249 PQ-WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             GG-GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             cc-cccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence            11 1122335779999999999999999999999999987654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-43  Score=342.13  Aligned_cols=269  Identities=25%  Similarity=0.370  Sum_probs=203.2

Q ss_pred             HHHHHHhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh--cccccccccceeecC--
Q 011005          199 DLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV--LHRNIVKLYGYCLHK--  274 (496)
Q Consensus       199 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~--  274 (496)
                      ......++|++.+.||+|+||.||+|.+. ++.||||++.....    ....+|.+++...  +||||+++++++...  
T Consensus        31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE----ASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc----chhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            33445688999999999999999999885 89999999865442    3345566666555  899999999999877  


Q ss_pred             --CeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCC--------CeEEeCCCCCceEecCC
Q 011005          275 --KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP--------SIIHRDISSNNILLNSK  344 (496)
Q Consensus       275 --~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~--------~i~H~dlkp~Nil~~~~  344 (496)
                        ...++||||+++|+|.+++...    .+++..++.++.|++.||+|||   ..        +|+||||||+||+++.+
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~  178 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKN  178 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred             CCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCC
Confidence              6899999999999999999754    5899999999999999999999   66        99999999999999999


Q ss_pred             CCeEEccccccccccCCCCC----ccccccccccccccccccCCcCcc------cchhhHHHHHHHHHhCCCCCcccccc
Q 011005          345 LEAFVADFGTARLLHADSSN----RTLLAGTYGYIAPELAYTMVMTEK------CDVYSFGVVTLEVLMGKHPRDILSSL  414 (496)
Q Consensus       345 ~~~kl~Dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~il~el~~g~~p~~~~~~~  414 (496)
                      +.+||+|||+++........    .....||+.|+|||++.+..++..      +||||||+++|||++|..|+......
T Consensus       179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~  258 (337)
T 3mdy_A          179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY  258 (337)
T ss_dssp             SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence            99999999999776443322    124579999999999988776665      99999999999999994444321111


Q ss_pred             CC-------CCCCcchhHh-hhcCCCCCCCCh--hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          415 SS-------SSDPKIMLID-VLDQRLPPPVDR--KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       415 ~~-------~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      ..       .......... ............  ........+.+++.+||+.||++|||+.|+++++....+..
T Consensus       259 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             cccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            00       0111111111 112222222221  11234456889999999999999999999999998765543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=9.1e-44  Score=338.61  Aligned_cols=255  Identities=24%  Similarity=0.394  Sum_probs=205.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      .++|++.+.||+|+||+||+|.+.++..||+|++......  .+.+.+|++++++++||||+++++++...+..++||||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC--HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            4678999999999999999999988999999999865432  25688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+++....  ..+++..++.++.|++.||.|||   +.+++||||||+||+++.++.++|+|||+++.......
T Consensus       101 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A          101 MANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             CTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred             cCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence            99999999997632  26899999999999999999999   77999999999999999999999999999986643211


Q ss_pred             -CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          364 -NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       364 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                       ......+|+.|+|||.+.+..++.++||||+|+++|+|++ |+.||....       ........... ......... 
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~-------~~~~~~~~~~~-~~~~~~~~~-  246 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-------NSETAEHIAQG-LRLYRPHLA-  246 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC-------HHHHHHHHHTT-CCCCCCTTC-
T ss_pred             ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC-------hhHHHHHHhcc-cCCCCCCcC-
Confidence             1223446788999999999999999999999999999998 999986322       11122222222 111111111 


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          442 RDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                        ...+.+++.+||+.||++|||++|+++++....
T Consensus       247 --~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          247 --SEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             --CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence              124778999999999999999999999987643

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=6.5e-44  Score=366.35  Aligned_cols=259  Identities=24%  Similarity=0.286  Sum_probs=211.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      .++|.+.+.||+|+||.||+|..+ +|+.||+|++....  .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999765 79999999997643  122345678999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||++||+|.+++..... ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       263 mEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            999999999999986542 25899999999999999999999   67999999999999999999999999999987643


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHh-hhcCCCCCCCChh
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLID-VLDQRLPPPVDRK  439 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  439 (496)
                      .. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.....    ......... ........+  . 
T Consensus       339 ~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~----~~~~~~i~~~i~~~~~~~p--~-  410 (576)
T 2acx_A          339 GQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK----KIKREEVERLVKEVPEEYS--E-  410 (576)
T ss_dssp             TC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS----CCCHHHHHHHHHHCCCCCC--T-
T ss_pred             Cc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc----chhHHHHHHHhhcccccCC--c-
Confidence            32 23446899999999999999999999999999999999999999974321    011111111 111111111  1 


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHhc
Q 011005          440 VIRDILLISTVSFACLQSNPKSRP-----TMQSVSQEFLITR  476 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~~~~~~  476 (496)
                        .....+.+|+.+||+.||++||     +++|+++|+|+..
T Consensus       411 --~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          411 --RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             --TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             --cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence              0112467899999999999999     8999999999975

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.4e-43  Score=344.32  Aligned_cols=257  Identities=24%  Similarity=0.398  Sum_probs=200.3

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCc----EEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGK----VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMF  278 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  278 (496)
                      .++|++.+.||+|+||+||+|.+. +++    .||+|.+.........+.+.+|+.++++++||||+++++++..+. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            357999999999999999999754 344    468888876554455678899999999999999999999998765 77


Q ss_pred             EEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccc
Q 011005          279 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL  358 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  358 (496)
                      +|+||+.+|+|.+++....  ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            9999999999999998643  26899999999999999999999   679999999999999999999999999999877


Q ss_pred             cCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCC
Q 011005          359 HADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP  435 (496)
Q Consensus       359 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  435 (496)
                      ......  .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||....        .......+......+
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--------~~~~~~~~~~~~~~~  239 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--------ASEISSILEKGERLP  239 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------GGGHHHHHHTTCCCC
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC--------HHHHHHHHHcCCCCC
Confidence            544332  223456789999999999999999999999999999999 999996322        112222222222111


Q ss_pred             CChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          436 VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       436 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ....   ....+.+++.+||+.||++|||+.|+++++.....
T Consensus       240 ~~~~---~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          240 QPPI---CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             CCTT---BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             CCcc---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            1111   12247789999999999999999999999876543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.8e-44  Score=348.61  Aligned_cols=263  Identities=23%  Similarity=0.306  Sum_probs=202.4

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhH----HHHHHHHHHHHHHHhhcccccccccceeecCCeE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEEL----AFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCM  277 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  277 (496)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|.+......    ...+.+.+|+.++++++||||+++++++......
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            4578999999999999999999875 5899999999754321    1224678999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          278 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      ++||||+++ +|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             EEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            999999986 8888887543  35788899999999999999999   77999999999999999999999999999987


Q ss_pred             ccCCCCCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcC------
Q 011005          358 LHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQ------  430 (496)
Q Consensus       358 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------  430 (496)
                      ............+|+.|+|||++.+. .++.++||||+|+++|+|++|.+||......       .....+...      
T Consensus       162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-------~~~~~i~~~~~~~~~  234 (346)
T 1ua2_A          162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-------DQLTRIFETLGTPTE  234 (346)
T ss_dssp             TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHHHCCCCT
T ss_pred             ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHHHcCCCCh
Confidence            76554445556799999999998764 5889999999999999999999998643210       000100000      


Q ss_pred             ----------------CCCC-CCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          431 ----------------RLPP-PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       431 ----------------~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                                      ..+. +...........+.+|+.+||+.||++|||++|+++|+|+....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence                            0000 00000011123578999999999999999999999999997654

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.3e-44  Score=349.59  Aligned_cols=268  Identities=26%  Similarity=0.355  Sum_probs=203.5

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      .++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            467999999999999999999765 58999999986543 2334466789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++++|.++.....   .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus       104 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999999988876543   5899999999999999999999   779999999999999999999999999999876554


Q ss_pred             CCCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCC---------CCCCcc-h---hHhh
Q 011005          362 SSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS---------SSDPKI-M---LIDV  427 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~---------~~~~~~-~---~~~~  427 (496)
                      ........||+.|+|||++.+. .++.++||||+|+++|+|++|+.||........         ...+.. .   ....
T Consensus       178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence            4444556789999999999875 789999999999999999999999964321100         000000 0   0000


Q ss_pred             hc-CCCCCCCCh-----hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          428 LD-QRLPPPVDR-----KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       428 ~~-~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      .. ...+.....     ........+.+|+.+||+.||++|||+.|+++|+|+...
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            00 001100000     000112357899999999999999999999999999764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.5e-44  Score=351.68  Aligned_cols=265  Identities=26%  Similarity=0.344  Sum_probs=210.2

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|++.+.||+|+||+||+|.+. +++.||+|.+.........+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            367999999999999999999765 6899999999876555556788999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++++|.+++....   .+++..+..++.|++.||.|||+  ..+|+||||||+||+++.++.++|+|||++.......
T Consensus       112 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  186 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  186 (360)
T ss_dssp             CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC
T ss_pred             CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc
Confidence            999999999997643   68999999999999999999994  1389999999999999999999999999997654322


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccC---------------------------
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS---------------------------  415 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~---------------------------  415 (496)
                        .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||.......                           
T Consensus       187 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (360)
T 3eqc_A          187 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  264 (360)
T ss_dssp             ------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred             --ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence              234578999999999999999999999999999999999999996422100                           


Q ss_pred             ----CCCCCc----chhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          416 ----SSSDPK----IMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       416 ----~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                          ......    ...........+.....   .....+.+|+.+||+.||++|||++|+++|+|+....
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSG---VFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             ---------CCCHHHHHHHHHHSCCCCCCTT---TSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             cccccCCCCcccchhhhhHHhccCCCCCCcc---cccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence                000000    00011111111111100   0122477999999999999999999999999998754

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.6e-43  Score=341.89  Aligned_cols=260  Identities=26%  Similarity=0.378  Sum_probs=210.6

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe------CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCCe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKC  276 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  276 (496)
                      .++|.+.+.||+|+||.||+|.+      .+++.||+|.+.........+.+.+|+.+++++ +||||+++++++..++.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            46799999999999999999974      357889999998765545567889999999999 89999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhCCCC---------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe
Q 011005          277 MFLIYEYMERGSLFCNLHNNED---------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL  341 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~  341 (496)
                      .++||||+++|+|.+++.....               ...+++..++.++.|++.||.|||   +.+++||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence            9999999999999999976532               124899999999999999999999   6799999999999999


Q ss_pred             cCCCCeEEccccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCC
Q 011005          342 NSKLEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSS  418 (496)
Q Consensus       342 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~  418 (496)
                      +.++.+||+|||++.........  .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||....      
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------  252 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP------  252 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC------
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc------
Confidence            99999999999999876544322  223457789999999999999999999999999999999 999986321      


Q ss_pred             CCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          419 DPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                       ....................   ....+.+++.+||+.||++|||+.|+++++...-
T Consensus       253 -~~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          253 -VDSKFYKMIKEGFRMLSPEH---APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             -SSHHHHHHHHHTCCCCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -chhHHHHHhccCCCCCCccc---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence             11122222222211111111   1234778999999999999999999999986543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=7.1e-44  Score=346.49  Aligned_cols=272  Identities=19%  Similarity=0.268  Sum_probs=213.5

Q ss_pred             ccccHHHHHHHHhCCCCc-ceeeecCCeeEEEEEeC-CCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhc-cccccccc
Q 011005          193 GRIVYEDLIEATEDFDIR-YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVL-HRNIVKLY  268 (496)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~  268 (496)
                      +.+.++......++|.+. +.||+|+||.||+|..+ +++.||+|++..... ......+.+|+.+++.+. ||||++++
T Consensus        16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~   95 (327)
T 3lm5_A           16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH   95 (327)
T ss_dssp             CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence            345555666778889887 88999999999999765 689999999876432 223467889999999995 79999999


Q ss_pred             ceeecCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC---CC
Q 011005          269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KL  345 (496)
Q Consensus       269 ~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~---~~  345 (496)
                      +++......++||||+++|+|.+++.... ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.   ++
T Consensus        96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~  171 (327)
T 3lm5_A           96 EVYENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLG  171 (327)
T ss_dssp             EEEECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBC
T ss_pred             EEEEeCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCC
Confidence            99999999999999999999999986542 236899999999999999999999   779999999999999998   78


Q ss_pred             CeEEccccccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhH
Q 011005          346 EAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLI  425 (496)
Q Consensus       346 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  425 (496)
                      .+||+|||+++...... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||....       ......
T Consensus       172 ~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~  243 (327)
T 3lm5_A          172 DIKIVDFGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED-------NQETYL  243 (327)
T ss_dssp             CEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHH
T ss_pred             cEEEeeCccccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------chHHHH
Confidence            99999999998764332 2334579999999999999999999999999999999999999996322       111222


Q ss_pred             hhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          426 DVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      .........+... .......+.+++.+||+.||++|||++|+++|+|+...
T Consensus       244 ~i~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~  294 (327)
T 3lm5_A          244 NISQVNVDYSEET-FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW  294 (327)
T ss_dssp             HHHHTCCCCCTTT-TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred             HHHhcccccCchh-hcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence            2222211111110 11122347789999999999999999999999998654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.3e-43  Score=362.92  Aligned_cols=263  Identities=27%  Similarity=0.345  Sum_probs=211.3

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhH------------HHHHHHHHHHHHHHhhcccccccccc
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEEL------------AFIKSFKNEAQVLSQVLHRNIVKLYG  269 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~e~~~l~~l~h~niv~~~~  269 (496)
                      ..++|.+.+.||+|+||+||+|..+ +++.||+|++......            ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3578999999999999999999765 6889999998764311            23467889999999999999999999


Q ss_pred             eeecCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC---C
Q 011005          270 YCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL---E  346 (496)
Q Consensus       270 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~---~  346 (496)
                      ++..+...++||||+++|+|.+.+....   .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCcc
Confidence            9999999999999999999999887643   6899999999999999999999   67999999999999998775   6


Q ss_pred             eEEccccccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHh
Q 011005          347 AFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLID  426 (496)
Q Consensus       347 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  426 (496)
                      +||+|||+++...... .....+||+.|+|||++.+ .++.++||||+|+++|+|++|+.||....       .......
T Consensus       188 ~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~  258 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQN-------DQDIIKK  258 (504)
T ss_dssp             EEECCCTTCEECCTTS-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHH
T ss_pred             EEEEECCCCEEcCCCC-ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHH
Confidence            9999999998765432 3345679999999999874 68999999999999999999999996321       2222333


Q ss_pred             hhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCC
Q 011005          427 VLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLV  481 (496)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~  481 (496)
                      +.......+. ..+......+.+|+.+||+.||.+|||++|+++|+|+.+.....
T Consensus       259 i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~  312 (504)
T 3q5i_A          259 VEKGKYYFDF-NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNI  312 (504)
T ss_dssp             HHHCCCCCCH-HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCC
T ss_pred             HHcCCCCCCc-cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcc
Confidence            3333322211 11112234578999999999999999999999999998876543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.3e-43  Score=340.12  Aligned_cols=261  Identities=16%  Similarity=0.197  Sum_probs=207.5

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      .++|++.+.||+|+||.||+|.. .+++.||+|.+......   +.+.+|+.+++.+ +|+|++++++++......++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc---HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            46799999999999999999975 57999999998654422   4578899999999 7999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCC-----eEEccccccc
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE-----AFVADFGTAR  356 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~-----~kl~Dfg~~~  356 (496)
                      ||+ +++|.+++....  ..+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.     +||+|||+++
T Consensus        86 e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             Eec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            999 999999998643  25899999999999999999999   789999999999999987776     9999999998


Q ss_pred             cccCCCC-------CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhc
Q 011005          357 LLHADSS-------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD  429 (496)
Q Consensus       357 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  429 (496)
                      .......       ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....    ............
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~~~~~~~~~~~~  235 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA----ATNKQKYERIGE  235 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS----CCHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc----cccHHHHHHHHh
Confidence            7754322       12345799999999999999999999999999999999999999974321    111111111111


Q ss_pred             CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          430 QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       430 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      .....+...........+.+++.+||+.||++|||++++++.+.....
T Consensus       236 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          236 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             hccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            111111100001112357899999999999999999999998876654

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=6.5e-44  Score=345.24  Aligned_cols=268  Identities=20%  Similarity=0.330  Sum_probs=202.3

Q ss_pred             HhCCCCc-ceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEE
Q 011005          204 TEDFDIR-YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV  280 (496)
                      .+.|.+. +.||+|+||+||+|... +++.||||++..... .....+.+|+.++.++ +||||+++++++..++..++|
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            3578874 78999999999999754 789999999976432 2346788999999985 799999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCC---eEEcccccccc
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE---AFVADFGTARL  357 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~~  357 (496)
                      |||+++|+|.+++....   .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.   +||+|||++..
T Consensus        90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           90 FEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             EEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            99999999999997643   6899999999999999999999   679999999999999998776   99999999976


Q ss_pred             ccCCCC-------Ccccccccccccccccccc-----CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCC-----
Q 011005          358 LHADSS-------NRTLLAGTYGYIAPELAYT-----MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDP-----  420 (496)
Q Consensus       358 ~~~~~~-------~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~-----  420 (496)
                      ......       .....+||+.|+|||++.+     ..++.++||||+|+++|+|++|+.||............     
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  243 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP  243 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence            542211       1223468999999999875     56889999999999999999999999754321111000     


Q ss_pred             ---cchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          421 ---KIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       421 ---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                         ......+.......+. .........+.+++.+||+.||++|||++|+++|+|+....+
T Consensus       244 ~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~  304 (316)
T 2ac3_A          244 ACQNMLFESIQEGKYEFPD-KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP  304 (316)
T ss_dssp             HHHHHHHHHHHHCCCCCCH-HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred             hHHHHHHHHHhccCcccCc-hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence               0011222222222111 111112235789999999999999999999999999976544

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.8e-43  Score=355.07  Aligned_cols=268  Identities=24%  Similarity=0.270  Sum_probs=202.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecC-----Ce
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK-----KC  276 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  276 (496)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++.... .....+.+.+|+.++++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999764 68899999997642 334457789999999999999999999999776     57


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      .++||||++ |+|.+++....   .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999986 59999997643   6899999999999999999999   7799999999999999999999999999998


Q ss_pred             cccCCCC----------------------Ccccccccccccccccc-ccCCcCcccchhhHHHHHHHHHhCCCCCccccc
Q 011005          357 LLHADSS----------------------NRTLLAGTYGYIAPELA-YTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSS  413 (496)
Q Consensus       357 ~~~~~~~----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~  413 (496)
                      .......                      .....+||+.|+|||++ .+..++.++||||+||++|||++|..||.....
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~  257 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT  257 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence            7654321                      12456799999999986 566799999999999999999997666542211


Q ss_pred             cCCCCCC--------------------------------------------cchhHhhhc---CCCCCCCChhHHHHHHH
Q 011005          414 LSSSSDP--------------------------------------------KIMLIDVLD---QRLPPPVDRKVIRDILL  446 (496)
Q Consensus       414 ~~~~~~~--------------------------------------------~~~~~~~~~---~~~~~~~~~~~~~~~~~  446 (496)
                      ......+                                            .......+.   ...+.............
T Consensus       258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  337 (432)
T 3n9x_A          258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD  337 (432)
T ss_dssp             GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred             cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence            1000000                                            000000000   00000000000111235


Q ss_pred             HHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          447 ISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       447 l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      +.+|+.+||+.||++|||++|+++|+|+....
T Consensus       338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  369 (432)
T 3n9x_A          338 GINLLESMLKFNPNKRITIDQALDHPYLKDVR  369 (432)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence            77999999999999999999999999998653

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.4e-43  Score=363.64  Aligned_cols=259  Identities=25%  Similarity=0.333  Sum_probs=205.7

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      ..++|++.+.||+|+||+||+|..+ ++..||+|++.... .......+.+|+.+++.++||||+++++++......++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3567999999999999999999765 68899999987643 122246688999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC---CCeEEcccccccc
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK---LEAFVADFGTARL  357 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~  357 (496)
                      |||+++|+|.+.+....   .+++..+..++.||+.||.|||   +.+|+||||||+|||++..   +.+||+|||++..
T Consensus       115 ~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          115 MECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            99999999998887543   6899999999999999999999   7799999999999999764   5599999999987


Q ss_pred             ccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          358 LHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       358 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                      ..... .....+||+.|+|||++. ..++.++||||+||++|+|++|+.||....       .......+.......+..
T Consensus       189 ~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~  259 (494)
T 3lij_A          189 FENQK-KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT-------DQEILRKVEKGKYTFDSP  259 (494)
T ss_dssp             CBTTB-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCCCCCSG
T ss_pred             CCCCc-cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCch
Confidence            65432 334467999999999886 468999999999999999999999996322       122222333332222111


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                       .+......+.+++.+||+.||++|||+.|+++|+|+...
T Consensus       260 -~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          260 -EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             -GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             -hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence             111222357799999999999999999999999999763

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.9e-43  Score=333.82  Aligned_cols=257  Identities=23%  Similarity=0.380  Sum_probs=203.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|.+.+.||+|+||.||+|.++ +++.||+|.+....  .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            67999999999999999999875 78999999987643  2233467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++++|.+++....   .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++......
T Consensus        91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           91 EYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             eccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            9999999999997643   6899999999999999999999   679999999999999999999999999999876433


Q ss_pred             CCCccccccccccccccccccCCc-CcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      . ......+++.|+|||.+.+..+ +.++||||+|+++|+|++|+.||....       ...............+..   
T Consensus       165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~---  233 (276)
T 2h6d_A          165 E-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-------VPTLFKKIRGGVFYIPEY---  233 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTT---
T ss_pred             c-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc-------HHHHHHHhhcCcccCchh---
Confidence            2 2234568999999999988765 589999999999999999999986321       111122222222111111   


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                        ....+.+++.+||+.||++|||+.|+++|+|+....+.
T Consensus       234 --~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~  271 (276)
T 2h6d_A          234 --LNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPS  271 (276)
T ss_dssp             --SCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCCG
T ss_pred             --cCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCchh
Confidence              11246789999999999999999999999999876543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.4e-44  Score=347.42  Aligned_cols=260  Identities=25%  Similarity=0.368  Sum_probs=202.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCC----e
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK----C  276 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~  276 (496)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|++....  .......+.+|+.++++++||||+++++++....    .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46899999999999999999975 578999999997642  3344567899999999999999999999987644    3


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      .++||||+++++|.+++....   .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            599999999999999997643   6899999999999999999999   6799999999999999999999999999998


Q ss_pred             cccCCCC---CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCC
Q 011005          357 LLHADSS---NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLP  433 (496)
Q Consensus       357 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  433 (496)
                      .......   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....       ..............
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-------~~~~~~~~~~~~~~  237 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-------PVSVAYQHVREDPI  237 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHCCCC
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHhcCCCC
Confidence            7644322   1233568999999999999999999999999999999999999996322       11122222222221


Q ss_pred             CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          434 PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       434 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      .+. .........+.+++.+||+.||++||++.+++++.|....
T Consensus       238 ~~~-~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          238 PPS-ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             CHH-HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             Ccc-cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            110 0001122347789999999999999999999999887643

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-43  Score=360.77  Aligned_cols=267  Identities=24%  Similarity=0.283  Sum_probs=189.6

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeec-----CCe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH-----KKC  276 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~  276 (496)
                      .++|++.+.||+|+||+||+|.++ +++.||||++.... .....+.+.+|+.++++++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            368999999999999999999754 78999999986532 33445778999999999999999999999844     357


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      .++||||+ +|+|.+++....   .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEecc-ccchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccch
Confidence            89999998 468998887643   6899999999999999999999   7799999999999999999999999999998


Q ss_pred             cccCCCC---------------------------Ccccccccccccccccc-ccCCcCcccchhhHHHHHHHHHh-----
Q 011005          357 LLHADSS---------------------------NRTLLAGTYGYIAPELA-YTMVMTEKCDVYSFGVVTLEVLM-----  403 (496)
Q Consensus       357 ~~~~~~~---------------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~el~~-----  403 (496)
                      .......                           .....+||+.|+|||++ .+..++.++||||+||++|||++     
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~  284 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN  284 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence            7643221                           12335789999999976 56679999999999999999999     


Q ss_pred             ------CCCCCccccccCCCCCCc-------------c---hhHhhh-----------------------cCCCCCCCCh
Q 011005          404 ------GKHPRDILSSLSSSSDPK-------------I---MLIDVL-----------------------DQRLPPPVDR  438 (496)
Q Consensus       404 ------g~~p~~~~~~~~~~~~~~-------------~---~~~~~~-----------------------~~~~~~~~~~  438 (496)
                            |+++|.............             .   .+.+.+                       ..........
T Consensus       285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (458)
T 3rp9_A          285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE  364 (458)
T ss_dssp             CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred             ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence                  455553322110000000             0   000000                       0000000000


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          439 KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       439 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ........+.+|+.+||..||++|||++|+++|+|+...
T Consensus       365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~  403 (458)
T 3rp9_A          365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV  403 (458)
T ss_dssp             GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence            001112347799999999999999999999999999865

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.5e-43  Score=335.80  Aligned_cols=254  Identities=25%  Similarity=0.388  Sum_probs=201.8

Q ss_pred             CCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeec----CCeEEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH----KKCMFL  279 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l  279 (496)
                      .|.+.+.||+|+||+||+|.+ .++..||+|.+.... .....+.+.+|+.++++++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            477788999999999999976 468899999987643 33445778999999999999999999998865    456899


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEeCCCCCceEec-CCCCeEEccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS--IIHRDISSNNILLN-SKLEAFVADFGTAR  356 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~  356 (496)
                      ||||+++|+|.+++....   .+++..++.++.|++.||.|||   +.+  ++||||||+||+++ .++.+||+|||++.
T Consensus       107 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            999999999999997643   6899999999999999999999   667  99999999999998 78999999999997


Q ss_pred             cccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCC
Q 011005          357 LLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV  436 (496)
Q Consensus       357 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  436 (496)
                      ....  .......||+.|+|||++.+ .++.++||||+|+++|+|++|+.||....      ..............+...
T Consensus       181 ~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~  251 (290)
T 1t4h_A          181 LKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ------NAAQIYRRVTSGVKPASF  251 (290)
T ss_dssp             GCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS------SHHHHHHHHTTTCCCGGG
T ss_pred             cccc--cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC------cHHHHHHHHhccCCcccc
Confidence            5433  23344578999999998874 58999999999999999999999996321      111111122212111111


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ..   .....+.+++.+||+.||++|||+.|+++|+|+...
T Consensus       252 ~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          252 DK---VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             GG---CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             CC---CCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            11   112347899999999999999999999999998654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.3e-43  Score=333.62  Aligned_cols=249  Identities=28%  Similarity=0.483  Sum_probs=192.6

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchh---HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEE---LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|+||.||+|.+. ++.||+|.++....   ....+.+.+|+++++.++||||+++++++..++..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            57889999999999999999884 88999999876432   223467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEEeCCCCCceEecC--------CCCeEEc
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS---IIHRDISSNNILLNS--------KLEAFVA  350 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~---i~H~dlkp~Nil~~~--------~~~~kl~  350 (496)
                      ||+++++|.+++...    .+++..++.++.|++.||.|||   +.+   ++||||||+||+++.        ++.++|+
T Consensus        86 e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~  158 (271)
T 3dtc_A           86 EFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT  158 (271)
T ss_dssp             ECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred             EcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence            999999999998643    6899999999999999999999   556   999999999999986        6789999


Q ss_pred             cccccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcC
Q 011005          351 DFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQ  430 (496)
Q Consensus       351 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  430 (496)
                      |||++.......  .....||+.|+|||.+.+..++.++||||+|+++|+|++|+.||....       ...........
T Consensus       159 Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~  229 (271)
T 3dtc_A          159 DFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID-------GLAVAYGVAMN  229 (271)
T ss_dssp             CCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC-------HHHHHHHHHTS
T ss_pred             cCCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHhhhcC
Confidence            999998664332  224578999999999999999999999999999999999999996322       11222222222


Q ss_pred             CCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          431 RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       431 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      ....+....   ....+.+++.+||+.||++|||+.|+++++.
T Consensus       230 ~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~  269 (271)
T 3dtc_A          230 KLALPIPST---CPEPFAKLMEDCWNPDPHSRPSFTNILDQLT  269 (271)
T ss_dssp             CCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCcc---cCHHHHHHHHHHhcCCcccCcCHHHHHHHHh
Confidence            222221111   1224778999999999999999999999974

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.2e-43  Score=334.51  Aligned_cols=255  Identities=25%  Similarity=0.357  Sum_probs=195.5

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCC----CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      .++|++.+.||+|+||.||+|.+..    +..||+|.+.........+.+.+|+.++++++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4678999999999999999997643    45799999887655555678899999999999999999999985 456789


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||||+++|+|.+++....  ..+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++...
T Consensus        93 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccC
Confidence            999999999999997543  25899999999999999999999   6799999999999999999999999999998765


Q ss_pred             CCCCC-ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          360 ADSSN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       360 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                      ..... .....+++.|+|||.+.+..++.++||||+|+++|||++ |..||....       .......+....... ..
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~-------~~~~~~~i~~~~~~~-~~  239 (281)
T 1mp8_A          168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENGERLP-MP  239 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-------GGGHHHHHHTTCCCC-CC
T ss_pred             cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC-------HHHHHHHHHcCCCCC-CC
Confidence            43221 223456789999999999999999999999999999996 999986322       111222222221111 11


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                      .   .....+.+++.+||+.||++|||+.|+++++...
T Consensus       240 ~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          240 P---NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1   1123477899999999999999999999998764

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.8e-43  Score=351.30  Aligned_cols=268  Identities=21%  Similarity=0.289  Sum_probs=212.5

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCC--eEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK--CMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lV  280 (496)
                      .++|.+.+.||+|+||+||+|.+. +++.||||++.........+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            357899999999999999999765 589999999987554444567789999999999999999999998755  78999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe----cCCCCeEEccccccc
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL----NSKLEAFVADFGTAR  356 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~----~~~~~~kl~Dfg~~~  356 (496)
                      |||+++|+|.+++........+++..++.++.||+.||+|||   +.+|+||||||+||++    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999987654445899999999999999999999   7799999999999999    777889999999998


Q ss_pred             cccCCCCCcccccccccccccccccc--------CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhh
Q 011005          357 LLHADSSNRTLLAGTYGYIAPELAYT--------MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVL  428 (496)
Q Consensus       357 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  428 (496)
                      ...... ......||+.|+|||++.+        ..++.++||||||+++|||++|+.||.....   ............
T Consensus       165 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~---~~~~~~~~~~~~  240 (396)
T 4eut_A          165 ELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG---PRRNKEVMYKII  240 (396)
T ss_dssp             ECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTC---TTTCHHHHHHHH
T ss_pred             EccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc---ccchHHHHHHHh
Confidence            764432 2334579999999999875        5678899999999999999999999974322   111112222222


Q ss_pred             cCCCC--------------------CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          429 DQRLP--------------------PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       429 ~~~~~--------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ....+                    +............+.+++.+||+.||++|||++|+++++...-..
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            22111                    001111233445678999999999999999999999998765443

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.8e-44  Score=339.76  Aligned_cols=262  Identities=26%  Similarity=0.406  Sum_probs=208.2

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceee--cCCeEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL--HKKCMFL  279 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~l  279 (496)
                      .++|++.+.||+|+||.||+|..+ +++.||+|.+.... .....+.+.+|+.++++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            367999999999999999999765 68999999997643 2344567899999999999999999999874  4668999


Q ss_pred             EEEecCCCChhhhhhCCC-CCccCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEEeCCCCCceEecCCCCeEEcccc
Q 011005          280 IYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPS-----IIHRDISSNNILLNSKLEAFVADFG  353 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~-----i~H~dlkp~Nil~~~~~~~kl~Dfg  353 (496)
                      ||||+++++|.+++.... ....+++..++.++.|++.||+|||   ..+     ++||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999987532 2234899999999999999999999   556     9999999999999999999999999


Q ss_pred             ccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCC
Q 011005          354 TARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLP  433 (496)
Q Consensus       354 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  433 (496)
                      +++.............|++.|+|||.+.+..++.++||||||+++|+|++|+.||....       .............+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~i~~~~~~  234 (279)
T 2w5a_A          162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-------QKELAGKIREGKFR  234 (279)
T ss_dssp             HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCCC
T ss_pred             hheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC-------HHHHHHHHhhcccc
Confidence            99876544333334578999999999999999999999999999999999999986322       11122222222221


Q ss_pred             CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          434 PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       434 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      .....    ....+.+++.+||+.||++|||+.|+++++|.....+
T Consensus       235 ~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  276 (279)
T 2w5a_A          235 RIPYR----YSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH  276 (279)
T ss_dssp             CCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred             cCCcc----cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence            11111    1234778999999999999999999999999876644

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.3e-43  Score=336.73  Aligned_cols=262  Identities=23%  Similarity=0.361  Sum_probs=204.1

Q ss_pred             CCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          206 DFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      +|.....||+|+||.||+|.+ .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch-HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            455566899999999999975 4688999999876542 33467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC-CCCeEEccccccccccCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      ++++|.+++........+++..+..++.|++.||.|||   +.+++||||||+||+++. ++.++|+|||++........
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence            99999999987654456788999999999999999999   679999999999999987 89999999999987654433


Q ss_pred             CccccccccccccccccccCC--cCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMV--MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                      ......|++.|+|||++.+..  ++.++||||||+++|+|++|+.||.....      ...................   
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~---  249 (295)
T 2clq_A          179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE------PQAAMFKVGMFKVHPEIPE---  249 (295)
T ss_dssp             --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS------HHHHHHHHHHHCCCCCCCT---
T ss_pred             cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc------hhHHHHhhccccccccccc---
Confidence            344567899999999987654  78999999999999999999999964321      1111111101111111111   


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          442 RDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      .....+.+++.+||+.||++|||+.|+++|+|+......
T Consensus       250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  288 (295)
T 2clq_A          250 SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKK  288 (295)
T ss_dssp             TSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC----
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcccc
Confidence            011246789999999999999999999999999765443

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-43  Score=347.87  Aligned_cols=266  Identities=23%  Similarity=0.273  Sum_probs=199.8

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCC------
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK------  275 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  275 (496)
                      .++|++.+.||+|+||.||+|.+ .+|+.||||++.... .....+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46799999999999999999976 479999999996532 3344567899999999999999999999997653      


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccc
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  355 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  355 (496)
                      ..++||||+ +++|.+++...    .+++..+..++.||+.||.|||   +.||+||||||+||+++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            469999999 78999998753    5899999999999999999999   779999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCC--------CCCCcch---
Q 011005          356 RLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS--------SSDPKIM---  423 (496)
Q Consensus       356 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~--------~~~~~~~---  423 (496)
                      +.....   ....++|+.|+|||++.+ ..++.++||||+||++|||++|+.||........        ...+...   
T Consensus       176 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  252 (367)
T 1cm8_A          176 RQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  252 (367)
T ss_dssp             EECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             cccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            875432   334578999999999887 6899999999999999999999999964321100        0000000   


Q ss_pred             -----hHhh---hcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          424 -----LIDV---LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       424 -----~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                           ....   +..................+.+|+.+||+.||++|||++|+++|+|+......
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence                 0000   00000000000001112347799999999999999999999999999875443

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.4e-43  Score=337.99  Aligned_cols=254  Identities=18%  Similarity=0.273  Sum_probs=202.8

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  279 (496)
                      ..++|++.+.||+|+||+||+|.+. +++.||+|.+.... .......+.+|+..+..+ +||||+++++++.+++..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4578999999999999999999775 79999999987642 223346788999999999 89999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCC-CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC--------------
Q 011005          280 IYEYMERGSLFCNLHNNED-AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK--------------  344 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~--------------  344 (496)
                      ||||+++++|.+++..... ...+++..++.++.||+.||+|||   +.+|+||||||+||+++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999975421 125899999999999999999999   7799999999999999844              


Q ss_pred             -----CCeEEccccccccccCCCCCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCCCC
Q 011005          345 -----LEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSS  418 (496)
Q Consensus       345 -----~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~  418 (496)
                           ..++|+|||.+.......    ...||+.|+|||.+.+. .++.++||||||+++|+|++|..|+....      
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------  235 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------  235 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------
T ss_pred             ccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------
Confidence                 479999999998764332    34589999999999876 56689999999999999999998754211      


Q ss_pred             CCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          419 DPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                          ..........+.....    ....+.+++.+||+.||++|||+.|+++|+|+...
T Consensus       236 ----~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          236 ----QWHEIRQGRLPRIPQV----LSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             ----HHHHHHTTCCCCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             ----HHHHHHcCCCCCCCcc----cCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence                1222222222211111    11247789999999999999999999999998764

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=9.7e-44  Score=346.11  Aligned_cols=258  Identities=17%  Similarity=0.185  Sum_probs=205.0

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      .++|++.+.||+|+||+||+|.. .+++.||||.+.....   .+.+.+|+.+++++ +||||+++++++..++..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            36799999999999999999975 5789999999875432   13578999999999 8999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCC-----eEEccccccc
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE-----AFVADFGTAR  356 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~-----~kl~Dfg~~~  356 (496)
                      ||+ +++|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.     +||+|||+++
T Consensus        85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             EeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            999 999999998642  26899999999999999999999   679999999999999998887     9999999998


Q ss_pred             cccCCCCC-------ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhc
Q 011005          357 LLHADSSN-------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD  429 (496)
Q Consensus       357 ~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  429 (496)
                      ........       .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....    .........+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~----~~~~~~~~~i~~  234 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA----DTLKERYQKIGD  234 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----SSHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc----ccHHHHHHHHHh
Confidence            76543321       2356799999999999999999999999999999999999999974321    111111111111


Q ss_pred             CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          430 QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       430 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                      .....+........+ .+.+++.+||+.||.+||+++++++.+...
T Consensus       235 ~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          235 TKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             HHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             hhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence            111111110000112 688999999999999999999998876543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.2e-43  Score=355.20  Aligned_cols=270  Identities=21%  Similarity=0.270  Sum_probs=203.5

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc------ccccccccceeecCCe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL------HRNIVKLYGYCLHKKC  276 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~~~  276 (496)
                      ..+|++.+.||+|+||+||+|.+. +++.||||++.....  ....+.+|+.+++.++      |+||+++++++.....
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR--FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccc--hHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            457999999999999999999654 689999999976542  3356788999988884      6799999999999999


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCC--eEEccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE--AFVADFGT  354 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~  354 (496)
                      .++||||+. ++|.+++..... ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.  +||+|||+
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            999999996 699988876542 25899999999999999999999   679999999999999999887  99999999


Q ss_pred             cccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCC--------CCCCcc----
Q 011005          355 ARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS--------SSDPKI----  422 (496)
Q Consensus       355 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~--------~~~~~~----  422 (496)
                      ++.....   ....+||+.|+|||++.+..++.++|||||||++|||++|+.||........        ......    
T Consensus       249 a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~  325 (429)
T 3kvw_A          249 SCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA  325 (429)
T ss_dssp             CEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             ceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence            9765322   3345789999999999999999999999999999999999999864321000        000000    


Q ss_pred             --hhHhhhcC---------------------------CC-CCCCChhHHH-----HHHHHHHHHHhcccCCCCCCCCHHH
Q 011005          423 --MLIDVLDQ---------------------------RL-PPPVDRKVIR-----DILLISTVSFACLQSNPKSRPTMQS  467 (496)
Q Consensus       423 --~~~~~~~~---------------------------~~-~~~~~~~~~~-----~~~~l~~li~~cl~~dP~~Rps~~e  467 (496)
                        .....+..                           .. ..+.......     ....+.+|+.+||++||++|||++|
T Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e  405 (429)
T 3kvw_A          326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ  405 (429)
T ss_dssp             BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence              00000000                           00 0000010111     1234789999999999999999999


Q ss_pred             HHHHHHHhccCCCCCc
Q 011005          468 VSQEFLITRKTPLVKH  483 (496)
Q Consensus       468 vl~~~~~~~~~~~~~~  483 (496)
                      +++|+|+.+..+....
T Consensus       406 ~L~Hpw~~~~~~~~~~  421 (429)
T 3kvw_A          406 ALRHPWLRRRLPKPPT  421 (429)
T ss_dssp             HHTSTTTC--------
T ss_pred             HhCChhhccCCCCCCc
Confidence            9999999987665443

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=8.3e-43  Score=344.87  Aligned_cols=263  Identities=23%  Similarity=0.248  Sum_probs=197.0

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCC------
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK------  275 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  275 (496)
                      .++|++.+.||+|+||.||+|... +++.||||++.... .....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            368999999999999999999754 68999999987532 2344567889999999999999999999997654      


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccc
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  355 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  355 (496)
                      ..++||||+++ +|.+.+..     .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence            78999999975 78887763     4789999999999999999999   679999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccC---------CCCCC------
Q 011005          356 RLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS---------SSSDP------  420 (496)
Q Consensus       356 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~---------~~~~~------  420 (496)
                      +..... .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.......         ....+      
T Consensus       175 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  253 (371)
T 2xrw_A          175 RTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  253 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred             cccccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            866432 22334678999999999999999999999999999999999999996432110         00000      


Q ss_pred             cchhHhh---------------hcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          421 KIMLIDV---------------LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       421 ~~~~~~~---------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      .......               ......+............+.+|+.+||+.||++|||++|+++|+|+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  324 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  324 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence            0000000               0000011111112233456889999999999999999999999999974

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.5e-43  Score=340.42  Aligned_cols=260  Identities=22%  Similarity=0.355  Sum_probs=208.9

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC--------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecC
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP--------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHK  274 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  274 (496)
                      .++|++.+.||+|+||.||+|.+.        +++.||+|.+.........+.+.+|+.+++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            468999999999999999999763        56789999998765555567889999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhCCCC-------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe
Q 011005          275 KCMFLIYEYMERGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL  341 (496)
Q Consensus       275 ~~~~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~  341 (496)
                      +..++||||+++|+|.+++.....             ...+++..++.++.||+.||.|||   +.+|+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence            999999999999999999986542             124899999999999999999999   6799999999999999


Q ss_pred             cCCCCeEEccccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCC
Q 011005          342 NSKLEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSS  418 (496)
Q Consensus       342 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~  418 (496)
                      +.++.+||+|||+++........  .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||....      
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------  264 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------  264 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC------
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC------
Confidence            99999999999999876543221  223456788999999999999999999999999999999 999986321      


Q ss_pred             CCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          419 DPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                       ............... ...   .....+.+++.+||+.||++|||+.|+++++.....
T Consensus       265 -~~~~~~~~~~~~~~~-~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          265 -VEELFKLLKEGHRMD-KPA---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             -HHHHHHHHHHTCCCC-CCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHHHHHHhcCCCCC-CCc---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence             111111222221111 111   112247789999999999999999999999876543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.6e-43  Score=337.85  Aligned_cols=261  Identities=26%  Similarity=0.383  Sum_probs=207.8

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ..++|++.+.||+|+||.||+|.++ +|+.||+|.+.....   .+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC---CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH---HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            4578999999999999999999765 589999999876432   356789999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++++|.+++....  ..+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++......
T Consensus       104 e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          104 EYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             ECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             ecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            9999999999986322  26899999999999999999999   779999999999999999999999999999877554


Q ss_pred             CCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                      ........|++.|+|||.+.+..++.++||||||+++|+|++|+.||.....       ............+....  ..
T Consensus       179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~--~~  249 (314)
T 3com_A          179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-------MRAIFMIPTNPPPTFRK--PE  249 (314)
T ss_dssp             BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCCCCCSS--GG
T ss_pred             ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHhcCCCcccCC--cc
Confidence            4444456789999999999999999999999999999999999999863221       11111111111111000  11


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          442 RDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      .....+.+++.+||+.||++|||+.++++|+|+......
T Consensus       250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~  288 (314)
T 3com_A          250 LWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGV  288 (314)
T ss_dssp             GSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCG
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcc
Confidence            112357799999999999999999999999999876544

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4e-43  Score=334.22  Aligned_cols=256  Identities=25%  Similarity=0.430  Sum_probs=207.6

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeec--------
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH--------  273 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  273 (496)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|.+....     ..+.+|++++++++||||+++++++..        
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            4578999999999999999999875 79999999997654     345789999999999999999998854        


Q ss_pred             --------CCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC
Q 011005          274 --------KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL  345 (496)
Q Consensus       274 --------~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~  345 (496)
                              ....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||   +.+++||||||+||+++.++
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETT
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCC
Confidence                    445899999999999999997542 236899999999999999999999   67999999999999999999


Q ss_pred             CeEEccccccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhH
Q 011005          346 EAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLI  425 (496)
Q Consensus       346 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  425 (496)
                      .+||+|||++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|..|+....         ....
T Consensus       160 ~~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------~~~~  229 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---------KFFT  229 (284)
T ss_dssp             EEEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---------HHHH
T ss_pred             CEEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH---------HHHH
Confidence            99999999998765433 2334568999999999999999999999999999999999999875321         1112


Q ss_pred             hhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCcc
Q 011005          426 DVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHA  484 (496)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~  484 (496)
                      ......++...+       ..+.+++.+||+.||++|||+.|++++++..++.+....+
T Consensus       230 ~~~~~~~~~~~~-------~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~~  281 (284)
T 2a19_B          230 DLRDGIISDIFD-------KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER  281 (284)
T ss_dssp             HHHTTCCCTTSC-------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-------
T ss_pred             HhhcccccccCC-------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcccc
Confidence            222222332222       2367899999999999999999999999999887765544

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.8e-43  Score=349.86  Aligned_cols=261  Identities=10%  Similarity=0.023  Sum_probs=187.0

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhh--cccccccccc-------eee
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQV--LHRNIVKLYG-------YCL  272 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l--~h~niv~~~~-------~~~  272 (496)
                      .+|.+.+.||+|+||+||+|.+. +++.||+|++....  .....+.+.+|+.+++.+  +||||++++.       ++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45889999999999999999865 78999999998744  334456778887666666  5999887553       332


Q ss_pred             cC-----------------CeEEEEEEecCCCChhhhhhCCCCCccCCHHHH------HHHHHHHHHHHHHHHhCCCCCe
Q 011005          273 HK-----------------KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR------VNIVKAMAHALAYLHHDCSPSI  329 (496)
Q Consensus       273 ~~-----------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~------~~i~~~i~~~l~~lh~~~~~~i  329 (496)
                      ..                 ...++||||++ |+|.+++.....  .+++..+      ..++.||+.||+|||   +++|
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~i  215 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQ---SKGL  215 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCC
Confidence            22                 34899999998 899999986421  2344455      678899999999999   7799


Q ss_pred             EEeCCCCCceEecCCCCeEEccccccccccCCCCCcccccccccccccccccc--CCcCcccchhhHHHHHHHHHhCCCC
Q 011005          330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHP  407 (496)
Q Consensus       330 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~p  407 (496)
                      +||||||+|||++.++.+||+|||+++....   ......+|+.|+|||++.+  ..++.++||||||+++|||++|+.|
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P  292 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP  292 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCC---CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999986532   2224456799999999987  7899999999999999999999999


Q ss_pred             CccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          408 RDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       408 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      |..........................+...   .....+.+|+.+||+.||++|||+.|+++|+|+...
T Consensus       293 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCT---PLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             TTBCCTTCTTCCCBCCTTSCCCCSCCCTTSS---CCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             CCCcCcccccchhhhhhhhccccccchhhcc---CCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            9754321111111100010001111111100   112347789999999999999999999999998754

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.7e-43  Score=339.70  Aligned_cols=264  Identities=23%  Similarity=0.360  Sum_probs=190.6

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeCCCc----EEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLPNGK----VFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCM  277 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  277 (496)
                      ..++|++.+.||+|+||+||+|.+....    .||||.++... .....+.+.+|+.++++++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            3568999999999999999999875432    79999997643 233457789999999999999999999999877654


Q ss_pred             ------EEEEEecCCCChhhhhhCCC---CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeE
Q 011005          278 ------FLIYEYMERGSLFCNLHNNE---DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF  348 (496)
Q Consensus       278 ------~lV~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~k  348 (496)
                            ++||||+++|+|.+++....   ....+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence                  99999999999999986432   2225899999999999999999999   67999999999999999999999


Q ss_pred             EccccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhH
Q 011005          349 VADFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLI  425 (496)
Q Consensus       349 l~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~  425 (496)
                      |+|||+++........  .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||....       ......
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-------~~~~~~  250 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE-------NAEIYN  250 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------GGGHHH
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC-------hHHHHH
Confidence            9999999876443221  223456788999999999999999999999999999999 999986322       122222


Q ss_pred             hhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          426 DVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      .............    ....+.+++.+||+.||++|||+.++++.+...-..+.
T Consensus       251 ~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          251 YLIGGNRLKQPPE----CMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             HHHTTCCCCCCTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HHhcCCCCCCCCc----cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence            2222221111111    12247799999999999999997777666655544443

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=335.01  Aligned_cols=254  Identities=31%  Similarity=0.499  Sum_probs=198.2

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      ++|++.+.||+|+||+||+|.+. ++.||+|.+....   ..+.+.+|+.++++++||||+++++++.+.  .++||||+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~lv~e~~   81 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES---ERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYA   81 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT---HHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--TEEEEECC
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh---HHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--cEEEEEcC
Confidence            57888999999999999999884 7889999997543   236788999999999999999999998744  68999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCC-eEEccccccccccCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE-AFVADFGTARLLHADSS  363 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~  363 (496)
                      ++|+|.+++........++...++.++.|++.||+|||+.+.++|+||||||+||+++.++. +||+|||++......  
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--  159 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence            99999999987665556889999999999999999999432279999999999999998886 799999999765432  


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhH-hhhcCCCCCCCChhHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLI-DVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  442 (496)
                       .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.....      ...... .......+. ....   
T Consensus       160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~-~~~~---  228 (307)
T 2eva_A          160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG------PAFRIMWAVHNGTRPP-LIKN---  228 (307)
T ss_dssp             ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS------SHHHHHHHHHTTCCCC-CBTT---
T ss_pred             -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc------cHHHHHHHHhcCCCCC-cccc---
Confidence             2234689999999999999999999999999999999999999963221      111111 111111111 1111   


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ....+.+++.+||+.||++|||++|+++.+....+
T Consensus       229 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          229 LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            12247789999999999999999999999876543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.7e-44  Score=341.66  Aligned_cols=265  Identities=26%  Similarity=0.399  Sum_probs=203.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-----CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecC--Ce
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-----PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK--KC  276 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~  276 (496)
                      .++|++.+.||+|+||+||+|.+     .+++.||||++..... ...+.+.+|+.++++++||||+++++++...  ..
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            46799999999999999999974     3688999999976543 3446789999999999999999999998653  45


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      .++||||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             eEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            899999999999999998653  25899999999999999999999   7799999999999999999999999999998


Q ss_pred             cccCCCC---CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCcccccc-----CCCCCCcc---hhH
Q 011005          357 LLHADSS---NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSL-----SSSSDPKI---MLI  425 (496)
Q Consensus       357 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~-----~~~~~~~~---~~~  425 (496)
                      .......   ......++..|+|||.+.+..++.++||||+|+++|+|++|..|+......     ........   ...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence            7654322   122345677899999999999999999999999999999999997532210     00111100   111


Q ss_pred             hhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          426 DVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      +........+...   .....+.+++.+||+.||++|||+.|+++.+....+
T Consensus       243 ~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          243 ELLKNNGRLPRPD---GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             HHHHTTCCCCCCT---TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhccCcCCCCc---CcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            1111111111111   112357789999999999999999999999876543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.6e-43  Score=341.93  Aligned_cols=259  Identities=24%  Similarity=0.318  Sum_probs=201.9

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-------hHHHHHHHHHHHHHHHhhcccccccccceeecC
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-------ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK  274 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  274 (496)
                      ..++|.+.+.||+|+||.||+|.+. +++.||||.+....       .......+.+|+.++++++||||+++++++..+
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            4578999999999999999999764 68899999986532       112234578999999999999999999998766


Q ss_pred             CeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCC---eEEcc
Q 011005          275 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE---AFVAD  351 (496)
Q Consensus       275 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~---~kl~D  351 (496)
                      . .++||||+++++|.+++....   .+++..+..++.||+.||.|||   +.+++||||||+||+++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence            5 899999999999999887643   6899999999999999999999   779999999999999987654   99999


Q ss_pred             ccccccccCCCCCccccccccccccccccc---cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhh
Q 011005          352 FGTARLLHADSSNRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVL  428 (496)
Q Consensus       352 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  428 (496)
                      ||+++..... .......||+.|+|||++.   ...++.++||||||+++|+|++|+.||.....      .........
T Consensus       161 fg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~  233 (322)
T 2ycf_A          161 FGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT------QVSLKDQIT  233 (322)
T ss_dssp             CTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC------SSCHHHHHH
T ss_pred             Cccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch------HHHHHHHHH
Confidence            9999876432 1223456899999999974   56788999999999999999999999963221      111111222


Q ss_pred             cCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          429 DQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      ...... ...........+.+++.+||+.||++|||+.|+++|+|+..
T Consensus       234 ~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          234 SGKYNF-IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             HTCCCC-CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             hCcccc-CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            222211 11111112335789999999999999999999999999854

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.2e-43  Score=342.84  Aligned_cols=256  Identities=23%  Similarity=0.356  Sum_probs=200.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcE----EEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKV----FALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      ++|++.+.||+|+||+||+|.+. +++.    ||+|.+...........+.+|+.+++.++||||+++++++. ....++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            57889999999999999999764 3443    78888765443333355678999999999999999999986 456889


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||||+.+|+|.+++....  ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        92 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            999999999999998642  36888999999999999999999   6799999999999999999999999999998875


Q ss_pred             CCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCC
Q 011005          360 ADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV  436 (496)
Q Consensus       360 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  436 (496)
                      .....  .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||....       ... ....+........
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-------~~~-~~~~~~~~~~~~~  238 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR-------LAE-VPDLLEKGERLAQ  238 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-------TTH-HHHHHHTTCBCCC
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC-------HHH-HHHHHHcCCCCCC
Confidence            43322  234567889999999999999999999999999999999 999996322       111 1111111111111


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ...   ....+.+++.+||+.||++|||+.|+++++....+
T Consensus       239 ~~~---~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          239 PQI---CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             CTT---BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             CCc---CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            000   11136688999999999999999999999876644

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-43  Score=340.57  Aligned_cols=260  Identities=25%  Similarity=0.395  Sum_probs=201.2

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeec------C
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLH------K  274 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~------~  274 (496)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|.+......  ...+.+|+.+++++ +||||+++++++..      .
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   99 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   99 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST--THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc--HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence            467899999999999999999976 47899999998754322  25688999999999 79999999999976      4


Q ss_pred             CeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccc
Q 011005          275 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  354 (496)
Q Consensus       275 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  354 (496)
                      ...++||||+++|+|.+++.... ...++...++.++.||+.||.|||   ..+++||||||+||+++.++.+||+|||+
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~  175 (326)
T 2x7f_A          100 DQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGV  175 (326)
T ss_dssp             CEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence            67899999999999999998643 236899999999999999999999   67999999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccccccccc-----cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhc
Q 011005          355 ARLLHADSSNRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD  429 (496)
Q Consensus       355 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  429 (496)
                      +..............|++.|+|||++.     +..++.++||||||+++|+|++|+.||.....       .........
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~  248 (326)
T 2x7f_A          176 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------MRALFLIPR  248 (326)
T ss_dssp             TC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHH
T ss_pred             ceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------HHHHHHhhc
Confidence            987654433344567899999999987     56788999999999999999999999863221       111111212


Q ss_pred             CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          430 QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       430 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ...+......   ....+.+++.+||+.||++|||+.|+++|+|+....
T Consensus       249 ~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  294 (326)
T 2x7f_A          249 NPAPRLKSKK---WSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP  294 (326)
T ss_dssp             SCCCCCSCSC---SCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred             CccccCCccc---cCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence            2111111110   112477899999999999999999999999997653

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1e-42  Score=342.15  Aligned_cols=279  Identities=21%  Similarity=0.277  Sum_probs=211.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecC-----CeE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK-----KCM  277 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  277 (496)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||.+...........+.+|+.++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999999765 68999999997655555557788999999999999999999988654     678


Q ss_pred             EEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          278 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      ++||||+. |+|.+++...    .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        90 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 5898888753    5899999999999999999999   77999999999999999999999999999987


Q ss_pred             ccCCCCC----------cccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccC----------C
Q 011005          358 LHADSSN----------RTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS----------S  416 (496)
Q Consensus       358 ~~~~~~~----------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~----------~  416 (496)
                      .......          .....||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||.......          .
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            6432211          122468999999998764 678999999999999999999999996432100          0


Q ss_pred             -------CCCCcchhHhhhcCCCCCCC---ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCcccc
Q 011005          417 -------SSDPKIMLIDVLDQRLPPPV---DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAI  486 (496)
Q Consensus       417 -------~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~~~  486 (496)
                             .........+........+.   ..........+.+++.+||+.||++|||++|+++|+|+............
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~  321 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEG  321 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCC
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCccccccc
Confidence                   00000001111111100000   00001122357799999999999999999999999999887665555444


Q ss_pred             cccc
Q 011005          487 QDIS  490 (496)
Q Consensus       487 ~~i~  490 (496)
                      +.++
T Consensus       322 ~~~~  325 (353)
T 2b9h_A          322 EPIP  325 (353)
T ss_dssp             CCCC
T ss_pred             CCCC
Confidence            4444

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=6.9e-44  Score=347.68  Aligned_cols=261  Identities=24%  Similarity=0.360  Sum_probs=208.9

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeCC------CcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCC
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKK  275 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  275 (496)
                      ..++|.+.+.||+|+||.||+|.+..      ...||+|.+.........+.+.+|+.+++++ +||||+++++++...+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            35789999999999999999997642      3479999998765555567889999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhCCC-----------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC
Q 011005          276 CMFLIYEYMERGSLFCNLHNNE-----------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK  344 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~  344 (496)
                      ..++||||+++|+|.+++....           ....+++..++.++.|++.||+|||   +.+|+||||||+||+++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCC
Confidence            9999999999999999987532           1235799999999999999999999   6799999999999999999


Q ss_pred             CCeEEccccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCc
Q 011005          345 LEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPK  421 (496)
Q Consensus       345 ~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~  421 (496)
                      +.+||+|||+++........  .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||....       ..
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-------~~  273 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL-------VN  273 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC-------SS
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc-------hh
Confidence            99999999999876543322  223456789999999999999999999999999999998 999986321       11


Q ss_pred             chhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          422 IMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       422 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      ..................   ....+.+++.+||+.||++|||+.|+++++....
T Consensus       274 ~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          274 SKFYKLVKDGYQMAQPAF---APKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             HHHHHHHHHTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCCC---CCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence            122222222211111111   1234778999999999999999999999886543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.4e-43  Score=344.92  Aligned_cols=260  Identities=24%  Similarity=0.304  Sum_probs=206.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecC-----CeE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK-----KCM  277 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  277 (496)
                      .++|++.+.||+|+||.||+|... +++.||+|++.........+.+.+|++++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999764 68899999998655555567889999999999999999999999765     368


Q ss_pred             EEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          278 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      ++||||++ |+|.+++...    .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       106 ~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999997 5899888753    5899999999999999999999   77999999999999999999999999999987


Q ss_pred             ccCCCCC---cccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhc----
Q 011005          358 LHADSSN---RTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD----  429 (496)
Q Consensus       358 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----  429 (496)
                      .......   ....+||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||......       .....+..    
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~~~~~  250 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL-------DQLNHILGILGS  250 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG-------GHHHHHHHHHCS
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH-------HHHHHHHHHhCC
Confidence            6433221   234579999999998764 45899999999999999999999999643211       11111000    


Q ss_pred             ------------------CCCCCCC----ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          430 ------------------QRLPPPV----DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       430 ------------------~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                                        ...+...    ..........+.+|+.+||+.||++|||+.|+++|+|+....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  321 (364)
T 3qyz_A          251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  321 (364)
T ss_dssp             CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence                              0000000    000001123477999999999999999999999999998753

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-42  Score=331.13  Aligned_cols=255  Identities=24%  Similarity=0.341  Sum_probs=205.1

Q ss_pred             hCCCCcc-eeeecCCeeEEEEEeC---CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          205 EDFDIRY-CIGTGGYGSVYKAQLP---NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       205 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      ++|.+.+ .||+|+||.||+|.+.   ++..||+|.++........+.+.+|+.++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4566666 8999999999999753   57889999998765555567899999999999999999999999 45568999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+++++|.+++....  ..+++..++.++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++.....
T Consensus        88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            99999999999997543  36899999999999999999999   77999999999999999999999999999987654


Q ss_pred             CCCC---ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCC
Q 011005          361 DSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV  436 (496)
Q Consensus       361 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  436 (496)
                      ....   .....+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||....       .............. ..
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-------~~~~~~~i~~~~~~-~~  234 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-------GPEVMAFIEQGKRM-EC  234 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-------THHHHHHHHTTCCC-CC
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-------HHHHHHHHhcCCcC-CC
Confidence            3321   222346789999999998899999999999999999998 999986322       11112222221111 11


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      ..   .....+.+++.+||+.||++|||+.|++++++...
T Consensus       235 ~~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  271 (287)
T 1u59_A          235 PP---ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  271 (287)
T ss_dssp             CT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC---CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11   11235778999999999999999999999987653

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.1e-43  Score=371.15  Aligned_cols=255  Identities=21%  Similarity=0.330  Sum_probs=214.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  279 (496)
                      .++|++.+.||+|+||.||+|.++ +++.||||+++...  .......+..|..++..+ +||+|+++++++.+.+..++
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            468999999999999999999765 68899999997642  223345678899999988 69999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||||++||+|.+++....   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       420 V~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            999999999999998654   6899999999999999999999   7799999999999999999999999999998755


Q ss_pred             CCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          360 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       360 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                      .........+||+.|+|||++.+..++.++||||||+++|||++|+.||...       ........+.......+..  
T Consensus       494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~-------~~~~~~~~i~~~~~~~p~~--  564 (674)
T 3pfq_A          494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-------DEDELFQSIMEHNVAYPKS--  564 (674)
T ss_dssp             CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHSSCCCCCTT--
T ss_pred             cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC-------CHHHHHHHHHhCCCCCCcc--
Confidence            5555556678999999999999999999999999999999999999999632       2233344444443332221  


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHHHHHHhc
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTM-----QSVSQEFLITR  476 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~~~~~~  476 (496)
                         ....+.+|+.+||+.||++||++     +|+++|+|+..
T Consensus       565 ---~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~  603 (674)
T 3pfq_A          565 ---MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  603 (674)
T ss_dssp             ---SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred             ---CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence               12246789999999999999998     99999999864

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.2e-43  Score=346.59  Aligned_cols=272  Identities=22%  Similarity=0.284  Sum_probs=205.0

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeec--------
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH--------  273 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  273 (496)
                      .++|++.+.||+|+||+||+|.+ .+|+.||+|++..... ......+.+|+.+++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            36899999999999999999976 5789999999865432 2223567899999999999999999999877        


Q ss_pred             CCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccc
Q 011005          274 KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG  353 (496)
Q Consensus       274 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  353 (496)
                      .+..++||||+++ +|.+.+....  ..+++..++.++.||+.||+|||   +.||+||||||+||+++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccch
Confidence            3468999999985 7777776543  25899999999999999999999   7799999999999999999999999999


Q ss_pred             ccccccCCC----CCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCcccccc-------------C
Q 011005          354 TARLLHADS----SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSL-------------S  415 (496)
Q Consensus       354 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~-------------~  415 (496)
                      +++.+....    .......||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||......             .
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            998764322    22344578999999999876 45899999999999999999999998643210             0


Q ss_pred             CCCCCcchhHhhhcCC-CCCCCChhHHH------HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCC
Q 011005          416 SSSDPKIMLIDVLDQR-LPPPVDRKVIR------DILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLV  481 (496)
Q Consensus       416 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~------~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~  481 (496)
                      ....+........... ...........      ....+.+|+.+||+.||++|||++|+++|+|+.......
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  322 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS  322 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence            0000000000000000 00000000000      123477999999999999999999999999998654443

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.7e-43  Score=335.82  Aligned_cols=277  Identities=16%  Similarity=0.229  Sum_probs=206.6

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhccccccccccee-ecCCeEEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC-LHKKCMFLI  280 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lV  280 (496)
                      ..++|++.+.||+|+||+||+|.+ .+++.||+|++......   ..+.+|+.+++.++|++++..+..+ ......++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            467899999999999999999975 57899999987654322   3578899999999988877776655 567788999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe---cCCCCeEEcccccccc
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKLEAFVADFGTARL  357 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~  357 (496)
                      |||+ +++|.+++.....  .+++..++.++.|++.||.|||   +.+|+||||||+||++   +.++.+||+|||+++.
T Consensus        84 ~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEcc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            9999 9999999975332  5899999999999999999999   7799999999999999   7889999999999987


Q ss_pred             ccCCCC-------CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcC
Q 011005          358 LHADSS-------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQ  430 (496)
Q Consensus       358 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  430 (496)
                      ......       ......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||.......    ...........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~  233 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT----KRQKYERISEK  233 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS----SSSHHHHHHHH
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhh----hhhhhhhhhcc
Confidence            654332       1234578999999999999999999999999999999999999997533211    11111111111


Q ss_pred             CCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCcccccccchhhh
Q 011005          431 RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDISISEL  494 (496)
Q Consensus       431 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~~~~~i~~~~~  494 (496)
                      ....+...........+.+++.+||+.||++|||++++++.+........  ......++|+.+
T Consensus       234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~--~~~~~~~dw~~~  295 (296)
T 4hgt_A          234 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG--FSYDYVFDWNML  295 (296)
T ss_dssp             HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT--CCTTCCCGGGGC
T ss_pred             cccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC--CCccCccchhhc
Confidence            11111100001112357899999999999999999999988766554322  222333445554

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=9e-43  Score=329.38  Aligned_cols=253  Identities=19%  Similarity=0.294  Sum_probs=204.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecC--CeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK--KCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lV  280 (496)
                      .++|.+.+.||+|+||+||+|.++ ++.||+|++.... .....+.+.+|+.++++++||||+++++++...  ...++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            367999999999999999999985 8899999997653 334456789999999999999999999999887  778999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEeCCCCCceEecCCCCeEEccccccccc
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS--IIHRDISSNNILLNSKLEAFVADFGTARLL  358 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  358 (496)
                      |||+++|+|.+++..... ..+++..++.++.|++.||+|||   +.+  ++||||||+||+++.++.++++|||++...
T Consensus        88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             EECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             ecccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            999999999999987532 25899999999999999999999   667  999999999999999999999999887543


Q ss_pred             cCCCCCccccccccccccccccccCCcCc---ccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCC
Q 011005          359 HADSSNRTLLAGTYGYIAPELAYTMVMTE---KCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP  435 (496)
Q Consensus       359 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  435 (496)
                      ..     ....||+.|+|||.+.+..++.   ++||||+|+++|+|++|+.||....       ................
T Consensus       164 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~~~~  231 (271)
T 3kmu_A          164 QS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS-------NMEIGMKVALEGLRPT  231 (271)
T ss_dssp             SC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC-------HHHHHHHHHHSCCCCC
T ss_pred             cc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC-------hHHHHHHHHhcCCCCC
Confidence            22     2346899999999998766554   7999999999999999999996322       1112222222222221


Q ss_pred             CChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          436 VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       436 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      ....   ....+.+++.+||+.||++|||++|+++.+....
T Consensus       232 ~~~~---~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          232 IPPG---ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            1111   1224778999999999999999999999987654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1e-43  Score=344.79  Aligned_cols=263  Identities=24%  Similarity=0.334  Sum_probs=211.7

Q ss_pred             HHHHhCCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecC
Q 011005          201 IEATEDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK  274 (496)
Q Consensus       201 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  274 (496)
                      ....++|++.+.||+|+||.||+|.+.      .++.||+|.+...........+.+|+.+++.++||||+++++++..+
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  100 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG  100 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence            335678999999999999999999754      37789999998765555556789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhCCC-------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCe
Q 011005          275 KCMFLIYEYMERGSLFCNLHNNE-------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEA  347 (496)
Q Consensus       275 ~~~~lV~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~  347 (496)
                      +..++||||+++|+|.+++....       ....+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+
T Consensus       101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~  177 (322)
T 1p4o_A          101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTV  177 (322)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCE
T ss_pred             CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeE
Confidence            99999999999999999987532       1135789999999999999999999   6799999999999999999999


Q ss_pred             EEccccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchh
Q 011005          348 FVADFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIML  424 (496)
Q Consensus       348 kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~  424 (496)
                      ||+|||+++........  .....+|+.|+|||.+.+..++.++||||+|+++|+|++ |+.||....       .....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-------~~~~~  250 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------NEQVL  250 (322)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-------HHHHH
T ss_pred             EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC-------HHHHH
Confidence            99999999866433221  223456889999999999999999999999999999999 899986321       11222


Q ss_pred             HhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          425 IDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ..............    ....+.+++.+||+.||++|||+.|+++++.....
T Consensus       251 ~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          251 RFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHcCCcCCCCCC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            22222222211111    12347789999999999999999999999876533

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.5e-43  Score=334.84  Aligned_cols=259  Identities=27%  Similarity=0.446  Sum_probs=194.6

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|++.+.||+|+||+||+|.+.+  .||+|+++... .....+.+.+|+.++++++||||+++++++. ....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEEE
Confidence            4689999999999999999998743  59999987543 3344577899999999999999999999664 456789999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++++|.+++....  ..+++..++.++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++.......
T Consensus       100 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A          100 WCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             ecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence            999999999997543  36899999999999999999999   6799999999999999999999999999997654322


Q ss_pred             --CCccccccccccccccccc---cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          363 --SNRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       363 --~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                        .......||+.|+|||.+.   +..++.++||||+|+++|+|++|+.||....      ...................
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~  248 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN------NRDQIIEMVGRGSLSPDLS  248 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC------CHHHHHHHHHHTSCCCCTT
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc------hHHHHHHHhcccccCcchh
Confidence              2223456899999999986   6678889999999999999999999996322      1111112222222222211


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      .........+.+++.+||+.||++|||+.|+++.+....
T Consensus       249 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            111112235789999999999999999999999987643

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.4e-43  Score=330.27  Aligned_cols=255  Identities=25%  Similarity=0.369  Sum_probs=208.0

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      ++|++.+.||+|+||.||+|.+.+++.||+|.+......  .+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            578889999999999999999988999999999875432  256889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC-
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS-  363 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  363 (496)
                      ++++|.+++....  ..+++..++.++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++........ 
T Consensus        86 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           86 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             TTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             CCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence            9999999997643  25889999999999999999999   77999999999999999999999999999986643211 


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                      ......+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||....       ............... ....   
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~~~~~~i~~~~~~~-~~~~---  229 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDISTGFRLY-KPRL---  229 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHTTCCCC-CCTT---
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC-------HHHHHHHHhcCCcCC-CCcc---
Confidence            1223456788999999999999999999999999999999 899986321       111222222221111 1110   


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ....+.+++.+||+.||++|||+.|+++++....+
T Consensus       230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          230 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            12247789999999999999999999999876554

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.5e-43  Score=346.73  Aligned_cols=276  Identities=22%  Similarity=0.263  Sum_probs=204.7

Q ss_pred             cHHHHHHHHhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccch----------hHHHHHHHHHHHHHHHhhcccccc
Q 011005          196 VYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE----------ELAFIKSFKNEAQVLSQVLHRNIV  265 (496)
Q Consensus       196 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------~~~~~~~~~~e~~~l~~l~h~niv  265 (496)
                      ..+++....++|.+.+.||+|+||.||+|...+|+.||||++....          .....+.+.+|+.++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            3567777889999999999999999999998889999999986532          122346789999999999999999


Q ss_pred             cccceeec-----CCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceE
Q 011005          266 KLYGYCLH-----KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNIL  340 (496)
Q Consensus       266 ~~~~~~~~-----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil  340 (496)
                      ++++++..     ....++||||++ |+|.+.+....  ..+++..+..++.||+.||.|||   +.+|+||||||+||+
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl  166 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNIL  166 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEE
Confidence            99999843     346899999998 58888887543  36899999999999999999999   679999999999999


Q ss_pred             ecCCCCeEEccccccccccCCCCCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCC---
Q 011005          341 LNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS---  416 (496)
Q Consensus       341 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~---  416 (496)
                      ++.++.+||+|||+++...... ......+|+.|+|||++.+ ..++.++||||+|+++|+|++|+.||........   
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  245 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK  245 (362)
T ss_dssp             ECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             EcCCCCEEEEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999997554332 2344578999999999887 6789999999999999999999999964221000   


Q ss_pred             ------CCCC-------cchhHhhhcCCCCCCCChhH----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          417 ------SSDP-------KIMLIDVLDQRLPPPVDRKV----IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       417 ------~~~~-------~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                            ....       ....................    ......+.+|+.+||+.||++|||+.|+++|+|+....
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  324 (362)
T 3pg1_A          246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF  324 (362)
T ss_dssp             HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence                  0000       00000111111111000000    01123477999999999999999999999999997653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.7e-42  Score=351.09  Aligned_cols=251  Identities=24%  Similarity=0.395  Sum_probs=203.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCC-eEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK-CMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lV~e  282 (496)
                      .++|++.+.||+|+||.||+|.++ ++.||||.++...   ..+.+.+|+.++++++||||+++++++.... ..++|||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            467888999999999999999885 7899999998654   2367899999999999999999999987655 7899999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++|+|.+++..... ..+++..++.++.||+.||+|||   +++++||||||+|||++.++.+||+|||+++..... 
T Consensus       268 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  342 (450)
T ss_dssp             CCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             ecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence            9999999999986432 24789999999999999999999   779999999999999999999999999999854322 


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcC-CCCCCCChhH
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ-RLPPPVDRKV  440 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  440 (496)
                        .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....       .......+... +++.+.    
T Consensus       343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~-------~~~~~~~i~~~~~~~~p~----  409 (450)
T 1k9a_A          343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVVPRVEKGYKMDAPD----  409 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC-------TTTHHHHHHTTCCCCCCT----
T ss_pred             --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHcCCCCCCCC----
Confidence              222357889999999999999999999999999999998 999996432       11122222221 222111    


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                       .....+.+++.+||+.||++|||+.++++.+.....
T Consensus       410 -~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          410 -GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence             112357789999999999999999999998876554

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.4e-43  Score=344.08  Aligned_cols=262  Identities=21%  Similarity=0.315  Sum_probs=209.2

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHH----------------HHHHHHHHHHHHHhhcccccccc
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELA----------------FIKSFKNEAQVLSQVLHRNIVKL  267 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~e~~~l~~l~h~niv~~  267 (496)
                      .++|.+.+.||+|+||.||+|.. +++.||+|.+.......                ..+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            36899999999999999999988 89999999987643211                11678999999999999999999


Q ss_pred             cceeecCCeEEEEEEecCCCChhhh------hhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe
Q 011005          268 YGYCLHKKCMFLIYEYMERGSLFCN------LHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL  341 (496)
Q Consensus       268 ~~~~~~~~~~~lV~e~~~~g~L~~~------l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~  341 (496)
                      ++++...+..++||||+++|+|.++      +.... ...+++..++.++.|++.||.|||+  ..|++||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEE
Confidence            9999999999999999999999998      55421 3478999999999999999999993  2799999999999999


Q ss_pred             cCCCCeEEccccccccccCCCCCccccccccccccccccccC-CcCc-ccchhhHHHHHHHHHhCCCCCccccccCCCCC
Q 011005          342 NSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM-VMTE-KCDVYSFGVVTLEVLMGKHPRDILSSLSSSSD  419 (496)
Q Consensus       342 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~il~el~~g~~p~~~~~~~~~~~~  419 (496)
                      +.++.++|+|||++......  ......|++.|+|||.+.+. .++. ++||||+|+++|+|++|+.||.....      
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------  257 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS------  257 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC------
T ss_pred             cCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc------
Confidence            99999999999999876433  33446789999999999887 6666 99999999999999999999964321      


Q ss_pred             CcchhHhhhcCCCCCCCC--------------hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          420 PKIMLIDVLDQRLPPPVD--------------RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       420 ~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ...............+..              .........+.+++.+||+.||++|||+.|+++|+|+...
T Consensus       258 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          258 LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             SHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence            011111222121111100              0001122357899999999999999999999999998654

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=9.1e-43  Score=337.11  Aligned_cols=261  Identities=23%  Similarity=0.340  Sum_probs=208.9

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEe------CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCC
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKK  275 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  275 (496)
                      ..++|.+.+.||+|+||+||+|.+      .+++.||||.+.........+.+.+|+.+++++ +||||+++++++...+
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  104 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  104 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence            457899999999999999999974      356899999998765555567889999999999 6999999999987754


Q ss_pred             -eEEEEEEecCCCChhhhhhCCCCC-------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe
Q 011005          276 -CMFLIYEYMERGSLFCNLHNNEDA-------------VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL  341 (496)
Q Consensus       276 -~~~lV~e~~~~g~L~~~l~~~~~~-------------~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~  341 (496)
                       ..++||||+++|+|.+++......             ..+++..++.++.|++.||.|||   +.+|+||||||+||++
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~  181 (316)
T 2xir_A          105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILL  181 (316)
T ss_dssp             SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEE
Confidence             589999999999999999875431             12789999999999999999999   6799999999999999


Q ss_pred             cCCCCeEEccccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCC
Q 011005          342 NSKLEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSS  418 (496)
Q Consensus       342 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~  418 (496)
                      +.++.+||+|||+++........  .....+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||....      
T Consensus       182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~------  255 (316)
T 2xir_A          182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK------  255 (316)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------
T ss_pred             CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc------
Confidence            99999999999999876543322  233567889999999999999999999999999999998 999986321      


Q ss_pred             CCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          419 DPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      ................ ....   ....+.+++.+||+.||++|||+.|+++++....
T Consensus       256 ~~~~~~~~~~~~~~~~-~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          256 IDEEFCRRLKEGTRMR-APDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             CSHHHHHHHHHTCCCC-CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhHHHHHHhccCccCC-CCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1111111111111111 1110   1224778999999999999999999999987654

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.1e-42  Score=333.43  Aligned_cols=276  Identities=16%  Similarity=0.224  Sum_probs=210.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhccccccccccee-ecCCeEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYC-LHKKCMFLIY  281 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lV~  281 (496)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|++......   +.+.+|+.+++.++|++++..+.++ ......++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            46899999999999999999976 57999999998664422   3578999999999988877666655 5667889999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEec---CCCCeEEccccccccc
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN---SKLEAFVADFGTARLL  358 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~  358 (496)
                      ||+ +++|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++   .++.+||+|||++...
T Consensus        85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Eec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            999 899999997433  26899999999999999999999   77999999999999994   7889999999999876


Q ss_pred             cCCCCC-------ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCC
Q 011005          359 HADSSN-------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQR  431 (496)
Q Consensus       359 ~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  431 (496)
                      ......       .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......    .............
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~  234 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA----TKRQKYERISEKK  234 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS----SSSSHHHHHHHHH
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCch----hhhhhhhhhcccc
Confidence            544321       23457999999999999999999999999999999999999999743321    1111111111111


Q ss_pred             CCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCcccccccchhhh
Q 011005          432 LPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDISISEL  494 (496)
Q Consensus       432 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~~~~~i~~~~~  494 (496)
                      ...+...........+.+++.+||+.||++|||++++++.+..........  ....++|+.+
T Consensus       235 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~--~~~~~dw~~~  295 (296)
T 3uzp_A          235 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS--YDYVFDWNML  295 (296)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC--SSCCCGGGGC
T ss_pred             cCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc--cccccccccc
Confidence            111110000111235789999999999999999999998877655443332  2233556554

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.9e-42  Score=330.31  Aligned_cols=262  Identities=22%  Similarity=0.272  Sum_probs=205.0

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh---HHHHHHHHHHHHHHHhhcccccccccceee--cCCe
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE---LAFIKSFKNEAQVLSQVLHRNIVKLYGYCL--HKKC  276 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~  276 (496)
                      ..++|.+.+.||+|+||.||+|... +++.||+|.+.....   ......+.+|+.++++++||||+++++++.  ....
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            3578999999999999999999764 688999999976432   234567899999999999999999999984  4557


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      .++||||++++ +.+++.... ...+++..+..++.||+.||.|||   +.+++||||||+||+++.++.++|+|||++.
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccc
Confidence            89999999876 766666533 236899999999999999999999   6799999999999999999999999999998


Q ss_pred             cccCCCC--CccccccccccccccccccCC--cCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCC
Q 011005          357 LLHADSS--NRTLLAGTYGYIAPELAYTMV--MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRL  432 (496)
Q Consensus       357 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  432 (496)
                      .......  ......||+.|+|||++.+..  ++.++||||+|+++|+|++|+.||....       .......+.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~i~~~~~  230 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-------IYKLFENIGKGSY  230 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHCCC
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-------HHHHHHHHhcCCC
Confidence            7643222  223456899999999988654  4779999999999999999999986321       1112222222222


Q ss_pred             CCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCC
Q 011005          433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLV  481 (496)
Q Consensus       433 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~  481 (496)
                      ..+..     ....+.+++.+||+.||++|||++|+++|+|+....+..
T Consensus       231 ~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  274 (305)
T 2wtk_C          231 AIPGD-----CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA  274 (305)
T ss_dssp             CCCSS-----SCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred             CCCCc-----cCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence            21111     112467899999999999999999999999998776543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.1e-43  Score=352.16  Aligned_cols=249  Identities=16%  Similarity=0.134  Sum_probs=192.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHH---HHhhccccccccc-------ce
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQV---LSQVLHRNIVKLY-------GY  270 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~---l~~l~h~niv~~~-------~~  270 (496)
                      .++|.+.+.||+|+||+||+|.+ .+|+.||||++....  .....+.+.+|+.+   +++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            36788899999999999999986 469999999987431  22345778899954   5555799999998       55


Q ss_pred             eecCC-----------------eEEEEEEecCCCChhhhhhCCCC----CccCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 011005          271 CLHKK-----------------CMFLIYEYMERGSLFCNLHNNED----AVELDWAKRVNIVKAMAHALAYLHHDCSPSI  329 (496)
Q Consensus       271 ~~~~~-----------------~~~lV~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i  329 (496)
                      +..++                 ..++||||+ +|+|.+++.....    ...+++..++.|+.||+.||+|||   +.+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            44432                 278999999 6799999975321    123445888899999999999999   6799


Q ss_pred             EEeCCCCCceEecCCCCeEEccccccccccCCCCCccccccccccccccccccC-----------CcCcccchhhHHHHH
Q 011005          330 IHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM-----------VMTEKCDVYSFGVVT  398 (496)
Q Consensus       330 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~il  398 (496)
                      +||||||+|||++.++.+||+|||+++...   ......+| +.|+|||++.+.           .++.++||||||+++
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~---~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il  303 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG---ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI  303 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETT---CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecC---CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence            999999999999999999999999998532   23344567 999999999988           899999999999999


Q ss_pred             HHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          399 LEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       399 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      |||++|+.||.......       ....... .. ...       ...+.+++.+||+.||++|||+.|+++|+|+..
T Consensus       304 ~elltg~~Pf~~~~~~~-------~~~~~~~-~~-~~~-------~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          304 YWIWCADLPITKDAALG-------GSEWIFR-SC-KNI-------PQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             HHHHHSSCCC------C-------CSGGGGS-SC-CCC-------CHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             HHHHHCCCCCccccccc-------chhhhhh-hc-cCC-------CHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            99999999996432211       1111111 11 111       124778999999999999999999999999865

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.6e-43  Score=338.75  Aligned_cols=261  Identities=25%  Similarity=0.377  Sum_probs=204.3

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ..++|++.+.||+|+||.||+|.++ +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH-HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            3568999999999999999999875 588999999876432 23467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++++|.+++....  ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        96 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           96 EFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             ECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             EeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999999887532  25899999999999999999999   679999999999999999999999999998654322


Q ss_pred             CCCccccccccccccccccc-----cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCC
Q 011005          362 SSNRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV  436 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  436 (496)
                      ........||+.|+|||++.     +..++.++||||||+++|+|++|+.||.....       ............+...
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~  243 (302)
T 2j7t_A          171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSDPPTLL  243 (302)
T ss_dssp             HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCCCCCS
T ss_pred             ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-------HHHHHHHhccCCcccC
Confidence            22233456899999999983     66788999999999999999999999864321       1112222222211111


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ..  ......+.+++.+||+.||++|||+.|+++|+|+....
T Consensus       244 ~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          244 TP--SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             SG--GGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             Cc--cccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence            11  11123477899999999999999999999999997654

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=9.4e-43  Score=339.18  Aligned_cols=260  Identities=18%  Similarity=0.225  Sum_probs=202.5

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-ccccccccceeec--CCeEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLH--KKCMFL  279 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~l  279 (496)
                      .++|++.+.||+|+||+||+|.+ .+++.||+|++.....    +.+.+|+.++++++ ||||+++++++..  ....++
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK----KKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCH----HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccch----HHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            36799999999999999999965 5789999999976442    56889999999997 9999999999987  567899


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC-CeEEccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-EAFVADFGTARLL  358 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  358 (496)
                      ||||+++++|.+++.      .++...+..++.|++.||+|||   +.+|+||||||+|||++.++ .+||+|||+++..
T Consensus       111 v~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             EEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            999999999998885      4788999999999999999999   77999999999999999776 8999999999876


Q ss_pred             cCCCCCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCC---------------------
Q 011005          359 HADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS---------------------  416 (496)
Q Consensus       359 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~---------------------  416 (496)
                      .... ......+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||........                     
T Consensus       182 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          182 HPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             CTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             CCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence            5433 3344578999999999887 6789999999999999999999999842110000                     


Q ss_pred             CCCCcchhHhhhcCCCCCCCC-----hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          417 SSDPKIMLIDVLDQRLPPPVD-----RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       417 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      .....................     .........+.+|+.+||+.||++|||++|+++|+|+...
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  326 (330)
T 3nsz_A          261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  326 (330)
T ss_dssp             TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence            000000000000000000000     0000112357899999999999999999999999999754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.5e-43  Score=355.87  Aligned_cols=256  Identities=25%  Similarity=0.424  Sum_probs=207.1

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      ..++|.+.+.||+|+||+||+|.++++..||||+++....  ..+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc--cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            3567889999999999999999998899999999986442  2467899999999999999999999986 556899999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++|+|.+++.... ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus       263 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             CCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             ecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            999999999997542 225788999999999999999999   6799999999999999999999999999998764321


Q ss_pred             C-CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcC-CCCCCCChh
Q 011005          363 S-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ-RLPPPVDRK  439 (496)
Q Consensus       363 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  439 (496)
                      . ......+++.|+|||++.+..++.++||||||+++|||++ |+.||....       .......+... +.+.+.   
T Consensus       339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~-------~~~~~~~i~~~~~~~~~~---  408 (454)
T 1qcf_A          339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-------NPEVIRALERGYRMPRPE---  408 (454)
T ss_dssp             HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHHHHHHHHHTCCCCCCT---
T ss_pred             eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHcCCCCCCCC---
Confidence            1 1122346778999999999999999999999999999999 999996322       11122222222 222211   


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                        .....+.+++.+||+.||++|||++++++.+.....
T Consensus       409 --~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          409 --NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             --TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             --CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence              112357789999999999999999999999876544

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=8.9e-43  Score=338.89  Aligned_cols=262  Identities=26%  Similarity=0.347  Sum_probs=206.9

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe------CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCM  277 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  277 (496)
                      .++|++.+.||+|+||.||+|.+      .+++.||||.+...........+.+|+.++++++||||+++++++......
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            47899999999999999999974      357789999997654445556789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCC----CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC---CCCeEEc
Q 011005          278 FLIYEYMERGSLFCNLHNNED----AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KLEAFVA  350 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~---~~~~kl~  350 (496)
                      ++||||+++|+|.+++.....    ...+++..++.++.|++.||.|||   +.+++||||||+||+++.   +..++|+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999986532    135899999999999999999999   779999999999999984   4569999


Q ss_pred             cccccccccCCCC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhh
Q 011005          351 DFGTARLLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDV  427 (496)
Q Consensus       351 Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~  427 (496)
                      |||++........  ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||....       ........
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-------~~~~~~~~  258 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------NQEVLEFV  258 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHHHHHHH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC-------HHHHHHHH
Confidence            9999986543322  2233567889999999999999999999999999999998 999986321       11112222


Q ss_pred             hcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          428 LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      ...........    ....+.+++.+||+.||++|||+.|++++++.....+
T Consensus       259 ~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          259 TSGGRMDPPKN----CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             HTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             hcCCCCCCCCC----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            22211111111    1224778999999999999999999999999876644

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-43  Score=346.21  Aligned_cols=259  Identities=26%  Similarity=0.405  Sum_probs=205.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe----CCCcEEEEEEcccch---hHHHHHHHHHHHHHHHhh-cccccccccceeecCC
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSE---ELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKK  275 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  275 (496)
                      .++|++.+.||+|+||.||+|..    .+++.||||+++...   .......+.+|+.+++++ +||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36799999999999999999976    478999999987532   112234567899999999 5999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccc
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  355 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  355 (496)
                      ..++||||+++|+|.+++....   .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            9999999999999999997643   6899999999999999999999   679999999999999999999999999999


Q ss_pred             ccccCCCC-Ccccccccccccccccccc--CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCC
Q 011005          356 RLLHADSS-NRTLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRL  432 (496)
Q Consensus       356 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  432 (496)
                      +....... .....+||+.|+|||++.+  ..++.++||||||+++|||++|+.||.....   ................
T Consensus       207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~  283 (355)
T 1vzo_A          207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE---KNSQAEISRRILKSEP  283 (355)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS---CCCHHHHHHHHHHCCC
T ss_pred             eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCc---cchHHHHHHHHhccCC
Confidence            86643222 2334579999999999986  3578899999999999999999999963221   1111111122222222


Q ss_pred             CCCCChhHHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHhc
Q 011005          433 PPPVDRKVIRDILLISTVSFACLQSNPKSRP-----TMQSVSQEFLITR  476 (496)
Q Consensus       433 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~~~~~~  476 (496)
                      +.+..     ....+.+++.+||+.||++||     |++|+++|+|+..
T Consensus       284 ~~~~~-----~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~  327 (355)
T 1vzo_A          284 PYPQE-----MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  327 (355)
T ss_dssp             CCCTT-----SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             CCCcc-----cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence            11111     112467899999999999999     9999999999975

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.6e-43  Score=340.34  Aligned_cols=264  Identities=25%  Similarity=0.388  Sum_probs=188.3

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|.+.+.||+|+||.||+|... +++.||||.+.........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            468999999999999999999764 6889999998765444445678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCC-----CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          283 YMERGSLFCNLHNN-----EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       283 ~~~~g~L~~~l~~~-----~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      |+++++|.+++...     .....+++..++.++.||+.||.|||   +.+++||||||+||+++.++.++|+|||++..
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  170 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAF  170 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence            99999999988631     12336899999999999999999999   67999999999999999999999999999987


Q ss_pred             ccCCCC-----Ccccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCC
Q 011005          358 LHADSS-----NRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQR  431 (496)
Q Consensus       358 ~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  431 (496)
                      ......     ......||+.|+|||.+.+ ..++.++||||+|+++|+|++|+.||.....       ...........
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~  243 (303)
T 2vwi_A          171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP-------MKVLMLTLQND  243 (303)
T ss_dssp             CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG-------GGHHHHHHTSS
T ss_pred             eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch-------hhHHHHHhccC
Confidence            643221     1233568999999999876 5689999999999999999999999964321       11111111111


Q ss_pred             CCCCCChh-----HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          432 LPPPVDRK-----VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       432 ~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      .+......     .......+.+++.+||+.||++|||+.|+++|+|+...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  294 (303)
T 2vwi_A          244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA  294 (303)
T ss_dssp             CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred             CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence            11000000     00011247789999999999999999999999998754

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.9e-42  Score=332.05  Aligned_cols=260  Identities=22%  Similarity=0.310  Sum_probs=209.9

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--------hHHHHHHHHHHHHHHHhhc-ccccccccceee
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--------ELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCL  272 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~  272 (496)
                      ..++|++.+.||+|+||.||+|.++ +++.||+|.+....        .....+.+.+|+.+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3578999999999999999999775 68999999986532        1233466789999999996 999999999999


Q ss_pred             cCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccc
Q 011005          273 HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF  352 (496)
Q Consensus       273 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Df  352 (496)
                      .+...++||||+++++|.+++....   .+++..++.++.||+.||.|||   +.+++||||||+||+++.++.++|+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecc
Confidence            9999999999999999999997643   6899999999999999999999   779999999999999999999999999


Q ss_pred             cccccccCCCCCccccccccccccccccc------cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHh
Q 011005          353 GTARLLHADSSNRTLLAGTYGYIAPELAY------TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLID  426 (496)
Q Consensus       353 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  426 (496)
                      |++....... ......+++.|+|||++.      ...++.++||||+|+++|+|++|+.||....       .......
T Consensus       169 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~  240 (298)
T 1phk_A          169 GFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-------QMLMLRM  240 (298)
T ss_dssp             TTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHH
T ss_pred             cchhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc-------HHHHHHH
Confidence            9998765432 334457899999999885      4568889999999999999999999986321       1112222


Q ss_pred             hhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          427 VLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ........+... .......+.+++.+||+.||++|||+.|+++|+|+...
T Consensus       241 ~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (298)
T 1phk_A          241 IMSGNYQFGSPE-WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  290 (298)
T ss_dssp             HHHTCCCCCTTT-GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             HhcCCcccCccc-ccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence            222222211110 11122357799999999999999999999999998654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.2e-43  Score=335.17  Aligned_cols=260  Identities=25%  Similarity=0.361  Sum_probs=192.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHH-HHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELA-FIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      .++|++.+.||+|+||+||+|.. .+++.||+|++....... ..+.+.++...++.++||||+++++++..++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46799999999999999999976 578999999997654322 2334455555677789999999999999999999999


Q ss_pred             EecCCCChhhhhhCC-CCCccCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          282 EYMERGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHHDCSP-SIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       282 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||+++ +|.+++... .....+++..++.++.|++.||+|||   +. +++||||||+||+++.++.+||+|||+++...
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99975 887776531 12236899999999999999999999   65 99999999999999999999999999998764


Q ss_pred             CCCCCcccccccccccccccc----ccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCC
Q 011005          360 ADSSNRTLLAGTYGYIAPELA----YTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP  435 (496)
Q Consensus       360 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  435 (496)
                      ... ......||+.|+|||++    .+..++.++||||+|+++|+|++|+.||...      ...............+..
T Consensus       162 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~~~~~~  234 (290)
T 3fme_A          162 DDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW------GTPFQQLKQVVEEPSPQL  234 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC------SCHHHHHHHHHHSCCCCC
T ss_pred             ccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc------CchHHHHHHHhccCCCCc
Confidence            432 23345789999999996    5667899999999999999999999999632      112222223333322221


Q ss_pred             CChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          436 VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       436 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ....   ....+.+++.+||+.||++|||+.|+++|+|+...
T Consensus       235 ~~~~---~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          235 PADK---FSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             CTTT---SCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             cccc---CCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence            1111   12247789999999999999999999999999764

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.4e-43  Score=345.63  Aligned_cols=265  Identities=22%  Similarity=0.258  Sum_probs=188.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecC------C
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK------K  275 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  275 (496)
                      .++|++.+.||+|+||.||+|.+ .+|+.||||++.... .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            46899999999999999999975 578999999996542 334456788999999999999999999998654      5


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccc
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  355 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  355 (496)
                      ..++|+|++ +++|.+++...    .+++..+..++.||+.||.|||   +.||+||||||+||+++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence            679999999 68998888652    6899999999999999999999   779999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccC---------CCC-------
Q 011005          356 RLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS---------SSS-------  418 (496)
Q Consensus       356 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~---------~~~-------  418 (496)
                      +.....   ....+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.......         ...       
T Consensus       180 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  256 (367)
T 2fst_X          180 RHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  256 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             cccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            865432   334578999999999887 678999999999999999999999996432110         000       


Q ss_pred             CCcchhHhhhcCCCC---CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          419 DPKIMLIDVLDQRLP---PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       419 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      ...............   .............+.+|+.+||+.||++|||+.|+++|+|+.....
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  320 (367)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence            000000011111000   0000000011234789999999999999999999999999986543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.2e-42  Score=328.60  Aligned_cols=252  Identities=29%  Similarity=0.482  Sum_probs=199.9

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhH---H---HHHHHHHHHHHHHhhcccccccccceeecCCe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEEL---A---FIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKC  276 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  276 (496)
                      .++|++.+.||+|+||+||+|.+ .+++.||+|.+......   .   ..+.+.+|+.++++++||||+++++++.... 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            36799999999999999999976 47899999998654321   1   1157889999999999999999999997776 


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEeCCCCCceEecCCCC-----eEE
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS--IIHRDISSNNILLNSKLE-----AFV  349 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dlkp~Nil~~~~~~-----~kl  349 (496)
                       ++||||+++|+|.+.+....  ..+++..++.++.|++.||+|||   +.+  ++||||||+||+++.++.     +||
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             -eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence             59999999999998887543  26899999999999999999999   678  999999999999988776     999


Q ss_pred             ccccccccccCCCCCcccccccccccccccc--ccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhh
Q 011005          350 ADFGTARLLHADSSNRTLLAGTYGYIAPELA--YTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDV  427 (496)
Q Consensus       350 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  427 (496)
                      +|||+++....   ......||+.|+|||++  .+..++.++||||+|+++|+|++|+.||.....     .........
T Consensus       171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~  242 (287)
T 4f0f_A          171 ADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY-----GKIKFINMI  242 (287)
T ss_dssp             CCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC-----CHHHHHHHH
T ss_pred             CCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc-----cHHHHHHHH
Confidence            99999975432   33446789999999998  455678999999999999999999999963221     111111222


Q ss_pred             hcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          428 LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      ............   ....+.+++.+||+.||++|||++|+++.+.
T Consensus       243 ~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  285 (287)
T 4f0f_A          243 REEGLRPTIPED---CPPRLRNVIELCWSGDPKKRPHFSYIVKELS  285 (287)
T ss_dssp             HHSCCCCCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hccCCCCCCCcc---cCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            222222222111   1234779999999999999999999999874

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=7.2e-43  Score=335.61  Aligned_cols=262  Identities=23%  Similarity=0.348  Sum_probs=203.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-----CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecC--CeE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-----PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK--KCM  277 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  277 (496)
                      .+|++.+.||+|+||.||+|.+     .+++.||+|++.........+.+.+|+.++++++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            5688899999999999999983     468999999998665444557789999999999999999999999876  668


Q ss_pred             EEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          278 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      ++||||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++..
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccc
Confidence            99999999999999996543  25899999999999999999999   77999999999999999999999999999987


Q ss_pred             ccCCCC---CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCcccccc----CCCCCCc---chhHhh
Q 011005          358 LHADSS---NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSL----SSSSDPK---IMLIDV  427 (496)
Q Consensus       358 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~----~~~~~~~---~~~~~~  427 (496)
                      ......   ......+|..|+|||.+.+..++.++||||+|+++|+|++|+.|+......    .......   ......
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT  255 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence            754432   123356788899999999999999999999999999999999986422100    0000001   111111


Q ss_pred             hcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          428 LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      .......+...   .....+.+++.+||+.||++|||+.|+++.+..
T Consensus       256 ~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          256 LKEGKRLPCPP---NCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             HHTTCCCCCCT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HhccCCCCCCC---CCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            11111111111   112347799999999999999999999998754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.6e-42  Score=335.72  Aligned_cols=260  Identities=23%  Similarity=0.332  Sum_probs=205.9

Q ss_pred             CCCcceeeecCCeeEEEEEeC-----CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeec--CCeEEE
Q 011005          207 FDIRYCIGTGGYGSVYKAQLP-----NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH--KKCMFL  279 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l  279 (496)
                      |++.+.||+|+||+||++.+.     +++.||||++.........+.+.+|++++++++||||+++++++..  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488999999999999998643     6889999999876555556789999999999999999999999987  467899


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||||+++|+|.+++...    .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus       113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            99999999999999764    4899999999999999999999   6799999999999999999999999999998775


Q ss_pred             CCCCC---ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCcccccc----CCCCCC---cchhHhhhc
Q 011005          360 ADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSL----SSSSDP---KIMLIDVLD  429 (496)
Q Consensus       360 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~----~~~~~~---~~~~~~~~~  429 (496)
                      .....   .....+|+.|+|||++.+..++.++||||+|+++|+|++|+.||......    ......   .....+.+.
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence            43321   23345788899999999999999999999999999999999998633210    000000   001112222


Q ss_pred             CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          430 QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       430 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      .....+....   ....+.+++.+||+.||++|||+.|+++.+....
T Consensus       266 ~~~~~~~~~~---~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          266 RGERLPRPDK---CPAEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             TTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccCCCCCcc---ccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            2222111111   1235789999999999999999999998876543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=5e-43  Score=358.90  Aligned_cols=256  Identities=25%  Similarity=0.405  Sum_probs=208.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCC-CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|++.+.||+|+||.||+|.++. +..||||.++....  ..+.+.+|+.++++++||||+++++++......++|||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            4578889999999999999998764 88999999976542  24678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++|+|.+++..... ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus       297 ~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          297 FMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             CCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             ccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            9999999999986432 36899999999999999999999   7799999999999999999999999999998764332


Q ss_pred             CC-ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          363 SN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       363 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      .. .....+++.|+|||++.+..++.++||||||+++|||++ |+.||....       .. ...+.+..........  
T Consensus       373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~-------~~-~~~~~~~~~~~~~~~~--  442 (495)
T 1opk_A          373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LS-QVYELLEKDYRMERPE--  442 (495)
T ss_dssp             EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-------GG-GHHHHHHTTCCCCCCT--
T ss_pred             eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC-------HH-HHHHHHHcCCCCCCCC--
Confidence            21 222345778999999999999999999999999999999 999986322       11 1222222222211111  


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                       .....+.+|+.+||+.||++|||+.++++.+....
T Consensus       443 -~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          443 -GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             -CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence             11234778999999999999999999999986543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3e-42  Score=327.75  Aligned_cols=256  Identities=26%  Similarity=0.323  Sum_probs=202.2

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCC----CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      .++|.+.+.||+|+||+||+|.+.+    +..||+|.+.........+.+.+|+.++++++||||+++++++.++ ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            4679999999999999999997532    3469999998765445567889999999999999999999998765 4689


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||||+++++|.+++....  ..+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus        90 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            999999999999997543  25899999999999999999999   7799999999999999999999999999998765


Q ss_pred             CCCC-CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          360 ADSS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       360 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                      .... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.....       .................
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~  237 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-------KDVIGVLEKGDRLPKPD  237 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG-------GGHHHHHHHTCCCCCCT
T ss_pred             cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh-------HHHHHHHhcCCCCCCCC
Confidence            4322 1233457889999999999999999999999999999998 9999863221       11111111111111111


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      .    ....+.+++.+||+.||++|||+.|+++++....
T Consensus       238 ~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          238 L----CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY  272 (281)
T ss_dssp             T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C----CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence            1    1224778999999999999999999999987643

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.9e-42  Score=345.83  Aligned_cols=262  Identities=19%  Similarity=0.270  Sum_probs=202.0

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc--------ccccccccceee--
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL--------HRNIVKLYGYCL--  272 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~--  272 (496)
                      .++|++.+.||+|+||+||+|.. .+++.||||++....  ...+.+.+|+.+++.++        |+||+++++++.  
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE--HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC--cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            46899999999999999999975 468899999997653  23467889999999996        788999999987  


Q ss_pred             --cCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEeCCCCCceEecCCC----
Q 011005          273 --HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP-SIIHRDISSNNILLNSKL----  345 (496)
Q Consensus       273 --~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~-~i~H~dlkp~Nil~~~~~----  345 (496)
                        .....++||||+ ++++.+.+.... ...+++..++.++.||+.||.|||   ++ ||+||||||+|||++.++    
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhh
Confidence              566899999999 566666665432 236899999999999999999999   66 999999999999999775    


Q ss_pred             ---------------------------------------------CeEEccccccccccCCCCCcccccccccccccccc
Q 011005          346 ---------------------------------------------EAFVADFGTARLLHADSSNRTLLAGTYGYIAPELA  380 (496)
Q Consensus       346 ---------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~  380 (496)
                                                                   .+||+|||++......   ....+||+.|+|||++
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHH
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhh
Confidence                                                         7999999999876433   3345789999999999


Q ss_pred             ccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCc--chhHhhhcC-----------------------CCCC-
Q 011005          381 YTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPK--IMLIDVLDQ-----------------------RLPP-  434 (496)
Q Consensus       381 ~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~-----------------------~~~~-  434 (496)
                      .+..++.++|||||||++|||++|+.||.............  ....+....                       .+.. 
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            99999999999999999999999999997433211000000  000000000                       0000 


Q ss_pred             -CCC---------hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          435 -PVD---------RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       435 -~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                       +..         .........+.+|+.+||+.||++|||++|+++|+|+.
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence             000         00123345688999999999999999999999999985

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=337.14  Aligned_cols=258  Identities=24%  Similarity=0.403  Sum_probs=199.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCc----EEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGK----VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMF  278 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  278 (496)
                      .++|++.+.||+|+||+||+|.+. +++    +||+|.+.........+.+.+|+.++++++||||+++++++..+. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            367999999999999999999764 444    357887765544444577899999999999999999999998765 78


Q ss_pred             EEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccc
Q 011005          279 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL  358 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  358 (496)
                      +|+|++.+|+|.+++.....  .+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            99999999999999986432  6899999999999999999999   779999999999999999999999999999876


Q ss_pred             cCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCC
Q 011005          359 HADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP  435 (496)
Q Consensus       359 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  435 (496)
                      ......  .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||....       . ......+......+
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-------~-~~~~~~~~~~~~~~  239 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-------A-SEISSILEKGERLP  239 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------G-GGHHHHHHTTCCCC
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC-------H-HHHHHHHHcCCCCC
Confidence            443222  223456788999999999999999999999999999999 999996322       1 12222222222111


Q ss_pred             CChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          436 VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       436 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ....   ....+.+++.+||+.||++|||+.|+++.+......
T Consensus       240 ~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          240 QPPI---CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CCTT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCcc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            1111   122477899999999999999999999998776543

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-42  Score=335.89  Aligned_cols=257  Identities=30%  Similarity=0.423  Sum_probs=201.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCC-----CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPN-----GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      ++|++.+.||+|+||.||+|.+..     +..||+|.++..........+.+|+.++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            467778999999999999997542     346999999875544555678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||||+++|+|.+++....  ..+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus       124 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            999999999999997542  26899999999999999999999   6799999999999999999999999999998765


Q ss_pred             CCCCC---ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcC-CCCC
Q 011005          360 ADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ-RLPP  434 (496)
Q Consensus       360 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~  434 (496)
                      .....   .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....       .......+... +.+.
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~-------~~~~~~~~~~~~~~~~  271 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------NHEVMKAINDGFRLPT  271 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHTTCCCCC
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC-------HHHHHHHHHCCCcCCC
Confidence            43221   122345778999999999999999999999999999999 999986321       11112222222 1111


Q ss_pred             CCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          435 PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       435 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      +.     .....+.+++.+||+.||++||++.|+++++......
T Consensus       272 ~~-----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          272 PM-----DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             CT-----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             cc-----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            11     1123477899999999999999999999998765543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=7.1e-42  Score=328.06  Aligned_cols=257  Identities=24%  Similarity=0.357  Sum_probs=201.7

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCC----CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceee-cCCeEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL-HKKCMFL  279 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~l  279 (496)
                      .+|++.+.||+|+||+||+|.+.+    +..||+|.+.........+.+.+|+.++++++||||+++++++. .++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            468888999999999999997543    23689999887655556678899999999999999999999864 4567899


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++...
T Consensus       105 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccc
Confidence            999999999999997643  36789999999999999999999   7799999999999999999999999999998664


Q ss_pred             CCC----CCccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCC
Q 011005          360 ADS----SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPP  434 (496)
Q Consensus       360 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  434 (496)
                      ...    .......+|+.|+|||.+.+..++.++||||+|+++|+|++ |.+||....       ...............
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-------~~~~~~~~~~~~~~~  252 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------TFDITVYLLQGRRLL  252 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC-------TTTHHHHHHTTCCCC
T ss_pred             ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC-------HHHHHHHHhcCCCCC
Confidence            322    11233457789999999999999999999999999999999 555654221       111122222222111


Q ss_pred             CCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          435 PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       435 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ....    ....+.+++.+||+.||++|||+.|+++.+.....
T Consensus       253 ~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          253 QPEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCcc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1111    11247789999999999999999999999876544

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-42  Score=341.47  Aligned_cols=258  Identities=24%  Similarity=0.354  Sum_probs=195.0

Q ss_pred             CCCCcceeeecCCeeEEEEEeC--C--CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeec-CCeEEEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP--N--GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH-KKCMFLI  280 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lV  280 (496)
                      .|.+.+.||+|+||+||+|.+.  +  +..||+|.+.........+.+.+|+.++++++||||+++++++.. .+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4667789999999999999753  2  246899998765554556789999999999999999999998754 5578999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+++|+|.+++....  ..+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       170 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            99999999999997643  25788999999999999999999   77999999999999999999999999999986643


Q ss_pred             CCC----CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCC
Q 011005          361 DSS----NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP  435 (496)
Q Consensus       361 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  435 (496)
                      ...    ......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||.....       ...............
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~-------~~~~~~~~~~~~~~~  317 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-------FDITVYLLQGRRLLQ  317 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS-------SCHHHHHHTTCCCCC
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH-------HHHHHHHHcCCCCCC
Confidence            321    1223457788999999999999999999999999999999 6777753221       111222222221111


Q ss_pred             CChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          436 VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       436 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      ...    ....+.+++.+||+.||++|||+.|+++++......-
T Consensus       318 p~~----~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          318 PEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             CCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            111    1224778999999999999999999999988765543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.1e-43  Score=351.58  Aligned_cols=264  Identities=22%  Similarity=0.287  Sum_probs=197.5

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCC------eEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK------CMF  278 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~  278 (496)
                      .+|.+.+.||+|+||+||+|.+..+..||+|++.....     ...+|+++++.++||||+++++++....      ..+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            57999999999999999999988777799998865432     2247999999999999999999985433      378


Q ss_pred             EEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEec-CCCCeEEcccccccc
Q 011005          279 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN-SKLEAFVADFGTARL  357 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~  357 (496)
                      +||||++++.+............+++..+..++.||+.||+|||   +.+|+||||||+|||++ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999987544433332222336899999999999999999999   77999999999999999 789999999999987


Q ss_pred             ccCCCCCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCC--------CCCCcchhH---
Q 011005          358 LHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS--------SSDPKIMLI---  425 (496)
Q Consensus       358 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~--------~~~~~~~~~---  425 (496)
                      ..... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||........        .........   
T Consensus       192 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~  270 (394)
T 4e7w_A          192 LIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN  270 (394)
T ss_dssp             CCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             ccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            64433 23345789999999998765 589999999999999999999999964321100        000000000   


Q ss_pred             -hhhcCCCCCCCChhHH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          426 -DVLDQRLPPPVDRKVI-----RDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       426 -~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                       .......+........     .....+.+|+.+||+.||++|||+.|+++|+|+..-
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred             hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence             0000111110000000     012357899999999999999999999999999753

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.3e-42  Score=352.14  Aligned_cols=255  Identities=27%  Similarity=0.416  Sum_probs=201.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      .++|++.+.||+|+||.||+|.++++..||||.++.....  .+.+.+|+.++++++||||+++++++.. +..++||||
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            4678889999999999999999988889999999865422  3578999999999999999999999876 568999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++|+|.+++.... ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......
T Consensus       260 ~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          260 MSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             CTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             hcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            99999999997431 125899999999999999999999   77999999999999999999999999999987643322


Q ss_pred             C-ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcC-CCCCCCChhH
Q 011005          364 N-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ-RLPPPVDRKV  440 (496)
Q Consensus       364 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  440 (496)
                      . .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....       .......+... +.+.+.    
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~-------~~~~~~~i~~~~~~~~~~----  404 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVLDQVERGYRMPCPP----  404 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHTTCCCCCCT----
T ss_pred             ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHcCCCCCCCC----
Confidence            1 223456788999999999999999999999999999999 999986322       11122222221 122111    


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                       .....+.+++.+||+.||++|||++++++.+.....
T Consensus       405 -~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          405 -ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             -TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             -CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence             112347789999999999999999999998865543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.8e-42  Score=330.45  Aligned_cols=257  Identities=26%  Similarity=0.403  Sum_probs=209.3

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ..++|++.+.||+|+||+||+|.++ +++.||+|.+.....  ..+.+.+|+.++++++||||+++++++..+...++||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST--HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            3567999999999999999999775 488999999976543  3467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+++++|.+++..... ..+++..++.++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++......
T Consensus        89 e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           89 EFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             ECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            99999999999986432 36899999999999999999999   679999999999999999999999999999876543


Q ss_pred             CCC-ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          362 SSN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       362 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                      ... .....+|+.|+|||.+.+..++.++||||+|+++|+|++ |..||....       .. ...+.+...........
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~-------~~-~~~~~~~~~~~~~~~~~  236 (288)
T 3kfa_A          165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LS-QVYELLEKDYRMERPEG  236 (288)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------GG-GHHHHHHTTCCCCCCTT
T ss_pred             ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-------HH-HHHHHHhccCCCCCCCC
Confidence            322 223456788999999999999999999999999999999 999986322       11 12222222222111111


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                         ....+.+++.+||+.||++|||+.|+++.+....
T Consensus       237 ---~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~  270 (288)
T 3kfa_A          237 ---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  270 (288)
T ss_dssp             ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence               1234779999999999999999999999876543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.3e-42  Score=329.67  Aligned_cols=260  Identities=24%  Similarity=0.335  Sum_probs=209.2

Q ss_pred             HHHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          202 EATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       202 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      ...++|++.+.||+|+||.||+|..+ +++.||+|.+.... .......+.+|+.++++++||||+++++++...+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            35678999999999999999999775 78999999986543 22234678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC---CCeEEccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK---LEAFVADFGTAR  356 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~  356 (496)
                      ||||+++++|.+.+....   .+++..++.++.||+.||.|||   +.+++||||||+||+++.+   +.+||+|||++.
T Consensus        99 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            999999999998887543   6899999999999999999999   6799999999999999764   469999999998


Q ss_pred             cccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCC
Q 011005          357 LLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV  436 (496)
Q Consensus       357 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  436 (496)
                      ...... ......+++.|+|||.+.+. ++.++||||+|+++|+|++|+.||....       ...............+.
T Consensus       173 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~  243 (287)
T 2wei_A          173 CFQQNT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN-------EYDILKRVETGKYAFDL  243 (287)
T ss_dssp             TBCCCS-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCS
T ss_pred             eecCCC-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCCCCc
Confidence            764332 22344688999999988764 8999999999999999999999986322       11122222222222211


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      .. .......+.+++.+||+.||++|||+.|+++|+|+...
T Consensus       244 ~~-~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          244 PQ-WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             GG-GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             hh-hhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            11 11112347789999999999999999999999999764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-42  Score=328.28  Aligned_cols=257  Identities=25%  Similarity=0.329  Sum_probs=202.2

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-C---CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeE-EEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-N---GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCM-FLI  280 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~lV  280 (496)
                      .|...+.||+|+||+||+|.+. +   +..||+|.+.........+.+.+|+.++++++||||+++++++...+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            3556788999999999999753 2   3379999998765555667889999999999999999999999876654 899


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+.+|+|.+++....  ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus       102 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            99999999999998643  36789999999999999999999   67999999999999999999999999999976533


Q ss_pred             CC----CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCC
Q 011005          361 DS----SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV  436 (496)
Q Consensus       361 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  436 (496)
                      ..    .......+++.|+|||.+.+..++.++||||+|+++|+|++|..|+..      ..... ............+.
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~------~~~~~-~~~~~~~~~~~~~~  249 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR------HIDPF-DLTHFLAQGRRLPQ  249 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTT------TSCGG-GHHHHHHTTCCCCC
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCc------cCCHH-HHHHHhhcCCCCCC
Confidence            21    222345678899999999999999999999999999999996555421      11111 12222222211111


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ...   ....+.+++.+||+.||++|||+.|+++.+.....
T Consensus       250 ~~~---~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          250 PEY---CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             CTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             Ccc---chHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            111   12247789999999999999999999999876543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=6.7e-42  Score=334.20  Aligned_cols=259  Identities=20%  Similarity=0.321  Sum_probs=205.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe--CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccc------cccccceeecCC
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN------IVKLYGYCLHKK  275 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~  275 (496)
                      .++|++.+.||+|+||+||+|.+  .+++.||+|++....  ...+.+.+|+.+++.++|++      ++++++++...+
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            46899999999999999999975  368899999997654  23467889999999998765      899999999999


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC------------
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS------------  343 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~------------  343 (496)
                      ..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.            
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             cEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccc
Confidence            999999999 8899999876532 35889999999999999999999   779999999999999987            


Q ss_pred             -------CCCeEEccccccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCC
Q 011005          344 -------KLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS  416 (496)
Q Consensus       344 -------~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~  416 (496)
                             ++.+||+|||+++.....   .....||+.|+|||++.+..++.++||||+|+++|||++|+.||....... 
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-  241 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE-  241 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH-
T ss_pred             cccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH-
Confidence                   668999999999765332   334578999999999999999999999999999999999999996432100 


Q ss_pred             CCCCcchhHhhhcCCCCC-------------------------------------CCChhHHHHHHHHHHHHHhcccCCC
Q 011005          417 SSDPKIMLIDVLDQRLPP-------------------------------------PVDRKVIRDILLISTVSFACLQSNP  459 (496)
Q Consensus       417 ~~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~~l~~li~~cl~~dP  459 (496)
                         ......... ...+.                                     ............+.+++.+||+.||
T Consensus       242 ---~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  317 (339)
T 1z57_A          242 ---HLAMMERIL-GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP  317 (339)
T ss_dssp             ---HHHHHHHHH-CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             ---HHHHHHHHh-CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence               000000000 00000                                     0000011223457899999999999


Q ss_pred             CCCCCHHHHHHHHHHhcc
Q 011005          460 KSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       460 ~~Rps~~evl~~~~~~~~  477 (496)
                      ++|||+.|+++|+|+...
T Consensus       318 ~~Rpt~~ell~hp~f~~~  335 (339)
T 1z57_A          318 AKRITLREALKHPFFDLL  335 (339)
T ss_dssp             TTSCCHHHHTTSGGGGGG
T ss_pred             ccccCHHHHhcCHHHHHH
Confidence            999999999999999753

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.7e-42  Score=331.97  Aligned_cols=266  Identities=20%  Similarity=0.285  Sum_probs=199.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++....  .......+.+|+.++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            35799999999999999999975 578999999987532  334456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCC-CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          281 YEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      |||+++++|.+++.... ....+++..++.++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            99999999999886421 1235899999999999999999999   7799999999999999999999999999998765


Q ss_pred             CCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          360 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       360 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                      ..........|++.|+|||.+.+..++.++||||||+++|+|++|+.||....     ...............+..... 
T Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~-  261 (310)
T 2wqm_A          188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLCKKIEQCDYPPLPSD-  261 (310)
T ss_dssp             -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCHHHHHHHHHTTCSCCCCTT-
T ss_pred             CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc-----hhHHHHHHHhhcccCCCCccc-
Confidence            44433445678999999999999999999999999999999999999985321     111111111222222211111 


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                        .....+.+++.+||+.||++|||+.++++.+........
T Consensus       262 --~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~  300 (310)
T 2wqm_A          262 --HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA  300 (310)
T ss_dssp             --TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             --ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence              112247789999999999999999999999877665443

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.4e-42  Score=332.68  Aligned_cols=262  Identities=23%  Similarity=0.359  Sum_probs=202.3

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhc--ccccccccceeecCCeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVL--HRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lV  280 (496)
                      .++|.+.+.||+|+||.||+|..++++.||+|.+.... .....+.+.+|+.++++++  |+||+++++++..+...++|
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  106 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  106 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred             cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence            46799999999999999999998889999999986542 3344577899999999997  59999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      || +.+++|.+++....   .+++..++.++.|++.||.|||   +.+++||||||+||++++ +.+||+|||+++....
T Consensus       107 ~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          107 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP  178 (313)
T ss_dssp             EC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred             Ee-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence            99 66889999998654   6899999999999999999999   679999999999999975 7999999999987644


Q ss_pred             CCCC--cccccccccccccccccc-----------CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhh
Q 011005          361 DSSN--RTLLAGTYGYIAPELAYT-----------MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDV  427 (496)
Q Consensus       361 ~~~~--~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  427 (496)
                      ....  .....|++.|+|||.+.+           ..++.++||||||+++|+|++|+.||....      .........
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~  252 (313)
T 3cek_A          179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------NQISKLHAI  252 (313)
T ss_dssp             -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC------SHHHHHHHH
T ss_pred             ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH------HHHHHHHHH
Confidence            3221  234568999999999875           468889999999999999999999986321      111122222


Q ss_pred             hcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCC
Q 011005          428 LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVK  482 (496)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~  482 (496)
                      .............   ...+.+++.+||+.||++|||+.|+++|+|+........
T Consensus       253 ~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~  304 (313)
T 3cek_A          253 IDPNHEIEFPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN  304 (313)
T ss_dssp             HCTTSCCCCCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-----
T ss_pred             HhcccccCCcccc---hHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCchh
Confidence            2222211111111   124778999999999999999999999999987655433

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1e-41  Score=333.60  Aligned_cols=273  Identities=23%  Similarity=0.347  Sum_probs=211.9

Q ss_pred             cHHHHHHHHhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHh--hcccccccccceeec
Q 011005          196 VYEDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQ--VLHRNIVKLYGYCLH  273 (496)
Q Consensus       196 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~  273 (496)
                      ...-.....++|.+.+.||+|+||.||+|.+ +++.||||.+....    ...+.+|.+++..  ++||||+++++++..
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG----HHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh----HHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            3334455678999999999999999999988 58999999997543    2556788888888  689999999999988


Q ss_pred             CC----eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEeCCCCCceEecCC
Q 011005          274 KK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC-----SPSIIHRDISSNNILLNSK  344 (496)
Q Consensus       274 ~~----~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-----~~~i~H~dlkp~Nil~~~~  344 (496)
                      ..    ..++||||+++|+|.+++...    .+++..++.++.|++.||.|||+..     +.+|+||||||+||+++.+
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~  183 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN  183 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC
Confidence            76    789999999999999999754    5899999999999999999999311     3589999999999999999


Q ss_pred             CCeEEccccccccccCCCCC----ccccccccccccccccccC------CcCcccchhhHHHHHHHHHhC----------
Q 011005          345 LEAFVADFGTARLLHADSSN----RTLLAGTYGYIAPELAYTM------VMTEKCDVYSFGVVTLEVLMG----------  404 (496)
Q Consensus       345 ~~~kl~Dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~el~~g----------  404 (496)
                      +.+||+|||++.........    .....||+.|+|||++.+.      .++.++||||||+++|||++|          
T Consensus       184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~  263 (342)
T 1b6c_B          184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY  263 (342)
T ss_dssp             SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence            99999999999876544321    2345789999999998876      344789999999999999999          


Q ss_pred             CCCCccccccCCCCCCcchhHhhhcCCCCCCCChh--HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          405 KHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK--VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       405 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      ..||......  .................+.....  .......+.+++.+||+.||++|||+.|+++++....+..
T Consensus       264 ~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          264 QLPYYDLVPS--DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             CCTTTTTSCS--SCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             ccCccccCcC--cccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence            6676532211  01111112222223333222221  1234456889999999999999999999999998776544

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=8.3e-42  Score=329.95  Aligned_cols=259  Identities=22%  Similarity=0.360  Sum_probs=195.9

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC----CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCC--
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK--  275 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--  275 (496)
                      ..++|.+.+.||+|+||.||+|.+.    .++.||+|.+.... .....+.+.+|+.++++++||||+++++++....  
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            3567889999999999999999653    34589999987543 3344567899999999999999999999998755  


Q ss_pred             ---eEEEEEEecCCCChhhhhhCC---CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEE
Q 011005          276 ---CMFLIYEYMERGSLFCNLHNN---EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFV  349 (496)
Q Consensus       276 ---~~~lV~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl  349 (496)
                         ..++||||+++|+|.+++...   .....+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEE
Confidence               359999999999999998532   22346899999999999999999999   789999999999999999999999


Q ss_pred             ccccccccccCCCC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHh
Q 011005          350 ADFGTARLLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLID  426 (496)
Q Consensus       350 ~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~  426 (496)
                      +|||+++.......  ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||....       .......
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-------~~~~~~~  261 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ-------NHEMYDY  261 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------GGGHHHH
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC-------HHHHHHH
Confidence            99999987643321  1233457889999999999999999999999999999999 889986322       1222222


Q ss_pred             hhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          427 VLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                      ............    ....+.+++.+||+.||++|||+.++++++...
T Consensus       262 ~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          262 LLHGHRLKQPED----CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             HHTTCCCCCBTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHcCCCCCCCcc----ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            222221111111    123477899999999999999999999998654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.2e-42  Score=340.71  Aligned_cols=269  Identities=21%  Similarity=0.236  Sum_probs=192.5

Q ss_pred             HHHHHHHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCC-
Q 011005          198 EDLIEATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK-  275 (496)
Q Consensus       198 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-  275 (496)
                      +......++|++.+.||+|+||+||+|.+. +++.||||++......  .....++++.++.++||||+++++++.... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC--CCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc--cHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            345566789999999999999999999774 6899999998654321  234567788888899999999999986533 


Q ss_pred             ------eEEEEEEecCCCChhhhhh-CCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC-CCCe
Q 011005          276 ------CMFLIYEYMERGSLFCNLH-NNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KLEA  347 (496)
Q Consensus       276 ------~~~lV~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~-~~~~  347 (496)
                            ..++||||+++ +|...+. .......+++..+..++.|++.||.|||.. +.+|+||||||+|||++. ++.+
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEE
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcE
Confidence                  37899999987 4443332 122233688999999999999999999943 569999999999999997 8999


Q ss_pred             EEccccccccccCCCCCccccccccccccccccccCC-cCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHh
Q 011005          348 FVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLID  426 (496)
Q Consensus       348 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  426 (496)
                      ||+|||+++...... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.....       ......
T Consensus       172 kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-------~~~~~~  243 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-------AGQLHE  243 (360)
T ss_dssp             EECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHH
T ss_pred             EEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-------HHHHHH
Confidence            999999998765433 233457899999999987654 89999999999999999999999964321       111111


Q ss_pred             hhc--------------CCCC---------CCCC----hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          427 VLD--------------QRLP---------PPVD----RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       427 ~~~--------------~~~~---------~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ...              ....         .+..    .........+.+|+.+||+.||++|||+.|+++|+|+....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  322 (360)
T 3e3p_A          244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH  322 (360)
T ss_dssp             HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred             HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence            100              0000         0000    00000234578999999999999999999999999998754

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=7.3e-42  Score=339.57  Aligned_cols=267  Identities=22%  Similarity=0.308  Sum_probs=204.6

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-cc-----ccccccceeecCC
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HR-----NIVKLYGYCLHKK  275 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~  275 (496)
                      ..++|++.+.||+|+||+||+|... +++.||||++....  .....+.+|+.+++.++ |+     +|+++++++...+
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            3578999999999999999999765 68899999997643  23466788999998885 44     4999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEec--CCCCeEEcccc
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN--SKLEAFVADFG  353 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~--~~~~~kl~Dfg  353 (496)
                      ..++||||+. |+|.+++..... ..+++..+..++.|++.||.|||+. ..+|+||||||+|||++  .++.+||+|||
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG  206 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG  206 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred             ceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence            9999999996 599999886532 2589999999999999999999953 46999999999999995  47789999999


Q ss_pred             ccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCC--------CCCCc----
Q 011005          354 TARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS--------SSDPK----  421 (496)
Q Consensus       354 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~--------~~~~~----  421 (496)
                      +++.....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||........        ...+.    
T Consensus       207 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  283 (382)
T 2vx3_A          207 SSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD  283 (382)
T ss_dssp             TCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             Cceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            99876432   2346789999999999999999999999999999999999999974321100        00000    


Q ss_pred             --chhHhhhcCC----------------CCCC----------------------CChhHHHHHHHHHHHHHhcccCCCCC
Q 011005          422 --IMLIDVLDQR----------------LPPP----------------------VDRKVIRDILLISTVSFACLQSNPKS  461 (496)
Q Consensus       422 --~~~~~~~~~~----------------~~~~----------------------~~~~~~~~~~~l~~li~~cl~~dP~~  461 (496)
                        ......+...                ...+                      .......+...+.+|+.+||+.||++
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~  363 (382)
T 2vx3_A          284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKT  363 (382)
T ss_dssp             TCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTT
T ss_pred             hhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhh
Confidence              0000000000                0000                      00001122346789999999999999


Q ss_pred             CCCHHHHHHHHHHhcc
Q 011005          462 RPTMQSVSQEFLITRK  477 (496)
Q Consensus       462 Rps~~evl~~~~~~~~  477 (496)
                      |||++|+++|+|+...
T Consensus       364 Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          364 RIQPYYALQHSFFKKT  379 (382)
T ss_dssp             SCCHHHHTTSGGGCC-
T ss_pred             CCCHHHHhcCcccccC
Confidence            9999999999999754

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.1e-42  Score=340.79  Aligned_cols=262  Identities=24%  Similarity=0.284  Sum_probs=199.5

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeE----
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCM----  277 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~----  277 (496)
                      .++|.+.+.||+|+||.||+|.+. +|+.||+|++.... .....+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999764 68999999997643 334457788999999999999999999999876654    


Q ss_pred             --EEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccc
Q 011005          278 --FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  355 (496)
Q Consensus       278 --~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  355 (496)
                        ++||||+. ++|.+.+..     .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999997 588877743     4899999999999999999999   679999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCC---------CC-------
Q 011005          356 RLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS---------SS-------  418 (496)
Q Consensus       356 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~---------~~-------  418 (496)
                      +.....   .....||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||........         ..       
T Consensus       192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (371)
T 4exu_A          192 RHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  268 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence            865332   334578999999999887 7889999999999999999999999964321000         00       


Q ss_pred             CCcchhHhhhcCCCCCCCC---hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          419 DPKIMLIDVLDQRLPPPVD---RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       419 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ...................   .........+.+|+.+||+.||++|||++|+++|+|+...
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  330 (371)
T 4exu_A          269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  330 (371)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence            0000000000000000000   0000112357899999999999999999999999999754

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.3e-42  Score=326.33  Aligned_cols=254  Identities=25%  Similarity=0.391  Sum_probs=203.6

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      .++|++.+.||+|+||.||+|..++++.||+|.+......  .+.+.+|++++++++||||+++++++.. +..++||||
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   88 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc--HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence            4678999999999999999999988889999999765422  3678899999999999999999999874 457899999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++++|.+++.... ...+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++........
T Consensus        89 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           89 MENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             CTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             CCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence            99999999987532 125899999999999999999999   77999999999999999999999999999987654322


Q ss_pred             C-ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          364 N-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       364 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                      . .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||....       ........... .......   
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-------~~~~~~~~~~~-~~~~~~~---  233 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVIQNLERG-YRMVRPD---  233 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHTT-CCCCCCT---
T ss_pred             ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC-------HHHHHHHHhcc-cCCCCcc---
Confidence            1 223456788999999999999999999999999999999 999986321       11111222111 1111111   


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          442 RDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                      .....+.+++.+||+.||++|||++++++.+...
T Consensus       234 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            1123577899999999999999999998877543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.8e-42  Score=330.95  Aligned_cols=260  Identities=23%  Similarity=0.306  Sum_probs=199.3

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|.+....  .....+.+.+|+.++++++||||+++++++..++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999765 68899999997643  233457789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+++++|.+++....   .+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.....
T Consensus       113 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            99999999999998643   6899999999999999999999   67999999999999999999999999999977644


Q ss_pred             CCC-CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          361 DSS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       361 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                      ... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.....        ......+....+.+. ..
T Consensus       187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~~~-~~  257 (309)
T 2h34_A          187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL--------SVMGAHINQAIPRPS-TV  257 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH--------HHHHHHHHSCCCCGG-GT
T ss_pred             cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH--------HHHHHHhccCCCCcc-cc
Confidence            322 22345689999999999999999999999999999999999999963221        112222222222110 00


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHHHhccC
Q 011005          440 VIRDILLISTVSFACLQSNPKSRP-TMQSVSQEFLITRKT  478 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~~~~~~~~  478 (496)
                      .......+.+++.+||+.||++|| |++++++.+...-..
T Consensus       258 ~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          258 RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence            111122477899999999999999 899999988765443

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.2e-42  Score=334.50  Aligned_cols=263  Identities=24%  Similarity=0.319  Sum_probs=179.9

Q ss_pred             HHhCCCCcc-eeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeec----CCe
Q 011005          203 ATEDFDIRY-CIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH----KKC  276 (496)
Q Consensus       203 ~~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~  276 (496)
                      ..++|.+.+ .||+|+||+||+|.++ +++.||+|++.....     ...+....++.+.||||+++++++..    +..
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  100 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRC  100 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence            357888855 6999999999999775 689999999876432     11222334566689999999999876    456


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC---CCCeEEcccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KLEAFVADFG  353 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg  353 (496)
                      .++||||+++|+|.+++..... ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.   ++.+||+|||
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            8999999999999999986532 36899999999999999999999   679999999999999986   4559999999


Q ss_pred             ccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCC
Q 011005          354 TARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLP  433 (496)
Q Consensus       354 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  433 (496)
                      +++.....  ......+|+.|+|||++.+..++.++||||+|+++|+|++|+.||................ .......+
T Consensus       177 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~  253 (336)
T 3fhr_A          177 FAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI-RLGQYGFP  253 (336)
T ss_dssp             TCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------CCC
T ss_pred             cceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhh-hccccccC
Confidence            99866432  2334578999999999999999999999999999999999999996433211100000000 00001111


Q ss_pred             CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          434 PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       434 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      .+...   .....+.+++.+||+.||++|||++|+++|+|+......
T Consensus       254 ~~~~~---~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  297 (336)
T 3fhr_A          254 NPEWS---EVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV  297 (336)
T ss_dssp             TTTST---TCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGS
T ss_pred             chhhc---cCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccC
Confidence            11101   112347789999999999999999999999999875443

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.1e-43  Score=346.19  Aligned_cols=258  Identities=24%  Similarity=0.317  Sum_probs=197.3

Q ss_pred             HHHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeec-------
Q 011005          202 EATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH-------  273 (496)
Q Consensus       202 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------  273 (496)
                      ...++|++.+.||+|+||+||+|.+ .+|+.||+|++.....     ...+|+++++.++||||+++++++..       
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            3467899999999999999999975 5799999999876532     23479999999999999999999843       


Q ss_pred             -------------------------------CCeEEEEEEecCCCChhhhhhCC-CCCccCCHHHHHHHHHHHHHHHHHH
Q 011005          274 -------------------------------KKCMFLIYEYMERGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYL  321 (496)
Q Consensus       274 -------------------------------~~~~~lV~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~l  321 (496)
                                                     ....++||||+++ +|.+.+... .....+++..+..++.||+.||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           3348899999984 777666531 1223689999999999999999999


Q ss_pred             HhCCCCCeEEeCCCCCceEec-CCCCeEEccccccccccCCCCCccccccccccccccccccC-CcCcccchhhHHHHHH
Q 011005          322 HHDCSPSIIHRDISSNNILLN-SKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTL  399 (496)
Q Consensus       322 h~~~~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~  399 (496)
                      |   +.||+||||||+||+++ .++.+||+|||+++...... ......+|+.|+|||++.+. .++.++||||+||++|
T Consensus       158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  233 (383)
T 3eb0_A          158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG  233 (383)
T ss_dssp             H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence            9   78999999999999997 68899999999998764433 33445789999999998875 4899999999999999


Q ss_pred             HHHhCCCCCccccccCCCCCCcchhHhhhc--------------C-----CCCCCCChhHH-----HHHHHHHHHHHhcc
Q 011005          400 EVLMGKHPRDILSSLSSSSDPKIMLIDVLD--------------Q-----RLPPPVDRKVI-----RDILLISTVSFACL  455 (496)
Q Consensus       400 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------~-----~~~~~~~~~~~-----~~~~~l~~li~~cl  455 (496)
                      ||++|+.||......       .....++.              .     ..+........     .....+.+|+.+||
T Consensus       234 ell~g~~pf~~~~~~-------~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  306 (383)
T 3eb0_A          234 ELILGKPLFSGETSI-------DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL  306 (383)
T ss_dssp             HHHHSSCSSCCSSHH-------HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred             HHHhCCCCCCCCChH-------HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence            999999999643211       00111000              0     00000000000     01234779999999


Q ss_pred             cCCCCCCCCHHHHHHHHHHhc
Q 011005          456 QSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       456 ~~dP~~Rps~~evl~~~~~~~  476 (496)
                      +.||++|||+.|+++|+|+..
T Consensus       307 ~~dP~~R~t~~e~l~hp~f~~  327 (383)
T 3eb0_A          307 RYEPDLRINPYEAMAHPFFDH  327 (383)
T ss_dssp             CSSGGGSCCHHHHHTSGGGHH
T ss_pred             cCChhhCCCHHHHhcCHHHHH
Confidence            999999999999999999864

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.4e-42  Score=333.54  Aligned_cols=256  Identities=26%  Similarity=0.455  Sum_probs=196.7

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeec--------
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH--------  273 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  273 (496)
                      ..++|++.+.||+|+||.||+|... +++.||+|.+....  ...+.+.+|+.++++++||||+++++++.+        
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM   81 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH--HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence            4578999999999999999999764 78999999996543  334678999999999999999999998754        


Q ss_pred             -----CCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeE
Q 011005          274 -----KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAF  348 (496)
Q Consensus       274 -----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~k  348 (496)
                           ....++||||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+|
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           82 TAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             ----CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEE
T ss_pred             cccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEE
Confidence                 456899999999999999998543  35788999999999999999999   67999999999999999999999


Q ss_pred             EccccccccccCCC--------------CCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccc
Q 011005          349 VADFGTARLLHADS--------------SNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSS  413 (496)
Q Consensus       349 l~Dfg~~~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~  413 (496)
                      |+|||++.......              .......||+.|+|||.+.+. .++.++||||+|+++|+|++   ||.....
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~  233 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME  233 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence            99999998664321              122345689999999999865 68999999999999999998   4431110


Q ss_pred             cCCCCCCcchhHhhhc--CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          414 LSSSSDPKIMLIDVLD--QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       414 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                            ..........  ...+.....   .....+.+++.+||+.||++|||+.|+++|+|+...
T Consensus       234 ------~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          234 ------RVNILKKLRSVSIEFPPDFDD---NKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             ------HHHHHHHHHSTTCCCCTTCCT---TTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             ------HHHHHHhccccccccCccccc---cchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence                  0011111111  111221111   112346789999999999999999999999998643

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.8e-42  Score=336.68  Aligned_cols=260  Identities=23%  Similarity=0.361  Sum_probs=193.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHH--HHhhcccccccccceee-----cCCe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQV--LSQVLHRNIVKLYGYCL-----HKKC  276 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~-----~~~~  276 (496)
                      .++|++.+.||+|+||+||+|.. +++.||||++.....    ..+..|.++  +..++||||+++++.+.     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR----QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch----hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            36799999999999999999987 689999999976543    233344444  44578999999997543     2346


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCC---------CeEEeCCCCCceEecCCCCe
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP---------SIIHRDISSNNILLNSKLEA  347 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~---------~i~H~dlkp~Nil~~~~~~~  347 (496)
                      .++||||+++|+|.+++...    ..++..+..++.||+.||+|||   +.         +|+||||||+|||++.++.+
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  159 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTC  159 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred             EEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcE
Confidence            78999999999999999765    3588999999999999999999   67         99999999999999999999


Q ss_pred             EEccccccccccCCC--------CCcccccccccccccccccc-------CCcCcccchhhHHHHHHHHHhCCCCCcccc
Q 011005          348 FVADFGTARLLHADS--------SNRTLLAGTYGYIAPELAYT-------MVMTEKCDVYSFGVVTLEVLMGKHPRDILS  412 (496)
Q Consensus       348 kl~Dfg~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~~g~~p~~~~~  412 (496)
                      ||+|||+++......        .......||+.|+|||++.+       ..++.++||||||+++|||++|..||....
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  239 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE  239 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence            999999998764321        11223569999999999987       466789999999999999999987764322


Q ss_pred             ccCCCCCC---------c-chhHh-hhcC----CCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          413 SLSSSSDP---------K-IMLID-VLDQ----RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       413 ~~~~~~~~---------~-~~~~~-~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      ........         . ..... ....    .++..... .......+.+++.+||+.||++|||++|+++.+....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE-NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCC-CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccccc-ccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            21110000         0 00000 1111    11111111 1223445889999999999999999999988876543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.6e-42  Score=342.15  Aligned_cols=257  Identities=18%  Similarity=0.264  Sum_probs=197.0

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCC------CcEEEEEEcccchhHH--H--------HHHHHHHHHHHHhhcccccccc
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELA--F--------IKSFKNEAQVLSQVLHRNIVKL  267 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~--~--------~~~~~~e~~~l~~l~h~niv~~  267 (496)
                      .++|.+.+.||+|+||+||+|.++.      ++.||||.+.......  +        ......|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4589999999999999999998764      4789999987643210  0        0123345556677789999999


Q ss_pred             cceeecC----CeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEec-
Q 011005          268 YGYCLHK----KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN-  342 (496)
Q Consensus       268 ~~~~~~~----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~-  342 (496)
                      ++++...    ...++||||+ +++|.+++....  ..+++..++.++.||+.||+|||   +.+|+||||||+|||++ 
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEES
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEec
Confidence            9998764    4589999999 999999997642  36899999999999999999999   67999999999999999 


Q ss_pred             -CCCCeEEccccccccccCCCCC-------ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCcccccc
Q 011005          343 -SKLEAFVADFGTARLLHADSSN-------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSL  414 (496)
Q Consensus       343 -~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~  414 (496)
                       .++.+||+|||+++.+......       .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... 
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~-  266 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK-  266 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT-
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc-
Confidence             8899999999999876433211       1334599999999999999999999999999999999999999974211 


Q ss_pred             CCCCCCcc----------hhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          415 SSSSDPKI----------MLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       415 ~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                          ....          ......+..++..      ..+..+.+++..||+.||++||+++++++.+...-.
T Consensus       267 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  329 (364)
T 3op5_A          267 ----DPKYVRDSKIRYRENIASLMDKCFPAA------NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK  329 (364)
T ss_dssp             ----CHHHHHHHHHHHHHCHHHHHHHHSCTT------CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ----CHHHHHHHHHHhhhhHHHHHHHhcccc------cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence                0000          0011111111100      012357889999999999999999999988765544

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.9e-42  Score=333.63  Aligned_cols=259  Identities=24%  Similarity=0.359  Sum_probs=203.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcE--EEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKV--FALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  279 (496)
                      .++|++.+.||+|+||.||+|.+. ++..  +|+|.+.........+.+.+|+.+++++ +||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            367999999999999999999764 4554  4999987655444556789999999999 89999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCC-------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCC
Q 011005          280 IYEYMERGSLFCNLHNNE-------------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE  346 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~  346 (496)
                      ||||+++|+|.+++....             ....+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCe
Confidence            999999999999998653             2236899999999999999999999   779999999999999999999


Q ss_pred             eEEccccccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhH
Q 011005          347 AFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLI  425 (496)
Q Consensus       347 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~  425 (496)
                      +||+|||+++..... .......+++.|+|||++.+..++.++||||+|+++|+|++ |+.||....       ......
T Consensus       181 ~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~-------~~~~~~  252 (327)
T 1fvr_A          181 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELYE  252 (327)
T ss_dssp             EEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHH
T ss_pred             EEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc-------HHHHHH
Confidence            999999999754322 12233456889999999999999999999999999999998 999986322       111112


Q ss_pred             hhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          426 DVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ......... ...   .....+.+++.+||+.||++|||++|+++++.....
T Consensus       253 ~~~~~~~~~-~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  300 (327)
T 1fvr_A          253 KLPQGYRLE-KPL---NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  300 (327)
T ss_dssp             HGGGTCCCC-CCT---TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhhcCCCCC-CCC---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            222211111 111   112347789999999999999999999999876544

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.9e-42  Score=330.45  Aligned_cols=252  Identities=22%  Similarity=0.396  Sum_probs=200.6

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCC-C-------cEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCC
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPN-G-------KVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK  275 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  275 (496)
                      .++|.+.+.||+|+||+||+|.+.. +       ..||+|.+..... ...+.+.+|+.++++++||||+++++++..++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR-NYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG-GGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            3678999999999999999996543 3       5799999866442 34467899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCC--------e
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE--------A  347 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~--------~  347 (496)
                      ..++||||+++|+|.+++....  ..+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.        +
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999998643  24899999999999999999999   779999999999999998887        9


Q ss_pred             EEccccccccccCCCCCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCC-CccccccCCCCCCcchhH
Q 011005          348 FVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHP-RDILSSLSSSSDPKIMLI  425 (496)
Q Consensus       348 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p-~~~~~~~~~~~~~~~~~~  425 (496)
                      ||+|||++.....    .....+|+.|+|||++.+ ..++.++||||+|+++|+|++|..| +...        ......
T Consensus       161 kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~--------~~~~~~  228 (289)
T 4fvq_A          161 KLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL--------DSQRKL  228 (289)
T ss_dssp             EECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS--------CHHHHH
T ss_pred             eeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc--------chHHHH
Confidence            9999999865422    233568889999999987 7789999999999999999996544 4321        111111


Q ss_pred             hhhcC--CCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          426 DVLDQ--RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       426 ~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      .....  ..+....       ..+.+++.+||+.||++|||+.|+++++...-....
T Consensus       229 ~~~~~~~~~~~~~~-------~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~  278 (289)
T 4fvq_A          229 QFYEDRHQLPAPKA-------AELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL  278 (289)
T ss_dssp             HHHHTTCCCCCCSS-------CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred             HHhhccCCCCCCCC-------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence            11111  2222221       136789999999999999999999999987655443

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=347.20  Aligned_cols=268  Identities=22%  Similarity=0.321  Sum_probs=186.9

Q ss_pred             HhCCCC-cceeeecCCeeEEEEEeC---CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceee--cCCeE
Q 011005          204 TEDFDI-RYCIGTGGYGSVYKAQLP---NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL--HKKCM  277 (496)
Q Consensus       204 ~~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~  277 (496)
                      .+.|.+ .++||+|+||+||+|.++   +++.||+|++.....   ...+.+|+.++++++||||+++++++.  .....
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            345666 457999999999999865   578999999976432   245789999999999999999999995  46789


Q ss_pred             EEEEEecCCCChhhhhhCC------CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe----cCCCCe
Q 011005          278 FLIYEYMERGSLFCNLHNN------EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL----NSKLEA  347 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~----~~~~~~  347 (496)
                      ++||||+++ +|.+++...      .....+++..++.++.||+.||+|||   +.+|+||||||+|||+    +.++.+
T Consensus        96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcE
Confidence            999999975 787776532      12225899999999999999999999   7799999999999999    677899


Q ss_pred             EEccccccccccCCC---CCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCC--Cc
Q 011005          348 FVADFGTARLLHADS---SNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSD--PK  421 (496)
Q Consensus       348 kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~--~~  421 (496)
                      ||+|||+++......   ......+||+.|+|||++.+. .++.++||||+||++|+|++|+.||...........  ..
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            999999998765332   123346789999999999874 589999999999999999999999964322100000  00


Q ss_pred             chhHhh---hcCCCCCCCCh----------------------hHHH--------HHHHHHHHHHhcccCCCCCCCCHHHH
Q 011005          422 IMLIDV---LDQRLPPPVDR----------------------KVIR--------DILLISTVSFACLQSNPKSRPTMQSV  468 (496)
Q Consensus       422 ~~~~~~---~~~~~~~~~~~----------------------~~~~--------~~~~l~~li~~cl~~dP~~Rps~~ev  468 (496)
                      .....+   +..........                      ....        ....+.+|+.+||+.||++|||++|+
T Consensus       252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~  331 (405)
T 3rgf_A          252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA  331 (405)
T ss_dssp             HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence            000000   00000000000                      0000        02246789999999999999999999


Q ss_pred             HHHHHHhccC
Q 011005          469 SQEFLITRKT  478 (496)
Q Consensus       469 l~~~~~~~~~  478 (496)
                      ++|+|+....
T Consensus       332 L~hp~f~~~~  341 (405)
T 3rgf_A          332 MQDPYFLEDP  341 (405)
T ss_dssp             HTSGGGTSSS
T ss_pred             hcChhhccCC
Confidence            9999998654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.1e-42  Score=333.52  Aligned_cols=264  Identities=24%  Similarity=0.361  Sum_probs=206.9

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-----CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceee--cCCe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-----PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL--HKKC  276 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~  276 (496)
                      .++|++.+.||+|+||.||+|.+     .+++.||+|++..... ...+.+.+|++++++++||||+++++++.  ....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP-DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH-HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            36799999999999999999983     4688999999976543 33467899999999999999999999886  4567


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      .++||||+++++|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             EEEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccce
Confidence            899999999999999997532  25899999999999999999999   7799999999999999999999999999998


Q ss_pred             cccCCCCC---ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCcccccc-----C--CCCCCcchhHh
Q 011005          357 LLHADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSL-----S--SSSDPKIMLID  426 (496)
Q Consensus       357 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~-----~--~~~~~~~~~~~  426 (496)
                      ........   .....+|+.|+|||++.+..++.++||||+|+++|+|++|+.||......     .  ...........
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE  255 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence            76543321   22345788899999999999999999999999999999999998533211     0  00000011112


Q ss_pred             hhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          427 VLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      ........+...   .....+.+++.+||+.||++|||+.|+++++....
T Consensus       256 ~~~~~~~~~~~~---~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  302 (327)
T 3lxl_A          256 LLEEGQRLPAPP---ACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW  302 (327)
T ss_dssp             HHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred             HhhcccCCCCCC---cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            222222111111   11234779999999999999999999999887543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=339.21  Aligned_cols=263  Identities=19%  Similarity=0.203  Sum_probs=196.7

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC----CCcEEEEEEcccchhHH----------HHHHHHHHHHHHHhhcccccccccce
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSEELA----------FIKSFKNEAQVLSQVLHRNIVKLYGY  270 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~~~~~  270 (496)
                      ++|.+.+.||+|+||.||+|.+.    .+..||+|.+.......          ....+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            57999999999999999999875    57889999987643110          11235678888999999999999999


Q ss_pred             eec----CCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC-
Q 011005          271 CLH----KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-  345 (496)
Q Consensus       271 ~~~----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~-  345 (496)
                      +..    ....++||||+ +++|.+++....   .+++..++.++.||+.||+|||   +.+|+||||||+||+++.++ 
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSST
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCC
Confidence            987    67899999999 999999998654   7899999999999999999999   67999999999999999887 


Q ss_pred             -CeEEccccccccccCCCC-------CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCC
Q 011005          346 -EAFVADFGTARLLHADSS-------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSS  417 (496)
Q Consensus       346 -~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~  417 (496)
                       .+||+|||+++.+.....       ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....   .
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~  266 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK---D  266 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT---C
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc---c
Confidence             999999999987643211       12345789999999999999999999999999999999999999963211   0


Q ss_pred             CCCcchhHhhhcCCCCCCCChhH--HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          418 SDPKIMLIDVLDQRLPPPVDRKV--IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ..............++.......  ......+.+++.+||+.||++|||++++++.+.....
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          267 PVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             cHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            00000011111111111000000  0112257899999999999999999999999876544

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-42  Score=349.38  Aligned_cols=262  Identities=23%  Similarity=0.318  Sum_probs=195.3

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecC------CeE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK------KCM  277 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~  277 (496)
                      .+|++.+.||+|+||.||+|.+. +++.||||++.....     ...+|++++++++||||+++++++...      ...
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            46889999999999999999875 689999999866432     235799999999999999999988532      246


Q ss_pred             EEEEEecCCCChhhhhhC-CCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC-CCeEEcccccc
Q 011005          278 FLIYEYMERGSLFCNLHN-NEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTA  355 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~  355 (496)
                      ++||||+++ ++.+.+.. ......+++..+..++.||+.||.|||   +.+|+||||||+|||++.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence            799999986 56555432 112236899999999999999999999   7899999999999999965 56899999999


Q ss_pred             ccccCCCCCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCC--------CCCCcchhHh
Q 011005          356 RLLHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS--------SSDPKIMLID  426 (496)
Q Consensus       356 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~--------~~~~~~~~~~  426 (496)
                      +...... .....+||+.|+|||++.+. .++.++||||+||++|||++|+.||........        ..........
T Consensus       205 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~  283 (420)
T 1j1b_A          205 KQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  283 (420)
T ss_dssp             EECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             hhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            8764432 23345789999999998765 789999999999999999999999964321000        0000000000


Q ss_pred             hhcC-----CCCCCCChhHH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          427 VLDQ-----RLPPPVDRKVI-----RDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       427 ~~~~-----~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                       ...     ..+......+.     .....+.+|+.+||+.||++|||+.|+++|+|+...
T Consensus       284 -~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          284 -MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             -HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             -hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence             000     01100000000     012357899999999999999999999999999653

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=329.50  Aligned_cols=264  Identities=21%  Similarity=0.349  Sum_probs=203.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceee----cCCeEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL----HKKCMF  278 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~  278 (496)
                      .++|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.    .....+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            36799999999999999999976 578999999886543 234567889999999999999999999987    345789


Q ss_pred             EEEEecCCCChhhhhhCCC-CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          279 LIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      +||||+++|+|.+++.... ....+++..++.++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            9999999999999887521 2236899999999999999999999   67999999999999999999999999999876


Q ss_pred             ccCCCCC---------ccccccccccccccccccCC---cCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhH
Q 011005          358 LHADSSN---------RTLLAGTYGYIAPELAYTMV---MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLI  425 (496)
Q Consensus       358 ~~~~~~~---------~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  425 (496)
                      .......         .....||+.|+|||++.+..   ++.++||||||+++|+|++|+.||.......     . ...
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~-~~~  257 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-----D-SVA  257 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-----S-CHH
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-----c-hhh
Confidence            5321111         11235789999999987654   6889999999999999999999996432110     0 111


Q ss_pred             hhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          426 DVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      .........+...   .....+.+++.+||+.||++|||+.|+++++......+.
T Consensus       258 ~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  309 (317)
T 2buj_A          258 LAVQNQLSIPQSP---RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP  309 (317)
T ss_dssp             HHHHCC--CCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred             HHhhccCCCCccc---cCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence            1111111111111   112247789999999999999999999999987765433

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.9e-42  Score=336.52  Aligned_cols=262  Identities=24%  Similarity=0.268  Sum_probs=182.7

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHH-HHHhhcccccccccceeecCCeEEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQ-VLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      ++|.+.+.||+|+||.||+|..+ +++.||||.+...........+..|+. +++.++||||+++++++...+..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            67899999999999999999774 789999999977543334455566665 6677799999999999999999999999


Q ss_pred             ecCCCChhhhhhCC--CCCccCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          283 YMERGSLFCNLHNN--EDAVELDWAKRVNIVKAMAHALAYLHHDCSP-SIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       283 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      |+++ +|.+++...  .....+++..+..++.|++.||.|||   .. +++||||||+||+++.++.+||+|||+++...
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            9985 777776531  11236899999999999999999999   66 99999999999999999999999999998764


Q ss_pred             CCCCCcccccccccccccccc----ccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCC
Q 011005          360 ADSSNRTLLAGTYGYIAPELA----YTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP  435 (496)
Q Consensus       360 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  435 (496)
                      ... ......||+.|+|||++    .+..++.++||||||+++|+|++|+.||.......      ...........+..
T Consensus       178 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~~  250 (327)
T 3aln_A          178 DSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF------DQLTQVVKGDPPQL  250 (327)
T ss_dssp             -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSCCCCC
T ss_pred             ccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH------HHHHHHhcCCCCCC
Confidence            332 22334689999999998    46678999999999999999999999996432110      00111111111110


Q ss_pred             CChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          436 VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       436 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ...........+.+++.+||+.||++|||+.|+++|+|+...
T Consensus       251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence            000000112247789999999999999999999999999764

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=7e-42  Score=331.38  Aligned_cols=260  Identities=22%  Similarity=0.256  Sum_probs=196.5

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceee----------
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL----------  272 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----------  272 (496)
                      .++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            467999999999999999999776 48999999987654 334567889999999999999999998873          


Q ss_pred             ----cCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEec-CCCCe
Q 011005          273 ----HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN-SKLEA  347 (496)
Q Consensus       273 ----~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~-~~~~~  347 (496)
                          .....++||||++ |+|.+++...    .+++..++.++.|++.||+|||   +.+|+||||||+||+++ +++.+
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEE
T ss_pred             ccccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeE
Confidence                3467899999998 5999988653    5889999999999999999999   77999999999999997 56799


Q ss_pred             EEccccccccccCCC---CCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcch
Q 011005          348 FVADFGTARLLHADS---SNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIM  423 (496)
Q Consensus       348 kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~  423 (496)
                      ||+|||+++......   .......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......       ..
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------~~  233 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL-------EQ  233 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HH
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH-------HH
Confidence            999999998764321   12233467899999998865 67899999999999999999999999643211       01


Q ss_pred             hHhhhcCC-------------------------CCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          424 LIDVLDQR-------------------------LPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       424 ~~~~~~~~-------------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ........                         ...+...........+.+++.+||+.||++|||++|+++|+|+....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (320)
T 2i6l_A          234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS  313 (320)
T ss_dssp             HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred             HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence            11110000                         00000000001123578999999999999999999999999998654


Q ss_pred             C
Q 011005          479 P  479 (496)
Q Consensus       479 ~  479 (496)
                      .
T Consensus       314 ~  314 (320)
T 2i6l_A          314 F  314 (320)
T ss_dssp             C
T ss_pred             C
Confidence            3

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.9e-42  Score=333.52  Aligned_cols=264  Identities=25%  Similarity=0.345  Sum_probs=204.2

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEe--CCCcEEEEEEcccchh-HHHHHHHHHHHHHHHhh---cccccccccceee----
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQV---LHRNIVKLYGYCL----  272 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~----  272 (496)
                      +.++|++.+.||+|+||.||+|.+  .+++.||+|++..... ......+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999987  4688999999875431 11123456788887777   7999999999987    


Q ss_pred             -cCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcc
Q 011005          273 -HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVAD  351 (496)
Q Consensus       273 -~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~D  351 (496)
                       .....++||||++ |+|.+++..... ..+++..++.++.|++.||.|||   +.|++||||||+||+++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEec
Confidence             5567899999998 599999876542 25899999999999999999999   77999999999999999999999999


Q ss_pred             ccccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhh---
Q 011005          352 FGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVL---  428 (496)
Q Consensus       352 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---  428 (496)
                      ||+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......       .....+.   
T Consensus       164 fg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~  235 (326)
T 1blx_A          164 FGLARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-------DQLGKILDVI  235 (326)
T ss_dssp             CCSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHHH
T ss_pred             CcccccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHHHc
Confidence            99997654322 233457899999999999999999999999999999999999999643210       0000000   


Q ss_pred             -------------------cCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          429 -------------------DQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       429 -------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                                         ......+...........+.+++.+||+.||++|||+.|+++|+|+.....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence                               000000000000111234678999999999999999999999999976543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=8.7e-42  Score=338.12  Aligned_cols=268  Identities=20%  Similarity=0.285  Sum_probs=204.9

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-----------cccccccccee
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-----------HRNIVKLYGYC  271 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~  271 (496)
                      .++|.+.+.||+|+||+||+|.+ .+++.||||.+.....  ....+.+|+.++++++           |+||+++++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc--chhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            36799999999999999999976 5789999999976442  3356789999999886           88999999999


Q ss_pred             ecCC----eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEeCCCCCceEec----
Q 011005          272 LHKK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP-SIIHRDISSNNILLN----  342 (496)
Q Consensus       272 ~~~~----~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~-~i~H~dlkp~Nil~~----  342 (496)
                      ...+    ..++|||++ +++|.+++..... ..+++..+..++.||+.||+|||   ++ +|+||||||+|||++    
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEET
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCC
Confidence            8654    789999999 8899999886433 25899999999999999999999   66 999999999999994    


Q ss_pred             --CCCCeEEccccccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCC
Q 011005          343 --SKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDP  420 (496)
Q Consensus       343 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~  420 (496)
                        ..+.+||+|||+++.....   .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-~  246 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK-D  246 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C-H
T ss_pred             CcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC-h
Confidence              4457999999999876432   234578999999999999999999999999999999999999997433210000 0


Q ss_pred             cchhHhhhc--CCCC------------------------C----CC-------ChhHHHHHHHHHHHHHhcccCCCCCCC
Q 011005          421 KIMLIDVLD--QRLP------------------------P----PV-------DRKVIRDILLISTVSFACLQSNPKSRP  463 (496)
Q Consensus       421 ~~~~~~~~~--~~~~------------------------~----~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rp  463 (496)
                      .........  ...+                        .    +.       ..........+.+|+.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence            000000000  0000                        0    00       000123345688999999999999999


Q ss_pred             CHHHHHHHHHHhccCCCCC
Q 011005          464 TMQSVSQEFLITRKTPLVK  482 (496)
Q Consensus       464 s~~evl~~~~~~~~~~~~~  482 (496)
                      |++|+++|+|+........
T Consensus       327 t~~ell~hp~f~~~~~~~~  345 (373)
T 1q8y_A          327 DAGGLVNHPWLKDTLGMEE  345 (373)
T ss_dssp             CHHHHHTCGGGTTCTTCTT
T ss_pred             CHHHHhhChhhhcccCccc
Confidence            9999999999988655443

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1e-41  Score=325.77  Aligned_cols=253  Identities=24%  Similarity=0.356  Sum_probs=199.7

Q ss_pred             HhCCCCcc-eeeecCCeeEEEEEe---CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEE
Q 011005          204 TEDFDIRY-CIGTGGYGSVYKAQL---PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMF  278 (496)
Q Consensus       204 ~~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  278 (496)
                      .++|.+.+ .||+|+||+||+|.+   ..++.||||.+.... .....+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            35688877 999999999999954   347889999997653 233457789999999999999999999999 556788


Q ss_pred             EEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccc
Q 011005          279 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL  358 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  358 (496)
                      +||||+++++|.+++....   .+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            9999999999999998654   5899999999999999999999   679999999999999999999999999999876


Q ss_pred             cCCCCC---ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCC
Q 011005          359 HADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPP  434 (496)
Q Consensus       359 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  434 (496)
                      ......   .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.....       . .....+......
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~-~~~~~~~~~~~~  239 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------S-EVTAMLEKGERM  239 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------H-HHHHHHHTTCCC
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-------H-HHHHHHHcCCCC
Confidence            543322   122346788999999999899999999999999999999 9999863221       1 122222221111


Q ss_pred             CCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          435 PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       435 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ....   .....+.+++.+||+.||++|||+.|+++.+..
T Consensus       240 ~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  276 (291)
T 1xbb_A          240 GCPA---GCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  276 (291)
T ss_dssp             CCCT---TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            1111   112347789999999999999999999988754

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=8e-42  Score=358.07  Aligned_cols=250  Identities=24%  Similarity=0.355  Sum_probs=195.9

Q ss_pred             CCCcc-eeeecCCeeEEEEEeC---CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          207 FDIRY-CIGTGGYGSVYKAQLP---NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       207 ~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      +.+.+ .||+|+||.||+|.+.   ++..||||.++........+.+.+|++++++++||||+++++++.. +..++|||
T Consensus       337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E  415 (613)
T 2ozo_A          337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME  415 (613)
T ss_dssp             EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence            33444 7999999999999663   5667999999875444445789999999999999999999999976 45899999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++|+|.+++....  ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus       416 ~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~  490 (613)
T 2ozo_A          416 MAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD  490 (613)
T ss_dssp             CCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred             eCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence            999999999997543  36899999999999999999999   7799999999999999999999999999998764332


Q ss_pred             CC---ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcC-CCCCCCC
Q 011005          363 SN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ-RLPPPVD  437 (496)
Q Consensus       363 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  437 (496)
                      ..   .....+++.|+|||++.+..++.++||||||+++|||++ |+.||....       .......+... ++..+. 
T Consensus       491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~-------~~~~~~~i~~~~~~~~p~-  562 (613)
T 2ozo_A          491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-------GPEVMAFIEQGKRMECPP-  562 (613)
T ss_dssp             -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------SHHHHHHHHTTCCCCCCT-
T ss_pred             ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC-------HHHHHHHHHcCCCCCCCC-
Confidence            21   122345688999999999999999999999999999998 999996322       11122222222 121111 


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                          .....+.+++.+||+.||++|||+.++++.+..
T Consensus       563 ----~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  595 (613)
T 2ozo_A          563 ----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  595 (613)
T ss_dssp             ----TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred             ----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                112357789999999999999999999766544

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=332.49  Aligned_cols=256  Identities=23%  Similarity=0.348  Sum_probs=187.2

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-ccccccccceee--------cC
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCL--------HK  274 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~--------~~  274 (496)
                      .+|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+.+++++. ||||+++++++.        ..
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE-EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH-HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch-HHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            57899999999999999999764 789999999865432 33467889999999996 999999999983        34


Q ss_pred             CeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEeCCCCCceEecCCCCeEEccc
Q 011005          275 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS--IIHRDISSNNILLNSKLEAFVADF  352 (496)
Q Consensus       275 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dlkp~Nil~~~~~~~kl~Df  352 (496)
                      ...++||||+. |+|.+++........+++..++.++.||+.||.|||   ..+  |+||||||+|||++.++.+||+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecC
Confidence            46899999996 699888875333346899999999999999999999   667  999999999999999999999999


Q ss_pred             cccccccCCCCC------------cccccccccccccccc---ccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCC
Q 011005          353 GTARLLHADSSN------------RTLLAGTYGYIAPELA---YTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSS  417 (496)
Q Consensus       353 g~~~~~~~~~~~------------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~  417 (496)
                      |+++........            .....||+.|+|||++   .+..++.++||||||+++|+|++|+.||......   
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---  259 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL---  259 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH---
Confidence            999876543221            1134589999999998   5677889999999999999999999999643211   


Q ss_pred             CCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          418 SDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                              .........+.....   ...+.+++.+||+.||++|||+.|++++++......
T Consensus       260 --------~~~~~~~~~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          260 --------RIVNGKYSIPPHDTQ---YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             --------------CCCCTTCCS---SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             --------HhhcCcccCCccccc---chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence                    011111111100000   112668899999999999999999999998876543

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=9.1e-42  Score=344.07  Aligned_cols=254  Identities=23%  Similarity=0.284  Sum_probs=190.3

Q ss_pred             CCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEEEEec
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      .|...+.||+|+||+||.+...+|+.||||++....    .+.+.+|+.+++++ +||||+++++++..++..++||||+
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            445567899999999987766789999999986543    24567899999987 7999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCcc----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC-------------CCe
Q 011005          285 ERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-------------LEA  347 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~----~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~-------------~~~  347 (496)
                      . |+|.+++........    .++..++.++.||+.||+|||   +.+|+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 699999986542211    123345789999999999999   6799999999999999754             489


Q ss_pred             EEccccccccccCCCCC----cccccccccccccccccc-------CCcCcccchhhHHHHHHHHHh-CCCCCccccccC
Q 011005          348 FVADFGTARLLHADSSN----RTLLAGTYGYIAPELAYT-------MVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLS  415 (496)
Q Consensus       348 kl~Dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~  415 (496)
                      ||+|||+++........    .....||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.....  
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--  245 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS--  245 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT--
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh--
Confidence            99999999877543221    234579999999999876       678899999999999999999 9999863211  


Q ss_pred             CCCCCcchhHhhhcCCCCCC--CChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          416 SSSDPKIMLIDVLDQRLPPP--VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                          .   ...........+  ...........+.+++.+||+.||++|||+.|+++|+|+..
T Consensus       246 ----~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          246 ----R---ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             ----H---HHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             ----h---HHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence                1   111222211111  11111223345789999999999999999999999999853

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=333.67  Aligned_cols=263  Identities=23%  Similarity=0.273  Sum_probs=199.6

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCe-----
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKC-----  276 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  276 (496)
                      .++|.+.+.||+|+||.||+|.++ +|+.||||.+.... .....+.+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            367899999999999999999764 68999999997643 33345678899999999999999999999987653     


Q ss_pred             -EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccc
Q 011005          277 -MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  355 (496)
Q Consensus       277 -~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  355 (496)
                       .++||||+. ++|.+.+..     .+++..+..++.||+.||.|||   +.+++||||||+||+++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 588877643     4899999999999999999999   679999999999999999999999999999


Q ss_pred             ccccCCCCCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCC---------CC-------
Q 011005          356 RLLHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS---------SS-------  418 (496)
Q Consensus       356 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~---------~~-------  418 (496)
                      +.....   .....+|+.|+|||++.+ ..++.++||||+|+++|+|++|+.||........         ..       
T Consensus       174 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          174 RHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             TC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred             cCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            765322   234578999999999887 6789999999999999999999999974321000         00       


Q ss_pred             CCcchhHhhhc---CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          419 DPKIMLIDVLD---QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       419 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ...........   .................+.+++.+||+.||++|||++|+++|+|+....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence            00000000000   0000000000111223578999999999999999999999999997543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4e-41  Score=332.26  Aligned_cols=246  Identities=15%  Similarity=0.181  Sum_probs=195.9

Q ss_pred             HhCCCCcceeeecCCeeEEEEE------eCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc---ccccccccceeecC
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQ------LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL---HRNIVKLYGYCLHK  274 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~  274 (496)
                      .++|.+.+.||+|+||+||+|.      ...++.||+|++.....    ..+.+|+.++++++   |+||+++++++...
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP----WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH----HHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh----hHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            4679999999999999999993      45688999999976542    45677888888876   99999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhCCC--CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC---------
Q 011005          275 KCMFLIYEYMERGSLFCNLHNNE--DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---------  343 (496)
Q Consensus       275 ~~~~lV~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~---------  343 (496)
                      +..++||||+++|+|.+++....  ....+++..++.++.||+.||+|||   +.+|+||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccc
Confidence            99999999999999999997421  2336899999999999999999999   789999999999999998         


Q ss_pred             --CCCeEEccccccccccCC--CCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCC
Q 011005          344 --KLEAFVADFGTARLLHAD--SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSD  419 (496)
Q Consensus       344 --~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~  419 (496)
                        ++.+||+|||+++.+...  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......     
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----  291 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG-----  291 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT-----
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC-----
Confidence              899999999999765422  22334567999999999999999999999999999999999999998643221     


Q ss_pred             CcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHH
Q 011005          420 PKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRP-TMQSVSQEF  472 (496)
Q Consensus       420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~~  472 (496)
                       ...    ..........      ...+.+++..|++.+|.+|+ +++++.+.+
T Consensus       292 -~~~----~~~~~~~~~~------~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l  334 (365)
T 3e7e_A          292 -ECK----PEGLFRRLPH------LDMWNEFFHVMLNIPDCHHLPSLDLLRQKL  334 (365)
T ss_dssp             -EEE----ECSCCTTCSS------HHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred             -cee----echhccccCc------HHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence             000    1111111111      12356788899999999996 555555433

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.2e-41  Score=330.76  Aligned_cols=261  Identities=22%  Similarity=0.325  Sum_probs=203.6

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CC-cEEEEEEcccchhHHHHHHHHHHHHHHHhhcccc------cccccceeecCC
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NG-KVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN------IVKLYGYCLHKK  275 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~  275 (496)
                      .++|++.+.||+|+||+||+|... ++ +.||+|+++....  ..+.+.+|+.++++++|++      ++.+++++...+
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK--YREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccccc--chhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            468999999999999999999764 34 6899999976432  3467789999999998776      889999999999


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe--------------
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL--------------  341 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~--------------  341 (496)
                      ..++||||+ ++++.+.+..... ..+++..++.++.||+.||+|||   +.+|+||||||+|||+              
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             eEEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccc
Confidence            999999999 6677777665432 25899999999999999999999   7899999999999999              


Q ss_pred             -----cCCCCeEEccccccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCC
Q 011005          342 -----NSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS  416 (496)
Q Consensus       342 -----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~  416 (496)
                           +.++.+||+|||+++.....   .....||+.|+|||++.+..++.++||||+|+++|||++|+.||....... 
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-  246 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE-  246 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred             ccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence                 56789999999999865332   234578999999999999999999999999999999999999996432100 


Q ss_pred             CCCCcchhHhhhcCCCC---------------------CCC----------------ChhHHHHHHHHHHHHHhcccCCC
Q 011005          417 SSDPKIMLIDVLDQRLP---------------------PPV----------------DRKVIRDILLISTVSFACLQSNP  459 (496)
Q Consensus       417 ~~~~~~~~~~~~~~~~~---------------------~~~----------------~~~~~~~~~~l~~li~~cl~~dP  459 (496)
                         ......... ...+                     ...                ..........+.+|+.+||+.||
T Consensus       247 ---~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  322 (355)
T 2eu9_A          247 ---HLVMMEKIL-GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP  322 (355)
T ss_dssp             ---HHHHHHHHH-CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             ---HHHHHHHHc-CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence               000000000 0000                     000                00011123357899999999999


Q ss_pred             CCCCCHHHHHHHHHHhccCC
Q 011005          460 KSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       460 ~~Rps~~evl~~~~~~~~~~  479 (496)
                      ++|||+.|+++|+|+..-.+
T Consensus       323 ~~Rpt~~e~l~hp~f~~~~~  342 (355)
T 2eu9_A          323 AQRITLAEALLHPFFAGLTP  342 (355)
T ss_dssp             TTSCCHHHHTTSGGGGGCCH
T ss_pred             hhCcCHHHHhcChhhcCCCh
Confidence            99999999999999986543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-42  Score=339.20  Aligned_cols=259  Identities=17%  Similarity=0.214  Sum_probs=201.3

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCC---------CcEEEEEEcccchhHHHHHHHHHHHHHHHhhccccccc---------
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPN---------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK---------  266 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~---------  266 (496)
                      ++|++.+.||+|+||.||+|.+..         ++.||+|.+...      +.+.+|++++++++||||++         
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            579999999999999999998763         789999998754      34679999999999999998         


Q ss_pred             ------ccceeec-CCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCce
Q 011005          267 ------LYGYCLH-KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  339 (496)
Q Consensus       267 ------~~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Ni  339 (496)
                            +++++.. +...++||||+ +++|.+++.... ...+++..++.++.||+.||.|||   +.+|+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHE
Confidence                  4566655 67889999999 999999998642 236899999999999999999999   67999999999999


Q ss_pred             EecCCC--CeEEccccccccccCCCC-------CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCcc
Q 011005          340 LLNSKL--EAFVADFGTARLLHADSS-------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDI  410 (496)
Q Consensus       340 l~~~~~--~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~  410 (496)
                      +++.++  .+||+|||+++.......       ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  899999999987643221       12335789999999999999999999999999999999999999974


Q ss_pred             ccccCCCCCCcchhHhhh---cCCCCCCCCh--hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          411 LSSLSSSSDPKIMLIDVL---DQRLPPPVDR--KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       411 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      ...      .........   ..........  ........+.+++.+||+.||++|||++++++.+........
T Consensus       271 ~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          271 CLP------NTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             GTT------CHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             CCc------CHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            321      011111111   1111100000  000012347789999999999999999999999876655433

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.3e-41  Score=345.29  Aligned_cols=259  Identities=17%  Similarity=0.263  Sum_probs=201.3

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcc-cccccccceeecCCeEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLH-RNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lV~  281 (496)
                      .++|.+.+.||+|+||.||+|.+ .+++.||||++......   ..+.+|+++++.++| +++..+..++...+..++||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            46899999999999999999975 57999999987654322   347889999999986 55666666777788899999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe---cCCCCeEEccccccccc
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKLEAFVADFGTARLL  358 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~  358 (496)
                      ||+ +++|.+++....  ..+++..++.|+.||+.||+|||   ..+|+||||||+|||+   +.++.+||+|||+++.+
T Consensus        83 e~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             ECC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            999 999999997533  26899999999999999999999   7799999999999999   58899999999999877


Q ss_pred             cCCCCC-------ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCC
Q 011005          359 HADSSN-------RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQR  431 (496)
Q Consensus       359 ~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  431 (496)
                      ......       .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....    .........+....
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~----~~~~~~~~~i~~~~  232 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA----GTKKQKYEKISEKK  232 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC----SSHHHHHHHHHHHH
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc----hhHHHHHHHHhhcc
Confidence            544321       2246799999999999999999999999999999999999999974321    11111111111111


Q ss_pred             CCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          432 LPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       432 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                      ...............+.+++.+||+.||++||++.++++.+...
T Consensus       233 ~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          233 VATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             ccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            11111110111123578999999999999999999998776554

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=9.9e-42  Score=325.82  Aligned_cols=259  Identities=25%  Similarity=0.386  Sum_probs=196.3

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC--CCc--EEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP--NGK--VFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCM  277 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  277 (496)
                      .++|++.+.||+|+||+||+|.+.  +++  .||+|.++...  .....+.+.+|+.++++++||||+++++++..+. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            367999999999999999999753  333  68999987542  2344577899999999999999999999998765 7


Q ss_pred             EEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          278 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      ++||||+++++|.+++....  ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence            89999999999999987542  36899999999999999999999   67999999999999999999999999999987


Q ss_pred             ccCCCCC---ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCC
Q 011005          358 LHADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLP  433 (496)
Q Consensus       358 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  433 (496)
                      .......   .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||....       ..............
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~~~~~~~~~~~~~  243 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-------GSQILHKIDKEGER  243 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHTSCCC
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC-------HHHHHHHHHccCCC
Confidence            6543322   223457788999999999999999999999999999999 999986322       11222222222111


Q ss_pred             CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          434 PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       434 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      .+...   .....+.+++.+||+.||++|||+.++++++......
T Consensus       244 ~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          244 LPRPE---DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CCCCc---CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence            11111   1123477899999999999999999999998776553

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.3e-41  Score=322.83  Aligned_cols=252  Identities=22%  Similarity=0.367  Sum_probs=196.5

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecC-CeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK-KCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lV~e  282 (496)
                      .++|++.+.||+|+||+||+|.++ |+.||+|.+....   ..+.+.+|+.++++++||||+++++++... +..++|||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            467999999999999999999884 8899999997654   236788999999999999999999987654 47899999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+++++|.+++.... ...+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++...... 
T Consensus        96 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-  170 (278)
T 1byg_A           96 YMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  170 (278)
T ss_dssp             CCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             cCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence            999999999997542 113788999999999999999999   779999999999999999999999999999765432 


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                        .....+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||....       ....... +..........   
T Consensus       171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-------~~~~~~~-~~~~~~~~~~~---  237 (278)
T 1byg_A          171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVVPR-VEKGYKMDAPD---  237 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-------GGGHHHH-HTTTCCCCCCT---
T ss_pred             --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHH-HhcCCCCCCcc---
Confidence              223457889999999999999999999999999999998 999986321       1111112 21111111111   


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          442 RDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      .....+.+++.+||+.||++|||+.|+++.+...+.
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          238 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence            112347789999999999999999999998876544

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=6.6e-42  Score=353.73  Aligned_cols=254  Identities=27%  Similarity=0.417  Sum_probs=204.6

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      .++|++.+.||+|+||.||+|.++++..||||+++.....  .+.+.+|+.++++++|+||+++++++.+ +..++||||
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            4678889999999999999999988889999999865422  3578999999999999999999999876 568999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++|+|.+++.... ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......
T Consensus       343 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          343 MSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             CTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred             hcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence            99999999997431 125899999999999999999999   77999999999999999999999999999986643211


Q ss_pred             -CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcC-CCCCCCChhH
Q 011005          364 -NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ-RLPPPVDRKV  440 (496)
Q Consensus       364 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  440 (496)
                       ......++..|+|||++.+..++.++||||||+++|||++ |+.||....       .......+... +++.+.    
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~-------~~~~~~~i~~~~~~~~~~----  487 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVLDQVERGYRMPCPP----  487 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC-------HHHHHHHHHTTCCCCCCT----
T ss_pred             ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHcCCCCCCCC----
Confidence             1122346778999999999999999999999999999999 999986321       11122222211 121111    


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                       .....+.+|+.+||+.||++|||++++++.+....
T Consensus       488 -~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          488 -ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             -CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence             11234778999999999999999999999887653

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.7e-41  Score=328.28  Aligned_cols=264  Identities=26%  Similarity=0.403  Sum_probs=205.2

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-----CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCC--e
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-----PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK--C  276 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~  276 (496)
                      .++|++.+.||+|+||.||+|.+     .+++.||+|++..... ...+.+.+|+.++++++||||+++++++...+  .
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS-HHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            35688999999999999999973     3688999999976542 34567899999999999999999999987654  6


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      .++||||+++++|.+++....  ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            799999999999999998653  25899999999999999999999   6799999999999999999999999999998


Q ss_pred             cccCCCCC---ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccc-----cCCCCCCcc---hhH
Q 011005          357 LLHADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSS-----LSSSSDPKI---MLI  425 (496)
Q Consensus       357 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~-----~~~~~~~~~---~~~  425 (496)
                      ........   .....++..|+|||.+.+..++.++||||||+++|+|++|..|+.....     .........   ...
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence            77544321   2234567789999999999999999999999999999999999763210     000111000   111


Q ss_pred             hhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          426 DVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      +.+......+...   .....+.+++.+||+.||++|||+.|+++.+...+
T Consensus       274 ~~~~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          274 ELLKNNGRLPRPD---GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             HHHHTTCCCCCCT---TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhhcCCCCCCCC---cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            2222211111111   11235778999999999999999999999887654

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.3e-41  Score=352.67  Aligned_cols=246  Identities=24%  Similarity=0.357  Sum_probs=194.6

Q ss_pred             ceeeecCCeeEEEEEe---CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCC
Q 011005          211 YCIGTGGYGSVYKAQL---PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMER  286 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~  286 (496)
                      +.||+|+||+||+|.+   +.++.||||+++... .....+.+.+|+.++++++|||||++++++..+ ..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEccCC
Confidence            4799999999999954   246789999997643 233457799999999999999999999999654 57899999999


Q ss_pred             CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC--
Q 011005          287 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN--  364 (496)
Q Consensus       287 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--  364 (496)
                      |+|.+++....   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++........  
T Consensus       454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            99999997654   6899999999999999999999   679999999999999999999999999999877543321  


Q ss_pred             -ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          365 -RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       365 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                       .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||....       .. .....+...........   
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~-------~~-~~~~~i~~~~~~~~p~~---  596 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GS-EVTAMLEKGERMGCPAG---  596 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HH-HHHHHHHTTCCCCCCTT---
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-------HH-HHHHHHHcCCCCCCCCC---
Confidence             223446788999999999999999999999999999998 999996322       11 12222222211111111   


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ....+.+++.+||+.||++|||++++++.+..
T Consensus       597 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          597 CPREMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            12357789999999999999999999988754

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-41  Score=326.60  Aligned_cols=255  Identities=22%  Similarity=0.348  Sum_probs=196.5

Q ss_pred             HHHHHHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhH-----HHHHHHHHHHHHHHhh----ccccccccc
Q 011005          199 DLIEATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEEL-----AFIKSFKNEAQVLSQV----LHRNIVKLY  268 (496)
Q Consensus       199 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l----~h~niv~~~  268 (496)
                      +.....++|++.+.||+|+||.||+|.+ .+++.||+|.+......     .....+.+|+.+++++    +|+||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            3444668899999999999999999976 46889999999764321     1223456799999999    899999999


Q ss_pred             ceeecCCeEEEEEEe-cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEec-CCCC
Q 011005          269 GYCLHKKCMFLIYEY-MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN-SKLE  346 (496)
Q Consensus       269 ~~~~~~~~~~lV~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~-~~~~  346 (496)
                      +++...+..++|||+ +.+++|.+++....   .+++..++.++.||+.||.|||   +.+++||||||+||+++ .++.
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~  178 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGC  178 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCe
Confidence            999999999999999 78999999997643   6899999999999999999999   67999999999999999 8899


Q ss_pred             eEEccccccccccCCCCCccccccccccccccccccCCcC-cccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhH
Q 011005          347 AFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMT-EKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLI  425 (496)
Q Consensus       347 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  425 (496)
                      +||+|||++......  ......|++.|+|||++.+..+. .++||||+|+++|+|++|+.||....             
T Consensus       179 ~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------------  243 (312)
T 2iwi_A          179 AKLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------------  243 (312)
T ss_dssp             EEECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------
T ss_pred             EEEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------------
Confidence            999999999876543  23445689999999999877764 58999999999999999999986321             


Q ss_pred             hhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          426 DVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      +........+..     ....+.+++.+||+.||++|||++|+++|+|+.....
T Consensus       244 ~~~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          244 EILEAELHFPAH-----VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             HHHHTCCCCCTT-----SCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             HHhhhccCCccc-----CCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence            111121111110     1124678999999999999999999999999976543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=340.86  Aligned_cols=253  Identities=21%  Similarity=0.299  Sum_probs=190.4

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      .+|.+.+.||+|+||+||.....+++.||||++.....    ..+.+|+.+++++ +||||+++++++.+....++||||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            46888899999999997666556899999999865432    2346899999999 799999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC-----CCCeEEccccccccc
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-----KLEAFVADFGTARLL  358 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~-----~~~~kl~Dfg~~~~~  358 (496)
                      +. |+|.+++.....  ......++.++.||+.||.|||   +.+|+||||||+|||++.     ...+||+|||+++..
T Consensus       100 ~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A          100 CA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            96 599999986542  3444556789999999999999   779999999999999953     235789999999876


Q ss_pred             cCCC---CCccccccccccccccccc---cCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCC
Q 011005          359 HADS---SNRTLLAGTYGYIAPELAY---TMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQR  431 (496)
Q Consensus       359 ~~~~---~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  431 (496)
                      ....   ......+||+.|+|||++.   ...++.++||||+||++|||++ |..||....       .. ...... ..
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~-------~~-~~~~~~-~~  244 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL-------QR-QANILL-GA  244 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT-------TH-HHHHHT-TC
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh-------HH-HHHHHh-cc
Confidence            5332   1233467999999999997   4567889999999999999999 999985211       11 111111 11


Q ss_pred             CCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          432 LPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       432 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      ...............+.+|+.+||+.||++|||+.|+++|+|+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          245 CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             CCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             CCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            111111111122334678999999999999999999999999853

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.6e-41  Score=328.90  Aligned_cols=250  Identities=21%  Similarity=0.296  Sum_probs=204.3

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhH-----HHHHHHHHHHHHHHhhc--ccccccccceeecC
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEEL-----AFIKSFKNEAQVLSQVL--HRNIVKLYGYCLHK  274 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~  274 (496)
                      ..++|++.+.||+|+||.||+|.. .+++.||||.+......     .....+.+|+.++++++  |+||+++++++..+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            457899999999999999999975 57899999998764311     11234678999999996  59999999999999


Q ss_pred             CeEEEEEEecCC-CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEec-CCCCeEEccc
Q 011005          275 KCMFLIYEYMER-GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN-SKLEAFVADF  352 (496)
Q Consensus       275 ~~~~lV~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~-~~~~~kl~Df  352 (496)
                      +..++|||++.+ ++|.+++....   .+++..++.++.||+.||+|||   +.+|+||||||+||+++ +++.+||+||
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             CcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            999999999986 89999987643   6899999999999999999999   77999999999999999 7889999999


Q ss_pred             cccccccCCCCCccccccccccccccccccCCc-CcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCC
Q 011005          353 GTARLLHADSSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQR  431 (496)
Q Consensus       353 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  431 (496)
                      |+++.....  ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....             .....
T Consensus       195 g~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------------~~~~~  259 (320)
T 3a99_A          195 GSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIRGQ  259 (320)
T ss_dssp             TTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHHCC
T ss_pred             ccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------------hhccc
Confidence            999876432  2334578999999999987766 6789999999999999999999863221             11111


Q ss_pred             CCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          432 LPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       432 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ...+..     ....+.+++.+||+.||++|||++|+++|+|+....
T Consensus       260 ~~~~~~-----~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          260 VFFRQR-----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             CCCSSC-----CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             cccccc-----CCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            111110     112477899999999999999999999999997654

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.8e-41  Score=325.32  Aligned_cols=259  Identities=23%  Similarity=0.303  Sum_probs=185.2

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHH-HHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELA-FIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      .++|++.+.||+|+||.||+|.++ +++.||||.+....... ..+.+.++..+++.++||||+++++++..++..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467899999999999999999775 78999999997654322 2334455556778889999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP-SIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      ||+ ++.+..+....  ...+++..+..++.|++.||.|||   .. +++||||||+||+++.++.+||+|||++.....
T Consensus       104 e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 45555554432  126899999999999999999999   53 999999999999999999999999999976644


Q ss_pred             CCCCccccccccccccccccc-----cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCC
Q 011005          361 DSSNRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP  435 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  435 (496)
                      .. ......+++.|+|||++.     +..++.++||||||+++|+|++|+.||....      ..............+..
T Consensus       178 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~  250 (318)
T 2dyl_A          178 DK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK------TDFEVLTKVLQEEPPLL  250 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC------SHHHHHHHHHHSCCCCC
T ss_pred             Cc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC------ccHHHHHHHhccCCCCC
Confidence            32 233456899999999984     5578889999999999999999999986321      11122222222222111


Q ss_pred             CChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          436 VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       436 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ...  ......+.+++.+||+.||++|||++|+++|+|+.+.
T Consensus       251 ~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          251 PGH--MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             CSS--SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             Ccc--CCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            100  0112247789999999999999999999999998754

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.1e-41  Score=353.14  Aligned_cols=268  Identities=25%  Similarity=0.285  Sum_probs=205.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeec------CCe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH------KKC  276 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  276 (496)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||++.........+.+.+|+.++++++||||+++++++..      ++.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            47899999999999999999976 46899999998775545556778999999999999999999998765      667


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCC---eEEcccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE---AFVADFG  353 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg  353 (496)
                      .++||||++||+|.+++........+++..++.++.|++.||+|||   +.||+||||||+||+++.++.   ++|+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            8999999999999999987665556899999999999999999999   679999999999999997765   8999999


Q ss_pred             ccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCC-------CCCCcchhHh
Q 011005          354 TARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS-------SSDPKIMLID  426 (496)
Q Consensus       354 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~-------~~~~~~~~~~  426 (496)
                      ++....... ......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||........       .........+
T Consensus       170 ~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  248 (676)
T 3qa8_A          170 YAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD  248 (676)
T ss_dssp             CCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred             ccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence            998765433 23446799999999999999999999999999999999999999853211000       0000000000


Q ss_pred             hh------cCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          427 VL------DQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       427 ~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      ..      ....+.+ ..........+.+++.+||++||++|||+.|+++|+|+..
T Consensus       249 ~l~g~~~~~~~lp~p-~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          249 DLTGAVKFSSVLPTP-NHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             CCSSSCCCCSSSCCS-CCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             hhccccccccccCCc-hhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence            00      0111111 1111123345789999999999999999999998888654

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.2e-40  Score=349.26  Aligned_cols=255  Identities=25%  Similarity=0.349  Sum_probs=202.0

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC----CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|.+.........+.+.+|+.++++++||||+++++++.+ +..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence            467888999999999999999764    2567999998876555556788999999999999999999999854 55889


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||||+++|+|.+++....  ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       468 v~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             EEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            999999999999997543  25899999999999999999999   6799999999999999999999999999998764


Q ss_pred             CCCCC-ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          360 ADSSN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       360 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                      ..... .....+|+.|+|||++.+..++.++||||||+++|||++ |..||....       .......+......... 
T Consensus       543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~-------~~~~~~~i~~~~~~~~~-  614 (656)
T 2j0j_A          543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENGERLPMP-  614 (656)
T ss_dssp             C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHHTCCCCCC-
T ss_pred             CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHcCCCCCCC-
Confidence            43221 223456789999999999999999999999999999997 999986322       11122222222111111 


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                      .   .....+.+++.+||+.||++|||+.|+++.+...
T Consensus       615 ~---~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          615 P---NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             c---cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1   1123577899999999999999999999987654

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.3e-41  Score=326.66  Aligned_cols=258  Identities=21%  Similarity=0.354  Sum_probs=197.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|++.+.||+|+||.||+|.+++  .+|+|.++... .....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            4679999999999999999998854  48999987542 12223456789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC-
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD-  361 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  361 (496)
                      |+++++|.+++....  ..+++..++.++.||+.||+|||   +.+++||||||+||+++ ++.++|+|||+++..... 
T Consensus       110 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          110 LCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             CCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred             cccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence            999999999997643  36889999999999999999999   67999999999999998 679999999998754321 


Q ss_pred             ----CCCcccccccccccccccccc---------CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhh
Q 011005          362 ----SSNRTLLAGTYGYIAPELAYT---------MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVL  428 (496)
Q Consensus       362 ----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  428 (496)
                          ........|++.|+|||++.+         ..++.++||||||+++|+|++|+.||....       .........
T Consensus       184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~  256 (319)
T 2y4i_B          184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP-------AEAIIWQMG  256 (319)
T ss_dssp             ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC-------HHHHHHHHH
T ss_pred             ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHhc
Confidence                122233568999999999875         457889999999999999999999986321       111222222


Q ss_pred             cCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          429 DQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                      ....+......   ....+.+++.+||+.||++|||+.++++.+....+..
T Consensus       257 ~~~~~~~~~~~---~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          257 TGMKPNLSQIG---MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             TTCCCCCCCSS---CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             cCCCCCCCcCC---CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence            22211111100   1123678999999999999999999999987766543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.2e-39  Score=310.79  Aligned_cols=241  Identities=23%  Similarity=0.353  Sum_probs=184.7

Q ss_pred             HhCCCCc-ceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHH-Hhhcccccccccceeec----CCe
Q 011005          204 TEDFDIR-YCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVL-SQVLHRNIVKLYGYCLH----KKC  276 (496)
Q Consensus       204 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~  276 (496)
                      .++|.+. +.||+|+||.||+|.. .+++.||+|.+...      ..+.+|+.++ +..+||||+++++++..    ...
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            3567776 7799999999999976 57899999998653      3456788888 44589999999999876    677


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC---CCCeEEcccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KLEAFVADFG  353 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg  353 (496)
                      .++||||+++|+|.+++..... ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.   ++.++|+|||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            8999999999999999986532 35899999999999999999999   779999999999999998   7889999999


Q ss_pred             ccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCC
Q 011005          354 TARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLP  433 (496)
Q Consensus       354 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  433 (496)
                      ++....                      +..++.++||||+|+++|+|++|+.||............   ..........
T Consensus       166 ~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~---~~~~~~~~~~  220 (299)
T 3m2w_A          166 FAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQYE  220 (299)
T ss_dssp             TCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS---CCSSCTTCCS
T ss_pred             cccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH---HHHHhhcccc
Confidence            986542                      234678999999999999999999999643321110000   0000001111


Q ss_pred             CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          434 PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       434 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      .+ ..........+.+++.+||+.||++|||+.|+++|+|+......
T Consensus       221 ~~-~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~  266 (299)
T 3m2w_A          221 FP-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV  266 (299)
T ss_dssp             SC-HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGS
T ss_pred             CC-chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccC
Confidence            00 00011123357899999999999999999999999999876543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3e-39  Score=343.81  Aligned_cols=239  Identities=25%  Similarity=0.372  Sum_probs=194.3

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC--CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCe-----
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP--NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKC-----  276 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  276 (496)
                      .++|++.+.||+|+||+||+|.+.  +++.||||.+...........+.+|+.++++++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            368999999999999999999875  6899999999765544555678999999999999999999999987654     


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      .++||||++|++|.+.+..     .+++..++.++.||+.||.|||   +.+|+||||||+||+++.+ .+||+|||+++
T Consensus       159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccch
Confidence            7999999999999887654     5899999999999999999999   6799999999999999986 89999999998


Q ss_pred             cccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCC
Q 011005          357 LLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV  436 (496)
Q Consensus       357 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  436 (496)
                      .....    ....||+.|+|||++.+.. +.++||||||+++|+|++|..||......                .++.  
T Consensus       230 ~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------------~~~~--  286 (681)
T 2pzi_A          230 RINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD----------------GLPE--  286 (681)
T ss_dssp             ETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS----------------SCCT--
T ss_pred             hcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc----------------cccc--
Confidence            76433    3457999999999987654 88999999999999999999887532110                0111  


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      ..........+.+++.+||+.||++||+..+.+.+.|.
T Consensus       287 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          287 DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence            11112223457899999999999999987776666554

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.7e-39  Score=317.01  Aligned_cols=248  Identities=16%  Similarity=0.145  Sum_probs=192.5

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccch-------hHHHHHHHHHHHHHHHhhc----------------
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-------ELAFIKSFKNEAQVLSQVL----------------  260 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~----------------  260 (496)
                      .++|++.+.||+|+||+||+|.+ +|+.||||++....       .....+.+.+|+.++++++                
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46799999999999999999988 68999999997642       1223367889999999997                


Q ss_pred             ----------ccccccccceeec-------------CCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHH
Q 011005          261 ----------HRNIVKLYGYCLH-------------KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA  317 (496)
Q Consensus       261 ----------h~niv~~~~~~~~-------------~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~  317 (496)
                                ||||+++++++..             ....++||||+++|++.+.+.+    ..+++..++.++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence                      6777777777665             6789999999999987777754    257999999999999999


Q ss_pred             HHHHHhCCCCCeEEeCCCCCceEecCCC--------------------CeEEccccccccccCCCCCccccccccccccc
Q 011005          318 LAYLHHDCSPSIIHRDISSNNILLNSKL--------------------EAFVADFGTARLLHADSSNRTLLAGTYGYIAP  377 (496)
Q Consensus       318 l~~lh~~~~~~i~H~dlkp~Nil~~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aP  377 (496)
                      |+|||+  +.+|+||||||+|||++.++                    .+||+|||+|+.....     ..+||+.|+||
T Consensus       174 L~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aP  246 (336)
T 2vuw_A          174 LAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDE  246 (336)
T ss_dssp             HHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCS
T ss_pred             HHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccCh
Confidence            999993  24899999999999999887                    8999999999876432     35799999999


Q ss_pred             cccccCCcCcccchhhHHHH-HHHHHhCCCCCccccccCCCCCCcchhHhhhcCC-C-CCCCChhHHHHHHHHHHHHHhc
Q 011005          378 ELAYTMVMTEKCDVYSFGVV-TLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQR-L-PPPVDRKVIRDILLISTVSFAC  454 (496)
Q Consensus       378 E~~~~~~~~~~~DvwslG~i-l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~l~~li~~c  454 (496)
                      |++.+.. +.++||||+|++ .+++++|..||....+.      ........... . ..............+.+|+.+|
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~  319 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL------HYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTM  319 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH------HHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHG
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh------hHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHH
Confidence            9998776 889999998777 77899999998532110      00111111111 1 1112222334556688999999


Q ss_pred             ccCCCCCCCCHHHHH-HHHHHh
Q 011005          455 LQSNPKSRPTMQSVS-QEFLIT  475 (496)
Q Consensus       455 l~~dP~~Rps~~evl-~~~~~~  475 (496)
                      |+.|     |++|++ +|+|+.
T Consensus       320 L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          320 LNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             GGSS-----SHHHHHHHCGGGC
T ss_pred             hccC-----CHHHHHhcCCCcC
Confidence            9976     999999 999973

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.9e-39  Score=321.99  Aligned_cols=248  Identities=16%  Similarity=0.128  Sum_probs=185.0

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcc-cccccccce----------
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH-RNIVKLYGY----------  270 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h-~niv~~~~~----------  270 (496)
                      ..|...+.||+|+||+||+|.+ .+|+.||||++....  .....+.+.+|+.+++.+.| +|......+          
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            3477788999999999999975 579999999987432  22235678899999999976 322211111          


Q ss_pred             -----------eec-----CCeEEEEEEecCCCChhhhhhC----CCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 011005          271 -----------CLH-----KKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII  330 (496)
Q Consensus       271 -----------~~~-----~~~~~lV~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~  330 (496)
                                 +..     ....+++|+++ +++|.+++..    ......+++..++.++.||+.||+|||   +++|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence                       111     12356777765 6799988851    122335788899999999999999999   77999


Q ss_pred             EeCCCCCceEecCCCCeEEccccccccccCCCCCcccccccccccccccc----------ccCCcCcccchhhHHHHHHH
Q 011005          331 HRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELA----------YTMVMTEKCDVYSFGVVTLE  400 (496)
Q Consensus       331 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwslG~il~e  400 (496)
                      ||||||+|||++.++.+||+|||+++.....   ....+| +.|+|||++          .+..++.++|||||||++||
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            9999999999999999999999999765432   344567 999999999          56678899999999999999


Q ss_pred             HHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          401 VLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       401 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      |++|+.||.......       .....+....  ..       ...+.+|+.+||+.||++|||+.|+++|+|+..
T Consensus       310 lltg~~Pf~~~~~~~-------~~~~~~~~~~--~~-------~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          310 IWCADLPNTDDAALG-------GSEWIFRSCK--NI-------PQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             HHHSSCCCCTTGGGS-------CSGGGGSSCC--CC-------CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHCCCCCCCcchhh-------hHHHHHhhcc--cC-------CHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence            999999996433211       1111111111  11       124779999999999999999999999998864

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=7.3e-38  Score=297.75  Aligned_cols=234  Identities=10%  Similarity=0.033  Sum_probs=183.0

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.+....  .....+.+.+|+.++++++||||+++++++..++..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            367999999999999999999775 48999999997643  234457789999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||++|++|.+++...     ....++..++.|++.||+|||   +.||+||||||+||+++.++.+||+++|       
T Consensus       110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc-------
Confidence            9999999999999642     355678899999999999999   7799999999999999999999998543       


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                                   |++|       ++.++||||||+++|||++|+.||.........   . ............ .....
T Consensus       175 -------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~---~-~~~~~~~~~~~~-~~~~~  229 (286)
T 3uqc_A          175 -------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL---A-PAERDTAGQPIE-PADID  229 (286)
T ss_dssp             -------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS---E-ECCBCTTSCBCC-HHHHC
T ss_pred             -------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh---H-HHHHHhccCCCC-hhhcc
Confidence                         3332       678999999999999999999999754321100   0 000000111110 00000


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ......+.+++.+||+.||++| |+.|+++.+......
T Consensus       230 ~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          230 RDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             TTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             cCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            1112347899999999999999 999999999876654

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=3.4e-32  Score=281.70  Aligned_cols=186  Identities=18%  Similarity=0.110  Sum_probs=132.7

Q ss_pred             eeecCCeeEEEEE-eCCCcEEEEEEcccc---------hhHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEEE
Q 011005          213 IGTGGYGSVYKAQ-LPNGKVFALKKLHTS---------EELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       213 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---------~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      .+.|+.|.+..++ .--|+.+++|.+...         ......+++.+|+++|+++ .|+||++++++++++...||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            3455555555542 224888999998653         1233456799999999999 6999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||++|++|.+++....   .++..   +|+.||+.||+|+|   ++||+||||||+|||++.++.+||+|||+|+.....
T Consensus       322 Eyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            9999999999998754   45544   48999999999999   789999999999999999999999999999887665


Q ss_pred             CCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCC
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPR  408 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~  408 (496)
                      .......+||+.|+|||++.+. +..++|+||+|++++++.++..++
T Consensus       393 ~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          393 CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence            5556667899999999998764 677899999999998887665553

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=9.5e-28  Score=247.06  Aligned_cols=184  Identities=14%  Similarity=0.163  Sum_probs=145.2

Q ss_pred             CCcceeeecCCeeEEEEEeCCCcEEEEEEcccch-------hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          208 DIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-------ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       208 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      ...+.||+|+||+||+|.. .++.+++|+.....       .....+.+.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4466899999999999955 57888888764321       112245689999999999999999777777677777999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||++|++|.+++..           +..++.|++.||+|||   +++|+||||||+|||++.  .+||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999875           4579999999999999   779999999999999999  999999999987744


Q ss_pred             CCCC-------cccccccccccccccccc--CCcCcccchhhHHHHHHHHHhCCCCC
Q 011005          361 DSSN-------RTLLAGTYGYIAPELAYT--MVMTEKCDVYSFGVVTLEVLMGKHPR  408 (496)
Q Consensus       361 ~~~~-------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~p~  408 (496)
                      ....       ....+||+.|+|||++..  ..|+..+|+||..+-..+-+.++.+|
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            3211       134679999999999987  67888999999999888888777665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=2.2e-24  Score=203.69  Aligned_cols=163  Identities=15%  Similarity=0.164  Sum_probs=127.2

Q ss_pred             HHHHHhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhH-----------------HHHHHHHHHHHHHHhhccc
Q 011005          200 LIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEEL-----------------AFIKSFKNEAQVLSQVLHR  262 (496)
Q Consensus       200 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~e~~~l~~l~h~  262 (496)
                      +......|.+.+.||+|+||.||+|.+.+|+.||+|.++.....                 .....+.+|+.++++++  
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            33344556677999999999999998888999999999653210                 13456889999999999  


Q ss_pred             ccccccceeecCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEec
Q 011005          263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN  342 (496)
Q Consensus       263 niv~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~  342 (496)
                      | +++.+++.. +..++||||++||+|.+ +..         .....++.|++.||.|||   ..||+||||||+|||++
T Consensus       163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~  227 (282)
T 1zar_A          163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS  227 (282)
T ss_dssp             T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE
T ss_pred             C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE
Confidence            5 777776544 45689999999999988 421         123469999999999999   77999999999999999


Q ss_pred             CCCCeEEccccccccccCCCCCcccccccccccccccccc----------CCcCcccchhh
Q 011005          343 SKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT----------MVMTEKCDVYS  393 (496)
Q Consensus       343 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Dvws  393 (496)
                       ++.+||+|||+++..             ..++|||++..          ..+...+|+|.
T Consensus       228 -~~~vkl~DFG~a~~~-------------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          228 -EEGIWIIDFPQSVEV-------------GEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             -TTEEEECCCTTCEET-------------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             -CCcEEEEECCCCeEC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence             999999999999632             34688998754          34556667765

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.81  E-value=6.4e-20  Score=171.04  Aligned_cols=138  Identities=20%  Similarity=0.242  Sum_probs=105.5

Q ss_pred             CCCcceeeecCCeeEEEEEe-CCCcE--EEEEEcccchh-----------------------HHHHHHHHHHHHHHHhhc
Q 011005          207 FDIRYCIGTGGYGSVYKAQL-PNGKV--FALKKLHTSEE-----------------------LAFIKSFKNEAQVLSQVL  260 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~-----------------------~~~~~~~~~e~~~l~~l~  260 (496)
                      |.+.+.||+|+||.||+|.+ .+|+.  ||||.++....                       ......+.+|+.+++++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56788999999999999987 68888  99998754311                       011235789999999999


Q ss_pred             cccc--ccccceeecCCeEEEEEEecCC-C----ChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeC
Q 011005          261 HRNI--VKLYGYCLHKKCMFLIYEYMER-G----SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRD  333 (496)
Q Consensus       261 h~ni--v~~~~~~~~~~~~~lV~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~d  333 (496)
                      |+++  +.+++.    ...++||||+.+ |    +|.+....      .++..+..++.|++.||.|||.  ..||+|||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~--~~givHrD  196 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQ--EAELVHAD  196 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHH--TSCEECSS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHH--HCCEEeCC
Confidence            8865  333332    245799999942 4    55554332      2344567899999999999994  35999999


Q ss_pred             CCCCceEecCCCCeEEccccccccc
Q 011005          334 ISSNNILLNSKLEAFVADFGTARLL  358 (496)
Q Consensus       334 lkp~Nil~~~~~~~kl~Dfg~~~~~  358 (496)
                      |||+|||++.  .++|+|||+|...
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCHHHEEEcC--cEEEEECcccccC
Confidence            9999999998  9999999999765

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=4.4e-18  Score=164.68  Aligned_cols=138  Identities=12%  Similarity=0.102  Sum_probs=98.3

Q ss_pred             CCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchh-------------HHHHHH--------HHHHHHHHHhhcccccc
Q 011005          207 FDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEE-------------LAFIKS--------FKNEAQVLSQVLHRNIV  265 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------~~~~~~--------~~~e~~~l~~l~h~niv  265 (496)
                      |.+.++||+|++|.||+|..++|+.||||+++....             ......        ..+|...+.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            888999999999999999999999999998753210             000011        23455555555444332


Q ss_pred             cccceeecCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC
Q 011005          266 KLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL  345 (496)
Q Consensus       266 ~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~  345 (496)
                      -..-+...  ..++||||++|++|..+...         .....++.|++.+|.+||   ..|||||||||.|||+++++
T Consensus       177 vp~p~~~~--~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          177 VPEPIAQS--RHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEK  242 (397)
T ss_dssp             CCCEEEEE--TTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEE
T ss_pred             CCeeeecc--CceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCC
Confidence            11111111  23699999999888654321         123468899999999999   67999999999999998876


Q ss_pred             C----------eEEccccccccc
Q 011005          346 E----------AFVADFGTARLL  358 (496)
Q Consensus       346 ~----------~kl~Dfg~~~~~  358 (496)
                      .          +.|+||+.+...
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCEET
T ss_pred             CcccccccccceEEEEeCCcccC
Confidence            3          789999988654

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.73  E-value=9.5e-18  Score=152.39  Aligned_cols=127  Identities=26%  Similarity=0.334  Sum_probs=108.9

Q ss_pred             CCccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            1 MYKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         1 ~n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      .|+|+.+|. .|..+++|+.|+|++|+|++..|+.|..+++|++|+|++|+|+...+..|..+++|+.|+|++|+|++..
T Consensus        41 ~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~  120 (220)
T 2v9t_B           41 QNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLR  120 (220)
T ss_dssp             SSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred             CCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeC
Confidence            477788777 7888999999999999999888889999999999999999999555556788999999999999999777


Q ss_pred             CccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCCCCCCC
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGN  128 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~~  128 (496)
                      |..|..+++|+.|+|++|.|++..+..|..+++|+. +.+.+|++.|+.
T Consensus       121 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~-L~L~~N~~~c~c  168 (220)
T 2v9t_B          121 VDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQT-MHLAQNPFICDC  168 (220)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE-EECCSSCEECSG
T ss_pred             HHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCE-EEeCCCCcCCCC
Confidence            888999999999999999999888888988988854 567888888753

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.72  E-value=1.2e-17  Score=151.80  Aligned_cols=127  Identities=20%  Similarity=0.247  Sum_probs=113.6

Q ss_pred             CCccccCCh--hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCC
Q 011005            1 MYKIGIIPP--EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGS   78 (496)
Q Consensus         1 ~n~~~~lp~--~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~   78 (496)
                      .|+++.++.  .|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++.
T Consensus        41 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  120 (220)
T 2v70_A           41 NNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCV  120 (220)
T ss_dssp             SSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCB
T ss_pred             CCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeE
Confidence            477777743  488999999999999999988888999999999999999999987777899999999999999999988


Q ss_pred             CCccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCCCCCCC
Q 011005           79 IPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGN  128 (496)
Q Consensus        79 ~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~~  128 (496)
                      .|..|..+++|+.|+|++|.|++..|..|..+++|+. +.+.+|++.|+.
T Consensus       121 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~-L~L~~N~l~c~c  169 (220)
T 2v70_A          121 GNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLST-LNLLANPFNCNC  169 (220)
T ss_dssp             CTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCE-EECCSCCEECSG
T ss_pred             CHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCE-EEecCcCCcCCC
Confidence            8899999999999999999999999999999999965 578889888863

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.71  E-value=2.8e-17  Score=145.96  Aligned_cols=124  Identities=25%  Similarity=0.353  Sum_probs=112.3

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      .|+++.+|..+.  ++|+.|+|++|+|+ .+|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|
T Consensus        19 ~~~l~~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~   95 (193)
T 2wfh_A           19 NKGLKVLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPP   95 (193)
T ss_dssp             TSCCSSCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCT
T ss_pred             CCCCCcCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCH
Confidence            478899998764  68999999999998 778999999999999999999998777889999999999999999997778


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCCCCCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGN  128 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~~  128 (496)
                      ..|..+++|+.|+|++|.|++..+..|..+++|+. +.+.+|++.|+.
T Consensus        96 ~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~-L~L~~N~~~C~c  142 (193)
T 2wfh_A           96 RTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSH-LAIGANPLYCDC  142 (193)
T ss_dssp             TTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCE-EECCSSCEECSG
T ss_pred             HHhCCCCCCCEEECCCCCCCeeChhhhhcCccccE-EEeCCCCeecCC
Confidence            88999999999999999999888888999999955 578899988864

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.70  E-value=2.4e-17  Score=146.42  Aligned_cols=124  Identities=27%  Similarity=0.331  Sum_probs=112.2

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCc-cCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPS-ALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~-~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      +|+++.+|..+..  +|+.|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..
T Consensus        17 ~~~l~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~   94 (192)
T 1w8a_A           17 GRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEIS   94 (192)
T ss_dssp             TSCCSSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEEC
T ss_pred             CCCcCcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccC
Confidence            4788999987755  999999999999976664 4899999999999999999888999999999999999999999888


Q ss_pred             CccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCCCCCC
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCG  127 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~  127 (496)
                      +..|..+++|+.|++++|+|++..|..|..+++|+. +.+++|++.|.
T Consensus        95 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~-L~L~~N~l~c~  141 (192)
T 1w8a_A           95 NKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTS-LNLASNPFNCN  141 (192)
T ss_dssp             SSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCE-EECTTCCBCCS
T ss_pred             HHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCE-EEeCCCCccCc
Confidence            888999999999999999999999999999999965 57888888875

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.70  E-value=9.6e-17  Score=146.74  Aligned_cols=126  Identities=28%  Similarity=0.277  Sum_probs=100.0

Q ss_pred             CCccccCC-hhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            1 MYKIGIIP-PEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         1 ~n~~~~lp-~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      +|++..++ ..|.++++|+.|+|++|+|+...+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+
T Consensus        49 ~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~l  127 (229)
T 3e6j_A           49 DNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-EL  127 (229)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SC
T ss_pred             CCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-cc
Confidence            36777764 46788888888888888887666667788888888888888888665666788888888888888888 77


Q ss_pred             CccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCCCCCCC
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGN  128 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~~  128 (496)
                      |..+..+++|+.|++++|+|++..+..|..+++|+. +.+.+|++.|..
T Consensus       128 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~-L~l~~N~~~c~c  175 (229)
T 3e6j_A          128 PRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTH-AYLFGNPWDCEC  175 (229)
T ss_dssp             CTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCE-EECTTSCBCTTB
T ss_pred             CcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCE-EEeeCCCccCCc
Confidence            888888888888888888888777777888888854 567778777753

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.67  E-value=3.3e-16  Score=145.38  Aligned_cols=115  Identities=22%  Similarity=0.302  Sum_probs=74.6

Q ss_pred             CccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            2 YKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         2 n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      |+++.++. .|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..+
T Consensus        45 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  124 (251)
T 3m19_A           45 TGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPS  124 (251)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             CCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcCh
Confidence            55666555 56667777777777777776666666667777777777777765555556666666666666666664444


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      ..+..+++|+.|++++|.|++..+..|..+++|+.+
T Consensus       125 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  160 (251)
T 3m19_A          125 GVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTL  160 (251)
T ss_dssp             TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             hHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEE
Confidence            455666666666666666666555566666666443

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.66  E-value=6.3e-16  Score=139.13  Aligned_cols=126  Identities=26%  Similarity=0.318  Sum_probs=97.3

Q ss_pred             CCccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            1 MYKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         1 ~n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      +|+++.+|. .|.++++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..
T Consensus        37 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  116 (208)
T 2o6s_A           37 TNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLP  116 (208)
T ss_dssp             SSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred             CCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccC
Confidence            367777776 4678888888888888888666666788888888888888888655556788888888888888888666


Q ss_pred             CccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCCCCCC
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCG  127 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~  127 (496)
                      +..+..+++|+.|++++|.+++..+..+..+++|+. +.+..|+..|.
T Consensus       117 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~-L~l~~N~~~~~  163 (208)
T 2o6s_A          117 DGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQY-IWLHDNPWDCT  163 (208)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE-EECCSCCBCCC
T ss_pred             HhHhccCCcCCEEECCCCccceeCHHHhccCCCccE-EEecCCCeecC
Confidence            666788888888888888888777777888888854 45666766553

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.65  E-value=7e-16  Score=146.25  Aligned_cols=124  Identities=29%  Similarity=0.289  Sum_probs=89.8

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |+++.+|..+..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..+.
T Consensus        87 N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~  166 (290)
T 1p9a_G           87 NQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAG  166 (290)
T ss_dssp             SCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTT
T ss_pred             CcCCcCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHH
Confidence            66777777777777778888888877766667777777788888888877765555667777788888888887754455


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCccccccccCCCCCCCC
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCG  127 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~  127 (496)
                      .+..+++|+.|++++|+|+ .+|..+..+.+|+. +.+.+|++.|+
T Consensus       167 ~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~-l~L~~Np~~C~  210 (290)
T 1p9a_G          167 LLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPF-AFLHGNPWLCN  210 (290)
T ss_dssp             TTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSE-EECCSCCBCCS
T ss_pred             HhcCcCCCCEEECCCCcCC-ccChhhcccccCCe-EEeCCCCccCc
Confidence            5677777888888888777 45556666666643 45677777775

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.65  E-value=9.8e-16  Score=134.11  Aligned_cols=124  Identities=26%  Similarity=0.299  Sum_probs=108.1

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      .|+++.+|..+.  ++|+.|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..+
T Consensus        16 ~~~l~~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~   93 (177)
T 2o6r_A           16 SKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPN   93 (177)
T ss_dssp             SSCCSSCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             CCCCccCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCH
Confidence            367888887554  699999999999998777788999999999999999997666678999999999999999997777


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCCCCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCG  127 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~  127 (496)
                      ..+..+++|+.|++++|.+++..+..+..+++|+. +.+.+|+..|.
T Consensus        94 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~-L~l~~N~~~~~  139 (177)
T 2o6r_A           94 GVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQK-IWLHTNPWDCS  139 (177)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE-EECCSSCBCCC
T ss_pred             HHhhCCcccCEEECcCCcceEeCHHHhcCCcccCE-EEecCCCeecc
Confidence            77899999999999999999888878899999965 46778877764

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.64  E-value=1.2e-15  Score=143.28  Aligned_cols=124  Identities=29%  Similarity=0.327  Sum_probs=69.4

Q ss_pred             CccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            2 YKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         2 n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      |+++.+|. .|.++++|++|+|++|++++..+..|..+++|++|+|++|+|++..|..+..+++|+.|+|++|++++..+
T Consensus        95 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  174 (272)
T 3rfs_A           95 NQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPE  174 (272)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             CccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCH
Confidence            45555554 34555666666666666655555555556666666666666654444445556666666666666654444


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCCCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLC  126 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c  126 (496)
                      ..+..+++|+.|++++|.+++..+..+..+++|+. +.+.+|+..|
T Consensus       175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~-L~l~~N~~~~  219 (272)
T 3rfs_A          175 GVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQY-IWLHDNPWDC  219 (272)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE-EECCSSCBCC
T ss_pred             HHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCE-EEccCCCccc
Confidence            44555666666666666666555555555555533 3445554444

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.64  E-value=2.2e-16  Score=170.20  Aligned_cols=130  Identities=37%  Similarity=0.643  Sum_probs=115.3

Q ss_pred             cCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccC
Q 011005            6 IIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITK   85 (496)
Q Consensus         6 ~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~   85 (496)
                      .+|..++++++|+.|||++|+++|.+|..|+++++|+.|+|++|+++|.+|..++++++|+.|||++|+++|.+|..+..
T Consensus       623 ~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~  702 (768)
T 3rgz_A          623 HTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSA  702 (768)
T ss_dssp             ECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGG
T ss_pred             cCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhC
Confidence            36778899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccccccccccCCCCCCCCCCCCCccccccccCCCCCCCCCCCCCCCCCCCC
Q 011005           86 LSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGNILDLPSCDTTK  139 (496)
Q Consensus        86 l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~~~~~~~~~~~~~  139 (496)
                      +++|+.|++++|+++|.+|.. ..+.++. -..+.+|++.||.+.  ++|....
T Consensus       703 l~~L~~L~ls~N~l~g~iP~~-~~~~~~~-~~~~~gN~~Lcg~~l--~~C~~~~  752 (768)
T 3rgz_A          703 LTMLTEIDLSNNNLSGPIPEM-GQFETFP-PAKFLNNPGLCGYPL--PRCDPSN  752 (768)
T ss_dssp             CCCCSEEECCSSEEEEECCSS-SSGGGSC-GGGGCSCTEEESTTS--CCCCSCC
T ss_pred             CCCCCEEECcCCcccccCCCc-hhhccCC-HHHhcCCchhcCCCC--cCCCCCc
Confidence            999999999999999999965 3344442 245789999999764  4776443

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.63  E-value=1.7e-15  Score=142.20  Aligned_cols=114  Identities=31%  Similarity=0.344  Sum_probs=62.8

Q ss_pred             CccccCChh-ccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            2 YKIGIIPPE-IGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         2 n~~~~lp~~-~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      |+++.+|.. |.++++|++|+|++|.+++..+..|..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+
T Consensus        71 n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~  150 (270)
T 2o6q_A           71 NKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPK  150 (270)
T ss_dssp             SCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             CccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCH
Confidence            455555553 3556666666666666665444555556666666666666654444455555555555555555554333


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCcccc
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHT  115 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~  115 (496)
                      ..+..+++|+.|++++|.+++..+..|..+++|+.
T Consensus       151 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  185 (270)
T 2o6q_A          151 GVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKT  185 (270)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred             hHccCCcccceeEecCCcCcEeChhHhccCCCcCE
Confidence            44555555555555555555554445555555533

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.62  E-value=9.2e-16  Score=139.25  Aligned_cols=120  Identities=23%  Similarity=0.289  Sum_probs=107.1

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      +|.++.+|..+.  ++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+
T Consensus        20 ~~~l~~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~   97 (220)
T 2v9t_B           20 GKGLTEIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPK   97 (220)
T ss_dssp             TSCCSSCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCT
T ss_pred             CCCcCcCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCH
Confidence            467889998765  689999999999998778899999999999999999998889999999999999999999996666


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN  123 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~  123 (496)
                      ..|..+++|+.|+|++|.|++..|..|..+++|+.+ .+++|.
T Consensus        98 ~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L-~L~~N~  139 (220)
T 2v9t_B           98 SLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLL-SLYDNK  139 (220)
T ss_dssp             TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE-ECCSSC
T ss_pred             hHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEE-ECCCCc
Confidence            678999999999999999999999999999999765 445443

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.61  E-value=2.8e-15  Score=139.10  Aligned_cols=125  Identities=25%  Similarity=0.317  Sum_probs=80.3

Q ss_pred             CccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            2 YKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         2 n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      |+++.++. .|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..+
T Consensus        69 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  148 (251)
T 3m19_A           69 NQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPA  148 (251)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             CcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCH
Confidence            55666555 46666777777777777765555666666777777777777765444455666777777777777765445


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCCCCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCG  127 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~  127 (496)
                      ..+..+++|+.|++++|.+++..+..+..+++|+. +.+.+|+..|.
T Consensus       149 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~-L~l~~N~~~c~  194 (251)
T 3m19_A          149 GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQT-ITLFGNQFDCS  194 (251)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE-EECCSCCBCTT
T ss_pred             HHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCE-EEeeCCceeCC
Confidence            56666667777777777776666666666666643 35566665554

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.59  E-value=1.3e-15  Score=135.24  Aligned_cols=104  Identities=29%  Similarity=0.462  Sum_probs=96.8

Q ss_pred             CCccccCChh--ccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCC
Q 011005            1 MYKIGIIPPE--IGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGS   78 (496)
Q Consensus         1 ~n~~~~lp~~--~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~   78 (496)
                      .|+++.+|..  |.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++.
T Consensus        38 ~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  117 (192)
T 1w8a_A           38 DNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCV  117 (192)
T ss_dssp             SCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEE
T ss_pred             CCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCee
Confidence            4788898874  89999999999999999998899999999999999999999988888899999999999999999988


Q ss_pred             CCccccCcccccccccccccCCCCCC
Q 011005           79 IPGEITKLSRLDYLNLSSNKLSGPVP  104 (496)
Q Consensus        79 ~~~~~~~l~~L~~l~l~~n~l~~~~~  104 (496)
                      .|..+..+++|+.|++++|++++..+
T Consensus       118 ~~~~~~~l~~L~~L~L~~N~l~c~c~  143 (192)
T 1w8a_A          118 MPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             CTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             CHHHhhcCCCCCEEEeCCCCccCcCc
Confidence            89999999999999999999996543

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.59  E-value=2.7e-15  Score=133.11  Aligned_cols=101  Identities=28%  Similarity=0.362  Sum_probs=94.3

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      .|+|+.+|..|.++++|+.|+|++|.|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+
T Consensus        40 ~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~  119 (193)
T 2wfh_A           40 GNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPE  119 (193)
T ss_dssp             SSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCT
T ss_pred             CCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeCh
Confidence            48899999999999999999999999998888899999999999999999998878889999999999999999996666


Q ss_pred             ccccCcccccccccccccCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSG  101 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~  101 (496)
                      ..|..+++|+.|++++|++..
T Consensus       120 ~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A          120 GAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             TTTTTCTTCCEEECCSSCEEC
T ss_pred             hhhhcCccccEEEeCCCCeec
Confidence            679999999999999999974

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.58  E-value=4e-15  Score=129.13  Aligned_cols=106  Identities=27%  Similarity=0.351  Sum_probs=53.6

Q ss_pred             CEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCcccccccccccc
Q 011005           18 IKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSN   97 (496)
Q Consensus        18 ~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~l~l~~n   97 (496)
                      +.|++++|+++ .+|..+.  ++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus        12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N   88 (170)
T 3g39_A           12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN   88 (170)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence            44555555555 3343332  45555555555555444455555555555555555555444444455555555555555


Q ss_pred             cCCCCCCCCCCCCCccccccccCCCCCCCC
Q 011005           98 KLSGPVPFSNNDLSSMHTVVSLSPNNGLCG  127 (496)
Q Consensus        98 ~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~  127 (496)
                      +|++..+..|..+++|+. +.+.+|++.|.
T Consensus        89 ~l~~~~~~~~~~l~~L~~-L~L~~N~~~c~  117 (170)
T 3g39_A           89 QLKSIPRGAFDNLKSLTH-IWLLNNPWDCA  117 (170)
T ss_dssp             CCCCCCTTTTTTCTTCCE-EECCSSCBCTT
T ss_pred             ccCEeCHHHhcCCCCCCE-EEeCCCCCCCC
Confidence            555544445555555532 34445554443

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.58  E-value=4.1e-15  Score=129.54  Aligned_cols=106  Identities=23%  Similarity=0.295  Sum_probs=59.9

Q ss_pred             CEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCcccccccccccc
Q 011005           18 IKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSN   97 (496)
Q Consensus        18 ~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~l~l~~n   97 (496)
                      +.+++++|+++ .+|..+.  ++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            45666666665 4444443  55666666666666555555666666666666666666433344556666666666666


Q ss_pred             cCCCCCCCCCCCCCccccccccCCCCCCCC
Q 011005           98 KLSGPVPFSNNDLSSMHTVVSLSPNNGLCG  127 (496)
Q Consensus        98 ~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~  127 (496)
                      +|++..+..|..+++|+. +.+.+|++.|.
T Consensus        92 ~l~~l~~~~~~~l~~L~~-L~L~~N~~~c~  120 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTH-IYLYNNPWDCE  120 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSE-EECCSSCBCTT
T ss_pred             ccceeCHHHhccccCCCE-EEeCCCCcccc
Confidence            666555555566666633 34555555543

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.58  E-value=1.2e-15  Score=146.41  Aligned_cols=124  Identities=34%  Similarity=0.516  Sum_probs=90.2

Q ss_pred             Cccc-cCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            2 YKIG-IIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         2 n~~~-~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      |++. .+|..+..++ |+.|+|++|.+++..|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|
T Consensus       184 N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p  261 (313)
T 1ogq_A          184 NRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLP  261 (313)
T ss_dssp             SEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCC
T ss_pred             CeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCC
Confidence            3444 3555555554 66666666666666667777777777777777777754443 7777888888888888887788


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCCCCCCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGNI  129 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~~~  129 (496)
                      ..+..+++|+.|++++|++++.+|.. ..+++|+ .+.+.+|++.|+.+
T Consensus       262 ~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~-~l~l~~N~~lc~~p  308 (313)
T 1ogq_A          262 QGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFD-VSAYANNKCLCGSP  308 (313)
T ss_dssp             GGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSC-GGGTCSSSEEESTT
T ss_pred             hHHhcCcCCCEEECcCCcccccCCCC-ccccccC-hHHhcCCCCccCCC
Confidence            88888888888888888888887776 6777774 45678888888853

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.58  E-value=1.1e-15  Score=129.61  Aligned_cols=113  Identities=22%  Similarity=0.223  Sum_probs=88.2

Q ss_pred             Cccc--cCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCC-
Q 011005            2 YKIG--IIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGS-   78 (496)
Q Consensus         2 n~~~--~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~-   78 (496)
                      |+++  .+|..+..+++|+.|+|++|.+++.  ..+..+++|++|+|++|++++.+|..+..+++|+.|++++|++++. 
T Consensus        27 n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~  104 (149)
T 2je0_A           27 SRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLS  104 (149)
T ss_dssp             CBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHH
T ss_pred             CcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChH
Confidence            5666  6887778888888888888888855  6788888888888888888866777777788888888888888842 


Q ss_pred             CCccccCcccccccccccccCCCCCC---CCCCCCCccccc
Q 011005           79 IPGEITKLSRLDYLNLSSNKLSGPVP---FSNNDLSSMHTV  116 (496)
Q Consensus        79 ~~~~~~~l~~L~~l~l~~n~l~~~~~---~~~~~l~~l~~~  116 (496)
                      .+..+..+++|+.|++++|++++..+   ..+..+++|+.+
T Consensus       105 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L  145 (149)
T 2je0_A          105 TIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYL  145 (149)
T ss_dssp             HHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEE
T ss_pred             HHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccc
Confidence            23678888888888888888886655   467777777554

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.58  E-value=3.2e-15  Score=144.38  Aligned_cols=100  Identities=23%  Similarity=0.326  Sum_probs=61.5

Q ss_pred             CCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCcccccccc
Q 011005           14 LKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLN   93 (496)
Q Consensus        14 l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~l~   93 (496)
                      +++|++|+|++|+|+ .+|..++.+++|+.|+|++|+++ .+|+.+..+++|+.|+|++|.+.+.+|..+..+++|+.|+
T Consensus       182 l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~  259 (328)
T 4fcg_A          182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLI  259 (328)
T ss_dssp             STTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEE
T ss_pred             CCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEE
Confidence            666666666666665 55555666666666666666666 3455566666666666666666556666666666666666


Q ss_pred             cccccCCCCCCCCCCCCCcccc
Q 011005           94 LSSNKLSGPVPFSNNDLSSMHT  115 (496)
Q Consensus        94 l~~n~l~~~~~~~~~~l~~l~~  115 (496)
                      +++|++.+.+|..+..+++|+.
T Consensus       260 L~~n~~~~~~p~~~~~l~~L~~  281 (328)
T 4fcg_A          260 LKDCSNLLTLPLDIHRLTQLEK  281 (328)
T ss_dssp             CTTCTTCCBCCTTGGGCTTCCE
T ss_pred             CCCCCchhhcchhhhcCCCCCE
Confidence            6666666666666666666643

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.58  E-value=8.6e-15  Score=133.70  Aligned_cols=118  Identities=27%  Similarity=0.314  Sum_probs=104.2

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      .|+++.+|..+.  ++|++|+|++|+|++..|..|..+++|+.|+|++|+|+...+..|..+++|+.|+|++|+|++..+
T Consensus        28 ~~~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~  105 (229)
T 3e6j_A           28 SKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPS  105 (229)
T ss_dssp             TSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             CCCcCccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccCh
Confidence            367888998665  899999999999999889999999999999999999996555678999999999999999997767


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccccccCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN  122 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n  122 (496)
                      ..|..+++|+.|++++|.|+ .+|..+..+++|+.+ .+++|
T Consensus       106 ~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L-~L~~N  145 (229)
T 3e6j_A          106 AVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHL-ALDQN  145 (229)
T ss_dssp             TTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEE-ECCSS
T ss_pred             hHhCcchhhCeEeccCCccc-ccCcccccCCCCCEE-ECCCC
Confidence            77899999999999999999 778888999999765 44544

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.57  E-value=8.1e-16  Score=156.71  Aligned_cols=121  Identities=22%  Similarity=0.229  Sum_probs=60.6

Q ss_pred             CccccCCh-hccCCCCCCEEeccCCccCCCCCccCC-CCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            2 YKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALG-SLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         2 n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~-~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      |+++.+++ .++++++|+.|+|++|.|++..|..+. .+++|+.|+|++|.|++. | .+..+++|+.|+|++|++++ +
T Consensus       130 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-~  206 (487)
T 3oja_A          130 NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-M  206 (487)
T ss_dssp             SCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-E
T ss_pred             CCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-c-ccccCCCCCEEECCCCCCCC-C
Confidence            44444432 455555555555555555554444443 455555555555555532 2 22235555555555555553 3


Q ss_pred             CccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCCCCCC
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCG  127 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~  127 (496)
                      |..+..+++|+.|++++|.|++ +|..+..+++|.. +.+++|+..|+
T Consensus       207 ~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~-L~l~~N~l~c~  252 (487)
T 3oja_A          207 GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEH-FDLRGNGFHCG  252 (487)
T ss_dssp             CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCE-EECTTCCBCHH
T ss_pred             CHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCE-EEcCCCCCcCc
Confidence            3335555555555555555553 3444555555532 34445554443

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.57  E-value=3e-15  Score=129.77  Aligned_cols=114  Identities=25%  Similarity=0.232  Sum_probs=98.9

Q ss_pred             CCccc--cCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCC
Q 011005            1 MYKIG--IIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGS   78 (496)
Q Consensus         1 ~n~~~--~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~   78 (496)
                      .|+++  .+|..+..+++|+.|+|++|.|++.  ..+..+++|++|+|++|++++.+|..+..+++|+.|+|++|++++.
T Consensus        33 ~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  110 (168)
T 2ell_A           33 NCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI  110 (168)
T ss_dssp             SCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSS
T ss_pred             CCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcc
Confidence            36777  8998889999999999999999865  7899999999999999999977888888899999999999999953


Q ss_pred             C-CccccCcccccccccccccCCCCCC---CCCCCCCccccc
Q 011005           79 I-PGEITKLSRLDYLNLSSNKLSGPVP---FSNNDLSSMHTV  116 (496)
Q Consensus        79 ~-~~~~~~l~~L~~l~l~~n~l~~~~~---~~~~~l~~l~~~  116 (496)
                      . +..+..+++|+.|++++|++++..+   ..+..+++|+.+
T Consensus       111 ~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L  152 (168)
T 2ell_A          111 STLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL  152 (168)
T ss_dssp             GGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEE
T ss_pred             hhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEe
Confidence            2 2789999999999999999997665   478888888665

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.56  E-value=1.4e-15  Score=145.89  Aligned_cols=120  Identities=34%  Similarity=0.584  Sum_probs=105.5

Q ss_pred             Cccc---cCChhccCCCCCCEEeccC-CccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCC
Q 011005            2 YKIG---IIPPEIGNLKNLIKLDVGS-NSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQG   77 (496)
Q Consensus         2 n~~~---~lp~~~~~l~~L~~L~l~~-n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~   77 (496)
                      |+++   .+|..|.++++|++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..+..+++|++|+|++|++++
T Consensus        60 ~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  139 (313)
T 1ogq_A           60 LNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG  139 (313)
T ss_dssp             CCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEES
T ss_pred             CCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCC
Confidence            5565   5888999999999999994 99998999999999999999999999998899999999999999999999998


Q ss_pred             CCCccccCcccccccccccccCCCCCCCCCCCCC-ccccccccCCC
Q 011005           78 SIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLS-SMHTVVSLSPN  122 (496)
Q Consensus        78 ~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~-~l~~~~~~~~n  122 (496)
                      .+|..+..+++|+.|++++|.+++.+|..+..++ +|+.+ .++.|
T Consensus       140 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L-~L~~N  184 (313)
T 1ogq_A          140 TLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM-TISRN  184 (313)
T ss_dssp             CCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEE-ECCSS
T ss_pred             cCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEE-ECcCC
Confidence            8999999999999999999999988999988887 77554 44444

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.56  E-value=6.3e-15  Score=133.71  Aligned_cols=119  Identities=22%  Similarity=0.220  Sum_probs=104.8

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCC-ccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIP-SALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p-~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      .|.++.+|..+.  +.++.|+|++|+|++..| ..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..
T Consensus        20 ~n~l~~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~   97 (220)
T 2v70_A           20 NQKLNKIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQ   97 (220)
T ss_dssp             SSCCSSCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred             CCCcccCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccC
Confidence            378889998764  357899999999997655 45899999999999999999777779999999999999999999877


Q ss_pred             CccccCcccccccccccccCCCCCCCCCCCCCccccccccCCC
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN  122 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n  122 (496)
                      +..|..+++|+.|+|++|.|++..|..|..+++|+.+ .++.|
T Consensus        98 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L-~L~~N  139 (220)
T 2v70_A           98 HKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLL-SLYDN  139 (220)
T ss_dssp             GGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEE-ECTTS
T ss_pred             HhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEE-ECCCC
Confidence            8889999999999999999999999999999999765 44444

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.56  E-value=3.8e-15  Score=140.93  Aligned_cols=120  Identities=25%  Similarity=0.268  Sum_probs=91.2

Q ss_pred             Cc-cccC-ChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            2 YK-IGII-PPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         2 n~-~~~l-p~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      |+ ++.+ |..|..+++|++|+|++|.+++..|..|..+++|++|+|++|++++..+..+..+++|+.|+|++|++++..
T Consensus        90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  169 (285)
T 1ozn_A           90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP  169 (285)
T ss_dssp             CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence            44 6776 447788888888888888888777777888888888888888888655566788888888888888887555


Q ss_pred             CccccCcccccccccccccCCCCCCCCCCCCCccccccccCCC
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN  122 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n  122 (496)
                      +..+..+++|+.|++++|.+++..|..+..+++|+.+ .+++|
T Consensus       170 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L-~l~~n  211 (285)
T 1ozn_A          170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL-YLFAN  211 (285)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE-ECCSS
T ss_pred             HHHhcCccccCEEECCCCcccccCHhHccCcccccEe-eCCCC
Confidence            5567788888888888888887777778777777554 34443

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.55  E-value=1.9e-14  Score=135.06  Aligned_cols=114  Identities=28%  Similarity=0.299  Sum_probs=77.7

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |++..++ .+..+++|++|+|++|.+++..+..|..+++|++|+|++|++++..|..+..+++|+.|+|++|++++..+.
T Consensus        73 n~l~~~~-~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  151 (272)
T 3rfs_A           73 NKLHDIS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKG  151 (272)
T ss_dssp             SCCCCCG-GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred             CCCCCch-hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHH
Confidence            5555543 566677777777777777766666667777777777777777755555567777777777777777755555


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      .+..+++|+.|++++|.+++..+..+..+++|+.+
T Consensus       152 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  186 (272)
T 3rfs_A          152 VFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDL  186 (272)
T ss_dssp             TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             HhccCccCCEEECCCCCcCccCHHHhcCCccCCEE
Confidence            56677777777777777776666666777777554

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.55  E-value=2.2e-14  Score=134.58  Aligned_cols=117  Identities=24%  Similarity=0.287  Sum_probs=89.9

Q ss_pred             CCccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            1 MYKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         1 ~n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      .|+++.+|. .|.++++|++|+|++|.|+...+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..
T Consensus        46 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  125 (270)
T 2o6q_A           46 SNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLP  125 (270)
T ss_dssp             SSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCC
T ss_pred             CCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeC
Confidence            366777776 6778888888888888888665666777888888888888888655566778888888888888888666


Q ss_pred             CccccCcccccccccccccCCCCCCCCCCCCCcccccc
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVV  117 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~  117 (496)
                      +..|..+++|+.|++++|.+++..+..|..+++|+.+.
T Consensus       126 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  163 (270)
T 2o6q_A          126 PRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELR  163 (270)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             HHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeE
Confidence            66778888888888888888877777777777776543

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.54  E-value=1e-14  Score=147.65  Aligned_cols=126  Identities=25%  Similarity=0.235  Sum_probs=112.0

Q ss_pred             CccccC-ChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            2 YKIGII-PPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         2 n~~~~l-p~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      |++..+ |..++++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..|..+..+++|+.|+|++|++++..|
T Consensus       285 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  364 (455)
T 3v47_A          285 SKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGD  364 (455)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECT
T ss_pred             ccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccCh
Confidence            555554 5578999999999999999998888899999999999999999998778899999999999999999998788


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCCCCCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGN  128 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~~  128 (496)
                      ..+..+++|+.|++++|++++..+..+..+++|+. +.+++|+..|..
T Consensus       365 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~-L~l~~N~l~~~~  411 (455)
T 3v47_A          365 QSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQK-IWLHTNPWDCSC  411 (455)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE-EECCSSCBCCCT
T ss_pred             hhccccccccEEECCCCccccCCHhHhccCCcccE-EEccCCCcccCC
Confidence            99999999999999999999888888899999965 567888887764

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.54  E-value=2.8e-15  Score=146.85  Aligned_cols=115  Identities=27%  Similarity=0.187  Sum_probs=86.9

Q ss_pred             CCccccCChh-cc-CCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCC
Q 011005            1 MYKIGIIPPE-IG-NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGS   78 (496)
Q Consensus         1 ~n~~~~lp~~-~~-~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~   78 (496)
                      .|+|+.++.. +. ++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++.
T Consensus        48 ~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~  127 (361)
T 2xot_A           48 HNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVV  127 (361)
T ss_dssp             SSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred             CCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEE
Confidence            4777777774 55 788888888888888877677788888888888888888866566788888888888888888866


Q ss_pred             CCccccCcccccccccccccCCCCCCCCC---CCCCcccc
Q 011005           79 IPGEITKLSRLDYLNLSSNKLSGPVPFSN---NDLSSMHT  115 (496)
Q Consensus        79 ~~~~~~~l~~L~~l~l~~n~l~~~~~~~~---~~l~~l~~  115 (496)
                      .|..|..+++|+.|+|++|.|++..+..|   ..+++|+.
T Consensus       128 ~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~  167 (361)
T 2xot_A          128 DRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLML  167 (361)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCE
T ss_pred             CHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCE
Confidence            67778888888888888888886555555   44566543

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.54  E-value=2.7e-14  Score=123.93  Aligned_cols=100  Identities=24%  Similarity=0.283  Sum_probs=91.1

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      +|+++.+|..+.  ++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+
T Consensus        18 ~n~l~~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~   95 (170)
T 3g39_A           18 GKSLASVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPR   95 (170)
T ss_dssp             TSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             CCCcCccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCH
Confidence            478999998774  899999999999998889999999999999999999997666678999999999999999997667


Q ss_pred             ccccCcccccccccccccCCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGP  102 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~  102 (496)
                      ..|..+++|+.|+|++|+++..
T Consensus        96 ~~~~~l~~L~~L~L~~N~~~c~  117 (170)
T 3g39_A           96 GAFDNLKSLTHIWLLNNPWDCA  117 (170)
T ss_dssp             TTTTTCTTCCEEECCSSCBCTT
T ss_pred             HHhcCCCCCCEEEeCCCCCCCC
Confidence            7799999999999999999854

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.53  E-value=2.5e-14  Score=135.47  Aligned_cols=104  Identities=29%  Similarity=0.355  Sum_probs=61.6

Q ss_pred             cCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCcccccc
Q 011005           12 GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDY   91 (496)
Q Consensus        12 ~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~   91 (496)
                      +.+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..+..|..+++|+.
T Consensus        74 ~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  152 (290)
T 1p9a_G           74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK  152 (290)
T ss_dssp             SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred             CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCE
Confidence            34455555555555555 44555566666666666666666544455666666666666666666444455566666666


Q ss_pred             cccccccCCCCCCCCCCCCCccccc
Q 011005           92 LNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        92 l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      |++++|+|++..+..|..+++|+.+
T Consensus       153 L~L~~N~l~~l~~~~~~~l~~L~~L  177 (290)
T 1p9a_G          153 LSLANNNLTELPAGLLNGLENLDTL  177 (290)
T ss_dssp             EECTTSCCSCCCTTTTTTCTTCCEE
T ss_pred             EECCCCcCCccCHHHhcCcCCCCEE
Confidence            6666666665555555666666443

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.53  E-value=1.2e-14  Score=140.42  Aligned_cols=111  Identities=23%  Similarity=0.379  Sum_probs=71.0

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcC---------CcccCeecccc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAS---------MKYLTQLDLSN   72 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~---------l~~L~~l~l~~   72 (496)
                      |++..+|..++++++|++|+|++|.++ .+|..|.++++|++|+|++|++.+.+|..+..         +++|+.|+|++
T Consensus       114 n~l~~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~  192 (328)
T 4fcg_A          114 AGLMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEW  192 (328)
T ss_dssp             SCCCCCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEE
T ss_pred             CCccchhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcC
Confidence            566667766777777777777777776 55666666777777777766666666655543         66666666666


Q ss_pred             cccCCCCCccccCcccccccccccccCCCCCCCCCCCCCcccc
Q 011005           73 NNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHT  115 (496)
Q Consensus        73 N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~  115 (496)
                      |+++ .+|..+..+++|+.|++++|.+++ +|..+..+++|+.
T Consensus       193 n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~  233 (328)
T 4fcg_A          193 TGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEE  233 (328)
T ss_dssp             ECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCE
T ss_pred             CCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCE
Confidence            6666 556666666666666666666663 3444555666544

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.53  E-value=4.9e-14  Score=126.66  Aligned_cols=118  Identities=28%  Similarity=0.300  Sum_probs=102.5

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      +.++.+|..+  .++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+.
T Consensus        17 ~~l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~   94 (208)
T 2o6s_A           17 QGRTSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNG   94 (208)
T ss_dssp             SCCSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred             CCccCCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHh
Confidence            5677788755  46899999999999977777899999999999999999976666789999999999999999976667


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCccccccccCCC
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN  122 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n  122 (496)
                      .+..+++|+.|++++|.+++..+..|..+++|+.+ .+++|
T Consensus        95 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L-~l~~N  134 (208)
T 2o6s_A           95 VFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDL-RLYQN  134 (208)
T ss_dssp             TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE-ECCSS
T ss_pred             HhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEE-ECCCC
Confidence            78999999999999999998888889999999765 44444

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.52  E-value=1.4e-14  Score=152.85  Aligned_cols=115  Identities=19%  Similarity=0.201  Sum_probs=69.7

Q ss_pred             CccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            2 YKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         2 n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      |+|+.+|+ .|.++++|++|+|++|+|+++.|+.|.++++|++|+|++|+|++..+..|.+|++|++|+|++|++++..+
T Consensus        62 N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~  141 (635)
T 4g8a_A           62 NPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN  141 (635)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTT
T ss_pred             CCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCCh
Confidence            55666654 56666666666666666665555566666666666666666664444456666666666666666664444


Q ss_pred             ccccCcccccccccccccCCC-CCCCCCCCCCccccc
Q 011005           81 GEITKLSRLDYLNLSSNKLSG-PVPFSNNDLSSMHTV  116 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~-~~~~~~~~l~~l~~~  116 (496)
                      ..|+++++|+.|++++|.+++ ..|..+..+++|+.+
T Consensus       142 ~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L  178 (635)
T 4g8a_A          142 FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL  178 (635)
T ss_dssp             CCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEE
T ss_pred             hhhhcCcccCeeccccCccccCCCchhhccchhhhhh
Confidence            556666666666666666654 245555566666443

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.52  E-value=2.5e-14  Score=125.10  Aligned_cols=104  Identities=24%  Similarity=0.318  Sum_probs=92.6

Q ss_pred             CCccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            1 MYKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         1 ~n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      +|+++.+|. .|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|++++..
T Consensus        37 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  116 (177)
T 2o6r_A           37 SNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVP  116 (177)
T ss_dssp             SSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred             CCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeC
Confidence            478888887 5789999999999999999777778899999999999999999776667899999999999999999666


Q ss_pred             CccccCcccccccccccccCCCCCC
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVP  104 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~  104 (496)
                      +..+..+++|+.|++++|++++..|
T Consensus       117 ~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A          117 DGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             TTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             HHHhcCCcccCEEEecCCCeeccCc
Confidence            6667899999999999999996543

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.52  E-value=5.1e-14  Score=122.59  Aligned_cols=99  Identities=25%  Similarity=0.344  Sum_probs=89.7

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      .|+++.+|..+.  ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+
T Consensus        21 ~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~   98 (174)
T 2r9u_A           21 NIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPR   98 (174)
T ss_dssp             SSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             CCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCH
Confidence            478999999775  899999999999998889999999999999999999997555567999999999999999996666


Q ss_pred             ccccCcccccccccccccCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSG  101 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~  101 (496)
                      ..|..+++|+.|+|++|++..
T Consensus        99 ~~~~~l~~L~~L~L~~N~~~c  119 (174)
T 2r9u_A           99 GAFDNLKSLTHIYLYNNPWDC  119 (174)
T ss_dssp             TTTTTCTTCSEEECCSSCBCT
T ss_pred             HHhccccCCCEEEeCCCCccc
Confidence            679999999999999999984

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.51  E-value=1.4e-14  Score=141.82  Aligned_cols=119  Identities=24%  Similarity=0.210  Sum_probs=102.1

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCC-CCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALG-SLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~-~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      .|+++.+|..+.  +.++.|+|++|+|++..+..|. .+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..
T Consensus        27 ~~~l~~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~  104 (361)
T 2xot_A           27 KQQLPNVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLD  104 (361)
T ss_dssp             SSCCSSCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             CCCcCccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCC
Confidence            367888888664  3689999999999987777787 8999999999999999777778999999999999999999766


Q ss_pred             CccccCcccccccccccccCCCCCCCCCCCCCccccccccCCC
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN  122 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n  122 (496)
                      +..|..+++|+.|+|++|.|++..|..|..+++|+.| .+++|
T Consensus       105 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L-~L~~N  146 (361)
T 2xot_A          105 EFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKL-YLSQN  146 (361)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE-ECCSS
T ss_pred             HHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEE-ECCCC
Confidence            7789999999999999999998889999999999765 44444

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.51  E-value=2.4e-14  Score=144.26  Aligned_cols=124  Identities=27%  Similarity=0.285  Sum_probs=104.2

Q ss_pred             CccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            2 YKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         2 n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      |.++.+|. .|.++++|+.|+|++|+++ .+| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..+
T Consensus       171 ~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  248 (440)
T 3zyj_A          171 KRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIER  248 (440)
T ss_dssp             TTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECT
T ss_pred             CCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEECh
Confidence            44555665 5778888888888888888 555 47888899999999999998778889999999999999999997778


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCCCCCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGN  128 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~~  128 (496)
                      ..|..+++|+.|+|++|+|++..+..|..+++|+. +.+++|++.|+.
T Consensus       249 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~-L~L~~Np~~CdC  295 (440)
T 3zyj_A          249 NAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLER-IHLHHNPWNCNC  295 (440)
T ss_dssp             TSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCE-EECCSSCEECSS
T ss_pred             hhhcCCCCCCEEECCCCCCCccChhHhccccCCCE-EEcCCCCccCCC
Confidence            88999999999999999999888888899998854 578889988864

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.51  E-value=2.1e-14  Score=151.38  Aligned_cols=126  Identities=25%  Similarity=0.265  Sum_probs=111.5

Q ss_pred             CccccCCh-hccCCCCCCEEeccCCccC-CCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            2 YKIGIIPP-EIGNLKNLIKLDVGSNSLI-GPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         2 n~~~~lp~-~~~~l~~L~~L~l~~n~i~-~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      |++..++. .+..+++|+.|+|++|++. +..|+.|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..
T Consensus       455 n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~  534 (635)
T 4g8a_A          455 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD  534 (635)
T ss_dssp             SCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCC
T ss_pred             cccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCC
Confidence            55666554 6788999999999999754 457889999999999999999999888999999999999999999999878


Q ss_pred             CccccCcccccccccccccCCCCCCCCCCCC-CccccccccCCCCCCCCC
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVPFSNNDL-SSMHTVVSLSPNNGLCGN  128 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l-~~l~~~~~~~~n~~~c~~  128 (496)
                      |..|..+++|+.|++++|+|++..|..+..+ ++|+ .+.+++||+.|+.
T Consensus       535 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~-~L~L~~Np~~C~C  583 (635)
T 4g8a_A          535 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLA-FLNLTQNDFACTC  583 (635)
T ss_dssp             CGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCC-EEECTTCCBCCSG
T ss_pred             hhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCC-EEEeeCCCCcccC
Confidence            8889999999999999999999999999988 5784 4688999999974

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.51  E-value=5.5e-14  Score=132.94  Aligned_cols=115  Identities=29%  Similarity=0.334  Sum_probs=72.4

Q ss_pred             CccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCc-CCCCCchhhcCCcccCeecccccccCCCC
Q 011005            2 YKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNK-LSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         2 n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~-l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      |+++.+|. .|.++++|++|+|++|.+++..|..|..+++|++|+|++|. ++...|..+..+++|++|+|++|++++..
T Consensus        42 n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  121 (285)
T 1ozn_A           42 NRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELG  121 (285)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCC
T ss_pred             CcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEEC
Confidence            45555554 46666666666666666665556666666666666666665 55444556666666666666666666555


Q ss_pred             CccccCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      |..+..+++|+.|++++|.+++..+..|..+++|+.+
T Consensus       122 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  158 (285)
T 1ozn_A          122 PGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHL  158 (285)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             HhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEE
Confidence            5666666666666666666665555556666666443

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.50  E-value=2.4e-14  Score=136.87  Aligned_cols=114  Identities=25%  Similarity=0.339  Sum_probs=73.8

Q ss_pred             CccccCCh--hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCC-CCchhhcCCcccCeecccccccCCC
Q 011005            2 YKIGIIPP--EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSG-KIPPEIASMKYLTQLDLSNNNIQGS   78 (496)
Q Consensus         2 n~~~~lp~--~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~-~~p~~~~~l~~L~~l~l~~N~l~~~   78 (496)
                      |+++.++.  .+..+++|++|+|++|.+++..|..|..+++|+.|+|++|.+++ .+|..+..+++|+.|+|++|++++.
T Consensus       111 n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~  190 (306)
T 2z66_A          111 SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL  190 (306)
T ss_dssp             SEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEE
T ss_pred             CcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCc
Confidence            55566554  56666777777777777666666666666667777776666664 3566666666666666666666655


Q ss_pred             CCccccCcccccccccccccCCCCCCCCCCCCCcccc
Q 011005           79 IPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHT  115 (496)
Q Consensus        79 ~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~  115 (496)
                      .|..+..+++|+.|++++|.+++..+..+..+++|+.
T Consensus       191 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  227 (306)
T 2z66_A          191 SPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV  227 (306)
T ss_dssp             CTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCE
T ss_pred             CHHHhcCCCCCCEEECCCCccCccChhhccCcccCCE
Confidence            5666666666666666666666655555666666644

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.49  E-value=4.4e-14  Score=142.79  Aligned_cols=124  Identities=24%  Similarity=0.262  Sum_probs=104.4

Q ss_pred             CccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            2 YKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         2 n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      |.++.+|. .|.++++|+.|+|++|++++ +| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..+
T Consensus       182 ~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  259 (452)
T 3zyi_A          182 KKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIER  259 (452)
T ss_dssp             TTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECT
T ss_pred             CCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECH
Confidence            45555665 57788888888888888884 45 47888999999999999998888889999999999999999997788


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCCCCCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGN  128 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~~  128 (496)
                      ..|..+++|+.|+|++|+|++..+..|..+++|+. +.+.+|++.|+.
T Consensus       260 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~-L~L~~Np~~CdC  306 (452)
T 3zyi_A          260 NAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVE-LHLHHNPWNCDC  306 (452)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCE-EECCSSCEECST
T ss_pred             HHhcCCCCCCEEECCCCcCCccChHHhccccCCCE-EEccCCCcCCCC
Confidence            88999999999999999999888888888998854 578888888864

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.48  E-value=6.2e-14  Score=131.90  Aligned_cols=114  Identities=19%  Similarity=0.188  Sum_probs=60.0

Q ss_pred             CccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            2 YKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         2 n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      |+++.++. .|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..|..|.++++|+.|++++|++++..+
T Consensus        38 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  117 (276)
T 2z62_A           38 NPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN  117 (276)
T ss_dssp             CCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTT
T ss_pred             CcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCc
Confidence            44444444 45555555555555555554444455555555555555555554444455555555555555555554434


Q ss_pred             ccccCcccccccccccccCCCC-CCCCCCCCCcccc
Q 011005           81 GEITKLSRLDYLNLSSNKLSGP-VPFSNNDLSSMHT  115 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~-~~~~~~~l~~l~~  115 (496)
                      ..+..+++|+.|++++|.+++. +|..+..+++|+.
T Consensus       118 ~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~  153 (276)
T 2z62_A          118 FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEH  153 (276)
T ss_dssp             CCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCE
T ss_pred             hhcccCCCCCEEECcCCccceecCchhhccCCCCCE
Confidence            3455555555555555555542 3555555555543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.48  E-value=4.3e-14  Score=146.07  Aligned_cols=97  Identities=30%  Similarity=0.389  Sum_probs=47.7

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC-C
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI-P   80 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~-~   80 (496)
                      |+|+.+|. |++|++|+.|+|++|+|+ .+|..|+.+++|+.|+|++|+|++ +| .+..|++|+.|+|++|+|++.. |
T Consensus       451 n~l~~lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p  526 (567)
T 1dce_A          451 KDLTVLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAI  526 (567)
T ss_dssp             SCCSSCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTT
T ss_pred             CCCCCCcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCc
Confidence            44444444 445555555555555554 444445555555555555555552 34 4445555555555555554333 4


Q ss_pred             ccccCcccccccccccccCCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGP  102 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~  102 (496)
                      ..+..|++|+.|+|++|+|++.
T Consensus       527 ~~l~~l~~L~~L~L~~N~l~~~  548 (567)
T 1dce_A          527 QPLVSCPRLVLLNLQGNSLCQE  548 (567)
T ss_dssp             GGGGGCTTCCEEECTTSGGGGS
T ss_pred             HHHhcCCCCCEEEecCCcCCCC
Confidence            4455555555555555555443

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.47  E-value=6.7e-14  Score=124.61  Aligned_cols=111  Identities=19%  Similarity=0.325  Sum_probs=84.3

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      +|+++.+| .+..+++|++|+|++|.++ .+ ..+..+++|++|+|++|++++..|..+..+++|+.|+|++|++++..|
T Consensus        53 ~n~i~~l~-~l~~l~~L~~L~l~~n~~~-~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~  129 (197)
T 4ezg_A           53 NINVTDLT-GIEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL  129 (197)
T ss_dssp             SSCCSCCT-TGGGCTTCSEEEEESCCCS-CC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGH
T ss_pred             CCCccChH-HHhcCCCCCEEEccCCCCC-cc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhH
Confidence            36777777 6788888888888888765 33 367788888888888888886677778888888888888888876667


Q ss_pred             ccccCccccccccccccc-CCCCCCCCCCCCCccccc
Q 011005           81 GEITKLSRLDYLNLSSNK-LSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~-l~~~~~~~~~~l~~l~~~  116 (496)
                      ..+..+++|+.|++++|. ++ .+| .+..+++|+.+
T Consensus       130 ~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L  164 (197)
T 4ezg_A          130 TKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSL  164 (197)
T ss_dssp             HHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEE
T ss_pred             HHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEE
Confidence            778888888888888887 55 444 56777777554

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.46  E-value=1.2e-13  Score=129.85  Aligned_cols=109  Identities=26%  Similarity=0.283  Sum_probs=61.2

Q ss_pred             CccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCC-C
Q 011005            2 YKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGS-I   79 (496)
Q Consensus         2 n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~-~   79 (496)
                      |+++.++. .|.++++|++|+|++|.+++..++.|.++++|++|++++|++++..+..+..+++|++|+|++|++++. +
T Consensus        62 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l  141 (276)
T 2z62_A           62 CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKL  141 (276)
T ss_dssp             CCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCC
T ss_pred             CcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecC
Confidence            45555554 456666666666666666655555566666666666666666544443555556666666666665532 3


Q ss_pred             CccccCcccccccccccccCCCCCCCCCCCC
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVPFSNNDL  110 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l  110 (496)
                      |..+..+++|+.|++++|.+++..+..+..+
T Consensus       142 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  172 (276)
T 2z62_A          142 PEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL  172 (276)
T ss_dssp             CGGGGGCTTCCEEECCSSCCCEECGGGGHHH
T ss_pred             chhhccCCCCCEEECCCCCCCcCCHHHhhhh
Confidence            5555555555555555555554444444333

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.46  E-value=6.8e-14  Score=136.25  Aligned_cols=98  Identities=24%  Similarity=0.211  Sum_probs=79.7

Q ss_pred             CccccCChhccCCCCCCEEeccC-CccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGS-NSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~-n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      |+++.||. |..+++|+.|+|++ |.|++..|..|..|++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++..+
T Consensus        19 n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~   97 (347)
T 2ifg_A           19 GALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSW   97 (347)
T ss_dssp             CCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCS
T ss_pred             CCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCH
Confidence            36888888 88888888888885 88887777788888888888888888887777788888888888888888885555


Q ss_pred             ccccCcccccccccccccCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSG  101 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~  101 (496)
                      ..+..++ |+.|+|.+|+|..
T Consensus        98 ~~~~~~~-L~~l~l~~N~~~c  117 (347)
T 2ifg_A           98 KTVQGLS-LQELVLSGNPLHC  117 (347)
T ss_dssp             TTTCSCC-CCEEECCSSCCCC
T ss_pred             HHcccCC-ceEEEeeCCCccC
Confidence            5565555 8888888888873

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.46  E-value=6.8e-14  Score=150.78  Aligned_cols=120  Identities=37%  Similarity=0.595  Sum_probs=88.5

Q ss_pred             Cccc-cCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            2 YKIG-IIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         2 n~~~-~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      |++. .+|..++++++|+.|+|++|.+++.+|..|+.+++|+.|+|++|++++.+|..+..+++|+.|+|++|++++.+|
T Consensus       404 n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  483 (768)
T 3rgz_A          404 NGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIP  483 (768)
T ss_dssp             SEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCC
T ss_pred             CccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCC
Confidence            4454 466777777777777777777777777777777777777777777777777777777777777777777777777


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccccccCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN  122 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n  122 (496)
                      ..+.++++|+.|++++|++++.+|.++..+++|+.+ .+++|
T Consensus       484 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L-~L~~N  524 (768)
T 3rgz_A          484 SGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAIL-KLSNN  524 (768)
T ss_dssp             GGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEE-ECCSS
T ss_pred             HHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEE-ECCCC
Confidence            777777777777777777777777777777777544 34443

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.46  E-value=9.8e-14  Score=145.23  Aligned_cols=120  Identities=18%  Similarity=0.196  Sum_probs=106.8

Q ss_pred             CccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            2 YKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         2 n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      |.++.+|. .+.++++|++|+|++|.|++..|..|..+++|++|+|++|.|++..|..|.++++|++|+|++|.+++..+
T Consensus        61 ~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~  140 (597)
T 3oja_B           61 STMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPR  140 (597)
T ss_dssp             CEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             CCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCH
Confidence            66788888 47889999999999999998888899999999999999999998888889999999999999999996556


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccccccCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN  122 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n  122 (496)
                      ..|.++++|+.|++++|.+++..|..|..+++|+.|. ++.|
T Consensus       141 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~-L~~N  181 (597)
T 3oja_B          141 GIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ-LSSN  181 (597)
T ss_dssp             TTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE-CTTS
T ss_pred             HHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEE-CcCC
Confidence            6679999999999999999999999999999997654 4444

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.45  E-value=1.3e-13  Score=136.46  Aligned_cols=121  Identities=17%  Similarity=0.196  Sum_probs=106.3

Q ss_pred             CCccccCChh-ccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            1 MYKIGIIPPE-IGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         1 ~n~~~~lp~~-~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      .|.++.+|.. +..+++|++|+|++|.+++..+..|..+++|++|+|++|++++..|..|..+++|++|+|++|+++...
T Consensus        54 ~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~  133 (390)
T 3o6n_A           54 NSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLP  133 (390)
T ss_dssp             SCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred             CCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCC
Confidence            3678889985 788999999999999999877789999999999999999999877888999999999999999999544


Q ss_pred             CccccCcccccccccccccCCCCCCCCCCCCCccccccccCCC
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN  122 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n  122 (496)
                      +..+..+++|+.|++++|.+++..|..+..+++|+.+. ++.|
T Consensus       134 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~-l~~n  175 (390)
T 3o6n_A          134 RGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ-LSSN  175 (390)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEE-CCSS
T ss_pred             HHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEE-CCCC
Confidence            45579999999999999999999899999999997654 4444

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.45  E-value=1.3e-13  Score=144.64  Aligned_cols=116  Identities=22%  Similarity=0.250  Sum_probs=88.6

Q ss_pred             CCccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            1 MYKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         1 ~n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      +|+++.++. .|.++++|++|+|++|++++..|+.|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..
T Consensus        41 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~  120 (606)
T 3vq2_A           41 FNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLE  120 (606)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSS
T ss_pred             CCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCcccccc
Confidence            366666666 6777888888888888887777777888888888888888888666777888888888888888887656


Q ss_pred             CccccCcccccccccccccCCC-CCCCCCCCCCccccc
Q 011005           80 PGEITKLSRLDYLNLSSNKLSG-PVPFSNNDLSSMHTV  116 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~-~~~~~~~~l~~l~~~  116 (496)
                      +..++++++|+.|++++|.+++ .+|..+.++++|+.+
T Consensus       121 ~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L  158 (606)
T 3vq2_A          121 SFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHV  158 (606)
T ss_dssp             SSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEE
T ss_pred             ccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEE
Confidence            5677788888888888888875 457777777777654

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.45  E-value=1.6e-14  Score=154.01  Aligned_cols=116  Identities=22%  Similarity=0.367  Sum_probs=74.3

Q ss_pred             ccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCcc
Q 011005            3 KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGE   82 (496)
Q Consensus         3 ~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~   82 (496)
                      ++...|..+..+++|+.|+|++|.|. .+|..+..+++|++|+|++|+|+ .+|..|.+|++|+.|+|++|+|+ .+|..
T Consensus       212 ~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~  288 (727)
T 4b8c_D          212 RMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAE  288 (727)
T ss_dssp             ----------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSS
T ss_pred             ceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChh
Confidence            34444556777777777777777776 55656667777777777777777 67777777777777777777777 66777


Q ss_pred             ccCcccccccccccccCCCCCCCCCCCCCccccccccCCCC
Q 011005           83 ITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN  123 (496)
Q Consensus        83 ~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~  123 (496)
                      |.+|++|+.|+|++|.|+ .+|..|..+++|+.| .+++|.
T Consensus       289 ~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L-~L~~N~  327 (727)
T 4b8c_D          289 LGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFL-GVEGNP  327 (727)
T ss_dssp             GGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCE-ECTTSC
T ss_pred             hcCCCCCCEEECCCCCCC-ccChhhhcCCCccEE-eCCCCc
Confidence            777777777777777776 556667777777543 444443

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.44  E-value=1.3e-13  Score=131.75  Aligned_cols=115  Identities=26%  Similarity=0.302  Sum_probs=82.4

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCC-ccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCC-CC
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIP-SALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQG-SI   79 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p-~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~-~~   79 (496)
                      |++..+|..+..+++|++|+|++|++++..+ ..+..+++|++|+|++|.+++..|..+..+++|+.|+|++|.+++ .+
T Consensus        88 n~i~~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  167 (306)
T 2z66_A           88 NGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL  167 (306)
T ss_dssp             CSEEEEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEE
T ss_pred             CccccChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccc
Confidence            5666677777777777777777777775443 467777777777777777776666677777777777777777764 45


Q ss_pred             CccccCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      |..+..+++|+.|++++|.+++..|..+..+++|+.+
T Consensus       168 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L  204 (306)
T 2z66_A          168 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL  204 (306)
T ss_dssp             CSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             hhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEE
Confidence            6677777777777777777777667777777777554

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.44  E-value=1.3e-13  Score=122.77  Aligned_cols=102  Identities=25%  Similarity=0.340  Sum_probs=59.2

Q ss_pred             hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccc-cCCCCCccccCccc
Q 011005           10 EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNN-IQGSIPGEITKLSR   88 (496)
Q Consensus        10 ~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~-l~~~~~~~~~~l~~   88 (496)
                      .+..+++|++|+|++|.+++..|..|..+++|++|+|++|++++..|..+..+++|+.|+|++|. ++ .+| .+..+++
T Consensus        83 ~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~  160 (197)
T 4ezg_A           83 PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPE  160 (197)
T ss_dssp             GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSS
T ss_pred             hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCC
Confidence            45556666666666666655455556666666666666666665555556666666666666665 44 333 4556666


Q ss_pred             ccccccccccCCCCCCCCCCCCCcccc
Q 011005           89 LDYLNLSSNKLSGPVPFSNNDLSSMHT  115 (496)
Q Consensus        89 L~~l~l~~n~l~~~~~~~~~~l~~l~~  115 (496)
                      |+.|++++|.+++..  .+..+++|+.
T Consensus       161 L~~L~l~~n~i~~~~--~l~~l~~L~~  185 (197)
T 4ezg_A          161 LKSLNIQFDGVHDYR--GIEDFPKLNQ  185 (197)
T ss_dssp             CCEEECTTBCCCCCT--TGGGCSSCCE
T ss_pred             CCEEECCCCCCcChH--HhccCCCCCE
Confidence            666666666665422  4555555543

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.44  E-value=1.1e-13  Score=140.95  Aligned_cols=100  Identities=26%  Similarity=0.324  Sum_probs=47.7

Q ss_pred             CCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCcccccccccc
Q 011005           16 NLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLS   95 (496)
Q Consensus        16 ~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~l~l~   95 (496)
                      +|+.|+|++|+|++..|..|.++++|++|+|++|.|++..|..|.++++|++|+|++|++++..+..|.++++|+.|+++
T Consensus        33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  112 (477)
T 2id5_A           33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDIS  112 (477)
T ss_dssp             TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECT
T ss_pred             CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECC
Confidence            44455555555544444444445555555555555444444444445555555555554443333334444455555555


Q ss_pred             cccCCCCCCCCCCCCCcccc
Q 011005           96 SNKLSGPVPFSNNDLSSMHT  115 (496)
Q Consensus        96 ~n~l~~~~~~~~~~l~~l~~  115 (496)
                      +|.+++..|..|..+++|+.
T Consensus       113 ~n~i~~~~~~~~~~l~~L~~  132 (477)
T 2id5_A          113 ENKIVILLDYMFQDLYNLKS  132 (477)
T ss_dssp             TSCCCEECTTTTTTCTTCCE
T ss_pred             CCccccCChhHccccccCCE
Confidence            55444444444444444433

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.44  E-value=4.7e-14  Score=123.17  Aligned_cols=82  Identities=21%  Similarity=0.270  Sum_probs=37.9

Q ss_pred             CCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc--cccCcccccccc
Q 011005           16 NLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG--EITKLSRLDYLN   93 (496)
Q Consensus        16 ~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~--~~~~l~~L~~l~   93 (496)
                      +|+.|+|++|.|++.  +.|..+++|++|+|++|+|++..|..+..+++|+.|+|++|+++ .+|.  .+..+++|+.|+
T Consensus        43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~  119 (176)
T 1a9n_A           43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC  119 (176)
T ss_dssp             CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred             CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence            455555555554432  34444455555555555554322222344455555555555554 3333  444444555555


Q ss_pred             cccccCC
Q 011005           94 LSSNKLS  100 (496)
Q Consensus        94 l~~n~l~  100 (496)
                      +++|+++
T Consensus       120 l~~N~i~  126 (176)
T 1a9n_A          120 ILRNPVT  126 (176)
T ss_dssp             CCSSGGG
T ss_pred             ecCCCCC
Confidence            5555544

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.43  E-value=4.5e-14  Score=148.78  Aligned_cols=119  Identities=15%  Similarity=0.314  Sum_probs=100.7

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCC-----------------CCccCC--CCCCCCEEeccCCcCCCCCchhhcCC
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGP-----------------IPSALG--SLTNLSNLDLSSNKLSGKIPPEIASM   62 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~-----------------~p~~~~--~l~~L~~l~l~~n~l~~~~p~~~~~l   62 (496)
                      |+++.+|..|+++++|++|+|++|.+++.                 +|+.++  ++++|++|+|++|++.+.+|+.+.++
T Consensus       193 n~l~~ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l  272 (636)
T 4eco_A          193 NNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL  272 (636)
T ss_dssp             CEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTC
T ss_pred             CCCccCCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcC
Confidence            57777899999999999999999999874                 888888  99999999999999998999999999


Q ss_pred             cccCeecccccc-cCC-CCCccccCc------ccccccccccccCCCCCCC--CCCCCCccccccccCCC
Q 011005           63 KYLTQLDLSNNN-IQG-SIPGEITKL------SRLDYLNLSSNKLSGPVPF--SNNDLSSMHTVVSLSPN  122 (496)
Q Consensus        63 ~~L~~l~l~~N~-l~~-~~~~~~~~l------~~L~~l~l~~n~l~~~~~~--~~~~l~~l~~~~~~~~n  122 (496)
                      ++|++|+|++|+ +++ .+|..+..+      ++|+.|++++|.++ .+|.  .+.++++|+.+ .++.|
T Consensus       273 ~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L-~L~~N  340 (636)
T 4eco_A          273 PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGML-ECLYN  340 (636)
T ss_dssp             SSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEE-ECCSC
T ss_pred             CCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEE-eCcCC
Confidence            999999999998 887 788877776      88999999999988 7777  88888888665 34433

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.42  E-value=1.9e-13  Score=145.69  Aligned_cols=121  Identities=27%  Similarity=0.346  Sum_probs=107.0

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      .|++..+|..+.+|++|++|+|++|.|+ .+|..|+.|++|++|+|++|+|+ .+|..|.+|++|+.|+|++|.|+ .+|
T Consensus       233 ~n~l~~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp  309 (727)
T 4b8c_D          233 NLQIFNISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLP  309 (727)
T ss_dssp             TSCCSCCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCC
T ss_pred             CCCCCCCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccC
Confidence            4889999999999999999999999999 88999999999999999999999 78999999999999999999998 788


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNG  124 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~  124 (496)
                      ..|..|++|+.|+|++|+|++.+|..+..+..+...+.+.+|..
T Consensus       310 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l  353 (727)
T 4b8c_D          310 WEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRP  353 (727)
T ss_dssp             SSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCC
T ss_pred             hhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcc
Confidence            88999999999999999999998888766544333344555543

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.42  E-value=1.9e-13  Score=142.32  Aligned_cols=125  Identities=25%  Similarity=0.332  Sum_probs=89.0

Q ss_pred             CccccCCh--hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCC-CCCchhhcCCcccCeecccccccCCC
Q 011005            2 YKIGIIPP--EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLS-GKIPPEIASMKYLTQLDLSNNNIQGS   78 (496)
Q Consensus         2 n~~~~lp~--~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~-~~~p~~~~~l~~L~~l~l~~N~l~~~   78 (496)
                      |++..++.  .+.++++|++|+|++|.+.+..|..|..+++|+.|+|++|.++ +.+|..+..+++|+.|+|++|++++.
T Consensus       406 n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~  485 (570)
T 2z63_A          406 SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL  485 (570)
T ss_dssp             SEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEE
T ss_pred             CccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccC
Confidence            44554433  5667777777777777777667777777777777777777776 45677777777777777777777766


Q ss_pred             CCccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCCCCCC
Q 011005           79 IPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCG  127 (496)
Q Consensus        79 ~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~  127 (496)
                      .|..+..+++|+.|++++|++++..|..|..+++|+. +.+.+|+..|.
T Consensus       486 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~-L~l~~N~~~~~  533 (570)
T 2z63_A          486 SPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQK-IWLHTNPWDCS  533 (570)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE-EECCSSCBCCC
T ss_pred             ChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcE-EEecCCcccCC
Confidence            6777777777777888777777777777777777744 45666766654

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.42  E-value=2e-13  Score=133.29  Aligned_cols=113  Identities=25%  Similarity=0.254  Sum_probs=74.4

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |.++.+|..+.  ++|++|+|++|+|++..++.|.++++|+.|+|++|+|++..|..|.++++|++|+|++|++++..+.
T Consensus        41 ~~l~~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~  118 (353)
T 2z80_A           41 GSLNSIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSS  118 (353)
T ss_dssp             TTCSSCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHH
T ss_pred             CCccccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHh
Confidence            55666776554  3677777777777755555677777777777777777765566677777777777777777743334


Q ss_pred             cccCcccccccccccccCCCCCC-CCCCCCCccccc
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVP-FSNNDLSSMHTV  116 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~-~~~~~l~~l~~~  116 (496)
                      .+..+++|+.|++++|++++..+ ..+..+++|+.+
T Consensus       119 ~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L  154 (353)
T 2z80_A          119 WFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQIL  154 (353)
T ss_dssp             HHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred             HhCCCccCCEEECCCCCCcccCchhhhccCCCCcEE
Confidence            46677777777777777774444 456666666544

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.42  E-value=1.2e-13  Score=127.03  Aligned_cols=111  Identities=18%  Similarity=0.286  Sum_probs=74.2

Q ss_pred             CccccCCh-hccCCCCCCEEeccCCc-cCCCCCccCCCCCCCCEEeccC-CcCCCCCchhhcCCcccCeecccccccCCC
Q 011005            2 YKIGIIPP-EIGNLKNLIKLDVGSNS-LIGPIPSALGSLTNLSNLDLSS-NKLSGKIPPEIASMKYLTQLDLSNNNIQGS   78 (496)
Q Consensus         2 n~~~~lp~-~~~~l~~L~~L~l~~n~-i~~~~p~~~~~l~~L~~l~l~~-n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~   78 (496)
                      |+++.+|. .|.++++|+.|+|++|+ +++..+..|.++++|++|+|++ |+|++..+..|..+++|+.|+|++|++++ 
T Consensus        41 n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-  119 (239)
T 2xwt_C           41 THLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-  119 (239)
T ss_dssp             CCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-
T ss_pred             CcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-
Confidence            56666666 56677777777777775 6655555667777777777776 77775444566677777777777777763 


Q ss_pred             CCccccCccccc---ccccccc-cCCCCCCCCCCCCCccc
Q 011005           79 IPGEITKLSRLD---YLNLSSN-KLSGPVPFSNNDLSSMH  114 (496)
Q Consensus        79 ~~~~~~~l~~L~---~l~l~~n-~l~~~~~~~~~~l~~l~  114 (496)
                      +|. +..+++|+   .|++++| .+++..+..|..+++|+
T Consensus       120 lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~  158 (239)
T 2xwt_C          120 FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNET  158 (239)
T ss_dssp             CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSE
T ss_pred             ccc-cccccccccccEEECCCCcchhhcCcccccchhcce
Confidence            554 66666666   7777777 67666666677777665

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.40  E-value=3.2e-13  Score=131.84  Aligned_cols=117  Identities=22%  Similarity=0.195  Sum_probs=102.9

Q ss_pred             CCccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            1 MYKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         1 ~n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      +|+++.+|. .|.++++|+.|+|++|++++..|+.|.++++|++|+|++|+|++..+..+..+++|++|+|++|++++..
T Consensus        61 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~  140 (353)
T 2z80_A           61 NNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLG  140 (353)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSC
T ss_pred             CCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccC
Confidence            478888888 7999999999999999999888889999999999999999999655455999999999999999999443


Q ss_pred             C-ccccCcccccccccccc-cCCCCCCCCCCCCCcccccc
Q 011005           80 P-GEITKLSRLDYLNLSSN-KLSGPVPFSNNDLSSMHTVV  117 (496)
Q Consensus        80 ~-~~~~~l~~L~~l~l~~n-~l~~~~~~~~~~l~~l~~~~  117 (496)
                      + ..+..+++|+.|++++| .+++..+..|.++++|+.+.
T Consensus       141 ~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~  180 (353)
T 2z80_A          141 ETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELE  180 (353)
T ss_dssp             SSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEE
T ss_pred             chhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEE
Confidence            3 47999999999999999 57777788999999997653

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.40  E-value=5.3e-13  Score=142.04  Aligned_cols=116  Identities=28%  Similarity=0.285  Sum_probs=91.2

Q ss_pred             CCccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            1 MYKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         1 ~n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      +|+++.+|. .|.++++|++|+|++|.+++..|+.|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..
T Consensus        34 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~  113 (680)
T 1ziw_A           34 HNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIK  113 (680)
T ss_dssp             SSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCC
T ss_pred             CCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccC
Confidence            366777776 5788888888888888888777777888888888888888888544446888888888888888887666


Q ss_pred             CccccCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      |..|.++++|+.|++++|.+++..|..+.++++|+.+
T Consensus       114 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L  150 (680)
T 1ziw_A          114 NNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQEL  150 (680)
T ss_dssp             SCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEE
T ss_pred             hhHccccCCCCEEECCCCcccccCchhhcccccCCEE
Confidence            6778888888888888888888878778888887655

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.40  E-value=1.9e-13  Score=148.93  Aligned_cols=90  Identities=26%  Similarity=0.366  Sum_probs=55.0

Q ss_pred             ccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCcccccccccccccCCCCCCCCCCCCCc
Q 011005           33 SALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSS  112 (496)
Q Consensus        33 ~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~  112 (496)
                      +.|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..+..+.  ++|+.|++++|+|++..|..|.++. 
T Consensus       474 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~-  550 (844)
T 3j0a_A          474 DVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLS-  550 (844)
T ss_dssp             SCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCC-
T ss_pred             hhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcC-
Confidence            3455556666666666666655555566666666666666666644444443  5666666666666666666655433 


Q ss_pred             cccccccCCCCCCCCC
Q 011005          113 MHTVVSLSPNNGLCGN  128 (496)
Q Consensus       113 l~~~~~~~~n~~~c~~  128 (496)
                         .+.+.+|++.|+.
T Consensus       551 ---~l~l~~Np~~C~c  563 (844)
T 3j0a_A          551 ---VLDITHNKFICEC  563 (844)
T ss_dssp             ---EEEEEEECCCCSS
T ss_pred             ---EEEecCCCccccc
Confidence               2467788888853

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.40  E-value=7.6e-14  Score=150.34  Aligned_cols=119  Identities=18%  Similarity=0.280  Sum_probs=101.8

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCC-----------------CCCccCC--CCCCCCEEeccCCcCCCCCchhhcCC
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIG-----------------PIPSALG--SLTNLSNLDLSSNKLSGKIPPEIASM   62 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~-----------------~~p~~~~--~l~~L~~l~l~~n~l~~~~p~~~~~l   62 (496)
                      |+++.||..|++|++|+.|+|++|+|++                 .+|+.++  ++++|+.|+|++|++.+.+|..|.+|
T Consensus       435 N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L  514 (876)
T 4ecn_A          435 NRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDL  514 (876)
T ss_dssp             CEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGC
T ss_pred             CcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCC
Confidence            6777799999999999999999999997                 2888887  99999999999999999999999999


Q ss_pred             cccCeecccccc-cCC-CCCccccCcc-------cccccccccccCCCCCCC--CCCCCCccccccccCCC
Q 011005           63 KYLTQLDLSNNN-IQG-SIPGEITKLS-------RLDYLNLSSNKLSGPVPF--SNNDLSSMHTVVSLSPN  122 (496)
Q Consensus        63 ~~L~~l~l~~N~-l~~-~~~~~~~~l~-------~L~~l~l~~n~l~~~~~~--~~~~l~~l~~~~~~~~n  122 (496)
                      ++|+.|+|++|+ +++ .+|..+..++       +|+.|++++|.++ .+|.  .+.++++|+.| .++.|
T Consensus       515 ~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L-~Ls~N  583 (876)
T 4ecn_A          515 PELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLL-DCVHN  583 (876)
T ss_dssp             SSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEE-ECTTS
T ss_pred             CCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEE-ECCCC
Confidence            999999999998 887 6787776665       8999999999999 7787  88888888665 34444

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.39  E-value=1.8e-13  Score=115.92  Aligned_cols=107  Identities=20%  Similarity=0.251  Sum_probs=94.1

Q ss_pred             CCCCCCEEeccCCccC-CCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCcccccc
Q 011005           13 NLKNLIKLDVGSNSLI-GPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDY   91 (496)
Q Consensus        13 ~l~~L~~L~l~~n~i~-~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~   91 (496)
                      ..++|+.|++++|.++ +.+|..+..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|++++.+|..+..+++|+.
T Consensus        15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~   92 (149)
T 2je0_A           15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH   92 (149)
T ss_dssp             CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred             CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence            4578999999999998 78888999999999999999999965  78999999999999999999778888888999999


Q ss_pred             cccccccCCCC-CCCCCCCCCccccccccCCC
Q 011005           92 LNLSSNKLSGP-VPFSNNDLSSMHTVVSLSPN  122 (496)
Q Consensus        92 l~l~~n~l~~~-~~~~~~~l~~l~~~~~~~~n  122 (496)
                      |++++|.+++. .+..+..+++|+.+ .+++|
T Consensus        93 L~ls~N~i~~~~~~~~~~~l~~L~~L-~l~~N  123 (149)
T 2je0_A           93 LNLSGNKIKDLSTIEPLKKLENLKSL-DLFNC  123 (149)
T ss_dssp             EECTTSCCCSHHHHGGGGGCTTCCEE-ECTTC
T ss_pred             EECCCCcCCChHHHHHHhhCCCCCEE-eCcCC
Confidence            99999999974 34788889998665 44444

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.39  E-value=5.5e-13  Score=139.96  Aligned_cols=119  Identities=23%  Similarity=0.286  Sum_probs=108.0

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      ++.++.+|..+.  ++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|
T Consensus        20 ~~~l~~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p   97 (606)
T 3vq2_A           20 DQKLSKVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSP   97 (606)
T ss_dssp             TSCCSSCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCT
T ss_pred             CCCcccCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccCh
Confidence            357888998765  789999999999998888899999999999999999998788899999999999999999998779


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccccccCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN  122 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n  122 (496)
                      ..|.++++|+.|++++|.+++..+..+.++++|+.+. ++.|
T Consensus        98 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~-L~~n  138 (606)
T 3vq2_A           98 GSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLN-VAHN  138 (606)
T ss_dssp             TSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEE-CCSS
T ss_pred             hhcCCcccCCEEEccCCccccccccccCCCCCCCEEe-CCCC
Confidence            9999999999999999999988889999999997764 4444

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.39  E-value=3.3e-13  Score=139.87  Aligned_cols=113  Identities=26%  Similarity=0.269  Sum_probs=67.5

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |.++.+|..+.  ++|++|+|++|++++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|++++..|.
T Consensus        15 ~~l~~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~   92 (549)
T 2z81_A           15 RSFTSIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSS   92 (549)
T ss_dssp             SCCSSCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHH
T ss_pred             CccccccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHH
Confidence            45556665443  4566666666666655555666666666666666666655555666666666666666666654444


Q ss_pred             cccCcccccccccccccCCC-CCCCCCCCCCccccc
Q 011005           82 EITKLSRLDYLNLSSNKLSG-PVPFSNNDLSSMHTV  116 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~-~~~~~~~~l~~l~~~  116 (496)
                      .++++++|+.|++++|.+++ ..|..+.++++|+.+
T Consensus        93 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L  128 (549)
T 2z81_A           93 WFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL  128 (549)
T ss_dssp             HHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred             HhccCCCCcEEECCCCcccccchhhhhhccCCccEE
Confidence            56666666666666666654 234555556655443

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.39  E-value=7e-13  Score=133.96  Aligned_cols=113  Identities=20%  Similarity=0.222  Sum_probs=80.0

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      +.++.+|..+.  ++|+.|+|++|+|++..|+.|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..+.
T Consensus        64 ~~l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  141 (452)
T 3zyi_A           64 RGLSEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSG  141 (452)
T ss_dssp             SCCSSCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTT
T ss_pred             CCcCccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChh
Confidence            34566666544  4677777777777766677777777777777777777766666777777777777777777755555


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      .|..+++|+.|++++|.|+...+..|..+++|+.|
T Consensus       142 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  176 (452)
T 3zyi_A          142 AFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRL  176 (452)
T ss_dssp             TSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEE
T ss_pred             hhcccCCCCEEECCCCCcceeCHhHHhcCCcccEE
Confidence            67777777777777777776666667777766554

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.39  E-value=2.3e-13  Score=140.17  Aligned_cols=111  Identities=22%  Similarity=0.225  Sum_probs=91.2

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      +|+++.+|..+.  ++|++|+|++|.|++..|+.|..+++|++|+|++|+|++..|..|..+++|++|+|++|+++ .+|
T Consensus         9 ~n~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp   85 (520)
T 2z7x_B            9 KNGLIHVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KIS   85 (520)
T ss_dssp             TSCCSSCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEE
T ss_pred             CCCccccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecC
Confidence            477888888766  78888888888888777778888888888888888888777888888888888888888888 566


Q ss_pred             ccccCcccccccccccccCCC-CCCCCCCCCCccccc
Q 011005           81 GEITKLSRLDYLNLSSNKLSG-PVPFSNNDLSSMHTV  116 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~-~~~~~~~~l~~l~~~  116 (496)
                      ..  .+++|+.|++++|.+++ ..|..|..+++|+.+
T Consensus        86 ~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L  120 (520)
T 2z7x_B           86 CH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFL  120 (520)
T ss_dssp             CC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEE
T ss_pred             cc--ccCCccEEeccCCccccccchhhhccCCcceEE
Confidence            55  78888888888888887 467888888888665

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.39  E-value=5.5e-13  Score=139.97  Aligned_cols=115  Identities=19%  Similarity=0.109  Sum_probs=71.7

Q ss_pred             CccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            2 YKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         2 n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      |+|+.+++ .|+++++|++|+|++|++++..|+.|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..+
T Consensus        43 n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~  122 (606)
T 3t6q_A           43 NVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDF  122 (606)
T ss_dssp             CCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGG
T ss_pred             CccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCc
Confidence            55555533 56666666666666666666666666666666666666666665556666666666666666666664445


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      ..+.++++|+.|++++|.+++.....+..+++|+.+
T Consensus       123 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  158 (606)
T 3t6q_A          123 IPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVL  158 (606)
T ss_dssp             SCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEE
T ss_pred             chhccCCcccEEECCCCcccccCcccccCCcccCEE
Confidence            566666666666666666665433333335555443

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.39  E-value=9.6e-13  Score=127.13  Aligned_cols=106  Identities=25%  Similarity=0.361  Sum_probs=66.9

Q ss_pred             CChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCc
Q 011005            7 IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKL   86 (496)
Q Consensus         7 lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l   86 (496)
                      .+..+.++++|+.|++++|.++ .+|..+.  ++|+.|+|++|++++..|..+..+++|+.|+|++|++++..+..+..+
T Consensus       163 ~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l  239 (330)
T 1xku_A          163 ENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT  239 (330)
T ss_dssp             CTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGS
T ss_pred             ChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCC
Confidence            4456677777777777777766 3444333  566666666666665556666666666666666666665555566666


Q ss_pred             ccccccccccccCCCCCCCCCCCCCccccc
Q 011005           87 SRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        87 ~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      ++|+.|++++|.++ .+|..+..+++|+.+
T Consensus       240 ~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L  268 (330)
T 1xku_A          240 PHLRELHLNNNKLV-KVPGGLADHKYIQVV  268 (330)
T ss_dssp             TTCCEEECCSSCCS-SCCTTTTTCSSCCEE
T ss_pred             CCCCEEECCCCcCc-cCChhhccCCCcCEE
Confidence            66666666666666 555566666666443

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.38  E-value=1.2e-13  Score=145.63  Aligned_cols=113  Identities=20%  Similarity=0.413  Sum_probs=103.2

Q ss_pred             CChhcc--CCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCc-CCC-CCchhhcCC------cccCeecccccccC
Q 011005            7 IPPEIG--NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNK-LSG-KIPPEIASM------KYLTQLDLSNNNIQ   76 (496)
Q Consensus         7 lp~~~~--~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~-l~~-~~p~~~~~l------~~L~~l~l~~N~l~   76 (496)
                      +|+.++  ++++|++|+|++|++.+.+|+.|+++++|++|+|++|+ +++ .+|..+..+      ++|+.|+|++|+++
T Consensus       239 ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~  318 (636)
T 4eco_A          239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK  318 (636)
T ss_dssp             TTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS
T ss_pred             CchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC
Confidence            999999  99999999999999999999999999999999999998 998 799988887      99999999999999


Q ss_pred             CCCCc--cccCcccccccccccccCCCCCCCCCCCCCccccccccCCC
Q 011005           77 GSIPG--EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN  122 (496)
Q Consensus        77 ~~~~~--~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n  122 (496)
                       .+|.  .+.++++|+.|++++|.++|.+| .+..+++|+.+ .++.|
T Consensus       319 -~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L-~L~~N  363 (636)
T 4eco_A          319 -TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASL-NLAYN  363 (636)
T ss_dssp             -SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEE-ECCSS
T ss_pred             -ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEE-ECCCC
Confidence             8888  89999999999999999998888 88888888665 34444

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.38  E-value=8.7e-13  Score=132.74  Aligned_cols=112  Identities=21%  Similarity=0.261  Sum_probs=70.8

Q ss_pred             ccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCcc
Q 011005            3 KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGE   82 (496)
Q Consensus         3 ~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~   82 (496)
                      .++.+|..+.  ++++.|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|++++..+..
T Consensus        54 ~l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~  131 (440)
T 3zyj_A           54 NLREVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGA  131 (440)
T ss_dssp             CCSSCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTT
T ss_pred             CcCcCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhH
Confidence            4555665443  45666666666666555566666666666666666666555566666666666666666666444445


Q ss_pred             ccCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           83 ITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        83 ~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      |..+++|+.|++++|.|+...+..|..+++|+.+
T Consensus       132 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  165 (440)
T 3zyj_A          132 FVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRL  165 (440)
T ss_dssp             SCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEE
T ss_pred             hhccccCceeeCCCCcccccCHHHhhhCcccCEe
Confidence            6666666666666666665555566666666443

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.38  E-value=9.1e-13  Score=127.41  Aligned_cols=106  Identities=20%  Similarity=0.245  Sum_probs=72.3

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |+++.+|..+.  ++|+.|+|++|.+++..|..|..+++|+.|+|++|+|++..|..+..+++|+.|+|++|+++ .+|.
T Consensus       182 n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~  258 (332)
T 2ft3_A          182 AKLTGIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPA  258 (332)
T ss_dssp             SBCSSCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCT
T ss_pred             CCCCccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecCh
Confidence            45555555443  56777777777777666666777777777777777777655556777777777777777777 6666


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCC
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDL  110 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l  110 (496)
                      .+..+++|+.|++++|+|++..+..|..+
T Consensus       259 ~l~~l~~L~~L~l~~N~l~~~~~~~~~~~  287 (332)
T 2ft3_A          259 GLPDLKLLQVVYLHTNNITKVGVNDFCPV  287 (332)
T ss_dssp             TGGGCTTCCEEECCSSCCCBCCTTSSSCS
T ss_pred             hhhcCccCCEEECCCCCCCccChhHcccc
Confidence            67777777777777777776666666543

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.38  E-value=6.3e-13  Score=138.37  Aligned_cols=116  Identities=19%  Similarity=0.204  Sum_probs=88.2

Q ss_pred             CCccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            1 MYKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         1 ~n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      +|+++.++. .|.++++|++|+|++|++++..|+.|.++++|++|+|++|++++..|..|..+++|++|+|++|++++..
T Consensus        37 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~  116 (570)
T 2z63_A           37 FNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE  116 (570)
T ss_dssp             SCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCST
T ss_pred             CCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCC
Confidence            366666655 6778888888888888887766777888888888888888887666677888888888888888887544


Q ss_pred             CccccCcccccccccccccCCC-CCCCCCCCCCccccc
Q 011005           80 PGEITKLSRLDYLNLSSNKLSG-PVPFSNNDLSSMHTV  116 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~-~~~~~~~~l~~l~~~  116 (496)
                      +..++++++|+.|++++|.+++ .+|..+.++++|+.+
T Consensus       117 ~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L  154 (570)
T 2z63_A          117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL  154 (570)
T ss_dssp             TCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEE
T ss_pred             CccccccccccEEecCCCccceecChhhhcccCCCCEE
Confidence            4467788888888888888876 357777777777654

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.38  E-value=5e-13  Score=115.64  Aligned_cols=99  Identities=25%  Similarity=0.346  Sum_probs=88.6

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCc--hhhcCCcccCeecccccccCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIP--PEIASMKYLTQLDLSNNNIQGS   78 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p--~~~~~l~~L~~l~l~~N~l~~~   78 (496)
                      .|+++.+ ..+..+++|++|+|++|++++.+|..+..+++|+.|+|++|+|++ +|  ..+..+++|+.|+|++|.+++.
T Consensus        58 ~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~l~~l~~L~~L~l~~N~l~~~  135 (168)
T 2ell_A           58 NVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD-ISTLEPLKKLECLKSLDLFNCEVTNL  135 (168)
T ss_dssp             SSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCS-SGGGGGGSSCSCCCEEECCSSGGGTS
T ss_pred             CCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCc-chhHHHHhcCCCCCEEEeeCCcCcch
Confidence            4778888 788999999999999999998788888889999999999999995 44  7899999999999999999955


Q ss_pred             CC---ccccCcccccccccccccCCC
Q 011005           79 IP---GEITKLSRLDYLNLSSNKLSG  101 (496)
Q Consensus        79 ~~---~~~~~l~~L~~l~l~~n~l~~  101 (496)
                      .+   ..+..+++|+.|++++|.+..
T Consensus       136 ~~~~~~~~~~l~~L~~L~l~~n~~~~  161 (168)
T 2ell_A          136 NDYRESVFKLLPQLTYLDGYDREDQE  161 (168)
T ss_dssp             TTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred             HHHHHHHHHhCccCcEecCCCCChhh
Confidence            44   489999999999999999983

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.38  E-value=3.5e-13  Score=137.20  Aligned_cols=117  Identities=25%  Similarity=0.272  Sum_probs=103.5

Q ss_pred             CCccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            1 MYKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         1 ~n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      +|+++.++. .|.++++|++|+|++|.|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|++++..
T Consensus        41 ~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~  120 (477)
T 2id5_A           41 KNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILL  120 (477)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEEC
T ss_pred             CCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCC
Confidence            477888765 8999999999999999999888999999999999999999999655566889999999999999999778


Q ss_pred             CccccCcccccccccccccCCCCCCCCCCCCCcccccc
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVV  117 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~  117 (496)
                      +..|..+++|+.|++++|.+++..+..|.++++|+.+.
T Consensus       121 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  158 (477)
T 2id5_A          121 DYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLT  158 (477)
T ss_dssp             TTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEE
T ss_pred             hhHccccccCCEEECCCCccceeChhhccCCCCCCEEE
Confidence            88899999999999999999988888999999887654

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.37  E-value=4.2e-13  Score=135.66  Aligned_cols=115  Identities=21%  Similarity=0.260  Sum_probs=83.2

Q ss_pred             CccccC-ChhccCCCCCCEEeccCCccCCCC-CccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            2 YKIGII-PPEIGNLKNLIKLDVGSNSLIGPI-PSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         2 n~~~~l-p~~~~~l~~L~~L~l~~n~i~~~~-p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      |+++.+ |..|+++++|++|+|++|.+.+.+ |..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++..
T Consensus        40 n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  119 (455)
T 3v47_A           40 NSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAV  119 (455)
T ss_dssp             SCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHH
T ss_pred             CccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccc
Confidence            566665 446777778888888887776433 556777788888888888877666777777888888888888777544


Q ss_pred             Ccc--ccCcccccccccccccCCCCCCCC-CCCCCccccc
Q 011005           80 PGE--ITKLSRLDYLNLSSNKLSGPVPFS-NNDLSSMHTV  116 (496)
Q Consensus        80 ~~~--~~~l~~L~~l~l~~n~l~~~~~~~-~~~l~~l~~~  116 (496)
                      +..  +..+++|+.|++++|.+++..|.. +.++++|+.+
T Consensus       120 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L  159 (455)
T 3v47_A          120 LSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVL  159 (455)
T ss_dssp             HHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEE
T ss_pred             cCcccccCcccCCEEECCCCccCccCcccccCCCCcccEE
Confidence            443  777778888888888887776665 6777777554

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.37  E-value=3e-13  Score=142.01  Aligned_cols=103  Identities=20%  Similarity=0.219  Sum_probs=63.9

Q ss_pred             ccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCC---CchhhcCCcccCeecccccccCCCCCccccCcc
Q 011005           11 IGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGK---IPPEIASMKYLTQLDLSNNNIQGSIPGEITKLS   87 (496)
Q Consensus        11 ~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~---~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~   87 (496)
                      +.++++|+.|+|++|.+.+..|..|..+++|+.|+|++|++++.   .+..+..+++|+.|+|++|++++..|..+..++
T Consensus       421 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~  500 (606)
T 3t6q_A          421 FQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLK  500 (606)
T ss_dssp             TTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred             hhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhcccc
Confidence            66666666666666666666666666666666666666666541   224456666666666666666655555666666


Q ss_pred             cccccccccccCCCCCCCCCCCCCcc
Q 011005           88 RLDYLNLSSNKLSGPVPFSNNDLSSM  113 (496)
Q Consensus        88 ~L~~l~l~~n~l~~~~~~~~~~l~~l  113 (496)
                      +|+.|++++|++++..|..+..+++|
T Consensus       501 ~L~~L~Ls~N~l~~~~~~~l~~l~~L  526 (606)
T 3t6q_A          501 MMNHVDLSHNRLTSSSIEALSHLKGI  526 (606)
T ss_dssp             TCCEEECCSSCCCGGGGGGGTTCCSC
T ss_pred             CCCEEECCCCccCcCChhHhCccccc
Confidence            66666666666666555555555555

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.37  E-value=6.2e-13  Score=138.20  Aligned_cols=112  Identities=22%  Similarity=0.219  Sum_probs=93.2

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      +|+++.+|..+.  ++|+.|+|++|.|++..|+.|.++++|++|+|++|+|++..|..|.++++|++|+|++|+++ .+|
T Consensus        40 ~~~L~~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp  116 (562)
T 3a79_B           40 NRNLTHVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NIS  116 (562)
T ss_dssp             TSCCCSCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EEC
T ss_pred             CCCCccCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccC
Confidence            467888888664  78999999999998777788999999999999999998777888889999999999999988 566


Q ss_pred             ccccCcccccccccccccCCC-CCCCCCCCCCcccccc
Q 011005           81 GEITKLSRLDYLNLSSNKLSG-PVPFSNNDLSSMHTVV  117 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~-~~~~~~~~l~~l~~~~  117 (496)
                      ..  .+++|+.|++++|.+++ ..|..|.++++|+.+.
T Consensus       117 ~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~  152 (562)
T 3a79_B          117 CC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLG  152 (562)
T ss_dssp             SC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEE
T ss_pred             cc--ccccCCEEECCCCCccccCchHhhcccCcccEEe
Confidence            65  78899999999999887 3467888888886653

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.37  E-value=5.8e-13  Score=138.01  Aligned_cols=117  Identities=24%  Similarity=0.245  Sum_probs=101.0

Q ss_pred             CCccccCC-hhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCC-C
Q 011005            1 MYKIGIIP-PEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQG-S   78 (496)
Q Consensus         1 ~n~~~~lp-~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~-~   78 (496)
                      +|+++.++ ..|.++++|++|+|++|++++..|+.|..+++|++|+|++|++++..|..|..+++|++|+|++|++++ .
T Consensus        35 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~  114 (549)
T 2z81_A           35 FNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLG  114 (549)
T ss_dssp             SSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSC
T ss_pred             CCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccc
Confidence            47788875 489999999999999999998888899999999999999999997777779999999999999999985 3


Q ss_pred             CCccccCcccccccccccccCCCCC-CCCCCCCCcccccc
Q 011005           79 IPGEITKLSRLDYLNLSSNKLSGPV-PFSNNDLSSMHTVV  117 (496)
Q Consensus        79 ~~~~~~~l~~L~~l~l~~n~l~~~~-~~~~~~l~~l~~~~  117 (496)
                      .|..+.++++|+.|++++|.+.+.+ +..|..+++|+.+.
T Consensus       115 ~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~  154 (549)
T 2z81_A          115 VTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELE  154 (549)
T ss_dssp             SSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEE
T ss_pred             hhhhhhccCCccEEECCCCccccccCHhhhhcccccCeee
Confidence            5678999999999999999854444 46888999887654

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.36  E-value=1.7e-12  Score=134.91  Aligned_cols=113  Identities=33%  Similarity=0.354  Sum_probs=64.6

Q ss_pred             ccCCCCCCEEeccCCccCCCCC-ccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCcccc
Q 011005           11 IGNLKNLIKLDVGSNSLIGPIP-SALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRL   89 (496)
Q Consensus        11 ~~~l~~L~~L~l~~n~i~~~~p-~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L   89 (496)
                      +.++++|+.|+|++|.+++.+| ..+..+++|+.|+|++|+|++.+|..+.  ++|+.|+|++|+++ .+|..+..+++|
T Consensus       399 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L  475 (562)
T 3a79_B          399 TKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQAL  475 (562)
T ss_dssp             TTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCC
T ss_pred             hcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCC
Confidence            3444444444444444443222 2244444444444444444433333222  56777777777777 566666678888


Q ss_pred             cccccccccCCCCCCCCCCCCCccccccccCCCCCCCC
Q 011005           90 DYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCG  127 (496)
Q Consensus        90 ~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~  127 (496)
                      +.|++++|+|++..+..+..+++|+. +.+++|++.|+
T Consensus       476 ~~L~L~~N~l~~l~~~~~~~l~~L~~-L~l~~N~~~c~  512 (562)
T 3a79_B          476 QELNVASNQLKSVPDGVFDRLTSLQY-IWLHDNPWDCT  512 (562)
T ss_dssp             SEEECCSSCCCCCCTTSTTTCTTCCC-EECCSCCBCCC
T ss_pred             CEEECCCCCCCCCCHHHHhcCCCCCE-EEecCCCcCCC
Confidence            88888888888544444777777744 56777777765

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.35  E-value=1.4e-12  Score=136.57  Aligned_cols=112  Identities=25%  Similarity=0.229  Sum_probs=98.2

Q ss_pred             CCccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            1 MYKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         1 ~n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      +|.++.+|+ .|+++++|++|+|++|.|++..|..|+.+++|++|+|++|.|++..+..|.++++|++|+|++|.+++..
T Consensus        84 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~  163 (597)
T 3oja_B           84 DLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIE  163 (597)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCC
T ss_pred             CCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCC
Confidence            477888876 8999999999999999999988888999999999999999999655555799999999999999999888


Q ss_pred             CccccCcccccccccccccCCCCCCCCCCCCCcccc
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHT  115 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~  115 (496)
                      |..|..+++|+.|++++|.+++...   ..+++|..
T Consensus       164 ~~~~~~l~~L~~L~L~~N~l~~~~~---~~l~~L~~  196 (597)
T 3oja_B          164 DDTFQATTSLQNLQLSSNRLTHVDL---SLIPSLFH  196 (597)
T ss_dssp             TTTTTTCTTCCEEECTTSCCSBCCG---GGCTTCSE
T ss_pred             hhhhhcCCcCcEEECcCCCCCCcCh---hhhhhhhh
Confidence            8899999999999999999997643   34445533

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.35  E-value=1.2e-12  Score=134.86  Aligned_cols=114  Identities=30%  Similarity=0.345  Sum_probs=66.2

Q ss_pred             hccCCCCCCEEeccCCccCCCCCc-cCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCccc
Q 011005           10 EIGNLKNLIKLDVGSNSLIGPIPS-ALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSR   88 (496)
Q Consensus        10 ~~~~l~~L~~L~l~~n~i~~~~p~-~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~   88 (496)
                      .+.++++|++|+|++|.+++.+|. .+..+++|+.|+|++|++++.+|..+.  ++|+.|+|++|+++ .+|..+..+++
T Consensus       369 ~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~  445 (520)
T 2z7x_B          369 MTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEA  445 (520)
T ss_dssp             HHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTT
T ss_pred             HHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCC
Confidence            344445555555555554442332 244445555555555555444443332  56777777777777 66666667777


Q ss_pred             ccccccccccCCCCCCCCCCCCCccccccccCCCCCCCC
Q 011005           89 LDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCG  127 (496)
Q Consensus        89 L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~  127 (496)
                      |+.|++++|++++..+..+..+++|+. +.+++|+..|+
T Consensus       446 L~~L~L~~N~l~~l~~~~~~~l~~L~~-L~l~~N~~~c~  483 (520)
T 2z7x_B          446 LQELNVASNQLKSVPDGIFDRLTSLQK-IWLHTNPWDCS  483 (520)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCTTCCE-EECCSSCBCCC
T ss_pred             CCEEECCCCcCCccCHHHhccCCcccE-EECcCCCCccc
Confidence            788888888777544444777777754 45667776664

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.35  E-value=1.3e-12  Score=127.08  Aligned_cols=106  Identities=23%  Similarity=0.238  Sum_probs=93.9

Q ss_pred             CEEeccCC-ccCCCCCccCCCCCCCCEEeccC-CcCCCCCchhhcCCcccCeecccccccCCCCCccccCcccccccccc
Q 011005           18 IKLDVGSN-SLIGPIPSALGSLTNLSNLDLSS-NKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLS   95 (496)
Q Consensus        18 ~~L~l~~n-~i~~~~p~~~~~l~~L~~l~l~~-n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~l~l~   95 (496)
                      ..++++++ +|+ .+|. +..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|+
T Consensus        11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            45799998 898 5788 99999999999996 99997777899999999999999999998888899999999999999


Q ss_pred             cccCCCCCCCCCCCCCccccccccCCCCCCCC
Q 011005           96 SNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCG  127 (496)
Q Consensus        96 ~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~  127 (496)
                      +|+|++..+..|..++ |+. +.+.+|+..|.
T Consensus        89 ~N~l~~~~~~~~~~~~-L~~-l~l~~N~~~c~  118 (347)
T 2ifg_A           89 FNALESLSWKTVQGLS-LQE-LVLSGNPLHCS  118 (347)
T ss_dssp             SSCCSCCCSTTTCSCC-CCE-EECCSSCCCCC
T ss_pred             CCccceeCHHHcccCC-ceE-EEeeCCCccCC
Confidence            9999988888887776 744 56788888875

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.35  E-value=1.7e-12  Score=125.42  Aligned_cols=115  Identities=23%  Similarity=0.304  Sum_probs=95.5

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |.++.+|..+.  ++|+.|+|++|.|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+++ .+|.
T Consensus        43 ~~l~~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~  119 (332)
T 2ft3_A           43 LGLKAVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPP  119 (332)
T ss_dssp             SCCSSCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCS
T ss_pred             CCccccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCc
Confidence            56777887664  68999999999998777788999999999999999999777888999999999999999998 6666


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCccccccccCCC
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN  122 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n  122 (496)
                      .+.  ++|+.|++++|.+++..+..|..+++|+.+ .++.|
T Consensus       120 ~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L-~l~~n  157 (332)
T 2ft3_A          120 NLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCI-EMGGN  157 (332)
T ss_dssp             SCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEE-ECCSC
T ss_pred             ccc--ccCCEEECCCCccCccCHhHhCCCccCCEE-ECCCC
Confidence            555  789999999999998777788888888665 34444

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.34  E-value=2e-12  Score=127.96  Aligned_cols=113  Identities=25%  Similarity=0.225  Sum_probs=97.6

Q ss_pred             CCccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            1 MYKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         1 ~n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      +|+++.+|. .|.++++|++|+|++|.+++..|..|..+++|++|+|++|+|+...+..|..+++|++|+|++|++++..
T Consensus        78 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~  157 (390)
T 3o6n_A           78 DLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIE  157 (390)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCC
T ss_pred             CCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccC
Confidence            477888876 8999999999999999999888888999999999999999999544444799999999999999999777


Q ss_pred             CccccCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      +..+..+++|+.|++++|.+++..   +..+++|+.+
T Consensus       158 ~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L  191 (390)
T 3o6n_A          158 DDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHA  191 (390)
T ss_dssp             TTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEE
T ss_pred             hhhccCCCCCCEEECCCCcCCccc---ccccccccee
Confidence            888999999999999999999763   4445555443

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.34  E-value=5.2e-13  Score=143.88  Aligned_cols=112  Identities=20%  Similarity=0.357  Sum_probs=99.4

Q ss_pred             CChhcc--CCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCc-CCC-CCchhhcCCc-------ccCeeccccccc
Q 011005            7 IPPEIG--NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNK-LSG-KIPPEIASMK-------YLTQLDLSNNNI   75 (496)
Q Consensus         7 lp~~~~--~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~-l~~-~~p~~~~~l~-------~L~~l~l~~N~l   75 (496)
                      +|..++  +|++|+.|+|++|++.+.+|..|+++++|+.|+|++|+ +++ .+|..+..++       +|+.|+|++|++
T Consensus       481 iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L  560 (876)
T 4ecn_A          481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL  560 (876)
T ss_dssp             TTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCC
T ss_pred             CChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcC
Confidence            999877  99999999999999999999999999999999999998 997 7888777766       999999999999


Q ss_pred             CCCCCc--cccCcccccccccccccCCCCCCCCCCCCCccccccccCCC
Q 011005           76 QGSIPG--EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN  122 (496)
Q Consensus        76 ~~~~~~--~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n  122 (496)
                      + .+|.  .+.++++|+.|++++|.++ .+| .|..+++|+.|. ++.|
T Consensus       561 ~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~-Ls~N  605 (876)
T 4ecn_A          561 E-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLK-LDYN  605 (876)
T ss_dssp             C-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEE-CCSS
T ss_pred             C-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEE-CcCC
Confidence            9 8888  8999999999999999999 777 888888886653 4444

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.34  E-value=7.7e-13  Score=136.74  Aligned_cols=102  Identities=25%  Similarity=0.393  Sum_probs=92.7

Q ss_pred             CCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCcccccccccc
Q 011005           16 NLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLS   95 (496)
Q Consensus        16 ~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~l~l~   95 (496)
                      .|+.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|..++.|++|+.|+|++|+|++ +| .++.+++|+.|+|+
T Consensus       442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls  516 (567)
T 1dce_A          442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC  516 (567)
T ss_dssp             TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred             CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence            58999999999995 676 999999999999999999 889999999999999999999995 77 89999999999999


Q ss_pred             cccCCCCC-CCCCCCCCccccccccCCCC
Q 011005           96 SNKLSGPV-PFSNNDLSSMHTVVSLSPNN  123 (496)
Q Consensus        96 ~n~l~~~~-~~~~~~l~~l~~~~~~~~n~  123 (496)
                      +|.|++.. |..+..+++|+.+ .+++|+
T Consensus       517 ~N~l~~~~~p~~l~~l~~L~~L-~L~~N~  544 (567)
T 1dce_A          517 NNRLQQSAAIQPLVSCPRLVLL-NLQGNS  544 (567)
T ss_dssp             SSCCCSSSTTGGGGGCTTCCEE-ECTTSG
T ss_pred             CCCCCCCCCcHHHhcCCCCCEE-EecCCc
Confidence            99999887 9999999999664 555554

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.34  E-value=2.2e-12  Score=137.27  Aligned_cols=118  Identities=21%  Similarity=0.245  Sum_probs=106.1

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      ++++.+|..+.  ++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+.
T Consensus        14 ~~L~~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~   91 (680)
T 1ziw_A           14 LKLTQVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDK   91 (680)
T ss_dssp             SCCSSCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTT
T ss_pred             CCccccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChh
Confidence            67888998775  7999999999999988888899999999999999999988899999999999999999999965556


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCccccccccCCC
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN  122 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n  122 (496)
                      .|+++++|+.|++++|.+++..|..|.++++|+.+ .++.|
T Consensus        92 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L-~Ls~n  131 (680)
T 1ziw_A           92 TFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITL-DLSHN  131 (680)
T ss_dssp             TTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEE-ECCSS
T ss_pred             hhccCCCCCEEECCCCccCccChhHccccCCCCEE-ECCCC
Confidence            79999999999999999998888999999999765 34444

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.33  E-value=2e-12  Score=124.94  Aligned_cols=110  Identities=25%  Similarity=0.333  Sum_probs=68.6

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      +.+..+|..+.  ++|+.|+|++|+|++..+..|.++++|++|+|++|++++..|..|..+++|++|+|++|+++ .+|.
T Consensus        41 ~~l~~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~  117 (330)
T 1xku_A           41 LGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPE  117 (330)
T ss_dssp             SCCCSCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCS
T ss_pred             CCccccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccCh
Confidence            44555665443  46666777777776555556666777777777777776555666666777777777777666 4554


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      .+.  ++|+.|++++|.+++..+..|.++++|+.+
T Consensus       118 ~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  150 (330)
T 1xku_A          118 KMP--KTLQELRVHENEITKVRKSVFNGLNQMIVV  150 (330)
T ss_dssp             SCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEE
T ss_pred             hhc--ccccEEECCCCcccccCHhHhcCCccccEE
Confidence            443  466666666666665555555666665443

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.33  E-value=5.3e-13  Score=127.87  Aligned_cols=98  Identities=20%  Similarity=0.262  Sum_probs=49.5

Q ss_pred             Cccc-cCChhc--cCCCCCCEEeccCCccCCCCCccCCCC-----CCCCEEeccCCcCCCCCchhhcCCcccCeeccccc
Q 011005            2 YKIG-IIPPEI--GNLKNLIKLDVGSNSLIGPIPSALGSL-----TNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNN   73 (496)
Q Consensus         2 n~~~-~lp~~~--~~l~~L~~L~l~~n~i~~~~p~~~~~l-----~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N   73 (496)
                      |+++ .+|..+  ..+++|++|+|++|++++. |..+..+     ++|++|+|++|+|++..|..|..+++|++|+|++|
T Consensus       105 n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  183 (312)
T 1wwl_A          105 LEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDN  183 (312)
T ss_dssp             EBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSC
T ss_pred             CcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCC
Confidence            3444 345543  5555555555555555544 4444444     55555555555555444455555555555555555


Q ss_pred             ccCCC--CCccc--cCcccccccccccccCC
Q 011005           74 NIQGS--IPGEI--TKLSRLDYLNLSSNKLS  100 (496)
Q Consensus        74 ~l~~~--~~~~~--~~l~~L~~l~l~~n~l~  100 (496)
                      ++.+.  .+..+  ..+++|+.|++++|.++
T Consensus       184 ~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~  214 (312)
T 1wwl_A          184 PELGERGLISALCPLKFPTLQVLALRNAGME  214 (312)
T ss_dssp             TTCHHHHHHHHSCTTSCTTCCEEECTTSCCC
T ss_pred             CcCcchHHHHHHHhccCCCCCEEECCCCcCc
Confidence            54432  12222  44455555555555544

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.32  E-value=5.7e-13  Score=127.97  Aligned_cols=121  Identities=22%  Similarity=0.255  Sum_probs=72.6

Q ss_pred             CccccCCh-hccCCCCCCEEeccCCccCCCCCccC-CCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            2 YKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSAL-GSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         2 n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~-~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      |+++.+++ .++.+++|+.|+|++|.+++..|..+ ..+++|++|+|++|+|++ +| ....+++|+.|+|++|+++ .+
T Consensus       130 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~-~~~~l~~L~~L~Ls~N~l~-~l  206 (317)
T 3o53_A          130 NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VK-GQVVFAKLKTLDLSSNKLA-FM  206 (317)
T ss_dssp             SCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EE-CCCCCTTCCEEECCSSCCC-EE
T ss_pred             CCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-cc-cccccccCCEEECCCCcCC-cc
Confidence            45555544 56666666666666666665555544 356666666666666663 33 2234666777777777776 34


Q ss_pred             CccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCCCCCC
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCG  127 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~  127 (496)
                      |..+..+++|+.|++++|.|+ .+|..+..+++|+. +.+++|+..|+
T Consensus       207 ~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~-L~l~~N~~~~~  252 (317)
T 3o53_A          207 GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEH-FDLRGNGFHCG  252 (317)
T ss_dssp             CGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCE-EECTTCCCBHH
T ss_pred             hhhhcccCcccEEECcCCccc-chhhHhhcCCCCCE-EEccCCCccCc
Confidence            444666677777777777776 34555666666643 34555655543

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.32  E-value=1.8e-12  Score=141.11  Aligned_cols=115  Identities=25%  Similarity=0.265  Sum_probs=68.5

Q ss_pred             CccccCC-hhccCCCCCCEEeccCCccCCCC-CccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            2 YKIGIIP-PEIGNLKNLIKLDVGSNSLIGPI-PSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         2 n~~~~lp-~~~~~l~~L~~L~l~~n~i~~~~-p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      |+|+.++ ..|.++++|++|+|++|.+.+.+ |+.|.++++|++|+|++|.|++..|..|.++++|++|+|++|.+++..
T Consensus        34 N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~  113 (844)
T 3j0a_A           34 NYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAV  113 (844)
T ss_dssp             CCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCC
T ss_pred             CcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCccc
Confidence            5555543 35666666666666666443333 555666666666666666666555666666666666666666666544


Q ss_pred             Ccc--ccCcccccccccccccCCCCCC-CCCCCCCccccc
Q 011005           80 PGE--ITKLSRLDYLNLSSNKLSGPVP-FSNNDLSSMHTV  116 (496)
Q Consensus        80 ~~~--~~~l~~L~~l~l~~n~l~~~~~-~~~~~l~~l~~~  116 (496)
                      |..  +.++++|+.|++++|.+++..+ ..|.++++|+.|
T Consensus       114 ~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L  153 (844)
T 3j0a_A          114 LKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSI  153 (844)
T ss_dssp             STTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEE
T ss_pred             ccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEE
Confidence            433  6666666666666666665443 345666666444

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.32  E-value=9e-13  Score=121.10  Aligned_cols=118  Identities=18%  Similarity=0.231  Sum_probs=91.2

Q ss_pred             CCc-cccCCh-hccCCCCCCEEeccC-CccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccC---eeccccc-
Q 011005            1 MYK-IGIIPP-EIGNLKNLIKLDVGS-NSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLT---QLDLSNN-   73 (496)
Q Consensus         1 ~n~-~~~lp~-~~~~l~~L~~L~l~~-n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~---~l~l~~N-   73 (496)
                      .|+ ++.+|. .|.++++|++|+|++ |++++..+..|..+++|+.|+|++|++++ +|. +..+++|+   .|++++| 
T Consensus        64 ~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~  141 (239)
T 2xwt_C           64 IDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNP  141 (239)
T ss_dssp             CCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCT
T ss_pred             CCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCc
Confidence            355 788877 788899999999998 88887767788889999999999999885 666 77888887   8888888 


Q ss_pred             ccCCCCCccccCccccc-ccccccccCCCCCCCCCCCCCccccccccCCC
Q 011005           74 NIQGSIPGEITKLSRLD-YLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN  122 (496)
Q Consensus        74 ~l~~~~~~~~~~l~~L~-~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n  122 (496)
                      ++++..+..|..+++|+ .|++++|.++...+..|.. ++|+.+ .+++|
T Consensus       142 ~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L-~L~~n  189 (239)
T 2xwt_C          142 YMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAV-YLNKN  189 (239)
T ss_dssp             TCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEE-ECTTC
T ss_pred             chhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEE-EcCCC
Confidence            88866666788888888 8888888888555555555 667554 34444

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.32  E-value=5.9e-12  Score=119.18  Aligned_cols=105  Identities=30%  Similarity=0.404  Sum_probs=60.2

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |.+..+|. +..+++|+.|+|++|++++..+  +..+++|++|+|++|++++ +| .+..+++|+.|+|++|++++ + .
T Consensus        56 ~~i~~~~~-~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~  128 (291)
T 1h6t_A           56 SDIKSVQG-IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-N  128 (291)
T ss_dssp             SCCCCCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-G
T ss_pred             CCcccChh-HhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-h
Confidence            45555543 5666666666666666664332  6666666666666666663 32 36666666666666666653 2 3


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCcccc
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHT  115 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~  115 (496)
                      .+..+++|+.|++++|.+++.  ..+..+++|+.
T Consensus       129 ~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~  160 (291)
T 1h6t_A          129 GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDT  160 (291)
T ss_dssp             GGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSE
T ss_pred             hhcCCCCCCEEEccCCcCCcc--hhhccCCCCCE
Confidence            455566666666666666543  34555555543

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.30  E-value=7e-13  Score=127.02  Aligned_cols=103  Identities=17%  Similarity=0.231  Sum_probs=85.0

Q ss_pred             CCCCCCEEeccCCccCCCCCccC--CCCCCCCEEeccCCcCCCCCchhhcCC-----cccCeecccccccCCCCCccccC
Q 011005           13 NLKNLIKLDVGSNSLIGPIPSAL--GSLTNLSNLDLSSNKLSGKIPPEIASM-----KYLTQLDLSNNNIQGSIPGEITK   85 (496)
Q Consensus        13 ~l~~L~~L~l~~n~i~~~~p~~~--~~l~~L~~l~l~~n~l~~~~p~~~~~l-----~~L~~l~l~~N~l~~~~~~~~~~   85 (496)
                      ++++|++|+|++|++++..|..+  ..+++|++|+|++|+|++. |..+..+     ++|++|+|++|++++..|..+..
T Consensus        93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~  171 (312)
T 1wwl_A           93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV  171 (312)
T ss_dssp             TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred             CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc
Confidence            78899999999999988888876  8899999999999999965 8888777     89999999999998777788999


Q ss_pred             cccccccccccccCCCC--CCCC--CCCCCccccc
Q 011005           86 LSRLDYLNLSSNKLSGP--VPFS--NNDLSSMHTV  116 (496)
Q Consensus        86 l~~L~~l~l~~n~l~~~--~~~~--~~~l~~l~~~  116 (496)
                      +++|+.|++++|++.+.  .+..  +..+++|+.+
T Consensus       172 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L  206 (312)
T 1wwl_A          172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVL  206 (312)
T ss_dssp             CSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEE
T ss_pred             CCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEE
Confidence            99999999999998764  2222  3677777654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.30  E-value=6e-12  Score=117.31  Aligned_cols=146  Identities=13%  Similarity=0.077  Sum_probs=113.0

Q ss_pred             HHHHhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-ccccccccceeecCCeEEE
Q 011005          201 IEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       201 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l  279 (496)
                      ....+.|.+...++.|+.+.||++... ++.+++|........ ....+.+|+.+++.+. +..+.++++++...+..++
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~-~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCC-CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            344567888888888899999999864 688999998753211 1235789999999995 6778889999988889999


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC----------------------------------  325 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~----------------------------------  325 (496)
                      ||||++|.++.+.+...        .....++.+++.++..||+..                                  
T Consensus        88 v~e~i~G~~l~~~~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T 3tm0_A           88 LMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEECCSSEEHHHHCCTT--------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred             EEEecCCeehhhccCCc--------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence            99999999987663211        123367889999999999610                                  


Q ss_pred             ----------------------CCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          326 ----------------------SPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       326 ----------------------~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                                            ...++|+|++|.||+++++..+.|+||+.+.
T Consensus       160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                  1459999999999999876666799998774

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.30  E-value=5.4e-12  Score=117.60  Aligned_cols=105  Identities=26%  Similarity=0.348  Sum_probs=67.4

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |+++.+| .+..+++|+.|+|++|+|++..+  +..+++|+.|+|++|+|++ +|... . ++|+.|+|++|++++ ++ 
T Consensus        51 n~i~~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~~-~-~~L~~L~L~~N~l~~-~~-  122 (263)
T 1xeu_A           51 SNIQSLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGIP-S-ACLSRLFLDNNELRD-TD-  122 (263)
T ss_dssp             SCCCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTCC-C-SSCCEEECCSSCCSB-SG-
T ss_pred             CCcccch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCccc-c-CcccEEEccCCccCC-Ch-
Confidence            5666666 56777777777777777774433  7777777777777777774 44322 2 666666666666663 33 


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      .+..+++|+.|++++|.+++. + .+..+++|+.+
T Consensus       123 ~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L  155 (263)
T 1xeu_A          123 SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVL  155 (263)
T ss_dssp             GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEE
T ss_pred             hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEE
Confidence            466677777777777777654 2 45566666443

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.29  E-value=7.2e-12  Score=116.72  Aligned_cols=116  Identities=25%  Similarity=0.345  Sum_probs=96.9

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      .|+++.+|. +.++++|+.|+|++|++++ +|.. .. ++|+.|+|++|+|++ +| .+..+++|+.|+|++|++++ ++
T Consensus        72 ~N~i~~~~~-l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~-~~  144 (263)
T 1xeu_A           72 HNQISDLSP-LKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKS-IV  144 (263)
T ss_dssp             SSCCCCCGG-GTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCB-CG
T ss_pred             CCccCCChh-hccCCCCCEEECCCCccCC-cCcc-cc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCC-Ch
Confidence            488899988 9999999999999999995 4543 33 999999999999995 44 69999999999999999995 44


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCCCCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCG  127 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~  127 (496)
                       .+..+++|+.|++++|++++.  ..+..+++|+.+ .+++|+..+.
T Consensus       145 -~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L-~l~~N~~~~~  187 (263)
T 1xeu_A          145 -MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWI-DLTGQKCVNE  187 (263)
T ss_dssp             -GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEE-EEEEEEEECC
T ss_pred             -HHccCCCCCEEECCCCcCcch--HHhccCCCCCEE-eCCCCcccCC
Confidence             689999999999999999977  678888888654 5556654443

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.28  E-value=9.2e-12  Score=117.86  Aligned_cols=106  Identities=32%  Similarity=0.460  Sum_probs=72.7

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |+++.++. +.++++|+.|+|++|.+++ +| .+..+++|+.|+|++|+|++ + +.+..+++|+.|+|++|++++.  .
T Consensus        78 n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~  150 (291)
T 1h6t_A           78 NKLTDIKP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--T  150 (291)
T ss_dssp             SCCCCCGG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--G
T ss_pred             CccCCCcc-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--h
Confidence            56666665 7777777777777777763 33 37777777777777777774 3 4567777777777777777743  4


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      .+..+++|+.|++++|.+++..|  +..+++|+.+
T Consensus       151 ~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L  183 (291)
T 1h6t_A          151 VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNL  183 (291)
T ss_dssp             GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             hhccCCCCCEEEccCCccccchh--hcCCCccCEE
Confidence            56777777777777777776554  6666666544

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.28  E-value=9.5e-12  Score=118.82  Aligned_cols=107  Identities=27%  Similarity=0.437  Sum_probs=79.1

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      +|++..+| .+..+++|+.|+|++|++++. +. +..+++|++|+|++|++++ +| .+..+++|+.|+|++|++++ ++
T Consensus        50 ~~~i~~l~-~~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~  123 (308)
T 1h6u_A           50 GTGVTTIE-GVQYLNNLIGLELKDNQITDL-AP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VT  123 (308)
T ss_dssp             TSCCCCCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CG
T ss_pred             CCCccCch-hhhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-ch
Confidence            35677776 577888888888888888744 43 7888888888888888874 43 67788888888888888874 44


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      . +..+++|+.|++++|.+++..+  +..+++|+.+
T Consensus       124 ~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L  156 (308)
T 1h6u_A          124 P-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYL  156 (308)
T ss_dssp             G-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred             h-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEE
Confidence            3 7778888888888888876544  6666777554

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.28  E-value=1e-11  Score=118.54  Aligned_cols=105  Identities=28%  Similarity=0.508  Sum_probs=56.6

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |+++.+|. +..+++|++|+|++|.+++ ++ .+..+++|+.|+|++|++++ +|. +..+++|+.|+|++|++++. +.
T Consensus        73 n~i~~~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~-~~  146 (308)
T 1h6u_A           73 NQITDLAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNI-SP  146 (308)
T ss_dssp             SCCCCCGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GG
T ss_pred             CcCCCChh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcC-cc
Confidence            44555554 5555666666666666553 22 45555666666666666553 332 55556666666666665532 22


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCcccc
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHT  115 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~  115 (496)
                       +..+++|+.|++++|.+++..+  +..+++|+.
T Consensus       147 -l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~  177 (308)
T 1h6u_A          147 -LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTT  177 (308)
T ss_dssp             -GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred             -ccCCCCccEEEccCCcCCCChh--hcCCCCCCE
Confidence             5555566666666665554333  455555543

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.26  E-value=7e-14  Score=124.59  Aligned_cols=115  Identities=27%  Similarity=0.292  Sum_probs=97.3

Q ss_pred             ccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCcc
Q 011005            3 KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGE   82 (496)
Q Consensus         3 ~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~   82 (496)
                      .++.+|..++.+++|++|+|++|++++ +| .+..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++ +| .
T Consensus        36 ~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~  110 (198)
T 1ds9_A           36 PIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-G  110 (198)
T ss_dssp             TCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-H
T ss_pred             cHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-c
Confidence            456666799999999999999999995 67 8999999999999999999 788888889999999999999995 55 6


Q ss_pred             ccCcccccccccccccCCCCCC-CCCCCCCccccccccCCCC
Q 011005           83 ITKLSRLDYLNLSSNKLSGPVP-FSNNDLSSMHTVVSLSPNN  123 (496)
Q Consensus        83 ~~~l~~L~~l~l~~n~l~~~~~-~~~~~l~~l~~~~~~~~n~  123 (496)
                      +..+++|+.|++++|.+++..+ ..+..+++|+.+ .+.+|+
T Consensus       111 ~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L-~l~~N~  151 (198)
T 1ds9_A          111 IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDL-LLAGNP  151 (198)
T ss_dssp             HHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEE-EECSCH
T ss_pred             cccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEE-EecCCc
Confidence            8899999999999999996433 467788888654 445554

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.26  E-value=7.5e-12  Score=121.69  Aligned_cols=114  Identities=28%  Similarity=0.440  Sum_probs=75.8

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |++..++. +..+++|+.|+|++|.+++. +. +..+++|++|+|++|.+++ + +.+..+++|+.|++++|++++ + .
T Consensus       209 n~l~~~~~-~~~~~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~-~  281 (347)
T 4fmz_A          209 NQITDITP-VANMTRLNSLKIGNNKITDL-SP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-I-S  281 (347)
T ss_dssp             SCCCCCGG-GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-C-G
T ss_pred             CCCCCCch-hhcCCcCCEEEccCCccCCC-cc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-C-h
Confidence            45555544 66777777777777777743 33 6777777777777777774 3 456777777777777777774 3 3


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCccccccccCCCC
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN  123 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~  123 (496)
                      .+..+++|+.|++++|++++..|..+..+++|+.+ .+++|+
T Consensus       282 ~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L-~L~~n~  322 (347)
T 4fmz_A          282 VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL-FLSQNH  322 (347)
T ss_dssp             GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEE-ECCSSS
T ss_pred             hhcCCCCCCEEECcCCcCCCcChhHhhccccCCEE-EccCCc
Confidence            46677777777777777776666667777777543 344443

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.26  E-value=1.8e-12  Score=113.08  Aligned_cols=97  Identities=25%  Similarity=0.241  Sum_probs=85.9

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCch--hhcCCcccCeecccccccCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPP--EIASMKYLTQLDLSNNNIQGS   78 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~--~~~~l~~L~~l~l~~N~l~~~   78 (496)
                      .|+++.+ +.+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|.  .+..+++|+.|+|++|.++ .
T Consensus        51 ~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~  127 (176)
T 1a9n_A           51 DNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-N  127 (176)
T ss_dssp             SSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-G
T ss_pred             CCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-C
Confidence            4777877 67899999999999999999665566699999999999999997 6776  8999999999999999998 5


Q ss_pred             CCcc----ccCcccccccccccccCC
Q 011005           79 IPGE----ITKLSRLDYLNLSSNKLS  100 (496)
Q Consensus        79 ~~~~----~~~l~~L~~l~l~~n~l~  100 (496)
                      +|..    +..+++|+.|++++|.+.
T Consensus       128 ~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A          128 KKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             cHhHHHHHHHHCCccceeCCCcCCHH
Confidence            6664    899999999999999875

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.24  E-value=2.3e-11  Score=126.44  Aligned_cols=105  Identities=32%  Similarity=0.457  Sum_probs=55.2

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |++..+|. +..|++|+.|+|++|.|++ +| .+..+++|+.|+|++|+|++ + +.+..|++|+.|+|++|++++.  .
T Consensus        75 N~l~~~~~-l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~  147 (605)
T 1m9s_A           75 NKLTDIKP-LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--T  147 (605)
T ss_dssp             SCCCCCGG-GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--G
T ss_pred             CCCCCChh-hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--h
Confidence            34444443 4455555555555555542 22 45555555555555555553 2 3355555555566655555532  3


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCcccc
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHT  115 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~  115 (496)
                      .+..|++|+.|+|++|.|++..|  +..+++|+.
T Consensus       148 ~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~  179 (605)
T 1m9s_A          148 VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQN  179 (605)
T ss_dssp             GGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred             hhcccCCCCEEECcCCcCCCchh--hccCCCCCE
Confidence            45556666666666666655444  555555543

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.24  E-value=7.9e-12  Score=121.72  Aligned_cols=114  Identities=18%  Similarity=0.190  Sum_probs=96.5

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCch-hhcCCcccCe-ecccccccCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPP-EIASMKYLTQ-LDLSNNNIQGS   78 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~-~~~~l~~L~~-l~l~~N~l~~~   78 (496)
                      .|+++.||..+  .+++++|+|++|+|+.+.++.|.++++|++|+|++|++.+.+|. .|.++++|+. +.+++|+++..
T Consensus        18 ~~~Lt~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l   95 (350)
T 4ay9_X           18 ESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYI   95 (350)
T ss_dssp             STTCCSCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEE
T ss_pred             CCCCCccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCccccc
Confidence            36789999877  36899999999999966667899999999999999999766664 6789999876 67778999977


Q ss_pred             CCccccCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           79 IPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        79 ~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      .|+.|..+++|+.|++++|.++...+..+....++..+
T Consensus        96 ~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l  133 (350)
T 4ay9_X           96 NPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLL  133 (350)
T ss_dssp             CTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEE
T ss_pred             CchhhhhccccccccccccccccCCchhhcccchhhhh
Confidence            78899999999999999999998888777666666444

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.23  E-value=1.7e-11  Score=127.41  Aligned_cols=113  Identities=27%  Similarity=0.390  Sum_probs=95.8

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      .|++..+| .+..|++|+.|+|++|+|++ + +.+..+++|+.|+|++|+|++.  ..+..|++|+.|+|++|+|++..|
T Consensus        96 ~N~l~~l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~  170 (605)
T 1m9s_A           96 ENKIKDLS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP  170 (605)
T ss_dssp             SSCCCCCT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred             CCCCCCCh-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence            37788776 78999999999999999985 3 4589999999999999999964  689999999999999999996555


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN  123 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~  123 (496)
                        +..+++|+.|+|++|.|++.  ..+..+++|+.| .++.|+
T Consensus       171 --l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L-~L~~N~  208 (605)
T 1m9s_A          171 --LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVL-ELFSQE  208 (605)
T ss_dssp             --GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEE-ECCSEE
T ss_pred             --hccCCCCCEEECcCCCCCCC--hHHccCCCCCEE-EccCCc
Confidence              99999999999999999975  357888888654 445544

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.22  E-value=1.7e-11  Score=113.95  Aligned_cols=136  Identities=17%  Similarity=0.148  Sum_probs=100.0

Q ss_pred             CCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccc--cccccceeecCCeEEEEEEe
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN--IVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lV~e~  283 (496)
                      .+.+....+.|..+.||++...+|+.+++|......    ...+.+|+.+++.+.+.+  +.+++++...++..++||||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            444433334555699999988778889999976542    145678999999997545  45688888887789999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC--------------------------------------  325 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--------------------------------------  325 (496)
                      ++|.++.  ...      .+   ...++.+++..+..||...                                      
T Consensus        97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            9998873  221      11   1256778888888888531                                      


Q ss_pred             -----------------CCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          326 -----------------SPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       326 -----------------~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                                       ...++|+|++|.||++++++.+.|+|||.+.
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                             1129999999999999887667799999874

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.22  E-value=6.3e-12  Score=120.23  Aligned_cols=104  Identities=20%  Similarity=0.150  Sum_probs=64.4

Q ss_pred             ccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCC--Cc--hhhcCCcccCeecccccccCCCCCc----c
Q 011005           11 IGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGK--IP--PEIASMKYLTQLDLSNNNIQGSIPG----E   82 (496)
Q Consensus        11 ~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~--~p--~~~~~l~~L~~l~l~~N~l~~~~~~----~   82 (496)
                      +..+++|++|+|++|++++..|..|..+++|++|+|++|++.+.  ++  ..+..+++|++|+|++|+++ .++.    .
T Consensus       141 ~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l  219 (310)
T 4glp_A          141 QWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAAL  219 (310)
T ss_dssp             TTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHH
T ss_pred             hhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHH
Confidence            34566677777777777666666666777777777777766531  11  12355666777777777665 3333    2


Q ss_pred             ccCcccccccccccccCCCCCCCCCCCC---Ccccc
Q 011005           83 ITKLSRLDYLNLSSNKLSGPVPFSNNDL---SSMHT  115 (496)
Q Consensus        83 ~~~l~~L~~l~l~~n~l~~~~~~~~~~l---~~l~~  115 (496)
                      +..+++|+.|++++|.+++..|..+..+   ++|+.
T Consensus       220 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~  255 (310)
T 4glp_A          220 AAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNS  255 (310)
T ss_dssp             HHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCC
T ss_pred             HhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCE
Confidence            4566777777777777777666666555   35544

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.22  E-value=1.2e-11  Score=118.25  Aligned_cols=118  Identities=22%  Similarity=0.266  Sum_probs=92.6

Q ss_pred             CCccccCCh-hccCCCCCCEEeccCCccCCC--C--CccCCCCCCCCEEeccCCcCCCCCch----hhcCCcccCeeccc
Q 011005            1 MYKIGIIPP-EIGNLKNLIKLDVGSNSLIGP--I--PSALGSLTNLSNLDLSSNKLSGKIPP----EIASMKYLTQLDLS   71 (496)
Q Consensus         1 ~n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~--~--p~~~~~l~~L~~l~l~~n~l~~~~p~----~~~~l~~L~~l~l~   71 (496)
                      .|+++.+|. .|+++++|++|+|++|++.+.  +  +..+..+++|++|+|++|+|+ .+|.    .+..+++|++|+|+
T Consensus       154 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls  232 (310)
T 4glp_A          154 QAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLS  232 (310)
T ss_dssp             CCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECT
T ss_pred             CCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECC
Confidence            477888775 789999999999999998642  2  233578999999999999998 4555    35788999999999


Q ss_pred             ccccCCCCCccccCc---ccccccccccccCCCCCCCCCCCCCccccccccCCCC
Q 011005           72 NNNIQGSIPGEITKL---SRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN  123 (496)
Q Consensus        72 ~N~l~~~~~~~~~~l---~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~  123 (496)
                      +|++++..|..+..+   ++|+.|++++|.|+ .+|..+.  ++|+.+ .++.|.
T Consensus       233 ~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L-~Ls~N~  283 (310)
T 4glp_A          233 HNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVL-DLSSNR  283 (310)
T ss_dssp             TSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCE-ECCSCC
T ss_pred             CCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEE-ECCCCc
Confidence            999997778777776   69999999999999 5566553  566443 445553

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.21  E-value=4.1e-12  Score=129.33  Aligned_cols=116  Identities=24%  Similarity=0.221  Sum_probs=92.8

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhc-CCcccCeecccccccCCCCC
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIA-SMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~-~l~~L~~l~l~~N~l~~~~~   80 (496)
                      |+++.+|.  ..+++|+.|+|++|.|++..|..|+.+++|+.|+|++|.|++..|..+. .+++|+.|+|++|.+++. |
T Consensus       109 N~l~~~~~--~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~  185 (487)
T 3oja_A          109 NNISRVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K  185 (487)
T ss_dssp             SCCCCEEE--CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E
T ss_pred             CcCCCCCc--cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-c
Confidence            55555554  3468899999999999988888899999999999999999987888776 799999999999999854 3


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNN  123 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~  123 (496)
                      . +..+++|+.|+|++|.|++..| .+..+++|+.+ ++++|.
T Consensus       186 ~-~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L-~Ls~N~  225 (487)
T 3oja_A          186 G-QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWI-SLRNNK  225 (487)
T ss_dssp             C-CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEE-ECTTSC
T ss_pred             c-cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEE-EecCCc
Confidence            3 4468999999999999997555 48888888654 455543

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.19  E-value=7.1e-14  Score=124.55  Aligned_cols=112  Identities=23%  Similarity=0.284  Sum_probs=96.1

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      +|+++.+| .+.++++|+.|+|++|.|+ .+|..+..+++|+.|+|++|+|++ +| .+..+++|+.|+|++|++++..+
T Consensus        57 ~n~l~~l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~  132 (198)
T 1ds9_A           57 TNNIEKIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGE  132 (198)
T ss_dssp             EEEESCCC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHH
T ss_pred             CCCCcccc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhH
Confidence            37788898 8999999999999999999 678888888999999999999995 55 79999999999999999994322


Q ss_pred             -ccccCcccccccccccccCCCCCCCC----------CCCCCccccc
Q 011005           81 -GEITKLSRLDYLNLSSNKLSGPVPFS----------NNDLSSMHTV  116 (496)
Q Consensus        81 -~~~~~l~~L~~l~l~~n~l~~~~~~~----------~~~l~~l~~~  116 (496)
                       ..+..+++|+.|++++|++++..|..          +..+++|+.+
T Consensus       133 ~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~L  179 (198)
T 1ds9_A          133 IDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL  179 (198)
T ss_dssp             HHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEE
T ss_pred             HHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEE
Confidence             47899999999999999998776653          6677777654

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.15  E-value=1.1e-10  Score=113.89  Aligned_cols=142  Identities=20%  Similarity=0.298  Sum_probs=105.9

Q ss_pred             cceeeecCCeeEEEEEeCCCcEEEEEEcc--cchhHHHHHHHHHHHHHHHhhc--ccccccccceeecC---CeEEEEEE
Q 011005          210 RYCIGTGGYGSVYKAQLPNGKVFALKKLH--TSEELAFIKSFKNEAQVLSQVL--HRNIVKLYGYCLHK---KCMFLIYE  282 (496)
Q Consensus       210 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~lV~e  282 (496)
                      .+.++.|.++.||+....+ ..+++|+..  ..........+.+|+.+++.+.  +..+++++.++.+.   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            4568999999999998754 678888876  4322122346789999999997  45578888888766   45789999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC-------------------------------------  325 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-------------------------------------  325 (496)
                      |++|..+.+...     ..++..++..++.+++.+|..||...                                     
T Consensus       122 ~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          122 FVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             CCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             ecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            999987754221     14677888899999999999999620                                     


Q ss_pred             ------------------CCCeEEeCCCCCceEecCCCC--eEEcccccccc
Q 011005          326 ------------------SPSIIHRDISSNNILLNSKLE--AFVADFGTARL  357 (496)
Q Consensus       326 ------------------~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~  357 (496)
                                        ...++|||++|.||+++.++.  +.++||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              257999999999999997753  68999998864

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.14  E-value=5.6e-12  Score=121.01  Aligned_cols=112  Identities=25%  Similarity=0.286  Sum_probs=95.6

Q ss_pred             CCccccCCh-hc-cCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCC
Q 011005            1 MYKIGIIPP-EI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGS   78 (496)
Q Consensus         1 ~n~~~~lp~-~~-~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~   78 (496)
                      .|+++.++. .+ ..+++|++|+|++|.|++. |. ...+++|+.|+|++|+|+ .+|+.+..+++|+.|+|++|+++ .
T Consensus       153 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~-~  228 (317)
T 3o53_A          153 LNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-L  228 (317)
T ss_dssp             TSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTSCCC-E
T ss_pred             CCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCC-cchhhhcccCcccEEECcCCccc-c
Confidence            367777654 55 4799999999999999855 43 445999999999999999 46677999999999999999999 6


Q ss_pred             CCccccCcccccccccccccCC-CCCCCCCCCCCccccc
Q 011005           79 IPGEITKLSRLDYLNLSSNKLS-GPVPFSNNDLSSMHTV  116 (496)
Q Consensus        79 ~~~~~~~l~~L~~l~l~~n~l~-~~~~~~~~~l~~l~~~  116 (496)
                      +|..+..+++|+.|++++|+++ +..|..+..+++|+.+
T Consensus       229 l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l  267 (317)
T 3o53_A          229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV  267 (317)
T ss_dssp             ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHH
T ss_pred             hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEE
Confidence            7888999999999999999999 7777888888887654

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.14  E-value=5.9e-11  Score=120.29  Aligned_cols=105  Identities=34%  Similarity=0.516  Sum_probs=64.8

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |++..++. +..+++|+.|+|++|.+++..+  +..+++|+.|+|++|++++. +. +..+++|+.|+|++|++++..| 
T Consensus       253 n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~L~~n~l~~~~~-  326 (466)
T 1o6v_A          253 NQISNLAP-LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI-SP-ISNLKNLTYLTLYFNNISDISP-  326 (466)
T ss_dssp             SCCCCCGG-GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCC-GG-GGGCTTCSEEECCSSCCSCCGG-
T ss_pred             Cccccchh-hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCc-hh-hcCCCCCCEEECcCCcCCCchh-
Confidence            55555554 6667777777777777764333  66667777777777777643 22 6666667777777776664433 


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCcccc
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHT  115 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~  115 (496)
                       +..+++|+.|++++|++++.  ..+..+++|+.
T Consensus       327 -~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~  357 (466)
T 1o6v_A          327 -VSSLTKLQRLFFYNNKVSDV--SSLANLTNINW  357 (466)
T ss_dssp             -GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCE
T ss_pred             -hccCccCCEeECCCCccCCc--hhhccCCCCCE
Confidence             55666666666666666654  24555555543

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.14  E-value=5e-11  Score=115.82  Aligned_cols=106  Identities=28%  Similarity=0.496  Sum_probs=66.1

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |+++.++. +..+++|+.|++++|.+++..+  +..+++|+.|+|++|++++ +|. +..+++|+.|++++|++++ + .
T Consensus       187 n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~-~  259 (347)
T 4fmz_A          187 NQIEDISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-I-N  259 (347)
T ss_dssp             SCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-G
T ss_pred             Cccccccc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCC-C-h
Confidence            55555554 6666677777777777664333  6666777777777777763 333 6666777777777777663 3 3


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      .+..+++|+.|++++|.+++.  ..+..+++|+.+
T Consensus       260 ~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L  292 (347)
T 4fmz_A          260 AVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSL  292 (347)
T ss_dssp             GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred             hHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEE
Confidence            466666777777777776654  235556666443

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.11  E-value=2.1e-10  Score=115.70  Aligned_cols=102  Identities=26%  Similarity=0.333  Sum_probs=73.2

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |+++.+| .++.+++|++|+|++|++++. |  ++.+++|++|+|++|+|++ +|  +..+++|++|+|++|++++ +| 
T Consensus        52 n~l~~~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~~N~l~~-l~-  122 (457)
T 3bz5_A           52 SSITDMT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTK-LD-  122 (457)
T ss_dssp             SCCCCCT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECCSSCCSC-CC-
T ss_pred             CCcccCh-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECCCCcCCe-ec-
Confidence            5666776 577778888888888887753 3  7777788888888888775 33  7777788888888888774 43 


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                       +..+++|+.|++++|.+++. +  +..+++|+.+
T Consensus       123 -~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L  153 (457)
T 3bz5_A          123 -VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTEL  153 (457)
T ss_dssp             -CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEE
T ss_pred             -CCCCCcCCEEECCCCcccee-c--cccCCcCCEE
Confidence             77777888888888887764 2  5566666443

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.10  E-value=1.6e-10  Score=117.10  Aligned_cols=111  Identities=32%  Similarity=0.547  Sum_probs=86.4

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |+++.++ .+..+++|+.|+|++|.+++..|  +..+++|+.|+|++|++++ +|. +..+++|+.|+|++|++++..+ 
T Consensus       231 n~l~~~~-~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~~~-  304 (466)
T 1o6v_A          231 NQLKDIG-TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISP-LAGLTALTNLELNENQLEDISP-  304 (466)
T ss_dssp             SCCCCCG-GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC-CGG-GTTCTTCSEEECCSSCCSCCGG-
T ss_pred             CCcccch-hhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCc-ccc-ccCCCccCeEEcCCCcccCchh-
Confidence            5666664 57788899999999999886544  8888999999999999885 444 8888999999999999885433 


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCccccccccCCC
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN  122 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n  122 (496)
                       +..+++|+.|++++|++++..|  +..+++|+.+. +.+|
T Consensus       305 -~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~-l~~n  341 (466)
T 1o6v_A          305 -ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLF-FYNN  341 (466)
T ss_dssp             -GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEE-CCSS
T ss_pred             -hcCCCCCCEEECcCCcCCCchh--hccCccCCEeE-CCCC
Confidence             7888899999999999987766  66777776543 3444

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.10  E-value=1.7e-10  Score=118.71  Aligned_cols=84  Identities=26%  Similarity=0.425  Sum_probs=43.0

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |+|+.+|. +.+  +|+.|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|.
T Consensus       110 N~l~~ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~  177 (571)
T 3cvr_A          110 NRLSTLPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE  177 (571)
T ss_dssp             SCCSCCCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC
T ss_pred             CCCCCcch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch
Confidence            45555555 433  55555555555553 343   34555555555555553 443   34555555555555553 443


Q ss_pred             cccCcccccccccccccCC
Q 011005           82 EITKLSRLDYLNLSSNKLS  100 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~  100 (496)
                       +.  ++|+.|+|++|.|+
T Consensus       178 -l~--~~L~~L~Ls~N~L~  193 (571)
T 3cvr_A          178 -LP--ESLEALDVSTNLLE  193 (571)
T ss_dssp             -CC--TTCCEEECCSSCCS
T ss_pred             -hh--CCCCEEECcCCCCC
Confidence             33  45555555555555

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.08  E-value=3e-10  Score=116.92  Aligned_cols=85  Identities=28%  Similarity=0.543  Sum_probs=40.3

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |+++.+|..+.  ++|+.|+|++|+|+ .+|   ..+++|+.|+|++|+|++ +|. +..  +|+.|+|++|+|++ +|.
T Consensus        69 n~L~~lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~  137 (571)
T 3cvr_A           69 LNLSSLPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE  137 (571)
T ss_dssp             SCCSCCCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC
T ss_pred             CCCCccCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC
Confidence            44555555442  45555555555555 344   234555555555555553 444 332  44555555555443 333


Q ss_pred             cccCcccccccccccccCC
Q 011005           82 EITKLSRLDYLNLSSNKLS  100 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~  100 (496)
                         .+++|+.|++++|.|+
T Consensus       138 ---~l~~L~~L~Ls~N~l~  153 (571)
T 3cvr_A          138 ---LPALLEYINADNNQLT  153 (571)
T ss_dssp             ---CCTTCCEEECCSSCCS
T ss_pred             ---cCccccEEeCCCCccC
Confidence               3344444444444444

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.06  E-value=1.7e-10  Score=112.26  Aligned_cols=122  Identities=18%  Similarity=0.167  Sum_probs=97.4

Q ss_pred             CCccccCCh-hccCCCCCCEEeccCCccCCCCC-ccCCCCCCCCE-EeccCCcCCCCCchhhcCCcccCeecccccccCC
Q 011005            1 MYKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIP-SALGSLTNLSN-LDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQG   77 (496)
Q Consensus         1 ~n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p-~~~~~l~~L~~-l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~   77 (496)
                      .|+|+.||+ .|.+|++|++|+|++|++.+.+| +.|.++++|+. +.++.|+|+...|..|..+++|+.|++++|++++
T Consensus        39 ~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~  118 (350)
T 4ay9_X           39 LTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH  118 (350)
T ss_dssp             SCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSS
T ss_pred             CCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccccccccccccc
Confidence            489999998 68999999999999999876555 57899998875 6777899997778889999999999999999996


Q ss_pred             CCCccccCccccccccccc-ccCCCCCCCCCCCCCccccccccCCC
Q 011005           78 SIPGEITKLSRLDYLNLSS-NKLSGPVPFSNNDLSSMHTVVSLSPN  122 (496)
Q Consensus        78 ~~~~~~~~l~~L~~l~l~~-n~l~~~~~~~~~~l~~l~~~~~~~~n  122 (496)
                      ..+..+....++..|++.+ |.++...+..|..+......+.++.|
T Consensus       119 ~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N  164 (350)
T 4ay9_X          119 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN  164 (350)
T ss_dssp             CCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSS
T ss_pred             CCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccc
Confidence            6666677777888888865 67776667777777643333444444

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.05  E-value=4.6e-10  Score=113.14  Aligned_cols=98  Identities=24%  Similarity=0.327  Sum_probs=82.3

Q ss_pred             ccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCcc
Q 011005            3 KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGE   82 (496)
Q Consensus         3 ~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~   82 (496)
                      .++.+  .++.+++|+.|+|++|++++ +|  +..+++|+.|++++|++++.   .+..+++|+.|+|++|++++ +|  
T Consensus       160 ~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--  228 (457)
T 3bz5_A          160 KITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--  228 (457)
T ss_dssp             CCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--
T ss_pred             ccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--
Confidence            34445  47889999999999999996 55  88999999999999999964   38889999999999999996 56  


Q ss_pred             ccCcccccccccccccCCCCCCCCCCCCC
Q 011005           83 ITKLSRLDYLNLSSNKLSGPVPFSNNDLS  111 (496)
Q Consensus        83 ~~~l~~L~~l~l~~n~l~~~~~~~~~~l~  111 (496)
                      +..+++|+.|++++|++++..+..+.++.
T Consensus       229 ~~~l~~L~~L~l~~N~l~~~~~~~l~~L~  257 (457)
T 3bz5_A          229 VTPLTQLTYFDCSVNPLTELDVSTLSKLT  257 (457)
T ss_dssp             CTTCTTCSEEECCSSCCSCCCCTTCTTCC
T ss_pred             ccccCCCCEEEeeCCcCCCcCHHHCCCCC
Confidence            88899999999999999987766665555

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.00  E-value=1e-09  Score=114.24  Aligned_cols=46  Identities=35%  Similarity=0.311  Sum_probs=21.4

Q ss_pred             cccCeecccccccCCCCCccccCcccccccccccccCCCCCCCCCCCCCcc
Q 011005           63 KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSM  113 (496)
Q Consensus        63 ~~L~~l~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l  113 (496)
                      ++|+.|+|++|+|+ .+|.   .+++|+.|++++|.|+ .+|..+.++++|
T Consensus       241 ~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L  286 (622)
T 3g06_A          241 SELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSE  286 (622)
T ss_dssp             TTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTT
T ss_pred             CcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhcccc
Confidence            44444444444444 2332   3344555555555555 334445555555

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=98.99  E-value=9e-12  Score=120.52  Aligned_cols=100  Identities=19%  Similarity=0.180  Sum_probs=49.8

Q ss_pred             CCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCC-CchhhcCCcccCeecccccccCCCCCccccCcccccccc
Q 011005           15 KNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGK-IPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLN   93 (496)
Q Consensus        15 ~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~-~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~l~   93 (496)
                      ++++.|++++|.+.+..+. +..+++|++|+|++|.+++. +|..+..+++|++|+|++|++++..+..++.+++|+.|+
T Consensus        70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~  148 (336)
T 2ast_B           70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN  148 (336)
T ss_dssp             TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred             ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence            4555555555555544333 33455555555555555433 444555555555555555555544444555555555555


Q ss_pred             cccc-cCCCC-CCCCCCCCCcccc
Q 011005           94 LSSN-KLSGP-VPFSNNDLSSMHT  115 (496)
Q Consensus        94 l~~n-~l~~~-~~~~~~~l~~l~~  115 (496)
                      +++| .+++. ++..+..+++|+.
T Consensus       149 L~~~~~l~~~~l~~~~~~~~~L~~  172 (336)
T 2ast_B          149 LSGCSGFSEFALQTLLSSCSRLDE  172 (336)
T ss_dssp             CTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred             CCCCCCCCHHHHHHHHhcCCCCCE
Confidence            5555 34431 3333444444433

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.97  E-value=3.9e-10  Score=107.35  Aligned_cols=183  Identities=21%  Similarity=0.198  Sum_probs=121.4

Q ss_pred             cceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-ccc--cccccceeecCC---eEEEEEEe
Q 011005          210 RYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRN--IVKLYGYCLHKK---CMFLIYEY  283 (496)
Q Consensus       210 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lV~e~  283 (496)
                      .+.++.|....||+..    ..+++|.....   .....+.+|+.+++.+. +..  +.+++.......   ..++||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4568999999999863    45888886543   22356889999999884 333  334444433333   34789999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC--------------------------------------  325 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--------------------------------------  325 (496)
                      ++|.++......     .++..++..++.+++..+..||+..                                      
T Consensus        98 i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           98 IKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             CCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             cCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            999888654331     4677777888888888888888510                                      


Q ss_pred             -----------------CCCeEEeCCCCCceEecC--CCCeEEccccccccccCCCCCcccccccccc---cccccccc-
Q 011005          326 -----------------SPSIIHRDISSNNILLNS--KLEAFVADFGTARLLHADSSNRTLLAGTYGY---IAPELAYT-  382 (496)
Q Consensus       326 -----------------~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~-  382 (496)
                                       ...++|+|++|.||++++  +..+.++||+.+...... ..   ......+   ..|+.... 
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~D---l~~~~~~~~~~~~~~~~~~  248 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-ND---FISLMEDDEEYGMEFVSKI  248 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HH---HHTTCCTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HH---HHHHHhhccccCHHHHHHH
Confidence                             135899999999999998  456789999998654211 00   0000011   12221110 


Q ss_pred             -------------CCcCcccchhhHHHHHHHHHhCCCCC
Q 011005          383 -------------MVMTEKCDVYSFGVVTLEVLMGKHPR  408 (496)
Q Consensus       383 -------------~~~~~~~DvwslG~il~el~~g~~p~  408 (496)
                                   .......+.|++|.++|.+.+|..+|
T Consensus       249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                         01122368999999999999998886

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=98.94  E-value=2.5e-09  Score=107.64  Aligned_cols=79  Identities=27%  Similarity=0.356  Sum_probs=43.3

Q ss_pred             CCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCccccccccc
Q 011005           15 KNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNL   94 (496)
Q Consensus        15 ~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~l~l   94 (496)
                      ++|++|+|++|++++ +| .|+++++|++|++++|++++ +|..+   .+|++|++++|++++ +| .+..+++|+.|++
T Consensus       131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l  202 (454)
T 1jl5_A          131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA  202 (454)
T ss_dssp             TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred             CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence            456666666666653 44 35666666666666666653 44322   355555555555553 34 3555555555555


Q ss_pred             ccccCCC
Q 011005           95 SSNKLSG  101 (496)
Q Consensus        95 ~~n~l~~  101 (496)
                      ++|.+++
T Consensus       203 ~~N~l~~  209 (454)
T 1jl5_A          203 DNNSLKK  209 (454)
T ss_dssp             CSSCCSS
T ss_pred             CCCcCCc
Confidence            5555553

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=98.94  E-value=3.1e-10  Score=118.16  Aligned_cols=99  Identities=25%  Similarity=0.333  Sum_probs=81.2

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |+++.+|.   .+++|+.|+|++|+|++ +|   ..+++|+.|+|++|+|+ .+|.   .+++|+.|+|++|+|+ .+|.
T Consensus       211 N~l~~l~~---~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~  278 (622)
T 3g06_A          211 NRLTSLPA---LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPE  278 (622)
T ss_dssp             SCCSSCCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCG
T ss_pred             CcccccCC---CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCH
Confidence            44444443   23778999999999985 55   45689999999999999 5776   6789999999999999 7899


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCc
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSS  112 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~  112 (496)
                      .+.++++|+.|++++|++++..|..+..+++
T Consensus       279 ~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~~  309 (622)
T 3g06_A          279 SLIHLSSETTVNLEGNPLSERTLQALREITS  309 (622)
T ss_dssp             GGGGSCTTCEEECCSCCCCHHHHHHHHHHHH
T ss_pred             HHhhccccCEEEecCCCCCCcCHHHHHhccc
Confidence            9999999999999999999887776665543

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=98.89  E-value=5.3e-11  Score=115.08  Aligned_cols=91  Identities=24%  Similarity=0.296  Sum_probs=53.0

Q ss_pred             CChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCC-cCCCC-CchhhcCCcccCeeccccc-ccCCC-CCcc
Q 011005            7 IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSN-KLSGK-IPPEIASMKYLTQLDLSNN-NIQGS-IPGE   82 (496)
Q Consensus         7 lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n-~l~~~-~p~~~~~l~~L~~l~l~~N-~l~~~-~~~~   82 (496)
                      +|..+..+++|++|+|++|.+++..|..+..+++|++|+|++| .+++. +|..+..+++|+.|+|++| .+++. ++..
T Consensus       110 ~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~  189 (336)
T 2ast_B          110 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA  189 (336)
T ss_dssp             HHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHH
T ss_pred             HHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHH
Confidence            4555666666666666666666555566666666666666666 45531 4444555666666666666 55532 3444


Q ss_pred             ccCcc-cccccccccc
Q 011005           83 ITKLS-RLDYLNLSSN   97 (496)
Q Consensus        83 ~~~l~-~L~~l~l~~n   97 (496)
                      +..++ +|+.|++++|
T Consensus       190 ~~~l~~~L~~L~l~~~  205 (336)
T 2ast_B          190 VAHVSETITQLNLSGY  205 (336)
T ss_dssp             HHHSCTTCCEEECCSC
T ss_pred             HHhcccCCCEEEeCCC
Confidence            44555 5555555555

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=98.88  E-value=4.6e-11  Score=117.96  Aligned_cols=107  Identities=15%  Similarity=0.168  Sum_probs=69.3

Q ss_pred             hhccCCCCCCEEeccCCccCC-----CCCccCCCCCCCCEEeccCCcCC----CCCchhhcCCcccCeecccccccCCC-
Q 011005            9 PEIGNLKNLIKLDVGSNSLIG-----PIPSALGSLTNLSNLDLSSNKLS----GKIPPEIASMKYLTQLDLSNNNIQGS-   78 (496)
Q Consensus         9 ~~~~~l~~L~~L~l~~n~i~~-----~~p~~~~~l~~L~~l~l~~n~l~----~~~p~~~~~l~~L~~l~l~~N~l~~~-   78 (496)
                      ..+..+++|+.|+|++|+|+.     ..|..+..+++|+.|+|++|.|+    +.+|..+..+++|+.|+|++|++++. 
T Consensus       181 ~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~  260 (386)
T 2ca6_A          181 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARG  260 (386)
T ss_dssp             HHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHH
T ss_pred             HHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhh
Confidence            355567777777777777652     23335667777777777777774    35666777777777777777777643 


Q ss_pred             ---CCccc--cCcccccccccccccCCC----CCCCCC-CCCCcccc
Q 011005           79 ---IPGEI--TKLSRLDYLNLSSNKLSG----PVPFSN-NDLSSMHT  115 (496)
Q Consensus        79 ---~~~~~--~~l~~L~~l~l~~n~l~~----~~~~~~-~~l~~l~~  115 (496)
                         ++..+  +.+++|+.|+|++|.+++    .+|..+ .++++|+.
T Consensus       261 ~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~  307 (386)
T 2ca6_A          261 AAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF  307 (386)
T ss_dssp             HHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCE
T ss_pred             HHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceE
Confidence               34455  336777777777777775    355544 44566644

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=98.86  E-value=1.8e-10  Score=112.68  Aligned_cols=106  Identities=22%  Similarity=0.193  Sum_probs=84.7

Q ss_pred             CccccCCh-hccCCCCCCEEeccCCccCCCCC----ccCCCCC-CCCEEeccCCcCCCCCchhhcCC-----cccCeecc
Q 011005            2 YKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIP----SALGSLT-NLSNLDLSSNKLSGKIPPEIASM-----KYLTQLDL   70 (496)
Q Consensus         2 n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p----~~~~~l~-~L~~l~l~~n~l~~~~p~~~~~l-----~~L~~l~l   70 (496)
                      |++....+ .+...++|++|+|++|.|++..+    +.|..++ +|++|+|++|+|++..+..+..+     ++|+.|+|
T Consensus         8 n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~L   87 (362)
T 3goz_A            8 HPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNL   87 (362)
T ss_dssp             CTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEEC
T ss_pred             ccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEEC
Confidence            55665444 44555569999999999997666    7788898 89999999999998778777775     99999999


Q ss_pred             cccccCCCCCccccC----c-ccccccccccccCCCCCCCCC
Q 011005           71 SNNNIQGSIPGEITK----L-SRLDYLNLSSNKLSGPVPFSN  107 (496)
Q Consensus        71 ~~N~l~~~~~~~~~~----l-~~L~~l~l~~n~l~~~~~~~~  107 (496)
                      ++|++++..+..+..    + ++|+.|++++|.+++..+..+
T Consensus        88 s~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l  129 (362)
T 3goz_A           88 SGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEF  129 (362)
T ss_dssp             CSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHH
T ss_pred             cCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHH
Confidence            999998666665444    3 899999999999987665443

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=98.85  E-value=1.4e-10  Score=114.49  Aligned_cols=97  Identities=26%  Similarity=0.328  Sum_probs=83.6

Q ss_pred             CChhccCCCCCCEEeccCCccC----CCCCccCCCCCCCCEEeccCCcCCCC----Cchhhc--CCcccCeecccccccC
Q 011005            7 IPPEIGNLKNLIKLDVGSNSLI----GPIPSALGSLTNLSNLDLSSNKLSGK----IPPEIA--SMKYLTQLDLSNNNIQ   76 (496)
Q Consensus         7 lp~~~~~l~~L~~L~l~~n~i~----~~~p~~~~~l~~L~~l~l~~n~l~~~----~p~~~~--~l~~L~~l~l~~N~l~   76 (496)
                      +|..+..+++|+.|+|++|.|+    +.+|..+..+++|+.|+|++|.|++.    +|..+.  .+++|+.|+|++|.++
T Consensus       208 ~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~  287 (386)
T 2ca6_A          208 LLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE  287 (386)
T ss_dssp             HHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred             HHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCC
Confidence            3447889999999999999995    56788899999999999999999865    566774  4999999999999999


Q ss_pred             C----CCCccc-cCcccccccccccccCCCCC
Q 011005           77 G----SIPGEI-TKLSRLDYLNLSSNKLSGPV  103 (496)
Q Consensus        77 ~----~~~~~~-~~l~~L~~l~l~~n~l~~~~  103 (496)
                      +    .+|..+ .++++|+.|++++|++++..
T Consensus       288 ~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~  319 (386)
T 2ca6_A          288 LDAVRTLKTVIDEKMPDLLFLELNGNRFSEED  319 (386)
T ss_dssp             HHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred             HHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence            6    377777 66899999999999999654

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=98.85  E-value=6.9e-09  Score=104.39  Aligned_cols=100  Identities=23%  Similarity=0.423  Sum_probs=72.5

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |+++.+|..   +++|+.|++++|++++ +|..   .++|++|+|++|++++ +| .+.++++|++|++++|++++ +|.
T Consensus       101 n~l~~lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~  170 (454)
T 1jl5_A          101 NSLTELPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPD  170 (454)
T ss_dssp             SCCSSCCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCC
T ss_pred             CcCCccccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCC
Confidence            556666643   3677888888888774 3321   2688888888888885 67 58888888888888888884 555


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      .+   .+|+.|++++|.+++ +| .+..+++|+.+
T Consensus       171 ~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L  200 (454)
T 1jl5_A          171 LP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAI  200 (454)
T ss_dssp             CC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEE
T ss_pred             Cc---ccccEEECcCCcCCc-Cc-cccCCCCCCEE
Confidence            43   488888888888886 45 57788887654

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=98.78  E-value=4.3e-10  Score=109.93  Aligned_cols=104  Identities=26%  Similarity=0.285  Sum_probs=83.6

Q ss_pred             CCccccCC-----hhccCCC-CCCEEeccCCccCCCCCccCCCC-----CCCCEEeccCCcCCCCCchhhcC----C-cc
Q 011005            1 MYKIGIIP-----PEIGNLK-NLIKLDVGSNSLIGPIPSALGSL-----TNLSNLDLSSNKLSGKIPPEIAS----M-KY   64 (496)
Q Consensus         1 ~n~~~~lp-----~~~~~l~-~L~~L~l~~n~i~~~~p~~~~~l-----~~L~~l~l~~n~l~~~~p~~~~~----l-~~   64 (496)
                      .|+++.++     ..+.+++ +|++|+|++|.|++..+..+..+     ++|++|+|++|+|++..+..+..    + ++
T Consensus        31 ~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~  110 (362)
T 3goz_A           31 LNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFT  110 (362)
T ss_dssp             TSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             CCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCC
Confidence            46777777     5677888 89999999999998777777775     99999999999999777665444    4 89


Q ss_pred             cCeecccccccCCCCCcccc----C-cccccccccccccCCCCCC
Q 011005           65 LTQLDLSNNNIQGSIPGEIT----K-LSRLDYLNLSSNKLSGPVP  104 (496)
Q Consensus        65 L~~l~l~~N~l~~~~~~~~~----~-l~~L~~l~l~~n~l~~~~~  104 (496)
                      |+.|+|++|++++..+..+.    . .++|+.|++++|.+++...
T Consensus       111 L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~  155 (362)
T 3goz_A          111 ITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSS  155 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCH
T ss_pred             ccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHH
Confidence            99999999999866555443    3 3699999999999985443

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=98.74  E-value=7.7e-09  Score=99.54  Aligned_cols=102  Identities=15%  Similarity=0.134  Sum_probs=92.0

Q ss_pred             CCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccC-eecccccccCCCCCccccCccccccc
Q 011005           14 LKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLT-QLDLSNNNIQGSIPGEITKLSRLDYL   92 (496)
Q Consensus        14 l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~-~l~l~~N~l~~~~~~~~~~l~~L~~l   92 (496)
                      +++|+.|+|++|+++.+.+..|.++++|+.|+|++| ++.+-+..|.+|++|+ .++|.+ .++...+..|.+|++|+.|
T Consensus       225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l  302 (329)
T 3sb4_A          225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV  302 (329)
T ss_dssp             CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred             cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence            789999999999999777788999999999999998 7756667899999999 999999 7775667899999999999


Q ss_pred             ccccccCCCCCCCCCCCCCcccccc
Q 011005           93 NLSSNKLSGPVPFSNNDLSSMHTVV  117 (496)
Q Consensus        93 ~l~~n~l~~~~~~~~~~l~~l~~~~  117 (496)
                      ++++|.++...+..|.++++|+.+.
T Consensus       303 ~l~~n~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          303 LATGDKITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             EECSSCCCEECTTTTCTTCCCCEEE
T ss_pred             EeCCCccCccchhhhcCCcchhhhc
Confidence            9999999989999999999997653

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.64  E-value=2.3e-10  Score=115.71  Aligned_cols=88  Identities=17%  Similarity=0.146  Sum_probs=40.5

Q ss_pred             CCCCCCEEeccCCccCCC----CCccCCCCCCCCEEeccCCcCCCCCchhhcC-----CcccCeecccccccCCC----C
Q 011005           13 NLKNLIKLDVGSNSLIGP----IPSALGSLTNLSNLDLSSNKLSGKIPPEIAS-----MKYLTQLDLSNNNIQGS----I   79 (496)
Q Consensus        13 ~l~~L~~L~l~~n~i~~~----~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~-----l~~L~~l~l~~N~l~~~----~   79 (496)
                      .+++|+.|+|++|+++..    ++..+..+++|+.|+|++|.+++..+..+..     .++|+.|+|++|.+++.    +
T Consensus       254 ~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l  333 (461)
T 1z7x_W          254 PSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHF  333 (461)
T ss_dssp             TTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             CCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHH
Confidence            355555555555555532    3444444555555555555554322222221     13455555555544422    2


Q ss_pred             CccccCcccccccccccccCC
Q 011005           80 PGEITKLSRLDYLNLSSNKLS  100 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~  100 (496)
                      +..+..+++|+.|++++|.++
T Consensus       334 ~~~l~~~~~L~~L~Ls~n~i~  354 (461)
T 1z7x_W          334 SSVLAQNRFLLELQISNNRLE  354 (461)
T ss_dssp             HHHHHHCSSCCEEECCSSBCH
T ss_pred             HHHHhhCCCccEEEccCCccc
Confidence            333334444455555544444

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.63  E-value=1.6e-09  Score=99.80  Aligned_cols=103  Identities=21%  Similarity=0.304  Sum_probs=71.4

Q ss_pred             ccCCCCCCE--EeccCCccCCCCCc----cCCCCCCCCEEeccCCcCCC--CCchhhcCCcccCeecccccccCCCCCcc
Q 011005           11 IGNLKNLIK--LDVGSNSLIGPIPS----ALGSLTNLSNLDLSSNKLSG--KIPPEIASMKYLTQLDLSNNNIQGSIPGE   82 (496)
Q Consensus        11 ~~~l~~L~~--L~l~~n~i~~~~p~----~~~~l~~L~~l~l~~n~l~~--~~p~~~~~l~~L~~l~l~~N~l~~~~~~~   82 (496)
                      +...+.|+.  ++++.|... .++.    ...++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..
T Consensus       137 l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~  213 (267)
T 3rw6_A          137 LRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RE  213 (267)
T ss_dssp             GGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GG
T ss_pred             cCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hh
Confidence            333444554  667777443 2222    22468899999999999996  3456778899999999999999854  33


Q ss_pred             ccCcc--cccccccccccCCCCCCC-------CCCCCCccccc
Q 011005           83 ITKLS--RLDYLNLSSNKLSGPVPF-------SNNDLSSMHTV  116 (496)
Q Consensus        83 ~~~l~--~L~~l~l~~n~l~~~~~~-------~~~~l~~l~~~  116 (496)
                      +..++  +|+.|+|++|++++..|.       .+..+++|..|
T Consensus       214 l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~L  256 (267)
T 3rw6_A          214 LDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRL  256 (267)
T ss_dssp             GGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEE
T ss_pred             hhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeE
Confidence            44444  899999999999876653       24555666443

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=98.60  E-value=4.7e-08  Score=93.96  Aligned_cols=52  Identities=19%  Similarity=0.100  Sum_probs=35.3

Q ss_pred             CcccCeecccccccCCCCCccccCcccccccccccccCCCCCCCCCCCCCccc
Q 011005           62 MKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMH  114 (496)
Q Consensus        62 l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~  114 (496)
                      +++|+.|+|++|+++...+..|.++.+|+.|++.+| ++...+.+|.++++|+
T Consensus       225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~  276 (329)
T 3sb4_A          225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLA  276 (329)
T ss_dssp             CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred             cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhcc
Confidence            566777777777776444556777777777777776 6666666777777665

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.59  E-value=1.3e-08  Score=93.68  Aligned_cols=80  Identities=26%  Similarity=0.379  Sum_probs=65.7

Q ss_pred             cCCCCCCEEeccCCccCCC--CCccCCCCCCCCEEeccCCcCCCCCchhhcCCc--ccCeecccccccCCCCCc------
Q 011005           12 GNLKNLIKLDVGSNSLIGP--IPSALGSLTNLSNLDLSSNKLSGKIPPEIASMK--YLTQLDLSNNNIQGSIPG------   81 (496)
Q Consensus        12 ~~l~~L~~L~l~~n~i~~~--~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~--~L~~l~l~~N~l~~~~~~------   81 (496)
                      .++++|+.|+|++|+|++.  +|+.+..+++|+.|+|++|+|++.  ..+..+.  +|+.|+|++|.+++.+|.      
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~  244 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS  244 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence            4689999999999999973  456677899999999999999964  4455555  999999999999876663      


Q ss_pred             -cccCcccccccc
Q 011005           82 -EITKLSRLDYLN   93 (496)
Q Consensus        82 -~~~~l~~L~~l~   93 (496)
                       .+..+++|+.||
T Consensus       245 ~il~~~P~L~~LD  257 (267)
T 3rw6_A          245 AIRERFPKLLRLD  257 (267)
T ss_dssp             HHHHHCTTCCEES
T ss_pred             HHHHHCcccCeEC
Confidence             367788888776

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.50  E-value=2e-09  Score=108.66  Aligned_cols=87  Identities=23%  Similarity=0.210  Sum_probs=45.5

Q ss_pred             CCCCCEEeccCCccCCC----CCccCCCCCCCCEEeccCCcCCCCC-----chhhcCCcccCeecccccccCCC----CC
Q 011005           14 LKNLIKLDVGSNSLIGP----IPSALGSLTNLSNLDLSSNKLSGKI-----PPEIASMKYLTQLDLSNNNIQGS----IP   80 (496)
Q Consensus        14 l~~L~~L~l~~n~i~~~----~p~~~~~l~~L~~l~l~~n~l~~~~-----p~~~~~l~~L~~l~l~~N~l~~~----~~   80 (496)
                      +++|+.|+|++|.++..    ++..+..+++|+.|+|++|.+++..     +..+..+++|+.|+|++|++++.    ++
T Consensus       198 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~  277 (461)
T 1z7x_W          198 PCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLC  277 (461)
T ss_dssp             CCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHH
T ss_pred             CCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHH
Confidence            44566666666665532    3444555566666666666555321     11122355566666666655522    34


Q ss_pred             ccccCcccccccccccccCC
Q 011005           81 GEITKLSRLDYLNLSSNKLS  100 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~  100 (496)
                      ..+..+++|+.|++++|.++
T Consensus       278 ~~l~~~~~L~~L~Ls~n~i~  297 (461)
T 1z7x_W          278 RVLRAKESLKELSLAGNELG  297 (461)
T ss_dssp             HHHHHCTTCCEEECTTCCCH
T ss_pred             HHHhhCCCcceEECCCCCCc
Confidence            44555556666666666554

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.50  E-value=9.6e-07  Score=83.79  Aligned_cols=136  Identities=18%  Similarity=0.153  Sum_probs=93.3

Q ss_pred             cceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhccc---ccccccceee-cCCeEEEEEEecC
Q 011005          210 RYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR---NIVKLYGYCL-HKKCMFLIYEYME  285 (496)
Q Consensus       210 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lV~e~~~  285 (496)
                      .+.++.|....||+.    +..+++|+....   .....+.+|+.+++.+.+.   .+.+.+.++. ..+..++|||+++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKSQ---QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESSH---HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCCc---hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            356888888899998    566788885332   2346788999999999742   3556666664 3456789999999


Q ss_pred             CCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 011005          286 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD-----------------------------------------  324 (496)
Q Consensus       286 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-----------------------------------------  324 (496)
                      |.++......     .++..+...++.++...|..||+.                                         
T Consensus        97 G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           97 GQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             SEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             CeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            9888653221     234444445555555555555532                                         


Q ss_pred             ----------------CCCCeEEeCCCCCceEecC---CCC-eEEcccccccc
Q 011005          325 ----------------CSPSIIHRDISSNNILLNS---KLE-AFVADFGTARL  357 (496)
Q Consensus       325 ----------------~~~~i~H~dlkp~Nil~~~---~~~-~kl~Dfg~~~~  357 (496)
                                      ....++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                            1345799999999999997   455 47999998854

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.49  E-value=9.1e-07  Score=82.32  Aligned_cols=134  Identities=19%  Similarity=0.170  Sum_probs=97.2

Q ss_pred             eeeecCCe-eEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-ccccccccceeecCCeEEEEEEecCCCC
Q 011005          212 CIGTGGYG-SVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKCMFLIYEYMERGS  288 (496)
Q Consensus       212 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lV~e~~~~g~  288 (496)
                      .+..|..| .||+.... ++..+++|.-....    ...+.+|...++.+. +--+.++++++.+.+..++|||+++|.+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~----~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV----ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETHH----HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCCC----HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            45556655 69998765 46678889865432    356788999998885 3346788888888899999999999988


Q ss_pred             hhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 011005          289 LFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC-------------------------------------------  325 (496)
Q Consensus       289 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-------------------------------------------  325 (496)
                      +.+.....       ......+..+++..|..||...                                           
T Consensus       107 ~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          107 AFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             HHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             ccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            77654421       1223346667777777777510                                           


Q ss_pred             ------------CCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          326 ------------SPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       326 ------------~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                                  ...++|+|+.+.||++++++.+-|+||+.+.
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                        1238999999999999988777799999874

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.26  E-value=1.1e-08  Score=99.99  Aligned_cols=88  Identities=22%  Similarity=0.250  Sum_probs=48.6

Q ss_pred             CCCCCEEeccCCccCCCCCccC-----CCCCCCCEEeccCCcCCC----CCchhhcCCcccCeecccccccCCC----CC
Q 011005           14 LKNLIKLDVGSNSLIGPIPSAL-----GSLTNLSNLDLSSNKLSG----KIPPEIASMKYLTQLDLSNNNIQGS----IP   80 (496)
Q Consensus        14 l~~L~~L~l~~n~i~~~~p~~~-----~~l~~L~~l~l~~n~l~~----~~p~~~~~l~~L~~l~l~~N~l~~~----~~   80 (496)
                      +++|+.|+|++|+|+......+     ...++|+.|+|++|.|+.    .++..+..+++|++|+|++|+|+..    ++
T Consensus       125 L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~  204 (372)
T 3un9_A          125 FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLA  204 (372)
T ss_dssp             HHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHH
T ss_pred             HHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHH
Confidence            4456666666666543222222     234566666666666653    1333445566667777777666521    23


Q ss_pred             ccccCcccccccccccccCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSG  101 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~  101 (496)
                      ..+..+++|+.|+|++|.|+.
T Consensus       205 ~~L~~~~~L~~L~Ls~N~i~~  225 (372)
T 3un9_A          205 AQLDRNRQLQELNVAYNGAGD  225 (372)
T ss_dssp             HHGGGCSCCCEEECCSSCCCH
T ss_pred             HHHhcCCCcCeEECCCCCCCH
Confidence            445555666777777776653

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.25  E-value=1.9e-06  Score=83.74  Aligned_cols=81  Identities=10%  Similarity=0.002  Sum_probs=55.6

Q ss_pred             cee-eecCCeeEEEEEeC-------CCcEEEEEEcccchh--HHHHHHHHHHHHHHHhhc-c--cccccccceeecC---
Q 011005          211 YCI-GTGGYGSVYKAQLP-------NGKVFALKKLHTSEE--LAFIKSFKNEAQVLSQVL-H--RNIVKLYGYCLHK---  274 (496)
Q Consensus       211 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~---  274 (496)
                      +.| +.|....+|+....       +++.+++|.......  ......+.+|+.+++.+. +  -.+.+++.++...   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            457 78888999998764       267888988654321  000134678999999885 3  2466778777655   


Q ss_pred             CeEEEEEEecCCCChhh
Q 011005          275 KCMFLIYEYMERGSLFC  291 (496)
Q Consensus       275 ~~~~lV~e~~~~g~L~~  291 (496)
                      +..++|||+++|..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999999877653

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=98.19  E-value=2.1e-06  Score=84.63  Aligned_cols=115  Identities=10%  Similarity=0.111  Sum_probs=86.0

Q ss_pred             ccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCC-----CCCchhhcCCcccCeecccccccC
Q 011005            3 KIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLS-----GKIPPEIASMKYLTQLDLSNNNIQ   76 (496)
Q Consensus         3 ~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~-----~~~p~~~~~l~~L~~l~l~~N~l~   76 (496)
                      .+..|+. .|.+ .+|+.+.|. |+++.+.+..|.++++|+.++|.+|.+.     ..-+..|.+|++|+.++|. |.++
T Consensus       236 ~l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~  312 (401)
T 4fdw_A          236 NVSTIGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIR  312 (401)
T ss_dssp             TCCEECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCC
T ss_pred             CccCcccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceE
Confidence            3555666 5556 789999994 5566566788999999999999888765     3445678889999999998 4476


Q ss_pred             CCCCccccCcccccccccccccCCCCCCCCCCCCCccccccccCCC
Q 011005           77 GSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN  122 (496)
Q Consensus        77 ~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n  122 (496)
                      ..-...|.+|.+|+.+.+.+| ++...+.+|.++ +|+.+....++
T Consensus       313 ~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~  356 (401)
T 4fdw_A          313 ILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTT  356 (401)
T ss_dssp             EECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSS
T ss_pred             EEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCC
Confidence            455678888999999999655 776778888888 88776544333

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.18  E-value=6e-06  Score=79.52  Aligned_cols=139  Identities=20%  Similarity=0.343  Sum_probs=80.5

Q ss_pred             eeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhccc--ccccccc------eeecCCeEEEEEEe
Q 011005          212 CIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR--NIVKLYG------YCLHKKCMFLIYEY  283 (496)
Q Consensus       212 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~------~~~~~~~~~lV~e~  283 (496)
                      .|+.|..+.||+....+| .+++|......     ..+..|..+++.+...  .+.+++.      +....+..++||+|
T Consensus        39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~-----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDSG-AVCLKRIHRPE-----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             ECC----CEEEEEEETTE-EEEEEEECSCH-----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eccccccCcEEEEEeCCC-CEEEEecCCCH-----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            455677899999987655 48899887632     2334566666666422  2344443      12345678999999


Q ss_pred             cCCCChh--------------hhhhCC---C--C-C-----ccCCHHHH-------------------------------
Q 011005          284 MERGSLF--------------CNLHNN---E--D-A-----VELDWAKR-------------------------------  307 (496)
Q Consensus       284 ~~~g~L~--------------~~l~~~---~--~-~-----~~~~~~~~-------------------------------  307 (496)
                      ++|..+.              ..++..   .  . .     ....|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542              011110   0  0 0     00122110                               


Q ss_pred             HHHHHHHHHHHHHHHh----------CCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          308 VNIVKAMAHALAYLHH----------DCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       308 ~~i~~~i~~~l~~lh~----------~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      ..+..++..++.+|+.          .....++|+|+.+.||+++.++.+.++||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            0111223345566652          015789999999999999888889999999774

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.17  E-value=9.7e-08  Score=93.21  Aligned_cols=90  Identities=19%  Similarity=0.307  Sum_probs=72.6

Q ss_pred             CCCCCCEEeccCCccCC----CCCccCCCCCCCCEEeccCCcCCCC----CchhhcCCcccCeecccccccCCC----CC
Q 011005           13 NLKNLIKLDVGSNSLIG----PIPSALGSLTNLSNLDLSSNKLSGK----IPPEIASMKYLTQLDLSNNNIQGS----IP   80 (496)
Q Consensus        13 ~l~~L~~L~l~~n~i~~----~~p~~~~~l~~L~~l~l~~n~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~----~~   80 (496)
                      ..++|+.|+|++|.|+.    .++..+..+++|++|+|++|.|++.    ++..+..+++|+.|+|++|.|+..    ++
T Consensus       153 ~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~  232 (372)
T 3un9_A          153 DQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALA  232 (372)
T ss_dssp             TTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHH
T ss_pred             cCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHH
Confidence            46789999999999974    2444557889999999999999842    356677889999999999999742    33


Q ss_pred             ccccCcccccccccccccCCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGP  102 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~  102 (496)
                      ..+..+++|+.|+|++|.|++.
T Consensus       233 ~~L~~~~~L~~L~Ls~N~i~~~  254 (372)
T 3un9_A          233 RAAREHPSLELLHLYFNELSSE  254 (372)
T ss_dssp             HHHHHCSSCCEEECTTSSCCHH
T ss_pred             HHHHhCCCCCEEeccCCCCCHH
Confidence            4555678999999999999854

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.13  E-value=2.3e-07  Score=96.63  Aligned_cols=92  Identities=20%  Similarity=0.124  Sum_probs=66.5

Q ss_pred             ccCCCCCCEEeccCCc--cCCCCCccCC-CCCCCCEEeccCCcCCC-CCchhhcCCcccCeecccccccCCC-CCccccC
Q 011005           11 IGNLKNLIKLDVGSNS--LIGPIPSALG-SLTNLSNLDLSSNKLSG-KIPPEIASMKYLTQLDLSNNNIQGS-IPGEITK   85 (496)
Q Consensus        11 ~~~l~~L~~L~l~~n~--i~~~~p~~~~-~l~~L~~l~l~~n~l~~-~~p~~~~~l~~L~~l~l~~N~l~~~-~~~~~~~   85 (496)
                      +.++++|+.|+|++|.  +++..+..+. .+++|++|+|++|++++ .++..+..+++|+.|+|++|.+++. ++..+..
T Consensus       432 ~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~  511 (592)
T 3ogk_B          432 LIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTK  511 (592)
T ss_dssp             HHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHH
T ss_pred             HHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHh
Confidence            5567888888886433  4443333333 47889999999999875 3455567889999999999998643 3444567


Q ss_pred             cccccccccccccCCCC
Q 011005           86 LSRLDYLNLSSNKLSGP  102 (496)
Q Consensus        86 l~~L~~l~l~~n~l~~~  102 (496)
                      +++|+.|++++|+++..
T Consensus       512 l~~L~~L~ls~n~it~~  528 (592)
T 3ogk_B          512 LPSLRYLWVQGYRASMT  528 (592)
T ss_dssp             CSSCCEEEEESCBCCTT
T ss_pred             cCccCeeECcCCcCCHH
Confidence            88999999999998855

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.06  E-value=4.4e-07  Score=79.22  Aligned_cols=92  Identities=16%  Similarity=0.199  Sum_probs=73.5

Q ss_pred             hccCCCCCCEEeccCC-ccCC----CCCccCCCCCCCCEEeccCCcCCCC----CchhhcCCcccCeecccccccCCC--
Q 011005           10 EIGNLKNLIKLDVGSN-SLIG----PIPSALGSLTNLSNLDLSSNKLSGK----IPPEIASMKYLTQLDLSNNNIQGS--   78 (496)
Q Consensus        10 ~~~~l~~L~~L~l~~n-~i~~----~~p~~~~~l~~L~~l~l~~n~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~--   78 (496)
                      .+...++|++|+|++| .|..    .+...+...++|++|+|++|+|...    +...+...++|++|+|++|.|...  
T Consensus        31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~  110 (185)
T 1io0_A           31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI  110 (185)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred             HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence            4567889999999999 8863    2345667789999999999999742    344566678999999999999742  


Q ss_pred             --CCccccCccccccccc--ccccCCC
Q 011005           79 --IPGEITKLSRLDYLNL--SSNKLSG  101 (496)
Q Consensus        79 --~~~~~~~l~~L~~l~l--~~n~l~~  101 (496)
                        +...+...++|+.|+|  ++|.|..
T Consensus       111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~  137 (185)
T 1io0_A          111 LALVEALQSNTSLIELRIDNQSQPLGN  137 (185)
T ss_dssp             HHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred             HHHHHHHHhCCCceEEEecCCCCCCCH
Confidence              4556778889999999  8899974

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=97.98  E-value=9.1e-06  Score=80.00  Aligned_cols=113  Identities=8%  Similarity=0.031  Sum_probs=90.5

Q ss_pred             CccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccC----
Q 011005            2 YKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQ----   76 (496)
Q Consensus         2 n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~----   76 (496)
                      +.+..|+. .|.++++|+.|+|..| ++.+...+|.+ .+|+.+.|. |.++..-+..|.+|++|+.+++.+|.+.    
T Consensus       212 ~~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~  288 (401)
T 4fdw_A          212 VTLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPE  288 (401)
T ss_dssp             TTCCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTT
T ss_pred             CchheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcc
Confidence            34667777 7889999999999875 56566677877 789999994 5566455678999999999999998875    


Q ss_pred             -CCCCccccCcccccccccccccCCCCCCCCCCCCCccccccc
Q 011005           77 -GSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVS  118 (496)
Q Consensus        77 -~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~  118 (496)
                       ...+..|.+|++|+.+.+. |.++.....+|.++++|..+..
T Consensus       289 ~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~l  330 (401)
T 4fdw_A          289 AMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTI  330 (401)
T ss_dssp             CEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEE
T ss_pred             cEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEE
Confidence             3456789999999999999 5588788889999999876643

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.97  E-value=2.2e-05  Score=77.34  Aligned_cols=76  Identities=12%  Similarity=0.103  Sum_probs=48.5

Q ss_pred             cceeeecCCeeEEEEEeC-CCcEEEEEEcccchh---H---HHHHHHHHHHHHHHhhcc--cc-cccccceeecCCeEEE
Q 011005          210 RYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE---L---AFIKSFKNEAQVLSQVLH--RN-IVKLYGYCLHKKCMFL  279 (496)
Q Consensus       210 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~---~~~~~~~~e~~~l~~l~h--~n-iv~~~~~~~~~~~~~l  279 (496)
                      .+.+|.|..+.||++... +++.+++|.......   .   .....+..|.++++.+..  +. +.+++.+.  .+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            456899999999999764 468899997653211   0   112345778899988852  33 34555442  334579


Q ss_pred             EEEecCCC
Q 011005          280 IYEYMERG  287 (496)
Q Consensus       280 V~e~~~~g  287 (496)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=97.97  E-value=7.2e-07  Score=92.93  Aligned_cols=83  Identities=12%  Similarity=0.139  Sum_probs=47.3

Q ss_pred             CCCCCCEEeccCCccCCC----CCccCCCCCCCCEEeccCCcCCC----CCchhhcCCcccCeecccccccCCCCCcccc
Q 011005           13 NLKNLIKLDVGSNSLIGP----IPSALGSLTNLSNLDLSSNKLSG----KIPPEIASMKYLTQLDLSNNNIQGSIPGEIT   84 (496)
Q Consensus        13 ~l~~L~~L~l~~n~i~~~----~p~~~~~l~~L~~l~l~~n~l~~----~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~   84 (496)
                      ++++|++|+|++|.+++.    ++..+..+++|+.|+|++|.+++    .++..+.++++|+.|+|++|.+. .+|..+.
T Consensus       162 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~-~l~~~~~  240 (592)
T 3ogk_B          162 HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEIL-ELVGFFK  240 (592)
T ss_dssp             HCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGG-GGHHHHH
T ss_pred             hCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHH-HHHHHHh
Confidence            556666666666665543    22233455666666666666652    22333445666666666666665 3555556


Q ss_pred             Cccccccccccc
Q 011005           85 KLSRLDYLNLSS   96 (496)
Q Consensus        85 ~l~~L~~l~l~~   96 (496)
                      .+++|+.|++++
T Consensus       241 ~~~~L~~L~l~~  252 (592)
T 3ogk_B          241 AAANLEEFCGGS  252 (592)
T ss_dssp             HCTTCCEEEECB
T ss_pred             hhhHHHhhcccc
Confidence            666666666654

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=97.97  E-value=2.6e-07  Score=80.72  Aligned_cols=94  Identities=16%  Similarity=0.205  Sum_probs=73.4

Q ss_pred             CChhccCCCCCCEEeccCCccCCC----CCccCCCCCCCCEEeccCCcCCCC----CchhhcCCcccCeecc--cccccC
Q 011005            7 IPPEIGNLKNLIKLDVGSNSLIGP----IPSALGSLTNLSNLDLSSNKLSGK----IPPEIASMKYLTQLDL--SNNNIQ   76 (496)
Q Consensus         7 lp~~~~~l~~L~~L~l~~n~i~~~----~p~~~~~l~~L~~l~l~~n~l~~~----~p~~~~~l~~L~~l~l--~~N~l~   76 (496)
                      +...+...++|++|+|++|.|...    +...+...++|++|+|++|.|++.    +...+...++|++|+|  ++|.|.
T Consensus        57 l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~  136 (185)
T 1io0_A           57 CAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLG  136 (185)
T ss_dssp             HHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred             HHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCC
Confidence            334566778999999999999742    344556678999999999999843    4566778889999999  889997


Q ss_pred             CC----CCccccCcccccccccccccCC
Q 011005           77 GS----IPGEITKLSRLDYLNLSSNKLS  100 (496)
Q Consensus        77 ~~----~~~~~~~l~~L~~l~l~~n~l~  100 (496)
                      ..    +...+...++|+.|+|++|.+.
T Consensus       137 ~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          137 NNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            43    3345566689999999999885

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.95  E-value=1.1e-06  Score=74.92  Aligned_cols=92  Identities=11%  Similarity=0.172  Sum_probs=64.4

Q ss_pred             CChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCc-CCCCCchhhcCC----cccCeecccccc-cCCCCC
Q 011005            7 IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNK-LSGKIPPEIASM----KYLTQLDLSNNN-IQGSIP   80 (496)
Q Consensus         7 lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~-l~~~~p~~~~~l----~~L~~l~l~~N~-l~~~~~   80 (496)
                      +|.....--+|+.|||+++.|+..--..+..+++|+.|+|++|. |++.--..+..+    ++|++|+|++|. |+..--
T Consensus        53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl  132 (176)
T 3e4g_A           53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI  132 (176)
T ss_dssp             SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH
T ss_pred             CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH
Confidence            45433222368999999998875544567889999999999985 764322345554    479999998874 764323


Q ss_pred             ccccCccccccccccccc
Q 011005           81 GEITKLSRLDYLNLSSNK   98 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~   98 (496)
                      ..+..+++|+.|++++++
T Consensus       133 ~~L~~~~~L~~L~L~~c~  150 (176)
T 3e4g_A          133 IALHHFRNLKYLFLSDLP  150 (176)
T ss_dssp             HHGGGCTTCCEEEEESCT
T ss_pred             HHHhcCCCCCEEECCCCC
Confidence            456778899999998875

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.89  E-value=0.00013  Score=68.97  Aligned_cols=138  Identities=20%  Similarity=0.247  Sum_probs=91.6

Q ss_pred             cceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc---ccccccccceeecCCeEEEEEEecCC
Q 011005          210 RYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL---HRNIVKLYGYCLHKKCMFLIYEYMER  286 (496)
Q Consensus       210 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lV~e~~~~  286 (496)
                      .+.|+.|....+|+... ++..+++|......    ...+..|+..++.+.   ...+++++.++...+..++||||++|
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERSY----RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGGG----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCccc----HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            45689999999999987 46788888875432    356788999999985   25678888888878889999999999


Q ss_pred             CChhh-----------hhhCCCC--C-----------------ccCCHHHHH---HHH----------------HHHHHH
Q 011005          287 GSLFC-----------NLHNNED--A-----------------VELDWAKRV---NIV----------------KAMAHA  317 (496)
Q Consensus       287 g~L~~-----------~l~~~~~--~-----------------~~~~~~~~~---~i~----------------~~i~~~  317 (496)
                      ..+..           .++....  .                 ..-+|.+..   ++.                .+++..
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            76521           1222211  0                 011344321   011                111212


Q ss_pred             H-HHHHh-CCCCCeEEeCCCCCceEecCCCCeEEcccc
Q 011005          318 L-AYLHH-DCSPSIIHRDISSNNILLNSKLEAFVADFG  353 (496)
Q Consensus       318 l-~~lh~-~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  353 (496)
                      + ..|.. .....++|+|+.+.|++++.++ +.++|++
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            2 23421 1256899999999999999887 8899974

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=97.81  E-value=1.3e-06  Score=90.96  Aligned_cols=103  Identities=16%  Similarity=0.170  Sum_probs=67.1

Q ss_pred             CCCCCCEEecc--C----CccCCCC-----CccCCCCCCCCEEeccCCcCCCCCchhhcC-CcccCeecccccccCCCCC
Q 011005           13 NLKNLIKLDVG--S----NSLIGPI-----PSALGSLTNLSNLDLSSNKLSGKIPPEIAS-MKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus        13 ~l~~L~~L~l~--~----n~i~~~~-----p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~-l~~L~~l~l~~N~l~~~~~   80 (496)
                      ++++|+.|+|+  +    |.++...     +..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+
T Consensus       395 ~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~  473 (594)
T 2p1m_B          395 NRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGM  473 (594)
T ss_dssp             HCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHH
T ss_pred             hCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHH
Confidence            57888888888  4    5555221     11256678888888876 666554455555 7888888888888864433


Q ss_pred             ccc-cCcccccccccccccCCCCCCC-CCCCCCccccc
Q 011005           81 GEI-TKLSRLDYLNLSSNKLSGPVPF-SNNDLSSMHTV  116 (496)
Q Consensus        81 ~~~-~~l~~L~~l~l~~n~l~~~~~~-~~~~l~~l~~~  116 (496)
                      ..+ ..+++|+.|++++|++++.... ....+++|+.+
T Consensus       474 ~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L  511 (594)
T 2p1m_B          474 HHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSL  511 (594)
T ss_dssp             HHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEE
T ss_pred             HHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEE
Confidence            333 5678888888888888543322 23346666544

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.65  E-value=0.00037  Score=66.23  Aligned_cols=158  Identities=15%  Similarity=0.130  Sum_probs=89.1

Q ss_pred             ccHHHHHHHHhCCCCc-----ceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccc--cccc
Q 011005          195 IVYEDLIEATEDFDIR-----YCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN--IVKL  267 (496)
Q Consensus       195 ~~~~~~~~~~~~~~~~-----~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~  267 (496)
                      ++.+++.....+|.+.     +.|+.|....+|+....+| .+++|.......   ...+..|+.+++.+...+  +.++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCcc
Confidence            4456666666677662     3456688889999987666 578898865321   134567888888875323  2333


Q ss_pred             cce------eecCCeEEEEEEecCCCChhh--------------hhhCC----CCCc--cC---CHHHHHH---------
Q 011005          268 YGY------CLHKKCMFLIYEYMERGSLFC--------------NLHNN----EDAV--EL---DWAKRVN---------  309 (496)
Q Consensus       268 ~~~------~~~~~~~~lV~e~~~~g~L~~--------------~l~~~----~~~~--~~---~~~~~~~---------  309 (496)
                      +..      ....+..+++++|++|..+..              .++..    ....  ..   .|.....         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            321      122356789999999865421              01110    0000  00   1211000         


Q ss_pred             ---HHHHHHHHHHHHHhC----CCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          310 ---IVKAMAHALAYLHHD----CSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       310 ---i~~~i~~~l~~lh~~----~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                         +...+...++.++..    ...+++|+|+.+.||+++++..+.++||+.+.
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence               001133444555421    14579999999999999987666899998774

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.63  E-value=0.00018  Score=71.35  Aligned_cols=78  Identities=13%  Similarity=0.063  Sum_probs=48.1

Q ss_pred             CCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCcccccc--ccccccccccccC---CcCcccchhhHHHHHHH
Q 011005          326 SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAG--TYGYIAPELAYTM---VMTEKCDVYSFGVVTLE  400 (496)
Q Consensus       326 ~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DvwslG~il~e  400 (496)
                      ...++|||++|.||+++.++ +.++||+.+....... .......  ...|.+|+.....   .-....++.+....+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            67899999999999999876 9999999886532110 0011111  1245666554321   11223455677777887


Q ss_pred             HHhCC
Q 011005          401 VLMGK  405 (496)
Q Consensus       401 l~~g~  405 (496)
                      .+++.
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77653

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.60  E-value=0.00035  Score=65.28  Aligned_cols=78  Identities=18%  Similarity=0.203  Sum_probs=54.6

Q ss_pred             CCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhccc---ccccccceeecCCeEEEEEEe
Q 011005          207 FDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR---NIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       207 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~lV~e~  283 (496)
                      ..-.+.+|.|..+.||+....+|+.|++|+...... .....+..|+..|+.+.-.   -+++++++.  .  .++||||
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~-~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv~e~   91 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP-ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLAMEW   91 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC-CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEEEEC
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc-chhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEEEEe
Confidence            444567999999999999999999999998654321 1123467899999988522   234444432  2  3689999


Q ss_pred             cCCCCh
Q 011005          284 MERGSL  289 (496)
Q Consensus       284 ~~~g~L  289 (496)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987654

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=97.58  E-value=1.1e-05  Score=78.06  Aligned_cols=103  Identities=17%  Similarity=0.209  Sum_probs=62.5

Q ss_pred             CCCCCEEeccCCccCCCCCccCC--CCCCCCEEeccC--CcCCCC-----Cchhh--cCCcccCeecccccccCCCCCcc
Q 011005           14 LKNLIKLDVGSNSLIGPIPSALG--SLTNLSNLDLSS--NKLSGK-----IPPEI--ASMKYLTQLDLSNNNIQGSIPGE   82 (496)
Q Consensus        14 l~~L~~L~l~~n~i~~~~p~~~~--~l~~L~~l~l~~--n~l~~~-----~p~~~--~~l~~L~~l~l~~N~l~~~~~~~   82 (496)
                      +++|+.|+|..|.+.......+.  .+++|+.|+|+.  |...+.     +...+  ..+++|+.|+|++|.+.+..+..
T Consensus       192 ~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~  271 (362)
T 2ra8_A          192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEM  271 (362)
T ss_dssp             CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHH
T ss_pred             CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHH
Confidence            67888888888877633222333  678888888853  221111     11222  24788888888888876333222


Q ss_pred             cc---CcccccccccccccCCCC----CCCCCCCCCccccc
Q 011005           83 IT---KLSRLDYLNLSSNKLSGP----VPFSNNDLSSMHTV  116 (496)
Q Consensus        83 ~~---~l~~L~~l~l~~n~l~~~----~~~~~~~l~~l~~~  116 (496)
                      +.   .+++|+.|+|+.|.|++.    ++..+..+++|+.|
T Consensus       272 la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L  312 (362)
T 2ra8_A          272 FLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFI  312 (362)
T ss_dssp             HHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEE
T ss_pred             HHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEE
Confidence            22   478888888888888753    23333445566544

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=97.56  E-value=3.1e-06  Score=88.12  Aligned_cols=86  Identities=20%  Similarity=0.205  Sum_probs=41.8

Q ss_pred             CCCCCCEEeccCCccCCCCCccCC-CCCCCCEEeccCC-cCCCC-CchhhcCCcccCeecccccccCCCCCcccc----C
Q 011005           13 NLKNLIKLDVGSNSLIGPIPSALG-SLTNLSNLDLSSN-KLSGK-IPPEIASMKYLTQLDLSNNNIQGSIPGEIT----K   85 (496)
Q Consensus        13 ~l~~L~~L~l~~n~i~~~~p~~~~-~l~~L~~l~l~~n-~l~~~-~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~   85 (496)
                      .+++|+.|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++..+..+++|++|+|++|.+++..+..+.    .
T Consensus       103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~  182 (594)
T 2p1m_B          103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT  182 (594)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred             hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence            345555566655555543333333 4555566665555 33321 223333555566666665555433322222    3


Q ss_pred             ccccccccccccc
Q 011005           86 LSRLDYLNLSSNK   98 (496)
Q Consensus        86 l~~L~~l~l~~n~   98 (496)
                      +++|+.|++++|.
T Consensus       183 ~~~L~~L~l~~~~  195 (594)
T 2p1m_B          183 YTSLVSLNISCLA  195 (594)
T ss_dssp             CCCCCEEECTTCC
T ss_pred             CCcCcEEEecccC
Confidence            4455555555554

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.53  E-value=0.0014  Score=62.38  Aligned_cols=158  Identities=15%  Similarity=0.189  Sum_probs=89.9

Q ss_pred             ccHHHHHHHHhCCCC-----cceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccc--cccc
Q 011005          195 IVYEDLIEATEDFDI-----RYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN--IVKL  267 (496)
Q Consensus       195 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~  267 (496)
                      ++.+.+....+.|.+     ...++ |....||+....+|+.+++|.......  ....+..|..+++.+...+  ++++
T Consensus        11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~   87 (328)
T 1zyl_A           11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAP   87 (328)
T ss_dssp             CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred             CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecce
Confidence            444555555555543     23466 888899999877787899999864321  1245667888888885323  3444


Q ss_pred             cce-----eecCCeEEEEEEecCCCChhh----h----------hhC----CC--CCccCCHHHH---------------
Q 011005          268 YGY-----CLHKKCMFLIYEYMERGSLFC----N----------LHN----NE--DAVELDWAKR---------------  307 (496)
Q Consensus       268 ~~~-----~~~~~~~~lV~e~~~~g~L~~----~----------l~~----~~--~~~~~~~~~~---------------  307 (496)
                      +..     ....+..+++|++++|..+..    .          ++.    ..  .....++...               
T Consensus        88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  167 (328)
T 1zyl_A           88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP  167 (328)
T ss_dssp             CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred             eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence            443     122456688999998854321    0          111    00  0011222111               


Q ss_pred             -------HHHHHHHHHHHHHHHh-CCCCCeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          308 -------VNIVKAMAHALAYLHH-DCSPSIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       308 -------~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                             ...+.+++..+..+-. .....++|+|+++.||+++ + .+.++||+.+..
T Consensus       168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                   1111222222222210 1145689999999999999 4 889999988754

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.42  E-value=0.00013  Score=59.10  Aligned_cols=55  Identities=24%  Similarity=0.375  Sum_probs=26.8

Q ss_pred             EEeccCCccC-CCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeeccccccc
Q 011005           19 KLDVGSNSLI-GPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNI   75 (496)
Q Consensus        19 ~L~l~~n~i~-~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l   75 (496)
                      .++.++++++ ..+|..+.  ++|+.|+|++|+|+...+..|..+++|+.|+|++|.+
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            4555566554 13333222  3455555555555533333445555555555555544

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.40  E-value=0.00065  Score=63.91  Aligned_cols=71  Identities=13%  Similarity=0.059  Sum_probs=45.5

Q ss_pred             cceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhccccc-ccccceeecCCeEEEEEEec-CCC
Q 011005          210 RYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI-VKLYGYCLHKKCMFLIYEYM-ERG  287 (496)
Q Consensus       210 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lV~e~~-~~g  287 (496)
                      .+.|+.|....+|+.     +.+++|........  .....+|+.+++.+...++ .++++.+.  +.-++++||+ +|.
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCc
Confidence            677999999999998     55788887653211  1123568888888864444 35554433  2346899999 664


Q ss_pred             Ch
Q 011005          288 SL  289 (496)
Q Consensus       288 ~L  289 (496)
                      ++
T Consensus        94 ~l   95 (301)
T 3dxq_A           94 TM   95 (301)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.39  E-value=0.00027  Score=57.29  Aligned_cols=57  Identities=25%  Similarity=0.350  Sum_probs=46.0

Q ss_pred             CEEeccCCcCC-CCCchhhcCCcccCeecccccccCCCCCccccCcccccccccccccCC
Q 011005           42 SNLDLSSNKLS-GKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS  100 (496)
Q Consensus        42 ~~l~l~~n~l~-~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~  100 (496)
                      ..++.++++|+ ..+|..+.  ++|+.|+|++|+|+...++.|..+++|+.|+|++|++.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            47889999987 34665543  46999999999999655667888999999999999986

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.37  E-value=0.00047  Score=65.92  Aligned_cols=141  Identities=16%  Similarity=0.178  Sum_probs=74.1

Q ss_pred             eeeecCCee-EEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccc--cccccceeecCCeEEEEEEecCCCC
Q 011005          212 CIGTGGYGS-VYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN--IVKLYGYCLHKKCMFLIYEYMERGS  288 (496)
Q Consensus       212 ~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lV~e~~~~g~  288 (496)
                      .|+.|+... +|+....+++.+++|.......    ..+..|+.+++.+...+  +.+++.+....+  +++||++.+..
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            455555444 6777765467777876544321    22456777887775323  455666544443  68999997766


Q ss_pred             hhhhhhCC---------------------CC--CccCCHHHHH-------H-H------------HHHHHHHHHHHH---
Q 011005          289 LFCNLHNN---------------------ED--AVELDWAKRV-------N-I------------VKAMAHALAYLH---  322 (496)
Q Consensus       289 L~~~l~~~---------------------~~--~~~~~~~~~~-------~-i------------~~~i~~~l~~lh---  322 (496)
                      +.+.+...                     ..  ...++.....       . +            ...+...+..+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            64333211                     00  0112111100       0 0            001111222221   


Q ss_pred             hCCCCCeEEeCCCCCceEecCC----CCeEEccccccccc
Q 011005          323 HDCSPSIIHRDISSNNILLNSK----LEAFVADFGTARLL  358 (496)
Q Consensus       323 ~~~~~~i~H~dlkp~Nil~~~~----~~~kl~Dfg~~~~~  358 (496)
                      ......++|||+.+.||+++.+    +.+.++||+.+...
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            1115689999999999999875    67899999988653

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.30  E-value=0.00057  Score=67.73  Aligned_cols=72  Identities=19%  Similarity=0.252  Sum_probs=49.2

Q ss_pred             ceeeecCCeeEEEEEeCC--------CcEEEEEEcccchhHHHHHHHHHHHHHHHhhccccc-ccccceeecCCeEEEEE
Q 011005          211 YCIGTGGYGSVYKAQLPN--------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI-VKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lV~  281 (496)
                      +.|+.|....+|++..++        ++.+++|+......   ...+.+|..+++.+...++ .++++.+..    .+|+
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            457888889999998753        57899998844211   1234579999998864444 456665542    2899


Q ss_pred             EecCCCCh
Q 011005          282 EYMERGSL  289 (496)
Q Consensus       282 e~~~~g~L  289 (496)
                      ||++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987444

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=97.30  E-value=0.00032  Score=68.44  Aligned_cols=104  Identities=15%  Similarity=0.159  Sum_probs=68.1

Q ss_pred             hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCcccc
Q 011005           10 EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRL   89 (496)
Q Consensus        10 ~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L   89 (496)
                      .|.++.+|+.+.+..+ ++.+-...|.++.+|+.+.+..+ ++..-...|.+|++|+.+.+.+|.++..-...|.++.+|
T Consensus       235 ~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L  312 (379)
T 4h09_A          235 AFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKL  312 (379)
T ss_dssp             TTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTC
T ss_pred             cccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCC
Confidence            4556666777777654 44344556777777777777554 442334567777778777777777764445677777777


Q ss_pred             cccccccccCCCCCCCCCCCCCccccc
Q 011005           90 DYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        90 ~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      +.+.+..+ ++..-..+|.++++|..+
T Consensus       313 ~~i~lp~~-l~~I~~~aF~~C~~L~~i  338 (379)
T 4h09_A          313 SSVTLPTA-LKTIQVYAFKNCKALSTI  338 (379)
T ss_dssp             CEEECCTT-CCEECTTTTTTCTTCCCC
T ss_pred             CEEEcCcc-ccEEHHHHhhCCCCCCEE
Confidence            77777644 665666777777777554

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=97.30  E-value=0.00029  Score=69.12  Aligned_cols=103  Identities=10%  Similarity=0.170  Sum_probs=79.2

Q ss_pred             hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCcccc
Q 011005           10 EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRL   89 (496)
Q Consensus        10 ~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L   89 (496)
                      .|.++.+|+.+.+.++... .....|.++++|+.+.+. +.++..-...|.+|.+|+.++|..| ++..-..+|.+|.+|
T Consensus       260 aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L  336 (394)
T 4gt6_A          260 AFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQL  336 (394)
T ss_dssp             TTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC
T ss_pred             eeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCC
Confidence            5778888999999776554 666788889999999986 4555344567888999999999765 553456688899999


Q ss_pred             cccccccccCCCCCCCCCCCCCccccc
Q 011005           90 DYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        90 ~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      +.+.+..+ ++..-..+|.++++|..+
T Consensus       337 ~~i~ip~s-v~~I~~~aF~~C~~L~~i  362 (394)
T 4gt6_A          337 ERIAIPSS-VTKIPESAFSNCTALNNI  362 (394)
T ss_dssp             CEEEECTT-CCBCCGGGGTTCTTCCEE
T ss_pred             CEEEECcc-cCEEhHhHhhCCCCCCEE
Confidence            99999654 776777889998888765

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=97.28  E-value=0.00034  Score=68.17  Aligned_cols=107  Identities=10%  Similarity=0.033  Sum_probs=84.7

Q ss_pred             cccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCcc
Q 011005            4 IGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGE   82 (496)
Q Consensus         4 ~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~   82 (496)
                      ++.++. .|.++.+|+.+.+..+ ++......|.++++|+.+.+.++.++.+-+..|.+|.+|+.+.|..+ ++..-..+
T Consensus       251 v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~a  328 (379)
T 4h09_A          251 VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYA  328 (379)
T ss_dssp             CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTT
T ss_pred             ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHH
Confidence            444555 5778899999999755 55466678999999999999999998555678999999999999865 66455678


Q ss_pred             ccCcccccccccccccCCCCCCCCCCCCCcc
Q 011005           83 ITKLSRLDYLNLSSNKLSGPVPFSNNDLSSM  113 (496)
Q Consensus        83 ~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l  113 (496)
                      |.++.+|+.+.+..+ ++..-..+|.++..+
T Consensus       329 F~~C~~L~~i~ip~~-v~~I~~~aF~~c~~~  358 (379)
T 4h09_A          329 FKNCKALSTISYPKS-ITLIESGAFEGSSIT  358 (379)
T ss_dssp             TTTCTTCCCCCCCTT-CCEECTTTTTTSSCC
T ss_pred             hhCCCCCCEEEECCc-cCEEchhHhhCCCCC
Confidence            999999999999765 666667778776544

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.25  E-value=0.0013  Score=63.78  Aligned_cols=141  Identities=20%  Similarity=0.276  Sum_probs=82.3

Q ss_pred             ceeeecCCeeEEEEEeC--------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhccccc-ccccceeecCCeEEEEE
Q 011005          211 YCIGTGGYGSVYKAQLP--------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI-VKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lV~  281 (496)
                      +.+..|-...+|+...+        +++.+++|+.....  .....+.+|..+++.+...++ .++++.+..    .+||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc--chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            45667888899999875        25789999863321  123456689999999863333 556666543    2999


Q ss_pred             EecCCCChhhh-----------------hhCCCC--CccCC--HHHHHHHHHHHHH-------------------HHHH-
Q 011005          282 EYMERGSLFCN-----------------LHNNED--AVELD--WAKRVNIVKAMAH-------------------ALAY-  320 (496)
Q Consensus       282 e~~~~g~L~~~-----------------l~~~~~--~~~~~--~~~~~~i~~~i~~-------------------~l~~-  320 (496)
                      ||++|.++..-                 ++....  .....  +.++.++..++-.                   .+.. 
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998665311                 121111  11122  3344444433321                   1222 


Q ss_pred             ---HHh-CCCCCeEEeCCCCCceEecCC----CCeEEcccccccc
Q 011005          321 ---LHH-DCSPSIIHRDISSNNILLNSK----LEAFVADFGTARL  357 (496)
Q Consensus       321 ---lh~-~~~~~i~H~dlkp~Nil~~~~----~~~kl~Dfg~~~~  357 (496)
                         |.. .....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               221 114579999999999999876    6899999998853

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=97.20  E-value=0.00025  Score=69.66  Aligned_cols=101  Identities=15%  Similarity=0.068  Sum_probs=70.7

Q ss_pred             hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCcccc
Q 011005           10 EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRL   89 (496)
Q Consensus        10 ~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L   89 (496)
                      .|.++..|+.+.+..+.+.   ...|..+.+|+.+.+.++ ++.+-..+|.++++|+.++|.++ ++..-..+|.++.+|
T Consensus       271 ~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L  345 (394)
T 4fs7_A          271 LFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSL  345 (394)
T ss_dssp             TTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTC
T ss_pred             ccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCC
Confidence            5667777887777766543   345777888888888765 55344456778888888888654 553445678888888


Q ss_pred             cccccccccCCCCCCCCCCCCCccccc
Q 011005           90 DYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        90 ~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      +.+.+..| ++..-..+|.++.+|+.+
T Consensus       346 ~~i~lp~~-l~~I~~~aF~~C~~L~~i  371 (394)
T 4fs7_A          346 SNINFPLS-LRKIGANAFQGCINLKKV  371 (394)
T ss_dssp             CEECCCTT-CCEECTTTBTTCTTCCEE
T ss_pred             CEEEECcc-ccEehHHHhhCCCCCCEE
Confidence            88888766 666667778888877654

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=97.20  E-value=2.2e-05  Score=75.88  Aligned_cols=107  Identities=18%  Similarity=0.198  Sum_probs=69.9

Q ss_pred             CChhccCCCCCCEEeccCCc-cCCCCCccCCCCCCCCEEeccCCcCCCCCchhhc--CCcccCeecccc--cccCCC---
Q 011005            7 IPPEIGNLKNLIKLDVGSNS-LIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIA--SMKYLTQLDLSN--NNIQGS---   78 (496)
Q Consensus         7 lp~~~~~l~~L~~L~l~~n~-i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~--~l~~L~~l~l~~--N~l~~~---   78 (496)
                      ++..+..+|+|+.|+|++|. +.  ++. +. +++|+.|+|..|.++......+.  .+|+|+.|+|+.  |...+.   
T Consensus       164 L~~ll~~~P~L~~L~L~g~~~l~--l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~  239 (362)
T 2ra8_A          164 LSPVLDAMPLLNNLKIKGTNNLS--IGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDM  239 (362)
T ss_dssp             CHHHHHTCTTCCEEEEECCBTCB--CCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCG
T ss_pred             HHHHHhcCCCCcEEEEeCCCCce--ecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhH
Confidence            44556788999999999884 32  333 43 89999999999988743333444  789999999863  332211   


Q ss_pred             --CCccc--cCcccccccccccccCCCCCCCCCC---CCCcccccc
Q 011005           79 --IPGEI--TKLSRLDYLNLSSNKLSGPVPFSNN---DLSSMHTVV  117 (496)
Q Consensus        79 --~~~~~--~~l~~L~~l~l~~n~l~~~~~~~~~---~l~~l~~~~  117 (496)
                        +...+  ..+++|+.|+|.+|.+.+..+..+.   .+++|+.|.
T Consensus       240 ~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~Ld  285 (362)
T 2ra8_A          240 NVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMD  285 (362)
T ss_dssp             GGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEE
T ss_pred             HHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEE
Confidence              11122  3578999999999998743222221   355665543

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=97.08  E-value=0.00041  Score=68.05  Aligned_cols=106  Identities=10%  Similarity=0.159  Sum_probs=79.0

Q ss_pred             ccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccc
Q 011005            5 GIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEI   83 (496)
Q Consensus         5 ~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~   83 (496)
                      ..+.. .|.++++|+.+.+. +.++.+....|.++++|+.++|..+ ++.+-..+|.+|.+|+.+.|..+ ++..-..+|
T Consensus       277 ~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF  353 (394)
T 4gt6_A          277 VSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAF  353 (394)
T ss_dssp             CEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGG
T ss_pred             ceecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHh
Confidence            33444 57789999999997 5566566678999999999999875 66455578999999999999765 664556789


Q ss_pred             cCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           84 TKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        84 ~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      .+|.+|+.+++.+|....   ..+....+|+.+
T Consensus       354 ~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i  383 (394)
T 4gt6_A          354 SNCTALNNIEYSGSRSQW---NAISTDSGLQNL  383 (394)
T ss_dssp             TTCTTCCEEEESSCHHHH---HTCBCCCCC---
T ss_pred             hCCCCCCEEEECCceeeh---hhhhccCCCCEE
Confidence            999999999999886542   244455555443

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=96.93  E-value=0.0012  Score=64.61  Aligned_cols=101  Identities=13%  Similarity=0.039  Sum_probs=74.2

Q ss_pred             hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCcccc
Q 011005           10 EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRL   89 (496)
Q Consensus        10 ~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L   89 (496)
                      .+.++.+|+.+.+..+... .....|..+..|+.+.+..+.+.   ...|..+.+|+.+.+..+ ++..-..+|.++.+|
T Consensus       248 ~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L  322 (394)
T 4fs7_A          248 VFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSL  322 (394)
T ss_dssp             TTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTC
T ss_pred             cccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCC
Confidence            5667788888888877654 66677888888888888776543   246778888888888765 553445678888888


Q ss_pred             cccccccccCCCCCCCCCCCCCccccc
Q 011005           90 DYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        90 ~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      +.+++.++ ++..-..+|.++++|+.+
T Consensus       323 ~~i~lp~~-v~~I~~~aF~~c~~L~~i  348 (394)
T 4fs7_A          323 VSIDLPYL-VEEIGKRSFRGCTSLSNI  348 (394)
T ss_dssp             CEECCCTT-CCEECTTTTTTCTTCCEE
T ss_pred             CEEEeCCc-ccEEhHHhccCCCCCCEE
Confidence            88888644 666667788888888654

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=96.91  E-value=6.1e-05  Score=64.16  Aligned_cols=85  Identities=8%  Similarity=0.164  Sum_probs=58.6

Q ss_pred             CccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccc-cCCCCCccccCc----cccccccccccc-CCCCCCC
Q 011005           32 PSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNN-IQGSIPGEITKL----SRLDYLNLSSNK-LSGPVPF  105 (496)
Q Consensus        32 p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~-l~~~~~~~~~~l----~~L~~l~l~~n~-l~~~~~~  105 (496)
                      |.....-.+|+.|||+++.|+..--..+..|++|+.|+|+++. |+..--..++.+    ++|+.|+|+++. ||..-=.
T Consensus        54 P~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~  133 (176)
T 3e4g_A           54 PTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGII  133 (176)
T ss_dssp             CCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHH
T ss_pred             CcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHH
Confidence            4433333479999999999986545668899999999999985 664323345554    479999999985 7643222


Q ss_pred             CCCCCCccccc
Q 011005          106 SNNDLSSMHTV  116 (496)
Q Consensus       106 ~~~~l~~l~~~  116 (496)
                      .+..+++|+.|
T Consensus       134 ~L~~~~~L~~L  144 (176)
T 3e4g_A          134 ALHHFRNLKYL  144 (176)
T ss_dssp             HGGGCTTCCEE
T ss_pred             HHhcCCCCCEE
Confidence            34456666554

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.84  E-value=0.0038  Score=59.66  Aligned_cols=66  Identities=9%  Similarity=0.097  Sum_probs=44.0

Q ss_pred             cCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcc---cccccccce------eecCCeEEEEEEecCC
Q 011005          216 GGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLH---RNIVKLYGY------CLHKKCMFLIYEYMER  286 (496)
Q Consensus       216 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~------~~~~~~~~lV~e~~~~  286 (496)
                      |....||+....+| .+++|+......       ..|+.+++.+..   +.+++++..      ....+..++||+|++|
T Consensus        34 g~~N~vy~v~~~~g-~~vLK~~~~~~~-------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G  105 (339)
T 3i1a_A           34 DTNAFAYQADSESK-SYFIKLKYGYHD-------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA  105 (339)
T ss_dssp             CSSCEEEEEECSSC-EEEEEEEECSSC-------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred             ccccceEEEEeCCC-CEEEEEecCccc-------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence            33679999988777 899998765431       356666766642   224444432      2335678999999998


Q ss_pred             CCh
Q 011005          287 GSL  289 (496)
Q Consensus       287 g~L  289 (496)
                      ..+
T Consensus       106 ~~~  108 (339)
T 3i1a_A          106 PNG  108 (339)
T ss_dssp             CBT
T ss_pred             CcC
Confidence            765

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.79  E-value=0.004  Score=61.99  Aligned_cols=74  Identities=18%  Similarity=0.182  Sum_probs=47.8

Q ss_pred             cceeeecCCeeEEEEEeCC-CcEEEEEEcccchhHHHHHHHHHHHHHHHhhccccc-ccccceeecCCeEEEEEEecCCC
Q 011005          210 RYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI-VKLYGYCLHKKCMFLIYEYMERG  287 (496)
Q Consensus       210 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lV~e~~~~g  287 (496)
                      .+.|+.|-...+|+....+ +..+++|+.......  .-...+|..+++.+...++ .++++.+.  +  .+||||++|.
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~--~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~  186 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE--IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY  186 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS--CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh--hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence            3468888889999998865 578888887442211  1112588999999975444 46666663  2  2599999885


Q ss_pred             Ch
Q 011005          288 SL  289 (496)
Q Consensus       288 ~L  289 (496)
                      ++
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            54

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.74  E-value=0.0045  Score=59.91  Aligned_cols=73  Identities=14%  Similarity=0.085  Sum_probs=44.8

Q ss_pred             ceeeecCCeeEEEEEeCC---------CcEEEEEEcccchhHHHHHHHHHHHHHHHhhccccc-ccccceeecCCeEEEE
Q 011005          211 YCIGTGGYGSVYKAQLPN---------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI-VKLYGYCLHKKCMFLI  280 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lV  280 (496)
                      ..++.|....+|+....+         ++.+++|+.......  ......|..+++.+...++ .++++..  .+  ++|
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v  112 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE--LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRI  112 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG--TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc--eecHHHHHHHHHHHHhcCCCCceEEec--CC--cEE
Confidence            457778888999998754         268888887653221  1123678888888864443 4566544  22  589


Q ss_pred             EEecCCCCh
Q 011005          281 YEYMERGSL  289 (496)
Q Consensus       281 ~e~~~~g~L  289 (496)
                      |||++|..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999988543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.65  E-value=0.01  Score=51.83  Aligned_cols=103  Identities=17%  Similarity=0.066  Sum_probs=66.7

Q ss_pred             CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCCcc
Q 011005          287 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT  366 (496)
Q Consensus       287 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  366 (496)
                      -+|.++|.....  .++++++|.++.|.+.+|.-.-.. ... ..+=+.|..|++..+|.|...+ +.+.          
T Consensus        33 vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc----------
Confidence            378888876543  799999999999999998877211 011 1233457889999999887763 1110          


Q ss_pred             ccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCC
Q 011005          367 LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP  407 (496)
Q Consensus       367 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p  407 (496)
                        .....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence              1122466888753 3456788999999999999965555

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.55  E-value=0.00044  Score=60.03  Aligned_cols=87  Identities=9%  Similarity=0.139  Sum_probs=64.0

Q ss_pred             cCCCCCCEEeccCC-ccCC----CCCccCCCCCCCCEEeccCCcCCCC----CchhhcCCcccCeecccccccCCC----
Q 011005           12 GNLKNLIKLDVGSN-SLIG----PIPSALGSLTNLSNLDLSSNKLSGK----IPPEIASMKYLTQLDLSNNNIQGS----   78 (496)
Q Consensus        12 ~~l~~L~~L~l~~n-~i~~----~~p~~~~~l~~L~~l~l~~n~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~----   78 (496)
                      .+-+.|+.|+|++| +|..    .+.+.+..-+.|+.|+|++|+|.+.    +.+.+..-+.|+.|+|+.|+|...    
T Consensus        38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a  117 (197)
T 1pgv_A           38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR  117 (197)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence            34567999999986 7752    2345567778999999999999732    334555668899999999999732    


Q ss_pred             CCccccCccccccccccccc
Q 011005           79 IPGEITKLSRLDYLNLSSNK   98 (496)
Q Consensus        79 ~~~~~~~l~~L~~l~l~~n~   98 (496)
                      +...+..-+.|+.|+|++|.
T Consensus       118 la~aL~~N~tL~~L~L~n~~  137 (197)
T 1pgv_A          118 LLRSTLVTQSIVEFKADNQR  137 (197)
T ss_dssp             HHHHTTTTCCCSEEECCCCS
T ss_pred             HHHHHhhCCceeEEECCCCc
Confidence            23356666789999998653

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=95.25  E-value=0.0017  Score=56.34  Aligned_cols=89  Identities=13%  Similarity=0.147  Sum_probs=60.0

Q ss_pred             hccCCCCCCEEeccCCccCC----CCCccCCCCCCCCEEeccCCcCCCC----CchhhcCCcccCeeccccccc---CC-
Q 011005           10 EIGNLKNLIKLDVGSNSLIG----PIPSALGSLTNLSNLDLSSNKLSGK----IPPEIASMKYLTQLDLSNNNI---QG-   77 (496)
Q Consensus        10 ~~~~l~~L~~L~l~~n~i~~----~~p~~~~~l~~L~~l~l~~n~l~~~----~p~~~~~l~~L~~l~l~~N~l---~~-   77 (496)
                      .+..-..|+.|+|++|+|..    .+.+.+..-+.|+.|+|+.|.|.+.    +-+.+..-+.|+.|+|++|..   .. 
T Consensus        65 aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~  144 (197)
T 1pgv_A           65 AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQ  144 (197)
T ss_dssp             HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHH
T ss_pred             HHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHH
Confidence            34455679999999999983    2334455668899999999999842    223455567799999997643   31 


Q ss_pred             ---CCCccccCccccccccccccc
Q 011005           78 ---SIPGEITKLSRLDYLNLSSNK   98 (496)
Q Consensus        78 ---~~~~~~~~l~~L~~l~l~~n~   98 (496)
                         .+...+..-+.|+.|+++.|.
T Consensus       145 g~~~ia~aL~~N~tL~~L~l~~~~  168 (197)
T 1pgv_A          145 VEMDMMMAIEENESLLRVGISFAS  168 (197)
T ss_dssp             HHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             HHHHHHHHHHhCCCcCeEeccCCC
Confidence               122344445677777775443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.05  E-value=0.084  Score=51.78  Aligned_cols=73  Identities=15%  Similarity=0.083  Sum_probs=48.1

Q ss_pred             ceeeecCCeeEEEEEeCC--------CcEEEEEEcccchhHHHHHHHHHHHHHHHhhccccc-ccccceeecCCeEEEEE
Q 011005          211 YCIGTGGYGSVYKAQLPN--------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI-VKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lV~  281 (496)
                      +.+..|-...+|+....+        ++.+++|+......  ..-...+|..+++.+...++ .++++.+  .+  ++||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~--~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~  149 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG--KFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE  149 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc--hhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence            456677888999998753        57899998654321  11224678999988864333 4555433  22  6899


Q ss_pred             EecCCCCh
Q 011005          282 EYMERGSL  289 (496)
Q Consensus       282 e~~~~g~L  289 (496)
                      ||++|..+
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998664

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.30  E-value=0.22  Score=48.51  Aligned_cols=30  Identities=30%  Similarity=0.452  Sum_probs=25.1

Q ss_pred             CeEEeCCCCCceEe------cCCCCeEEcccccccc
Q 011005          328 SIIHRDISSNNILL------NSKLEAFVADFGTARL  357 (496)
Q Consensus       328 ~i~H~dlkp~Nil~------~~~~~~kl~Dfg~~~~  357 (496)
                      .++|+|+.+.||++      +++..+.++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46799999999999      4567799999998854

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=94.13  E-value=0.074  Score=33.09  Aligned_cols=11  Identities=18%  Similarity=0.310  Sum_probs=4.2

Q ss_pred             HHHHHHhHhhc
Q 011005          160 FACLLLAKRKY  170 (496)
Q Consensus       160 ~~~~~~~~r~~  170 (496)
                      ++++++.+||+
T Consensus        29 ~~~~~~~RRr~   39 (44)
T 2ks1_B           29 LGIGLFMRRRH   39 (44)
T ss_dssp             HHHHHHHHTTT
T ss_pred             HHHHHHhhhhH
Confidence            33333434433

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=93.52  E-value=0.11  Score=32.31  Aligned_cols=14  Identities=7%  Similarity=-0.104  Sum_probs=5.6

Q ss_pred             CCccchhhhhhHHH
Q 011005          140 PATLFVEIFLPLTI  153 (496)
Q Consensus       140 ~~~~~~~i~~~~~~  153 (496)
                      +....+...++.++
T Consensus         7 s~~~aIA~gVVgGv   20 (44)
T 2l2t_A            7 ARTPLIAAGVIGGL   20 (44)
T ss_dssp             CSSHHHHHHHHHHH
T ss_pred             CCcceEEEeehHHH
Confidence            33334444444433

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=91.89  E-value=0.61  Score=40.61  Aligned_cols=118  Identities=8%  Similarity=0.107  Sum_probs=80.6

Q ss_pred             cccccccccceeecCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCce
Q 011005          260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  339 (496)
Q Consensus       260 ~h~niv~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Ni  339 (496)
                      .||+.++. .+-...+.+.+.++.-+.+.-...+.      ..+...+++++.+|+....+++     .-+|--++|+|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik------~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK------SFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG------GSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH------hcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceE
Confidence            47777766 45556666666666544332222233      5788999999999999887766     357889999999


Q ss_pred             EecCCCCeEEccccccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccc
Q 011005          340 LLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIL  411 (496)
Q Consensus       340 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~  411 (496)
                      +++.++.+++.=.|+...+.                 |.     ..++..=.-.+=+++..+++++..|+..
T Consensus       111 ~f~~~~~p~i~~RGik~~l~-----------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l  160 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNVVD-----------------PL-----PVSEAEFLTRYKALVICAFNEKQSFDAL  160 (215)
T ss_dssp             EECTTSCEEESCCEETTTBS-----------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHH
T ss_pred             EEcCCCCEEEEEccCccCCC-----------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence            99999999998777653332                 11     1111222345677888999999998643

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=91.73  E-value=0.18  Score=31.23  Aligned_cols=17  Identities=24%  Similarity=0.303  Sum_probs=6.8

Q ss_pred             HHHHHHHHHHHHhHhhc
Q 011005          154 VLSVIVFACLLLAKRKY  170 (496)
Q Consensus       154 ~~~~i~~~~~~~~~r~~  170 (496)
                      ++++++++++++.+||+
T Consensus        23 l~vi~~l~~~~~~RRR~   39 (44)
T 2jwa_A           23 LVVVLGVVFGILIKRRQ   39 (44)
T ss_dssp             HHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHhheehhh
Confidence            33333334344444443

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=86.95  E-value=2.3  Score=37.05  Aligned_cols=117  Identities=12%  Similarity=0.128  Sum_probs=79.7

Q ss_pred             cccccccccceeecCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEEeCCCCCc
Q 011005          260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA-YLHHDCSPSIIHRDISSNN  338 (496)
Q Consensus       260 ~h~niv~~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~-~lh~~~~~~i~H~dlkp~N  338 (496)
                      .||++  -...-.+.+.+.+.++.-+++.-...+.      ..+..++++++.+|+.... +++     .-+|--++|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCce
Confidence            47777  3444466777777777655544444443      5688899999999988777 555     46888999999


Q ss_pred             eEecCCCCeEEccccccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccc
Q 011005          339 ILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDIL  411 (496)
Q Consensus       339 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~  411 (496)
                      ++++.++.+++.=.|+-..+                 +|.-     .++..=.-++=+++..++.++..|+..
T Consensus       115 L~f~~~~~p~i~hRGi~~~l-----------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe~l  165 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKESL-----------------PPDE-----WDDERLLREVKATVLALTEGEYRFDEY  165 (219)
T ss_dssp             EEECTTCCEEESCCEETTTB-----------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHHH
T ss_pred             EEEeCCCcEEEEEcCCcccC-----------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence            99999999999877765333                 2221     111112335667888888888888643

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=85.30  E-value=0.093  Score=52.21  Aligned_cols=61  Identities=10%  Similarity=0.047  Sum_probs=17.3

Q ss_pred             CcceeeecCCeeEEEEEeCC-CcEEEE------EEcccch-hHHHHHHHHHHHHHHHhhcccccccccceee
Q 011005          209 IRYCIGTGGYGSVYKAQLPN-GKVFAL------KKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCL  272 (496)
Q Consensus       209 ~~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  272 (496)
                      +.+.+|   ||.||+|.+.. ..+|||      |..+... ..+....+.+|..+++..+|+|+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            345566   99999998754 357888      7665432 2233456788999999999999999987664

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	496
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	7e-64
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-62
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-62
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-62
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-60
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-59
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-57
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-57
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-57
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-57
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-57
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-56
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-56
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-56
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-56
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-56
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-56
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-56
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-55
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-55
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-55
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-54
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-53
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-53
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-53
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-52
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-52
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-52
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-51
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-51
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-51
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-50
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-50
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-49
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-49
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-48
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-48
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-48
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-47
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-46
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-46
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-45
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-43
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-43
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-43
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-43
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-43
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-43
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-43
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-42
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-41
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-40
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-40
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-39
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-39
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-34
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-34
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-32
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-20
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	9e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-12
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	6e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-05
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-12
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-08
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-07
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-05
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.002
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-10
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-08
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-07
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-06
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.003
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.003
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-04
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-04
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-06
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-06
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-05
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-05
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	5e-06
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	6e-06
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	9e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	5e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.001
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.002
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	8e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	5e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	7e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	1e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	1e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	5e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	9e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.001

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 7e-64
 Identities = 72/274 (26%), Positives = 126/274 (45%), Gaps = 20/274 (7%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELA-FIKSFKNEAQVLSQVLHRN 263
               +   IG+G +G+VYK +       A+K L+ +      +++FKNE  VL +  H N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           I+   GY      + ++ ++ E  SL+ +LH  E   + +  K ++I +  A  + YLH 
Sbjct: 66  ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHA 122

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAPELAY 381
               SIIHRD+ SNNI L+  L   + DFG A +    S +     L+G+  ++APE+  
Sbjct: 123 ---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179

Query: 382 TM---VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR 438
                  + + DVY+FG+V  E++ G+ P       S+ ++   ++  V    L P + +
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLP------YSNINNRDQIIFMVGRGYLSPDLSK 233

Query: 439 KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
                   +  +   CL+     RP    +    
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (516), Expect = 2e-62
 Identities = 64/270 (23%), Positives = 116/270 (42%), Gaps = 20/270 (7%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E   +   +G G +G V+          A+K L          +F  EA ++ Q+ H+ +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRL 70

Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+LY     +  +++I EYME GSL   L      ++L   K +++   +A  +A++   
Sbjct: 71  VRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEER 128

Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN-RTLLAGTYGYIAPELAYTM 383
                IHRD+ + NIL++  L   +ADFG ARL+  +    R        + APE     
Sbjct: 129 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185

Query: 384 VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR-KVIR 442
             T K DV+SFG++  E++               ++P+++       R+  P +  + + 
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPY-----PGMTNPEVIQNLERGYRMVRPDNCPEELY 240

Query: 443 DILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            ++        C +  P+ RPT   +    
Sbjct: 241 QLMR------LCWKERPEDRPTFDYLRSVL 264

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 2e-62
 Identities = 74/300 (24%), Positives = 120/300 (40%), Gaps = 42/300 (14%)

Query: 203 ATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLH 261
             +DF+    +G G  G V+K    P+G V A K +H   + A       E QVL +   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
             IV  YG       + +  E+M+ GSL   L        +       +  A+   L YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYL 120

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
                  I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y++PE   
Sbjct: 121 REKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF--VGTRSYMSPERLQ 176

Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHP-------------------------------RDI 410
               + + D++S G+  +E+ +G++P                                  
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236

Query: 411 LSSLSSSSDPKIMLIDVLDQRL--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
           LSS    S P + + ++LD  +  PPP     +  +     V+  CL  NP  R  ++ +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN-KCLIKNPAERADLKQL 295

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 2e-62
 Identities = 66/273 (24%), Positives = 119/273 (43%), Gaps = 22/273 (8%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEEL-AFIKSFKNEAQVLSQVLHR 262
           ED+++ Y IGTG YG   K +   +GK+   K+L       A  +   +E  +L ++ H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 263 NIVKLYGYCLHK--KCMFLIYEYMERGSLFCNLHNNEDAVE-LDWAKRVNIVKAMAHALA 319
           NIV+ Y   + +    ++++ EY E G L   +       + LD    + ++  +  AL 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 320 YLH--HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
             H   D   +++HRD+   N+ L+ K    + DFG AR+L+ D+S      GT  Y++P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183

Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD 437
           E    M   EK D++S G +  E+     P         +   K +   + + +      
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-------AFSQKELAGKIREGKFRRIPY 236

Query: 438 R--KVIRDILLISTVSFACLQSNPKSRPTMQSV 468
           R    + +I+         L      RP+++ +
Sbjct: 237 RYSDELNEIIT------RMLNLKDYHRPSVEEI 263

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 2e-60
 Identities = 85/267 (31%), Positives = 133/267 (49%), Gaps = 23/267 (8%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTS--EELAFIKSFKNEAQVLSQVLH 261
           EDF+I   +G G +G+VY A+   +  + ALK L  +  E+       + E ++ S + H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
            NI++LYGY      ++LI EY   G+++  L       + D  +    +  +A+AL+Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYC 122

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
           H   S  +IHRDI   N+LL S  E  +ADFG +   HA SS RT L GT  Y+ PE+  
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV--HAPSSRRTTLCGTLDYLPPEMIE 177

Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI 441
             +  EK D++S GV+  E L+GK P +     +++       I  ++   P  V     
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFE-----ANTYQETYKRISRVEFTFPDFVTEGA- 231

Query: 442 RDILLISTVSFACLQSNPKSRPTMQSV 468
           RD++         L+ NP  RP ++ V
Sbjct: 232 RDLIS------RLLKHNPSQRPMLREV 252

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 9e-59
 Identities = 70/269 (26%), Positives = 112/269 (41%), Gaps = 21/269 (7%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           ED+D+   +G G YG V  A      +  A+K +     +   ++ K E  +   + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           +VK YG+       +L  EY   G LF  +  +     +           +   + YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLH- 120

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAPELAY 381
                I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+APEL  
Sbjct: 121 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 382 TM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV 440
                 E  DV+S G+V   +L G+ P D        SD      D  +++      +K+
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWD------QPSDSCQEYSDWKEKKTYLNPWKKI 232

Query: 441 IRDIL-LISTVSFACLQSNPKSRPTMQSV 468
               L L+       L  NP +R T+  +
Sbjct: 233 DSAPLALLH----KILVENPSARITIPDI 257

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  190 bits (485), Expect = 2e-57
 Identities = 75/308 (24%), Positives = 132/308 (42%), Gaps = 39/308 (12%)

Query: 205 EDFDIRY----CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEEL--AFIKSFKNEAQVLS 257
           +D +  +     IG G +G+VY A+ + N +V A+KK+  S +      +    E + L 
Sbjct: 11  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 258 QVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 317
           ++ H N ++  G  L +   +L+ EY    +      + +    L   +   +       
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQG 127

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 377
           LAYLH   S ++IHRD+ + NILL+      + DFG+A ++   +S      GT  ++AP
Sbjct: 128 LAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAP 180

Query: 378 ELAYTMVM---TEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPP 434
           E+   M       K DV+S G+  +E+   K P         + +    L  +     P 
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-------NMNAMSALYHIAQNESPA 233

Query: 435 PVDRKV---IRDILLISTVSFACLQSNPKSRPTMQSVSQ-EFLITRKTPLVKHAAIQDI- 489
                     R+ +       +CLQ  P+ RPT + + +  F++  + P V    IQ   
Sbjct: 234 LQSGHWSEYFRNFVD------SCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTK 287

Query: 490 -SISELRN 496
            ++ EL N
Sbjct: 288 DAVRELDN 295

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  190 bits (484), Expect = 2e-57
 Identities = 82/310 (26%), Positives = 131/310 (42%), Gaps = 46/310 (14%)

Query: 183 IDVFSIWNYDGRIVYEDLIEATEDFD---------IRYCIGTGGYGSVYKAQLP----NG 229
           ID F+         +ED  EA  +F          I   IG G +G V    L       
Sbjct: 4   IDPFT---------FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKRE 54

Query: 230 KVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSL 289
              A+K L +       + F +EA ++ Q  H N++ L G       + +I E+ME GSL
Sbjct: 55  IFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL 114

Query: 290 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFV 349
              L  N+   +    + V +++ +A  + YL        +HRD+++ NIL+NS L   V
Sbjct: 115 DSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKV 169

Query: 350 ADFGTARLLHADSSNRTLLA-----GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM- 403
           +DFG +R L  D+S+ T  +         + APE       T   DV+S+G+V  EV+  
Sbjct: 170 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY 229

Query: 404 GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD-RKVIRDILLISTVSFACLQSNPKSR 462
           G+ P          ++  ++     D RLPPP+D    +  ++L       C Q +   R
Sbjct: 230 GERP------YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLML------DCWQKDRNHR 277

Query: 463 PTMQSVSQEF 472
           P    +    
Sbjct: 278 PKFGQIVNTL 287

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 2e-57
 Identities = 65/283 (22%), Positives = 118/283 (41%), Gaps = 27/283 (9%)

Query: 198 EDLIEATEDFDIR-YCIGTGGYGSVYKAQL---PNGKVFALKKLHTSEELAFIKSFKNEA 253
           + L    ++  I    +G G +GSV +            A+K L    E A  +    EA
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 254 QVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 313
           Q++ Q+ +  IV+L G C   + + L+ E    G L   L    +  E+  +    ++  
Sbjct: 61  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQ 117

Query: 314 MAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN---RTLLAG 370
           ++  + YL      + +HRD+++ N+LL ++  A ++DFG ++ L AD S    R+    
Sbjct: 118 VSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174

Query: 371 TYGYIAPELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLD 429
              + APE       + + DV+S+GV   E L  G+ P            P++M      
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK------KMKGPEVMAFIEQG 228

Query: 430 QRLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQE 471
           +R+  P +    +  ++        C     + RP   +V Q 
Sbjct: 229 KRMECPPECPPELYALMS------DCWIYKWEDRPDFLTVEQR 265

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 3e-57
 Identities = 57/270 (21%), Positives = 111/270 (41%), Gaps = 24/270 (8%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           ++  +   IG G +G V       G   A+K +         ++F  EA V++Q+ H N+
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNL 62

Query: 265 VKLYGYCLH-KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           V+L G  +  K  ++++ EYM +GSL   L +   +V L     +     +  A+ YL  
Sbjct: 63  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLE- 120

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTM 383
               + +HRD+++ N+L++    A V+DFG  +     SS +        + APE     
Sbjct: 121 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREK 175

Query: 384 VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR-KVIR 442
             + K DV+SFG++  E+                    ++       ++  P      + 
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 230

Query: 443 DILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           +++        C   +   RP+   + ++ 
Sbjct: 231 EVMK------NCWHLDAAMRPSFLQLREQL 254

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 7e-57
 Identities = 61/271 (22%), Positives = 110/271 (40%), Gaps = 20/271 (7%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           +D      +GTG +G V   +       A+K +           F  EA+V+  + H  +
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKL 61

Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+LYG C  ++ +F+I EYM  G L   L            + + + K +  A+ YL   
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK 119

Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGYIAPELAYTM 383
                +HRD+++ N L+N +    V+DFG +R +  D    ++       +  PE+    
Sbjct: 120 Q---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176

Query: 384 VMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR 442
             + K D+++FGV+  E+  +GK P +                + + Q L          
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYE--------RFTNSETAEHIAQGLRLYRPHLASE 228

Query: 443 DILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
            +    T+ ++C       RPT + +    L
Sbjct: 229 KVY---TIMYSCWHEKADERPTFKILLSNIL 256

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 2e-56
 Identities = 65/272 (23%), Positives = 115/272 (42%), Gaps = 24/272 (8%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
           E   +   +G G +G V+          A+K L         ++F  EAQV+ ++ H  +
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKL 74

Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+LY     +  ++++ EYM +GSL  +    E    L   + V++   +A  +AY+   
Sbjct: 75  VQLYAVVSEEP-IYIVTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132

Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD-SSNRTLLAGTYGYIAPELAYTM 383
                +HRD+ + NIL+   L   VADFG ARL+  +  + R        + APE A   
Sbjct: 133 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189

Query: 384 VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV--- 440
             T K DV+SFG++  E+                      ++D +++    P   +    
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPY-------PGMVNREVLDQVERGYRMPCPPECPES 242

Query: 441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           + D++        C +  P+ RPT + +    
Sbjct: 243 LHDLMC------QCWRKEPEERPTFEYLQAFL 268

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 2e-56
 Identities = 65/293 (22%), Positives = 109/293 (37%), Gaps = 38/293 (12%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQ 258
                   +G G +G V +A              A+K L  S  L   ++  +E +VLS 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 259 VL-HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNN---------------EDAVEL 302
           +  H NIV L G C       +I EY   G L   L                  +D + L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 303 DWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS 362
           D    ++    +A  +A+L    S + IHRD+++ NILL       + DFG AR +  DS
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 363 SN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDP 420
           +   +        ++APE  +  V T + DV+S+G+   E+                   
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY------PGMPV 253

Query: 421 KIMLIDVLDQRLPPPVDRKVIRDIL-LISTVSFACLQSNPKSRPTMQSVSQEF 472
                 ++ +            ++  ++      C  ++P  RPT + + Q  
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMK----TCWDADPLKRPTFKQIVQLI 302

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 2e-56
 Identities = 57/270 (21%), Positives = 107/270 (39%), Gaps = 20/270 (7%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
            +      IG+G +G V+     N    A+K +         + F  EA+V+ ++ H  +
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKL 62

Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
           V+LYG CL +  + L++E+ME G L    +             + +   +      + + 
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEG---MAYL 117

Query: 325 CSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL-LAGTYGYIAPELAYTM 383
               +IHRD+++ N L+       V+DFG  R +  D    +        + +PE+    
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177

Query: 384 VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR-KVIR 442
             + K DV+SFGV+  EV              + S+ +++       RL  P      + 
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKI-----PYENRSNSEVVEDISTGFRLYKPRLASTHVY 232

Query: 443 DILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            I+        C +  P+ RP    + ++ 
Sbjct: 233 QIMN------HCWKERPEDRPAFSRLLRQL 256

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 3e-56
 Identities = 66/283 (23%), Positives = 114/283 (40%), Gaps = 28/283 (9%)

Query: 197 YEDL---IEATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNE 252
           YE +   +   + ++I   +G G +G VYKAQ      + A K + T  E   ++ +  E
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-EELEDYMVE 59

Query: 253 AQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK 312
             +L+   H NIVKL     ++  ++++ E+   G++   +   E    L  ++   + K
Sbjct: 60  IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCK 117

Query: 313 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTY 372
               AL YLH      IIHRD+ + NIL     +  +ADFG +         R    GT 
Sbjct: 118 QTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTP 174

Query: 373 GYIAPELAYTMVM-----TEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDV 427
            ++APE+             K DV+S G+  +E+   + P           +P  +L+ +
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH-------ELNPMRVLLKI 227

Query: 428 LDQRLPPPVDRKVIRDIL--LISTVSFACLQSNPKSRPTMQSV 468
                P               +      CL+ N  +R T   +
Sbjct: 228 AKSEPPTLAQPSRWSSNFKDFLK----KCLEKNVDARWTTSQL 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 3e-56
 Identities = 67/264 (25%), Positives = 112/264 (42%), Gaps = 25/264 (9%)

Query: 213 IGTGGYGSVYKAQLP-NGKVFALKKLHTSEEL-AFIKSFKNEAQVLSQVLHRNIVKLYGY 270
           IG G + +VYK          A  +L   +   +  + FK EA++L  + H NIV+ Y  
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 271 CL----HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 326
                  KKC+ L+ E M  G+L   L   +    +      +  + +   L +LH    
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTP 133

Query: 327 PSIIHRDISSNNILLNSKL-EAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVM 385
           P IIHRD+  +NI +        + D G A L  A  +    + GT  ++APE+ Y    
Sbjct: 134 P-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA--VIGTPEFMAPEM-YEEKY 189

Query: 386 TEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDIL 445
            E  DVY+FG+  LE+   ++P       S   +   +   V     P   D+  I ++ 
Sbjct: 190 DESVDVYAFGMCMLEMATSEYP------YSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243

Query: 446 -LISTVSFACLQSNPKSRPTMQSV 468
            +I      C++ N   R +++ +
Sbjct: 244 EIIE----GCIRQNKDERYSIKDL 263

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 4e-56
 Identities = 69/291 (23%), Positives = 127/291 (43%), Gaps = 30/291 (10%)

Query: 204 TEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR 262
            + +     IG G  G+VY A  +  G+  A+++++  ++    +   NE  V+ +  + 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNP 77

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
           NIV      L    ++++ EY+  GSL   +         D  +   + +    AL +LH
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLH 133

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYT 382
              S  +IHRDI S+NILL       + DFG    +  + S R+ + GT  ++APE+   
Sbjct: 134 ---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190

Query: 383 MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV-- 440
                K D++S G++ +E++ G+ P        + +  + + +   +         K+  
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPP------YLNENPLRALYLIATNGTPELQNPEKLSA 244

Query: 441 -IRDILLISTVSFACLQSNPKSRPTMQSVSQ-EFLITRK-----TPLVKHA 484
             RD L        CL  + + R + + + Q +FL   K     TPL+  A
Sbjct: 245 IFRDFLN------RCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAA 289

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  186 bits (472), Expect = 7e-56
 Identities = 70/287 (24%), Positives = 122/287 (42%), Gaps = 25/287 (8%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
            D  +++ +G G YG VY+          A+K L   E+   ++ F  EA V+ ++ H N
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPN 74

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           +V+L G C  +   ++I E+M  G+L   L       E+     + +   ++ A+ YL  
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE- 132

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR-TLLAGTYGYIAPELAYT 382
               + IHRD+++ N L+       VADFG +RL+  D+            + APE    
Sbjct: 133 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190

Query: 383 MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR 442
              + K DV++FGV+  E+            LS        + ++L++            
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPEGCPE 243

Query: 443 DIL-LISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQD 488
            +  L+     AC Q NP  RP+   + Q F       + + ++I D
Sbjct: 244 KVYELMR----ACWQWNPSDRPSFAEIHQAF-----ETMFQESSISD 281

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 3e-55
 Identities = 62/298 (20%), Positives = 111/298 (37%), Gaps = 31/298 (10%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELA--FIKSFKNEAQVLSQVLH 261
           EDF     +G G + +V  A+ L   + +A+K L     +    +     E  V+S++ H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
              VKLY      + ++    Y + G L   +         D          +  AL YL
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYL 124

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAPEL 379
           H      IIHRD+   NILLN  +   + DFGTA++L  +S         GT  Y++PEL
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD-R 438
                  +  D+++ G +  +++ G  P         + +  ++   ++      P    
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFR-------AGNEYLIFQKIIKLEYDFPEKFF 234

Query: 439 KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDISISELRN 496
              RD++         L  +   R   + +     +        H   + ++   L  
Sbjct: 235 PKARDLVE------KLLVLDATKRLGCEEMEGYGPL------KAHPFFESVTWENLHQ 280

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 5e-55
 Identities = 58/298 (19%), Positives = 112/298 (37%), Gaps = 47/298 (15%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQ 258
           E+ +    +G+G +G V  A              A+K L    + +  ++  +E ++++Q
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 259 VL-HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNN--------------------E 297
           +  H NIV L G C     ++LI+EY   G L   L +                     E
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 298 DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL 357
           D   L +   +     +A  + +L      S +HRD+++ N+L+       + DFG AR 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 358 LHADSSNRTL--LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS 415
           + +DS+            ++APE  +  + T K DV+S+G++  E+              
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN------PY 267

Query: 416 SSSDPKIMLIDVLDQRLPPPVDRKV---IRDILLISTVSFACLQSNPKSRPTMQSVSQ 470
                      ++               I  I+       +C   + + RP+  +++ 
Sbjct: 268 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQ------SCWAFDSRKRPSFPNLTS 319

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 9e-55
 Identities = 63/268 (23%), Positives = 115/268 (42%), Gaps = 28/268 (10%)

Query: 213 IGTGGYGSVYKAQLPN---GKVFALKKLH-TSEELAFIKSFKNEAQVLSQVLHRNIVKLY 268
           +G+G +G+V K         K  A+K L   + + A       EA V+ Q+ +  IV++ 
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74

Query: 269 GYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 328
           G C  +  M L+ E  E G L   L  N     +     + +V  ++  + YL      +
Sbjct: 75  GICEAESWM-LVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE---SN 127

Query: 329 IIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN---RTLLAGTYGYIAPELAYTMVM 385
            +HRD+++ N+LL ++  A ++DFG ++ L AD +    +T       + APE       
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187

Query: 386 TEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD-RKVIRD 443
           + K DV+SFGV+  E    G+ P             ++  +    +R+  P    + + D
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKP------YRGMKGSEVTAMLEKGERMGCPAGCPREMYD 241

Query: 444 ILLISTVSFACLQSNPKSRPTMQSVSQE 471
           ++        C   + ++RP   +V   
Sbjct: 242 LMN------LCWTYDVENRPGFAAVELR 263

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  181 bits (461), Expect = 4e-54
 Identities = 63/299 (21%), Positives = 118/299 (39%), Gaps = 46/299 (15%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQ 258
            + +    IG G +G V++A+ P         + A+K L           F+ EA ++++
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNN---------------------E 297
             + NIVKL G C   K M L++EYM  G L   L +                       
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 298 DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARL 357
               L  A+++ I + +A  +AYL        +HRD+++ N L+   +   +ADFG +R 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 358 LHADSSNR--TLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS 415
           +++    +     A    ++ PE  +    T + DV+++GVV  E+              
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY------ 243

Query: 416 SSSDPKIMLIDVLDQRLPPPVDR--KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
                + ++  V D  +    +     + +++        C    P  RP+  S+ +  
Sbjct: 244 YGMAHEEVIYYVRDGNILACPENCPLELYNLMR------LCWSKLPADRPSFCSIHRIL 296

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 1e-53
 Identities = 63/297 (21%), Positives = 112/297 (37%), Gaps = 36/297 (12%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
               ++  IG G +G V++ +   G+  A+K   + EE ++    + E      + H NI
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF--REAEIYQTVMLRHENI 59

Query: 265 VKLYGYC----LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           +               ++L+ +Y E GSLF  L+       +     + +  + A  LA+
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAH 115

Query: 321 LHHDC-----SPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN----RTLLAGT 371
           LH +       P+I HRD+ S NIL+       +AD G A    + +           GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

Query: 372 YGYIAPELAYTMVM------TEKCDVYSFGVVTLEVLMGKHPRDILSSLS--------SS 417
             Y+APE+    +        ++ D+Y+ G+V  E+        I             S 
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235

Query: 418 SDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFA--CLQSNPKSRPTMQSVSQEF 472
              + M   V +Q+L P +  +      L         C  +N  +R T   + +  
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 2e-53
 Identities = 67/316 (21%), Positives = 124/316 (39%), Gaps = 29/316 (9%)

Query: 180 TNNIDVFSIWNYDGRIVYEDLIEATEDFDIRY--CIGTGGYGSVYKAQLPNGK----VFA 233
           T +ID+ ++ N +     + ++       + +   IG G +G VY   L +        A
Sbjct: 1   TVHIDLSAL-NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 59

Query: 234 LKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH-KKCMFLIYEYMERGSLFCN 292
           +K L+   ++  +  F  E  ++    H N++ L G CL  +    ++  YM+ G L   
Sbjct: 60  VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 119

Query: 293 LHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF 352
           + N      +       +  A       +    S   +HRD+++ N +L+ K    VADF
Sbjct: 120 IRNETHNPTVKDLIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVADF 174

Query: 353 GTARLLHADS----SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPR 408
           G AR ++        N+T       ++A E   T   T K DV+SFGV+  E++    P 
Sbjct: 175 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 234

Query: 409 DILSSLSSSSDPKIMLIDVLDQRLPPPVDR-KVIRDILLISTVSFACLQSNPKSRPTMQS 467
                    +   I +  +  +RL  P      + +++L       C     + RP+   
Sbjct: 235 Y-----PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML------KCWHPKAEMRPSFSE 283

Query: 468 VSQEFLITRKTPLVKH 483
           +         T + +H
Sbjct: 284 LVSRISAIFSTFIGEH 299

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  179 bits (456), Expect = 9e-53
 Identities = 66/292 (22%), Positives = 121/292 (41%), Gaps = 27/292 (9%)

Query: 185 VFSIWNYD----GRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHT 239
           VF IW         I ++ +++    +DI   +GTG +G V++      G  FA K + T
Sbjct: 5   VFDIWKQYYPQPVEIKHDHVLD---HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT 61

Query: 240 SEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDA 299
             E +  ++ + E Q +S + H  +V L+        M +IYE+M  G LF  + +  + 
Sbjct: 62  PHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK 120

Query: 300 VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFV--ADFGTARL 357
             +   + V  ++ +   L ++H +     +H D+   NI+  +K    +   DFG    
Sbjct: 121 --MSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175

Query: 358 LHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSS 417
           L    S +    GT  + APE+A    +    D++S GV++  +L G  P         +
Sbjct: 176 LDPKQSVKV-TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG-----GEN 229

Query: 418 SDPKIMLIDVLDQRLPPPVDRKVIRDIL-LISTVSFACLQSNPKSRPTMQSV 468
            D  +  +   D  +       +  D    I       L ++P +R T+   
Sbjct: 230 DDETLRNVKSCDWNMDDSAFSGISEDGKDFIR----KLLLADPNTRMTIHQA 277

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 2e-52
 Identities = 72/277 (25%), Positives = 112/277 (40%), Gaps = 25/277 (9%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNG-----KVFALKKLHTSEELAFIKSFKNEAQVLSQV 259
                +  IG G +G VYK  L           A+K L           F  EA ++ Q 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            H NI++L G     K M +I EYME G+   +    E   E    + V +++ +A    
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAG-- 122

Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLA---GTYGYIA 376
            + +  + + +HRD+++ NIL+NS L   V+DFG +R+L  D       +       + A
Sbjct: 123 -MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV 436
           PE       T   DV+SFG+V  EV+               S+ ++M       RLP P+
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPY-----WELSNHEVMKAINDGFRLPTPM 236

Query: 437 DR-KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           D    I  +++       C Q     RP    +    
Sbjct: 237 DCPSAIYQLMM------QCWQQERARRPKFADIVSIL 267

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 3e-52
 Identities = 65/286 (22%), Positives = 112/286 (39%), Gaps = 33/286 (11%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNG---KVFALKKLHTSEELAFIKSFKNEAQVLSQVL- 260
            D   +  IG G +G V KA++         A+K++         + F  E +VL ++  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHN-------------NEDAVELDWAKR 307
           H NI+ L G C H+  ++L  EY   G+L   L               N  A  L   + 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 308 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL 367
           ++    +A  + YL        IHRD+++ NIL+     A +ADFG +R        +T+
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTM 185

Query: 368 LAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDV 427
                 ++A E     V T   DV+S+GV+  E++               +  ++     
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELYEKLP 240

Query: 428 LDQRLPPPVDR-KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
              RL  P++    + D++        C +  P  RP+   +    
Sbjct: 241 QGYRLEKPLNCDDEVYDLMR------QCWREKPYERPSFAQILVSL 280

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  178 bits (452), Expect = 4e-52
 Identities = 63/268 (23%), Positives = 112/268 (41%), Gaps = 20/268 (7%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN 263
           + +DI   +G+G +G V++      G+VF  K ++T   L    + KNE  +++Q+ H  
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHHPK 87

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           ++ L+     K  M LI E++  G LF  +   +   ++  A+ +N ++     L ++H 
Sbjct: 88  LINLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMH- 144

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFV--ADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
               SI+H DI   NI+  +K  + V   DFG A  L+ D   +     T  + APE+  
Sbjct: 145 --EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV-TTATAEFAAPEIVD 201

Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI 441
              +    D+++ GV+   +L G  P              +  +   D          V 
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFA-----GEDDLETLQNVKRCDWEFDEDAFSSVS 256

Query: 442 RDIL-LISTVSFACLQSNPKSRPTMQSV 468
            +    I       LQ  P+ R T+   
Sbjct: 257 PEAKDFIK----NLLQKEPRKRLTVHDA 280

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 2e-51
 Identities = 65/280 (23%), Positives = 112/280 (40%), Gaps = 28/280 (10%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLP----NGKVFALKKLHTS--EELAFIKSFKNEAQVLSQ 258
           +D  +   +G G +G V + +           A+K L      +   +  F  E   +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
           + HRN+++LYG       M ++ E    GSL   L  ++    L    R      +A  +
Sbjct: 68  LDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGM 124

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN---RTLLAGTYGYI 375
            YL    S   IHRD+++ N+LL ++    + DFG  R L  +  +   +      + + 
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 376 APELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPP 434
           APE   T   +   D + FGV   E+   G+ P         +    +  ID   +RLP 
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-----GLNGSQILHKIDKEGERLPR 236

Query: 435 PVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL 473
           P D  + I ++++       C    P+ RPT  ++    L
Sbjct: 237 PEDCPQDIYNVMV------QCWAHKPEDRPTFVALRDFLL 270

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 2e-51
 Identities = 65/275 (23%), Positives = 110/275 (40%), Gaps = 25/275 (9%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           E  ++  CIG G +G V++    +        A+K        +  + F  EA  + Q  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H +IVKL G    +  +++I E    G L            LD A  +     ++ ALAY
Sbjct: 67  HPHIVKLIGVI-TENPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAY 123

Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR-TLLAGTYGYIAPEL 379
           L    S   +HRDI++ N+L++S     + DFG +R +   +  + +       ++APE 
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180

Query: 380 AYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD- 437
                 T   DV+ FGV   E+LM G  P           +  ++      +RLP P + 
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQ------GVKNNDVIGRIENGERLPMPPNC 234

Query: 438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
              +  ++        C   +P  RP    +  + 
Sbjct: 235 PPTLYSLMT------KCWAYDPSRRPRFTELKAQL 263

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 3e-51
 Identities = 66/296 (22%), Positives = 120/296 (40%), Gaps = 33/296 (11%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEEL--AFIKSFKNEAQVLSQVL- 260
           EDF +   +G G +G V+ A+     + FA+K L     L    ++    E +VLS    
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           H  +  ++     K+ +F + EY+  G L  ++ +     + D ++       +   L +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQF 118

Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELA 380
           L    S  I++RD+  +NILL+      +ADFG  +      +      GT  YIAPE+ 
Sbjct: 119 L---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175

Query: 381 YTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV 440
                    D +SFGV+  E+L+G+ P           + ++     +D    P    K 
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFH------GQDEEELFHSIRMDNPFYPRWLEKE 229

Query: 441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDISISELRN 496
            +D+L+            P+ R  ++             + +H   ++I+  EL  
Sbjct: 230 AKDLLV------KLFVREPEKRLGVRGD-----------IRQHPLFREINWEELER 268

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  172 bits (436), Expect = 2e-50
 Identities = 67/287 (23%), Positives = 113/287 (39%), Gaps = 25/287 (8%)

Query: 204 TEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR 262
            + +D R  +GTG +  V  A+     K+ A+K +          S +NE  VL ++ H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
           NIV L         ++LI + +  G LF  +                ++  +  A+ YLH
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLH 124

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAF---VADFGTARLLHADSSNRTLLAGTYGYIAPEL 379
                 I+HRD+   N+L  S  E     ++DFG +++    S   T   GT GY+APE+
Sbjct: 125 DLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYVAPEV 180

Query: 380 AYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK 439
                 ++  D +S GV+   +L G  P         +       I   +     P    
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGYPPFY-----DENDAKLFEQILKAEYEFDSPYWDD 235

Query: 440 V---IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKH 483
           +    +D +         ++ +P+ R T +   Q   I   T L K+
Sbjct: 236 ISDSAKDFIR------HLMEKDPEKRFTCEQALQHPWIAGDTALDKN 276

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 6e-50
 Identities = 65/292 (22%), Positives = 122/292 (41%), Gaps = 21/292 (7%)

Query: 202 EATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL 260
           E  E + I   +G G +G V++     + K +  K +            K E  +L+   
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIAR 59

Query: 261 HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 320
           HRNI+ L+      + + +I+E++    +F  ++ +  A EL+  + V+ V  +  AL +
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQF 117

Query: 321 LHHDCSPSIIHRDISSNNILLNSKLEAFV--ADFGTARLLHADSSNRTLLAGTYGYIAPE 378
           LH   S +I H DI   NI+  ++  + +   +FG AR L    + R  L     Y APE
Sbjct: 118 LH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYAPE 173

Query: 379 LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR 438
           +    V++   D++S G +   +L G +P       + ++   I  I   +        +
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFL-----AETNQQIIENIMNAEYTFDEEAFK 228

Query: 439 KVIRDIL-LISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDI 489
           ++  + +  +       L    KSR T     Q   + +K   V    I+ +
Sbjct: 229 EISIEAMDFVD----RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTL 276

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 2e-49
 Identities = 67/283 (23%), Positives = 122/283 (43%), Gaps = 25/283 (8%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVF----ALKKLHTSEELAFIKSFKNEAQVLSQV 259
            +F     +G+G +G+VYK   +P G+      A+K+L  +      K   +EA V++ V
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 260 LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 319
            + ++ +L G CL    + LI + M  G L   +  ++D   +     +N    +A  + 
Sbjct: 69  DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMN 125

Query: 320 YLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 377
           YL       ++HRD+++ N+L+ +     + DFG A+LL A+              ++A 
Sbjct: 126 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVL-MGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV 436
           E     + T + DV+S+GV   E++  G  P D          P   +  +L++    P 
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD--------GIPASEISSILEKGERLPQ 234

Query: 437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
                 D+ +I      C   +  SRP  + +  EF    + P
Sbjct: 235 PPICTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMARDP 274

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  167 bits (425), Expect = 4e-49
 Identities = 65/285 (22%), Positives = 123/285 (43%), Gaps = 33/285 (11%)

Query: 204 TEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLH--TSEELAFIKSFKNEAQVLSQVL 260
           ++ +++   +G GG   V+ A+ L   +  A+K L    + + +F   F+ EAQ  + + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 261 HRNIVKLYGYCLHK----KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 316
           H  IV +Y     +       +++ EY++  +L   +H       +   + + ++     
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 122

Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL---LAGTYG 373
           AL +        IIHRD+   NI++++     V DFG AR +    ++ T    + GT  
Sbjct: 123 ALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 374 YIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLP 433
           Y++PE A    +  + DVYS G V  EVL G+ P       +  S   +    V +  +P
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP------FTGDSPVSVAYQHVREDPIP 233

Query: 434 PPVDRKVI----RDILLISTVSFACLQSNPKSRP-TMQSVSQEFL 473
           P    + +      ++L        L  NP++R  T   +  + +
Sbjct: 234 PSARHEGLSADLDAVVL------KALAKNPENRYQTAAEMRADLV 272

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  167 bits (424), Expect = 1e-48
 Identities = 72/296 (24%), Positives = 123/296 (41%), Gaps = 33/296 (11%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTS--EELAFIKSFKNEAQVLSQVLH 261
           +DF I   +GTG +G V+  +   NG+ +A+K L       L  ++   +E  +LS V H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
             I++++G     + +F+I +Y+E G LF  L  ++                 A     L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY------AAEVCLAL 117

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
            +  S  II+RD+   NILL+      + DFG A+ +         L GT  YIAPE+  
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYTLCGTPDYIAPEVVS 174

Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLP-PPVDRKV 440
           T    +  D +SFG++  E+L G  P          S+       +L+  L  PP   + 
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFY-------DSNTMKTYEKILNAELRFPPFFNED 227

Query: 441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDISISELRN 496
           ++D+L         +  +   R        E +         H   +++   +L +
Sbjct: 228 VKDLLS------RLITRDLSQRLGNLQNGTEDVK-------NHPWFKEVVWEKLLS 270

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 1e-48
 Identities = 62/285 (21%), Positives = 109/285 (38%), Gaps = 32/285 (11%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQ 258
           E   +   +G G +G VY+               A+K ++ +  +     F NEA V+ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLH-------NNEDAVELDWAKRVNIV 311
               ++V+L G     +   +I E M RG L   L        NN        +K + + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 312 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNR--TLLA 369
             +A  +AYL    +   +HRD+++ N ++       + DFG  R ++     R      
Sbjct: 140 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 370 GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD 429
               +++PE     V T   DV+SFGVV  E+                   + +L  V++
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ------PYQGLSNEQVLRFVME 250

Query: 430 QRLPPPVDR--KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
             L    D    ++ +++        C Q NPK RP+   +    
Sbjct: 251 GGLLDKPDNCPDMLFELMR------MCWQYNPKMRPSFLEIISSI 289

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 3e-48
 Identities = 58/277 (20%), Positives = 107/277 (38%), Gaps = 31/277 (11%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLH-----TSEELAFIKSFKNEAQVLSQ 258
           + +D    +G+G +  V K +    G  +A K +      +S      +  + E  +L +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
           + H N++ L+    +K  + LI E +  G LF  L   E   E + A        +   L
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEF-----LKQIL 123

Query: 319 AYLHHDCSPSIIHRDISSNNILLNS----KLEAFVADFGTARLLHADSSNRTLLAGTYGY 374
             +++  S  I H D+   NI+L      K    + DFG A  +   +     + GT  +
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEF 182

Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPP 434
           +APE+     +  + D++S GV+T  +L G  P         +    +  +  ++     
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL-----GDTKQETLANVSAVNYEFED 237

Query: 435 PVDRKV---IRDILLISTVSFACLQSNPKSRPTMQSV 468
                     +D +         L  +PK R T+Q  
Sbjct: 238 EYFSNTSALAKDFIR------RLLVKDPKKRMTIQDS 268

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 9e-47
 Identities = 58/293 (19%), Positives = 111/293 (37%), Gaps = 39/293 (13%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLP--------NGKVFALKKLHTSEELAFIKSFKNEAQVL 256
           +   +   +G G +G V  A+               A+K L +      +    +E +++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 257 SQVL-HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNN-------------EDAVEL 302
             +  H+NI+ L G C     +++I EY  +G+L   L                    +L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 303 DWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS 362
                V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H   
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 363 SNRTLLA--GTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDP 420
             +          ++APE  +  + T + DV+SFGV+  E+                   
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-----PGVPVE 244

Query: 421 KIMLIDVLDQRLPPPVD-RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           ++  +     R+  P +    +  ++        C  + P  RPT + + ++ 
Sbjct: 245 ELFKLLKEGHRMDKPSNCTNELYMMMR------DCWHAVPSQRPTFKQLVEDL 291

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  163 bits (414), Expect = 1e-46
 Identities = 58/303 (19%), Positives = 104/303 (34%), Gaps = 39/303 (12%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLH-----TSEELAFIKSFKNEAQVLSQ 258
            DF +   IG GG+G VY  +    GK++A+K L        +      + +    ++S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
                IV +         +  I + M  G L  +L  +    E D          +   L
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF---YAAEIILGL 120

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE 378
            ++H   +  +++RD+   NILL+      ++D G A        + +   GT+GY+APE
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPE 175

Query: 379 -LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD 437
            L   +      D +S G +  ++L G  P                 ID +   +   + 
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR------QHKTKDKHEIDRMTLTMAVELP 229

Query: 438 RKV---IRDILLISTVSFACLQSNPKSRPTMQSVS-QEFLITRKTPLVKHAAIQDISISE 493
                 +R +L         LQ +   R        QE          +    + +    
Sbjct: 230 DSFSPELRSLLE------GLLQRDVNRRLGCLGRGAQEVK--------ESPFFRSLDWQM 275

Query: 494 LRN 496
           +  
Sbjct: 276 VFL 278

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  161 bits (407), Expect = 2e-46
 Identities = 62/281 (22%), Positives = 113/281 (40%), Gaps = 33/281 (11%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTS--------EELAFIKSFKNEAQV 255
           E+++ +  +G G    V +    P  K +A+K +  +        E     ++   E  +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 256 LSQVL-HRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM 314
           L +V  H NI++L          FL+++ M++G LF  L        L   +   I++A+
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRAL 119

Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGY 374
              +  LH     +I+HRD+   NILL+  +   + DFG +  L      R  + GT  Y
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-VCGTPSY 175

Query: 375 IAPELAYTMVM------TEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVL 428
           +APE+    +        ++ D++S GV+   +L G  P              + +I   
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-----HRKQMLMLRMIMSG 230

Query: 429 DQRLPPPVDRKVIRDIL-LISTVSFACLQSNPKSRPTMQSV 468
           + +   P        +  L+S      L   P+ R T +  
Sbjct: 231 NYQFGSPEWDDYSDTVKDLVS----RFLVVQPQKRYTAEEA 267

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  158 bits (399), Expect = 3e-45
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 25/283 (8%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHRN 263
           E +     IG G YG VYKAQ   G+ FALKK+    E+     +   E  +L ++ H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           IVKLY     KK + L++E++    L   L   E  +E   AK       +   L  + +
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSF-----LLQLLNGIAY 115

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAYT 382
                ++HRD+   N+L+N + E  +ADFG AR         T    T  Y AP+ L  +
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 383 MVMTEKCDVYSFGVVTLEVLMGKHP----------RDILSSLSSSSDPKIMLIDVLDQRL 432
              +   D++S G +  E++ G               I   L + +      +  L +  
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235

Query: 433 PPPVDRKVIRDILLISTVSFA-------CLQSNPKSRPTMQSV 468
           P     + +     +  +  +        L+ +P  R T +  
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (389), Expect = 1e-43
 Identities = 46/282 (16%), Positives = 91/282 (32%), Gaps = 33/282 (11%)

Query: 207 FDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIV 265
           + +   IG+G +G +Y    +  G+  A+K      +         E+++   +     +
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGI 65

Query: 266 KLYGYCLH-KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
               +C        ++ E +           +    +      + +   M   + Y+H  
Sbjct: 66  PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIH-- 120

Query: 325 CSPSIIHRDISSNNILLNSK---LEAFVADFGTARLLHADSSN-------RTLLAGTYGY 374
            S + IHRD+  +N L+         ++ DFG A+      ++          L GT  Y
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPP 434
            +      +  + + D+ S G V +   +G  P   L   +++   K   I       P 
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK--AATKRQKYERISEKKMSTPI 237

Query: 435 PVDRKVI----RDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
            V  K         L        C       +P    + Q F
Sbjct: 238 EVLCKGYPSEFATYLN------FCRSLRFDDKPDYSYLRQLF 273

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 1e-43
 Identities = 60/278 (21%), Positives = 109/278 (39%), Gaps = 28/278 (10%)

Query: 213 IGTGGYGSVYKAQLPN-GKVFALKKLH----TSEELAFIKSFKNEAQVLSQVLHRNIVKL 267
           +G G + +VYKA+  N  ++ A+KK+     +  +    ++   E ++L ++ H NI+ L
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 268 YGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 327
                HK  + L++++ME         N+                 M   L  L +    
Sbjct: 66  LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAY------MLMTLQGLEYLHQH 119

Query: 328 SIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVM-T 386
            I+HRD+  NN+LL+      +ADFG A+   + +   T    T  Y APEL +   M  
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 387 EKCDVYSFGVVTLEVLMGKHP----------RDILSSLSSSSDPKI----MLIDVLDQRL 432
              D+++ G +  E+L+                I  +L + ++ +      L D +  + 
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 433 PPPVDRKVIRDILLISTVSF--ACLQSNPKSRPTMQSV 468
            P +    I        +         NP +R T    
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 2e-43
 Identities = 61/290 (21%), Positives = 112/290 (38%), Gaps = 35/290 (12%)

Query: 205 EDFDIRYCIGTGGYGSVYKA------QLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQ 258
           +   +   +G G +G V +A      +    +  A+K L      +  ++  +E ++L  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 259 VLHR-NIVKLYGYCLHK-KCMFLIYEYMERGSLFCNLHNNEDAVE-------------LD 303
           + H  N+V L G C      + +I E+ + G+L   L +  +                L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 304 WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS 363
               +     +A  + +L    S   IHRD+++ NILL+ K    + DFG AR ++ D  
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 364 N--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPK 421
              +        ++APE  +  V T + DV+SFGV+  E+            +    +  
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKIDEEFC 247

Query: 422 IMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQE 471
             L +    R P     ++ + +L        C    P  RPT   + + 
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQTMLD-------CWHGEPSQRPTFSELVEH 290

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 2e-43
 Identities = 67/275 (24%), Positives = 116/275 (42%), Gaps = 27/275 (9%)

Query: 205 EDFDI-RYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-H 261
           +D+ +    +G G  G V +       + FALK L    +       + E ++  +    
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK------ARREVELHWRASQC 64

Query: 262 RNIVKLYGYC----LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 317
            +IV++          +KC+ ++ E ++ G LF  + +  D       +   I+K++  A
Sbjct: 65  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEA 123

Query: 318 LAYLHHDCSPSIIHRDISSNNILLNSKLE---AFVADFGTARLLHADSSNRTLLAGTYGY 374
           + YLH   S +I HRD+   N+L  SK       + DFG A+   + +S  T    T  Y
Sbjct: 124 IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP-CYTPYY 179

Query: 375 IAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPP 434
           +APE+       + CD++S GV+   +L G  P      L+ S   K   I +     P 
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-TRIRMGQYEFPN 238

Query: 435 PVDRKVIRDIL-LISTVSFACLQSNPKSRPTMQSV 468
           P   +V  ++  LI       L++ P  R T+   
Sbjct: 239 PEWSEVSEEVKMLIR----NLLKTEPTQRMTITEF 269

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 3e-43
 Identities = 64/293 (21%), Positives = 109/293 (37%), Gaps = 27/293 (9%)

Query: 200 LIEATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQ 258
           + +    +     IG G YG V  A    N    A+KK+   E   + +    E ++L +
Sbjct: 3   VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 62

Query: 259 VLHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
             H NI+ +           +   Y+    +  +L+       L        +  +   L
Sbjct: 63  FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGL 122

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL---LAGTYGYI 375
            Y+H   S +++HRD+  +N+LLN+  +  + DFG AR+   D  +         T  Y 
Sbjct: 123 KYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179

Query: 376 APELAYT-MVMTEKCDVYSFGVVTLEVLMGKHP-------------RDILSSLSSSSDPK 421
           APE+       T+  D++S G +  E+L  +                 IL S S      
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239

Query: 422 IMLIDVLDQRLPPPVDRKVIRDILLISTVSFA------CLQSNPKSRPTMQSV 468
           I+ +   +  L  P   KV  + L  +  S A       L  NP  R  ++  
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 5e-43
 Identities = 60/297 (20%), Positives = 109/297 (36%), Gaps = 32/297 (10%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELA--FIKSFKNEAQVLSQVLH 261
            DFD    +G G +G V   +    G+ +A+K L     +A   +     E++VL    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
             +  L         +  + EY   G LF +L       E             A  ++ L
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER------ARFYGAEIVSAL 118

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
            +  S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+APE+  
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178

Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD-RKV 440
                   D +  GVV  E++ G+ P         + D + +   +L + +  P      
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFY-------NQDHERLFELILMEEIRFPRTLSPE 231

Query: 441 IRDILLISTVSFACLQSNPKSRPTMQSVS-QEFLITRKTPLVKHAAIQDISISELRN 496
            + +L         L+ +PK R        +E +        +H     I+  ++  
Sbjct: 232 AKSLLA------GLLKKDPKQRLGGGPSDAKEVM--------EHRFFLSINWQDVVQ 274

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 5e-43
 Identities = 56/273 (20%), Positives = 101/273 (36%), Gaps = 35/273 (12%)

Query: 206 DFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTS-----EELAFIKSFKNEAQVLSQV 259
            + +   +G+GG+GSVY    + +    A+K +         EL        E  +L +V
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 260 --LHRNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 317
                 +++L  +        LI E  E      +      A  L      +    +  A
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 122

Query: 318 LAYLHHDCSPSIIHRDISSNNILLN-SKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
           + +     +  ++HRDI   NIL++ ++ E  + DFG+  LL    +  T   GT  Y  
Sbjct: 123 VRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSP 177

Query: 377 PE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPP 435
           PE + Y         V+S G++  +++ G  P +         +  I       QR+   
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE-------HDEEIIRGQVFFRQRVSSE 230

Query: 436 VDRKVIRDILLISTVSFACLQSNPKSRPTMQSV 468
                 + ++        CL   P  RPT + +
Sbjct: 231 C-----QHLIR------WCLALRPSDRPTFEEI 252

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 5e-43
 Identities = 65/301 (21%), Positives = 115/301 (38%), Gaps = 28/301 (9%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQVLHR 262
           E+F     IG G YG VYKA+    G+V ALKK+   +E      +   E  +L ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
           NIVKL      +  ++L++E++ +        +    + L   K       +   L  L 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGLA 116

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPE-LAY 381
              S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y APE L  
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHP-------------RDILSSLSSSSDPKIMLIDVL 428
               +   D++S G +  E++  +                  L +      P +  +   
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 429 DQRLPPPVDRKVIRDILLISTVSF----ACLQSNPKSRPTMQSVSQ-EFL--ITRKTPLV 481
               P    +   + +  +           L  +P  R + ++     F   +T+  P +
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL 296

Query: 482 K 482
           +
Sbjct: 297 R 297

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 2e-42
 Identities = 65/311 (20%), Positives = 116/311 (37%), Gaps = 34/311 (10%)

Query: 206 DFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI 264
            +     IG G +G VY+A+L  +G++ A+KK+   +          E Q++ ++ H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNI 75

Query: 265 VKLYGYCLH------KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 318
           V+L  +         +  + L+ +Y+         H +     L        +  +  +L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 319 AYLHHDCSPSIIHRDISSNNILLNSKLEAF-VADFGTARLLHADSSNRTLLAGTYGYIAP 377
           AY+H   S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y     
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 192

Query: 378 ELAYTMVMTEKCDVYSFGVVTLEVLMGKHP----------RDILSSLSSSSDPKIMLIDV 427
            +      T   DV+S G V  E+L+G+             +I+  L + +  +I  ++ 
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252

Query: 428 LDQRLPPPVDRKVIRDILLISTVSFA-------CLQSNPKSRPTMQSVSQ-EFLITRKTP 479
                  P  +      +                L+  P +R T        F    + P
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312

Query: 480 LVKHAAIQDIS 490
            VK    +D  
Sbjct: 313 NVKLPNGRDTP 323

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 1e-41
 Identities = 56/285 (19%), Positives = 114/285 (40%), Gaps = 27/285 (9%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQVLHR 262
           + ++    IG G YG+V+KA+     ++ ALK++    ++     S   E  +L ++ H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 263 NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 322
           NIV+L+      K + L++E+ ++         N D               +   L  L 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKS------FLFQLLKGLG 115

Query: 323 HDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY- 381
              S +++HRD+   N+L+N   E  +A+FG AR         +    T  Y  P++ + 
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175

Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHP-----------RDILSSLSSSSDPKIMLIDVLDQ 430
             + +   D++S G +  E+     P           + I   L + ++ +   +  L  
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235

Query: 431 RLPPPVDRKVIRDILLISTVSFA-------CLQSNPKSRPTMQSV 468
             P P+       + ++  ++          L+ NP  R + +  
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 2e-40
 Identities = 62/292 (21%), Positives = 111/292 (38%), Gaps = 32/292 (10%)

Query: 203 ATEDFDIRYCIGTGGYGSVYKAQ--LPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQV 259
           A + ++    IG G YG V+KA+     G+  ALK++   + E     S   E  VL  +
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 260 L---HRNIVKLYGYCL-----HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIV 311
               H N+V+L+  C       +  + L++E++++          E    +      +++
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMM 122

Query: 312 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGT 371
             +   L +LH      ++HRD+   NIL+ S  +  +ADFG AR+     +  + +  T
Sbjct: 123 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-VVVT 178

Query: 372 YGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP----------RDILSSLSSSSDPK 421
             Y APE+          D++S G +  E+   K              IL  +    +  
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 422 IMLIDVLDQRLPPPVDRKVIRDILLISTVSF-----ACLQSNPKSRPTMQSV 468
                 L ++       + I   +             CL  NP  R +  S 
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 2e-40
 Identities = 72/307 (23%), Positives = 121/307 (39%), Gaps = 40/307 (13%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQL----PNGKVFALKKLHTS---EELAFIKSFKNEAQVLS 257
           E+F++   +GTG YG V+  +       GK++A+K L  +   ++    +  + E QVL 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 258 QVLHR-NIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 316
            +     +V L+     +  + LI +Y+  G LF +L   E   E +          +  
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY------VGE 137

Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRT-LLAGTYGYI 375
            +  L H     II+RDI   NILL+S     + DFG ++   AD + R     GT  Y+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197

Query: 376 APELAYTMVM--TEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLP 433
           AP++         +  D +S GV+  E+L G  P                 I     +  
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT-----VDGEKNSQAEISRRILKSE 252

Query: 434 PPVDRKV---IRDILLISTVSFACLQSNPKSRPTMQSVS-QEFLITRKTPLVKHAAIQDI 489
           PP  +++    +D++         L  +PK R         E          +H   Q I
Sbjct: 253 PPYPQEMSALAKDLIQ------RLLMKDPKKRLGCGPRDADEIK--------EHLFFQKI 298

Query: 490 SISELRN 496
           +  +L  
Sbjct: 299 NWDDLAA 305

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 1e-39
 Identities = 59/299 (19%), Positives = 106/299 (35%), Gaps = 41/299 (13%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLH-TSEELAFIKSFKNEAQVLSQVLHR 262
             ++    IG G +G V+KA+    G+  ALKK+   +E+  F  +   E ++L  + H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 263 NIVKLYGYCL--------HKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM 314
           N+V L   C          K  ++L++++ E        +       L   KRV     M
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRV-----M 123

Query: 315 AHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS----NRTLLAG 370
              L  L++     I+HRD+ + N+L+       +ADFG AR      +      T    
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 371 TYGYIAPE-LAYTMVMTEKCDVYSFGVVTLEVLMGKHP-------------RDILSSLSS 416
           T  Y  PE L          D++  G +  E+                     +  S++ 
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243

Query: 417 SSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFA-------CLQSNPKSRPTMQSV 468
              P +   ++ ++       ++ ++D L                L  +P  R      
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  143 bits (360), Expect = 1e-39
 Identities = 42/280 (15%), Positives = 87/280 (31%), Gaps = 27/280 (9%)

Query: 207 FDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRN-I 264
           + +   IG G +G +++   L N +  A+K      +       ++E +    +     I
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGI 63

Query: 265 VKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 324
             +Y +        L+ + +                +          K M   +  +H  
Sbjct: 64  PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIH-- 118

Query: 325 CSPSIIHRDISSNNILLNSKLE-----AFVADFGTARLLHADSSN-------RTLLAGTY 372
              S+++RDI  +N L+           +V DFG  +      +        +  L+GT 
Sbjct: 119 -EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 373 GYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRL 432
            Y++         + + D+ + G V +  L G  P   L   ++++  K   I    Q  
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK--AATNKQKYERIGEKKQST 235

Query: 433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEF 472
           P         +                 + P    +   F
Sbjct: 236 PLRELCAGFPEEF--YKYMHYARNLAFDATPDYDYLQGLF 273

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  142 bits (359), Expect = 6e-39
 Identities = 59/262 (22%), Positives = 104/262 (39%), Gaps = 24/262 (9%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLH 261
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 262 RNIVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 321
             +VKL         ++++ EY+  G +F +L                    +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYL 157

Query: 322 HHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIAPELAY 381
           H   S  +I+RD+   N+L++ +    V DFG A+ +         L GT   +APE+  
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWTLCGTPEALAPEIIL 211

Query: 382 TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI 441
           +    +  D ++ GV+  E+  G  P        +    +I    V  +   P      +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP------FFADQPIQIYEKIVSGKVRFPSHFSSDL 265

Query: 442 RDILLISTVSFACLQSNPKSRP 463
           +D+L         LQ +   R 
Sbjct: 266 KDLLR------NLLQVDLTKRF 281

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 1e-34
 Identities = 61/303 (20%), Positives = 113/303 (37%), Gaps = 41/303 (13%)

Query: 197 YEDLIEATEDFDIRY----CIGTGGYGSVYKAQ-LPNGKVFALKKLH-TSEELAFIKSFK 250
            +++ +   +    Y     +G+G YG+V  A     G   A+KKL+   +   F K   
Sbjct: 6   RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY 65

Query: 251 NEAQVLSQVLHRNIVKLYGYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDW 304
            E ++L  + H N++ L       + +      +L+  +M  G+    L  +E   +L  
Sbjct: 66  RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE---KLGE 120

Query: 305 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN 364
            +   +V  M   L Y+H   +  IIHRD+   N+ +N   E  + DFG AR   ADS  
Sbjct: 121 DRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEM 175

Query: 365 RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP--------------RDI 410
              +   +      +   M  T+  D++S G +  E++ GK                +  
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235

Query: 411 LSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFA-----CLQSNPKSRPTM 465
            +  +               +  P +++K    IL  ++          L  + + R T 
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295

Query: 466 QSV 468
              
Sbjct: 296 GEA 298

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  128 bits (322), Expect = 7e-34
 Identities = 54/315 (17%), Positives = 110/315 (34%), Gaps = 51/315 (16%)

Query: 187 SIWNYDGRIVYEDLIEATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAF 245
             W+Y+  +V     +   D+ +   +G G Y  V++A  + N +   +K L   ++   
Sbjct: 20  EYWDYESHVVEWGNQD---DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--- 73

Query: 246 IKSFKNEAQVLSQV-LHRNIVKLYGYCLH--KKCMFLIYEYMERGSLFCNLHNNEDAVEL 302
            K  K E ++L  +    NI+ L         +   L++E++                 L
Sbjct: 74  -KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------L 126

Query: 303 DWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTARLLHAD 361
                   +  +  AL Y H      I+HRD+  +N++++ +  +  + D+G A   H  
Sbjct: 127 TDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183

Query: 362 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP-------------- 407
                 +A  Y      L    +     D++S G +   ++  K P              
Sbjct: 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 243

Query: 408 ---------RDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSF-----A 453
                     D +   +   DP+    D+L +      +R V  +   + +         
Sbjct: 244 AKVLGTEDLYDYIDKYNIELDPR--FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301

Query: 454 CLQSNPKSRPTMQSV 468
            L+ + +SR T +  
Sbjct: 302 LLRYDHQSRLTAREA 316

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 4e-32
 Identities = 60/297 (20%), Positives = 108/297 (36%), Gaps = 35/297 (11%)

Query: 196 VYEDLIEATEDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTS-EELAFIKSFKNEA 253
           + + + E  E +     +G+G YGSV  A     G   A+KKL    + +   K    E 
Sbjct: 9   LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 68

Query: 254 QVLSQVLHRNIVKLYGYC-----LHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV 308
           ++L  + H N++ L         L +     +  ++    L   +       +L      
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQ 124

Query: 309 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLL 368
            ++  +   L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D      +
Sbjct: 125 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYV 179

Query: 369 AGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHP---RDILSSLSSSSDPKIMLI 425
           A  +      +   M   +  D++S G +  E+L G+      D +  L           
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 239

Query: 426 DVLDQRLPPPVDRKVIRDILLISTVSFA----------------CLQSNPKSRPTMQ 466
             L +++     R  I+ +  +  ++FA                 L  +   R T  
Sbjct: 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 8e-32
 Identities = 59/302 (19%), Positives = 97/302 (32%), Gaps = 48/302 (15%)

Query: 205 EDFDIRYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTS-EELAFIKSFKNEAQVLSQVLHR 262
           + +     IG+G  G V  A      +  A+KKL    +     K    E  ++  V H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 263 NIVKLYGYCLHKKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 316
           NI+ L      +K +      +L+ E M+                 D  +   ++  M  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLC 130

Query: 317 ALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTLLAGTYGYIA 376
            + +LH      IIHRD+  +NI++ S     + DFG AR     S   T    T  Y A
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRA 186

Query: 377 PELAYTMVMTEKCDVYSFGVVTLEVLMGKHP-----------------RDILSSLSSSSD 419
           PE+   M   E  D++S G +  E++  K                               
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246

Query: 420 PKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFA-------------CLQSNPKSRPTMQ 466
           P +        +       K+  D L  +                   L  +P  R ++ 
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306

Query: 467 SV 468
             
Sbjct: 307 DA 308

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  110 bits (276), Expect = 2e-27
 Identities = 56/296 (18%), Positives = 110/296 (37%), Gaps = 30/296 (10%)

Query: 208 DIRY----CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR 262
           D RY     +G G + +V+ A+ + N    A+K +   +   + ++ ++E ++L +V   
Sbjct: 12  DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDA 69

Query: 263 N-----------IVKLYGYCLH----KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR 307
           +           I+KL  +  H       + +++E +    L          + L + K+
Sbjct: 70  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129

Query: 308 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-LEAFVADFGTARLLHADSSNRT 366
             I K +   L Y+H  C   IIH DI   N+L+        +     A L +A   +  
Sbjct: 130 --ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 185

Query: 367 --LLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDP-KIM 423
                 T  Y +PE+          D++S   +  E++ G    +     S + D   I 
Sbjct: 186 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245

Query: 424 LIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP 479
            I  L   LP  + R         ++       S  K  P    +++++  ++   
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 86.4 bits (213), Expect = 3e-20
 Identities = 25/164 (15%), Positives = 56/164 (34%), Gaps = 19/164 (11%)

Query: 213 IGTGGYGSVYKAQLPNGKVFALKKLHTS---------EELAFIKSFKNEAQVLSQVLHRN 263
           +G G   +V+           +K              +       F   A   ++   R 
Sbjct: 8   MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67

Query: 264 IVKLYGYCLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 323
           + KL G  + K   +      E  ++   L + ++   +       ++  +   +A  +H
Sbjct: 68  LQKLQGLAVPKVYAW------EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121

Query: 324 DCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSNRTL 367
                I+H D+S  N+L+ S+   ++ DF  +  +  +     L
Sbjct: 122 RG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREIL 161

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 71.7 bits (174), Expect = 2e-14
 Identities = 30/74 (40%), Positives = 40/74 (54%), Gaps = 4/74 (5%)

Query: 62  MKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSP 121
            K L  LDL NN I G++P  +T+L  L  LN+S N L G +P   N L     V + + 
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN-LQRF-DVSAYAN 300

Query: 122 NNGLCGNILDLPSC 135
           N  LCG+   LP+C
Sbjct: 301 NKCLCGSP--LPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 69.8 bits (169), Expect = 9e-14
 Identities = 24/68 (35%), Positives = 39/68 (57%), Gaps = 3/68 (4%)

Query: 39  TNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNK 98
            NL+ LDL +N++ G +P  +  +K+L  L++S NN+ G IP +   L R D    ++NK
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302

Query: 99  L--SGPVP 104
                P+P
Sbjct: 303 CLCGSPLP 310

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 65.9 bits (159), Expect = 2e-12
 Identities = 21/66 (31%), Positives = 34/66 (51%), Gaps = 1/66 (1%)

Query: 15  KNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNN 74
           KNL  LD+ +N + G +P  L  L  L +L++S N L G+I P+  +++       +NN 
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNK 302

Query: 75  IQGSIP 80
                P
Sbjct: 303 CLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 58.2 bits (139), Expect = 6e-10
 Identities = 19/54 (35%), Positives = 26/54 (48%), Gaps = 2/54 (3%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNK-LSGKIPP 57
           G +P  +  LK L  L+V  N+L G IP   G+L        ++NK L G   P
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLP 310

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 45.1 bits (105), Expect = 1e-05
 Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 5/134 (3%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIG--PIPSALGSLTNLSNLDLSSN-KLSGKIPPEIAS 61
           G++         +  LD+   +L    PIPS+L +L  L+ L +     L G IPP IA 
Sbjct: 40  GVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAK 99

Query: 62  MKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSP 121
           +  L  L +++ N+ G+IP  ++++  L  L+ S N LSG +P   +  S  + V     
Sbjct: 100 LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP--PSISSLPNLVGITFD 157

Query: 122 NNGLCGNILDLPSC 135
            N + G I D    
Sbjct: 158 GNRISGAIPDSYGS 171

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 65.4 bits (158), Expect = 4e-12
 Identities = 26/120 (21%), Positives = 49/120 (40%), Gaps = 24/120 (20%)

Query: 8   PPEIGNLKNLIKLDVGSNSLIGPIPSALGS--------------------LTNLSNLDLS 47
              +  L  L +L +G+N +    P A  +                    L NL+ L L 
Sbjct: 256 LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLY 315

Query: 48  SNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSN 107
            N +S   P  ++S+  L +L  +NN +       +  L+ +++L+   N++S   P +N
Sbjct: 316 FNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLAN 371

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.9 bits (128), Expect = 2e-08
 Identities = 37/123 (30%), Positives = 52/123 (42%), Gaps = 26/123 (21%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
            I P  I    NL +L +  N L       L SLTNL++LDL++N++S   P  ++ +  
Sbjct: 211 DITPLGILT--NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTK 264

Query: 65  LTQLDLSNNNIQGSIP--------------------GEITKLSRLDYLNLSSNKLSGPVP 104
           LT+L L  N I    P                      I+ L  L YL L  N +S   P
Sbjct: 265 LTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP 324

Query: 105 FSN 107
            S+
Sbjct: 325 VSS 327

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 51.5 bits (122), Expect = 1e-07
 Identities = 16/71 (22%), Positives = 29/71 (40%), Gaps = 4/71 (5%)

Query: 37  SLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSS 96
           +L       L    ++  +      +  +T L      I+ SI G +  L+ L  +N S+
Sbjct: 20  ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 75

Query: 97  NKLSGPVPFSN 107
           N+L+   P  N
Sbjct: 76  NQLTDITPLKN 86

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.6 bits (104), Expect = 2e-05
 Identities = 22/72 (30%), Positives = 39/72 (54%), Gaps = 4/72 (5%)

Query: 36  GSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLS 95
             LTNL +L  ++N++S   P  I  +  L +L L+ N ++    G +  L+ L  L+L+
Sbjct: 194 AKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249

Query: 96  SNKLSGPVPFSN 107
           +N++S   P S 
Sbjct: 250 NNQISNLAPLSG 261

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 14/84 (16%), Positives = 32/84 (38%), Gaps = 22/84 (26%)

Query: 13  NLKNLIKLDVGSNSLIGPIP--------------------SALGSLTNLSNLDLSSNKLS 52
            L   +K  +G  ++   +                       +  L NL+ ++ S+N+L+
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLT 79

Query: 53  GKIPPEIASMKYLTQLDLSNNNIQ 76
              P  + ++  L  + ++NN I 
Sbjct: 80  DITP--LKNLTKLVDILMNNNQIA 101

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 57.7 bits (138), Expect = 7e-10
 Identities = 24/108 (22%), Positives = 43/108 (39%), Gaps = 4/108 (3%)

Query: 31  IPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLD 90
           +P  L    + + LDL +NK++     +  ++K L  L L NN I    PG    L +L+
Sbjct: 25  VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82

Query: 91  YLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGNILDLPSCDTT 138
            L LS N+L          L  +      +    +  ++ +  +    
Sbjct: 83  RLYLSKNQLKELPEKMPKTLQELRV--HENEITKVRKSVFNGLNQMIV 128

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 55.0 bits (131), Expect = 5e-09
 Identities = 28/123 (22%), Positives = 52/123 (42%), Gaps = 5/123 (4%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLT 66
           +P ++    +   LD+ +N +         +L NL  L L +NK+S   P   A +  L 
Sbjct: 25  VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82

Query: 67  QLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLC 126
           +L LS N ++  +P ++ K  +   L +  N+++       N L+ M  V   +      
Sbjct: 83  RLYLSKNQLK-ELPEKMPKTLQ--ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS 139

Query: 127 GNI 129
           G  
Sbjct: 140 GIE 142

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 53.1 bits (126), Expect = 3e-08
 Identities = 33/130 (25%), Positives = 52/130 (40%), Gaps = 7/130 (5%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
            I   +  NLKNL  L + +N +    P A   L  L  L LS N+L   +P ++   K 
Sbjct: 45  EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKT 101

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNG 124
           L +L +  N I          L+++  + L +N L      S  +  +   +  LS    
Sbjct: 102 LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK----SSGIENGAFQGMKKLSYIRI 157

Query: 125 LCGNILDLPS 134
              NI  +P 
Sbjct: 158 ADTNITTIPQ 167

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 48.9 bits (115), Expect = 5e-07
 Identities = 33/123 (26%), Positives = 52/123 (42%), Gaps = 5/123 (4%)

Query: 1   MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIA 60
           +   GI       +K L  + +   ++   IP  L    +L+ L L  NK++      + 
Sbjct: 136 LKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGL--PPSLTELHLDGNKITKVDAASLK 192

Query: 61  SMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLS 120
            +  L +L LS N+I     G +     L  L+L++NKL   VP    D   +  VV L 
Sbjct: 193 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYI-QVVYLH 250

Query: 121 PNN 123
            NN
Sbjct: 251 NNN 253

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 47.0 bits (110), Expect = 2e-06
 Identities = 32/127 (25%), Positives = 47/127 (37%), Gaps = 31/127 (24%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKI------- 55
            I  IP   G   +L +L +  N +     ++L  L NL+ L LS N +S          
Sbjct: 161 NITTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT 218

Query: 56  ----------------PPEIASMKYLTQLDLSNNNIQG------SIPGEITKLSRLDYLN 93
                           P  +A  KY+  + L NNNI          PG  TK +    ++
Sbjct: 219 PHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVS 278

Query: 94  LSSNKLS 100
           L SN + 
Sbjct: 279 LFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 42.7 bits (99), Expect = 5e-05
 Identities = 26/137 (18%), Positives = 44/137 (32%), Gaps = 26/137 (18%)

Query: 1   MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKL--------- 51
                I P     L  L +L +  N L         +L  L   +    K+         
Sbjct: 65  NKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLN 124

Query: 52  --------------SGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSN 97
                         SG        MK L+ + +++ NI  +IP  +     L  L+L  N
Sbjct: 125 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGN 181

Query: 98  KLSGPVPFSNNDLSSMH 114
           K++     S   L+++ 
Sbjct: 182 KITKVDAASLKGLNNLA 198

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 53.2 bits (127), Expect = 2e-09
 Identities = 28/114 (24%), Positives = 45/114 (39%), Gaps = 4/114 (3%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLT 66
           +   +  L  +  LD+  N L    P+ L +L  L  L  S N    +    +A++  L 
Sbjct: 12  VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNA--LENVDGVANLPRLQ 68

Query: 67  QLDLSNNNIQG-SIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSL 119
           +L L NN +Q  +    +    RL  LNL  N L             + +V S+
Sbjct: 69  ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.8 bits (132), Expect = 6e-09
 Identities = 14/91 (15%), Positives = 29/91 (31%), Gaps = 5/91 (5%)

Query: 16  NLIKLDVGSNSLI-GPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM----KYLTQLDL 70
           ++  LD+    L        L  L     + L    L+     +I+S       L +L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 71  SNNNIQGSIPGEITKLSRLDYLNLSSNKLSG 101
            +N +       + +  +     +    L  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.9 bits (122), Expect = 9e-08
 Identities = 15/83 (18%), Positives = 27/83 (32%), Gaps = 9/83 (10%)

Query: 13  NLKNLIKLDVGSNSL----IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAS-----MK 63
               L  L +    +       + + L +  +L  LDLS+N L      ++         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 64  YLTQLDLSNNNIQGSIPGEITKL 86
            L QL L +      +   +  L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.6 bits (116), Expect = 6e-07
 Identities = 15/75 (20%), Positives = 26/75 (34%), Gaps = 9/75 (12%)

Query: 11 IGNLKNLIKLDVGSNSL----IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM---- 62
          +  L+    + +    L       I SAL     L+ L+L SN+L       +       
Sbjct: 23 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82

Query: 63 -KYLTQLDLSNNNIQ 76
             + +L L N  + 
Sbjct: 83 SCKIQKLSLQNCCLT 97

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.7 bits (111), Expect = 2e-06
 Identities = 16/75 (21%), Positives = 29/75 (38%), Gaps = 9/75 (12%)

Query: 39  TNLSNLDLSSNKLSGKIPPEIASM----KYLTQLDLSNNNIQGSIPGEITK-----LSRL 89
           + L  L L+   +S      +A+       L +LDLSNN +  +   ++ +        L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 90  DYLNLSSNKLSGPVP 104
           + L L     S  + 
Sbjct: 429 EQLVLYDIYWSEEME 443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (89), Expect = 9e-04
 Identities = 12/75 (16%), Positives = 24/75 (32%), Gaps = 11/75 (14%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGS-----LTNLSNLDLSSNKLSGKIPPEIAS 61
           +   +    +L +LD+ +N L       L          L  L L     S ++      
Sbjct: 389 LAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME----- 443

Query: 62  MKYLTQLDLSNNNIQ 76
              L  L+    +++
Sbjct: 444 -DRLQALEKDKPSLR 457

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 55.2 bits (131), Expect = 7e-09
 Identities = 21/88 (23%), Positives = 36/88 (40%), Gaps = 10/88 (11%)

Query: 6   IIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYL 65
            I        +L +L+V +N LI  +P+       L  L  S N L+ ++P    +   L
Sbjct: 275 EIRSLCDLPPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLA-EVPELPQN---L 326

Query: 66  TQLDLSNNNIQGSIPGEITKLSRLDYLN 93
            QL +  N ++   P     +  L  +N
Sbjct: 327 KQLHVEYNPLR-EFPDIPESVEDL-RMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.1 bits (97), Expect = 1e-04
 Identities = 15/70 (21%), Positives = 26/70 (37%), Gaps = 11/70 (15%)

Query: 3   KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
           K+  +P     L+   +L    N L   +P       NL  L +  N L  + P    S 
Sbjct: 295 KLIELPALPPRLE---RLIASFNHL-AEVPE---LPQNLKQLHVEYNPLR-EFPDIPES- 345

Query: 63  KYLTQLDLSN 72
             +  L +++
Sbjct: 346 --VEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.7 bits (96), Expect = 2e-04
 Identities = 15/55 (27%), Positives = 23/55 (41%), Gaps = 4/55 (7%)

Query: 46  LSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
              N  S +I         L +L++SNN +   +P    +L RL     S N L+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA 317

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 37.5 bits (85), Expect = 0.003
 Identities = 10/38 (26%), Positives = 17/38 (44%), Gaps = 4/38 (10%)

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
           +   +L+L+N  +  S+P     L  L     S N L+
Sbjct: 38  RQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT 71

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 37.5 bits (85), Expect = 0.003
 Identities = 15/63 (23%), Positives = 29/63 (46%), Gaps = 8/63 (12%)

Query: 15 KNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNN 74
          +   +L++ +  L   +P       +L +L  S N L+ ++P    S   L  L + NNN
Sbjct: 38 RQAHELELNNLGL-SSLPE---LPPHLESLVASCNSLT-ELPELPQS---LKSLLVDNNN 89

Query: 75 IQG 77
          ++ 
Sbjct: 90 LKA 92

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.1 bits (118), Expect = 2e-07
 Identities = 14/63 (22%), Positives = 26/63 (41%), Gaps = 3/63 (4%)

Query: 36 GSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLS 95
            + +   ++     L+  +PP++   K  T L LS N +       +   +RL  LNL 
Sbjct: 7  SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 96 SNK 98
            +
Sbjct: 64 RAE 66

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.9 bits (107), Expect = 4e-06
 Identities = 14/67 (20%), Positives = 28/67 (41%), Gaps = 3/67 (4%)

Query: 10 EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLD 69
          E+  + + ++++    +L   +P  L    + + L LS N L       +     LTQL+
Sbjct: 5  EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 70 LSNNNIQ 76
          L    + 
Sbjct: 62 LDRAELT 68

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.9 bits (102), Expect = 2e-05
 Identities = 19/68 (27%), Positives = 24/68 (35%), Gaps = 1/68 (1%)

Query: 6   IIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYL 65
           + P  +     L KL + +N+L       L  L NL  L L  N L   IP        L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197

Query: 66  TQLDLSNN 73
               L  N
Sbjct: 198 PFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.6 bits (96), Expect = 1e-04
 Identities = 14/100 (14%), Positives = 35/100 (35%), Gaps = 7/100 (7%)

Query: 47  SSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS---GPV 103
           ++N L+      +  ++ L  L L  N++  +IP        L +  L  N        +
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEIL 214

Query: 104 PFSN---NDLSSMHTVVSLSPNNGLCGNILDLPSCDTTKP 140
            F     ++  +++          +  N+  +   ++ K 
Sbjct: 215 YFRRWLQDNAENVYVWKQGVDVKAMTSNVASVQCDNSDKF 254

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.8 bits (86), Expect = 0.002
 Identities = 12/47 (25%), Positives = 16/47 (34%), Gaps = 1/47 (2%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKL 51
            +    +  L+NL  L +  NSL   IP        L    L  N  
Sbjct: 162 ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.1 bits (113), Expect = 6e-07
 Identities = 19/72 (26%), Positives = 29/72 (40%), Gaps = 4/72 (5%)

Query: 1   MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIA 60
                     + NL  L  L    N +    P  L SL NL  + L +N++S   P  +A
Sbjct: 159 GNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LA 214

Query: 61  SMKYLTQLDLSN 72
           +   L  + L+N
Sbjct: 215 NTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.4 bits (106), Expect = 5e-06
 Identities = 13/64 (20%), Positives = 26/64 (40%), Gaps = 4/64 (6%)

Query: 13 NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSN 72
           L N IK+  G +++   +  A   L  ++ L      ++      +  +  L  L+L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72

Query: 73 NNIQ 76
          N I 
Sbjct: 73 NQIT 76

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 5e-04
 Identities = 14/52 (26%), Positives = 25/52 (48%), Gaps = 2/52 (3%)

Query: 56  PPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSN 107
              +A++  LT L   +N I    P  +  L  L  ++L +N++S   P +N
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLAN 215

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.0 bits (110), Expect = 2e-06
 Identities = 20/91 (21%), Positives = 34/91 (37%), Gaps = 4/91 (4%)

Query: 6   IIPPEIGNL--KNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAS-M 62
           + P   G L  + +I      + +  P+     S   + ++DLS++ +       I S  
Sbjct: 12  LHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVSTLHGILSQC 70

Query: 63  KYLTQLDLSNNNIQGSIPGEITKLSRLDYLN 93
             L  L L    +   I   + K S L  LN
Sbjct: 71  SKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.9 bits (94), Expect = 2e-04
 Identities = 9/58 (15%), Positives = 24/58 (41%), Gaps = 2/58 (3%)

Query: 44  LDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSG 101
           LDL+   L   +   + S + +       + +   +  E     R+ +++LS++ +  
Sbjct: 5   LDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEV 60

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.3 bits (108), Expect = 3e-06
 Identities = 26/122 (21%), Positives = 40/122 (32%), Gaps = 2/122 (1%)

Query: 5   GIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKY 64
            +      +L NL  L +  N +      A   L +L  L L  N+++   P     +  
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNG 124
           L  L L  NN+       +  L  L YL L+ N            L +       S +  
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR--ARPLWAWLQKFRGSSSEV 260

Query: 125 LC 126
            C
Sbjct: 261 PC 262

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.3 bits (108), Expect = 4e-06
 Identities = 23/100 (23%), Positives = 39/100 (39%), Gaps = 4/100 (4%)

Query: 2   YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAS 61
               + P    +L  L+ L + +N+L      AL  L  L  L L+ N            
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC-DCRARPL 246

Query: 62  MKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSG 101
             +L +   S++ +  S+P     L+  D   L++N L G
Sbjct: 247 WAWLQKFRGSSSEVPCSLPQR---LAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.8 bits (104), Expect = 1e-05
 Identities = 27/109 (24%), Positives = 35/109 (32%)

Query: 6   IIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYL 65
           + P     L  L  L +    L    P     L  L  L L  N L          +  L
Sbjct: 96  VDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNL 155

Query: 66  TQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMH 114
           T L L  N I          L  LD L L  N+++   P +  DL  + 
Sbjct: 156 THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM 204

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.9 bits (99), Expect = 5e-05
 Identities = 30/126 (23%), Positives = 45/126 (35%), Gaps = 1/126 (0%)

Query: 1   MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIA 60
                + P     L  L  L +  N+L          L NL++L L  N++S        
Sbjct: 115 CGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFR 174

Query: 61  SMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLS 120
            +  L +L L  N +    P     L RL  L L +N LS  +P            + L+
Sbjct: 175 GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLN 233

Query: 121 PNNGLC 126
            N  +C
Sbjct: 234 DNPWVC 239

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 44.8 bits (104), Expect = 5e-06
 Identities = 17/99 (17%), Positives = 39/99 (39%), Gaps = 4/99 (4%)

Query: 1   MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIA 60
                I       L  L  L++  N +   +P +   L +L++L+L+SN  +        
Sbjct: 88  NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC-NCHLAW 146

Query: 61  SMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKL 99
             ++L +  L+    +   P   +K+  +   +L  ++ 
Sbjct: 147 FAEWLRKKSLNGGAARCGAP---SKVRDVQIKDLPHSEF 182

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.4 bits (104), Expect = 6e-06
 Identities = 22/118 (18%), Positives = 47/118 (39%), Gaps = 6/118 (5%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGK--IPPEIASMKY 64
             P++      + L+  S+ +   +     ++  L +L+LS+N+L     +   +     
Sbjct: 34  SDPDLVAQNIDVVLNRRSS-MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPN 92

Query: 65  LTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN 122
           L  L+LS N ++     +  K  +L+ L L  N LS       +  + +  +    P 
Sbjct: 93  LKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR---DQSTYISAIRERFPK 147

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (90), Expect = 3e-04
 Identities = 22/111 (19%), Positives = 46/111 (41%), Gaps = 11/111 (9%)

Query: 4   IGIIPPEIGNLKNLIKLDVGSNSL--IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAS 61
              +     N+  L+ L++ +N L  +  + S +    NL  L+LS N+L  +   +   
Sbjct: 54  AATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIK 113

Query: 62  MKYLTQLDLSNNNIQGSIPGE-------ITKLSRLDYLNLSSNKLSGPVPF 105
              L +L L  N++  +   +         +  +L  L+   ++L  P+ F
Sbjct: 114 GLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHELPPPIAF 162

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 45.3 bits (105), Expect = 9e-06
 Identities = 21/123 (17%), Positives = 37/123 (30%), Gaps = 4/123 (3%)

Query: 18  IKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGK----IPPEIASMKYLTQLDLSNN 73
           +KLD  +      + + L    ++  + LS N +  +    +   IAS K L   + S+ 
Sbjct: 10  LKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDI 69

Query: 74  NIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGNILDLP 133
                       L  L    L   KL       N    +    +    +       L L 
Sbjct: 70  FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLH 129

Query: 134 SCD 136
           +  
Sbjct: 130 NNG 132

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 41.4 bits (95), Expect = 1e-04
 Identities = 14/66 (21%), Positives = 23/66 (34%), Gaps = 11/66 (16%)

Query: 46  LSSNKLSGKIPPEIASM------KYLTQLDLSNNNIQGSIPGEI-----TKLSRLDYLNL 94
           L+   LS +    +           L  L L  N I+      +      K+  L +L L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309

Query: 95  SSNKLS 100
           + N+ S
Sbjct: 310 NGNRFS 315

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 41.0 bits (94), Expect = 2e-04
 Identities = 9/61 (14%), Positives = 20/61 (32%), Gaps = 6/61 (9%)

Query: 34  ALGSLTNLSNLDLSSNKLSGKIPPEIAS-----MKYLTQLDLSNNNIQGSIPGEITKLSR 88
           +      L  L L  N++       + +     M  L  L+L+ N         + ++  
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIRE 326

Query: 89  L 89
           +
Sbjct: 327 V 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.9 bits (91), Expect = 5e-04
 Identities = 7/74 (9%), Positives = 24/74 (32%), Gaps = 4/74 (5%)

Query: 7  IPPEIGNLKNLIKLDVGSNSL----IGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASM 62
          +   +    ++ ++ +  N++       +   + S  +L   + S             ++
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82

Query: 63 KYLTQLDLSNNNIQ 76
          + L Q  L    + 
Sbjct: 83 RLLLQALLKCPKLH 96

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.2 bits (103), Expect = 1e-05
 Identities = 17/91 (18%), Positives = 37/91 (40%), Gaps = 8/91 (8%)

Query: 21  DVGSNSLIGPIP----SALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQ 76
            +GS ++  P P     +  +       +L    ++  +      +  + Q+  +N++I+
Sbjct: 2   PLGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 59

Query: 77  GSIPGEITKLSRLDYLNLSSNKLSGPVPFSN 107
                 I  L  +  L L+ NKL+   P +N
Sbjct: 60  SVQG--IQYLPNVTKLFLNGNKLTDIKPLAN 88

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 2e-04
 Identities = 15/41 (36%), Positives = 20/41 (48%), Gaps = 2/41 (4%)

Query: 32  PSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSN 72
              L  LT L NL LS N +S      +A +K L  L+L +
Sbjct: 171 IVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 0.001
 Identities = 13/41 (31%), Positives = 18/41 (43%), Gaps = 2/41 (4%)

Query: 56  PPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSS 96
              +A +  L  L LS N+I   +   +  L  LD L L S
Sbjct: 171 IVPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.002
 Identities = 12/41 (29%), Positives = 16/41 (39%), Gaps = 2/41 (4%)

Query: 8   PPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSS 48
              +  L  L  L +  N +      AL  L NL  L+L S
Sbjct: 171 IVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.8 bits (96), Expect = 8e-05
 Identities = 9/58 (15%), Positives = 19/58 (32%), Gaps = 4/58 (6%)

Query: 1   MYKIGIIPPEI-GNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPP 57
              +  +P ++       + LD+    +       L +L  L      + K   K+P 
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.5 bits (90), Expect = 5e-04
 Identities = 6/43 (13%), Positives = 13/43 (30%)

Query: 31  IPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNN 73
                   +    LD+S  ++       + ++K L      N 
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (88), Expect = 7e-04
 Identities = 8/47 (17%), Positives = 17/47 (36%), Gaps = 1/47 (2%)

Query: 53  GKIPPEI-ASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNK 98
            ++P ++         LD+S   I       +  L +L   +  + K
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.2 bits (95), Expect = 1e-04
 Identities = 16/71 (22%), Positives = 28/71 (39%), Gaps = 4/71 (5%)

Query: 38  LTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSN 97
           L       L    ++  +      +  +T L      I+ SI G +  L+ L  +N S+N
Sbjct: 17  LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNN 72

Query: 98  KLSGPVPFSNN 108
           +L+   P  N 
Sbjct: 73  QLTDITPLKNL 83

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.2 bits (95), Expect = 1e-04
 Identities = 12/65 (18%), Positives = 25/65 (38%), Gaps = 4/65 (6%)

Query: 13 NLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSN 72
           L   +K  +G  ++   +      L  ++ L      +   I   +  +  LTQ++ SN
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 71

Query: 73 NNIQG 77
          N +  
Sbjct: 72 NQLTD 76

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (88), Expect = 5e-04
 Identities = 21/92 (22%), Positives = 36/92 (39%), Gaps = 3/92 (3%)

Query: 9   PEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQL 68
            +  N     +LD+     I  I +   +L     +D S N++  +       ++ L  L
Sbjct: 12  AQYTNAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTL 68

Query: 69  DLSNNNIQGSIPGEITKLSRLDYLNLSSNKLS 100
            ++NN I     G    L  L  L L++N L 
Sbjct: 69  LVNNNRICRIGEGLDQALPDLTELILTNNSLV 100

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.8 bits (86), Expect = 9e-04
 Identities = 22/123 (17%), Positives = 37/123 (30%), Gaps = 4/123 (3%)

Query: 9   PEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIAS-MKYLTQ 67
           P+         L    +  +      L    NL+ L + + +    +       +  L  
Sbjct: 2   PDACCPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60

Query: 68  LDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCG 127
           L +  + ++   P       RL  LNLS N L      +          + LS N   C 
Sbjct: 61  LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQ--GLSLQELVLSGNPLHCS 118

Query: 128 NIL 130
             L
Sbjct: 119 CAL 121

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (85), Expect = 0.001
 Identities = 23/121 (19%), Positives = 42/121 (34%), Gaps = 2/121 (1%)

Query: 7   IPPEIGNLKNLIKLDVGSNSLIGPIPS-ALGSLTNLSNLDLSSNKLSGKIPPEIASMKYL 65
               +   +NL +L + +   +  +    L  L  L NL +  + L    P        L
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82

Query: 66  TQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGL 125
           ++L+LS N ++ S+  +  +   L  L LS N L                +  +      
Sbjct: 83  SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQ 141

Query: 126 C 126
           C
Sbjct: 142 C 142

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	496
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.7
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.57
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.54
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.54
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.49
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.48
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.48
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.48
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.43
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.42
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.41
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.37
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.34
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.34
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.28
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.23
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.15
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.13
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.11
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.08
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.05
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.04
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.04
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.04
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.93
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.89
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.79
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.62
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.56
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.56
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.55
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.52
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.37
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.17
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	97.89
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	97.71
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	97.67
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	97.65
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	97.62
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.57
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	97.56
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.41
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.37
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.19
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.02
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.67
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.06
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	95.56

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-56  Score=417.30  Aligned_cols=261  Identities=25%  Similarity=0.358  Sum_probs=211.0

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|++.+.||+|+||+||+|.++ +|+.||||++......+..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            357999999999999999999764 6899999999765544445678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      ||++|+|.+++....   .+++.+++.++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+|+......
T Consensus        84 y~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          84 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            999999999997644   7899999999999999999999   7799999999999999999999999999998765432


Q ss_pred             --CCccccccccccccccccccCCc-CcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          363 --SNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       363 --~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                        ......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||....      .................... 
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~------~~~~~~~~~~~~~~~~~~~~-  230 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS------DSCQEYSDWKEKKTYLNPWK-  230 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS------TTSHHHHHHHTTCTTSTTGG-
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC------hHHHHHHHHhcCCCCCCccc-
Confidence              22345689999999999988876 578999999999999999999996322      11222222222222211111 


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                        .....+.+|+.+||+.||++|||++|+++|+|+.+..+
T Consensus       231 --~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l~  268 (271)
T d1nvra_         231 --KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  268 (271)
T ss_dssp             --GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             --cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence              11234678999999999999999999999999976543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-55  Score=416.14  Aligned_cols=259  Identities=24%  Similarity=0.370  Sum_probs=216.8

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      ++|++.+.||+|+||+||+|.+ .+|+.||||++...... ..+.+.+|++++++++|||||++++++.+++..++||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            4799999999999999999976 46999999998764422 246789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      |+||+|.+++.+.    .+++.++..++.||+.||+|||   ++||+||||||+|||++.++.+||+|||+|+.+.....
T Consensus        99 ~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~  171 (293)
T d1yhwa1          99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (293)
T ss_dssp             CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             cCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence            9999999988753    5899999999999999999999   77999999999999999999999999999998766555


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCC-CCCChhHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLP-PPVDRKVIR  442 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  442 (496)
                      .....+||+.|+|||++.+..++.++||||+||++|+|++|+.||....       .............+ .....   .
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-------~~~~~~~~~~~~~~~~~~~~---~  241 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-------PLRALYLIATNGTPELQNPE---K  241 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-------HHHHHHHHHHHCSCCCSSGG---G
T ss_pred             cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC-------HHHHHHHHHhCCCCCCCCcc---c
Confidence            5666789999999999999999999999999999999999999996322       11122222222111 11111   1


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCC
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLV  481 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~  481 (496)
                      ....+.+|+.+||+.||++|||++|+++|+|+....|..
T Consensus       242 ~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~~~~  280 (293)
T d1yhwa1         242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLS  280 (293)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCCCGG
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCCCCC
Confidence            123477899999999999999999999999997665544

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-55  Score=409.33  Aligned_cols=253  Identities=31%  Similarity=0.478  Sum_probs=213.0

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|+||+||+|.++ +++.||+|++....  +....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999775 68999999987543  2234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      |||++|+|.+++....   .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            9999999999998644   6899999999999999999999   779999999999999999999999999999866432


Q ss_pred             CCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                        ......||+.|+|||++.+..++.++||||+||++|||++|+.||....       .......+.......+..    
T Consensus       160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-------~~~~~~~i~~~~~~~p~~----  226 (263)
T d2j4za1         160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-------YQETYKRISRVEFTFPDF----  226 (263)
T ss_dssp             --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-------HHHHHHHHHTTCCCCCTT----
T ss_pred             --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC-------HHHHHHHHHcCCCCCCcc----
Confidence              3345679999999999999999999999999999999999999996321       222223333333222111    


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          442 RDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                       ....+.+|+.+||+.||++|||++|+++|+|+...
T Consensus       227 -~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         227 -VTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             -SCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             -CCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence             11246789999999999999999999999999754

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-55  Score=410.86  Aligned_cols=267  Identities=22%  Similarity=0.345  Sum_probs=218.2

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|+||+||+|.+ .+|+.||||++....  .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5799999999999999999976 468999999997543  2234467899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||++||+|.+++....   .+++..++.++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+|+.+...
T Consensus        88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccC
Confidence            9999999999887654   6899999999999999999999   779999999999999999999999999999877543


Q ss_pred             CC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          362 SS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       362 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                      ..  .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+       .......+.......+..  
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~~~~~~~i~~~~~~~p~~--  232 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-------EYLIFQKIIKLEYDFPEK--  232 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHTTCCCCCTT--
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC-------HHHHHHHHHcCCCCCCcc--
Confidence            32  2344679999999999999999999999999999999999999996321       222223333333222111  


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCcccccccchhhhc
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHAAIQDISISELR  495 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~~~~~i~~~~~~  495 (496)
                         ....+.+|+.+||+.||++|||++|++++.|..      .++.+++|.|++++
T Consensus       233 ---~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~------~Hpff~~i~w~~l~  279 (288)
T d1uu3a_         233 ---FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK------AHPFFESVTWENLH  279 (288)
T ss_dssp             ---CCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHH------TSGGGTTCCCTTGG
T ss_pred             ---CCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHH------cCCccCCCCHHHhh
Confidence               112467899999999999999999988887764      35677778887765

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-55  Score=409.81  Aligned_cols=259  Identities=26%  Similarity=0.414  Sum_probs=198.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeec--CCeEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH--KKCMFLI  280 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lV  280 (496)
                      ++|++.+.||+|+||+||+|.. .+|+.||+|.+.... .....+.+.+|++++++++|||||++++++.+  .+..++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5799999999999999999976 468999999987653 33445678999999999999999999999865  4568999


Q ss_pred             EEecCCCChhhhhhCCC-CCccCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          281 YEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDC--SPSIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      ||||++|+|.+++.+.. ....+++..++.++.||+.||+|||+..  ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            99999999999986432 2236899999999999999999999531  13499999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          358 LHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       358 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                      ...........+||+.|+|||++.+..++.++|||||||++|||+||+.||...+       .......+.....+....
T Consensus       164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~-------~~~~~~~i~~~~~~~~~~  236 (269)
T d2java1         164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-------QKELAGKIREGKFRRIPY  236 (269)
T ss_dssp             C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHTCCCCCCT
T ss_pred             cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC-------HHHHHHHHHcCCCCCCCc
Confidence            7655544556789999999999999999999999999999999999999996322       122222333333222111


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      .    ....+.+|+.+||+.||++|||++|+++|+|.
T Consensus       237 ~----~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         237 R----YSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             T----SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             c----cCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            1    11247789999999999999999999999984

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-55  Score=412.36  Aligned_cols=258  Identities=26%  Similarity=0.353  Sum_probs=211.3

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      +.|++.+.||+|+||+||+|.++ +++.||||++..... ...+.+.+|++++++++|||||++++++.+++..++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS-GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            46889999999999999999764 689999999876432 2346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      |++|+|.+++....  ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.......
T Consensus        91 ~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~  165 (288)
T d2jfla1          91 CAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  165 (288)
T ss_dssp             CTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred             CCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence            99999999876532  25899999999999999999999   77999999999999999999999999999976644333


Q ss_pred             Cccccccccccccccccc-----cCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCCh
Q 011005          364 NRTLLAGTYGYIAPELAY-----TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR  438 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  438 (496)
                      .....+||+.|+|||++.     +..|+.++||||+||++|||++|+.||....       .......+.....+.... 
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~-------~~~~~~~i~~~~~~~~~~-  237 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN-------PMRVLLKIAKSEPPTLAQ-  237 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC-------GGGHHHHHHHSCCCCCSS-
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC-------HHHHHHHHHcCCCCCCCc-
Confidence            334568999999999984     4568899999999999999999999996322       222333333333222111 


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          439 KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       439 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                       .......+.+|+.+||+.||++|||++|+++|+|+...
T Consensus       238 -~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         238 -PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             -GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             -cccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence             11122357799999999999999999999999999643

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=417.42  Aligned_cols=265  Identities=26%  Similarity=0.379  Sum_probs=210.8

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|++.+.||+|+||+||+|.+ .+|+.||+|+++..........+.+|+.++++++|||||+++++|.+++..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            46899999999999999999976 47899999999765444455778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |++||+|.+++.+..   .+++..+..++.|++.||.|||+  .++|+||||||+|||++.++.+||+|||+|+......
T Consensus        85 y~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  159 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  159 (322)
T ss_dssp             CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred             cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence            999999999998654   68999999999999999999994  2489999999999999999999999999998764332


Q ss_pred             CCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccC----------CCC--------------
Q 011005          363 SNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS----------SSS--------------  418 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~----------~~~--------------  418 (496)
                        ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.......          ...              
T Consensus       160 --~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (322)
T d1s9ja_         160 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  237 (322)
T ss_dssp             --C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred             --cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence              334689999999999999999999999999999999999999996422100          000              


Q ss_pred             -------CCcc---hhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          419 -------DPKI---MLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       419 -------~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                             .+..   ..........++.....  .....+.+|+.+||+.||++|||++|+++|+|+.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSG--VFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             --------CCCCHHHHHHHHHTSCCCCCCBT--TBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cccccccccchhHHHHHhhhhccCCccCccc--cCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence                   0000   00000001111111000  011247789999999999999999999999999764

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.2e-54  Score=410.52  Aligned_cols=262  Identities=23%  Similarity=0.303  Sum_probs=198.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .+.|++.+.||+|+||+||+|.++ +++.||||.+.........+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            467999999999999999999765 6899999999765543444668899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEec---CCCCeEEcccccccccc
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN---SKLEAFVADFGTARLLH  359 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~  359 (496)
                      ||+||+|.+++....   .+++..+..++.||+.||+|||   +++|+||||||+||++.   +++.+||+|||+|+...
T Consensus        88 ~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          88 LVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             ccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            999999999998654   6899999999999999999999   77999999999999995   57899999999998664


Q ss_pred             CCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChh
Q 011005          360 ADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRK  439 (496)
Q Consensus       360 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (496)
                      .. ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||....       .......+.......+... 
T Consensus       162 ~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~-  232 (307)
T d1a06a_         162 PG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN-------DAKLFEQILKAEYEFDSPY-  232 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHTTCCCCCTTT-
T ss_pred             CC-CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC-------HHHHHHHHhccCCCCCCcc-
Confidence            33 23345679999999999999999999999999999999999999996321       1222233333322211110 


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          440 VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       440 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      .......+.+|+.+||+.||++|||++|+++|+|+......
T Consensus       233 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~  273 (307)
T d1a06a_         233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTAL  273 (307)
T ss_dssp             TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCCC
T ss_pred             ccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCcc
Confidence            11112347799999999999999999999999999865443

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=398.42  Aligned_cols=249  Identities=25%  Similarity=0.401  Sum_probs=200.7

Q ss_pred             CCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeec----CCeEEEEE
Q 011005          208 DIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH----KKCMFLIY  281 (496)
Q Consensus       208 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lV~  281 (496)
                      .+.+.||+|+||+||+|.++ +++.||+|++.... .....+.+.+|++++++++|||||++++++..    +..+++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45678999999999999765 68899999987643 33445678999999999999999999999865    35689999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEeCCCCCceEec-CCCCeEEccccccccc
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS--IIHRDISSNNILLN-SKLEAFVADFGTARLL  358 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~  358 (496)
                      ||+++|+|.+++.+..   .+++..++.++.||+.||+|||   +++  |+||||||+|||++ +++.+||+|||+|+..
T Consensus        92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             eCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            9999999999997654   6899999999999999999999   556  99999999999996 5789999999999864


Q ss_pred             cCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCC-CCCCC
Q 011005          359 HADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRL-PPPVD  437 (496)
Q Consensus       359 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  437 (496)
                      ..  ......+||+.|+|||++.+ .++.++||||+||++|||++|+.||....       ........+.... +....
T Consensus       166 ~~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-------~~~~~~~~i~~~~~~~~~~  235 (270)
T d1t4ha_         166 RA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQIYRRVTSGVKPASFD  235 (270)
T ss_dssp             CT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHHHHHHHTTTCCCGGGG
T ss_pred             cC--CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc-------cHHHHHHHHHcCCCCcccC
Confidence            32  23445689999999999876 59999999999999999999999996321       1122222222222 21111


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                      .   .....+.+|+.+||+.||++|||++|+++|+|++
T Consensus       236 ~---~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         236 K---VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             G---CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             c---cCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            1   1122477999999999999999999999999974

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-54  Score=401.39  Aligned_cols=259  Identities=27%  Similarity=0.458  Sum_probs=203.3

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|++.+.||+|+||+||+|.+++  .||||+++... +....+.+.+|+.++++++|||||++++++.. +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            3679999999999999999998743  59999997542 33456789999999999999999999998765 45789999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      ||++|+|.+++.....  .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+......
T Consensus        84 y~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            9999999999976432  6899999999999999999999   6799999999999999999999999999998765432


Q ss_pred             C--Ccccccccccccccccccc---CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhh-cCCCCCCC
Q 011005          363 S--NRTLLAGTYGYIAPELAYT---MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVL-DQRLPPPV  436 (496)
Q Consensus       363 ~--~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  436 (496)
                      .  ......||+.|+|||++.+   ..|+.++|||||||++|||+||+.||....       ......... .....+..
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~-------~~~~~~~~~~~~~~~p~~  231 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-------NRDQIIFMVGRGYLSPDL  231 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-------CHHHHHHHHHHTSCCCCG
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC-------hHHHHHHHHhcCCCCCcc
Confidence            2  2344679999999999864   357899999999999999999999996322       111222222 22222211


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      .......+..+.+|+.+||+.||++|||++|+++++....+
T Consensus       232 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            11111223357899999999999999999999999887654

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.7e-54  Score=407.23  Aligned_cols=257  Identities=26%  Similarity=0.365  Sum_probs=212.4

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      +.|+..+.||+|+||+||+|.+ .+++.||||++....  .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            4589999999999999999975 478899999987543  3344567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      |||.+|++..++....   .+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||+|+.... 
T Consensus        95 E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             ECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            9999999987665443   6899999999999999999999   77999999999999999999999999999986543 


Q ss_pred             CCCcccccccccccccccccc---CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCCh
Q 011005          362 SSNRTLLAGTYGYIAPELAYT---MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDR  438 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  438 (496)
                         ....+||+.|+|||++.+   ..|+.++|||||||++|||++|+.||...       ..............+.....
T Consensus       168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~-------~~~~~~~~i~~~~~~~~~~~  237 (309)
T d1u5ra_         168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-------NAMSALYHIAQNESPALQSG  237 (309)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-------CHHHHHHHHHHSCCCCCSCT
T ss_pred             ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC-------CHHHHHHHHHhCCCCCCCCC
Confidence               234579999999999864   45899999999999999999999998632       12222333333333322222


Q ss_pred             hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCC
Q 011005          439 KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLV  481 (496)
Q Consensus       439 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~  481 (496)
                      ..   ...+.+|+.+||+.||++|||++|+++|+|+.+..+..
T Consensus       238 ~~---s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~~  277 (309)
T d1u5ra_         238 HW---SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT  277 (309)
T ss_dssp             TS---CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTT
T ss_pred             CC---CHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCCch
Confidence            11   22477999999999999999999999999998876553

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-53  Score=396.41  Aligned_cols=254  Identities=24%  Similarity=0.368  Sum_probs=198.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      ++|++.+.||+|+||+||+|.+++++.||||+++.....  .+.+.+|++++++++|||||+++|++..++..++||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc--HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            468889999999999999999988999999999765432  367899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      ++|+|.+++....  ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++........
T Consensus        83 ~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          83 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             TTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             CCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence            9999999987643  26889999999999999999999   779999999999999999999999999999877544322


Q ss_pred             -ccccccccccccccccccCCcCcccchhhHHHHHHHHHhC-CCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          365 -RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG-KHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       365 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                       .....||+.|+|||++.+..++.++|||||||++|||+|+ ++|+..       .........+....... ....   
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~-------~~~~~~~~~i~~~~~~~-~p~~---  226 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-------RSNSEVVEDISTGFRLY-KPRL---  226 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-------CCHHHHHHHHHHTCCCC-CCTT---
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC-------CCHHHHHHHHHhcCCCC-Cccc---
Confidence             2335689999999999999999999999999999999995 555432       11112222222221111 1111   


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      ....+.+++.+||+.||++|||++|+++++....
T Consensus       227 ~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence            1234779999999999999999999999987543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.4e-53  Score=401.07  Aligned_cols=254  Identities=28%  Similarity=0.447  Sum_probs=197.3

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCC-C---cEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPN-G---KVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      ++|++.+.||+|+||+||+|.++. +   ..||||.+.........+.+.+|++++++++|||||++++++..++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            456677899999999999998752 2   368999987765555667899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      ||||++|+|.+++....  ..+++.+++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus       106 ~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            99999999999887643  26899999999999999999999   67999999999999999999999999999987754


Q ss_pred             CCCC-----ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcC-CCC
Q 011005          361 DSSN-----RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQ-RLP  433 (496)
Q Consensus       361 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~  433 (496)
                      ....     .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||....       .......+... +++
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~-------~~~~~~~i~~~~~~~  253 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT-------NQDVINAIEQDYRLP  253 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHTTCCCC
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC-------HHHHHHHHHcCCCCC
Confidence            3322     112457899999999999999999999999999999998 899986322       11122222222 222


Q ss_pred             CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          434 PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       434 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                      .+..     ....+.+|+.+||+.||++|||+.|+++.+...
T Consensus       254 ~~~~-----~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         254 PPMD-----CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             CCTT-----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCcc-----chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            2211     223477899999999999999999999998644

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.3e-52  Score=406.07  Aligned_cols=260  Identities=23%  Similarity=0.304  Sum_probs=214.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||++..... ...+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            36899999999999999999976 4799999999976543 234678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC--CCCeEEccccccccccC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS--KLEAFVADFGTARLLHA  360 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~  360 (496)
                      ||+||+|.+++....  ..+++..+..++.||+.||.|||   +++|+||||||+|||++.  ++.+||+|||+++....
T Consensus       104 ~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         104 FMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             cCCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            999999999986543  26899999999999999999999   779999999999999964  57899999999987754


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      . .......||+.|+|||++.+..++.++||||+||++|+|++|+.||...       ........+.......+.. ..
T Consensus       179 ~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-------~~~~~~~~i~~~~~~~~~~-~~  249 (350)
T d1koaa2         179 K-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-------NDDETLRNVKSCDWNMDDS-AF  249 (350)
T ss_dssp             T-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHTCCCSCCG-GG
T ss_pred             c-cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC-------CHHHHHHHHHhCCCCCCcc-cc
Confidence            3 3344568999999999999999999999999999999999999999632       1222233333333222111 11


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ......+.+|+.+||+.||++|||++|+++|+|+....
T Consensus       250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         250 SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            11123467899999999999999999999999997543

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=388.95  Aligned_cols=251  Identities=24%  Similarity=0.398  Sum_probs=209.3

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      ++|++.+.||+|+||+||+|.+++++.||||+++.....  .+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~--~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC--HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC--HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            579999999999999999999988999999999865432  257899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      ++|+|.+++....  ..+++..+++++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++........
T Consensus        82 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          82 ANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             TTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             CCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence            9999999877543  26889999999999999999999   679999999999999999999999999999876544332


Q ss_pred             -ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          365 -RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       365 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                       .....||+.|+|||.+.+..++.++||||||+++|||+| |+.||+...       .......+.... ..+...   .
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~-------~~~~~~~i~~~~-~~~~p~---~  225 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-------NSETAEHIAQGL-RLYRPH---L  225 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-------HHHHHHHHHTTC-CCCCCT---T
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC-------HHHHHHHHHhCC-CCCCcc---c
Confidence             334668999999999999999999999999999999998 899987332       122222222221 111111   1


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      ....+.+|+.+||+.||++|||++|+++|+.
T Consensus       226 ~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  256 (258)
T d1k2pa_         226 ASEKVYTIMYSCWHEKADERPTFKILLSNIL  256 (258)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             ccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence            1235789999999999999999999999974

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=397.98  Aligned_cols=259  Identities=25%  Similarity=0.312  Sum_probs=212.5

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-----hHHHHHHHHHHHHHHHhhcccccccccceeecCCeE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-----ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCM  277 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  277 (496)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||++....     .....+.+.+|++++++++|||||++++++.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            46799999999999999999976 479999999986532     112346789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC----CeEEcccc
Q 011005          278 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL----EAFVADFG  353 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~----~~kl~Dfg  353 (496)
                      ++|||||++|+|.+++....   .+++..++.++.||+.||+|||   +.+|+||||||+||+++.++    .+|++|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchh
Confidence            99999999999999997654   6899999999999999999999   77999999999999998776    49999999


Q ss_pred             ccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCC
Q 011005          354 TARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLP  433 (496)
Q Consensus       354 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  433 (496)
                      +++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||....       .......+......
T Consensus       163 ~a~~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~~~~~~~i~~~~~~  234 (293)
T d1jksa_         163 LAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-------KQETLANVSAVNYE  234 (293)
T ss_dssp             TCEECTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHTTCCC
T ss_pred             hhhhcCCC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC-------HHHHHHHHHhcCCC
Confidence            99877543 23345678999999999999999999999999999999999999996321       22222222222222


Q ss_pred             CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          434 PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       434 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      .+ ..........+.+|+.+||+.||++|||++|+++|+|+...
T Consensus       235 ~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         235 FE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             CC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             CC-chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            11 11111223357799999999999999999999999999654

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.2e-52  Score=404.82  Aligned_cols=260  Identities=23%  Similarity=0.297  Sum_probs=213.9

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||++...... ....+.+|+.++++++|||||++++++.+++..++|||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            35799999999999999999976 47999999998765432 34678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEec--CCCCeEEccccccccccC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN--SKLEAFVADFGTARLLHA  360 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~--~~~~~kl~Dfg~~~~~~~  360 (496)
                      ||+||+|.+.+....  ..+++.+++.|+.||+.||+|||   ++||+||||||+|||++  .++.+||+|||+|+.+..
T Consensus       107 ~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         107 FLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             CCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             cCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence            999999998876543  26899999999999999999999   77999999999999998  578999999999988754


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      . .......||+.|+|||++.+..++.++||||+||++|+|++|+.||....       .......+.......+... .
T Consensus       182 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~-~  252 (352)
T d1koba_         182 D-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-------DLETLQNVKRCDWEFDEDA-F  252 (352)
T ss_dssp             T-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-------HHHHHHHHHHCCCCCCSST-T
T ss_pred             C-CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCCCCccc-c
Confidence            3 23445679999999999999999999999999999999999999996321       1222233333322211110 1


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ......+.+|+.+||+.||++|||++|+++|+|+....
T Consensus       253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            11123467999999999999999999999999997643

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=402.04  Aligned_cols=254  Identities=22%  Similarity=0.311  Sum_probs=215.6

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|+||+||+|.. .+|+.||+|++....  .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5799999999999999999976 479999999997643  2234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      |||+||+|.+++....   .+++..++.++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.....
T Consensus        85 ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            9999999999998754   6899999999999999999999   779999999999999999999999999999877655


Q ss_pred             CCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                      .......+||+.|+|||++.+..|+.++||||+||++|||++|++||...+       ............+..+..    
T Consensus       159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~-------~~~~~~~i~~~~~~~p~~----  227 (337)
T d1o6la_         159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-------HERLFELILMEEIRFPRT----  227 (337)
T ss_dssp             TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCCCCTT----
T ss_pred             CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC-------HHHHHHHHhcCCCCCCcc----
Confidence            555666789999999999999999999999999999999999999996322       222233333333322211    


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHHHHhc
Q 011005          442 RDILLISTVSFACLQSNPKSRPT-----MQSVSQEFLITR  476 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~~~~~~  476 (496)
                       ....+.+|+.+||++||++||+     ++|+++|+|+..
T Consensus       228 -~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         228 -LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             -SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             -CCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence             1124678999999999999994     899999999854

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.9e-52  Score=396.99  Aligned_cols=251  Identities=27%  Similarity=0.388  Sum_probs=211.6

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|+||+||+|.+ .+|+.||||+++...  .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5799999999999999999986 469999999997543  2234567899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      |||+||++..++....   .++...+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            9999999999888655   6788899999999999999999   889999999999999999999999999999876432


Q ss_pred             CCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                         ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...       ........+.......+..    
T Consensus       158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~-------~~~~~~~~i~~~~~~~p~~----  223 (316)
T d1fota_         158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-------NTMKTYEKILNAELRFPPF----  223 (316)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-------SHHHHHHHHHHCCCCCCTT----
T ss_pred             ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc-------CHHHHHHHHHcCCCCCCCC----
Confidence               34568999999999999999999999999999999999999999632       2222333333333322211    


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHhc
Q 011005          442 RDILLISTVSFACLQSNPKSRP-----TMQSVSQEFLITR  476 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~~~~~~  476 (496)
                       ....+.+++.+||+.||.+|+     |++|+++|+|+..
T Consensus       224 -~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~  262 (316)
T d1fota_         224 -FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  262 (316)
T ss_dssp             -SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             -CCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence             112467899999999999996     9999999999854

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=401.63  Aligned_cols=256  Identities=23%  Similarity=0.379  Sum_probs=206.0

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCC------CcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCCeE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCM  277 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  277 (496)
                      ++|++.+.||+|+||+||+|.+..      ...||+|.+...........+.+|+.+++++ +|||||++++++.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            678999999999999999997642      2369999987765555557789999999999 899999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCCCC--------------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCC
Q 011005          278 FLIYEYMERGSLFCNLHNNED--------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSN  337 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~  337 (496)
                      ++|||||++|+|.+++.....                    ...+++..++.++.||+.||+|||   +++|+||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchh
Confidence            999999999999999976432                    134899999999999999999999   779999999999


Q ss_pred             ceEecCCCCeEEccccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCcccccc
Q 011005          338 NILLNSKLEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSL  414 (496)
Q Consensus       338 Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~  414 (496)
                      ||+++.++.+||+|||+|+........  .....||+.|+|||++.+..++.++|||||||++|||+| |+.||....  
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~--  271 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP--  271 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC--
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC--
Confidence            999999999999999999876554432  234568999999999999999999999999999999998 899996322  


Q ss_pred             CCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          415 SSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       415 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                           ........+......+.....   ...+.+|+.+||+.||++|||++||++++-
T Consensus       272 -----~~~~~~~~~~~~~~~~~p~~~---~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         272 -----VDANFYKLIQNGFKMDQPFYA---TEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             -----CSHHHHHHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -----HHHHHHHHHhcCCCCCCCCcC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence                 222333333333222221111   235789999999999999999999999974

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-52  Score=392.64  Aligned_cols=251  Identities=25%  Similarity=0.380  Sum_probs=201.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      .++|++.+.||+|+||+||+|.+++++.||||+++.....  .+.+.+|++++++++|||||++++++.+ +..++||||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC--HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            3578889999999999999999988899999999765432  3678999999999999999999998865 456899999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++|+|.+++.... ...+++..++.|+.||+.||.|||   +++|+||||||+|||+++++.+||+|||+|+.......
T Consensus        89 ~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~  164 (272)
T d1qpca_          89 MENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (272)
T ss_dssp             CTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             CCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence            99999998876542 235899999999999999999999   67999999999999999999999999999987754322


Q ss_pred             -CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          364 -NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       364 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                       ......||+.|+|||++.+..++.++|||||||++|||+||..|+...      .... .....+...........   
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~------~~~~-~~~~~i~~~~~~~~p~~---  234 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG------MTNP-EVIQNLERGYRMVRPDN---  234 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT------CCHH-HHHHHHHTTCCCCCCTT---
T ss_pred             ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC------CCHH-HHHHHHHhcCCCCCccc---
Confidence             233456899999999999999999999999999999999966554311      1111 12222222221111111   


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQE  471 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~  471 (496)
                      ....+.+|+.+||+.||++|||++|+++.
T Consensus       235 ~~~~l~~li~~cl~~~P~~Rpt~~ei~~~  263 (272)
T d1qpca_         235 CPEELYQLMRLCWKERPEDRPTFDYLRSV  263 (272)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ChHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            12247789999999999999999999884

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-52  Score=396.38  Aligned_cols=256  Identities=25%  Similarity=0.372  Sum_probs=208.9

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|++.+.||+|+||+||+|.++ +++.||||+++....  ..+.+.+|+.++++++|||||++++++.+++..++|||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc--hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            357888999999999999999775 588999999976543  23678999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      ||++|+|.+++..... ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+......
T Consensus        94 ~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          94 FMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             CCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             cccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            9999999999876432 36899999999999999999999   6799999999999999999999999999998775443


Q ss_pred             CC-ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          363 SN-RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       363 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                      .. .....|++.|+|||++.+..++.++|||||||++|||++|..|+...       .......+.+......+..... 
T Consensus       170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~-------~~~~~~~~~i~~~~~~~~~~~~-  241 (287)
T d1opja_         170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-------IDLSQVYELLEKDYRMERPEGC-  241 (287)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT-------CCHHHHHHHHHTTCCCCCCTTC-
T ss_pred             ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc-------chHHHHHHHHhcCCCCCCCccc-
Confidence            32 23345788999999999999999999999999999999977775321       1112222333333222222211 


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          442 RDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                        ...+.+|+.+||+.||++|||++|+++.+...
T Consensus       242 --~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         242 --PEKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             --CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             --hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence              23478999999999999999999999887544

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=388.61  Aligned_cols=250  Identities=24%  Similarity=0.352  Sum_probs=201.3

Q ss_pred             hCCCCcce-eeecCCeeEEEEEeC---CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEE
Q 011005          205 EDFDIRYC-IGTGGYGSVYKAQLP---NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       205 ~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      ++|.+.+. ||+|+||+||+|.++   ++..||||+++........+.+.+|++++++++|||||++++++..+ ..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEE
Confidence            45666664 999999999999764   35579999998765555667899999999999999999999998754 57899


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+++|+|.+++....  ..+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus        87 mE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence            99999999999886543  26899999999999999999999   77999999999999999999999999999987754


Q ss_pred             CCCC---ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCC
Q 011005          361 DSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV  436 (496)
Q Consensus       361 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  436 (496)
                      ....   .....||+.|+|||++.+..++.++|||||||++|||+| |+.||....       .......+.....+. .
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~-------~~~~~~~i~~~~~~~-~  233 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-------GPEVMAFIEQGKRME-C  233 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-------THHHHHHHHTTCCCC-C
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC-------HHHHHHHHHcCCCCC-C
Confidence            3322   233568899999999999999999999999999999998 999996322       111222222222111 1


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQE  471 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~  471 (496)
                      ...   .+..+.+|+.+||+.||++|||+.++++.
T Consensus       234 p~~---~~~~l~~li~~cl~~~p~~RPs~~~i~~~  265 (285)
T d1u59a_         234 PPE---CPPELYALMSDCWIYKWEDRPDFLTVEQR  265 (285)
T ss_dssp             CTT---CCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCc---CCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            111   12357799999999999999999999554

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=395.62  Aligned_cols=265  Identities=23%  Similarity=0.288  Sum_probs=217.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      .++|++.+.||+|+||+||+|.++ +++.||||.++.....  ...+.+|++++++++|||||++++++.+++.+|+|||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~--~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH--HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc--HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            468999999999999999999765 6889999999875533  2567899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCC--CCeEEccccccccccC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK--LEAFVADFGTARLLHA  360 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~--~~~kl~Dfg~~~~~~~  360 (496)
                      ||+||+|.+++....  ..+++.+++.++.||+.||+|||   +.||+||||||+|||++.+  ..+||+|||+++....
T Consensus        82 ~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          82 FISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             cCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            999999999997643  26899999999999999999999   7799999999999999854  5799999999987643


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      . .......+|+.|+|||.+.+..++.++||||+||++|+|++|+.||...       ........+.......+. ...
T Consensus       157 ~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~-------~~~~~~~~i~~~~~~~~~-~~~  227 (321)
T d1tkia_         157 G-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE-------TNQQIIENIMNAEYTFDE-EAF  227 (321)
T ss_dssp             T-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS-------SHHHHHHHHHHTCCCCCH-HHH
T ss_pred             C-CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHhCCCCCCh-hhc
Confidence            2 2344567899999999999999999999999999999999999999632       222233334443333221 111


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCCCCcc
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPLVKHA  484 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~~~~~  484 (496)
                      ......+.+|+.+||..||++|||++|+++|+|+.+..+.....
T Consensus       228 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~~~~~~  271 (321)
T d1tkia_         228 KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTK  271 (321)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGGSCCC
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCccccChh
Confidence            11223478999999999999999999999999998765444433

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=388.65  Aligned_cols=259  Identities=27%  Similarity=0.363  Sum_probs=201.4

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCC-----cEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNG-----KVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      +.|++.+.||+|+||+||+|.+++.     ..||||++...........+.+|+.++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4688889999999999999976532     47999999776555555678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||||+.+|++.+.+....  ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        87 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            999999999998876543  26899999999999999999999   7799999999999999999999999999998765


Q ss_pred             CCCCC---ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCC
Q 011005          360 ADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPV  436 (496)
Q Consensus       360 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  436 (496)
                      .....   .....||+.|+|||++.+..++.++|||||||++|||++|..|+...      . ........+......+.
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~------~-~~~~~~~~i~~~~~~~~  234 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE------L-SNHEVMKAINDGFRLPT  234 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT------C-CHHHHHHHHHTTCCCCC
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc------C-CHHHHHHHHhccCCCCC
Confidence            43222   22346899999999999999999999999999999999976664311      1 11122222333222222


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ...   .+..+.+|+.+||+.||++|||+.|+++.+....+.
T Consensus       235 ~~~---~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         235 PMD---CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             CTT---CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             chh---hHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            221   223478999999999999999999999988654443

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.5e-51  Score=386.06  Aligned_cols=258  Identities=22%  Similarity=0.329  Sum_probs=211.6

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch--------hHHHHHHHHHHHHHHHhhc-ccccccccceeecC
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--------ELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHK  274 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~  274 (496)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++....        .....+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6899999999999999999976 579999999986532        1223456889999999997 99999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccc
Q 011005          275 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGT  354 (496)
Q Consensus       275 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  354 (496)
                      +..++|||||++|+|.+++....   .+++..++.++.||+.||+|||   .++|+||||||+||+++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchh
Confidence            99999999999999999997644   6899999999999999999999   67999999999999999999999999999


Q ss_pred             cccccCCCCCcccccccccccccccccc------CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhh
Q 011005          355 ARLLHADSSNRTLLAGTYGYIAPELAYT------MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVL  428 (496)
Q Consensus       355 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  428 (496)
                      ++...... .....+||+.|+|||.+.+      ..++.++||||+||++|||++|+.||...       ........+.
T Consensus       157 a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~-------~~~~~~~~i~  228 (277)
T d1phka_         157 SCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-------KQMLMLRMIM  228 (277)
T ss_dssp             CEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHH
T ss_pred             eeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC-------CHHHHHHHHH
Confidence            98875433 3445689999999999864      34678999999999999999999999632       1222223333


Q ss_pred             cCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          429 DQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ......+... .......+.+|+.+||+.||++|||++|+++|+|+.+.
T Consensus       229 ~~~~~~~~~~-~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         229 SGNYQFGSPE-WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             HTCCCCCTTT-GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             hCCCCCCCcc-cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            3332211111 11222357799999999999999999999999998653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-51  Score=383.36  Aligned_cols=242  Identities=25%  Similarity=0.367  Sum_probs=192.7

Q ss_pred             ceeeecCCeeEEEEEeC---CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEecCC
Q 011005          211 YCIGTGGYGSVYKAQLP---NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYMER  286 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~  286 (496)
                      +.||+|+||+||+|.++   .++.||||+++... +....+.+.+|++++++++|||||++++++..+ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            46999999999999754   35689999997543 334457799999999999999999999998654 57899999999


Q ss_pred             CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC--
Q 011005          287 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN--  364 (496)
Q Consensus       287 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--  364 (496)
                      |+|.+++....   .+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++........  
T Consensus        92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            99999998654   6899999999999999999999   679999999999999999999999999999876544322  


Q ss_pred             -ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          365 -RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       365 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                       .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||....       .. .....+......+....   
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-------~~-~~~~~i~~~~~~~~p~~---  234 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GS-EVTAMLEKGERMGCPAG---  234 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HH-HHHHHHHTTCCCCCCTT---
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC-------HH-HHHHHHHcCCCCCCCcc---
Confidence             223568999999999999999999999999999999998 899996322       11 22222222111111111   


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQ  470 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~  470 (496)
                      .+..+.+|+.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~li~~cl~~dp~~RPs~~~i~~  262 (277)
T d1xbba_         235 CPREMYDLMNLCWTYDVENRPGFAAVEL  262 (277)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             cCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            1235778999999999999999999954

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-51  Score=391.77  Aligned_cols=262  Identities=23%  Similarity=0.336  Sum_probs=206.5

Q ss_pred             HhCCCCcc-eeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeec----CCe
Q 011005          204 TEDFDIRY-CIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLH----KKC  276 (496)
Q Consensus       204 ~~~~~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~  276 (496)
                      .++|.+.. .||+|+||+||+|.+ .+++.||||+++..      ..+.+|+.++.++ +|||||++++++.+    ...
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            36788875 599999999999976 57899999998653      3467899987666 79999999999865    457


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC---CCCeEEcccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KLEAFVADFG  353 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg  353 (496)
                      +++|||||+||+|.+++..... ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.   .+.+||+|||
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccc
Confidence            8999999999999999986432 36899999999999999999999   779999999999999986   4679999999


Q ss_pred             ccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCC
Q 011005          354 TARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLP  433 (496)
Q Consensus       354 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  433 (496)
                      +|+...... .....+||+.|+|||++.+..|+.++||||+||++|+|+||+.||........   ..............
T Consensus       160 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~~i~~~~~~  235 (335)
T d2ozaa1         160 FAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMGQYE  235 (335)
T ss_dssp             TCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSSS
T ss_pred             eeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHHHHHhcCCCC
Confidence            998775433 34456899999999999999999999999999999999999999974332110   00011111111111


Q ss_pred             CCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          434 PPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       434 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                      .+. .........+.+|+.+||+.||++|||+.|+++|+|+......
T Consensus       236 ~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~  281 (335)
T d2ozaa1         236 FPN-PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV  281 (335)
T ss_dssp             CCT-THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSS
T ss_pred             CCC-cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCC
Confidence            111 1122233457899999999999999999999999999766544

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.1e-51  Score=394.71  Aligned_cols=251  Identities=22%  Similarity=0.319  Sum_probs=212.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~  281 (496)
                      ++|++.+.||+|+||+||+|.++ +|+.||||++....  .....+.+.+|+++++.++||||+++++++......++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999764 79999999987543  2234467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCC
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHAD  361 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  361 (496)
                      ||+.+|+|..++....   .+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus       121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            9999999999987654   6899999999999999999999   779999999999999999999999999999877432


Q ss_pred             CCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHH
Q 011005          362 SSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVI  441 (496)
Q Consensus       362 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  441 (496)
                         .....||+.|||||++.+..++.++||||+||++|||+||+.||...       ........+.......+..    
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~-------~~~~~~~~i~~~~~~~p~~----  260 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-------QPIQIYEKIVSGKVRFPSH----  260 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHCCCCCCTT----
T ss_pred             ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc-------CHHHHHHHHhcCCCCCCcc----
Confidence               33567999999999999999999999999999999999999999632       2222333333333332211    


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHhc
Q 011005          442 RDILLISTVSFACLQSNPKSRP-----TMQSVSQEFLITR  476 (496)
Q Consensus       442 ~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~~~~~~  476 (496)
                       ....+.+++.+||+.||.+|+     |++|+++|+|+..
T Consensus       261 -~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~  299 (350)
T d1rdqe_         261 -FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             -CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             -CCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence             112467899999999999994     9999999999854

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-51  Score=391.98  Aligned_cols=254  Identities=24%  Similarity=0.369  Sum_probs=210.9

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch--hHHHHHHHHHHHHHHH-hhcccccccccceeecCCeEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--ELAFIKSFKNEAQVLS-QVLHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lV  280 (496)
                      ++|++.+.||+|+||+||+|.++ +++.||||+++...  .....+.+.+|..++. .++|||||++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999765 68999999997543  2223455667777665 57999999999999999999999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccC
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHA  360 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  360 (496)
                      |||+++|+|.+++....   .+++..+..++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccc
Confidence            99999999999998654   6899999999999999999999   67999999999999999999999999999987765


Q ss_pred             CCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          361 DSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       361 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                      .........||+.|+|||++.+..++.++||||+||++|||++|+.||...       ........+.......+..   
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~-------~~~~~~~~i~~~~~~~p~~---  225 (320)
T d1xjda_         156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-------DEEELFHSIRMDNPFYPRW---  225 (320)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHCCCCCCTT---
T ss_pred             ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC-------CHHHHHHHHHcCCCCCCcc---
Confidence            555566678999999999999999999999999999999999999999632       1222223333333222111   


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHH-HHHHHHHHhc
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQ-SVSQEFLITR  476 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~-evl~~~~~~~  476 (496)
                        ....+.+|+.+||+.||++|||+. |+++|+|+..
T Consensus       226 --~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         226 --LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             --SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             --CCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence              122477999999999999999995 8999999854

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-51  Score=388.42  Aligned_cols=263  Identities=23%  Similarity=0.254  Sum_probs=200.5

Q ss_pred             cceeeecCCeeEEEEEeC-CCcEEEEEEcccchhH----HHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          210 RYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEEL----AFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       210 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      ++.||+|+||+||+|.++ +|+.||||+++.....    ...+.+.+|+.++++++|||||++++++..++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            578999999999999864 6899999999754321    12346889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      .++++..+.....   .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++........
T Consensus        83 ~~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          83 ETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             SEEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             cchHHhhhhhccc---CCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            9987776665433   6888999999999999999999   779999999999999999999999999999887665555


Q ss_pred             ccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccC----------C---CCCCcc-hh-Hhhh
Q 011005          365 RTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS----------S---SSDPKI-ML-IDVL  428 (496)
Q Consensus       365 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~----------~---~~~~~~-~~-~~~~  428 (496)
                      ....+||+.|+|||++.+. .++.++||||+||++|||++|+.||.......          .   ...... .. ....
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT  236 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence            5567899999999998754 67999999999999999999999996332110          0   000000 00 0000


Q ss_pred             cCCCCCCC-ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          429 DQRLPPPV-DRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       429 ~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ....+... ..........+.+|+.+||+.||++|||++|+++|+|+....
T Consensus       237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence            00000000 000001123478999999999999999999999999997653

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-51  Score=384.63  Aligned_cols=257  Identities=25%  Similarity=0.391  Sum_probs=200.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEec
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEYM  284 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  284 (496)
                      ++|++.+.||+|+||+||+|.+++++.||||+++.....  .+.+.+|+.++++++|||||++++++.++ ..++||||+
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~lv~Ey~   93 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYM   93 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEECCC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC--HHHHHHHHHHHHhcccCCEeEEEEEEecC-CeEEEEEec
Confidence            679999999999999999999988889999999765432  36789999999999999999999998654 578999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC-
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS-  363 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  363 (496)
                      ++|+|.+++.... ...+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....... 
T Consensus        94 ~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          94 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence            9999998887532 225899999999999999999999   67999999999999999999999999999987643322 


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIRD  443 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  443 (496)
                      ......||+.|+|||++.+..++.++||||||+++|||++|..|+...       .........+......+.....   
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~-------~~~~~~~~~i~~~~~~~~~~~~---  239 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------MVNREVLDQVERGYRMPCPPEC---  239 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-------CCHHHHHHHHHTTCCCCCCTTS---
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC-------CCHHHHHHHHHhcCCCCCCccc---
Confidence            233467899999999999999999999999999999999976665321       1122222222222222222211   


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHH--HHhccC
Q 011005          444 ILLISTVSFACLQSNPKSRPTMQSVSQEF--LITRKT  478 (496)
Q Consensus       444 ~~~l~~li~~cl~~dP~~Rps~~evl~~~--~~~~~~  478 (496)
                      ...+.+++.+||+.||++|||+++|++.+  |+....
T Consensus       240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            23477999999999999999999999844  444433

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.5e-50  Score=392.51  Aligned_cols=254  Identities=22%  Similarity=0.273  Sum_probs=202.3

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchh--HHHHHHHHH---HHHHHHhhcccccccccceeecCCeEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEE--LAFIKSFKN---EAQVLSQVLHRNIVKLYGYCLHKKCMF  278 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~---e~~~l~~l~h~niv~~~~~~~~~~~~~  278 (496)
                      ++|++.+.||+|+||+||+|.++ +|+.||||++.....  ......+.+   ++.+++.++|||||++++++.+++..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999765 699999999865321  111223344   456666678999999999999999999


Q ss_pred             EEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccc
Q 011005          279 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL  358 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  358 (496)
                      +|||||+||+|.+++....   .+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+..
T Consensus        84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            9999999999999997654   6789999999999999999999   789999999999999999999999999999876


Q ss_pred             cCCCCCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhh-hcCCCCCCC
Q 011005          359 HADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDV-LDQRLPPPV  436 (496)
Q Consensus       359 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  436 (496)
                      ...  .....+||+.|+|||++.+ ..|+.++||||+||++|||+||+.||.....     ......... .......+ 
T Consensus       158 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~~~~~~~~~~~~~-  229 (364)
T d1omwa3         158 SKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-----KDKHEIDRMTLTMAVELP-  229 (364)
T ss_dssp             SSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS-----SCHHHHHHHSSSCCCCCC-
T ss_pred             CCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhcccCCCCCC-
Confidence            543  2345679999999999874 5689999999999999999999999963221     111111111 11111111 


Q ss_pred             ChhHHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHHHHHHhc
Q 011005          437 DRKVIRDILLISTVSFACLQSNPKSRPT-----MQSVSQEFLITR  476 (496)
Q Consensus       437 ~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~~~~~~  476 (496)
                       ..   ....+.+|+.+||+.||++|||     ++|+++|+|+..
T Consensus       230 -~~---~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         230 -DS---FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  270 (364)
T ss_dssp             -SS---SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred             -CC---CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence             11   1124679999999999999999     799999999864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-50  Score=376.84  Aligned_cols=255  Identities=25%  Similarity=0.352  Sum_probs=197.0

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeCC----CcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      .++|++.+.||+|+||+||+|.+..    +..||||.++........+.+.+|+.++++++||||+++++++.+ +..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence            3578999999999999999997642    456899998776555566789999999999999999999999964 56899


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ||||+++|++.+++....  ..+++..++.++.||+.||.|||   +++|+||||||+||+++.++.+||+|||+|+...
T Consensus        85 v~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheecc
Confidence            999999999998876543  26899999999999999999999   7799999999999999999999999999998765


Q ss_pred             CCCC-CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCC
Q 011005          360 ADSS-NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVD  437 (496)
Q Consensus       360 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (496)
                      .... ......||+.|+|||.+.+..++.++|||||||++|||++ |.+||....       .......+......+.. 
T Consensus       160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~-------~~~~~~~i~~~~~~~~~-  231 (273)
T d1mp8a_         160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENGERLPMP-  231 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-------GGGHHHHHHTTCCCCCC-
T ss_pred             CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC-------HHHHHHHHHcCCCCCCC-
Confidence            4332 2334568999999999999999999999999999999998 899986432       22222222322222111 


Q ss_pred             hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          438 RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       438 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                      ..   ....+.+|+.+||+.||++|||++|+++++...
T Consensus       232 ~~---~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         232 PN---CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC---CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11   123578999999999999999999999998654

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=383.90  Aligned_cols=268  Identities=22%  Similarity=0.282  Sum_probs=204.2

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchh-HHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEE-LAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      ++|++.+.||+|+||+||+|.+ .+|+.||||+++.... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5799999999999999999976 5799999999976432 2234678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      |+.++.+. .+.... ...+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+......
T Consensus        82 ~~~~~~~~-~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKK-FMDASA-LTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHH-HHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhh-hhhhhc-ccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence            99765444 443322 236899999999999999999999   7799999999999999999999999999998876655


Q ss_pred             CCccccccccccccccccccCC-cCcccchhhHHHHHHHHHhCCCCCccccccC----------CCCC-CcchhHhh--h
Q 011005          363 SNRTLLAGTYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGKHPRDILSSLS----------SSSD-PKIMLIDV--L  428 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~p~~~~~~~~----------~~~~-~~~~~~~~--~  428 (496)
                      .......||+.|+|||.+.... ++.++||||+||++|+|++|+.||...+...          .... ........  .
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence            5566678999999999877765 4789999999999999999999996432100          0000 00000000  0


Q ss_pred             cCCCCCCCChh----HHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          429 DQRLPPPVDRK----VIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       429 ~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ....+......    .......+.+|+.+||+.||++|||++|+++|+|+..-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            00000000000    00111346789999999999999999999999999653

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-50  Score=383.31  Aligned_cols=259  Identities=25%  Similarity=0.379  Sum_probs=210.2

Q ss_pred             HHhCCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCe
Q 011005          203 ATEDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKC  276 (496)
Q Consensus       203 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  276 (496)
                      ..++|++.+.||+|+||+||+|+++      +++.||||+++........+.+.+|+.++++++||||+++++++...+.
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            4578999999999999999999764      4578999999876555566789999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhCCC---------------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCC
Q 011005          277 MFLIYEYMERGSLFCNLHNNE---------------------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDIS  335 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlk  335 (496)
                      .++||||+++|+|.+++....                     ....+++..++.|+.|++.||+|||   +++++|||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlK  167 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA  167 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEc
Confidence            999999999999999986432                     1234889999999999999999999   7799999999


Q ss_pred             CCceEecCCCCeEEccccccccccCCCC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCC-CCCcccc
Q 011005          336 SNNILLNSKLEAFVADFGTARLLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK-HPRDILS  412 (496)
Q Consensus       336 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~-~p~~~~~  412 (496)
                      |+|||++.++.+||+|||+|+.......  ......|++.|+|||.+.+..++.++|||||||++|||++|. +||... 
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~-  246 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM-  246 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC-
Confidence            9999999999999999999987644322  233467889999999999999999999999999999999996 566522 


Q ss_pred             ccCCCCCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          413 SLSSSSDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       413 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                            ........+.....++....    .+..+.+|+.+||+.||++||||.||++.+...
T Consensus       247 ------~~~e~~~~v~~~~~~~~p~~----~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         247 ------AHEEVIYYVRDGNILACPEN----CPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             ------CHHHHHHHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             ------CHHHHHHHHHcCCCCCCCcc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence                  22223333333333222111    122477999999999999999999999987654

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-50  Score=384.02  Aligned_cols=255  Identities=25%  Similarity=0.411  Sum_probs=201.0

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCc----EEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGK----VFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  279 (496)
                      ++|++.+.||+|+||+||+|.+. +|+    +||+|+++...+....+.+.+|++++++++|||||++++++.++. .++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeE
Confidence            46999999999999999999764 443    689999877655555678999999999999999999999998764 678


Q ss_pred             EEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccccccc
Q 011005          280 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLH  359 (496)
Q Consensus       280 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  359 (496)
                      ++|++.+|+|.+.+....  ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        88 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence            889999999998887643  36899999999999999999999   6799999999999999999999999999998875


Q ss_pred             CCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhc-CCCCCC
Q 011005          360 ADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLD-QRLPPP  435 (496)
Q Consensus       360 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  435 (496)
                      .....  .....||+.|+|||++.+..++.++|||||||++|||+| |+.||+...       .......+.. .+++.+
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~-------~~~~~~~i~~~~~~~~p  235 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-------ASEISSILEKGERLPQP  235 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-------GGGHHHHHHHTCCCCCC
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC-------HHHHHHHHHcCCCCCCC
Confidence            44332  233468999999999999999999999999999999998 788986322       1112222222 222222


Q ss_pred             CChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          436 VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       436 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ..     ....+.+|+.+||+.||++|||+.|+++++....+
T Consensus       236 ~~-----~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         236 PI-----CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             TT-----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cc-----cCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence            11     12347789999999999999999999999876543

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.8e-50  Score=382.76  Aligned_cols=265  Identities=25%  Similarity=0.306  Sum_probs=203.6

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  283 (496)
                      ++|++.+.||+|+||+||+|.+++|+.||||++.... .....+.+.+|+.++++++||||+++++++..++..+++||+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5799999999999999999999999999999996643 223346789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +.++.+..+.....   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||.+........
T Consensus        82 ~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            98877776665443   7899999999999999999999   67999999999999999999999999999988766555


Q ss_pred             CccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccC-------------CCCCCcchhHhhhc
Q 011005          364 NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS-------------SSSDPKIMLIDVLD  429 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~-------------~~~~~~~~~~~~~~  429 (496)
                      ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.......             ..............
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence            55566789999999998765 56899999999999999999999996432100             00000000000000


Q ss_pred             C----CCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          430 Q----RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       430 ~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                      .    ....+...........+.+|+.+||+.||++|||++|+++|+|+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~  285 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK  285 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence            0    000000000011122467999999999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-50  Score=374.63  Aligned_cols=250  Identities=23%  Similarity=0.371  Sum_probs=196.1

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeec-CCeEEEEEEe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH-KKCMFLIYEY  283 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lV~e~  283 (496)
                      ++|++.+.||+|+||.||+|.+ .|+.||||+++....   .+.+.+|++++++++||||++++|++.+ ++..++||||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHHH---HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            5688899999999999999998 478899999976542   3668999999999999999999999865 4568999999


Q ss_pred             cCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCC
Q 011005          284 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSS  363 (496)
Q Consensus       284 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  363 (496)
                      +++|+|.+++.... ...+++..+++|+.||+.||.|||   +.+|+||||||+||+++.++.+|++|||+++.....  
T Consensus        83 ~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--  156 (262)
T d1byga_          83 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  156 (262)
T ss_dssp             CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC--
Confidence            99999999997542 225899999999999999999999   779999999999999999999999999999865432  


Q ss_pred             CccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhHHH
Q 011005          364 NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKVIR  442 (496)
Q Consensus       364 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (496)
                       .....+++.|+|||++.+..++.++||||||+++|||+| |++||....       .......+.....+ +.....  
T Consensus       157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~-------~~~~~~~i~~~~~~-~~~~~~--  225 (262)
T d1byga_         157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVVPRVEKGYKM-DAPDGC--  225 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-------GGGHHHHHTTTCCC-CCCTTC--
T ss_pred             -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC-------HHHHHHHHHcCCCC-CCCccC--
Confidence             334567889999999999999999999999999999998 688875321       22222222222222 111111  


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          443 DILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       443 ~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                       ...+.+|+.+||+.||++|||+.|+++++...+
T Consensus       226 -~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         226 -PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             -CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -CHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence             235779999999999999999999999987554

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.8e-50  Score=376.58  Aligned_cols=257  Identities=25%  Similarity=0.375  Sum_probs=199.8

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCC----e
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK----C  276 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~  276 (496)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||+++...  +....+.+.+|++++++++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999975 579999999997543  3344567899999999999999999999987643    4


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      .++||||++||+|.+++....   .+++.+++.++.||+.||+|||   +++|+||||||+||+++.++..+++|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhh
Confidence            899999999999999887654   6899999999999999999999   7799999999999999999999999999987


Q ss_pred             cccCCCC---CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCC
Q 011005          357 LLHADSS---NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLP  433 (496)
Q Consensus       357 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  433 (496)
                      .......   .....+||+.|+|||++.+..++.++||||+||++|||+||++||....       ........+.....
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-------~~~~~~~~~~~~~~  232 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-------PVSVAYQHVREDPI  232 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHCCCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC-------HHHHHHHHHhcCCC
Confidence            6543322   2344679999999999999999999999999999999999999996322       12222222222222


Q ss_pred             CCCChhHHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHHHH
Q 011005          434 PPVDRKVIRDILLISTVSFACLQSNPKSRP-TMQSVSQEFLI  474 (496)
Q Consensus       434 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~~~~  474 (496)
                      .+. .........+.+++.+||+.||++|| |++++++.+..
T Consensus       233 ~~~-~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         233 PPS-ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             CGG-GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCc-hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            111 00111123577899999999999999 78888776654

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-49  Score=377.34  Aligned_cols=259  Identities=23%  Similarity=0.332  Sum_probs=196.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecC-C
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHK-K  275 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~  275 (496)
                      .++|++.+.||+|+||.||+|.+.      +++.||||+++........+.+.+|..++.++ +|+||+.+++++... .
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            367999999999999999999753      35689999998765555567788888888888 589999999988664 4


Q ss_pred             eEEEEEEecCCCChhhhhhCCCC-------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEec
Q 011005          276 CMFLIYEYMERGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN  342 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~  342 (496)
                      ..++|||||++|+|.+++.....             ...+++..++.++.||+.||+|||   +++|+||||||+|||++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeEC
Confidence            68999999999999999875421             235899999999999999999999   77999999999999999


Q ss_pred             CCCCeEEccccccccccCCCC--CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCC-CCCccccccCCCCC
Q 011005          343 SKLEAFVADFGTARLLHADSS--NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK-HPRDILSSLSSSSD  419 (496)
Q Consensus       343 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~-~p~~~~~~~~~~~~  419 (496)
                      .++.+||+|||+|+.......  .....+||+.|+|||++.+..++.++|||||||++|||++|. .||....       
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~-------  241 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-------  241 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC-------
Confidence            999999999999987654332  234467999999999999999999999999999999999875 5665221       


Q ss_pred             CcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          420 PKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                      ........+......+....   ....+.+++.+||+.||++|||++|+++|+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         242 IDEEFCRRLKEGTRMRAPDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             CSHHHHHHHHHTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCCCcc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            11222222222111111111   122477899999999999999999999998643

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-50  Score=375.72  Aligned_cols=248  Identities=21%  Similarity=0.309  Sum_probs=201.5

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchh-----HHHHHHHHHHHHHHHhhc--ccccccccceeecCC
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEE-----LAFIKSFKNEAQVLSQVL--HRNIVKLYGYCLHKK  275 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~  275 (496)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||++.....     ......+.+|+.++++++  |||||++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            35799999999999999999976 4789999999865321     111234678999999997  899999999999999


Q ss_pred             eEEEEEEecCC-CChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC-CCCeEEcccc
Q 011005          276 CMFLIYEYMER-GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KLEAFVADFG  353 (496)
Q Consensus       276 ~~~lV~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg  353 (496)
                      ..++||||+.+ +++.+++....   .+++.+++.++.||+.||+|||   +++|+||||||+|||++. ++.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccc
Confidence            99999999986 57777776543   6899999999999999999999   779999999999999985 4799999999


Q ss_pred             ccccccCCCCCccccccccccccccccccCCc-CcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCC
Q 011005          354 TARLLHADSSNRTLLAGTYGYIAPELAYTMVM-TEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRL  432 (496)
Q Consensus       354 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  432 (496)
                      +|+.....  ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....             +......
T Consensus       157 ~a~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------------~i~~~~~  221 (273)
T d1xwsa_         157 SGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIRGQV  221 (273)
T ss_dssp             TCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHHCCC
T ss_pred             cceecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------------HHhhccc
Confidence            99865432  3445689999999999988766 567899999999999999999996322             1111211


Q ss_pred             CCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       433 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ..+..     ....+.+|+.+||+.||++|||++|+++|+|+...
T Consensus       222 ~~~~~-----~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         222 FFRQR-----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             CCSSC-----CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             CCCCC-----CCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            11111     01246789999999999999999999999999654

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-50  Score=373.67  Aligned_cols=254  Identities=24%  Similarity=0.384  Sum_probs=194.8

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC--CC--cEEEEEEcccch--hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP--NG--KVFALKKLHTSE--ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMF  278 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  278 (496)
                      ++|++.+.||+|+||+||+|.+.  ++  ..||||++....  ..+..+.+.+|+.++++++||||++++|++.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            56899999999999999999753  22  368999987542  334457899999999999999999999999765 568


Q ss_pred             EEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccc
Q 011005          279 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL  358 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  358 (496)
                      +||||+++|++.+.+....  ..+++..++.++.||+.||.|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence            9999999999998877532  36899999999999999999999   679999999999999999999999999999987


Q ss_pred             cCCCCC---ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCCCCcchhHhhhcCCCCC
Q 011005          359 HADSSN---RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSSDPKIMLIDVLDQRLPP  434 (496)
Q Consensus       359 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  434 (496)
                      ......   .....|+..|+|||.+.+..++.++||||||+++|||+| |+.||....       .......+.......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~-------~~~~~~~i~~~~~~~  234 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-------GSQILHKIDKEGERL  234 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHTSCCCC
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC-------HHHHHHHHHhCCCCC
Confidence            544332   223457889999999999999999999999999999998 899986322       222223333332222


Q ss_pred             CCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          435 PVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       435 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      +.....   ...+.+|+.+||+.||++|||+.|+++.+..
T Consensus       235 ~~~~~~---~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         235 PRPEDC---PQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             CCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCcccc---cHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            222211   2247799999999999999999999877654

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-49  Score=378.12  Aligned_cols=257  Identities=24%  Similarity=0.344  Sum_probs=202.3

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCC-Cc--EEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCCeEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPN-GK--VFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKCMFLI  280 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV  280 (496)
                      ++|++.+.||+|+||+||+|.+++ +.  .||||++.........+.+.+|+++++++ +|||||++++++.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            678999999999999999997753 43  57888886655444557799999999999 799999999999999999999


Q ss_pred             EEecCCCChhhhhhCC-------------CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCe
Q 011005          281 YEYMERGSLFCNLHNN-------------EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEA  347 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~  347 (496)
                      |||+++|+|.++++..             .....+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            9999999999999764             23347899999999999999999999   7799999999999999999999


Q ss_pred             EEccccccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCC-CCccccccCCCCCCcchhHh
Q 011005          348 FVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKH-PRDILSSLSSSSDPKIMLID  426 (496)
Q Consensus       348 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~-p~~~~~~~~~~~~~~~~~~~  426 (496)
                      ||+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|.. ||...       ........
T Consensus       167 kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-------~~~~~~~~  238 (309)
T d1fvra_         167 KIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-------TCAELYEK  238 (309)
T ss_dssp             EECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-------CHHHHHHH
T ss_pred             EEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC-------CHHHHHHH
Confidence            999999997654332 2334568999999999999999999999999999999999764 66422       12222222


Q ss_pred             hhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          427 VLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      +.....+. ....   ....+.+|+.+||+.||++|||++|+++++....
T Consensus       239 i~~~~~~~-~~~~---~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         239 LPQGYRLE-KPLN---CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             GGGTCCCC-CCTT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhcCCCC-CCcc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            22222111 1111   1235789999999999999999999999875544

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=372.16  Aligned_cols=254  Identities=24%  Similarity=0.349  Sum_probs=202.8

Q ss_pred             cceeeecCCeeEEEEEeCCC----cEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeec-CCeEEEEEEec
Q 011005          210 RYCIGTGGYGSVYKAQLPNG----KVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH-KKCMFLIYEYM  284 (496)
Q Consensus       210 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lV~e~~  284 (496)
                      .+.||+|+||+||+|.+.++    ..||||+++...+....+.+.+|++++++++||||++++|++.. +...++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46799999999999986532    35899999765555666889999999999999999999999875 56899999999


Q ss_pred             CCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCCCC
Q 011005          285 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADSSN  364 (496)
Q Consensus       285 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  364 (496)
                      ++|+|.+++.....  ..++..++.++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999999886543  5678889999999999999999   779999999999999999999999999999876543222


Q ss_pred             ----ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCCCCCChhH
Q 011005          365 ----RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLPPPVDRKV  440 (496)
Q Consensus       365 ----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  440 (496)
                          .....||+.|+|||.+.+..++.++||||||+++|||+||+.||.....      .......+.....+.....  
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~------~~~~~~~i~~g~~~~~p~~--  258 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN------TFDITVYLLQGRRLLQPEY--  258 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHHHHHTTCCCCCCTT--
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC------HHHHHHHHHcCCCCCCccc--
Confidence                2235689999999999999999999999999999999998888753211      1112222222222211111  


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          441 IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       441 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                        ....+.+|+.+||+.||++|||+.||++++......
T Consensus       259 --~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         259 --CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             --CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence              123477999999999999999999999998776553

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=371.45  Aligned_cols=266  Identities=23%  Similarity=0.335  Sum_probs=201.6

Q ss_pred             hCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCC----eEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK----CMFLI  280 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lV  280 (496)
                      .+|.+.+.||+|+||+||+|.+ +|+.||||++.......  .....|+..+..++||||+++++++.+.+    ..++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~--~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS--WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHH--HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhH--HHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            4577888999999999999987 68899999997654322  22234555556779999999999997643    68999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEeCCCCCceEecCCCCeEEcccccc
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD-----CSPSIIHRDISSNNILLNSKLEAFVADFGTA  355 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-----~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  355 (496)
                      ||||++|+|.+++++.    .+++..+++++.|++.||+|+|+.     ..++|+||||||+|||++.++.+||+|||++
T Consensus        80 ~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            9999999999999864    589999999999999999999952     1369999999999999999999999999999


Q ss_pred             ccccCCCC----CccccccccccccccccccCC------cCcccchhhHHHHHHHHHhCCCCCccccccCCCC-------
Q 011005          356 RLLHADSS----NRTLLAGTYGYIAPELAYTMV------MTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSS-------  418 (496)
Q Consensus       356 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~-------  418 (496)
                      +.......    .....+||+.|+|||++.+..      ++.++|||||||++|||+||..|+..........       
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            87754432    223467999999999987653      6779999999999999999998876433221111       


Q ss_pred             -CCcchhHhhhcCCCCCCCCh--hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          419 -DPKIMLIDVLDQRLPPPVDR--KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       419 -~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                       ...............+....  ........+.+|+.+||+.||++|||+.|+++++.....
T Consensus       236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence             01111222233333222212  122344558899999999999999999999998876543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=373.81  Aligned_cols=258  Identities=26%  Similarity=0.369  Sum_probs=209.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe------CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecCCe
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHKKC  276 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  276 (496)
                      .++|++.+.||+|+||.||+|.+      .+++.||||+++..........+.+|+.+++++ +|||||++++++.++..
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            36788999999999999999975      356789999998765555567889999999999 69999999999999999


Q ss_pred             EEEEEEecCCCChhhhhhCCC---------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe
Q 011005          277 MFLIYEYMERGSLFCNLHNNE---------------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL  341 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~  341 (496)
                      .++|||||++|+|.+++....               ....+++..+..++.||+.||+|||   +++++||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccc
Confidence            999999999999999987543               1235889999999999999999999   6799999999999999


Q ss_pred             cCCCCeEEccccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHhC-CCCCccccccCCCC
Q 011005          342 NSKLEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMG-KHPRDILSSLSSSS  418 (496)
Q Consensus       342 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g-~~p~~~~~~~~~~~  418 (496)
                      +.++.++++|||.++........  ....+||+.|+|||.+.+..++.++||||||+++|||+|+ .+|+...       
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~-------  251 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-------  251 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-------
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC-------
Confidence            99999999999999877543332  2345789999999999999999999999999999999995 5555421       


Q ss_pred             CCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          419 DPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                      .......+.+...........   ....+.+|+.+||+.||++|||++|+++.+..
T Consensus       252 ~~~~~~~~~i~~~~~~~~~~~---~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         252 PVDSKFYKMIKEGFRMLSPEH---APAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             CSSHHHHHHHHHTCCCCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CHHHHHHHHHhcCCCCCCccc---ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            122223333333222222221   12347899999999999999999999998753

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=371.89  Aligned_cols=257  Identities=24%  Similarity=0.367  Sum_probs=205.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC--------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhh-cccccccccceeecC
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP--------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQV-LHRNIVKLYGYCLHK  274 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  274 (496)
                      .++|++.+.||+|+||.||+|+..        ++..||||+++..........+.+|...+.++ +|||||++++++.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            367889999999999999999753        23479999998766555667889999999998 799999999999999


Q ss_pred             CeEEEEEEecCCCChhhhhhCCCC-------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEe
Q 011005          275 KCMFLIYEYMERGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL  341 (496)
Q Consensus       275 ~~~~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~  341 (496)
                      +..++||||+++|+|.+++.....             ...+++..++.++.||+.||+|||   +.+|+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence            999999999999999999976532             236899999999999999999999   7799999999999999


Q ss_pred             cCCCCeEEccccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHh-CCCCCccccccCCCC
Q 011005          342 NSKLEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLM-GKHPRDILSSLSSSS  418 (496)
Q Consensus       342 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~p~~~~~~~~~~~  418 (496)
                      +.++.+||+|||+++........  .....+++.|+|||.+.+..|+.++||||||+++|||++ |+.||....      
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~------  242 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------  242 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC------
Confidence            99999999999999877554322  344678999999999999999999999999999999998 788886322      


Q ss_pred             CCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Q 011005          419 DPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLI  474 (496)
Q Consensus       419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~  474 (496)
                       .. ...+.+......+.....   ...+.+|+.+||+.||++|||+.|+++.+..
T Consensus       243 -~~-~~~~~i~~~~~~~~p~~~---~~~l~~li~~cl~~dP~~Rps~~eil~~L~~  293 (299)
T d1fgka_         243 -VE-ELFKLLKEGHRMDKPSNC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  293 (299)
T ss_dssp             -HH-HHHHHHHTTCCCCCCSSC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -HH-HHHHHHHcCCCCCCCccc---hHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence             11 222232222222222211   2247899999999999999999999998754

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-49  Score=377.81  Aligned_cols=267  Identities=24%  Similarity=0.317  Sum_probs=199.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CC-CcEEEEEEcccchh-HHHHHHHHHHHHHHHhh---cccccccccceeec----
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PN-GKVFALKKLHTSEE-LAFIKSFKNEAQVLSQV---LHRNIVKLYGYCLH----  273 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~----  273 (496)
                      .++|++.+.||+|+||+||+|.+ ++ ++.||||+++.... ......+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            47899999999999999999976 34 66799999865421 11223456788887776   69999999999853    


Q ss_pred             -CCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccc
Q 011005          274 -KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADF  352 (496)
Q Consensus       274 -~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Df  352 (496)
                       ....+++||+++++.+........  ..+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecch
Confidence             346899999999887765544332  36899999999999999999999   779999999999999999999999999


Q ss_pred             cccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccC----------CC-----
Q 011005          353 GTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS----------SS-----  417 (496)
Q Consensus       353 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~----------~~-----  417 (496)
                      |+++..... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.......          ..     
T Consensus       161 g~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         161 GLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             CSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             hhhhhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence            999765332 23445689999999999999999999999999999999999999996432100          00     


Q ss_pred             CCCcchhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          418 SDPKIMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      .................+...........+.+|+.+||+.||++|||++|+++|+|+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~  298 (305)
T d1blxa_         240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD  298 (305)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred             cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence            00000000000011111111101111224678999999999999999999999999864

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-48  Score=369.81  Aligned_cols=258  Identities=24%  Similarity=0.332  Sum_probs=210.6

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC------CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCCeE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCM  277 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  277 (496)
                      .++|++.+.||+|+||+||+|.++      .++.||||+++..........+.+|+.++++++||||+++++++..++..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            468899999999999999999763      35789999998765555567789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhCC-------CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEc
Q 011005          278 FLIYEYMERGSLFCNLHNN-------EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVA  350 (496)
Q Consensus       278 ~lV~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~  350 (496)
                      ++||||+++|+|.+++...       .....+++..+..++.|++.||.|||   +++|+||||||+|||++.++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEe
Confidence            9999999999999987642       22235789999999999999999999   6799999999999999999999999


Q ss_pred             cccccccccCCCCC--ccccccccccccccccccCCcCcccchhhHHHHHHHHHhCC-CCCccccccCCCCCCcchhHhh
Q 011005          351 DFGTARLLHADSSN--RTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGK-HPRDILSSLSSSSDPKIMLIDV  427 (496)
Q Consensus       351 Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~-~p~~~~~~~~~~~~~~~~~~~~  427 (496)
                      |||+++........  .....||+.|+|||.+.+..++.++||||||+++|||+||. .||...       ........+
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-------~~~~~~~~i  248 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-------SNEQVLRFV  248 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-------CHHHHHHHH
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-------CHHHHHHHH
Confidence            99999876544332  23346899999999999999999999999999999999985 666522       222233333


Q ss_pred             hcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHh
Q 011005          428 LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLIT  475 (496)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~  475 (496)
                      .+...+.....    ....+.+++.+||+.||++|||++|+++++...
T Consensus       249 ~~~~~~~~p~~----~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         249 MEGGLLDKPDN----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             HTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HhCCCCCCccc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            34333322111    123578999999999999999999999987543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-48  Score=375.53  Aligned_cols=266  Identities=23%  Similarity=0.265  Sum_probs=197.9

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCC------
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK------  275 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  275 (496)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||+++... .....+.+.+|++++++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            46899999999999999999976 469999999997543 3344577899999999999999999999997654      


Q ss_pred             eEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccccc
Q 011005          276 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTA  355 (496)
Q Consensus       276 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  355 (496)
                      ..++||||+ +++|..+....    .+++..++.++.||+.||+|||   ++||+||||||+|||++.++.+|++|||+|
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccce
Confidence            579999999 56777776543    6899999999999999999999   789999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCC--------CCCCc-----
Q 011005          356 RLLHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS--------SSDPK-----  421 (496)
Q Consensus       356 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~--------~~~~~-----  421 (496)
                      +.....   ....+||+.|+|||.+.+. .++.++||||+||++|+|++|+.||........        ...+.     
T Consensus       169 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (346)
T d1cm8a_         169 RQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  245 (346)
T ss_dssp             EECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             eccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence            876432   3456799999999998764 568999999999999999999999964321100        00000     


Q ss_pred             ------chhHhhhcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCCC
Q 011005          422 ------IMLIDVLDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTPL  480 (496)
Q Consensus       422 ------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~~  480 (496)
                            .........................+.+|+.+||+.||++|||++|+++|+|+......
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~  310 (346)
T d1cm8a_         246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  310 (346)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence                  00000000000010000001112246789999999999999999999999999765433

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-48  Score=370.75  Aligned_cols=268  Identities=19%  Similarity=0.227  Sum_probs=198.5

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeec--------
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH--------  273 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  273 (496)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||++.... .......+.+|++++++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            36899999999999999999976 579999999986543 22334668899999999999999999998855        


Q ss_pred             CCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEcccc
Q 011005          274 KKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFG  353 (496)
Q Consensus       274 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  353 (496)
                      +...++||||+.++.+........   .++...++.++.|++.||.|||   +.||+||||||+|||++.++.+|++|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecc
Confidence            345899999998876665444332   6889999999999999999999   7799999999999999999999999999


Q ss_pred             ccccccCCCC----CccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccC-------------
Q 011005          354 TARLLHADSS----NRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS-------------  415 (496)
Q Consensus       354 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~-------------  415 (496)
                      +++.......    .....+||+.|+|||.+.+. .++.++||||+||++|||++|+.||+......             
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9987653221    23335799999999998765 68999999999999999999999996322100             


Q ss_pred             CCCC---CcchhHhhhcCCCCCCCCh-hH---HHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          416 SSSD---PKIMLIDVLDQRLPPPVDR-KV---IRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       416 ~~~~---~~~~~~~~~~~~~~~~~~~-~~---~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      ....   ................... ..   ......+.+|+.+||+.||++|||++|+++|+|+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            0000   0000000000000000000 00   0112346789999999999999999999999999864

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-48  Score=373.49  Aligned_cols=269  Identities=22%  Similarity=0.256  Sum_probs=201.7

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeecCC----eEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKK----CMF  278 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~  278 (496)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++.........+.+.+|+.++++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            46799999999999999999965 5899999999987655555678899999999999999999999987643    234


Q ss_pred             EEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccc
Q 011005          279 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLL  358 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  358 (496)
                      ++++++.+|+|.+++...    .+++..++.++.||+.||+|||   ++||+||||||+|||++.++.+||+|||+++..
T Consensus        87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            455667799999999754    5899999999999999999999   779999999999999999999999999999876


Q ss_pred             cCCCC---Cccccccccccccccccc-cCCcCcccchhhHHHHHHHHHhCCCCCccccccC---------CCCCCc----
Q 011005          359 HADSS---NRTLLAGTYGYIAPELAY-TMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS---------SSSDPK----  421 (496)
Q Consensus       359 ~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~---------~~~~~~----  421 (496)
                      .....   .....+||+.|+|||++. +..++.++||||+||++|+|++|+.||.......         ......    
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            44322   234467999999999985 4567889999999999999999999996332100         000000    


Q ss_pred             ---chhHhh---hcCCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccCC
Q 011005          422 ---IMLIDV---LDQRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKTP  479 (496)
Q Consensus       422 ---~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~~  479 (496)
                         ......   .......+...........+.+|+.+||+.||++|||++|+++|+|+.....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence               000000   0000000000000011124779999999999999999999999999875444

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-47  Score=359.53  Aligned_cols=268  Identities=21%  Similarity=0.261  Sum_probs=209.4

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecCCeEEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHKKCMFLIYE  282 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  282 (496)
                      ++|++.+.||+|+||+||+|.+ .+++.||||+++... .......+.+|+.+++.++||||+++++++......++|++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5799999999999999999976 578999999986543 23445778999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccccccCCC
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTARLLHADS  362 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  362 (496)
                      ++.++++..++....   .+++..+..++.|++.||+|||   .++|+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            999999988877654   6789999999999999999999   7799999999999999999999999999999876655


Q ss_pred             CCccccccccccccccccccCC-cCcccchhhHHHHHHHHHhCCCCCcccccc-----------CCCCC-CcchhHhhhc
Q 011005          363 SNRTLLAGTYGYIAPELAYTMV-MTEKCDVYSFGVVTLEVLMGKHPRDILSSL-----------SSSSD-PKIMLIDVLD  429 (496)
Q Consensus       363 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~p~~~~~~~-----------~~~~~-~~~~~~~~~~  429 (496)
                      .......+++.|+|||.+.+.. ++.++||||+||++|||++|+.||......           ..... ..........
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence            5555667888999999987665 689999999999999999999996321110           00000 0000000000


Q ss_pred             CC----C--CCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          430 QR----L--PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       430 ~~----~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ..    .  ..............+.+|+.+||+.||++|||++|+++|+|+....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence            00    0  0000000011112467899999999999999999999999996543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-47  Score=370.96  Aligned_cols=263  Identities=24%  Similarity=0.301  Sum_probs=196.6

Q ss_pred             CCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccccccceeec------CCeEE
Q 011005          206 DFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH------KKCMF  278 (496)
Q Consensus       206 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~~  278 (496)
                      +|+..+.||+|+||+||+|.+. +|+.||||++.....     ...+|++++++++||||+++++++..      ..+.+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            5888899999999999999764 699999999976542     23579999999999999999999854      23578


Q ss_pred             EEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC-CeEEcccccccc
Q 011005          279 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-EAFVADFGTARL  357 (496)
Q Consensus       279 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~  357 (496)
                      +|||||+++.+..+.........+++..++.++.||+.||+|||   ++||+||||||+|||++.++ .+||+|||+++.
T Consensus        96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence            99999987654444433233347899999999999999999999   88999999999999999775 899999999987


Q ss_pred             ccCCCCCcccccccccccccccccc-CCcCcccchhhHHHHHHHHHhCCCCCccccccCC--------CCCCcchhHhhh
Q 011005          358 LHADSSNRTLLAGTYGYIAPELAYT-MVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS--------SSDPKIMLIDVL  428 (496)
Q Consensus       358 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~--------~~~~~~~~~~~~  428 (496)
                      ..... .....+||+.|+|||.+.+ ..++.++||||+||++|||++|+.||........        ............
T Consensus       173 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         173 LVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             CCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             ccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence            65433 3344679999999998775 5789999999999999999999999963321000        000000000000


Q ss_pred             ----cCCCCCCCC----h-hHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          429 ----DQRLPPPVD----R-KVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       429 ----~~~~~~~~~----~-~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                          ....+....    . ........+.+|+.+||+.||++|||+.|+++|+|+..-
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence                000000000    0 000112246789999999999999999999999998653

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3e-46  Score=360.70  Aligned_cols=258  Identities=18%  Similarity=0.224  Sum_probs=198.7

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-ccccccccceeec--CCeEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLH--KKCMFLI  280 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lV  280 (496)
                      ++|++.+.||+|+||+||+|.+ .+|+.||||+++...    .+.+.+|+++++.++ ||||+++++++..  ....++|
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            6799999999999999999976 579999999997654    256789999999995 9999999999874  4568999


Q ss_pred             EEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCC-CeEEcccccccccc
Q 011005          281 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKL-EAFVADFGTARLLH  359 (496)
Q Consensus       281 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~  359 (496)
                      |||+++++|.....      .+++..+..++.||+.||+|||   ++||+||||||+|||++.++ .+||+|||+|+...
T Consensus       111 ~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         111 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             EECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             EeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceecc
Confidence            99999999976642      5899999999999999999999   78999999999999998655 68999999998765


Q ss_pred             CCCCCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccCC---------------------C
Q 011005          360 ADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSS---------------------S  417 (496)
Q Consensus       360 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~---------------------~  417 (496)
                      ... .....++|+.|+|||.+.+. .++.++||||+||++|+|++|+.||........                     .
T Consensus       182 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         182 PGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             TTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             CCC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence            432 34456789999999998765 479999999999999999999999863221000                     0


Q ss_pred             CCCcchhHhhhcCCCCCC-----CChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhc
Q 011005          418 SDPKIMLIDVLDQRLPPP-----VDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITR  476 (496)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~  476 (496)
                      ..................     ...........+.+|+.+||+.||++|||++|+++|+|+..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~  324 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  324 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            000000000000000000     00000111224678999999999999999999999999854

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=366.62  Aligned_cols=258  Identities=26%  Similarity=0.397  Sum_probs=205.3

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC----CCcEEEEEEcccch---hHHHHHHHHHHHHHHHhhcc-cccccccceeecCCe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSE---ELAFIKSFKNEAQVLSQVLH-RNIVKLYGYCLHKKC  276 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~  276 (496)
                      ++|++.+.||+|+||+||+|...    +|+.||||.++...   +....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999999642    48899999986532   22233567899999999987 899999999999999


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      .++||||+.+|+|.+++....   .++...+..++.||+.||+|+|   +.+|+||||||+||+++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchh
Confidence            999999999999999998665   5678889999999999999999   7799999999999999999999999999998


Q ss_pred             cccCCCC-CccccccccccccccccccC--CcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCCC
Q 011005          357 LLHADSS-NRTLLAGTYGYIAPELAYTM--VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRLP  433 (496)
Q Consensus       357 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  433 (496)
                      .+..... ......|++.|+|||.+.+.  .++.++||||+||++|+|++|+.||......   ...............+
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~---~~~~~i~~~~~~~~~~  254 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK---NSQAEISRRILKSEPP  254 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC---CCHHHHHHHHHHCCCC
T ss_pred             hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcccCCCC
Confidence            7644322 23456799999999998765  4678999999999999999999999743221   1111111222222222


Q ss_pred             CCCChhHHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHHHHhc
Q 011005          434 PPVDRKVIRDILLISTVSFACLQSNPKSRP-----TMQSVSQEFLITR  476 (496)
Q Consensus       434 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~~~~~~  476 (496)
                      .+.     .....+.+|+.+||++||++||     |++|+++|+|+..
T Consensus       255 ~~~-----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         255 YPQ-----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             CCT-----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             Ccc-----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence            111     1123577899999999999999     5899999999854

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-46  Score=363.84  Aligned_cols=263  Identities=23%  Similarity=0.229  Sum_probs=195.4

Q ss_pred             hCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeec------CCe
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLH------KKC  276 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  276 (496)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++.... +....+.+.+|+.++++++||||+++++++..      ..+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67999999999999999999765 69999999997543 23445678999999999999999999999964      468


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      .|+||||+.++.+ +.+..     .+++..++.++.||+.||.|||   ..||+||||||+|||++.++.++++|||+++
T Consensus        97 ~~iv~Ey~~~~l~-~~~~~-----~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHH-HHHTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHH-Hhhhc-----CCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhh
Confidence            8999999976544 44432     5789999999999999999999   7799999999999999999999999999987


Q ss_pred             cccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccC----------C-----CCCCc
Q 011005          357 LLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS----------S-----SSDPK  421 (496)
Q Consensus       357 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~----------~-----~~~~~  421 (496)
                      ..... ......++|+.|+|||++.+..+++++||||+||++|+|++|+.||...+...          .     .....
T Consensus       168 ~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         168 TAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred             ccccc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence            66433 33445679999999999999999999999999999999999999995322100          0     00000


Q ss_pred             chhHhhhcC---------------CCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhcc
Q 011005          422 IMLIDVLDQ---------------RLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRK  477 (496)
Q Consensus       422 ~~~~~~~~~---------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~  477 (496)
                      .........               ................+.+|+.+||+.||++|||++|+++|+|+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            000111111               11111222233344567899999999999999999999999999763

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-46  Score=362.60  Aligned_cols=264  Identities=22%  Similarity=0.236  Sum_probs=199.1

Q ss_pred             HhCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccch-hHHHHHHHHHHHHHHHhhcccccccccceeecC-----Ce
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSE-ELAFIKSFKNEAQVLSQVLHRNIVKLYGYCLHK-----KC  276 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  276 (496)
                      .++|++.+.||+|+||+||+|.+ .+|+.||||++.... +....+.+.+|+.++++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46899999999999999999975 579999999997643 334456788999999999999999999998643     34


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      .+++++++.+|+|.+++...    .+++..+..++.||+.||+|||   ++||+||||||+|||++.++.+|++|||.+.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhc
Confidence            46677788899999998653    5899999999999999999999   7799999999999999999999999999997


Q ss_pred             cccCCCCCccccccccccccccccccC-CcCcccchhhHHHHHHHHHhCCCCCccccccC---------CC-------CC
Q 011005          357 LLHADSSNRTLLAGTYGYIAPELAYTM-VMTEKCDVYSFGVVTLEVLMGKHPRDILSSLS---------SS-------SD  419 (496)
Q Consensus       357 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~p~~~~~~~~---------~~-------~~  419 (496)
                      ....   ......|++.|+|||...+. .++.++||||+||++|+|++|+.||...+...         ..       ..
T Consensus       170 ~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  246 (348)
T d2gfsa1         170 HTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  246 (348)
T ss_dssp             CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             ccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence            6532   23446789999999987765 46889999999999999999999996322100         00       00


Q ss_pred             CcchhHhhhcCCCCCCCC----hhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHhccC
Q 011005          420 PKIMLIDVLDQRLPPPVD----RKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFLITRKT  478 (496)
Q Consensus       420 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~~~~~~  478 (496)
                      ......... ........    .........+.+|+.+||+.||++|||++|+++|+|+....
T Consensus       247 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         247 SSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             CCHHHHHHH-TTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             cchhhhhhh-hhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence            000000000 01110000    00001123467899999999999999999999999998643

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-45  Score=350.31  Aligned_cols=263  Identities=16%  Similarity=0.231  Sum_probs=195.3

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhccccccc-ccceeecCCeEEEEEE
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIVK-LYGYCLHKKCMFLIYE  282 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~lV~e  282 (496)
                      ++|++.+.||+|+||+||+|.+ .+|+.||||.+......   ..+.+|+++++.++|++++. +.+++.+++..++|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            5799999999999999999976 56899999988764422   34678999999998766554 4556677888999999


Q ss_pred             ecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC---CCCeEEcccccccccc
Q 011005          283 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KLEAFVADFGTARLLH  359 (496)
Q Consensus       283 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~  359 (496)
                      |+ ++++.+.+....  ..+++..+..++.|++.||+|||   +++|+||||||+|||++.   +..++++|||+|+.+.
T Consensus        84 ~~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          84 LL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             Ec-CCchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            99 456666655432  26899999999999999999999   779999999999999864   4579999999999875


Q ss_pred             CCCC-------CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhcCCC
Q 011005          360 ADSS-------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLDQRL  432 (496)
Q Consensus       360 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  432 (496)
                      ....       ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........    ..........
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~----~~~~~~~~~~  233 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ----KYERISEKKM  233 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----------HHHHHHHHH
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH----HHHHhhcccC
Confidence            4322       1234579999999999999999999999999999999999999997443211111    1111111111


Q ss_pred             CCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHH---HHHHHHhccCCC
Q 011005          433 PPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSV---SQEFLITRKTPL  480 (496)
Q Consensus       433 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev---l~~~~~~~~~~~  480 (496)
                      ..+........+..+.+++.+||+.||++||+++++   +++++.......
T Consensus       234 ~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~  284 (299)
T d1ckia_         234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY  284 (299)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCC
T ss_pred             CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCC
Confidence            111100011112357889999999999999998755   667766555444

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.1e-45  Score=345.50  Aligned_cols=257  Identities=16%  Similarity=0.208  Sum_probs=199.4

Q ss_pred             HhCCCCcceeeecCCeeEEEEEeC-CCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcc-cccccccceeecCCeEEEEE
Q 011005          204 TEDFDIRYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLH-RNIVKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       204 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lV~  281 (496)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++......   ..+.+|++.++.+.| +|++.+++++..+...++||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            367999999999999999999764 6899999988654322   346788999999975 89999999999999999999


Q ss_pred             EecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecC-----CCCeEEccccccc
Q 011005          282 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-----KLEAFVADFGTAR  356 (496)
Q Consensus       282 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~-----~~~~kl~Dfg~~~  356 (496)
                      ||+ +++|.+++.....  .++..++..++.|++.||+|||   +.||+||||||+||+++.     ++.+||+|||+|+
T Consensus        81 e~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          81 DLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             ECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             Eec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence            999 6899988875432  6899999999999999999999   889999999999999974     5789999999998


Q ss_pred             cccCCCC-------CccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCCcchhHhhhc
Q 011005          357 LLHADSS-------NRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDPKIMLIDVLD  429 (496)
Q Consensus       357 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  429 (496)
                      .+.....       .....+||+.|+|||++.+..++.++||||||+++|||++|+.||.....    .........+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~----~~~~~~~~~i~~  230 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA----ATNKQKYERIGE  230 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS----CCHHHHHHHHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc----hhHHHHHHHHHh
Confidence            7654321       13345799999999999999999999999999999999999999973321    111111111111


Q ss_pred             CCCCCCCChhHHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Q 011005          430 QRLPPPVDRKVIRDILLISTVSFACLQSNPKSRPTMQSVSQEFL  473 (496)
Q Consensus       430 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~~~  473 (496)
                      .....+........+..+.+++..|+..+|++||+++.+.+.+.
T Consensus       231 ~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~  274 (293)
T d1csna_         231 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS  274 (293)
T ss_dssp             HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             ccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence            11111111100111235788999999999999999888766543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.1e-41  Score=331.53  Aligned_cols=266  Identities=19%  Similarity=0.236  Sum_probs=194.9

Q ss_pred             hCCCCcceeeecCCeeEEEEEe-CCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-----------ccccccccceee
Q 011005          205 EDFDIRYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-----------HRNIVKLYGYCL  272 (496)
Q Consensus       205 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~  272 (496)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++....  ..+.+.+|+.++++++           |+||+++++++.
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~--~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc--chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            4599999999999999999976 5799999999986542  2356788999888875           578999998886


Q ss_pred             cC--CeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCC----
Q 011005          273 HK--KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLE----  346 (496)
Q Consensus       273 ~~--~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~----  346 (496)
                      ..  ...+++++++..+..............+++..+..++.||+.||+|||+  ..||+||||||+|||++.++.    
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccc
Confidence            53  4567777776665544443333444478999999999999999999995  369999999999999986653    


Q ss_pred             --eEEccccccccccCCCCCccccccccccccccccccCCcCcccchhhHHHHHHHHHhCCCCCccccccCCCCCC----
Q 011005          347 --AFVADFGTARLLHADSSNRTLLAGTYGYIAPELAYTMVMTEKCDVYSFGVVTLEVLMGKHPRDILSSLSSSSDP----  420 (496)
Q Consensus       347 --~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~p~~~~~~~~~~~~~----  420 (496)
                        ++++|||.+......   ....+||+.|+|||++.+..++.++||||+||++++|++|+.||............    
T Consensus       169 ~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             ceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence              899999999865432   23467999999999999999999999999999999999999999643221100000    


Q ss_pred             ----------cchh------Hhhhc-----CCCCCCC-----------ChhHHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 011005          421 ----------KIML------IDVLD-----QRLPPPV-----------DRKVIRDILLISTVSFACLQSNPKSRPTMQSV  468 (496)
Q Consensus       421 ----------~~~~------~~~~~-----~~~~~~~-----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ev  468 (496)
                                ....      .....     .......           ..........+.+|+.+||..||++|||++|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence                      0000      00000     0000000           00012334468899999999999999999999


Q ss_pred             HHHHHHhcc
Q 011005          469 SQEFLITRK  477 (496)
Q Consensus       469 l~~~~~~~~  477 (496)
                      ++|+|+...
T Consensus       326 L~Hp~f~~~  334 (362)
T d1q8ya_         326 VNHPWLKDT  334 (362)
T ss_dssp             HTCGGGTTC
T ss_pred             hcCcccCCC
Confidence            999999844

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=1.1e-24  Score=191.57  Aligned_cols=164  Identities=15%  Similarity=0.205  Sum_probs=119.8

Q ss_pred             CCcceeeecCCeeEEEEEeCCCcEEEEEEcccchh-----------------HHHHHHHHHHHHHHHhhcccccccccce
Q 011005          208 DIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEE-----------------LAFIKSFKNEAQVLSQVLHRNIVKLYGY  270 (496)
Q Consensus       208 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------------~~~~~~~~~e~~~l~~l~h~niv~~~~~  270 (496)
                      .+.+.||+|+||+||+|..++|+.||||+++....                 ........+|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            45788999999999999988999999998753210                 1112344678888999999999887765


Q ss_pred             eecCCeEEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEeCCCCCceEecCCCCeEEc
Q 011005          271 CLHKKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKLEAFVA  350 (496)
Q Consensus       271 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~H~dlkp~Nil~~~~~~~kl~  350 (496)
                      ..    .+++|||++++.+.          .++......++.|++.+++|||   ..||+||||||+|||+++++ ++|+
T Consensus        83 ~~----~~lvme~~~~~~~~----------~l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~~-~~li  144 (191)
T d1zara2          83 EG----NAVLMELIDAKELY----------RVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEEG-IWII  144 (191)
T ss_dssp             ET----TEEEEECCCCEEGG----------GCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETTE-EEEC
T ss_pred             cC----CEEEEEeecccccc----------chhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCCC-EEEE
Confidence            32    26999999886543          2334445679999999999999   67999999999999999764 8899


Q ss_pred             cccccccccCCCCCccccccccccccc--c---ccccCCcCcccchhhHHHH
Q 011005          351 DFGTARLLHADSSNRTLLAGTYGYIAP--E---LAYTMVMTEKCDVYSFGVV  397 (496)
Q Consensus       351 Dfg~~~~~~~~~~~~~~~~gt~~y~aP--E---~~~~~~~~~~~DvwslG~i  397 (496)
                      |||+|+....+...        .|...  +   ....+.|+.++|+||+.--
T Consensus       145 DFG~a~~~~~~~~~--------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         145 DFPQSVEVGEEGWR--------EILERDVRNIITYFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CCTTCEETTSTTHH--------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred             ECCCcccCCCCCcH--------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence            99999765432211        11111  0   1124678889999996543

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.70  E-value=1.6e-17  Score=145.34  Aligned_cols=125  Identities=26%  Similarity=0.330  Sum_probs=112.0

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCC-CCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIG-PIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~-~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      .|+++.||..+.  +++++|+|++|+|++ ..+..|..+++|+.|+|++|+++...+..+..+++|+.|+|++|+|+...
T Consensus        17 ~~~L~~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~   94 (192)
T d1w8aa_          17 GRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEIS   94 (192)
T ss_dssp             TSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEEC
T ss_pred             CCCcCccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccC
Confidence            478899998774  689999999999986 44667899999999999999999888899999999999999999999777


Q ss_pred             CccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCCCCCCC
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGN  128 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~~  128 (496)
                      +..|.++++|+.|+|++|+|++..+.+|..+++|+. +.+.+|++.|..
T Consensus        95 ~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~-l~L~~N~~~~~~  142 (192)
T d1w8aa_          95 NKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTS-LNLASNPFNCNC  142 (192)
T ss_dssp             SSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCE-EECTTCCBCCSG
T ss_pred             HHHHhCCCcccccccCCccccccCHHHhcCCccccc-cccccccccccc
Confidence            888999999999999999999999999999999965 467888887753

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.57  E-value=1.8e-15  Score=121.60  Aligned_cols=98  Identities=30%  Similarity=0.382  Sum_probs=77.5

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC-
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI-   79 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~-   79 (496)
                      .|+++.+|. ++++++|++|+|++|+|+ .+|+.|+.+++|+.|++++|+|+ .+| .+..+++|++|++++|+|+... 
T Consensus         7 ~n~l~~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~~~~~   82 (124)
T d1dcea3           7 HKDLTVLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAA   82 (124)
T ss_dssp             TSCCSSCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCCSSST
T ss_pred             CCCCCCCcc-cccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCccCCCCC
Confidence            477887864 788888888888888887 56777888888888888888888 454 5888888888888888887432 


Q ss_pred             CccccCcccccccccccccCCCC
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGP  102 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~  102 (496)
                      ...+..+++|+.|++++|+++..
T Consensus        83 ~~~l~~~~~L~~L~l~~N~i~~~  105 (124)
T d1dcea3          83 IQPLVSCPRLVLLNLQGNSLCQE  105 (124)
T ss_dssp             TGGGGGCTTCCEEECTTSGGGGS
T ss_pred             chhhcCCCCCCEEECCCCcCCcC
Confidence            24678888888888888888743

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=1.5e-14  Score=132.99  Aligned_cols=125  Identities=29%  Similarity=0.288  Sum_probs=93.3

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |++..+|..+.++++|+.|++++|.+.+..+..+..+.+|+.|++++|.++...+..+..+++|+.|++++|++++..+.
T Consensus        87 N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~  166 (266)
T d1p9ag_          87 NQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAG  166 (266)
T ss_dssp             SCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTT
T ss_pred             ccccccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCcc
Confidence            45555555555666666666666666655555566666666667777777755556677888999999999999977777


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCccccccccCCCCCCCCC
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGN  128 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~~  128 (496)
                      .|..+++|+.|+|++|.|+ .+|..+..+++|+ .+.+.+||+.|+.
T Consensus       167 ~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~-~L~L~~Np~~CdC  211 (266)
T d1p9ag_         167 LLNGLENLDTLLLQENSLY-TIPKGFFGSHLLP-FAFLHGNPWLCNC  211 (266)
T ss_dssp             TTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCS-EEECCSCCBCCSG
T ss_pred             ccccccccceeecccCCCc-ccChhHCCCCCCC-EEEecCCCCCCCc
Confidence            8899999999999999999 6777777888885 4678899998874

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.54  E-value=8.4e-15  Score=127.72  Aligned_cols=102  Identities=28%  Similarity=0.434  Sum_probs=93.4

Q ss_pred             CCcccc-CCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCC
Q 011005            1 MYKIGI-IPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGS   78 (496)
Q Consensus         1 ~n~~~~-lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~   78 (496)
                      .|+|+. ++. .|.++++|+.|+|++|.+....++.|..+++|+.|+|++|+|+...|..|.++++|++|+|++|+|++.
T Consensus        38 ~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i  117 (192)
T d1w8aa_          38 DNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCV  117 (192)
T ss_dssp             SCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEE
T ss_pred             CCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCcccccc
Confidence            488865 545 789999999999999999999999999999999999999999977778899999999999999999977


Q ss_pred             CCccccCcccccccccccccCCCC
Q 011005           79 IPGEITKLSRLDYLNLSSNKLSGP  102 (496)
Q Consensus        79 ~~~~~~~l~~L~~l~l~~n~l~~~  102 (496)
                      .++.|..+++|+.|+|++|++...
T Consensus       118 ~~~~f~~l~~L~~l~L~~N~~~~~  141 (192)
T d1w8aa_         118 MPGSFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             CTTSSTTCTTCCEEECTTCCBCCS
T ss_pred             CHHHhcCCcccccccccccccccc
Confidence            788899999999999999999754

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.49  E-value=6.2e-15  Score=139.17  Aligned_cols=117  Identities=36%  Similarity=0.603  Sum_probs=101.3

Q ss_pred             cCChhccCCCCCCEEeccC-CccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCcccc
Q 011005            6 IIPPEIGNLKNLIKLDVGS-NSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEIT   84 (496)
Q Consensus         6 ~lp~~~~~l~~L~~L~l~~-n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~   84 (496)
                      .+|+++++|++|++|+|++ |+++|.+|..|++|++|++|+|++|+|++..|..+..+++|+.+++++|.+.+.+|..+.
T Consensus        67 ~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~  146 (313)
T d1ogqa_          67 PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS  146 (313)
T ss_dssp             ECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGG
T ss_pred             CCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhc
Confidence            4888999999999999986 888888999999999999999999999988888889999999999999998888889999


Q ss_pred             CcccccccccccccCCCCCCCCCCCCCccccccccCCC
Q 011005           85 KLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN  122 (496)
Q Consensus        85 ~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n  122 (496)
                      ++++|+.+++++|.+++.+|..+..+..+...+....|
T Consensus       147 ~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n  184 (313)
T d1ogqa_         147 SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN  184 (313)
T ss_dssp             GCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSS
T ss_pred             cCcccceeeccccccccccccccccccccccccccccc
Confidence            99999999999999998889888888877555554444

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.48  E-value=6.2e-15  Score=124.40  Aligned_cols=109  Identities=22%  Similarity=0.190  Sum_probs=69.6

Q ss_pred             ccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCccccc
Q 011005           11 IGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLD   90 (496)
Q Consensus        11 ~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~   90 (496)
                      +.++.+|++|+|++|+|+ .+|+.+..+++|+.|+|++|+|+ .+ +.+..+++|++|+|++|+++...+..+..+++|+
T Consensus        14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~   90 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   90 (162)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-cc-CCcccCcchhhhhcccccccCCCccccccccccc
Confidence            456667777777777776 44555666777777777777777 34 3467777777777777777744444455677777


Q ss_pred             ccccccccCCCCCC-CCCCCCCccccccccCCCC
Q 011005           91 YLNLSSNKLSGPVP-FSNNDLSSMHTVVSLSPNN  123 (496)
Q Consensus        91 ~l~l~~n~l~~~~~-~~~~~l~~l~~~~~~~~n~  123 (496)
                      .|++++|+|+.... ..+..+++|+.+ .+.+|+
T Consensus        91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L-~l~~N~  123 (162)
T d1a9na_          91 ELILTNNSLVELGDLDPLASLKSLTYL-CILRNP  123 (162)
T ss_dssp             EEECCSCCCCCGGGGGGGGGCTTCCEE-ECCSSG
T ss_pred             cceeccccccccccccccccccccchh-hcCCCc
Confidence            77777777764322 345566666443 344443

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.48  E-value=3.5e-14  Score=113.85  Aligned_cols=101  Identities=26%  Similarity=0.384  Sum_probs=86.4

Q ss_pred             CEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCcccccccccccc
Q 011005           18 IKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSN   97 (496)
Q Consensus        18 ~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~l~l~~n   97 (496)
                      ++|+|++|+|+ .++ .+..+++|++|+|++|+|+ .+|+.+..+++|+.|++++|+|+ .+| .+..+++|+.|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence            58999999999 555 4899999999999999999 68889999999999999999999 455 5899999999999999


Q ss_pred             cCCCCCC-CCCCCCCccccccccCCCCC
Q 011005           98 KLSGPVP-FSNNDLSSMHTVVSLSPNNG  124 (496)
Q Consensus        98 ~l~~~~~-~~~~~l~~l~~~~~~~~n~~  124 (496)
                      +|+.... ..+..+++|+.+ .+.+|+.
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L-~l~~N~i  102 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLL-NLQGNSL  102 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEE-ECTTSGG
T ss_pred             ccCCCCCchhhcCCCCCCEE-ECCCCcC
Confidence            9996543 567888888654 5666653

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.48  E-value=2.3e-14  Score=133.20  Aligned_cols=112  Identities=24%  Similarity=0.271  Sum_probs=56.6

Q ss_pred             ccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            3 KIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         3 ~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      .++.++. .|.++++|++|+|++|.+....+..+..+++|+.+++++|+|++..+..|..+++|+.|+|++|++++..+.
T Consensus        92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~  171 (284)
T d1ozna_          92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER  171 (284)
T ss_dssp             TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred             ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchh
Confidence            3444433 455555555555555555544444455555555555555555533334444555555555555555544444


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCccc
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMH  114 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~  114 (496)
                      .|.++++|+.+++++|.+++..|..|..+++|+
T Consensus       172 ~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~  204 (284)
T d1ozna_         172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM  204 (284)
T ss_dssp             TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred             hhccccccchhhhhhccccccChhHhhhhhhcc
Confidence            455555555555555555554455555554443

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.43  E-value=4.6e-14  Score=133.08  Aligned_cols=121  Identities=34%  Similarity=0.512  Sum_probs=100.1

Q ss_pred             hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCcccc
Q 011005           10 EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRL   89 (496)
Q Consensus        10 ~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L   89 (496)
                      .+.++.. ..+++++|.+.+.+|..+..+++|+.|++++|.+++. ++.+..+++|+.|+|++|+++|.+|..++++++|
T Consensus       193 ~~~~l~~-~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~-~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L  270 (313)
T d1ogqa_         193 TFANLNL-AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD-LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFL  270 (313)
T ss_dssp             GGGGCCC-SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCB-GGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTC
T ss_pred             ccccccc-ccccccccccccccccccccccccccccccccccccc-ccccccccccccccCccCeecccCChHHhCCCCC
Confidence            4444433 3566666666677788888899999999999999965 4578899999999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCCCCccccccccCCCCCCCCCCCCCCCCC
Q 011005           90 DYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGNILDLPSCD  136 (496)
Q Consensus        90 ~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~~~~~~~~~~  136 (496)
                      +.|+|++|+|+|.+|. +.++++|+ .+.+.+|+..|+.+  +|+|+
T Consensus       271 ~~L~Ls~N~l~g~iP~-~~~L~~L~-~l~l~~N~~l~g~p--lp~c~  313 (313)
T d1ogqa_         271 HSLNVSFNNLCGEIPQ-GGNLQRFD-VSAYANNKCLCGSP--LPACT  313 (313)
T ss_dssp             CEEECCSSEEEEECCC-STTGGGSC-GGGTCSSSEEESTT--SSCCC
T ss_pred             CEEECcCCcccccCCC-cccCCCCC-HHHhCCCccccCCC--CCCCC
Confidence            9999999999998884 57888884 56788999999864  56773

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.42  E-value=1.5e-13  Score=114.99  Aligned_cols=109  Identities=21%  Similarity=0.205  Sum_probs=60.9

Q ss_pred             CCCEEeccCCccCCCCCccCCCCCCCCEEeccCC-cCCCCCchhhcCCcccCeecccccccCCCCCccccCccccccccc
Q 011005           16 NLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSN-KLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNL   94 (496)
Q Consensus        16 ~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n-~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~l~l   94 (496)
                      ..+.++++++++. ..|..+..+++|+.|+|++| .|+...++.|.++++|+.|+|++|+|+...+..|..+++|+.|+|
T Consensus         9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L   87 (156)
T d2ifga3           9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL   87 (156)
T ss_dssp             SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred             CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence            3445666666655 44555666666666666544 355444445666666666666666666444555666666666666


Q ss_pred             ccccCCCCCCCCCCCCCccccccccCCCCCCCC
Q 011005           95 SSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCG  127 (496)
Q Consensus        95 ~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~  127 (496)
                      ++|+|+...+..|..+ +|+. +.+++|++.|+
T Consensus        88 s~N~l~~l~~~~~~~~-~l~~-L~L~~Np~~C~  118 (156)
T d2ifga3          88 SFNALESLSWKTVQGL-SLQE-LVLSGNPLHCS  118 (156)
T ss_dssp             CSSCCSCCCSTTTCSC-CCCE-EECCSSCCCCC
T ss_pred             cCCCCcccChhhhccc-cccc-cccCCCcccCC
Confidence            6666664444444433 3433 34555665554

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.41  E-value=4.6e-14  Score=118.93  Aligned_cols=112  Identities=20%  Similarity=0.257  Sum_probs=92.4

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      +|+|+.+|..+..+++|+.|+|++|+|+. ++ .|..+++|+.|+|++|+|+...+..+..+++|+.|+|++|+|+ .++
T Consensus        27 ~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~-~~~  103 (162)
T d1a9na_          27 GYKIPVIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELG  103 (162)
T ss_dssp             TSCCCSCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGG
T ss_pred             CCCCCccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccccceecccccc-ccc
Confidence            58999998877889999999999999994 44 5899999999999999999654555678999999999999998 444


Q ss_pred             --ccccCcccccccccccccCCCCCC---CCCCCCCcccc
Q 011005           81 --GEITKLSRLDYLNLSSNKLSGPVP---FSNNDLSSMHT  115 (496)
Q Consensus        81 --~~~~~l~~L~~l~l~~n~l~~~~~---~~~~~l~~l~~  115 (496)
                        ..+..+++|+.|++++|+++....   ..+..+++|+.
T Consensus       104 ~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~  143 (162)
T d1a9na_         104 DLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRV  143 (162)
T ss_dssp             GGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSE
T ss_pred             cccccccccccchhhcCCCccccccchHHHHHHHCCCcCe
Confidence              468899999999999999984431   23555666643

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.37  E-value=7.7e-13  Score=122.67  Aligned_cols=126  Identities=24%  Similarity=0.257  Sum_probs=112.9

Q ss_pred             CccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            2 YKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         2 n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      |.+..++. .+..+++|+.+++++|+|+++.+..|..+++|+.|+|++|+|++..+..|.++++|+.+++++|++++..|
T Consensus       115 n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~  194 (284)
T d1ozna_         115 CGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP  194 (284)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred             cccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccCh
Confidence            56666666 67789999999999999997778889999999999999999997778889999999999999999998889


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccccccCCCCCCCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPNNGLCGN  128 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~~c~~  128 (496)
                      ..|..+++|+.|++++|.+++..+..|..+++|+. +.+++|++.|+.
T Consensus       195 ~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~-L~l~~N~l~C~C  241 (284)
T d1ozna_         195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY-LRLNDNPWVCDC  241 (284)
T ss_dssp             TTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCE-EECCSSCEECSG
T ss_pred             hHhhhhhhcccccccccccccccccccccccccCE-EEecCCCCCCCc
Confidence            99999999999999999999998899999999964 578899988863

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.34  E-value=1.6e-12  Score=119.18  Aligned_cols=113  Identities=27%  Similarity=0.321  Sum_probs=75.5

Q ss_pred             CCccccCCh-hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC
Q 011005            1 MYKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI   79 (496)
Q Consensus         1 ~n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~   79 (496)
                      .|+|+.+|. .|.++++|++|+|++|+|+ .+| .++.+++|+.|+|++|+++ ..+..+..+++|+.|++++|.+.+..
T Consensus        40 ~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~  116 (266)
T d1p9ag_          40 ENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLP  116 (266)
T ss_dssp             TSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCC
T ss_pred             CCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccc-ccccccccccccccccccccccceee
Confidence            477888776 6788888888888888887 344 3567788888888888877 45566666666666666666555333


Q ss_pred             ------------------------CccccCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           80 ------------------------PGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        80 ------------------------~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                                              +..+..+++|+.|++++|+|++..+..|..+++|+.|
T Consensus       117 ~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L  177 (266)
T d1p9ag_         117 LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL  177 (266)
T ss_dssp             SSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEE
T ss_pred             ccccccccccccccccccccceeccccccccccchhcccccccccccCcccccccccccee
Confidence                                    3344455566666666666666666666666666443

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.34  E-value=1.4e-12  Score=108.87  Aligned_cols=98  Identities=23%  Similarity=0.161  Sum_probs=85.1

Q ss_pred             CccccCChhccCCCCCCEEeccCC-ccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSN-SLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n-~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      +.+..+|..+..+++|+.|+|++| .|+.+.++.|.++++|+.|+|++|+|+...|..|..+++|++|+|++|+|+ .+|
T Consensus        18 ~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~   96 (156)
T d2ifga3          18 DGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLS   96 (156)
T ss_dssp             SCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCC
T ss_pred             CCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccC
Confidence            566778899999999999999766 588777788999999999999999999777888999999999999999999 555


Q ss_pred             ccccCcccccccccccccCC
Q 011005           81 GEITKLSRLDYLNLSSNKLS  100 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~  100 (496)
                      .......+|+.|+|++|++.
T Consensus        97 ~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          97 WKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             STTTCSCCCCEEECCSSCCC
T ss_pred             hhhhccccccccccCCCccc
Confidence            54444457999999999996

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.28  E-value=4.6e-12  Score=118.61  Aligned_cols=121  Identities=26%  Similarity=0.294  Sum_probs=96.6

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |++..+|..+  +++|+.|++++|.+++..+..|..++.++.|++++|.+++..+..+.++++|++|+|++|+|+ .+|.
T Consensus       160 n~l~~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~  236 (305)
T d1xkua_         160 TNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPG  236 (305)
T ss_dssp             SCCCSCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCT
T ss_pred             CCccccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-cccc
Confidence            5666776643  578899999999888888888999999999999999999777888899999999999999998 6788


Q ss_pred             cccCcccccccccccccCCCCCCCCCC------CCCccccccccCCCCCCC
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNN------DLSSMHTVVSLSPNNGLC  126 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~------~l~~l~~~~~~~~n~~~c  126 (496)
                      ++..+++|+.|+|++|+|+......|.      .+.+|+. +.+.+|++.+
T Consensus       237 ~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~-L~L~~N~~~~  286 (305)
T d1xkua_         237 GLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSG-VSLFSNPVQY  286 (305)
T ss_dssp             TTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSE-EECCSSSSCG
T ss_pred             ccccccCCCEEECCCCccCccChhhccCcchhcccCCCCE-EECCCCcCcc
Confidence            899999999999999999876555554      3344533 3566776544

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.23  E-value=5.9e-14  Score=122.56  Aligned_cols=115  Identities=27%  Similarity=0.292  Sum_probs=95.0

Q ss_pred             ccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCcc
Q 011005            3 KIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGE   82 (496)
Q Consensus         3 ~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~   82 (496)
                      .+..+|.+++.|++|++|+|++|+|+. ++ .+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++. + ..
T Consensus        36 ~i~~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~  110 (198)
T d1m9la_          36 PIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SG  110 (198)
T ss_dssp             TCCCCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HH
T ss_pred             chhhhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-cc
Confidence            356677789999999999999999994 44 5889999999999999999 677777777899999999999994 4 35


Q ss_pred             ccCcccccccccccccCCCCCC-CCCCCCCccccccccCCCC
Q 011005           83 ITKLSRLDYLNLSSNKLSGPVP-FSNNDLSSMHTVVSLSPNN  123 (496)
Q Consensus        83 ~~~l~~L~~l~l~~n~l~~~~~-~~~~~l~~l~~~~~~~~n~  123 (496)
                      +..+++|+.|++++|.|+.... ..+..+++|+.+ .+++|+
T Consensus       111 ~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L-~L~~N~  151 (198)
T d1m9la_         111 IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDL-LLAGNP  151 (198)
T ss_dssp             HHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEE-EECSSH
T ss_pred             ccccccccccccccchhccccccccccCCCcccee-ecCCCc
Confidence            8899999999999999985432 457788888654 455554

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.15  E-value=3e-11  Score=112.87  Aligned_cols=112  Identities=29%  Similarity=0.279  Sum_probs=92.0

Q ss_pred             Ccccc-CChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            2 YKIGI-IPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         2 n~~~~-lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      |.+.. .+..|.+++.++.|++++|.+++..+..|.++++|++|+|++|+|+ .+|+.+.++++|+.|+|++|+|+....
T Consensus       181 n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~  259 (305)
T d1xkua_         181 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGS  259 (305)
T ss_dssp             SCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCT
T ss_pred             CcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccCh
Confidence            44444 4458899999999999999999888899999999999999999999 689999999999999999999994432


Q ss_pred             c------cccCcccccccccccccCC--CCCCCCCCCCCccc
Q 011005           81 G------EITKLSRLDYLNLSSNKLS--GPVPFSNNDLSSMH  114 (496)
Q Consensus        81 ~------~~~~l~~L~~l~l~~n~l~--~~~~~~~~~l~~l~  114 (496)
                      .      .+..+.+|+.|++++|+++  ...|.+|..+...+
T Consensus       260 ~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~~~  301 (305)
T d1xkua_         260 NDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRA  301 (305)
T ss_dssp             TSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGG
T ss_pred             hhccCcchhcccCCCCEEECCCCcCccCcCCHhHhcccccCc
Confidence            2      3446789999999999986  35566666555443

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.13  E-value=1.8e-13  Score=119.46  Aligned_cols=100  Identities=25%  Similarity=0.303  Sum_probs=85.0

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      .|+|+.++ .+.+|++|+.|+|++|+|+ .+|..+..+++|+.|++++|+|+. + +.+..+++|+.|+|++|+|+ .++
T Consensus        57 ~n~I~~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L~~L~L~~N~i~-~~~  131 (198)
T d1m9la_          57 TNNIEKIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNLRVLYMSNNKIT-NWG  131 (198)
T ss_dssp             EEEESCCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHSSEEEESEEECC-CHH
T ss_pred             ccCCCCcc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccccccccccccccchhc-ccc
Confidence            37788886 5899999999999999998 567666667889999999999994 4 46889999999999999998 444


Q ss_pred             --ccccCcccccccccccccCCCCCCC
Q 011005           81 --GEITKLSRLDYLNLSSNKLSGPVPF  105 (496)
Q Consensus        81 --~~~~~l~~L~~l~l~~n~l~~~~~~  105 (496)
                        ..+..+++|+.|++++|+++...+.
T Consensus       132 ~~~~l~~l~~L~~L~L~~N~l~~~~~~  158 (198)
T d1m9la_         132 EIDKLAALDKLEDLLLAGNPLYNDYKE  158 (198)
T ss_dssp             HHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred             ccccccCCCccceeecCCCccccCccc
Confidence              4689999999999999999755443

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.11  E-value=9.5e-11  Score=102.07  Aligned_cols=112  Identities=29%  Similarity=0.496  Sum_probs=91.6

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      .|+++.+++ ++++++|+.|++++|.+. .++ .+.++++|+.|++++|.+.. + +.+..+++|+.|++++|++. .++
T Consensus        71 ~N~l~~~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~l~~n~l~-~~~  144 (199)
T d2omxa2          71 NNQLTDITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITD-I-DPLKNLTNLNRLELSSNTIS-DIS  144 (199)
T ss_dssp             SSCCCCCGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCC-CCG
T ss_pred             cccccCccc-ccCCcccccccccccccc-ccc-cccccccccccccccccccc-c-cccchhhhhHHhhhhhhhhc-ccc
Confidence            477888775 899999999999999988 444 48899999999999999884 3 45888999999999999998 444


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccccccCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN  122 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n  122 (496)
                       .+..+++|+.|++.+|.+++..  .+.++++|+.+ .+++|
T Consensus       145 -~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L-~ls~N  182 (199)
T d2omxa2         145 -ALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERL-DISSN  182 (199)
T ss_dssp             -GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEE-ECCSS
T ss_pred             -cccccccccccccccccccCCc--cccCCCCCCEE-ECCCC
Confidence             5888999999999999998654  37788888665 44554

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.08  E-value=2.8e-10  Score=99.00  Aligned_cols=107  Identities=31%  Similarity=0.459  Sum_probs=89.1

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |.|..++ .+..+++|++|+|++|+|++..|  ++++++|+.|++++|.+. .++ .+.++++|+.|++++|.+.. . .
T Consensus        50 ~~i~~l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~-~-~  122 (199)
T d2omxa2          50 LGIKSID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITD-I-D  122 (199)
T ss_dssp             SCCCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-C-G
T ss_pred             CCCCCcc-ccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-cccccccccccccccccccc-c-c
Confidence            5677774 58899999999999999996533  999999999999999998 455 58999999999999999984 3 3


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCcccccc
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVV  117 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~  117 (496)
                      .+..+++|+.|++++|++... + .+..+++++.+.
T Consensus       123 ~~~~l~~L~~L~l~~n~l~~~-~-~l~~~~~L~~L~  156 (199)
T d2omxa2         123 PLKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLN  156 (199)
T ss_dssp             GGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCSEEE
T ss_pred             ccchhhhhHHhhhhhhhhccc-c-cccccccccccc
Confidence            588899999999999999853 3 467777776554

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.05  E-value=1.8e-10  Score=101.11  Aligned_cols=112  Identities=33%  Similarity=0.449  Sum_probs=87.4

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCC
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIP   80 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~   80 (496)
                      +|+++.++. +++|++|+.|++++|+|++ +| .+..+++|+.|++++|.+. .+ +.+..+++|+.+++++|.+++  +
T Consensus        77 ~n~i~~l~~-~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~--~  149 (210)
T d1h6ta2          77 GNKLTDIKP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD--I  149 (210)
T ss_dssp             SSCCCCCGG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECCSSCCCC--C
T ss_pred             CccccCccc-cccCccccccccccccccc-cc-ccccccccccccccccccc-cc-ccccccccccccccccccccc--c
Confidence            477888874 7889999999999999984 55 5889999999999999987 34 467888888888888888873  3


Q ss_pred             ccccCcccccccccccccCCCCCCCCCCCCCccccccccCCC
Q 011005           81 GEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN  122 (496)
Q Consensus        81 ~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n  122 (496)
                      ..+..+++|+.+++++|++++..+  +.++++|+.+. ++.|
T Consensus       150 ~~~~~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~-Ls~N  188 (210)
T d1h6ta2         150 TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY-LSKN  188 (210)
T ss_dssp             GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEE-CCSS
T ss_pred             cccccccccccccccccccccccc--ccCCCCCCEEE-CCCC
Confidence            356778888888888888886543  67777776543 4444

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.04  E-value=1.4e-10  Score=111.66  Aligned_cols=108  Identities=31%  Similarity=0.431  Sum_probs=60.8

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCC--------------------chhhcC
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKI--------------------PPEIAS   61 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~--------------------p~~~~~   61 (496)
                      |+++.+| .+..+++|+.|++++|.+++..+  +..+++|+.|++++|++++..                    +..+..
T Consensus       229 n~l~~~~-~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~  305 (384)
T d2omza2         229 NQLKDIG-TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN  305 (384)
T ss_dssp             SCCCCCG-GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGG
T ss_pred             CCCCCcc-hhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCccccccccccccccccccccccccch
Confidence            4444443 45555666666666666553322  555555555555555554321                    123555


Q ss_pred             CcccCeecccccccCCCCCccccCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           62 MKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        62 l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      +++|+.|++++|++++. + .+..+++|+.|++++|+|++. + .+.++++|+.+
T Consensus       306 ~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~l-~-~l~~l~~L~~L  356 (384)
T d2omza2         306 LKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSDV-S-SLANLTNINWL  356 (384)
T ss_dssp             CTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCCC-G-GGGGCTTCCEE
T ss_pred             hcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCCC-h-hHcCCCCCCEE
Confidence            66677777777777643 2 266677777777777777642 2 46666666543

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.04  E-value=4.5e-10  Score=98.54  Aligned_cols=111  Identities=31%  Similarity=0.404  Sum_probs=90.6

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |+++.++ .+..+++|++|+|++|.|++. + .++.+++|++|++++|+|+ .+| .+..+++|+.|++++|.+. .+ .
T Consensus        56 ~~i~~l~-~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~-~  128 (210)
T d1h6ta2          56 SDIKSVQ-GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DI-N  128 (210)
T ss_dssp             SCCCCCT-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-CC-G
T ss_pred             CCCCCch-hHhhCCCCCEEeCCCccccCc-c-ccccCcccccccccccccc-ccc-ccccccccccccccccccc-cc-c
Confidence            5677776 488999999999999999954 4 3789999999999999999 455 6899999999999999997 44 4


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCccccccccCCC
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVVSLSPN  122 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~~~~~n  122 (496)
                      .+..+++|+.+++++|.+++.  ..+..+++|+.+ .+++|
T Consensus       129 ~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l-~l~~n  166 (210)
T d1h6ta2         129 GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTL-SLEDN  166 (210)
T ss_dssp             GGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEE-ECCSS
T ss_pred             ccccccccccccccccccccc--cccccccccccc-ccccc
Confidence            688999999999999999854  346677788554 34444

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.04  E-value=2.9e-10  Score=101.12  Aligned_cols=113  Identities=28%  Similarity=0.438  Sum_probs=76.9

Q ss_pred             CCccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCc------------------------
Q 011005            1 MYKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIP------------------------   56 (496)
Q Consensus         1 ~n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p------------------------   56 (496)
                      +|+|+.++ .++.|++|+.|+|++|+|++..|  +..+++|+.+++++|.++. ++                        
T Consensus        50 ~~~i~~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i~~l~~l~~L~~l~l~~~~~~~~~~~  125 (227)
T d1h6ua2          50 GTGVTTIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQITDVTPL  125 (227)
T ss_dssp             TSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CGGGTTCTTCCEEECTTSCCCCCGGG
T ss_pred             CCCCCcch-hHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc-cccccccccccccccccccccccchh
Confidence            36677774 57788888888888888875433  6666666666666666552 11                        


Q ss_pred             -------------------hhhcCCcccCeecccccccCCCCCccccCcccccccccccccCCCCCCCCCCCCCcccccc
Q 011005           57 -------------------PEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTVV  117 (496)
Q Consensus        57 -------------------~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~~  117 (496)
                                         ..+..+++|+.|++++|.+++ . ..+.++++|+.|++++|++++..+  +.++++|+.+ 
T Consensus       126 ~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~-~-~~l~~l~~L~~L~Ls~n~l~~l~~--l~~l~~L~~L-  200 (227)
T d1h6ua2         126 AGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSD-L-TPLANLSKLTTLKADDNKISDISP--LASLPNLIEV-  200 (227)
T ss_dssp             TTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEE-
T ss_pred             ccccchhhhhchhhhhchhhhhcccccccccccccccccc-c-hhhcccccceecccCCCccCCChh--hcCCCCCCEE-
Confidence                               124455667777777777763 2 247889999999999999986533  7788888654 


Q ss_pred             ccCCC
Q 011005          118 SLSPN  122 (496)
Q Consensus       118 ~~~~n  122 (496)
                      .+++|
T Consensus       201 ~Ls~N  205 (227)
T d1h6ua2         201 HLKNN  205 (227)
T ss_dssp             ECTTS
T ss_pred             ECcCC
Confidence            45555

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.93  E-value=5.4e-10  Score=107.53  Aligned_cols=106  Identities=25%  Similarity=0.431  Sum_probs=89.3

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCc
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPG   81 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~   81 (496)
                      |++..++ .+.+++.++.++++.|++++.  ..+..+++++.|+|++|+|++. + .+..+++|+.|+|++|+++ .++ 
T Consensus       273 ~~l~~~~-~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~-~l~-  345 (384)
T d2omza2         273 NQISNIS-PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVS-DVS-  345 (384)
T ss_dssp             SCCCCCG-GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCC-CCG-
T ss_pred             cccCCCC-ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCC-CCh-
Confidence            5566665 477889999999999999853  3588999999999999999964 3 4889999999999999998 455 


Q ss_pred             cccCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           82 EITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        82 ~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      .+.++++|+.|++++|+|++..|  +.++++|+.|
T Consensus       346 ~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L  378 (384)
T d2omza2         346 SLANLTNINWLSAGHNQISDLTP--LANLTRITQL  378 (384)
T ss_dssp             GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEE
T ss_pred             hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEe
Confidence            68999999999999999998765  7788888654

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.89  E-value=9.4e-10  Score=98.72  Aligned_cols=101  Identities=21%  Similarity=0.295  Sum_probs=84.9

Q ss_pred             CccccCChhccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCc-hhhcCCcccCeeccc-ccccCCCC
Q 011005            2 YKIGIIPPEIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIP-PEIASMKYLTQLDLS-NNNIQGSI   79 (496)
Q Consensus         2 n~~~~lp~~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p-~~~~~l~~L~~l~l~-~N~l~~~~   79 (496)
                      +.++.+|..+.  +++++|+|++|+|+...+..|.++++|++|+|++|.+...+| ..|..++.++.+.+. .|.+....
T Consensus        18 ~~l~~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~   95 (242)
T d1xwdc1          18 SKVTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYIN   95 (242)
T ss_dssp             CSCSSCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEEC
T ss_pred             CCCCCcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccc
Confidence            45788997664  589999999999996666789999999999999999886544 468899999999886 47887677


Q ss_pred             CccccCcccccccccccccCCCCCC
Q 011005           80 PGEITKLSRLDYLNLSSNKLSGPVP  104 (496)
Q Consensus        80 ~~~~~~l~~L~~l~l~~n~l~~~~~  104 (496)
                      +..|..+++|+.|++++|.++...+
T Consensus        96 ~~~~~~l~~L~~l~l~~~~l~~~~~  120 (242)
T d1xwdc1          96 PEAFQNLPNLQYLLISNTGIKHLPD  120 (242)
T ss_dssp             TTSEECCTTCCEEEEESCCCCSCCC
T ss_pred             cccccccccccccccchhhhccccc
Confidence            7889999999999999999985544

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.79  E-value=4.4e-09  Score=93.30  Aligned_cols=99  Identities=28%  Similarity=0.391  Sum_probs=80.7

Q ss_pred             hccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCcccc
Q 011005           10 EIGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRL   89 (496)
Q Consensus        10 ~~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L   89 (496)
                      .+...+.+..+.++++.+...  ..+..+++|+.|++++|.+++.  ..+.++++|+.|+|++|++++ ++ .++++++|
T Consensus       124 ~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L  197 (227)
T d1h6ua2         124 PLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISD-IS-PLASLPNL  197 (227)
T ss_dssp             GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTC
T ss_pred             hhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--hhhcccccceecccCCCccCC-Ch-hhcCCCCC
Confidence            466788899999999998743  3477889999999999999843  348899999999999999984 44 38899999


Q ss_pred             cccccccccCCCCCCCCCCCCCccccc
Q 011005           90 DYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        90 ~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      +.|++++|+|++..|  +.++++|+.+
T Consensus       198 ~~L~Ls~N~lt~i~~--l~~l~~L~~L  222 (227)
T d1h6ua2         198 IEVHLKNNQISDVSP--LANTSNLFIV  222 (227)
T ss_dssp             CEEECTTSCCCBCGG--GTTCTTCCEE
T ss_pred             CEEECcCCcCCCCcc--cccCCCCCEE
Confidence            999999999996544  6677777543

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.62  E-value=2.1e-08  Score=89.59  Aligned_cols=114  Identities=18%  Similarity=0.156  Sum_probs=69.5

Q ss_pred             CccccCCh-hccCCCCCCEEeccCCccCCCCC-------------------------ccCCCCC-CCCEEeccCCcCCCC
Q 011005            2 YKIGIIPP-EIGNLKNLIKLDVGSNSLIGPIP-------------------------SALGSLT-NLSNLDLSSNKLSGK   54 (496)
Q Consensus         2 n~~~~lp~-~~~~l~~L~~L~l~~n~i~~~~p-------------------------~~~~~l~-~L~~l~l~~n~l~~~   54 (496)
                      |++..++. .|.++++|+.|++++|++....+                         ..|..++ .++.|++++|+++ .
T Consensus        89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~-~  167 (242)
T d1xwdc1          89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-E  167 (242)
T ss_dssp             TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-E
T ss_pred             ccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc-c
Confidence            45555554 57788888888888887763222                         2222222 4555666666666 3


Q ss_pred             CchhhcCCcccCee-cccccccCCCCCccccCcccccccccccccCCCCCCCCCCCCCccccc
Q 011005           55 IPPEIASMKYLTQL-DLSNNNIQGSIPGEITKLSRLDYLNLSSNKLSGPVPFSNNDLSSMHTV  116 (496)
Q Consensus        55 ~p~~~~~l~~L~~l-~l~~N~l~~~~~~~~~~l~~L~~l~l~~n~l~~~~~~~~~~l~~l~~~  116 (496)
                      ++......++++.+ ++++|+++...+..|.++++|+.|++++|+|+...+..|.++++|+.+
T Consensus       168 i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l  230 (242)
T d1xwdc1         168 IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR  230 (242)
T ss_dssp             ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESS
T ss_pred             cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccC
Confidence            44444444454443 566777774334457777888888888888876666667777776543

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.56  E-value=2.9e-09  Score=88.90  Aligned_cols=105  Identities=19%  Similarity=0.160  Sum_probs=70.3

Q ss_pred             ccCCCCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCC--chhhcCCcccCeecccccccCCCCCccccCccc
Q 011005           11 IGNLKNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKI--PPEIASMKYLTQLDLSNNNIQGSIPGEITKLSR   88 (496)
Q Consensus        11 ~~~l~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~--p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~   88 (496)
                      +..+..+..+++.+|.+. .++..+..+++|++|+|++|+|+..-  +..+..+++|+.|+|++|.|+...+-......+
T Consensus        38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~  116 (162)
T d1koha1          38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK  116 (162)
T ss_dssp             TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred             hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence            344444555555555544 44555567889999999999998532  345778899999999999998433323334457


Q ss_pred             ccccccccccCCCCCCCC-------CCCCCccccc
Q 011005           89 LDYLNLSSNKLSGPVPFS-------NNDLSSMHTV  116 (496)
Q Consensus        89 L~~l~l~~n~l~~~~~~~-------~~~l~~l~~~  116 (496)
                      |+.|++++|+++......       +..+++|..|
T Consensus       117 L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~L  151 (162)
T d1koha1         117 LEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRL  151 (162)
T ss_dssp             CSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEE
T ss_pred             cceeecCCCCcCcCcccchhHHHHHHHHCCCCCEE
Confidence            899999999998654432       3455666443

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.56  E-value=1.5e-09  Score=90.80  Aligned_cols=103  Identities=21%  Similarity=0.133  Sum_probs=54.2

Q ss_pred             CCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCC--CccccCcccccccc
Q 011005           16 NLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSI--PGEITKLSRLDYLN   93 (496)
Q Consensus        16 ~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~--~~~~~~l~~L~~l~   93 (496)
                      ..+.|+++++...   + .+..+..+..+++.+|.+. .++..+..+++|+.|+|++|+|+..-  +..+..+++|+.|+
T Consensus        23 ~~~~Ldls~l~~~---~-~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~   97 (162)
T d1koha1          23 SQQALDLKGLRSD---P-DLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN   97 (162)
T ss_dssp             SSCCBCCCCCSSC---T-TTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred             hhCeeecccCCCC---c-hhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence            3455666554422   2 2444444555555555444 34444556777777777777776321  23455667777777


Q ss_pred             cccccCCCCCCCCCCCCCccccccccCCCCC
Q 011005           94 LSSNKLSGPVPFSNNDLSSMHTVVSLSPNNG  124 (496)
Q Consensus        94 l~~n~l~~~~~~~~~~l~~l~~~~~~~~n~~  124 (496)
                      +++|.|+...+..+....+|.. +.+.+|+.
T Consensus        98 Ls~N~i~~l~~l~~l~~~~L~~-L~L~~Npl  127 (162)
T d1koha1          98 LSGNELKSERELDKIKGLKLEE-LWLDGNSL  127 (162)
T ss_dssp             CTTSCCCCGGGHHHHTTCCCSS-CCCTTSTT
T ss_pred             cccCccccchhhhhhhccccce-eecCCCCc
Confidence            7777777544323323333433 33455543

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.55  E-value=1.8e-07  Score=88.11  Aligned_cols=76  Identities=26%  Similarity=0.383  Sum_probs=33.0

Q ss_pred             CCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCccccccccc
Q 011005           15 KNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNL   94 (496)
Q Consensus        15 ~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~l~l   94 (496)
                      ++|++|+|++|+|+ .+|+.   +.+|+.|++++|+++ .+++.   .+.|++|++++|+++ .+|. +..+++|+.|++
T Consensus        58 ~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l  127 (353)
T d1jl5a_          58 PHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDV  127 (353)
T ss_dssp             TTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEEC
T ss_pred             CCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhhh---ccccccccccccccc-cccc-hhhhccceeecc
Confidence            34444455555444 33432   234444444444444 22211   123455555555544 3332 344445555555


Q ss_pred             ccccCC
Q 011005           95 SSNKLS  100 (496)
Q Consensus        95 ~~n~l~  100 (496)
                      ++|.++
T Consensus       128 ~~~~~~  133 (353)
T d1jl5a_         128 DNNSLK  133 (353)
T ss_dssp             CSSCCS
T ss_pred             cccccc
Confidence            554444

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.52  E-value=2.4e-07  Score=83.56  Aligned_cols=149  Identities=13%  Similarity=0.097  Sum_probs=101.1

Q ss_pred             HHHHHHHhCCCCcceeeecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhc-ccccccccceeecCCe
Q 011005          198 EDLIEATEDFDIRYCIGTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVL-HRNIVKLYGYCLHKKC  276 (496)
Q Consensus       198 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  276 (496)
                      .++....+.|...+..+-++.+.||+... +++.+++|+....... ....+.+|..+++.+. +--+.+++.+...++.
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            45666667777666544455578999876 4566778877654321 1234678888888774 3335677888888888


Q ss_pred             EEEEEEecCCCChhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 011005          277 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC-------------------------------  325 (496)
Q Consensus       277 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~-------------------------------  325 (496)
                      .++||++++|.++........     .   ...++.++++.+..||+..                               
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~~-----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDEQ-----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTCS-----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred             eEEEEEecccccccccccccc-----c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence            999999999988765443211     1   1224555666666666410                               


Q ss_pred             -------------------------CCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          326 -------------------------SPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       326 -------------------------~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                                               ...++|+|+.|.||++++++.+-|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                     2238999999999999987667799999874

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.37  E-value=5.8e-07  Score=84.39  Aligned_cols=89  Identities=25%  Similarity=0.372  Sum_probs=71.3

Q ss_pred             CCCCEEeccCCccCCCCCccCCCCCCCCEEeccCCcCCCCCchhhcCCcccCeecccccccCCCCCccccCccccccccc
Q 011005           15 KNLIKLDVGSNSLIGPIPSALGSLTNLSNLDLSSNKLSGKIPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNL   94 (496)
Q Consensus        15 ~~L~~L~l~~n~i~~~~p~~~~~l~~L~~l~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~l~l   94 (496)
                      .+|+.|||++|+++ .+|+.   +++|++|+|++|+|+ .+|+.+   .+|+.|++++|+++ .++..   .+.|+.|++
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L  105 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV  105 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence            36899999999998 67853   578999999999999 788654   57999999999998 55432   146999999


Q ss_pred             ccccCCCCCCCCCCCCCcccccc
Q 011005           95 SSNKLSGPVPFSNNDLSSMHTVV  117 (496)
Q Consensus        95 ~~n~l~~~~~~~~~~l~~l~~~~  117 (496)
                      ++|.++. +|. +..+++|+.+.
T Consensus       106 ~~n~l~~-lp~-~~~l~~L~~L~  126 (353)
T d1jl5a_         106 SNNQLEK-LPE-LQNSSFLKIID  126 (353)
T ss_dssp             CSSCCSS-CCC-CTTCTTCCEEE
T ss_pred             ccccccc-ccc-hhhhccceeec
Confidence            9999995 453 56788887654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.17  E-value=2.1e-06  Score=76.81  Aligned_cols=130  Identities=18%  Similarity=0.153  Sum_probs=87.4

Q ss_pred             eeeecCC-eeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhccc--ccccccceeecCCeEEEEEEecCCCC
Q 011005          212 CIGTGGY-GSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHR--NIVKLYGYCLHKKCMFLIYEYMERGS  288 (496)
Q Consensus       212 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~~~~lV~e~~~~g~  288 (496)
                      .+..|.. +.||+....++..+++|.......    ..+..|...++.+...  .+.+++.+..+++..++||++++|.+
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            3455554 679999988888888998665432    3467788888888533  35667888888888999999999866


Q ss_pred             hhhhhhCCCCCccCCHHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 011005          289 LFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH---------------------------------------------  323 (496)
Q Consensus       289 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---------------------------------------------  323 (496)
                      +.+..        ....   ..+.++...+.-||.                                             
T Consensus        93 ~~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (255)
T d1nd4a_          93 LLSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  161 (255)
T ss_dssp             TTTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             ccccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence            53211        1111   122333344444442                                             


Q ss_pred             ------C----CCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          324 ------D----CSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       324 ------~----~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                            .    ....++|+|+.|.||+++++..+-|+||+.+.
T Consensus       162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                  0    02348999999999999987767899999774

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.89  E-value=2.8e-07  Score=89.93  Aligned_cols=91  Identities=25%  Similarity=0.315  Sum_probs=56.6

Q ss_pred             hccCCCCCCEEeccCCccCC----CCCccCCCCCCCCEEeccCCcCCCC----Cchhhc-CCcccCeecccccccCCC--
Q 011005           10 EIGNLKNLIKLDVGSNSLIG----PIPSALGSLTNLSNLDLSSNKLSGK----IPPEIA-SMKYLTQLDLSNNNIQGS--   78 (496)
Q Consensus        10 ~~~~l~~L~~L~l~~n~i~~----~~p~~~~~l~~L~~l~l~~n~l~~~----~p~~~~-~l~~L~~l~l~~N~l~~~--   78 (496)
                      -+..+++|+.|+|++|+|+.    .++..+..+++|++|||++|+|+..    +...+. ...+|+.|+|++|++++.  
T Consensus        22 l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~  101 (460)
T d1z7xw1          22 LLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC  101 (460)
T ss_dssp             HHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGH
T ss_pred             HHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCcccccc
Confidence            34556777777777777662    2234456777777777777777521    111221 124677777777777532  


Q ss_pred             --CCccccCcccccccccccccCC
Q 011005           79 --IPGEITKLSRLDYLNLSSNKLS  100 (496)
Q Consensus        79 --~~~~~~~l~~L~~l~l~~n~l~  100 (496)
                        ++..+..+++|+.|++++|.++
T Consensus       102 ~~l~~~l~~~~~L~~L~L~~N~i~  125 (460)
T d1z7xw1         102 GVLSSTLRTLPTLQELHLSDNLLG  125 (460)
T ss_dssp             HHHHHHTTSCTTCCEEECCSSBCH
T ss_pred             ccccchhhccccccccccccccch
Confidence              3445666777777777777765

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.71  E-value=1.5e-06  Score=79.24  Aligned_cols=59  Identities=24%  Similarity=0.273  Sum_probs=27.0

Q ss_pred             CCCCCEEeccCCcCCCC-CchhhcCCcccCeecccccccCCCCCccccCccccccccccc
Q 011005           38 LTNLSNLDLSSNKLSGK-IPPEIASMKYLTQLDLSNNNIQGSIPGEITKLSRLDYLNLSS   96 (496)
Q Consensus        38 l~~L~~l~l~~n~l~~~-~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~l~~L~~l~l~~   96 (496)
                      ..+|++|||++|.+++. ++..+..+++|++|+|++|.+++..+..++.+++|+.|++++
T Consensus        45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~  104 (284)
T d2astb2          45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG  104 (284)
T ss_dssp             CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred             CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence            33455555555444321 122334445555555555544433344444445555555544

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.67  E-value=3e-07  Score=89.74  Aligned_cols=107  Identities=19%  Similarity=0.272  Sum_probs=77.1

Q ss_pred             CCCCEEeccCCccCCCC-CccCCCCCCCCEEeccCCcCCC----CCchhhcCCcccCeecccccccCCC----CCcccc-
Q 011005           15 KNLIKLDVGSNSLIGPI-PSALGSLTNLSNLDLSSNKLSG----KIPPEIASMKYLTQLDLSNNNIQGS----IPGEIT-   84 (496)
Q Consensus        15 ~~L~~L~l~~n~i~~~~-p~~~~~l~~L~~l~l~~n~l~~----~~p~~~~~l~~L~~l~l~~N~l~~~----~~~~~~-   84 (496)
                      .+|+.|||++|+|+... ...+..+++|++|+|++|.|+.    .++..+..+++|+.|||++|+|+..    +...+. 
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~   81 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   81 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence            36899999999998521 3446678999999999999883    2345678899999999999998621    222232 


Q ss_pred             CcccccccccccccCCCC----CCCCCCCCCccccccccCCC
Q 011005           85 KLSRLDYLNLSSNKLSGP----VPFSNNDLSSMHTVVSLSPN  122 (496)
Q Consensus        85 ~l~~L~~l~l~~n~l~~~----~~~~~~~l~~l~~~~~~~~n  122 (496)
                      ...+|+.|++++|.+++.    ++..+..+++|+.+ .+++|
T Consensus        82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L-~L~~N  122 (460)
T d1z7xw1          82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL-HLSDN  122 (460)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEE-ECCSS
T ss_pred             CCCCCCEEECCCCCccccccccccchhhcccccccc-ccccc
Confidence            235799999999999753    34456667777654 34444

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.65  E-value=1.4e-05  Score=72.46  Aligned_cols=84  Identities=23%  Similarity=0.295  Sum_probs=65.2

Q ss_pred             CCCCCEEeccCCc--cCC-CCCccCCCCCCCCEEeccCC-cCCCCCchhhcCCcccCeecccc-cccCCCCCccccCccc
Q 011005           14 LKNLIKLDVGSNS--LIG-PIPSALGSLTNLSNLDLSSN-KLSGKIPPEIASMKYLTQLDLSN-NNIQGSIPGEITKLSR   88 (496)
Q Consensus        14 l~~L~~L~l~~n~--i~~-~~p~~~~~l~~L~~l~l~~n-~l~~~~p~~~~~l~~L~~l~l~~-N~l~~~~~~~~~~l~~   88 (496)
                      .++|+.|+++++.  ++. .+...+.++++|+.|+|++| .+++.....+..+++|++|+|++ +.+++.-...++++++
T Consensus       147 ~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~  226 (284)
T d2astb2         147 SETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT  226 (284)
T ss_dssp             CTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTT
T ss_pred             ccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCC
Confidence            4789999998753  332 12233456899999999986 57777778889999999999998 4677555567888999


Q ss_pred             ccccccccc
Q 011005           89 LDYLNLSSN   97 (496)
Q Consensus        89 L~~l~l~~n   97 (496)
                      |+.|+++++
T Consensus       227 L~~L~l~~~  235 (284)
T d2astb2         227 LKTLQVFGI  235 (284)
T ss_dssp             CCEEECTTS
T ss_pred             CCEEeeeCC
Confidence            999999887

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=97.62  E-value=1.9e-06  Score=80.94  Aligned_cols=95  Identities=18%  Similarity=0.179  Sum_probs=70.6

Q ss_pred             CChhccCCCCCCEEeccCCccCCC-----CCccCCCCCCCCEEeccCCcCCCC----CchhhcCCcccCeecccccccCC
Q 011005            7 IPPEIGNLKNLIKLDVGSNSLIGP-----IPSALGSLTNLSNLDLSSNKLSGK----IPPEIASMKYLTQLDLSNNNIQG   77 (496)
Q Consensus         7 lp~~~~~l~~L~~L~l~~n~i~~~-----~p~~~~~l~~L~~l~l~~n~l~~~----~p~~~~~l~~L~~l~l~~N~l~~   77 (496)
                      +...+...++|+.|+|++|+|+..     +...+..+++|+.|+|++|.++..    +...+..+++|++|+|++|.|++
T Consensus       178 l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~  257 (344)
T d2ca6a1         178 WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA  257 (344)
T ss_dssp             HHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred             ccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCc
Confidence            334456788999999999998731     334577889999999999998632    34567788999999999999874


Q ss_pred             CCC----ccccC--cccccccccccccCCC
Q 011005           78 SIP----GEITK--LSRLDYLNLSSNKLSG  101 (496)
Q Consensus        78 ~~~----~~~~~--l~~L~~l~l~~n~l~~  101 (496)
                      .-.    ..+..  .+.|+.|++++|+|+.
T Consensus       258 ~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~  287 (344)
T d2ca6a1         258 RGAAAVVDAFSKLENIGLQTLRLQYNEIEL  287 (344)
T ss_dssp             HHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred             hhhHHHHHHhhhccCCCCCEEECCCCcCCh
Confidence            322    22322  3579999999999864

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.57  E-value=5.5e-05  Score=71.85  Aligned_cols=78  Identities=13%  Similarity=0.122  Sum_probs=47.8

Q ss_pred             cceeeecCCeeEEEEEeCC-CcEEEEEEcccch-----h-HHHHHHHHHHHHHHHhhc-c--cccccccceeecCCeEEE
Q 011005          210 RYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSE-----E-LAFIKSFKNEAQVLSQVL-H--RNIVKLYGYCLHKKCMFL  279 (496)
Q Consensus       210 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-----~-~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~l  279 (496)
                      .+.||.|....||+....+ ++.++||.-....     . .....+...|++.++.+. +  ..+++++.+.  ++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence            3458999999999997654 6788998653211     0 011233456888887774 2  3455555543  344578


Q ss_pred             EEEecCCCCh
Q 011005          280 IYEYMERGSL  289 (496)
Q Consensus       280 V~e~~~~g~L  289 (496)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987543

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=97.56  E-value=2.7e-06  Score=79.79  Aligned_cols=91  Identities=21%  Similarity=0.206  Sum_probs=70.5

Q ss_pred             cCCCCCCEEeccCCccCCC----CCccCCCCCCCCEEeccCCcCCCC-----CchhhcCCcccCeecccccccCCC----
Q 011005           12 GNLKNLIKLDVGSNSLIGP----IPSALGSLTNLSNLDLSSNKLSGK-----IPPEIASMKYLTQLDLSNNNIQGS----   78 (496)
Q Consensus        12 ~~l~~L~~L~l~~n~i~~~----~p~~~~~l~~L~~l~l~~n~l~~~-----~p~~~~~l~~L~~l~l~~N~l~~~----   78 (496)
                      ...+.|+.|++++|.++..    +...+...++|+.|+|++|+|+..     +...+..+++|+.|+|++|.++..    
T Consensus       155 ~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~  234 (344)
T d2ca6a1         155 KNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSA  234 (344)
T ss_dssp             HTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHH
T ss_pred             ccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccc
Confidence            4567899999999988732    233456778999999999998732     234567789999999999998622    


Q ss_pred             CCccccCcccccccccccccCCCC
Q 011005           79 IPGEITKLSRLDYLNLSSNKLSGP  102 (496)
Q Consensus        79 ~~~~~~~l~~L~~l~l~~n~l~~~  102 (496)
                      +...+..+++|+.|++++|.|++.
T Consensus       235 L~~~l~~~~~L~~L~Ls~n~i~~~  258 (344)
T d2ca6a1         235 LAIALKSWPNLRELGLNDCLLSAR  258 (344)
T ss_dssp             HHHHGGGCTTCCEEECTTCCCCHH
T ss_pred             ccccccccccchhhhhhcCccCch
Confidence            345677889999999999998753

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.41  E-value=1.7e-05  Score=65.71  Aligned_cols=90  Identities=10%  Similarity=0.117  Sum_probs=68.2

Q ss_pred             cCCCCCCEEeccCC-ccCCC----CCccCCCCCCCCEEeccCCcCCC----CCchhhcCCcccCeecccccccCCC----
Q 011005           12 GNLKNLIKLDVGSN-SLIGP----IPSALGSLTNLSNLDLSSNKLSG----KIPPEIASMKYLTQLDLSNNNIQGS----   78 (496)
Q Consensus        12 ~~l~~L~~L~l~~n-~i~~~----~p~~~~~l~~L~~l~l~~n~l~~----~~p~~~~~l~~L~~l~l~~N~l~~~----   78 (496)
                      .+.++|+.|+|+++ .++..    +-..+...++|+.|+|++|.+..    .+...+...+.|+.|+|++|.++..    
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~   91 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR   91 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence            45689999999975 46521    23356778899999999999873    2334566778999999999999732    


Q ss_pred             CCccccCcccccccccccccCCC
Q 011005           79 IPGEITKLSRLDYLNLSSNKLSG  101 (496)
Q Consensus        79 ~~~~~~~l~~L~~l~l~~n~l~~  101 (496)
                      +-..+...++|+.|++++|.+..
T Consensus        92 l~~aL~~n~sL~~L~l~~n~~~~  114 (167)
T d1pgva_          92 LLRSTLVTQSIVEFKADNQRQSV  114 (167)
T ss_dssp             HHHHTTTTCCCSEEECCCCSSCC
T ss_pred             HHHHHHhCCcCCEEECCCCcCCC
Confidence            23357777899999999998763

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.37  E-value=0.0005  Score=63.20  Aligned_cols=136  Identities=15%  Similarity=0.186  Sum_probs=79.0

Q ss_pred             CeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhcccccc--ccc-----ceeecCCeEEEEEEecCCCChh
Q 011005          218 YGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNIV--KLY-----GYCLHKKCMFLIYEYMERGSLF  290 (496)
Q Consensus       218 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv--~~~-----~~~~~~~~~~lV~e~~~~g~L~  290 (496)
                      --.||++..++|+.|++|..+.....  .+++..|...+..+...++.  ..+     ..+......+.++++++|..+.
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~~s--~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPERWT--ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTTSC--HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCCCC--HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            35899999999999999998764321  24567888988888633321  111     1223455688999999874431


Q ss_pred             h----h----------hh----CC--CCCccCCH-------------------H---HHHHHHHHHHHHHHHH-HhCCCC
Q 011005          291 C----N----------LH----NN--EDAVELDW-------------------A---KRVNIVKAMAHALAYL-HHDCSP  327 (496)
Q Consensus       291 ~----~----------l~----~~--~~~~~~~~-------------------~---~~~~i~~~i~~~l~~l-h~~~~~  327 (496)
                      .    .          ++    ..  ......+.                   .   .....+.++...+.-. ......
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence            1    0          00    00  00001111                   1   1122233333333222 112246


Q ss_pred             CeEEeCCCCCceEecCCCCeEEcccccccc
Q 011005          328 SIIHRDISSNNILLNSKLEAFVADFGTARL  357 (496)
Q Consensus       328 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  357 (496)
                      +++|+|+.+.|||++++  ..++||+-+..
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhccc
Confidence            79999999999999754  45899998853

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.19  E-value=0.0041  Score=56.42  Aligned_cols=159  Identities=13%  Similarity=0.062  Sum_probs=88.0

Q ss_pred             cccHHHHHHHHhCCCCccee-----eecCCeeEEEEEeCCCcEEEEEEcccchhHHHHHHHHHHHHHHHhhccccc--cc
Q 011005          194 RIVYEDLIEATEDFDIRYCI-----GTGGYGSVYKAQLPNGKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI--VK  266 (496)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~l-----g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~  266 (496)
                      .++.+++.....+|.+.+..     ..|---+.|+....+|+ +++|++....+.   +.+..|++++..+...++  ..
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~---~~l~~~~~~l~~L~~~g~pvp~   77 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPL   77 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCC
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCH---HHHHHHHHHHHhhhhccccccc
Confidence            35567888888899886554     34555788999886665 889988654322   345567788888753332  11


Q ss_pred             ccc------eeecCCeEEEEEEecCCCChhhh--------------hh---CC---CCCcc------------------C
Q 011005          267 LYG------YCLHKKCMFLIYEYMERGSLFCN--------------LH---NN---EDAVE------------------L  302 (496)
Q Consensus       267 ~~~------~~~~~~~~~lV~e~~~~g~L~~~--------------l~---~~---~~~~~------------------~  302 (496)
                      .+.      +.........++.+..+......              ++   ..   .....                  .
T Consensus        78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (316)
T d2ppqa1          78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  157 (316)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence            111      11224456677777766433110              00   00   00000                  0


Q ss_pred             CHHHHHHHHHHHHHHHHHHHh-CCCCCeEEeCCCCCceEecCCCCeEEccccccc
Q 011005          303 DWAKRVNIVKAMAHALAYLHH-DCSPSIIHRDISSNNILLNSKLEAFVADFGTAR  356 (496)
Q Consensus       303 ~~~~~~~i~~~i~~~l~~lh~-~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  356 (496)
                      ........+......+...+. ....|++|+|+.++||+++++...-++||+.+.
T Consensus       158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            001111122222222332221 225789999999999999998777899999874

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.02  E-value=5.2e-05  Score=62.60  Aligned_cols=88  Identities=14%  Similarity=0.129  Sum_probs=62.3

Q ss_pred             hccCCCCCCEEeccCCccCC----CCCccCCCCCCCCEEeccCCcCCCC----CchhhcCCcccCeecccccccCCC---
Q 011005           10 EIGNLKNLIKLDVGSNSLIG----PIPSALGSLTNLSNLDLSSNKLSGK----IPPEIASMKYLTQLDLSNNNIQGS---   78 (496)
Q Consensus        10 ~~~~l~~L~~L~l~~n~i~~----~~p~~~~~l~~L~~l~l~~n~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~---   78 (496)
                      .+...++|+.|+|++|.+..    .+.+.+...+.|+.|+|++|.|++.    +-..+...+.|+.|+|++|.+...   
T Consensus        39 ~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~  118 (167)
T d1pgva_          39 AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQ  118 (167)
T ss_dssp             HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHH
T ss_pred             HHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHH
Confidence            45567889999999999873    2334556678999999999999842    223566778899999999987622   


Q ss_pred             ----CCccccCcccccccccccc
Q 011005           79 ----IPGEITKLSRLDYLNLSSN   97 (496)
Q Consensus        79 ----~~~~~~~l~~L~~l~l~~n   97 (496)
                          +...+...++|+.|+++.+
T Consensus       119 ~~~~l~~~L~~n~sL~~l~l~~~  141 (167)
T d1pgva_         119 VEMDMMMAIEENESLLRVGISFA  141 (167)
T ss_dssp             HHHHHHHHHHHCSSCCEEECCCC
T ss_pred             HHHHHHHHHHhCCCccEeeCcCC
Confidence                2233444566666666443

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.67  E-value=0.0039  Score=58.63  Aligned_cols=72  Identities=19%  Similarity=0.252  Sum_probs=48.7

Q ss_pred             ceeeecCCeeEEEEEeCC--------CcEEEEEEcccchhHHHHHHHHHHHHHHHhhccccc-ccccceeecCCeEEEEE
Q 011005          211 YCIGTGGYGSVYKAQLPN--------GKVFALKKLHTSEELAFIKSFKNEAQVLSQVLHRNI-VKLYGYCLHKKCMFLIY  281 (496)
Q Consensus       211 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lV~  281 (496)
                      +.|+.|-.-.+|++..++        .+.|++++.-....   .....+|..+++.+.-.++ .++++++..    .+|+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            457778888999998654        35677777653222   1345689999998864444 466776643    5899


Q ss_pred             EecCCCCh
Q 011005          282 EYMERGSL  289 (496)
Q Consensus       282 e~~~~g~L  289 (496)
                      ||++|..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987554

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.06  E-value=0.00043  Score=56.73  Aligned_cols=91  Identities=18%  Similarity=0.229  Sum_probs=64.7

Q ss_pred             hccCCCCCCEEeccC-CccCCC----CCccCCCCCCCCEEeccCCcCCCC----CchhhcCCcccCeecccccccCCC--
Q 011005           10 EIGNLKNLIKLDVGS-NSLIGP----IPSALGSLTNLSNLDLSSNKLSGK----IPPEIASMKYLTQLDLSNNNIQGS--   78 (496)
Q Consensus        10 ~~~~l~~L~~L~l~~-n~i~~~----~p~~~~~l~~L~~l~l~~n~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~--   78 (496)
                      ...+.++|+.|+|++ +.|+..    +-..+...++|+.|+|++|.++..    +-..+...++|+.+++++|.+...  
T Consensus        12 ~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~   91 (166)
T d1io0a_          12 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI   91 (166)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred             HHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhH
Confidence            345678999999998 456521    234556889999999999998743    223456678999999999998622  


Q ss_pred             --CCccccCccccccccc--ccccCC
Q 011005           79 --IPGEITKLSRLDYLNL--SSNKLS  100 (496)
Q Consensus        79 --~~~~~~~l~~L~~l~l--~~n~l~  100 (496)
                        +...+...++|+.++|  ++|.+.
T Consensus        92 ~~l~~~l~~~~~L~~l~L~l~~n~i~  117 (166)
T d1io0a_          92 LALVEALQSNTSLIELRIDNQSQPLG  117 (166)
T ss_dssp             HHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred             HHHHHHHHhCccccEEeeccCCCcCc
Confidence              2346677788886544  567775

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=95.56  E-value=0.00044  Score=56.68  Aligned_cols=89  Identities=17%  Similarity=0.223  Sum_probs=63.6

Q ss_pred             hccCCCCCCEEeccCCccCCC----CCccCCCCCCCCEEeccCCcCCCC----CchhhcCCcccCeecc--cccccCC--
Q 011005           10 EIGNLKNLIKLDVGSNSLIGP----IPSALGSLTNLSNLDLSSNKLSGK----IPPEIASMKYLTQLDL--SNNNIQG--   77 (496)
Q Consensus        10 ~~~~l~~L~~L~l~~n~i~~~----~p~~~~~l~~L~~l~l~~n~l~~~----~p~~~~~l~~L~~l~l--~~N~l~~--   77 (496)
                      .+...++|+.|+|++|.++..    +...+...++|+.|++++|.++..    +-..+...++|+.++|  ++|.+..  
T Consensus        41 al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~  120 (166)
T d1io0a_          41 ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNV  120 (166)
T ss_dssp             HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHH
T ss_pred             HHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHH
Confidence            345788999999999998743    233456678999999999998732    2245677888987555  5677752  


Q ss_pred             --CCCccccCccccccccccccc
Q 011005           78 --SIPGEITKLSRLDYLNLSSNK   98 (496)
Q Consensus        78 --~~~~~~~~l~~L~~l~l~~n~   98 (496)
                        .+...+...++|+.|+++.+.
T Consensus       121 ~~~La~~L~~n~~L~~L~l~~~~  143 (166)
T d1io0a_         121 EMEIANMLEKNTTLLKFGYHFTQ  143 (166)
T ss_dssp             HHHHHHHHHHCSSCCEEECCCSS
T ss_pred             HHHHHHHHHhCCCcCEEeCcCCC
Confidence              234456677888888886554